0001193125-24-002445.txt : 20240104 0001193125-24-002445.hdr.sgml : 20240104 20240104161616 ACCESSION NUMBER: 0001193125-24-002445 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 130 CONFORMED PERIOD OF REPORT: 20240104 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240104 DATE AS OF CHANGE: 20240104 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Complete Solaria, Inc. CENTRAL INDEX KEY: 0001838987 STANDARD INDUSTRIAL CLASSIFICATION: SEMICONDUCTORS & RELATED DEVICES [3674] ORGANIZATION NAME: 04 Manufacturing IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40117 FILM NUMBER: 24512117 BUSINESS ADDRESS: STREET 1: C/O MAPLES CORPORATE SERVICES LIMITED STREET 2: UGLAND HOUSE, PO BOX 309 CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1104 BUSINESS PHONE: (212) 618-1798 MAIL ADDRESS: STREET 1: C/O MAPLES CORPORATE SERVICES LIMITED STREET 2: UGLAND HOUSE, PO BOX 309 CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1104 FORMER COMPANY: FORMER CONFORMED NAME: Freedom Acquisition I Corp. DATE OF NAME CHANGE: 20210105 8-K 1 d474289d8k.htm 8-K 8-K
false0001838987CAIncludes zero and $1.4 million of other income for the three and nine months ended September 30, 2022, respectively, recognized upon the conversion of related party convertible notes and SAFEs.Includes $0.7 million of other expense for each of the thirteen and thirty-nine weeks ended October 1, 2023 for bonus shares issued to related parties in connection with the Mergers.Includes $0.3 million of other income for each of the thirteen and thirty-nine weeks ended October 1, 2023 for forward purchase agreements entered into with related parties.Includes $5.9 million of other expense for each of the thirteen and thirty-nine weeks ended October 1, 2023 for forward purchase agreements entered into with related parties.Includes $30.7 million of other expense for each of the thirteen and thirty-nine weeks ended October 1, 2023 for shares issued to related parties in connection with the forward purchase agreements.Issuance of common stock bonus shares to related parties in connection with the Mergers includes other expense of $0.7 million for each of the thirteen and thirty-nine weeks ended October 1, 2023, and zero for each of the three and nine months ended September 30, 2022. Issuance of common stock in connection with forward purchase agreements includes other expense from related parties of $30.7 million for each of the thirteen and thirty-nine weeks ended October 1, 2023, and zero for each of the three and nine months ended September 30, 2022. Non-cash interest expense to related parties of $0.3 million, $0.7 million and $0.2 million during the years ended December 31, 2022, 2021 and 2020, respectively.Gain on extinguishment of convertible notes and SAFEs includes other income from related parties of $1.4 million, zero and zero during the years ended December 31, 2022, 2021 and 2020, respectively. Includes interest expense to related parties of $0.3 million, $0.7 million and $0.2 million during the years ended December 31, 2022, 2021 and 2020, respectively.Other income (expense), net includes other income from related parties of $1.4 million, zero and zero during the years ended December 31, 2022, 2021 and 2020, respectively.Includes 4,508,488 shares of Complete Solaria Common Stock issued to related parties.Includes 120,000 shares of Complete Solaria Common Stock issued to related parties.Reclassification of pre-funded PIPE was transacted with a related party.Includes 1,315,287 shares of Series D-1 redeemable convertible preferred stock with a carrying value of $6.3 million, issued to related parties.Gain on extinguishment of convertible notes and SAFEs includes other income from related parties of zero during each of the thirteen and thirty-nine weeks ended October 1, 2023, and zero and $1.4 million during the three and nine months ended September 30, 2022, respectively. Issuance of forward purchase agreements includes other income from related parties of $0.3 million for each of the thirteen and thirty-nine weeks ended October 1, 2023, and zero for each of the three and nine months ended September 30, 2022. Change in fair value of forward purchase agreement liabilities includes other expense from related parties of $5.9 million for each of the thirteen and thirty-nine weeks ended October 1, 2023, and zero for each of the three and nine months ended September 30, 2022. Includes interest expense to related parties of less than $0.1 million and $0.4 million during the thirteen and thirty-nine weeks ended October 1, 2023, respectively, and zero and $0.1 million during the three and nine months ended September 30, 2022, respectively.Other income (expense), net includes other expense, net to related parties of $36.9 million for each of the thirteen and thirty-nine weeks ended October 1, 2023, and other income, net of zero and $1.4 million during the three and nine months ended September 30, 2022, respectively.Non-cash interest expense to related parties of $0.1 million and $0.4 million during the thirteen and thirty-nine weeks ended October 1, 2023, respectively, and zero and $0.1 million during the three and nine months ended September 30, 2022, respectively.Includes $1.4 million of other income recognized upon the conversion of related party convertible notes and SAFEs 0001838987 2023-10-01 0001838987 2022-12-31 0001838987 2021-12-31 0001838987 2022-01-01 2022-12-31 0001838987 2021-01-01 2021-12-31 0001838987 2020-01-01 2020-12-31 0001838987 2023-07-01 2023-10-01 0001838987 2022-07-01 2022-09-30 0001838987 2023-01-01 2023-10-01 0001838987 2022-01-01 2022-09-30 0001838987 2023-09-30 0001838987 2023-07-02 2023-10-01 0001838987 2023-01-02 2023-10-01 0001838987 2020-01-31 0001838987 2022-11-30 0001838987 2021-04-01 2021-04-30 0001838987 2022-02-01 2022-02-28 0001838987 2019-01-01 2019-12-31 0001838987 2023-07-01 2023-09-30 0001838987 2023-01-01 2023-09-30 0001838987 2022-01-01 2023-09-30 0001838987 2022-10-01 2023-06-01 0001838987 2022-12-31 2022-12-31 0001838987 2023-10-31 2023-10-31 0001838987 2024-01-04 2024-01-04 0001838987 2023-10-31 0001838987 2020-12-31 0001838987 2022-03-01 2022-03-31 0001838987 2023-06-30 0001838987 2023-07-01 2023-07-31 0001838987 2023-05-11 2023-05-11 0001838987 2023-07-03 2023-10-01 0001838987 2023-02-01 2023-02-28 0001838987 2023-07-31 2023-07-31 0001838987 2023-03-16 2023-03-16 0001838987 2023-03-31 0001838987 2021-07-22 2021-07-22 0001838987 2023-08-01 2023-08-24 0001838987 2023-10-01 2023-10-01 0001838987 2023-07-31 0001838987 2022-12-01 2022-12-31 0001838987 2023-02-28 0001838987 2023-09-01 2023-09-30 0001838987 2023-09-28 2023-10-01 0001838987 2020-06-29 2020-06-29 0001838987 2019-12-31 0001838987 2022-09-30 0001838987 us-gaap:CommonClassAMember 2022-12-31 0001838987 us-gaap:CommonClassBMember 2022-12-31 0001838987 cslr:BusinessCombinationMember 2022-12-31 0001838987 us-gaap:TrademarksAndTradeNamesMember 2022-12-31 0001838987 us-gaap:DevelopedTechnologyRightsMember 2022-12-31 0001838987 us-gaap:CustomerRelationshipsMember 2022-12-31 0001838987 cslr:AssembledWorkforceMember 2022-12-31 0001838987 us-gaap:TrademarksMember 2022-12-31 0001838987 cslr:TwoThousandAndTwentyTwoConvertibleNotesMember 2022-12-31 0001838987 cslr:RestrictedCashMember 2022-12-31 0001838987 srt:MinimumMember 2022-12-31 0001838987 srt:MaximumMember 2022-12-31 0001838987 us-gaap:CommonStockMember 2022-12-31 0001838987 cslr:TwoThousandAndNineteenAConvertibleNotesMember us-gaap:NonrelatedPartyMember 2022-12-31 0001838987 cslr:TwoThousandAndTwentySeriesAConvertibleNotesMember us-gaap:NonrelatedPartyMember 2022-12-31 0001838987 cslr:TwoThousandAndTwentyOneSeriesAConvertibleNotesMember us-gaap:NonrelatedPartyMember 2022-12-31 0001838987 us-gaap:NonrelatedPartyMember 2022-12-31 0001838987 cslr:TwoThousandAndTwentySeriesAConvertibleNotesMember us-gaap:RelatedPartyMember 2022-12-31 0001838987 cslr:TwoThousandAndTwentyOneSeriesAConvertibleNotesMember us-gaap:RelatedPartyMember 2022-12-31 0001838987 cslr:ConvertiblePromissoryNotesWithEcoSystemIntegrityFundTwoLlcMember us-gaap:RelatedPartyMember 2022-12-31 0001838987 cslr:TwoThousandTwentyThreeEquityIncentivePlanMember 2022-12-31 0001838987 cslr:SeriesCWarrantsMember 2022-12-31 0001838987 cslr:TwoThousandAndTwentyTwoConvertibleNotesMember us-gaap:RelatedPartyMember 2022-12-31 0001838987 us-gaap:FurnitureAndFixturesMember 2022-12-31 0001838987 cslr:ManufacturingEquipmentMember 2022-12-31 0001838987 us-gaap:SoftwareDevelopmentMember 2022-12-31 0001838987 us-gaap:LeaseholdImprovementsMember 2022-12-31 0001838987 cslr:SponsorMember 2022-12-31 0001838987 cslr:PrivateInvestmentInPublicEquityMember 2022-12-31 0001838987 cslr:ForwardPurchaseAgreementsMember 2022-12-31 0001838987 us-gaap:CommonClassAMember cslr:LegacyCompleteSolariaMember 2022-12-31 0001838987 us-gaap:SeriesDPreferredStockMember 2022-12-31 0001838987 cslr:TwoThousandTwentyAConvertibleNotesMember 2022-12-31 0001838987 cslr:TwoThousandTwentyOneSafeMember 2022-12-31 0001838987 us-gaap:SeriesCPreferredStockMember 2022-12-31 0001838987 cslr:ConvertiblePromissoryNotesMember 2022-12-31 0001838987 cslr:LegacyCompleteSolariaMember 2022-12-31 0001838987 cslr:TwoThousandTwentyOneAConvertibleNotesMember 2022-12-31 0001838987 cslr:LegalMattersMember 2022-12-31 0001838987 us-gaap:FairValueInputsLevel1Member 2022-12-31 0001838987 us-gaap:FairValueInputsLevel2Member 2022-12-31 0001838987 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001838987 cslr:TwoThousandNineteenConvertibleNotesMember 2022-12-31 0001838987 cslr:TwoThousandTwentyTwoConvertibleNotesMember 2022-12-31 0001838987 us-gaap:RelatedPartyMember 2022-12-31 0001838987 cslr:MaxeonMember 2022-12-31 0001838987 us-gaap:StandbyLettersOfCreditMember srt:ScenarioPreviouslyReportedMember 2022-12-31 0001838987 us-gaap:StandbyLettersOfCreditMember 2022-12-31 0001838987 cslr:SeriesD7WarrantsMember 2022-12-31 0001838987 cslr:TwoZeroOneEightBridgeNotesMember 2022-12-31 0001838987 cslr:SCITermLoanAndRevolverLoanMember 2022-12-31 0001838987 cslr:RevolvingLoanMember 2022-12-31 0001838987 cslr:CSSoilsMember 2022-12-31 0001838987 us-gaap:RelatedPartyMember cslr:SeriesDOneRedeemableConvertiblePreferredStockMember 2022-12-31 0001838987 us-gaap:RelatedPartyMember cslr:SeriesDFourRedeemableConvertiblePreferredStockMember cslr:IssuanceOfRedeemableConvertiblePreferredStockUponAcquisitionMember 2022-12-31 0001838987 us-gaap:RelatedPartyMember cslr:SeriesDFiveRedeemableConvertiblePreferredStockMember cslr:IssuanceOfRedeemableConvertiblePreferredStockUponAcquisitionMember 2022-12-31 0001838987 us-gaap:RelatedPartyMember cslr:SeriesDSevenRedeemableConvertiblePreferredStockMember cslr:IssuanceOfRedeemableConvertiblePreferredStockUponAcquisitionMember 2022-12-31 0001838987 us-gaap:RelatedPartyMember cslr:SeriesDEightRedeemableConvertiblePreferredStockMember cslr:IssuanceOfRedeemableConvertiblePreferredStockUponConversionOfSimpleAgreementOfFutureEquityNotesMember 2022-12-31 0001838987 us-gaap:EquipmentMember srt:MinimumMember 2022-12-31 0001838987 us-gaap:EquipmentMember srt:MaximumMember 2022-12-31 0001838987 us-gaap:FurnitureAndFixturesMember srt:MinimumMember 2022-12-31 0001838987 us-gaap:FurnitureAndFixturesMember srt:MaximumMember 2022-12-31 0001838987 us-gaap:LeaseholdImprovementsMember srt:MinimumMember 2022-12-31 0001838987 us-gaap:LeaseholdImprovementsMember srt:MaximumMember 2022-12-31 0001838987 cslr:AssembledWorkforceOneMember 2022-12-31 0001838987 us-gaap:DomesticCountryMember 2022-12-31 0001838987 us-gaap:StateAndLocalJurisdictionMember 2022-12-31 0001838987 us-gaap:ResearchMember 2022-12-31 0001838987 srt:MaximumMember us-gaap:MeasurementInputExpectedTermMember cslr:CommonStockWarrantsMember 2022-12-31 0001838987 srt:MinimumMember us-gaap:MeasurementInputExpectedTermMember cslr:CommonStockWarrantsMember 2022-12-31 0001838987 srt:MaximumMember us-gaap:MeasurementInputPriceVolatilityMember cslr:CommonStockWarrantsMember 2022-12-31 0001838987 srt:MinimumMember us-gaap:MeasurementInputPriceVolatilityMember cslr:CommonStockWarrantsMember 2022-12-31 0001838987 srt:MaximumMember us-gaap:MeasurementInputRiskFreeInterestRateMember cslr:CommonStockWarrantsMember 2022-12-31 0001838987 srt:MinimumMember us-gaap:MeasurementInputRiskFreeInterestRateMember cslr:CommonStockWarrantsMember 2022-12-31 0001838987 us-gaap:MeasurementInputExpectedDividendRateMember cslr:CommonStockWarrantsMember 2022-12-31 0001838987 cslr:TwoThousandAndTwentyTwoConvertibleNotesMember us-gaap:NonrelatedPartyMember 2022-12-31 0001838987 cslr:TwoThousandAndElevenEquityIncentivePlanMember 2022-12-31 0001838987 cslr:TwoThousandAndTwentyOneEquityIncentivePlanMember 2022-12-31 0001838987 cslr:TwoThousandAndTwentyTwoEquityIncentivePlanMember 2022-12-31 0001838987 cslr:TwoThousandAndNineteenAConvertibleNotesMember 2022-12-31 0001838987 cslr:TwoThousandAndTwentyAConvertibleNotesMember 2022-12-31 0001838987 cslr:TwoThousandAndTwentyOneConvertibleNotesMember 2022-12-31 0001838987 cslr:TwoThousandAndTwentyOneAConvertibleNotesWithEmbeddedDerivativeLiabilityMember 2022-12-31 0001838987 cslr:LoanAndSecurityAgreementMember us-gaap:NotesPayableOtherPayablesMember 2022-12-31 0001838987 cslr:TwoZeroTwoOnePromissoryNotesMember us-gaap:NotesPayableOtherPayablesMember 2022-12-31 0001838987 cslr:CurrentInsightPromissoryNoteMember us-gaap:NotesPayableOtherPayablesMember 2022-12-31 0001838987 us-gaap:NotesPayableOtherPayablesMember 2022-12-31 0001838987 cslr:TwoThousandTwentyTwoConvertibleNotesMember us-gaap:RelatedPartyMember 2022-12-31 0001838987 cslr:TwoThousandTwentyTwoConvertibleNotesMember us-gaap:NonrelatedPartyMember 2022-12-31 0001838987 cslr:LoanAndSecurityAgreementMember 2022-12-31 0001838987 cslr:TrancheOneMember cslr:TwoThousandTwentyOneAConvertibleNotesMember 2022-12-31 0001838987 cslr:TwoThousandTwentyOneAConvertibleNotesMember cslr:TrancheTwoMember 2022-12-31 0001838987 cslr:TwoZeroOneEightBridgeNotesMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001838987 us-gaap:FairValueInputsLevel1Member 2023-10-01 0001838987 us-gaap:FairValueInputsLevel2Member 2023-10-01 0001838987 us-gaap:FairValueInputsLevel3Member 2023-10-01 0001838987 us-gaap:CommonClassAMember 2023-10-01 0001838987 us-gaap:CommonClassBMember 2023-10-01 0001838987 cslr:BusinessCombinationMember 2023-10-01 0001838987 us-gaap:LeaseholdImprovementsMember 2023-10-01 0001838987 us-gaap:SoftwareDevelopmentMember 2023-10-01 0001838987 cslr:ManufacturingEquipmentMember 2023-10-01 0001838987 us-gaap:FurnitureAndFixturesMember 2023-10-01 0001838987 us-gaap:TrademarksMember 2023-10-01 0001838987 us-gaap:CustomerRelationshipsMember 2023-10-01 0001838987 us-gaap:DevelopedTechnologyRightsMember 2023-10-01 0001838987 cslr:AssembledWorkforceMember 2023-10-01 0001838987 cslr:TwoThousandAndTwentyTwoConvertibleNotesMember 2023-10-01 0001838987 cslr:RestrictedCashMember 2023-10-01 0001838987 srt:MinimumMember 2023-10-01 0001838987 srt:MaximumMember 2023-10-01 0001838987 cslr:SeriesCWarrantsMember 2023-10-01 0001838987 cslr:TwoThousandAndTwentyTwoConvertibleNotesMember us-gaap:RelatedPartyMember 2023-10-01 0001838987 cslr:SponsorMember 2023-10-01 0001838987 cslr:PrivateInvestmentInPublicEquityMember 2023-10-01 0001838987 cslr:ForwardPurchaseAgreementsMember 2023-10-01 0001838987 us-gaap:CommonClassAMember cslr:LegacyCompleteSolariaMember 2023-10-01 0001838987 cslr:TwoThousandTwentyAConvertibleNotesMember 2023-10-01 0001838987 cslr:TwoThousandNinteenSAFEMember 2023-10-01 0001838987 us-gaap:SeriesCPreferredStockMember 2023-10-01 0001838987 cslr:FreedomAcquisitionICorpMember 2023-10-01 0001838987 cslr:ConvertiblePromissoryNotesMember 2023-10-01 0001838987 us-gaap:AdditionalPaidInCapitalMember 2023-10-01 0001838987 cslr:LegacyCompleteSolariaMember 2023-10-01 0001838987 cslr:TwoThousandTwentyOneAConvertibleNotesMember 2023-10-01 0001838987 cslr:LegalMattersMember 2023-10-01 0001838987 cslr:FPASMember 2023-10-01 0001838987 cslr:CompleteSolariaCommonStockMember 2023-10-01 0001838987 cslr:TwoThousandNineteenConvertibleNotesMember 2023-10-01 0001838987 us-gaap:WarrantMember 2023-10-01 0001838987 cslr:TwoThousandTwentyTwoConvertibleNotesMember 2023-10-01 0001838987 us-gaap:RelatedPartyMember 2023-10-01 0001838987 cslr:MaxeonMember 2023-10-01 0001838987 us-gaap:RelatedPartyMember 2023-10-01 0001838987 us-gaap:StandbyLettersOfCreditMember 2023-10-01 0001838987 cslr:PublicPrivatePlacementAndWorkingCapitalWarrantsMember us-gaap:PrivatePlacementMember 2023-10-01 0001838987 cslr:TwoZeroOneEightBridgeNotesMember 2023-10-01 0001838987 cslr:SCITermLoanAndRevolverLoanMember 2023-10-01 0001838987 cslr:RevolvingLoanMember 2023-10-01 0001838987 us-gaap:CommonStockMember 2023-10-01 0001838987 cslr:CSSoilsMember 2023-10-01 0001838987 cslr:SolarEnergySystemInstallationsMember 2022-01-01 2022-09-30 0001838987 cslr:SoftwareServicesMember 2022-01-01 2022-09-30 0001838987 cslr:BusinessCombinationMember 2022-01-01 2022-09-30 0001838987 cslr:AssembledWorkforceMember 2022-01-01 2022-09-30 0001838987 us-gaap:TrademarksMember 2022-01-01 2022-09-30 0001838987 us-gaap:CustomerRelationshipsMember 2022-01-01 2022-09-30 0001838987 us-gaap:DevelopedTechnologyRightsMember 2022-01-01 2022-09-30 0001838987 us-gaap:StockCompensationPlanMember us-gaap:CostOfSalesMember 2022-01-01 2022-09-30 0001838987 us-gaap:StockCompensationPlanMember cslr:SalesAndMarketingMember 2022-01-01 2022-09-30 0001838987 us-gaap:StockCompensationPlanMember us-gaap:GeneralAndAdministrativeExpenseMember 2022-01-01 2022-09-30 0001838987 us-gaap:RelatedPartyMember 2022-01-01 2022-09-30 0001838987 us-gaap:StockCompensationPlanMember 2022-01-01 2022-09-30 0001838987 us-gaap:SegmentContinuingOperationsMember 2022-01-01 2022-09-30 0001838987 us-gaap:CommitmentsMember 2022-01-01 2022-09-30 0001838987 cslr:PreviouslyReportedOneMember us-gaap:RetainedEarningsUnappropriatedMember 2022-01-01 2022-09-30 0001838987 cslr:PreviouslyReportedOneMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-09-30 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:CommonStockMember 2022-01-01 2022-09-30 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:RetainedEarningsUnappropriatedMember 2022-01-01 2022-09-30 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-09-30 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-09-30 0001838987 srt:ScenarioPreviouslyReportedMember 2022-01-01 2022-09-30 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:RedeemableConvertiblePreferredStockMember 2022-01-01 2022-09-30 0001838987 cslr:PreviouslyReportedOneMember us-gaap:CommonStockMember 2022-01-01 2022-09-30 0001838987 cslr:PreviouslyReportedOneMember us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-09-30 0001838987 cslr:PreviouslyReportedOneMember 2022-01-01 2022-09-30 0001838987 cslr:PreviouslyReportedOneMember us-gaap:RedeemableConvertiblePreferredStockMember 2022-01-01 2022-09-30 0001838987 cslr:TwoThousandTwentyAConvertibleNotesMember 2022-01-01 2022-09-30 0001838987 cslr:AdjustedMember us-gaap:CommonStockMember 2022-01-01 2022-09-30 0001838987 cslr:AdjustedMember us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-09-30 0001838987 cslr:AdjustedMember us-gaap:RetainedEarningsUnappropriatedMember 2022-01-01 2022-09-30 0001838987 cslr:AdjustedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-09-30 0001838987 cslr:AdjustedMember 2022-01-01 2022-09-30 0001838987 cslr:AdjustedMember us-gaap:RedeemableConvertiblePreferredStockMember 2022-01-01 2022-09-30 0001838987 cslr:CSSoilsMember 2022-01-01 2022-09-30 0001838987 cslr:SeriesDFourRedeemableConvertiblePreferredStockMember 2022-01-01 2022-09-30 0001838987 cslr:SolarEnergySystemInstallationsMember 2022-07-01 2022-09-30 0001838987 cslr:SoftwareServicesMember 2022-07-01 2022-09-30 0001838987 cslr:BusinessCombinationMember 2022-07-01 2022-09-30 0001838987 cslr:AssembledWorkforceMember 2022-07-01 2022-09-30 0001838987 us-gaap:TrademarksMember 2022-07-01 2022-09-30 0001838987 us-gaap:CustomerRelationshipsMember 2022-07-01 2022-09-30 0001838987 us-gaap:DevelopedTechnologyRightsMember 2022-07-01 2022-09-30 0001838987 us-gaap:StockCompensationPlanMember us-gaap:CostOfSalesMember 2022-07-01 2022-09-30 0001838987 us-gaap:StockCompensationPlanMember cslr:SalesAndMarketingMember 2022-07-01 2022-09-30 0001838987 us-gaap:StockCompensationPlanMember us-gaap:GeneralAndAdministrativeExpenseMember 2022-07-01 2022-09-30 0001838987 us-gaap:RelatedPartyMember 2022-07-01 2022-09-30 0001838987 us-gaap:StockCompensationPlanMember 2022-07-01 2022-09-30 0001838987 us-gaap:SegmentContinuingOperationsMember 2022-07-01 2022-09-30 0001838987 us-gaap:CommitmentsMember 2022-07-01 2022-09-30 0001838987 us-gaap:RetainedEarningsUnappropriatedMember srt:ScenarioPreviouslyReportedMember 2022-07-01 2022-09-30 0001838987 us-gaap:AccumulatedOtherComprehensiveIncomeMember srt:ScenarioPreviouslyReportedMember 2022-07-01 2022-09-30 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember srt:ScenarioPreviouslyReportedMember 2022-07-01 2022-09-30 0001838987 us-gaap:CommonStockMember srt:ScenarioPreviouslyReportedMember 2022-07-01 2022-09-30 0001838987 us-gaap:AdditionalPaidInCapitalMember srt:ScenarioPreviouslyReportedMember 2022-07-01 2022-09-30 0001838987 srt:ScenarioPreviouslyReportedMember 2022-07-01 2022-09-30 0001838987 cslr:TwoThousandTwentyAConvertibleNotesMember 2022-07-01 2022-09-30 0001838987 cslr:AdjustedMember us-gaap:RedeemableConvertiblePreferredStockMember 2022-07-01 2022-09-30 0001838987 cslr:AdjustedMember us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001838987 cslr:AdjustedMember us-gaap:RetainedEarningsUnappropriatedMember 2022-07-01 2022-09-30 0001838987 cslr:AdjustedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-07-01 2022-09-30 0001838987 cslr:AdjustedMember us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001838987 cslr:AdjustedMember 2022-07-01 2022-09-30 0001838987 cslr:CSSoilsMember 2022-07-01 2022-09-30 0001838987 cslr:SeriesDFourRedeemableConvertiblePreferredStockMember 2022-07-01 2022-09-30 0001838987 cslr:SolarEnergySystemInstallationsMember 2023-01-01 2023-10-01 0001838987 cslr:SoftwareServicesMember 2023-01-01 2023-10-01 0001838987 us-gaap:WarrantMember 2023-01-01 2023-10-01 0001838987 cslr:ConvertiblePromissoryNotesMember 2023-01-01 2023-10-01 0001838987 cslr:FreedomAcquisitionICorpMember 2023-01-01 2023-10-01 0001838987 cslr:PrivateInvestmentInPublicEquityMember 2023-01-01 2023-10-01 0001838987 cslr:BusinessCombinationMember 2023-01-01 2023-10-01 0001838987 cslr:AssembledWorkforceMember 2023-01-01 2023-10-01 0001838987 us-gaap:TrademarksMember 2023-01-01 2023-10-01 0001838987 us-gaap:CustomerRelationshipsMember 2023-01-01 2023-10-01 0001838987 us-gaap:DevelopedTechnologyRightsMember 2023-01-01 2023-10-01 0001838987 us-gaap:StockCompensationPlanMember us-gaap:CostOfSalesMember 2023-01-01 2023-10-01 0001838987 us-gaap:StockCompensationPlanMember cslr:SalesAndMarketingMember 2023-01-01 2023-10-01 0001838987 us-gaap:StockCompensationPlanMember us-gaap:GeneralAndAdministrativeExpenseMember 2023-01-01 2023-10-01 0001838987 us-gaap:StockCompensationPlanMember 2023-01-01 2023-10-01 0001838987 cslr:PIPEInvestorsMember 2023-01-01 2023-10-01 0001838987 us-gaap:CommonClassAMember 2023-01-01 2023-10-01 0001838987 cslr:SolariaMember 2023-01-01 2023-10-01 0001838987 cslr:TwoThousandTwentyAConvertibleNotesMember 2023-01-01 2023-10-01 0001838987 cslr:TwoThousandTwentyOneAConvertibleNotesMember 2023-01-01 2023-10-01 0001838987 us-gaap:RelatedPartyMember 2023-01-01 2023-10-01 0001838987 us-gaap:RelatedPartyMember 2023-01-01 2023-10-01 0001838987 cslr:TwoThousandTwentyOneAConvertibleNotesMember 2023-01-01 2023-10-01 0001838987 cslr:TwoThousandTwentyTwoConvertibleNotesMember 2023-01-01 2023-10-01 0001838987 cslr:FPASMember 2023-01-01 2023-10-01 0001838987 cslr:PIPESubscriptionAgreementMember 2023-01-01 2023-10-01 0001838987 cslr:ForwardPurchaseAgreementsMember 2023-01-01 2023-10-01 0001838987 cslr:SeriesBRedeemableConvertiblePreferredStockWarrantMember 2023-01-01 2023-10-01 0001838987 cslr:SeriesCRedeemableConvertiblePreferredStockWarrantMember 2023-01-01 2023-10-01 0001838987 cslr:SeriesD7RedeemableConvertiblePreferredStockWarrantMember 2023-01-01 2023-10-01 0001838987 us-gaap:FairValueInputsLevel1Member 2023-01-01 2023-10-01 0001838987 us-gaap:FairValueInputsLevel2Member 2023-01-01 2023-10-01 0001838987 us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-10-01 0001838987 us-gaap:SegmentContinuingOperationsMember 2023-01-01 2023-10-01 0001838987 us-gaap:SegmentDiscontinuedOperationsMember 2023-01-01 2023-10-01 0001838987 cslr:SeriesC1WarrantsMember 2023-01-01 2023-10-01 0001838987 cslr:SVBCommonStockWarrantsMember 2023-01-01 2023-10-01 0001838987 cslr:CRSEFSolisHoldingsLLCMember cslr:CarlyleWarrantsMember 2023-01-01 2023-10-01 0001838987 cslr:BlackScholesModelMember cslr:CarlyleWarrantsMember 2023-01-01 2023-10-01 0001838987 cslr:CarlyleWarrantsMember 2023-01-01 2023-10-01 0001838987 cslr:PublicPrivatePlacementAndWorkingCapitalWarrantsMember 2023-01-01 2023-10-01 0001838987 cslr:PublicPrivatePlacementAndWorkingCapitalWarrantsMember us-gaap:PrivatePlacementMember 2023-01-01 2023-10-01 0001838987 cslr:SCITermLoanAndRevolverLoanMember 2023-01-01 2023-10-01 0001838987 cslr:ServiceBasedOptionMember 2023-01-01 2023-10-01 0001838987 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-10-01 0001838987 cslr:PIPEFinancingMember 2023-01-01 2023-10-01 0001838987 cslr:SeriesCWarrantsMember 2023-01-01 2023-10-01 0001838987 us-gaap:CommitmentsMember 2023-01-01 2023-10-01 0001838987 us-gaap:ConvertibleNotesPayableMember us-gaap:RelatedPartyMember 2023-01-01 2023-10-01 0001838987 cslr:TwoThousandNinteenSAFEMember 2023-01-01 2023-10-01 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:RetainedEarningsUnappropriatedMember 2023-01-01 2023-10-01 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-10-01 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:RedeemableConvertiblePreferredStockMember 2023-01-01 2023-10-01 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:CommonStockMember 2023-01-01 2023-10-01 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-10-01 0001838987 srt:ScenarioPreviouslyReportedMember 2023-01-01 2023-10-01 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember 2023-01-01 2023-10-01 0001838987 us-gaap:RetainedEarningsUnappropriatedMember 2023-01-01 2023-10-01 0001838987 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-10-01 0001838987 us-gaap:CommonStockMember 2023-01-01 2023-10-01 0001838987 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-10-01 0001838987 cslr:SVBCommonStockWarrantsMember srt:MaximumMember 2023-01-01 2023-10-01 0001838987 cslr:SVBCommonStockWarrantsMember srt:MinimumMember 2023-01-01 2023-10-01 0001838987 cslr:SolariaAcquisitionMember 2023-01-01 2023-10-01 0001838987 us-gaap:SeriesDPreferredStockMember cslr:TwoThousandTwentyAConvertibleNotesMember 2023-01-01 2023-10-01 0001838987 us-gaap:ConvertibleNotesPayableMember 2023-01-01 2023-10-01 0001838987 cslr:PurchaseAgreementsMember 2023-01-01 2023-10-01 0001838987 cslr:ChinaBridgeMember 2023-01-01 2023-10-01 0001838987 srt:MaximumMember 2023-01-01 2023-10-01 0001838987 cslr:SeriesD7WarrantsMember 2023-01-01 2023-10-01 0001838987 srt:MinimumMember cslr:TwoThousandTwentyTwoConvertibleNotesMember 2023-01-01 2023-10-01 0001838987 srt:MaximumMember cslr:TwoThousandTwentyTwoConvertibleNotesMember 2023-01-01 2023-10-01 0001838987 cslr:SAFEMember 2023-01-01 2023-10-01 0001838987 cslr:PublicPrivatePlacementAndWorkingCapitalWarrantsMember cslr:PublicWarrantsMember 2023-01-01 2023-10-01 0001838987 srt:MinimumMember 2023-01-01 2023-10-01 0001838987 cslr:RevolvingLoanMember 2023-01-01 2023-10-01 0001838987 cslr:RodgersMasseyMember 2023-01-01 2023-10-01 0001838987 cslr:CSSoilsMember 2023-01-01 2023-10-01 0001838987 us-gaap:RelatedPartyMember cslr:InConnectionWithForwardPurchaseAgreementsMember 2023-01-01 2023-10-01 0001838987 us-gaap:RelatedPartyMember cslr:IssueOfBonusSharesInConnectionWithMergerMember 2023-01-01 2023-10-01 0001838987 cslr:SeriesDFourRedeemableConvertiblePreferredStockMember 2023-01-01 2023-10-01 0001838987 cslr:SolarEnergySystemInstallationsMember 2023-07-01 2023-10-01 0001838987 cslr:SoftwareServicesMember 2023-07-01 2023-10-01 0001838987 us-gaap:TrademarksMember 2023-07-01 2023-10-01 0001838987 us-gaap:CustomerRelationshipsMember 2023-07-01 2023-10-01 0001838987 us-gaap:DevelopedTechnologyRightsMember 2023-07-01 2023-10-01 0001838987 cslr:AssembledWorkforceMember 2023-07-01 2023-10-01 0001838987 us-gaap:RelatedPartyMember 2023-07-01 2023-10-01 0001838987 us-gaap:RelatedPartyMember 2023-07-01 2023-10-01 0001838987 us-gaap:SegmentContinuingOperationsMember 2023-07-01 2023-10-01 0001838987 us-gaap:SegmentDiscontinuedOperationsMember 2023-07-01 2023-10-01 0001838987 us-gaap:CommitmentsMember 2023-07-01 2023-10-01 0001838987 us-gaap:ConvertibleNotesPayableMember us-gaap:RelatedPartyMember 2023-07-01 2023-10-01 0001838987 cslr:TwoThousandTwentyAConvertibleNotesMember 2023-07-01 2023-10-01 0001838987 us-gaap:ConvertibleNotesPayableMember 2023-07-01 2023-10-01 0001838987 cslr:PurchaseAgreementsMember 2023-07-01 2023-10-01 0001838987 srt:MinimumMember 2023-07-01 2023-10-01 0001838987 cslr:RevolvingLoanMember 2023-07-01 2023-10-01 0001838987 cslr:CSSoilsMember 2023-07-01 2023-10-01 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:RetainedEarningsUnappropriatedMember 2023-07-03 2023-10-01 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-03 2023-10-01 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:RedeemableConvertiblePreferredStockMember 2023-07-03 2023-10-01 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:CommonStockMember 2023-07-03 2023-10-01 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:AdditionalPaidInCapitalMember 2023-07-03 2023-10-01 0001838987 srt:ScenarioPreviouslyReportedMember 2023-07-03 2023-10-01 0001838987 us-gaap:CommonStockMember 2023-07-03 2023-10-01 0001838987 us-gaap:AdditionalPaidInCapitalMember 2023-07-03 2023-10-01 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember 2023-07-03 2023-10-01 0001838987 us-gaap:RetainedEarningsUnappropriatedMember 2023-07-03 2023-10-01 0001838987 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-03 2023-10-01 0001838987 us-gaap:RelatedPartyMember 2023-07-03 2023-10-01 0001838987 cslr:SeriesDFourRedeemableConvertiblePreferredStockMember 2023-07-03 2023-10-01 0001838987 cslr:AssembledWorkforceMember 2021-12-31 0001838987 cslr:RestrictedCashMember 2021-12-31 0001838987 us-gaap:CommonStockMember 2021-12-31 0001838987 cslr:TwoThousandAndNineteenAConvertibleNotesMember us-gaap:NonrelatedPartyMember 2021-12-31 0001838987 cslr:TwoThousandAndTwentySeriesAConvertibleNotesMember us-gaap:NonrelatedPartyMember 2021-12-31 0001838987 cslr:TwoThousandAndTwentyOneSeriesAConvertibleNotesMember us-gaap:NonrelatedPartyMember 2021-12-31 0001838987 us-gaap:NonrelatedPartyMember 2021-12-31 0001838987 cslr:TwoThousandAndTwentySeriesAConvertibleNotesMember us-gaap:RelatedPartyMember 2021-12-31 0001838987 cslr:TwoThousandAndTwentyOneSeriesAConvertibleNotesMember us-gaap:RelatedPartyMember 2021-12-31 0001838987 cslr:ConvertiblePromissoryNotesWithEcoSystemIntegrityFundTwoLlcMember us-gaap:RelatedPartyMember 2021-12-31 0001838987 us-gaap:SoftwareDevelopmentMember 2021-12-31 0001838987 cslr:ManufacturingEquipmentMember 2021-12-31 0001838987 us-gaap:FurnitureAndFixturesMember 2021-12-31 0001838987 us-gaap:LeaseholdImprovementsMember 2021-12-31 0001838987 cslr:LegalMattersMember 2021-12-31 0001838987 us-gaap:FairValueInputsLevel1Member 2021-12-31 0001838987 us-gaap:FairValueInputsLevel2Member 2021-12-31 0001838987 us-gaap:FairValueInputsLevel3Member 2021-12-31 0001838987 us-gaap:RelatedPartyMember 2021-12-31 0001838987 cslr:CurrentInsightPromissoryNoteMember 2021-12-31 0001838987 us-gaap:DomesticCountryMember 2021-12-31 0001838987 us-gaap:StateAndLocalJurisdictionMember 2021-12-31 0001838987 us-gaap:ResearchMember 2021-12-31 0001838987 srt:MaximumMember us-gaap:MeasurementInputExpectedTermMember cslr:CommonStockWarrantsMember 2021-12-31 0001838987 srt:MinimumMember us-gaap:MeasurementInputExpectedTermMember cslr:CommonStockWarrantsMember 2021-12-31 0001838987 us-gaap:MeasurementInputPriceVolatilityMember cslr:CommonStockWarrantsMember 2021-12-31 0001838987 srt:MaximumMember us-gaap:MeasurementInputRiskFreeInterestRateMember cslr:CommonStockWarrantsMember 2021-12-31 0001838987 srt:MinimumMember us-gaap:MeasurementInputRiskFreeInterestRateMember cslr:CommonStockWarrantsMember 2021-12-31 0001838987 us-gaap:MeasurementInputExpectedDividendRateMember cslr:CommonStockWarrantsMember 2021-12-31 0001838987 cslr:TwoThousandAndTwentyTwoConvertibleNotesMember us-gaap:NonrelatedPartyMember 2021-12-31 0001838987 cslr:TwoThousandAndTwentyTwoConvertibleNotesMember us-gaap:RelatedPartyMember 2021-12-31 0001838987 cslr:TwoThousandAndTwentyTwoEquityIncentivePlanMember 2021-12-31 0001838987 cslr:TwoThousandAndElevenEquityIncentivePlanMember 2021-12-31 0001838987 cslr:TwoThousandAndTwentyOneEquityIncentivePlanMember 2021-12-31 0001838987 cslr:TwoThousandAndNineteenAConvertibleNotesMember 2021-12-31 0001838987 cslr:TwoThousandAndTwentyAConvertibleNotesMember 2021-12-31 0001838987 cslr:TwoThousandAndTwentyOneConvertibleNotesMember 2021-12-31 0001838987 cslr:TwoThousandAndTwentyOneAConvertibleNotesWithEmbeddedDerivativeLiabilityMember 2021-12-31 0001838987 cslr:ExpectedFairValueOfPreferredStockMember cslr:SimpleAgreementForFutureEquityInstrumentsMember 2021-12-31 0001838987 cslr:LoanAndSecurityAgreementMember us-gaap:NotesPayableOtherPayablesMember 2021-12-31 0001838987 cslr:TwoZeroTwoOnePromissoryNotesMember us-gaap:NotesPayableOtherPayablesMember 2021-12-31 0001838987 cslr:CurrentInsightPromissoryNoteMember us-gaap:NotesPayableOtherPayablesMember 2021-12-31 0001838987 us-gaap:NotesPayableOtherPayablesMember 2021-12-31 0001838987 cslr:TwoThousandAndTwentyOneSeriesAConvertibleNotesMember 2021-12-31 0001838987 cslr:TwoThousandAndTwentySeriesAConvertibleNotesMember 2021-12-31 0001838987 cslr:TwoThousandAndTwentyOneSimpleAgreementForFutureEquityMember 2021-12-31 0001838987 cslr:TwoThousandTwentyOneAConvertibleNotesMember cslr:TrancheOneMember 2021-12-31 0001838987 cslr:TwoThousandTwentyOneAConvertibleNotesMember cslr:TrancheTwoMember 2021-12-31 0001838987 us-gaap:MeasurementInputExpectedTermMember cslr:SimpleAgreementForFutureEquityInstrumentsMember 2021-12-31 0001838987 us-gaap:MeasurementInputRiskFreeInterestRateMember cslr:SimpleAgreementForFutureEquityInstrumentsMember 2021-12-31 0001838987 cslr:SimpleAgreementForFutureEquityInstrumentsMember us-gaap:MeasurementInputPriceVolatilityMember 2021-12-31 0001838987 cslr:SolarEnergySystemInstallationsMember 2022-01-01 2022-12-31 0001838987 cslr:SoftwareServicesMember 2022-01-01 2022-12-31 0001838987 cslr:SeriesD7RedeemableConvertiblePreferredStockWarrantMember 2022-01-01 2022-12-31 0001838987 cslr:SeriesBRedeemableConvertiblePreferredStockWarrantMember 2022-01-01 2022-12-31 0001838987 cslr:SeriesCRedeemableConvertiblePreferredStockWarrantMember 2022-01-01 2022-12-31 0001838987 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001838987 cslr:BusinessCombinationMember 2022-01-01 2022-12-31 0001838987 us-gaap:CostOfSalesMember us-gaap:StockCompensationPlanMember 2022-01-01 2022-12-31 0001838987 cslr:SalesAndMarketingMember us-gaap:StockCompensationPlanMember 2022-01-01 2022-12-31 0001838987 us-gaap:GeneralAndAdministrativeExpenseMember us-gaap:StockCompensationPlanMember 2022-01-01 2022-12-31 0001838987 us-gaap:StockCompensationPlanMember 2022-01-01 2022-12-31 0001838987 srt:ScenarioPreviouslyReportedMember 2022-01-01 2022-12-31 0001838987 cslr:SolariaMember 2022-01-01 2022-12-31 0001838987 us-gaap:CommonClassAMember 2022-01-01 2022-12-31 0001838987 cslr:SolariaMember 2022-01-01 2022-12-31 0001838987 cslr:PIPEInvestorsMember 2022-01-01 2022-12-31 0001838987 cslr:TwoThousandTwentyAConvertibleNotesMember 2022-01-01 2022-12-31 0001838987 cslr:TwoThousandTwentyOneAConvertibleNotesMember 2022-01-01 2022-12-31 0001838987 us-gaap:RelatedPartyMember 2022-01-01 2022-12-31 0001838987 cslr:TwoThousandTwentyOneAConvertibleNotesMember 2022-01-01 2022-12-31 0001838987 cslr:TwoThousandTwentyTwoConvertibleNotesMember 2022-01-01 2022-12-31 0001838987 cslr:PIPESubscriptionAgreementMember 2022-01-01 2022-12-31 0001838987 cslr:ConvertiblePromissoryNotesMember 2022-01-01 2022-12-31 0001838987 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001838987 cslr:CarlyleWarrantsMember cslr:CRSEFSolisHoldingsLLCMember 2022-01-01 2022-12-31 0001838987 us-gaap:SeriesCPreferredStockMember 2022-01-01 2022-12-31 0001838987 cslr:SVBCommonStockWarrantsMember 2022-01-01 2022-12-31 0001838987 cslr:SCITermLoanAndRevolverLoanMember 2022-01-01 2022-12-31 0001838987 cslr:SolariaAcquisitionMember cslr:ConvertiblePromissoryNotesMember 2022-01-01 2022-12-31 0001838987 cslr:PIPEFinancingMember 2022-01-01 2022-12-31 0001838987 us-gaap:CommitmentsMember 2022-01-01 2022-12-31 0001838987 cslr:IssueOfRedeemableConvertiblePreferredStockUponAcquisitionMember cslr:AdjustedMember us-gaap:RedeemableConvertiblePreferredStockMember 2022-01-01 2022-12-31 0001838987 cslr:IssuanceOfRedeemableConvertiblePreferredStockUponConversionOfSimpleAgreementOfFutureEquityNotesMember cslr:AdjustedMember us-gaap:RedeemableConvertiblePreferredStockMember 2022-01-01 2022-12-31 0001838987 us-gaap:RelatedPartyMember us-gaap:ConvertibleNotesPayableMember 2022-01-01 2022-12-31 0001838987 cslr:TwoThousandTwentyOneSafeMember 2022-01-01 2022-12-31 0001838987 cslr:TwoThousandNinteenSAFEMember 2022-01-01 2022-12-31 0001838987 us-gaap:DevelopedTechnologyRightsMember 2022-01-01 2022-12-31 0001838987 us-gaap:CustomerRelationshipsMember 2022-01-01 2022-12-31 0001838987 us-gaap:TrademarksMember 2022-01-01 2022-12-31 0001838987 cslr:AssembledWorkforceMember 2022-01-01 2022-12-31 0001838987 cslr:PreviouslyReportedOneMember us-gaap:RedeemableConvertiblePreferredStockMember 2022-01-01 2022-12-31 0001838987 cslr:PreviouslyReportedOneMember us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001838987 cslr:PreviouslyReportedOneMember us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001838987 cslr:PreviouslyReportedOneMember us-gaap:RetainedEarningsUnappropriatedMember 2022-01-01 2022-12-31 0001838987 cslr:PreviouslyReportedOneMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001838987 cslr:PreviouslyReportedOneMember 2022-01-01 2022-12-31 0001838987 cslr:SolariaAcquisitionMember 2022-01-01 2022-12-31 0001838987 us-gaap:SeriesDPreferredStockMember cslr:TwoThousandTwentyAConvertibleNotesMember 2022-01-01 2022-12-31 0001838987 cslr:SeriesD7WarrantsMember 2022-01-01 2022-12-31 0001838987 cslr:SAFEMember 2022-01-01 2022-12-31 0001838987 cslr:AdjustedMember us-gaap:RedeemableConvertiblePreferredStockMember 2022-01-01 2022-12-31 0001838987 cslr:AdjustedMember us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001838987 cslr:AdjustedMember us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001838987 cslr:AdjustedMember us-gaap:RetainedEarningsUnappropriatedMember 2022-01-01 2022-12-31 0001838987 cslr:AdjustedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001838987 cslr:AdjustedMember 2022-01-01 2022-12-31 0001838987 srt:MinimumMember 2022-01-01 2022-12-31 0001838987 srt:MaximumMember 2022-01-01 2022-12-31 0001838987 cslr:IssuanceOfRedeemableConvertiblePreferredStockUponConversionOfConvertibleNotesAndSimpleAgreementForFutureEquityNotesMember cslr:AdjustedMember us-gaap:RedeemableConvertiblePreferredStockMember 2022-01-01 2022-12-31 0001838987 cslr:RevolvingLoanMember 2022-01-01 2022-12-31 0001838987 cslr:CSSoilsMember 2022-01-01 2022-12-31 0001838987 us-gaap:SegmentDiscontinuedOperationsMember 2022-01-01 2022-12-31 0001838987 cslr:IssuanceOfTemporaryEquityUponConversionOfConvertibleDebtMember 2022-01-01 2022-12-31 0001838987 us-gaap:GeneralAndAdministrativeExpenseMember 2022-01-01 2022-12-31 0001838987 cslr:TwoThousandAndTwentyThreeMember 2022-01-01 2022-12-31 0001838987 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001838987 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001838987 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2022-01-01 2022-12-31 0001838987 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember cslr:SupplierThreeMember 2022-01-01 2022-12-31 0001838987 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember cslr:CustomerOneMember 2022-01-01 2022-12-31 0001838987 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember cslr:CustomerOneMember 2022-01-01 2022-12-31 0001838987 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember cslr:CustomerTwoMember 2022-01-01 2022-12-31 0001838987 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember cslr:CustomerThreeMember 2022-01-01 2022-12-31 0001838987 us-gaap:WarrantMember cslr:SeriesDWarrantsTrancheAMember 2022-01-01 2022-12-31 0001838987 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember cslr:SeriesDWarrantsTrancheAMember 2022-01-01 2022-12-31 0001838987 cslr:SimpleAgreementForFutureEquityMember cslr:SeriesDWarrantsTrancheAMember 2022-01-01 2022-12-31 0001838987 us-gaap:WarrantMember cslr:SeriesDWarrantsTrancheBMember 2022-01-01 2022-12-31 0001838987 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember cslr:SeriesDWarrantsTrancheBMember 2022-01-01 2022-12-31 0001838987 cslr:SimpleAgreementForFutureEquityMember cslr:SeriesDWarrantsTrancheBMember 2022-01-01 2022-12-31 0001838987 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001838987 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2022-01-01 2022-12-31 0001838987 cslr:SimpleAgreementForFutureEquityMember 2022-01-01 2022-12-31 0001838987 us-gaap:WarrantMember cslr:ConversionOfSafesFromSolariaAcquisitionIntoPreferredSharesMember 2022-01-01 2022-12-31 0001838987 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember cslr:ConversionOfSafesFromSolariaAcquisitionIntoPreferredSharesMember 2022-01-01 2022-12-31 0001838987 cslr:SimpleAgreementForFutureEquityMember cslr:ConversionOfSafesFromSolariaAcquisitionIntoPreferredSharesMember 2022-01-01 2022-12-31 0001838987 us-gaap:WarrantMember cslr:ConversionOfDebtIntoPreferredSharesMember 2022-01-01 2022-12-31 0001838987 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember cslr:ConversionOfDebtIntoPreferredSharesMember 2022-01-01 2022-12-31 0001838987 cslr:SimpleAgreementForFutureEquityMember cslr:ConversionOfDebtIntoPreferredSharesMember 2022-01-01 2022-12-31 0001838987 us-gaap:WarrantMember cslr:ConversionOfSafesIntoPreferredSharesMember 2022-01-01 2022-12-31 0001838987 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember cslr:ConversionOfSafesIntoPreferredSharesMember 2022-01-01 2022-12-31 0001838987 cslr:SimpleAgreementForFutureEquityMember cslr:ConversionOfSafesIntoPreferredSharesMember 2022-01-01 2022-12-31 0001838987 srt:MinimumMember us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0001838987 srt:MaximumMember us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0001838987 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0001838987 cslr:TwoThousandAndElevenEquityIncentivePlanMember 2022-01-01 2022-12-31 0001838987 cslr:TwoThousandAndElevenEquityIncentivePlanMember cslr:IncentiveStockOptionMember 2022-01-01 2022-12-31 0001838987 cslr:TwoThousandAndElevenEquityIncentivePlanMember cslr:TenPercentStockHolderMember 2022-01-01 2022-12-31 0001838987 cslr:TwoThousandAndTwentyOneEquityIncentivePlanMember 2022-01-01 2022-12-31 0001838987 cslr:TwoThousandAndTwentyOneEquityIncentivePlanMember cslr:IncentiveStockOptionMember 2022-01-01 2022-12-31 0001838987 cslr:TwoThousandAndTwentyOneEquityIncentivePlanMember cslr:TenPercentStockHolderMember 2022-01-01 2022-12-31 0001838987 cslr:TwoThousandAndTwentyTwoEquityIncentivePlanMember 2022-01-01 2022-12-31 0001838987 cslr:TwoThousandAndTwentyTwoEquityIncentivePlanMember cslr:IncentiveStockOptionMember 2022-01-01 2022-12-31 0001838987 cslr:TwoThousandAndTwentyTwoEquityIncentivePlanMember cslr:TenPercentStockHolderMember 2022-01-01 2022-12-31 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember cslr:SeriesBWarrantsMember 2022-01-01 2022-12-31 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember cslr:SeriesCWarrantsMember 2022-01-01 2022-12-31 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember 2022-01-01 2022-12-31 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember cslr:SeriesDTrancheAWarrantsMember 2022-01-01 2022-12-31 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember cslr:SeriesDTrancheBWarrantsMember 2022-01-01 2022-12-31 0001838987 cslr:TwoThousandAndNineteenAConvertibleNotesMember 2022-01-01 2022-12-31 0001838987 cslr:TwoThousandAndTwentyAConvertibleNotesMember 2022-01-01 2022-12-31 0001838987 cslr:TwoThousandAndTwentyOneConvertibleNotesMember 2022-01-01 2022-12-31 0001838987 cslr:TwoThousandAndTwentyOneAConvertibleNotesWithEmbeddedDerivativeLiabilityMember 2022-01-01 2022-12-31 0001838987 cslr:TwoThousandNineteenConvertibleNotesMember 2022-01-01 2022-12-31 0001838987 cslr:TwoThousandTwentyAConvertibleNotesMember 2022-01-01 2022-12-31 0001838987 cslr:TwoThousandNineteenConvertibleNotesMember srt:MaximumMember 2022-01-01 2022-12-31 0001838987 cslr:TwoThousandTwentyAConvertibleNotesMember srt:MaximumMember 2022-01-01 2022-12-31 0001838987 cslr:TwoThousandAndTwentyTwoSimpleAgreementForFutureEquityMember 2022-01-01 2022-12-31 0001838987 cslr:SolariaMember 2023-01-02 2023-10-01 0001838987 us-gaap:DevelopedTechnologyRightsMember 2023-01-02 2023-10-01 0001838987 us-gaap:CustomerRelationshipsMember 2023-01-02 2023-10-01 0001838987 us-gaap:TrademarksMember 2023-01-02 2023-10-01 0001838987 cslr:AssembledWorkforceMember 2023-01-02 2023-10-01 0001838987 cslr:SolariaAcquisitionMember 2022-11-04 2022-11-04 0001838987 cslr:SolariaAcquisitionMember us-gaap:PreferredStockMember 2022-11-04 2022-11-04 0001838987 cslr:SolariaAcquisitionMember us-gaap:CommonStockMember 2022-11-04 2022-11-04 0001838987 cslr:SolariaAcquisitionMember us-gaap:WarrantMember us-gaap:PreferredStockMember 2022-11-04 2022-11-04 0001838987 cslr:SolariaAcquisitionMember us-gaap:WarrantMember us-gaap:CommonStockMember 2022-11-04 2022-11-04 0001838987 us-gaap:StockOptionMember cslr:SolariaAcquisitionMember 2022-11-04 2022-11-04 0001838987 cslr:SolariaAcquisitionMember 2022-11-04 0001838987 us-gaap:TrademarksAndTradeNamesMember 2023-09-30 0001838987 us-gaap:DevelopedTechnologyRightsMember 2023-09-30 0001838987 us-gaap:CustomerRelationshipsMember 2023-09-30 0001838987 us-gaap:RelatedPartyMember cslr:SeriesDOneRedeemableConvertiblePreferredStockMember cslr:UponConversionOfConvertibleNotesAndSimpleAgreementForFutureEquityMember 2023-09-30 0001838987 us-gaap:StockCompensationPlanMember us-gaap:CostOfSalesMember 2023-07-02 2023-10-01 0001838987 us-gaap:StockCompensationPlanMember cslr:SalesAndMarketingMember 2023-07-02 2023-10-01 0001838987 us-gaap:StockCompensationPlanMember us-gaap:GeneralAndAdministrativeExpenseMember 2023-07-02 2023-10-01 0001838987 us-gaap:StockCompensationPlanMember 2023-07-02 2023-10-01 0001838987 us-gaap:SeriesBPreferredStockMember 2016-02-29 0001838987 cslr:SeriesBWarrantsMember 2016-02-29 0001838987 cslr:RedeemableConvertiblePreferredStockWarrantLiabilityMember cslr:DespacAcquisitionAssumptionExercisePriceOneMember cslr:SeriesDPreferredStockWarrantsTrancheOneMember 2016-02-29 0001838987 cslr:RedeemableConvertiblePreferredStockWarrantLiabilityMember cslr:DespacAcquisitionAssumptionExercisePriceOneMember cslr:SeriesDPreferredStockWarrantsTrancheTwoMember 2016-02-29 0001838987 cslr:WarrantsRemainingPrivateAssumptionExercisePriceOneMember cslr:SeriesDPreferredStockWarrantsTrancheOneMember 2016-02-29 0001838987 cslr:WarrantsRemainingPrivateAssumptionExercisePriceOneMember cslr:SeriesDPreferredStockWarrantsTrancheTwoMember 2016-02-29 0001838987 cslr:RedeemableConvertiblePreferredStockWarrantLiabilityMember cslr:SpacExistsMember 2016-02-29 0001838987 cslr:RedeemableConvertiblePreferredStockWarrantLiabilityMember cslr:WarrantsRemainingPrivateMember 2016-02-29 0001838987 cslr:SeriesBWarrantsMember us-gaap:CommonClassAMember 2023-07-01 2023-07-18 0001838987 us-gaap:SeriesCPreferredStockMember 2023-07-01 2023-07-18 0001838987 cslr:SeriesCWarrantsMember 2016-07-30 0001838987 cslr:SeriesC1WarrantsMember 2020-01-31 0001838987 cslr:SVBCommonStockWarrantsMember srt:MinimumMember 2021-05-31 0001838987 srt:MinimumMember cslr:SVBCommonStockWarrantsMember us-gaap:CommonStockMember 2021-05-31 0001838987 srt:MinimumMember 2021-05-31 0001838987 srt:MaximumMember 2021-08-31 0001838987 cslr:PromissoryNoteCommonStockWarrantsMember 2021-10-01 2021-10-31 0001838987 cslr:TwoZeroTwoOnePromissoryNotesMember 2021-10-01 2021-10-31 0001838987 cslr:PromissoryNoteCommonStockWarrantsMember 2021-10-31 0001838987 cslr:TwoZeroTwoOnePromissoryNotesMember 2021-10-31 0001838987 cslr:CarlyleWarrantsMember 2022-02-28 0001838987 cslr:CarlyleWarrantsMember us-gaap:CommonStockMember 2022-02-28 0001838987 cslr:CarlyleWarrantsMember us-gaap:WarrantMember 2022-02-28 0001838987 cslr:July2023CommonStockWarrantsMember us-gaap:PrivatePlacementMember 2023-07-01 2023-07-31 0001838987 cslr:WarrantConsiderationMember 2023-07-01 2023-07-31 0001838987 srt:BoardOfDirectorsChairmanMember 2023-07-01 2023-07-31 0001838987 cslr:CarlyleWarrantsMember 2023-07-01 2023-07-31 0001838987 cslr:July2023CommonStockWarrantsMember 2023-07-01 2023-07-31 0001838987 cslr:ClassACommonStockEqualsOrExceedsThresholdTwoMember us-gaap:PrivatePlacementMember 2023-07-01 2023-07-31 0001838987 cslr:TwoThousandTwentyThreeEquityIncentivePlanMember 2023-07-31 0001838987 cslr:July2023CommonStockWarrantsMember 2023-07-31 0001838987 cslr:CarlyleWarrantsMember 2023-07-31 0001838987 cslr:ConvertiblePromissoryNotesMember 2023-07-31 0001838987 us-gaap:WarrantMember 2022-11-30 0001838987 cslr:November2022CommonStockWarrantsMember cslr:BusinessCombinationMember 2022-11-01 2022-11-30 0001838987 cslr:November2022CommonStockWarrantsMember 2022-11-01 2022-11-30 0001838987 cslr:November2022CommonStockWarrantsMember 2023-05-01 2023-05-31 0001838987 cslr:ConversionAmountMember 2021-04-01 2021-04-30 0001838987 cslr:PaycheckProtectionProgrammeLoanMember 2021-04-01 2021-04-30 0001838987 cslr:LoanAndSecurityAgreementMember 2020-01-01 2020-01-20 0001838987 srt:MaximumMember 2020-01-01 2020-01-20 0001838987 srt:MinimumMember 2020-01-01 2020-01-20 0001838987 us-gaap:WarrantMember 2021-12-31 2021-12-31 0001838987 srt:MinimumMember 2021-12-31 2021-12-31 0001838987 srt:MaximumMember 2021-12-31 2021-12-31 0001838987 cslr:TwoThousandAndNineteenAConvertibleNotesMember 2021-12-31 2021-12-31 0001838987 cslr:TwoThousandAndTwentyOneAConvertibleNotesWithEmbeddedDerivativeLiabilityMember 2021-12-31 2021-12-31 0001838987 cslr:TwoThousandAndTwentyAConvertibleNotesMember 2021-12-31 2021-12-31 0001838987 cslr:TwoThousandAndTwentyOneConvertibleNotesMember 2021-12-31 2021-12-31 0001838987 cslr:TwoZeroTwoOnePromissoryNotesMember 2021-07-01 2021-07-31 0001838987 cslr:TwoZeroTwoOnePromissoryNotesMember 2021-07-31 0001838987 cslr:TwoZeroOneEightBridgeNotesMember 2018-12-01 2018-12-31 0001838987 cslr:CurrentInsightPromissoryNoteMember 2021-01-01 0001838987 us-gaap:AccountingStandardsUpdate201602Member 2021-01-01 0001838987 cslr:CurrentInsightPromissoryNoteMember 2021-01-01 2021-01-31 0001838987 cslr:SeriesBWarrantsMember 2022-12-01 2022-12-31 0001838987 srt:MinimumMember 2022-12-01 2022-12-31 0001838987 srt:MaximumMember 2022-12-01 2022-12-31 0001838987 cslr:SecuredCreditFacilityMember 2022-12-01 2022-12-31 0001838987 cslr:SettlementAgreementMember 2023-09-01 2023-09-30 0001838987 cslr:PolarSettlementAgreementMember 2023-09-28 2023-10-01 0001838987 cslr:ISOsUnderThe2023PlanMember 2023-07-31 2023-07-31 0001838987 cslr:TwoThousandTwentyTwoConvertibleNotesMember 2022-12-31 2022-12-31 0001838987 cslr:RevolvingLoanMember 2022-12-31 2022-12-31 0001838987 cslr:TwoThousandAndNineteenAConvertibleNotesMember 2022-12-31 2022-12-31 0001838987 cslr:TwoThousandAndTwentyOneAConvertibleNotesWithEmbeddedDerivativeLiabilityMember 2022-12-31 2022-12-31 0001838987 cslr:TwoThousandAndTwentyAConvertibleNotesMember 2022-12-31 2022-12-31 0001838987 cslr:TwoThousandAndTwentyOneConvertibleNotesMember 2022-12-31 2022-12-31 0001838987 cslr:TwoThousandAndTwentyThreeConvertibleNotesMember 2023-01-01 2023-01-31 0001838987 cslr:SolarParkKoreaCoLTDMember 2023-01-01 2023-01-31 0001838987 cslr:SecuredCreditFacilityMember 2023-02-01 2023-02-28 0001838987 cslr:SolarEnergySystemInstallationsMember 2020-01-01 2020-12-31 0001838987 cslr:SoftwareServicesMember 2020-01-01 2020-12-31 0001838987 us-gaap:CostOfSalesMember us-gaap:StockCompensationPlanMember 2020-01-01 2020-12-31 0001838987 cslr:SalesAndMarketingMember us-gaap:StockCompensationPlanMember 2020-01-01 2020-12-31 0001838987 us-gaap:GeneralAndAdministrativeExpenseMember us-gaap:StockCompensationPlanMember 2020-01-01 2020-12-31 0001838987 us-gaap:StockCompensationPlanMember 2020-01-01 2020-12-31 0001838987 srt:ScenarioPreviouslyReportedMember 2020-01-01 2020-12-31 0001838987 cslr:TwoThousandTwentyAConvertibleNotesMember 2020-01-01 2020-12-31 0001838987 us-gaap:RelatedPartyMember 2020-01-01 2020-12-31 0001838987 cslr:AdjustedMember us-gaap:RedeemableConvertiblePreferredStockMember 2020-01-01 2020-12-31 0001838987 cslr:IssuanceOfRedeemableConvertiblePreferredStockUponConversionOfTwoThousandAndSeventeenConvertibleNotesAndTwoThousandAndTwoThousandAndNineteenSimpleAgreementForFutureEquityMember cslr:AdjustedMember us-gaap:RedeemableConvertiblePreferredStockMember 2020-01-01 2020-12-31 0001838987 cslr:PreviouslyReportedOneMember us-gaap:CommonStockMember 2020-01-01 2020-12-31 0001838987 cslr:PreviouslyReportedOneMember us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0001838987 cslr:PreviouslyReportedOneMember us-gaap:RetainedEarningsUnappropriatedMember 2020-01-01 2020-12-31 0001838987 cslr:PreviouslyReportedOneMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-12-31 0001838987 cslr:PreviouslyReportedOneMember 2020-01-01 2020-12-31 0001838987 cslr:PreviouslyReportedOneMember us-gaap:RedeemableConvertiblePreferredStockMember 2020-01-01 2020-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:RedeemableConvertiblePreferredStockMember 2020-01-01 2020-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:CommonStockMember 2020-01-01 2020-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:RetainedEarningsUnappropriatedMember 2020-01-01 2020-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-12-31 0001838987 cslr:ConversionOfConvertibleNotesMember cslr:AdjustedMember us-gaap:RedeemableConvertiblePreferredStockMember 2020-01-01 2020-12-31 0001838987 cslr:AdjustedMember us-gaap:CommonStockMember 2020-01-01 2020-12-31 0001838987 cslr:AdjustedMember us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0001838987 cslr:AdjustedMember us-gaap:RetainedEarningsUnappropriatedMember 2020-01-01 2020-12-31 0001838987 cslr:AdjustedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-12-31 0001838987 cslr:AdjustedMember 2020-01-01 2020-12-31 0001838987 us-gaap:GeneralAndAdministrativeExpenseMember 2020-01-01 2020-12-31 0001838987 us-gaap:SupplierConcentrationRiskMember us-gaap:CostOfGoodsTotalMember 2020-01-01 2020-12-31 0001838987 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0001838987 us-gaap:SupplierConcentrationRiskMember us-gaap:CostOfGoodsTotalMember cslr:SupplierTwoMember 2020-01-01 2020-12-31 0001838987 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember cslr:CustomerOneMember 2020-01-01 2020-12-31 0001838987 cslr:TwoThousandNineteenConvertibleNotesMember srt:MaximumMember 2020-01-01 2020-12-31 0001838987 cslr:TwoThousandTwentyAConvertibleNotesMember srt:MaximumMember 2020-01-01 2020-12-31 0001838987 cslr:SolarEnergySystemInstallationsMember 2021-01-01 2021-12-31 0001838987 cslr:SoftwareServicesMember 2021-01-01 2021-12-31 0001838987 cslr:SeriesBRedeemableConvertiblePreferredStockWarrantMember 2021-01-01 2021-12-31 0001838987 cslr:SeriesCRedeemableConvertiblePreferredStockWarrantMember 2021-01-01 2021-12-31 0001838987 us-gaap:CostOfSalesMember us-gaap:StockCompensationPlanMember 2021-01-01 2021-12-31 0001838987 cslr:SalesAndMarketingMember us-gaap:StockCompensationPlanMember 2021-01-01 2021-12-31 0001838987 us-gaap:GeneralAndAdministrativeExpenseMember us-gaap:StockCompensationPlanMember 2021-01-01 2021-12-31 0001838987 us-gaap:StockCompensationPlanMember 2021-01-01 2021-12-31 0001838987 srt:ScenarioPreviouslyReportedMember 2021-01-01 2021-12-31 0001838987 cslr:TwoThousandTwentyOneAConvertibleNotesMember 2021-01-01 2021-12-31 0001838987 us-gaap:RelatedPartyMember 2021-01-01 2021-12-31 0001838987 cslr:SeriesD7RedeemableConvertiblePreferredStockWarrantMember 2021-01-01 2021-12-31 0001838987 us-gaap:SeriesCPreferredStockMember 2021-01-01 2021-12-31 0001838987 us-gaap:CommitmentsMember 2021-01-01 2021-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:RetainedEarningsUnappropriatedMember 2021-01-01 2021-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:RedeemableConvertiblePreferredStockMember 2021-01-01 2021-12-31 0001838987 cslr:AcquisitionOfAssembledWorkforceMember cslr:AdjustedMember us-gaap:RedeemableConvertiblePreferredStockMember 2021-01-01 2021-12-31 0001838987 cslr:AcquisitionOfAssembledWorkforceMember cslr:AdjustedMember us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001838987 cslr:AcquisitionOfAssembledWorkforceMember cslr:AdjustedMember us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001838987 cslr:AcquisitionOfAssembledWorkforceMember cslr:AdjustedMember us-gaap:RetainedEarningsUnappropriatedMember 2021-01-01 2021-12-31 0001838987 cslr:AcquisitionOfAssembledWorkforceMember cslr:AdjustedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001838987 cslr:AcquisitionOfAssembledWorkforceMember cslr:AdjustedMember 2021-01-01 2021-12-31 0001838987 cslr:AdjustedMember us-gaap:RedeemableConvertiblePreferredStockMember 2021-01-01 2021-12-31 0001838987 cslr:AdjustedMember us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001838987 cslr:AdjustedMember us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001838987 cslr:AdjustedMember us-gaap:RetainedEarningsUnappropriatedMember 2021-01-01 2021-12-31 0001838987 cslr:AdjustedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001838987 cslr:AdjustedMember 2021-01-01 2021-12-31 0001838987 us-gaap:GeneralAndAdministrativeExpenseMember 2021-01-01 2021-12-31 0001838987 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001838987 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2021-01-01 2021-12-31 0001838987 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001838987 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember cslr:SupplierFourMember 2021-01-01 2021-12-31 0001838987 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember cslr:CustomerOneMember 2021-01-01 2021-12-31 0001838987 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember cslr:CustomerOneMember 2021-01-01 2021-12-31 0001838987 us-gaap:WarrantMember us-gaap:ConvertibleDebtMember 2021-01-01 2021-12-31 0001838987 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:ConvertibleDebtMember 2021-01-01 2021-12-31 0001838987 cslr:SimpleAgreementForFutureEquityMember us-gaap:ConvertibleDebtMember 2021-01-01 2021-12-31 0001838987 us-gaap:WarrantMember cslr:RogersSafeMember 2021-01-01 2021-12-31 0001838987 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember cslr:RogersSafeMember 2021-01-01 2021-12-31 0001838987 cslr:SimpleAgreementForFutureEquityMember cslr:RogersSafeMember 2021-01-01 2021-12-31 0001838987 us-gaap:WarrantMember 2021-01-01 2021-12-31 0001838987 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2021-01-01 2021-12-31 0001838987 cslr:SimpleAgreementForFutureEquityMember 2021-01-01 2021-12-31 0001838987 srt:MinimumMember us-gaap:EmployeeStockOptionMember 2021-01-01 2021-12-31 0001838987 srt:MaximumMember us-gaap:EmployeeStockOptionMember 2021-01-01 2021-12-31 0001838987 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-12-31 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember cslr:SeriesBWarrantsMember 2021-01-01 2021-12-31 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember cslr:SeriesCWarrantsMember 2021-01-01 2021-12-31 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember 2021-01-01 2021-12-31 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember cslr:SeriesDTrancheAWarrantsMember 2021-01-01 2021-12-31 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember cslr:SeriesDTrancheBWarrantsMember 2021-01-01 2021-12-31 0001838987 cslr:TwoThousandNineteenConvertibleNotesMember 2021-01-01 2021-12-31 0001838987 cslr:TwoThousandTwentyAConvertibleNotesMember 2021-01-01 2021-12-31 0001838987 cslr:TwoThousandNineteenConvertibleNotesMember srt:MaximumMember 2021-01-01 2021-12-31 0001838987 cslr:TwoThousandTwentyAConvertibleNotesMember srt:MaximumMember 2021-01-01 2021-12-31 0001838987 cslr:TwoThousandAndTwentyOneSimpleAgreementForFutureEquityMember us-gaap:OtherNonoperatingIncomeExpenseMember 2021-01-01 2021-12-31 0001838987 cslr:TwoThousandTwentyTwoConvertibleNotesMember 2022-10-01 2023-06-01 0001838987 cslr:ConvertiblePromissoryNotesMember cslr:SolariaAcquisitionMember 2022-10-01 2023-06-30 0001838987 cslr:SolariaCommonStockMember 2023-10-31 2023-10-31 0001838987 us-gaap:CommonClassAMember 2023-03-01 2023-03-31 0001838987 cslr:TwoThousandAndTwentyThreeConvertibleNotesMember 2023-01-31 0001838987 cslr:CurrentInsightMember 2021-01-21 2021-01-21 0001838987 cslr:CurrentInsightMember us-gaap:CommonStockMember 2021-01-21 2021-01-21 0001838987 us-gaap:InvestmentCreditMember 2020-06-29 0001838987 us-gaap:CommonClassAMember cslr:SeriesBWarrantsMember 2021-12-01 2021-12-31 0001838987 cslr:TwoThousandAndTwentyOneSimpleAgreementForFutureEquityMember 2021-12-01 2021-12-31 0001838987 us-gaap:AccountingStandardsUpdate201602Member 2021-01-01 2021-01-01 0001838987 cslr:VendorSettlementMember 2023-01-10 0001838987 cslr:WarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember 2024-01-04 2024-01-04 0001838987 cslr:CommonStockParValue0.0001PerShareMember 2024-01-04 2024-01-04 0001838987 cslr:TwoThousandAndNineteenAConvertibleNotesMember 2020-12-31 2020-12-31 0001838987 cslr:TwoThousandAndTwentyOneAConvertibleNotesWithEmbeddedDerivativeLiabilityMember 2020-12-31 2020-12-31 0001838987 cslr:TwoThousandAndTwentyAConvertibleNotesMember 2020-12-31 2020-12-31 0001838987 cslr:TwoThousandAndTwentyOneConvertibleNotesMember 2020-12-31 2020-12-31 0001838987 cslr:TwoThousandAndNineteenSimpleAgreementForFutureEquityMember 2019-07-31 0001838987 cslr:TwoThousandAndNineteenSimpleAgreementForFutureEquityMember 2019-12-31 0001838987 cslr:ProbabilityOfConversionIntoEquityInstrumentsOneMember cslr:TwoThousandAndNineteenSimpleAgreementForFutureEquityMember 2019-12-31 0001838987 cslr:TwoThousandAndNineteenSimpleAgreementForFutureEquityMember cslr:ProbabilityOfConversionIntoEquityInstrumentsTwoMember 2019-12-31 0001838987 cslr:TwoThousandAndNineteenSimpleAgreementForFutureEquityMember 2019-01-01 2019-12-31 0001838987 cslr:PaycheckProtectionProgrammeLoanMember 2020-04-01 2020-04-30 0001838987 cslr:TwoThousandAndNineteenSimpleAgreementForFutureEquityMember 2019-07-01 2019-07-31 0001838987 cslr:AdjustedMember us-gaap:RedeemableConvertiblePreferredStockMember 2021-12-31 0001838987 cslr:AdjustedMember us-gaap:CommonStockMember 2021-12-31 0001838987 cslr:AdjustedMember us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001838987 cslr:AdjustedMember us-gaap:RetainedEarningsUnappropriatedMember 2021-12-31 0001838987 cslr:AdjustedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001838987 cslr:AdjustedMember 2021-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-09-30 0001838987 cslr:AdjustedMember us-gaap:RedeemableConvertiblePreferredStockMember 2022-09-30 0001838987 cslr:AdjustedMember us-gaap:CommonStockMember 2022-09-30 0001838987 cslr:AdjustedMember us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001838987 cslr:AdjustedMember us-gaap:RetainedEarningsUnappropriatedMember 2022-09-30 0001838987 cslr:AdjustedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-09-30 0001838987 cslr:AdjustedMember 2022-09-30 0001838987 cslr:AdjustedMember us-gaap:RedeemableConvertiblePreferredStockMember 2022-06-30 0001838987 cslr:AdjustedMember us-gaap:CommonStockMember 2022-06-30 0001838987 cslr:AdjustedMember us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001838987 cslr:AdjustedMember us-gaap:RetainedEarningsUnappropriatedMember 2022-06-30 0001838987 cslr:AdjustedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0001838987 cslr:AdjustedMember 2022-06-30 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:RedeemableConvertiblePreferredStockMember 2022-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:RetainedEarningsUnappropriatedMember 2022-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001838987 srt:ScenarioPreviouslyReportedMember 2022-12-31 0001838987 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001838987 us-gaap:RetainedEarningsUnappropriatedMember 2022-12-31 0001838987 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember 2022-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:CommonStockMember 2022-12-31 0001838987 us-gaap:AdditionalPaidInCapitalMember 2023-10-01 0001838987 us-gaap:RetainedEarningsUnappropriatedMember 2023-10-01 0001838987 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-10-01 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember 2023-10-01 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember srt:ScenarioPreviouslyReportedMember 2023-07-02 0001838987 us-gaap:AdditionalPaidInCapitalMember srt:ScenarioPreviouslyReportedMember 2023-07-02 0001838987 us-gaap:RetainedEarningsUnappropriatedMember 2023-07-02 0001838987 us-gaap:AccumulatedOtherComprehensiveIncomeMember srt:ScenarioPreviouslyReportedMember 2023-07-02 0001838987 srt:ScenarioPreviouslyReportedMember 2023-07-02 0001838987 cslr:AdjustedMember us-gaap:CommonStockMember 2023-07-02 0001838987 cslr:AdjustedMember us-gaap:AdditionalPaidInCapitalMember 2023-07-02 0001838987 cslr:AdjustedMember us-gaap:RetainedEarningsUnappropriatedMember 2023-07-02 0001838987 cslr:AdjustedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-02 0001838987 cslr:AdjustedMember 2023-07-02 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember cslr:AdjustedMember 2023-07-02 0001838987 us-gaap:CommonStockMember srt:ScenarioPreviouslyReportedMember 2023-07-02 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:RedeemableConvertiblePreferredStockMember 2022-09-30 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:CommonStockMember 2022-09-30 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001838987 srt:ScenarioPreviouslyReportedMember 2022-09-30 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:RetainedEarningsUnappropriatedMember 2022-09-30 0001838987 cslr:PreviouslyReportedOneMember us-gaap:CommonStockMember 2022-12-31 0001838987 cslr:PreviouslyReportedOneMember us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001838987 cslr:PreviouslyReportedOneMember us-gaap:RetainedEarningsUnappropriatedMember 2022-12-31 0001838987 cslr:PreviouslyReportedOneMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001838987 cslr:PreviouslyReportedOneMember 2022-12-31 0001838987 cslr:AdjustedMember us-gaap:CommonStockMember 2022-12-31 0001838987 cslr:AdjustedMember us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001838987 cslr:AdjustedMember us-gaap:RetainedEarningsUnappropriatedMember 2022-12-31 0001838987 cslr:AdjustedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001838987 cslr:AdjustedMember 2022-12-31 0001838987 cslr:PreviouslyReportedOneMember us-gaap:RedeemableConvertiblePreferredStockMember 2022-12-31 0001838987 cslr:AdjustedMember us-gaap:RedeemableConvertiblePreferredStockMember 2022-12-31 0001838987 us-gaap:WarrantMember 2022-12-31 0001838987 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2022-12-31 0001838987 cslr:SimpleAgreementForFutureEquityMember 2022-12-31 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember cslr:SeriesBWarrantsMember 2022-12-31 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember cslr:SeriesCWarrantsMember 2022-12-31 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember cslr:SeriesDTrancheAWarrantsMember 2022-12-31 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember cslr:SeriesDTrancheBWarrantsMember 2022-12-31 0001838987 cslr:TwoThousandTwentyOneAConvertibleNotesMember 2022-12-31 0001838987 cslr:TwoThousandTwentyAConvertibleNotesMember 2022-12-31 0001838987 cslr:PreviouslyReportedOneMember us-gaap:CommonStockMember 2021-12-31 0001838987 cslr:PreviouslyReportedOneMember us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001838987 cslr:PreviouslyReportedOneMember us-gaap:RetainedEarningsUnappropriatedMember 2021-12-31 0001838987 cslr:PreviouslyReportedOneMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001838987 cslr:PreviouslyReportedOneMember 2021-12-31 0001838987 cslr:PreviouslyReportedOneMember us-gaap:RedeemableConvertiblePreferredStockMember 2021-12-31 0001838987 cslr:PreviouslyReportedOneMember us-gaap:CommonStockMember 2019-12-31 0001838987 cslr:PreviouslyReportedOneMember us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001838987 cslr:PreviouslyReportedOneMember us-gaap:RetainedEarningsUnappropriatedMember 2019-12-31 0001838987 cslr:PreviouslyReportedOneMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001838987 cslr:PreviouslyReportedOneMember 2019-12-31 0001838987 cslr:AdjustedMember us-gaap:CommonStockMember 2019-12-31 0001838987 cslr:AdjustedMember us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001838987 cslr:AdjustedMember us-gaap:RetainedEarningsUnappropriatedMember 2019-12-31 0001838987 cslr:AdjustedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001838987 cslr:AdjustedMember 2019-12-31 0001838987 cslr:AdjustedMember us-gaap:RedeemableConvertiblePreferredStockMember 2019-12-31 0001838987 cslr:PreviouslyReportedOneMember us-gaap:RedeemableConvertiblePreferredStockMember 2019-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:CommonStockMember 2020-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:RetainedEarningsUnappropriatedMember 2020-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001838987 srt:ScenarioPreviouslyReportedMember 2020-12-31 0001838987 cslr:AdjustedMember us-gaap:CommonStockMember 2020-12-31 0001838987 cslr:AdjustedMember us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001838987 cslr:AdjustedMember us-gaap:RetainedEarningsUnappropriatedMember 2020-12-31 0001838987 cslr:AdjustedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001838987 cslr:AdjustedMember 2020-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:RedeemableConvertiblePreferredStockMember 2020-12-31 0001838987 cslr:AdjustedMember us-gaap:RedeemableConvertiblePreferredStockMember 2020-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:CommonStockMember 2021-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:RetainedEarningsUnappropriatedMember 2021-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001838987 srt:ScenarioPreviouslyReportedMember 2021-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:RedeemableConvertiblePreferredStockMember 2021-12-31 0001838987 us-gaap:WarrantMember 2020-12-31 0001838987 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2020-12-31 0001838987 cslr:SimpleAgreementForFutureEquityMember 2020-12-31 0001838987 us-gaap:WarrantMember 2021-12-31 0001838987 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2021-12-31 0001838987 cslr:SimpleAgreementForFutureEquityMember 2021-12-31 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember cslr:SeriesBWarrantsMember 2020-12-31 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember cslr:SeriesCWarrantsMember 2020-12-31 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember 2020-12-31 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember cslr:SeriesDTrancheAWarrantsMember 2020-12-31 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember cslr:SeriesDTrancheBWarrantsMember 2020-12-31 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember cslr:SeriesBWarrantsMember 2021-12-31 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember cslr:SeriesCWarrantsMember 2021-12-31 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember 2021-12-31 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember cslr:SeriesDTrancheAWarrantsMember 2021-12-31 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember cslr:SeriesDTrancheBWarrantsMember 2021-12-31 0001838987 cslr:TwoThousandNineteenConvertibleNotesMember 2020-12-31 0001838987 cslr:TwoThousandTwentyAConvertibleNotesMember 2020-12-31 0001838987 cslr:TwoThousandTwentyOneAConvertibleNotesMember 2020-12-31 0001838987 cslr:TwoThousandNineteenConvertibleNotesMember 2021-12-31 0001838987 cslr:TwoThousandTwentyAConvertibleNotesMember 2021-12-31 0001838987 cslr:TwoThousandTwentyOneAConvertibleNotesMember 2021-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:CommonStockMember 2022-06-30 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:RetainedEarningsUnappropriatedMember 2022-06-30 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0001838987 srt:ScenarioPreviouslyReportedMember 2022-06-30 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:RedeemableConvertiblePreferredStockMember 2022-06-30 iso4217:USD utr:Year xbrli:shares xbrli:pure iso4217:USD xbrli:shares cslr:SEGMENT cslr:CUSTOMER cslr:SUPPLIER utr:Y
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM
8-K
 
 
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 4, 2024
 
 
Complete Solaria, Inc.
(Exact name of registrant as specified in its charter)
 
 
 
Delaware
 
001-40117
 
93-2279786
(State or other jurisdiction
of incorporation)
 
(Commission
File Number)
 
(IRS Employer
Identification No.)
 
45700 Northport Loop East, Fremont, CA
 
94538
(Address of principal executive offices)
 
(Zip Code)
Registrant’s telephone number, including area code: (510)
270-2507
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
 
 
Check the appropriate box below if the Form
8-K
filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
Soliciting material pursuant to Rule
14a-12
under the Exchange Act (17 CFR
240.14a-12)
 
Pre-commencement
communications pursuant to Rule
14d-2(b)
under the Exchange Act (17 CFR
240.14d-2(b))
 
Pre-commencement
communications pursuant to Rule
13e-4(c)
under the Exchange Act (17 CFR
240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
 
Trading
Symbol(s)
 
Name of each exchange
on which registered
Common Stock, par value $0.0001 per share   CSLR   The Nasdaq Global Market
Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share   CSLRW   The Nasdaq Capital Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule
12b-2
of the Securities Exchange Act of 1934
(§240.12b-2
of this chapter).
Emerging growth company  
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  
 
 
 

Item 8.01
Other Events.
As previously disclosed on a Current Report on Form
8-K
filed with the Securities and Exchange Commission (the “
SEC
”), on July 24, 2023, Complete Solaria, Inc. (f/k/a Complete Solar Holding Corporation), a Delaware corporation (“
Legacy Complete Solaria
”), FACT Acquisition I Corp., a Cayman Islands exempted company (“
FACT
”), Jupiter Merger Sub I Corp., a Delaware corporation and wholly-owned subsidiary of FACT (“
First Merger Sub
”), Jupiter Merger Sub II LLC, a Delaware limited liability company and a wholly-owned subsidiary of FACT (“
Second Merger Sub
”) and The Solaria Corporation, a Delaware corporation and a wholly-owned indirect subsidiary of Complete Solaria (“
Solaria
”), consummated the closing of the transactions contemplated by that certain Amended and Restated Business Combination Agreement, dated as of May 26, 2023 (the transactions contemplated therein, the “
Business Combination Agreement
” and the “
Business Combination
”). Pursuant to the terms and subject to the conditions of the Business Combination, on July 18, 2023, (i) First Merger Sub merged with and into Legacy Complete Solaria with Legacy Complete Solaria surviving as a wholly-owned subsidiary of FACT (the “
First Merger
”), (ii) immediately thereafter and as part of the same overall transaction, Legacy Complete Solaria merged with and into Second Merger Sub, with Second Merger Sub surviving as a wholly-owned subsidiary of FACT (the “
Second Merger
”), and FACT changed its name to “Complete Solaria, Inc.” (the “
Company
”) and Second Merger Sub changed its name to “CS, LLC” and (iii) immediately after the consummation of the Second Merger and as part of the same overall transaction, Solaria merged with and into a newly formed Delaware limited liability company and wholly-owned subsidiary of FACT and changed its name to “SolarCA LLC” (“
Third Merger Sub
”), with Third Merger Sub (now renamed “SolarCA LLC” (“
SolarCA
”)) surviving as a wholly-owned subsidiary of the Company.
Pursuant to the Business Combination Agreement, the Business Combination was accounted for as a reverse recapitalization (the “
Reverse Recapitalization
”) in accordance with U.S. generally accepted accounting principles. Under this method of accounting, FACT was treated as the “acquired” company and Legacy Complete Solaria was treated as the acquirer for financial reporting purposes. The Reverse Recapitalization was treated as the equivalent of Legacy Complete Solaria issuing stock for the net assets of FACT, accompanied by a recapitalization.
Within the recast financial statements, the assets, liabilities and results of operations are those of Legacy Complete Solaria for all periods presented. Additionally, the equity structure has been retroactively restated for all prior periods to reflect the exchange ratio used to determine the number of shares of common stock, $0.0001 par value per share, issued to Legacy Complete Solaria stockholders in connection with the Business Combination. As such, the shares and corresponding capital amounts and earnings per share related to Legacy Complete Solaria common stock prior to Business Combination have been retroactively restated as shares reflecting the exchange ratio established in the Business Combination. All exercise prices for stock options and warrants have similarly been retroactively restated to reflect the exchange ratio established in the Business Combination.
As previously disclosed on a Current Report on Form
8-K
filed with the SEC on September 21, 2023, we and SolarCA LLC, on September 19, 2023, entered into an asset purchase agreement (the “
Agreement
”) with Maxeon Solar Technologies, Ltd., a Singapore public limited company (“
Maxeon
”). Pursuant to the Agreement, SolarCA sold, assigned and transferred its rights, title and interest in certain of the assets and contractual rights associated with the sale of photovoltaic cells and solar modules (the “
Business
”) and certain of SolarCA’s intellectual property including the patents, patent applications, trademarks, and domain names used in the Business (collectively, the “
Purchased Assets
”) to Maxeon, subject to the terms and conditions therein. On October 6, 2023, pursuant to the Agreement, the parties consummated the sale, thereby completing the disposition of the Purchased Assets. As consideration for the Purchased Assets, we received 1,100,000 Maxeon ordinary shares.
We are filing this Current Report on Form 8-K to recast our consolidated financial statements for the years ended December 31, 2021 and 2022 as previously incorporated by reference in our Current Report on Form 8-K filed with the Securities and Exchange Commission on July 24, 2023 to reflect the effects of the Reverse Recapitalization. In addition, the disposition of the Purchased Assets met the definition of a discontinued operation as of October 1, 2023. Accordingly, the assets and liabilities associated with these operations were classified as assets and liabilities of discontinued operations as of and for the year ended December 31, 2022 as set forth in our historical consolidated financial statements. Accordingly, we have recast our historical consolidated financial statements and accompanying management’s discussion and analysis of results of operations to reflect the disposition of the Purchased Assets as a discontinued operation. Attached to this Form 8-K are the following exhibits:
 
 
 
Exhibit 99.1: Recast Consolidated Financial Statements of Complete Solaria, Inc.
 
 
 
Exhibit 99.2: Management’s Discussion and Analysis of Results of Operations
 
 
 
Exhibit 99.3: Unaudited Pro Forma Condensed Combined Financial Information
The information included in Exhibits 99.1, 99.2 and 99.3 to this Current Report is presented in connection with the reporting changes described above. Except for the matter noted above, Exhibits 99.1, 99.2 and 99.3 to this Current Report do not reflect events occurring after we filed our Quarterly Report on Form
10-Q
for the period ended October 1, 2023 (the “
Third Quarter Form 10-Q
”). Information contained in Exhibits 99.1, 99.2 and 99.3 should be read in conjunction with and as a supplement to information contained in the Third Quarter Form
10-Q.
Exhibit 99.2 also contains information related to our quarter ended October 1, 2023 but does not amend or restate any portion of the Third Quarter Form 10-Q. For information on events occurring since the filing of the Third Quarter Form
10-Q,
please refer to our subsequent filings with the SEC.
In addition, attached as Exhibit 99.4 are the consolidated financial statements of The Solaria Corporation. There are no changes to such financial statements from those previously included in the final prospectus filed pursuant to Rule 424(b)(3) to that certain Registration Statement on Form S-4 (File No. 333-269674) by FACT on July 10, 2023.

Forward-Looking Statements
This Current Report on Form
8-K
contains forward-looking statements that involve risks and uncertainties. All statements, other than statements of present or historical fact included in or incorporated by reference in this Current Report on Form
8-K,
regarding the Company’s future financial performance, as well as the Company’s strategy, future operations, financial position, estimated revenues, and losses, projected costs, prospects, plans and objectives of management are forward-looking statements. When used herein, the words “potential,” “believe,” “expect,” “expects,” “expected,” “anticipate,” “may,” “will,” “enable,” “should,” “seek,” “approximately,” “intends,” “intended,” “plans,” “planned,” “planning,” “estimates,” “benefits,” or the negative of these words or other comparable terminology and similar expressions, as they relate to the Company or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information available to the Company as of the date of this Current Report on Form
8-K
and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s performance to differ materially from those expressed in, or implied by, these forward-looking statements. These risks and uncertainties include, among other things, risks related to the Company’s product development activities and ongoing commercial business operations; risks related to the Company’s ability and that of its business partners to implement development plans, launch plans, forecasts and other business expectations; risks related to unexpected variations in market growth and demand for the Company’s commercial and developmental products and technologies; risks related to the Company’s liquidity and its ability to maintain capital resources sufficient to conduct required clinical studies; the Company’s ability to retain its listing on the Nasdaq exchange; and risks relating to the Company’s ability to obtain regulatory approvals for its developmental product candidates. These forward-looking statements should be considered together with the risks and uncertainties that may affect the Company’s business and future results included in the Company’s filings with the SEC at www.sec.gov. These forward-looking statements are based on information currently available to the Company, and the Company assumes no obligation to update any forward-looking statements except as required by applicable law.
Item 9.01 – Financial Statements and Exhibits
(b) Pro Forma financial information.
The information set forth in Item 8.01 of this Current Report is incorporated herein by reference in its entirety.
(d) Exhibits.
 
Exhibit
Number
  
Description
99.1    Recast Consolidated Financial Statements of Complete Solaria, Inc.
99.2    Management’s Discussion and Analysis of Results of Operations.
99.3    Unaudited Pro Forma Condensed Combined Financial Information
99.4    Consolidated Financial Statements of The Solaria Corporation
104    Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
   
C
OMPLETE
S
OLARIA
, I
NC
.
Dated: January 4, 2024  
    By:  
/s/ Chris Lundell
      Chris Lundell
      Chief Executive Officer
EX-99.1 2 d474289dex991.htm EX-99.1 EX-99.1
21354546000000028445500.621000345050002074000130000.70.36.00.80.764
Exhibit 99.1
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Shareholders and the Board of Directors of Complete Solaria, Inc.
Opinion on the Financial Statements
We have audited the accompanying consolidated balance sheets of Complete Solaria, Inc. (formerly Complete Solar, Inc.) and subsidiaries (the “Company”) as of December 31, 2022 and 2021, the related consolidated statements of operations and comprehensive loss, redeemable convertible preferred stock and stockholders’ equity (deficit), and cash flows, for each of the three years in the period ended December 31, 2022, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2022, in conformity with accounting principles generally accepted in the United States of America.
Going Concern
The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1(c) to the financial statements, the Company has been incurring net losses, accumulated deficit, and cash outflows from operations that raise substantial doubt about its ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 1(c). The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Basis for Opinion
These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.
Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
/s/ Deloitte & Touche LLP
San Francisco, California
April 7, 2023 (December 22, 2023, as to the effects of the reverse recapitalization described in Note 3 and the divestiture described in Note 5)
We have served as the Company’s auditor since 2022.

COMPLETE SOLARIA, INC. AND SUBSIDIARIES
Consolidated Balance Sheets
(
in thousands except number of shares
)
 
    
As of December 31,
 
    
2022
   
2021
 
Assets
 
Current assets:
    
Cash and cash equivalents
   $ 4,409     $ 5,276  
Accounts receivable, net
     27,717       9,037  
Inventories
     13,059       4,409  
Prepaid expenses and other current assets
     10,071       4,955  
  
 
 
   
 
 
 
Total current assets
     55,256       23,677  
Long-term deposits
     —         70  
Restricted cash
     3,907       —    
Property and equipment, net
     3,476       1,758  
Operating lease
right-of-use
assets
     2,182       826  
Intangible assets, net
     —         72  
Other noncurrent assets
     1,330       —    
Long-term assets held for sale - discontinued operations
     162,032       —    
  
 
 
   
 
 
 
Total assets
   $ 228,183     $ 26,403  
  
 
 
   
 
 
 
Liabilities, redeemable convertible preferred stock and stockholders’ deficit
    
Current liabilities
    
Accounts payable
   $ 14,474     $ 5,190  
Accrued expenses and other current liabilities
     19,830       9,347  
SAFE agreements
     —         6,397  
Convertible notes, net
     —         1,890  
Convertible notes, net due to related parties
     —         6,820  
Notes payable, net
     20,403       9,507  
Deferred revenue
     5,407       3,852  
  
 
 
   
 
 
 
Total current liabilities
     60,114       43,003  
Warranty provision, noncurrent
     3,214       1,681  
Warrant liability
     14,152       1,129  
Derivative liability
     —         1,481  
Long-term debt with CS Solis
     25,204       —    
Convertible notes, net, noncurrent
     3,434       —    
Convertible notes, net due to related parties, noncurrent
     15,510       —    
Operating lease liabilities, net of current portion
     1,274       499  
  
 
 
   
 
 
 
Total liabilities
     122,902       47,793  
  
 
 
   
 
 
 
Commitments and contingencies (Note 17)
    
Stockholders’ equity (deficit):
    
Common stock, $0.0001 par value. Authorized 28,978,185 and 13,547,943 shares as of
    
December 31, 2022 and 2
0
21, respectively; issued and outstanding 19,932,429 and 9,806,143 shares as of December 31, 2022 and 2021, respectively
     3       1  
Additional
paid-in
capital
     190,624       34,504  
Accumulated other comprehensive income
     27       —    
Accumulated deficit
     (85,373     (55,896
  
 
 
   
 
 
 
Total stockholders’ equity (deficit)
     105,281       (21,390
  
 
 
   
 
 
 
Total liabilities and stockholders’ deficit
   $ 228,183     $ 26,403  
  
 
 
   
 
 
 
The accompanying notes are an integral part of these consolidated financial statements.

COMPLETE SOLARIA, INC. AND SUBSIDIARIES
Consolidated Statements of Operations and Comprehensive Loss
(
in thousands except number of shares
)
 
    
For the Years Ended

December 31,
 
    
2022
   
2021
   
2020
 
Revenues
   $ 66,475     $ 68,816     $ 29,378  
Cost of revenues
     46,647       40,123       17,097  
  
 
 
   
 
 
   
 
 
 
Gross profit
     19,828       28,693       12,281  
Operating expenses:
      
Sales commissions
     21,195       25,061       10,410  
Sales and marketing
     6,156       5,179       3,185  
General and administrative
     13,634       5,780       3,801  
  
 
 
   
 
 
   
 
 
 
Operating expenses
     40,985       36,020       17,396  
  
 
 
   
 
 
   
 
 
 
Loss from operations
     (21,157     (7,327     (5,115
Interest expense
1
     (4,986     (1,712     (523
Interest income
     5       —         —    
Other income (expense), net
2
     (1,858     (240     (41
  
 
 
   
 
 
   
 
 
 
Loss from continuing operations before income taxes
     (27,996     (9,279     (5,679
Income tax provision
     (27     (3     (3
  
 
 
   
 
 
   
 
 
 
Net loss from continuing operations
   $ (28,023   $ (9,282   $ (5,682
Loss on discontinued operations, net of tax
     (1,454     —         —    
  
 
 
   
 
 
   
 
 
 
Net loss
   $ (29,477   $ (9,282   $ (5,682
  
 
 
   
 
 
   
 
 
 
Comprehensive income (loss):
      
Foreign currency translation adjustment
     27       —         —    
  
 
 
   
 
 
   
 
 
 
Comprehensive loss (net of tax)
   $ (29,450   $ (9,282   $ (5,682
  
 
 
   
 
 
   
 
 
 
Net loss from continuing operations per share attributable to common stockholders, basic and diluted
   $ (1.24   $ (0.77   $ (0.58
  
 
 
   
 
 
   
 
 
 
Net loss from discontinued operations per share attributable to common stockholders, basic and diluted
   $ (0.07)     $ —       $ —    
  
 
 
   
 
 
   
 
 
 
Net loss per share attributable to common stockholders, basic and diluted
   $ (1.31)     $ (0.77   $ (0.58
  
 
 
   
 
 
   
 
 
 
Weighted-average shares used to compute net loss per share attributable to common stockholders’, basic and diluted
     22,524,400       11,990,015       9,760,018  
  
 
 
   
 
 
   
 
 
 
 
1.
Includes interest expense to related parties of $0.3 million, $0.7 million and $0.2 million during the years ended December 31, 2022, 2021 and 2020, respectively.
2.
Other income (expense), net includes other income from related parties of $1.4 million, zero and zero during the years ended December 31, 2022, 2021 and 2020, respectively.
The accompanying notes are an integral part of these consolidated financial statements.
COMPLETE SOLARIA, INC. AND SUBSIDIARIES
Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders’ Equity (Deficit)
(
in thousands except number of shares
)
 
   
Redeemable Convertible

Preferred Stock
   
Common Stock
   
Additional

Paid-in-Capital
   
Accumulated

Deficit
   
Accumulated

Other
Comprehensive
Income
   
Total

Stockholders’

Equity (Deficit)
 
   
Shares
   
Amount
   
Shares
   
Amount
 
Balance at January
 1, 2020
    13,090,720     $ 22,788       1,103,289     $        $ 180     $ (40,932   $        $ (40,752
Retroactive application of recapitalization (Note 3)
    (13,090,720     (22,788     5,751,955       2       22,786                         22,788  
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Balance at January 1, 2020, as adjusted
                      6,855,244       2       22,966       (40,932              (17,964
Issuances of Series
C-1
redeemable convertible preferred Stock upon conversion of
2017-A
convertible note and 2019 SAFE
    2,800,283       7,419       —         —         —         —         —         —    
Issuance of Series C redeemable convertible preferred stock upon conversion of convertible notes
    2,322,150       3,661       —         —         —         —         —         —    
Conversion of redeemable convertible preferred stock to common stock
    (1,648,783     (2,330     1,648,783                2,330                         2,330  
Issuance of common stock warrant
    —         (137     —                  137                         137  
Exercise of common stock options
                      942,500                84                         84  
Stock-based compensation
    —                  —                  109                         109  
Net loss
    —                  —                           (5,682              (5,682
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Balance as of December 31, 2020, as previously reported
    3,473,650       8,613       2,591,893                2,660       (5,682              (3,022
Retroactive application of recapitalization (Note 3)
    (3,473,650     (8,613     2,929,165                8,613                         8,613  
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Balance as of December 31, 2020
 
 
  
 
 
$
  
 
 
 
9,784,409
 
 
$
2
 
 
$
34,239
 
 
$
(46,614
 
$
  
 
 
$
(12,373
Issuance of common stock upon asset acquisition of assembled workforce
                      30,000                17                         17  
Issuance of common stock warrant
    —                  —                  42                         42  
Exercise of common stock options
                      15,000                6                         6  
Stock-based compensation
    —                  —                  200                         200  
Net loss
    —                  —                           (9,282              (9,282
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Balance as of December 31, 2021, as previously reported
                      45,000                265       (9,282              (9,017
Retroactive application of recapitalization (Note 3)
                      21,734                                               
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Balance as of December 31, 2021
 
 
  
 
 
$
  
 
 
 
9,806,143
 
 
$
2
 
 
$
34,504
 
 
$
(55,896
 
$
   
 
 
$
(21,390
Issuance of Series
D-1,
D-2,
and
D-3
redeemable convertible preferred stock upon conversion of convertible notes and SAFEs
1
    2,771,551       11,558                                                        
Issuance of Series
D-4,
D-5,
D-6
and
D-7
redeemable convertible preferred stock upon acquisition
2
    6,803,550       52,201       —         —         —         —         —         —    
Issuance of Series
D-8
redeemable convertible preferred stock upon conversion of SAFE
3
    8,171,662       60,470       —         —         —         —         —         —    
Issuance of common stock in connection with business combination
                      2,884,550                27,295                         27,295  
Issuance of common stock warrants
    —                  —                  3,589                         3,589  
Exercise of common stock options
                      335,496                105                         105  
Stock-based compensation
    —                  —                  903                         903  
Net loss
    —                  —                           (29,477              (29,477
Foreign currency translation adjustment
    —                  —                                    27       27  
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Balance as of December 31, 2022, as previously reported
    17,746,763       124,229       3,220,046                31,892       (29,477     27       27  
Retroactive application of recapitalization (Note 3)
    (17,746,763     (124,299     10,126,286       1       124,228                             
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Balance as of December 31, 2022
 
 
  
 
 
$
  
 
 
 
19,932,429
 
 
$
3
 
 
$
190,624
 
 
$
(85,373
 
$
27
 
 
$
105,281
 
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
 
(1)
Includes 1,315,287 shares of Series
D-1
redeemable convertible preferred stock with a carrying value of $6.3 million, issued to related parties.
(2)
Includes 2,007,556 shares of Series
D-4
redeemable convertible preferred stock with a carrying value of $14.3 million, 127,472 shares of Series
D-5
redeemable convertible preferred stock with a carrying value of $1.0 million, and 3,105,837 shares of Series
D-7
redeemable convertible preferred stock with a carrying value of $24.9 million, respectively, issued to related parties.
(3)
Includes 4,426,320 shares of Series
D-8
redeemable convertible preferred stock with a carrying value of $32.8 million issued to related parties.
The accompanying notes are an integral part of these consolidated financial statements.
COMPLETE SOLARIA, INC. AND SUBSIDIARIES
Consolidated Statements of Cash Flows
(
in thousands except number of shares
)
 
    
For the Years Ended

December 31,
 
    
2022
   
2021
   
2020
 
Cash flows from operating activities
      
Net loss
   $ (29,477   $ (9,282   $ (5,682
Less: Net loss from discontinued operations, net of tax
   $ (1,454   $ —       $ —    
  
 
 
   
 
 
   
 
 
 
Net loss from continuing operations, net of tax
   $ (28,023   $ (9,282   $ (5,682
Adjustments to reconcile net loss to net cash used in operating activities:
      
Non-cash
interest expense
(1)
     4,810       1,330       462  
Gain on extinguishment of convertible notes and SAFEs
(2)
     (3,235     —         —    
Stock-based compensation expense
     433       200       109  
Provision for doubtful accounts
     2,074       364       337  
Change in reserve for excess and obsolete inventory
     3,631       798       100  
Depreciation and amortization
     648       463       298  
Change in fair value of warrant liability
     5,211       330       (24
Change in fair value of derivative liability
     —         336       50  
Change in fair value of convertible notes
     —         1,306       15  
Forgiveness of Paycheck Protection Plan loans
     —         (1,754     —    
Non-cash
lease expense
     468       334       —    
Changes in operating assets and liabilities:
      
Accounts receivable, net
     (9,683     (4,789     (2,044
Inventories
     (4,953     (3,047     (1,315
Prepaid expenses and other current assets
     1,600       (3,038     (930
Long-term deposits
     (15     19       (29
Other noncurrent assets
     (1,132     —         —    
Accounts payable
     3,252       3,009       (1,062
Accrued expenses and other current liabilities
     (1,154     2,946       2,472  
Operating lease
right-of-use
assets and lease liabilities
     (617     (409     —    
Warranty provision, noncurrent
     157       526       (484
Deferred revenue
     1,311       (637     1,521  
Deferred rent
     —         —         17  
  
 
 
   
 
 
   
 
 
 
Net cash used in operating activities from continuing operations
     (25,217     (10,995     (6,189
  
 
 
   
 
 
   
 
 
 
Net cash used in operating activities from discontinued operations
     (6,296     —         —    
  
 
 
   
 
 
   
 
 
 
Net cash used in operating activities
     (31,513     (10,995     (6,189
  
 
 
   
 
 
   
 
 
 
Cash flows from investing activities
      
Purchase of property and equipment
     —         (9     (61
Capitalization of
internal-use
software costs
     (1,513     (1,054     (523
Payments for acquisition of business, net of cash acquired
     4,848       —         —    
  
 
 
   
 
 
   
 
 
 
Net cash provided by (used in) investing activities from continuing operations
     3,335       (1,063     (584
  
 
 
   
 
 
   
 
 
 
Cash flows from financing activities
      
Proceeds from exercise of common stock options
     128       6       84  
Proceeds from issuance of convertible notes, net, noncurrent
     3,400       1,150       510  
Proceeds from issuance of convertible notes to related parties, net, noncurrent
     8,600       3,600       3,274  
Proceeds from issuance of SAFE agreements
     —         5,000       —    
Proceeds from issuance of notes payable, net
     5,501       7,239       3,987  
Payments for issuance costs of Series
D-1,
D-2
and
D-3
redeemable convertible preferred stock
     (1,431     —         —    
Proceeds from issuance of long-term debt with CS Solis, net of issuance costs
     25,000       —         —    
Principal repayment of notes payable
     (9,507     —         —    
Principal repayment of convertible notes
     —         (100     (1,500
Repayment of convertible notes to related parties
     (500     —         —    
  
 
 
   
 
 
   
 
 
 
Net cash provided by financing activities from continuing operations
     31,191       16,895       6,355  
  
 
 
   
 
 
   
 
 
 

    
For the Years Ended

December 31,
 
    
2022
    
2021
    
2020
 
Effect of exchange rate changes
     27        —          —    
  
 
 
    
 
 
    
 
 
 
Net increase (decrease) in cash, cash equivalents and restricted cash
     3,040        4,837        (418
Cash, cash equivalents and restricted cash at beginning of period
     5,276        439        857  
  
 
 
    
 
 
    
 
 
 
Cash, cash equivalents and restricted cash at end of period
   $ 8,316      $ 5,276      $ 439  
  
 
 
    
 
 
    
 
 
 
Supplemental disclosures of cash flow information:
        
Cash paid during the year for income taxes
     6          —          —    
Cash paid during the year for interest
     162        365        150  
Supplemental schedule of noncash investing and financing activities:
        
Issuance of common stock warrants
     3,589        42        137  
Issuance of Series C redeemable convertible preferred stock upon conversion of convertible
debt
     —          —          1,330  
Issuance of Series
C-1
redeemable convertible preferred stock upon conversion of convertible debt
     —          —          7,420  
Fair value of debt derivative liabilities related to issuance of convertible notes
     —          1,754        —    
Common stock issued in asset purchase
     —          17        —    
Notes payable issued in asset purchase
     —          120        —    
Operating lease
right-of-use
assets obtained in exchange for new operating lease liabilities
     245        1,157        —    
Issuance of Series
D-1,
D-2
and
D-3
redeemable convertible preferred stock upon conversion of convertible debt, net of issuance costs of $1,431
     11,558        —          —    
Acquisition of business through issuance of common stock and stock options
     27,295        —          —    
Acquisition of business through issuance of Series D redeemable convertible preferred stock
     52,201        —          —    
Acquisition of business through issuance of Series D redeemable convertible preferred stock warrants
     7,812        —          —    
Issuance of Series D redeemable convertible preferred stock upon conversion of SAFE
     60,470        —          —    
 
1.
Non-cash
interest expense to related parties of $0.3 million, $0.7 million and $0.2 million during the years ended December 31, 2022, 2021 and 2020, respectively.
2.
Gain on extinguishment of convertible notes and SAFEs includes other income from related parties of $1.4 million, zero and zero during the years ended December 31, 2022, 2021 and 2020, respectively.
The accompanying notes are an integral part of these consolidated financial statements.

COMPLETE SOLARIA, INC. AND SUBSIDIARIES
Notes to Financial Statements
 
(1)
Organization
 
(a)
Description of Business
Complete Solaria, Inc. (the “Company” or “Complete Solaria”) is a residential solar installer headquartered in Fremont, California, which was formed through Complete Solar Holding Corporation’s acquisition of The Solaria Corporation (“Solaria).
Complete Solar, Inc. (“Complete Solar”) was incorporated in Delaware on February 22, 2010. Through February 2022, the Company operated as a single legal entity as Complete Solar, Inc. In February 2022, the Company implemented a holding company reorganization (the “Reorganization”) in which the Company created and incorporated Complete Solar Holding Corporation (“Complete Solar Holdings”). As a result of the Reorganization, Complete Solar Holdings became the successor entity to Complete Solar, Inc. The capitalization structure was not changed because of the Reorganization as all shares of Complete Solar, Inc common stock and preferred stock were exchanged on a one for one basis with shares of Complete Solar Holdings common stock and preferred stock. The Reorganization was accounted for as a change in reporting entity for entities under common control. The historical assets and liabilities of Complete Solar, Inc. are transferred to Complete Solar Holdings at their carrying value, and there is no change to net income, other comprehensive income, or any related per share amounts reported in the consolidated financial statements requiring retrospective application.
In October 2022, the Company entered into a business combination agreement, as amended on December 26, 2022 and January 17, 2023 (“Original Business Combination Agreement”) and as amended on May 26, 2023 (“Amended and Restated Business Combination Agreement”), with Jupiter Merger Sub I Corp., a Delaware corporation and a wholly owned subsidiary of Freedom Acquisition I Corp. (“FACT”) (“First Merger Sub”), Jupiter Merger Sub II LLC, a Delaware limited liability company and a wholly owned subsidiary of FACT (“Second Merger Sub”), Complete Solar Holding Corporation, a Delaware corporation, and Solaria, a Delaware corporation.
The transactions contemplated by the Amended and Restated Business Combination Agreement were consummated on July 18, 2023 (“Closing Date”). Following the consummation of the Merger on the Closing Date, FACT changed its name to “Complete Solaria, Inc.”
As part of the transactions contemplated by the Amended and Restated Business Combination Agreement, FACT affected a deregistration under the Cayman Islands Companies Act and a domestication under Section 388 of the Delaware’s General Corporation Law (the “DGCL” or “Domestication”). On the Closing Date, following the Domestication, First Merger Sub merged with and into Complete Solaria, with Complete Solaria surviving such merger as a wholly owned subsidiary of FACT (the “First Merger”), and immediately following the First Merger, Complete Solaria merged with and into Second Merger Sub, with Second Merger Sub surviving as a wholly owned subsidiary of FACT (the “Second Merger”), and Second Merger Sub changed its name to CS, LLC, and immediately following the Second Merger, Solaria merged with and into a newly formed Delaware limited liability company and wholly-owned subsidiary of FACT and changed its name to The Solaria Corporation LLC (“Third Merger Sub”), with Third Merger Sub surviving as a wholly-owned subsidiary of FACT (the “Additional Merger”, and together with the First Merger and the Second Merger, the “Mergers”).
In connection with the closing of the Mergers:
 
   
Each share of the Company’s capital stock, inclusive of shares converted from 2022 Convertible Notes, issued and outstanding immediately prior to the Closing (“Legacy Complete Solaria Capital Stock”) were cancelled and exchanged into an aggregate of 25,494,332 shares of Complete Solaria Common Stock.
 
   
In July 2023, (i) Meteora Special Opportunity Fund I, LP (“MSOF”), Meteora Capital Partners, LP (“MCP”) and Meteora Select Trading Opportunities Master, LP (“MSTO”) (with MSOF, MCP, and

 
MSTO collectively as “Meteora”); (ii) Polar Multi-Strategy Master Fund (“Polar”), and (iii) Diametric True Alpha Market Neutral Master Fund, LP, Diametric True Alpha Enhanced Market Neutral Master Fund, LP, and Pinebridge Partners Master Fund, LP (collectively, “Sandia”) (together, the “FPA Funding PIPE Investors”) entered into separate subscription agreements (the “FPA Funding Amount PIPE Subscription Agreements”) pursuant to which, the FPA Funding PIPE Investors subscribed for on the Closing Date, an aggregate of 6,300,000 shares of FACT Class A Ordinary Shares, less, in the case of Meteora, 1,161,512 FACT Class A Ordinary Shares purchased by Meteora separately from third parties through a broker in the open market (“Recycled Shares”) in connection with the Forward Purchase Agreements (“FPAs”). Subsequent to the Closing Date, Complete Solaria entered into an additional FPA Funding PIPE Subscription Agreement with Meteora, to subscribe for and purchase, and Complete Solaria agreed to issue and sell, an aggregate of 420,000 shares of Complete Solaria Common Stock. The Company issued shares of Complete Solaria Common Stock underlying the FPAs as of the latter of the closing of the Mergers or execution of the FPAs.
 
   
All certain investors (the “PIPE Investors”) purchased from the Company an aggregate of 1,570,000 shares of Complete Solaria Common Stock (the “PIPE Shares”) for a purchase price of $10.00 per share, for aggregate gross proceeds of $15.7 million (the “PIPE Financing”), including $3.5 million that was funded prior to the Closing Date, pursuant to subscription agreements (the “Subscription Agreements”). At the time of the PIPE Financing, Complete Solaria issued an additional 60,000 shares to certain investors as an incentive to participate in the PIPE Financing.
 
   
On or around the Closing Date, pursuant to the New Money PIPE Subscription Agreements, certain investors affiliated with the New Money PIPE Subscription Agreements (“New Money PIPE Investors”) agreed to subscribe for and purchase, and Complete Solaria agreed to issue and sell to the New Money PIPE Investors an aggregate of 120,000 shares of Complete Solaria Common Stock for a purchase price of $5.00 per share, for aggregate gross proceeds of $0.6 million. Pursuant to its New Money PIPE Subscription Agreement, Complete Solaria issued an additional 60,000 shares of Complete Solaria Common Stock in consideration of certain services provided by it in the structuring of its FPA and the transactions described therein.
 
   
Subsequent to the Closing, Complete Solaria issued an additional 193,976 shares of Complete Solaria Common Stock to the sponsors for reimbursing sponsors’ transfer to certain counterparties and issued an additional 150,000 shares of Complete Solaria Common Stock to an FPA investor for services provided in connection with the Mergers.
 
   
In March 2023, holders of 23,256,504 of the originally issued 34,500,000 FACT Class A Ordinary shares exercised their rights to redeem those shares for cash, and immediately prior to the Closing there were 11,243,496 FACT Class A Ordinary Shares that remained outstanding. At the Closing, holders of 7,784,739 shares of Class A common stock of FACT exercised their rights to redeem those shares for cash, for an aggregate of approximately $82.2 million which was paid to such holders at Closing. The remaining FACT Class A Ordinary Share converted, on a one-for-one basis, into one share of Complete Solaria Common Stock.
 
   
Each issued and outstanding FACT Class B Ordinary Share converted, on a one-for-one basis, into one share of Complete Solaria Common Stock.
In November 2022, Complete Solar Holdings acquired Solaria (as described in Note 4 – Business Combination) and changed its name to Complete Solaria, Inc. On August 18, 2023, the Company entered into a Non-Binding Letter of Intent to sell certain of Complete Solaria’s North American solar panel assets to Maxeon, Inc. (“Maxeon”). In October 2023, the Company completed the sale of its solar panel business to Maxeon. The disposition met the criteria for held for sale and discontinued operations classification. Refer to Note 1(b) – Divestiture and Note 5 – Divestiture.
 
(b)
Divestiture
On August 18, 2023, the Company entered into a Non-Binding Letter of Intent to sell certain of Complete
Solaria’s North American solar panel assets to Maxeon. Subsequent to the execution of the Non-Binding Letter of Intent, on September 20, 2023, the Company and Maxeon entered into an Asset Purchase Agreement (the “Disposal Agreement”) for the sale of certain assets, inclusive of certain intellectual property and customer contracts, to Maxeon. On October 6, 2023, the Company completed the sale of certain of Complete Solaria’s North American solar panel assets, inclusive of certain intellectual property and customer contracts, to Maxeon, pursuant to the terms of the Disposal Agreement. Under the terms of the Disposal Agreement, Maxeon agreed to acquire certain assets and employees of Complete Solaria, for an aggregate purchase price consisting of 1,100,000 shares of Maxeon common stock.
This divestiture represents a strategic shift in Complete Solaria’s business and qualifies as held for sale and as a discontinued operation. As a result, the Company classified the results of its solar panel business in discontinued operations in its consolidated statements of operations and comprehensive income (loss) for all periods presented. The cash flows related to discontinued operations have been segregated and are included in the consolidated statements of cash flows for all periods presented. Unless otherwise noted, discussion within the notes to the consolidated financial statements relates to continuing operations only and excludes the historical activities of the North American panel business. See Note 5 – Divestiture for additional information.
 
(c)
Liquidity and Going Concern
Since inception, the Company has incurred recurring losses and negative cash flows from operations. The Company incurred net losses of $29.5 million, $9.2 million and $5.6 million during the years ended December 31, 2022, 2021 and 2020, respectively, and had an accumulated deficit of $85.4 million as of December 31, 2022. The Company had cash and cash equivalents of $4.4 million as of December 31, 2022. Historically, the Company’s activities have been financed through private placements of equity securities and debt. The Company expects to incur significant operating expenses as it continues to grow its business. The Company believes that its operating losses and negative operating cash flows will continue into the foreseeable future. The Company’s history of recurring losses, negative operating cash flows since inception and the need to raise additional funding to meet its obligations and finance its operations raise substantial doubt about the Company’s ability to continue as a going concern. The Company’s ability to continue as a going concern requires that the Company obtains sufficient funding to meet its obligations and finance its operations. These actions could materially impact the Company’s business, results of operations and future prospects. While the Company has been able to raise multiple rounds of financing, there can be no assurance that in the event the Company requires additional financing, such financing will be available on terms that are favorable, or at all. Failure to generate sufficient cash flows from operations, raise additional capital or reduce certain discretionary spending would have a material adverse effect on the Company’s ability to achieve its intended business objectives.
Therefore, there is substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the financial statements are issued. The accompanying financial statements have been prepared assuming the Company will continue to operate as a going concern, which contemplates the realization of assets and settlement of liabilities in the normal course of business. They do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from uncertainty related to its ability to continue as a going concern.
 
(d)
Basis of Presentation
The financial statements and accompanying notes have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.

(2)
Summary of Significant Accounting Policies
 
(a)
Use of Estimates
The
preparation
of the Company’s financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses, as well as related disclosure of contingent assets and liabilities. Significant estimates and assumptions made by management include, but are not limited to, the determination of:
 
   
The allocation of the transaction price to identified performance obligations;
 
   
Fair value of warrant liabilities;
 
   
The fair value of assets acquired and liabilities assumed for business combination;
 
   
The reserve methodology for inventory obsolescence;
 
   
The reserve methodology for product warranty;
To the extent that there are material differences between these estimates and actual results, the Company’s financial condition or operating results will be affected. The Company bases its estimates on past experience and other assumptions that the Company believes are reasonable under the circumstances, and the Company evaluates these estimates on an ongoing basis. The Company has assessed the impact and are not aware of any specific events or circumstances that required an update to the Company’s estimates and assumptions or materially affected the carrying value of the Company’s assets or liabilities as of the date of issuance of this report. These estimates may change as new events occur and additional information is obtained.
 
(b)
Supply Chain Constraints and Risk;
COVID-19
The Company relies on a very small number of suppliers of solar energy systems and other equipment. If any of Company’s suppliers was unable or unwilling to provide the Company with contracted quantities in a timely manner at prices, quality levels and volumes acceptable to the Company, the Company would have very limited alternatives for supply, and the Company may not be able find suitable replacements for the Company’s customers, or at all. Such an event could materially adversely affect the Company’s business, prospects, financial condition and results of operations.
The ongoing
COVID-19
pandemic has resulted and may continue to result in widespread adverse effects on the global and U.S. economies. Ongoing government and business responses to
COVID-19,
along with
COVID-19
variants and the resurgence of related disruptions, could have a continued material adverse impact on economic and market conditions and trigger a period of continued global and U.S. economic slowdown.
In addition, the global supply chain and the Company’s industry have experienced significant disruptions in recent periods. The Company have seen supply chain challenges and logistics constraints increase, including shortages of panels, inverters, batteries and associated component parts for inverters and solar energy systems available for purchase. In certain cases, this has caused delays in critical equipment and inventory, longer lead times, and has resulted in cost volatility. These shortages and delays can be attributed in part to the
COVID-19
pandemic and resulting government action, broader macroeconomic conditions, and have been exacerbated by the ongoing conflict in Russia and Ukraine. While the Company believes that a majority of the Company’s suppliers have secured sufficient supply to permit them to continue delivery and installations through the end of 2023, if these shortages and delays persist into 2024, they could adversely affect the timing of when battery energy storage systems can be delivered and installed, and when (or if) the Company can begin to generate revenue from those systems. In addition, the Company has experienced and is experiencing varying levels of volatility in costs of equipment and labor resulting in part from disruptions caused by general global economic conditions, including inflationary pressures and the
COVID-19
pandemic.

The Company cannot predict the full effects these events will have on the Company’s business, cash flows, liquidity, financial condition and results of operations at this time due to numerous uncertainties. In the event the Company is unable to mitigate the impact of delays or price volatility in solar energy systems, raw materials, and freight, it could materially adversely affect the Company’s business, prospects, financial condition and results of operations. For additional information on risk factors that could impact the Company’s results, please refer to “Risk
Factors
” located elsewhere in this prospectus.
 
(c)
Segment Information
The Company conducts its business in one operating segment that provides custom solar solutions through a standardized platform to its residential solar providers and companies to facilitate the sale and installation of solar energy systems under a single product group. The Company’s Chief Executive Officer (“CEO”) is the Chief Operating Decision Maker (“CODM”). The CODM allocates resources and makes operating decisions based on financial information presented on a consolidated basis. The profitability of the Company’s product group is not a determining factor in allocating resources and the CODM does not evaluate profitability below the level of the consolidated company. All the Company’s long-lived assets are maintained in the United States of America. Disaggregated revenue by primary geographical market for the Company’s single segment is included in the discussion of revenue recognition within this Note 2, below.
 
(d)
Concentration of Risks
Concentration of credit risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. The Company’s cash and cash equivalents are on deposit with major financial institutions. Such deposits may be in excess of insured limits. The Company believes that the financial institutions that hold the Company’s cash are financially sound, and accordingly, minimum credit risk exists with respect to these balances. The Company has not experienced any losses due to institutional failure or bankruptcy. The Company performs credit evaluations of its customers and generally does not require collateral for sales on credit. The Company reviews accounts receivable balances to determine if any receivables will potentially be uncollectible and includes any amounts that are determined to be uncollectible in the allowance for doubtful accounts. As of December 31, 2022, three single customers had outstanding balances that represented 27%, 18%, and 14%, respectively, of the total accounts receivable balance, compared to December 31, 2021, as a single customer had an outstanding balance that represented 50%, of the total accounts receivable balance.
Concentration of customers
The Company defines major customers as those customers who generate revenues that exceed 10% of the Company’s annual net revenues. For the years ended December 31, 2022, 2021 and 2020, one customer represented 47%, 63% and 81% of gross revenues, respectively.
Concentration of suppliers
For the year ended December 31, 2022, three suppliers represented 74% of the Company’s inventory purchases. For the year ended December 31, 2021, four supplier represented 87% of the Company’s inventory purchases. For the year ended December 31, 2020, two suppliers represented 89% of the Company’s inventory purchases.
 
(e)
Cash and Cash Equivalents
The
Company considers all highly liquid securities that mature within three months or less from the original date of purchase to be cash equivalents. The Company maintains the majority of its cash balances with

commercial banks in interest bearing accounts. Cash and cash equivalents include cash held in checking and savings accounts and money market accounts consisting of highly liquid securities with original maturity dates of three months or less from the original date of purchase.
 
(f)
Restricted Cash
The Company classifies all cash for which usage is limited by contractual provisions as restricted cash. Restricted cash balance as of December 31, 2022 and 2021, was $3.9 million, and zero, respectively. The restricted cash consists of deposits in money market accounts, which is used as cash collateral backing letters of credit related to customs duty authorities’ requirements. The Company has presented these balances under restricted cash, as a long term asset, in the consolidated balance sheets.
Total cash, cash equivalents and restricted cash is presented in the table below (in thousands):
 
    
As of December 31,
 
    
2022
    
2021
 
Cash and cash equivalents
   $ 4,409      $ 5,276  
Restricted cash
     3,907            
  
 
 
    
 
 
 
Total cash, cash equivalents and restricted cash
   $ 8,316      $ 5,276  
  
 
 
    
 
 
 
 
(g)
Accounts Receivable, Net
Accounts receivable are recorded at the invoiced amount and do not bear interest. The Company maintains an allowance for doubtful accounts for estimated losses inherent in its accounts receivable portfolio. In establishing the required allowance, management considers historical losses adjusted to take into account current market conditions and customers’ financial condition, the amount of receivables in dispute, the current receivables aging and customer payment patterns. Account balances are written off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. Recoveries of accounts receivable previously written off are recorded when received.
The following table summarizes the allowance for doubtful accounts as of December 31, 2022, 2021, and 2020 (in thousands):
 
    
As of December 31,
 
    
2022
    
2021
    
2020
 
Balance at beginning of period
   $ (2,569    $ (2,288    $ (1,965
Provision charged to earnings
     (2,243      (364      (337
Amounts written off, recoveries and other adjustments
               83        14  
  
 
 
    
 
 
    
 
 
 
Balance at end of period
   $ (4,812    $ (2,569    $ (2,288
  
 
 
    
 
 
    
 
 
 
The Company does
not
have any
off-balance
sheet credit exposure related to its customers.
 
(h)
Inventories
Inventories consists of solar panels and the components of solar energy systems which the Company classifies as finished goods. Costs are computed under the average cost method. The Company identifies inventory which is considered obsolete or in excess of anticipated demand based on a consideration of marketability and product life cycle stage, component cost trends, demand forecasts, historical revenues, and assumptions about future demand and market conditions to state inventory at the lower of cost or net realizable value.

(i)
Revenue Recognition
Revenue is recognized when a customer obtains control of promised products and services and the Company has satisfied its performance obligations. The amount of revenue recognized reflects the consideration which the Company expects to be entitled to receive in exchange for the products and services. To achieve this core principle, the Company applies the following five steps:
Step 1. Identification of the contract(s) with a customer;
Step 2. Identification of the performance obligations in the contracts(s);
Step 3. Determination of the transaction price;
Step 4. Allocation of the transaction price to the performance obligations;
Step 5. Recognition of the revenue when, or as, the Company satisfies a performance obligation.
Service Revenues – Solar Energy System Installations
The Company generates revenue primarily from the design and installation of a solar energy system and performing post-installation services. The Company’s contracts with customers include three primary contract types:
 
   
Cash agreements
– The Company contracts directly with homeowners who purchase the solar energy system and related services from the Company. Customers are invoiced on a billing schedule, where the majority of the transaction price is due upon installation with an additional payment due when the system passes inspection by the authority having jurisdiction.
 
   
Financing partner agreements
– In its financing partner agreements, the Company contracts directly with homeowners for the purchase of the solar energy system and related services. The Company refers the homeowner to a financing partner to finance the system, and the homeowner makes payments directly to the financing partner. The Company receives consideration from the financing partner on a billing schedule where the majority of the transaction price is due upon installation with an additional payment due when the system passes inspection by the authority having jurisdiction.
 
   
Power purchase agreements
– The Company contracts directly with a distribution partner to perform the solar energy system installation, and the homeowner will finance the system through a power purchase agreement, which is signed with the Company’s distribution partner. The Company considers the distribution partner to be its customer, as the Company does not contract directly with the homeowner. The Company receives consideration from the distribution partner on a billing schedule where the majority of the transaction price is due upon installation with an additional payment due when the system passes inspection by the authority having jurisdiction.
In each of the Company’s customer contract types, the Company’s revenue consists of two performance obligations, which include the performance of the installation of the solar energy system and post-installation services.
Installation includes the design of a solar energy system, the delivery of the components of the solar energy system (i.e., photovoltaic system, inverter, battery storage, etc.), installation services and services facilitating the connection of the solar energy system to the power grid. The Company accounts for these services as inputs to a combined output, resulting in a single service-based performance obligation. The Company recognizes revenue upon the completion of installation services, which occurs upon the transfer of control of the solar energy system and title of the related hardware components to the homeowner or distribution partner.
Post-installation services consist primarily of administrative services and customer support, which the Company performs between the completion of installation and the date of inspection of the solar energy system by the authority having jurisdiction. The Company recognizes revenue at a point in time, which is when the inspection occurs.

As the Company’s contracts with customers contain multiple performance obligations, the transaction price is allocated to each performance obligation based on its standalone selling price. The Company generally determines the standalone selling price based on the estimated costs incurred in the delivery of each performance obligation, relative to the total costs to be incurred under the contract.
The Company records deferred revenue for amounts invoiced that are not subject to refund upon termination. In certain contracts with customers, the Company arranges for a third-party financing partner to provide financing to the customer. The Company collects upfront from the financing partner and the customer will provide installment payments to the financing partner. The Company records revenue in the amount received from the financing partner, net of any financing fees charged to the homeowner, which the Company considers to be a customer incentive. None of the Company’s contracts contain a significant financing component.
The Company guarantees to customers certain specified minimum solar energy production output of the solar energy system for
10-years
after the installation. The Company monitors the solar energy systems to determine whether these specified minimum outputs are being achieved. The Company will issue payments to customers if the output falls below contractually stated thresholds over the performance guarantee period. Revenue is recognized to the extent it is probable that a significant reversal of such revenue will not occur.
Revenues – Software Enhanced Services
The Company generates revenue from software enhanced services through the provision of design and proposal services. The Company’s customers for design services are solar installers who leverage the Company’s expertise and software platforms to obtain structural letters, computer aided designs and electrical reviews. The Company charges the customer a per design fixed fee for each type of service that is performed, and the Company recognizes revenue in the period the services are performed. The customer contracts contain the customer right to terminate the contract each month and are therefore enforceable only for the contracted services purchased each month. Revenue is recognized for design services in the month the services are performed.
The Company’s customers for proposal services for solar sales organizations who contract with the Company to develop proposals for their potential residential solar customers. The Company generates proposals for the customer using the HelioQuote platform. Customers may purchase a fixed number of proposals for a given month or may contract on a pay as you go basis, and the performance obligation is defined by the number of proposals purchased by the customer each month. The customer contracts contain the customer right to terminate the contract each month and are therefore enforceable only for the services purchased each month. Revenue is recognized for proposal services in the month the services are performed.
Warranties
The Company typically provides a
10-year
warranty on its solar energy system installations, which provides assurance over the workmanship in performing the installation, including roof leaks caused by the Company’s performance. For solar panel sales recognized prior to the Disposal Transaction, the Company provides a
30-year
warranty that the products will be free from defects in material and workmanship.
When the revenues are recognized for the solar energy systems installations services, the Company accrues liabilities for the estimated future costs of meeting its warranty obligations. The Company makes and revises these estimates based primarily on the volume of new sales that contain warranties, historical experience with and projections of warranty claims, and estimated solar energy system and panel replacement costs. The Company records a provision for estimated warranty expenses in cost of revenues within the accompanying consolidated statements of operations and comprehensive loss.

Shipping and handling costs and certain taxes
Revenues are recognized net of taxes collected from customers and remitted to governmental authorities. Shipping and handling costs associated with outbound freight are accounted for as a fulfillment cost and are included in both revenues and cost of revenues in the accompanying consolidated statements of operations and comprehensive loss.
Deferred revenue
The Company typically invoices its customers upon completion of set milestones, generally upon installation of the solar energy system with the remaining balance invoiced upon passing final building inspection. Standard payment terms to customers range from 30 to 60 days. When the Company receives consideration, or when such consideration is unconditionally due, from a customer prior to delivering goods or services to the customer under the terms of a customer agreement, the Company records deferred revenue. As installation projects are typically completed within
12-months,
the Company’s deferred revenue is reflected in current liabilities in the accompanying consolidated balance sheets. The amount of revenue recognized during the years ended December 31, 2022 and 2021 that was included in deferred revenue at the beginning of each period was $3.9 million and $4.5 million, respectively.
Disaggregation of revenue
Refer to the table below for the Company’s revenue recognized by product and service type (in thousands):
 
    
Years Ended December 31,
 
    
2022
    
2021
    
2020
 
Solar energy system installations
   $ 62,896      $ 66,958      $ 29,378  
Software enhanced services
     3,579        1,858            
  
 
 
    
 
 
    
 
 
 
Total revenue
   $ 66,475      $ 68,816      $ 29,378  
  
 
 
    
 
 
    
 
 
 
For the years ended December 31, 2022, 2021 and 2020, all revenue recognized was generated in the United States.
Remaining performance obligations
The Company has elected the practical expedient not to disclose remaining performance obligations for contracts that are less than one year in length. As of December 31, 2022, the Company has deferred $1.3 million associated with a long-term service contract, which will be recognized evenly through 2028.
Incremental costs of obtaining customer contracts
Incremental costs of obtaining customer contracts consist of sales commissions, which are costs paid to third-party vendors who source residential customer contracts for the sale of solar energy systems by the Company. The Company defers sales commissions and recognizes expense in accordance with the timing of the related revenue recognition. Amortization of deferred commissions is recorded as sales commissions in the accompanying consolidated statements of operations and comprehensive loss. As of December 31, 2022 and December 31, 2021, deferred commissions were $2.8 million and $4.8 million, respectively, which included in prepaid expenses and other current assets in the accompanying consolidated balance sheets.
 
(j)
Property and Equipment, Net
Property and equipment are stated at cost less accumulated depreciation and amortization. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gain or loss is included in the current period. Repair and maintenance costs are expensed as

incurred. Depreciation and amortization are calculated using the straight-line method over the following estimated useful lives of the assets:
 
    
Useful Lives
 
Manufacturing equipment
    
1-3 years
 
Developed software
     5 years  
Furniture & equipment
    
3-5
years
 
Leasehold improvements
    
3-5 years
 
 
(k)
Internal-Use
Software
The Company capitalizes costs to develop its
internal-use
software when preliminary development efforts are successfully completed, management has authorized and committed project funding, it is probable that the project will be completed, and the software will be utilized as intended. These costs include personnel and related employee benefits and expenses for employees who are directly associated with and who devote time to software projects, and external direct costs of materials and services consumed in developing or obtaining software. Costs incurred prior to meeting these criteria, together with costs incurred for training and maintenance, are expensed as incurred. Costs incurred for enhancements that are expected to provide additional material functionality are capitalized and amortized over the estimated useful life of the related upgrade. During the years ended December 31, 2022, 2021 and 2020, the Company capitalized $1.5 million, $1.1 million and $0.5 million, respectively, of
internal-use
software development costs. The remaining unamortized balance as of December 31, 2022 and December 31, 2021 of $2.7 million and $1.7 million, respectively, is included in property and equipment, net within the accompanying consolidated balance sheets.
 
(l)
Cost of Revenues
Cost of revenues includes actual cost of material, labor and related overhead incurred for revenue-producing units, and includes associated warranty costs, freight and delivery costs, depreciation, and amortization of internally developed software.
 
(m)
Advertising and Promotional Expenses
Advertising
and promotional costs are expensed as incurred and included in sales and marketing expense in the accompanying consolidated statements of operations and comprehensive loss. Advertising costs were not material for the years ended December 31, 2022, 2021 and 2020..
 
(n)
Income Taxes
Income taxes are accounted for under the
asset-and-liability
method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company recognizes the effect of income tax positions only if those positions are more likely than not to be sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company recognizes accrued interest and penalties, if any, related to unrecognized tax benefits in income tax provision.
 
(o)
Foreign Currency
The Company’s reporting currency is the US dollar. The functional currency for each of the Company’s foreign subsidiaries is the local currency, as it is the monetary unit of account of the principal economic

environments in which the Company’s foreign subsidiaries operate. Assets and liabilities of the foreign subsidiaries are translated at the current exchange rate as of the end of the period, and revenue and expenses are translated at the average exchange rates in effect during the period. The gain or loss resulting from the process of translating foreign currency financial statements into US dollar financial statements is accounted for as a foreign currency cumulative translation adjustment and is reported as a component of accumulated other comprehensive loss. Foreign currency transaction gains and losses resulting from transactions denominated in a currency other than the functional currency are recognized in Other Income (expense), net in the consolidated statements of operations and comprehensive loss.
 
(p)
Comprehensive Loss
Comprehensive loss consists of two components, net loss and other comprehensive income (loss), net. The Company’s other comprehensive loss consists of foreign currency translation adjustments that result from the consolidation of its foreign entities and is reported net of tax effects.
 
(q)
Impairment of Long-Lived Assets
Long-lived assets, such as property and equipment, ROU assets, and intangible assets subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require a long-lived asset or asset group be tested for possible impairment, the Company first compares undiscounted cash flows expected to be generated by that asset or asset group to its carrying value. If the carrying value of the long-lived asset or asset group is not recoverable on an undiscounted cash flow basis, an impairment is recognized to the extent that the carrying value exceeds its fair value. Fair value is determined through various valuation techniques including discounted cash flow models, and quoted market values, as considered necessary.
There were no impairment charges for the years ended December 31, 2022, 2021 and 2020.
 
(r)
Business Combinations
The Company allocates the fair value of purchase consideration to the tangible assets acquired, liabilities assumed, and intangible assets acquired based on their estimated fair values. The excess of the fair value of purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. Such valuations require management to make significant estimates and assumptions, especially with respect to intangible assets. Significant estimates in valuing certain intangible assets include, but are not limited to, future expected cash flows from customer relationships, acquired technology, trade names from a market participant perspective, useful lives and discount rates. Management’s estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates. During the measurement period, which is one year from the acquisition date, the Company may record adjustments to the assets acquired and liabilities assumed, with the corresponding offset to goodwill. Upon the conclusion of the measurement period, any subsequent adjustments are recorded in the consolidated statements of operations and comprehensive loss.
 
(s)
Intangibles Assets, Net
Intangible assets are recorded at the cost, less accumulated amortization. Amortization is recorded using the straight-line method. All intangible assets that have been determined to have definite lives are amortized over their estimated useful life as indicated below:
 
    
Estimated Useful Life
 
Assembled workforce
     2 years  

(t)
Deferred Transaction Costs
Deferred transaction costs, which consist of direct incremental legal, consulting and accounting fees related to the merger with Freedom, are capitalized until they are recorded against proceeds upon the consummation of the transaction. As of December 31, 2022, the Company has recorded $1.1 million of deferred transaction costs in other noncurrent assets on the consolidated balance sheets.
 
(u)
Redeemable Convertible Preferred Stock Warrants
The Company has issued redeemable convertible preferred stock warrants exercisable into shares of the Company’s redeemable convertible preferred stock. The Company classifies warrants to purchase shares of convertible preferred stock that are redeemable or include an antidilution feature as liabilities. Such redeemable convertible preferred stock warrants are measured and recognized at fair value, and subject to remeasurement at each balance sheet date. At the end of each reporting period, changes in fair value during the period are recognized as a component of other income (expense), net in the accompanying consolidated statements of operations and comprehensive loss. The Company will continue to adjust the redeemable convertible preferred stock warrant liability for changes in the fair value until the earlier of the exercise or expiration of such warrants or the completion of a liquidation event, including completion of an initial public offering (“IPO”), at which time all such redeemable convertible preferred stock warrants will be converted into warrants to purchase shares of common stock, and the liability will be reclassified to additional
paid-in
capital. See Note 10 – Fair Value Measurements for details on the valuation methodology. Also see Note 14 – Warrants.
 
(v)
Stock-Based Compensation
The Company recognizes stock-based compensation expense over the requisite service period on a straight-line basis for all stock-based payments that are expected to vest to employees,
non-employees
and directors, including grants of employee stock options and other stock-based awards. Equity-classified awards issued to employees,
non-employees
such as consultants and
non-employee
directors are measured at the grant-date fair value of the award. Forfeitures are recognized as they occur. For accounting purposes, the Company estimates grant-date fair value of stock options using the Black-Scholes option pricing model. The
Black-Scholes
option pricing model requires the input of highly subjective assumptions, including the fair value of the underlying common stock prior to the Mergers, the expected term of the option the expected volatility of the price of the Company’s common stock and expected dividend yield. The Company determines these inputs as follows:
Expected Term
—Expected term represents the period that the Company’s stock-based awards are expected to be outstanding and is determined using the simplified method.
Expected Volatility
—Expected volatility is estimated by studying the volatility of comparable public companies for similar terms.
Expected Dividend
—The Black-Scholes valuation model calls for a single expected dividend yield as an input. The Company has never paid dividends and has no plans to pay dividends.
Risk-free Interest Rate
—The Company derives the risk-free interest rate assumption from the U.S. Treasury’s rates for the U.S. Treasury
zero-coupon
bonds with maturities similar to those of the expected term of the awards being valued.
Forfeitures
—The Company recognizes forfeitures as they occur.
 
(w)
Fair Value Measurements
The Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible. The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market.

When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels:
 
   
Level 1 inputs: Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date.
 
   
Level 2 inputs: Other than quoted prices included in Level 1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability.
 
   
Level 3 inputs: Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at the measurement date.
The Company’s financial instruments include cash, accounts receivable, accounts payable, accrued expenses, convertible notes, SAFE agreements, notes payable, common stock warrants and redeemable convertible preferred stock warrants. The carrying amounts of cash, accounts receivable, accounts payable, accrued expenses, convertible notes and notes payable approximate their fair value because of their short- term nature (classified as level 1). The Company measures and discloses the fair value of SAFE agreements, common stock warrants and redeemable convertible preferred stock warrants under the provisions of ASC Topic 820—Fair Value Measurement (classified as level 3).
 
(x)
Net Loss Per Share
The Company computes net loss per share in accordance with ASC 260, Earnings Per Share (“ASC 260”). Basic net loss per share is measured as the income or loss available to common stockholders divided by the weighted-average common shares outstanding for the period. Diluted net loss per share presents the dilutive effect on a per-share basis from the potential exercise of options and/or warrants. The potentially dilutive effect of options or warrants are computed using the treasury stock method. Securities that potentially have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the diluted loss per share calculation.
 
(y)
Convertible Debt Embedded Derivative Liabilities
The Company evaluates the embedded conversion feature within its convertible debt instruments under ASC
815-15
and ASC
815-40
to determine if the conversion feature meets the definition of a liability and, if so, whether to bifurcate the conversion feature and account for it as a separate derivative liability. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then
re-valued
at each reporting date, with changes in the fair value reported in the consolidated statements of operations and comprehensive loss. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the consolidated balance sheets as current or
non-current
based on whether
net-cash
settlement of the derivative instrument could be required within twelve months after the balance sheet date. The derivative is subject to
re-measurement
at the end of each reporting period, with changes in fair value recognized as a component of other income (expense), net, in the consolidated statements of operations and comprehensive loss. The Company’s embedded derivative liabilities were extinguished in the first quarter of 2022.
 
(z)
Leases
Effective January 1, 2021, the Company early adopted Accounting Standards Update (“ASU”)
No. 2016-02,
Leases (Topic 842), as amended (“ASC 842”). The Company determines if a contract is a lease or contains a lease at the inception of the contract and reassesses that conclusion if the contract is modified. The Company’s lease agreements generally contain lease and
non-lease
components. Payments under lease
arrangements are primarily fixed. The Company combines lease and
non-lease
components and accounts for them together as a single lease component. All leases are assessed for classification as an operating lease or a finance lease. Operating lease
right-of-use
(“ROU”) assets are presented separately on the Company’s consolidated balance sheets. Operating lease liabilities are separated into a current portion and
non-current
portion and are presented separately on the Company’s consolidated balance sheets. The Company does not have finance lease ROU assets or liabilities.
ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent its obligation to make lease payments arising from the lease. The Company does not obtain and control its right to use the identified asset until the lease commencement date.
The Company’s lease liabilities are recognized at the later of January 1, 2021 and applicable lease commencement date based on the present value of the lease payments required to be paid over the lease term. Because the rate implicit in the lease is not readily determinable, the Company generally uses its incremental borrowing rate to discount the lease payments to present value. The estimated incremental borrowing rate is derived from information available at the lease commencement date. The Company’s lease terms include periods under options to extend or terminate the lease when it is reasonably certain that we will exercise that option. We generally use the base,
non-cancelable,
lease term when determining the lease assets and liabilities. The Company also records a corresponding
right-of-use
asset at the later of January 1, 2021 and applicable lease commencement date, which is calculated based on the amount of the lease liability, adjusted for any advance lease payments made, lease incentives received, and initial direct costs incurred.
Right-of-use
assets are subject to evaluation for impairment or disposal on a basis consistent with other long-lived assets.
The Company has elected, for all classes of underlying assets, not to recognize ROU assets and lease liabilities for leases with a term of twelve months or less. Lease cost for short-term leases is recognized on a straight-line basis over the lease term.
Before the adoption of ASU
2016-02
on January 1, 2021, the Company categorizes leases at their inception as either operating or capital leases, with the Company’s current lease portfolio only consisting of operating leases for office spaces. In certain lease agreements, it may receive rent holidays and other incentives. For operating leases, the Company recognizes lease costs on a straight-line basis once control of the space is achieved, without regard to deferred payment terms such as rent holidays that defer the commencement date of required payments. Additionally, incentives received are treated as a reduction of costs over the term of the agreement.
 
(aa)
Recently Adopted Accounting Pronouncements
In December 2019, the FASB issued ASU
2019-12,
Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes
. ASU
2019-12
removes certain exceptions to the general principles in Topic 740 and clarifies and amends existing guidance to improve consistent application. ASU
2019-12
will be effective for public entities for interim and annual periods beginning after December 15, 2020, with early adoption permitted. ASU
2019-12
will be effective for private entities for annual periods beginning after December 15, 2021, and interim periods beginning after December 15, 2020, with early adoption permitted. The Company adopted ASU
2019-12
under the private company transition guidance beginning January 1, 2022, and the adoption did not have an impact on the Company’s consolidated financial statements.
In May 2021, the FASB issued ASU
2021-04,
Earnings Per Share (Topic 260), Debt—Modifications and Extinguishments (Subtopic
470-50),
Compensation—Stock Compensation (Topic 718), and Derivatives and
Hedging—Contracts in Entity’s Own Equity (Subtopic
815-40):
Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options (a consensus of the FASB Emerging Issues Task Force)
. This guidance clarifies certain aspects of the current guidance to promote consistency among reporting of an issuer’s accounting for modifications or exchanges of freestanding equity-classified written call options (for example, warrants) that remain equity classified after

modification or exchange. The amendments in this update are effective for all entities for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted for all entities, including adoption in an interim period. The Company adopted ASU
2021-04
under the private company transition guidance beginning January 1, 2022, the adoption did not have an impact on the Company’s consolidated financial statements.
In August 2020, the FASB issued ASU
2020-06,
Debt—Debt with Conversion and Other Options (Subtopic
470-20)
and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic
815-40):
Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, which simplifies the accounting for convertible instruments by reducing the number of accounting models available for convertible debt instruments. This guidance also eliminates the treasury stock method to calculate diluted earnings per share for convertible instruments and requires the use of the
if-converted
method. ASU
2020-06
is effective for public and private companies’ fiscal years beginning after December 15, 2021, and December 15, 2023, respectively, and interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company adopted ASU
2020-06
under the private company transition guidance on January 1, 2022, and the adoption did not have an impact on the Company’s consolidated financial statements.
 
(ab)
Accounting Pronouncements Not Yet Adopted
In June 2016, the FASB issued ASU
2016-13,
Financial instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments
, and subsequent related ASUs, which amends the guidance on the impairment of financial instruments by requiring measurement and recognition of expected credit losses for financial assets held. ASU
2016-13
is effective for public and private companies’ fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2019, and December 15, 2022, respectively. The Company expects to adopt ASU
2016-13
under the private company transition guidance beginning January 1, 2023 and is currently evaluating the impact on the Company’s consolidated financial statements.
 
(3)
Reverse Recapitalization
As discussed in Note 1 – Organization, on July 18, 2023, the Company consummated the Mergers pursuant to the Amended and Restated Business Combination Agreement. The Mergers was accounted for as a reverse recapitalization, rather than a business combination, for financial accounting and reporting purposes. Accordingly, Complete Solaria was deemed the accounting acquirer (and legal acquiree) and FACT was treated as the accounting acquiree (and legal acquirer). Complete Solaria has been determined to be the accounting acquirer based on evaluation of the following facts and circumstances:
 
   
Complete Solaria’s pre-combination stockholders have the majority of the voting power in the post-merged company;
 
   
Legacy Complete Solaria’s stockholders have the ability to appoint a majority of the Complete Solaria Board of Directors;
 
   
Legacy Complete Solaria’s management team is considered the management team of the post-merged company;
 
   
Legacy Complete Solaria’s prior operations is comprised of the ongoing operations of the post-merged company;
 
   
Complete Solaria is the larger entity based on historical revenues and business operations; and
 
   
the post-merged company has assumed Complete Solaria’s operating name.
Under this method of accounting, the reverse recapitalization was treated as the equivalent of Complete Solaria issuing stock for the net assets of FACT, accompanied by a recapitalization. The net assets of FACT

are stated at historical cost, with no goodwill or other intangible assets recorded. The consolidated assets, liabilities, and results of operations prior to the Mergers are those of Legacy Complete Solaria. All periods prior to the Mergers have been retrospectively adjusted in accordance with the Amended and Restated Business Combination Agreement for the equivalent number of preferred or common shares outstanding immediately after the Mergers to effect the reverse recapitalization.
Upon the closing of the Mergers and the PIPE Financing in July 2023, the Company received net cash proceeds of $19.7 million. Immediately upon closing of the Mergers, the Company had 45,290,553 shares issued and outstanding of Class A Common Stock. The following table presents the number of shares of Complete Solaria Common Stock outstanding immediately following the consummation of the Mergers:
 
    
Recapitalization
 
FACT Class A Ordinary Shares, outstanding prior to Mergers
     34,500,000  
FACT Class B Ordinary Shares, outstanding prior to Mergers
     8,625,000  
Bonus shares issued to sponsor
     193,976  
Bonus shares issued to PIPE investors
     120,000  
Bonus shares issued to FPA investors
     150,000  
Shares issued from PIPE financing
     1,690,000  
Shares issued from FPA agreements, net of recycled shares
     5,558,488  
Less: redemption of FACT Class A Ordinary Shares
     (31,041,243
  
 
 
 
Total shares from the Mergers and PIPE Financing
     19,796,221  
Legacy Complete Solaria shares
     20,034,257  
2022 Convertible Note Shares
     5,460,075  
  
 
 
 
Shares of Complete Solaria Common stock immediately after Mergers
     45,290,553  
  
 
 
 
In
connection
with the Mergers, the Company incurred direct and incremental costs of approximately $15.8 million related to legal, accounting, and other professional fees, which were offset against the Company’s additional paid-in capital. Of the $15.8 million, $5.2 million was incurred by Legacy Complete Solaria and $10.6 million was incurred by FACT. As a result of the Closing, outstanding 2022 Convertible Notes were converted into shares of Complete Solaria Common Stock.
 
(4)
Business Combination
Solaria Acquisition
On November 4, 2022, Complete Solar Holdings acquired Solaria for aggregate consideration paid of $89.1 million, comprising of $0.1 million in cash, 2,884,550 shares of common stock with an aggregate fair value of $17.3 million, 6,803,549 shares of preferred stock with an aggregate fair value of $52.2 million, 78,962 common stock warrants for an aggregate value of $0.2 million, 1,376,414 preferred stock warrants for an aggregate fair value of $7.8 million, 5,382,599 stock options with an aggregate fair value of $10.0 million attributable to services provided prior to the acquisition date, and the payment of seller incurred transaction expenses of $1.5 million. In addition, the Company assumed $14.1 million of unvested Solaria stock options, which will be recorded as stock-based expense over the remaining service period. Solaria designs, develops, manufactures, and generates revenue from the sale of silicon photovoltaic solar panels and licensing of its technology to third parties. This transaction was accounted for as a business combination in accordance with ASC 805,
Business Combinations
. Subsequent to the acquisition as discussed above, the Company sold certain intangible assets constituting the Solaria business in October of 2023, resulting in the Solaria business to be reflected as discontinued operations and certain intangible assets and goodwill to be recognized as held-for-sale. Refer to Note 5 – Divestitures for further details.

Acquisition costs of $1.3 million were expensed by the Company and are included in general and administrative expenses within the consolidated statements of operations and comprehensive loss for the year ended December 31, 2022.
The fair value of assets acquired and liabilities assumed was based upon a preliminary valuation and the Company’s estimates and assumptions are subject to change within the measurement period. The following table summarized the provisional fair value of identifiable assets acquired and liabilities assumed (in thousands):
 
Cash, cash equivalents and restricted cash
   $ 5,402  
Accounts receivable
     4,822  
Inventories
     5,354  
Prepaid expenses and other current assets
     8,569  
Property and equipment
     830  
Operating lease
right-of-use
asset
     1,619  
Intangible assets
     43,100  
Other
non-current
assets
     112  
  
 
 
 
Total identifiable assets acquired
     69,808  
Accounts payable
     4,210  
Accrued expenses and other current liabilities
     11,845  
Notes payable
     20,823  
Deferred revenue
     73  
Operating lease liabilities, net of current portion
     1,132  
Warranty provision, noncurrent
     1,566  
SAFE agreements
     60,470  
  
 
 
 
Total identifiable liabilities assumed
     100,119  
  
 
 
 
Net identifiable liabilities assumed
     30,311  
Goodwill
     119,422  
  
 
 
 
Total aggregate consideration paid
   $ 89,111  
  
 
 
 
Goodwill represents the excess of the preliminary estimated consideration transferred over the fair value of the net tangible and intangible assets acquired and has been allocated to the Company’s single reporting unit. Goodwill was subsequently reclassified to long-term assets held-for-sale – discontinued operations, on the Company’s balance sheet as of December 31, 2022, stemming from the sale of the Solaria business discussed in Note 5 below.
Intangible assets acquired and subsequently disposed of as part of the Solaria disposition discussed in Note 5 below are as follows (in thousands):
 
Trademarks
   $ 5,700  
Developed technology
     12,700  
Customer relationships
     24,700  
  
 
 
 
Total intangible asset
   $ 43,100  
  
 
 
 
The income approach, using the relief from royalty method, was used to value trademarks and developed technology. Significant assumptions included in the valuation of trademarks and developed technology include projected revenues, the selected royalty rate and the economic life of the underlying asset.
The income approach, using the multi-period excess earning method, was used to value customer relationships. Significant assumptions included in the valuation of customer relationships include projected revenues, customer attrition and expense growth over the forecasted period.

As a result of the Solaria acquisition, the Company recognized $45.9 million of deferred tax assets. Due to the uncertainty surrounding the Company’s ability to realize such deferred income tax assets, a full valuation allowance has been established. Refer to Note 18 – Income Taxes for additional details.
 
(5)
Divestiture
Discontinued
operations
As previously described in Note 1 – Organization, on August 18, 2023, the Company entered into a Non-Binding Letter of Intent to sell certain of Complete Solaria’s North American solar panel assets, inclusive of intellectual property and customer contracts, to Maxeon. In October 2023, the Company completed the sale of its solar panel business to Maxeon. The assets sold to Maxeon were the assets that allowed for the Solaria business to operate as a product manufacturer of solar panels. As such, the Company determined that the sale of these assets in effect represented a disposition of the Solaria business and constituted a strategic shift in the Company’s operations, therefore qualifying as a discontinued operation. Accordingly, the results of operations and cash flows relating to Solaria have been reflected as discontinued operations in the consolidated statements of operations and comprehensive income (loss) for the year ended December 31, 2022 and the consolidated statements of cash flows for the year ended December 31, 2022.
Components of amounts reflected in the consolidated statements of operations and comprehensive income (loss) related to discontinued operations are presented in the table, as follows (in thousands):
 
    
December 31, 2022
 
Revenues
   $ 13,325  
Cost of revenues
     12,847  
  
 
 
 
Gross profit
     478  
Operating expenses:
  
Sales and marketing
     1,315  
General and administrative
     617  
  
 
 
 
Total operating expenses
     1,932  
  
 
 
 
Net loss from discontinued operations
   $ (1,454
  
 
 
 
Held for sale
As previously described in Note 1 – Organization, certain assets of the Solaria, Inc. have been reflected as assets held for sale in the periods preceding the divestiture.
The following is a summary of the major categories of assets and liabilities held for sale (in thousands):
 
    
December 31, 2022
 
Intangible assets, net
   $ 42,610  
Goodwill
     119,422  
  
 
 
 
Long-term assets held for sale
   $ 162,032  
  
 
 
 
In October 2023, in conjunction with the divestiture, the Company recorded impairment expense of $119.4 million and $28.1 million associated with the goodwill and intangible assets, respectively, assigned to Solaria and a loss on disposal of $1.8 million.
Cash flows from discontinued operations included depreciation and amortization of $0.5 million and stock-based compensation expense of $0.5 million for year ended December 31, 2022.

(6)
Prepaid Expenses and Other Current Assets
Prepaid expenses and other current assets consists of the following (in thousands):
 
    
As of December 31,
 
    
2022
    
2021
 
Inventory deposits. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
   $ 6,255      $     
Prepaid sales commissions . . . . . . . . . . . . . . . . . . . . . . .
     2,838        4,771  
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
     978        184  
  
 
 
    
 
 
 
Total prepaid expenses and other current assets . . .
   $ 10,071      $ 4,955  
  
 
 
    
 
 
 
 
(7)
Property and Equipment, Net
Property and equipment, net consists of the following (in thousands):
 
    
As of December 31,
 
    
2022
    
2021
 
Developed software
   $ 5,054      $ 3,540  
Manufacturing equipment.
     102        70  
Furniture & equipment
     90            
Leasehold improvements
     708            
  
 
 
    
 
 
 
Total property and equipment
     5,954        3,610  
Less accumulated depreciation and amortization
     (2,478      (1,852
  
 
 
    
 
 
 
Total property and equipment, net
   $ 3,476      $ 1,758  
  
 
 
    
 
 
 
Depreciation and amortization expense totaled $0.6 million, $0.5 million and $0.3 million for the years ended December 31, 2022, 2021 and 2020, respectively.
 
(8)
Intangible Assets, Net
Intangible assets consisted of the following (in thousands, except years data):
 
    
As of December 31, 2022
    
As of December 31, 2021
 
    
Weighted-
Average
Remaining
Life (Years)
    
Gross
Carrying
Amount
    
Accumulated
Amortization
   
Net
Amount
    
Gross
Carrying
Amount
    
Accumulated
Amortization
   
Net
Amount
 
Assembled workforce
     0.1      $  137      $  (133   $  4      $  137      $ (65   $  72  
Amortization expense related to intangible assets for the years ended December 31, 2022, 2021, and 2020 was $0.1 million, $0.1 million and zero, respectively.
For the year ended December 31, 2022, amortization expense related to intangible assets of $0.1 million and $0.1 million, respectively, was recorded in general and administrative expense on the accompanying consolidated statements of operations and comprehensive loss.
For the year ended December 31, 2020, amortization expense related to intangible assets was zero.
As of December 31, 2022, amortization expense for intangible assets for 2023 is expected to be $0.1 million. Amortization expense for intangible assets is
not
expected to be material for periods subsequent to 2023.

Assembled workforce
On January 21, 2021, the Company entered into an agreement to purchase the business assets of Current Insight, an engineering firm that develops designs for residential solar installations in a cost-effective manner for its customers. Consideration for the asset acquisition amounted to an aggregate purchase price of $0.2 million, comprised of a promissory note for $0.1 million and 30,000 shares of the Company’s common stock with an aggregate fair value of less than $0.1 million. The transaction was accounted for as an asset purchase in accordance with ASC 805,
Business Combinations
.
The Company concluded that tangible and other assets acquired in the transaction did not have material value and, as such, ascribed no consideration to them. The total purchase price was allocated exclusively to the acquired assembled workforce, which is amortized on a straight-line basis over an estimated useful life of two years.
 
(9)
Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities consist of the following (in thousands):
 
    
December 31,
 
    
2022
    
2021
 
Accrued compensation and benefits
   $ 3,940      $  3,498  
Accrued term loan and revolving loan amendment and final payment fees
     2,400            
Uninvoiced contract costs
     1,914        2,180  
Accrued legal settlements
     1,853            
Accrued taxes
     1,245            
Accrued rebates and credits
     1,076            
Inventory received but not invoiced
     972            
Operating lease liabilities, current
     958        390  
Customer deposits
     930        1,375  
Warranty provision, current
     767        600  
Other accrued liabilities
     3,775        1,304  
  
 
 
    
 
 
 
Total accrued expenses and other current liabilities
   $ 19,830      $ 9,347  
  
 
 
    
 
 
 

(10)
Fair Value Measurements
The following table sets forth the Company’s financial assets and liabilities that were measured at fair value, on a recurring basis (in thousands):
The following table presents a reconciliation of the Company’s financial liabilities measured at fair value as of December 31, 2022 using significant unobservable inputs (Level 3), and the change in fair value recorded in other income (expense), net in the accompanying consolidated statements of operations and comprehensive loss (in thousands):
 
    
Warrant
    
Convertible
Debt
Embedded
Derivatives
    
SAFEs
 
Balance as of December 31, 2020
   $ 799      $ 579      $ 91  
Issuance of
2021-A
Convertible Notes
               566            
Issuance of 2021-Rogers SAFE
                         5,000  
Change in fair value
     330        336        1,306  
  
 
 
    
 
 
    
 
 
 
Balance as of December 31, 2021
   $ 1,129      $ 1,481      $ 6,397  
Conversion of debt into preferred shares
               (1,481          
Conversion of SAFEs into preferred shares
                         (6,397
Assumption of SAFEs in Solaria acquisition
                         60,470  
Conversion of SAFEs from Solaria acquisition into preferred shares
                         (60,470
Issuance of Series D Warrants Tranche A
     6,527                      
Issuance of Series D Warrants Tranche B
     1,285                      
Change in fair value
     5,211                      
  
 
 
    
 
 
    
 
 
 
Balance as of December 31, 2022
   $  14,152      $         $     
  
 
 
    
 
 
    
 
 
 
The fair value of accounts receivable, accounts payable, and accrued expenses approximated their carrying values as of December 31, 2022 and December 31, 2021, due to their short-term nature. As of December 31, 2022, all of the Company’s outstanding debit is carried at an amortized cost basis.
There were no transfers between Level 1, Level 2 or Level 3 fair value hierarchy categories of financial instruments for the years ended December 31, 2022 and December 31, 2021.
 
    
As of December 31, 2022
 
    
Level 1
    
Level 2
    
Level 3
    
Total
 
Financial Liabilities
           
Redeemable convertible preferred stock warrant liability
   $   —         $   —         $  14,152      $  14,152  
  
 
 
    
 
 
    
 
 
    
 
 
 
Total
   $ —        $ —        $ 14,152      $ 14,152  
  
 
 
    
 
 
    
 
 
    
 
 
 
    
As of December 31, 2021
 
    
Level 1
    
Level 2
    
Level 3
    
Total
 
Financial Liabilities
           
Redeemable convertible preferred stock warrant liability
   $ —        $ —        $ 1,129      $ 1,129  
Convertible debt embedded derivatives
     —          —          1,481        1,481  
SAFE agreements
     —          —          6,397        6,397  
  
 
 
    
 
 
    
 
 
    
 
 
 
Total
   $ —        $ —        $ 9,007      $ 9,007  
  
 
 
    
 
 
    
 
 
    
 
 
 
Redeemable Convertible Preferred Stock Warrant Liability
The Company historically issued redeemable convertible warrants to a bank to purchase shares of Series B preferred stock in February 2016 and issued redeemable convertible warrants to an investor to purchase shares of Series C preferred stock. Refer to Note 14 - Warrants. The Company issued Series D preferred stock warrants in conjunction with the merger agreement with Solaria. Refer to
Note 3-Business
Combination. The exercise prices for the two tranches of Series D preferred stock warrants are based on a future round of stock price, with an assumption of $2.50 and $5.00 upon consummation of a deSPAC acquisition and $2.04 and $4.09 upon remaining private, respectively. As the warrants have a contingent exercise price, the Company valuated the warrants based on a Black Scholes option pricing model, using a probability weighted estimate of the warrant valuations, given a deSPAC exist scenario and a stay private scenario, weighted at 70% and 30%, respectively. The following assumptions were used to calculate the fair value of the redeemable convertible preferred stock warrant liability:
Series B Redeemable Convertible Preferred Stock Warrant
 
    
December 31,
 
    
2022
   
2021
 
Expected term
     3.1 years       4.1 years  
Expected volatility
     72.5     73.0
Risk-free interest rate
     4.2     1.1
Expected dividend yield
     0.0     0.0
Series C Redeemable Convertible Preferred Stock Warrant
 
    
December 31,
 
    
2022
   
2021
 
Expected term
     3.6 years       4.6 years  
Expected volatility
     72.5     73.0
Risk-free interest rate
     4.0     1.2
Expected dividend yield
     0.0     0.0
Series D Redeemable Convertible Preferred Stock Warrant
 
    
December 31,
 
    
2022
   
2021
 
Expected term
     1.5 years       —    
Expected volatility
     78.5         
Risk-free interest rate
     4.7         
Expected dividend yield
     0.0         
The redeemable convertible preferred stock warrant liabilities were measured at fair value at the issuance date and as of each subsequent fiscal year end with changes in the fair value recorded within other income (expense), net in the accompanying consolidated statements of operations and comprehensive loss.

The table below reconciles the change in value of the redeemable convertible preferred stock warrant liability from each warrant to the total redeemable convertible preferred stock warrant liability recorded within the accompanying consolidated balance sheets (amounts in thousands):
 
    
Series B
Warrants
    
Series C
Warrants
    
Series D

Tranche A
Warrants
    
Series D
Tranche B
Warrants
    
Total
 
Balance as of December 31, 2020
   $ 5      $ 794      $         $         $ 799  
Change in fair value
     3        327                            330  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Balance as of December 31, 2021
     8        1,121                            1,129  
Change in fair value
     42        5,169                            5,211  
Issuance of warrants in connection with acquisition of Solaria (Note 3)
                         6,527        1,285        7,812  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Balance as of December 31, 2022
   $  50      $  6,290      $  6,527      $  1,285      $  14,152  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Convertible Debt Embedded Derivatives
2019-A
Notes
The Company recorded a convertible debt embedded derivative liability associated with the issuance of the 2019-A Convertible Notes. The derivative liability is recorded within derivative liability on the accompanying consolidated balance sheets. See Note 13 – Borrowing Arrangements. The fair value of the convertible debt embedded derivative liability was computed as the difference between the estimated value of the convertible debt with and without features that allow the holders to convert the notes at a discount upon the Company’s subsequent equity financing (“Next Equity Financing”). The 2019-A Convertible Notes also contain a feature to convert the notes at a price of $75.0 million divided by the fully diluted capitalization table (“2019-A Valuation Cap Conversion”), which is not bifurcated as an embedded derivative.
The fair value of the convertible notes with the embedded derivative is estimated based on a probability- weighted analysis of the discounted value of the notes converting under a Next Equity Financing, a change in control, default, or maturity. The significant assumptions included in the fair value of the
2019-A
Convertible Notes with the embedded derivative liability include the time until a Next Equity Financing, the probabilities of the notes settling under each scenario, and a discount rate that reconciles the amount paid for the debt at issuance date, adjusted to reflect market changes subsequent to issuance. The fair value of the convertible notes without the embedded derivative liability is estimated based on the same methodology other than the settlement value upon a Next Equity Financing being set as the principal plus accrued interest, excluding the value of the conversion at a discount to the Next Equity Financing.
The embedded derivative liabilities in the convertible notes were measured at fair value at the issuance date and as of each subsequent fiscal year end with changes in the fair value recorded within other income (expense), net in the accompanying consolidated statements of operations and comprehensive loss.
The fair value of the
2019-A
Convertible Notes was approximately $0.1 million as of December 31, 2021. The
2019-A
Convertible notes and related derivative liability were extinguished in FY22 as part of the Series D redeemable convertible preferred stock issuance.
2020-A
Convertible Notes
The Company recorded a convertible debt embedded derivative liability associated with the issuance of the
2020-A
Convertible Notes. The derivative liability is recorded within derivative liability on the accompanying consolidated balance sheets. See Note 13 – Borrowing Arrangements. The fair value of the convertible debt embedded derivative liability was computed as the difference between the estimated value of the convertible debt with and without features that allow the holders to convert the notes at a discount upon the Company’s subsequent equity financing (“Next Equity Financing”).

The fair value of the convertible notes with the embedded derivative is estimated based on a probability- weighted analysis of the discounted value of the notes converting under a Next Equity Financing, a change in control, default, or maturity. The significant assumptions included in the fair value of the
2020-A
Convertible Notes with the embedded derivative liability include the time until a Next Equity Financing, the probabilities of the notes settling under each scenario, and a discount rate that reconciles the amount paid for the debt at issuance date, adjusted to reflect market changes subsequent to issuance. The fair value of the convertible notes without the embedded derivative liability is estimated based on the same methodology other than the settlement value upon a Next Equity Financing being set as the principal plus accrued interest, excluding the value of the conversion at a discount to the Next Equity Financing.
The embedded derivative liabilities in the convertible notes were measured at fair value at the issuance date and as of each subsequent fiscal year end with changes in the fair value recorded within other income (expense), net in the accompanying consolidated statements of operations and comprehensive loss.
The fair value of the
2020-A
Convertible Notes was approximately $4.6 million as of December 31, 2021. The
2020-A
Convertible notes and related derivative liability were extinguished as part of the Series D redeemable convertible preferred stock issuance.
2021-A
Convertible Notes
The Company recorded a convertible debt embedded derivative liability associated with the issuance of the
2021-A
Convertible Notes. The embedded derivative liability is recorded within derivative liability on the accompanying consolidated balance sheets. See Note 13 – Borrowing Arrangements. The fair value of the convertible debt embedded derivative liability was computed as the difference between the estimated value of the convertible debt with and without features that allow the holders to convert the notes at a discount upon the Company’s subsequent equity financing (“Next Equity Financing”). Certain of the notes from the
2021-A
Convertible Notes also contain a feature to convert the notes at a price of $200.0 million divided by the fully diluted capitalization table
(“2021-A
Valuation Cap Conversion”), which is not bifurcated as an embedded derivative.
The fair value of the convertible notes with the embedded derivative is estimated based on a probability- weighted analysis of the discounted value of the notes converting under a Next Equity Financing, a change in control, default, or maturity. The significant assumptions included in the fair value of the
2021-A
Convertible Notes with the embedded derivative liability include the time until a Next Equity Financing, the probabilities of the notes settling under each scenario, and a discount rate that reconciles the amount paid for the debt at issuance date, adjusted to reflect market changes subsequent to issuance. The fair value of the convertible notes without the embedded derivative liability is estimated based on the same methodology other than the settlement value upon a Next Equity Financing being set as the principal plus accrued interest, excluding the value of the conversion at a discount to the Next Equity Financing.
The embedded derivative liabilities in the convertible notes were measured at fair value at the issuance date and as of each subsequent fiscal year end with changes in the fair value recorded within other income (expense), net in the accompanying consolidated statements of operations and comprehensive loss.
The fair value of the
2021-A
Convertible Notes was approximately $4.8 million as of December 31, 2021, respectively. The
2021-A
Convertible notes and related derivative liability were extinguished as part of the Series D redeemable convertible preferred stock issuance.

The table below reconciles the embedded derivative liability from each of the series of convertible notes to the total derivative liability recorded on the accompanying consolidated balance sheets (amounts in thousands)
 
    
2019-A

Convertible
Notes
    
2020-A

Convertible
Notes
    
2021-A

Convertible
Notes
    
Totals
 
Balance as of December 31, 2020
   $ 18      $ 561      $         $ 579  
Issuance of
2021-A
Convertible Notes
                         566        566  
Change in fair value
     17        234        85        366  
  
 
 
    
 
 
    
 
 
    
 
 
 
Balance as of December 31, 2021
     35        795        651        1,481  
Extinguishment upon Series D issuance
     (35      (795      (651      (1,481
  
 
 
    
 
 
    
 
 
    
 
 
 
Balance as of December 31, 2022
   $          $         $         $     
  
 
 
    
 
 
    
 
 
    
 
 
 
Simple Agreement for Future Equity (“SAFE”)
2019 SAFE
In July 2019, the Company entered into a SAFE agreement (“2019 SAFE”) with an investor. At the issuance date, the Company received $0.1 million in cash. The SAFE is classified as a liability in the scope of Accounting Standards Codification Topic 480 (“ASC 480”),
Distinguishing Liabilities from Equity
, as the SAFE is redeemable upon events that are outside the control of the issuer. The 2019 SAFE converts to equity at the lower of $50.0 million divided by the fully diluted capitalization table (“2019 SAFE Valuation Cap Conversion”) and a 20% discount from the share price paid by other investors upon the Next Equity Financing. The SAFE also contains features that allow for cash settlement at the $0.1 million purchase price in the event of a liquidation or dissolution event.
The fair value of the 2019 SAFE was determined based on the probability-weighted expected return method (“PWERM”), which assigns value to the multiple settlement scenarios based on the probability of occurrence. The significant assumptions included in the fair value of the 2019 SAFE include the probability of conversion under a next equity financing (estimated between 60% at issuance and 80% as of December 31, 2022) and the realizable value upon a Next Equity Financing. The realizable value upon the Next Equity Financing was determined based on the following inputs that were included in a Black-Scholes model, which contains the following inputs:
 
    
December 31,
 
    
2022
  
2021
 
Expected fair value of preferred stock
   N/A    $ 4.84  
Expected term
   N/A      0.2 years  
Volatility
   N/A      76.4
Risk-free interest rate
   N/A      0.1
The 2019 SAFE was measured at fair value at the issuance date and as of each subsequent fiscal year end with changes in the fair value recorded within other income (expense), net in the consolidated statements of operations and comprehensive loss.
In March 2022, as part of the Company’s Series D preferred stock financing, the 2019 SAFE converted into shares of Series
D-3
preferred stock. As part of the extinguishment of the 2019 SAFE, the Company recorded a gain of less than $0.1 million in other income (expense), net in the consolidated statements of operations and comprehensive loss.
2021 SAFE
In December 2021, the Company entered into a SAFE agreement (“2021 SAFE”) with an investor. At the issuance date, the Company received $5.0 million in cash. The SAFE is classified as a liability in the scope of

Accounting Standards Codification Topic 480 (“ASC 480”),
Distinguishing Liabilities from Equity
, as the SAFE is redeemable upon events that are outside the control of the issuer. The 2021 SAFE converts to equity at the lower of $175.0 million divided by the fully diluted capitalization table (“2021 SAFE Valuation Cap Conversion”) and a 20% discount from the share price paid by other investors upon the Next Equity Financing. At the time of negotiating the SAFE, the Company was in advanced negotiations to raise its next equity financing. As such, the Company recorded the fair value of the 2021 SAFE based on the value to be received upon a conversion at a 20% discount from the Next Equity Financing. As a result, the Company recorded $1.3 million to other income (expense), net for the increase in the fair value of the 2021 SAFE over its issuance price.
In March 2022, as part of the Company’s Series D preferred stock financing, the 2021 SAFE converted into shares of Series
D-1
preferred stock. As part of the extinguishment of the 2021 SAFE, the Company recorded a gain of $1.4 million in other income (expense), net in the consolidated statements of operations and comprehensive loss.
2022 SAFE
In connection with the Solaria acquisition, Complete Solar Holdings entered into the SAFE Amendment, Assignment and Assumption Agreement whereby Complete Solar Holdings assumed the rights and interests in and obligations under the SAFE from Solaria immediately at the effective time of the acquisition of Solaria. In accordance with the terms and conditions of the Merger Agreement, the SAFE was required to be converted into redeemable convertible preferred stock of the Company within 10 business days of the close of the acquisition. Immediately subsequent to acquisition close, the SAFE converted into 8,171,662 shares of series
D-8
redeemable convertible preferred stock.
 
(11)
Employee Benefit Plan
The Company sponsors a 401(k) defined contribution and profit-sharing plan (“401(k) Plan”) for its eligible employees. This 401(k) Plan provides for
tax-deferred
salary deductions for all eligible employees. Employee contributions are voluntary. Employees may contribute the maximum amount allowed by law, as limited by the annual maximum amount as determined by the Internal Revenue Service. The Company may match employee contributions in amounts to be determined at the Company’s sole discretion. The Company made no contributions to the 401(k) Plan for the years ended December 31, 2022, 2021 and 2020.
 
(12)
Other Income (Expense), Net
Other income (expense), net consists of the following (in thousands):
 
    
Years Ended December 31,
 
    
2022
    
2021
   
2020
 
Change in fair value of SAFE agreements
   $         $  (1,306   $  (15
Change in fair value of derivative liabilities
               (336     (50
Change in fair value of warrant liabilities
     (5,211      (330     24  
Gain on extinguishment of convertible notes and SAFE agreements
(1)
     3,235                     
Forgiveness of Paycheck Protection Plan loan
               1,754           
Other, net
     118        (22         
  
 
 
    
 
 
   
 
 
 
Total other income (expense), net
   $  (1,858 )    $ (240)     $  (41
  
 
 
    
 
 
   
 
 
 
 
(1)
Includes $1.4 million of other income recognized upon the conversion of related party convertible notes and SAFEs
 
(13)
Common Stock
The Company has authorized the issuance of 28,978,046 and 13,547,878 shares of common stock as of December 31, 2022 and December 31, 2021, respectively.

The Company has reserved shares of common stock for issuance related to the following redeemable convertible preferred stock, stock options, common stock warrants, redeemable convertible preferred stock warrants, and future grants:
 
    
As of December 31,
 
    
2022
    
2021
 
Common stock warrants
     3,389,005        690,236  
Stock options, issued and outstanding
     4,970,395        2,135,454  
Stock options, authorized for future issuance
     369,907        141,644  
SAFE agreement
               341,604  
Convertible notes
               1,621,299  
  
 
 
    
 
 
 
Total shares reserved
     8,729,307        4,930,237  
  
 
 
    
 
 
 
 
(14)
Warrants
Series B Warrants (Converted to Common Stock Warrants)
In February 2016, the Company issued a warrant to purchase 5,054 shares of Series B preferred stock (the “Series B warrant”) in connection with the 2016 Credit Facility. The Series B warrant is immediately exercisable at an exercise price of $4.30 per share and has an expiration date of February 2026. The fair value of the Series B warrant, as determined in accordance with the methodology described in Note 10 – Fair Value Measurements, was less than $0.1 million as of December 31, 2022 and December 31, 2021, respectively. The relative fair value of the Series B warrant at issuance was recorded into debt issuance costs and other non-current liabilities on the accompanying consolidated balance sheets, and changes in fair value have been recorded in other income (expense), net on the accompanying consolidated statements of operations and comprehensive loss for the years ended December 31, 2022, 2021 and 2020.
Series C Warrants (Converted to Common Stock Warrants)
In July 2016, the Company issued a warrant to purchase 148,477 shares of Series C preferred stock (the “Series C warrant”) in connection with the Series C financing. The Series C warrant agreement also provided for an additional number of Series C shares calculated on a monthly basis commencing on June 2016 based on the principal balance outstanding of the notes payable outstanding. The maximum number of shares exercisable under the Series C warrant agreement is 482,969 shares of Series C preferred stock. The Series C warrant was immediately exercisable at an exercise price of $1.00 per share and has an expiration date of July 2026. The fair value of the Series C warrant, as determined in accordance with the methodology described in Note 10 – Fair Value Measurements, was $6.3 million and $1.1 million as of December 31, 2022 and December 31, 2021, respectively. The relative fair value of the Series C warrant at issuance as recorded as Series C preferred stock issuance costs and other non-current liabilities on the accompanying consolidated balance sheets, and changes in fair value have been recorded in other income (expense), net on the accompanying consolidated statements of operations and comprehensive loss for the years ended December 31, 2022, 2021 and 2020.
Series C-1 Warrants (Converted to Common Stock Warrants)
In January 2020, the Company issued a warrant to purchase 173,067 shares of common stock in conjunction with the Series
C-1
preferred stock financing. The warrant is immediately exercisable at an exercise price of $0.01 per share and has an expiration date of January 2030. The warrant remains outstanding as of December 31, 2022. At issuance, the relative fair value of the warrant was determined to be $0.1 million using the Black-Scholes model, which was recorded within additional
paid-in
capital on the consolidated balance sheets. The warrant is not remeasured in future periods as it meets the conditions for equity classification.

SVB Common Stock Warrants
In May and August 2021, the Company issued warrants to purchase 2,472 and 2,525 shares of common stock, respectively, in conjunction with the Fifth and Sixth Amendments to the Loan and Security Agreement with Silicon Valley Bank. The warrants are immediately exercisable at exercise prices of $0.38 and $0.62 per share, respectively, and have expiration dates in 2033. The warrants remain outstanding as of December 31, 2022. At issuance, the relative fair value of the warrants were determined to be less than $0.1 million in aggregate using the Black-Scholes model, which was recorded within additional
paid-in-capital
on the accompanying consolidated balance sheets. The warrants are not remeasured in future periods as they meet the conditions for equity classification.
Promissory Notes Common Stock Warrants
In October 2021, the Company issued a warrant to purchase 24,148 shares of common stock in conjunction with the issuance of a short-term promissory note. The warrant is immediately exercisable at an exercise price of $0.01 per share and has an expiration date of October 2031. The warrant remains outstanding as of December 31, 2022. At issuance, the relative fair value of the warrant was determined to be less than $0.1 million using the Black-Scholes model, which was recorded within additional
paid-in
capital on the consolidated balance sheets. The warrant is not remeasured in future periods as it meets the conditions for equity classification.
Carlyle Warrants
In February 2022, as part of a debt financing from CRSEF Solis Holdings, LLC (“Carlyle”) (refer to Note 13 – Borrowing Arrangements), the Company issued a warrant to purchase 2,887,643 shares of common stock in conjunction with the redeemable investment in CS Solis. The warrant contains two tranches, the first of which is immediately exercisable for 1,995,870 shares. The second tranche, which was determined to be a separate unit of account, was exercisable upon a subsequent investment from Carlyle in CS Solis. No subsequent investment was made and investment period expired on December 31, 2022 and the second tranche of warrants expired prior to becoming exercisable. The vested warrant has an exercise price of $0.01 per share and has an expiration date of February 2029. The warrant remains outstanding as of December 31, 2022. At issuance, the relative fair value of the warrant was determined to be $3.4 million using the Black-Scholes model, which was recorded within additional
paid-in
capital and as a discount on the long-term debt in CS Solis on the consolidated balance sheets. The warrant is not remeasured in future periods as it meets the conditions for equity classification.
Series D-7 Warrants (Converted to Common Stock Warrants)
In November 2022, the company issued warrants to purchase 656,630 shares of Series D-7 preferred stock (the “Series D-7 warrants”) in conjunction with the merger agreement with Solaria. The warrant contains two tranches. The first tranche of 518,752 shares of Series D-7 preferred stock is exercisable at an exercise price of $2.50 per share upon consummation of a deSPAC transaction, or at an exercise price of $2.04 per share upon remaining private and has an expiration date of April 2024. The second tranche of 137,878 shares of Series D-7 preferred stock is exercisable at an exercise price of $
5.00
per share upon consummation of a deSPAC transaction, or at an exercise price of $
4.09
per share upon remaining private and has an expiration date of April 2024. The warrants remain outstanding as of December 31, 2022. The fair value of the Series D-7 warrants, as determined in accordance with the methodology described in Note 10 – Fair Value Measurements, was $
7.8
million as of December 31, 2022.
All of the Series B, Series C, and Series D preferred stock warrants remained outstanding as of December 31, 2022 and December 31, 2021.
November 2022 Common Stock Warrants
In November 2022, the Company issued a warrant to a third-party service provider to purchase 38,136 shares of common stock in conjunction with the Business Combination. The warrant is immediately

exercisable at an exercise price of $8.00 per share and has an expiration date of April 2024. The warrant remains outstanding as of December 31, 2022. At issuance, the relative fair value of the warrant was determined to be $0.1 million using the Black-Scholes model, which was recorded within additional
paid-in
capital on the consolidated balance sheets. The warrant is not remeasured in future periods as it meets the conditions for equity classification.
The following assumptions were used to calculate the fair value of the common stock warrants issued:
 
    
Years Ended December 31,
     2022   2021
Expected term
  
1.5 
7.0 years
 
10.0 - 12.0 years
Expected volatility
  
73.0 - 78.5%
  73.0%
Risk-free interest rate
   1.9 - 4.7%   1.3% - 1.7%
Expected dividends
   0.0%   0.0%
 
(15)
Borrowing Arrangements
Convertible notes, net and convertible notes, net due to related parties
As of December 31, 2022 and December 31, 2021, the Company’s convertible notes consisted of the following (in thousands):
 
   
As of December 31,
 
   
2022
    
2021
 
Convertible notes, net
    
2019-A
Convertible Notes
  $         $ 115  
2020-A
Convertible Notes
              630  
2021-A
Convertible Notes
              1,145  
 
 
 
    
 
 
 
Convertible notes, net
              1,890  
 
 
 
    
 
 
 
Convertible notes, net due to related parties
    
2020-A
Convertible Notes
              3,260  
2021-A
Convertible Notes
              3,050  
Convertible Promissory Notes with Ecosystem Integrity Fund II, LP.
              510  
 
 
 
    
 
 
 
Convertible notes, net due to related parties
              6,820  
 
 
 
    
 
 
 
Convertible notes, net, noncurrent
    
2022 Convertible Notes
    3,434            
 
 
 
    
 
 
 
Convertible notes, net, noncurrent
    3,434            
 
 
 
    
 
 
 
Convertible notes, net due to related parties, noncurrent
    
2022 Convertible Notes
    15,510            
 
 
 
    
 
 
 
Convertible notes, net due to related parties, noncurrent
    15,510            
 
 
 
    
 
 
 
Total convertible notes
  $ 18,944      $ 8,710  
 
 
 
    
 
 
 
Convertible Promissory Notes with Ecosystem Integrity Fund II, LP.
On April 30, 2021, the Company issued a short-term Subordinated Convertible Promissory Note to Ecosystem Integrity Fund II, LP (“EIF”) for a total principal of $0.5 million plus accrued interest of 3.0% per annum due on June 30, 2021. The Note included a conversion feature which allows the holder to convert any portion of the note plus any unpaid accrued interest (“Conversion Amount”) into shares of Series
C-1
Preferred Stock on the maturity date of June 30, 2021 or thereafter. As of December 31, 2021 the principal and accrued interest remained outstanding and the holder did not elect to covert the note into Series
C-1
Preferred shares. The principal and accrued interest of $0.5 million was repaid in February 2022.

2019-A
Convertible Notes
In 2019, the Company issued a series of convertible notes
(“2019-A
Convertible Notes”) for $0.1 million in proceeds, with immaterial debt issuance costs, and which were due and payable on demand by the holders after August 2020. The notes carried simple interest of 6.0% and contained a conversion feature whereby the notes would convert at 80% of the issuance price of the preferred shares in the next equity financing. The notes also contained other embedded features such as conversion options that were exercisable upon the occurrence of various contingencies. All of the embedded features were analyzed to determine whether they should be bifurcated and separately accounted for as a derivative. Pursuant to such analysis, the Company valued and bifurcated the share-settled redemption feature, which enabled the holders to convert the notes to the preferred shares at a predefined discount from the issuance price and recorded its initial fair value of less than $0.1 million as a discount on the convertible notes face amount. The debt discount was amortized to interest expense at a weighted-average effective interest rate of 17.6% through the maturity dates of the notes.
The fair value of the share-settled redemption feature was determined in accordance with the methodology described in Note 8 – Fair Value Measurements, and the changes in fair value were recognized as a component of other income (expense), net in the accompanying consolidated statements of operations and comprehensive loss. The Company recorded zero, less than $0.1 million, and less than $0.1 million in expense during the years ended December 31, 2022, 2021 and 2020, respectively, related to the change in the fair value of the convertible notes embedded derivative liability. The convertible notes were carried within the accompanying consolidated balance sheets at their original issuance value, net of unamortized debt discount and issuance costs. In March 2022, as part of the Company’s Series D Preferred Stock issuance, the
2019-A
Convertible Notes converted into 62,500 shares of Series
D-2
redeemable convertible preferred stock. The Company recognized a loss on the conversion of less than $0.1 million in other income (expense), net on the consolidated statements of operations and comprehensive loss.
The net carrying amount of the convertible notes was as follows (in thousands):
 
    
As of December 31,
 
    
2022
   
2021
 
Principal
   $ 100     $ 100  
Unamortized debt discount
                  
PIK interest added to principal balance
     16       15  
Conversion to Series D-2 redeemable convertible preferred stock
     (116         
  
 
 
   
 
 
 
Net carrying amount
   $        $ 115  
  
 
 
   
 
 
 
Interest expense related to the convertible notes was as follows (in thousands):
 
    
As of December 31,
 
    
2022
    
2021
    
2020
 
Amortization of debt discount
   $         $         $ 4  
PIK interest
     1        12        3  
  
 
 
    
 
 
    
 
 
 
Total
non-cash
interest expense
   $ 1      $ 12      $ 7  
  
 
 
    
 
 
    
 
 
 
2020-A
Convertible Notes
In 2020, the Company issued a series of convertible notes
(“2020-A
Convertible Notes”) for $3.8 million in proceeds, with immaterial debt issuance costs, and which are due and payable on demand by the holders after April 2021. The notes carried simple interest of 2.0% and contained a conversion feature whereby the

notes would convert at 80% of the issuance price of the preferred shares in the next equity financing. The notes also contained other embedded features such as conversion options that were exercisable upon the occurrence of various contingencies. All of the embedded features were analyzed to determine whether they should be bifurcated and separately accounted for as a derivative. Pursuant to such analysis, the Company valued and bifurcated the share-settled redemption feature, which enables the holders to convert the notes to the preferred shares at a predefined discount from the issuance price and recorded its initial fair value of $0.5 million as a discount on the convertible notes face amount. The debt discount was amortized to interest expense at a weighted-average effective interest rate of 25.6% through the maturity dates of the notes.
The fair value of the share-settled redemption feature was determined in accordance with the methodology described in Note 8 – Fair Value Measurements, and the changes in fair value were recognized as a component of other income (expense), net in the accompanying consolidated statements of operations and comprehensive loss. The Company recorded zero, less than $0.1 million, and less than $0.1 million in expense during the years ended December 31, 2022, 2021 and 2020 respectively, related to the change in the fair value of the convertible notes embedded derivative liability. The convertible notes were carried within the accompanying consolidated balance sheets at their original issuance value, net of unamortized debt discount and issuance costs. In March 2022, as part of the Company’s Series D Preferred Stock issuance, the
2020-A
Convertible Notes converted into 785,799 shares of Series
D-1
redeemable convertible preferred stock. The Company recognized a gain on the conversion of $0.9 million in other income (expense), net on the consolidated statements of operations and comprehensive loss.
The net carrying amount of the convertible notes was as follows (in thousands):
 
    
As of December 31,
 
    
2022
    
2021
 
Principal
   $ 3,784      $ 3,784  
Unamortized debt discount
                   
PIK interest added to principal balance
     122        106  
Conversion to Series
D-1
redeemable convertible preferred stock
     (3,906          
  
 
 
    
 
 
 
Net carrying amount
   $         $ 3,890  
  
 
 
    
 
 
 
Interest expense related to the convertible notes was as follows (in thousands):
 
    
As of December 31,
 
    
2022
    
2021
    
2020
 
Amortization of debt discount . . . . . . . . . . . . . . . . . . . . . . . . .
   $         $ 281      $ 235  
PIK interest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
     16        74        32  
  
 
 
    
 
 
    
 
 
 
Total
non-cash
interest expense . . . . . . . . . . . . . . . . . . . . . . . .
   $ 16      $ 355      $ 267  
  
 
 
    
 
 
    
 
 
 
2021-A
Convertible Notes
In 2020, the Company issued a series of convertible notes
(“2021-A
Convertible Notes”) for $4.3 million in proceeds, with immaterial debt issuance costs, and which are due and payable on demand by the holders after February 2022. The holders are existing investors and are not expected to demand cash settlement, as the Company expects to raise additional preferred financing under which the notes will convert into preferred shares. The notes carry simple interest of 2.0% and contained a conversion feature whereby the notes would convert at 80% of the issuance price of the preferred shares in the next equity financing. The notes also contained other embedded features such as conversion options that were exercisable upon the occurrence of various contingencies. All of the embedded features were analyzed to determine whether they should be bifurcated and separately accounted for as a derivative. Pursuant to such analysis, the Company

valued and bifurcated the share-settled redemption feature, which enables the holders to convert the notes to the preferred shares at a predefined discount from the issuance price and recorded its initial fair value of $0.6 million as a discount on the convertible notes face amount. The debt discount is amortized to interest expense at a weighted-average effective interest rate of 18.1% through the maturity dates of the notes.
The fair value of the share-settled redemption feature was determined in accordance with the methodology described in Note 10 – Fair Value Measurements, and the changes in fair value were recognized as a component of other income (expense), net in the consolidated statements of operations and comprehensive loss. The Company recorded zero and $0.2 million and in expense during the year ended December 31, 2022 and December 31, 2021, respectively, related to the change in the fair value of the convertible notes embedded derivative liability. The convertible notes were carried on the consolidated balance sheets at their original issuance value, net of unamortized debt discount and issuance costs. In March 2022, as part of the Company’s Series D Preferred Stock issuance, the
2021-A
Convertible Notes converted into 869,640 shares of Series
D-1
redeemable convertible preferred stock. The Company recognized a gain on the conversion of $0.8 million in other income (expense), net on the consolidated statements of operations and comprehensive loss.
The net carrying amount of the convertible notes was as follows (in thousands):
 
    
As of December 31,
 
    
2022
    
2021
 
Principal
   $ 4,250      $ 4,250  
Unamortized debt discount
               (112
PIK interest added to principal balance
     74        57  
Conversion to Series
D-1
redeemable convertible preferred stock
     (4,324          
  
 
 
    
 
 
 
Net carrying amount
   $         $ 4,195  
  
 
 
    
 
 
 
Interest expense related to the convertible notes was as follows (in thousands):
 
    
As of December 31,
 
    
2022
    
2021
    
2020
 
Amortization of debt discount . . . . . . . . . . . . . . . . . . . . . . . . .
   $ 112      $ 454      $     
PIK interest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
     17        57            
  
 
 
    
 
 
    
 
 
 
Total
non-cash
interest expense . . . . . . . . . . . . . . . . . . . . . . . .
   $ 129      $ 511      $     
  
 
 
    
 
 
    
 
 
 
As part of the
2021-A
Convertible Notes financing, the Company entered into an additional convertible note with an existing investor for $0.5 million. The note carries PIK interest of 3.0% and is due and payable on demand at any time after June 30, 2021. The note contains an embedded conversion feature, which allows the holder to convert the note into a fixed number of shares of Series
C-1
preferred stock at any time after
June 30, 2021. The Company concluded the conversion feature is not required to be bifurcated as an embedded derivative liability, and the note is carried at its principal plus accrued PIK interest.
The net carrying amount of the
2021-A
convertible note without an embedded derivative liability was as follows (in thousands):
 
    
As of December 31,
 
    
2022
   
2021
 
Principal
   $ 500     $ 500  
Unamortized debt discount
                  
PIK interest added to principal balance
     10       10  
Repayment of principal and accrued interest
     (510         
  
 
 
   
 
 
 
Net carrying amount
   $        $ 510  
  
 
 
   
 
 
 

Interest expense related to the note was as follows (in thousands):
 
    
As of December 31,
 
    
2022
    
2021
    
2020
 
Amortization of debt discount
   $         $         $     
PIK interest
               10            
  
 
 
    
 
 
    
 
 
 
Total
non-cash
interest expense
   $         $ 10      $     
  
 
 
    
 
 
    
 
 
 
2022 Convertible Notes
In connection with the Business Combination Agreement, the Company has raised a series of convertible notes (“2022 Convertible Notes”) in November 2022, December 2022, and February 2023 with additional investors, with an aggregate purchase price of $12.0 million. Additionally, as part of the acquisition of Solaria, the Company assumed a note from an existing investor for its fair value of $6.7 million. The note contains the same terms as the other 2022 Convertible Notes. The Company did not incur significant issuance costs associated with the 2022 Convertible Notes. The 2022 Convertible Notes will convert to common shares of Complete Solaria, Inc. at the close of the deSPAC transaction. The 2022 Convertible Notes accrue interest at a rate of 5% per annum. Immediately prior to the closing of the expected deSPAC transaction, the 2022 Convertible Notes will be converted into that number of shares of common stock of Complete Solaria equal to (x) the principal amount together with all accrued interest of the 2022 Convertible Notes divided by 0.75, divided by (y) the price of a share of common stock of Complete Solaria used to determine the conversion ratio in the Business Combination Agreement. As of December 31, 2022, the 2022 Convertible Notes have accrued $0.2 million. The carrying values of $15.5 million and $3.4 million are recorded within convertible notes, net due to related parties and convertible notes, net on the consolidated balance sheets, respectively, as of December 31, 2022. As of December 31, 2022, the total estimated fair value of the Company’s 2022 Convertible Notes was $19.8 million, which was estimated based on Level 3 inputs.
SAFE Agreements
2019 SAFE
In September 2019, the Company issued the 2019 SAFE for $0.1 million in proceeds, with immaterial debt issuance costs. No interest was accrued on the 2019 SAFE. The 2019 SAFE contained conversion features that allowed the holder to convert the 2019 SAFE into shares of preferred stock upon the next equity financing, subject to a valuation cap. The 2019 SAFE was reported at fair value in accordance with the methodology described in Note 8 – Fair Value Measurements. The fair value of the 2019 SAFE was $0.2 million as of December 31, 2021 which is recorded in SAFE Agreements in the accompanying consolidated balance sheets. In March 2022, the Company converted the 2019 SAFE into 48,258 shares of Series
D-3
redeemable convertible preferred stock. The Company recognized a gain on the conversion of the 2019 SAFE of less than $0.1 million in other income (expense), net on the consolidated statements of operations and comprehensive loss.
2021 SAFE
In December 2021, the Company issued the 2021 SAFE for $5.0 million in proceeds, with immaterial debt issuance costs. No interest is accrued on the 2021 SAFE. The 2021 SAFE contained conversion features that allowed the holder to convert the 2021 SAFE into shares of preferred stock upon the next equity financing, subject to a valuation cap. The 2021 SAFE was reported at fair value in accordance with the methodology described in Note 10 – Fair Value Measurements. The fair value of the 2021 SAFE was $6.3 million as of December 31, 2021 which is recorded in SAFE Agreements in the accompanying consolidated balance sheets. In

March 2022, the Company converted the 2021 SAFE into 1,005,366 shares of Series
D-1
redeemable convertible preferred stock. The Company recognized a gain on the conversion of the 2021 SAFE of $1.4 million in other income (expense), net on the consolidated statements of operations and comprehensive loss.
Solaria SAFE
As part of the acquisition of Solaria (refer to Note 4 – Business Combination) the Company acquired the Solaria SAFEs. The number of shares to be issued upon conversion of the SAFE notes contained various features to convert or redeem the Solaria SAFEs in the event of an equity financing, public offering, change of control or a dissolution event.
The Company historically elected to account for all of the SAFE notes at estimated fair value pursuant to the fair value option and recorded the change in estimated fair value as other income (expense), net in the consolidated statements of operations and comprehensive loss until the notes are converted or settled. The SAFE notes were amended through the SAFE Assumption Amendment, Assignment and Assumption Agreement on November 4, 2022, as part of the merger with Complete Solar, whereby all the SAFE notes were assumed by Complete Solar. As part of the purchase price accounting discussed in Note 4 - Business Combination, the estimated fair value of the SAFE notes was determined to be $60.5 million. Post consummation of the merger the SAFE notes were converted to 8,171,662 shares of Series
D-8
preferred stock as discussed in Note 4 - Business Combination.
Notes Payable
Loan and Security Agreement
In January 2020, the Company entered into a Loan and Security Agreement (the “Loan Agreement”) with Silicon Valley Bank (“SVB”). The Loan Agreement, as amended, provided for a line of credit up to $7.0 million and has a maturity date of February 2022. Advances under the line of credit bore interest at the greater of 5.25% or the prime rate (as published in the Wall Street Journal) plus 3.5% per annum. All borrowings under the line of credit were to be secured by substantially all of the Company’s assets. As of December 31, 2021, the Company had outstanding borrowings under the line of credit of $7.0 million.
During 2021, the Company entered into several amendments to the Loan Agreement, and in May and August 2021 in connection with the Fifth and Sixth Amendments, the Company issued warrants to purchase 5,122 shares and 5,229 shares of common stock at exercise prices of $0.38 per share and $0.62 per share, respectively. The fair value of the warrants were recorded as deferred issuance costs and amortized to interest expense. As of December 31, 2022 and December 31, 2021, there were no unamortized debt issuance costs.
Under the Loan Agreement, the Company was subject to certain reporting covenants, such as a requirement for the Company’s monthly unaudited financial statements and Compliance Certificate, as well as a financial covenant to maintain a minimum liquidity ratio of 1.75 to 1.00. In 2021, the Loan Agreement was amended to add a new financial covenant, requiring the Company to obtain new equity of at least $15.0 million by a specified date, which the Company did not meet; however, the default was later waived by SVB. The Company was in compliance with all reporting and financial covenants as of December 31, 2021.
In February 2022, as part of the transaction to raise long-term debt in CS Solis, the Company repaid the principal and accrued interest of the Loan Agreement of $6.7 million, which terminated the agreement with SVB.
2021 Promissory Notes
In July 2021, the Company issued a
short-term
promissory note for $0.5 million in proceeds, with immaterial debt issuance costs. The promissory note carried simple interest of 2.0% and were due and payable after February 2022. As of December 31, 2021, the carrying value of the promissory note was

$0.5 million and was recorded in Notes Payable in the accompanying consolidated balance sheets. In February 2022, the Company repaid the 2021 Promissory Note, and no amounts remain outstanding as of December 31, 2022.
In October 2021, the Company issued a short-term promissory note for $2.0 million in proceeds, with immaterial debt issuance costs. The promissory note contained a financing fee of $0.3 million, which was due and payable along with the principal amount in January 2022. In connection with the promissory note, the Company issued a warrant to purchase 50,000 shares of common stock at an exercise price of $0.01 per share. The fair value of the warrant was recorded as a debt discount and amortized to interest expense. As of December 31, 2021, the carrying value of the promissory note was $2.0 million, which was recorded in Notes Payable in the accompanying consolidated balance sheets, and the remaining unamortized debt discount was nil. The principal and accrued interest of the note payable was repaid in January 2022, and no amounts remain outstanding as of December 31, 2022.
Paycheck Protection Program Loan
In April 2020 and April 2021, the Company received loans in principal amounts of $0.9 million and $0.9 million, respectively, under the Paycheck Protection Program (the “PPP Loans”), which was established under the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) administered by the U.S. Small Business Administration (the “SBA”). The PPP Loans were evidenced by promissory notes and bore interest at 1% with no payments for the first 6 months. The PPP Loans were subject to partial or full forgiveness if the Company used all proceeds for eligible purposes, maintained certain employment levels and maintained certain compensation levels in accordance with and subject to the CARES Act and the rules, regulations and guidance. In June and October 2021, the principal and accrued interest on the PPP Loans were forgiven.
Current Insight Promissory Note
In January 2021, the Company issued a promissory note for principal of $0.1 million in connection with the purchase of Current Insight, with immaterial debt issuance costs. The promissory note bears interest at 0.14% per annum and has equal monthly installments due and payable through the maturity date of January 2022. As of December 31, 2021, the carrying value of the promissory note was less than $0.1 million. The principal and accrued interest was repaid in January 2022 and no amounts remain outstanding as of December 31, 2022.
The following table summarizes the Company’s outstanding notes payable (in thousands):
 
    
As of December 31,
 
    
  2022  
    
  2021  
 
Loan and Security Agreement
   $         $ 6,987  
2021 Promissory Notes
               2,500  
Current Insight Promissory Note
               20  
  
 
 
    
 
 
 
               9,507  
Less: Unamortized debt issuance costs and discounts
                   
  
 
 
    
 
 
 
   $         $ 9,507  
  
 
 
    
 
 
 
2018 Bridge Notes
In December 2018, Solaria Corporation issued senior subordinated convertible secured notes (“2018 Notes”) totaling approximately $3.4 million in exchange for cash. The notes bear interest at the rate of 8% per annum and the investors are entitled to receive twice of the face value of the notes at maturity. The 2018 Notes are secured by substantially all of the assets of Solaria Corporation. In 2021, the 2018 Notes were amended extending the maturity date to December 13, 2022. In connection with the 2021 amendment,

Solaria had issued warrants to purchase shares of
Series E-1
redeemable convertible preferred stock of Solaria. The warrants were exercisable immediately in whole or in part at and expire on December 13, 2031. As part of the merger with Complete Solar, all the outstanding warrants issued to the lenders were assumed by the parent company, Complete Solaria as discussed in Note 4 – Business Combination.
As part of the purchase price accounting discussed in Note 4 – Business Combination, the estimated fair value of the 2018 Notes was determined to be $9.1 million.
In December 2022, the Company entered into an amendment to the 2018 Notes extending the maturity date from December 13, 2022 to December 13, 2023. In connection with the amendment, the notes will continue to bear interest at 8% per annum and are entitled to an increased repayment premium from 110% to 120% of the principal and accrued interest at the time of repayment.
The Company concluded that the modification was a troubled debt restructuring as the Company was experiencing financial difficulty and the amended terms resulted in a concession to the Company. As the future undiscounted cash payments under the modified terms exceeded the carrying amount of the Solaria 2018 Notes on the date of modification, the modification was accounted for prospectively. The incremental repayment premium is being amortized to interest expense using the effective interest rate method. As of December 31, 2022, the carrying value of the 2018 Notes was $9.8 million. Interest expense recognized from the date of the acquisition through December 31, 2022 was $0.7 million. As of December 31, 2022, the total estimated fair value of the Company’s 2018 Bridge Notes was $9.1 million, which was estimated based on Level 3 inputs.
SCI Term Loan and Revolver Loan
In October 2020, Solaria entered into a loan agreement (“Loan Agreement”) with Structural Capital Investments III, LP (“SCI”).
The Loan Agreement with SCI comprises of two facilities, a term loan (the “Term Loan”) and a revolving loan (the “Revolving Loan”) (together “Original Agreement”) for $5.0 million each with a maturity date of October 31, 2023. Both the Term Loan and the Revolving Loan were fully drawn upon closing. The Term Loan was repaid prior to the acquisition of Solaria by Complete Solar and was not included in the business combination.
The Revolving Loan also has a term of
thirty-six
months, principal repayments at the end of the term and an annual interest rate of 7.75% or Prime rate plus 4.5%, whichever is higher. The Loan Agreement required the Company to meet certain financial covenants relating to maintenance of specified restricted cash balance, achieving specified revenue target and maintaining specified contribution margin (“Financial covenants”) over the term of each of the Revolving Loan. The Revolving Loan is collateralized substantially by all assets and property of the Company.
In the years ended December 31, 2022 and December 31, 2021, Solaria entered into several Amended and Restated Loan and Security Agreements as a forbearance agreement for SCI to forbear from exercising any rights and remedies available to it as a result of Company not meeting certain Financial Covenants required by the Original Agreement. As a result of these amendment changes were made to the financial covenants and Solaria recorded a total of $1.9 million amendment fees in Other Liabilities and was included in the acquired liabilities for purchase price accounting.
Solaria had historically issued warrants to purchase shares of Series
E-1
redeemable convertible preferred stock of Solaria (“SCI Series
E-1
warrants”). The warrants were fully exercisable in whole or in part at any time during the term of the Original agreement. As part of the merger with Complete Solar, all the outstanding SCI Series
E-1
warrants were assumed by the parent company, Complete Solaria as discussed in Note 4 – Business Combination.
The Revolving loan outstanding on the date of merger was fair valued at $5.0 million for the purpose of purchase price accounting discussed in Note 3. The revolving loan principal balance at December 31, 2022 amounted to $5.0 million and is due on October 2023. Interest expense recognized from the date of merger to December 31,

2022 amounted to $0.1 million. The Company was in compliance with all the covenants as of December 31, 2022. As of December 31, 2022, the fair value of the Revolving Loan approximates its carrying value.
Secured Credit Facility
In December 2022, the Company entered into a secured credit facility agreement with Kline Hill Partners IV SPV LLC and Kline Hill Partners Opportunity IV SPV LLC. The secured credit facility agreement matures in April 2023, which allows the Company to borrow up to 70% of the net amount of its eligible vendor purchase orders with a maximum amount of $10.0 million at any point in time. The purchase orders are backed by relevant customer sales orders which serves as a collateral. The amounts drawn under the secured credit facility may be reborrowed provided that the aggregate borrowing does not exceed $20.0 million. The repayment under the secured credit facility is the borrowed amount multiplied by 1.15x if repaid within 75 days and borrowed amount multiplied by 1.175x if repaid after 75 days. The Company may prepay any borrowed amount without premium or penalty.
In December 2022, the Company borrowed an amount of $5.5 million against the secured credit facility. In February 2023, the Company made a repayment of $6.3 million which included aggregate financing cost amounting to $0.8 million. At December 31, 2022, the outstanding net Debt amounted to $5.6 million, including accrued financing cost of $0.1 million. As of December 31, 2022, the fair value of the Secured Credit Facility approximates its carrying value.
Long-term debt in CS Solis
As described above, as part of the reorganization in February 2022 of the Company, the Company received an investment from CRSEF. The investment was made pursuant to a subscription agreement, under which Carlyle contributed $25.6 million in exchange for 100 Class B Membership Units of CS Solis and the Company contributed the net assets of Complete Solar, Inc. in exchange for 100 Class A Membership. The Class B Membership Units are mandatorily redeemable by the Company on the three-year anniversary of the effective date of the CS Solis amended and restated LLC agreement (February 14, 2025). The Class B Membership Units accrue interest that is payable upon redemption at a rate of 10.5% (which is structured as a dividend payable based on 25% of the investment amount measured quarterly), compounded annually, and subject to increases in the event the Company declares any dividends. In connection with the investment, the Company issued a warrant to purchase 5,978,960 shares of the Company’s common stock at a price of $0.01 per share, of which, 4,132,513 shares are immediately exercisable. The Company has accounted for the mandatorily redeemable investment from Carlyle in accordance with ASC 480,
Distinguishing Liabilities from Equity
, and has recorded the investment as a liability, which is accreted to its redemption value under the effective interest method. The Company has recorded the warrants as a discount to the liability. Refer to Note 13 – Common Stock, for further discussion of the warrants issued in connection with the Class B Membership Units. As of December 31, 2022, the Company has recorded a liability of $25.2 million included in long-term debt in CS Solis on the consolidated balance sheets. For the year ended December 31, 2022, the Company has recorded accretion of the liability as interest expense of $2.4 million, and the Company has recorded the amortization of issuance costs as interest expense of $1.2 million. As of December 31, 2022, the total estimated fair value of the Company’s 2018 long-term debt in CS Solis was $24.0 million, which was estimated based on Level 3 inputs.
 
(16)
Stock-Based Compensation
In 2011, the Company’s Board of Directors and stockholders approved the adoption of the 2011 Stock Plan (the “2011 Plan”). The 2011 Plan provides for the granting of incentive stock options, nonstatutory stock options, and restricted stock to employees,
non-employee
directors, and consultants of the Company. Options may be granted at a price per share not less than 100% of the fair market value at date of grant. If an incentive stock option is granted to a 10% stockholder, then the purchase or exercise price per share shall not be less than 110% of the fair market value per share of common stock on the grant date. Options granted

under the 2011 Plan continue to vest until the last day of employment and generally vest over four years and expire 10 years from the date of grant. A total of 2,596,764 shares of common stock was reserved for the 2011 Plan, as amended, as of December 31, 2022 and December 31, 2021.
In 2021, the Company’s Board of Directors and stockholders approved the adoption of the 2021 Stock Plan (the “2021 Plan”). The 2021 Plan provides for the granting of incentive stock options, nonstatutory stock options, and restricted stock to employees,
non-employee
directors, and consultants of the Company. Options may be granted at a price per share not less than 100% of the fair market value at date of grant. If an incentive stock option is granted to a 10% stockholder, then the purchase or exercise price per share shall not be less than 110% of the fair market value per share of common stock on the grant date. Options granted under the 2021 Plan continue to vest until the last day of employment and generally vest over four years and expire 10 years from the date of grant. A total of 241,484 shares of common stock was initially reserved for the 2021 Plan. Any shares of common stock that would have otherwise been returned to the Company’s 2011 Plan as a result of forfeiture, expiration, cancellation, termination or net issuances of awards thereunder shall be returned to the share reserve under the 2021 Plan.
In 2022, the Company’s Board of Directors and stockholders approved the adoption of the 2022 Stock Plan (the “2022 Plan”). The 2022 Plan provides for the granting of incentive stock options, nonstatutory stock options, and restricted stock to employees,
non-employee
directors, and consultants of the Company. Options may be granted at a price per share not less than 100% of the fair market value at date of grant. If an incentive stock option is granted to a 10% stockholder, then the purchase or exercise price per share shall not be less than 110% of the fair market value per share of common stock on the grant date. Options granted under the 2022 Plan continue to vest until the last day of employment and generally vest over four years and expire 10 years from the date of grant. A total of 3,225,237 shares of common stock was initially reserved for the 2022 Plan. Any shares of common stock that would have otherwise been returned to the Company’s 2011 Plan and 2021 Plan as a result of forfeiture, expiration, cancellation, termination or net issuances of awards thereunder shall be returned to the share reserve under the 2022 Plan. The 2011 Plan, 2021 Plan, and 2022 Plan are collectively referred to as the “Plans” in the notes to the financial statements, unless otherwise noted.
A summary of stock option activity for the years ended December 31, 2022 and December 31, 2021 under the Plans is as follows:
 
   
Options outstanding
 
   
Number of
shares
   
Weighted
average
exercise
price per
share
   
Weighted
average
contractual
term
(in years)
   
Aggregate
intrinsic

value
(in thousands)
 
Outstanding—January 1, 2021
    1,968,580     $ 0.58       7.87     $ 1,044  
Options granted
    212,434       0.89      
Options exercised
    (7,245     0.83      
Options canceled
    (38,315     0.62      
 
 
 
   
 
 
   
 
 
   
 
 
 
Outstanding—December 31, 2021
    2,135,454     $ 0.62       6.99     $ 2,263  
Options granted
    3,088,350       7.45      
Options exercised
    (162,034     0.48      
Options canceled
    (91,376     0.83      
 
 
 
   
 
 
   
 
 
   
 
 
 
Outstanding—December 31, 2022
    4,970,395     $ 4.87       6.99     $ 34,180  
 
 
 
   
 
 
   
 
 
   
 
 
 
Vested and expected to vest—December 31, 2022
    4,970,395     $ 4.87       6.99     $ 34,180  
 
 
 
   
 
 
   
 
 
   
 
 
 
Vested and exercisable—December 31, 2022
    2,794,862     $ 4.35       6.29     $ 22,204  
 
 
 
   
 
 
   
 
 
   
 
 
 
The weighted-average grant-date fair value of options granted for the years ended December 31, 2022 and December 31, 2021, was $7.99 per share and $0.72 per share, respectively. The total fair value of options vested for the years ended December 31, 2022 and December 31, 2021, was $10.5 million and $0.2 million, respectively. The aggregate intrinsic value of options exercised for the years ended December 31, 2022 and December 31, 2021, was $0.2 million and less than $0.1 million, respectively.

Determination of Fair Value
Prior to the Mergers, the Company estimated grant-date fair value of stock options using the Black-Scholes-Merton option- pricing model. The determination of the fair value of each stock award using this option-pricing model is affected by the Company’s assumptions regarding a number of complex and subjective variables. These variables include, but are not limited to, the expected stock price volatility over the term of the awards. Stock-based compensation is measured at the grant date based on the fair value of the award and is recognized as expense on a straight-line basis over the requisite service period, which is generally the vesting period of the respective award.
The following assumptions were used to calculate the fair value of stock-based compensation:
 
    
Years Ended December 31,
    
2022
  
2021
Expected term
   1.0 – 7.5 years    5.0 – 6.1 years
Expected volatility
   60.0% – 78.5%    52.6% – 56.7%
Risk-free interest rate
   3.4% – 4.8%    0.8% – 1.3%
Expected dividends
   0.0%    0.0%
Expected term
— The Company has opted to use the “simplified method” for estimating the expected term of options, whereby the expected term equals the arithmetic average of the vesting term and the original contractual term of the option (generally
10
years).
Expected volatility
— Due to the Company’s limited operating history and a lack of company specific historical and implied volatility data, the Company has based its estimate of expected volatility on the historical volatility of a group of peer companies that are publicly traded. The historical volatility data was computed using the daily closing prices for the selected companies’ shares during the equivalent period of the calculated expected term of the stock-based awards.
Risk-free interest rate
— The risk-free rate assumption is based on U.S. Treasury instruments with maturities similar to the expected term of the Company’s stock options.
Expected dividends
— The Company has not issued any dividends in its history and does not expect to issue dividends over the life of the options and therefore has estimated the dividend yield to be zero.
Fair value of common stoc
k — The fair value of the shares of common stock underlying the stock-based awards has historically been determined by the Board of Directors, with input from management. Because there has been no public market for the Company’s common stock, the Board of Directors has determined the fair value of the common stock on the grant-date of the stock-based award by considering a number of objective and subjective factors. Such factors include a valuation of the Company’s common stock performed by an unrelated third-party specialist, valuations of comparable companies, sales of the Company’s redeemable convertible preferred stock to unrelated third-parties, operating and financial performance, the lack of liquidity of the Company’s capital stock, as well as general and industry-specific economic outlooks. For financial reporting purposes, the Company considers the amount of time between the valuation date and the grant date to determine whether to use the latest common stock valuation or a straight-line interpolation between the two valuation dates. The determination included an evaluation of whether the subsequent valuation indicated that any significant change in valuation had occurred between the previous valuation and the grant date.

Stock-based compensation expense
The following table summarizes stock-based compensation expense and its allocation within the accompanying consolidated statements of operations and comprehensive loss (in thousands):
 
    
Years Ended December 31,
 
    
  2022  
    
  2021  
    
  2020  
 
Cost of revenues
   $ 22      $ 19      $ 8  
Sales and marketing
     168        68        37  
General and administrative
     243        113        64  
Loss from discontinued operations, net of tax
     470                      
  
 
 
    
 
 
    
 
 
 
Total stock-based compensation expense
   $ 903      $ 200      $ 109  
  
 
 
    
 
 
    
 
 
 
As of December 31, 2022 there was a total of $
5.4
 million of unrecognized stock-based compensation costs related to
non-vested
stock option awards, which is expected to be recognized over a weighted-average period of approximately
2.2
years.
 
(17)
Commitments and Contingencies
Operating Leases
The Company leases its facilities under
non-cancelable
operating lease agreements. The Company’s leases have remaining terms of 0.3 years to 3.8 years. Options to renew or extend leases beyond their initial term have been excluded from measurement of the ROU assets and lease liabilities as exercise is not reasonably certain. Operating leases are reflected on the consolidated balance sheets within operating lease ROU assets and the related current and
non-current
operating lease liabilities. ROU assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make lease payments arising from lease agreement. Operating lease ROU assets and liabilities are recognized at the commencement date, or the date on which the lessor makes the underlying asset available for use, based upon the present value of the lease payments over the respective lease term. Lease expense is recognized on a straight-line basis over the lease term, subject to any changes in the lease or expectation regarding the terms. Variable lease costs such as common area maintenance, property taxes and insurance are expensed as incurred. Variable lease cost was $0.2 million for the year ended December 31, 2022 and immaterial for the year ended December 31, 2021. Total operating lease expense for the years ended December 31, 2022 and December 31, 2021 was $0.7 million and $0.4 million, respectively.
The Company made $1.0 million and $0.4 million of cash payments related to operating leases during the years ended December 31, 2022 and December 31, 2021, respectively. New operating lease
right-of-use
assets obtained in exchange for operating lease liabilities were $1.9 million and $1.2 million during the years ended December 31, 2022 and December 31, 2021, respectively, including the impact of adopting ASC 842. On the date of adoption, January 1, 2021, the Company recognized right-of-use assets of approximately $1.1 million and lease liabilities of approximately $1.2 million, of which $0.4 million was included in accrued and other current liabilities and $0.8 million was included in operating lease liabilities, net of current portion on the consolidated balance sheets.
The weighted average remaining lease term and the discount rate for the Company’s operating leases are as follows:
 
    
December 31, 2022
 
Remaining average remaining lease term (years)
     3.24  
Weighted average discount rate
     14.47

Future minimum lease payments under
non-cancelable
operating leases, and future payments under the Lease Termination Agreement, as of December 31, 2022 are as follows (in thousands):
 
2023
   $ 1,048  
2024
     743  
2025
     592  
2026
     477  
2027 and thereafter
         
  
 
 
 
Total undiscounted liabilities
     2,860  
  
 
 
 
Less imputed interest
     (628
  
 
 
 
Present value of operation lease liabilities
   $ 2,232  
  
 
 
 
Accounting under ASC 840
Prior to the adoption of ASC 842, rent expense on operating leases was recognized on a straight-line basis over the term of the lease. In addition, certain of the Company’s operating lease agreements for facilities also include rent escalations or rent abatements during the initial lease term. The Company recorded the rent escalations as deferred rent, net of current portion on the accompanying balance sheets. The Company recognized the deferred rent liability on a straight-line basis into rent expense over the lease term commencing on the date the Company took possession of the leased space. Rent expense was $0.3 million for the year ended December 31, 2020.
Warranty Provision
The Company accrues warranty costs when revenue is recognized for solar energy systems sales and panel sales, based on the estimated future costs of meeting its warranty obligations. Warranty costs primarily consist of replacement materials and equipment and labor costs for service personnel.
Activity by period relating to the Company’s warranty provision was as follows:
 
    
Years Ended December 31,
 
    
2022
    
2021
    
2020
 
Warranty provision, beginning of period
   $ 2,281      $ 1,652      $ 1,816  
Warranty liability from the Business Combination
     1,943        
Accruals for new warranties issued
     1,492        1,516        607  
Settlements
     (1,735      (887      (771
  
 
 
    
 
 
    
 
 
 
Warranty provision, end of period
   $ 3,981      $ 2,281      $ 1,652  
  
 
 
    
 
 
    
 
 
 
Warranty provision, current
   $ 767      $ 600      $ 497  
Warranty provision, noncurrent
   $ 3,214      $ 1,681      $ 1,155  
Indemnification Agreements
From time to time, in its normal course of business, the Company may indemnify other parties, with which it enters into contractual relationships, including customers, lessors, and parties to other transactions with the Company. The Company may agree to hold other parties harmless against specific losses, such as those that could arise from breach of representation, covenant or third-party infringement claims. It may not be possible to determine the maximum potential amount of liability under such indemnification agreements due to the unique facts and circumstances that are likely to be involved in each particular claim and indemnification provision. Historically, there have been no such indemnification claims. In the opinion of management, any liabilities resulting from these agreements will not have a material adverse effect on the business, financial position, results of operations, or cash flows.

Legal Matters
The Company is a party to various legal proceedings and claims which arise in the ordinary course of business. The Company records a liability when it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. If the Company determines that a loss is reasonably possible and the loss or range of loss can be reasonably estimated, the Company discloses the reasonably possible loss. The Company adjusts its accruals to reflect the impact of negotiations, settlements, rulings, advice of legal counsel and other information and events pertaining to a particular case. Legal costs are expensed as incurred. Although claims are inherently unpredictable, the Company is not aware of any matters that have a material adverse effect on the business, financial position, results of operations, or cash flows. The Company has recorded $1.9 million and $0.2 million as a loss contingency in accrued expenses and other current liabilities on the consolidated balance sheets as of December 31, 2022 and December 31, 2021, respectively, primarily associated with the pending settlement of the following legal matters.
Katerra Litigation
On July 22, 2022, Katerra, Inc. filed a complaint for breach of contract and turnover of property under Section 542(b) of the Bankruptcy Code in the United States Bankruptcy Court for the Southern District of Texas. The complaint seeks damages for the amounts due under the Settlement Agreement and for attorney’s fees. The Company filed an answer to the complaint on September 6, 2022. No discovery has occurred.
Vendor Settlement
On January 10, 2023, a vendor entered into an agreement with the Company to settle past due performance related payments related to various tools. As part of the agreement, the Company agreed to pay $0.9 million in three equal installments. The Company paid the first installment on January 12, 2023 and will pay the second and third installments on March 31, 2023 and June 30, 2023, respectively.
SolarPark Litigation
In January 2023, SolarPark Korea Co., LTD (“
SolarPark
”) demanded approximately $80.0 million during discussions between the Company and SolarPark. In February 2023, the Company submitted its statement of claim seeking approximately $26.4 million in damages against SolarPark. The ultimate outcome of this arbitration is currently unknown and could result in a material liability to the Company. However, the Company believes that the allegations lack merit and intends to vigorously defend all claims asserted. No liability has been recorded in the Company’s consolidated financial statements as the likelihood of a loss is not probable at this time.
On March 16, 2023, SolarPark filed a complaint against Solaria and the Company in the United States District Court for the Northern District of California. The complaint alleges a civil conspiracy involving misappropriation of trade secrets, defamation, tortious interference with contractual relations, inducement to breach of contract, and violation of California’s Unfair Competition Law. The complaint indicates that SolarPark has suffered in excess of $220 million in damages. The ultimate outcome of this litigation is currently unknown and could result in a material liability to the Company. However, the Company believes that the allegations lack merit and intends to vigorously defend all claims asserted. No liability has been recorded in the Company’s consolidated financial statements as the likelihood of a loss is not probable at this time.
Letters of Credit
The Company had $3.5 million of outstanding letters of credit related to normal business transactions as of December 31, 2022. These agreements require the Company to maintain specified amounts of cash as collateral in segregated accounts to support the letters of credit issued thereunder. As discussed in Note 1, the cash collateral in these restricted cash accounts was $3.7 million as of December 31, 2022. The Company did not have any outstanding letters of credit as of December 31, 2021.

(18)
Income Taxes
The provision for income taxes consisted of the following (in thousands):
 
    
Years Ended December 31,
 
    
  2022  
    
  2021  
    
  2020  
 
Current:
        
Federal
   $         $         $     
State
     27        3        3  
Foreign
                             
  
 
 
    
 
 
    
 
 
 
Total current
   $ 27      $ 3      $ 3  
  
 
 
    
 
 
    
 
 
 
Deferred:
        
Federal
   $         $         $     
State
                             
Foreign
                             
  
 
 
    
 
 
    
 
 
 
Total deferred
                             
  
 
 
    
 
 
    
 
 
 
Total provision
   $ 27      $ 3      $ 3  
  
 
 
    
 
 
    
 
 
 
The reconciliation of federal statutory income tax rate to our effective income tax rate is as follows (in thousands):
 
    
Years Ended December 31,
 
    
2022
    
2021
    
2020
 
Statutory federal income tax
   $ (6,184    $ (1,918    $ (1,454
State income taxes, net of federal tax benefits
     (1,207      (353      (336
Stock compensation
     64        42        22  
Non-deductible
interest expense
     78        689        257  
Mark to market adjustments
     397                      
Nondeductible Expenses
     279        2        4  
PPP Loan
               (368          
Foreign earnings taxed at different rates
     157                      
Other
     (8                    
Valuation allowance
     6,451        1,910        1,510  
  
 
 
    
 
 
    
 
 
 
Tax Provision
   $ 27      $ 4      $ 3  
  
 
 
    
 
 
    
 
 
 

Significant components of our deferred tax assets and liabilities are as follows (in thousands):
 
    
Years Ended December 31,
 
    
      2022      
    
      2021      
 
NOL carryforwards
   $ 60,710      $ 7,931  
Credits
     195            
Bad debt reserve
     1,382        946  
Inventory reserve
     2,724        680  
Warranty reserve
     651        631  
Revenue warranty
     155        111  
Interest expense carryover
     3,445        170  
Accrued compensation
     678        687  
Deferred revenue
     195        639  
ASC 842 leases
     12        17  
Assembled workforce
               15  
Fixed assets
     328            
Capitalized research and development
     509            
Other
     2,837        28  
Total
     73,821        11,855  
Valuation allowance
     (63,737      (11,348
  
 
 
    
 
 
 
Net deferred tax assets
   $ 10,084      $ 507  
Deferred Tax Liabilities
     
Accounting method change
     (18      (38
Capitalized software
     (234      (468
Fixed assets
               (1
Intangibles
     (9,084          
Convertible debt
     (748          
  
 
 
    
 
 
 
Refundable and deferred income taxes
   $         $     
  
 
 
    
 
 
 
The Company has established a valuation allowance to offset the gross deferred tax assets as of December 31, 2022 and December 31, 2021, due to the uncertainty of realizing future tax benefits from its net operating loss carryforwards and other deferred tax assets. The valuation allowance balance was $63.7 million and $11.3 million for the years ended December 31, 2022 and December 31, 2021, respectively.
In assessing the realizability of deferred income tax assets, the Company considered whether it is more likely than not that some portion or all of its deferred income tax assets will be realized. The ultimate realization of deferred income tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Due to the uncertainty surrounding the Company’s ability to realize such deferred income tax assets, a full valuation allowance has been established. The valuation allowance increased by $52.4 million during the year ended December 31, 2022, and $1.9 million during the year ended December 31, 2021. During 2022 the valuation allowance increased $45.9 million due to acquired deferred tax assets.
As of December 31, 2022 and 2021, the Company had federal net operating loss carryforwards of approximately $237.7 million and $28.0 million and state net operating loss carryforwards of approximately $157.1 million and $30.2 million, respectively. Federal net operating losses that will expire between the years 2030 and 2037 total $114.6 million.
As of December 31, 2022 and 2021, the Company had state research and development credit carryforwards of approximately $1.6 million and zero, respectively. The credits do not expire.
The utilization of the Company’s net operating loss and R&D credit carryforwards may be subject to limitation due to the “change in ownership provisions” under Section 382 of the Internal Revenue Code and similar foreign provisions. Such limitations may result in the expiration of these carryforwards before their

utilization. The Company’s acquired net operating loss carryforwards have been reduced based on the estimated amount which will be lost due to these limitations.
The Company is subject to income taxes in the U.S. federal jurisdiction, and various foreign jurisdictions. Tax regulations within each jurisdiction are subject to the interpretation of the related tax laws and regulations and require significant judgment to apply. The Company’s tax years remain open for examination by all tax authorities since inception. The Company is not currently under examination in any tax jurisdictions.
As of December 31, 2022 and 2021, the Company had unrecognized tax benefits of $1.3 million and zero, respectively. The reversal of the uncertain tax benefits would not affect the Company’s effective tax rate to the extent that it continues to maintain a full valuation allowance against its deferred tax assets.
The Company applies the provisions set forth in FASB ASC Topic 740, Income Taxes, to account for the uncertainty in income taxes. In the preparation of income tax returns in federal and state jurisdictions, the Company asserts certain tax positions based on its understanding and interpretation of income tax laws.
The following is a tabular reconciliation of the total amounts of unrecognized tax benefits (in thousands):
 
    
Years Ended December 31,
 
    
    2022    
    
    2021    
 
Unrecognized tax benefits as of beginning of year
   $         $     
Increases related to prior year tax positions
     1,335            
Increases related to current year tax positions
                   
Decreases related to prior year tax positions
                   
Unrecognized tax benefits as of end of year
     —              
  
 
 
    
 
 
 
   $ 1,335      $     
  
 
 
    
 
 
 
The Company recognizes interest and penalties related to unrecognized tax benefits within the income tax expense line in the statements of operations and comprehensive loss. Accrued interest and penalties are included as part of income tax payable in the consolidated balance sheets. No accrued interest or penalties have been recorded for year ended December 31, 2022 or December 31, 2021.
The Company has not provided U.S. income or foreign withholding taxes on the undistributed earnings of its foreign subsidiary as of December 31, 2022 and December 31, 2021 because it intends to permanently reinvest such earnings outside of the United States. If these foreign earnings were to be repatriated in the future, the related U.S. tax liability will be immaterial, due to the participation exemption put in place under the 2017 Tax Cuts and Jobs Act.
On March 18, 2020, the Families First Coronavirus Response Act (FFCR Act) and, on March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) were each enacted in response to the
COVID-19
pandemic. The FFCR Act and the CARES Act contain numerous income tax provisions relating to refundable payroll tax credits, deferment of employer side social security payments, net operating loss carryback periods, alternative minimum tax credit refunds, modifications to the net interest deduction limitations and technical corrections to tax depreciation methods for qualified improvement property. The Company analyzed the provisions of the Act and determined there was no significant impact to its 2022 or 2021 tax provision.
On June 29, 2020, the California Governor signed Assembly Bill 85 (“A.B. 85”) which includes several tax measures, provides for a three-year suspension of the use of net operating losses for medium and large businesses and a three-year cap on the use of business incentive tax credits to offset no more than $5 million of tax per year. Generally, A.B. 85 suspends the use of net operating losses for taxable years 2020, 2021, and 2022 for taxpayers with taxable income of $1 million or more. The Company analyzed the provisions of the A.B. 85 and determined there was no significant impact to its 2022 or 2021 tax provision.

On December 27, 2020, the “Consolidated Appropriations Act, 2021” (the “CAA”) was signed into law. The CAA includes provisions meant to clarify and modify certain items put forth in CARES Act, while providing aid to businesses affected by the pandemic. The CAA allows deductions for expenses paid for by Paycheck Protection Program (“PPP”) and Economic Injury Disaster Loan (“EIDL”) . The Program, clarifies forgiveness of EIDL advances, and other business provisions. The Company analyzed the provisions of the CAA and determined there was no significant impact to its 2022 and 2021 tax provision.
 
(19)
Basic and Diluted Net Loss Per Share
The Company computes net loss per share in accordance with ASC 260. No dividends were declared or paid for the years ended December 31, 2022 and December 31, 2021. Undistributed earnings for each period are allocated to participating securities, including the redeemable convertible preferred stock, based on the contractual participation rights of the security to share in the current earnings as if all current period earnings had been distributed. As there is no contractual obligation for the redeemable convertible preferred stock to share in losses, the Company’s basic net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted-average shares of common stock outstanding during periods with undistributed losses.
The following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common stockholders for the years ended December 31, 2022, 2021 and 2020 (in thousands, except share and per share amounts):
 
    
Years Ended December 31,
 
    
2022
    
2021
    
2020
 
Numerator:
        
Net loss from continuing operations
   $ (28,023    $ (9,282    $ (5,682
Net loss from discontinued operations
     (1,454      —          —    
  
 
 
    
 
 
    
 
 
 
Net loss
   $ (29,477    $ (9,282    $ (5,682
  
 
 
    
 
 
    
 
 
 
Denominator:
        
Weighted average common shares outstanding, basic and diluted
     22,524,400        11,990,015        9,760,018  
Net loss per share:
        
Continuing operations – basic and diluted
   $ (1.24    $ (0.77    $ (0.58
Discontinued operations – basic and diluted
   $ (0.07    $ —        $ —    
Net loss per share – basic and diluted
   $ (1.31    $ (0.77    $ (0.58
Basic and diluted net loss per share attributable to common stockholders is the same for the years ended December 31, 2022, 2021 and 2020 because the inclusion of potential shares of common stock would have been anti-dilutive for the periods presented.
The following table presents the potential common shares outstanding that were excluded from the computation of diluted net loss per share of common stock as of the periods presented because including them would have been antidilutive:
 
    
As of December 31,
 
    
2022
    
2021
    
2020
 
Stock options issued and outstanding
     4,970,419        2,135,464        1,968,590  
Convertible notes
     1,912,493        1,618,585        812,531  
Preferred stock warrants
     1,152,790        488,024        488,024  
SAFE agreements
               388,785        19,562  
Common stock warrants
     43,135        4,999            
  
 
 
    
 
 
    
 
 
 
Potential common shares excluded from diluted net loss per share
     8,078,837        4,635,857        3,288,706  
  
 
 
    
 
 
    
 
 
 

(20)
Related Party Transactions
Related Party Convertible Promissory Notes
In 2020, the Company issued convertible promissory notes (“2020 Convertible Notes”) of approximately $3.8 million to various investors, out of which $3.3 million was issued to nine related parties. The related party debt is presented as convertible notes, net in the accompanying consolidated balance sheets, adjusted for deferred interest, allocated debt financing costs and derivative liability recorded as debt discount. The principal amount of the outstanding balance accrued interest at 2.0% per annum.
In 2021, the Company issued convertible promissory notes (“2021 Convertible Notes”) of approximately $4.8 million to various investors, out of which $3.6 million was issued to four related parties. The related party debt is presented as convertible notes, net’ in the accompanying consolidated balance sheets, adjusted for deferred interest, and allocated debt financing costs. The principal amount of the outstanding balance accrued interest at 2.0% per annum.
In March 2022, as part of the Company’s Series D redeemable convertible preferred stock issuance, the Company converted all of the outstanding convertible note series. As part of the conversion, the Company recognized a gain on the extinguishment of related party convertible notes of $1.4 million, which was recorded in other income (expense), net on the consolidated statements of operations and comprehensive loss.
In October through December 2022, the Company issued convertible promissory notes (“2022 Convertible Notes”) of approximately $12.0 million to various investors, out of which $8.6 million was issued to four related parties. Additionally, the Company acquired a related party convertible note, on the same terms as the 2022 Convertible Notes as part of the acquisition of Solaria with a fair value of $6.7 million at the time of the acquisition. The related party debt is presented as convertible notes, net due to related parties, noncurrent in the accompanying consolidated balance sheets. The principal amount of the outstanding balance on the 2022 Convertible Notes accrues at 5.0%, compounded annually. For the year-ended December 31, 2022, the Company has recognized $0.2 million in interest expense related to the related party 2022 Convertible Notes.
There were no other material related party transactions during the years ended December 31, 2022, 2021 or 2020.
 
(21)
Subsequent Events
In connection with the Business Combination Agreement, the Company has raised a series of convertible notes (“2023 Convertible Notes”) in January 2023 and February 2023 with additional investors, with an aggregate purchase price of $11.0 million. The 2023 Convertible Notes will convert to common shares of Complete Solaria, Inc. at the Closing. The 2022 Notes accrue interest at a rate of 5% per annum. Immediately prior to the Closing, the 2023 Convertible Notes will be converted into that number of shares of common stock of Complete Solaria equal to (x) the principal amount together with all accrued interest of the 2023 Convertible Notes divided by 0.75, divided by (y) the price of a share of common stock of Complete Solaria used to determine the conversion ratio in the Business Combination Agreement.
On March 10, 2023, the Federal Deposit Insurance Corporation (“FDIC”) announced the closure of Silicon Valley Bank (“SVB”). On March 13, 2023, pursuant to a joint statement released by the U.S. Department of the Treasury, the U.S. Federal Reserve, and the FDIC, the U.S. government reassured that all depositors will be fully protected. As of the date the accompanying consolidated financial statements were issued, the Company has transferred substantially all of its cash out of SVB to other financial institutions. The Company does not currently anticipate any disruption to its ongoing operations.

ITEM 1. FINANCIAL STATEMENTS
COMPLETE SOLARIA, INC.
Unaudited Condensed Consolidated Balance Sheets
(
in thousands except share and per share amounts
)
 
    
As of
 
    
October 1,
2023
   
December 31,
2022
 
Assets
    
Current assets:
    
Cash and cash equivalents
   $ 1,661     $ 4,409  
Accounts receivable, net of allowance for credit losses of $10,425 and $5,396 as of October 1, 2023 and December 31, 2022, respectively
     26,003       27,717  
Inventories
     12,503       13,059  
Prepaid expenses and other current assets
     9,947       10,071  
  
 
 
   
 
 
 
Total current assets
     50,114       55,256  
Restricted cash
     3,758       3,907  
Property and equipment, net
     4,185       3,476  
Operating lease
right-of-use
assets
     1,465       2,182  
Other noncurrent assets
     198       1,330  
Long-term assets held for sale – discontinued operations
     12,299       162,032  
  
 
 
   
 
 
 
Total assets
   $ 72,019     $ 228,183  
  
 
 
   
 
 
 
Liabilities and stockholders’ (deficit) equity
    
Current liabilities:
    
Accounts payable
   $ 14,571     $ 14,474  
Accrued expenses and other current liabilities
     26,674       19,830  
Notes payable, net
(1)
     27,934       20,403  
Deferred revenue, current
     2,421       5,407  
Short-term debt with CS Solis
     29,194       —    
Forward purchase agreement liabilities
(2)
     6,586       —    
  
 
 
   
 
 
 
Total current liabilities
     107,380       60,114  
Warranty provision, noncurrent
     3,416       3,214  
Warrant liability
     10,240       14,152  
Long-term debt with CS Solis
     —         25,204  
Convertible notes, net, noncurrent
     —         3,434  
Convertible notes due to related parties, noncurrent
     —         15,510  
Deferred revenue, noncurrent
     976       —    
Operating lease liabilities, net of current portion
     790       1,274  
  
 
 
   
 
 
 
Total liabilities
     122,802       122,902  
  
 
 
   
 
 
 
Commitments and contingencies (Note 19)
    
Stockholders’ (deficit) equity:
    
Common stock, $0.0001 par value. 1,000,000,000 shares and 60,000,000 shares authorized at October 1, 2023 and December 31, 2022, respectively; 45,312,243 shares and 19,932,429 shares issued and outstanding at October 1, 2023 and December 31, 2022, respectively
     7       3  
Additional
paid-in
capital
     276,438       190,624  
Accumulated other comprehensive income
     51       27  
Accumulated deficit
     (327,279     (85,373
  
 
 
   
 
 
 
Total stockholders’ (deficit) equity
     (50,783     105,281  
  
 
 
   
 
 
 
Total liabilities and stockholders’ deficit
   $ 72,019     $ 228,183  
  
 
 
   
 
 
 
 
(1)
 
Includes $0.5 million and zero due to related parties as of October 1, 2023 and December 31, 2022, respectively.
(2)
 
Includes $5.6 million and zero of liabilities due to related parties as of October 1, 2023 and December 31, 2022, respectively.
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

COMPLETE SOLARIA, INC.
Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)
(
in thousands except share and per share amounts
)
 
    
Thirteen Weeks
Ended
October 1,
2023
   
Three Months
Ended
September 30,
2022
   
Thirty-Nine
Weeks Ended
October 1,
2023
   
Nine Months
Ended
September 30,
2022
 
Revenues
   $ 24,590     $ 12,260     $ 66,887     $ 48,974  
Cost of revenues
     18,354       8,266       51,788       33,792  
  
 
 
   
 
 
   
 
 
   
 
 
 
Gross profit
     6,236       3,994       15,099       15,182  
Operating expenses:
        
Sales commissions
     8,755       3,572       23,221       15,694  
Sales and marketing
     2,214       1,604       5,216       4,607  
General and administrative
     6,345       2,027       22,965       6,194  
  
 
 
   
 
 
   
 
 
   
 
 
 
Total operating expenses
     17,314       7,203       51,402       26,495  
  
 
 
   
 
 
   
 
 
   
 
 
 
Loss from continuing operations
     (11,078     (3,209     (36,303     (11,313
Interest expense
(1)
     (1,902     (941     (8,870     (2,672
Interest income
     9       —         26       —    
Other income (expense), net
(2)
     (38,003     4       (28,302     3,180  
  
 
 
   
 
 
   
 
 
   
 
 
 
Loss from continuing operations before income taxes
     (50,974     (4,146     (73,449     (10,805
Income tax benefit (provision)
     1       —         1       (4
  
 
 
   
 
 
   
 
 
   
 
 
 
Net loss from continuing operations
     (50,973     (4,146     (73,448     (10,809
Discontinued operations (Note 8):
        
Loss from discontinued operations, net of tax
     (8,404     —         (20,953     —    
Impairment loss from discontinued operations
     (147,505     —         (147,505     —    
  
 
 
   
 
 
   
 
 
   
 
 
 
Net loss from discontinued operations
     (155,909     —         (168,458     —    
  
 
 
   
 
 
   
 
 
   
 
 
 
Net loss
   $ (206,882   $ (4,146   $ (241,906   $ (10,809
  
 
 
   
 
 
   
 
 
   
 
 
 
Comprehensive income (loss):
        
Foreign currency translation adjustment
     10       —         24       —    
  
 
 
   
 
 
   
 
 
   
 
 
 
Comprehensive income (loss), net of tax
   $ (206,872   $ (4,146   $ (241,882   $ (10,809
  
 
 
   
 
 
   
 
 
   
 
 
 
Net loss from continuing operations per share attributable to common stockholders, basic and diluted
   $ (1.28   $ (0.31   $ (4.33   $ (0.83
  
 
 
   
 
 
   
 
 
   
 
 
 
Net loss from discontinued operations per share attributable to common stockholders, basic and diluted
   $ (3.92            $ (9.92         
  
 
 
   
 
 
   
 
 
   
 
 
 
Net loss per share attributable to common stockholders, basic and diluted
   $ (5.20   $ (0.31   $ (14.25   $ (0.83
  
 
 
   
 
 
   
 
 
   
 
 
 
Weighted-average shares used to compute net loss per share attributable to common stockholders, basic and diluted
     39,821,078       13,431,410       16,969,979       13,053,367  
  
 
 
   
 
 
   
 
 
   
 
 
 
 
(1)
 
Includes interest expense to related parties of less than $0.1 million and $0.4 million during the thirteen and thirty-nine weeks ended October 1, 2023, respectively, and zero and $0.1 million during the three and nine months ended September 30, 2022, respectively.
(2)
 
Other income (expense), net includes other expense, net to related parties of $36.9 million for each of the thirteen and thirty-nine weeks ended October 1, 2023, and other income, net of zero and $1.4 million during the three and nine months ended September 30, 2022, respectively.
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
COMPLETE SOLARIA, INC.
Unaudited Condensed Consolidated Statements of Stockholders’ Deficit
(
in thousands except number of shares
)
 
   
Thirteen Week Period Ended October 1, 2023
 
   
Redeemable Convertible
Preferred Stock
   
Common Stock
   
Additional
Paid-in

Capital
   
Accumulated

Deficit
   
Accumulated
Other
Comprehensive

Income
   
Total
Stockholders’
(Deficit)

Equity
 
   
Shares
   
Amount
   
Shares
   
Amount
 
Balance as of July 2, 2023, as previously reported
    34,311,133     $ 155,630       7,089,948     $ —       $ 37,096     $ (120,397   $ 41     $ (83,260
Retroactive application of recapitalization (Note 4)
    (34,311,133     (155,630     12,909,773       3       155,627                         155,630  
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Balance as of July 2, 2023, as adjusted
             —         19,999,721       3       192,723       (120,397     41       72,370  
Conversion of 2022 Convertible Notes into common stock
                      5,460,075       2       40,950                         40,952  
Issuance of common stock upon the reverse capitalization, net of offering costs
                      13,458,293       2       5,218                         5,220  
Reclassification of prepaid PIPE
(2)
                      350,000                3,500                         3,500  
Reclassification of warrant liabilities to equity
    —                  —                  4,697                         4,697  
Reclassification of Legacy Complete Solaria common stock into Complete Solaria Common Stock
    —                  —         (1     2                         1  
Issuance of common stock in connection with forward purchase agreements
(3)
                      5,558,488       1       35,489                         35,490  
Issuance of common stock bonus shares in connection with Mergers
(4)
                      463,976                2,394                         2,394  
Residual Mergers proceeds
    —                  —                  161                         161  
Modification of Carlyle warrant
    —                  —                  (10,862                       (10,862
Stock-based compensation
    —                  —                  2,114                         2,114  
Vesting of restricted stock units
                      21,690                52                         52  
Foreign currency translation
    —                  —                                    10       10  
Net loss
    —                  —                           (206,882              (206,882
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Balance as of October 1, 2023
           $ —         45,312,243     $ 7     $ 276,438     $ (327,279   $ 51     $ (50,783
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

COMPLETE SOLARIA, INC.
Unaudited Condensed Consolidated Statements of Stockholders’ Deficit (continued)
(
in thousands except number of shares
)
 
   
Thirty-Nine Week Period Ended October 1, 2023
 
   
Redeemable Convertible
Preferred Stock
   
Common Stock
   
Additional
Paid-in

Capital
   
Accumulated

Deficit
   
Accumulated
Other
Comprehensive

Income
   
Total
Stockholders’
(Deficit)

Equity
 
   
Shares
   
Amount
   
Shares
   
Amount
 
Balance as of December 31, 2022, as previously reported
    34,311,133     $ 155,630       6,959,618    
$
—  
 
  $ 34,997     $ (85,373   $ 27     $ (50,349
Retroactive application of recapitalization (Note 4)
    (34,311,133     (155,630     12,972,811       3       155,627                         155,630  
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Balance as of December 31, 2022, as adjusted
             —         19,932,429       3       190,624       (85,373     27       105,281  
Conversion of 2022 Convertible Notes into common stock
                      5,460,075       2       40,950                         40,952  
Issuance of common stock upon the reverse capitalization, net of offering costs
                      13,458,293       2       5,218                         5,220  
Reclassification of prepaid PIPE
(2)
                      350,000                3,500                         3,500  
Reclassification of warrant liabilities to equity
    —                  —                  4,697                         4,697  
Reclassification of Legacy Complete Solaria common stock into Complete Solaria Common Stock
    —                  —         (1     2                         1  
Issuance of common stock in connection with forward purchase agreements
(3)
                      5,558,488       1       35,489                         35,490  
Issuance of common stock bonus shares in connection with Mergers
(4)
                      463,976                2,394                         2,394  
Residual Mergers proceeds
    —                  —                  161                         161  
Modification of Carlyle warrant
    —                  —                  (10,862                       (10,862
Exercise of common stock options
                      67,292                57                         57  
Stock-based compensation
    —                  —                  4,156                         4,156  
Vesting of restricted stock units
                      21,690                52                         52  
Foreign currency translation
    —                  —                                    24       24  
Net loss
    —                  —                           (241,906              (241,906
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Balance as of October 1, 2023
           $ —         45,312,243     $ 7     $ 276,438     $ (327,279   $ 51     $ (50,783
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
COMPLETE SOLARIA, INC.
Unaudited Condensed Consolidated Statements of Stockholders’ Deficit (continued)
(
in thousands except number of shares
)
 
   
Three Month Period Ended September 30, 2022
 
   
Redeemable Convertible
Preferred Stock
   
Common Stock
   
Additional
Paid-in

Capital
   
Accumulated

Deficit
   
Accumulated
Other
Comprehensive

Income
   
Total
Stockholders’
(Deficit)

Equity
 
   
Shares
   
Amount
   
Shares
   
Amount
 
Balance as of June 30, 2022, as previously reported
    19,335,921     $ 42,959       3,931,068     $        $ 6,703     $ (62,559   $        $ (55,856
Retroactive application of recapitalization (Note 4)
    (19,335,921     (42,959     7,306,130       1       42,958                         42,959  
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Balance as of June 30, 2022, as adjusted
                      11,237,198       1       49,661       (62,559              (12,897
Exercise of common stock options
                      10,867                9                         9  
Stock-based compensation
    —                  —                  85                         85  
Net loss
    —                  —                           (4,146              (4,146
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Balance as of September 30, 2022, as adjusted
           $          11,248,065     $ 1     $ 49,755     $ (66,705   $        $ (16,949
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

COMPLETE SOLARIA, INC.
Unaudited Condensed Consolidated Statements of Stockholders’ Deficit (continued)
(
in thousands except number of shares
)
 
   
Nine Month Period Ended September 30, 2022
 
   
Redeemable Convertible
Preferred Stock
   
Common Stock
   
Additional
Paid-in

Capital
   
Accumulated

Deficit
   
Accumulated
Other
Comprehensive

Income
   
Total
Stockholders’
(Deficit)

Equity
 
   
Shares
   
Amount
   
Shares
   
Amount
 
Balance as of December 31, 2021, as previously reported
    16,564,370     $ 31,401       3,739,572     $        $ 3,105     $ (55,896   $        $ (52,791
Retroactive application of recapitalization (Note 4)
    (16,564,370     (31,401     6,066,571       1       31,400                         31,401  
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Balance at December 31, 2021, as adjusted
                      9,806,143       1       34,505       (55,896              (21,390
Issuance of Series
D-1,
D-2,
and
D-3
redeemable convertible preferred stock upon conversion of convertible notes and SAFEs
(1)
    2,771,551       11,558                                                        
Issuance of common stock options
                      103,353                28                         28  
Issuance of common stock warrants
    —                  —                  3,447                         3,447  
Stock-based compensation
    —                  —                  217                         217  
Net loss
    —                  —                           (10,809              (10,809
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Balance as of September 30, 2022, as previously reported
    2,771,551       11,558       9,909,496       1       38,197       (66,705              (28,507
Retroactive application of recapitalization (Note 4)
    (2,771,551     (11,558     1,338,569                11,558                         11,558  
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Balance as of September 30, 2022, as adjusted
           $          11,248,065     $ 1     $ 49,755     $ (66,705   $        $ (16,949
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
 
(1)
 
Includes 1,315,287 shares of Series
D-1
redeemable convertible preferred stock with a carrying value of $6.3 million, issued to related parties.
(2)
 
Reclassification of
pre-funded
PIPE was transacted with a related party.
(3)
 
Includes 4,508,488 shares of Complete Solaria Common Stock issued to related parties.
(4)
 
Includes 120,000 shares of Complete Solaria Common Stock issued to related parties.
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

COMPLETE SOLARIA, INC.
Unaudited Condensed Consolidated Statements of Cash Flows
(
in thousands except number of shares
)
 
    
Thirty-Nine

Weeks Ended
October 1,
2023
   
Nine
Months Ended
September 30,
2022
 
Cash flows from operating activities from continuing operations
    
Net loss
   $ (241,906   $ (10,809
Loss from discontinued operations, net of income taxes
     (168,458     —    
  
 
 
   
 
 
 
Net loss from continuing operations, net of tax
     (73,448     (10,809
Adjustments to reconcile net loss from continuing operations to net cash used in operating activities:
    
Stock-based compensation expense
     2,321       217  
Non-cash
interest expense
(1)
     4,009       (76
Non-cash
lease expense
     717       304  
Gain on extinguishment of convertible notes and SAFEs
(2)
     —         (3,235
Depreciation and amortization
     622       463  
Provision for credit losses
     4,269       716  
Change in reserve for excess and obsolete inventory
     2,144       3,091  
Issuance of forward purchase agreements
(3)
     (76     —    
Change in fair value of forward purchase agreement liabilities
(4)
     6,661       —    
Loss on CS Solis debt extinguishment
     10,338       —    
Change in fair value of warrant liabilities
     (26,314     142  
Accretion of debt in CS Solis
     2,493       2,581  
Issuance of common stock in connection with forward purchase agreements
(5)
     35,490       —    
Issuance of common stock bonus shares in connection with the Mergers
(6)
     2,394       —    
Issuance of restricted stock units in connection with vendor services
     52       —    
Changes in operating assets and liabilities:
    
Accounts receivable, net
     (11,823     (3,036
Inventories
     (3,896     (5,047
Prepaid expenses and other current assets
     (8,326     504  
Other noncurrent assets
     1,132       (15
Accounts payable
     4,372       190  
Accrued expenses and other current liabilities
     1,587       (2,056
Operating lease liabilities
     (359     (316
Warranty provision, noncurrent
     255       (584
Deferred revenue
     (1,766     (231
  
 
 
   
 
 
 
Net cash used in operating activities from continuing operations
     (47,152     (17,197
Net cash provided by operating activities from discontinued operations
     190       —    
  
 
 
   
 
 
 
Net cash used in operating activities
     (46,962     (17,197
  
 
 
   
 
 
 
Cash flows from investing activities from continuing operations
    
Purchase of property and equipment
     (29     —    
Capitalization of
internal-use
software costs
     (1,505     (1,048
  
 
 
   
 
 
 
Net cash used in investing activities from continuing operations
     (1,534     (1,048
  
 
 
   
 
 
 
Cash flows from financing activities from continuing operations
    
Proceeds from issuance of notes payable, net
     14,102       —    
Principal repayment of notes payable
     (9,653     (9,507
Proceeds from issuance of convertible notes, net of issuance cost
     17,750       —    
Proceeds from issuance of convertible notes, net of issuance cost, due to related parties
     3,500       —    
Repayment of convertible notes to related parties
     —         (500
Proceeds from issuance of long-term debt with CS Solis, net of issuance cost
     —         25,000  
Proceeds from exercise of common stock options
     57       28  
Proceeds from Mergers and PIPE Financing
     4,219       —    
Proceeds from Mergers and PIPE Financing from related parties
     15,600       —    
Payments for issuance of Series D redeemable convertible preferred stock
     —         (1,317
  
 
 
   
 
 
 
Net cash provided by financing activities from continuing operations
     45,575       13,704  
  
 
 
   
 
 
 
Effect of exchange rate changes
     24       —    
  
 
 
   
 
 
 
Net decrease in cash, cash equivalents and restricted cash
     (2,897     (4,541
Cash, cash equivalents, and restricted cash at beginning of period
     8,316       5,276  
  
 
 
   
 
 
 
Cash, cash equivalents, and restricted cash at end of period
   $ 5,419     $ 735  
  
 
 
   
 
 
 

    
Thirty-Nine

Weeks Ended
October 1,
2023
   
Nine
Months Ended
September 30,
2022
 
Supplemental disclosures of cash flow information:
    
Cash paid during the year for interest
     1,602       1  
Cash paid during the year for income taxes
     —         38  
Supplemental schedule of noncash investing and financing activities:
    
Operating lease
right-of-use
assets obtained in exchange for new operating lease liabilities
     —         245  
Carlyle warrant modification
     (10,862     —    
Reclassification of liability-classified warrants to equity-classified warrants
     30,625       —    
Issuance of common stock warrants
     202       3,447  
Issuance of Series D redeemable convertible preferred stock upon conversion of SAFE
     —         6,550  
Issuance of Series D redeemable convertible preferred stock upon conversion of convertible debt
     —         10,680  
Conversion of 2022 Convertible Notes into common stock
     21,561       —    
Conversion of 2022 Convertible Notes issued to related parties into common stock
     19,390       —    
Conversion of preferred stock into common stock
     155,630       —    
Issuance of common stock in connection with forward purchase agreements
(5)
     35,490       —    
Issuance of common stock bonus shares in connection with the Mergers
(6)
     2,394       —    
Recapitalization of Legacy Complete Solaria Common stock into Complete Solaria Common Stock
     1       —    
Reclassification of investor related to PIPE funds
     3,500       —    
 
(1)
 
Non-cash
interest expense to related parties of $0.1 million and $0.4 million during the thirteen and thirty-nine weeks ended October 1, 2023, respectively, and zero and $0.1 million during the three and nine months ended September 30, 2022, respectively.
(2)
 
Gain on extinguishment of convertible notes and SAFEs includes other income from related parties of zero during each of the thirteen and thirty-nine weeks ended October 1, 2023, and zero and $1.4 million during the three and nine months ended September 30, 2022, respectively.
(3)
 
Issuance of forward purchase agreements includes other income from related parties of $0.3 million for each of the thirteen and thirty-nine weeks ended October 1, 2023, and zero for each of the three and nine months ended September 30, 2022.
(4)
 
Change in fair value of forward purchase agreement liabilities includes other expense from related parties of $5.9 million for each of the thirteen and thirty-nine weeks ended October 1, 2023, and zero for each of the three and nine months ended September 30, 2022.
(5)
 
Issuance of common stock in connection with forward purchase agreements includes other expense from related parties of $30.7 million for each of the thirteen and thirty-nine weeks ended October 1, 2023, and zero for each of the three and nine months ended September 30, 2022.
(6)
 
Issuance of common stock bonus shares to related parties in connection with the Mergers includes other expense of $0.7 million for each of the thirteen and thirty-nine weeks ended October 1, 2023, and zero for each of the three and nine months ended September 30, 2022.
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

Notes to Condensed Consolidated Financial Statements
 
(1)
Organization
 
(a)
Description of Business
Complete Solaria, Inc. (the “Company” or “Complete Solaria”) is a residential solar installer headquartered in Fremont, California, which was formed through Complete Solar Holding Corporation’s acquisition of The Solaria Corporation (“Solaria”).
Complete Solar, Inc. (“Complete Solar”) was incorporated in Delaware on February 22, 2010. Through February 2022, the Company operated as a single legal entity as Complete Solar, Inc. In February 2022, the Company implemented a holding company reorganization (the “Reorganization”) in which the Company created and incorporated Complete Solar Holding Corporation (“Complete Solar Holdings”). As a result of the Reorganization, Complete Solar Holdings became the successor entity to Complete Solar, Inc. The capitalization structure was not changed because of the Reorganization as all shares of Complete Solar, Inc common stock and preferred stock were exchanged on a one for one basis with shares of Complete Solar Holdings common stock and preferred stock. The Reorganization was accounted for as a change in reporting entity for entities under common control. The historical assets and liabilities of Complete Solar, Inc. are transferred to Complete Solar Holdings at their carrying value, and there is no change to net income, other comprehensive income (loss), or any related per share amounts reported in the unaudited condensed consolidated financial statements requiring retrospective application.
In October 2022, the Company entered into a business combination agreement, as amended on December 26, 2022 and January 17, 2023 (“Original Business Combination Agreement”) and as amended on May 26, 2023 (“Amended and Restated Business Combination Agreement”), with Jupiter Merger Sub I Corp., a Delaware corporation and a wholly owned subsidiary of Freedom Acquisition I Corp. (“FACT”) (“First Merger Sub”), Jupiter Merger Sub II LLC, a Delaware limited liability company and a wholly owned subsidiary of FACT (“Second Merger Sub”), Complete Solar Holding Corporation, a Delaware corporation, and Solaria, a Delaware corporation.
The transactions contemplated by the Amended and Restated Business Combination Agreement were consummated on July 18, 2023 (“Closing Date”). Following the consummation of the Merger on the Closing Date, FACT changed its name to “Complete Solaria, Inc.”
As part of the transactions contemplated by the Amended and Restated Business Combination Agreement, FACT affected a deregistration under the Cayman Islands Companies Act and a domestication under Section 388 of the Delaware’s General Corporation Law (the “DGCL” or “Domestication”). On the Closing Date, following the Domestication, First Merger Sub merged with and into Complete Solaria, with Complete Solaria surviving such merger as a wholly owned subsidiary of FACT (the “First Merger”), and immediately following the First Merger, Complete Solaria merged with and into Second Merger Sub, with Second Merger Sub surviving as a wholly owned subsidiary of FACT (the “Second Merger”), and Second Merger Sub changed its name to CS, LLC, and immediately following the Second Merger, Solaria merged with and into a newly formed Delaware limited liability company and wholly-owned subsidiary of FACT and changed its name to The Solaria Corporation LLC (“Third Merger Sub”), with Third Merger Sub surviving as a wholly-owned subsidiary of FACT (the “Additional Merger”, and together with the First Merger and the Second Merger, the “Mergers”).
In connection with the closing of the Mergers:
 
   
Each share of the Company’s capital stock, inclusive of shares converted from 2022 Convertible Notes, issued and outstanding immediately prior to the Closing (“Legacy Complete Solaria Capital Stock”) were cancelled and exchanged into an aggregate of 25,494,332 shares of Complete Solaria Common Stock.

In July 2023, (i) Meteora Special Opportunity Fund I, LP (“MSOF”), Meteora Capital Partners, LP (“MCP”) and Meteora Select Trading Opportunities Master, LP (“MSTO”) (with MSOF, MCP, and MSTO collectively as “Meteora”); (ii) Polar Multi-Strategy Master Fund (“Polar”), and (iii) Diametric True Alpha Market Neutral Master Fund, LP, Diametric True Alpha Enhanced Market Neutral Master Fund, LP, and Pinebridge Partners Master Fund, LP (collectively, “Sandia”) (together, the “FPA Funding PIPE Investors”) entered into separate subscription agreements (the “FPA Funding Amount PIPE Subscription Agreements”) pursuant to which, the FPA Funding PIPE Investors subscribed for on the Closing Date, an aggregate of 6,300,000 shares of FACT Class A Ordinary Shares, less, in the case of Meteora, 1,161,512 FACT Class A Ordinary Shares purchased by Meteora separately from third parties through a broker in the open market (“Recycled Shares”) in connection with the Forward Purchase Agreements (“FPAs”). Subsequent to the Closing Date, Complete Solaria entered into an additional FPA Funding PIPE Subscription Agreement with Meteora, to subscribe for and purchase, and Complete Solaria agreed to issue and sell, an aggregate of 420,000 shares of Complete Solaria Common Stock. The Company issued shares of Complete Solaria Common Stock underlying the FPAs as of the latter of the closing of the Mergers or execution of the FPAs.
 
   
All certain investors (the “PIPE Investors”) purchased from the Company an aggregate of 1,570,000 shares of Complete Solaria Common Stock (the “PIPE Shares”) for a purchase price of $10.00 per share, for aggregate gross proceeds of $15.7 million (the “PIPE Financing”), including $3.5 million that was funded prior to the Closing Date, pursuant to subscription agreements (the “Subscription Agreements”). At the time of the PIPE Financing, Complete Solaria issued an additional 60,000 shares to certain investors as an incentive to participate in the PIPE Financing.
 
   
On or around the Closing Date, pursuant to the New Money PIPE Subscription Agreements, certain investors affiliated with the New Money PIPE Subscription Agreements (“New Money PIPE Investors”) agreed to subscribe for and purchase, and Complete Solaria agreed to issue and sell to the New Money PIPE Investors an aggregate of 120,000 shares of Complete Solaria Common Stock for a purchase price of $5.00 per share, for aggregate gross proceeds of $0.6 million. Pursuant to its New Money PIPE Subscription Agreement, Complete Solaria issued an additional 60,000 shares of Complete Solaria Common Stock in consideration of certain services provided by it in the structuring of its FPA and the transactions described therein.
 
   
Subsequent to the Closing, Complete Solaria issued an additional 193,976 shares of Complete Solaria Common Stock to the sponsors for reimbursing sponsors’ transfer to certain counterparties and issued an additional 150,000 shares of Complete Solaria Common Stock to an FPA investor for services provided in connection with the Mergers.
 
   
In March 2023, holders of 23,256,504 of the originally issued 34,500,000 FACT Class A Ordinary shares exercised their rights to redeem those shares for cash, and immediately prior to the Closing there were 11,243,496 FACT Class A Ordinary Shares that remained outstanding. At the Closing, holders of 7,784,739 shares of Class A common stock of FACT exercised their rights to redeem those shares for cash, for an aggregate of approximately $82.2 million which was paid to such holders at Closing. The remaining FACT Class A Ordinary Share converted, on a
one-for-one
basis, into one share of Complete Solaria Common Stock;
 
   
Each issued and outstanding FACT Class B Ordinary Share converted, on a
one-for-one
basis, into one share of Complete Solaria Common Stock.
In November 2022, Complete Solar Holdings acquired Solaria (as described in Note 6 – Business Combination) and changed its name to Complete Solaria, Inc. On August 18, 2023, the Company entered into a
Non-Binding
Letter of Intent to sell certain of Complete Solaria’s North American solar panel assets to Maxeon, Inc. (“Maxeon”). In October 2023, the Company completed the sale of its solar panel business to Maxeon. The disposition met the criteria for held for sale and discontinued operations classification as of October 1, 2023. Refer to Note 1(c) – Divestiture, Note 8 – Divestiture, and Note 22 – Subsequent Events.

(b)
Basis of Presentation of Unaudited Interim Condensed Consolidated Financial Statements
The accompanying unaudited interim condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions for interim reporting as prescribed by the Securities and Exchange Commission. Accordingly, they do not include all of the information and footnotes required by GAAP for complete condensed consolidated financial statements. The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. Intercompany accounts and transactions are eliminated upon consolidation.
Effective January 1, 2023, the Company changed its fiscal quarters to four thirteen-week periods within a standard calendar year. Each annual reporting period begins on January 1 and ends on December 31. Since the fiscal quarter change was made after the end of fiscal 2022, the Company will continue to report prior year financial information based on its prior year fiscal calendar. The Company’s financial results for the thirteen and thirty-nine weeks ended October 1, 2023 are compared to its results for the three and nine months ended September 30, 2022. The comparison of these periods is primarily affected by the difference of one day between the first three quarters of fiscal 2023 and first three quarters of 2022, which the Company notes is immaterial.
In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary to make the unaudited condensed consolidated financial statements not misleading have been included. The information included in this report should be read in conjunction with the audited consolidated financial statements as of and for the year ended December 31, 2022, as filed with the Securities and Exchange Commission (“SEC”) on Form
S-4.
The condensed consolidated balance sheet as of December 31, 2022 included herein was derived from the audited consolidated financial statements as of that date.
Interim financial results are not necessarily indicative of the results that may be expected for any future period.
 
(c)
Divestiture
On August 18, 2023, the Company entered into a
Non-Binding
Letter of Intent to sell certain of Complete Solaria’s North American solar panel assets to Maxeon. On September 20, 2023, the Company and Maxeon entered into an Asset Purchase Agreement (the “Disposal Agreement”) for the sale of certain assets, inclusive of certain intellectual property and customer contracts, to Maxeon. On October 6, 2023, the Company completed the sale of certain of Complete Solaria’s North American solar panel assets, inclusive of certain intellectual property and customer contracts, to Maxeon, pursuant to the terms of the Disposal Agreement. Under the terms of the Disposal Agreement, Maxeon agreed to acquire certain assets and employees of Complete Solaria, for an aggregate purchase price consisting of 1,100,000 shares of Maxeon common stock.
This divestiture represents a strategic shift in Complete Solaria’s business and qualifies as held for sale and as a discontinued operation as of October 1, 2023. Based on the held for sale classification of the assets, the Company has reduced the carrying value of the disposal group to its fair value, less cost to sell and recorded an impairment loss associated with the held for sale intangible assets and goodwill. As a result, the Company classified the results of its solar panel business in discontinued operations in its unaudited condensed consolidated statements of operations and comprehensive income (loss) for all periods presented. The cash flows related to discontinued operations have been segregated and are included in the unaudited condensed consolidated statements of cash flows for all periods presented. Unless otherwise noted, discussion within the notes to the unaudited condensed consolidated financial statements relates to continuing operations only and excludes the historical activities of the North American panel business. See Note 8 – Divestiture for additional information.

(d)
Liquidity and Going Concern
Since inception, the Company has incurred recurring losses and negative cash flows from operations. The Company incurred net losses of $51.0 million and $73.4 million during the thirteen and thirty-nine weeks ended October 1, 2023, respectively, and net losses of $4.1 million and $10.8 million during the three and nine months ended September 30, 2022, respectively, and had an accumulated deficit of $327.3 million as of October 1, 2023. The Company had cash and cash equivalents of $1.7 million as of October 1, 2023. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. These unaudited condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. Historically, the Company’s activities have been financed through private placements of equity securities, debt and proceeds from the Merger. The Company expects to incur significant operating expenses as it continues to grow its business. The Company believes that its operating losses and negative operating cash flows will continue into the foreseeable future. The Company’s history of recurring losses, negative operating cash flows since inception and the need to raise additional funding to meet its obligations and finance its operations raise substantial doubt about the Company’s ability to continue as a going concern. The Company’s ability to continue as a going concern requires that the Company obtains sufficient funding to meet its obligations and finance its operations. If the Company is not able to secure adequate additional funding when needed, the Company will need to reevaluate its operating plan and may be forced to make reductions in spending, extend payment terms with suppliers, liquidate assets where possible, or suspend or curtail planned programs or cease operations entirely. These actions could materially impact the Company’s business, results of operations and future prospects. While the Company has been able to raise multiple rounds of financing, there can be no assurance that in the event the Company requires additional financing, such financing will be available on terms that are favorable, or at all. Failure to generate sufficient cash flows from operations, raise additional capital or reduce certain discretionary spending would have a material adverse effect on the Company’s ability to achieve its intended business objectives.
Therefore, there is substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the unaudited condensed consolidated financial statements are issued. The accompanying unaudited condensed consolidated financial statements have been prepared assuming the Company will continue to operate as a going concern, which contemplates the realization of assets and settlement of liabilities in the normal course of business. They do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from uncertainty related to its ability to continue as a going concern.
 
(e)
Immaterial Correction of Prior Period Financial Statements
Subsequent to the issuance of the Company’s unaudited condensed consolidated financial statements for the three and nine months ended September 30, 2022, the Company identified a misstatement in redeemable convertible preferred stock and other income (expense), net, related to the accounting for the issuance of its Series D preferred stock and conversion of SAFEs and convertible notes. Such misstatement relates to the use of an incorrect factor for the conversion of these instruments into preferred stock.
The Company considered both quantitative and qualitative factors and determined the effect of the misstatement was immaterial to the previously issued unaudited condensed consolidated financial statements for the three and nine months ended September 30, 2022. The Company identified and corrected the misstatement prior to the issuance of the consolidated financial statements for the year ended December 31, 2022, which were filed in FACT’s
S-4
registration statement. The adjustment in the fourth quarter resulted in a $4.4 million decrease in redeemable convertible preferred stock and other income (expense), net, as well as net loss.
The accompanying unaudited condensed consolidated statements of operations and comprehensive income (loss) and statements of stockholders’ deficit for the three and nine months ended September 30, 2022

reflect such adjustment. Accordingly, the accompanying unaudited condensed consolidated statements of cash flows reflect such adjustment, and there was no change to net cash used in operating activities from continuing operations, net cash used in investing activities from continuing operations, or net cash provided by financing activities from continuing operations for the nine months ended September 
30
,
2022
.
 
(2)
Summary of Significant Accounting Policies
 
(a)
Use of Estimates
The preparation of the Company’s unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses, as well as related disclosure of contingent assets and liabilities. Significant estimates and assumptions made by management include, but are not limited to, the determination of:
 
   
the allocation of the transaction price to identified performance obligations;
 
   
fair value of warrant liabilities;
 
   
the fair value of assets acquired and liabilities assumed for business combinations;
 
   
the reserve methodology for inventory obsolescence;
 
   
the reserve methodology for product warranty;
 
   
the reserve methodology for the allowance for credit losses; and
 
   
the fair value of the forward purchase agreements.
To the extent that there are material differences between these estimates and actual results, the Company’s financial condition or operating results will be affected.
 
(b)
Supply Chain Constraints and Risk
The Company relies on a very small number of suppliers of solar energy systems and other equipment. If any of the Company’s suppliers was unable or unwilling to provide the Company with contracted quantities in a timely manner at prices, quality levels and volumes acceptable to the Company, the Company would have very limited alternatives for supply, and the Company may not be able find suitable replacements for the Company’s customers, or at all. Such an event could materially adversely affect the Company’s business, prospects, financial condition and results of operations.
In addition, the global supply chain and the Company’s industry have experienced significant disruptions in recent periods. The Company has seen supply chain challenges and logistics constraints increase, including shortages of panels, inverters, batteries and associated component parts for inverters and solar energy systems available for purchase. In certain cases, this has caused delays in critical equipment and inventory, longer lead times, and has resulted in cost volatility. These shortages and delays can be attributed in part to the
COVID-19
pandemic and resulting government action, broader macroeconomic conditions, and have been exacerbated by the ongoing conflicts in Ukraine and Israel. While the Company believes that a majority of the Company’s suppliers have secured sufficient supply to permit them to continue delivery and installations through the end of 2023, if these shortages and delays persist into 2024, they could adversely affect the timing of when battery energy storage systems can be delivered and installed, and when (or if) the Company can begin to generate revenue from those systems. In addition, the Company has experienced and is experiencing varying levels of volatility in costs of equipment and labor resulting in part from disruptions caused by general global economic conditions, including inflationary pressures and the
COVID-19
pandemic.

The Company cannot predict the full effects these events will have on the Company’s business, cash flows, liquidity, financial condition and results of operations at this time due to numerous uncertainties. In the event the Company is unable to mitigate the impact of delays or price volatility in solar energy systems, raw materials, and freight, it could materially adversely affect the Company’s business, prospects, financial condition and results of operations.
 
(c)
Segment Information
The Company conducts its business in one operating segment that provides custom solar solutions through a standardized platform to its residential solar providers and companies to facilitate the sale and installation of solar energy systems under a single product group. The Company’s Chief Executive Officer (“CEO”) is the Chief Operating Decision Maker (“CODM”). The CODM allocates resources and makes operating decisions based on financial information presented on a consolidated basis. The profitability of the Company’s product group is not a determining factor in allocating resources and the CODM does not evaluate profitability below the level of the consolidated company. All the Company’s long-lived assets are maintained in the United States of America.
 
(d)
Restricted Cash
The Company classifies all cash for which usage is limited by contractual provisions as restricted cash. Restricted cash balance as of October 1, 2023 and December 31, 2022, was $3.8 million and $3.9 million, respectively. The restricted cash consists of deposits in money market accounts, which is used as cash collateral backing letters of credit related to customs duty authorities’ requirements. The Company has presented these balances under restricted cash, as a long-term asset, in the unaudited condensed consolidated balance sheets. The Company reconciles cash, cash equivalents, and restricted cash reported in the unaudited condensed consolidated balance sheets that aggregate to the beginning and ending balances shown in the unaudited condensed consolidated statements of cash flows as follows (in thousands):
 
    
As of
 
    
October 1,
2023
    
December 31,
2022
 
Cash and cash equivalents
   $ 1,661      $ 4,409  
Restricted cash
     3,758        3,907  
  
 
 
    
 
 
 
Total cash, cash equivalents, and restricted cash
   $ 5,419      $ 8,316  
  
 
 
    
 
 
 
 
(e)
Revenue Recognition
Disaggregation of revenue
Refer to the table below for the Company’s revenue recognized by product and service type (in thousands):
 
    
Thirteen
Weeks
Ended
October 1,
2023
    
Three
Months
Ended
September 30,
2022
    
Thirty-Nine

Weeks
Ended
October 1,
2023
    
Nine Months
Ended
September 30,
2022
 
Solar energy system installations
   $ 23,915      $ 11,120      $ 64,511      $ 46,214  
Software enhanced services
     675        1,140        2,376        2,760  
  
 
 
    
 
 
    
 
 
    
 
 
 
Total revenue
   $ 24,590      $ 12,260      $ 66,887      $ 48,974  
  
 
 
    
 
 
    
 
 
    
 
 
 
All of the Company’s revenue recognized by geography based on the location of the customer for the thirteen and thirty-nine weeks ended October 1, 2023 and three and nine months ended September 30, 2022 was in the United States.

Remaining performance obligations
The Company has elected the practical expedient not to disclose remaining performance obligations for contracts that are less than one year in length. The Company has deferred $1.0 million and $1.3 million associated with a long-term service contract as of October 1, 2023 and December 31, 2022, respectively.
Incremental costs of obtaining customer contracts
Incremental costs of obtaining customer contracts consist of sales commissions, which are costs paid to third-party vendors who source residential customer contracts for the sale of solar energy systems by the Company. The Company defers sales commissions and recognizes expense in accordance with the timing of the related revenue recognition. Amortization of deferred commissions is recorded as sales commissions in the accompanying unaudited condensed consolidated statements of operations and comprehensive income (loss). As of October 1, 2023 and December 31, 2022, deferred commissions were $5.5 million and $2.8 million, respectively, which were included in prepaid expenses and other current assets in the accompanying unaudited condensed consolidated balance sheets.
Deferred revenue
The Company typically invoices its customers upon completion of set milestones, generally upon installation of the solar energy system with the remaining balance invoiced upon passing the final building inspection. Standard payment terms to customers range from 30 to 60 days. When the Company receives consideration, or when such consideration is unconditionally due, from a customer prior to delivering goods or services to the customer under the terms of a customer agreement, the Company records deferred revenue. As installation projects are typically completed within
12-months,
the majority of the Company’s deferred revenue is reflected in current liabilities in the accompanying unaudited condensed consolidated balance sheets. The Company also has deferred revenue associated with a long-term service contract which is reflected in
non-current
liabilities in the accompanying unaudited condensed consolidated balance sheets. The amount of revenue recognized during the thirty-nine weeks ended October 1, 2023 and the nine months ended September 30, 2022 that was included in deferred revenue at the beginning of the year was $2.5 million and $3.9 million, respectively.
 
(f)
Fair Value Measurements
The Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible. The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market.
When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels:
 
   
Level 1 inputs: Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date.
 
   
Level 2 inputs: Other than quoted prices included in Level 1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability.
 
   
Level 3 inputs: Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at the measurement date.
Financial assets and liabilities held by the Company measured at fair value on a recurring basis as of October 1, 2023 and December 31, 2022 include cash and cash equivalents, accounts receivable, accounts payable, accrued expenses, the warrant liabilities and FPA liabilities.

The carrying amounts of cash, accounts receivable, accounts payable and accrued expenses approximate their fair value because of their short-term nature (classified as Level 1).
The warrant liabilities and FPA liabilities are measured at fair value using Level 3 inputs. The Company records subsequent adjustments to reflect the increase or decrease in estimated fair value at each reporting date within the unaudited condensed consolidated statements of operations and comprehensive income (loss) as a component of other income (expense), net.
 
(g)
Direct Offering Costs
Direct offering costs represent legal, accounting and other direct costs related to the Mergers, which was consummated in July 2023. In accounting for the Mergers, direct offering costs of approximately $5.7 million were reclassified to additional
paid-in
capital and netted against the Mergers proceeds received upon close. As of October 1, 2023 and December 31, 2022, the Company had no deferred offering costs included within prepaid expenses and other current assets in its unaudited condensed consolidated balance sheets.
 
(h)
Warrant Liabilities
The Company accounts for its warrant liabilities in accordance with the guidance in ASC
815-40,
Derivatives and Hedging – Contracts in Entity’s Own Equity
, under which the warrants that do not meet the criteria for equity classification and must be recorded as liabilities. The warrant liabilities are measured at fair value at inception and at each reporting date in accordance with the guidance in ASC 820,
Fair Value Measurement
, with any subsequent changes in fair value recognized in other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive income (loss). Refer to Note 3 – Fair Value Measurements and Note 15 – Warrants.
 
(i)
Forward Purchase Agreements
The Company accounts for its FPAs in accordance with the guidance in ASC 480,
Distinguishing Liabilities from Equity
, as the agreements embody an obligation to transfer assets to settle a forward contract. The warrant liabilities are measured at fair value at inception and at each reporting date in accordance with the guidance in ASC 820,
Fair Value Measurement
, with any subsequent changes in fair value recognized in other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive income (loss). Refer to Note 3 – Fair Value Measurements and Note 5 – Forward Purchase Agreements.
 
(j)
Net Loss Per Share
The Company computes net loss per share following ASC 260,
Earnings Per Share
. Basic net loss per share is measured as the income or loss available to common stockholders divided by the weighted average common shares outstanding for the period. Diluted net loss per share presents the dilutive effect on a
per-share
basis from the potential exercise of options and/or warrants. The potentially dilutive effect of options or warrants are computed using the treasury stock method. Securities that potentially have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the diluted loss per share calculation.
 
(k)
Recently Adopted Accounting Pronouncements
In June 2016, the FASB issued ASU
2016-13,
Financial instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments
, and subsequent related ASUs, which amends the guidance on the impairment of financial instruments by requiring measurement and recognition of expected

credit losses for financial assets held. ASU
2016-13
is effective for public and private companies’ fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2019, and December 15, 2022, respectively. The Company adopted ASU
2016-13
under the private company transition guidance beginning January 1, 2023. The adoption did not have a material impact on the Company’s unaudited condensed consolidated financial statements.
 
(3)
Fair Value Measurements
The following table sets forth the Company’s financial assets and liabilities that were measured at fair value, on a recurring basis (in thousands):
 
    
As of October 1, 2023
 
    
Level 1
    
Level 2
    
Level 3
    
Total
 
Financial Liabilities
           
Carlyle warrants
   $ —        $ —        $ 7,683      $ 7,683  
Public warrants
     1,413        —          —          1,413  
Private placement warrants
     —          1,027        —          1,027  
Working capital warrants
     —          117        —          117  
Forward purchase agreement liabilities
     —          —          6,586        6,586  
  
 
 
    
 
 
    
 
 
    
 
 
 
Total
   $ 1,413      $ 1,144      $ 14,269      $ 16,826  
  
 
 
    
 
 
    
 
 
    
 
 
 
    
As of December 31, 2022
 
    
Level 1
    
Level 2
    
Level 3
    
Total
 
Financial Liabilities
           
Redeemable convertible preferred stock warrant liability
   $ —        $ —        $ 14,152      $ 14,152  
  
 
 
    
 
 
    
 
 
    
 
 
 
Total
   $ —        $ —        $ 14,152      $ 14,152  
  
 
 
    
 
 
    
 
 
    
 
 
 
Carlyle Warrants
As part of the Company’s amended and restated warrant agreement with CRSEF Solis Holdings, LLC (“Carlyle”), the Company issued Carlyle a warrant to purchase up to 2,745,879 shares of Complete Solaria Common Stock at a price per share of $0.01, which is inclusive of the outstanding warrant to purchase 1,995,879 shares at the time of modification. The warrant, which expires on July 18, 2030, provides Carlyle with the right to purchase shares of Complete Solaria Common Stock based on (a) the greater of (i) 1,995,879 shares and (ii) the number of shares equal to 2.795% of Complete Solaria’s issued and outstanding shares of common stock, on a fully-diluted basis; plus (b) on and after the date that is ten (10) days after the date of the amended and restated warrant agreement, an additional 350,000 shares; plus (c) on and after the date that is thirty (30) days after the date of the amended and restated warrant agreement, if the original investment amount has not been repaid, an additional 150,000 shares; plus (d) on and after the date that is ninety (90) days after the date of the amended and restated warrant agreement, if the original investment amount has not been repaid, an additional 250,000 shares, in each case, of Complete Solaria Common Stock at a price of $0.01 per share. As the warrant is exercisable into a variable number of shares based on the Company’s fully diluted capitalization table, the Company has classified the warrants as liabilities. The Company valued the warrants based on a Black-Scholes Option Pricing Method, which included the following inputs:
 
    
October 1,
2023
   
December 31,
2022
 
Expected term
     7.0 years        
Expected volatility
     77.0     —    
Risk-free interest rate
     3.92     —    
Expected dividend yield
     0.0     —    

Public, Private Placement and Working Capital Warrants
The public, private placement and working capital warrants are measured at fair value on a recurring basis. The public warrants were valued based on the closing price of the publicly traded instrument. The private placement and working capital warrants were valued using observable inputs for similar publicly traded instruments.
Forward Purchase Agreement Liabilities
The FPA liabilities are measured at fair value on a recurring basis using a Monte Carlo simulation analysis. The expected volatility is determined based on the historical equity volatility of comparable companies over a period that matches the simulation period, which included the following inputs:
 
    
October 1,
2023
   
December 31,
2022
 
Common stock trading price
   $ 2.10       —    
Simulation period
     1.8 years        
Risk-free rate
     5.12     —    
Volatility
     178.0     —    
Redeemable Convertible Preferred Stock Warrant Liabilities
The Company historically issued redeemable convertible warrants, which were classified as liabilities and adjusted to fair value using the Black Scholes Option Pricing Method. The terms of the redeemable convertible preferred stock warrants are described in Note 15 – Warrants.
Series B Redeemable Convertible Preferred Stock Warrant
 
    
October 1,
2023
    
December 31,
2022
 
Expected term
     —         
3.1 
years
 
Expected volatility
     —          72.5
Risk-free interest rate
     —          4.2
Expected dividend yield
     —          0.0
Series C Redeemable Convertible Preferred Stock Warrant
 
    
October 1,
2023
    
December 31,
2022
 
Expected term
     —          3.6 years  
Expected volatility
     —          72.5
Risk-free interest rate
     —          4.0
Expected dividend yield
     —          0.0
Series
D-7
Redeemable Convertible Preferred Stock Warrant
 
    
October 1,
2023
    
December 31,
2022
 
Expected term
     —          1.5 years  
Expected volatility
     —          78.5
Risk-free interest rate
     —          4.7
Expected dividend yield
     —          0.0

The redeemable convertible preferred stock warrant liabilities were measured at fair value at the issuance date and as of each subsequent reporting period with changes in the fair value recorded within other income (expense), net in the accompanying unaudited condensed consolidated statements of operations and comprehensive income (loss). As described in Note 15 – Warrants, the redeemable convertible preferred stock warrant liabilities were reclassified to additional
paid-in
capital upon the closing of the Mergers.
 
(4)
Reverse Recapitalization
As discussed in Note 1 – Organization, on July 18, 2023, the Company consummated the Mergers pursuant to the Amended and Restated Business Combination Agreement. The Mergers was accounted for as a reverse recapitalization, rather than a business combination, for financial accounting and reporting purposes. Accordingly, Complete Solaria was deemed the accounting acquirer (and legal acquiree) and FACT was treated as the accounting acquiree (and legal acquirer). Complete Solaria has been determined to be the accounting acquirer based on evaluation of the following facts and circumstances:
 
   
Complete Solaria’s
pre-combination
stockholders have the majority of the voting power in the post-merged company;
 
   
Legacy Complete Solaria’s stockholders have the ability to appoint a majority of the Complete Solaria Board of Directors;
 
   
Legacy Complete Solaria’s management team is considered the management team of the post-merged company;
 
   
Legacy Complete Solaria’s prior operations is comprised of the ongoing operations of the post-merged company;
 
   
Complete Solaria is the larger entity based on historical revenues and business operations; and
 
   
the post-merged company has assumed Complete Solaria’s operating name.
Under this method of accounting, the reverse recapitalization was treated as the equivalent of Complete Solaria issuing stock for the net assets of FACT, accompanied by a recapitalization. The net assets of FACT are stated at historical cost, with no goodwill or other intangible assets recorded. The consolidated assets, liabilities, and results of operations prior to the Mergers are those of Legacy Complete Solaria. All periods prior to the Mergers have been retrospectively adjusted in accordance with the Amended and Restated Business Combination Agreement for the equivalent number of preferred or common shares outstanding immediately after the Mergers to effect the reverse recapitalization.
Upon the closing of the Mergers and the PIPE Financing in July 2023, the Company received net cash proceeds of $19.7 million. The following table reconciles the elements of the Mergers to the unaudited condensed consolidated statements of cash flows and the unaudited condensed consolidated statements of stockholders’ deficit for the thirty-nine week ended October 1, 2023 (in thousands):
 
    
Recapitalization
 
Cash proceeds from FACT, net of redemptions
   $ 36,539  
Cash proceeds from PIPE Financing
     12,800  
Less: cash payment of FACT transaction costs and underwriting fees
     (10,680
Less: cash payment to FPA investors for rebates and recycled shares
     (17,831
Less: cash payment for Promissory Note
     (1,170
  
 
 
 
Net cash proceeds upon the closing of the Mergers and PIPE financing
     19,658  
Less:
non-cash
net liabilities assumed from FACT
     (10,135
  
 
 
 
Net contributions from the Mergers and PIPE financing upon closing
   $ 9,523  
  
 
 
 

Immediately upon closing of the Mergers, the Company had 45,290,553 shares issued and outstanding of Class A Common Stock. The following table presents the number of shares of Complete Solaria Common Stock outstanding immediately following the consummation of the Mergers:
 
    
Recapitalization
 
FACT Class A Ordinary Shares, outstanding prior to Mergers
     34,500,000  
FACT Class B Ordinary Shares, outstanding prior to Mergers
     8,625,000  
Bonus shares issued to sponsor
     193,976  
Bonus shares issued to PIPE investors
     120,000  
Bonus shares issued to FPA investors
     150,000  
Shares issued from PIPE financing
     1,690,000  
Shares issued from FPA agreements, net of recycled shares
     5,558,488  
Less: redemption of FACT Class A Ordinary Shares
     (31,041,243
  
 
 
 
Total shares from the Mergers and PIPE Financing
     19,796,221  
Legacy Complete Solaria shares
     20,034,257  
2022 Convertible Note Shares
     5,460,075  
  
 
 
 
Shares of Complete Solaria Common stock immediately after Mergers
     45,290,553  
  
 
 
 
In
connection
with the Mergers, the Company incurred direct and incremental costs of approximately $15.8 million related to legal, accounting, and other professional fees, which were offset against the Company’s additional
paid-in
capital. Of the $15.8 million, $5.2 million was incurred by Legacy Complete Solaria and $10.6 million was incurred by FACT. As of October 1, 2023, the Company made cash payments totaling $5.4 million to settle transaction costs. As a result of the Closing, outstanding 2022 Convertible Notes were converted into shares of Complete Solaria Common Stock.
 
(5)
Forward Purchase Agreements
In July 2023, FACT and Legacy Complete Solaria, Inc. entered into FPAs with each of (i) Meteora; (ii) Polar, and (iii) Sandia (each individually, a “Seller”, and together, the “FPA Sellers”).
Pursuant to the terms of the FPAs, the FPA Sellers may (i) purchase through a broker in the open market, from holders of Shares other than the Company or affiliates thereof, FACT’s ordinary shares, par value of $0.0001 per share, (the “Shares”). While the FPA Sellers have no obligation to purchase any Shares under the FPAs, the aggregate total Shares that may be purchased under the FPAs shall be no more than 6,720,000 in aggregate. The FPA Sellers may not beneficially own greater than 9.9% of issued and outstanding Shares following the Mergers as per the Amended and Restated Business Combination Agreement.
The key terms of the forward contracts are as follows:
 
   
The FPA Sellers can terminate the transaction following the Optional Early Termination (“OET”) Date which shall specify the quantity by which the number of shares is to be reduced (such quantity, the “Terminated Shares”). Seller shall terminate the transaction in respect of any shares sold on or prior to the maturity date. The counterparty is entitled to an amount from the seller equal to the number of terminated shares multiplied by a reset price. The reset price is initially $10.56 (the “Initial Price”) and is subject to a $5.00 floor.
 
   
The FPA contains multiple settlement outcomes. Per the terms of the agreements, the FPAs will (1) settle in cash in the event the Company is due cash upon settlement from the FPA Sellers or (2) settle in either cash or shares, at the discretion of the Company, should the settlement amount adjustment exceed the settlement amount. Should the Company elect to settle via shares, the equity will be issued in Complete Solaria Common Stock, with a per share price based on the volume-weighted average price (“VWAP”) Price over 15 scheduled trading days. The magnitude of the settlement is based on the Settlement Amount, an amount equal to the product of: (1) Number of shares issued to the

 
FPA Seller pursuant to the FPA, less the number of Terminated Shares multiplied by (2) the VWAP Price over the valuation period. The Settlement amount will be reduced by the Settlement Adjustment, an amount equal to the product of (1) Number of shares in the Pricing Date Notice, less the number of Terminated Shares multiplied by $2.00.
 
   
The Settlement occurs as of the Valuation Date, which is the earlier to occur of (a) the date that is two years after the date of the Closing Date of the Mergers (b) the date specified by Seller in a written notice to be delivered to Counterparty at Seller’s discretion (which Valuation Date shall not be earlier than the day such notice is effective) after the occurrence of certain triggering events; and (c) 90 days after delivery by the Counterparty of a written notice in the event that for any 20 trading days during a 30 consecutive trading
day-period
(the “Measurement Period”) that occurs at least 6 months after the Closing Date, the VWAP Price is less than the then applicable Reset Price.
The Company entered into four separate FPAs, three of which, associated with the obligation to issue 6,300,000 Shares, were entered into prior to the closing of the Mergers. Upon signing the FPAs, the Company incurred an obligation to issue a fixed number of shares to the FPA Sellers contingent upon the closing of the Mergers in addition to the terms and conditions associated with the settlement of the FPAs. The Company accounted for the contingent obligation to issue shares in accordance with ASC 815,
Derivatives and Hedging
, and recorded a liability and other income (expense), net based on the fair value upon of the obligation upon the signing of the FPAs. The liability was extinguished in July 2023 upon the issuance of Complete Solaria Common Stock to the FPA sellers.
Additionally, in accordance with ASC 480,
Distinguishing Liabilities from Equity
, the Company has determined that the prepaid forward contract is a financial instrument other than a share that represent or are indexed to obligations to repurchase the issuer’s equity shares by transferring assets, referred to herein as the “prepaid forward purchase liability” on its unaudited condensed consolidated balance sheets. The Company initially measured the prepaid forward purchase liability at fair value and has subsequently remeasured at fair value with changes in fair value recognized in earnings.
Through the date of issuance of the Complete Solaria Common Stock in satisfaction of the Company’s obligation to issue shares around the closing of the Mergers, the Company recorded $35.5 million to other income (expense), net associated with the issuance of 6,720,000 shares of Complete Solaria Common Stock.
As of the closing of the Mergers and issuance of the Complete Solaria Common Stock underlying the FPAs, the fair value of the prepaid FPAs was an asset balance of $0.1 million and was recorded on the Company’s unaudited condensed consolidated balance sheets and within other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive income (loss). Subsequently, the change of fair value of the prepaid forward purchase liability amounted to an expense of $6.7 million for the thirteen and thirty-nine weeks ended October 1, 2023. As of October 1, 2023, the prepaid forward purchase liabilities amounted to $6.6 million.
 
(6)
Business Combination
Solaria Acquisition
On November 4, 2022, Complete Solar Holdings acquired Solaria for aggregate consideration paid of $89.1 million, comprising of $0.1 million in cash, 2,844,550 shares of common stock with an aggregate fair value of $17.3 million, 6,803,549 shares of preferred stock with an aggregate fair value of $52.2 million, 78,962 common stock warrants for an aggregate value of $0.2 million, 1,376,414 preferred stock warrants for an aggregate fair value of $7.8 million, 5,382,599 stock options with an aggregate fair value of $10.0 million attributable to services provided prior to the acquisition date, and the payment of seller incurred transaction expenses of $1.5 million. In addition, the Company assumed $14.1 million of unvested Solaria stock options, which has been and will be recorded as stock-based expense over the remaining service period. Solaria designs, develops, manufactures, and generates revenue from the sale of silicon photovoltaic solar panels and licensing of its technology to third parties. At the time of the acquisition, the

Company believed that the acquisition of Solaria would establish the Company as a full system operator, with a compelling customer offering with
best-in-class
technology, financing, and project fulfilment, which would enable the Company to sell more product across more geographies in the United States and Europe. This transaction was accounted for as a business combination in accordance with ASC 805,
Business Combinations
. Refer to Note 8 – Divestiture for further details.
The following table summarized the provisional fair value of identifiable assets acquired and liabilities assumed (in thousands):
 
    
Amount
 
Cash, cash equivalents and restricted cash
   $ 5,402  
Accounts receivable
     4,822  
Inventories
     5,354  
Prepaid expenses and other current assets
     8,569  
Property and equipment
     830  
Operating lease
right-of-use
assets
     1,619  
Intangible assets
     43,100  
Other
non-current
assets
     112  
  
 
 
 
Total identifiable assets acquired
     69,808  
Accounts payable
     4,210  
Accrued expenses and other current liabilities
     11,845  
Notes payable
     20,823  
Deferred revenue
     73  
Operating lease liabilities, net of current portion
     1,132  
Warranty provision, noncurrent
     1,566  
SAFE agreements
     60,470  
  
 
 
 
Total identifiable liabilities assumed
     100,119  
  
 
 
 
Net identifiable liabilities assumed
     30,311  
Goodwill
     119,422  
  
 
 
 
Total aggregate consideration paid
   $ 89,111  
  
 
 
 
Goodwill represents the excess of the preliminary estimated consideration transferred over the fair value of the net tangible and intangible assets acquired and has been allocated to the Company’s single reporting unit. Goodwill is primarily attributable to expected post-acquisition synergies from assembled workforce and also from the expectation of integrating Solaria’s products and solutions into the Company’s own businesses to provide access to more features and resources and offers incremental revenue opportunities. Goodwill of $119.4 million is deductible over 15 years for U.S. income tax purposes.
Intangible assets acquired are as follows (in thousands):
 
    
Amount
 
Trademarks
   $ 5,700  
Developed technology
     12,700  
Customer relationships
     24,700  
  
 
 
 
Total intangible assets
   $ 43,100  
  
 
 
 
The income approach, using the relief from royalty method, was used to value trademarks and developed technology. Significant assumptions included in the valuation of trademarks and developed technology include projected revenues, the selected royalty rate and the economic life of the underlying asset.
The income approach, using the multi-period excess earning method, was used to value customer relationships. Significant assumptions included in the valuation of customer relationships include projected revenues, customer attrition and expense growth over the forecasted period.

As a result of the Solaria acquisition, the Company recognized $45.9 million of deferred tax assets. Due to the uncertainty surrounding the Company’s ability to realize such deferred income tax assets, a full valuation allowance has been established.
As of October 1, 2023, the goodwill and intangible assets recognized from the Solaria acquisition have been included in long-term held for sale – discontinued operations on the unaudited condensed consolidated balance sheets, as further described in Note 8 – Divestiture.
Unaudited Pro Forma Information
The following unaudited pro forma financial information gives effect to the acquisition of Solaria as if it were consummated on January 1, 2022 including pro forma adjustments relating to the valuation and allocation of the aggregate consideration paid, amortization of intangible assets, incremental stock-based compensation and direct transaction costs. The historical condensed consolidated financial statements have been adjusted in the unaudited combined financial information to give effect to events that are directly attributable to the Business Combination and are factually supportable. This data is presented for informational purposes only and is not intended to represent or be indicative of the results of operations that would have been reported had the acquisition occurred on January 1, 2022. Actual results may differ from the unaudited combined pro forma information presented below (in thousands):
 
    
Three Months
Ended
September 30,
2022
    
Nine Months
Ended
September 30,
2022
 
Revenues
   $ 22,267      $ 79,800  
Net loss
   $ (26,498    $ (49,935
 
(7)
Prepaid Expenses and Other Current Assets
Prepaid expenses and other current assets consists of the following (in thousands):
 
    
As of
 
    
October 1,
2023
    
December 31,
2022
 
Inventory deposits
   $ 3,497      $ 6,255  
Prepaid sales commissions
     5,509        2,838  
  
 
 
    
 
 
 
Other
     941        978  
  
 
 
    
 
 
 
Total prepaid expenses and other current assets
   $ 9,947      $ 10,071  
  
 
 
    
 
 
 
 
(8)
Divestiture
Discontinued operations
As previously described in Note 1 – Organization, on August 18, 2023, the Company entered into a
Non-Binding
Letter of Intent to sell certain of Complete Solaria’s North American solar panel assets, inclusive of intellectual property and customer contracts, to Maxeon. In October 2023, the Company completed the sale of its solar panel business to Maxeon. The Company determined that this divestiture represented a strategic shift in the Company’s business and qualified as a discontinued operation. Accordingly, the results of operations and cash flows relating to Solaria have been reflected as discontinued operations in the unaudited condensed consolidated statements of operations and comprehensive income (loss) for the thirteen and thirty-nine weeks ended October 1, 2023 and the unaudited condensed consolidated statements of cash flows for the thirty-nine weeks ended October 1, 2023.

Components of amounts reflected in the unaudited condensed consolidated statements of operations and comprehensive income (loss) related to discontinued operations are presented in the table, as follows (in thousands):
 
    
Thirteen Weeks
Ended
October 1,
2023
    
Thirty-Nine
Weeks Ended
October 1,
2023
 
Revenues
   $ 3,774      $ 29,048  
Cost of revenues
     4,102        30,609  
  
 
 
    
 
 
 
Gross loss
     (328      (1,561
Operating expenses:
     
Sales and marketing
     2,425        6,855  
General and administrative
     5,681        12,572  
  
 
 
    
 
 
 
Total operating expenses
     8,106        19,427  
  
 
 
    
 
 
 
Loss from discontinued operations
     (8,434      (20,988
Other income (expense), net
     31        32  
  
 
 
    
 
 
 
Loss from discontinued operations before income taxes
     (8,403      (20,956
Income tax benefit (provision)
     (1      3  
Impairment loss from discontinued operations
     (147,505      (147,505
  
 
 
    
 
 
 
Net loss from discontinued operations
   $ (155,909    $ (168,458
  
 
 
    
 
 
 
Held for sale
As previously described in Note 1 – Organization, certain assets of the Solaria, Inc. have been reflected as assets held for sale in the periods preceding the divestiture.
The following is a summary of the major categories of assets and liabilities held for sale (in thousands):
 
    
As of
 
    
October 1,
2023
    
December 31,
2022
 
Intangible assets, net
   $ 12,299      $ 42,610  
Goodwill
     —          119,422  
  
 
 
    
 
 
 
Long-term assets held for sale
   $ 12,299      $ 162,032  
  
 
 
    
 
 
 
 
(9)
Property and Equipment, Net
Property and equipment, net consists of the following (in thousands, except year data):
 
    
Estimated
    
As of
 
    
Useful Lives
(Years)
    
October 1,
2023
    
December 31,
2022
 
Developed software
     5      $ 6,559      $ 5,054  
Manufacturing equipment
     3        131        102  
Furniture and equipment
     3        90        90  
Leasehold improvements
     5        708        708  
     
 
 
    
 
 
 
Total property and equipment
        7,488        5,954  
Less: accumulated depreciation and amortization
        (3,303      (2,478
     
 
 
    
 
 
 
Total property and equipment, net
      $ 4,185      $ 3,476  
     
 
 
    
 
 
 
Depreciation and amortization expense on tangible assets totaled $0.3 million and $0.6 million for the thirteen and thirty-nine weeks ended October 1, 2023, respectively, and $0.2 million and $0.4 million for the three and nine months ended September 30, 2022, respectively. There were no impairment charges on tangible assets recognized for the thirteen or thirty-nine weeks ended October 1, 2023, or for the three or nine months ended September 30, 202
2
.
 
(10)
Goodwill and Intangible Assets
Goodwill
During the thirteen and thirty-nine weeks ended October 1, 2023, the Company recorded $119.4 million of goodwill impairment related to the goodwill assigned to Solaria, Inc. See Note 8 – Divestiture for additional information regarding the divestiture. The goodwill balances as of October 1, 2023 and December 31, 2022 were zero and $119.4 million, respectively. See Note 6 – Business Combination for additional information regarding the Company’s acquisitions including recognition of goodwill.
Intangible Assets
The following table provides a reconciliation of intangible assets reported as of October 1, 2023 and December 31, 2022 (in thousands, except years data):
 
    
As of October 1, 2023
 
    
Gross
Carrying
Amount
    
Impairment
    
Held for
Sale
    
Accumulated
Amortization
    
Net
Amount
 
Assembled workforce
   $ 137      $         $           (137    $     
Trademarks
     5,700        (3,714      (1,463      (523          
Customer relationship
     24,700        (16,094      (7,577      (1,029          
Developed technology
     12,700        (8,275      (3,259      (1,166          
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Total intangible assets
   $ 43,237      $ (28,083    $ (12,299    $ (2,855    $     
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
 
    
As of December 31, 2022
 
    
Weighted-
Average
Remaining
Life
(Years)
    
Gross
Carrying
Amount
    
Accumulated
Amortization
    
Net
Amount
 
Assembled workforce
     0.1      $ 137      $ (133    $ 4  
Trademarks
     9.8        5,700        (95      5,605  
Customer relationship
     21.8        24,700        (187      24,513  
Developed technology
     9.8        12,700        (212      12,488  
     
 
 
    
 
 
    
 
 
 
Total intangible assets
      $ 43,237      $ (627    $ 42,610  
     
 
 
    
 
 
    
 
 
 
Amortization expense related to intangible assets for the thirteen and thirty-nine weeks ended October 1, 2023 and the three and nine months ended September 30, 2022 were as follows (in thousands):
 
    
Thirteen Weeks
Ended
October 1,
2023
    
Three Months
Ended
September 30,
2022
    
Thirty-Nine

Weeks Ended
October 1,
2023
    
Nine Months
Ended
September 30,
2022
 
Assembled workforce
   $         $ 17      $ 4      $ 51  
Trademarks
     142                  428            
Customer relationship
     279                  843            
Developed technology
     317                  953            
  
 
 
    
 
 
    
 
 
    
 
 
 
Total amortization expense
   $ 738      $ 17      $ 2,228      $ 51  
  
 
 
    
 
 
    
 
 
    
 
 
 

Amortization expense for the thirteen and thirty-nine weeks ended October 1, 2023 was recorded as loss from discontinued operations on the accompanying unaudited condensed consolidated statements of operations and comprehensive income (loss). For the three and nine months ended September 30, 2022, amortization expense related to intangible assets of less than $0.1 million was recorded to general and administrative expense on the accompanying unaudited condensed consolidated statements of operations and comprehensive income (loss).
The Company does not expect to recognize any future amortization expense of intangible assets as of October 1, 2023.
 
(11)
Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities consist of the following (in thousands):
 
    
As of
 
    
October 1,
2023
    
December 31,
2022
 
Accrued compensation and benefits
   $ 3,666      $ 3,940  
Customer deposits
     1,167        930  
Uninvoiced contract costs
     3,554        1,914  
Inventory received but not invoiced
     1,391        972  
Accrued term loan and revolving loan amendment and final payment fees
     2,175        2,400  
Accrued legal settlements
     2,955        1,853  
Accrued taxes
     931        1,245  
Accrued rebates and credits
     880        1,076  
Operating lease liabilities, current
     720        958  
Revenue warranty
     918            
Deferred underwriters’ discount payable
     3,019            
Accrued warranty, current
     605        767  
Other accrued liabilities
     4,693        3,775  
  
 
 
    
 
 
 
Total accrued expenses and other current liabilities
   $ 26,674      $ 19,830  
  
 
 
    
 
 
 
 
(12)
Employee Benefit Plan
The Company sponsors a 401(k) defined contribution and profit-sharing plan (“401(k) Plan”) for its eligible employees. This 401(k) Plan provides for
tax-deferred
salary deductions for all eligible employees. Employee contributions are voluntary. Employees may contribute the maximum amount allowed by law, as limited by the annual maximum amount as determined by the Internal Revenue Service. The Company may match employee contributions in amounts to be determined at the Company’s sole discretion. The Company made no contributions to the 401(k) Plan for the thirteen or thirty-nine weeks ended October 1, 2023 and for the three or nine months ended September 30, 2022.

(13) Other Income (Expense), Net
Other income (expense), net consists of the following (in thousands):
 
    
Thirteen
Weeks
Ended
October 1,
2023
   
Three

Months
Ended
September 30,
2022
    
Thirty-Nine

Weeks
Ended

October 1,
2023
   
Nine
Months
Ended
September 30,
2022
 
Change in fair value of redeemable convertible preferred stock warrant liability
   $ 39     $ 3      $ 9,455     $ (142
Change in fair value of Carlyle warrants
     12,689       —          12,689       —    
Change in fair value of FACT public, private placement and working capital warrants
     4,170       —          4,170       —    
Gain on extinguishment of convertible notes and SAFE agreements
(1)
     —         —          —         3,235  
Loss on CS Solis debt extinguishment
     (10,338     —          (10,338     —    
Bonus shares issued in connection with the Mergers
(2)
     (2,394     —          (2,394     —    
Issuance of forward purchase agreements
(3)
     76       —          76       —    
Change in fair value of forward purchase agreement liabilities
(4)
     (6,661     —          (6,661     —    
Issuance of shares in connection with the forward purchase agreements
(5)
     (35,490     —          (35,490     —    
Other, net
     (94     1        191       87  
  
 
 
   
 
 
    
 
 
   
 
 
 
Total other income (expense), net
   $ (38,003   $ 4      $ (28,302   $ 3,180  
  
 
 
   
 
 
    
 
 
   
 
 
 
 
(1)
 
Includes zero and $1.4 million of other income for the three and nine months ended September 30, 2022, respectively, recognized upon the conversion of related party convertible notes and SAFEs.
(2)
 
Includes $0.7 million of other expense for each of the thirteen and thirty-nine weeks ended October 1, 2023 for bonus shares issued to related parties in connection with the Mergers.
(3)
 
Includes $0.3 million of other income for each of the thirteen and thirty-nine weeks ended October 1, 2023 for forward purchase agreements entered into with related parties.
(4)
 
Includes $5.9 million of other expense for each of the thirteen and thirty-nine weeks ended October 1, 2023 for forward purchase agreements entered into with related parties.
(5)
 
Includes $30.7 million of other expense for each of the thirteen and thirty-nine weeks ended October 1, 2023 for shares issued to related parties in connection with the forward purchase agreements.
 
(14)
Common Stock
The Company has authorized the issuance of 1,000,000,000 shares of common stock and 10,000,000 shares of preferred stock as of October 1, 2023. No preferred stock has been issued.
The Company has reserved shares of common stock for issuance related to the following:
 
    
As of
October 1,
2023
 
Common stock warrants
     27,637,266  
Employee stock purchase plan
     2,628,996  
Stock options and RSUs, issued and outstanding
     7,013,514  
Stock options and RSUs, authorized for future issuance
     8,625,023  
  
 
 
 
Total shares reserved
     45,904,799  
  
 
 
 

(15)
Warrants
Series B Warrants (Converted to Common Stock Warrants)
In February 2016, the Company issued a warrant to purchase 5,054 shares of Series B preferred stock (the “Series B warrant”) in connection with a 2016 credit facility. The Series B warrant is immediately exercisable at an exercise price of $4.30 per share and has an expiration date of February 2026. The fair value of the Series B warrant was less than $0.1 million as of December 31, 2022 and as of July 18, 2023, when the Series B warrant was reclassified from warrant liability to additional
paid-in
capital, as the warrant is exercisable into shares of Complete Solaria Common Stock upon the close of the Mergers. The relative fair value of the Series B warrant at issuance was recorded as a debt issuance cost within other
non-current
liabilities on the accompanying unaudited condensed consolidated balance sheets, and changes in fair value have been recorded in other income (expense), net on the accompanying unaudited condensed consolidated statements of operations and comprehensive income (loss) for the thirteen and thirty-nine weeks ended October 1, 2023 and the three and nine months ended September 30, 2022.
Series C Warrants (Converted to Common Stock Warrants)
In July 2016, the Company issued a warrant to purchase 148,477 shares of Series C preferred stock (the “Series C warrant”) in connection with the Series C financing. The Series C warrant agreement also provided for an additional number of Series C shares calculated on a monthly basis commencing on June 2016 based on the principal balance outstanding of the notes payable outstanding. The maximum number of shares exercisable under the Series C warrant agreement is 482,969 shares of Series C preferred stock. The Series C warrant was immediately exercisable at an exercise price of $1.00 per share and has an expiration date of July 2026. The fair value of the Series C warrant was $6.3 million as of December 31, 2022. The fair value of the Series C warrant was $2.3 million as of July 18, 2023, when the Series B warrant was reclassified from redeemable convertible preferred stock warrant liability to additional
paid-in
capital, as the warrant is exercisable into shares of Complete Solaria Common Stock upon the close of the Mergers. The relative fair value of the Series C warrant at issuance was recorded as Series C preferred stock issuance costs and redeemable convertible preferred stock warrant liability on the accompanying unaudited condensed consolidated balance sheets, and changes in fair value have been recorded in other income (expense), net on the accompanying unaudited condensed consolidated statements of operations and comprehensive income (loss) for the thirteen and thirty-nine weeks ended October 1, 2023 and the three and nine months ended September 30, 2022.
Series
C-1
Warrants (Converted to Common Stock Warrants)
In January 2020, the Company issued a warrant to purchase 173,067 shares of common stock in conjunction with the Series
C-1
preferred stock financing. The warrant is immediately exercisable at an exercise price of $0.01 per share and has an expiration date of January 2030. The warrant remains outstanding as of October 1, 2023. At issuance, the relative fair value of the warrant was determined to be $0.1 million using the Black-Scholes model with the following weighted average assumptions: expected term of 10 years; expected volatility of 62.5%; risk-free interest rate of 1.5%; and no dividend yield. The fair value of the warrant was recorded within additional
paid-in
capital on the unaudited condensed consolidated balance sheets. The warrant is not remeasured in future periods as it meets the conditions for equity classification.
SVB Common Stock Warrants
In May and August 2021, the Company issued warrants to purchase 2,473 and 2,525 shares of common stock, respectively, in conjunction with the Fifth and Sixth Amendments to the Loan and Security Agreement (“Loan Agreement”) with Silicon Valley Bank (“SVB”). The warrants are immediately exercisable at exercise prices of $0.38 and $0.62 per share, respectively, and have expiration dates in 2033. The warrants remain outstanding as of October 1, 2023. At issuance, the relative fair value of the warrants

were determined to be less than $0.1 million in aggregate using the Black-Scholes model with the following weighted average assumptions: expected term of 12 years; expected volatility of 73.0%; risk-free interest rate of 1.7% and 1.3% for the May and August 2021 warrants, respectively; and no dividend yield. The fair value of the warrant was recorded within additional
paid-in-capital
on the accompanying unaudited condensed consolidated balance sheets. The warrants are not remeasured in future periods as they meet the conditions for equity classification.
Promissory Note Common Stock Warrants
In October 2021, the Company issued a warrant to purchase 24,148 shares of common stock in conjunction with the issuance of a short-term promissory note. The warrant is immediately exercisable at an exercise price of $0.01 per share and has an expiration date of October 2031. The warrant remains outstanding as of October 1, 2023. At issuance, the relative fair value of the warrant was determined to be less than $0.1 million using the Black-Scholes model with the following weighted average assumptions: expected term of 10 years; expected volatility of 73.0%; risk-free interest rate of 1.5%; and no dividend yield. The fair value of the warrant was recorded within additional
paid-in
capital on the unaudited condensed consolidated balance sheets. The warrant is not remeasured in future periods as it meets the conditions for equity classification.
Carlyle Warrants
In February 2022, as part of a debt financing from Carlyle (refer to Note 16 – Borrowing Arrangements), the Company issued a warrant to purchase 2,886,952 shares of common stock in conjunction with the redeemable investment in CS Solis. The warrant contained two tranches, the first of which is immediately exercisable for 1,995,879 shares. The second tranche, which was determined to be a separate unit of account, was exercisable upon a subsequent investment from Carlyle in CS Solis. No subsequent investment was made and the investment period expired on December 31, 2022 and the second tranche of warrants expired prior to becoming exercisable. The vested warrant had an exercise price of $0.01 per share and had an expiration date of February 2029.
At issuance, the relative fair value of the warrant was determined to be $3.4 million using the Black-Scholes model with the following weighted average assumptions: expected term of 7 years; expected volatility of 73.0%; risk-free interest rate of 1.9%; and no dividend yield. The fair value of the warrant was recorded within additional
paid-in
capital and as a discount on the long-term debt in CS Solis on the unaudited condensed consolidated balance sheets as of December 31, 2022.
In July 2023, and in connection with the closing of the Mergers, the Carlyle debt and warrants were modified. Based on the exchange ratio included in the Mergers, the 1,995,879 outstanding warrants to purchase Legacy Complete Solaria Common Stock prior to modification were exchanged into warrants to purchase 1,995,879 shares of Complete Solaria Common Stock. As part of the modification, the warrant, which expires on July 18, 2030, provides Carlyle with the right to purchase shares of Complete Solaria Common Stock based on (a) the greater of (i) 1,995,879 shares and (ii) the number of shares equal to 2.795% of Complete Solaria’s issued and outstanding shares of common stock, on a fully-diluted basis; plus (b) on and after the date that is ten (10) days after the date of the agreement, an additional 350,000 shares; plus (c) on and after the date that is thirty (30) days after the date of the agreement, if the original investment amount has not been repaid, an additional 150,000 shares; plus (d) on and after the date that is ninety (90) days after the date of the agreement, if the original investment amount has not been repaid, an additional 250,000 shares, in each case, of Complete Solaria Common Stock at a price of $0.01 per share. Of the additional warrants that become exercisable after the modification, the tranches of 350,000 warrants vesting ten days after the date of the agreement and 150,000 warrants vesting thirty days after the date of the agreement are exercisable as of October 1, 2023.
The modification of the warrant resulted in the reclassification of previously equity classified warrants to liability classification, which was accounted for in accordance with ASC 815 and ASC 718. The Company

recorded the fair value of the modified warrants as a warrant liability of $20.4 million, the
pre-modification
fair value of the warrants as a reduction to additional
paid-in
capital of $10.9 million and $9.5 million to other income (expense), net equal to the incremental value of the warrants upon the modification. The fair value of the warrant was determined based on its intrinsic value, given a nominal exercise price. At issuance, the relative fair value of the warrant was determined to be less than $20.4 million using the
Black-Scholes
model with the following weighted average assumptions: expected term of 7 years; expected volatility of 77.0%; risk-free interest rate of 3.9%; and no dividend yield. As of October 1, 2023, the fair value of the warrant was $7.7 million, and the Company recorded the adjustment of $12.7 million as other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive income (loss).
Series
D-7
Warrants (Converted to Common Stock Warrants)
In November 2022, the Company issued warrants to purchase 656,630 shares of Series
D-7
preferred stock (the “Series
D-7
warrants”) in conjunction with the Business Combination. The warrant contains two tranches. The first tranche of 518,752 shares of Series
D-7
preferred stock is exercisable at an exercise price of $2.50 per share upon consummation of a merger transaction, or at an exercise price of $2.04 per share upon remaining private and has an expiration date of April 2024. The second tranche of 137,878 shares of Series
D-7
preferred stock is exercisable at an exercise price of $5.00 per share upon consummation of a merger transaction, or at an exercise price of $4.09 per share upon remaining private and has an expiration date of April 2024. The fair value of the Series
D-7
warrants was $7.8 million as of December 31, 2022 and $2.4 million as of July 18, 2023 when the warrants were reclassified from redeemable convertible preferred stock warrant liability to additional
paid-in
capital, as the exercise price of the warrants is fixed at $2.50 per share of Complete Solaria Common Stock for the first tranche and $5.00 per share of Complete Solaria Common Stock for the second tranche upon the closing of the Mergers.
The Series
D-7
Warrants remain outstanding as of October 1, 2023.
November 2022 Common Stock Warrants
In November 2022, the Company issued a warrant to a third-party service provider to purchase 78,962 shares of common stock in conjunction with the Business Combination. The warrant was immediately exercisable at an exercise price of $8.00 per share and had an expiration date of April 2024. In May 2023, the Company amended the warrant, modifying the shares of common stock to be purchased to 31,680, the exercise price to $0.01, and the expiration date to the earlier of October 2026 or the closing of an IPO. The impact of the modification was not material to the unaudited condensed consolidated financial statements. At issuance and upon the modification, the relative fair value of the warrant was determined to be $0.1 million using the Black-Scholes model with the following weighted average assumptions: expected term of 1.5 years; expected volatility of 78.5%; risk-free interest rate of 4.7%; and no dividend yield. The fair value of the warrant was recorded within additional
paid-in
capital on the unaudited condensed consolidated balance sheets. The warrant is not remeasured in future periods as it meets the conditions for equity classification. Upon the Closing of the Mergers, the warrant was net exercised into 31,680 shares of Complete Solaria Common Stock.
July 2023 Common Stock Warrants
In July 2023, the Company issued a warrant to a third-party service provider to purchase 38,981 shares of common stock in exchange for services provided in obtaining financing at the Closing of the Mergers. The warrant is immediately exercisable at a price of $0.01 per share and has an expiration date of July 2028. At issuance, the fair value of the warrant was determined to be $0.2 million, based on the intrinsic value of the warrant and the $0.01 per share exercise price. As the warrant is accounted for as an equity issuance cost, the warrant is recorded only within additional
paid-in
capital on the unaudited condensed consolidated balance sheets. The warrant is not remeasured in future periods as it meets the conditions for equity classification.

Warrant Consideration
In July 2023, in connection with the Mergers, the Company issued 6,266,572 warrants to purchase Complete Solaria Common Stock to holders of Legacy Complete Solaria Redeemable Convertible Preferred Stock, Legacy Complete Solaria Common Stock. The exercise price of the common stock warrants is $11.50 per share and the warrants expire 10 years from the date of the Mergers. The warrant consideration was issued as part of the close of the Mergers and was recorded within additional
paid-in
capital, net of the issuance costs of the Mergers. As of October 1, 2023, all warrants issued as warrant consideration remain outstanding.
Public, Private Placement, and Working Capital Warrants
In conjunction with the Mergers, Complete Solaria, as accounting acquirer, was deemed to assume 6,266,667 warrants to purchase FACT Class A Ordinary Shares that were held by the sponsor at an exercise price of $11.50 (“Private Placement Warrants”) and 8,625,000 warrants to purchase FACT’s shareholders FACT Class A Ordinary Shares at an exercise price of $11.50 (“Public Warrants”). Subsequent to the Mergers, the Private Placement Warrants and Public Warrants are exercisable for shares of Complete Solaria Common Stock and meet liability classification requirements since the warrants may be required to be settled in cash under a tender offer. In addition, Private Placement Warrants are potentially subject to a different settlement amount as a result of being held by the Sponsor which precludes the Private Placement Warrants from being considered indexed to the entity’s own stock. Therefore, these warrants are classified as liabilities on the unaudited condensed consolidated balance sheets.
The Company determined the Public and Private warrants to be classified as a liability and fair valued the warrants on the issuance date using the publicly available price for the warrants of $6.4 million. The fair value of these warrants was $2.4 million as of October 1, 2023, and the Company recorded the change in fair value of $4.0 million in other income (expense), net in the unaudited condensed consolidated statements of operations and comprehensive income (loss) for the thirteen and thirty-nine weeks ended October 1, 2023.
Additionally, at the closing of the Mergers, the Company issued 716,668 Working Capital warrants, which have identical terms as the Private Placement Warrants to the sponsor in satisfaction of certain liabilities of FACT. The warrants were fair valued at $0.3 million upon the closing of the Mergers, which was recorded in warrant liability on the unaudited condensed consolidated balance sheets. As of October 1, 2023, the Working Capital warrants had a fair value of $0.1 million, and the Company recorded the change in fair value of $0.2 million as other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive income (loss).
 
(16)
Borrowing Arrangements
Convertible notes, net and convertible notes, net, due to related parties
As of October 1, 2023 and December 31, 2022, the Company’s convertible notes consisted of the following (in thousands):
 
    
As of
 
    
October 1,
2023
    
December 31,
2022
 
Convertible notes, net, noncurrent
     
2022 Convertible Notes
   $   —      $ 3,434  
2022 Convertible Notes due to related parties
       —        15,510  
  
 
 
    
 
 
 
Total convertible notes
   $   —      $ 18,944  
  
 
 
    
 
 
 
Convertible Promissory Notes with Ecosystem Integrity Fund II, LP.
On April 30, 2021, the Company issued a short-term Subordinated Convertible Promissory Note to Ecosystem Integrity Fund II, LP (“EIF”) for a total principal of $0.5 million plus accrued interest of 3.0% per annum due on June 30, 2021. The Note included a conversion feature which allows the holder to convert any portion of the note plus any unpaid accrued interest (“Conversion Amount”) into shares of Series
C-1
Preferred Stock on the maturity date of June 30, 2021 or thereafter. As of December 31, 2021 the principal and accrued interest remained outstanding and the holder did not elect to covert the note into Series
C-1
Preferred shares. The principal and accrued interest of $0.5 million was repaid in February 2022, and as such, the balance remaining at December 31, 2022 and thereafter remained zero.
2019-A
Convertible Notes
In 2019, the Company issued a series of convertible notes
(“2019-A
Convertible Notes”) for $0.1 million in proceeds, with immaterial debt issuance costs, and which were due and payable on demand by the holders after August 2020. The notes carried simple interest of 6.0% and contained a conversion feature whereby the notes would convert at 80% of the issuance price of the preferred shares in the next equity financing. The notes also contained other embedded features such as conversion options that were exercisable upon the occurrence of various contingencies. All of the embedded features were analyzed to determine whether they should be bifurcated and separately accounted for as a derivative. Pursuant to such analysis, the Company valued and bifurcated the share-settled redemption feature, which enabled the holders to convert the notes to the preferred shares at a predefined discount from the issuance price and recorded its initial fair value of less than $0.1 million as a discount on the convertible notes face amount. The debt discount was amortized to interest expense at a weighted-average effective interest rate of 17.6% through the maturity dates of the notes.
The fair value of the share-settled redemption feature was estimated based on a probability-weighted analysis of the discounted value of the notes converting under a Next Equity Financing, a change in control, default, or maturity, and the changes in fair value were recognized as a component of other income (expense), net in the accompanying unaudited condensed consolidated statements of operations and comprehensive income (loss). The Company recorded zero in expense during the thirteen and thirty-nine weeks ended October 1, 2023 and the three and nine months ended September 30, 2022, related to the change in the fair value of the convertible notes embedded derivative liability. The convertible notes were carried within the accompanying unaudited condensed consolidated balance sheets at their original issuance value, net of unamortized debt discount and issuance costs. In March 2022, as part of the Company’s Series D Preferred Stock issuance, the
2019-A
Convertible Notes converted into 62,500 shares of Series
D-2
redeemable convertible preferred stock. The Company recognized a gain on the conversion of less than $0.1 million in other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive income (loss). As the full carrying value of the note was converted to Series D Preferred Stock, the balance remaining for the note at December 31, 2022 and thereafter remained zero.
The Company did not recognize any interest expense related to the
2019-A
Convertible Notes during the thirteen and thirty-nine weeks ended October 1, 2023 and the three months ended September 2022. Interest expense recognized related to the
2019-A
Convertible Notes during the nine months ended September 30, 2022 was immaterial.
2020-A
Convertible Notes
In 2020, the Company issued a series of convertible notes
(“2020-A
Convertible Notes”) for $3.8 million in proceeds, with immaterial debt issuance costs, and which are due and payable on demand by the holders after April 2021. The notes carried simple interest of 2.0% and contained a conversion feature whereby the notes would convert at 80% of the issuance price of the preferred shares in the next equity financing. The notes also contained other embedded features such as conversion options that were exercisable upon the

occurrence of various contingencies. All of the embedded features were analyzed to determine whether they should be bifurcated and separately accounted for as a derivative. Pursuant to such analysis, the Company valued and bifurcated the share-settled redemption feature, which enables the holders to convert the notes to the preferred shares at a predefined discount from the issuance price and recorded its initial fair value of $0.5 million as a discount on the convertible notes face amount. The debt discount was amortized to interest expense at a weighted-average effective interest rate of 25.6% through the maturity dates of the notes.
The fair value of the share-settled redemption feature was estimated based on a probability-weighted analysis of the discounted value of the notes converting under a Next Equity Financing, a change in control, default, or maturity, and the changes in fair value were recognized as a component of other income (expense), net in the accompanying unaudited condensed consolidated statements of operations and comprehensive income (loss). The Company recorded zero in expense during the thirteen and thirty-nine weeks ended October 1, 2023 and the three and nine months ended September 30, 2022, related to the change in the fair value of the convertible notes embedded derivative liability. The convertible notes were carried within the accompanying unaudited condensed consolidated balance sheets at their original issuance value, net of unamortized debt discount and issuance costs. In March 2022, as part of the Company’s Series D Preferred Stock issuance, the
2020-A
Convertible Notes converted into 785,799 shares of
Series D-1
redeemable convertible preferred stock. The Company recognized a gain on the conversion of $0.9 million in other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive income (loss). As the full carrying value of the note was converted to Series D Preferred Stock, the balance remaining for the note at December 31, 2022 and thereafter remained zero.
The Company did not recognize any interest expense related to the
2020-A
Convertible Notes during the thirteen and thirty-nine weeks ended October 1, 2023 and the three months ended September 2022. Interest expense recognized during the nine months ended September 30, 2022 was immaterial.
2021-A
Convertible Notes
In 2020, the Company issued a series of convertible notes
(“2021-A
Convertible Notes”) for $4.3 million in proceeds, with immaterial debt issuance costs, and which are due and payable on demand by the holders after February 2022. The holders are existing investors and are not expected to demand cash settlement, as the Company expects to raise additional preferred financing under which the notes will convert into preferred shares. The notes carry simple interest of 2.0% and contained a conversion feature whereby the notes would convert at 80% of the issuance price of the preferred shares in the next equity financing. The notes also contained other embedded features such as conversion options that were exercisable upon the occurrence of various contingencies. All of the embedded features were analyzed to determine whether they should be bifurcated and separately accounted for as a derivative. Pursuant to such analysis, the Company valued and bifurcated the share-settled redemption feature, which enables the holders to convert the notes to the preferred shares at a predefined discount from the issuance price and recorded its initial fair value of $0.6 million as a discount on the convertible notes face amount. The debt discount is amortized to interest expense at a weighted-average effective interest rate of 18.1% through the maturity dates of the notes.
The fair value of the share-settled redemption feature was estimated based on a probability-weighted analysis of the discounted value of the notes converting under a Next Equity Financing, a change in control, default, or maturity, and the changes in fair value were recognized as a component of other income (expense), net in the unaudited condensed consolidated statements of operations and comprehensive income (loss). The Company recorded zero in expense during the thirteen and thirty-nine weeks ended October 1, 2023 and the three and nine months ended September 30, 2022, related to the change in the fair value of the convertible notes embedded derivative liability. The convertible notes were carried on the unaudited condensed consolidated balance sheets at their original issuance value, net of unamortized debt discount and issuance costs. In March 2022, as part of the Company’s Series D Preferred Stock issuance, the
2021-A
Convertible Notes converted into 869,640 shares of Series
D-1
redeemable convertible preferred stock. The Company recognized a gain on the conversion of $0.8 million in other income (expense), net on the

unaudited condensed consolidated statements of operations and comprehensive income (loss). As the full carrying value of the note was converted to Series D Preferred Stock, the balance remaining for the note at December 31, 2022 and thereafter remained zero.
As part of the
2021-A
Convertible Notes financing, the Company entered into an additional convertible note with an existing investor for $0.5 million. The note carries PIK interest of 3.0% and is due and payable on demand at any time after June 30, 2021. The note contains an embedded conversion feature, which allows the holder to convert the note into a fixed number of shares of Series
C-1
preferred stock at any time after June 30, 2021. The Company concluded the conversion feature is not required to be bifurcated as an embedded derivative liability, and the note is carried at its principal plus accrued PIK interest. As the full carrying value of the note was converted to Series D Preferred Stock, the balance remaining for the note at December 31, 2022 and thereafter remained zero.
The Company did not recognize any interest expense related to the
2021-A
Convertible Notes during the thirteen and thirty-nine weeks ended October 1, 2023 and the three months ended September 30, 2022. Interest expense recognized during the nine months ended September 30, 2022 was immaterial.
2022 Convertible Notes
In connection with the Original Business Combination Agreement, the Company has raised a series of convertible notes (“2022 Convertible Notes”) during the fiscal year ended December 31, 2022 with an aggregate purchase price of $12.0 million, and during the thirty-nine weeks ended October 1, 2023 for an additional total purchase price of $21.3 million. Additionally, as part of the acquisition of Solaria, the Company assumed a note from an existing investor for its fair value of $6.7 million. The note contained the same terms as the other 2022 Convertible Notes. The Company did not incur significant issuance costs associated with the 2022 Convertible Notes. The 2022 Convertible Notes accrued interest at a rate of 5% per annum. Immediately prior to the closing of the Mergers, the 2022 Convertible Notes were converted into the number of shares of common stock of Complete Solaria equal to (x) the principal amount together with all accrued interest of the 2022 Convertible Notes divided by 0.75, divided by (y) the price of a share of common stock of Complete Solaria used to determine the conversion ratio in the Amended and Restated Business Combination Agreement. This resulted in the issuance of 5,316,460 shares of Complete Solaria common stock to the noteholders and no debt remains outstanding associated with the 2022 Convertible Notes as of October 1, 2023.
The Company has recognized interest expense of less than $0.1 million and $0.7 million related to the 2022 Convertible Notes during the thirteen and thirty-nine weeks ended October 1, 2023. The Company did not recognize any interest expense related to the 2022 Convertible Notes during the three and nine months ended September 30, 2022.
SAFE Agreements
2019 SAFE
In September 2019, the Company issued the 2019 SAFE for $0.1 million in proceeds, with immaterial debt issuance costs. No interest was accrued on the 2019 SAFE. The 2019 SAFE contained conversion features that allowed the holder to convert the 2019 SAFE into shares of preferred stock upon the next equity financing, subject to a valuation cap. The 2019 SAFE was reported at fair value based on the probability-weighted expected return method (“PWERM”), which assigns value to the multiple settlement scenarios based on the probability of occurrence. The fair value of the 2019 SAFE was $0.2 million as of December 31, 2021 was recorded in SAFE Agreements in the accompanying unaudited condensed consolidated balance sheets. In March 2022, the Company converted the 2019 SAFE into 48,258 shares of Series
D-3
redeemable convertible preferred stock. The Company recognized a gain on the conversion of the 2019 SAFE of less than $0.1 million in other income (expense), net on the unaudited condensed

consolidated statements of operations and comprehensive income (loss). As the full carrying value of the SAFE was converted to Series D Preferred Stock, the balance remaining for the SAFE at December 31, 2022 and thereafter remained zero.
2021 SAFE
In December 2021, the Company issued the 2021 SAFE for $5.0 million in proceeds, with immaterial debt issuance costs. No interest is accrued on the 2021 SAFE. The 2021 SAFE contained conversion features that allowed the holder to convert the 2021 SAFE into shares of preferred stock upon the next equity financing, subject to a valuation cap. The 2019 SAFE was reported at fair value based on the PWERM, which assigns value to the multiple settlement scenarios based on the probability of occurrence. The fair value of the 2021 SAFE was $6.3 million as of December 31, 2021 is recorded in SAFE Agreements in the accompanying unaudited condensed consolidated balance sheets. In March 2022, the Company converted the 2021 SAFE into 1,005,366 shares of Series
D-1
redeemable convertible preferred stock. The Company recognized a gain on the conversion of the 2021 SAFE of $1.4 million in other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive income (loss). As the full carrying value of the SAFE was converted to Series D Preferred Stock, the balance remaining for the SAFE at December 31, 2022 and thereafter remained zero.
Solaria SAFE
As part of the acquisition of Solaria (refer to Note 6 – Business Combination) the Company acquired the Solaria SAFEs. The number of shares to be issued upon conversion of the SAFE notes contained various features to convert or redeem the Solaria SAFEs in the event of an equity financing, public offering, change of control or a dissolution event.
The Company historically elected to account for all of the SAFE notes at estimated fair value pursuant to the fair value option and recorded the change in estimated fair value as other income (expense), net in the unaudited condensed consolidated statements of operations and comprehensive income (loss) until the notes are converted or settled. The SAFE notes were amended through the SAFE Assumption Amendment, Assignment and Assumption Agreement on November 4, 2022, as part of the Business Combination with Complete Solar, whereby all the SAFE notes were assumed by Complete Solar. As part of the purchase price accounting discussed in Note 4 – Reverse Recapitalization, the estimated fair value of the SAFE notes was determined to be $60.5 million. Post consummation of the Business Combination the SAFE notes were converted to 8,171,662 shares of Series
D-8
preferred stock as discussed in Note 6 – Business Combination.
Notes Payable
Loan and Security Agreement
In January 2020, the Company entered into the Loan Agreement with SVB. The Loan Agreement, as amended, provided for a line of credit up to $7.0 million and has a maturity date of February 2022. Advances under the line of credit bore interest at the greater of 5.25% or the prime rate (as published in the Wall Street Journal) plus 3.5% per annum. All borrowings under the line of credit were to be secured by substantially all of the Company’s assets.
During 2021, the Company entered into several amendments to the Loan Agreement, and in May and August 2021 in connection with the Fifth and Sixth Amendments, the Company issued warrants to purchase 5,122 shares and 5,229 shares of common stock at exercise prices of $0.38 per share and $0.62 per share, respectively. The fair value of the warrants were recorded as deferred issuance costs and amortized to interest expense. As of December 31, 2022 and thereafter, there were no unamortized debt issuance costs.

Under the Loan Agreement, the Company was subject to certain reporting covenants, such as a requirement for the Company’s monthly unaudited condensed consolidated financial statements and compliance certificate, as well as a financial covenant to maintain a minimum liquidity ratio of 1.75 to 1.00. In 2021, the Loan Agreement was amended to add a new financial covenant, requiring the Company to obtain new equity of at least $15.0 million by a specified date, which the Company did not meet; however, the default was later waived by SVB.
In February 2022, as part of the transaction to raise long-term debt in CS Solis, the Company repaid the principal and accrued interest of the Loan Agreement of $6.7 million, which terminated the agreement with SVB. As such, as of December 31, 2022 and thereafter, there was no debt related to this agreement on the Company’s balance sheet.
2021 Promissory Notes
In July 2021, the Company issued a short-term promissory note for $0.5 million in proceeds, with immaterial debt issuance costs. The promissory note carried simple interest of 2.0% and were due and payable after February 2022. In February 2022, the Company repaid the 2021 Promissory Note.
In October 2021, the Company issued a short-term promissory note for $2.0 million in proceeds, with immaterial debt issuance costs. The promissory note contained a financing fee of $0.3 million, which was due and payable along with the principal amount in January 2022. In connection with the promissory note, the Company issued a warrant to purchase 50,000 shares of common stock at an exercise price of $0.01 per share. The principal and accrued interest of the note payable was repaid in January 2022, and no amounts remained outstanding as of December 31, 2022 and thereafter.
Current Insight Promissory Note
In January 2021, the Company issued a promissory note for a principal amount of $0.1 million in connection with the purchase of Current Insight, with immaterial debt issuance costs. The promissory note bears interest at 0.14% per annum and has equal monthly installments due and payable through the maturity date of January 2022. The principal and accrued interest was repaid in January 2022, and no amounts remained outstanding as of December 31, 2022 and thereafter.
2018 Bridge Notes
In December 2018, Solaria Corporation issued senior subordinated convertible secured notes (“2018 Notes”) totaling approximately $3.4 million in exchange for cash. The notes bear interest at the rate of 8% per annum and the investors are entitled to receive twice of the face value of the notes at maturity. The 2018 Notes are secured by substantially all of the assets of Solaria Corporation. In 2021, the 2018 Notes were amended extending the maturity date to December 13, 2022. In connection with the 2021 amendment, Solaria had issued warrants to purchase shares of Series
E-1
redeemable convertible preferred stock of Solaria. The warrants were exercisable immediately in whole or in part at and expire on December 13, 2031. As part of the Business Combination with Complete Solar, all the outstanding warrants issued to the lenders were assumed by the parent company, Complete Solaria as discussed in Note 6 – Business Combination.
In December 2022, the Company entered into an amendment to the 2018 Bridge Notes extending the maturity date from December 13, 2022 to December 13, 2023. In connection with the amendment, the notes will continue to bear interest at 8% per annum and are entitled to an increased repayment premium from 110% to 120% of the principal and accrued interest at the time of repayment.
The Company concluded that the modification was a troubled debt restructuring as the Company was experiencing financial difficulty and the amended terms resulted in a concession to the Company. As the future undiscounted cash payments under the modified terms exceeded the carrying amount of the Solaria

Bridge Notes on the date of modification, the modification was accounted for prospectively. The incremental repayment premium is being amortized to interest expense using the effective interest rate method. As of October 1, 2023 and December 31, 2022, the carrying value of the Bridge Notes was $10.7 million and $9.8 million, respectively. Interest expense recognized for the thirteen and thirty-nine weeks ended October 1, 2023 was $0.3 million and $1.0 million, respectively. The Company did not recognize any interest expense related to the 2018 Bridge Notes during the three and nine months ended September 30, 2022. As of October 1, 2023, the carrying value of the 2018 Bridge Notes approximates their fair value.
SCI Term Loan and Revolver Loan
In October 2020, Solaria entered into a loan agreement (“SCI Loan Agreement”) with Structural Capital Investments III, LP (“SCI”).
The SCI Loan Agreement comprises of two facilities, a term loan (the “Term Loan”) and a revolving loan (the “Revolving Loan”) (together “Original Agreement”) for $5.0 million each with a maturity date of October 31, 2023. Both the Term Loan and the Revolving Loan were fully drawn upon closing. The Term Loan was repaid prior to the acquisition of Solaria by Complete Solar and was not included in the Business Combination.
The Revolving Loan also has a term of
thirty-six
months, principal repayments at the end of the term and an annual interest rate of 7.75% or Prime rate plus 4.5%, whichever is higher. The SCI Loan Agreement required the Company to meet certain financial covenants relating to maintenance of specified restricted cash balance, achieving specified revenue target and maintaining specified contribution margin (“Financial Covenants”) over the term of each of the Revolving Loan. The Revolving Loan is collateralized substantially by all assets and property of the Company.
In the years ended December 31, 2022 and December 31, 2021, Solaria entered into several Amended and Restated Loan and Security Agreements as a forbearance agreement for SCI to forbear from exercising any rights and remedies available to it as a result of Company not meeting certain Financial Covenants required by the Original Agreement. As a result of these amendment changes were made to the Financial Covenants and Solaria recorded a total of $1.9 million amendment fees in Other Liabilities and was included in the acquired liabilities for purchase price accounting.
Solaria had historically issued warrants to purchase shares of Series
E-1
redeemable convertible preferred stock of Solaria (“SCI Series
E-1
warrants”). The warrants were fully exercisable in whole or in part at any time during the term of the Original agreement. As part of the Business Combination with Complete Solar, all the outstanding SCI Series
E-1
warrants were assumed by the parent company, Complete Solaria as discussed in Note 6 – Business Combination.
The Revolving Loan outstanding on the date of the Business Combination was fair valued at $5.0 million for the purpose of purchase price accounting discussed in Note 6 – Business Combination. The Revolving Loan principal balance at October 1, 2023 and December 31, 2022 amounted to $5.0 million. Interest expense recognized for the thirteen and thirty-nine weeks ended October 1, 2023 was $0.2 million and $0.5 million, respectively. The Company was in compliance with all the Financial Covenants as of October 1, 2023. In October 2023, the Company entered into an Assignment and Acceptance Agreement whereby Structural Capital Investments III, LP assigns the SCI debt to Kline Hill Partners Fund LP, Kline Hill Partners IV SPV LLC, Kline Hill Partners Opportunity IV SPV LLC, and Rodgers Massey Revocable Living Trust for a total purchase price of $5.0 million, as discussed in Note 22 – Subsequent Events.
Secured Credit Facility
In December 2022, the Company entered into a secured credit facility agreement with Kline Hill Partners IV SPV LLC and Kline Hill Partners Opportunity IV SPV LLC. The secured credit facility agreement allows

the Company to borrow up to 70% of the net amount of its eligible vendor purchase orders with a maximum amount of $10.0 million at any point in time. The purchase orders are backed by relevant customer sales orders which serves as a collateral. The amounts drawn under the secured credit facility may be reborrowed provided that the aggregate borrowing does not exceed $20.0 million. The repayment under the secured credit facility is the borrowed amount multiplied by 1.15x if repaid within 75 days and borrowed amount multiplied by 1.175x if repaid after 75 days. The Company may prepay any borrowed amount without premium or penalty. Under the original terms, the secured credit facility agreement was due to mature in April 2023. The Company is in the process of amending the secured credit facility agreement to extend its maturity date.
At October 1, 2023, the outstanding net debt amounted to $11.7 million, including accrued financing cost of $4.1 million, compared to December 31, 2022, where the outstanding net debt amounted to $5.6 million, including accrued financing cost of $0.1 million. The Company has recognized interest expense of zero and $3.1 million related to the Secured Credit Facility during the thirteen and thirty-nine weeks ended October 1, 2023, respectively. The Company did not recognize any interest expense related to the Secured Credit Facility during the three and nine months ended September 30, 2022. As of October 1, 2023, the total estimated fair value of the Secured Credit Facility approximates its carrying value.
Polar Settlement Agreement
In September 2023, in connection with the Mergers, the Company entered into a settlement and release agreement with Polar Multi-Strategy Master Fund (“Polar”) for the settlement of a working capital loan that had been made by Polar to the Sponsor, prior to the closing of the Mergers. As part of the settlement agreement, the Company agreed to pay Polar $0.5 million as a return of capital, which is paid in ten equal monthly installments and does not accrue interest. During the thirteen and thirty-nine weeks ended October 1, 2023, the Company made one payment of less than $0.1 million, and as of October 1, 2023, and $0.5 million remains outstanding.
Debt in CS Solis
As described above, as part of the reorganization in February 2022 of the Company, the Company received an investment from Carlyle. The investment was made pursuant to a subscription agreement, under which Carlyle contributed $25.6 million in exchange for 100 Class B Membership Units of CS Solis and the Company contributed the net assets of Complete Solar, Inc. in exchange for 100 Class A Membership Units. The Class B Membership Units are mandatorily redeemable by the Company on the three-year anniversary of the effective date of the CS Solis amended and restated LLC agreement (February 14, 2025). The Class B Membership Units accrue interest that is payable upon redemption at a rate of 10.5% (which is structured as a dividend payable based on 25% of the investment amount measured quarterly), compounded annually, and subject to increases in the event the Company declares any dividends. In connection with the investment, the Company issued a warrant to purchase 5,978,960 shares of the Company’s common stock at a price of $0.01 per share, of which, 4,132,513 shares are immediately exercisable. The Company has accounted for the mandatorily redeemable investment from Carlyle in accordance with ASC 480, Distinguishing Liabilities from Equity, and has recorded the investment as a liability, which was accreted to its redemption value under the effective interest method. The Company has recorded the warrants as a discount to the liability. Refer to Note 14 – Common Stock, for further discussion of the warrants issued in connection with the Class B Membership Units.
On July 17 and July 18, 2023, and in connection with obtaining consent for the Mergers, Legacy Complete Solaria, FACT and Carlyle entered into an Amended and Restated Consent to the Business Combination Agreement (“Carlyle Debt Modification Agreement”) and an amended and restated warrant agreement (“Carlyle Warrant Amendment”), which modified the terms of the mandatorily redeemable investment made by Carlyle in Legacy Complete Solaria.

The Carlyle Debt Modification Agreement accelerates the redemption date of the investment, which was previously February 14, 2025 and is March 31, 2024 subsequent to the modification. Additionally, as part of the amendment, the parties entered into an amended and restated warrant agreement. As part of the Carlyle Warrant Amendment, Complete Solaria issued Carlyle a warrant to purchase up to 2,745,879 shares of Complete Solaria Common Stock at a price per share of $0.01, which is inclusive of the outstanding warrant to purchase 1,995,879 shares at the time of modification. The warrant, which expires on July 18, 2030, provides Carlyle with the right to purchase shares of Complete Solaria Common Stock based on (a) the greater of (i) 1,995,879 shares and (ii) the number of shares equal to 2.795% of Complete Solaria’s issued and outstanding shares of common stock, on a fully-diluted basis; plus (b) on and after the date that is ten (10) days after the date of the agreement, an additional 350,000 shares; plus (c) on and after the date that is thirty (30) days after the date of the agreement, if the original investment amount has not been repaid, an additional 150,000 shares; plus (d) on and after the date that is ninety (90) days after the date of the agreement, if the original investment amount has not been repaid, an additional 250,000 shares, in each case, of Complete Solaria Common Stock at a price of $0.01 per share. The warrants are classified as liabilities under ASC 815 and are recorded within warrant liability on the unaudited condensed consolidated statements of operations and comprehensive income (loss).
The Company accounted for the modification of the long-term debt in CS Solis as a debt extinguishment in accordance with ASC 480 and ASC 470. As a result of the extinguishment, the Company recorded a loss on extinguishment, of $10.3 million, which is recorded within other expense on the unaudited condensed consolidated statements of operations and comprehensive income (loss). As of the modification date, the Company recorded the fair value of the new debt of $28.4 million as short-term debt in CS Solis, and the amount will be accreted to its redemption value of $31.9 million under the effective interest method.
The Company has recorded a liability of $29.2 million and zero included in short-term debt in CS Solis on the unaudited condensed consolidated balance sheets as of October 1, 2023 and December 31, 2022, respectively. The Company has recorded a liability of zero and $25.2 million included in long-term debt in CS Solis on the unaudited condensed consolidated balance sheets as of October 1, 2023 and December 31, 2022, respectively. The Company has recorded accretion of the liability as interest expense of $1.2 million and $2.7 million for the thirteen and thirty-nine weeks ended October 1, 2023, respectively, and made payments of interest expense of $0.2 million for each of the thirteen and thirty-nine weeks ended October 1, 2023. The Company has recorded accretion of the liability as interest expense of $0.7 million and $1.7 million for the three and nine months ended September 30, 2022, respectively. During the thirteen and thirty-nine weeks ended October 1, 2023, the Company recorded amortization of issuance costs as interest expense of less than $0.1 million and $0.7 million, respectively. During the three and nine months ended September 30, 2022, the Company recorded the amortization of issuance costs as interest expense of $0.4 million and $0.9 million, respectively. As of October 1, 2023, the total estimated fair value of the Company’s debt in CS Solis was $29.1 million, which was estimated based on Level 3 inputs.
 
(17)
Stock-Based Compensation
In July 2023, the Company’s board of directors adopted and stockholders approved the 2023 Incentive Equity Plan (the “2023 Plan”). The 2023 Plan became effective immediately upon the closing of the Amended and Restated Business Combination Agreement. Initially, a maximum number of 8,763,322 shares of Complete Solaria Common Stock may be issued under the 2023 Plan. In addition, the number of shares of Complete Solaria Common Stock reserved for issuance under the 2023 Plan will automatically increase on January 1 of each year, starting on January 1, 2024 and ending on January 1, 2033, in an amount equal to the lesser of (1) 4% of the total number of shares of Complete Solaria’s Common Stock outstanding on December 31 of the preceding year, or (2) a lesser number of shares of Complete Solaria Common Stock determined by Complete Solaria’s Board prior to the date of the increase. The maximum number of shares of Complete Solaria Common Stock that may be issued on the exercise of ISOs under the 2023 Plan is three times the number of shares available for issuance upon the 2023 Plan becoming effective (or 26,289,966 shares).

Historically, awards were granted under the Amended and Restated Complete Solaria Omnibus Incentive Plan (“2022 Plan”), the Complete Solar 2011 Stock Plan (“2011 Plan”), the Solaria Corporation 2016 Stock Plan (“2016 Plan”) and the Solaria Corporation 2006 Stock Plan (“2006 Plan”) (together with the Complete Solaria, Inc. 2023 Incentive Equity Plan (“2023 Plan”), “the Plans”). The 2022 Plan is the successor of the Complete Solar 2021 Stock Plan, which was amended and assumed in connection with the acquisition of Solaria. The 2011 Plan is the Complete Solar 2011 Stock Plan that was assumed by Complete Solaria in the Required Transaction. The 2016 Plan and the 2006 Plan are the Solaria stock plans that were assumed by Complete Solaria in the Required Transaction.
Under the Plans, the Company has granted service and performance-based stock options and restricted stock units (“RSUs”).
A summary of stock option activity for the thirty-nine weeks ended October 1, 2023 under the Plans is as follows:
 
   
Options Outstanding
 
   
Number of
Shares
   
Weighted
Average
Exercise
Price per
Share
   
Weighted
Average
Contractual
Term
(Years)
   
Aggregate
Intrinsic
Value

(in thousands)
 
Outstanding—December 31, 2022
    4,970,419     $ 4.86       6.99     $ 34,180  
Options granted
    2,164,946       5.18      
Options exercised
    (67,292     0.83      
Options canceled
    (142,218     9.46      
 
 
 
   
 
 
   
 
 
   
 
 
 
Outstanding—October 1, 2023
    6,925,855     $ 4.91       7.80     $ 2,727  
 
 
 
   
 
 
   
 
 
   
 
 
 
Vested and expected to vest—October 1, 2023
    6,925,855     $ 4.91       7.80     $ 2,727  
 
 
 
   
 
 
   
 
 
   
 
 
 
Vested and exercisable—October 1, 2023
    3,037,856     $ 5.16       6.40     $ 2,245  
 
 
 
   
 
 
   
 
 
   
 
 
 
A summary of RSU activity for the thirty-nine weeks ended October 1, 2023 under the Plans is as follows:
 
    
Number of
RSUs
    
Weighted
Average
Grant
Date
Fair Value
 
Unvested at December 31, 2022
     —       
Granted
     728,600      $ 5.00  
Vested and released
     (155,473    $ 4.84  
Cancelled or forfeited
     (485,468    $ 5.07  
  
 
 
    
Unvested at October 1, 2023
     87,659      $ 5.07  
  
 
 
    

Stock-based compensation expense
The following table summarizes stock-based compensation expense and its allocation within the accompanying unaudited condensed consolidated statements of operations and comprehensive income (loss) (in thousands):
 
   
Thirteen
Weeks Ended
October 1,
2023
   
Three
Months Ended
September 30,
2022
   
Thirty-Nine

Weeks Ended
October 1,
2023
   
Nine
Months Ended
September 30,
2022
 
Cost of revenues
  $ 20     $ 1     $ 51     $ 6  
Sales and marketing
    143       37       337       91  
General and administrative
    1,416       47       1,933       120  
Loss from discontinued operations, net of tax
    535       —         1,835       —    
 
 
 
   
 
 
   
 
 
   
 
 
 
Total stock-based compensation expense
  $ 2,114     $ 85     $ 4,156     $ 217  
 
 
 
   
 
 
   
 
 
   
 
 
 
As of October 1, 2023, there was a total of $16.4 million and $0.2 million of unrecognized stock-based compensation costs related to service-based options and RSUs, respectively. Such compensation cost is expected to be recognized over a weighted-average period of approximately 2.13 years and 4.75 years for service-based options and RSUs, respectively.
In July 2023, the Company’s board of directors approved the modification to accelerate the vesting of 52,167 options for employees that were terminated. Additionally, at the same time, the board of directors approved an extension of the post termination exercise period for 280,412 vested options of terminated employees. In connection with the modifications, the Company recorded incremental stock-based compensation expense of $0.1 million.
 
(18)
Employee Stock Purchase Plan
The Company adopted an Employee Stock Purchase Plan (the “ESPP Plan”) in connection with the consummation of the Mergers in July 2023. All qualified employees may voluntarily enroll to purchase the Company’s common stock through payroll deductions at a price equal to 85% of the lower of the fair market values of the stock of the offering periods or the applicable purchase date. As of October 1, 2023, 2,628,996 shares were reserved for future issuance under the ESPP Plan.
 
(19)
Commitments and Contingencies
Operating Leases
The Company leases its facilities under
non-cancelable
operating lease agreements. The Company’s leases have remaining terms of 0.3 years to 3.1 years. Options to renew or extend leases beyond their initial term have been excluded from measurement of the ROU assets and lease liabilities as exercise is not reasonably certain. Operating leases are reflected on the unaudited condensed consolidated balance sheets within operating lease ROU assets and the related current and
non-current
operating lease liabilities. ROU assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make lease payments arising from lease agreement. Operating lease ROU assets and liabilities are recognized at the commencement date, or the date on which the lessor makes the underlying asset available for use, based upon the present value of the lease payments over the respective lease term. Lease expense is recognized on a straight-line basis over the lease term, subject to any changes in the lease or expectation regarding the terms. Variable lease costs such as common area maintenance, property taxes and insurance are expensed as incurred. Variable lease cost was $0.1 million and $0.3 million for the thirteen and thirty-nine weeks ended October 1, 2023, respectively, and $0.1 million and $0.2 million for the three and nine months September 30, 2022, respectively. Total lease expense for the thirteen and thirty-nine weeks ended October 1, 2023 was $0.3 million and $1.0 million, respectively, and for the three and nine months ended September 30, 2022 was $0.2 million and $0.5 million, respectively.

The Company made $0.3 million and $0.8 million of cash payments related to operating leases during the thirteen and thirty-nine weeks ended October 1, 2023, respectively and made $0.1 million and $0.4 million of cash payments related to operating leases during the three and nine months ended September 30, 2022, respectively. New operating lease
right-of-use
assets obtained in exchange for operating lease liabilities were zero during the thirteen and thirty-nine weeks ended October 1, 2023 and zero and $0.2 million during the three and nine months ended September 30, 2022, respectively.
The weighted average remaining lease term and the discount rate for the Company’s operating leases are as follows:
 
    
October 1,
2023
Remaining average remaining lease term
   2.61 years
Weighted average discount rate
   15.20%
Future minimum lease payments under
non-cancelable
operating leases as of October 1, 2023 are as follows (in thousands):
 
2023 (excluding the thirty-nine weeks ended October 1, 2023)
   $ 263  
2024
     743  
2025
     592  
2026
     477  
2027 and thereafter
         
  
 
 
 
Total undiscounted liabilities
     2,075  
  
 
 
 
Less: imputed interest
     (565
  
 
 
 
Present value of operating lease liabilities
   $ 1,510  
  
 
 
 
Warranty Provision
The Company typically provides a
10-year
warranty on its solar energy system installations, which provides assurance over the workmanship in performing the installation, including roof leaks caused by the Company’s performance. For solar panel sales, the Company provides a
30-year
warranty that the products will be free from defects in material and workmanship. The Company will retain its warranty obligation associated with its panel sales, subsequent to the disposal of its panel business.
The Company accrues warranty costs when revenue is recognized for solar energy systems sales and panel sales, based primarily on the volume of new sales that contain warranties, historical experience with and projections of warranty claims, and estimated solar energy system and panel replacement costs. The Company records a provision for estimated warranty expenses in cost of revenues within the accompanying unaudited condensed consolidated statements of operations and comprehensive income (loss). Warranty costs primarily consist of replacement materials and equipment and labor costs for service personnel.

Activity by period relating to the Company’s warranty provision was as follows (in thousands):
 
    
Thirty-Nine

Weeks Ended
October 1,
2023
    
Year Ended
December 31,
2022
 
Warranty provision, beginning of period
   $ 3,981      $ 2,281  
Warranty liability from Business Combination
               1,943  
Accruals for new warranties issued
     2,100        1,492  
Settlements
     (2,060      (1,735
  
 
 
    
 
 
 
Warranty provision, end of period
   $ 4,021      $ 3,981  
  
 
 
    
 
 
 
Warranty provision, current
   $ 605      $ 767  
Warranty provision, noncurrent
   $ 3,416      $ 3,214  
Indemnification Agreements
From time to time, in its normal course of business, the Company may indemnify other parties, with which it enters into contractual relationships, including customers, lessors, and parties to other transactions with the Company. The Company may agree to hold other parties harmless against specific losses, such as those that could arise from breach of representation, covenant or third-party infringement claims. It may not be Possible to determine the maximum potential amount of liability under such indemnification agreements due to the unique facts and circumstances that are likely to be involved in each particular claim and indemnification provision. Historically, there have been no such indemnification claims. In the opinion of management, any liabilities resulting from these agreements will not have a material adverse effect on the business, financial position, results of operations, or cash flows.
Legal Matters
The Company is a party to various legal proceedings and claims which arise in the ordinary course of business. The Company records a liability when it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. If the Company determines that a loss is reasonably possible and the loss or range of loss can be reasonably estimated, the Company discloses the reasonably possible loss. The Company adjusts its accruals to reflect the impact of negotiations, settlements, rulings, advice of legal counsel and other information and events pertaining to a particular case. Legal costs are expensed as incurred. Although claims are inherently unpredictable, the Company is not aware of any matters that have a material adverse effect on the business, financial position, results of operations, or cash flows. The Company has recorded $3.0 million and $1.9 million as a loss contingency in accrued expenses and other current liabilities on the unaudited condensed consolidated balance sheets as of October 1, 2023 and December 31, 2022, respectively, primarily associated with the pending settlement of the following legal matters.
Katerra Litigation
On July 22, 2022, Katerra, Inc. filed a complaint for breach of contract and turnover of property under Section 542(b) of the Bankruptcy Code in the United States Bankruptcy Court for the Southern District of Texas. The complaint seeks damages for the amounts due under the Settlement Agreement and for attorney’s fees. The Company filed an answer to the complaint on September 6, 2022. On May 11, 2023, the parties reached a settlement in which Solaria agreed to pay Katerra $0.8 million, paid in monthly payments beginning on May 25, 2023 and ending by October 25, 2023. As of October 1, 2023, the remaining balance of payments owed in relation to the settlement was $0.1 million.

SolarPark Litigation
In January 2023, SolarPark Korea Co., LTD (“SolarPark”) demanded approximately $80.0 million during discussions between the Company and SolarPark. In February 2023, the Company submitted its statement of claim seeking approximately $26.4 million in damages against SolarPark. The ultimate outcome of this arbitration is currently unknown and could result in a material liability to the Company. However, the Company believes that the allegations lack merit and intends to vigorously defend all claims asserted. No liability has been recorded in the Company’s unaudited condensed consolidated financial statements as the likelihood of a loss is not probable at this time.
On March 16, 2023, SolarPark filed a complaint against Solaria and the Company in the United States District Court for the Northern District of California (“the court”). The complaint alleges a civil conspiracy involving misappropriation of trade secrets, defamation, tortious interference with contractual relations, inducement to breach of contract, and violation of California’s Unfair Competition Law. The complaint indicates that SolarPark has suffered in excess of $220.0 million in damages.
On May 11, 2023, SolarPark filed a motion for preliminary injunction to seek an order restraining the Company from using or disclosing SolarPark’s trade secrets, making or selling shingled modules other than those produced by SolarPark, and from soliciting solar module manufacturers to produce shingled modules using Solaria’s shingled patents. On May 18, 2023, the Company responded by filing a motion for partial dismissal and stay. On June 1, 2023, SolarPark filed an opposition to the Company’s motion for dismissal and stay and a reply in support of their motion for preliminary injunction. On June 8, 2023, the Company replied in support of its motion for partial dismissal and stay. On July 11, 2023, the court conducted a hearing to consider SolarPark and the Company’s respective motions. On August 3, 2023, the court issued a ruling, which granted the preliminary injunction motion with respect to any purported misappropriation of SolarPark’s trade secrets. The court’s ruling does not prohibit the Company from producing shingled modules or from utilizing its own patents for the manufacture of shingled modules. The court denied SolarPark’s motion seeking a defamation injunction. The court denied the Company’s motion to dismiss and granted the Company’s motion to stay the entire litigation pending the arbitration in Singapore. On September 1, 2023, the Company filed a Limited Notice of Appeal to appeal the August 2023 order granting SolarPark’s motion for preliminary injunction. On September 26, 2023, Solaria filed a Notice of Withdrawal of Appeal and will not appeal the Court’s Preliminary Injunction Order. No liability has been recorded in the Company’s unaudited condensed consolidated financial statements as the likelihood of a loss is not probable at this time.
Siemens Litigation
On July 22, 2021, Siemens filed a lawsuit for breach of contract and warranty against the Company and demanded $6.9 million plus legal fees. The case is currently in trial. The Company has recorded $2.0 million and zero as a loss contingency related to this litigation in accrued expenses and other current liabilities on the unaudited condensed consolidated balance sheets as of October 1, 2023 and December 31, 2022, respectively.
China Bridge Litigation
On August 24 2023, China Bridge Capital Limited (“China Bridge”) alleged breach of contract and demanded $6.0 million. The complaint names FACT as the defendant. The complaint alleges China Bridge and FACT entered into a financial advisory agreement in October 2022 whereby FACT engaged China Bridge to advise and assist FACT in identifying a company for FACT to acquire. As part of the agreement, China Bridge claims that FACT agreed to pay China Bridge a $6.0 million advisory fee if FACT completed such an acquisition. China Bridge claims it introduced Complete Solaria to FACT and is therefore owed the $6.0 million advisory fee. The Company believes that the allegations lack merit and intends to vigorously defend all claims asserted. No liability has been recorded in the Company’s unaudited condensed consolidated financial statements as the likelihood of a loss is not probable at this time.

Letters of Credit
The Company had $3.5 million of outstanding letters of credit related to normal business transactions as of October 1, 2023. These agreements require the Company to maintain specified amounts of cash as collateral in segregated accounts to support the letters of credit issued thereunder. As discussed in Note 2 – Summary of Significant Accounting Policies, the cash collateral in these restricted cash accounts was $3.8 million and $3.9 million as of October 1, 2023 and December 31, 2022, respectively.
 
(20)
Basic and Diluted Net Loss Per Share
The Company uses the
two-class
method to calculate net loss per share. No dividends were declared or paid for the thirteen or thirty-nine weeks ended October 1, 2023 or for the three or nine months ended September 30, 2022. Undistributed earnings for each period are allocated to participating securities, including the redeemable convertible preferred stock, based on the contractual participation rights of the security to share in the current earnings as if all current period earnings had been distributed. As there is no contractual obligation for the redeemable convertible preferred stock to share in losses, the Company’s basic net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted-average shares of common stock outstanding during periods with undistributed losses.
The unaudited basic and diluted shares and net loss per share for the three and nine months ended September 30, 2022 have been retroactively restated to give effect to the conversion of shares of legal acquiree’s convertible instruments into shares of legal acquiree common stock as though the conversion had occurred as of the beginning of the period. The retroactive restatement is consistent with the presentation on the accompanying unaudited condensed consolidated statements of stockholders’ deficit.
The following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common stockholders for the thirteen and thirty-nine weeks ended October 1, 2023 and three and nine months ended September 30, 2022 (in thousands, except share and per share amounts):
 
   
Thirteen
Weeks Ended
October 1,
2023
   
Three
Months Ended
September 30,
2022
   
Thirty-Nine

Weeks Ended
October 1,
2023
   
Nine
Months Ended
September 30,
2022
 
Numerator:
       
Net loss from continuing operations
  $ (50,973   $ (4,146   $ (73,448   $ (10,809
Net loss from discontinued operations
    (155,909     —         (168,458     —    
 
 
 
   
 
 
   
 
 
   
 
 
 
Net loss
  $ (206,882   $ (4,146   $ (241,906   $ (10,809
Denominator:
       
Weighted average common shares outstanding, basic and diluted
    39,821,078       13,431,410       16,969,979       13,053,367  
Net loss per share:
       
Continuing operations – basic and diluted
  $ (1.28   $ (0.31   $ (4.33   $ (0.83
 
 
 
   
 
 
   
 
 
   
 
 
 
Discontinued operations – basic and diluted
  $ (3.92   $        $ (9.92   $     
 
 
 
   
 
 
   
 
 
   
 
 
 
Net loss per share – basic and diluted
  $ (5.20   $ (0.31   $ (14.25   $ (0.83
 
 
 
   
 
 
   
 
 
   
 
 
 
Basic and diluted net loss per share attributable to common stockholders is the same for the thirteen and thirty-nine weeks ended October 1, 2023 and three and nine months ended September 30, 2022 because the inclusion of potential shares of common stock would have been anti-dilutive for the periods presented.

The following table presents the potential common shares outstanding that were excluded from the computation of diluted net loss per share of common stock as of the periods presented because including them would have been antidilutive:
 
    
As of
 
    
October 1,
2023
    
December 31,
2022
 
Common stock warrants
     23,626,132        2,000,878  
Preferred stock warrants
     —          488,024  
Stock options and RSUs issued and outstanding
     7,013,514        2,430,949  
  
 
 
    
 
 
 
Potential common shares excluded from diluted net loss per share
     30,639,646        4,919,851  
  
 
 
    
 
 
 
 
(21)
Related Party Transactions
Related Party Convertible Promissory Notes
In 2020, the Company issued convertible promissory notes
(“2020-A
Convertible Notes”) of approximately $3.8 million to various investors, out of which $3.3 million was issued to nine related parties. The principal amount of the outstanding balance accrued interest at 2.0% per annum. In 2021, the Company subsequently issued convertible promissory notes
(“2021-A
Convertible Notes”) of approximately $4.8 million to various investors, out of which $3.6 million was issued to four related parties. The principal amount of the outstanding balance accrued interest at 2.0% per annum. Refer to Note 16 – Borrowing Arrangements for further details.
In March 2022, as part of the Company’s Series D redeemable convertible preferred stock issuance, the Company converted all of the outstanding convertible note series. As part of the conversion, the Company recognized a gain on the extinguishment of related party convertible notes of $1.4 million, which was recorded in other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive income (loss).
In October 2022 through June 2023, the Company issued convertible promissory notes (“2022 Convertible Notes”) of approximately $33.3 million to various investors, out of which $12.1 million was issued to five related parties. Additionally, the Company acquired a related party convertible note, on the same terms as the 2022 Convertible Notes as part of the acquisition of Solaria, with a fair value of $6.7 million at the time of the acquisition. The related party debt is presented as convertible notes, net, due to related parties, noncurrent in the accompanying unaudited condensed consolidated balance sheets. The principal amount of the outstanding balance on the 2022 Convertible Notes accrues at 5.0%, compounded annually. For the thirteen and thirty-nine weeks ended October 1, 2023, the Company has recognized less than $0.1 million and $0.4 million, respectively, in interest expense related to the related party 2022 Convertible Promissory Notes.
In June 2023, the Company received $3.5 million of prefunded PIPE proceeds from a related party investor in conjunction with the Company’s merger with Freedom Acquisition I Corp (refer to Note 1(a) – Description of Business and Note 4 – Reverse Recapitalization). The $3.5 million investment converted to equity for reclassification of prepaid PIPE, which is reflected in the unaudited condensed consolidated statements of redeemable convertible preferred stock and stockholders’ deficit for the thirteen and thirty-nine weeks ended October 1, 2023.
In July 2023, in connection with the Mergers, in addition to the $3.5 million of related party PIPE proceeds noted above, the Company received additional PIPE proceeds from related parties of $12.1 million, which is reflected in the unaudited condensed consolidated statements of redeemable convertible preferred stock and stockholders’ deficit for the thirteen and thirty-nine weeks ended October 1, 2023.

In July 2023, in connection with the Mergers, the Company issued 120,000 shares to a related party as a transaction bonus. As a result of the issuance, the Company recognized $0.7 million of expense within other income (expense), net in its unaudited condensed consolidated statements of operations and comprehensive income (loss) for the thirteen and thirty-nine weeks ended October 1, 2023.
In July 2023, the Company entered into a series of FPAs as described in Note 5 – Forward Purchase Agreements. In connection with the FPAs, the Company recognized other expense of $30.7 million for each of the thirteen and thirty-nine weeks ended October 1, 2023 in connection with the issuance of 5,670,000 shares of Complete Solaria Common Stock to the related party FPA Sellers. The Company also recognized other income of $0.3 million in connection with the issuance of the FPAs with related parties. As of October 1, 2023, the Company has recognized a liability associated with the FPAs of $5.6 million due to related parties in its unaudited condensed consolidated balance sheets, and the Company has recognized other expense associated with the change in fair value of the FPA liability due to related parties of $5.9 million in its unaudited condensed consolidated statements of operations and comprehensive income (loss) for both the thirteen and thirty-nine weeks ended October 1, 2023.
In September 2023, in connection with the Mergers, the Company entered into a settlement and release agreement with a related party for the settlement of a working capital loan made to the Sponsor, prior to the closing of the Mergers. As part of the settlement agreement, the Company agreed to pay the related party $0.5 million as a return of capital, which is paid in ten equal monthly installments and does not accrue interest. During each of the thirteen and thirty-nine weeks ended October 1, 2023, the Company made one payment of $0.1 million. As of October 1, 2023, $0.5 million remains outstanding.
There were no other material related party transactions during the thirteen and thirty-nine weeks ended October 1, 2023 or the three and nine months ended September 30, 2022.
(22) Subsequent Events
In preparing the unaudited condensed consolidated financial statements as of and for the thirty-nine weeks ended October 1, 2023, the Company evaluated subsequent events for recognition and measurement purposes through November 14, 2023, which is the date the financial statements were available to be issued. The Company noted no subsequent events through November 14, 2023 that would materially impact the unaudited condensed consolidated financial statements, except for the following:
In October 2023, the Company entered into an Assignment and Acceptance Agreement (“Assignment Agreement”), whereby Structural Capital Investments III, LP assigns the SCI debt to Kline Hill Partners Fund LP, Kline Hill Partners IV SPV LLC, Kline Hill Partners Opportunity IV SPV LLC, and Rodgers Massey Revocable Living Trust for a total purchase price of $5.0 million. The Company has identified this as a related party transaction.
In October 2023, in connection with the Assignment Agreement, the Company also entered into the First Amendment to Warrant to Purchase Stock Agreements with the holders of the Series
D-7
warrants. Pursuant to the terms of the agreement, the warrants to purchase 1,376,414 shares of Series
D-7
preferred stock converted into warrants to purchase 656,630 shares of common stock (the “replacement warrants”). As a result of the warrant amendment, the Company reclassified the replacement warrants from equity to liability. The replacement warrants were remeasured to the fair value on the amendment effective date and the Company will record subsequent changes in fair value in other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive income (loss).
In October 2023, the Company completed the sale of its solar panel business to Maxeon, pursuant to the terms of the Asset Purchase Agreement (the “Disposal Agreement”). Under the terms of the Disposal Agreement, Maxeon agreed to acquire certain assets and employees of Complete Solaria, for an aggregate purchase price of approximately $11.0 million consisting of 1,100,000 shares of Maxeon ordinary shares. The Company recorded an impairment charge of $1.7 million related to a decline in the fair value of the Maxeon shares between the end of the fiscal quarter on October 1, 2023 and the disposal date of October 6, 2023. No significant transaction costs were incurred subsequent to the balance sheet date.
EX-99.2 3 d474289dex992.htm EX-99.2 EX-99.2

Exhibit 99.2

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

You should read the following discussion and analysis of our financial condition and results of operations together with our consolidated financial statements and the related notes appearing at the end of this prospectus. Some of the information contained in this discussion and analysis or set forth elsewhere in this prospectus, including information with respect to our plans and strategy for our business and related financing, includes forward-looking statements that involve risks, uncertainties and assumptions. You should read the “Special Note Regarding Forward-Looking Statements” and “Risk Factors” sections of this prospectus for a discussion of important factors that could cause actual results to differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis.

Overview

Complete Solaria was formed in November 2022 through the merger of Complete Solar and Solaria. Founded in 2010, Complete Solar created a technology platform to offer clean energy products to homeowners by enabling a national network of sales partners and build partners. Our sales partners generate solar installation contracts with homeowners on our behalf. To facilitate this process, we provide the software tools, sales support and brand identity to its sales partners, making them competitive with national providers. This turnkey solution makes it easy for anyone to sell solar.

We fulfill our customer contracts by engaging with local construction specialists. We manage the customer experience and complete all pre-construction activities prior to delivering build-ready projects including hardware, engineering plans, and building permits to its builder partners. We manage and coordinate this process through our proprietary HelioTrackTM software system.

Effective January 1, 2023, we changed our fiscal quarters to four, thirteen-week periods within a standard calendar year. Each annual reporting period begins on January 1 and ends on December 31. Since the fiscal quarter change was made after the end of fiscal 2022, we will continue to report prior year financial information based on its prior year fiscal calendar. Our financial results for the thirty-nine weeks ended October 1, 2023 are compared to our results for the nine months ended September 30, 2022. The comparison of these two periods is primarily affected by the difference of one day between the first three quarters of fiscal 2023 and the first three quarters of 2022.

There is substantial doubt about the entity’s ability to continue as a going concern within one year after the date the unaudited condensed consolidated financial statements are issued. The accompanying unaudited condensed consolidated financial statements have been prepared assuming the Company will continue to operate as a going concern, which contemplates the realization of assets and settlement of liabilities in the normal course of business. They do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from uncertainty relating to its ability to continue as a going concern.

Growth Strategy and Outlook

Complete Solaria’s growth strategy contains the following elements:

 

   

Increase revenue by expanding installation capacity and developing new geographic markets – We continue to expand our network of partners who will install systems resulting from sales generated by our sales partners. By leveraging this network of skilled builders, we aim to increase our installation capacity in our traditional markets and expand our offering into new geographies throughout the United States. This will enable greater sales growth in existing markets and create new revenue in expansion markets.


   

Increase revenue and margin by engaging national-scale sales partners – We aim to offer a turnkey solar solution to prospective sales partners with a national footprint. These include electric vehicle manufacturers, national home security providers, and real estate brokerages. We expect to create a consistent offering with a single execution process for such sales partners throughout their geographic territories. These national accounts have unique customer relationships that we believe will facilitate meaningful sales opportunities and low cost of acquisition to both increase revenue and improve margin.

The Business Combination

Complete Solar entered into a Business Combination Agreement with FACT, First Merger Sub, Second Merger Sub, and Solaria on October 3, 2022. The Business Combination was consummated on July 18, 2023. Upon the terms and subject to the conditions of the Business Combination, (i) First Merger Sub merged with and into Complete Solaria with Complete Solaria surviving as a wholly-owned subsidiary of FACT (the “First Merger”), (ii) immediately thereafter and as part of the same overall transaction, Complete Solaria merged with and into Second Merger Sub, with Second Merger Sub surviving as a wholly-owned subsidiary of FACT (the “Second Merger”), and FACT changed its name to “Complete Solaria, Inc.” and Second Merger Sub changed its name to “CS, LLC” and (iii) immediately after the consummation of the Second Merger and as part of the same overall transaction, Solaria merged with and into a newly formed Delaware limited liability company and wholly-owned subsidiary of FACT and changed its name to “SolarCA LLC” (“Third Merger Sub”), with Third Merger Sub surviving as a wholly-owned subsidiary of FACT (the “Additional Merger”, and together with the First Merger and the Second Merger, the “Mergers”).

The merger between Complete Solaria and FACT has been accounted for as a reverse recapitalization. Under this method of accounting, FACT was treated as the acquired company for financial statement reporting purposes. This determination was primarily based on the Company having a majority of the voting power of the post-combination company, the Company’s senior management comprising substantially all of the senior management of the post-combination company, and the Company’s operations comprising the ongoing operations of the post-combination company. Accordingly, for accounting purposes, the Mergers have been treated as the equivalent of a capital transaction in which Complete Solaria is issuing stock for the net assets of FACT. The net assets of FACT have been stated at historical cost, with no goodwill or other intangible assets recorded.

Disposal Transaction

On August 18, 2023, we entered into a Non-Binding Letter of Intent to sell certain of our North American solar panel assets, inclusive of certain intellectual property and customer contracts, to Maxeon Solar Technologies, Ltd. (“Maxeon”). Subsequent to the execution of the Non-Binding Letter of Intent, on September 20, 2023, we entered into an asset purchase agreement (the “Disposal Agreement”) for the sale of certain assets to Maxeon. The Disposal Agreement also includes a supply agreement for Maxeon to supply its premium, high-performance, high-efficiency solar panels to Complete Solaria. The transaction closed on October 6, 2023. Under the terms of the Disposal Agreement, Maxeon agreed to acquire the identified assets and certain employees of Complete Solaria for an aggregate purchase price consisting of 1,100,000 Maxeon Common Shares (the “Disposal Transaction”).

As part of the Disposal Transaction, we determined that the criteria were met for held for sale and discontinued operations classification as of the end of our third fiscal quarter as the divestiture represents a strategic shift in our business. We recorded an impairment of $147.5 million associated with the recording of the assets as held for sale during the thirty-nine weeks ended October 1, 2023 and loss on disposal of $1.8 million during the fourth quarter.

Below, we have discussed our historical results of continuing operations, which excludes our product revenues and related metrics, as all results of operations associated with the solar panel business have been presented as discontinued operations, unless otherwise noted.


Key Financial Definitions/Components of Results of Operations

Revenues

We generate revenue by providing customer solar solutions through a standardized platform to our residential solar providers and companies to facilitate the sale and installation of solar energy systems. Our contracts consist of two performance obligations, which include solar installation services and post-installation services that are performed prior to inspection by the authority having jurisdiction. The significant majority of our revenue is recognized at a point in time upon the completion of the installation and the remainder is recognized upon inspection. Revenue is recognized net of a reserve for the performance guarantee of solar output.

We enter into three types of customer contracts for solar energy installations. The majority of our revenue is recognized through contracts where the homeowner enters into a power purchase agreement with our distribution partner. We perform the solar energy installation services on behalf of our distribution partner, who owns the solar energy system upon installation. Additionally, we enter into a Solar Purchase and Installation Agreement directly with homeowners, whereby the homeowner either pays cash or obtains financing through a third-party loan partner. In cash contracts with homeowners, we recognize revenue based on the price we charge to the homeowner. We record revenue in the amount received from the financing partner, net of any financing fees charged to the homeowner, which we consider to be a customer incentive.

As part of our revenue, we also enter into contracts to provide our software enhanced service offerings, including design and proposal services, to customers that include solar installers and solar sales organizations. We perform these leveraging our HelioQuoteTM platform and other software tools to create computer aided drawings, structural letters, and electrical reviews for installers and proposals for installers. We charge a fixed fee per service offering, which we recognize in the period the service is performed.

Operating Expenses

Cost of Revenues

Cost of revenues consists primarily of the cost of solar energy systems, and installation and other subcontracting costs. Cost of revenue also includes associated warranty costs, shipping and handling, allocated overhead costs, depreciation, and amortization of internally developed software.

Sales Commissions

Sales commissions are direct and incremental costs of obtaining customer contracts. These costs are paid to third-party vendors who source residential customer contracts for the sale of solar energy systems.

Sales and Marketing

Sales and marketing expenses primarily consist of personnel related costs, including salaries and employee benefits, stock-based compensation, and other promotional and advertising expenses. We expense certain sales and marketing, including promotional expenses, as incurred.

General and Administrative

General and administrative expenses consist primarily of personnel and related expenses for our employees, in our finance, research, engineering and administrative teams including salaries, bonuses, payroll taxes, and stock-based compensation. It also consists of legal, consulting, and professional fees, rent expenses pertaining to our offices, business insurance costs and other costs. We expect an increase in audit, tax, accounting, legal and other costs related to compliance with applicable securities and other regulations, as well as additional insurance, investor relations, and other costs associated with being a public company.


Interest Expense

Interest expense primarily relates to interest expense on the issuance of debt and convertible notes and the amortization of debt issuance costs.

Other Income (Expense), Net

Other income (expense), net consists of changes in the fair value of our convertible notes, the impact of debt extinguishment, and changes in the fair value of stock warrant liabilities and forward purchase agreements.

Income Tax Expense

Income tax expense primarily consists of income taxes in certain foreign and state jurisdictions in which we conduct business.

Supply Chain Constraints and Risk

We rely on a small number of suppliers of solar energy systems and other equipment. If any of our suppliers was unable or unwilling to provide us with contracted quantities in a timely manner at prices, quality levels and volumes acceptable to us, we would have very limited alternatives for supply, and we may not be able find suitable replacements for our customers, or at all. Such an event could materially adversely affect our business, prospects, financial condition and results of operations.

In addition, the global supply chain and our industry have experienced significant disruptions in recent periods. We have seen supply chain challenges and logistics constraints increase, including shortages of panels, inverters, batteries and associated component parts for inverters and solar energy systems available for purchase, which materially impacted our results of operations. In an effort to mitigate unpredictable lead times, we experienced substantial build up in inventory on hand commencing in early 2022 in response to global supply chain constraints. In certain cases, this has caused delays in critical equipment and inventory, longer lead times, and has resulted in cost volatility. These shortages and delays can be attributed in part to the COVID-19 pandemic and resulting government action, as well as broader macroeconomic conditions and have been exacerbated by the ongoing conflicts in Ukraine and Israel. While we believe that a majority of our suppliers have secured sufficient supply to permit them to continue delivery and installations through the end of 2023, if these shortages and delays persist into 2024, they could adversely affect the timing of when battery energy storage systems can be delivered and installed, and when (or if) we can begin to generate revenue from those systems. If any of our suppliers of solar modules experienced disruptions in the supply of the modules’ component parts, for example semiconductor solar wafers or investors, this may decrease production capabilities and restrict our inventory and sales. In addition, we have experienced and are experiencing varying levels of volatility in costs of equipment and labor resulting in part from disruptions caused by general global economic conditions. While inflationary pressures have resulted in higher costs of products, in part due to an increase in cost of the materials and wage rates, these additional costs have been offset by the related rise in electricity rates.

We cannot predict the full effects the supply chain constraints will have on our business, cash flows, liquidity, financial condition and results of operations at this time due to numerous uncertainties. Given the dynamic nature of these circumstances on our ongoing business, results of operations and overall financial performance, the full impact of macroeconomic factors, including the conflicts in Ukraine and Israel, cannot be reasonably estimated at this time. In the event we are unable to mitigate the impact of delays or price volatility in solar energy systems, raw materials, and freight, it could materially adversely affect our business, prospects, financial condition and results of operations. For additional information on risk factors that could impact our results, please refer to “Risk Factors” located elsewhere in this prospectus.


Critical Accounting Policies and Estimates

Our discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”). GAAP requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses and related disclosures. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. In many instances, we could have reasonably used different accounting estimates, and in other instances, changes in the accounting estimates are reasonably likely to occur from period-to-period. Actual results could differ significantly from our estimates. Our future financial statements will be affected to the extent that our actual results materially differ from these estimates. For further information on all of our significant accounting policies, see Note 2, Summary of Significant Accounting Policies, to our consolidated financial statements included elsewhere in this prospectus.

We believe that policies associated with our revenue recognition, product warranties, inventory excess and obsolescence and stock-based compensation have the greatest impact on our consolidated financial statements. Therefore, we consider these to be our critical accounting policies and estimates.

Revenue Recognition

We recognize revenue when control of goods or services is transferred to customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those services.

Revenue – Solar Energy System Installations

The majority of our revenue is generated from the installation of solar energy systems. We identify two performance obligations, which include installation services and post-installation services, and we recognize revenue when control transfers to the customer, upon the completion of the installation and upon the solar energy system passes inspection by the authority having jurisdiction, respectively. We apply judgment in allocating the transaction price between the installation and post-installation performance obligations, based on the estimated costs to perform our services. Changes in such estimates could have a material impact on the timing of our revenue recognition.

Our contracts with customers generally contain a performance guarantee of system output, and we will issue payments to customers if output falls below contractually stated thresholds over the performance guarantee period, which is typically 10 years. We apply judgment in estimating the reduction in revenue associated with the performance guarantee, which is historically not material. However, due to the long-term nature of the guarantee, changes in future estimates could have a material impact on the estimate of our revenue reserve.

Revenue – Software Enhanced Services

We recognize revenue from software enhanced services, which include proposals generated from our HelioQuoteTM platform and design services performed using internally developed and external software applications. We contract with solar installers to generate proposals and we contract with solar sales entities to perform design services for their potential customers. Under each type of customer contract, we generate a fixed number of proposals or designs for the customer in the month the services are contracted. Contracts with customers are enforceable on a month-to-month basis and we recognize revenue each month based on the volume of services performed.

Product Warranties

We typically provide a 10-year, warranty on our solar energy system installations, which provides assurance over the workmanship in performing the installation, including roof leaks caused by our performance. For solar


panel sales, recognized prior to the Disposal Transaction we provide a 30-year warranty that the products will be free from defects in material and workmanship. We record a liability for estimated future warranty claims based on historical trends and new installations. To the extent that warranty claim behavior differs from historical trends, we may experience a material change in our warranty liability.

Inventory Excess and Obsolescence

Our inventory consists of completed solar energy systems and related components, which we classify as finished goods. We record a reserve for inventory which is considered obsolete or in excess of anticipated demand based on a consideration of marketability and product life cycle stage, component cost trends, demand forecasts, historical revenues, and assumptions about future demand and market conditions. We apply judgment in estimating the excess and obsolete inventory, and changes in demand for our inventory components could have a material impact on our inventory reserve balance.

Stock-Based Compensation

We recognize stock-based compensation expense over the requisite service period on a straight-line basis for all stock-based payments that are expected to vest to employees, non-employees and directors, including grants of employee stock options and other stock-based awards. Equity-classified awards issued to employees, non-employees such as consultants and non-employee directors are measured at the grant-date fair value of the award. Forfeitures are recognized as they occur. For accounting purposes, we estimate grant-date fair value of stock options using the Black-Scholes option pricing model. The Black-Scholes option pricing model requires the input of highly subjective assumptions, including the fair value of the underlying common stock prior to the Business Combination, the expected term of the option the expected volatility of the price of our common stock and expected dividend yield. We determine these inputs as follows:

 

   

Expected Term - Expected term represents the period that our stock-based awards are expected to be outstanding and is determined using the simplified method.

 

   

Expected Volatility - Expected volatility is estimated by studying the volatility of comparable public companies for similar terms.

 

   

Expected Dividend -The Black-Scholes valuation model calls for a single expected dividend yield as an input. We have never paid dividends and have no plans to pay dividends.

 

   

Risk-free Interest Rate - We derive the risk-free interest rate assumption from the U.S. Treasury’s rates for the U.S. Treasury zero-coupon bonds with maturities similar to those of the expected term of the awards being valued.

 

   

Forfeitures - We recognize forfeitures as they occur.

If any assumptions used in the Black-Scholes option pricing model change significantly, stock-based compensation for future awards may differ materially compared to the awards granted previously. For the thirty-nine weeks ended October 1, 2023, stock-based compensation expense was $4.2 million, of which $1.8 million, related to discontinued operations. As of October 1, 2023, we had approximately $16.6 million of total unrecognized stock-based compensation expense related to stock options.

Recent Accounting Pronouncements

A discussion of recently issued accounting standards applicable to Complete Solaria is described in Note 2, Summary of Significant Accounting Policies in the Notes to Financial Statements and Note 2, Summary of Significant Accounting Policies in the Notes to Unaudited Condensed Consolidated Financial Statements.


Results of Operations

Thirteen weeks ended October 1, 2023 compared to three months ended September 30, 2022

The following table sets forth our unaudited statements of operations data for the thirteen weeks ended October 1, 2023 and the three months ended September 30, 2022, respectively. We have derived this data from our unaudited condensed consolidated financial statements included elsewhere in this prospectus. This information should be read in conjunction with our unaudited condensed consolidated financial statements and related notes included elsewhere in this prospectus. The results of historical periods are not necessarily indicative of the results of operations for any future period.

 

(in thousands)

   Thirteen
Weeks Ended

October 1,
2023
    Three Months
Ended
September 30,
2022
    $ Change      % Change  

Revenues

   $ 24,590     $ 12,260     $ 12,330        101

Cost of revenues(1)

     18,354       8,266       10,088        122
  

 

 

   

 

 

   

 

 

    

 

 

 

Gross profit

     6,236       3,994       2,242        56

Gross margin %

     25     33     

Operating expenses:

         

Sales commissions

     8,755       3,572       5,183        145

Sales and marketing(1)

     2,214       1,604       610        38

General and administrative(1)

     6,345       2,027       4,318        213
  

 

 

   

 

 

   

 

 

    

 

 

 

Total operating expenses

     17,314       7,203       10,111        140
  

 

 

   

 

 

   

 

 

    

 

 

 

Loss from operations

     (11,078     (3,209     (7,869      245

Interest expense(2)

     (1,902     (941     (961      102

Interest income

     9       —         9        —    

Other income (expense), net(3)

     (38,003     4       (38,007      *  
  

 

 

   

 

 

   

 

 

    

 

 

 

Loss from continuing operations before taxes

     (50,974     (4,146     (46,828      *  

Income tax benefit (provision)

     1       —         1        —    
  

 

 

   

 

 

   

 

 

    

 

 

 

Net loss from continuing operations

     (50,973     (4,146     (46,827      *  

Loss on discontinued operations, net of tax

     (155,909     —         (155,909      *  
  

 

 

   

 

 

   

 

 

    

 

 

 

Net loss

   $ (206,882   $ (4,146   $ (202,736      *  
  

 

 

   

 

 

   

 

 

    

 

 

 

 

*

Percentage change not meaningful

 

(1)

Includes stock-based compensation expense as follows (in thousands):

 

     Thirteen Weeks
Ended
October 1,
2023
     Three Months
Ended
September 30,
2022
 

Cost of revenues

   $ 20      $ 1  

Sales and marketing

     143        37  

General and administrative

     1,416        47  
  

 

 

    

 

 

 

Total stock-based compensation expense

   $ 1,579      $ 85  
  

 

 

    

 

 

 

 

(2)

Includes interest expense to related party of $0.1 million and zero during the thirteen weeks ended October 1, 2023 and the three months ended September 30, 2022, respectively.


(3)

Includes other income (expense), net from related parties of $36.9 million and zero during the thirteen weeks ended October 1, 2023 and the three months ended September 30, 2022, respectively.

Revenues

We disaggregate our revenues based on the following types of services (in thousands):

 

     Thirteen
Weeks Ended
October 1,
2023
     Three Months
Ended
September 30,
2022
     $
Change
     %
Change
 

Solar energy system installations

   $ 23,915      $ 11,120      $ 12,795        115

Software enhanced services

     675        1,140        (465      (41 )% 
  

 

 

    

 

 

    

 

 

    

Total revenue

   $ 24,590      $ 12,260      $ 12,330        101
  

 

 

    

 

 

    

 

 

    

Revenues from solar energy system installations for the thirteen weeks ended October 1, 2023 was $23.9 million compared to $11.1 million for the three months ended September 30, 2022. The increase in solar energy system installation revenues of $12.8 million was primarily due to an increase in the volume of solar energy system installations, as well as an increase in average selling price of solar energy system installations.

Revenues from software enhanced services for the thirteen weeks ended October 1, 2023 was $0.7 million compared to $1.1 million for the three months ended September 30, 2022. The decrease of $0.5 million was the result of a shift in focus towards solar energy installations.

Cost of Revenues

Cost of revenues for the thirteen weeks ended October 1, 2023 was $18.4 million compared to $8.3 million for the three months ended September 30, 2022. The increase in cost of revenues of $10.1 million, or 122%, was primarily due to the increase in revenue of 101%, coupled with rising costs associated with supply chain constraints, and a small increase in excess and obsolete inventory reserves.

Gross Margin

Gross margin decreased 8% year over year, from 33% for the three months ended September 30, 2022 to 25% for the thirteen weeks ended October 1, 2023. The decrease in gross margin was primarily attributed to the increasing cost of revenues as described above.

Sales Commissions

Sales commissions for the thirteen weeks ended October 1, 2023 was $8.8 million compared to $3.6 million for the three months ended September 30, 2022. The increase of $5.2 million, or 145%, was primarily due to the increase in revenue of 101%.

Sales and Marketing

Sales and marketing expense for the thirteen weeks ended October 1, 2023 increased by $0.6 million, or 38%, compared to the three months ended September 30, 2022. The increase is attributable to an increase of $0.3 million in related to office and operating related expenses, an increase of $0.1 million in travel related expenses, an increase of $0.1 million in stock-based compensation expenses due to options issued during the thirteen weeks ended October 1, 2023, and an increase of $0.1 million in outside services, offset by decrease in payroll of $0.1 million.


General and Administrative

General and administrative costs for the thirteen weeks ended October 1, 2023 increased by $4.3 million, or 213%, compared to the three months ended September 30, 2022. The increase was primarily attributed to increase in payroll of $1.7 million, increase of $1.0 million in stock-based compensation expenses due to options and RSUs issued in the thirteen weeks ended October 1, 2023, increase in travel costs of $0.5 million, increase in office occupancy related costs of $0.5 million, and increases in contractors and outside services costs of $0.4 million related to the Mergers.

Interest Expense

Interest expense for the thirteen weeks ended October 1, 2023 increased by $1.0 million, or 102%, compared to the three months ended September 30, 2022. The increase was primarily attributed $0.5 million of interest related to debt acquired as part of the acquisition of Solaria in November 2022, which was retained upon the divestiture from the business, as well as an increase of $0.3 million in interest expense related to the convertible notes and long-term debt in CS Solis for the thirteen weeks ended October 1, 2023.

Other Income (Expense), Net

Other income (expense), net for the thirteen weeks ended October 1, 2023 increased by $38.0 million compared to the three months ended September 30, 2022. The increase was primarily attributed to an increase of $35.5 million in other expense related to the issuance of common stock in connection with the FPAs, the loss on extinguishment of debt in CS Solis of $10.3 million, an increase of $6.7 million in other expense associated with the change in fair value of the FPAs, and an increase of $2.4 million driven by Company’s issuance of bonus shares in connection with the Mergers, offset by decreases in the fair value of the Company’s warrant liabilities of $16.9 million.

Net Loss from Continuing Operations

As a result of the factors discussed above, our net loss from continuing operations for the thirteen weeks ended October 1, 2023 was $51.0 million, an increase of $46.8 million, as compared to a net loss from continuing operations of $4.1 million for the three months ended September 30, 2022.

Loss of Discontinued Operations, Net of Tax

As a result of the disposition of the Solaria business as described above, we recognized a loss on discontinued operations of $155.9 million for the thirteen weeks ended October 1, 2023. Loss on discontinued operations was comprised of revenues of $3.8 million, offset by cost of revenues of $4.1 million, selling and marketing expenses of $2.4 million, general and administrative expenses of $5.7 million, and impairment of goodwill and intangible assets assigned to Solaria of $119.4 million and $28.1 million, respectively.

Thirty-nine weeks ended October 1, 2023 compared to nine months ended September 30, 2022

The following table sets forth our unaudited statements of operations data for the thirty-nine weeks ended October 1, 2023 and the nine months ended September 30, 2022, respectively. We have derived this data from our unaudited condensed consolidated financial statements included elsewhere in this prospectus. This information should be read in conjunction with our unaudited condensed consolidated financial statements and


related notes included elsewhere in this prospectus. The results of historical periods are not necessarily indicative of the results of operations for any future period.

 

(In thousands)

   Thirty-Nine
Weeks Ended
October 1,
2023
    Nine Months
Ended
September 30,
2022
    $ Change      % Change  

Revenues

   $ 66,887     $ 48,974     $ 17,913        37

Cost of revenues(1)

     51,788       33,792       17,996        53
  

 

 

   

 

 

   

 

 

    

 

 

 

Gross profit

     15,099       15,182       (83      (1 %) 

Gross margin %

     23     31     

Operating expenses:

         

Sales commissions

     23,221       15,694       7,527        48

Sales and marketing(1)

     5,216       4,607       609        13

General and administrative(1)

     22,965       6,194       16,771        271
  

 

 

   

 

 

   

 

 

    

 

 

 

Total operating expenses

     51,402       26,495       24,907        94
  

 

 

   

 

 

   

 

 

    

 

 

 

Loss from operations

     (36,303     (11,313     (24,990      221

Interest expense(2)

     (8,870     (2,672     (6,198      232

Interest income

     26       —         26        —    

Other income (expense), net(3)

     (28,302     3,180       (31,482      *  
  

 

 

   

 

 

   

 

 

    

 

 

 

Loss from continuing operations before income taxes

     (73,449     (10,805     (62,644      580

Income tax benefit (provision)

     1       (4     5        (125 %) 
  

 

 

   

 

 

   

 

 

    

 

 

 

Net loss from continuing operations

     (73,448     (10,809     (62,639      *  

Loss on discontinued operations, net of tax

     (168,458     —         (168,458      *  
  

 

 

   

 

 

   

 

 

    

 

 

 

Net loss

   $ (241,906   $ (10,809   $ (237,097      *  
  

 

 

   

 

 

   

 

 

    

 

 

 

 

*

Percentage change not meaningful

 

(1)

Includes stock-based compensation expense as follows:

 

(In thousands)

   Thirty-Nine
Weeks
ended
October 1,
2023
     Nine Months
Ended
September 30,
2022
 

Cost of sales

   $ 51      $ 6  

Sales and marketing

     337        91  

General and administrative

     1,933        120  
  

 

 

    

 

 

 

Total stock-based compensation expense

   $ 2,321      $ 217  
  

 

 

    

 

 

 

 

(2)

Includes interest expense to related party of $0.4 million and $0.1 million during the thirty-nine weeks ended October 1, 2023 and the nine months ended September 30, 2022, respectively.

(3)

Includes other income (expense), net from related parties of $36.9 million and $1.4 million during the thirty-nine weeks ended October 1, 2023 and the nine months ended September 30, 2022, respectively.


Revenues

We disaggregate our revenues based on the following types of services:

 

(In thousands)

   Thirty-Nine
Weeks
ended
October 1,
2023
     Nine Months
Ended
September 30,
2022
     $
Change
     %
Change
 

Solar energy system installations

   $ 64,511      $ 46,214      $ 18,297        40

Software enhanced services

     2,376        2,760        (384      (14 %) 
  

 

 

    

 

 

    

 

 

    

Total service revenues

   $ 66,887      $ 48,794      $ 17,913        37
  

 

 

    

 

 

    

 

 

    

Revenues from solar energy system installations for the thirty-nine weeks ended October 1, 2023 was $64.5 million compared to $46.2 million for the nine months ended September 30, 2022. The increase in solar energy system installation revenues of $18.3 million, or 40%, was primarily due to an increase in the volume of solar energy systems installations, a portion of which related to the fulfillment of delayed installations experienced in the first quarter of 2023 due to unusual inclement California weather, as well as an increase in average selling price of solar energy system installations.

Revenues from software enhanced services for the thirty-nine weeks ended October 1, 2023 was $2.4 compared to $2.8 million for the nine months ended September 30, 2022. The decrease of $0.4 million was the result of a shift in focus towards solar energy installations.

Cost of Revenues

Cost of revenues for the thirty-nine weeks ended October 1, 2023 was $51.8 million compared to $33.8 million for the nine months ended September 30, 2022. The increase in cost of revenues of $18.0 million, or 53%, was primarily due to the increase in revenues of 37%, coupled with rising costs associated with supply chain constraints.

Gross Margin

Gross margin decreased 8% year over year, from 31% for the nine months ended September 30, 2022 to 23% for the thirty-nine weeks ended October 1, 2023. The decrease in gross margin is primarily attributed to increasing cost of revenues as described above.

Sales Commissions

Sales commissions for the thirty-nine weeks ended October 1, 2023, increased by $7.5 million, or 48%, compared to the nine months ended September 30, 2022. The increase in sales commissions is primarily due to the increase in solar system installation revenue of 40%.

Sales and Marketing

Sales and marketing expense for the thirty-nine weeks ended October 1, 2023 increased by $0.6 million, or 13%, compared to the nine months ended September 30, 2022. The increase is primarily attributable to an increase of $0.4 million in office and operating related expense, increase of $0.2 million in stock-based compensation expenses due to options issued in the thirty-nineteen weeks ended October 1, 2023, an increase of $0.2 million in outside services, and an increase of $0.1 million in travel related expenses, offset by decrease in payroll of $0.4 million.


General and Administrative

General and administrative costs for the thirty-nine weeks ended October 1, 2023 increased by $16.8 million, or 271%, compared to the nine months ended September 30, 2022. The increase was primarily attributed to increases in contractors and outside services costs of $6.6 million related to the Business Combination, increase in payroll of $3.9 million, an increase in bad debt expense of $3.4 million, increase of $1.8 million in stock-based compensation expenses due to options and RSUs issued, and increase in office occupancy related costs of $1.1 million for the thirty-nine weeks ended October 1, 2023.

Interest Expense

Interest expense for the thirty-nine weeks ended October 1, 2023 increased by $6.2 million, or 232%, compared to the nine months ended September 30, 2022. The increase was primarily attributed $4.6 million of interest related to debt acquired as part of the acquisition of Solaria in November 2022, which was retained upon the divestiture from the business, as well as an increase of $1.4 million in interest expense related to the convertible notes and long-term debt in CS Solis for the thirty-nine weeks ended October 1, 2023.

Other Income (Expense), Net

Other income (expense), net for the thirty-nine weeks ended October 1, 2023 increased by $31.5 million compared to the nine months ended September 30, 2022. The increase was primarily attributed to an increase of $35.5 million in other expense related to the issuance of common stock in connection with the FPAs, the loss on extinguishment of debt in CS Solis of $10.3 million, an increase of $6.7 million in other expense associated with the change in fair value of FPAs, an increase of $2.4 million driven by Company’s issuance of bonus shares in connection with the Business Combination, and $3.2 million related to the conversion of convertible debts and SAFE agreements in March 2022, offset by decreases in the change in fair value of the Company’s warrant liabilities of $26.5 million.

Net Loss from Continuing Operations

As a result of the factors discussed above, our net loss from continuing operations for the thirty-nine weeks ended October 1, 2023 was $73.4 million, an increase of $62.6 million, as compared to a net loss from continuing operations of $10.8 million for the nine months ended September 30, 2022.

Loss of Discontinued Operations, Net of Tax

As a result of the disposition of the Solaria business as described above, we recognized a loss on discontinued operations of $168.5 million for the thirty-nine weeks ended October 1, 2023. Loss on discontinued operations was comprised of revenues of $29.0 million, offset by cost of revenues of $30.6 million, selling and marketing expenses of $6.8 million, general and administrative expenses of $12.6 million, and impairment of goodwill and intangible assets assigned to Solaria of $119.4 million and $28.1 million, respectively.


Results of Operations

Year ended December 31, 2022 compared to year ended December 31, 2021

The following table sets forth our unaudited statements of operations data for the years ended December 31, 2022 and 2021, respectively. We have derived this data from our audited annual financial statements included elsewhere in this prospectus. This information should be read in conjunction with our audited annual financial statements and related notes included elsewhere in this prospectus. The results of historical periods are not necessarily indicative of the results of operations for any future period.

 

     Years Ended December 31               

(In thousands)

        2022               2021          $ Change      % Change  

Revenues

   $ 66,475     $ 68,816     $ (2,341      (3 %) 

Cost of revenues(1)

     46,647       40,123       6,524        16
  

 

 

   

 

 

   

 

 

    

 

 

 

Gross profit

     19,828       28,693       (8,865      (31 %) 

Gross margin %

     30     42     

Operating expenses:

         

Sales commissions

     21,195       25,061       (3,866      (15 %) 

Sales and marketing(1)

     6,156       5,179       977        19

General and administrative(1)

     13,634       5,780       7,854        136
  

 

 

   

 

 

   

 

 

    

 

 

 

Total operating expenses

     40,985       36,020       4,965        14
  

 

 

   

 

 

   

 

 

    

 

 

 

Loss from operations

     (21,157     (7,327     (13,830      189

Interest expense(2)

     (4,986     (1,712     (3,274      191

Interest income

     5       —         5        100

Other income (expense), net(3)

     (1,858     (240     (1,618      *  
  

 

 

   

 

 

   

 

 

    

 

 

 

Loss from continuing operations before income taxes

     (27,996     (9,279     (18,717      202

Income tax benefit (provision)

     (27     (3     (24      *  
  

 

 

   

 

 

   

 

 

    

 

 

 

Net loss from continuing operations

     (28,023     (9,282     (18,741      202

Loss on discontinued operations, net of tax

     (1,454     —         (1,454      *  
  

 

 

   

 

 

   

 

 

    

 

 

 

Net loss

   $ (29,477   $ (9,282   $ (20,195      *  
  

 

 

   

 

 

   

 

 

    

 

 

 

 

*

Percentage change not meaningful

(1)

Includes stock-based compensation expense as follows (in thousands):

 

     Years Ended December 31,  
         2022              2021      

Cost of sales

   $ 22      $ 19  

Sales and marketing

     168        68  

General and administrative

     243        113  
  

 

 

    

 

 

 

Total stock-based compensation expense

   $ 433      $ 200  
  

 

 

    

 

 

 

 

(2)

Includes interest expense to related parties of $0.3 million and $0.7 million during the year ended December 31, 2022 and 2021, respectively

(3)

Includes other income from related parties of $1.4 million, and zero during the years ended December 31, 2022 and 2021, respectively.


Revenues

The Company disaggregates its revenues based on the following types of services:

 

     Years Ended December 31,      Change
$
     Change
%
 
(In thousands)        2022              2021      

Solar energy system installations

   $ 62,896      $ 66,958      $ (4,062      (6 %) 

Software enhanced services

     3,579        1,858        1,721        93
  

 

 

    

 

 

    

 

 

    

Total revenues

   $ 66,475      $ 68,816      $ (2,341      (3 %) 
  

 

 

    

 

 

    

 

 

    

Revenues from solar energy system installations for the year ended December 31, 2022 was $62.9 million compared to $67.0 million for the year ended December 31, 2021. The decrease in solar energy system installation revenues of $4.1 million is primarily due to constraints on the supply of solar panels available to purchase for fulfillment of our customer contracts. These supply constraints resulted from economic sanctions such as the Dec 21, 2021 Uyghur Forced Labor Prevention Act and supplier reactions to the Auxin Solar Tariff Petition. Without the necessary equipment to fulfill customer contracts, our projects were pushed into subsequent quarters.

Revenues from software enhanced services for the year ended December 31, 2022 was $3.6 million compared to $1.9 million for the year ended December 31, 2021. The increase in software enhanced services revenues is primarily due to increased sales and marketing for proposal and design services.

Cost of Revenues

Cost of revenues for the year ended December 31, 2022 was $46.6 million compared to $40.1 million for the year ended December 31, 2021. The increase of cost of revenues of $6.5 million was primarily driven by an increase in the reserve for excess and obsolete inventory of $3.6 million, an increase in warranty costs of $0.9 million and the effect of increasing materials prices for our solar energy systems. The increase in the reserve was a result of a substantial build up in inventory on hand commencing in early 2022 in response to global supply chain constraints, a general product shift relating to market demand for higher voltage solar panels, and certain inventory management adjustments associated with inventories maintained by inactive installers.

Gross Margin

Gross margin decreased 12% year over year, from 42% for the year ended December 31, 2021 to 30% for the year ended December 31, 2022. The decrease in margin is primarily due to the increases in cost of revenues as described above.

Sales Commissions

Sales commission decreased by $3.8 million, or 15%, from $25.0 million in the year ended December 31, 2021 to $21.2 million in the year ended December 31, 2022. The decrease in commissions is due to the diversification of our sales partner channels to deliver greater services and value it is able to capture more contribution margin by reducing sales commissions.

Sales and Marketing

Sales and marketing expense increased by $1.0 million, or 19%, from $5.2 million in the year ended December 31, 2021 to $6.2 million in the year ended December 31, 2022. The increase was due to an increase in personnel-related costs.

General and Administrative

General and administrative expense increased by $7.9 million, or 136%, from $5.8 million in the year ended December 31, 2021 to $13.6 million in the year ended December 31, 2022. The increase was primarily attributed


outside services for finance and legal costs of $3.5 million related to the Mergers, an increase in bad debt expense of $1.7 million, an increase in payroll related costs of $1.3 million, an increase in office and occupancy related costs due to new offices for $0.8 million, an increase in, and an increase in stock-based compensation for $0.5 million.

Interest Expense

Interest expense increased by $3.3 million, or 191%, from $1.7 million in the year ended December 31, 2021 to $5.0 million in the year ended December 31, 2022. The increase was primarily attributed to accretion of $2.4 million and the amortization of issuance costs of $1.2 million related to long term debt in CS Solis LLC that occurred in February of 2022 and a $0.2 million increase in interest expense related to the 2022 Convertible Notes. The increase was offset by a $0.8 million reduction in interest expense, as we repaid or converted debt instruments in February 2022, which were outstanding during 2021.

Other Income (Expense), Net

Other income (expense), net increased by $1.6 million, or 674%, from $0.2 million in the year ended December 31, 2021 to $1.8 million in the year ended December 31, 2022. The increase was primarily attributed to an increase in the fair value of preferred stock warrants of $5.2 million, partially offset by a gain on the extinguishment of our convertible debt and safe agreements in March 2022 of $3.2 million.

Net Loss from Continuing Operations

As a result of the factors discussed above, our net loss for the year ended December 31, 2022 was $28.0 million, an increase of $18.7 million, or 202%, as compared to $9.3 million for the year ended December 31, 2021.

Loss of Discontinued Operations, Net of Tax

As a result of the disposition of the Solaria business as described above, we recognized a loss on discontinued operations of $1.5 million for the year ended December 31, 2022. Loss on discontinued operations was comprised of revenues of $13.3 million, offset by cost of revenues of $12.9 million, selling and marketing expenses of $1.3 million and general and administrative expenses of $0.6 million.


Year ended December 31, 2021 compared to year ended December 31, 2020

The following table sets forth our statement of operations data for 2021 and 2020. We have derived this data from our audited annual financial statements included elsewhere in this prospectus. This information should be read in conjunction with our audited annual financial statements and related notes included elsewhere in this prospectus. The results of historical periods are not necessarily indicative of the results of operations for any future period.

 

     Years Ended December 31              

(In thousands)

       2021             2020         $ Change     % Change  

Revenues

   $ 68,816     $ 29,378     $ 39,438       134

Cost of revenues(1)

     40,123       17,097       23,026       135
  

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit

     28,693       12,281       16,412       134

Gross margin %

     42     42    

Operating expenses:

        

Sales commissions

     25,061       10,410       14,651       141

Sales and marketing(1)

     5,179       3,185       1,994       63

General and administrative(1)

     5,780       3,801       1,979       52
  

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     36,020       17,396       18,624       107
  

 

 

   

 

 

   

 

 

   

 

 

 

Loss from operations

     (7,327     (5,115     (2,212     43

Interest expense(2)

     (1,712     (523     (1,189     227

Interest income

     —         —         —         —    

Other income (expense), net

     (240     (41     (199     485
  

 

 

   

 

 

   

 

 

   

 

 

 

Loss from continuing operations before income taxes

     (9,279     (5,679     (3,600     63

Income tax benefit (provision)

     (3     (3     —         0
  

 

 

   

 

 

   

 

 

   

 

 

 

Net loss from continuing operations

   $ (9,282   $ (5,682   $ (3,600     63
  

 

 

   

 

 

   

 

 

   

 

 

 

 

(1)

Includes stock-based compensation expense as follows:

 

     Years Ended December 31,  

(In thousands)

       2021              2020      

Cost of sales

   $ 19      $ 8  

Sales and marketing

     68        37  

General and administrative

     113        64  
  

 

 

    

 

 

 

Total stock-based compensation expense

   $ 200      $ 109  
  

 

 

    

 

 

 

 

(2)

Includes interest expense to related party of $0.7 million and $0.2 million during the years ended December 31, 2021 and 2020, respectively.

Revenues

Total revenue for the year ended December 31, 2021 was $68.8 million which compares with total revenue of $29.4 million for the year ended December 31, 2020. The increase in 2021 revenue is significantly impacted by the change in the business coming out of the COVID-19 pandemic. Solar revenue (including the installation and completion of solar systems) increased by $37.0 million. The increase is driven primarily by the volume of transactions in 2021. Other revenues, including design services and proposal services, increased by $1.6 million, the increase in revenues is driven by greater internal focus on performing such services in 2021.


Cost of Revenues

Cost of revenues for the year ended December 31, 2021 was $40.1 million compared to $17.1 million for the year ended December 31, 2020. The 135% increase in cost of revenue for the year ended December 31, 2021 over for the year ended December 31, 2020 grew proportionately with the increase in revenue during the same comparable periods, as well as slight increase in raw material costs.

Gross Profit

Our gross profits for the year ended December 31, 2021 increased by $16.4 million, or 134%, as compared to the year ended December 31, 2020. Gross margins of 42% remained flat year-over-year.

Sales Commission

Sales commissions for the year ended December 31, 2021 increased by $14.7 million, or 141%, compared to the year ended December 31, 2020. The increase in sales commissions expenses is primarily attributable to a corresponding increase of 134% in revenue.

Sales and Marketing

Sales and marketing expense for the year ended December 31, 2021 increased by $2.0 million, or 63%, compared to the year ended December 31, 2020. The increase was primarily attributable to an increase of $1.4 million in personnel-related expenses as a result of increased headcount in our sales and marketing organization, $0.2 million increase in office supplies, and $0.1 million increase in due and subscription expense.

General and Administrative

General and administrative expense for the year ended December 31, 2021 increased by $2.0 million, or 52%, compared to the year ended December 31, 2020. The increase was primarily attributable to an increase of $0.5 million in accounting, legal, and other contract labor costs, $0.3 million in personnel-related expenses, as a result of increased headcount, $0.2 million increase in office and occupancy related costs, $0.2 million increase in customer support, $0.2 million increase in amortization of internal software, a $0.1 million increase in stock-based compensation expense related to additional stock-based awards granted in fiscal year 2022, and a $0.1 million increase in recruitment and reallocation expenses.

Interest Expense

Interest expense for the year ended December 31, 2021 increased by $1.2 million, or 227%, compared to the year ended December 31, 2020. The increase is attributable to a $0.6 million increase in interest expense related to amortization of debt discount primarily due to the 2020-A and 2021-A notes, a $0.3 million increase in interest expense related to our SVB operating loan, and a $0.3 million increase in financing costs associated with a 2021 short-term bridge loan.

Other Income (Expense), Net

Other income (expense), net for the year ended December 31, 2021 increased by $0.2 million, or 485%, compared to the year ended December 31, 2020. The increase was primarily due to increase of $1.3 million related to the fair value measurement of the SAFEs, $0.3 million related to revaluation of derivative liabilities of 2019-A 2020-A and 2021-A notes, and $0.3 million related to fair value remeasurement of Series B and Series C preferred stock warrants. These expenses were partially offset by other income relating to PPP loan forgiveness of approximately $1.7 million.


Net Loss from Continuing Operations

As a result of the factors discussed above, our net loss from continuing operations for the year ended December 31, 2021 was $9.3 million, an increase of $3.6 million, or 63%, as compared to $5.7 million for the year ended December 31, 2020.

Liquidity and Capital Resources

Since our inception, we have financed our operations primarily through sales of equity securities, issuance of convertible notes and cash generated from operations. Our principal uses of cash in recent periods have been funding our operations and investing in capital expenditures. As of October 1, 2023, our principal sources of liquidity were cash and cash equivalents of $1.7 million, which were held for working capital purposes. Our cash equivalents are on deposit with major financial institutions. Our cash position raises substantial doubt regarding our ability to continue as a going concern for twelve months following the issuance of the condensed consolidated financial statements.

We will receive the proceeds from any cash exercise of any Warrants. The aggregate amount of proceeds could be up to $254.1 million if all the Warrants are exercised for cash. However, to the extent the Warrants are exercised on a “cashless basis,” the amount of cash we would receive from the exercise of the Warrants will decrease. The Private Warrants and Working Capital Warrants may be exercised for cash or on a “cashless basis.” The Public Warrants and the Merger Warrants may only be exercised for cash provided there is then an effective registration statement registering the shares of common stock issuable upon the exercise of such warrants. If there is not a then-effective registration statement, then such warrants may be exercised on a “cashless basis,” pursuant to an available exemption from registration under the Securities Act. We expect to use any such proceeds for general corporate and working capital purposes, which would increase our liquidity. As of December 21, 2023, the price of our common stock was $1.52 per share. We believe the likelihood that warrant holders will exercise their Warrants, and therefore the amount of cash proceeds that we would receive, is dependent upon the market price of our common stock. If the market price for our common stock is less than $11.50 per share, we believe warrant holders will be unlikely to exercise. We do not expect to rely on the cash exercise of Warrants to fund our operations. Instead, we intend to rely on other sources of cash discussed elsewhere in this prospectus to continue to fund our operations.

The Resale Securities represent a substantial percentage of our shares of outstanding commons stock. The number of Resale Securities exceeds the number of shares of common stock constituting our public float, and represents approximately 190% of our public float and approximately 105% of outstanding common stock (after giving effect to the issuance of shares of common stock upon exercise of the Warrants) as of December 21, 2023. Any of these resales, or the perception in the market that the holders of a large number of shares intend to resell shares, could cause the market price of our shares of common stock to decline or increase the volatility in the market price of our shares of common stock.

Given the substantial number of shares of common stock being registered for potential resale by the selling securityholders pursuant to this prospectus, the sale of Resale Securities by the selling securityholders, or the perception in the market that the selling securityholders intend to sell a large number of shares, could increase the volatility of the market price of common stock or result in a significant decline in the public trading price of our common stock.

While we received cash of $19.8 million from the completion of the Business Combination in July 2023, and despite results of the closing of the Disposal Transaction and our recent cost cutting measures, additional capital infusion will be necessary in order to fund planned operations while meeting obligations as they come due. It is currently unlikely that warrant holders will exercise their warrants based on the current price of our common stock, and additional financing is required from outside sources. We may not be able to raise it on terms acceptable to us or at all. If we are not able to secure adequate additional funding when needed, the Company


will need to reevaluate its operating plan and may be forced to make reductions in spending, extend payment terms with suppliers, liquidate assets where possible, or suspend or curtail planned programs or cease operations entirely.

Debt Financings

2018 Bridge Notes

In December 2018, Solaria Corporation issued senior subordinated convertible secured notes (“2018 Notes”) totaling approximately $3.4 million in exchange for cash. The notes bear interest at the rate of 8% per annum and the investors are entitled to receive twice of the face value of the notes at maturity. The 2018 Notes were assumed in the acquisition by Complete Solaria and are secured by substantially all of the assets of Complete Solaria. In 2021, the 2018 Notes were amended extending the maturity date to December 13, 2022. In connection with the 2021 amendment, Solaria had issued warrants to purchase shares of Series E-1 redeemable convertible preferred stock of Solaria. The warrants were exercisable immediately in whole or in part at and expire on December 13, 2031. As part of the merger with Complete Solar, all the outstanding warrants issued to the lenders were assumed by the parent company, Complete Solaria.

In December 2022, we entered into an amendment to the 2018 Notes extending the maturity date from December 13, 2022 to December 13, 2023. In connection with the amendment, the notes will continue to bear interest at 8% per annum and are entitled to an increased repayment premium from 110% to 120% of the principal and accrued interest at the time of repayment.

The Company concluded that the modification was a troubled debt restructuring as the Company was experiencing financial difficulty and the amended terms resulted in a concession to the Company. As the future undiscounted cash payments under the modified terms exceeded the carrying amount of the Solaria Bridge Notes on the date of modification, the modification was accounted for prospectively. The incremental repayment premium is being amortized to interest expense using the effective interest rate method. As of October 1, 2023 and December 31, 2022, the carrying value of the 2018 Notes was $10.7 million and $9.8 million, respectively. Interest expense recognized for the thirty-nine weeks ended October 1, 2023 was $1.0 million.

SCI Term Loan and Revolver Loan

In October 2020, Solaria entered into a loan agreement (“Loan Agreement”) with Structural Capital Investments III, LP (“SCI”). The Loan Agreement with SCI comprises of two facilities, a term loan (the “Term Loan”) and a revolving loan (the “Revolving Loan”) for $5.0 million each with a maturity date of October 31, 2023. Both the Term Loan and the Revolving Loan were fully drawn upon closing. The Term Loan was repaid prior to the acquisition of Solaria by Complete Solar and was not included in the business combination.

The Revolving Loan has a term of thirty-six months, principal repayments at the end of the term and an annual interest rate of 7.75% or Prime rate plus 4.5%, whichever is higher. Interest expense recognized for the thirty-nine weeks ended October 1, 2023 was $0.5 million. In October 2023, the Company entered into an Assignment and Acceptance Agreement whereby Structural Capital Investments III, LP assigns the SCI debt to Kline Hill Partners Fund LP, Kline Hill Partners IV SPV LLC, Kline Hill Partners Opportunity IV SPV LLC, and Rodgers Massey Revocable Living Trust for a total purchase price of $5.0 million, as discussed in Note 22 – Subsequent Events of the accompanying notes to the unaudited condensed consolidated financial statements.

Secured Credit Facility

In December 2022, we entered into a secured credit facility agreement with Kline Hill Partners IV SPV LLC and Kline Hill Partners Opportunity IV SPV LLC. The secured credit facility agreement, which matures in April 2023, allows us to borrow up to 70% of the net amount of our eligible vendor purchase orders with a maximum amount of $10.0 million at any point in time. The purchase orders are backed by relevant customer sales orders


which serve as collateral. The amounts drawn under the secured credit facility may be reborrowed provided that the aggregate borrowing does not exceed $20.0 million. The repayment under the secured credit facility is the borrowed amount multiplied by 1.15x if repaid within 75 days and borrowed amount multiplied by 1.175x if repaid after 75 days. We may prepay any borrowed amount without premium or penalty. Under the original terms, the secured credit facility agreement was due to mature in April 2023. We are in the process of amending the secured credit facility agreement to extend its maturity date.

At October 1, 2023, the outstanding net debt amounted to $11.7 million, including accrued financing cost of $4.1 million, compared to December 31, 2022, where the outstanding net debt amounted to $5.6 million, including accrued financing cost of $0.1 million.

Debt in CS Solis

In February 2022, we received an investment from CRSEF Solis Holdings, LLC (“CRSEF”). The investment was made pursuant to a subscription agreement, under which CRSEF contributed $25.6 million in exchange for 100 Class B Membership Units of CS Solis. The Class B Membership Units are mandatorily redeemable by us on the three-year anniversary of the effective date of the CS Solis amended and restated LLC agreement. The Class B Membership Units accrue interest that is payable upon redemption at a rate of 10.5% which is accrued as an unpaid dividend, compounded annually, and subject to increases in the event we declare any dividends. In July 2023, we amended the debt of with CSREF as part of the closing of the Business Combination. The modification did not change the interest rate. The modification accelerates the redemption date of the investment, which was previously February 14, 2025, and is March 31, 2024 subsequent to the modification. As of October 1, 2023 and December 31, 2022, we have recorded a liability of $29.2 million and zero, respectively, included in short-term debt in CS Solis on the unaudited condensed consolidated balance sheets. As of October 1, 2023 and December 31, 2022, we have recorded a liability of zero and $25.2 million, respectively, included in net long-term debt in CS Solis on the unaudited condensed consolidated balance sheets. For the thirty-nine weeks ended October 1, 2023, we have recorded accretion of the liability as interest expense of $2.7 million, and we have recorded the amortization of issuance costs as interest expense of $0.7 million.

Cash Flows for the Thirty-Nine Weeks Ended October 1, 2023 and the Nine Months Ended September 30, 2022

The following table summarizes Complete Solaria’s cash flows from operating, investing, and financing activities for the thirty-nine weeks ended October 1, 2023 and the nine months ended September 30, 2022:

 

(in thousands)

   Thirty-Nine
Weeks Ended
October 1, 2023
     Nine Months
Ended
September 30, 2022
 

Net cash used in operating activities from continuing operations

   $ (47,152    $ (17,197

Net cash used in investing activities from continuing operations

   $ (1,534    $ (1,048

Net cash provided by financing activities from continuing operations

   $ 45,575      $ 13,704  

Cash Flows from Operating Activities

Net cash used in operating activities from continuing operations of $47.2 million for the thirty-nine weeks ended October 1, 2023 was primarily due to the net loss from continuing operations, net of tax of $73.4 million and net cash outflows of $18.8 million from changes in our operating assets and liabilities, adjusted for non-cash charges of $45.1 million. Non-cash charges primarily consisted of $35.5 million for the issuance of common stock in connection with FPAs, $10.3 million loss on CS Solis debt extinguishment, $6.7 million change in fair value of FPAs, $4.3 million change in allowance for credit losses, $4.0 million interest expense, $2.5 million


accretion of long-term debt in CS Solis, $2.4 million related to the issuance of bonus common stock shares in connection with the Business Combination $2.3 million of stock-based compensation expense, and $2.1 million relating to the change in reserve for excess and obsolete inventory, partially offset by a decrease in the fair value of warrant liabilities of $26.3 million. The main drivers of net cash inflows derived from the changes in operating assets and liabilities were related to an increase in accounts receivable, net of $11.8 million, an increase in prepaid expenses and other current assets of $8.3 million, an increase in inventory of $3.9 million, and a decrease in deferred revenue of $0.8 million, partially offset by an increase in accounts payable of $4.4 million, an increase in accrued expenses and other current liabilities of $1.6 million and a decrease in other noncurrent assets of $1.1 million.

Net cash used in operating activities from continuing operations of $17.2 million for the nine months ended September 30, 2022 was primarily due to the net loss from continuing operations, net of tax of $10.8 million and net cash outflows of $10.6 million from changes in operating assets and liabilities, adjusted for non-cash charges of $4.2 million. The main drivers of net cash outflows derived from the changes in operating assets and liabilities were related to an increase in inventory of $5.0 million, an increase in accounts receivable, net of $3.0 million, a decrease in accrued expenses and other current liabilities of $2.1 million and a decrease in warranty provision, noncurrent of $0.6 million. Non-cash charges primarily consisted of a change in reserve for obsolete inventory of $3.1 million, accretion of long-term debt in CS Solis of $2.6 million, $0.7 million change in allowance for credit losses, and $0.5 million in depreciation and amortization expense, partially offset by a gain on extinguishment of convertible notes and SAFEs of $3.2 million.

The net increase in cash, cash equivalents and restricted cash from discontinued operations of $0.2 million for the thirty-nine weeks ended October 1, 2023 was entirely attributable to net cash provided by operating activities from discontinued operations. This increase was primarily due to the net loss from discontinued operations, net of tax of $168.5 million, adjusted for non-cash charges of $152.9 million and net cash inflows of $15.8 million from changes in our operating assets and liabilities. Non-cash charges primarily consisted of impairment of goodwill of $119.4 million, impairment of intangible assets of $28.1 million, depreciation and amortization expense of $2.4 million, stock-based compensation expense of $1.8 million and a $1.1 million change in allowance for credit losses. The main drivers of net cash inflows derived from the changes in operating assets and liabilities were related to a decrease in accounts receivable, net of $8.2 million an increase in accrued expenses and other current liabilities of $6.0 million, a decrease of long-term deposits of $2.8 million and a decrease in inventories of $2.3 million, partially offset by a decrease of $2.9 million in accounts payable.

Cash Flows from Investing Activities

Net cash used in investing activities of $1.5 million for the thirty-nine weeks ended October 1, 2023 was primarily due to additions to internal-use-software.

Net cash used in investing activities of $1.0 million for the nine months ended September 30, 2022 was due to additions to internal-use-software.

Cash Flows from Financing Activities

Net cash provided by financing activities of $45.6 million for the thirty-nine weeks ended October 1, 2023 was primarily due to $21.3 million in net proceeds from the issuance of convertible notes, $19.8 million in proceeds from the Business Combination and PIPE Financing and $14.1 million in net proceeds from the issuance of notes payable, partially offset by repayment of notes payable of $9.7 million.

Net cash provided by financing activities of $13.7 million for the nine months ended September 30, 2022 was primarily due to net proceeds from the issuance of long-term debt in CS Solis of $25.0 million, partially offset by repayment of notes payable of $9.5 million, payments for issuance of Series D redeemable convertible preferred stock of $1.3 million and the repayment of convertible notes payable to related parties of $0.5 million.


Cash Flows for the Years Ended December 31, 2022 and 2021

The following table summarizes Complete Solaria’s cash flows from operating, investing, and financing activities for the years ended December 31, 2022 and 2021:

 

     Years Ended December 31,  
(in thousands)        2022              2021      

Net cash used in operating activities from continuing operations

   $ (25,217    $ 10,995  

Net cash used in investing activities from continuing operations

   $ 3,335      $ (1,063

Net cash provided by financing activities from continuing operations

   $ 31,191      $ 16,895  

Cash Flows from Operating Activities

Net cash used in operating activities from continuing operations of $25.2 million for the year ended December 31, 2022 was primarily due the net loss from continuing operations of $28.0 million, and net cash outflows of $11.2 million from changes in our operating assets and liabilities, adjusted for non-cash charges of $13.8 million. The main drivers of net cash outflows derived from the changes in operating assets and liabilities were related to an increase in accounts receivable of $9.7 million, and an increase in inventories of $4.9 million, and an decrease in prepaid expenses and other current assets of $1.6 million, partially offset by an increase in accounts as payable of $3.3 million and a decrease in prepaid expenses and other current assets of $1.2 million. Non-cash charges primarily consisted of $5.2 million change in the fair value of warrant liability, interest expense primarily related to long-term debt in CS Solis of $4.8 million, reserve for obsolete inventory of $3.6 million, increase in the allowance for doubtful accounts of $2.1 million, and depreciation and amortization expense of $0.6 million, partially offset by non-cash income recognized upon conversion of convertible notes and SAFE agreements of $3.2 million.

Net cash used in operating activities of $11.0 million for the year ended December 31, 2021 was primarily due to the net loss of $9.3 million, and net cash outflows of $5.4 million from changes in our operating assets and liabilities, adjusted for non-cash charges of $3.7 million. The main drivers of net cash outflows derived from the changes in operating assets and liabilities were related to an increase in accounts receivable of $4.8 million, an increase in inventory of $3.0 million and an increase in prepaid expenses and other current assets of $3.0 million, partially offset by an increase in accounts payable of $3.0 million, and an increase in accrued expenses and other current liabilities of $2.9 million. Non-cash charges primarily consisted of non-cash interest expense of $1.3 million, change in fair value of convertible notes of $1.3 million, change in reserve for obsolete inventory of $0.8 million, depreciation and amortization of $0.5 million, change in the allowance of allowance of doubtful accounts of $0.4 million, non-cash lease expense of $0.3 million, and change in fair value of warrant liabilities of $0.3 million, partially offset by $1.8 million in forgiveness of PPP loan.

Cash Flows from Investing Activities

Net cash provided by investing activities of $3.3 million for the year ended December 31, 2022, was primarily due to cash acquired in the acquisition of Solaria of $4.8 million, partially offset by additions to internal-use-software of $1.5 million.

Net cash used in investing activities of $1.1 million for the year ended December 31, 2021, was due to additions to internal-use-software.

Cash Flows from Financing Activities

Net cash provided by financing activities of $31.2 million for the year ended December 31, 2022 was primarily due to net proceeds from issuance of long-term debt in CS Solis of $25.0 million, proceeds from the issuance of the 2022 Convertible Notes of $12.0 million, and proceeds from the issuance of notes payable of $5.5 million. This was partially offset by the repayment of notes payable of $9.5 million, payments for issuance costs


of Series D redeemable convertible preferred shares of $1.4 million, and repayment of convertible notes payable to related parties of $0.5 million.

Net cash provided by financing activities of $16.9 million for fiscal year 2021 was primarily related to net proceeds from the issuance of notes payable of $7.2 million, the issuance of SAFE agreements of $5.0 million, issuance of our convertible promissory notes to related parties of $3.6 million and proceeds from the issuance of convertible promissory notes of $1.2 million.

Cash Flows for the Years Ended December 31, 2021 and 2020

The following table summarizes Complete Solaria’s cash flows from operating, investing, and financing activities for the years ended December 31, 2021 and 2020:

 

     Years Ended December 31,  
(in thousands)        2021              2020      

Net cash used in operating activities from continuing operations

   $ (10,995    $ (6,189

Net cash used in investing activities from continuing operations

     (1,063      (584

Net cash provided by financing activities from continuing operations

     16,895        6,355  

Cash Flows from Operating Activities

Net cash used in operating activities of $11.0 million for the year ended December 31, 2021 was primarily due to the net loss of $9.3 million, and net cash outflows of $5.4 million from changes in our operating assets and liabilities, adjusted for non-cash charges of $3.7 million. The main drivers of net cash outflows derived from the changes in operating assets and liabilities were related to an increase in accounts receivable of $4.8 million, an increase in inventory of $3.0 million, and an increase in prepaid expenses and other current assets of $3.0 million, partially offset by an increase in accounts payable of $3.0 million and an increase in accrued expenses and other current liabilities of $2.9 million. Non-cash charges primarily consisted of non-cash interest expense of $1.3 million, change in fair value of convertible notes of $1.3 million, change in reserve for obsolete inventory of $0.8 million, depreciation and amortization of $0.5 million, change in the allowance of doubtful accounts of $0.4 million, non-cash lease expense of $0.3 million, and change in fair value of warrant liabilities of $0.3 million, partially offset by $1.8 million in forgiveness of PPP loan.

Net cash used in operating activities of $6.2 million for year ended December 31, 2020 was primarily related to our net loss of $5.6 million, and net cash outflows of $1.9 million provided by changes in our operating assets and liabilities, adjusted for non-cash charges of $1.3 million. The main drivers of net cash outflows were derived from the changes in operating assets and liabilities and were related to an increase in accounts receivable of $2.0 million, an increase in inventory of $1.3 million, a decrease in accounts payable of $1.1 million, an increase in prepaid expenses and other current assets of $0.9 million, partially offset by an increase in accrued expenses and other current liabilities of $2.4 million, and an increase in deferred revenue of $1.5 million. Non-cash charges primarily consisted of non-cash interest of $0.5 million, increase in the allowance for doubtful accounts of $0.3 million, and depreciation and amortization of $0.3 million.

Cash Flows from Investing Activities

Net cash used in investing activities of $1.1 million for the year ended December 31, 2021 was due to additions to internal-use software.

Net cash used in investing activities of $0.6 million for fiscal year 2020 was due to additions to internal-use software.


Cash Flows from Financing Activities

Net cash provided by financing activities of $16.9 million for the year ended December 31, 2021 was primarily related to net proceeds from the issuance of notes payable of $7.2 million, the issuance of SAFE agreements of $5.0 million, issuance of our convertible promissory notes to related parties of $3.6 million, and proceeds from the issuance of convertible promissory notes of $1.2 million.

Net cash provided by financing activities of $6.4 million for the year ended December 31, 2020 was primarily related to net proceeds from issuance of notes payable of $4.0 million, proceeds from the issuance of convertible promissory notes to related parties of $3.3 million, and proceeds from the issuance of convertible promissory notes of $0.7 million, partially offset by repayment of convertible notes of $1.5 million.

Proceeds from Warrants

We will not receive any of the proceeds from sales of Warrants, except with respect to amounts we may receive upon the cash exercise of the Warrants. Whether warrantholders will exercise their Warrants, and therefore the amount of cash proceeds we would receive upon exercise, is dependent upon the trading price of the common stock, the last reported sales price for which was $1.52 per share on December 21, 2023. Each Warrant is exercisable for one share of common stock at an exercise price of $11.50. Therefore, if and when the trading price of the common stock is less than $11.50 per share, we expect that warrantholders would not exercise their Warrants. To the extent the Warrants are exercised on a “cashless basis,” the amount of cash we would receive from the exercise of the Warrants will decrease. The Private Warrants and Working Capital Warrants may be exercised for cash or on a “cashless basis.” The Public Warrants and the Merger Warrants may only be exercised for cash provided there is then an effective registration statement registering the shares of common stock issuable upon the exercise of such warrants. If there is not a then-effective registration statement, then such warrants may be exercised on a “cashless basis,” pursuant to an available exemption from registration under the Securities Act.

We could receive up to an aggregate of approximately $254.1 million if all of the Warrants are exercised for cash, but we would only receive such proceeds if and when the warrantholders exercise their Warrants, which, based on the current trading price of our common stock, is unlikely unless there is a significant increase in the trading price of our common stock. The Warrants may not be, or remain, in the money during the period they are exercisable and prior to their expiration and, therefore, it is possible that the Warrants may not be exercised prior to their maturity, even if they are in the money, and as such, may expire worthless with minimal proceeds received by us, if any, from the exercise of the Warrants. To the extent that any of the Warrants are exercised on a “cashless basis,” we will not receive any proceeds upon such exercise. As a result, we do not expect to rely on the cash exercise of Warrants to fund our operations. Instead, we intend to rely on other sources of cash discussed elsewhere in this prospectus to continue to fund our operations.

Forward Purchase Agreements

On and around July 13, FACT entered into multiple forward purchase agreements with certain FPA Investors, pursuant to which FACT (now to Complete Solaria following the Closing) agreed to purchase in the aggregate, up to 5,618,488 shares of common stock then held by the FPA Investors (subject to certain conditions and purchase limits set forth in the forward purchase agreements). Pursuant to the terms of the forward purchase agreements, each FPA Investor further agreed not to redeem any of the FACT Class A Ordinary Shares owned by it at such time. The per price at which the FPA Investors have the right to sell the shares to us on the Maturity Date is not less than $5.00 per share.

If the FPA Investors hold some or all of the 5,618,488 forward purchase agreement shares on the Maturity Date, and the per share trading price of our common stock is less than the per share price at which the FPA Investors have the right to sell the common stock to us on the Maturity Date, we would expect that the FPA Investors will exercise this repurchase right with respect to such shares. In the event that we are required to repurchase these forward purchase


agreement shares, or in the event that the forward purchase agreements are terminated the amount of cash arising from the Business Combination that would ultimately be available to fund our liquidity and capital resource requirements would reduce accordingly, which would adversely affect our ability to fund our growth plan in the manner we had contemplated when entering into the forward purchase agreements.

Off Balance Sheet Arrangements

As of the date of this prospectus, Complete Solaria does not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures, or capital resources that are material to investors. The term “off-balance sheet arrangement” generally means any transaction, agreement, or other contractual arrangement to which an entity unconsolidated with Complete Solaria is a party, under which it has any obligation arising under a guaranteed contract, derivative instrument, or variable interest or a retained or contingent interest in assets transferred to such entity or similar arrangement that serves as credit, liquidity, or market risk support for such assets.

Currently, Complete Solaria does not engage in off-balance sheet financing arrangements.

Emerging Growth Company Status

Section 102(b)(1) of the Jumpstart Our Business Startups Act of 2012, or the JOBS Act, exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can choose not to take advantage of the extended transition period and comply with the requirements that apply to non-emerging growth companies, and any such election to not take advantage of the extended transition period is irrevocable.

Complete Solaria is an “emerging growth company” as defined in Section 2(a) of the Securities Act, and has elected to take advantage of the benefits of the extended transition period for new or revised financial accounting standards. Following the closing of the Merger, our Post-Combination Company will remain an emerging growth company until the earliest of (i) the last day of the fiscal year in which the market value of common stock that is held by non-affiliates exceeds $700 million as of the end of that year’s second fiscal quarter, (ii) the last day of the fiscal year in which we has total annual gross revenue of $1.235 billion or more during such fiscal year (as indexed for inflation), (iii) the date on which we have issued more than $1.0 billion in non-convertible debt in the prior three-year period, or (iv) December 31, 2025. Complete Solaria expects to continue to take advantage of the benefits of the extended transition period, although it may decide to early adopt such new or revised accounting standards to the extent permitted by such standards. This may make it difficult or impossible to compare our financial results with the financial results of another public company that is either not an emerging growth company or is an emerging growth company that has chosen not to take advantage of the extended transition period exemptions because of the potential differences in accounting standards used.

Quantitative and Qualitative Disclosures About Market Risk

Complete Solaria’s operations expose Complete Solaria to a variety of market risks. Complete Solaria monitors and manages these financial exposures as an integral part of its overall risk management program.

Interest Rate Risk

We do not have significant exposure to interest rate risk that could affect the balance sheet, statement of operations, and the statement of cash flows, as we do not have any outstanding variable rate debt as of October 1, 2023.


Concentrations of Credit Risk and Major Customers

Our customer base consists primarily of residential homeowners. We do not require collateral on our accounts receivable. Further, our accounts receivable are with individual homeowners and we are exposed to normal industry credit risks. We continually evaluate our reserves for potential credit losses and establish reserves for such losses.

As of October 1, 2023, one customer accounted for 10% or more of total accounts receivable, net balance. As of September 30, 2022, one customer accounted for 10% or more of the total accounts receivable, net balance.

For the thirty-nine weeks ended October 1, 2023, one customer accounted for 10% or more of the total revenues. For the nine months ended September 30, 2022, two customers accounted for 10% or more of total revenues.

Recent Developments

In October 2023, the Company entered into an Assignment and Acceptance Agreement (“Assignment Agreement”), whereby Structural Capital Investments III, LP assigns the SCI debt to Kline Hill Partners Fund LP, Kline Hill Partners IV SPV LLC, Kline Hill Partners Opportunity IV SPV LLC, and Rodgers Massey Revocable Living Trust for a total purchase price of $5.0 million. The Company has identified this as a related party transaction.

In October 2023, in connection with the Assignment Agreement, the Company also entered into the First Amendment to Warrant to Stock Purchase Agreements with the holders of the Series D-7 warrants. Pursuant to the terms of the agreement, the warrants to purchase 1,376,414 shares of Series D-7 preferred stock converted into warrants to purchase 656,630 shares of common stock (the “replacement warrants”). As a result of the warrant amendment, the Company reclassified the replacement warrants from equity to liability. The replacement warrants were remeasured to the fair value on the amendment effective date and the Company will record subsequent changes in fair value in other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive income (loss).

As noted above, in October 2023, we completed the sale of our solar panel business to Maxeon, pursuant to the terms of the Disposal Agreement.

EX-99.3 4 d474289dex993.htm EX-99.3 EX-99.3

Exhibit 99.3

UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION

The following unaudited pro forma condensed combined financial information has been prepared in accordance with Article 11 of Regulation S-X. The unaudited pro forma condensed combined financial information presents the pro forma effects of the Business Combination, inclusive of the Mergers and the Domestication of FACT, as described below and the pro forma effects of the Disposal Transaction, as described below. The Business Combination and related transactions, as further described elsewhere in the unaudited pro forma financial information, were completed on or around July 18, 2023.

FACT is a blank check company incorporated as a Cayman Islands exempted company in December 2020. FACT was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. On March 2, 2021, FACT consummated its initial public offering (the “IPO”) generating gross proceeds of $345.0 million. Simultaneously with the closing of the IPO, FACT consummated the sale of 6,266,667 Private Warrants at a purchase price of $1.50 per warrant in a private placement to FACT’s sponsor, Freedom Acquisition I LLC, a Delaware limited liability company (the “Sponsor”), generating gross proceeds of $9.4 million. Following the Extension Amendment Redemptions on March 2, 2023, 11,243,496 Class A Ordinary Shares remained outstanding. As of the Closing Date, holders of 7,784,739 shares of Class A Ordinary Shares had validly elected to redeem their Class A Ordinary Shares for a full pro rata portion of the trust account holding the proceeds from FACT’s initial public offering, or approximately $10.56 per share and $82.2 million in the aggregate.

Complete Solar, Inc., a Delaware corporation (“Complete Solar”), was incorporated in the State of Delaware in 2010 and provides solar services such as sales enablement, project management, partner coordination and customer communication. Legacy Complete Solaria is the result of the business combination of Complete Solar and The Solaria Corporation, which was consummated on November 4, 2022. As discussed below, the disposition of The Solaria Corporation (“Solaria”) was consummated in October 2023. Complete Solaria’s unaudited condensed consolidated balance sheet as of October 1, 2023 and unaudited condensed consolidated statement of operations and comprehensive income (loss) for the thirty-nine week period ended October 1, 2023 have been recast to give effect to the disposition.

The unaudited pro forma condensed combined financial information also includes the impact of the following:

 

   

The final disposition, which was consummated on October 6, 2023, of certain North American solar panel assets, inclusive of certain intellectual property and customer contracts, not reflected in Compete Solaria’s unaudited condensed consolidated balance sheet as of October 1, 2023 (the “Disposal Transaction”). In connection with the Disposal Transaction, Maxeon agreed to hire certain employees of Complete Solaria who, upon closing, became employees of Maxeon.

 

   

In conjunction with the Disposal Transaction, on October 5, 2023, Complete Solaria amended certain warrants, dated November 2, 2022, originally issued by the Complete Solaria to six warrant holders, which warrants are exercisable for (a) an aggregate of 1,486,268 shares of Complete Solaria’s common stock, par value $0.001 per share, or (b) if designated and issued, a future series of preferred stock of Complete Solaria.

 

   

Complete Solaria, Inc. previously announced in its Current Report on Form 8-K filed with the SEC on July 14, 2023 that the Company and Freedom Acquisition I Corp. entered into separate agreements (each a “Forward Purchase Agreement”, and together, the “Forward Purchase Agreements”) with each of (i) Meteora; (ii) Polar, and (iii) Sandia (each of Meteora, Polar, and Sandia, individually, a “Seller”, and together, the “Sellers”) for OTC Equity Prepaid Forward Transactions.

On December 18, 2023, Complete Solaria and each Seller entered into separate amendments to the Forward Purchase Agreements (the “Amendments”). The Amendments lower the reset price of each


Forward Purchase Agreement from $5.00 to $3.00 and allow the Company to raise up to $10,000,000 of equity from existing stockholders without triggering certain anti-dilution provisions contained in the Forward Purchase Agreements.

 

   

On December 19, 2023, the Complete Solaria entered into separate common stock purchase agreements (the “Purchase Agreements”) with the Rodgers Massey Freedom and Free Markets Charitable Trust and the Rodgers Massey Revocable Living Trust (each a “Purchaser”, and together, the “Purchasers”). Pursuant to the terms of the Purchase Agreements, each Purchaser purchased 1,838,235 shares of Complete Solaria Common Stock, par value $0.001, (the “Shares”), at a price per share of $1.36, representing an aggregate purchase price of $5.0 million. The Purchasers paid for the Shares in cash. Thurman J. Rodgers is a trustee of each Purchaser and is the Executive Chairman of the board of directors of Complete Solaria.

Description of the Business Combination

The Domestication – As part of the Business Combination, FACT affected a deregistration under the Cayman Islands Companies Act and a domestication under Section 388 of the DGCL (the “Domestication”). Upon the effectiveness of the Domestication, FACT changed its name to Complete Solaria, Inc. (“New Complete Solaria”).

In connection with the Domestication, (i) each issued and outstanding FACT Class A Ordinary Share and each issued and outstanding FACT Class B Ordinary Share converted into one share of Complete Solaria Common Stock. Additionally, each issued and outstanding whole warrant to purchase one FACT Class A Ordinary Share at an exercise price of $11.50 per share converted, on a one-for-one basis, to purchase one share of Complete Solaria Common Stock at an exercise price of $11.50 per share.

The Mergers – On July 18, 2023 (the “Closing Date”) and following the approval at an extraordinary general meeting of the shareholders of FACT held on July 11, 2023, as contemplated by the Business Combination Agreement, the parties consummated the closing of the transactions contemplated by the Business Combination Agreement (collectively, the “Business Combination”), whereby (i) First Merger Sub merged with and into Legacy Complete Solaria, with Legacy Complete Solaria surviving as a wholly-owned subsidiary of the Company (the “First Merger”), (ii) immediately thereafter and as part of the same overall transaction, Legacy Complete Solaria merged with and into Second Merger Sub, with Second Merger Sub surviving as a wholly-owned subsidiary of the Company (the “Second Merger”), and Second Merger Sub changed its name to “CS, LLC”, and (iii) immediately after the consummation of the Second Merger and as part of the same overall transaction, Solaria merged with and into a newly formed Delaware limited liability company and wholly-owned subsidiary of the Company and changed its name to “SolarCA LLC” (“Third Merger Sub”), with Third Merger Sub surviving as a wholly-owned subsidiary of the Company (the “Additional Merger”, and together with the First Merger and the Second Merger, the “Mergers”).

As a condition to the closing of the Business Combination, Complete Solar was required to consummate a merger with Solaria. On October 3, 2022, Complete Solar entered into the Required Transaction Merger Agreement, pursuant to which, and on the terms and subject to the conditions of which, Complete Solar would acquire all of the outstanding shares of capital stock of Solaria. The merger between Complete Solar and Solaria was consummated on November 4, 2022. As a result, Solaria became a wholly-owned subsidiary of Complete Solar, forming Legacy Complete Solaria. As discussed below, the disposition of Solaria was consummated in October 2023. Complete Solaria’s unaudited condensed consolidated balance sheet as of October 1, 2023 and unaudited condensed consolidated statement of operations and comprehensive income (loss) for the thirty-nine week period ended October 1, 2023 have been recast to give effect to the disposition.

The equity exchange and financing related matters associated with the Business Combination are summarized as follows:

 

i.

Legacy Complete Solaria has raised the 2022 Convertible Notes in November 2022, December 2022, February 2023, May 2023 and June 2023 with additional investors, with an aggregate purchase price of $33.3 million. Additionally, Legacy Complete Solaria assumed a note from an existing investor for


  $6.7 million, which was modified as of the close of the acquisition of Solaria to contain the same terms as the other 2022 Convertible Notes. At the Closing, the principle and accrued interest (“Conversion Amount”) of the 2022 Convertible Notes converted into a number of shares of Complete Solaria Common Stock equal to the Conversion Amount divided by 0.75 divided by the price per share of Common Stock of Complete Solaria (“Convertible Note Conversion Shares”).

 

ii.

At the Closing, each share of Legacy Complete Solaria Capital Stock, inclusive of the 2022 Convertible Note Conversion Shares, issued and outstanding immediately prior to the Closing were cancelled and exchanged into an aggregate of 33,805,245 shares of Complete Solaria Common Stock (at a deemed value of $10.00 per share) equal to the Aggregate Merger Consideration. Additionally, each holder of Legacy Complete Solaria Capital Stock received Complete Solaria Warrants equal to a portion of the Aggregate Warrant Consideration, calculated on a pro rata basis based on the percentage interest of issued and outstanding shares of Legacy Complete Solaria Capital Stock held by the holder of such share of Legacy Complete Solaria Capital Stock.

 

iii.

At the Closing, all Legacy Complete Solaria Options and Legacy Complete Solaria Warrants outstanding as of immediately prior to such time were converted into options of Complete Solaria (“Complete Solaria Options”) and Complete Solaria Warrants, respectively. Each such Complete Solaria Option and Complete Solaria Warrant relates to a number of whole shares of Complete Solaria Common Stock (rounded down to the nearest whole share) equal to (i) the number of shares of Legacy Complete Solaria Common Stock subject to the applicable Legacy Complete Solaria Option or Legacy Complete Solaria Warrant multiplied by (ii) the Merger Consideration Per Fully Diluted Share. The exercise price for each Complete Solaria Option and Complete Solaria Warrant equals (i) the exercise price per share of the applicable Complete Solaria Option or Complete Solaria Warrant divided by (ii) the Merger Consideration Per Fully Diluted Share (rounded up to the nearest full cent).

 

iv.

At the Closing, the Sponsor transferred to the convertible note investors a pro rata percentage of (i) 666,651 shares of Complete Solaria Common Stock in exchange for payment by such investor to FACT of $0.0001 per share and (ii) 484,364 FACT Private Warrants held by the Sponsor. In addition, convertible note investors are entitled to receive, on a pro rata basis, up to an additional (i) 333,333 shares of Complete Solaria Common Stock, at a purchase price of $0.0001 per share, if within the first 12 months following the Closing Date, the volume weighted average price of Complete Solaria Common Stock equals or exceeds $12.50 per share for a period of at least 20 days out of 30 consecutive days on which the shares of Complete Solaria Common Stock are traded on a stock exchange, and (ii) 333,333 shares of Complete Solaria Common Stock, at a purchase price of $0.0001 per share, if within the first 12 months following the Closing Date, the volume weighted average price of Complete Solaria Common Stock equals or exceeds $15.00 per share for a period of at least 20 days out of 30 consecutive days on which the shares of Complete Solaria Common Stock are traded on a stock exchange. The transfer of Complete Solaria Common Stock and Private Warrants from the Sponsor to the Legacy Complete Solaria convertible noteholders is an exchange between investors, which does not result in a pro forma adjustment.

 

v.

On or around the Closing, Complete Solaria entered into New Money PIPE Subscription Agreements with certain investors to subscribe for and purchase 120,000 FACT Class A Ordinary Shares for a purchase price of $5.00 and aggregate proceeds of $0.6 million. Additionally, Complete Solaria issued an additional 60,000 shares of Complete Solaria Common Stock in consideration for certain services provided in the structuring of the Forward Purchase Agreements.

 

vi.

On or around the Closing Date, Complete Solaria entered into Subscription Agreements with certain PIPE Investors who purchased 1,570,000 shares of Complete Solaria Common Stock for aggregate proceeds of $15.7 million, including $3.5 million that was funded prior to the Closing Date.

 

vii.

On or around the Closing Date, the Sponsor transferred 4,333,333 FACT Class B Ordinary Shares to certain third parties pursuant to working capital lending arrangements, non-redemption agreements, PIPE Investments and the settlement of FACT’s accrued expenses associated with the Business Combination. Additionally, Complete Solaria issued and transferred 193,976 shares of Complete Solaria Common Stock


  to the Sponsor, 120,000 shares of Complete Solaria Common Stock to PIPE Investors and 150,000 shares of Complete Solaria Common Stock to Sellers in connection with the Forward Purchase Agreements.

 

viii.

On July 17 and July 18, and in connection with obtaining consent for the Business Combination, Legacy Complete Solaria, FACT and CSREF Solis Holdings, LLC (“Carlyle”) entered into an amended and restated consent to the Business Combination Agreement and an amended and restated warrant agreement, which modified the terms of the mandatorily redeemable investment made by Carlyle in Legacy Complete Solaria.

The Carlyle investment of $25.6 million was mandatorily redeemable on the three-year anniversary of the effective date of the CS Solis amended and restated LLC agreement (February 14, 2025) and accrued interest at a rate of 10.5%, which was structured as a a dividend payable based on 25% of the investment amount measured quarterly, compounded annually, and subject to increases in the event Legacy Complete Solaria declared any dividend. In connection with the investment, Legacy Complete Solaria issued a warrant to purchase up to 5,978,960 shares of its common stock at a price of $0.01 per share, of which, 4,132,513 shares were immediately exercisable and, were outstanding as of the date of modification. At Closing, the Legacy Complete Solaria warrants were exchanged for 1,995,879 warrants to purchase shares of Complete Solaria Common Stock. Legacy Complete Solaria accounted for the mandatorily redeemable investment from Carlyle in accordance with ASC 480 — Distinguishing Liabilities from Equity and recorded the investment as a liability, which was accreted to its redemption value under the effective interest method.

Among other changes to the investment agreement, the modification accelerates the redemption date of the investment, which was previously February 14, 2025 and is March 31, 2024 subsequent to the modification. Additionally, as part of the amendment, the parties entered into an amended and restated warrant agreement. As part of the warrant agreement, Complete Solaria will issue Carlyle a warrant to purchase up to 2,745,879 shares of Complete Solaria Common Stock at a price per share of $0.01, which is inclusive of the outstanding warrant to purchase 1,995,879 shares at the time of modification. The warrant, which expires on July 18, 2030, provides Carlyle with the right to purchase shares of Complete Solaria Common Stock based on (a) the greater of (i) 1,995,879 shares and (ii) the number of shares equal to 2.795% of the Complete Solaria’s issued and outstanding shares of common stock, on a fully-diluted basis; plus (b) on and after the date that is ten (10) days after the date of the agreement, an additional 350,000 shares; plus (c) on and after the date that is thirty (30) days after the date of the agreement, if the original investment amount has not been repaid, an additional 150,000 shares; plus (d) on and after the date that is ninety (90) days after the date of the agreement, if the original investment amount has not been repaid, an additional 250,000 shares, in each case, of Complete Solaria Common Stock at a price of $0.01 per share.

Description of the Disposal Transaction

On August 18, 2023, Complete Solaria entered into a Non-Binding Letter of Intent to sell certain of Complete Solaria’s North American solar panel assets, inclusive of certain intellectual property and customer contracts, to Maxeon. Subsequent to the execution of the Non-Binding Letter of Intent, on September 20, 2023, Complete Solaria entered into an asset purchase agreement with Maxeon for the sale of certain assets to Maxeon. . The agreement also includes a supply agreement for Maxeon to supply its premium, high-performance, high- efficiency solar panels to Complete Solaria. On October 6, 2023, Complete Solaria completed the sale of its solar panel business to Maxeon, pursuant to the terms of the Disposal Agreement. Under the terms of the Disposal Agreement, Maxeon agreed to acquire certain assets and employees of Complete Solaria, for an aggregate purchase price of approximately $11.0 million, consisting of 1,100,000 shares of Maxeon ordinary shares.

In conjunction with the Disposal Transaction, on October 5, 2023, Complete Solaria amended certain warrants, dated November 2, 2022, originally issued by the Complete Solaria to six warrant holders (the “Holders”), which warrants are exercisable for (a) an aggregate of 1,486,268 shares of Complete Solaria’s common stock, par value $0.001 per share, or (b) if designated and issued, a future series of preferred stock of Complete Solaria (the “Amendments”). The Amendments were made in connection with the Holders assigning loans they previously made to SolarCA LLC, a Delaware limited liability company (successor in interest to The Solaria Corporation and a wholly owned subsidiary of Complete Solaria) in order to provide the Holders with the


benefits of the protective provisions of the original warrants to fix at a set number the number of shares of Common Stock issuable thereunder, as well as the exercise price per share. Pursuant to the Amendments, the warrants may be exercised for (a) Common Stock, at an exercise price of $0.75 per share, or (b) if designated and issued, a future series of preferred stock, at an exercise of 25% of the lowest price Complete Solaria receives for such share of future series of preferred stock. In connection with the Amendments, Complete Solaria agreed to provide the warrant holders with certain registration rights pursuant to that certain A&R Registration Rights Agreement, dated July 18, 2023, which the was previously filed by Complete Solaria as Exhibit 4.1 to the Complete Solaria’s Current Report on Form 8-K filed on July 24, 2023.

Accounting for the Business Combination

This unaudited pro forma condensed combined financial information should be read together with the historical financial statements and related notes of FACT, Legacy Complete Solaria and Solaria and other financial information filed with the Securities and Exchange Commission.

Legacy Complete Solaria has been determined to be the accounting acquirer of FACT and Solaria based on the following facts and circumstances:

 

   

Legacy Complete Solaria’s existing shareholders are expected to have the greatest voting interest in the combined entity. Excluding warrant and option holders, Legacy Complete Solaria’s existing shareholders have an approximately 57.8% voting interest. On a fully diluted basis, Legacy Complete Solaria’s existing shareholders have approximately 56.4% ownership.

 

   

Legacy Complete Solaria’s existing shareholders have the ability to control decisions regarding election and removal of the majority of the combined entity’s executive board of directors.

 

   

Legacy Complete Solaria’s senior management is the senior management of the combined entity.

 

   

The combined company name is Complete Solaria, Inc., i.e. the combined entity assumed Legacy Complete Solaria’s name.

The weighting of evidence as described above is indicative that Legacy Complete Solaria is the accounting acquirer of FACT. Accordingly, the merger between Legacy Complete Solaria and FACT has been accounted for as a reverse recapitalization, with FACT being treated as the “acquired” company for financial reporting purposes. For accounting purposes, the reverse recapitalization is the equivalent of Legacy Complete Solaria issuing stock for the net assets of FACT, accompanied by a recapitalization. As a result of the Business Combination being an in-substance capital transaction, Legacy Complete Solaria’s qualifying transaction costs are treated as an equivalent to equity issuance costs, reflected as a reduction in additional paid-in capital, rather than as an expense, in the unaudited pro forma condensed combined financial information. The net assets of FACT have been stated at historical cost, with no goodwill or other intangible assets recorded. Operations prior to the reverse recapitalization are those of Legacy Complete Solaria.

Outstanding vested and unvested share-based awards of Legacy Complete Solaria (including options and RSUs) were converted into the right to receive upon vesting or exercise such awards for common shares of Complete Solaria Common Stock after applying the Merger Consideration Per Fully Diluted Share. Because no terms of such share-based awards are modified upon consummation of the Business Combination, no accounting impact for such outstanding awards was recognized.

Public and private warrants of FACT were not modified as a result of the Business Combination and continue to be liabilities in the New Complete Solaria’s financial statements. The shares of New Complete Solaria Common Stock issuable upon the achievement of trading targets are expected to be classified in equity of New Complete Solaria pursuant to guidance in ASC 815-40.

Complete Solaria has accounted for the modification of the long-term debt in CS Solis as debt extinguishment in accordance with ASC 480 and ASC 470. As a result of the extinguishment, Complete Solaria has recorded a loss on extinguishment and adjusted the value of the debt in CS Solis to its fair value.


Additionally, the modification of the warrant resulted in the reclassification of previously equity classified warrants to liability classification, which was accounted for in accordance with ASC 815 and ASC 718. Complete Solaria recorded a reduction in additional paid-in capital for the value of the warrants prior to the modification, recorded a warrant liability for the value of the warrants after the modification and recorded other expense equal to the different between the reduction in additional paid-in capital and the warrant liability.

Accounting for the Disposal Transaction

On October 6, 2023, Complete Solaria completed the sale of certain assets to Maxeon, pursuant to the terms of the Disposal Agreement. During the third fiscal quarter of 2023, Complete Solaria determined that the Disposal Transaction met the criteria for held-for-sale and discontinued operations classification. Complete Solaria concluded that the disposition of the solar panel business qualifies as a disposal of a business. Complete Solaria has recorded an impairment of $147.5 million, predominately related to Complete Solaria’s intangible assets and goodwill, in the third fiscal quarter of 2023 which is equal to the difference between the carrying value of the disposal group and the fair value of the disposal group less costs to sell. Based on Complete Solaria’s assessment of the Disposal Transaction, Complete Solaria has presented Solaria as held-for-sale and discontinued operations in its Quarterly Report on Form 10-Q for the quarterly period ended October 1, 2023. During the fourth fiscal quarter of 2023, upon consummation of the Disposal Transaction, Complete Solaria recognized a loss on disposal of $1.8 million.

In conjunction with the Disposal Transaction, on October 5, 2023, Complete Solaria amended certain warrants, dated November 2, 2022, originally issued by the Complete Solaria to six warrant holders. The warrants that were amended were historically liability classified and were subsequently reclassified to equity as part of the close of the Business Combination. Upon the modification of the warrants, the warrants are liability classified in accordance with the guidance of ASC 815. In accordance with ASC 718, Complete Solaria will account for the modification of the warrants by reducing additional paid-in capital by the value of the warrants immediately before the modification, recording a warrant liability for the value of the warrants immediately after the modification, and recording the difference as an expense in the consolidated statements of operations.

Complete Solaria has included the adjustments as of December 22, 2023 in the Pro Forma Accounting Adjustments column of the unaudited pro forma condensed combined statements of operations for the thirty-nine weeks ended October 1, 2023 and the year ended December 31, 2022 and the unaudited pro forma condensed combined balance sheet as of October 1, 2023.

Basis of Pro Forma Presentation

The adjustments in the unaudited pro forma condensed combined financial information have been identified and presented to provide relevant information of Complete Solaria upon consummation of the Business Combination and other events contemplated by the Business Combination as well as the effects of the Disposal Transaction. Assumptions and estimates underlying the unaudited pro forma adjustments set forth in the unaudited pro forma condensed combined financial information are described in the accompanying notes.

The unaudited pro forma condensed combined financial information has been presented for illustrative purposes only and is not necessarily indicative of the operating results and financial position that would have been achieved had the Business Combination and Disposal Transaction occurred on the dates indicated. The Business Combination proceeds remaining after the payment for the redemption of public shares, and payment of transaction costs related to the Merger are expected to be used for other general corporate purposes. The consideration shares received for the Disposal Transaction are expected to be classified as investment in equity securities. Further, the unaudited pro forma condensed combined financial information does not purport to project the future operating results or financial position of New Complete Solaria following the completion of the Business Combination and Disposal Transaction. The unaudited pro forma adjustments represent management’s estimates based on information available as of the date of this unaudited pro forma condensed combined financial information and are subject to change as additional information becomes available and analyses are performed.


Other than certain ordinary course of business sale and purchase transactions between Complete Solar and Solaria, FACT, Complete Solar, and Solaria have not had any historical relationship prior to the transactions associated with the Business Combination.

The following table presents the pro forma New Complete Solaria common stock issued and outstanding immediately after the Business Combination, which does not give effect to the potential exercise of any warrants:

 

    Number of Shares     Percentage of
Outstanding Shares
 

FACT Public Stockholders(4)

    3,458,757       7.6

Founder Shares (1), (2), (3), (4)

    8,152,325       18.0

Complete Solaria shareholders

    20,034,257       44.3

Complete Solaria convertible noteholders (3)

    6,126,726       13.5

PIPE Investors

    7,518,488       16.6
 

 

 

   

Total

    45,290,553       100.0
 

 

 

   

 

(1)

The above table includes 122,500 FACT Class B Ordinary Shares transferred to FACT directors, employees and consultants.

(2)

The table excludes the transfer of 4,333,333 shares of FACT Class B Ordinary Shares from the Sponsor to certain third parties pursuant to working capital lending arrangements, non-redemption agreements and PIPE Investments and the settlement of FACT’s accrued expenses associated with the Business Combination.

(3)

The above table includes the transfer of 666,651 shares of New Complete Solaria Common Stock from the Sponsor to Complete Solaria convertible noteholders and excludes up to 666,666 shares of New Complete Solaria Common Stock issuable by the New Complete Solaria to convertible noteholders based on the trading price of New Complete Solaria Common Stock. The issuance of New Complete Solaria Common Stock to the Complete Solaria convertible noteholders would further increase the ownership percentages of Complete Solaria convertible noteholders and would dilute the ownership of all stockholders.

(4)

The above table excludes the transfer of shares of a number FACT Class A Ordinary Shares held by Sponsor as of the Closing equal the difference of (i) 3,300,000 minus (ii) the number of shares, if any, of FACT Class A Ordinary Shares transferred by Sponsor to holders of 2022 Convertible Notes minus (iii) the number of shares, if any, of FACT Class A Ordinary Shares transferred by Sponsor to certain counterparties in consideration for loans and other amounts paid to finance the working capital loans due to the Sponsor and extension fees as consideration for such holders agreeing to enter into non-redemption agreements and/or such FACT PIPE Investment investors agreeing to make FACT PIPE Investment, as applicable.

Of the 666,666 shares of Complete Solaria Common Stock issuable by Complete Solaria to convertible noteholders based on the trading price of Complete Solaria Common Stock, 333,333 shares will vest if, from Closing of the Business Combination until the 12 month anniversary thereof, the average price of Complete Solaria Common Stock exceeds $12.50 for any 20 trading days within any 30 trading day period and 333,333 will vest if, from the Closing of the Business Combination until the 12 month anniversary thereof, the average price of Complete Solaria Common Stock exceeds $15.00 for any 20 trading days within any 30 trading day period. The issuance of such shares would dilute the value of all shares of Complete Solaria Common Stock outstanding at that time. Assuming the current capitalization structure, the 666,666 shares that would become vested upon meeting the price threshold would represent approximately 1.5% of total shares outstanding.

The management of New Complete Solaria has concluded that the contingently issuable shares are equity-classified instruments, which do not have an impact on the unaudited pro forma condensed combined statement of operations for the periods ended December 31, 2022 and October 1, 2023.


UNAUDITED PRO FORMA CONDENSED COMBINED BALANCE SHEET

As of October 1, 2023

(in thousands)

 

    Complete
Solaria
(Historical)
    Pro Forma
Accounting
Adjustments
          Pro Forma
Complete
Solaria
 

ASSETS

       

Current Assets:

       

Cash and cash equivalents

  $ 1,661     $ 5,000       A     $ 6,661  

Investment in equity securities

    —         10,989       B       10,989  

Accounts receivable, net

    26,003       —           26,003  

Inventories

    12,503       —           12,503  

Prepaid expenses and other current assets

    9,947       —           9,947  
 

 

 

   

 

 

     

 

 

 

Total current assets

    50,114       15,989         66,103  

Restricted cash

    3,758       —           3,758  

Property and equipment, net

    4,185       —           4,185  

Operating lease right-of-use assets

    1,465       —           1,465  

Other noncurrent assets

    198       —           198  

Long-term assets held for sale – discontinued operations

    12,299       (12,299     C       —    
 

 

 

   

 

 

     

 

 

 

Total assets

  $ 72,019     $ (3,690     $ 75,709  
 

 

 

   

 

 

     

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)

       

Current liabilities:

       

Accounts payable

  $ 14,571     $ —         $ 14,571  

Accrued expenses and other current liabilities

    26,674       450       D       27,124  

Notes payable, net

    27,934       —           27,934  

Deferred Revenue, current

    2,421       —           2,421  

Short-term debt with CS Solis

    29,194       —           29,194  

Forward purchase agreement liabilities

    6,586       403       E       6,989  
 

 

 

   

 

 

     

 

 

 

Total current liabilities

    107,380       853         108,233  

Warranty provision, noncurrent

    3,416       —           3,416  

Warrant liability

    10,240       1,464       F       11,704  

Deferred revenue, noncurrent

    976       —           976  

Operating lease liabilities, net of current portion

    790       —           790  
 

 

 

   

 

 

     

 

 

 

Total liabilities

    122,802       2,317         125,119  
 

 

 

   

 

 

     

 

 

 

Common Stock

    7       —           7  

Additional paid-in capital

    276,438       4,632       G       281,070  

Accumulated other comprehensive income (loss)

    51       —           51  

Retained earnings (accumulated deficit)

    (327,279     (3,259     H       (330,538
 

 

 

   

 

 

     

 

 

 

Total stockholders’ equity (deficit)

    (50,783 )      1,373         (49,410 ) 
 

 

 

   

 

 

     

 

 

 

Total liabilities and stockholders’ equity (deficit)

  $ 72,019     $ 3,690       $ 75,709  
 

 

 

   

 

 

     

 

 

 


UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS

For the thirty-nine weeks ended October 1, 2023

(in thousands, except per share amounts)

 

     Complete
Solaria
(Historical)
    Freedom
Acquisition
Corp
(Historical
Adjustments)
    Complete
Solaria
Combined
    Pro Forma
Accounting
Adjustments
         Pro Forma
Combined
 

Revenues

   $ 66,887     $ —       $ 66,887     $ —          $ 66,887  

Cost of revenues

     51,788       —         51,788       —            51,788  
  

 

 

   

 

 

   

 

 

   

 

 

      

 

 

 

Gross Profit

     15,099       —         15,099       —            15,099  
  

 

 

   

 

 

   

 

 

   

 

 

      

 

 

 

Operating Expenses:

             

Sales commissions

     23,221       —         23,221       —            23,221  

Operating costs

     —         7,002       7,002       —            7,002  

Sales and marketing

     5,216       —         5,216       —            5,216  

General and administrative

     22,965       —         22,965       —            22,965  
  

 

 

   

 

 

   

 

 

   

 

 

      

 

 

 

Total operating expenses

     51,402       7,002       58,404       —            58,404  
  

 

 

   

 

 

   

 

 

   

 

 

      

 

 

 

Loss from operations

     (36,303     (7,002     (43,305     —            (43,305
  

 

 

   

 

 

   

 

 

   

 

 

      

 

 

 

Foreign currency exchange gain (loss)

     —         —         —         —            —    

Interest income on marketable securities held in Trust Account

     —         4,225       4,225       (4,225   AA      —    

Change in fair value of warrant liabilities

     —         (3,440     (3,440     —            (3,440

Change in fair value of convertible note

     —         (273     (273     273     BB      —    

Offering expenses related to warrant issuance

     —         —         —         —            —    

Interest expense

     (8,870     —         (8,870     742     CC      (8,128

Interest income

     26       —         26       —            26  

Other income (expense), net

     (28,302     —         (28,302     (9,455   DD      (37,757
  

 

 

   

 

 

   

 

 

   

 

 

      

 

 

 

Loss before income taxes

     (73,449     (6,490     (79,939     (12,665        (92,604
  

 

 

   

 

 

   

 

 

   

 

 

      

 

 

 

Income tax (benefit) provision, net

     (5     —         (5     —            (5
  

 

 

   

 

 

   

 

 

   

 

 

      

 

 

 

Net income (loss) from continuing operations

   $ (73,444   $ (6,490   $ (79,934   $ (12,665      $ (92,599
  

 

 

   

 

 

   

 

 

   

 

 

      

 

 

 

Weighted average shares outstanding, used in computing net loss per share attributable to common stockholders, basic and diluted

     16,969,979                51,160,118  

Net loss per share attributable to common stockholders, basis and diluted

   $ (4.33            $ (1.81


UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS

For the year ended December 31, 2022

(in thousands, except per share amounts)

 

     Complete
Solaria
(Historical)
    Freedom
Acquisition
Corp
(Historical)
    Complete
Solaria
Combined
    Pro Forma
Accounting
Adjustments
         Pro Forma
Combined
 

Revenues

   $ 66,475     $ —       $ 66,475     $ —          $ 66,475  

Cost of revenues

     46,647       —         46,647       —            46,647  
  

 

 

   

 

 

   

 

 

   

 

 

      

 

 

 

Gross Profit

     19,828       —         19,828       —            19,828  
  

 

 

   

 

 

   

 

 

   

 

 

      

 

 

 

Operating Expenses:

             

Sales commissions

     21,195       —         21,195       —            21,195  

Operating costs

     —         4,407       4,407       —            4,407  

Sales and marketing

     6,156       —         6,156       —            6,156  

General and administrative

     13,634       —         13,634       —            13,634  
  

 

 

   

 

 

   

 

 

   

 

 

      

 

 

 

Total operating expenses

     40,985       4,407       45,392       —            45,392  
  

 

 

   

 

 

   

 

 

   

 

 

      

 

 

 

Loss from operations

     (21,157     (4,407     (25,564     —            (25,564
  

 

 

   

 

 

   

 

 

   

 

 

      

 

 

 

Foreign currency exchange gain (loss)

     —         (18     (18     —            (18

Interest income on marketable securities held in Trust Account

     —         4,822       4,822       (4,822   AA
     —    

Change in fair value of warrant liabilities

     —         5,510       5,510       —            5,510  

Change in fair value of convertible note

     —         (196     (196     196     BB
     —    

Interest expense

     (4,986     —         (4,986     221     CC
     (4,765

Interest income

     5       —         5       —            5  

Forgiveness of debt

     —         272       272       —            272  

Other income (expense), net

     (1,858     —         (1,858     5,211     DD
     3,353  
  

 

 

   

 

 

   

 

 

   

 

 

      

 

 

 

Loss before income taxes

     (27,996     5,983       (22,013     806          (21,207
  

 

 

   

 

 

   

 

 

   

 

 

      

 

 

 

Income tax (benefit) provision, net

     27       —         27       —            27  
  

 

 

   

 

 

   

 

 

   

 

 

      

 

 

 

Net income (loss) from continuing operations

   $ (28,023   $ 5,983     $ (22,040   $ 806        $ (21,234
  

 

 

   

 

 

   

 

 

   

 

 

      

 

 

 

Weighted average shares outstanding, used in computing net loss per share attributable to common stockholders, basic and diluted,

     8,366,296                51,160,118  

Net loss per share attributable to common stockholders, basis and diluted

   $ (3.35            $ (0.42


NOTES TO UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION

Note 1 — Basis of Presentation

The merger between Legacy Complete Solaria and FACT has been accounted for as a reverse recapitalization, with FACT being treated as the “acquired” company for financial reporting purposes. For accounting purposes, the reverse recapitalization was the equivalent of Legacy Complete Solaria issuing stock for the net assets of FACT, accompanied by a recapitalization. The net assets of FACT were stated at historical cost, with no goodwill or other intangible assets recorded. Operations prior to the reverse recapitalization will be those of Legacy Complete Solaria.

The unaudited pro forma condensed combined statement of operations of Complete Solaria for the thirty-nine weeks ended October 1, 2023 and for the year ended December 31, 2022, gives pro forma effect to the Business Combination as if it had been consummated on January 1, 2022.

On October 6, 2023, Complete Solaria completed the sale of certain of Complete Solaria’s North American solar panel assets, inclusive of certain intellectual property and customer contracts, to Maxeon, pursuant to the terms of the Disposal Agreement. The Disposal Transaction was accounted for as discontinued operations for financial reporting purposes.

In July 2023, Complete Solaria and Freedom Acquisition I Corp. entered into separate agreements (each a “Forward Purchase Agreement”, and together, the “Forward Purchase Agreements”) with each of (i) Meteora; (ii) Polar, and (iii) Sandia (each of Meteora, Polar, and Sandia, individually, a “Seller”, and together, the “Sellers”) for OTC Equity Prepaid Forward Transactions.On December 18, 2023, Complete Solaria and each Seller entered into separate amendments to the Forward Purchase Agreements (the “Amendments”). The Amendments lower the reset price of each Forward Purchase Agreement from $5.00 to $3.00 and allow the Company to raise up to $10,000,000 of equity from existing stockholders without triggering certain anti-dilution provisions contained in the Forward Purchase Agreements.

On December 18, 2023, the Complete Solaria entered into separate common stock purchase agreements (the “Purchase Agreements”) with the Rodgers Massey Freedom and Free Markets Charitable Trust and the Rodgers Massey Revocable Living Trust (each a “Purchaser”, and together, the “Purchasers”). Pursuant to the terms of the Purchase Agreements, each Purchaser purchased 1,838,235 shares of common stock of the Company, par value $0.0001, (the “Shares”), at a price per share of $1.36, representing an aggregate purchase price of $5.0 million. The Purchasers paid for the Shares in cash. Thurman J. Rodgers is a trustee of each Purchaser and is the Executive Chairman of the board of directors of the Company.

The unaudited pro forma balance sheet of Complete Solaria as of October 1, 2023, gives pro forma effect to these transactions as if they had been consummated on October 1, 2023. The unaudited pro forma condensed combined statements of operations of Complete Solaria for the year ended December 31, 2022, and for the thirty-nine weeks ended October 1, 2023, presents pro forma effect to the transactions as if it had been completed on January 1, 2022. As the Disposal Transaction was consummated in October 2023. Complete Solaria’s unaudited condensed consolidated balance sheet as of October 1, 2023 and unaudited condensed consolidated statement of operations and comprehensive income (loss) for the thirty-nine week period ended October 1, 2023 have been recast to give effect to the disposition. Further, as the Disposal Transaction is related to the disposition of certain assets acquired in the Required Transaction, which occurred on November 4, 2022, there is is no pro forma impact associated with periods prior to the year ended December 31, 2022.

The unaudited pro forma combined balance sheet as of October 1, 2023, and unaudited pro forma condensed combined statement of operations for the thirty-nine weeks ended October 1, 2023, have been prepared using, and should be read in conjunction with, the following:

 

   

unaudited condensed consolidated financial statements of Complete Solaria as of and for thirty-nine weeks ended October 1, 2023, and the related notes, included in the Proxy Statement;


The unaudited pro forma condensed combined statement of operations for the year ended December 31, 2022 has been prepared using, and should be read in conjunction with, the following:

 

   

audited statements of operations of FACT for the fiscal year ended December 31, 2022 included in the Proxy Statement; and

 

   

audited statements of operations of Legacy Complete Solaria for the fiscal year ended December 31, 2022 included in the Proxy Statement.

Additionally, in giving pro forma effect to the Disposal Transaction as if it had been consummated on January 1, 2022, the unaudited pro forma condensed combined statement of operations was prepared using the unaudited statement of operations of Solaria for the period from January 1, 2022 through the close of the Disposal Transaction.

Management has made significant estimates and assumptions in its determination of the Pro Forma Accounting Adjustments. As the unaudited pro forma condensed combined financial information has been prepared based on these preliminary estimates, the final amounts recorded may differ materially from the information presented.

The following unaudited pro forma condensed combined financial information has been prepared in accordance with Article 11 of Regulation S-X. The pro forma adjustments reflecting the consummation of the Business Combination and the Disposal Transaction are based on certain currently available information and certain assumptions and methodologies that Legacy Complete Solaria believes are reasonable under the circumstances. The unaudited Pro Forma Accounting Adjustments, which are described in the accompanying notes, may be revised as additional information becomes available and is evaluated. Therefore, it is likely that the actual adjustments will differ from the Pro Forma Accounting Adjustments and it is possible such differences may be material. Complete Solaria believes that these assumptions and methodologies provide a reasonable basis for presenting all of the significant effects of the Business Combination and Disposal Transaction are based on information available to management at the time and that the Pro Forma Accounting Adjustments give appropriate effect to those assumptions and are properly applied in the unaudited pro forma combined financial information.

The unaudited pro forma condensed combined financial information does not give effect to any anticipated synergies, operating efficiencies, tax savings, or cost savings that may be associated with the Business Combination or Disposal Transaction.

The unaudited pro forma condensed combined financial information is not necessarily indicative of what the actual results of operations and financial position would have been had the Business Combination and Disposal Transaction taken place on the dates indicated, nor are they indicative of the future consolidated results of operations or financial position of Complete Solaria. They should be read in conjunction with the historical financial statements and notes thereto of FACT and Legacy Complete Solaria.

Note 2 — Accounting Policies

Upon completion of the Business Combination, management performed a comprehensive review of FACT’s and Legacy Complete Solaria’s accounting policies. Based on its initial analysis, management has not identified any material differences in accounting policies that would have a material impact on the unaudited pro forma condensed combined financial information.

Note 3 — Adjustments to Unaudited Pro Forma Condensed Combined Financial Information

Article 11 of Regulation S-X allows for the presentation of reasonably estimable synergies and other transaction effects that have occurred or are reasonably expected to occur (“Management’s Adjustments”). Complete Solaria has elected not to present Management’s Adjustments and will only be presenting Pro Forma Accounting Adjustments in the following unaudited pro forma condensed combined financial information.


The unaudited pro forma condensed combined financial information has been prepared to illustrate the effect of the Business Combination and Disposal Transaction and has been prepared for informational purposes only.

The pro forma condensed combined provision for income taxes does not necessarily reflect the amounts that would have resulted had Complete Solaria filed consolidated income tax returns during the periods presented.

The unaudited pro forma basic and diluted net loss per share amounts presented in the unaudited pro forma condensed combined statement of operations are based upon the number of shares of Complete Solaria outstanding, assuming the Business Combination occurred on January 1, 2022.

Adjustments to Unaudited Pro Forma Combined Balance Sheet

The pro forma Transaction Accounting Adjustments, based on preliminary estimates that could change materially as additional information is obtained, are as follows:

 

  (A)

Reflects the proceeds received associated with the Common Stock Purchase Agreements with a related-party investor for the sale of 3,676,470 shares of Complete Solaria Common Stock for a purchase price of $1.36 per share.

 

  (B)

Reflects the fair value of 1,100,000 Maxeon Ordinary Shares received as consideration for the Disposal Transaction.

 

  (C)

Reflects the disposition of solar panel assets, inclusive of certain intellectual property and customer contracts, transferred in conjunction with the Disposal Transaction.

 

  (D)

Reflects the accrual of $0.5 million of transaction costs that were incurred from October 2, 2023 through the closing date of the Disposal Transaction. As these costs were not accrued as of October 1, 2023, their accrual is reflected as a reduction in retained earnings.

 

  (E)

Reflects the change in fair value of the forward purchase agreement liabilities resulting from the Amendments of the Forward Purchase Agreements.

 

  (F)

Represents the adjustment for the reclassification of warrants upon the modification from equity classified to liability classified in accordance with the guidance of ASC 815.

 

  (G)

Represents Pro Forma Accounting Adjustments to the additional paid-in-capital balance to reflect the following (in thousands):

 

Reclassification of warrants upon the modification from equity classified to liability classified in accordance with the guidance of ASC 815

   $ (368

Issuance of 3,676,470 shares of Complete Solaria Common Stock to a related-party investor

     5,000  
  

 

 

 

Total

   $ 4,632  
  

 

 

 

 

  (H)

Represents Pro Forma Accounting Adjustments to the retained earnings (accumulated deficit) balance to reflect the following (in thousands):

 

Reflects transaction costs that were incurred from October 2, 2023 through the closing date of the Disposal Transaction

   $ (450

Reflects the loss on disposal associated with the Disposal Transaction

     (1,310

Amendments of Forward Purchase Agreements

     (403

Reclassification of warrants upon the modification from equity classified to liability classified in accordance with the guidance of ASC 815

     (1,096
  

 

 

 

Total

   $ (3,259
  

 

 

 


Adjustments to Unaudited Pro Forma Condensed Combined Statement of Operations

The pro forma adjustments included in the unaudited pro forma condensed combined statement of operations for the year ended December 31, 2022, and the thirty-nine weeks ended October 1, 2023 are as follows:

 

  (AA)

Reflects the elimination of historical investment income earned on FACT’s Trust Account. The pro forma Transaction Accounting Adjustments are $(4.3) million and $(4.8) million for the thirty-nine weeks ended October 1, 2023, and the year ended December 31, 2022, respectively.

 

  (BB)

Reflects change in fair value on FACT promissory note. The pro forma adjustments are $0.3 million and $0.2 million for the thirty-nine weeks ended October 1, 2023, and the year ended December 31, 2022, respectively.

 

  (CC)

Reflects interest expense of $0.7 million and $0.2 million associated with the 2022 Convertible Notes for the thirty-nine weeks ended October 1, 2023, and the year ended December 31, 2022, respectively, which was assumed in the acquisition of Solaria and converted into Complete Solaria Common Stock upon the Close of the Business Combination.

 

  (DD)

Reflects the elimination of change in fair value of Legacy Complete Solaria’s Preferred Stock warrant liability. The pro forma Transaction Accounting Adjustments are $(9.5) million and $5.2 million for the thirty-nine weeks ended October 1, 2023, and the year ended December 31, 2022, respectively.

Note 4 — Net Loss Per Share

Represents the net loss per share calculated using the historical weighted average shares outstanding and the issuance of additional shares in connection with the Business Combination, and other related events, assuming such additional shares were outstanding since January 1, 2022. As the Business Combination and other related events are being reflected as if they had occurred as of January 1, 2022, the calculation of weighted average shares outstanding for basic and diluted net loss per share assumes the shares issued in connection with the Business Combination, other related events have been outstanding for the entire periods presented.

 

(in thousands, except for share

and per share data)

   For the year ended
December 31, 2022
     For the thirty-nine
weeks ended
October 1, 2023
 

Pro forma loss attributable to common stockholders –  Complete Solaria

   $ (21,234    $ (92,599

Pro forma weighted-average shares outstanding, basic and diluted

     51,160,118        51,160,118  

Net loss per share – basic and diluted

   $ (0.42    $ (1.81

The following summarizes the number of shares of Complete Solaria Common Stock outstanding used for pro forma presentation purposes for the year ended December 31, 2022, and for the thirty-nine weeks ended October 1, 2023:

 

Pro forma weighted-average shares outstanding—basic and diluted

      

Public Shareholders

     3,458,757  

Founder Shares

     8,152,325  

PIPE Investors

     7,518,488  

Legacy Complete Solaria Shareholders

     29,837,453  

Legacy Complete Solaria – equity classified penny warrants

     2,193,095  
  

 

 

 

Pro forma weighted-average shares outstanding—basic and diluted

     51,160,118  
  

 

 

 


(1)

Excludes approximately 7,624,716 shares of Complete Solaria Common Stock which remain reserved for options and restricted stock units outstanding. At the Closing, Legacy Complete Solaria options and restricted stock units will be converted into Complete Solaria options and restricted stock units, upon substantially the same terms and conditions as in effect with respect to the corresponding Complete Solaria option and restricted stock units.

 

(2)

Excludes approximately 1,156,884 shares of Complete Solaria Common Stock which remain reserve for non-penny warrants outstanding. At the Closing, Legacy Complete Solaria warrants converted into Complete Solaria Warrants, upon substantially the same terms and conditions as in effect with respect to the corresponding Legacy Complete Solaria warrants.

 

(3)

Includes 7,518,488 shares related to PIPE investors, which, prior to the Closing, will convert into Legacy Complete Solaria Common Stock, and will convert into Complete Solaria Common Stock upon the Closing.

 

(4)

The table excludes the transfer of 4,333,333 shares of FACT Class B Ordinary Shares from the Sponsor to certain third parties pursuant to working capital lending arrangements, non-redemption agreements, PIPE Investments, and the settlement of accrued expenses related to the Business Combination.

 

(5)

Excludes the transfer of shares of a number FACT Class A Ordinary Shares held by Sponsor as of the Closing equal the difference of (i) 3,300,000 minus (ii) the number of shares, if any, of FACT Class A Ordinary Shares transferred by Sponsor to holders of 2022 Convertible Notes minus (iii) the number of shares, if any, of FACT Class A Ordinary Shares transferred by Sponsor to certain counterparties in consideration for loans and other amounts paid to finance the working capital loans due to the Sponsor and extension fees as consideration for such holders agreeing to enter into non-redemption agreements and/or such FACT PIPE Investment investors agreeing to make FACT PIPE Investment, as applicable.

 

(6)

Does not reflect the transfer of 666,651 shares of Complete Solaria Common Stock from the Sponsor to Legacy Complete Solaria convertible noteholders upon Closing.

The following potential outstanding securities were excluded from the computation of pro forma net loss per share, basic and diluted, because their effect would have been anti-dilutive or issuance of such shares is contingent upon the satisfaction of certain conditions which are not satisfied as of the period end for pro forma presentation purposes.

 

Share Type

   Shares  

Public Warrants

     8,625,000  

Private Warrants

     6,266,667  

Private Warrants in Connection with Promissory Notes held by the Sponsor and its affiliates

     716,667  

Aggregate Warrant Consideration

     6,266,572  

Shares issuable upon achievement of trading price targets

     666,666  

Options (unvested and vested)

     7,624,716  

Warrants (non-penny warrants)

     1,156,884  
EX-99.4 5 d474289dex994.htm EX-99.4 EX-99.4

Exhibit 99.4

INDEPENDENT AUDITOR’S REPORT

To the shareholders and the Board of Directors of The Solaria Corporation

Opinion

We have audited the consolidated financial statements of The Solaria Corporation and subsidiaries (the “Company”), which comprise the Consolidated Balance Sheets as of December 31, 2021 and 2020, and the related Consolidated Statements of Operations and Comprehensive Loss, Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders’ Deficit, and Consolidated Statements of Cash Flows for the years then ended, and the related notes to the consolidated financial statements (collectively referred to as the “financial statements”).

In our opinion, the accompanying financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020, and the results of its operations and its cash flows for the years then ended in accordance with accounting principles generally accepted in the United States of America.

Basis for Opinion

We conducted our audits in accordance with auditing standards generally accepted in the United States of America (GAAS). Our responsibilities under those standards are further described in the Auditor’s Responsibilities for the Audit of the Financial Statements section of our report. We are required to be independent of the Company and to meet our other ethical responsibilities, in accordance with the relevant ethical requirements relating to our audits. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.

Substantial Doubt About the Company’s Ability to Continue as a Going Concern

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the financial statements, the Company has experienced net operating losses from operations and negative cash flows from operations and has stated that substantial doubt exists about the Company’s ability to continue as a going concern. Management’s evaluation of the events and conditions and management’s plans regarding these matters are also described in Note 1. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Our opinion is not modified with respect to this matter.

Responsibilities of Management for the Financial Statements

Management is responsible for the preparation and fair presentation of the financial statements in accordance with accounting principles generally accepted in the United States of America, and for the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, management is required to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern for one year after the date that the financial statements are issued.

Auditor’s Responsibilities for the Audit of the Financial Statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion.

 

1


Reasonable assurance is a high level of assurance but is not absolute assurance and therefore is not a guarantee that an audit conducted in accordance with GAAS will always detect a material misstatement when it exists. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control. Misstatements are considered material if there is a substantial likelihood that, individually or in the aggregate, they would influence the judgment made by a reasonable user based on the financial statements.

In performing an audit in accordance with GAAS, we:

 

 

Exercise professional judgment and maintain professional skepticism throughout the audit.

 

 

Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, and design and perform audit procedures responsive to those risks. Such procedures include examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.

 

 

Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control. Accordingly, no such opinion is expressed.

 

 

Evaluate the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluate the overall presentation of the financial statements.

 

 

Conclude whether, in our judgment, there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern for a reasonable period of time.

We are required to communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit, significant audit findings, and certain internal control-related matters that we identified during the audit.

/s/ Deloitte & Touche LLP

San Francisco, California

February 9, 2023

 

2


THE SOLARIA CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

AS OF DECEMBER 31, 2021 AND 2020

(In thousands, except par value and share amounts)

 

     December 31,     December 31,  
     2021     2020  

ASSETS

    

CURRENT ASSETS:

    

Cash and cash equivalents

   $ 9,113     $ 9,802  

Accounts receivable, net

     6,288       13,318  

Inventory, net

     16,928       10,448  

Prepaid expenses and other current assets

     2,053       9,160  
  

 

 

   

 

 

 

Total current assets

     34,382       42,728  

Restricted cash

     4,802       3,747  

Operating lease right-of-use assets, net and other noncurrent assets

     1,755       2,534  

Property and equipment, net

     999       4,928  
  

 

 

   

 

 

 

TOTAL ASSETS

   $ 41,938     $ 53,937  
  

 

 

   

 

 

 

LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ DEFICIT

    

CURRENT LIABILITIES:

    

Accounts payable

   $ 5,489     $ 4,459  

Accrued expenses and other current liabilities

     11,713       9,975  

Deferred revenue

     75       2,070  

Notes payable, net

     10,912       5,938  

Operating lease liability

     283       390  
  

 

 

   

 

 

 

Total current liabilities

     28,472       22,832  

NONCURRENT LIABILITIES:

    

Redeemable convertible preferred stock warrants liability

     4,955       1,725  

Operating lease liability, net of current portion

     1,674       2,139  

Other liabilities, noncurrent

     2,341       2,280  

Notes payable, net of current portion

     41,197       11,171  
  

 

 

   

 

 

 

Total liabilities

     78,639       40,147  
  

 

 

   

 

 

 

COMMITMENTS AND CONTINGENCIES (NOTE 14)

    

MEZZANINE REDEEMABLE CONVERTIBLE PREFERRED STOCK

    

Redeemable convertible preferred stock: par value of $0.001 per share; 13,500,285 shares authorized as of December 31, 2021 and 2020; issued and outstanding of 11,147,927 shares and 10,920,447 shares as of December 31, 2021 and 2020, respectively; aggregate liquidation value of $71.7 million and $71.3 million as of December 31, 2021 and 2020, respectively

     72,061       71,152  
  

 

 

   

 

 

 

STOCKHOLDERS’ DEFICIT

    

Common stock; par value $0.001 per share; 27,000,000 shares authorized as of December 31, 2021 and 2020; issued and outstanding of 2,001,357 shares and 1,841,452 shares as of December 31, 2021 and 2020, respectively

     521       521  

Class B common stock; par value $0.001 per share; 815 shares authorized as of December 31, 2021 and 2020; 815 shares issued and outstanding as of December 31, 2021 and 2020

     1       1  

Additional paid-in capital

     178,309       175,285  

Accumulated other comprehensive loss

     (55     (68

Accumulated deficit

     (287,538     (233,101
  

 

 

   

 

 

 

Total stockholders’ deficit

     (108,762     (57,362
  

 

 

   

 

 

 

TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ DEFICIT

   $ 41,938     $ 53,937  
  

 

 

   

 

 

 

See accompanying notes to consolidated financial statements

 

3


THE SOLARIA CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020

(In thousands)

 

     Years Ended December 31,  
     2021     2020  

Product revenue, net

   $ 59,763     $ 48,328  

Cost of revenue

     61,144       47,950  
  

 

 

   

 

 

 

Gross profit (loss)

     (1,381     378  

Operating expenses

    

Research and engineering

     4,345       2,964  

Sales and marketing

     7,244       7,349  

General and administrative

     9,789       9,905  

Litigation-related costs

     5,485       2,311  

Impairment and related charges (Note 3)

     17,052       395  
  

 

 

   

 

 

 

Total operating expenses

     43,915       22,924  

Loss from operations

     (45,296     (22,546

Interest expense

     (5,221     (2,763

Interest income

     6       130  

Loss on extinguishment of debt (Note 7)

     (5,384     —    

Other income (expense), net

     1,458       1,404  
  

 

 

   

 

 

 

Total other expenses, net

     (9,141     (1,229
  

 

 

   

 

 

 

Loss before provision for income taxes

     (54,437     (23,775

Provision for income taxes

     —         80  
  

 

 

   

 

 

 

Net loss

     (54,437     (23,855

OTHER COMPREHENSIVE INCOME (LOSS):

    

Currency translation adjustment, net of tax effect of $0, for the years ended December 31, 2021 and 2020

     13       (68
  

 

 

   

 

 

 

Net loss and comprehensive loss

     (54,424     (23,923

Redeemable convertible preferred stock accretion

     21       36  
  

 

 

   

 

 

 

Net loss and comprehensive loss to common stockholders

   $ (54,403   $ (23,887
  

 

 

   

 

 

 

See accompanying notes to consolidated financial statements

 

4


THE SOLARIA CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND

STOCKHOLDERS’ DEFICIT

FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020

(In thousands, except number of shares)

 

                                                    Accumulated
Other
Comprehensive
Loss
             
                                                         

Total

Stockholders’

 
    Redeemable
Convertible
                                 

Additional

Paid-in

    Accumulated  
    Preferred Stock           Common Stock     Class B Common Stock     Capital     Deficit     Deficit  
    Shares     Amount           Shares     Amount     Shares     Amount     Amount     Amount     Amount     Amount  

Balance at December 29, 2019

    10,151,638     $ 64,193           1,816,452     $ 521       815     $ 1     $ 172,469     $ —       $ (209,246   $ (36,255

Exercise of options

    —         —             25,000       —         —         —         10       —         —         10  

Issuance of Series E-1 redeemable convertible preferred stock

    768,809       6,748           —         —         —         —         —         —         —         —    

Stock-based compensation

    —         175           —         —         —         —         2,842       —         —         2,842  

Currency translation adjustment

    —         —             —         —         —         —         —         (68     —         (68

Redeemable convertible preferred stock accretion

    —         36           —         —         —         —         (36     —         —         (36

Net loss

    —         —             —         —         —         —         —         —         (23,855     (23,855
 

 

 

   

 

 

       

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Balance at December 31, 2020

    10,920,447     $ 71,152           1,841,452     $ 521       815     $ 1     $ 175,285     $ (68   $ (233,101   $ (57,362
 

 

 

   

 

 

       

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Exercise of warrants

    246,564       762           25,000       —         —         —         2       —         —         2  

Exercise of options

    —         —             159,583       —         —         —         370       —         —         370  

Repurchase of common stock

    —         —             (24,678     —         —         —         —         —         —         —    

Rescission of Series E-1 redeemable convertible preferred stock

    (19,084     —             —         —         —         —         —         —         —         —    

Stock-based compensation

    —         126           —         —         —         —         2,673       —         —         2,673  

Currency translation adjustment

    —         —             —         —         —         —         —         13       —         13  

Redeemable convertible preferred stock accretion

    —         21           —         —         —         —         (21     —         —         (21

Net loss

    —         —             —         —         —         —         —         —         (54,437     (54,437
 

 

 

   

 

 

       

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Balance at December 31, 2021

    11,147,927     $ 72,061           2,001,357     $ 521       815     $ 1     $ 178,309     $ (55   $ (287,538   $ (108,762
 

 

 

   

 

 

       

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

See accompanying notes to consolidated financial statements

 

5


THE SOLARIA CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

 

     Years Ended  
     December 31,     December 31,  
     2021     2020  

Cash Flows from Operating Activities

    

Net loss

   $ (54,437   $ (23,855

Adjustments to reconcile net loss to net cash used in operating activities:

    

Debt amortization and non-cash interest expense

     3,555       2,036  

Loss on extinguishment of debt

     5,384       —    

Stock-based compensation

     2,799       3,017  

Change in fair value of redeemable convertible preferred stock warrant liability

     (358     (1,085

Depreciation expense

     1,290       451  

Allowance for doubtful accounts expense

     —         183  

Impairment and related charges

     17,052       395  

Impairment of investment in privately held company

     250       —    

Noncash operating lease expense

     283       336  

Forgiveness of Paycheck Protection Plan (PPP) Loan

     (1,433     —    

Other

     13       135  

Changes in operating assets and liabilities:

    

Accounts receivable, net

     7,030       (501

Inventory, net

     (15,168     2,393  

Prepaid expenses and other current assets

     2,970       (4,413

Accounts payable

     1,030       (2,189

Accrued expenses and other current liabilities

     (1     3,216  

Deferred revenue

     (1,995     (1,582

Operating lease liability

     (309     (52

Other liabilities, noncurrent

     60       1,629  
  

 

 

   

 

 

 

Net cash used in operating activities

     (31,985     (19,886

Cash Flows from Investing Activities

    

Purchases of property and equipment

     (1,827     (2,935

Proceeds from sale of property and equipment

     248       —    
  

 

 

   

 

 

 

Net cash used in investing activities

     (1,579     (2,935

Cash Flows from Financing Activities

    

Proceeds from issuance of notes payable, net

     33,415       21,933  

Repayment of notes payable, net

     (382     (15,835

Proceeds from issuance of preferred stock, net

     —         6,748  

Proceeds from exercise of redeemable convertible preferred stock warrants

     512       —    

Proceeds from exercise of stock options

     372       10  
  

 

 

   

 

 

 

Net cash provided by financing activities

     33,917       12,856  
  

 

 

   

 

 

 

Effect of Exchange Rate Changes

     13       (67

Net Change in Cash, Cash Equivalents and Restricted Cash

     366       (10,032

Cash, Cash Equivalents and Restricted Cash, beginning of year

     13,549       23,581  
  

 

 

   

 

 

 

Cash, Cash Equivalents and Restricted Cash, end of year

   $ 13,915     $ 13,549  
  

 

 

   

 

 

 

 

6


THE SOLARIA CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

 

     Years Ended  
     December 31,     December 31,  
     2021     2020  

Supplemental Cash Flow Information

    

Taxes paid

   $ 73     $ 98  
  

 

 

   

 

 

 

Interest paid

   $ 860     $ 353  
  

 

 

   

 

 

 

Non-Cash Investing and Financing Activities

    

Preferred stock warrants issued in connection with the 2018 Bridge notes modification

   $ (731   $ —    
  

 

 

   

 

 

 

Forgiveness of PPP Loan

   $ (1,433   $ —    
  

 

 

   

 

 

 

See accompanying notes to consolidated financial statements

 

7


THE SOLARIA CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2021, AND 2020

(In thousands, except share and per share amounts)

 

1.

ORGANIZATION

Description of Business

The Solaria Corporation was incorporated as a Delaware corporation on May 5, 2006. The Solaria Corporation (together with its subsidiaries, the “Company” or “Solaria”) designs, develops, manufactures, and generates revenue from the sale of silicon photovoltaic solar panels and licensing of its technology to third parties. The Company operates from its headquarters in Fremont, California.

Liquidity and Going Concern — Since inception, the Company has incurred recurring losses and negative cash flows from operations. The Company incurred net losses of $54.4 million and $23.9 million during the year ended December 31, 2021 and 2020, respectively, and had an accumulated deficit of $287.5 million as of December 31, 2021. The Company had cash and cash equivalents of $9.1 million as of December 31, 2021. Historically, the Company’s activities have been financed through private placements of equity securities and debt. The Company expects to incur significant operating expenses as it continues to grow its business. The Company believes that its operating losses and negative operating cash flows will continue into the foreseeable future. The Company’s history of recurring losses, negative operating cash flows and the need to raise additional funding to finance its operations raise substantial doubt about the Company’s ability to continue as a going concern.

As more fully described in Note 17, the Company was acquired by Complete Solar Holding Corporation (“Complete Solar”) in November 2022 and formed Complete Solaria, Inc. (“Complete Solaria”). As a result, the Company became a wholly-owned indirect subsidiary of “Complete Solaria” at that time. Subsequent to the acquisition, the combined company does business as Complete Solaria. The Company’s ability to continue as a going concern is dependent on its and Complete Solaria’s ability to improve profitability and cash flows as well as Complete Solaria’s ability to raise additional funds through debt and/or equity raises. As discussed in Note 17, Complete Solaria’s plan is to seek additional funding through completion of a business combination with Freedom Acquisition Corp. (“Freedom”), a special purpose acquisition corporation (“SPAC”). At this time, Complete Solaria is focused on completing the business combination, which is subject to approval of the shareholders of both companies, regulatory approval from the Securities and Exchange Commission (“SEC”) and other customary closing conditions and is limited in its efforts to raise additional capital from secondary sources.

If Complete Solaria fails to complete this business combination, it plans to continue to fund its operations and capital funding needs through a combination of private equity offerings, debt financings and other sources. If Complete Solaria is not able to secure adequate additional funding when needed, the Company will need to reevaluate its operating plan and may be forced to make reductions in spending, extend payment terms with suppliers, liquidate assets where possible, or suspend or curtail planned programs or cease operations entirely. These actions could materially impact the Company’s business, results of operations and future prospects.

While Complete Solaria and Solaria have historically been able to raise multiple rounds of financing, there can be no assurance that in the event additional financing is required, such financing will be available on terms that are favorable, or at all. Failure to generate sufficient cash flows from operations, raise additional capital or reduce certain discretionary spending would have a material adverse effect on the Company’s ability to achieve their intended business objectives.

Therefore, there is substantial doubt about Solaria’s ability to continue as a going concern within one year after the date that the financial statements are issued. The accompanying financial statements have been prepared assuming Solaria will continue to operate as a going concern, which contemplates the realization

 

8


of assets and settlement of liabilities in the normal course of business. They do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from uncertainty related to its ability to continue as a going concern.

 

2.

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation — The Company’s consolidated financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Solaria Australia Pty. Ltd and TSC PowerHome BVd PLV Inc. All intercompany balances and transactions have been eliminated in consolidation.

The Company had 52 or 53 week fiscal year that ended on the Sunday nearest to December 31 of each year. Beginning 2020 the Company changed the fiscal year end to calendar year end.

Significant Risks and Uncertainties — The Company is subject to a number of risks that are similar to those which other companies of similar size in its industry are facing, including, but not limited to, the need for successful development of products, the need for additional capital (or financing) to fund operations, competition from substitute products and services from larger companies, ability to develop sales channels and to onboard channel partners, as defined, protection of proprietary technology, patent litigation, dependence on key customers, dependence on key individuals, and risks associated with changes in information technology.

In March 2020, the World Health Organization declared the outbreak of a novel corona virus as a pandemic. The pandemic has reached every region of the world and has resulted in widespread impacts on the global economy. In response, the Company has modified certain business and workforce practices (including discontinuing non-essential business travel, implementing a temporary work-from-home policy for employees who can execute their work remotely and encouraging employees to adhere to local and regional social distancing guidelines, more stringent hygiene and cleaning protocols across the Company’s facilities and operations and self-quarantining recommendations) to conform to restrictions and best practices encouraged by governmental and regulatory authorities.

The quarantine of personnel or the inability to access the Company’s facilities or customer sites could adversely affect the Company’s operations. As of the date of this report, the Company’s efforts to respond to the challenges presented by the conditions described above have allowed the Company to minimize the impacts of these challenges to its business.

Use of Estimates—The preparation of financial statements in accordance with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements, and the reported amounts of income and expense during the reporting period. Such estimates include warranty cost, allowances for doubtful accounts, determination of the net realizable value of inventory, determination of the useful lives of property and equipment, assessment of the recoverability and fair values of property and equipment, valuation of deferred tax assets and liabilities, estimation of other accruals and reserves, determination of the fair value of debt, redeemable convertible preferred stock, common stock, simple agreements for future equity, stock option and restricted stock grants, and redeemable convertible preferred stock and common stock warrants. Management evaluates its estimates and assumptions on an ongoing basis using historical trends, market pricing, current events and other relevant assumptions and data points. Actual results could differ from those estimates and such differences may be material to the consolidated financial statements.

Foreign Currency—The Company’s reporting currency is the US dollar. The functional currency for each of the Company’s foreign subsidiaries is the local currency, as it is the monetary unit of account of the principal economic environments in which the Company’s foreign subsidiaries operate. Assets and

 

9


liabilities of the foreign subsidiaries are translated at the current exchange rate as of the end of the period, and revenue and expenses are translated at the average exchange rates in effect during the period. The gain or loss resulting from the process of translating foreign currency financial statements into US dollar financial statements is accounted for as a foreign currency cumulative translation adjustment and is reported as a component of accumulated other comprehensive loss. Foreign currency transaction gains and losses resulting from transactions denominated in a currency other than the functional currency are recognized in Other Income (expense), net in the Consolidated Statements of Operations and Comprehensive Loss.

Comprehensive Loss—Comprehensive loss consists of two components, net loss and other comprehensive income (loss), net. Other comprehensive income (loss), net is defined as revenue, expenses, gains, and losses that under US GAAP are recorded as an element of stockholders’ deficit but are excluded from net loss. The Company’s other comprehensive loss consists of foreign currency translation adjustments that result from the consolidation of its foreign entities and is reported net of tax effects.

Cash and Cash Equivalents— The Company considers all highly liquid investments with an original maturity of three months or less at the time of purchase to be cash equivalents. Cash equivalents are recorded at cost, which approximates fair value. As of December 31, 2021 and 2020, cash and cash equivalents consist primarily of checking and savings deposits.

Restricted Cash— The Company classifies all cash for which usage is limited by contractual provisions as restricted cash. Restricted cash consists of $4.8 million and $3.7 million deposited in money market account, which is used as cash collateral backing letters of credit related to customs duty authorities’ requirements as of December 31, 2021 and 2020, respectively. The Company has presented these balances under noncurrent assets in the consolidated balance sheets.

Total cash, cash equivalents and restricted cash is presented in the table below (in thousands):

 

     As of December 31,  
     2021      2020  

Cash and cash equivalents

   $ 9,113      $ 9,802  

Restricted cash

     4,802        3,747  
  

 

 

    

 

 

 

Total cash, cash equivalents and restricted cash

   $ 13,915      $ 13,549  
  

 

 

    

 

 

 

Accounts Receivable, net— Accounts receivable are recorded at invoiced amounts less allowances for bad debts that management believes will be adequate to absorb estimated losses on existing balances, or net realizable value. On a periodic basis, management evaluates accounts receivable and determines whether to record an allowance, or whether any account balances should be written off based on past history of write-offs, collections, and current credit conditions. A receivable is considered past due if the Company has not received payments based on agreed-upon payment terms. The Company generally does not require any security or collateral to support its accounts receivable. For the year ended December 31, 2021, accounts receivable write-offs and bad debt expense were zero. For the year ended December 31, 2020 accounts receivable write-offs were $0.1 million and bad debt expense was $0.2 million, respectively. As of December 31, 2021 and 2020, the allowance for doubtful accounts was $0.6 million. The Company did not record any impairment losses on accounts receivable in fiscal years 2020 and 2021.

Simple Agreement for Future Equity notes— The Company’s Simple Agreement for Future Equity notes (“SAFE”) are financial instruments whereby an investor provides an investment into the Company, and the note is subsequently converted into a preferred equity security at a discount to the price paid by other investors when and if preferred equity is issued through a qualifying capital raise. The SAFE notes are classified as liabilities as of December 31, 2021 and 2020 and key terms of such notes are described in Note 7.

The Company elected the fair value option for SAFE financial instruments, which requires these to be remeasured to fair value each reporting period with changes in fair value recorded in Other Income (expense), net in the Consolidated Statements of Operations and Other Comprehensive Loss, except for

 

10


changes in fair value that result from a change in the instrument specific credit risk which are presented separately within other comprehensive income (loss). The fair value estimate includes significant inputs not observable in the market, which represent a Level 3 measurement within the fair value hierarchy. The decision to elect the fair value option is made on an instrument-by-instrument basis on the date the instrument is initially recognized, is applied to the entire instrument, and is irrevocable once elected. As a result of applying the fair value option, direct costs and fees related to issuance of SAFE were expensed as incurred.

As more fully described in Note 17, post consummation of the merger in November 2022, all SAFE notes were assumed by Complete Solar.

Fair Value Measurements— As more fully described in Note 7, the Company follows ASC 820, Fair Value Measurements, which establishes a common definition of fair value to be applied when U.S. GAAP requires the use of fair value, establishes a framework for measuring fair value, and requires certain disclosure about such fair value measurements. Valuation techniques used to measure fair value maximize the use of observable inputs and minimize the use of unobservable inputs. Fair value accounting is applied to all assets and liabilities and nonfinancial assets and liabilities that are recognized or disclosed at fair value in the consolidated financial statements on a recurring basis (at least annually). Fair value is defined as the exchange price that would be received for an asset or the exit price that would be paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date.

Concentration of Credit Risk— Financial instruments that potentially subject the Company to concentration of credit risk consist of cash and cash equivalents and accounts receivable. Concentration risk for cash and cash equivalents is mitigated by banking with a creditworthy financial institution. At times, cash deposits have exceeded the federally insurable limit; however, the Company has not experienced any losses on its cash deposits and cash equivalents since inception. The Company generally does not require collateral or other security to support its accounts receivable. Credit is extended to customers based on an evaluation of their financial condition and other factors. The Company performs ongoing credit evaluations of its customers and maintains an allowance for doubtful accounts as appropriate.

The Company had one major customer for the years ended December 31, 2021, and 2020, respectively. Major customers are defined as customers generating revenue greater than 10% of the Company’s revenue. Revenue from the major customer accounted for 69% and 58% of revenue for the years ended December 31, 2021, and 2020, respectively. Accounts receivable from the major customer totaled $3.6 million and $9.2 million as of December 31, 2021, and 2020, respectively.

For the year ended December 31, 2021, three suppliers represented 56% of the Company’s inventory purchases. For the year ended December 31, 2020, three suppliers represented 41% of the Company’s inventory purchases.

Inventory, net— Inventory, net consist of raw materials, work-in-progress, and finished goods, stated at the lower of actual cost (which approximates first-in, first-out basis) or net realizable value. The determination of net realizable value involves numerous judgments, including estimated future demand and selling prices. Inventory that is obsolete, in excess of the Company’s forecasted demand or is anticipated to be sold at a loss is written down to its estimated realizable value based on product life cycle, development plans, expected demand or quality issues.

Property and Equipment, net— Property and equipment, net is stated at cost and depreciated on a straight-line basis over the assets’ estimated useful lives. Equipment purchased but not yet placed into service is classified as construction in progress and is not depreciated until it is placed in service. Upon retirement or sale, costs and related accumulated depreciation are removed from the balance sheets and the resulting gain or loss is included in operating expense in the Consolidated Statements of Operations and Comprehensive Loss. Maintenance and repairs costs are charged to operations as incurred.

 

11


Depreciation is calculated on a straight-line basis over the estimated useful lives of those assets, ranging from three years to five years. Leasehold improvements are amortized over the shorter of the estimated useful life of the asset or the remaining lease term.

Investment in Privately Held Company— In June 2015, the Company invested $0.3 million in a privately held company and accounted for such investment using the cost method. As of December 31, 2020, this investment is included in other noncurrent assets in the consolidated Balance Sheet. The Company monitors the investment for impairment and makes appropriate reductions in carrying value if the Company determines that an impairment charge is required based primarily on the financial condition and near-term prospects of the investee. In December 2021, the Company determined the investment carrying value to be fully impaired and recorded a $0.3 million expense to Other Income (expense), net in the Consolidated Statements of Operations and Comprehensive Loss.

Impairment of Long-Lived Assets— The Company periodically evaluates the carrying value of long-lived assets to be held and used when indicators of impairment exist. The carrying value of a long-lived asset to be held and used is considered impaired when the estimated separately identifiable undiscounted cash flows expected to result from the use of the asset and its eventual disposition are less than the carrying value of the asset. In that event, a loss is recognized based on the amount by which the carrying value exceeds the fair value of the long-lived asset. Fair value is determined primarily using the estimated cash flows discounted at a rate commensurate with the risk involved. As discussed in Note 3, in December 2021, the Company recorded a write-down of assets associated with its Solar Park contract manufacturer in Korea. Equipment with a net carrying value of $4.2 million was fully written off as part of the Solar Park write-down. In addition, as discussed in Note 5, in March of 2020, the Company recorded an impairment charge of $0.4 million related to the abandonment of certain manufacturing equipment which was no longer expected to be completed. No other significant impairment charges have been recorded in the periods presented.

Commitments and Contingencies— The Company is and may become involved in various legal proceedings arising from its business activities. While management is not aware of any litigation matter that in and of itself would have a material adverse impact on the Company’s consolidated results of operations, cash flows or financial position, litigation is inherently unpredictable, and depending on the nature and timing of a proceeding, an unfavorable resolution could materially affect the Company’s future consolidated results of operations, cash flows or financial position in a particular period. The Company assesses contingencies to determine the degree of probability and range of possible loss for potential accrual or disclosure in the Company’s consolidated financial statements.

An estimated loss contingency is accrued in the Company’s consolidated financial statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because litigation is inherently unpredictable and unfavorable resolutions could occur, assessing contingencies is highly subjective and requires judgments about future events. When evaluating contingencies, the Company may be unable to provide a meaningful estimate due to a number of factors, including the procedural status of the matter in question, the presence of complex or novel legal theories, and/or the ongoing discovery and development of information important to the matters. In addition, damage amounts claimed in litigation against the Company may be unsupported, exaggerated or unrelated to reasonably possible outcomes, and as such are not meaningful indicators of the Company’s potential liability.

Revenue Recognition— In May 2014, the Financial Accounting Standards Board (“FASB”) issued new accounting guidance, Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers that supersedes nearly all U.S. GAAP on revenue recognition and eliminates legacy industry-specific guidance. Since its issuance, the FASB has issued several amendments to ASC 606. The Company adopted ASC 606 on January 1, 2018, using the modified retrospective method.

The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its arrangements with customers:

 

   

Identify the contract with a customer;

 

   

Identify the performance obligations in the contract;

 

12


   

Determine the transaction price;

 

   

Allocate the transaction price to the performance obligations in the contract; and

 

   

Recognize revenue as performance obligations are satisfied.

ASC 606 provides a unified model in determining when and how revenue is recognized with the core principle that revenue should be recognized when a customer obtains control of the promised goods or services in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The Company generates revenues from the sale of silicon photovoltaic solar panels and licensing of the Company’s technology to third parties.

The Company contracts with customers under non-cancellable arrangements. While customers, including distributors, may cancel master purchase agreements for convenience at any time, customers may not cancel or modify purchase orders placed under the terms of such master purchase agreements after 4 weeks from the scheduled delivery date. Each purchase order is therefore a contract with the customer, i.e., the purchase of a quantity of any given, single product; further, purchase orders do not commit the customer to purchase any further volumes over time. Contract modifications do not carry revenue recognition implications as no revenue is recognized until control over products, or intellectual property, as applicable, has transferred to the customer.

The Company’s contracts with customers consist of a single performance obligation as the Company has no practice of selling products and licensing its intellectual property under the same arrangement. Products and licensed intellectual property are distinct performance obligations. Customers can benefit from the panels and intellectual property on their own – the panels and intellectual property can be used on their own, and the panels do not require integration with other offerings, do not modify or customize (or are being modified or customized by) other offerings, and are not highly interrelated or interdependent with other offerings. Similarly, no purchase of panels is required for the customer to be able to use the intellectual property as intended, and updates, if any, to the intellectual property being licensed are not critical to the customer’s ability to derive the intended benefits from such licensing arrangement over the licensing term. The Company does not offer extended warranty for customers to purchase, nor does the Company sell any services related to the panels. Further, while customers do have the option to purchase additional quantities of any given products, such options do not grant material rights to the customer as all such options are priced similarly to the upfront transaction and the pricing of each purchase order is highly variable.

The transaction price is determined based on the total consideration specified in the contract, including variable consideration. Variable consideration consists of a variety of incentives, such as volume-based rebates and price protection. The Company uses the expected-value method to estimate variable consideration, which results in a reduction of the transaction price.

The pricing of each purchase order is separately negotiated and is reflective of management’s pricing objectives in agreeing to honor such purchase order once agreed to. No reallocation of the transaction price is generally required as contracts with customers typically include a single performance obligation.

The Company recognizes revenue from sales of products as control is transferred to the customer, generally upon delivery to the customer’s premises as customers do not have rights of return and the Company does not have significant obligations post shipment. In instances where the price of a licensing arrangement is fixed at arrangement inception, license revenue is recognized at the time control over the related intellectual property has transferred to the customer. In instances where the pricing of a licensing arrangement is royalty-based, revenue is recognized based on estimates of the licensee’s estimated use of the licensed intellectual property in the period of reference, with a true up being recorded as actual use becomes known based on royalty reports received from the licensee.

Revenue is recognized net of sales taxes charged to customers. The Company accounts for shipping and handling costs as fulfillment costs.

Capitalized Contract Acquisition Costs and Fulfillment Cost— Contract acquisition costs primarily consist of commissions that the Company incurs to obtain a contract with a customer. These costs are

 

13


incremental (i.e., no commissions are due and payable unless a contract is entered into with a customer) and recoverable. However, as the period from fulfillment of the performance obligation to rights to payment does not exceed a year, commission, costs, as permitted by the practical expedient, are expensed upon control of the product transferring to the customer, generally upon delivery because based on the above, these costs do not benefit future periods.

Cost of RevenueCost of revenue consists primarily of direct production costs, including labor, materials, and subcontractor costs, indirect labor and overhead costs related to manufacturing activities; depreciation of production equipment, and allocated facilities costs.

Shipping and HandlingThe Company considers shipping and handling to represent activities performed in fulfilling the contract with the customer. When shipping is charged to the customer, the Company nets such charges against actual shipping costs incurred. Taxes imposed by governmental authorities on the Company’s revenue producing activities, such as sales taxes, are excluded from net sales.

Warranty CostThe Company warrants that its products will operate substantially in conformity with published product specifications, generally for a period of twenty-five years. The Company does not sell extended warranty coverage. The warranties provide the purchaser with protection in the event of defect or failure to perform as warranted. In fiscal year 2020, the Company changed its warranty accrual calculation methodology from a revenue-based methodology to a cost of goods sold-based methodology. Management concluded that the impact of such change in the period of change and in all periods prior to such change was de minimis and therefore reflected the impact of the change in the period the change was effected. Therefore, all periods presented are materially consistent. The Company accrues the estimated cost of warranties in the period the related revenue is recognized based on historical and projected warranty claim rates, historical and projected cost per claim, and knowledge of specific product failures outside the Company’s typical experience. Estimated warranty obligations as of December 31, 2021 and 2020 were $1.7 million and $1.2 million, respectively, and are included in Accrued expenses and other current liabilities in the consolidated balance sheets.

The following table is a roll forward of warranty cost as of December 31, 2021, and 2020 (in thousands):

 

     As of December 31,  
     2021      2020  

Beginning balance

   $ 1,248      $ 929  

Warranty settlements

     (135      (224

Additions to warranty accrual

     625        543  
  

 

 

    

 

 

 

Ending balance

   $ 1,738      $ 1,248  
  

 

 

    

 

 

 

Warranty cost, current

   $ 87      $ 62  

Warranty cost, noncurrent

     1,651        1,186  
  

 

 

    

 

 

 

Total warranty cost

   $ 1,738      $ 1,248  
  

 

 

    

 

 

 

Research and EngineeringResearch and engineering costs that do not meet the criteria for capitalization are expensed as incurred. Research and engineering costs primarily consist of compensation, employee benefits, stock-based compensation related to technology developers and product management employees, as well as fees paid for outside services.

Sales and MarketingSales and marketing costs are charged to expense as incurred. The Company incurred advertising costs amounting to $0.6 million and $0.3 million for the years ended December 31, 2021 and 2020, respectively.

General and AdministrativeGeneral and administrative expenses primarily consist of employee compensation, including stock-based compensation and benefits for the Company’s finance, human resources, legal, and general management functions as well as facilities and professional services.

 

14


Litigation-Related Costs – primarily consist of legal costs incurred in connection with the Company’s patent infringement claims against Canadian Solar, Inc (“Canadian Solar”) filed by Solaria in March 2020 in the Federal District Court for the Northern District of California and in the United States International Trade Commission (ITC) and related to Solaria’s proprietary shingled solar module technology. An initial determination in favor of the Company by the Chief Administrative Law Judge of the United States International Trade Commission was reached in October 2021. ln June 2022, the Company announced that it has settled its patents infringement claims and would terminate the litigation against Canadian Solar in return for Canadian Solar ceasing its importation of shingled solar panels into the United States for seven years.

Stock-Based CompensationThe Company accounts for stock-based compensation in accordance with ASC 718, Compensation – Stock Compensation (“ASC 718”).

The Company grants stock options to its employees, directors and consultants for a fixed number of shares with an exercise price equal to the fair value of the shares at the date of grant. All stock-based payments to employees and non-employees, including grants of stock options, are recognized in the consolidated financial statements based on their respective grant date fair values.

The Company estimates the fair value of stock-based payments on the date of grant using the Black-Sholes-Merton option pricing model. The model requires management to make a number of assumptions, including the expected volatility of the Company’s stock, the expected life of the option, the risk-free interest rate, expected dividends, and forfeiture rates. The fair value of the stock options, adjusted for forfeitures, is expensed over the related service period which is typically the vesting period.

Redeemable Convertible Preferred Stock WarrantsThe Company accounts for the outstanding warrants exercisable into shares of the Company’s redeemable convertible preferred stock in accordance with FASB Accounting Standards Codification (ASC) Topic 480, Distinguishing Liabilities from Equity. Under Topic 480, the Company is required to classify certain warrants to purchase shares of stock as liabilities and adjust the warrant instruments to fair value at each reporting period. At the end of each reporting period, changes in fair value during the period are recognized as a component of Other Income (expense), net in the Consolidated Statements of Operations and Comprehensive Loss. The Company will continue to adjust the preferred stock warrant liability for changes in the fair value until the earlier of the exercise or expiration of the warrants or the completion of a liquidation event, including completion of an initial public offering, at which time the warrant liability will be reclassified to additional paid-in capital.

Income TaxesThe Company accounts for income taxes using the asset and liability method as described in ASC 740, Income Taxes. Deferred income taxes are recognized by applying enacted statutory tax rates applicable to future years to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases, and operating loss and income tax credit carryforwards. The effect on deferred income tax assets and liabilities of a change in income tax rates is recognized in the Consolidated Statements of Operations and Comprehensive Loss in the period that includes the enactment date. Deferred income taxes are netted and classified as a noncurrent asset or liability on the consolidated balance sheets.

In evaluating the ability to recover its deferred income tax assets, the Company considers all available positive and negative evidence, including its operating results, ongoing tax planning and forecasts of future taxable income on a jurisdiction-by-jurisdiction basis. In the event the Company determines that it would be able to realize its deferred income tax assets in the future in excess of their net recorded amount, it would make an adjustment to the valuation allowance that would reduce the provision for income taxes. Conversely, in the event that all or part of the net deferred tax assets are determined not to be realizable in the future, an adjustment to the valuation allowance would be charged to earnings in the period when such determination is made. As more fully discussed in Note 12, as of December 31, 2021 and 2020 the Company had fully reserved its deferred tax assets.

The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than

 

15


50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs.

Leases The Company early adopted Accounting Standards Update (“ASU”) No. 2016-02, Leases (Topic 842), as amended (“ASC 842”) effective January 1, 2018 using the modified retrospective transition approach by applying the new standard to all leases existing at the date of initial application. ASC 842 requires all lessees to recognize most leases on their balance sheets as lease right-of-use (“ROU”) assets with corresponding lease liabilities.

Operating lease right-of-use assets and operating lease liabilities are recognized at the present value of the future lease payments, generally for the base lease term, at the lease commencement date for each lease. The interest rate used to determine the present value of the future lease payments is the Company’s incremental borrowing rate because the interest rate implicit in most of the Company’s leases is not readily determinable. The Company’s incremental borrowing rate is estimated to approximate the interest rate that the Company would pay to borrow on a collateralized basis with similar terms and payments as the lease, and in economic environments where the leased asset is located.

Operating lease right-of-use assets also include any prepaid lease payments and lease incentives. The Company’s lease agreements generally contain lease and non-lease components. Non-lease components, which primarily include payments for maintenance and utilities, are combined with lease payments and accounted for as a single lease component. The Company includes the fixed non-lease components in the determination of the right-of-use assets and operating lease liabilities. The Company records the amortization of the right-of-use asset and the accretion of lease liability as rent expense included in general and administrative, cost of revenue, research and engineering and sales and marketing in the consolidated statement of operations and comprehensive loss. The Company did not identify any finance leases at December 31, 2021 and 2020.

When lease agreements provide allowances for leasehold improvements, the Company assesses whether it is the owner of the leasehold improvements for accounting purposes. When the Company concludes that it is the owner, the Company capitalizes the leasehold improvement assets and recognizes the related depreciation expense on a straight-line basis over the lesser of the lease term or the estimated useful life of the asset. Additionally, the Company recognizes the amounts of allowances to be received from the lessor as a reduction of the lease liability and the associated right-of-use asset. When the Company concludes that it is not the owner, the payments that the Company makes towards the leasehold improvements are accounted as a component of the lease payments.

Accounting Pronouncements Recently Adopted — In August 2018, the FASB issued ASU No. 2018-15, Intangibles-Goodwill and Other-Internal-Use Software (350-40) Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement. This guidance evaluated such costs for capitalization using the same criteria as for internal-use software development costs, with amortization expense being recorded in the same income statement expense line as the hosted service costs and over the expected term of the hosting arrangement. This ASU is effective for the Company on January 1, 2021. The adoption of this ASU on January 1, 2021 did not have a material impact to the Company’s consolidated financial statements.

In August 2020, the FASB issued ASU 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”). The amendments in ASU 2020-06 simplify accounting for convertible instruments by removing major separation models required under current U.S. GAAP. Consequently, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded conversion features. ASU 2020-06 removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception. Also, ASU 2020-06 requires the application of the if-converted method for calculating diluted earnings per share and the treasury stock method will no longer be available. ASU 2020-06 is effective for interim and annual reporting periods beginning after December 15, 2023, with early adoption permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods

 

16


within those fiscal year. The Company adopted the new standard on January 1, 2022 under the modified retrospective approach resulting in a cumulative catch-up adjustment of $1.1 million to accumulated deficit and additional paid-in capital as of the date of adoption related to the beneficial conversion feature related to the 2018 Bridge Notes as discussed in Note 7.

Recent Accounting Pronouncements Not Yet Adopted

The Company currently qualifies as an EGC under the JOBS Act. Accordingly, the Company has the option to adopt new or revised accounting guidance either (i) within the same periods as those otherwise applicable to non-emerging growth companies or (ii) within the same time periods as private companies. The Company has elected to adopt new or revised accounting guidance within the same time period as private companies, unless, as indicated below, management determines it is preferable to take advantage of early adoption provisions offered within the applicable guidance.

In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which amends the FASB’s guidance on the impairment of financial instruments. Topic 326 adds to GAAP an impairment model (known as the “current expected credit loss model”) that is based on expected losses rather than incurred losses. ASU 2016-13 is effective for the Company’s annual and interim periods beginning after December 15, 2022 with early adoption permitted. The Company does not expect to early adopt the new standard. The Company is currently evaluating the impact of ASU 2016-13 on its consolidated financial statements.

In December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes, which simplifies the accounting for income taxes, eliminates certain exceptions within ASC 740, Income Taxes, and clarifies certain aspects of the current guidance to promote consistency among reporting entities. ASU 2019-12 is effective for fiscal years beginning after December 15, 2021 and for interim periods within fiscal years beginning after December 15, 2022. Most amendments within this accounting standard are required to be applied on a prospective basis, while certain amendments must be applied on a retrospective or modified retrospective basis. The Company adopted ASU 2019-12 under the private company transition guidance beginning January 1, 2022, the adoption did not have an impact on the Company’s financial statements.

In May 2021, the FASB issued ASU 2021-04, Earnings Per Share (Topic 260), Debt—Modifications and Extinguishments (Subtopic 470-50), Compensation—Stock Compensation (Topic 718), and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options (a consensus of the FASB Emerging Issues Task Force). This guidance clarifies certain aspects of the current guidance to promote consistency among reporting of an issuer’s accounting for modifications or exchanges of freestanding equity-classified written call options (for example, warrants) that remain equity classified after modification or exchange. The amendments in this update are effective for all entities for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted for all entities, including adoption in an interim period. The Company adopted ASU 2021-04 under the private company transition guidance beginning January 1, 2022, the adoption did not have an impact on the Company’s financial statements.

 

3.

SOLAR PARK RELATED COSTS

In December 2021 the Company determined that it would no longer utilize Solar Park Korea Co., Ltd. (“Solar Park”), a contract manufacturer, for production of solar panels. Solar Park was experiencing serious financial issues during the fourth quarter of 2021.

As of December 31, 2021, the Company evaluated the relevant facts and circumstances, determined that substantially all Company assets associated with Solar Park were at risk. Accordingly, the Company wrote off the full carrying value of the assets described below Solar Park as a component of operating expenses in

 

17


the consolidated statement of operations and comprehensive loss for the year ended December 31, 2021 (in thousands):

 

Description

   Amount  

Inventory and related advances write-down

   $ 9,123  

Equipment and related advances write-down

     7,928  
  

 

 

 

Total

   $ 17,052  
  

 

 

 

These amounts include inventory of $8.7 million, inventory-related advances of $0.4 million, equipment of $4.2 million and equipment-related advances of $3.7 million. The Company utilized inventory held outside of Solar Park to facilitate its transition to a new provider during fiscal year 2022.

As discussed in Notes 14 and 17, in June 2022, the Company filed a notice of arbitration with the Singapore International Arbitration Centre (“SIAC”) seeking approximately $47.0 million in damages against Solar Park in connection with the write-downs described above and other costs related to the loss of Solar Park’s production and transition to a new provider. Solar Park filed a response with SIAC in June 2022 asserting damages of approximately $30.0 million against the Company. The arbitration hearing, is expected to occur during the first half of 2024.

 

4.

REVENUE

The Company generates revenues from the sale of silicon photovoltaic solar panels and licensing of the Company’s technology to third parties.

Product SalesThe Company recognizes revenue from sales of products as control is transferred to customers, which generally occurs upon delivery to the customer’s premises. Other than standard warranty obligations, there are no rights of return or significant post-shipment obligations with respect to the Company’s products. Contracts with customers consist of a single performance obligation, hence the entire transaction price is allocated to this single performance obligation. In determining the transaction price in contracts with customers, the Company reduces revenue for the estimated costs of customer and distributor programs and incentive offerings such as price protection and rebates. Any provision for customer and distributor programs and other discounts is recorded as a reduction of revenue at the time of sale based on an evaluation of the contract terms and historical experience.

License Revenue — The Company derives revenue from the licensing of the Company’s technology to third parties. Revenue from functional IP licensing arrangements is recognized at a point in time when control over the licensed technology is transferred to the customer. License fees, i.e., royalties, that are not fixed at contract inception are recognized over time upon occurrence of the later of the subsequent technology sale or usage, or satisfaction of the performance obligation to which some or all of the usage-based royalty relates. The Company recorded license revenue amounting to $0.03 million and $0.2 million for the years ended December 31, 2021, and 2020, respectively, which is included under product revenue, net in the Consolidated Statements of Operations and Comprehensive Loss.

Disaggregated revenue by primary geographical market and business activity are as follows (in thousands):

 

         Years Ended December 31,      
         2021      2020      

Primary geographical markets

     

U.S.

   $ 56,577      $ 46,158  

International

     3,186        2,170  
  

 

 

    

 

 

 

Total

   $ 59,763      $ 48,328  
  

 

 

    

 

 

 

Product sales

   $ 59,737      $ 48,098  

Royalty

     26        230  
  

 

 

    

 

 

 

Total revenue

   $ 59,763      $ 48,328  
  

 

 

    

 

 

 

 

18


Contract Balances Contract liabilities consist of deferred revenue or customer deposits and relate to amounts invoiced to or advance consideration received from customers, which precede the Company’s satisfaction of the associated performance obligation(s).

The following table is a roll forward of deferred revenue balances as of December 31, 2021, and 2020 (in thousands):

 

     Years Ended
December 31,
 
     2021      2020  

Deferred revenue—beginning balance

   $ 2,070      $ 2,246  

Additions

     1,494        5,624  

Revenue recognized

     (3,489      (5,800
  

 

 

    

 

 

 

Deferred revenue—ending balance

   $ 75      $ 2,070  
  

 

 

    

 

 

 

As of December 31, 2021, and 2020, the Company’s deferred revenue is expected to be recognized during the succeeding 12-month period and is therefore presented as deferred revenue, current, in the consolidated balance sheets.

 

5.

FINANCIAL STATEMENT COMPONENTS

Inventories, Net—The components of inventories as of December 31, 2021 and 2020, respectively, were as follows (in thousands):

 

     As of December 31,  
     2021      2020  

Finished goods

   $ 16,928      $ 5,029  

Work in progress

     —          1,712  

Raw materials

     —          3,707  
  

 

 

    

 

 

 

Total inventory, net

   $ 16,928      $ 10,448  
  

 

 

    

 

 

 

As of December 31, 2021 and 2020 reserves for inventory obsolescence were $0.1 million and $0.2 million, respectively.

As more fully discussed in Note 3, in December 2021, the Company wrote off approximately $8.7 million of inventory which is held at the Solar Park contract manufacturer’s site in Korea and is not expected to be recoverable.

Property and Equipment, netProperty and equipment, net as of December 31, 2021 and 2020, consist of the following (in thousands):

 

     As of December 31,  
     2021      2020  

Manufacturing equipment

   $ 3,195      $ 7,316  

Leasehold improvement

     864        1,080  

Furniture, fixtures and office equipment

     66        100  
  

 

 

    

 

 

 
     $4,125      $8,496  

Less: Accumulated depreciation

     (3,126      (3,568
  

 

 

    

 

 

 

Total property and equipment, net

   $ 999      $ 4,928  
  

 

 

    

 

 

 

Total depreciation expense for the years ended December 31, 2021, and 2020 was $1.3 million and $0.5 million, respectively.

 

19


In addition, in March of 2020, the Company recorded an impairment charge of $0.4 million related to the abandonment of certain manufacturing equipment which was no longer expected to be completed. These assets were previously included as a component of Construction in Progress within Property and Equipment. The write-down was included in the Consolidated Statement of Operations and Comprehensive Loss as Impairment and Related Charges.

As more fully discussed in Note 3, the Company wrote off approximately $4.2 million net carrying value of manufacturing equipment which is held at the Solar Park contract manufacturer’s site in Korea and is not expected to be recoverable.

Accrued Expenses and Other Current LiabilitiesAccrued expenses and other current liabilities consist of the following (in thousands):

 

     As of December 31,  
     2021      2020  

Accrued purchases

   $ 2,657      $ 1,400  

Accrued rebates and credits

     1,967        2,313  

Warranty cost, current

     87        62  

Other taxes payable

     1,053        2,275  

Customer deposits

     773        452  

Accrued payroll

     784        1,099  

Current portion of amount payable to a vendor (Note 14)

     1,699        1,252  

SCI Term Loan and Revolving Loan amendment fees
(Note 7)

     1,700        —    

Other accrued liabilities

     993        1,122  
  

 

 

    

 

 

 

Total accrued expenses and other current liabilities

   $ 11,713      $ 9,975  
  

 

 

    

 

 

 

Other income (expense), net

Other income (expense), net consists of the following (in thousands):

 

         Years Ended December 31,      
         2021      2020      

Forgiveness of Paycheck Protection Program Loan (Note 7)

   $ 1,433      $ —    

Change in fair value of redeemable convertible preferred stock warrant liability (Note 8)

     358        1,085  

Write-off of Investment in Privately Held Company

     (250      —    

Others

     (83      319  
  

 

 

    

 

 

 

Total other income (expense), net

   $ 1,458      $ 1,404  
  

 

 

    

 

 

 

 

6.

LEASES

Operating LeasesIn April 2018, the Company entered into a 56-month lease agreement for an office space in Oakland, California for $0.8 million in total payments. Effective June 2021, the Company terminated the lease agreement and agreed to settle the unpaid rent and related legal costs for $0.3 million. As a result, the Company derecognized the Oakland right-of use asset and corresponding lease liability and recognized a loss of $0.01 million as Other Income (Expense), net in the Consolidated Statement of Operations and Comprehensive Loss for the year ended December 31, 2021.

 

20


In November 2019, the Company entered an 84-month lease for office and manufacturing space in Fremont, California (“Fremont facility”) for $3.3 million in total payment. The Company has an option to renew the lease for five years. Lease renewals are not assumed in the determination of the lease term until the exercise of the renewals are deemed to be reasonably certain.

Operating lease right of use assets and lease liability as of December 31, 2021 and 2020 were as follows (in thousands):

 

     As of December 31,  
     2021      2020  

Operating lease right-of-use assets, net

   $ 1,642      $ 2,156  
  

 

 

    

 

 

 

Lease liabilities:

     

Current

   $ 283      $ 390  

Noncurrent

     1,674        2,139  
  

 

 

    

 

 

 

Total lease liabilities

   $ 1,957      $ 2,529  
  

 

 

    

 

 

 

For the years ended December 31, 2021 and 2020, the Company incurred operating leases expenses of $0.7 million and $0.8 million, respectively, which is included in research and engineering, sale and marketing and general and administrative expenses in the consolidated statement of operations and comprehensive loss.

Supplemental cash flow information and non-cash activity related to the Company’s operating leases for the years ended December 31, 2021 and 2020, respectively, were as follows (in thousands):

 

         As of December 31,      
         2021      2020      

Cash payments included in the measurement of operating lease liability – operating cash flows

   $ 991      $ 441  
  

 

 

    

 

 

 

As of December 31, 2021, future minimum lease payments under the noncancellable lease agreements are as follows (in thousands):

 

Future Operating Lease Payments

   Amount  

2022

   $ 512  

2023

     528  

2024

     548  

2025

     559  

Thereafter

     477  
  

 

 

 

Reasonably certain future lease payments

     2,624  

Less imputed interest

     (667
  

 

 

 

Total operating lease liability

     1,957  

Less current portion

     283  
  

 

 

 

Operating lease liability, noncurrent

   $ 1,674  
  

 

 

 

 

     As of December 31,  
     2021     2020  

Weighted-average remaining lease term

     4.4 Years       5.3 Years  

Weighted-average lease discount rate

     12.75     12.75

As of December 31, 2021 and 2020, the discount rate of 12.75% for the operating lease was determined based on recent debt financing transaction.

 

21


7.

NOTES PAYABLE, NET

Notes payable, net consists of the following (in thousands):

 

     As of December 31,  
     2021      2020  

2018 Bridge Notes

   $ 7,076      $ 4,422  

Payroll Protection Program Loan

     1,414        1,433  

Simple Agreement for Future Equity Note

     34,001        2,000  

Term and Revolver Loan

     9,618        9,254  
  

 

 

    

 

 

 

Total notes payable, net

     52,109        17,109  

Less current portion

     (10,912      (5,938
  

 

 

    

 

 

 

Notes payable, net of current portion

   $ 41,197      $ 11,171  
  

 

 

    

 

 

 

2018 Bridge Notes

In December 2018, the Company issued senior subordinated convertible secured notes (“2018 Notes”) totaling approximately $3.4 million in exchange for cash. The notes bear interest at the rate of 8% per annum and the investors are entitled to receive twice of the face value of the notes at maturity. The 2018 Notes are secured by substantially all of the Company’s assets.

In connection with the 2018 Notes, the Company originally issued warrants to purchase 486,240 shares of its common stock at $0.01 per share. The warrants, which were exercisable upon issuance, expire in December 2023. At issuance, the Company determined the relative fair value of the warrants to be $1.1 million. The Company recorded the fair value of the warrant as a debt discount within additional paid-in capital. After allocating $1.1 million to the warrant, the fair value of preferred stock in which the notes could be converted exceeded the carrying value of the notes. As such the conversion feature under the notes was considered a beneficial conversion feature which was treated as debt discount and amortized to interest expense using the effective interest rate method. The Company recorded an additional $1.1 million discount to the notes within additional paid-in capital.

In December 2021, the Company entered into an amendment to the 2018 Notes extending the maturity date from December 13, 2021 to December 13, 2022. In connection with the amendment, the notes will continue to bear interest at 8% per annum and are entitled to a repayment premium of 110% of the principal and accrued interest at the time of repayment. Additionally, the Company issued warrants to purchase 196,462 shares of Series E-1 redeemable convertible preferred stock (“Series E-1 warrants”) at $4.59 per share in connection with the amendment. The warrants were exercisable immediately and expire on December 13, 2031. Upon issuance, the Company determined the fair value of the warrants to be $0.7 million using the Black-Scholes option-pricing model using the following assumptions: no dividends; risk-free interest rate of 1.42%; contractual life of 10 years; and expected volatility of 54.4%. The Series E-1 warrants qualified as liabilities as the underlying preferred stock were contingently redeemable upon the occurrence of a change in control, which is outside the control of the Company. At December 31, 2021, all of the warrants issued remain outstanding.

The Company concluded that the modification was a troubled debt restructuring as the Company was experiencing financial difficulty and the amended terms resulted in a concession to the Company. As the future undiscounted cash payments under the modified terms exceeded the carrying amount of the 2018 Notes on the date of modification, the modification was accounted for prospectively. Additionally, the Company recorded the fair value of the Series E-1 warrants as a reduction of Notes payable, net of discounts to the restructured notes on the date of modification. The debt discount and incremental repayment premium are being amortized to interest expense using the effective interest rate method.

 

22


The net carrying value of 2018 Bridge Notes was as below (in thousands):

 

     As of December 31,  
     2021      2020  

Principal

   $ 7,777      $ 5,555  

Less: unamortized debt discount

     (701      (1,133
  

 

 

    

 

 

 

Net carrying value

     7,076        4,422  

Less: current portion

     (7,076      (4,422
  

 

 

    

 

 

 

Total noncurrent portion

   $ —        $ —    
  

 

 

    

 

 

 

The following table sets forth the total interest expense recognized related to the 2018 Bridge Notes (in thousands):

 

     As of December 31,  
     2021     2020  

Amortization of debt discount

   $ 1,160     $ 643  

Contractual interest expense

     2,223       1,335  
  

 

 

   

 

 

 

Total interest expense

   $ 3,383     $ 1,978  
  

 

 

   

 

 

 

Effective interest rate of the liability component

     32.6     32.6
  

 

 

   

 

 

 

Paycheck Protection Program Loan

In May 2020, the Company entered into an unsecured promissory note under the Payroll Protection Program (“PPP Loan”), with a bank under the PPP administered by the United States Small Business Administration (“SBA”) and authorized by the Keeping American Workers Employed and Paid Act, which is part of the CARES Act, enacted on March 27, 2020. The PPP Loan may be prepaid, in full or in part, at any time prior to maturity with no prepayment penalties. Under the terms of the PPP, the Company can apply for, and be granted, forgiveness for all or a portion of the PPP Loan. The principal amount of the PPP Loan is $1.4 million. The PPP Loan is non-interest bearing and has a maturity date of less than a year. The PPP Loan was forgiven in full in March 2021 and as a result gain on forgiveness of debt of $1.4 million is recorded within Other income (expense), net in the Company’s Consolidated Statements of Operations and Comprehensive Loss for the year ended December 31, 2021.

In February 2021, the Company obtained a PPP Loan with a principal amount of $1.4 million. The PPP Loan bears interest at less than 1% per annum and has a maturity date of less than one year. The PPP Loan principal and accrued interest was forgiven in full in January 2022.

Simple Agreement for Future Equity Notes

The Company entered into various interest free unsecured SAFE notes agreements and raised $32.0 million in fiscal 2021 and $2.0 million in fiscal 2020. The number of shares to be issued upon conversion of the SAFE notes are subject to the following:

Equity Financing In the event of certain equity financing before the termination of the SAFE note, on the initial closing of such equity financing, the SAFE note will automatically convert into the number of shares of SAFE preferred stock in accordance with the terms of the SAFE agreement. In the event of certain other financing before the termination of the SAFE note, the investor may elect to convert the SAFE note into preferred stock equal based on the terms of the SAFE agreement.

Public Offering – If there is an Initial Public Offering (“IPO”) before the termination of the SAFE note, the SAFE note will automatically convert into the right to receive the number of shares of common stock according to the terms of the SAFE agreement.

 

23


Change of Control – If there is a Change of Control before the termination of the SAFE note, the SAFE note will automatically convert into the right to receive a portion of proceeds according to the terms of the SAFE agreement.

Dissolution Event – If there is a Dissolution Event before the termination of the SAFE note, the investor will automatically be entitled to receive a portion of proceeds according to the terms of the SAFE agreement.

Valuation Caps the SAFE notes are subject to a valuation cap. The valuation cap is $190.0 million for each of 33 notes with aggregate principal of $30.0 million. Two notes with principal balance of $2.0 million each have valuation caps of $219.1 million and $221.1 million, respectively.

The Company elected to account for all of the SAFE notes at estimated fair value pursuant to the fair value option and recorded the change in estimated fair value as Other income (expense), net in the Consolidated Statements of Operations and Comprehensive Loss until the notes are converted or settled.

The estimated fair values of SAFE notes approximated the face value and is considered a Level 3 fair value measurement.

Term and Revolver Loan

In October 2020, the Company entered into a loan agreement (“Loan Agreement”) with Structural Capital Investments III, LP (“SCI”).

The Loan Agreement with SCI comprises of two facilities, a term loan (the “Term Loan”) and a revolving loan (the “Revolving Loan”) (together “Original Agreement”) for $5.0 million each with a maturity date of October 31, 2023. Both the Term Loan and the Revolving Loan were fully drawn upon closing.

The Term Loan has a term of thirty-six months, equal monthly payments of principal beginning November 2021 until the end of the term and an annual interest rate of 9.25% or Prime rate plus 6%, whichever is higher. The Revolving Loan also has a term of thirty-six months, principal repayments at the end of the term and an annual interest rate of 7.75% or Prime rate plus 4.5%, whichever is higher. The Loan Agreement required the Company to meet certain financial covenants relating to maintenance of specified restricted cash balance, achieving specified revenue target and maintaining specified contribution margin (“Financial covenants”) over the term of each of the Term Loan and Revolving Loan.

In October 2020, the Company recorded debt issuance costs discount totaling $0.8 million related to the Original agreement. The total debt issuance costs and discount is being amortized to interest expense using the effective interest method.

In February 2021, the Company entered into an Amended and Restated Loan and Security Agreement as a First Amendment to the Original Agreement (“First Amendment”) to revise certain financial covenants within the Original Agreement.

In July 2021, the Company entered into an amendment to the Original Agreement (“Second Amendment”) as a forbearance agreement for SCI to forbear from exercising any rights and remedies available to it as a result of Company not meeting certain Financial Covenants required by the Original Agreement. As a result of this amendment changes were made to the financial covenants. The Company incurred $1.2 million in amendment fee related to the Second Amendment which was recognized as loss on extinguishment of debt discussed below.

In connection with the Second Amendment, the Company issued E-1 Warrants to purchase 305,342 shares of Series E-1 redeemable convertible preferred stock (“SCI Series E-1 warrants”) at $4.59 per share. The warrants were fully exercisable in whole or in part at any time during the term of the Original agreement. The SCI Series E-1 Warrants are scheduled to expire on July 30, 2031. Upon issuance, the Company determined the fair value of the warrants to be $1.2 million using the Black-Scholes option-pricing model using the following assumptions: no dividends; risk-free interest rate of 1.44%; contractual life of 10 years; and expected volatility of 55.7%. The Series E-1 warrants qualified as liabilities as the underlying preferred stock were contingently redeemable upon the occurrence of a change in control, which is outside the control of the Company.

 

24


The Company concluded that the modification to the terms of the Second Amendment changed the present value of cash flows by more than 10% and, as such, was treated as a debt extinguishment. The Company recognized a loss on extinguishment of debt of $3.0 million in the Consolidated Statements of Operations and Comprehensive Loss in July 2021 which included the fair value of SCI Series E-1 warrants of $1.2 million issued in connection with the modification and $1.2 million amendment fee.

In December 2021, the Company entered into an amendment to the Original Agreement (“Third Amendment”) as a forbearance agreement for SCI to forbear from exercising any rights and remedies available to it as a result of Company not meeting certain Financial Covenants required by the Original agreement. As a result of this amendment changes were made to the financial covenants. The Company incurred $0.5 million in amendment fee related to the Third Amendment and also paid default interest amounting to $0.3 million for the period April 2021 through November 2021. In connection with the Third Amendment, the Company further amended the exercise price of the Series D-1 Preferred Stock Warrants to $2.17 per share and also amended the number of warrants. As of the date of the Amendment, the Company determined the fair value of the amended Series D-1 Preferred Stock warrants to be $2.9 million using the Black-Scholes option-pricing model using the following assumptions: no dividends; risk-free interest rate of 1.35%; contractual life of 6 years; and expected volatility of 57.7%.

Additionally, the Company amended the exercise price of the Series E-1 Preferred Stock Warrants to $2.29 per share. As of the date of the Amendment, the Company determined the fair value of the amended Series E-1 Preferred Stock warrants to be $1.3 million using the Black-Scholes option-pricing model using the following assumptions: no dividends; risk-free interest rate of 1.44%; contractual life of 9.6 years; and expected volatility of 57.6%.

The Company concluded that the modification to the terms of the Third Amendment changed the present value of cash flows by more than 10% and, as such, was treated as a debt extinguishment. The Company recognized a loss on extinguishment of debt of $2.4 million in the Consolidated Statements of Operations and Comprehensive Loss in December 2021 which included the incremental fair value of the Series D-1 warrants of $1.7 million and incremental fair value of the Series E-1 warrants of $0.2 million relating to the modification.

The Term Loan and Revolving Loan consisted of the following (in thousands):

 

     As of December 31,  
     2021      2020  

Principal

   $ 9,618      $ 10,000  

Less: unamortized debt discount

     —          (746
  

 

 

    

 

 

 

Net carrying value

     9,618        9,254  

Less: current portion

     (2,421      (83
  

 

 

    

 

 

 

Total noncurrent portion

   $ 7,197      $ 9,171  
  

 

 

    

 

 

 

The following table sets forth the total interest expense recognized related to the SCI term Loan and revolving Loan (in thousands):

 

     As of December 31,  
     2021      2020  

Amortization of debt discount

   $ 170      $ 49  

Contractual interest expense

     860        151  
  

 

 

    

 

 

 

Total interest expense

   $ 1,030      $ 200  
  

 

 

    

 

 

 

 

25


The scheduled maturities of the SCI term loan and revolving loan, at December 31, 2021 are as follows (in thousands):

 

Year

   Amount  

2022

   $ 2,421  

2023

     7,197  
  

 

 

 

Total term and revolver loan

   $ 9,618  
  

 

 

 

 

8.

REDEEMABLE CONVERTIBLE PREFERRED STOCK WARRANTS

In 2010, in connection with a loan agreement, the Company issued a warrant to purchase 211,270 shares of Series A-1 preferred stock at an exercise price of $1.52 per share. These warrants were exercised in March 2021.

In connection with the Series B-1 preferred stock financing in February 2015, the Company amended certain previously outstanding common stock warrants into a warrant to purchase 35,294 shares of Series B-1 at an exercise price of $5.40 per share. These warrants were exercised in March 2021.

In 2017, in connection with a Loan and Security Agreement with Structural Capital Investments II, LP and El Dorado Investment Company, the Company issued warrants to purchase 147,551 shares of Series C-1 at an exercise price of $8.66 per share. In 2018, in connection with a second amendment to Loan and Security Agreement and the cancellation of the C-1 Warrants, the Company issued warrants to purchase 375,801 shares of Series D-1 at an exercise price of $4.33 per share. As fully discussed in Note 7, in December 2021, in connection with the Third Amendment to the Original Agreement, the Company amended certain terms of the warrant to purchase Series D-1 preferred stock. As amended, the Series D-1 preferred stock warrants are calculated based on a percentage of the Company’s fully diluted capitalization at an exercise price of $2.17 per share. As of December 31, 2021, 742,679 units of Series D-1 preferred stock warrants are outstanding. The warrants were exercisable upon issuance and expire on December 22, 2027.

As fully discussed in Note 7, in July 2021, in connection with the Second Amendment to Original Agreement, the Company issued warrants to purchase 305,342 shares of Series E-1 at an exercise price of $4.59 per share. In December 2021, in connection with the Third Amendment to the Original Agreement, the Company amended the exercise price of the Series E-1 preferred stock warrants to $2.29 per share.

As fully discussed in Note 7, in December 2021, in connection with the amendment to the 2018 Notes, the Company issued warrants to purchase 196,462 shares of Series E-1 Preferred Stock at an exercise price of $4.59 per share. The Series E-1 warrants remain outstanding as of December 31, 2021.

All of the above preferred stock warrants qualified as liabilities as the underlying preferred stock were contingently redeemable upon the occurrence of a change in control, which is outside the control of the Company. The preferred stock warrants have been recorded as a preferred stock warrant liability and are revalued to fair value each reporting period.

 

26


The changes in value of the preferred stock warrant liability are summarized below (in thousands):

 

     Amount  

Balance, December 31, 2019

   $ 2,810  

Change in Fair Value included in Other income (expense), net

     (1,085
  

 

 

 

Balance, December 31, 2020

   $ 1,725  
  

 

 

 

Series E-1 warrants issued in connection with SCI Second amendment—included in Loss on debt extinguishment

   $ 1,191  

Series E-1 warrants issued in connection with 2018 Bridge notes amendment—included in Notes payable, net of discounts

     731  

Exercise of warrant

     (251

Change in Fair Value included in Loss on debt extinguishment relating to SCI Third amendment

     1,917  

Change in Fair Value included in Other income (expense), net

     (358
  

 

 

 

Balance, December 31, 2021

   $ 4,955  
  

 

 

 

Fair Value Measurement The Company follows ASC 820 which establishes disclosure requirements and a common definition of fair value to be applied when U.S. GAAP requires the use of fair value. The ASC 820 fair value hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to measurements involving significant unobservable inputs (Level 3 measurements).

The three levels of the fair value hierarchy are as follows:

Level 1—Observable inputs that reflect quoted prices in active markets for identical assets or liabilities.

Level 2—Observable inputs that reflect quoted prices for identical assets and liabilities in markets that are not active, quoted prices for similar assets or liabilities in active markets, inputs other than quoted prices that are observable for the assets or liabilities, or inputs that are derived principally from or corroborated by observable market data by correlation or other means.

Level 3—Inputs that are generally unobservable and are supported by little or no market activity, and typically reflect management’s estimate of assumptions that market participants would use in pricing the asset or liability.

The level in the fair value hierarchy within which a fair value measurement in its entirety falls is based on the lowest-level input that is significant to the fair value measurement in its entirety.

The consolidated financial statements as of and for the years ended December 31, 2021, and 2020, do not include any nonrecurring fair value measurements relating to assets or liabilities.

 

27


There were no transfers between Level 1 or Level 2 of the fair value hierarchy during the years ended December 31, 2021 and 2020.

 

     As of December 31, 2021  
     Level 1      Level 2      Level 3      Total  

Financial liabilities:

           

Simple Agreement for Future Equity Note

   $ —        $ —        $ 34,001      $ 34,001  

Redeemable convertible preferred stock warrants liability

     —          —          4,955        4,955  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total financial liabilities

   $ —        $ —        $ 38,956      $ 38,956  
  

 

 

    

 

 

    

 

 

    

 

 

 
     As of December 31, 2020  
     Level 1      Level 2      Level 3      Total  

Financial liabilities:

           

SAFE Note

   $ —        $ —        $ 2,000      $ 2,000  

Redeemable convertible preferred stock warrants liability

     —          —          1,725        1,725  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total financial liabilities

   $ —        $ —        $ 3,725      $ 3,725  
  

 

 

    

 

 

    

 

 

    

 

 

 

The estimated fair values of SAFE notes as of December 31, 2021 and December 31, 2020, was determined to be same as face value.

As of December 31, 2021, the redeemable convertible preferred stock warrants were valued using the Black-Scholes option pricing model with the following assumptions:

 

     Years Ended December 31,  
     2021      2020  

Expected term (in years)

     5.98 -9.95      0.25 - 6.98  

Expected volatility

     54.0% - 57.7%        65.4% - 67.1%  

Risk-free interest rate

     1.35% - 1.52%        0.09% - 0.65%  

Expected dividend yield

     0%        0%  

9. REDEEMABLE CONVERTIBLE PREFERRED STOCK

As of December 31, 2021, the Company is authorized to issue 13,500,285 shares of redeemable convertible preferred stock with a par value of $0.001 per share (collectively, Preferred Stock). Redeemable convertible preferred stock as of December 31, 2021 and 2020, consisted of the following (in thousands, except share and per share data):

 

     As of December 31, 2021  
     Shares
Authorized
     Shares
Issued and
Outstanding
     Net Carrying
Value
     Conversion
Price Per
Share
     Aggregate
Liquidation
Preference
 

Series E-1

     7,324,607        5,348,050      $ 49,186      $ 9.17      $ 49,042  

Series D-1

     375,801        —          —          —          —    

Series C-1

     1,509,508        1,509,508        13,060        8.66        13,072  

Series B-1

     785,471        785,471        4,237        5.40        4,242  

Series A-1

     3,504,898        3,504,898        5,578        1.52        5,327  
  

 

 

    

 

 

    

 

 

       

 

 

 
     13,500,285        11,147,927      $ 72,061         $ 71,683  
  

 

 

    

 

 

    

 

 

       

 

 

 

 

 

28


     As of December 31, 2020  
     Shares
Authorized
     Shares
Issued and
Outstanding
     Net Carrying
Value
     Conversion
Price Per
Share
     Aggregate
Liquidation
Preference
 

Series E-1

     7,324,607        5,367,134      $ 49,054      $ 9.17      $ 49,217  

Series D-1

     375,801        —          —          —          —    

Series C-1

     1,509,508        1,509,508        13,055        8.66        13,072  

Series B-1

     785,471        750,177        4,037        5.40        4,051  

Series A-1

     3,504,898        3,293,628        5,006        1.52        5,006  
  

 

 

    

 

 

    

 

 

       

 

 

 
     13,500,285        10,920,447      $ 71,152         $ 71,346  
  

 

 

    

 

 

    

 

 

       

 

 

 

During March 2021, the Company issued 211,270 Series A-1 preferred stock and 35,294 Series B-1 preferred stock in connection with the exercise of warrants discussed in Note 8 above. Additionally, the Company entered into an agreement with an employee to reduce Series E-1 preferred stock by 19,084.

During March and April 2020, the Company issued 768,809 Series E-1 preferred stock at an issuance price of $9.17 per share for $6.7 million. Of the 768,809 shares, 32,715 shares were issued to a Board member as compensation.

The holders of Preferred Stock have the following rights, preferences, privileges and restrictions:

DividendsThe holders of the outstanding shares of Preferred Stock are entitled to receive, when and if declared by the Board of Directors, noncumulative dividends at the annual rate of 8% per share of Preferred Stock. Dividends on Preferred Stock are payable in preference to any dividends on common stock or Class B common stock. In any year, after payment of dividends on Preferred Stock, any additional dividends declared by the Board of Directors will be paid among the holders of Preferred Stock, common stock, and Class B common stock pro rata on an if-converted basis. No dividends have been declared or paid for the years ended December 31, 2021 and 2020.

LiquidationUpon liquidation, dissolution, or winding up of the Company, including a change of control of the Company, holders of Preferred Stock will be entitled to receive, on a pro rata basis, prior and in preference to any distribution to holders of any series of common stock, an amount equal to $9.17 per share of Series E-1, $8.66 per share of Series D-1, $8.66 per share of Series C-1, $5.40 per share of Series B-1 and $1.52 per share of Series A-1, plus any declared but unpaid dividends on such shares. If the assets and funds thus available for distribution among holders of Preferred Stock are insufficient to provide such holders their full aforesaid preferential amount, then the entire amount of the assets and funds of the Company legally available for distribution will be distributed ratably among all holders of Preferred Stock.

After the distribution to the holders of Preferred Stock, any remaining assets of the Company legally available for distribution will be distributed pro rata, on an if-converted basis, to all holders of common stock and Class B common stock.

ConversionEach share of Preferred Stock is convertible at the option of the holder into that number of common shares that is equal to the original issuance price of the Preferred Stock divided by the conversion price, as defined in the Company’s Certificate of Incorporation, subject to adjustment for events of dilution. Holders of Preferred Stock may elect to convert their shares into common stock at any time.

Each share of Preferred Stock will automatically convert into shares of common stock at the then effective conversion rate for each such share (i) immediately prior to the closing of a qualified public offering of the Company’s common stock in which gross proceeds exceed $15.0 million or (ii) upon the receipt by the Company of a written request for such conversion from the holders of a majority of the then outstanding Preferred Stock.

VotingEach share of Preferred Stock has voting rights equivalent to the number of shares of common stock into which it is convertible.

 

29


Protective ProvisionsAs long as 250,000 shares of Preferred Stock remain outstanding, the majority vote of the holders of the then outstanding shares of Preferred Stock is necessary for consummation of certain transactions, including but not limited to: increasing or decreasing the authorized capital stock; creating any senior or pari passu security, privileges, preferences or voting rights senior to or on parity with those granted to the Preferred Stock; altering or changing the preferred series rights; redeeming or repurchasing the Company’s equity securities; and entering into any transaction deemed to be a liquidation or dissolution of the Company.

RedemptionAt any time after 7 years from the issuance of respective series of Preferred Shares, the holders of a majority of the outstanding voting Preferred Stock Series may vote to require the Company to redeem all outstanding shares of Preferred Stock Series in three equal annual installments by paying in cash an amount per share equal to the original issuance price of the Preferred Stock Series, plus any accrued but unpaid dividends. If the Company does not have sufficient funds legally available to redeem all shares of Preferred Stock, then the Company will redeem the maximum possible number of shares ratably among the holders of such shares and will redeem the remaining shares as soon as sufficient funds are legally available. After 7 years from the issuance of respective series of Preferred Shares, the Preferred shares are then currently redeemable at the option of the holder and have been classified in the mezzanine section of the Consolidated Balance Sheets.

Preferred Shares are also contingently redeemable upon liquidation and certain deemed liquidation events such as acquisition, merger, consolidation or the sale, lease transfer, exclusive license or other disposition by the Company of all or substantially all of the assets of the Company. These events are outside the control of the Company and therefore the Preferred Stock have been classified in the mezzanine section of the Consolidated Balance Sheets.

The Company records its redeemable convertible preferred stock at the amount of cash proceeds received on the date of issuance, net of issuance costs. Since the preferred stock is probable of becoming redeemable at the option of the holder at a future date, accretion of the preferred stock will be recognized over the period of time from the date of issuance to the earliest redemption date. The accretion is recorded as additional paid-in capital. Accretion of preferred stock was $0.02 million and $0.04 million for the years ended December 31, 2021 and 2020, respectively.

 

10.

COMMON STOCK

As of December 31, 2021 and 2020, the Company is authorized to issue two classes of common stock, designated as common stock and Class B common stock. The two classes of common stock have similar rights, except holders of common stock are entitled to one vote per share while holders of Class B common stock have no voting rights. Each share of Class B common stock will automatically convert into one share of common stock immediately prior to a qualified initial public offering of the Company’s common stock or upon the consummation of a liquidation event (as defined in the Certificate of Incorporation). As of December 31, 2021 and 2020, the Company is authorized to issue 27,000,000 shares of common stock with a par value of $0.001 per share and 815 shares are designated as Class B common stock.

In April 2021, 25,000 warrants to purchase common stock were exercised. In March 2021, 12,674 warrants to purchase common stock expired unexercised.

 

11.

RELATED PARTY TRANSACTIONS

The Company defines related parties as directors, executive officers, nominees for director, stockholders that have significant influence over the Company, or are a greater than 5% beneficial owner of the Company’s capital and their affiliates or immediate family members. As of and for the years ended

 

30


December 31, 2021 and 2020, there were no significant related party transactions or balances other than the following:

As discussed in Note 7, in December 2018, the Company issued the 2018 Notes totaling approximately $3.4 million in exchange for cash. Three of the notes with aggregate principal of $0.2 million were issued to related parties including two officers and a trust affiliated with a Board member. The aggregate liability, inclusive of interest and principal accretion, totaled $0.4 million and $0.3 million as of December 31, 2021 and 2020, respectively. These amounts are included in the Consolidated Balance Sheets as Notes Payable, Net.

As discussed in Note 9, during March and April 2020, the Company issued 32,715 shares of Series E-1 preferred stock, at an issuance price of $9.17 per share, to a Board Member, as compensation for serving as President of the Company on an interim basis. Further as discussed in Note 9, in March 2021, the Company and the individual agreed to reduce the number of shares issued by 19,084.

 

12.

INCOME TAXES

Loss before provision for income taxes for the year ended December 31, 2021 and 2020, was as follows (in thousands):

 

         Years Ended December 31,      
         2021          2020      

Domestic

   $ (53,282    $ (23,452

Foreign

     (1,155      (323
  

 

 

    

 

 

 

Total

   $ (54,437    $ (23,775
  

 

 

    

 

 

 

The Company did not record a provision for income taxes for the year ended December 31, 2021. For the year ended December 31, 2020 the provision for income taxes was $0.1 million related to foreign withholding tax.

The reconciliation of federal statutory income tax rate to our effective income tax rate is as follows:

 

         Years Ended December 31,      
         2021         2020  

Income tax provision at statutory rate

     21.0     21.0

State income taxes, net of federal benefit

     5.0     3.2

Non-deductible expenses and other

     -0.4     -0.2

Non-deductible warrant expense

     0.2     1.0

Share-based compensation

     -0.8     -1.3

Change in valuation allowance, net

     -24.5     -23.3

Research and development credits

     0.1     0.1

Foreign rate differential

     -0.4     -0.4

Forgiveness PPP loan

     0.6     0.0

Expired loss carry forward

     -0.6     -0.5
  

 

 

   

 

 

 

Effective tax rate

     0.0     -0.3
  

 

 

   

 

 

 

The Company’s effective tax rate could also fluctuate due to changes in the valuation of its deferred tax assets or liabilities, or by changes in tax laws, regulations, and accounting principles.

 

31


Significant components of the Company’s deferred taxes as of December 31, 2021 and 2020 were as follows (in thousands):

 

     As of December 31,  
     2021      2020  

Deferred tax assets:

     

Net operating loss carryforwards

   $ 72,714      $ 61,488  

Operating lease liability

     508        647  

Property and equipment, net

     430        —    

Research and development credit carryforward

     672        597  

Inventory reserve

     1,499        1,506  

Accrued expenses and other reserves

     2,652        1,325  

Stock-based compensation

     2,086        1,876  
  

 

 

    

 

 

 

Total deferred tax assets

     80,561        67,439  

Deferred tax liabilities:

     

Property and equipment, net

     —          85  

Operating lease right-of-use assets

     426        552  
  

 

 

    

 

 

 

Total deferred tax liabilities

     426        637  

Gross deferred tax assets

     80,135        66,802  

Less valuation allowance

     (80,135      (66,802
  

 

 

    

 

 

 

Net deferred tax asset

   $ —        $ —    
  

 

 

    

 

 

 

The Company has established a valuation allowance to offset the gross deferred tax assets as of December 31, 2021 and 2020, due to the uncertainty of realizing future tax benefits from its net operating loss carryforwards and other deferred tax assets. The valuation allowance balance was $80.1 million and $66.8 million for the years ended December 31, 2021 and 2020, respectively.

In assessing the realizability of deferred income tax assets, the Company considered whether it is more likely than not that some portion or all of its deferred income tax assets will be realized. The ultimate realization of deferred income tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Due to the uncertainty surrounding the Company’s ability to realize such deferred income tax assets, a full valuation allowance has been established. The valuation allowance increased by $13.3 million during year ended December 31, 2021 and $5.5 million during year ended December 31, 2020.

As of December 31, 2021, the Company had federal net operating loss carryforward (“NOL”) of approximately $269.5 million which will begin to expire in 2023, a California net NOL of approximately $232.3 million which will start to expire, if not used, in 2028.

As of December 31, 2021, the Company had federal research and development credit carryforward (“R&D carryforward”) of approximately $1.8 million which will expire, if not used, in 2026, and a California R&D carryforward of approximately $1.6 million which can carry forward indefinitely.

As of December 31, 2020, the Company had federal a R&D carryforward of approximately $1.8 million which will expire, if not used, in 2026, and a California R&D carryforward of approximately $1.5 million which can carry forward indefinitely.

The utilization of the Company’s NOL’s and R&D carryforwards may be subject to limitation due to the “change in ownership provisions” under Section 382 of the Internal Revenue Code and similar foreign provisions. Such limitations may result in the expiration of these carryforwards before their utilization.

 

32


The Company is subject to income taxes in the U.S. federal jurisdiction, and various foreign jurisdictions. Tax regulations within each jurisdiction are subject to the interpretation of the related tax laws and regulations and require significant judgment to apply. The Company’s tax years remain open for examination by all tax authorities since inception. The Company is not currently under examination in any tax jurisdictions.

The Company had unrecognized tax benefits of $1.3 million for federal and $1.3 million for state related to R&D credits generated as of December 31, 2021. As of December 31, 2020, the total amount of unrecognized tax benefits for federal and state was $1.3 million and $1.3 million, respectively. The reversal of the uncertain tax benefits would not affect the Company’s effective tax rate to the extent that it continues to maintain a full valuation allowance against its deferred tax assets.

The Company applies the provisions set forth in FASB ASC Topic 740, Income Taxes, to account for the uncertainty in income taxes. In the preparation of income tax returns in federal and state jurisdictions, the Company asserts certain tax positions based on its understanding and interpretation of income tax laws. The taxing authorities may challenge such positions, and the resolution of such matters could result in recognition of income tax expense in the Company’s financial statements.

The following is a tabular reconciliation of the total amounts of unrecognized tax benefits (in thousands):

 

         Years Ended December 31,      
         2021          2020  

Unrecognized tax benefits as of beginning of year

   $ 2,649      $ 2,635  

Increases related to current year tax positions

     20        14  
  

 

 

    

 

 

 
   $ 2,669      $ 2,649  
  

 

 

    

 

 

 

The Company recognizes interest and penalties related to unrecognized tax benefits within the income tax expense line in the statements of operations. Accrued interest and penalties are included as part of income tax payable in the consolidated balance sheets. No accrued interest or penalties have been recorded for year ended December 31, 2021 or December 31, 2020.

The Company has not provided U.S. income or foreign withholding taxes on the undistributed earnings of its foreign subsidiary as of December 31, 2022 and December 31, 2021 because it intends to permanently reinvest such earnings outside of the United States. If these foreign earnings were to be repatriated in the future, the related U.S. tax liability will be immaterial, due to the participation exemption put in place under the 2017 Tax Cuts and Jobs Act.

On March 18, 2020, the Families First Coronavirus Response Act (FFCR Act) and, on March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) were each enacted in response to the COVID-19 pandemic. The FFCR Act and the CARES Act contain numerous income tax provisions relating to refundable payroll tax credits, deferment of employer side social security payments, net operating loss carryback periods, alternative minimum tax credit refunds, modifications to the net interest deduction limitations and technical corrections to tax depreciation methods for qualified improvement property. The Company analyzed the provisions of the Act and determined there was no significant impact to its 2020 or 2021 tax provision.

On June 29, 2020, the California Governor signed Assembly Bill 85 (“A.B. 85”) which includes several tax measures, provides for a three-year suspension of the use of net operating losses for medium and large businesses and a three-year cap on the use of business incentive tax credits to offset no more than $5 million of tax per year. Generally, A.B. 85 suspends the use of net operating losses for taxable years 2020, 2021, and 2022 for taxpayers with taxable income of $1.0 million or more. The Company analyzed the provisions of the A.B. 85 and determined there was no significant impact to its 2021 or 2020 tax provision.

 

33


On December 27, 2020, the “Consolidated Appropriations Act, 2021” (the “CAA”) was signed into law. The CAA includes provisions meant to clarify and modify certain items put forth in CARES Act, while providing aid to businesses affected by the pandemic. The CAA allows deductions for expenses paid for by Paycheck Protection Program (“PPP”) and Economic Injury Disaster Loan (“EIDL”) Program, clarifies forgiveness of EIDL advances, and other business provisions. The Company analyzed the provisions of the CAA and determined there was no significant impact to its 2021 and 2020 tax provision.

 

13.

STOCK-BASED COMPENSATION

The Company has two stock option plans: the 2006 Stock Option Plan and the 2016 Stock Option Plan (collectively, the Plans). Options granted under the Plans may be either incentive stock options (ISOs) or nonqualified stock options (NSOs). ISOs may be granted only to Company employees (including officers and directors who are also employees). NSOs may be granted to Company employees, directors and consultants. Options under the Plans may be granted with contractual terms of up to ten years (five years if granted to holders of more than 10% of the Company’s vesting stock). All options issued through December 31, 2021 have a ten-year contractual term. The exercise price of an ISO and NSO will not be less than 100% and 85% of the estimated fair value of the shares on the date of grant, respectively, as determined by the Company’s Board of Directors.

The exercise price of an ISO and NSO granted to a 10% stockholder will not be less than 110% of the estimated fair value of the shares on the date of grant, as determined by the Board of Directors. Options generally vest over four to five years at a rate of 20% to 25% upon the first anniversary of the commencement date and monthly thereafter.

As of December 31, 2021 and 2020, there were 335,538 and 577,568 shares of common stock available to be granted under the Plan.

The Company estimated the fair values of each option awarded on the date of grant using the Black-Scholes-Merton option pricing model utilizing the assumptions noted below. The expected term of the options is based on the average period the stock options are expected to remain outstanding calculated as the midpoint of the options vesting term, and contractual expiration period, as the Company did not have sufficient historical information to develop reasonable expectations about future exercise patterns and post vesting employment termination behavior. The expected stock price volatility for the Company’s stock was determined by examining the historical volatilities of its industry peers as the Company did not have any trading history of its common stock. The risk-free interest rate was calculated using the average of the published interest rates for U.S. Treasury zero-coupon issues with maturities that approximate the expected term. The dividend yield assumption is zero as the Company has no history of, nor plans of, dividend payments. The estimated forfeiture rates are based on the Company’s historical forfeiture activity of unvested stock options.

The assumptions used under the Black-Scholes-Merton option pricing model and the weighted average calculated fair value of the options granted to employees for the years ended December 31, 2021 and 2020 are as follows:

 

         Years Ended December 31,      
     2021     2020  

Grant date fair value

   $ 1.00     $ 1.56  

Expected term (in years)

     6.04       5.97  

Expected volatility

     60     56

Risk-free interest rate

     1.19     0.85

Expected dividend yield

     0     0

 

 

34


A summary of the Company’s stock option and restricted stock unit activity and related information for the years ended December 31, 2021 and 2020 is as follows:

 

     Options outstanding     Restricted stock units  
     Number of
shares
    Weighted
average exercise
price
    Weighted
average
remaining
contractual
term (years)
    Aggregate
intrinsic
values
($‘000s)
    Number of
plan shares
outstanding
    Weighted
average grant

date fair value
per share
 

Balances, December 29, 2019

     4,397,782     $ 3.60       8.46     $ 3,802       —       $ —    

Options granted

     3,042,592       3.01           120,000       3.91  

Options exercised

     (25,000     0.40          

Options forfeited

     (1,290,613     4.42          
  

 

 

         

 

 

   

Balances, December 31, 2020

     6,124,761       3.15       8.30       942       120,000       3.91  

Options granted

     2,700,752       1.78          

Options exercised

     (159,583     2.31          

Options forfeited

     (1,781,017     3.20          
  

 

 

   

 

 

       

 

 

   

Balances, December 31, 2021

     6,884,913       2.62       8.01       288       120,000       3.91  
  

 

 

         

 

 

   

Options vested and exercisable — December 31, 2020

     2,633,335       3.19       7.25       942      

Options vested and exercisable — December 31, 2021

     3,727,228       2.85       7.31       288      

Stock-based compensation is allocated on a departmental basis, based on the classification of the option holder or grant recipient. No income tax benefits have been recognized in the statements of operations for stock-based compensation arrangements and no stock-based compensation costs are capitalized as part of inventory or property and equipment as of December 31, 2021 and 2020.

Stock-based compensation expense is as follows for the years ended December 31, 2021 and 2020 in thousands):

 

         Years Ended December 31,      
         2021          2020      

Cost of revenues

   $ 119      $ 147  

Research and development

     456        539  

Sales and marketing

     638        684  

General and administrative

     1,586        1,647  
  

 

 

    

 

 

 

Total stock-based compensation

   $ 2,799      $ 3,017  
  

 

 

    

 

 

 

Future stock-based compensation for unvested options granted and outstanding as of December 31, 2021 is $3.4 million to be recognized over the weighted-average remaining requisite service period of 2.83 years. The aggregate intrinsic value of options exercised was zero and $0.1 million for the years ended December 31, 2021 and 2020, respectively.

 

14.

COMMITMENTS AND CONTINGENCIES

As more fully discussed in Note 3, Solar Park has asserted damages of $30.0 million against the Company in response to the Company’s arbitration claim seeking approximately $47.0 million in damages against Solar Park. The Company believes that the allegations lack merit and intends to vigorously defend all claims asserted. No liability has been recorded in the Company’s consolidated financial statements as the

 

35


likelihood of a loss is not probable at this time; and the Company does not believe a reasonably possible loss would be material to, nor does it expect the ultimate resolution of these cases will have a material adverse effect on, the Company’s financial condition, results of operations or cash flows.

As of December 31, 2021, the Company was contesting a $1.8 million liability to a vendor for the purchase of factory equipment which was intended to be used in Solar Park. The $1.8 million liability was included in the December 31, 2021 Consolidated Balance Sheet as Accrued Expenses and Other Current Liabilities of $1.7 million and Other Liabilities, noncurrent of $0.1 million. As of December 31, 2020 the liability was $1.6 million and was included in the Consolidated Balance Sheet as Accrued Expenses and Other Liabilities of $1.3 million and Other Liabilities, noncurrent of $0.3 million. On January 10, 2023, the Company reached an agreement with the vendor which reduced the liability from $1.8 million to $0.9 million.

In July 2020, the Company became aware that it might be subject to Antidumping and Countervailing Duties (“ADCVD”) on certain components manufactured in China and used in the solar panel production process in Korea. The Company applied for a definitive ruling from the U.S. Department of Commerce (“DoC”) while in parallel shifting its component supply from China. The DoC issued its ruling in April 2021. Because of the specificity of the DoC ruling in the Solaria case and prior case law under similar circumstances, the Company concluded that such ADCVD was not probable to be incurred for purchases in periods prior to the DoC ruling and immediately started paying appropriate ADCVD deposits on all entries after April 2021. No liability has been recorded in the Company’s consolidated financial statements as the likelihood of a loss is not probable at this time.

The Company is involved in other lawsuits and claims which arise in the normal course of business. These claims individually and in the aggregate are not expected to result in a material effect on the Company’s financial condition, results of operations or cash flows.

The Company had $4.5 million of outstanding letters of credit related to normal business transactions as of December 31, 2021. These agreements require the Company to maintain specified amounts of cash as collateral in segregated accounts to support the letters of credit issued thereunder. As discussed in Note 2, the cash collateral in these restricted cash accounts was $4.8 million and $3.7 million as of December 31, 2021 and 2020, respectively.

 

15.

EMPLOYEE BENEFIT PLAN

The Company has a 401(k) plan to provide defined contribution retirement benefits for all employees. Participants may contribute a portion of their compensation to the plan, subject to limitations under the Code. The Company’s contributions to the plan are at the discretion of the Board of Directors. The Company has not made any contributions to the plan since inception.

 

16.

GEOGRAPHIC INFORMATION

The following table summarize revenues by geographic area (in thousands):

 

     Years Ended December 31,  
     2021     2020  
     Amount      Percent     Amount      Percent  

Total revenue, net

                          

United States

   $ 56,577        94.7   $ 46,158        95.5

Europe

     2,888        4.8     1,262        2.6

Australia

     298        0.5     908        1.9
  

 

 

    

 

 

   

 

 

    

 

 

 

Total

   $ 59,763        100.0   $ 48,328        100.0
  

 

 

    

 

 

   

 

 

    

 

 

 

 

 

36


17.

SUBSEQUENT EVENTS

Management has evaluated subsequent events through February 9, 2023, the date of issuance of these financial statements and has determined that there are no subsequent events outside the ordinary scope of business that require adjustment to, or disclosure in, the financial statements other than those described below.

In January 2022, the PPP Loan principal and accrued interest was forgiven in full.

Effective March 23, 2022, the Company’s board of directors approved an offer, to certain eligible employees, to exchange existing stock options, with an exercise price above $1.36, for new replacement stock options. The exercise price of the replacement stock options is $1.36 per share, which was the estimated fair market value on the exchange date, as determined with assistance from third-party valuation specialists. Eligible employees elected to exchange an aggregate of 991,195 outstanding stock options, with exercise prices ranging from $1.64 to $3.91 per share, for new replacement stock options. The replacement stock options have a grant date of March 23, 2022 and a contractual term of 10 years. The exchange offer applied to both vested and unvested shares. Previously vested shares were exchanged for vested replacement stock options. Unvested shares were exchanged for shares which vest in accordance with the board-approved grant approval schedule with the service period ranging from 1.0 to 4.3 years. The repricing was accounted for as a modification and resulted in incremental stock-based compensation expense of $0.4 million.

In April 2022, the Company entered into an amendment to the Original Agreement (“Fourth Amendment”) as a forbearance agreement for SCI to forbear from exercising any rights and remedies available to it as a result of the Company not meeting certain Financial Covenants required by the Original Agreement. As a result of this amendment, changes were made to the financial covenants. The Company paid $0.15 million in amendment fee related to the Fourth Amendment.

In June 2022, the Company entered into an amendment to the Original Agreement (“Fifth Amendment”) related to SCI which resulted in certain changes to financial covenants including updates to quarterly revenue requirements and contribution margin requirements.

In May 2022, the Company issued a secured promissory note to a trust affiliated with Thurman J. (T.J.) Rodgers, a director of Solaria amounting to $6.5 million in exchange for cash. The secured promissory note accrues paid-in-kind interest at a rate of 7.5% per annum and the note had an original maturity date of July 11, 2022. In conjunction with the Agreement and Plan of Merger with Complete Solar discussed below, both the parties agreed to extend the note term beyond its original maturity date. The secured promissory note with the original principal value of $6.5 million and paid-in-kind interest of $0.2 million was finally terminated in October 2022, in exchange for the issuance of a new convertible note by Complete Solar.

In June 2022, as discussed in Notes 3 and 15, the Company filed a notice of arbitration with the Singapore International Arbitration Centre (“SIAC”) seeking approximately $47.0 million in damages against Solar Park in connection with the write-downs described in Note 3 and other costs related to the loss of Solar Park’s production and transition to a new provider. Solar Park filed a response with SIAC in June 2022 asserting damages of approximately $30.0 million against the Company. The parties stayed the arbitration to attend a mediation in early 2023, which was not successful. The arbitration is scheduled for February 2024.

In September 2022, the Company paid off the total outstanding principal and interest of the Term Loan related to the Loan Agreement with SCI in the amount of $2.8 million.

In October 2022, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Complete Solar and formed Complete Solaria. As a result, the Company became a wholly-owned indirect subsidiary of Complete Solaria effective on the date of consummation of the merger in November 2022.

In October 2022, the Company entered into an amendment to the Original Agreement (“Sixth Amendment”) related to SCI, which resulted in removal of certain financial covenants related to revenue and contribution margin requirements.

 

37


In November 2022 Complete Solaria entered into a definitive business combination agreement with Freedom Acquisition I Corp. (NYSE: FACT) (“Freedom”), a Special Purpose Acquisition Company (“SPAC”). Upon closing of the business combination, which is expected in the first half of 2023, the combined Company is expected to be listed on the New York Stock Exchange under the new ticker “CSLR”.

In November 2022, the Company entered into an amendment to the 2018 Notes extending the maturity date from December 13, 2022 to December 13, 2023. In connection with the amendment, the terms of the notes will continue to bear interest at 8% per annum and are entitled to a repayment premium of 120% of the principal and accrued interest due. Additionally, in connection with the amendment and cancellation of 196,462 shares of Series E-1 warrants of Solaria, Complete Solaria, issued warrants to purchase 304,234 shares of Series D-7 preferred stock at $3.84 per share.

 

38


THE SOLARIA CORPORATION AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except par value and share amounts)

 

     September 30,
2022
    December 31,
2021
 

ASSETS

    

CURRENT ASSETS:

    

Cash and cash equivalents

   $ 2,107     $ 9,113  

Accounts receivable, net

     3,885       6,288  

Inventory, net

     4,010       16.928  

Prepaid expenses and other current assets

     10,442       2,053  
  

 

 

   

 

 

 

Total current assets

     20,444       34,382  

Restricted cash

     3,742       4,802  

Operating lease right-of-use assets, net and other noncurrent assets

     1,571       1,755  

Property and equipment, net

     836       999  
  

 

 

   

 

 

 

TOTAL ASSETS

   $ 26,593     $ 41,938  
  

 

 

   

 

 

 

LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ DEFICIT

    

CURRENT LIABILITIES:

    

Accounts payable

   $ 2,386     $ 5,489  

Accrued expenses and other current liabilities

     11,383       11,713  

Deferred revenue

     73       75  

Notes payable, net

     15,760       10,912  

Operating lease liability

     324       283  
  

 

 

   

 

 

 

Total current liabilities

     29,926       28,472  

NONCURRENT LIABILITIES:

    

Redeemable convertible preferred stock warrants liability

     4,180       4,955  

Operating lease liability, net of current portion

     1,427       1,674  

Other liabilities, noncurrent

     3,374       2,341  

Notes payable, net of current portion

     55,187       41,197  
  

 

 

   

 

 

 

Total liabilities

     94,094       78,639  
  

 

 

   

 

 

 

COMMITMENTS AND CONTINGENCIES (NOTE 13)

    

MEZZANINE REDEEMABLE CONVERTIBLE PREFERRED STOCK

    

Redeemable convertible preferred stock: par value of $0.001 per share; 13,500,285 shares authorized as of September 30, 2022 and December 31, 2021; 11,147,927 issued and outstanding as of September 30, 2022 and December 31, 2021; aggregate liquidation value of $71.7 million as of September 30, 2022 and December 31, 2021

     72,070       72,061  
  

 

 

   

 

 

 

STOCKHOLDERS’ DEFICIT

    

Common stock; par value $0.001 per share; 27,000,000 shares authorized as of September 30, 2022 and December 31, 2021; 3,412,907 and 2,001,357 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively

     523       521  

Class B common stock; par value $0.001 per share; 815 shares authorized as of September 30, 2022 and December 31, 2021; 815 shares issued and outstanding as of September 30, 2022 and December 31, 2021

     1       1  

Additional paid-in capital

     179,388       178,309  

Accumulated other comprehensive loss

     71       (55

Accumulated deficit

     (319,554     (287,538
  

 

 

   

 

 

 

Total stockholders’ deficit

     (139,571     (108,762
  

 

 

   

 

 

 

TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ DEFICIT

   $ 26,593     $ 41,938  
  

 

 

   

 

 

 

See accompanying notes to unaudited condensed consolidated financial statements

 

39


THE SOLARIA CORPORATION AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (In thousands)

 

     Nine Months Ended
September 30,
 
     2022     2021  

Product revenue, net

   $ 30,826     $ 47,961  

Cost of revenue

     31,504       48,664  
  

 

 

   

 

 

 

Gross loss

     (678     (703

Operating expenses

    

Research and engineering

     3,180       3,332  

Sales and marketing

     4,517       5,571  

General and administrative

     7,284       6,695  

Litigation-related costs

     451       5,395  

Transaction-related costs

     1,893       —    
  

 

 

   

 

 

 

Total operating expenses

     17,325       20,993  

Loss from operations

     (18,003     (21,696

Interest expense

     (2,941     (3,735

Interest income

     10       4  

Change in fair value of Simple Agreement for Future Equity (SAFE) Notes

     (14,229     —    

Loss on extinguishment of debt (Note 6)

     —         (2,967

Other income, net

     2,096       1,725  
  

 

 

   

 

 

 

Total other expense, net

     (15,064     (4,973
  

 

 

   

 

 

 

Loss before provision for income taxes

     (33,067     (26,669

Provision for income taxes

     —         —    
  

 

 

   

 

 

 

Net loss

     (33,067     (26,669

OTHER COMPREHENSIVE INCOME (LOSS):

    

Currency translation adjustment, net of tax effect of $0, for the nine months ended September 30, 2022 and 2021

     126       (42
  

 

 

   

 

 

 

Net loss and comprehensive loss

     (32,941     (26,711

Redeemable convertible preferred stock accretion

     (9     (16
  

 

 

   

 

 

 

Net loss and comprehensive loss to common stockholders

   $ (32,950   $ (26,727
  

 

 

   

 

 

 

See accompanying notes to unaudited condensed consolidated financial statements

 

40


THE SOLARIA CORPORATION. AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ DEFICIT

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2022 AND 2021

(In thousands, except number of shares)

 

     Redeemable Convertible
Preferred Stock
     Common Stock      Class B Common
Stock
     Additional
Paid-
in Capital
    Accumulated
Other
Comprehensive
Loss
    Accumulated
Deficit
    Total
Stockholders’
Deficit
 
     Shares     Amount      Shares     Amount      Shares      Amount      Amount     Amount     Amount     Amount  

Balance at December 31, 2020

     10,920,447     $ 71,152        1,841,452     $ 521        815      $ 1      $ 175,285     $ (68   $ (233,101)     $ (57,362

Exercise of warrants

     246,564       762        25,000       —          —          —          2       —         —         2  

Exercise of options

     —         —          89,583       —          —          —          255       —         —         255  

Repurchase of common stock

     —         —          (24,678     —          —          —          —         —         —         —    

Rescission of Series E-1 redeemable convertible preferred stock

     (19,084     —          —         —          —          —          —         —         —         —    

Stock- based compensation

     —         —          —         —          —          —          1,947       —         —         1,947  

Currency translation adjustment

     —         —          —         —          —          —          —         (42     —         (42

Redeemable convertible preferred stock accretion

     —         16        —         —          —          —          (16     —         —         (16

Net loss

     —         —          —         —          —          —          —         —         (26,669     (26,669
  

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

Balance at September 30, 2021

     11,147,927     $  71,930        1,931,357     $ 521        815      $ 1      $  177,473     $ (110   $  (259,770)     $ (81,885
  

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

Balance at December 31, 2021

     11,147,927     $ 72,061        2,001,357     $ 521        815      $ 1      $ 178,309     $ (55   $ (287,538)     $ (108,762

Adoption of ASU 2020-06

     —         —          —         —          —          —          (1,051     —         1,051       —    

Exercise of warrants

     —         —          1,311,651       2        —          —          128       —         —         130  

Repurchase of common stock

     —         —          (101     —          —          —          —         —         —         —    

Stock- based compensation

     —         —          100,000       —          —          —          2,011       —         —         2,011  

Currency translation adjustment

     —         —          —         —          —          —          —         126       —         126  

Redeemable convertible preferred stock accretion

     —         9        —         —          —          —          9       —         —         (9

Net loss

     —         —          —         —          —          —          —         —         (33,067     (33,067
  

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

Balance at September 30, 2022

     11,147,927     $ 72,070        3,412,907     $ 523        815      $ 1      $ 179,388     $ 71     $ (319,554)     $ (139,571
  

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

See accompanying notes to the unaudited condensed consolidated financial statements

 

41


THE SOLARIA CORPORATION AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

 

     Nine Months Ended
September 30,
 
     2022     2021  

Cash Flows from Operating Activities

    

Net loss

   $ (33,067   $ (26,669

Adjustments to reconcile net loss to net cash used in operating activities:

    

Debt amortization and non- cash interest expense

     2,337       2,742  

Loss on extinguishment of debt

     —         2,967  

Stock- based compensation

     2,011       1,947  

Change in fair value of redeemable convertible preferred stock warrant liability

     (775     (339

Bad debt expense

     472       —    

Depreciation expense

     219       918  

Change in fair value of SAFE Notes

     14,229       —    

Forgiveness of Paycheck Protection Plan Loan

     (1,414     (1,433

Noncash operating lease expense

     184       261  

Other

     44       23  

Changes in operating assets and liabilities:

       —    

Accounts receivable, net

     1,930       1,121  

Inventory, net

     12,918       (10,759

Prepaid expenses and other current assets

     (8,388     3,923  

Accounts payable

     (3,103     (162

Accrued expenses and other current liabilities

     (572     1,714  

Deferred revenue

     (1     (1,995

Operating lease liability

     (207     (286

Other liabilities, noncurrent

     1,035       401  
  

 

 

   

 

 

 

Net cash used in operating activities

     (12,148     (25,626

Cash Flows from Investing Activities

    

Purchases of property and equipment

     (207     (1,436

Proceeds from sale of property and equipment

     151       248  
  

 

 

   

 

 

 

Net cash used in investing activities

     (56     (1,188

Cash Flows from Financing Activities

    

Proceeds from issuance of notes payable, net

     8,500       33,415  

Repayment of notes payable, net

     (4,618     —    

Proceeds from exercise of redeemable convertible preferred stock warrants

     —         515  

Proceeds from exercise of stock options

     130       255  
  

 

 

   

 

 

 

Net cash provided by financing activities

     4,012       34,185  
  

 

 

   

 

 

 

Effect of Exchange Rate Changes

     126       (42

Net Change in Cash, Cash Equivalents and Restricted Cash

     (8,066     7,329  

Cash, Cash Equivalents and Restricted Cash, beginning of year

     13,915       13,549  
  

 

 

   

 

 

 

Cash, Cash Equivalents and Restricted Cash, end of year

   $ 5,849     $ 20,878  
  

 

 

   

 

 

 

Non- Cash Investing and Financing Activities

    

Forgiveness of Paycheck Protection Plan Loan

   $ (1,414   $ (1,433
  

 

 

   

 

 

 

See accompanying notes to the unaudited condensed consolidated financial statements

 

42


THE SOLARIA CORPORATION AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF SEPTEMBER 30, 2022 AND DECEMBER 31, 2021 AND

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2022 AND 2021

(In thousands, except share and per share amounts)

 

1.

ORGANIZATION

Description of Business

The Solaria Corporation was incorporated as a Delaware corporation on May 5, 2006. The Solaria Corporation (together with its subsidiaries, the “Company” or “Solaria”) designs, develops, manufactures, and generates revenue from the sale of silicon photovoltaic solar panels and licensing of its technology to third parties. The Company operates from its headquarters in Fremont, California.

Liquidity and Going Concern — Since inception, the Company has incurred recurring losses and negative cash flows from operations. The Company incurred net losses of $33.1 million and $26.7 million during the nine months ended September 30, 2022 and 2021, respectively, and had an accumulated deficit of $319.5 million as of September 30, 2022. The Company had cash and cash equivalents of $2.1 million as of September 30, 2022. Historically, the Company’s activities have been financed through private placements of equity securities and debt. The Company expects to incur significant operating expenses as it continues to grow its business. The Company believes that its operating losses and negative operating cash flows will continue into the foreseeable future. The Company’s history of recurring losses, negative operating cash flows and the need to raise additional funding to finance its operations raise substantial doubt about the Company’s ability to continue as a going concern. The Company’s ability to continue as a going concern requires that the Company obtain sufficient funding to finance its operations.

As more fully described in Note 16, the Company was acquired by Complete Solar Holding Corporation (“Complete Solar”) in November 2022 and formed Complete Solaria, Inc. (“Complete Solaria”). As a result, the Company became a wholly-owned indirect subsidiary of Complete Solaria at that time. Subsequent to the acquisition, the combined company does business as Complete Solaria. As discussed in Note 16, Complete Solaria’s plan is to seek additional funding through completion of a business combination with Freedom Acquisition Corp. (“Freedom”), a special purpose acquisition corporation (“SPAC”). At this time, Complete Solaria is focused on completing the business combination, which is subject to approval of the shareholders of both companies, regulatory approval from the Securities and Exchange Commission (“SEC”) and other customary closing conditions and is limited in its efforts to raise additional capital from secondary sources.

If Complete Solaria fails to complete this business combination, it plans to continue to fund its operations and capital funding needs through a combination of private equity offerings, debt financings and other sources. If Complete Solaria is not able to secure adequate additional funding when needed, it will need to reevaluate its operating plan and may be forced to make reductions in spending, extend payment terms with suppliers, liquidate assets where possible, or suspend or curtail planned programs or cease operations entirely. These actions could materially impact Complete Solaria and its subsidiary Solaria’s, results of operations and future prospects.

While Complete Solaria and Solaria have historically been able to raise multiple rounds of financing, there can be no assurance that in the event additional financing is required, such financing will be available on terms that are favorable, or at all. Failure to generate sufficient cash flows from operations, raise additional capital or reduce certain discretionary spending would have a material adverse effect on Complete Solaria and its subsidiary Solaria’s ability to achieve their intended business objectives.

Therefore, there is substantial doubt about Solaria’s ability to continue as a going concern within one year after the date that the financial statements are issued. The accompanying financial statements have been prepared assuming Solaria will continue to operate as a going concern, which contemplates the realization of assets and settlement of liabilities in the normal course of business. They do not include any adjustments

 

43


to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from uncertainty related to its ability to continue as a going concern.

 

2.

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation— The Company’s unaudited condensed consolidated financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Solaria Australia Pty. Ltd and TSC PowerHome BVd PLV Inc. All intercompany balances and transactions have been eliminated in consolidation.

Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. Accordingly, these unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and accompanying notes for the years ended December 31, 2021 and 2020. The unaudited condensed consolidated balance sheet as of December 31, 2021, included herein, was derived from the audited consolidated balance sheet of the Company as of that date. In the opinion of management, these unaudited condensed consolidated financial statements reflect all normal recurring adjustments, or a description of the nature and amount of any adjustments other than normal recurring adjustments, necessary to present fairly the Company’s financial position as of September 30, 2022 and December 31, 2021, the Company’s results of operations and comprehensive loss, redeemable convertible preferred stock and stockholders’ deficit activities, and cash flows for the nine months ended September 30, 2022 and 2021.

Significant Risks and Uncertainties— The Company is subject to a number of risks that are similar to those which other companies of similar size in its industry are facing, including, but not limited to, the need for successful development of products, the need for additional capital (or financing) to fund operations, competition from substitute products and services from larger companies, ability to develop sales channels and to onboard channel partners, as defined, protection of proprietary technology, patent litigation, dependence on key customers, dependence on key individuals, and risks associated with changes in information technology.

In March 2020, the World Health Organization declared the outbreak of a novel corona virus as a pandemic. The pandemic has reached every region of the world and has resulted in widespread impacts on the global economy. In response, the Company has modified certain business and workforce practices (including discontinuing non-essential business travel, implementing a temporary work-from-home policy for employees who can execute their work remotely and encouraging employees to adhere to local and regional social distancing guidelines, more stringent hygiene and cleaning protocols across the Company’s facilities and operations and self-quarantining recommendations) to conform to restrictions and best practices encouraged by governmental and regulatory authorities.

The quarantine of personnel or the inability to access the Company’s facilities or customer sites could adversely affect the Company’s operations. As of the date of this report, the Company’s efforts to respond to the challenges presented by the conditions described above have allowed the Company’s to minimize the impacts of these challenges to its business.

Concentration of Credit Risk— Financial instruments that potentially subject the Company to concentration of credit risk consist of cash and cash equivalents and accounts receivable. Concentration risk for cash and cash equivalents is mitigated by banking with a creditworthy financial institution. At times, cash deposits have exceeded the federally insurable limit; however, the Company has not experienced any losses on its cash deposits and cash equivalents since inception. The Company generally does not require collateral or other security to support its accounts receivable. Credit is extended to customers based on an evaluation of their financial condition and other factors. The Company performs ongoing credit evaluations of its customers and maintains an allowance for doubtful accounts as appropriate.

 

44


The Company had two major customers for the nine months ended September 30, 2022 and 2021, respectively. Major customers are defined as customers generating revenue greater than 10% of the Company’s product revenue. Revenue from the major customers accounted for 76% and 79% of revenue for the nine months ended September 30, 2022 and 2021, respectively. Accounts receivable from the two major customers totaled $2.2 million and $3.6 million as of September 30, 2022 and December 31, 2021, respectively.

Use of Estimates—The preparation of unaudited condensed consolidated financial statements in accordance with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements, and the reported amounts of income and expense during the reporting period. Such estimates include warranty cost, allowances for doubtful accounts, determination of the net realizable value of inventory, determination of the useful lives of property and equipment, assessment of the recoverability and fair values of property and equipment, valuation of deferred tax assets and liabilities, estimation of other accruals and reserves, determination of the fair value of debt, redeemable convertible preferred stock, common stock, simple agreements for future equity, stock option and restricted stock grants, and redeemable convertible preferred stock and common stock warrants. Management evaluates its estimates and assumptions on an ongoing basis using historical trends, market pricing, current events and other relevant assumptions and data points. Actual results could differ from those estimates and such differences may be material to the unaudited condensed consolidated financial statements.

Transaction-Related Costs – Such costs primarily consist of legal and professional fees incurred in connection with the Company’s merger with Complete Solar which is discussed in Note 16.

Significant Accounting Policies – There have been no material changes in the significant accounting policies described in our audited financial statements for the years ended December 31, 2021 and 2020.

Accounting Pronouncements Recently Adopted — In August 2020, the FASB issued ASU 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”). The amendments in ASU 2020-06 simplify accounting for convertible instruments by removing major separation models required under current U.S. GAAP. Consequently, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded conversion features. ASU 2020-06 removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception. Also, ASU 2020-06 requires the application of the if-converted method for calculating diluted earnings per share and the treasury stock method will no longer be available. ASU 2020-06 is effective for interim and annual reporting periods beginning after December 15, 2023, with early adoption permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal year. The Company adopted the new standard on January 1, 2022 under the modified retrospective approach resulting in a cumulative catch-up adjustment of $1.1 million to accumulated deficit and additional paid-in capital as of the date of adoption related to the beneficial conversion feature related to the 2018 Bridge Notes as discussed in Note 6.

In May 2021, the FASB issued ASU 2021-04, Earnings Per Share (Topic 260), Debt—Modifications and Extinguishments (Subtopic 470-50), Compensation—Stock Compensation (Topic 718), and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options (a consensus of the FASB Emerging Issues Task Force). This guidance clarifies certain aspects of the current guidance to promote consistency among reporting of an issuer’s accounting for modifications or exchanges of freestanding equity-classified written call options (for example, warrants) that remain equity classified after modification or exchange. The amendments in this update are effective for all entities for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is

 

45


permitted for all entities, including adoption in an interim period. The Company adopted ASU 2021-04 under the private company transition guidance beginning January 1, 2022, the adoption did not have an impact on the Company’s financial statements.

In December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes, which simplifies the accounting for income taxes, eliminates certain exceptions within ASC 740, Income Taxes, and clarifies certain aspects of the current guidance to promote consistency among reporting entities. ASU 2019-12 is effective for fiscal years beginning after December 15, 2021 and for interim periods within fiscal years beginning after December 15, 2022. Most amendments within this accounting standard are required to be applied on a prospective basis, while certain amendments must be applied on a retrospective or modified retrospective basis. The Company adopted ASU 2019-12 under the private company transition guidance beginning January 1, 2022, the adoption did not have an impact on the Company’s financial statements.

Recent Accounting Pronouncements Not Yet Adopted

In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which amends the FASB’s guidance on the impairment of financial instruments. Topic 326 adds to GAAP an impairment model (known as the “current expected credit loss model”) that is based on expected losses rather than incurred losses. ASU 2016-13 is effective for the Company’s annual and interim periods beginning after December 15, 2022 with early adoption permitted. The Company does not expect to early adopt the new standard. The Company is currently evaluating the impact of ASU 2016-13 on its unaudited condensed consolidated financial statements.

 

3.

REVENUE

The Company generates revenues from the sale of silicon photovoltaic solar panels and licensing of the Company’s technology to third parties.

Product SalesThe Company recognizes revenue from sales of products as control is transferred to customers, which generally occurs upon delivery to the customer’s premises. Other than standard warranty obligations, there are no rights of return or significant post-shipment obligations with respect to the Company’s products. Contracts with customers consist of a single performance obligation, hence the entire transaction price is allocated to this single performance obligation. In determining the transaction price in contracts with customers, the Company reduces revenue for the estimated costs of customer and distributor programs and incentive offerings such as price protection and rebates. Any provision for customer and distributor programs and other discounts is recorded as a reduction of revenue at the time of sale based on an evaluation of the contract terms and historical experience.

License Revenue The Company derives revenue from the licensing of the Company’s technology to third parties. Revenue from functional IP licensing arrangements is recognized at a point in time when control over the licensed technology is transferred to the customer. License fees, i.e., royalties, that are not fixed at contract inception are recognized over time upon occurrence of the later of the subsequent technology sale or usage, or satisfaction of the performance obligation to which some or all of the usage-based royalty relates. In March 2022, the Company settled litigation with a customer in relation to an arrangement for which $4.5 million had been recognized in license revenue in fiscal year 2019. The $0.45 million loss incurred upon settlement is included in General and administrative expenses in the Unaudited Condensed Consolidated Statement of Operations and Comprehensive Loss for the nine months ended September 30, 2022. The Company recognized license revenue amounting to $0.01 million and $0.02 million for the nine months ended September 30, 2022, and 2021, respectively.

 

46


Disaggregated revenue by primary geographical market and business activity are as follows (in thousands):

 

     Nine months ended
September 30,
 
     2022      2021  

Primary geographical markets

     

U.S.

   $         26,566      $         46,159  

International

     4,260        1,802  
  

 

 

    

 

 

 

Total

   $ 30,826      $ 47,961  
  

 

 

    

 

 

 

Product sales

   $ 30,817      $ 47,938  

Royalty

     9        23  
  

 

 

    

 

 

 

Total revenue

   $ 30,826      $ 47,961  
  

 

 

    

 

 

 

Contract Balances Contract liabilities consist of deferred revenue or customer deposits and relate to amounts invoiced-to or advance consideration received from customers, which precede the Company’s satisfaction of the associated performance obligation(s).

The following table is a rollforward of deferred revenue as of September 30, 2022 and December 31, 2021 (in thousands):

 

     September 30,      December 31,  
     2022      2021  

Deferred revenue—beginning balance

   $ 75      $ 2,070  

Additions

     291        1,494  

Revenue recognized

     (293      (3,489
  

 

 

    

 

 

 

Deferred revenue—ending balance

   $ 73      $ 75  
  

 

 

    

 

 

 

As of September 30, 2022 and December 31, 2021, the Company’s deferred revenue is expected to be recognized during the succeeding 12-month period and is therefore presented as deferred revenue, current, in the Unaudited Condensed Consolidated Balance Sheets.

 

4.

FINANCIAL STATEMENT COMPONENTS

Restricted Cash— The Company classifies all cash for which usage is limited by contractual provisions as restricted cash. Restricted cash consists of $3.7 million and $4.8 million deposited in money market account, which is used as cash collateral backing letters of credit related to customs duty authorities’ requirements as of September 30, 2022 and December 31, 2021, respectively. The Company has presented these balances under noncurrent assets in the Unaudited Condensed Consolidated Balance Sheets.

Total cash, cash equivalents and restricted cash is presented in the table below (in thousands):

 

     September 30,      December 31,  
     2022      2021  

Cash and cash equivalents

   $ 2,107      $ 9,113  

Restricted cash

     3,742        4,802  
  

 

 

    

 

 

 

Total cash, cash equivalents and restricted cash

   $ 5,849      $ 13,915  
  

 

 

    

 

 

 

 

47


Inventories—The components of inventories as of September 30, 2022 and December 31, 2021, respectively, were as follows (in thousands):

 

     September 30,      December 31,  
     2022      2021  

Finished goods

   $ 4,010      $ 16,928  

Work in progress

     —          —    

Raw materials

     —          —    
  

 

 

    

 

 

 

Total inventory, net

   $ 4,010      $ 16,928  
  

 

 

    

 

 

 

As of September 30, 2022 and December 31, 2021 reserves for inventory obsolescence were both $0.1 million.

Property and Equipment, netProperty and equipment, net as of September 30, 2022 and December 31, 2021, consist of the following (in thousands):

 

     September 30,      December 31,  
     2022      2021  

Manufacturing equipment

   $ 3,227      $ 3,195  

Leasehold improvement

     875        864  

Furniture, fixtures and office equipment

     79        66  
  

 

 

    

 

 

 
     4,181        4,125  

Less: Accumulated depreciation

     (3,345      (3,126
  

 

 

    

 

 

 

Total property and equipment, net

   $ 836      $ 999  
  

 

 

    

 

 

 

Total depreciation expense for the nine months ended September 30, 2022 and 2021, was $0.2 million and $0.9 million, respectively.

Accrued Expenses and Other Current LiabilitiesAccrued expenses and other current liabilities consist of the following (in thousands):

 

     September 30,      December 31,  
     2022      2021  

Accrued purchases

   $ 3,950      $ 2,657  

Accrued rebates and credits

     696        1,967  

Warranty cost, current

     93        87  

Other taxes payable

     956        1,053  

Customer deposits

     786        773  

Accrued payroll

     629        784  

Accrued interest

     150        —    

Current portion of amount payable to a vendor (Note 13)

     1,420        1,699  

SCI Term Loan and Revolving Loan amendment fees (Note 6)

     1,700        1,700  

Other accrued liabilities

     1,003        993  
  

 

 

    

 

 

 

Total accrued expenses and other current liabilities

   $ 11,383      $ 11,713  
  

 

 

    

 

 

 

 

48


Warranty Cost— The following table is a roll forward of warranty cost as of September 30, 2022 and December 31, 2021 (in thousands):

 

     September 30,      December 31,  
     2022      2021  

Beginning balance

   $ 1,738      $ 1,248  

Warranty settlements

     (148      (135

Additions to warranty accrual

     277        625  
  

 

 

    

 

 

 

Ending balance

   $ 1,867      $ 1,738  
  

 

 

    

 

 

 

Warranty cost, current

   $ 93      $ 87  

Warranty cost, noncurrent

     1,774        1,651  
  

 

 

    

 

 

 

Total warranty cost

   $ 1,867      $ 1,738  
  

 

 

    

 

 

 

Other Income, net

Other income, net consists of the following (in thousands):

 

     Nine Months Ended
September 30,
 
       2022         2021    

Forgiveness of Paycheck Protection Program Loan (Note 6)

   $ 1,414       1,433  

Change in fair value of preferred stock warrants liability (Note 7)

     775       339  

Others

     (93     (47
  

 

 

   

 

 

 

Total other income, net

   $ 2,096     $ 1,725  
  

 

 

   

 

 

 

 

5.

LEASES

Operating LeasesIn April 2018, the Company entered into a 56-month lease agreement for an office space in Oakland, California for $0.8 million in total payments. Effective June 2021, the Company terminated the lease agreement and agreed to settle the unpaid rent and related legal costs for $0.3 million. As a result, the Company derecognized the Oakland right-of use asset and corresponding lease liability and recognized a loss of $0.01 million as Other income (expense), net in the Unaudited Condensed Consolidated Statement of Operations and Comprehensive Loss for the nine months ended September 30, 2021.

In November 2019, the Company entered an 84-month lease for office and manufacturing space in Fremont, California (“Fremont facility”) for $3.3 million in total payment. The Company has an option to renew the lease for five years. Lease renewals are not assumed in the determination of the lease term until the exercise of the renewals are deemed to be reasonably certain.

 

49


6.

NOTES PAYABLE, NET

Notes payable, net consists of the following (in thousands):

 

     September 30,      December 31,  
     2022      2021  

2018 Bridge Notes

   $ 9,086      $ 7,076  

Payroll Protection Program Loan

     —          1,414  

Simple Agreement for Future Equity Note

     50,230        34,001  

Term and Revolver Loan

     4,957        9,618  

Promissory Note

     6,674        —    
  

 

 

    

 

 

 

Total notes payable, net

     70,947        52,109  

Less current portion

     (15,760      (10,912
  

 

 

    

 

 

 

Notes payable, net of current portion

   $ 55,187      $ 41,197  
  

 

 

    

 

 

 

2018 Bridge Notes

In connection with the 2018 Notes, the Company originally issued warrants to purchase 486,240 shares of its common stock at $0.01 per share. The warrants, which were exercisable upon issuance, expire in December 2023. At issuance, the Company determined the relative fair value of the warrants to be $1.1 million. The Company recorded the fair value of the warrant as a debt discount within additional paid-in capital. After allocating $1.1 million to the warrant, the fair value of preferred stock in which the notes could be converted exceeded the carrying value of the notes. As such the conversion feature under the notes was considered a beneficial conversion feature which was treated as debt discount and amortized to interest expense using the effective interest rate method. The Company recorded an additional $1.1 million discount to the notes within additional paid-in capital. As discussed in Note 2, in January 1, 2022, in connection with the adoption of ASU 2020-06, the Company derecognized the beneficial conversion feature which resulted in a $1.1 million decrease in additional paid-in capital and cumulative catch-up adjustment to accumulated deficit.

In December 2021, the Company entered into an amendment to the 2018 Notes extending the maturity date from December 13, 2021 to December 13, 2022. In connection with the amendment, the notes will continue to bear interest at 8% per annum and are entitled to a repayment premium of 110% of the principal and accrued interest at the time of repayment. Additionally, the Company issued warrants to purchase 196,462 shares of Series E-1 redeemable convertible preferred stock (“Series E-1 warrants”) at $4.59 per share in connection with the amendment. The warrants were exercisable immediately and expire on December 13, 2031. Upon issuance, the Company determined the fair value of the warrants to be $0.7 million using the Black-Scholes option-pricing model using the following assumptions: no dividends; risk-free interest rate of 1.42%; contractual life of 10 years; and expected volatility of 54.4%. The Series E-1 warrants qualified as liabilities as the underlying preferred stock were contingently redeemable upon the occurrence of a change in control, which is outside the control of the Company. At September 30, 2022, the warrants remain outstanding.

The Company concluded that the modification was a troubled debt restructuring as the Company was experiencing financial difficulty and the amended terms resulted in a concession to the Company. As the future undiscounted cash payments under the modified terms exceeded the carrying amount of the 2018 Notes on the date of modification, the modification was accounted for prospectively. Additionally, the Company recorded the fair value of the Series E-1 warrants as a reduction of Notes payable, net of discounts to the restructured notes on the date of modification. The debt discount and incremental repayment premium are being amortized to interest expense using the effective interest rate method.

 

50


The net carrying value of 2018 Bridge Notes was as below (in thousands):

 

     September 30,      December 31,  
     2022      2021  

Principal

   $ 9,258      $ 7,777  

Less: unamortized debt discount

     (172      (701
  

 

 

    

 

 

 

Net carrying value

     9,086        7,076  

Less: current portion

     (9,086      (7,076
  

 

 

    

 

 

 

Total noncurrent portion

   $ —        $ —    
  

 

 

    

 

 

 

The following table sets forth the total interest expense recognized related to the 2018 Bridge Notes (in thousands):

 

     September 30,     September 30,  
     2022     2021  

Amortization of debt discount

   $ 467     $ 1,160  

Contractual interest expense

     1,482       2,223  
  

 

 

   

 

 

 

Total interest expense

   $       1,949     $       3,383  
  

 

 

   

 

 

 

Effective interest rate of the liability component

     32.6     32.6
  

 

 

   

 

 

 

Paycheck Protection Program Loan

In May 2020, the Company entered into an unsecured promissory note under the Payroll Protection Program (“PPP Loan”), with a bank under the PPP administered by the United States Small Business Administration (“SBA”) and authorized by the Keeping American Workers Employed and Paid Act, which is part of the CARES Act, enacted on March 27, 2020. The PPP Loan may be prepaid, in full or in part, at any time prior to maturity with no prepayment penalties. Under the terms of the PPP, the Company can apply for, and be granted, forgiveness for all or a portion of the PPP Loan. The principal amount of the PPP Loan is $1.4 million. The PPP Loan is non-interest bearing and has a maturity date of less than a year. The PPP Loan was forgiven in full in March 2021 and as a result gain on forgiveness of debt of $1.4 million is recorded within Other income (expense), net in the Company’s Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss for the nine months ended September 30, 2021.

In February 2021, the Company obtained a PPP Loan with a principal amount of $1.4 million. The PPP Loan bears interest at less than 1% per annum and has a maturity date of less than one year. The PPP Loan principal and accrued interest was forgiven in full in January 2022 and as a result the gain on forgiveness of debt of $1.4 million is recorded within Other income (expense), net in the Company’s Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss for the nine months ended September 30, 2022.

Promissory Note

In May 2022, the Company issued a secured promissory note to a trust affiliated with Thurman J. (T.J.) Rodgers, a director of Solaria amounting to $6.5 million in exchange for cash. The secured promissory note accrues paid-in-kind interest at a rate of 7.5% per annum and the note had an original maturity date of July 11, 2022, collateralized by substantially all of the Company’s personal property, including all assets, inventory, equipment, general intangibles, financial assets, investment property, securities, deposit accounts and excluding intellectual property. As of September 30, 2022, the secured promissory note remained outstanding. In conjunction with the transaction with Complete Solar, both the parties agreed to extend the note term beyond its original maturity date. The secured promissory note with the original principal value of $6.5 million and paid-in-kind interest of $0.2 million was finally terminated in October 2022, in exchange for the issuance of a new convertible note by Complete Solar.

 

51


Simple Agreement for Future Equity Notes

The Company entered into various interest free unsecured Simple Agreement for Future Equity Notes (“SAFE”) notes agreements and raised $32.0 million in fiscal 2021 and $2.0 million in fiscal 2020. The number of shares to be issued upon conversion of the SAFE notes are subject to the following:

Equity Financing In the event of certain equity financing before the termination of the SAFE note, on the initial closing of such equity financing, the SAFE note will automatically convert into the number of shares of SAFE preferred stock in accordance with the terms of the SAFE agreement. In the event of certain other financing before the termination of the SAFE note, the investor may elect to convert the SAFE note into preferred stock equal based on the terms of the SAFE agreement.

Public Offering – If there is an Initial Public Offering (“IPO”) before the termination of the SAFE note, the SAFE note will automatically convert into the right to receive the number of shares of common stock according to the terms of the SAFE agreement.

Change of Control – If there is a Change of Control before the termination of the SAFE note, the SAFE note will automatically convert into the right to receive a portion of proceeds according to the terms of the SAFE agreement.

Dissolution Event – If there is a Dissolution Event before the termination of the SAFE note, the investor will automatically be entitled to receive a portion of proceeds according to the terms of the SAFE agreement.

Valuation Caps the SAFE notes are subject to a valuation cap. The valuation cap is $190.0 million for each of 33 notes with aggregate principal of $30.0 million. Two notes with principal balance of $2.0 million each have valuation caps of $219.1 million and $221.1 million, respectively.

The Company elected to account for all of the SAFE notes at estimated fair value pursuant to the fair value option and recorded the change in estimated fair value as other income (expense), net in the Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss until the notes are converted or settled.

The estimated fair value and face value of these notes was $50.2 million and $34.0 at September 30, 2022 and December 31, 2021, respectively, and is considered Level 3 fair value measurement. The Company recorded a loss of $14.2 million relating to the change in estimated fair value of these notes as change in fair value of Simple Agreement for Future Equity Notes in the Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss for the nine months ended September 30, 2022. There was no change in estimated fair value of these notes for the year ended December 31, 2021.

As more fully described in Note 16, post consummation of the merger in November 2022, all SAFE notes were assumed by Complete Solar.

Term Loan and Revolver Loan

In October 2020, the Company entered into a loan agreement (“Loan Agreement”) with Structural Capital Investments III, LP (“SCI”).

The Loan Agreement with SCI comprises of two facilities, a term loan (the “Term Loan”) and a revolving loan (the “Revolving Loan”) (together “Original Agreement”) for $5.0 million each with a maturity date of October 31, 2023. Both the Term Loan and the Revolving Loan were fully drawn upon closing.

The Term Loan has a term of thirty-six months, equal monthly payments of principal beginning November 2021 until the end of the term and an annual interest rate of 9.25% or Prime rate plus 6%, whichever is higher. The Revolving Loan also has a term of thirty-six months, principal repayments at the end of the term and an annual interest rate of 7.75% or Prime rate plus 4.5%, whichever is higher. The Loan Agreement required the Company to meet certain financial covenants relating to maintenance of specified restricted cash balance, achieving specified revenue target and maintaining specified contribution margin (“Financial covenants”) over the term of each of the Term Loan and Revolving Loan. The Term Loan and Revolving Loan are collateralized substantially by all assets and property of the Company.

 

52


In October 2020, the Company recorded debt issuance costs discount totaling $0.8 million related to the Original agreement. The total debt issuance costs and discount is being amortized to interest expense using the effective interest method.

In February 2021, the Company entered into an Amended and Restated Loan and Security Agreement as a First Amendment to the Original Agreement (“First Amendment”) to revise certain financial covenants within the Original Agreement.

In July 2021, the Company entered into an amendment to the Original Agreement (“Second Amendment”) as a forbearance agreement for SCI to forbear from exercising any rights and remedies available to it as a result of Company not meeting certain Financial Covenants required by the Original Agreement. As a result of this amendment changes were made to the financial covenants. The Company incurred $1.2 million in amendment fee related to the Second Amendment which was recognized as loss on extinguishment of debt discussed below.

In connection with the Second Amendment, the Company issued E-1 Warrants to purchase 305,342 shares of Series E-1 redeemable convertible preferred stock (“SCI Series E-1 warrants”) at $4.59 per share. The warrants were fully exercisable in whole or in part at any time during the term of the Original agreement. The SCI Series E-1 Warrants are scheduled to expire on July 30, 2031. Upon issuance, the Company determined the fair value of the warrants to be $1.2 million using the Black-Scholes option-pricing model using the following assumptions: no dividends; risk-free interest rate of 1.44%; contractual life of 10 years; and expected volatility of 55.7%. The Series E-1 warrants qualified as liabilities as the underlying preferred stock were contingently redeemable upon the occurrence of a change in control, which is outside the control of the Company.

The Company concluded that the modification to the terms of the Second Amendment changed the present value of cash flows by more than 10% and, as such, was treated as a debt extinguishment. The Company recognized a loss on extinguishment of debt of $3.0 million in the Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss in July 2021 which included the fair value of SCI Series E-1 warrants of $1.2 million issued in connection with the modification and $1.2 million amendment fee.

In December 2021, the Company entered into an amendment to the Original Agreement (“Third Amendment”) as a forbearance agreement for SCI to forbear from exercising any rights and remedies available to it as a result of Company not meeting certain Financial Covenants required by the Original agreement. As a result of this amendment, changes were made to the financial covenants. The Company incurred $0.5 million in amendment fee related to the Third Amendment and also paid default interest amounting to $0.3 million for the period April 2021 through November 2021.

In connection with the Third Amendment, the Company further amended the exercise price of the Series D-1 Preferred Stock Warrants to $2.17 per share and also amended the number of warrants. As of the date of the Amendment, the Company determined the fair value of the amended Series D-1 Preferred Stock warrants to be $2.9 million using the Black-Scholes option-pricing model using the following assumptions: no dividends; risk-free interest rate of 1.35%; contractual life of 6 years; and expected volatility of 57.7%.

Additionally, the Company amended the exercise price of the Series E-1 Preferred Stock Warrants to $2.29 per share. As of the date of the Amendment, the Company determined the fair value of the amended Series E-1 Preferred Stock warrants to be $1.3 million using the Black-Scholes option-pricing model using the following assumptions: no dividends; risk-free interest rate of 1.44%; contractual life of 9.6 years; and expected volatility of 57.6%.

The Company concluded that the modification to the terms of the Third Amendment changed the present value of cash flows by more than 10% and, as such, was treated as a debt extinguishment. The Company recognized a loss on extinguishment of debt of $2.4 million in the Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss in December 2021 which included the incremental fair value of the Series D-1 warrants of $1.7 million and incremental fair value of the Series E-1 warrants of $0.2 million relating to the modification.

 

53


In April 2022, the Company entered into an amendment to the Original Agreement (“Fourth Amendment”) as a forbearance agreement for SCI to forbear from exercising any rights and remedies available to it as a result of the Company not meeting certain Financial Covenants required by the Original Agreement. As a result of this amendment, changes were made to the financial covenants. The Company incurred $0.15 million in amendment fee related to the Fourth Amendment.

In June 2022, the Company entered into an amendment to the Original Agreement (“Fifth Amendment”) related to SCI which resulted in certain changes to financial covenants including updates to quarterly revenue requirements and contribution margin requirements.

In September 2022, the Company paid off the total outstanding principal and interest of the Term Loan related to the Loan Agreement with SCI in the amount of $2.8 million. The remaining unamortized debt discount of $0.04 million on the date of pay off was recorded as amortization of debt discount and included as interest expense.

The Term Loan and Revolving Loan consisted of the following (in thousands):

 

     September 30,      December 31,  
     2022      2021  

Principal

   $ 5,000      $ 9,618  

Less: unamortized debt discount

     (43      —    
  

 

 

    

 

 

 

Net carrying value

     4,957        9,618  

Less: current portion

     —          (2,421
  

 

 

    

 

 

 

Total noncurrent portion

   $ 4,957      $ 7,197  
  

 

 

    

 

 

 

The revolving loan principal balance at September 30, 2022 amounted to $5.0 million and is due on October 2023.

The following table sets forth the total interest expense recognized related to the SCI term loan and revolving Loan (in thousands):

 

     September 30,      September 31,  
     2022      2021  

Amortization of debt discount

   $ 64      $ 170  

Contractual interest expense

     692        664  
  

 

 

    

 

 

 

Total interest expense

   $ 756      $ 834  
  

 

 

    

 

 

 

 

7.

REDEEMABLE PREFERRED STOCK WARRANTS

In 2010, in connection with a loan agreement, the Company issued a warrant to purchase 211,270 shares of Series A-1 preferred stock at an exercise price of $1.52 per share. These warrants were exercised in March 2021.

In connection with the Series B-1 preferred stock financing in February 2015, the Company amended certain previously outstanding common stock warrants into a warrant to purchase 35,294 shares of Series B-1 at an exercise price of $5.40 per share. These warrants were exercised in March 2021.

In 2017, in connection with a Loan and Security Agreement with Structural Capital Investments II, LP and El Dorado Investment Company, the Company issued warrants to purchase 147,551 shares of Series C-1 at an exercise price of $8.66 per share. In 2018, in connection with a second amendment to Loan and Security Agreement and the cancellation of the C-1 Warrants, the Company issued warrants to purchase 375,801 shares of Series D-1 at an exercise price of $4.33 per share. As fully discussed in Note 6, in December 2021, in connection with the Third Amendment to the Original Agreement, the Company amended certain terms

 

54


of the warrant to purchase Series D-1 preferred stock. As amended, the Series D-1 preferred stock warrants are calculated based on a percentage of the Company’s fully diluted capitalization at an exercise price of $2.17 per share. As of September 30, 2022, 745,001 units of Series D-1 preferred stock warrants are outstanding. The warrants were exercisable upon issuance and expire on December 22, 2027.

As fully discussed in Note 6, in July 2021, in connection with the Second Amendment to Original Agreement, the Company issued warrants to purchase 305,342 shares of Series E-1 at an exercise price of $4.59 per share. In December 2021, in connection with the Third Amendment to the Original Agreement, the Company amended the exercise price of the Series E-1 preferred stock warrants to $2.29 per share.

As fully discussed in Note 6, in December 2021, in connection with the amendment to the 2018 Notes, the Company issued warrants to purchase 196,462 shares of Series E-1 Preferred Stock at an exercise price of $4.59 per share. The Series E-1 warrants remain outstanding as of September 30, 2022 and December 31, 2021.

All of the above preferred stock warrants qualified as liabilities as the underlying preferred stock were contingently redeemable upon the occurrence of a change in control, which is outside the control of the Company. The preferred stock warrants have been recorded as a preferred stock warrant liability and are revalued to fair value each reporting period.

The changes in value of the preferred stock warrant liability are summarized below (in thousands):

 

     Nine Months Ended September 30,  
     2022      2021  

Beginning Balance—January 1

   $ 4,955      $ 1,725  

Change in Fair Value included in Other income (expense), net

     (775      (339

Exercise of warrant

     —          (250

Series E-1 warrants issued in connection with SCI Second amendment—included in Loss on debt extinguishment

     —          1,191  
  

 

 

    

 

 

 

Ending Balance—September 30

   $ 4,180      $ 2,327  
  

 

 

    

 

 

 

Fair Value MeasurementThe Company follows ASC 820 which establishes disclosure requirements and a common definition of fair value to be applied when U.S. GAAP requires the use of fair value. The ASC 820 fair value hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to measurements involving significant unobservable inputs (Level 3 measurements).

The three levels of the fair value hierarchy are as follows:

Level 1—Observable inputs that reflect quoted prices in active markets for identical assets or liabilities.

Level 2—Observable inputs that reflect quoted prices for identical assets and liabilities in markets that are not active, quoted prices for similar assets or liabilities in active markets, inputs other than quoted prices that are observable for the assets or liabilities, or inputs that are derived principally from or corroborated by observable market data by correlation or other means.

Level 3—Inputs that are generally unobservable and are supported by little or no market activity, and typically reflect management’s estimate of assumptions that market participants would use in pricing the asset or liability.

The level in the fair value hierarchy within which a fair value measurement in its entirety falls is based on the lowest-level input that is significant to the fair value measurement in its entirety.

The unaudited condensed consolidated financial statements as of and for the nine months ended September 30, 2022 and year ended December 31, 2021, do not include any nonrecurring fair value measurements relating to assets or liabilities.

 

55


There were no transfers between Level 1 or Level 2 of the fair value hierarchy during the nine months ended September 30, 2022 and year ended December 31, 2021.

 

     As of September 30, 2022  
     Level 1      Level 2      Level 3      Total  

Financial liabilities:

           

SAFE Note

   $     —        $     —        $ 50,230      $ 50,230  

Redeemable convertible preferred stock warrants liability

     —          —          4,180        4,180  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total financial liabilities

   $ —        $ —        $ 54,410      $ 54,410  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

     As of December 31, 2021  
     Level 1      Level 2      Level 3      Total  

Financial liabilities:

           

SAFE Note

   $     —        $     —        $ 34,001      $ 34,001  

Redeemable convertible preferred stock warrants liability

     —          —          4,955        4,955  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total financial liabilities

   $ —        $ —        $ 38,956      $ 38,956  
  

 

 

    

 

 

    

 

 

    

 

 

 

The following table summarizes the significant unobservable inputs used in the fair value measurement of the SAFE Notes as of September 30, 2022:

 

Fair Value

(in thousands)

  

Valuation Technique

  

Unobservable Input

   Input  
$50,230    Scenario-based analysis   

Discount rate

     20
     

Probability of SPAC business combination

     80
     

Probability of continuing business under non

  
     

merger scenario

     20

The estimated fair values of SAFE notes as of December 31, 2021, was determined to be same as face value.

As of September 30, 2022 and December 31, 2021, the warrants were valued using the Black— Scholes option pricing model with the following assumptions:

 

     September 30,    December 31,
     2022    2021

Expected term (in years)

   5.23 - 9.20    5.98 - 9.95

Expected volatility

   55.4% - 58.6%    54.0% - 57.7%

Risk-free interest rate

   3.83% - 4.06%    1.35% - 1.52%

Expected dividend yield

   0%    0%

 

56


8.

REDEEMABLE CONVERTIBLE PREFERRED STOCK

As of September 30, 2022, the Company is authorized to issue 13,500,285 shares of redeemable convertible preferred stock with a par value of $0.001 per share (collectively, Preferred Stock). Redeemable convertible preferred stock as of September 30, 2022 and December 31, 2021 consisted of the following (in thousands, except share and per share data):

 

     As of September 30, 2022  
     Shares
Authorized
     Shares
Issued and
Outstanding
     Net
Carrying
Value
     Conversion
Price Per
Share
     Aggregate
Liquidation
Preference
 

Series E-1

     7,324,607        5,348,050      $ 49,191      $ 9.17      $  49,042  

Series D-1

     375,801        —          —          —          —    

Series C-1

     1,509,508        1,509,508        13,063        8.66        13,072  

Series B-1

     785,471        785,471        4,238        5.40        4,242  

Series A-1

     3,504,898        3,504,898        5,578        1.52        5,327  
  

 

 

    

 

 

    

 

 

       

 

 

 
     13,500,285      11,147,927      $72,070             $ 71,683  
  

 

 

    

 

 

    

 

 

       

 

 

 

 

     As of December 31, 2021  
     Shares
Authorized
     Shares
Issued and
Outstanding
     Net
Carrying
Value
     Conversion
Price Per
Share
     Aggregate
Liquidation
Preference
 

Series E-1

     7,324,607        5,348,050      $ 49,186      $ 9.17      $  49,042  

Series D-1

     375,801        —          —          —          —    

Series C-1

     1,509,508        1,509,508        13,060        8.66        13,072  

Series B-1

     785,471        785,471        4,237        5.40        4,242  

Series A-1

     3,504,898        3,504,898        5,578        1.52        5,327  
  

 

 

    

 

 

    

 

 

       

 

 

 
     13,500,285      11,147,927      $72,061             $ 71,683  
  

 

 

    

 

 

    

 

 

       

 

 

 

During March 2021, the Company issued 211,270 Series A-1 preferred stock and 35,294 Series B-1 preferred stock in connection with the exercise of warrants discussed in Note 7.

The holders of Preferred Stock have the following rights, preferences, privileges, and restrictions:

DividendsThe holders of the outstanding shares of Preferred Stock are entitled to receive, when and if declared by the Board of Directors, noncumulative dividends at the annual rate of 8% per share of Preferred Stock. Dividends on Preferred Stock are payable in preference to any dividends on common stock or Class B common stock. In any year, after payment of dividends on Preferred Stock, any additional dividends declared by the Board of Directors will be paid among the holders of Preferred Stock, common stock, and Class B common stock pro rata on an if-converted basis. No dividends have been declared or paid during the nine months ended September 30, 2022 and 2021.

LiquidationUpon liquidation, dissolution, or winding up of the Company, including a change of control of the Company, holders of Preferred Stock will be entitled to receive, on a pro rata basis, prior and in preference to any distribution to holders of any series of common stock, an amount equal to $9.17 per share of Series E-1, $8.66 per share of Series D-1, $8.66 per share of Series C-1, $5.40 per share of Series B-1 and $1.52 per share of Series A-1, plus any declared but unpaid dividends on such shares. If the assets and funds thus available for distribution among holders of Preferred Stock are insufficient to provide such holders their full aforesaid preferential amount, then the entire amount of the assets and funds of the Company legally available for distribution will be distributed ratably among all holders of Preferred Stock.

After the distribution to the holders of Preferred Stock, any remaining assets of the Company legally available for distribution will be distributed pro rata, on an if-converted basis, to all holders of common stock and Class B common stock.

 

57


ConversionEach share of Preferred Stock is convertible at the option of the holder into that number of common shares that is equal to the original issuance price of the Preferred Stock divided by the conversion price, as defined in the Company’s Certificate of Incorporation, subject to adjustment for events of dilution. Holders of Preferred Stock may elect to convert their shares into common stock at any time.

Each share of Preferred Stock will automatically convert into shares of common stock at the then effective conversion rate for each such share (i) immediately prior to the closing of a qualified public offering of the Company’s common stock in which gross proceeds exceed $15.0 million or (ii) upon the receipt by the Company of a written request for such conversion from the holders of a majority of the then outstanding Preferred Stock.

VotingEach share of Preferred Stock has voting rights equivalent to the number of shares of common stock into which it is convertible.

Protective ProvisionsAs long as 250,000 shares of Preferred Stock remain outstanding, the majority vote of the holders of the then outstanding shares of Preferred Stock is necessary for consummation of certain transactions, including but not limited to: increasing or decreasing the authorized capital stock; creating any senior or pari passu security, privileges, preferences or voting rights senior to or on parity with those granted to the Preferred Stock; altering or changing the preferred series rights; redeeming or repurchasing the Company’s equity securities; and entering into any transaction deemed to be a liquidation or dissolution of the Company.

RedemptionAt any time after 7 years from the issuance of respective series of Preferred Shares, the holders of a majority of the outstanding voting Preferred Stock Series may vote to require the Company to redeem all outstanding shares of Preferred Stock Series in three equal annual installments by paying in cash an amount per share equal to the original issuance price of the Preferred Stock Series, plus any accrued but unpaid dividends. If the Company does not have sufficient funds legally available to redeem all shares of Preferred Stock, then the Company will redeem the maximum possible number of shares ratably among the holders of such shares and will redeem the remaining shares as soon as sufficient funds are legally available. After 7 years from the issuance of respective series of Preferred Shares, the Preferred shares are then currently redeemable at the option of the holder and have been classified in the mezzanine section of the Unaudited Condensed Consolidated Balance Sheets.

Preferred Shares are also contingently redeemable upon liquidation and certain deemed liquidation events such as acquisition, merger, consolidation or the sale, lease transfer, exclusive license or other disposition by the Company of all or substantially all of the assets of the Company. These events are outside the control of the Company and therefore the Preferred Stock have been classified in the mezzanine section of the Unaudited Condensed Consolidated Balance Sheets.

The Company records its redeemable convertible preferred stock at the amount of cash proceeds received on the date of issuance, net of issuance costs. Since the preferred stock is probable of becoming redeemable at the option of the holder at a future date, accretion of the preferred stock will be recognized over the period of time from the date of issuance to the earliest redemption date. The accretion is recorded as additional paid-in capital. Accretion of preferred stock was $0.01 million and $0.02 million for the nine months ended September 30, 2022 and 2021, respectively.

 

9.

COMMON STOCK

As of September 30, 2022 and December 31, 2021, the Company is authorized to issue two classes of common stock, designated as common stock and Class B common stock. The two classes of common stock have similar rights, except holders of common stock are entitled to one vote per share while holders of Class B common stock have no voting rights. Each share of Class B common stock will automatically convert into one share of common stock immediately prior to a qualified initial public offering of the Company’s common stock or upon the consummation of a liquidation event (as defined in the Certificate of Incorporation). As of September 30, 2022 and December 31, 2021, the Company is authorized to issue

 

58


27,000,000 shares of common stock with a par value of $0.001 per share and 815 shares are designated as Class B common stock.

In April 2021, 25,000 warrants to purchase common stock were exercised. In March 2021, 12,674 warrants to purchase common stock expired unexercised.

During the nine months ended September 30, 2022, 1,311,651 warrants to purchase common stock were exercised and 505,672 warrants to purchase common stock expired unexercised. As of September 30, 2022 and December 31, 2021, 1,156,624 units and 2,973,947 units, respectively, of common stock warrants are outstanding.

 

10.

RELATED PARTY TRANSACTIONS

The Company defines related parties as directors, executive officers, nominees for director, stockholders that have significant influence over the Company, or are a greater than 5% beneficial owner of the Company’s capital and their affiliates or immediate family members. As of September 30, 2022 and December 31, 2021 and during the nine months ended September 30, 2022 and September 30, 2021 there were no significant transactions with related parties other than the following:

As discussed in Note 6, in May 2022, the Company issued a $6.5 million secured promissory note to a trust affiliated with Thurman J. (T.J.) Rodgers, a director of Solaria amounting in exchange for cash. The secured promissory note with the original principal value of $6.5 million and paid-in-kind interest of $0.2 million was terminated in October 2022, in exchange for the issuance of a new convertible note by Complete Solar.

As discussed in Note 6, in December 2018, the Company issued the 2018 Notes totaling approximately $3.4 million in exchange for cash. Three of the notes with aggregate principal of $0.2 million were issued to related parties including two officers and a trust affiliated with a Board member. The aggregate liability, inclusive of interest and principal accretion totaled $0.5 million and $0.4 million as of September 30, 2022 and December 31, 2021, respectively. These amounts are included in the Unaudited Condensed Consolidated Balance Sheets as Notes Payable, Net.

 

11.

INCOME TAXES

The Company did not record income tax expense during the nine months ended September 30, 2022 and 2021, respectively due to losses incurred and a full valuation allowance recorded against net deferred tax assets. The Company’s tax loss carryforwards differ from financial statement losses primarily due to stock-based compensation which is not deductible for income tax purposes.

The Company’s deferred tax assets principally result from net operating loss carryforwards. Utilization of the Company’s net operating loss carryforwards is dependent upon future levels of taxable income and may be subject to limitation due to the “change in ownership provisions” under Section 382 of the Internal Revenue Code and similar foreign provisions. Such limitations may result in the expiration of these carryforwards before their utilization.

During the nine months ended September 30, 2022, there were no significant changes to the total amount of unrecognized tax benefits. As of December 31, 2021, the Company had unrecognized tax benefits of $1.3 million for federal and $1.3 million for state related to R&D credits generated as of December 31, 2021.

 

12.

STOCK-BASED COMPENSATION

The Company has two stock option plans: the 2006 Stock Option Plan and the 2016 Stock Option Plan (collectively, the Plans). Options granted under the Plans may be either incentive stock options (ISOs) or nonqualified stock options (NSOs). ISOs may be granted only to Company employees (including officers and directors who are also employees). NSOs may be granted to Company employees, directors and consultants. Options under the Plans may be granted with contractual terms of up to ten years (five years if

 

59


granted to holders of more than 10% of the Company’s vesting stock). All options issued through September 30, 2022 have a ten-year contractual term. The exercise price of an ISO and NSO will not be less than 100% and 85% of the estimated fair value of the shares on the date of grant, respectively, as determined by the Company’s Board of Directors.

The exercise price of an ISO and NSO granted to a 10% stockholder will not be less than 110% of the estimated fair value of the shares on the date of grant, as determined by the Board of Directors. Options generally vest over four to five years at a rate of 20% to 25% upon the first anniversary of the commencement date and monthly thereafter.

As of September 30, 2022 and December 31, 2021, there were 926,435 and 335,538 shares of common stock available to be granted under the Plan.

The Company estimated the fair values of each option awarded on the date of grant using the Black-Scholes-Merton option pricing model utilizing the assumptions noted below. The expected term of the options is based on the average period the stock options are expected to remain outstanding calculated as the midpoint of the options vesting term, and contractual expiration period, as the Company did not have sufficient historical information to develop reasonable expectations about future exercise patterns and post vesting employment termination behavior. The expected stock price volatility for the Company’s stock was determined by examining the historical volatilities of its industry peers as the Company did not have any trading history of its common stock. The risk-free interest rate was calculated using the average of the published interest rates for U.S. Treasury issues with maturities that approximate the expected term. The dividend yield assumption is zero as the Company has no history of, nor plans of, dividend payments. The estimated forfeiture rates are based on the Company’s historical forfeiture activity of unvested stock options.

The assumptions used under the Black-Scholes-Merton option pricing model and the weighted average calculated fair value of the options granted to employees for the nine months ended September 30, 2022 and 2021 are as follows:

 

     Nine Months Ended
September 30,
 
     2022     2021  

Grant date fair value

   $ 1.03     $ 1.34  

Expected term (in years)

     6.21       6.13  

Expected volatility

     60     60

Risk- free interest rate

     1.98     1.01

Expected dividend yield

     0     0

A summary of the Company’s stock option and restricted stock unit activity and related information for the nine months ended September 30, 2022 is as follows:

 

     Options outstanding      Restricted stock units  
     Number of
shares
    Weighted
average
exercise
price
     Weighted
average
remaining
contractual
term
(years)
     Aggregate
intrinsic
values
($‘000s)
     Number of
plan shares
outstanding
    Weighted
average grant
date fair value
per share
 

Balances, December 31, 2021

     6,884,913     $ 2.62        8.01      $ 288        120,000     $ 3.91  

Options granted

     756,060       1.78             

Options exercised

     —         —               

Options forfeited

     (702,426     3.39              (120,000  
  

 

 

   

 

 

          

 

 

   

Balances, September 30, 2022

     6,938,547       2.18        7.94        9,441        —      
  

 

 

            

 

 

   

Options vested and exercisable -

               

September 30, 2022

     3,770,809       2.43        7.27        4,332       

 

60


Stock- based compensation is allocated on a departmental basis, based on the classification of the option holder or grant recipient. No income tax benefits have been recognized in the statements of operations for stock- based compensation arrangements and no stock- based compensation costs are capitalized as part of inventory or property and equipment as of September 30, 2022 and December 31, 2021.

Stock- based compensation expense is as follows for the nine months ended September 30, 2022 and 2021 in thousands):

 

     Nine Months Ended
September 30,
 
     2022      2021  

Cost of revenues

   $ 37      $ 93  

Research and development

     339        347  

Sales and marketing

     466        477  

General and administrative

     1,169        1,030  
  

 

 

    

 

 

 

Total stock- based compensation

   $     2,011      $     1,947  
  

 

 

    

 

 

 

Repricing of Options

Effective March 23, 2022, the Company’s board of directors approved an offer, to certain eligible employees, to exchange existing stock options, with an exercise price above $1.36, for new replacement stock options. The exercise price of the replacement stock options is $1.36 per share, which was the estimated fair market value on the exchange date, as determined with assistance from third- party valuation specialists. Eligible employees elected to exchange an aggregate of 991,195 outstanding stock options, with exercise prices ranging from $1.64 to $3.91 per share, for new replacement stock options. The replacement stock options have a grant date of March 23, 2022 and a contractual term of 10 years.

The exchange offer applied to both vested and unvested shares. Previously vested shares were exchanged for vested replacement stock options. Unvested shares were exchanged for shares which vest in accordance with the board-approved grant approval schedule with the service period ranging from 1.0 to 4.3 years.

The March 23, 2022 share exchange was accounted for as a modification and resulted in incremental stock-based compensation expense of $0.4 million of which $0.2 million related to vested options which was recognized immediately and $0.2 million related to unvested options which is being amortized on a straight-line basis over the 3.0 year weighted-average vesting period for those options.

 

13.

COMMITMENTS AND CONTINGENCIES

In June 2022, the Company filed a notice of arbitration with the Singapore International Arbitration Centre (“SIAC”) seeking approximately $47.0 million in damages against Solar Park Korea Co., LTD (“Solar Park”), a contract manufacturer of solar panels. The arbitration relates to write- downs recorded by the Company in December 2021 and other costs related to the loss of Solar Park’s production and transition to a new provider. Solar Park filed a response with SIAC in June 2022 asserting damages of approximately $30.0 million against the Company. The arbitration is expected to occur during the first half of 2024. On March 16, 2023, Solar Park filed a lawsuit against the Company and Complete Solaria claiming misappropriation of trade secrets, defamation, and tortious interference with contractual relations, among other things, in the United States District Court for the Northern District of California.

The Company believes that Solar Park’s allegations in the arbitration and the litigation lack merit and intends to vigorously defend all claims asserted. No liability has been recorded in the Company’s unaudited condensed consolidated financial statements as the likelihood of a loss is not probable at this time, and the Company does not believe a reasonably possible loss would be material to, nor does it expect that the ultimate resolution of these cases will have a material adverse effect on the Company’s financial condition, results of operations or cash flows.

 

61


As of September 30, 2022, the Company was contesting a $1.8 million liability to a vendor for the purchase of factory equipment which was intended to be used in Solar Park. The liability was included in the September 30, 2022 Unaudited Condensed Consolidated Balance Sheet as Accounts Payable of $0.4 million and Accrued Expenses and Other Current Liabilities of $1.4 million. The liability was included in the December 31, 2021 Unaudited Condensed Consolidated Balance Sheet as Accrued Expenses and Other Current Liabilities of $1.7 million and Other Liabilities, noncurrent of $0.1 million. On January 2023, the Company reached a settlement agreement with the vendor which reduced the liability from $1.8 million to $0.9 million.

In July 2020, the Company became aware that it might be subject to Antidumping and Countervailing Duties (“ADCVD”) on certain components manufactured in China and used in the solar panel production process in Korea. The Company applied for a definitive ruling from the U.S. Department of Commerce (“DoC”) while in parallel shifting its component supply from China. The DoC issued its ruling in April 2021. Because of the specificity of the DoC ruling in the Solaria case and prior case law under similar circumstances, the Company concluded that such ADCVD was not probable to be incurred for purchases in periods prior to the DoC ruling and immediately started paying appropriate ADCVD deposits on all entries after April 2021. No liability has been recorded in the Company’s consolidated financial statements as the likelihood of a loss is not probable at this time.

The Company is involved in other lawsuits and claims which arise in the normal course of business. These claims individually and in the aggregate are not expected to result in a material effect on the Company’s financial condition, results of operations or cash flows.

The Company had $3.5 million of outstanding letters of credit related to normal business transactions as of September 30, 2022. These agreements require the Company to maintain specified amounts of cash as collateral in segregated accounts to support the letters of credit issued thereunder. As discussed in Note 4, the cash collateral in these restricted cash accounts was $3.7 million and $4.8 million as of September 30, 2022 and December 31, 2021, respectively.

 

14.

EMPLOYEE BENEFIT PLAN

The Company has a 401(k) plan to provide defined contribution retirement benefits for all employees. Participants may contribute a portion of their compensation to the plan, subject to limitations under the Code. The Company’s contributions to the plan are at the discretion of the Board of Directors. The Company has not made any contributions to the plan since inception.

 

15.

GEOGRAPHIC INFORMATION

The following table summarizes revenue by geographic area for the nine months ended September 30, 2022 and 2021 (in thousands):

 

     Nine Months Ended September 30,  
     2022     2021  
     Amount      Percent     Amount      Percent  

Total revenue, net

          

United States

   $ 26,566        86.2   $ 46,159        96.2

Europe

     4,260        13.8     1,674        3.5

Australia

     —          0.0     128        0.3
  

 

 

    

 

 

   

 

 

    

 

 

 

Total

   $ 30,826        100.0   $ 47,961        100.0
  

 

 

    

 

 

   

 

 

    

 

 

 

 

62


16.

SUBSEQUENT EVENTS

Management has evaluated subsequent events through February 9, 2023, the date of issuance of these financial statements and has determined that there are no subsequent events outside the ordinary scope of business that require adjustment to, or disclosure in, the financial statements other than those described below.

In October 2022, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Complete Solar and formed Complete Solaria. As a result, the Company became a wholly-owned indirect subsidiary of Complete Solaria effective on the date of consummation of merger in November 2022.

In October 2022, the Company entered into an amendment to the Original Agreement (“Sixth Amendment”) related to SCI which resulted in removal of quarterly revenue and contribution margin requirements.

In October 2022, in conjunction with the Merger Agreement with Complete Solar discussed above, the secured promissory note, issued in May 2022, to a trust affiliated with Thurman J. (T.J.) Rodgers, was terminated in exchange for issuance of a convertible note by Complete Solar.

In November 2022 Complete Solaria entered into a definitive business combination agreement with Freedom Acquisition I Corp. (NYSE: FACT) (“Freedom”), a Special Purpose Acquisition Company (“SPAC”). Upon closing of the business combination, which is expected in the first half of 2023, the combined Company is expected to be listed on the New York Stock Exchange under the new ticker “CSLR”.

In November 2022, the Company entered into an amendment to the 2018 Notes extending the maturity date from December 13, 2022 to December 13, 2023. In connection with the amendment, the terms of the notes will continue to bear interest at 8% per annum and are entitled to a repayment premium of 120% of the principal and accrued interest due. Additionally, in connection with the amendment and cancellation of 196,462 shares of Series E-1 warrants of Solaria, Complete Solaria issued warrants to purchase 304,234 shares of Series D-7 preferred stock at $3.84 per share.

 

63

EX-101.SCH 6 cslr-20240104.xsd XBRL TAXONOMY EXTENSION SCHEMA 1001 - Document - Cover Page link:presentationLink link:definitionLink link:calculationLink 1002 - Statement - Unaudited Condensed Consolidated Balance Sheets link:presentationLink link:definitionLink link:calculationLink 1003 - Statement - Unaudited Condensed Consolidated Balance Sheets (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 1004 - Statement - Unaudited Condensed Consolidated Statements Of Operations And Comprehensive Income (Loss) link:presentationLink link:definitionLink link:calculationLink 1005 - Statement - Unaudited Condensed Consolidated Statements Of Operations And Comprehensive Income (Loss) (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 1006 - Statement - Unaudited Condensed Consolidated Statements of Stockholders' Deficit link:presentationLink link:definitionLink link:calculationLink 1007 - Statement - Unaudited Condensed Consolidated Statements of Stockholders' Deficit (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 1008 - Statement - Unaudited Condensed Consolidated Statements of Cash Flows link:presentationLink link:definitionLink link:calculationLink 1009 - Statement - Unaudited Condensed Consolidated Statements of Cash Flows (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 1010 - Disclosure - Organization link:presentationLink link:definitionLink link:calculationLink 1011 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 1012 - Disclosure - Fair Value Measurements link:presentationLink link:definitionLink link:calculationLink 1013 - Disclosure - Reverse Recapitalization link:presentationLink link:definitionLink link:calculationLink 1014 - Disclosure - Forward Purchase Agreements link:presentationLink link:definitionLink link:calculationLink 1015 - Disclosure - Business Combination link:presentationLink link:definitionLink link:calculationLink 1016 - Disclosure - Prepaid Expenses and Other Current Assets link:presentationLink link:definitionLink link:calculationLink 1017 - Disclosure - Divestiture link:presentationLink link:definitionLink link:calculationLink 1018 - Disclosure - Property and Equipment, Net link:presentationLink link:definitionLink link:calculationLink 1019 - Disclosure - Goodwill and Intangible Assets link:presentationLink link:definitionLink link:calculationLink 1020 - Disclosure - Accrued Expenses and Other Current Liabilities link:presentationLink link:definitionLink link:calculationLink 1021 - Disclosure - Employee Benefit Plan link:presentationLink link:definitionLink link:calculationLink 1022 - Disclosure - Other Income (Expense), Net link:presentationLink link:definitionLink link:calculationLink 1023 - Disclosure - Common Stock link:presentationLink link:definitionLink link:calculationLink 1024 - Disclosure - Warrants link:presentationLink link:definitionLink link:calculationLink 1025 - Disclosure - Borrowing Arrangements link:presentationLink link:definitionLink link:calculationLink 1026 - Disclosure - Stock-Based Compensation link:presentationLink link:definitionLink link:calculationLink 1027 - Disclosure - Employee Stock Purchase Plan link:presentationLink link:definitionLink link:calculationLink 1028 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 1029 - Disclosure - Income Taxes link:presentationLink link:definitionLink link:calculationLink 1030 - Disclosure - Basic and Diluted Net Loss Per Share link:presentationLink link:definitionLink link:calculationLink 1031 - Disclosure - Related Party Transactions link:presentationLink link:definitionLink link:calculationLink 1032 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 1033 - Disclosure - Accounting Policies, by Policy (Policies) link:presentationLink link:definitionLink link:calculationLink 1034 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:definitionLink link:calculationLink 1035 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:definitionLink link:calculationLink 1036 - Disclosure - Reverse Recapitalization (Tables) link:presentationLink link:definitionLink link:calculationLink 1037 - Disclosure - Business Combination (Tables) link:presentationLink link:definitionLink link:calculationLink 1038 - Disclosure - Prepaid Expenses and Other Current Assets (Tables) link:presentationLink link:definitionLink link:calculationLink 1039 - Disclosure - Divestiture (Tables) link:presentationLink link:definitionLink link:calculationLink 1040 - Disclosure - Property and Equipment, Net (Tables) link:presentationLink link:definitionLink link:calculationLink 1041 - Disclosure - Goodwill and Intangible Assets (Tables) link:presentationLink link:definitionLink link:calculationLink 1042 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables) link:presentationLink link:definitionLink link:calculationLink 1043 - Disclosure - Other Income (Expense), Net (Tables) link:presentationLink link:definitionLink link:calculationLink 1044 - Disclosure - Common Stock (Tables) link:presentationLink link:definitionLink link:calculationLink 1045 - Disclosure - Warrants (Tables) link:presentationLink link:definitionLink link:calculationLink 1046 - Disclosure - Borrowing Arrangements (Tables) link:presentationLink link:definitionLink link:calculationLink 1047 - Disclosure - Stock-Based Compensation (Tables) link:presentationLink link:definitionLink link:calculationLink 1048 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:definitionLink link:calculationLink 1049 - Disclosure - Income Taxes (Tables) link:presentationLink link:definitionLink link:calculationLink 1050 - Disclosure - Basic and Diluted Net Loss Per Share (Tables) link:presentationLink link:definitionLink link:calculationLink 1051 - Disclosure - Organization (Details) link:presentationLink link:definitionLink link:calculationLink 1052 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:definitionLink link:calculationLink 1053 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of Consolidated Statements of Cash Flows link:presentationLink link:definitionLink link:calculationLink 1054 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of Allowance for Doubtful Accounts link:presentationLink link:definitionLink link:calculationLink 1055 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of Revenue Recognized By Product and Services link:presentationLink link:definitionLink link:calculationLink 1056 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule Of Property, Plant and Equipment Useful Lives link:presentationLink link:definitionLink link:calculationLink 1057 - Disclosure - Summary of Significant Accounting Policies (Details) -Schedule of Finite-Lived Intangible Assets link:presentationLink link:definitionLink link:calculationLink 1058 - Disclosure - Fair Value Measurements (Details) link:presentationLink link:definitionLink link:calculationLink 1059 - Disclosure - Fair Value Measurements (Details) - Schedule of Financial Assets and Liabilities link:presentationLink link:definitionLink link:calculationLink 1060 - Disclosure - Fair Value Measurements (Details) - Schedule of Warrants Based on a Black Scholes Option Pricing Method. link:presentationLink link:definitionLink link:calculationLink 1061 - Disclosure - Fair Value Measurements (Details) - Schedule of Significant Unobservable Inputs (Level 3), and the Change in Fair Value Recorded in Other Income (Expense),net link:presentationLink link:definitionLink link:calculationLink 1062 - Disclosure - Fair Value Measurements (Details) - Schedule of Reconciles the Change in Value of the Redeemable Convertible Preferred Stock Warrant Liability link:presentationLink link:definitionLink link:calculationLink 1063 - Disclosure - Fair Value Measurements (Details) - Schedule of Reconciliation of Embedded Derivative Liability link:presentationLink link:definitionLink link:calculationLink 1064 - Disclosure - Fair Value Measurements (Details) - Schedule of Next Equity Financing Based on Inputs Included in a Black-Scholes Model link:presentationLink link:definitionLink link:calculationLink 1065 - Disclosure - Reverse Recapitalization (Details) link:presentationLink link:definitionLink link:calculationLink 1066 - Disclosure - Reverse Recapitalization (Details) - Schedule of Reconciles Elements of the Merger link:presentationLink link:definitionLink link:calculationLink 1067 - Disclosure - Reverse Recapitalization (Details) - Schedule of Common Stock Outstanding link:presentationLink link:definitionLink link:calculationLink 1068 - Disclosure - Forward Purchase Agreements (Details) link:presentationLink link:definitionLink link:calculationLink 1069 - Disclosure - Business Combination (Details) link:presentationLink link:definitionLink link:calculationLink 1070 - Disclosure - Business Combination (Details) - Schedule of Assets Acquired and Liabilities Assumed link:presentationLink link:definitionLink link:calculationLink 1071 - Disclosure - Business Combination (Details) - Schedule of Intangible Assets Acquired link:presentationLink link:definitionLink link:calculationLink 1072 - Disclosure - Business Combination (Details) - Schedule of Unaudited Combined Pro Forma Information link:presentationLink link:definitionLink link:calculationLink 1073 - Disclosure - Prepaid Expenses and Other Current Assets (Details) - Schedule of Prepaid Expenses and Other Current Assets link:presentationLink link:definitionLink link:calculationLink 1074 - Disclosure - Divestiture (Details) - Schedule of Operations and Comprehensive Income (Loss) Related to Discontinued Operations link:presentationLink link:definitionLink link:calculationLink 1075 - Disclosure - Divestiture (Details) - Schedule of Major Categories of Assets and Liabilities Held for Sale link:presentationLink link:definitionLink link:calculationLink 1076 - Disclosure - Divestiture (Details) link:presentationLink link:definitionLink link:calculationLink 1077 - Disclosure - Property and Equipment, Net (Details) - Schedule of Property and Equipment, Net link:presentationLink link:definitionLink link:calculationLink 1078 - Disclosure - Property and Equipment, Net (Details) link:presentationLink link:definitionLink link:calculationLink 1079 - Disclosure - Goodwill and Intangible Assets (Details) link:presentationLink link:definitionLink link:calculationLink 1080 - Disclosure - Goodwill and Intangible Assets (Details) - Schedule of Intangible Assets link:presentationLink link:definitionLink link:calculationLink 1081 - Disclosure - Goodwill and Intangible Assets (Details) - Schedule of Amortization Expense Related to Intangible Assets link:presentationLink link:definitionLink link:calculationLink 1082 - Disclosure - Accrued Expenses and Other Current Liabilities (Details) - Schedule of Accrued Expenses and Other Current Liabilities link:presentationLink link:definitionLink link:calculationLink 1083 - Disclosure - Other Income (Expense), Net (Details) link:presentationLink link:definitionLink link:calculationLink 1084 - Disclosure - Other Income (Expense), Net (Details) - Schedule of Other Income (Expense), Net link:presentationLink link:definitionLink link:calculationLink 1085 - Disclosure - Common Stock (Details) link:presentationLink link:definitionLink link:calculationLink 1086 - Disclosure - Common Stock (Details) - Schedule of Reserved Shares of Common Stock link:presentationLink link:definitionLink link:calculationLink 1087 - Disclosure - Warrants (Details) link:presentationLink link:definitionLink link:calculationLink 1088 - Disclosure - Warrants - Schedule of Fair Value of The Common Stock Warrants (Details) link:presentationLink link:definitionLink link:calculationLink 1089 - Disclosure - Borrowing Arrangements (Details) link:presentationLink link:definitionLink link:calculationLink 1090 - Disclosure - Borrowing Arrangements (Details) - Schedule of Convertible Notes link:presentationLink link:definitionLink link:calculationLink 1091 - Disclosure - Borrowing Arrangements (Details) - Schedule of Net Carrying Amount of the Convertible Notes link:presentationLink link:definitionLink link:calculationLink 1092 - Disclosure - Borrowing Arrangements (Details) - Schedule Of Interest Expense On Convertible Debt link:presentationLink link:definitionLink link:calculationLink 1093 - Disclosure - Borrowing Arrangements (Details) - Schedule of Company's outstanding notes payable link:presentationLink link:definitionLink link:calculationLink 1094 - Disclosure - Stock-Based Compensation (Details) link:presentationLink link:definitionLink link:calculationLink 1095 - Disclosure - Stock-Based Compensation (Details) - Summary of summary of stock option activity link:presentationLink link:definitionLink link:calculationLink 1096 - Disclosure - Stock-Based Compensation (Details) - Summary of summary of stock option activity (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 1097 - Disclosure - Stock-Based Compensation (Details) - Schedule of summary of RSU activity link:presentationLink link:definitionLink link:calculationLink 1098 - Disclosure - Stock-Based Compensation (Details) - Schedule Of Calculate The Fair Value Of Stock-based Compensation link:presentationLink link:definitionLink link:calculationLink 1099 - Disclosure - Stock-Based Compensation (Details) - Schedule of stock-based compensation expense and its allocation within the accompanying unaudited condensed consolidated statements of operations and comprehensive loss link:presentationLink link:definitionLink link:calculationLink 1100 - Disclosure - Employee Stock Purchase Plan (Details) link:presentationLink link:definitionLink link:calculationLink 1101 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:definitionLink link:calculationLink 1102 - Disclosure - Commitments and Contingencies (Details) - Schedule of Weighted Average Remaining Lease Term and the Discount Rate link:presentationLink link:definitionLink link:calculationLink 1103 - Disclosure - Commitments and Contingencies (Details) - Schedule of Future Minimum Lease Payments under Non-Cancelable link:presentationLink link:definitionLink link:calculationLink 1104 - Disclosure - Commitments and Contingencies (Details) - Schedule of Activity Period Relating to the Company's Warranty Provision link:presentationLink link:definitionLink link:calculationLink 1105 - Disclosure - Income Taxes (Details) - Schedule of Provision For Income Taxes link:presentationLink link:definitionLink link:calculationLink 1106 - Disclosure - Income Taxes (Details) - Schedule of Reconciliation of Effective Income Tax Rate link:presentationLink link:definitionLink link:calculationLink 1107 - Disclosure - Income Taxes (Details) - Schedule of Components of Deferred Tax Assets And Liabilities link:presentationLink link:definitionLink link:calculationLink 1108 - Disclosure - Income Taxes (Details) - Schedule of Unrecognized Tax Benefits link:presentationLink link:definitionLink link:calculationLink 1109 - Disclosure - Income Taxes (Details) link:presentationLink link:definitionLink link:calculationLink 1110 - Disclosure - Basic and Diluted Net Loss Per Share (Details) - Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders link:presentationLink link:definitionLink link:calculationLink 1111 - Disclosure - Basic and Diluted Net Loss Per Share (Details) - Schedule of Potential Common Shares Excluded from Diluted Net Loss Per Share link:presentationLink link:definitionLink link:calculationLink 1112 - Disclosure - Related Party Transactions (Details) link:presentationLink link:definitionLink link:calculationLink 1113 - Disclosure - Subsequent Events (Details) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 7 cslr-20240104_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 cslr-20240104_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 cslr-20240104_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 10 cslr-20240104_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.23.4
Cover Page
Jan. 04, 2024
Document Information [Line Items]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jan. 04, 2024
Entity File Number 001-40117
Entity Registrant Name Complete Solaria, Inc.
Entity Central Index Key 0001838987
Entity Tax Identification Number 93-2279786
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 45700 Northport Loop East
Entity Address, City or Town Fremont
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94538
City Area Code 510
Local Phone Number 270-2507
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Entity Ex Transition Period false
Common Stock Par Value 0.0001 Per Share [Member]  
Document Information [Line Items]  
Title of 12(b) Security Common Stock, par value $0.0001 per share
Trading Symbol CSLR
Security Exchange Name NASDAQ
Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share [Member]  
Document Information [Line Items]  
Title of 12(b) Security Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
Trading Symbol CSLRW
Security Exchange Name NASDAQ
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.4
Unaudited Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Oct. 01, 2023
Dec. 31, 2022
Dec. 31, 2021
Current assets:      
Cash and cash equivalents $ 1,661 $ 4,409 $ 5,276
Accounts receivable, net 26,003 27,717 9,037
Inventories 12,503 13,059 4,409
Prepaid expenses and other current assets 9,947 10,071 4,955
Total current assets 50,114 55,256 23,677
Long-term deposits   70
Restricted cash 3,758 3,907
Property and equipment, net 4,185 3,476 1,758
Operating lease right-of-use assets 1,465 2,182 826
Intangible assets, net   43,100 72
Other noncurrent assets 198 1,330
Long-term assets held for sale – discontinued operations 12,299 162,032
Total assets 72,019 228,183 26,403
Current liabilities:      
Accounts payable 14,571 14,474 5,190
Accrued expenses and other current liabilities 26,674 19,830 9,347
SAFE agreements   6,397
Convertible notes, net   1,890
Notes payable, net 27,934 [1] 20,403 [1] 9,507
Deferred revenue, current 2,421 5,407 3,852
Short-term debt with CS Solis 29,194  
Forward purchase agreement liabilities [2] 6,586  
Total current liabilities 107,380 60,114 43,003
Warranty provision, noncurrent 3,416 3,214 1,681
Warrant liability 10,240 14,152 1,129
Derivative liability   1,481
Long-term debt with CS Solis 25,204
Convertible notes, net, noncurrent 3,434  
Convertible notes due to related parties, noncurrent   15,510
Deferred revenue, noncurrent 976  
Operating lease liabilities, net of current portion 790 1,274 499
Total liabilities 122,802 122,902 47,793
Commitments and contingencies (Note 19)
Stockholders' (deficit) equity:      
Common stock 7 3 1
Additional paid-in capital 276,438 190,624 34,504
Accumulated other comprehensive income 51 27
Accumulated deficit (327,279) (85,373) (55,896)
Total stockholders' (deficit) equity (50,783) 105,281 (21,390)
Total liabilities and stockholders' deficit 72,019 228,183 26,403
Related Party      
Current liabilities:      
Convertible notes, net, noncurrent     $ 6,820
Convertible notes due to related parties, noncurrent $ 15,510  
[1] Includes $0.5 million and zero due to related parties as of October 1, 2023 and December 31, 2022, respectively.
[2] Includes $5.6 million and zero of liabilities due to related parties as of October 1, 2023 and December 31, 2022, respectively.
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.23.4
Unaudited Condensed Consolidated Balance Sheets (Parentheticals) - USD ($)
$ in Thousands
Oct. 01, 2023
Dec. 31, 2022
Dec. 31, 2021
Statement of Financial Position [Abstract]      
Accounts receivable, net of allowance for credit losses (in Dollars) $ 10,425 $ 5,396
Common stock, par value (in Dollars per share) $ 0.0001 $ 0.0001 $ 0.0001
Common stocks, shares authorized 1,000,000,000 60,000,000 13,547,943
Common stock, shares issued 45,312,243 19,932,429 9,806,143
Common stock, shares outstanding 45,312,243 19,932,429 9,806,143
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.4
Unaudited Condensed Consolidated Statements Of Operations And Comprehensive Income (Loss) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Oct. 01, 2023
Sep. 30, 2022
Oct. 01, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]              
Revenues $ 24,590 $ 12,260 $ 66,887 $ 48,974 $ 66,475 $ 68,816 $ 29,378
Cost of revenues 18,354 8,266 51,788 33,792 46,647 40,123 17,097
Gross profit 6,236 3,994 15,099 15,182 19,828 28,693 12,281
Operating expenses:              
Sales commissions 8,755 3,572 23,221 15,694 21,195 25,061 10,410
Sales and marketing 2,214 1,604 5,216 4,607 6,156 5,179 3,185
General and administrative 6,345 2,027 22,965 6,194 13,634 5,780 3,801
Total operating expenses 17,314 7,203 51,402 26,495 40,985 36,020 17,396
Loss from continuing operations (11,078) (3,209) (36,303) (11,313) (21,157) (7,327) (5,115)
Interest expense (1,902) [1] (941) [1] (8,870) [1] (2,672) [1] (4,986) [2] (1,712) [2] (523) [2]
Interest income 9 26 5
Other income (expense), net (38,003) [3] 4 [3] (28,302) [3] 3,180 [3] (1,858) [4] (240) [4] (41) [4]
Loss from continuing operations before income taxes (50,974) (4,146) (73,449) (10,805) (27,996) (9,279) (5,679)
Income tax benefit (provision) 1 1 (4) (27) (3) (3)
Net loss from continuing operations (50,973) (4,146) (73,448) (10,809) (28,023) (9,282) (5,682)
Discontinued operations (Note 8):              
Loss from discontinued operations, net of tax (8,404) (20,953) (1,454)
Impairment loss from discontinued operations (147,505) (147,505)      
Net loss from discontinued operations (155,909) (168,458) (1,454)
Net loss (206,882) (4,146) (241,906) (10,809) (29,477) (9,282) (5,682)
Comprehensive income (loss):              
Foreign currency translation adjustment 10 24 27
Comprehensive income (loss), net of tax $ (206,872) $ (4,146) $ (241,882) $ (10,809) $ (29,450) $ (9,282) $ (5,682)
Net loss from continuing operations per share attributable to common stockholders, basic $ (1.28) $ (0.31) $ (4.33) $ (0.83) $ (1.24) $ (0.77) $ (0.58)
Net loss from continuing operations per share attributable to common stockholders, diluted (1.28) (0.31) (4.33) (0.83) (1.24) (0.77) (0.58)
Net loss from discontinued operations per share attributable to common stockholders, basic (3.92) 0 (9.92) 0 (0.07)
Net loss from discontinued operations per share attributable to common stockholders, diluted (3.92) 0 (9.92) 0 (0.07)
Net loss per share attributable to common stockholders, basic (5.2) (0.31) (14.25) (0.83) (1.31) (0.77) (0.58)
Net loss per share attributable to common stockholders, diluted $ (5.2) $ (0.31) $ (14.25) $ (0.83) $ (1.31) $ (0.77) $ (0.58)
Weighted-average shares used to compute net loss per share attributable to common stockholders, basic 39,821,078 13,431,410 16,969,979 13,053,367 22,524,400 11,990,015 9,760,018
Weighted-average shares used to compute net loss per share attributable to common stockholders, diluted 39,821,078 13,431,410 16,969,979 13,053,367 22,524,400 11,990,015 9,760,018
[1] Includes interest expense to related parties of less than $0.1 million and $0.4 million during the thirteen and thirty-nine weeks ended October 1, 2023, respectively, and zero and $0.1 million during the three and nine months ended September 30, 2022, respectively.
[2] Includes interest expense to related parties of $0.3 million, $0.7 million and $0.2 million during the years ended December 31, 2022, 2021 and 2020, respectively.
[3] Other income (expense), net includes other expense, net to related parties of $36.9 million for each of the thirteen and thirty-nine weeks ended October 1, 2023, and other income, net of zero and $1.4 million during the three and nine months ended September 30, 2022, respectively.
[4] Other income (expense), net includes other income from related parties of $1.4 million, zero and zero during the years ended December 31, 2022, 2021 and 2020, respectively.
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.4
Unaudited Condensed Consolidated Statements Of Operations And Comprehensive Income (Loss) (Parentheticals) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Oct. 01, 2023
Sep. 30, 2022
Oct. 01, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Line Items]              
Interest Expense $ 1,902 [1] $ 941 [1] $ 8,870 [1] $ 2,672 [1] $ 4,986 [2] $ 1,712 [2] $ 523 [2]
Other income (expense), net (38,003) [3] 4 [3] (28,302) [3] 3,180 [3] (1,858) [4] (240) [4] (41) [4]
Related Party              
Income Statement [Line Items]              
Interest Expense 100 0 400 100 300 700 200
Other income (expense), net $ 36,900 $ 0 $ 36,900 $ 1,400 $ 1,400 $ 0 $ 0
[1] Includes interest expense to related parties of less than $0.1 million and $0.4 million during the thirteen and thirty-nine weeks ended October 1, 2023, respectively, and zero and $0.1 million during the three and nine months ended September 30, 2022, respectively.
[2] Includes interest expense to related parties of $0.3 million, $0.7 million and $0.2 million during the years ended December 31, 2022, 2021 and 2020, respectively.
[3] Other income (expense), net includes other expense, net to related parties of $36.9 million for each of the thirteen and thirty-nine weeks ended October 1, 2023, and other income, net of zero and $1.4 million during the three and nine months ended September 30, 2022, respectively.
[4] Other income (expense), net includes other income from related parties of $1.4 million, zero and zero during the years ended December 31, 2022, 2021 and 2020, respectively.
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.4
Unaudited Condensed Consolidated Statements of Stockholders' Deficit - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit
Accumulated Other Comprehensive Income
Redeemable Convertible Preferred Stock [Member]
Previously Reported [Member]
Previously Reported [Member]
Common Stock [Member]
Previously Reported [Member]
Additional Paid-in Capital [Member]
Previously Reported [Member]
Accumulated Deficit
Previously Reported [Member]
Accumulated Other Comprehensive Income
Previously Reported [Member]
Redeemable Convertible Preferred Stock [Member]
Adjusted [Member]
Adjusted [Member]
Acquisition Of Assembled Workforce [Member]
Adjusted [Member]
Common Stock [Member]
Adjusted [Member]
Common Stock [Member]
Acquisition Of Assembled Workforce [Member]
Adjusted [Member]
Additional Paid-in Capital [Member]
Adjusted [Member]
Additional Paid-in Capital [Member]
Acquisition Of Assembled Workforce [Member]
Adjusted [Member]
Accumulated Deficit
Adjusted [Member]
Accumulated Deficit
Acquisition Of Assembled Workforce [Member]
Adjusted [Member]
Accumulated Other Comprehensive Income
Adjusted [Member]
Accumulated Other Comprehensive Income
Acquisition Of Assembled Workforce [Member]
Adjusted [Member]
Redeemable Convertible Preferred Stock [Member]
Adjusted [Member]
Redeemable Convertible Preferred Stock [Member]
Issuance Of Redeemable Convertible Preferred Stock Upon Conversion Of Two Thousand And Seventeen Convertible Notes And Two Thousand And Two Thousand And Nineteen Simple Agreement For Future Equity [Member]
Adjusted [Member]
Redeemable Convertible Preferred Stock [Member]
Conversion Of Convertible Notes [Member]
Adjusted [Member]
Redeemable Convertible Preferred Stock [Member]
Acquisition Of Assembled Workforce [Member]
Adjusted [Member]
Redeemable Convertible Preferred Stock [Member]
Issuance Of Redeemable Convertible Preferred Stock Upon Conversion Of Convertible Notes And Simple Agreement For Future Equity Notes [Member]
Adjusted [Member]
Redeemable Convertible Preferred Stock [Member]
Issue Of Redeemable Convertible Preferred Stock Upon Acquisition [Member]
Adjusted [Member]
Redeemable Convertible Preferred Stock [Member]
Issuance Of Redeemable Convertible Preferred Stock Upon Conversion Of Simple Agreement Of Future Equity Notes [Member]
Previously Reported [Member]
Previously Reported [Member]
Common Stock [Member]
Previously Reported [Member]
Additional Paid-in Capital [Member]
Previously Reported [Member]
Accumulated Deficit
Previously Reported [Member]
Accumulated Other Comprehensive Income
Previously Reported [Member]
Redeemable Convertible Preferred Stock [Member]
Balance at Dec. 31, 2019                         $ (17,964)   $ 2   $ 22,966   $ (40,932)   $ 0                 $ (40,752) $ 0 $ 180 $ (40,932) $ 0  
Balance (in Shares) at Dec. 31, 2019                             6,855,244                               1,103,289        
Redeemable, Balance at Dec. 31, 2019                                             $ 0                       $ 22,788
Redeemable, Balance (in Shares) at Dec. 31, 2019                                             0                       13,090,720
Redeemable convertible preferred Stock upon conversion note                                             $ 7,419 $ 3,661                      
Redeemable convertible preferred Stock upon conversion note (in Shares)                                             2,800,283 2,322,150                      
Retroactive application of recapitalization             $ 8,613 $ 0 $ 8,613 $ 0 $ 0 $ (8,613)                                   22,788 $ 2 22,786 0 0 $ (22,788)
Retroactive application of recapitalization (in Shares)               2,929,165       (3,473,650)                                     5,751,955       (13,090,720)
Reclassification of prepaid PIPE(2)                         2,330   $ 0   2,330   0   0       $ (2,330)                    
Reclassification of prepaid PIPE(2) (in Shares)                             1,648,783                   (1,648,783)                    
Exercise of common stock options                         84   $ 0   84   0   0   $ 0                        
Exercise of common stock options (in Shares)                             942,500               0                        
Issuance of common stock warrants                         137   $ 0   137   0   0   $ (137)                        
Stock-based compensation                         109   0   109   0   0   0                        
Net loss $ (5,682)                       (5,682)   0   0   (5,682)   0   0                        
Balance at Dec. 31, 2020             (3,022) $ 0 2,660 (5,682) 0   (12,373)   $ 2   34,239   (46,614)   0                            
Balance (in Shares) at Dec. 31, 2020               2,591,893             9,784,409                                        
Redeemable, Balance at Dec. 31, 2020                       $ 8,613                     $ 0                        
Redeemable, Balance (in Shares) at Dec. 31, 2020                       3,473,650                     0                        
Retroactive application of recapitalization             0 $ 0 0 0 0 $ 0                                              
Retroactive application of recapitalization (in Shares)               21,734       0                                              
Issuance of common stock in connection with forward purchase agreements(3)                           $ 17   $ 0   $ 17   $ 0   $ 0       $ 0                  
Issuance of common stock in connection with forward purchase agreements(3) (in Shares)                               30,000                   0                  
Exercise of common stock options                         6   $ 0   6   0   0   $ 0                        
Exercise of common stock options (in Shares) 7,245                           15,000               0                        
Issuance of common stock warrants                         42   $ 0   42   0   0   $ 0                        
Stock-based compensation                         200   0   200   0   0   0                        
Net loss $ (9,282)                       (9,282)   0   0   (9,282)   0   0                        
Balance at Dec. 31, 2021 (21,390)           (9,017) $ 0 265 (9,282) 0   (21,390)   $ 1   34,505   (55,896)   0   $ 0             (52,791) $ 0 3,105 (55,896) 0 $ 31,401
Balance (in Shares) at Dec. 31, 2021               45,000             9,806,143               0               3,739,572       16,564,370
Redeemable, Balance at Dec. 31, 2021                       $ 0                     $ 0                        
Redeemable, Balance (in Shares) at Dec. 31, 2021                       0                     0                        
Retroactive application of recapitalization             11,558 $ 0 11,558 0 0 $ (11,558)                                   31,401 $ 1 31,400 0 0 $ (31,401)
Retroactive application of recapitalization (in Shares)               1,338,569       (2,771,551)                                     6,066,571       (16,564,370)
Issuance of common stock bonus shares in connection with Merger(4) [1]                                                                    
Issuance of Series D-1, D-2, and D-3 redeemable convertible preferred stock upon conversion of convertible notes and SAFEs(1) [2]                         0   $ 0   0   0   0   $ 11,558                        
Issuance of Series D-1, D-2, and D-3 redeemable convertible preferred stock upon conversion of convertible notes and SAFEs(1) (in Shares) [2]                             0               2,771,551                        
Issuance of common stock options                         28   $ 0   28   0   0   $ 0                        
Issuance of common stock options (in Shares)                             103,353               0                        
Issuance of common stock warrants                       3,447   $ 0   3,447   0   0   $ 0                        
Stock-based compensation                         217   0   217   0   0   0                        
Net loss (10,809)                       (10,809)   0   0   (10,809)   0   0                        
Balance at Sep. 30, 2022             (28,507) $ 1 38,197 (66,705) 0 $ 11,558 (16,949)   $ 1   49,755   (66,705)   0   $ 0                        
Balance (in Shares) at Sep. 30, 2022               9,909,496       2,771,551     11,248,065               0                        
Balance at Dec. 31, 2021 $ (21,390)           (9,017) $ 0 265 (9,282) 0   (21,390)   $ 1   34,505   (55,896)   0   $ 0             (52,791) $ 0 3,105 (55,896) 0 $ 31,401
Balance (in Shares) at Dec. 31, 2021               45,000             9,806,143               0               3,739,572       16,564,370
Redeemable, Balance at Dec. 31, 2021                       $ 0                     $ 0                        
Redeemable, Balance (in Shares) at Dec. 31, 2021                       0                     0                        
Redeemable convertible preferred Stock upon conversion note                                                       $ 52,201 $ 60,470            
Redeemable convertible preferred Stock upon conversion note (in Shares)                                                       6,803,550 8,171,662            
Retroactive application of recapitalization                                                           0 $ 1 124,228 0 0 $ (124,299)
Retroactive application of recapitalization (in Shares)                                                             10,126,286       (17,746,763)
Conversion of 2022 Convertible Notes into common stock (in Shares) 62,500                                                                    
Issuance of common stock in connection with business combination                         27,295   $ 0   27,295   0   0   $ 0                        
Issuance of common stock in connection with business combination (in Shares)                             2,884,550               0                        
Exercise of common stock options                         105   $ 0   105   0   0   $ 0                        
Exercise of common stock options (in Shares) 162,034                           335,496               0                        
Issuance of Series D-1, D-2, and D-3 redeemable convertible preferred stock upon conversion of convertible notes and SAFEs(1)                         0   $ 0   0   0   0           $ 11,558                
Issuance of Series D-1, D-2, and D-3 redeemable convertible preferred stock upon conversion of convertible notes and SAFEs(1) (in Shares)                             0                       2,771,551                
Issuance of common stock warrants                         3,589   $ 0   3,589   0   0   $ 0                        
Stock-based compensation                         903   0   903   0   0   0                        
Foreign currency translation                         27   0   0   0   27   0                        
Net loss $ (29,477)                       (29,477)   0   0   (29,477)   0   0                        
Balance at Dec. 31, 2022 105,281 $ 3 $ 190,624 $ (85,373) $ 27   (50,349)   34,997 (85,373) 27 $ 155,630 105,281   $ 3   190,624   (85,373)   27                 27 $ 0 31,892 (29,477) 27  
Balance (in Shares) at Dec. 31, 2022   19,932,429       0   6,959,618       34,311,133     19,932,429                               3,220,046        
Redeemable, Balance at Dec. 31, 2022                                             $ 0                       $ 124,229
Redeemable, Balance (in Shares) at Dec. 31, 2022                                             0                       17,746,763
Balance at Jun. 30, 2022             (55,856) $ 0 6,703 (62,559) 0 $ 42,959 (12,897)   $ 1   49,661   (62,559)   0   $ 0                        
Balance (in Shares) at Jun. 30, 2022               3,931,068       19,335,921     11,237,198               0                        
Retroactive application of recapitalization             42,959 $ 1 42,958 0 0 $ (42,959)                                              
Retroactive application of recapitalization (in Shares)               7,306,130       (19,335,921)                                              
Issuance of common stock bonus shares in connection with Merger(4) [1]                                                                    
Exercise of common stock options                         9   $ 0   9   0   0   $ 0                        
Exercise of common stock options (in Shares)                             10,867               0                        
Issuance of common stock warrants                                                                    
Stock-based compensation                         85   $ 0   85   0   0   $ 0                        
Net loss (4,146)                       (4,146)   0   0   (4,146)   0   0                        
Balance at Sep. 30, 2022             (28,507) $ 1 38,197 (66,705) 0 $ 11,558 (16,949)   $ 1   49,755   (66,705)   0   $ 0                        
Balance (in Shares) at Sep. 30, 2022               9,909,496       2,771,551     11,248,065               0                        
Balance at Dec. 31, 2022 105,281 $ 3 190,624 (85,373) 27   (50,349)   34,997 (85,373) 27 $ 155,630 105,281   $ 3   190,624   (85,373)   27                 $ 27 $ 0 $ 31,892 $ (29,477) $ 27  
Balance (in Shares) at Dec. 31, 2022   19,932,429       0   6,959,618       34,311,133     19,932,429                               3,220,046        
Retroactive application of recapitalization             155,630 $ 3 155,627 0 0 $ (155,630)                                              
Retroactive application of recapitalization (in Shares)               12,972,811       (34,311,133)                                              
Conversion of 2022 Convertible Notes into common stock $ 40,952 $ 2 40,950 0 0 $ 0                                                          
Conversion of 2022 Convertible Notes into common stock (in Shares) 62,500 5,460,075       0                                                          
Issuance of common stock upon the reverse capitalization, net of offering costs $ 5,220 $ 2 5,218 0 0 $ 0                                                          
Issuance of common stock upon the reverse capitalization, net of offering costs (in Shares)   13,458,293       0                                                          
Reclassification of prepaid PIPE(2) [3] 3,500 $ 0 3,500 0 0 $ 0                                                          
Reclassification of prepaid PIPE(2) (in Shares) [3]   350,000       0                                                          
Conversion of preferred warrant 4,697 $ 0 4,697 0 0 $ 0                                                          
Reclassification of Legacy Complete Solaria common stock into Complete Solaria Common Stock 1 (1) 2 0 0 0                                                          
Issuance of common stock in connection with forward purchase agreements(3) [4] $ 35,490 $ 1 35,489 0 0 $ 0                                                          
Issuance of common stock in connection with forward purchase agreements(3) (in Shares) 2,745,879 5,558,488 [4]       0 [4]                                                          
Issuance of common stock bonus shares in connection with Merger(4) [5] $ 2,394 [1] $ 0 2,394 0 0 $ 0                                                          
Issuance of common stock bonus shares in connection with Merger(4) (in Shares) [5]   463,976       0                                                          
Residual Merger proceeds 161 $ 0 161 0 0 $ 0                                                          
Modification of Carlyle warrant (10,862) 0 (10,862) 0 0 0                                                          
Exercise of common stock options $ 57 $ 0 57 0 0 $ 0                                                          
Exercise of common stock options (in Shares) 67,292 67,292       0                                                          
Issuance of common stock warrants $ 12,689                                                                    
Stock-based compensation 4,156 $ 0 4,156 0 0 $ 0                                                          
Vesting of restricted stock units 52 $ 0 52 0 0 $ 0                                                          
Vesting of restricted stock units (in Shares)   21,690       0                                                          
Foreign currency translation 24 $ 0 0 0 24 $ 0                                                          
Net loss (241,906) 0 0 (241,906) 0 $ 0                                                          
Balance at Oct. 01, 2023 (50,783) $ 7 276,438 (327,279) 51                                                            
Balance (in Shares) at Oct. 01, 2023   45,312,243       0                                                          
Balance at Jul. 02, 2023       (120,397)     (83,260)   37,096   41 $ 155,630 $ 72,370   $ 3   $ 192,723   $ (120,397)   $ 41                            
Balance (in Shares) at Jul. 02, 2023               7,089,948       34,311,133     19,999,721               0                        
Retroactive application of recapitalization             $ 155,630 $ 3 $ 155,627 $ 0 $ 0 $ (155,630)                                              
Retroactive application of recapitalization (in Shares)               12,909,773       (34,311,133)                                              
Conversion of 2022 Convertible Notes into common stock 40,952 $ 2 40,950 0 0 $ 0                                                          
Conversion of 2022 Convertible Notes into common stock (in Shares)   5,460,075       0                                                          
Issuance of common stock upon the reverse capitalization, net of offering costs 5,220 $ 2 5,218 0 0 $ 0                                                          
Issuance of common stock upon the reverse capitalization, net of offering costs (in Shares)   13,458,293       0                                                          
Reclassification of prepaid PIPE(2) [3] 3,500 $ 0 3,500 0 0 $ 0                                                          
Reclassification of prepaid PIPE(2) (in Shares)   350,000 [3]       0                                                          
Conversion of preferred warrant 4,697 $ 0 4,697 0 0 $ 0                                                          
Reclassification of Legacy Complete Solaria common stock into Complete Solaria Common Stock 1 (1) 2 0 0 0                                                          
Issuance of common stock in connection with forward purchase agreements(3) [4] 35,490 $ 1 35,489 0 0 $ 0                                                          
Issuance of common stock in connection with forward purchase agreements(3) (in Shares) [4]   5,558,488       0                                                          
Issuance of common stock bonus shares in connection with Merger(4) [5] 2,394 $ 0 2,394 0 0 $ 0                                                          
Issuance of common stock bonus shares in connection with Merger(4) (in Shares) [5]   463,976       0                                                          
Residual Merger proceeds 161 $ 0 161 0 0 $ 0                                                          
Modification of Carlyle warrant (10,862) 0 (10,862) 0 0 0                                                          
Stock-based compensation 2,114 0 2,114 0 0 0                                                          
Vesting of restricted stock units 52 $ 0 52 0 0 $ 0                                                          
Vesting of restricted stock units (in Shares)   21,690       0                                                          
Foreign currency translation 10 $ 0 0 0 10 $ 0                                                          
Net loss (206,882) 0 0 (206,882) 0 $ 0                                                          
Balance at Oct. 01, 2023 $ (50,783) $ 7 $ 276,438 $ (327,279) $ 51                                                            
Balance (in Shares) at Oct. 01, 2023   45,312,243       0                                                          
[1] Includes $0.7 million of other expense for each of the thirteen and thirty-nine weeks ended October 1, 2023 for bonus shares issued to related parties in connection with the Mergers.
[2] Includes 1,315,287 shares of Series D-1 redeemable convertible preferred stock with a carrying value of $6.3 million, issued to related parties.
[3] Reclassification of pre-funded PIPE was transacted with a related party.
[4] Includes 4,508,488 shares of Complete Solaria Common Stock issued to related parties.
[5] Includes 120,000 shares of Complete Solaria Common Stock issued to related parties.
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.4
Unaudited Condensed Consolidated Statements of Stockholders' Deficit (Parentheticals) - Related Party [Member] - USD ($)
$ in Millions
9 Months Ended
Oct. 01, 2023
Sep. 30, 2023
Dec. 31, 2022
In Connection With Forward Purchase Agreements [Member]      
Stock issued during the period shares new issues 4,508,488    
Issue Of Bonus Shares In Connection With Merger [Member]      
Stock issued during the period shares new issues 120,000    
Series D One Redeemable Convertible Preferred Stock [Member]      
Temporary equity shares issued     1,315,287
Redeemable non controlling interest equity preferred carrying amount     $ 6.3
Series D One Redeemable Convertible Preferred Stock [Member] | Upon Conversion Of Convertible Notes And Simple Agreement For Future Equity [Member]      
Temporary equity shares issued   1,315,287  
Redeemable non controlling interest equity preferred carrying amount   $ 6.3  
Series D Four Redeemable Convertible Preferred Stock [Member] | Issuance Of Redeemable Convertible Preferred Stock Upon Acquisition [Member]      
Temporary equity shares issued     2,007,556
Redeemable non controlling interest equity preferred carrying amount     $ 14.3
Series D Five Redeemable Convertible Preferred Stock [Member] | Issuance Of Redeemable Convertible Preferred Stock Upon Acquisition [Member]      
Temporary equity shares issued     127,472
Redeemable non controlling interest equity preferred carrying amount     $ 1.0
Series D Seven Redeemable Convertible Preferred Stock [Member] | Issuance Of Redeemable Convertible Preferred Stock Upon Acquisition [Member]      
Temporary equity shares issued     3,105,837
Redeemable non controlling interest equity preferred carrying amount     $ 24.9
Series D Eight Redeemable Convertible Preferred Stock [Member] | Issuance Of Redeemable Convertible Preferred Stock Upon Conversion Of Simple Agreement Of Future Equity Notes [Member]      
Temporary equity shares issued     4,426,320
Redeemable non controlling interest equity preferred carrying amount     $ 32.8
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.23.4
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended 12 Months Ended
Oct. 01, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities from continuing operations          
Net loss $ (241,906) $ (10,809) $ (29,477) $ (9,282) $ (5,682)
Loss from discontinued operations, net of income taxes (168,458) (1,454)
Net loss from continuing operations, net of tax (73,448) (10,809) (28,023) (9,282) (5,682)
Adjustments to reconcile net loss from continuing operations to net cash used in operating activities:          
Stock-based compensation expense 2,321 217 433 200 109
Non-cash interest expense 4,009 [1] (76) [1] 4,810 [2] 1,330 [2] 462 [2]
Non-cash lease expense     468 334
Non-cash lease expense 717 304 700 400  
Gain on extinguishment of convertible notes and SAFEs(2) [3] (3,235) [3] (3,235) [4] [4] [4]
Depreciation and amortization 622 463 648 463 298
Provision for credit losses 4,269 716 2,074 364 337
Change in reserve for excess and obsolete inventory 2,144 3,091 3,631 798 100
Issuance of forward purchase agreements [5] (76)      
Change in fair value of forward purchase agreement liabilities [6] 6,661      
Loss on CS Solis debt extinguishment 10,338      
Change in fair value of warrant liabilities (26,314) 142 5,211 330 (24)
Accretion of debt in CS Solis 2,493 2,581      
Issuance of common stock in connection with forward purchase agreements [7] 35,490      
Issuance of common stock bonus shares in connection with the Mergers [8] 2,394      
Issuance of restricted stock units in connection with vendor services 52      
Change in fair value of derivative liability     336 50
Change in fair value of convertible notes     1,306 15
Forgiveness of Paycheck Protection Plan loans     (1,754)
Changes in operating assets and liabilities:          
Accounts receivable, net (11,823) (3,036) (9,683) (4,789) (2,044)
Inventories (3,896) (5,047) (4,953) (3,047) (1,315)
Prepaid expenses and other current assets (8,326) 504 1,600 (3,038) (930)
Long-term deposits     (15) 19 (29)
Other noncurrent assets 1,132 (15) (1,132)
Accounts payable 4,372 190 3,252 3,009 (1,062)
Accrued expenses and other current liabilities 1,587 (2,056) (1,154) 2,946 2,472
Operating lease liabilities (359) (316)      
Operating lease right-of-use assets and lease liabilities     (617) (409)
Warranty provision, noncurrent 255 (584) 157 526 (484)
Deferred revenue (1,766) (231) 1,311 (637) 1,521
Deferred rent     17
Net cash used in operating activities from continuing operations (47,152) (17,197) (25,217) (10,995) (6,189)
Net cash provided by operating activities from discontinued operations 190 (6,296)
Net cash used in operating activities (46,962) (17,197) (31,513) (10,995) (6,189)
Cash flows from investing activities from continuing operations          
Purchase of property and equipment (29) (9) (61)
Capitalization of internal-use software costs (1,505) (1,048) (1,513) (1,054) (523)
Payments for acquisition of business, net of cash acquired     4,848
Net cash used in investing activities from continuing operations (1,534) (1,048) 3,335 (1,063) (584)
Cash flows from financing activities from continuing operations          
Proceeds from issuance of notes payable, net 14,102      
Principal repayment of notes payable (9,653) (9,507) (9,507)
Proceeds from issuance of convertible notes, net of issuance cost 17,750 3,400 1,150 510
Proceeds from issuance of convertible notes, net of issuance cost, due to related parties 3,500 8,600 3,600 3,274
Repayment of convertible notes to related parties (500) (500)
Proceeds from issuance of long-term debt with CS Solis, net of issuance cost 25,000 25,000
Proceeds from exercise of common stock options 57 28 128 6 84
Proceeds from Mergers and PIPE Financing 4,219      
Proceeds from Mergers and PIPE Financing from related parties 15,600      
Payments for issuance of Series D redeemable convertible preferred stock (1,317)      
Proceeds from issuance of SAFE agreements     5,000
Proceeds from issuance of notes payable, net     5,501 7,239 3,987
Payments for issuance costs of Series D-1, D-2 and D-3 redeemable convertible preferred stock     (1,431)
Principal repayment of notes payable     (100) (1,500)
Net cash provided by financing activities from continuing operations 45,575 13,704 31,191 16,895 6,355
Effect of exchange rate changes 24 27
Net decrease in cash, cash equivalents and restricted cash (2,897) (4,541) 3,040 4,837 (418)
Cash, cash equivalents, and restricted cash at beginning of period 8,316 5,276 5,276 439 857
Cash, cash equivalents, and restricted cash at end of period 5,419 735 8,316 5,276 439
Supplemental disclosures of cash flow information:          
Cash paid during the year for interest 1,602 1 162 365 150
Cash paid during the year for income taxes 38 6
Supplemental schedule of noncash investing and financing activities:          
Operating lease right-of-use assets obtained in exchange for new operating lease liabilities 245 245 1,157
Carlyle warrant modification (10,862)      
Reclassification of liability-classified warrants to equity-classified warrants 30,625      
Issuance of common stock warrants 202 3,447 3,589 42 137
Issuance of Series D redeemable convertible preferred stock upon conversion of SAFE 6,550 60,470
Issuance of Series D redeemable convertible preferred stock upon conversion of convertible debt 10,680      
Conversion of 2022 Convertible Notes into common stock 21,561      
Conversion of 2022 Convertible Notes issued to related parties into common stock 19,390      
Conversion of preferred stock into common stock 155,630      
Issuance of common stock bonus shares in connection with the Mergers(6) [8] 2,394      
Recapitalization of Legacy Complete Solaria Common stock into Complete Solaria Common Stock 1      
Reclassification of investor related to PIPE funds $ 3,500      
Issuance of Series C redeemable convertible preferred stock upon conversion of convertible debt     1,330
Issuance of Series C-1 redeemable convertible preferred stock upon conversion of convertible     7,420
Fair value of debt derivative liabilities related to issuance of convertible notes     1,754
Common stock issued in asset purchase     17
Notes payable issued in asset purchase     120
Issuance of Series D-1, D-2 and D-3 redeemable convertible preferred stock upon conversion of convertible debt, net of issuance costs of $1,431     11,558
Acquisition of business through issuance of common stock and stock options     27,295
Acquisition of business through issuance of Series D redeemable convertible preferred stock     52,201
Acquisition of business through issuance of Series D redeemable convertible preferred stock warrants     $ 7,812
[1] Non-cash interest expense to related parties of $0.1 million and $0.4 million during the thirteen and thirty-nine weeks ended October 1, 2023, respectively, and zero and $0.1 million during the three and nine months ended September 30, 2022, respectively.
[2] Non-cash interest expense to related parties of $0.3 million, $0.7 million and $0.2 million during the years ended December 31, 2022, 2021 and 2020, respectively.
[3] Gain on extinguishment of convertible notes and SAFEs includes other income from related parties of zero during each of the thirteen and thirty-nine weeks ended October 1, 2023, and zero and $1.4 million during the three and nine months ended September 30, 2022, respectively.
[4] Gain on extinguishment of convertible notes and SAFEs includes other income from related parties of $1.4 million, zero and zero during the years ended December 31, 2022, 2021 and 2020, respectively.
[5] Issuance of forward purchase agreements includes other income from related parties of $0.3 million for each of the thirteen and thirty-nine weeks ended October 1, 2023, and zero for each of the three and nine months ended September 30, 2022.
[6] Change in fair value of forward purchase agreement liabilities includes other expense from related parties of $5.9 million for each of the thirteen and thirty-nine weeks ended October 1, 2023, and zero for each of the three and nine months ended September 30, 2022.
[7] Issuance of common stock in connection with forward purchase agreements includes other expense from related parties of $30.7 million for each of the thirteen and thirty-nine weeks ended October 1, 2023, and zero for each of the three and nine months ended September 30, 2022.
[8] Issuance of common stock bonus shares to related parties in connection with the Mergers includes other expense of $0.7 million for each of the thirteen and thirty-nine weeks ended October 1, 2023, and zero for each of the three and nine months ended September 30, 2022.
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.23.4
Unaudited Condensed Consolidated Statements of Cash Flows (Parentheticals) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Oct. 01, 2023
Sep. 30, 2022
Oct. 01, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Series D Four Redeemable Convertible Preferred Stock [Member]              
Forward purchase agreement other income $ 300 $ 0 $ 300 $ 0      
Issuance Of Temporary Equity Upon Conversion Of Convertible Debt [Member]              
Temporary equity stock issuance costs         $ 1,431    
Related Party [Member]              
Non cash interest expenses 100 0 400 100 300 $ 700 $ 200
Gain on extinguishment of convertible notes and simple agreement for future equity 0 0 0 1,400 $ 1,400 $ 0 $ 0
Forward purchase agreement other expense 5,900 0 5,900 0      
Common stock issued forward purchase agreements expenses incurred 30,700 0 30,700 0      
Common stock bonues shares issued in connection with merger expenses $ 700 $ 0 $ 700 $ 0      
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.23.4
Organization
9 Months Ended 12 Months Ended
Oct. 01, 2023
Dec. 31, 2022
Organization [Abstract]    
Organization
(1)
Organization
 
(a)
Description of Business
Complete Solaria, Inc. (the “Company” or “Complete Solaria”) is a residential solar installer headquartered in Fremont, California, which was formed through Complete Solar Holding Corporation’s acquisition of The Solaria Corporation (“Solaria”).
Complete Solar, Inc. (“Complete Solar”) was incorporated in Delaware on February 22, 2010. Through February 2022, the Company operated as a single legal entity as Complete Solar, Inc. In February 2022, the Company implemented a holding company reorganization (the “Reorganization”) in which the Company created and incorporated Complete Solar Holding Corporation (“Complete Solar Holdings”). As a result of the Reorganization, Complete Solar Holdings became the successor entity to Complete Solar, Inc. The capitalization structure was not changed because of the Reorganization as all shares of Complete Solar, Inc common stock and preferred stock were exchanged on a one for one basis with shares of Complete Solar Holdings common stock and preferred stock. The Reorganization was accounted for as a change in reporting entity for entities under common control. The historical assets and liabilities of Complete Solar, Inc. are transferred to Complete Solar Holdings at their carrying value, and there is no change to net income, other comprehensive income (loss), or any related per share amounts reported in the unaudited condensed consolidated financial statements requiring retrospective application.
In October 2022, the Company entered into a business combination agreement, as amended on December 26, 2022 and January 17, 2023 (“Original Business Combination Agreement”) and as amended on May 26, 2023 (“Amended and Restated Business Combination Agreement”), with Jupiter Merger Sub I Corp., a Delaware corporation and a wholly owned subsidiary of Freedom Acquisition I Corp. (“FACT”) (“First Merger Sub”), Jupiter Merger Sub II LLC, a Delaware limited liability company and a wholly owned subsidiary of FACT (“Second Merger Sub”), Complete Solar Holding Corporation, a Delaware corporation, and Solaria, a Delaware corporation.
The transactions contemplated by the Amended and Restated Business Combination Agreement were consummated on July 18, 2023 (“Closing Date”). Following the consummation of the Merger on the Closing Date, FACT changed its name to “Complete Solaria, Inc.”
As part of the transactions contemplated by the Amended and Restated Business Combination Agreement, FACT affected a deregistration under the Cayman Islands Companies Act and a domestication under Section 388 of the Delaware’s General Corporation Law (the “DGCL” or “Domestication”). On the Closing Date, following the Domestication, First Merger Sub merged with and into Complete Solaria, with Complete Solaria surviving such merger as a wholly owned subsidiary of FACT (the “First Merger”), and immediately following the First Merger, Complete Solaria merged with and into Second Merger Sub, with Second Merger Sub surviving as a wholly owned subsidiary of FACT (the “Second Merger”), and Second Merger Sub changed its name to CS, LLC, and immediately following the Second Merger, Solaria merged with and into a newly formed Delaware limited liability company and wholly-owned subsidiary of FACT and changed its name to The Solaria Corporation LLC (“Third Merger Sub”), with Third Merger Sub surviving as a wholly-owned subsidiary of FACT (the “Additional Merger”, and together with the First Merger and the Second Merger, the “Mergers”).
In connection with the closing of the Mergers:
 
   
Each share of the Company’s capital stock, inclusive of shares converted from 2022 Convertible Notes, issued and outstanding immediately prior to the Closing (“Legacy Complete Solaria Capital Stock”) were cancelled and exchanged into an aggregate of 25,494,332 shares of Complete Solaria Common Stock.
In July 2023, (i) Meteora Special Opportunity Fund I, LP (“MSOF”), Meteora Capital Partners, LP (“MCP”) and Meteora Select Trading Opportunities Master, LP (“MSTO”) (with MSOF, MCP, and MSTO collectively as “Meteora”); (ii) Polar Multi-Strategy Master Fund (“Polar”), and (iii) Diametric True Alpha Market Neutral Master Fund, LP, Diametric True Alpha Enhanced Market Neutral Master Fund, LP, and Pinebridge Partners Master Fund, LP (collectively, “Sandia”) (together, the “FPA Funding PIPE Investors”) entered into separate subscription agreements (the “FPA Funding Amount PIPE Subscription Agreements”) pursuant to which, the FPA Funding PIPE Investors subscribed for on the Closing Date, an aggregate of 6,300,000 shares of FACT Class A Ordinary Shares, less, in the case of Meteora, 1,161,512 FACT Class A Ordinary Shares purchased by Meteora separately from third parties through a broker in the open market (“Recycled Shares”) in connection with the Forward Purchase Agreements (“FPAs”). Subsequent to the Closing Date, Complete Solaria entered into an additional FPA Funding PIPE Subscription Agreement with Meteora, to subscribe for and purchase, and Complete Solaria agreed to issue and sell, an aggregate of 420,000 shares of Complete Solaria Common Stock. The Company issued shares of Complete Solaria Common Stock underlying the FPAs as of the latter of the closing of the Mergers or execution of the FPAs.
 
   
All certain investors (the “PIPE Investors”) purchased from the Company an aggregate of 1,570,000 shares of Complete Solaria Common Stock (the “PIPE Shares”) for a purchase price of $10.00 per share, for aggregate gross proceeds of $15.7 million (the “PIPE Financing”), including $3.5 million that was funded prior to the Closing Date, pursuant to subscription agreements (the “Subscription Agreements”). At the time of the PIPE Financing, Complete Solaria issued an additional 60,000 shares to certain investors as an incentive to participate in the PIPE Financing.
 
   
On or around the Closing Date, pursuant to the New Money PIPE Subscription Agreements, certain investors affiliated with the New Money PIPE Subscription Agreements (“New Money PIPE Investors”) agreed to subscribe for and purchase, and Complete Solaria agreed to issue and sell to the New Money PIPE Investors an aggregate of 120,000 shares of Complete Solaria Common Stock for a purchase price of $5.00 per share, for aggregate gross proceeds of $0.6 million. Pursuant to its New Money PIPE Subscription Agreement, Complete Solaria issued an additional 60,000 shares of Complete Solaria Common Stock in consideration of certain services provided by it in the structuring of its FPA and the transactions described therein.
 
   
Subsequent to the Closing, Complete Solaria issued an additional 193,976 shares of Complete Solaria Common Stock to the sponsors for reimbursing sponsors’ transfer to certain counterparties and issued an additional 150,000 shares of Complete Solaria Common Stock to an FPA investor for services provided in connection with the Mergers.
 
   
In March 2023, holders of 23,256,504 of the originally issued 34,500,000 FACT Class A Ordinary shares exercised their rights to redeem those shares for cash, and immediately prior to the Closing there were 11,243,496 FACT Class A Ordinary Shares that remained outstanding. At the Closing, holders of 7,784,739 shares of Class A common stock of FACT exercised their rights to redeem those shares for cash, for an aggregate of approximately $82.2 million which was paid to such holders at Closing. The remaining FACT Class A Ordinary Share converted, on a
one-for-one
basis, into one share of Complete Solaria Common Stock;
 
   
Each issued and outstanding FACT Class B Ordinary Share converted, on a
one-for-one
basis, into one share of Complete Solaria Common Stock.
In November 2022, Complete Solar Holdings acquired Solaria (as described in Note 6 – Business Combination) and changed its name to Complete Solaria, Inc. On August 18, 2023, the Company entered into a
Non-Binding
Letter of Intent to sell certain of Complete Solaria’s North American solar panel assets to Maxeon, Inc. (“Maxeon”). In October 2023, the Company completed the sale of its solar panel business to Maxeon. The disposition met the criteria for held for sale and discontinued operations classification as of October 1, 2023. Refer to Note 1(c) – Divestiture, Note 8 – Divestiture, and Note 22 – Subsequent Events.
(b)
Basis of Presentation of Unaudited Interim Condensed Consolidated Financial Statements
The accompanying unaudited interim condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions for interim reporting as prescribed by the Securities and Exchange Commission. Accordingly, they do not include all of the information and footnotes required by GAAP for complete condensed consolidated financial statements. The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. Intercompany accounts and transactions are eliminated upon consolidation.
Effective January 1, 2023, the Company changed its fiscal quarters to four thirteen-week periods within a standard calendar year. Each annual reporting period begins on January 1 and ends on December 31. Since the fiscal quarter change was made after the end of fiscal 2022, the Company will continue to report prior year financial information based on its prior year fiscal calendar. The Company’s financial results for the thirteen and thirty-nine weeks ended October 1, 2023 are compared to its results for the three and nine months ended September 30, 2022. The comparison of these periods is primarily affected by the difference of one day between the first three quarters of fiscal 2023 and first three quarters of 2022, which the Company notes is immaterial.
In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary to make the unaudited condensed consolidated financial statements not misleading have been included. The information included in this report should be read in conjunction with the audited consolidated financial statements as of and for the year ended December 31, 2022, as filed with the Securities and Exchange Commission (“SEC”) on Form
S-4.
The condensed consolidated balance sheet as of December 31, 2022 included herein was derived from the audited consolidated financial statements as of that date.
Interim financial results are not necessarily indicative of the results that may be expected for any future period.
 
(c)
Divestiture
On August 18, 2023, the Company entered into a
Non-Binding
Letter of Intent to sell certain of Complete Solaria’s North American solar panel assets to Maxeon. On September 20, 2023, the Company and Maxeon entered into an Asset Purchase Agreement (the “Disposal Agreement”) for the sale of certain assets, inclusive of certain intellectual property and customer contracts, to Maxeon. On October 6, 2023, the Company completed the sale of certain of Complete Solaria’s North American solar panel assets, inclusive of certain intellectual property and customer contracts, to Maxeon, pursuant to the terms of the Disposal Agreement. Under the terms of the Disposal Agreement, Maxeon agreed to acquire certain assets and employees of Complete Solaria, for an aggregate purchase price consisting of 1,100,000 shares of Maxeon common stock.
This divestiture represents a strategic shift in Complete Solaria’s business and qualifies as held for sale and as a discontinued operation as of October 1, 2023. Based on the held for sale classification of the assets, the Company has reduced the carrying value of the disposal group to its fair value, less cost to sell and recorded an impairment loss associated with the held for sale intangible assets and goodwill. As a result, the Company classified the results of its solar panel business in discontinued operations in its unaudited condensed consolidated statements of operations and comprehensive income (loss) for all periods presented. The cash flows related to discontinued operations have been segregated and are included in the unaudited condensed consolidated statements of cash flows for all periods presented. Unless otherwise noted, discussion within the notes to the unaudited condensed consolidated financial statements relates to continuing operations only and excludes the historical activities of the North American panel business. See Note 8 – Divestiture for additional information.
(d)
Liquidity and Going Concern
Since inception, the Company has incurred recurring losses and negative cash flows from operations. The Company incurred net losses of $51.0 million and $73.4 million during the thirteen and thirty-nine weeks ended October 1, 2023, respectively, and net losses of $4.1 million and $10.8 million during the three and nine months ended September 30, 2022, respectively, and had an accumulated deficit of $327.3 million as of October 1, 2023. The Company had cash and cash equivalents of $1.7 million as of October 1, 2023. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. These unaudited condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. Historically, the Company’s activities have been financed through private placements of equity securities, debt and proceeds from the Merger. The Company expects to incur significant operating expenses as it continues to grow its business. The Company believes that its operating losses and negative operating cash flows will continue into the foreseeable future. The Company’s history of recurring losses, negative operating cash flows since inception and the need to raise additional funding to meet its obligations and finance its operations raise substantial doubt about the Company’s ability to continue as a going concern. The Company’s ability to continue as a going concern requires that the Company obtains sufficient funding to meet its obligations and finance its operations. If the Company is not able to secure adequate additional funding when needed, the Company will need to reevaluate its operating plan and may be forced to make reductions in spending, extend payment terms with suppliers, liquidate assets where possible, or suspend or curtail planned programs or cease operations entirely. These actions could materially impact the Company’s business, results of operations and future prospects. While the Company has been able to raise multiple rounds of financing, there can be no assurance that in the event the Company requires additional financing, such financing will be available on terms that are favorable, or at all. Failure to generate sufficient cash flows from operations, raise additional capital or reduce certain discretionary spending would have a material adverse effect on the Company’s ability to achieve its intended business objectives.
Therefore, there is substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the unaudited condensed consolidated financial statements are issued. The accompanying unaudited condensed consolidated financial statements have been prepared assuming the Company will continue to operate as a going concern, which contemplates the realization of assets and settlement of liabilities in the normal course of business. They do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from uncertainty related to its ability to continue as a going concern.
 
(e)
Immaterial Correction of Prior Period Financial Statements
Subsequent to the issuance of the Company’s unaudited condensed consolidated financial statements for the three and nine months ended September 30, 2022, the Company identified a misstatement in redeemable convertible preferred stock and other income (expense), net, related to the accounting for the issuance of its Series D preferred stock and conversion of SAFEs and convertible notes. Such misstatement relates to the use of an incorrect factor for the conversion of these instruments into preferred stock.
The Company considered both quantitative and qualitative factors and determined the effect of the misstatement was immaterial to the previously issued unaudited condensed consolidated financial statements for the three and nine months ended September 30, 2022. The Company identified and corrected the misstatement prior to the issuance of the consolidated financial statements for the year ended December 31, 2022, which were filed in FACT’s
S-4
registration statement. The adjustment in the fourth quarter resulted in a $4.4 million decrease in redeemable convertible preferred stock and other income (expense), net, as well as net loss.
The accompanying unaudited condensed consolidated statements of operations and comprehensive income (loss) and statements of stockholders’ deficit for the three and nine months ended September 30, 2022
reflect such adjustment. Accordingly, the accompanying unaudited condensed consolidated statements of cash flows reflect such adjustment, and there was no change to net cash used in operating activities from continuing operations, net cash used in investing activities from continuing operations, or net cash provided by financing activities from continuing operations for the nine months ended September 
30
,
2022
.
(1)
Organization
 
(a)
Description of Business
Complete Solaria, Inc. (the “Company” or “Complete Solaria”) is a residential solar installer headquartered in Fremont, California, which was formed through Complete Solar Holding Corporation’s acquisition of The Solaria Corporation (“Solaria).
Complete Solar, Inc. (“Complete Solar”) was incorporated in Delaware on February 22, 2010. Through February 2022, the Company operated as a single legal entity as Complete Solar, Inc. In February 2022, the Company implemented a holding company reorganization (the “Reorganization”) in which the Company created and incorporated Complete Solar Holding Corporation (“Complete Solar Holdings”). As a result of the Reorganization, Complete Solar Holdings became the successor entity to Complete Solar, Inc. The capitalization structure was not changed because of the Reorganization as all shares of Complete Solar, Inc common stock and preferred stock were exchanged on a one for one basis with shares of Complete Solar Holdings common stock and preferred stock. The Reorganization was accounted for as a change in reporting entity for entities under common control. The historical assets and liabilities of Complete Solar, Inc. are transferred to Complete Solar Holdings at their carrying value, and there is no change to net income, other comprehensive income, or any related per share amounts reported in the consolidated financial statements requiring retrospective application.
In October 2022, the Company entered into a business combination agreement, as amended on December 26, 2022 and January 17, 2023 (“Original Business Combination Agreement”) and as amended on May 26, 2023 (“Amended and Restated Business Combination Agreement”), with Jupiter Merger Sub I Corp., a Delaware corporation and a wholly owned subsidiary of Freedom Acquisition I Corp. (“FACT”) (“First Merger Sub”), Jupiter Merger Sub II LLC, a Delaware limited liability company and a wholly owned subsidiary of FACT (“Second Merger Sub”), Complete Solar Holding Corporation, a Delaware corporation, and Solaria, a Delaware corporation.
The transactions contemplated by the Amended and Restated Business Combination Agreement were consummated on July 18, 2023 (“Closing Date”). Following the consummation of the Merger on the Closing Date, FACT changed its name to “Complete Solaria, Inc.”
As part of the transactions contemplated by the Amended and Restated Business Combination Agreement, FACT affected a deregistration under the Cayman Islands Companies Act and a domestication under Section 388 of the Delaware’s General Corporation Law (the “DGCL” or “Domestication”). On the Closing Date, following the Domestication, First Merger Sub merged with and into Complete Solaria, with Complete Solaria surviving such merger as a wholly owned subsidiary of FACT (the “First Merger”), and immediately following the First Merger, Complete Solaria merged with and into Second Merger Sub, with Second Merger Sub surviving as a wholly owned subsidiary of FACT (the “Second Merger”), and Second Merger Sub changed its name to CS, LLC, and immediately following the Second Merger, Solaria merged with and into a newly formed Delaware limited liability company and wholly-owned subsidiary of FACT and changed its name to The Solaria Corporation LLC (“Third Merger Sub”), with Third Merger Sub surviving as a wholly-owned subsidiary of FACT (the “Additional Merger”, and together with the First Merger and the Second Merger, the “Mergers”).
In connection with the closing of the Mergers:
 
   
Each share of the Company’s capital stock, inclusive of shares converted from 2022 Convertible Notes, issued and outstanding immediately prior to the Closing (“Legacy Complete Solaria Capital Stock”) were cancelled and exchanged into an aggregate of 25,494,332 shares of Complete Solaria Common Stock.
 
   
In July 2023, (i) Meteora Special Opportunity Fund I, LP (“MSOF”), Meteora Capital Partners, LP (“MCP”) and Meteora Select Trading Opportunities Master, LP (“MSTO”) (with MSOF, MCP, and
 
MSTO collectively as “Meteora”); (ii) Polar Multi-Strategy Master Fund (“Polar”), and (iii) Diametric True Alpha Market Neutral Master Fund, LP, Diametric True Alpha Enhanced Market Neutral Master Fund, LP, and Pinebridge Partners Master Fund, LP (collectively, “Sandia”) (together, the “FPA Funding PIPE Investors”) entered into separate subscription agreements (the “FPA Funding Amount PIPE Subscription Agreements”) pursuant to which, the FPA Funding PIPE Investors subscribed for on the Closing Date, an aggregate of 6,300,000 shares of FACT Class A Ordinary Shares, less, in the case of Meteora, 1,161,512 FACT Class A Ordinary Shares purchased by Meteora separately from third parties through a broker in the open market (“Recycled Shares”) in connection with the Forward Purchase Agreements (“FPAs”). Subsequent to the Closing Date, Complete Solaria entered into an additional FPA Funding PIPE Subscription Agreement with Meteora, to subscribe for and purchase, and Complete Solaria agreed to issue and sell, an aggregate of 420,000 shares of Complete Solaria Common Stock. The Company issued shares of Complete Solaria Common Stock underlying the FPAs as of the latter of the closing of the Mergers or execution of the FPAs.
 
   
All certain investors (the “PIPE Investors”) purchased from the Company an aggregate of 1,570,000 shares of Complete Solaria Common Stock (the “PIPE Shares”) for a purchase price of $10.00 per share, for aggregate gross proceeds of $15.7 million (the “PIPE Financing”), including $3.5 million that was funded prior to the Closing Date, pursuant to subscription agreements (the “Subscription Agreements”). At the time of the PIPE Financing, Complete Solaria issued an additional 60,000 shares to certain investors as an incentive to participate in the PIPE Financing.
 
   
On or around the Closing Date, pursuant to the New Money PIPE Subscription Agreements, certain investors affiliated with the New Money PIPE Subscription Agreements (“New Money PIPE Investors”) agreed to subscribe for and purchase, and Complete Solaria agreed to issue and sell to the New Money PIPE Investors an aggregate of 120,000 shares of Complete Solaria Common Stock for a purchase price of $5.00 per share, for aggregate gross proceeds of $0.6 million. Pursuant to its New Money PIPE Subscription Agreement, Complete Solaria issued an additional 60,000 shares of Complete Solaria Common Stock in consideration of certain services provided by it in the structuring of its FPA and the transactions described therein.
 
   
Subsequent to the Closing, Complete Solaria issued an additional 193,976 shares of Complete Solaria Common Stock to the sponsors for reimbursing sponsors’ transfer to certain counterparties and issued an additional 150,000 shares of Complete Solaria Common Stock to an FPA investor for services provided in connection with the Mergers.
 
   
In March 2023, holders of 23,256,504 of the originally issued 34,500,000 FACT Class A Ordinary shares exercised their rights to redeem those shares for cash, and immediately prior to the Closing there were 11,243,496 FACT Class A Ordinary Shares that remained outstanding. At the Closing, holders of 7,784,739 shares of Class A common stock of FACT exercised their rights to redeem those shares for cash, for an aggregate of approximately $82.2 million which was paid to such holders at Closing. The remaining FACT Class A Ordinary Share converted, on a one-for-one basis, into one share of Complete Solaria Common Stock.
 
   
Each issued and outstanding FACT Class B Ordinary Share converted, on a one-for-one basis, into one share of Complete Solaria Common Stock.
In November 2022, Complete Solar Holdings acquired Solaria (as described in Note 4 – Business Combination) and changed its name to Complete Solaria, Inc. On August 18, 2023, the Company entered into a Non-Binding Letter of Intent to sell certain of Complete Solaria’s North American solar panel assets to Maxeon, Inc. (“Maxeon”). In October 2023, the Company completed the sale of its solar panel business to Maxeon. The disposition met the criteria for held for sale and discontinued operations classification. Refer to Note 1(b) – Divestiture and Note 5 – Divestiture.
 
(b)
Divestiture
On August 18, 2023, the Company entered into a Non-Binding Letter of Intent to sell certain of Complete
Solaria’s North American solar panel assets to Maxeon. Subsequent to the execution of the Non-Binding Letter of Intent, on September 20, 2023, the Company and Maxeon entered into an Asset Purchase Agreement (the “Disposal Agreement”) for the sale of certain assets, inclusive of certain intellectual property and customer contracts, to Maxeon. On October 6, 2023, the Company completed the sale of certain of Complete Solaria’s North American solar panel assets, inclusive of certain intellectual property and customer contracts, to Maxeon, pursuant to the terms of the Disposal Agreement. Under the terms of the Disposal Agreement, Maxeon agreed to acquire certain assets and employees of Complete Solaria, for an aggregate purchase price consisting of 1,100,000 shares of Maxeon common stock.
This divestiture represents a strategic shift in Complete Solaria’s business and qualifies as held for sale and as a discontinued operation. As a result, the Company classified the results of its solar panel business in discontinued operations in its consolidated statements of operations and comprehensive income (loss) for all periods presented. The cash flows related to discontinued operations have been segregated and are included in the consolidated statements of cash flows for all periods presented. Unless otherwise noted, discussion within the notes to the consolidated financial statements relates to continuing operations only and excludes the historical activities of the North American panel business. See Note 5 – Divestiture for additional information.
 
(c)
Liquidity and Going Concern
Since inception, the Company has incurred recurring losses and negative cash flows from operations. The Company incurred net losses of $29.5 million, $9.2 million and $5.6 million during the years ended December 31, 2022, 2021 and 2020, respectively, and had an accumulated deficit of $85.4 million as of December 31, 2022. The Company had cash and cash equivalents of $4.4 million as of December 31, 2022. Historically, the Company’s activities have been financed through private placements of equity securities and debt. The Company expects to incur significant operating expenses as it continues to grow its business. The Company believes that its operating losses and negative operating cash flows will continue into the foreseeable future. The Company’s history of recurring losses, negative operating cash flows since inception and the need to raise additional funding to meet its obligations and finance its operations raise substantial doubt about the Company’s ability to continue as a going concern. The Company’s ability to continue as a going concern requires that the Company obtains sufficient funding to meet its obligations and finance its operations. These actions could materially impact the Company’s business, results of operations and future prospects. While the Company has been able to raise multiple rounds of financing, there can be no assurance that in the event the Company requires additional financing, such financing will be available on terms that are favorable, or at all. Failure to generate sufficient cash flows from operations, raise additional capital or reduce certain discretionary spending would have a material adverse effect on the Company’s ability to achieve its intended business objectives.
Therefore, there is substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the financial statements are issued. The accompanying financial statements have been prepared assuming the Company will continue to operate as a going concern, which contemplates the realization of assets and settlement of liabilities in the normal course of business. They do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from uncertainty related to its ability to continue as a going concern.
 
(d)
Basis of Presentation
The financial statements and accompanying notes have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.23.4
Summary of Significant Accounting Policies
9 Months Ended 12 Months Ended
Oct. 01, 2023
Dec. 31, 2022
Significant Accounting Policies [Abstract]    
Summary of Significant Accounting Policies
(2)
Summary of Significant Accounting Policies
 
(a)
Use of Estimates
The preparation of the Company’s unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses, as well as related disclosure of contingent assets and liabilities. Significant estimates and assumptions made by management include, but are not limited to, the determination of:
 
   
the allocation of the transaction price to identified performance obligations;
 
   
fair value of warrant liabilities;
 
   
the fair value of assets acquired and liabilities assumed for business combinations;
 
   
the reserve methodology for inventory obsolescence;
 
   
the reserve methodology for product warranty;
 
   
the reserve methodology for the allowance for credit losses; and
 
   
the fair value of the forward purchase agreements.
To the extent that there are material differences between these estimates and actual results, the Company’s financial condition or operating results will be affected.
 
(b)
Supply Chain Constraints and Risk
The Company relies on a very small number of suppliers of solar energy systems and other equipment. If any of the Company’s suppliers was unable or unwilling to provide the Company with contracted quantities in a timely manner at prices, quality levels and volumes acceptable to the Company, the Company would have very limited alternatives for supply, and the Company may not be able find suitable replacements for the Company’s customers, or at all. Such an event could materially adversely affect the Company’s business, prospects, financial condition and results of operations.
In addition, the global supply chain and the Company’s industry have experienced significant disruptions in recent periods. The Company has seen supply chain challenges and logistics constraints increase, including shortages of panels, inverters, batteries and associated component parts for inverters and solar energy systems available for purchase. In certain cases, this has caused delays in critical equipment and inventory, longer lead times, and has resulted in cost volatility. These shortages and delays can be attributed in part to the
COVID-19
pandemic and resulting government action, broader macroeconomic conditions, and have been exacerbated by the ongoing conflicts in Ukraine and Israel. While the Company believes that a majority of the Company’s suppliers have secured sufficient supply to permit them to continue delivery and installations through the end of 2023, if these shortages and delays persist into 2024, they could adversely affect the timing of when battery energy storage systems can be delivered and installed, and when (or if) the Company can begin to generate revenue from those systems. In addition, the Company has experienced and is experiencing varying levels of volatility in costs of equipment and labor resulting in part from disruptions caused by general global economic conditions, including inflationary pressures and the
COVID-19
pandemic.
The Company cannot predict the full effects these events will have on the Company’s business, cash flows, liquidity, financial condition and results of operations at this time due to numerous uncertainties. In the event the Company is unable to mitigate the impact of delays or price volatility in solar energy systems, raw materials, and freight, it could materially adversely affect the Company’s business, prospects, financial condition and results of operations.
 
(c)
Segment Information
The Company conducts its business in one operating segment that provides custom solar solutions through a standardized platform to its residential solar providers and companies to facilitate the sale and installation of solar energy systems under a single product group. The Company’s Chief Executive Officer (“CEO”) is the Chief Operating Decision Maker (“CODM”). The CODM allocates resources and makes operating decisions based on financial information presented on a consolidated basis. The profitability of the Company’s product group is not a determining factor in allocating resources and the CODM does not evaluate profitability below the level of the consolidated company. All the Company’s long-lived assets are maintained in the United States of America.
 
(d)
Restricted Cash
The Company classifies all cash for which usage is limited by contractual provisions as restricted cash. Restricted cash balance as of October 1, 2023 and December 31, 2022, was $3.8 million and $3.9 million, respectively. The restricted cash consists of deposits in money market accounts, which is used as cash collateral backing letters of credit related to customs duty authorities’ requirements. The Company has presented these balances under restricted cash, as a long-term asset, in the unaudited condensed consolidated balance sheets. The Company reconciles cash, cash equivalents, and restricted cash reported in the unaudited condensed consolidated balance sheets that aggregate to the beginning and ending balances shown in the unaudited condensed consolidated statements of cash flows as follows (in thousands):
 
    
As of
 
    
October 1,
2023
    
December 31,
2022
 
Cash and cash equivalents
   $ 1,661      $ 4,409  
Restricted cash
     3,758        3,907  
  
 
 
    
 
 
 
Total cash, cash equivalents, and restricted cash
   $ 5,419      $ 8,316  
  
 
 
    
 
 
 
 
(e)
Revenue Recognition
Disaggregation of revenue
Refer to the table below for the Company’s revenue recognized by product and service type (in thousands):
 
    
Thirteen
Weeks
Ended
October 1,
2023
    
Three
Months
Ended
September 30,
2022
    
Thirty-Nine

Weeks
Ended
October 1,
2023
    
Nine Months
Ended
September 30,
2022
 
Solar energy system installations
   $ 23,915      $ 11,120      $ 64,511      $ 46,214  
Software enhanced services
     675        1,140        2,376        2,760  
  
 
 
    
 
 
    
 
 
    
 
 
 
Total revenue
   $ 24,590      $ 12,260      $ 66,887      $ 48,974  
  
 
 
    
 
 
    
 
 
    
 
 
 
All of the Company’s revenue recognized by geography based on the location of the customer for the thirteen and thirty-nine weeks ended October 1, 2023 and three and nine months ended September 30, 2022 was in the United States.
Remaining performance obligations
The Company has elected the practical expedient not to disclose remaining performance obligations for contracts that are less than one year in length. The Company has deferred $1.0 million and $1.3 million associated with a long-term service contract as of October 1, 2023 and December 31, 2022, respectively.
Incremental costs of obtaining customer contracts
Incremental costs of obtaining customer contracts consist of sales commissions, which are costs paid to third-party vendors who source residential customer contracts for the sale of solar energy systems by the Company. The Company defers sales commissions and recognizes expense in accordance with the timing of the related revenue recognition. Amortization of deferred commissions is recorded as sales commissions in the accompanying unaudited condensed consolidated statements of operations and comprehensive income (loss). As of October 1, 2023 and December 31, 2022, deferred commissions were $5.5 million and $2.8 million, respectively, which were included in prepaid expenses and other current assets in the accompanying unaudited condensed consolidated balance sheets.
Deferred revenue
The Company typically invoices its customers upon completion of set milestones, generally upon installation of the solar energy system with the remaining balance invoiced upon passing the final building inspection. Standard payment terms to customers range from 30 to 60 days. When the Company receives consideration, or when such consideration is unconditionally due, from a customer prior to delivering goods or services to the customer under the terms of a customer agreement, the Company records deferred revenue. As installation projects are typically completed within
12-months,
the majority of the Company’s deferred revenue is reflected in current liabilities in the accompanying unaudited condensed consolidated balance sheets. The Company also has deferred revenue associated with a long-term service contract which is reflected in
non-current
liabilities in the accompanying unaudited condensed consolidated balance sheets. The amount of revenue recognized during the thirty-nine weeks ended October 1, 2023 and the nine months ended September 30, 2022 that was included in deferred revenue at the beginning of the year was $2.5 million and $3.9 million, respectively.
 
(f)
Fair Value Measurements
The Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible. The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market.
When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels:
 
   
Level 1 inputs: Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date.
 
   
Level 2 inputs: Other than quoted prices included in Level 1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability.
 
   
Level 3 inputs: Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at the measurement date.
Financial assets and liabilities held by the Company measured at fair value on a recurring basis as of October 1, 2023 and December 31, 2022 include cash and cash equivalents, accounts receivable, accounts payable, accrued expenses, the warrant liabilities and FPA liabilities.
The carrying amounts of cash, accounts receivable, accounts payable and accrued expenses approximate their fair value because of their short-term nature (classified as Level 1).
The warrant liabilities and FPA liabilities are measured at fair value using Level 3 inputs. The Company records subsequent adjustments to reflect the increase or decrease in estimated fair value at each reporting date within the unaudited condensed consolidated statements of operations and comprehensive income (loss) as a component of other income (expense), net.
 
(g)
Direct Offering Costs
Direct offering costs represent legal, accounting and other direct costs related to the Mergers, which was consummated in July 2023. In accounting for the Mergers, direct offering costs of approximately $5.7 million were reclassified to additional
paid-in
capital and netted against the Mergers proceeds received upon close. As of October 1, 2023 and December 31, 2022, the Company had no deferred offering costs included within prepaid expenses and other current assets in its unaudited condensed consolidated balance sheets.
 
(h)
Warrant Liabilities
The Company accounts for its warrant liabilities in accordance with the guidance in ASC
815-40,
Derivatives and Hedging – Contracts in Entity’s Own Equity
, under which the warrants that do not meet the criteria for equity classification and must be recorded as liabilities. The warrant liabilities are measured at fair value at inception and at each reporting date in accordance with the guidance in ASC 820,
Fair Value Measurement
, with any subsequent changes in fair value recognized in other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive income (loss). Refer to Note 3 – Fair Value Measurements and Note 15 – Warrants.
 
(i)
Forward Purchase Agreements
The Company accounts for its FPAs in accordance with the guidance in ASC 480,
Distinguishing Liabilities from Equity
, as the agreements embody an obligation to transfer assets to settle a forward contract. The warrant liabilities are measured at fair value at inception and at each reporting date in accordance with the guidance in ASC 820,
Fair Value Measurement
, with any subsequent changes in fair value recognized in other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive income (loss). Refer to Note 3 – Fair Value Measurements and Note 5 – Forward Purchase Agreements.
 
(j)
Net Loss Per Share
The Company computes net loss per share following ASC 260,
Earnings Per Share
. Basic net loss per share is measured as the income or loss available to common stockholders divided by the weighted average common shares outstanding for the period. Diluted net loss per share presents the dilutive effect on a
per-share
basis from the potential exercise of options and/or warrants. The potentially dilutive effect of options or warrants are computed using the treasury stock method. Securities that potentially have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the diluted loss per share calculation.
 
(k)
Recently Adopted Accounting Pronouncements
In June 2016, the FASB issued ASU
2016-13,
Financial instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments
, and subsequent related ASUs, which amends the guidance on the impairment of financial instruments by requiring measurement and recognition of expected
credit losses for financial assets held. ASU
2016-13
is effective for public and private companies’ fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2019, and December 15, 2022, respectively. The Company adopted ASU
2016-13
under the private company transition guidance beginning January 1, 2023. The adoption did not have a material impact on the Company’s unaudited condensed consolidated financial statements.
 
(2)
Summary of Significant Accounting Policies
 
(a)
Use of Estimates
The
preparation
of the Company’s financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses, as well as related disclosure of contingent assets and liabilities. Significant estimates and assumptions made by management include, but are not limited to, the determination of:
 
   
The allocation of the transaction price to identified performance obligations;
 
   
Fair value of warrant liabilities;
 
   
The fair value of assets acquired and liabilities assumed for business combination;
 
   
The reserve methodology for inventory obsolescence;
 
   
The reserve methodology for product warranty;
To the extent that there are material differences between these estimates and actual results, the Company’s financial condition or operating results will be affected. The Company bases its estimates on past experience and other assumptions that the Company believes are reasonable under the circumstances, and the Company evaluates these estimates on an ongoing basis. The Company has assessed the impact and are not aware of any specific events or circumstances that required an update to the Company’s estimates and assumptions or materially affected the carrying value of the Company’s assets or liabilities as of the date of issuance of this report. These estimates may change as new events occur and additional information is obtained.
 
(b)
Supply Chain Constraints and Risk;
COVID-19
The Company relies on a very small number of suppliers of solar energy systems and other equipment. If any of Company’s suppliers was unable or unwilling to provide the Company with contracted quantities in a timely manner at prices, quality levels and volumes acceptable to the Company, the Company would have very limited alternatives for supply, and the Company may not be able find suitable replacements for the Company’s customers, or at all. Such an event could materially adversely affect the Company’s business, prospects, financial condition and results of operations.
The ongoing
COVID-19
pandemic has resulted and may continue to result in widespread adverse effects on the global and U.S. economies. Ongoing government and business responses to
COVID-19,
along with
COVID-19
variants and the resurgence of related disruptions, could have a continued material adverse impact on economic and market conditions and trigger a period of continued global and U.S. economic slowdown.
In addition, the global supply chain and the Company’s industry have experienced significant disruptions in recent periods. The Company have seen supply chain challenges and logistics constraints increase, including shortages of panels, inverters, batteries and associated component parts for inverters and solar energy systems available for purchase. In certain cases, this has caused delays in critical equipment and inventory, longer lead times, and has resulted in cost volatility. These shortages and delays can be attributed in part to the
COVID-19
pandemic and resulting government action, broader macroeconomic conditions, and have been exacerbated by the ongoing conflict in Russia and Ukraine. While the Company believes that a majority of the Company’s suppliers have secured sufficient supply to permit them to continue delivery and installations through the end of 2023, if these shortages and delays persist into 2024, they could adversely affect the timing of when battery energy storage systems can be delivered and installed, and when (or if) the Company can begin to generate revenue from those systems. In addition, the Company has experienced and is experiencing varying levels of volatility in costs of equipment and labor resulting in part from disruptions caused by general global economic conditions, including inflationary pressures and the
COVID-19
pandemic.
The Company cannot predict the full effects these events will have on the Company’s business, cash flows, liquidity, financial condition and results of operations at this time due to numerous uncertainties. In the event the Company is unable to mitigate the impact of delays or price volatility in solar energy systems, raw materials, and freight, it could materially adversely affect the Company’s business, prospects, financial condition and results of operations. For additional information on risk factors that could impact the Company’s results, please refer to “Risk
Factors
” located elsewhere in this prospectus.
 
(c)
Segment Information
The Company conducts its business in one operating segment that provides custom solar solutions through a standardized platform to its residential solar providers and companies to facilitate the sale and installation of solar energy systems under a single product group. The Company’s Chief Executive Officer (“CEO”) is the Chief Operating Decision Maker (“CODM”). The CODM allocates resources and makes operating decisions based on financial information presented on a consolidated basis. The profitability of the Company’s product group is not a determining factor in allocating resources and the CODM does not evaluate profitability below the level of the consolidated company. All the Company’s long-lived assets are maintained in the United States of America. Disaggregated revenue by primary geographical market for the Company’s single segment is included in the discussion of revenue recognition within this Note 2, below.
 
(d)
Concentration of Risks
Concentration of credit risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. The Company’s cash and cash equivalents are on deposit with major financial institutions. Such deposits may be in excess of insured limits. The Company believes that the financial institutions that hold the Company’s cash are financially sound, and accordingly, minimum credit risk exists with respect to these balances. The Company has not experienced any losses due to institutional failure or bankruptcy. The Company performs credit evaluations of its customers and generally does not require collateral for sales on credit. The Company reviews accounts receivable balances to determine if any receivables will potentially be uncollectible and includes any amounts that are determined to be uncollectible in the allowance for doubtful accounts. As of December 31, 2022, three single customers had outstanding balances that represented 27%, 18%, and 14%, respectively, of the total accounts receivable balance, compared to December 31, 2021, as a single customer had an outstanding balance that represented 50%, of the total accounts receivable balance.
Concentration of customers
The Company defines major customers as those customers who generate revenues that exceed 10% of the Company’s annual net revenues. For the years ended December 31, 2022, 2021 and 2020, one customer represented 47%, 63% and 81% of gross revenues, respectively.
Concentration of suppliers
For the year ended December 31, 2022, three suppliers represented 74% of the Company’s inventory purchases. For the year ended December 31, 2021, four supplier represented 87% of the Company’s inventory purchases. For the year ended December 31, 2020, two suppliers represented 89% of the Company’s inventory purchases.
 
(e)
Cash and Cash Equivalents
The
Company considers all highly liquid securities that mature within three months or less from the original date of purchase to be cash equivalents. The Company maintains the majority of its cash balances with
commercial banks in interest bearing accounts. Cash and cash equivalents include cash held in checking and savings accounts and money market accounts consisting of highly liquid securities with original maturity dates of three months or less from the original date of purchase.
 
(f)
Restricted Cash
The Company classifies all cash for which usage is limited by contractual provisions as restricted cash. Restricted cash balance as of December 31, 2022 and 2021, was $3.9 million, and zero, respectively. The restricted cash consists of deposits in money market accounts, which is used as cash collateral backing letters of credit related to customs duty authorities’ requirements. The Company has presented these balances under restricted cash, as a long term asset, in the consolidated balance sheets.
Total cash, cash equivalents and restricted cash is presented in the table below (in thousands):
 
    
As of December 31,
 
    
2022
    
2021
 
Cash and cash equivalents
   $ 4,409      $ 5,276  
Restricted cash
     3,907        —    
  
 
 
    
 
 
 
Total cash, cash equivalents and restricted cash
   $ 8,316      $ 5,276  
  
 
 
    
 
 
 
 
(g)
Accounts Receivable, Net
Accounts receivable are recorded at the invoiced amount and do not bear interest. The Company maintains an allowance for doubtful accounts for estimated losses inherent in its accounts receivable portfolio. In establishing the required allowance, management considers historical losses adjusted to take into account current market conditions and customers’ financial condition, the amount of receivables in dispute, the current receivables aging and customer payment patterns. Account balances are written off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. Recoveries of accounts receivable previously written off are recorded when received.
The following table summarizes the allowance for doubtful accounts as of December 31, 2022, 2021, and 2020 (in thousands):
 
    
As of December 31,
 
    
2022
    
2021
    
2020
 
Balance at beginning of period
   $ (2,569    $ (2,288    $ (1,965
Provision charged to earnings
     (2,243      (364      (337
Amounts written off, recoveries and other adjustments
     —          83        14  
  
 
 
    
 
 
    
 
 
 
Balance at end of period
   $ (4,812    $ (2,569    $ (2,288
  
 
 
    
 
 
    
 
 
 
The Company does
not
have any
off-balance
sheet credit exposure related to its customers.
 
(h)
Inventories
Inventories consists of solar panels and the components of solar energy systems which the Company classifies as finished goods. Costs are computed under the average cost method. The Company identifies inventory which is considered obsolete or in excess of anticipated demand based on a consideration of marketability and product life cycle stage, component cost trends, demand forecasts, historical revenues, and assumptions about future demand and market conditions to state inventory at the lower of cost or net realizable value.
(i)
Revenue Recognition
Revenue is recognized when a customer obtains control of promised products and services and the Company has satisfied its performance obligations. The amount of revenue recognized reflects the consideration which the Company expects to be entitled to receive in exchange for the products and services. To achieve this core principle, the Company applies the following five steps:
Step 1. Identification of the contract(s) with a customer;
Step 2. Identification of the performance obligations in the contracts(s);
Step 3. Determination of the transaction price;
Step 4. Allocation of the transaction price to the performance obligations;
Step 5. Recognition of the revenue when, or as, the Company satisfies a performance obligation.
Service Revenues – Solar Energy System Installations
The Company generates revenue primarily from the design and installation of a solar energy system and performing post-installation services. The Company’s contracts with customers include three primary contract types:
 
   
Cash agreements
– The Company contracts directly with homeowners who purchase the solar energy system and related services from the Company. Customers are invoiced on a billing schedule, where the majority of the transaction price is due upon installation with an additional payment due when the system passes inspection by the authority having jurisdiction.
 
   
Financing partner agreements
– In its financing partner agreements, the Company contracts directly with homeowners for the purchase of the solar energy system and related services. The Company refers the homeowner to a financing partner to finance the system, and the homeowner makes payments directly to the financing partner. The Company receives consideration from the financing partner on a billing schedule where the majority of the transaction price is due upon installation with an additional payment due when the system passes inspection by the authority having jurisdiction.
 
   
Power purchase agreements
– The Company contracts directly with a distribution partner to perform the solar energy system installation, and the homeowner will finance the system through a power purchase agreement, which is signed with the Company’s distribution partner. The Company considers the distribution partner to be its customer, as the Company does not contract directly with the homeowner. The Company receives consideration from the distribution partner on a billing schedule where the majority of the transaction price is due upon installation with an additional payment due when the system passes inspection by the authority having jurisdiction.
In each of the Company’s customer contract types, the Company’s revenue consists of two performance obligations, which include the performance of the installation of the solar energy system and post-installation services.
Installation includes the design of a solar energy system, the delivery of the components of the solar energy system (i.e., photovoltaic system, inverter, battery storage, etc.), installation services and services facilitating the connection of the solar energy system to the power grid. The Company accounts for these services as inputs to a combined output, resulting in a single service-based performance obligation. The Company recognizes revenue upon the completion of installation services, which occurs upon the transfer of control of the solar energy system and title of the related hardware components to the homeowner or distribution partner.
Post-installation services consist primarily of administrative services and customer support, which the Company performs between the completion of installation and the date of inspection of the solar energy system by the authority having jurisdiction. The Company recognizes revenue at a point in time, which is when the inspection occurs.
As the Company’s contracts with customers contain multiple performance obligations, the transaction price is allocated to each performance obligation based on its standalone selling price. The Company generally determines the standalone selling price based on the estimated costs incurred in the delivery of each performance obligation, relative to the total costs to be incurred under the contract.
The Company records deferred revenue for amounts invoiced that are not subject to refund upon termination. In certain contracts with customers, the Company arranges for a third-party financing partner to provide financing to the customer. The Company collects upfront from the financing partner and the customer will provide installment payments to the financing partner. The Company records revenue in the amount received from the financing partner, net of any financing fees charged to the homeowner, which the Company considers to be a customer incentive. None of the Company’s contracts contain a significant financing component.
The Company guarantees to customers certain specified minimum solar energy production output of the solar energy system for
10-years
after the installation. The Company monitors the solar energy systems to determine whether these specified minimum outputs are being achieved. The Company will issue payments to customers if the output falls below contractually stated thresholds over the performance guarantee period. Revenue is recognized to the extent it is probable that a significant reversal of such revenue will not occur.
Revenues – Software Enhanced Services
The Company generates revenue from software enhanced services through the provision of design and proposal services. The Company’s customers for design services are solar installers who leverage the Company’s expertise and software platforms to obtain structural letters, computer aided designs and electrical reviews. The Company charges the customer a per design fixed fee for each type of service that is performed, and the Company recognizes revenue in the period the services are performed. The customer contracts contain the customer right to terminate the contract each month and are therefore enforceable only for the contracted services purchased each month. Revenue is recognized for design services in the month the services are performed.
The Company’s customers for proposal services for solar sales organizations who contract with the Company to develop proposals for their potential residential solar customers. The Company generates proposals for the customer using the HelioQuote platform. Customers may purchase a fixed number of proposals for a given month or may contract on a pay as you go basis, and the performance obligation is defined by the number of proposals purchased by the customer each month. The customer contracts contain the customer right to terminate the contract each month and are therefore enforceable only for the services purchased each month. Revenue is recognized for proposal services in the month the services are performed.
Warranties
The Company typically provides a
10-year
warranty on its solar energy system installations, which provides assurance over the workmanship in performing the installation, including roof leaks caused by the Company’s performance. For solar panel sales recognized prior to the Disposal Transaction, the Company provides a
30-year
warranty that the products will be free from defects in material and workmanship.
When the revenues are recognized for the solar energy systems installations services, the Company accrues liabilities for the estimated future costs of meeting its warranty obligations. The Company makes and revises these estimates based primarily on the volume of new sales that contain warranties, historical experience with and projections of warranty claims, and estimated solar energy system and panel replacement costs. The Company records a provision for estimated warranty expenses in cost of revenues within the accompanying consolidated statements of operations and comprehensive loss.
Shipping and handling costs and certain taxes
Revenues are recognized net of taxes collected from customers and remitted to governmental authorities. Shipping and handling costs associated with outbound freight are accounted for as a fulfillment cost and are included in both revenues and cost of revenues in the accompanying consolidated statements of operations and comprehensive loss.
Deferred revenue
The Company typically invoices its customers upon completion of set milestones, generally upon installation of the solar energy system with the remaining balance invoiced upon passing final building inspection. Standard payment terms to customers range from 30 to 60 days. When the Company receives consideration, or when such consideration is unconditionally due, from a customer prior to delivering goods or services to the customer under the terms of a customer agreement, the Company records deferred revenue. As installation projects are typically completed within
12-months,
the Company’s deferred revenue is reflected in current liabilities in the accompanying consolidated balance sheets. The amount of revenue recognized during the years ended December 31, 2022 and 2021 that was included in deferred revenue at the beginning of each period was $3.9 million and $4.5 million, respectively.
Disaggregation of revenue
Refer to the table below for the Company’s revenue recognized by product and service type (in thousands):
 
    
Years Ended December 31,
 
    
2022
    
2021
    
2020
 
Solar energy system installations
   $ 62,896      $ 66,958      $ 29,378  
Software enhanced services
     3,579        1,858        —    
  
 
 
    
 
 
    
 
 
 
Total revenue
   $ 66,475      $ 68,816      $ 29,378  
  
 
 
    
 
 
    
 
 
 
For the years ended December 31, 2022, 2021 and 2020, all revenue recognized was generated in the United States.
Remaining performance obligations
The Company has elected the practical expedient not to disclose remaining performance obligations for contracts that are less than one year in length. As of December 31, 2022, the Company has deferred $1.3 million associated with a long-term service contract, which will be recognized evenly through 2028.
Incremental costs of obtaining customer contracts
Incremental costs of obtaining customer contracts consist of sales commissions, which are costs paid to third-party vendors who source residential customer contracts for the sale of solar energy systems by the Company. The Company defers sales commissions and recognizes expense in accordance with the timing of the related revenue recognition. Amortization of deferred commissions is recorded as sales commissions in the accompanying consolidated statements of operations and comprehensive loss. As of December 31, 2022 and December 31, 2021, deferred commissions were $2.8 million and $4.8 million, respectively, which included in prepaid expenses and other current assets in the accompanying consolidated balance sheets.
 
(j)
Property and Equipment, Net
Property and equipment are stated at cost less accumulated depreciation and amortization. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gain or loss is included in the current period. Repair and maintenance costs are expensed as
incurred. Depreciation and amortization are calculated using the straight-line method over the following estimated useful lives of the assets:
 
    
Useful Lives
 
Manufacturing equipment
    
1-3 years
 
Developed software
     5 years  
Furniture & equipment
    
3-5
years
 
Leasehold improvements
    
3-5 years
 
 
(k)
Internal-Use
Software
The Company capitalizes costs to develop its
internal-use
software when preliminary development efforts are successfully completed, management has authorized and committed project funding, it is probable that the project will be completed, and the software will be utilized as intended. These costs include personnel and related employee benefits and expenses for employees who are directly associated with and who devote time to software projects, and external direct costs of materials and services consumed in developing or obtaining software. Costs incurred prior to meeting these criteria, together with costs incurred for training and maintenance, are expensed as incurred. Costs incurred for enhancements that are expected to provide additional material functionality are capitalized and amortized over the estimated useful life of the related upgrade. During the years ended December 31, 2022, 2021 and 2020, the Company capitalized $1.5 million, $1.1 million and $0.5 million, respectively, of
internal-use
software development costs. The remaining unamortized balance as of December 31, 2022 and December 31, 2021 of $2.7 million and $1.7 million, respectively, is included in property and equipment, net within the accompanying consolidated balance sheets.
 
(l)
Cost of Revenues
Cost of revenues includes actual cost of material, labor and related overhead incurred for revenue-producing units, and includes associated warranty costs, freight and delivery costs, depreciation, and amortization of internally developed software.
 
(m)
Advertising and Promotional Expenses
Advertising
and promotional costs are expensed as incurred and included in sales and marketing expense in the accompanying consolidated statements of operations and comprehensive loss. Advertising costs were not material for the years ended December 31, 2022, 2021 and 2020..
 
(n)
Income Taxes
Income taxes are accounted for under the
asset-and-liability
method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company recognizes the effect of income tax positions only if those positions are more likely than not to be sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company recognizes accrued interest and penalties, if any, related to unrecognized tax benefits in income tax provision.
 
(o)
Foreign Currency
The Company’s reporting currency is the US dollar. The functional currency for each of the Company’s foreign subsidiaries is the local currency, as it is the monetary unit of account of the principal economic
environments in which the Company’s foreign subsidiaries operate. Assets and liabilities of the foreign subsidiaries are translated at the current exchange rate as of the end of the period, and revenue and expenses are translated at the average exchange rates in effect during the period. The gain or loss resulting from the process of translating foreign currency financial statements into US dollar financial statements is accounted for as a foreign currency cumulative translation adjustment and is reported as a component of accumulated other comprehensive loss. Foreign currency transaction gains and losses resulting from transactions denominated in a currency other than the functional currency are recognized in Other Income (expense), net in the consolidated statements of operations and comprehensive loss.
 
(p)
Comprehensive Loss
Comprehensive loss consists of two components, net loss and other comprehensive income (loss), net. The Company’s other comprehensive loss consists of foreign currency translation adjustments that result from the consolidation of its foreign entities and is reported net of tax effects.
 
(q)
Impairment of Long-Lived Assets
Long-lived assets, such as property and equipment, ROU assets, and intangible assets subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require a long-lived asset or asset group be tested for possible impairment, the Company first compares undiscounted cash flows expected to be generated by that asset or asset group to its carrying value. If the carrying value of the long-lived asset or asset group is not recoverable on an undiscounted cash flow basis, an impairment is recognized to the extent that the carrying value exceeds its fair value. Fair value is determined through various valuation techniques including discounted cash flow models, and quoted market values, as considered necessary.
There were no impairment charges for the years ended December 31, 2022, 2021 and 2020.
 
(r)
Business Combinations
The Company allocates the fair value of purchase consideration to the tangible assets acquired, liabilities assumed, and intangible assets acquired based on their estimated fair values. The excess of the fair value of purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. Such valuations require management to make significant estimates and assumptions, especially with respect to intangible assets. Significant estimates in valuing certain intangible assets include, but are not limited to, future expected cash flows from customer relationships, acquired technology, trade names from a market participant perspective, useful lives and discount rates. Management’s estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates. During the measurement period, which is one year from the acquisition date, the Company may record adjustments to the assets acquired and liabilities assumed, with the corresponding offset to goodwill. Upon the conclusion of the measurement period, any subsequent adjustments are recorded in the consolidated statements of operations and comprehensive loss.
 
(s)
Intangibles Assets, Net
Intangible assets are recorded at the cost, less accumulated amortization. Amortization is recorded using the straight-line method. All intangible assets that have been determined to have definite lives are amortized over their estimated useful life as indicated below:
 
    
Estimated Useful Life
 
Assembled workforce
     2 years  
(t)
Deferred Transaction Costs
Deferred transaction costs, which consist of direct incremental legal, consulting and accounting fees related to the merger with Freedom, are capitalized until they are recorded against proceeds upon the consummation of the transaction. As of December 31, 2022, the Company has recorded $1.1 million of deferred transaction costs in other noncurrent assets on the consolidated balance sheets.
 
(u)
Redeemable Convertible Preferred Stock Warrants
The Company has issued redeemable convertible preferred stock warrants exercisable into shares of the Company’s redeemable convertible preferred stock. The Company classifies warrants to purchase shares of convertible preferred stock that are redeemable or include an antidilution feature as liabilities. Such redeemable convertible preferred stock warrants are measured and recognized at fair value, and subject to remeasurement at each balance sheet date. At the end of each reporting period, changes in fair value during the period are recognized as a component of other income (expense), net in the accompanying consolidated statements of operations and comprehensive loss. The Company will continue to adjust the redeemable convertible preferred stock warrant liability for changes in the fair value until the earlier of the exercise or expiration of such warrants or the completion of a liquidation event, including completion of an initial public offering (“IPO”), at which time all such redeemable convertible preferred stock warrants will be converted into warrants to purchase shares of common stock, and the liability will be reclassified to additional
paid-in
capital. See Note 10 – Fair Value Measurements for details on the valuation methodology. Also see Note 14 – Warrants.
 
(v)
Stock-Based Compensation
The Company recognizes stock-based compensation expense over the requisite service period on a straight-line basis for all stock-based payments that are expected to vest to employees,
non-employees
and directors, including grants of employee stock options and other stock-based awards. Equity-classified awards issued to employees,
non-employees
such as consultants and
non-employee
directors are measured at the grant-date fair value of the award. Forfeitures are recognized as they occur. For accounting purposes, the Company estimates grant-date fair value of stock options using the Black-Scholes option pricing model. The
Black-Scholes
option pricing model requires the input of highly subjective assumptions, including the fair value of the underlying common stock prior to the Mergers, the expected term of the option the expected volatility of the price of the Company’s common stock and expected dividend yield. The Company determines these inputs as follows:
Expected Term
—Expected term represents the period that the Company’s stock-based awards are expected to be outstanding and is determined using the simplified method.
Expected Volatility
—Expected volatility is estimated by studying the volatility of comparable public companies for similar terms.
Expected Dividend
—The Black-Scholes valuation model calls for a single expected dividend yield as an input. The Company has never paid dividends and has no plans to pay dividends.
Risk-free Interest Rate
—The Company derives the risk-free interest rate assumption from the U.S. Treasury’s rates for the U.S. Treasury
zero-coupon
bonds with maturities similar to those of the expected term of the awards being valued.
Forfeitures
—The Company recognizes forfeitures as they occur.
 
(w)
Fair Value Measurements
The Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible. The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market.
When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels:
 
   
Level 1 inputs: Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date.
 
   
Level 2 inputs: Other than quoted prices included in Level 1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability.
 
   
Level 3 inputs: Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at the measurement date.
The Company’s financial instruments include cash, accounts receivable, accounts payable, accrued expenses, convertible notes, SAFE agreements, notes payable, common stock warrants and redeemable convertible preferred stock warrants. The carrying amounts of cash, accounts receivable, accounts payable, accrued expenses, convertible notes and notes payable approximate their fair value because of their short- term nature (classified as level 1). The Company measures and discloses the fair value of SAFE agreements, common stock warrants and redeemable convertible preferred stock warrants under the provisions of ASC Topic 820—Fair Value Measurement (classified as level 3).
 
(x)
Net Loss Per Share
The Company computes net loss per share in accordance with ASC 260, Earnings Per Share (“ASC 260”). Basic net loss per share is measured as the income or loss available to common stockholders divided by the weighted-average common shares outstanding for the period. Diluted net loss per share presents the dilutive effect on a per-share basis from the potential exercise of options and/or warrants. The potentially dilutive effect of options or warrants are computed using the treasury stock method. Securities that potentially have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the diluted loss per share calculation.
 
(y)
Convertible Debt Embedded Derivative Liabilities
The Company evaluates the embedded conversion feature within its convertible debt instruments under ASC
815-15
and ASC
815-40
to determine if the conversion feature meets the definition of a liability and, if so, whether to bifurcate the conversion feature and account for it as a separate derivative liability. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then
re-valued
at each reporting date, with changes in the fair value reported in the consolidated statements of operations and comprehensive loss. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the consolidated balance sheets as current or
non-current
based on whether
net-cash
settlement of the derivative instrument could be required within twelve months after the balance sheet date. The derivative is subject to
re-measurement
at the end of each reporting period, with changes in fair value recognized as a component of other income (expense), net, in the consolidated statements of operations and comprehensive loss. The Company’s embedded derivative liabilities were extinguished in the first quarter of 2022.
 
(z)
Leases
Effective January 1, 2021, the Company early adopted Accounting Standards Update (“ASU”)
No. 2016-02,
Leases (Topic 842), as amended (“ASC 842”). The Company determines if a contract is a lease or contains a lease at the inception of the contract and reassesses that conclusion if the contract is modified. The Company’s lease agreements generally contain lease and
non-lease
components. Payments under lease
arrangements are primarily fixed. The Company combines lease and
non-lease
components and accounts for them together as a single lease component. All leases are assessed for classification as an operating lease or a finance lease. Operating lease
right-of-use
(“ROU”) assets are presented separately on the Company’s consolidated balance sheets. Operating lease liabilities are separated into a current portion and
non-current
portion and are presented separately on the Company’s consolidated balance sheets. The Company does not have finance lease ROU assets or liabilities.
ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent its obligation to make lease payments arising from the lease. The Company does not obtain and control its right to use the identified asset until the lease commencement date.
The Company’s lease liabilities are recognized at the later of January 1, 2021 and applicable lease commencement date based on the present value of the lease payments required to be paid over the lease term. Because the rate implicit in the lease is not readily determinable, the Company generally uses its incremental borrowing rate to discount the lease payments to present value. The estimated incremental borrowing rate is derived from information available at the lease commencement date. The Company’s lease terms include periods under options to extend or terminate the lease when it is reasonably certain that we will exercise that option. We generally use the base,
non-cancelable,
lease term when determining the lease assets and liabilities. The Company also records a corresponding
right-of-use
asset at the later of January 1, 2021 and applicable lease commencement date, which is calculated based on the amount of the lease liability, adjusted for any advance lease payments made, lease incentives received, and initial direct costs incurred.
Right-of-use
assets are subject to evaluation for impairment or disposal on a basis consistent with other long-lived assets.
The Company has elected, for all classes of underlying assets, not to recognize ROU assets and lease liabilities for leases with a term of twelve months or less. Lease cost for short-term leases is recognized on a straight-line basis over the lease term.
Before the adoption of ASU
2016-02
on January 1, 2021, the Company categorizes leases at their inception as either operating or capital leases, with the Company’s current lease portfolio only consisting of operating leases for office spaces. In certain lease agreements, it may receive rent holidays and other incentives. For operating leases, the Company recognizes lease costs on a straight-line basis once control of the space is achieved, without regard to deferred payment terms such as rent holidays that defer the commencement date of required payments. Additionally, incentives received are treated as a reduction of costs over the term of the agreement.
 
(aa)
Recently Adopted Accounting Pronouncements
In December 2019, the FASB issued ASU
2019-12,
Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes
. ASU
2019-12
removes certain exceptions to the general principles in Topic 740 and clarifies and amends existing guidance to improve consistent application. ASU
2019-12
will be effective for public entities for interim and annual periods beginning after December 15, 2020, with early adoption permitted. ASU
2019-12
will be effective for private entities for annual periods beginning after December 15, 2021, and interim periods beginning after December 15, 2020, with early adoption permitted. The Company adopted ASU
2019-12
under the private company transition guidance beginning January 1, 2022, and the adoption did not have an impact on the Company’s consolidated financial statements.
In May 2021, the FASB issued ASU
2021-04,
Earnings Per Share (Topic 260), Debt—Modifications and Extinguishments (Subtopic
470-50),
Compensation—Stock Compensation (Topic 718), and Derivatives and
Hedging—Contracts in Entity’s Own Equity (Subtopic
815-40):
Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options (a consensus of the FASB Emerging Issues Task Force)
. This guidance clarifies certain aspects of the current guidance to promote consistency among reporting of an issuer’s accounting for modifications or exchanges of freestanding equity-classified written call options (for example, warrants) that remain equity classified after
modification or exchange. The amendments in this update are effective for all entities for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted for all entities, including adoption in an interim period. The Company adopted ASU
2021-04
under the private company transition guidance beginning January 1, 2022, the adoption did not have an impact on the Company’s consolidated financial statements.
In August 2020, the FASB issued ASU
2020-06,
Debt—Debt with Conversion and Other Options (Subtopic
470-20)
and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic
815-40):
Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, which simplifies the accounting for convertible instruments by reducing the number of accounting models available for convertible debt instruments. This guidance also eliminates the treasury stock method to calculate diluted earnings per share for convertible instruments and requires the use of the
if-converted
method. ASU
2020-06
is effective for public and private companies’ fiscal years beginning after December 15, 2021, and December 15, 2023, respectively, and interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company adopted ASU
2020-06
under the private company transition guidance on January 1, 2022, and the adoption did not have an impact on the Company’s consolidated financial statements.
 
(ab)
Accounting Pronouncements Not Yet Adopted
In June 2016, the FASB issued ASU
2016-13,
Financial instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments
, and subsequent related ASUs, which amends the guidance on the impairment of financial instruments by requiring measurement and recognition of expected credit losses for financial assets held. ASU
2016-13
is effective for public and private companies’ fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2019, and December 15, 2022, respectively. The Company expects to adopt ASU
2016-13
under the private company transition guidance beginning January 1, 2023 and is currently evaluating the impact on the Company’s consolidated financial statements.
 
XML 22 R12.htm IDEA: XBRL DOCUMENT v3.23.4
Fair Value Measurements
9 Months Ended 12 Months Ended
Oct. 01, 2023
Dec. 31, 2022
Fair Value Measurements [Abstract]    
Fair Value Measurements
(3)
Fair Value Measurements
The following table sets forth the Company’s financial assets and liabilities that were measured at fair value, on a recurring basis (in thousands):
 
    
As of October 1, 2023
 
    
Level 1
    
Level 2
    
Level 3
    
Total
 
Financial Liabilities
           
Carlyle warrants
   $ —        $ —        $ 7,683      $ 7,683  
Public warrants
     1,413        —          —          1,413  
Private placement warrants
     —          1,027        —          1,027  
Working capital warrants
     —          117        —          117  
Forward purchase agreement liabilities
     —          —          6,586        6,586  
  
 
 
    
 
 
    
 
 
    
 
 
 
Total
   $ 1,413      $ 1,144      $ 14,269      $ 16,826  
  
 
 
    
 
 
    
 
 
    
 
 
 
    
As of December 31, 2022
 
    
Level 1
    
Level 2
    
Level 3
    
Total
 
Financial Liabilities
           
Redeemable convertible preferred stock warrant liability
   $ —        $ —        $ 14,152      $ 14,152  
  
 
 
    
 
 
    
 
 
    
 
 
 
Total
   $ —        $ —        $ 14,152      $ 14,152  
  
 
 
    
 
 
    
 
 
    
 
 
 
Carlyle Warrants
As part of the Company’s amended and restated warrant agreement with CRSEF Solis Holdings, LLC (“Carlyle”), the Company issued Carlyle a warrant to purchase up to 2,745,879 shares of Complete Solaria Common Stock at a price per share of $0.01, which is inclusive of the outstanding warrant to purchase 1,995,879 shares at the time of modification. The warrant, which expires on July 18, 2030, provides Carlyle with the right to purchase shares of Complete Solaria Common Stock based on (a) the greater of (i) 1,995,879 shares and (ii) the number of shares equal to 2.795% of Complete Solaria’s issued and outstanding shares of common stock, on a fully-diluted basis; plus (b) on and after the date that is ten (10) days after the date of the amended and restated warrant agreement, an additional 350,000 shares; plus (c) on and after the date that is thirty (30) days after the date of the amended and restated warrant agreement, if the original investment amount has not been repaid, an additional 150,000 shares; plus (d) on and after the date that is ninety (90) days after the date of the amended and restated warrant agreement, if the original investment amount has not been repaid, an additional 250,000 shares, in each case, of Complete Solaria Common Stock at a price of $0.01 per share. As the warrant is exercisable into a variable number of shares based on the Company’s fully diluted capitalization table, the Company has classified the warrants as liabilities. The Company valued the warrants based on a Black-Scholes Option Pricing Method, which included the following inputs:
 
    
October 1,
2023
   
December 31,
2022
 
Expected term
     7.0 years        
Expected volatility
     77.0     —    
Risk-free interest rate
     3.92     —    
Expected dividend yield
     0.0     —    
Public, Private Placement and Working Capital Warrants
The public, private placement and working capital warrants are measured at fair value on a recurring basis. The public warrants were valued based on the closing price of the publicly traded instrument. The private placement and working capital warrants were valued using observable inputs for similar publicly traded instruments.
Forward Purchase Agreement Liabilities
The FPA liabilities are measured at fair value on a recurring basis using a Monte Carlo simulation analysis. The expected volatility is determined based on the historical equity volatility of comparable companies over a period that matches the simulation period, which included the following inputs:
 
    
October 1,
2023
   
December 31,
2022
 
Common stock trading price
   $ 2.10       —    
Simulation period
     1.8 years        
Risk-free rate
     5.12     —    
Volatility
     178.0     —    
Redeemable Convertible Preferred Stock Warrant Liabilities
The Company historically issued redeemable convertible warrants, which were classified as liabilities and adjusted to fair value using the Black Scholes Option Pricing Method. The terms of the redeemable convertible preferred stock warrants are described in Note 15 – Warrants.
Series B Redeemable Convertible Preferred Stock Warrant
 
    
October 1,
2023
    
December 31,
2022
 
Expected term
     —         
3.1 
years
 
Expected volatility
     —          72.5
Risk-free interest rate
     —          4.2
Expected dividend yield
     —          0.0
Series C Redeemable Convertible Preferred Stock Warrant
 
    
October 1,
2023
    
December 31,
2022
 
Expected term
     —          3.6 years  
Expected volatility
     —          72.5
Risk-free interest rate
     —          4.0
Expected dividend yield
     —          0.0
Series
D-7
Redeemable Convertible Preferred Stock Warrant
 
    
October 1,
2023
    
December 31,
2022
 
Expected term
     —          1.5 years  
Expected volatility
     —          78.5
Risk-free interest rate
     —          4.7
Expected dividend yield
     —          0.0
The redeemable convertible preferred stock warrant liabilities were measured at fair value at the issuance date and as of each subsequent reporting period with changes in the fair value recorded within other income (expense), net in the accompanying unaudited condensed consolidated statements of operations and comprehensive income (loss). As described in Note 15 – Warrants, the redeemable convertible preferred stock warrant liabilities were reclassified to additional
paid-in
capital upon the closing of the Mergers.
(10)
Fair Value Measurements
The following table sets forth the Company’s financial assets and liabilities that were measured at fair value, on a recurring basis (in thousands):
The following table presents a reconciliation of the Company’s financial liabilities measured at fair value as of December 31, 2022 using significant unobservable inputs (Level 3), and the change in fair value recorded in other income (expense), net in the accompanying consolidated statements of operations and comprehensive loss (in thousands):
 
    
Warrant
    
Convertible
Debt
Embedded
Derivatives
    
SAFEs
 
Balance as of December 31, 2020
   $ 799      $ 579      $ 91  
Issuance of
2021-A
Convertible Notes
     —          566        —    
Issuance of 2021-Rogers SAFE
     —          —          5,000  
Change in fair value
     330        336        1,306  
  
 
 
    
 
 
    
 
 
 
Balance as of December 31, 2021
   $ 1,129      $ 1,481      $ 6,397  
Conversion of debt into preferred shares
     —          (1,481      —    
Conversion of SAFEs into preferred shares
     —          —          (6,397
Assumption of SAFEs in Solaria acquisition
     —          —          60,470  
Conversion of SAFEs from Solaria acquisition into preferred shares
     —          —          (60,470
Issuance of Series D Warrants Tranche A
     6,527        —          —    
Issuance of Series D Warrants Tranche B
     1,285        —          —    
Change in fair value
     5,211        —          —    
  
 
 
    
 
 
    
 
 
 
Balance as of December 31, 2022
   $  14,152      $ —        $ —    
  
 
 
    
 
 
    
 
 
 
The fair value of accounts receivable, accounts payable, and accrued expenses approximated their carrying values as of December 31, 2022 and December 31, 2021, due to their short-term nature. As of December 31, 2022, all of the Company’s outstanding debit is carried at an amortized cost basis.
There were no transfers between Level 1, Level 2 or Level 3 fair value hierarchy categories of financial instruments for the years ended December 31, 2022 and December 31, 2021.
 
    
As of December 31, 2022
 
    
Level 1
    
Level 2
    
Level 3
    
Total
 
Financial Liabilities
           
Redeemable convertible preferred stock warrant liability
   $   —         $   —         $  14,152      $  14,152  
  
 
 
    
 
 
    
 
 
    
 
 
 
Total
   $ —        $ —        $ 14,152      $ 14,152  
  
 
 
    
 
 
    
 
 
    
 
 
 
    
As of December 31, 2021
 
    
Level 1
    
Level 2
    
Level 3
    
Total
 
Financial Liabilities
           
Redeemable convertible preferred stock warrant liability
   $ —        $ —        $ 1,129      $ 1,129  
Convertible debt embedded derivatives
     —          —          1,481        1,481  
SAFE agreements
     —          —          6,397        6,397  
  
 
 
    
 
 
    
 
 
    
 
 
 
Total
   $ —        $ —        $ 9,007      $ 9,007  
  
 
 
    
 
 
    
 
 
    
 
 
 
Redeemable Convertible Preferred Stock Warrant Liability
The Company historically issued redeemable convertible warrants to a bank to purchase shares of Series B preferred stock in February 2016 and issued redeemable convertible warrants to an investor to purchase shares of Series C preferred stock. Refer to Note 14 - Warrants. The Company issued Series D preferred stock warrants in conjunction with the merger agreement with Solaria. Refer to
Note 3-Business
Combination. The exercise prices for the two tranches of Series D preferred stock warrants are based on a future round of stock price, with an assumption of $2.50 and $5.00 upon consummation of a deSPAC acquisition and $2.04 and $4.09 upon remaining private, respectively. As the warrants have a contingent exercise price, the Company valuated the warrants based on a Black Scholes option pricing model, using a probability weighted estimate of the warrant valuations, given a deSPAC exist scenario and a stay private scenario, weighted at 70% and 30%, respectively. The following assumptions were used to calculate the fair value of the redeemable convertible preferred stock warrant liability:
Series B Redeemable Convertible Preferred Stock Warrant
 
    
December 31,
 
    
2022
   
2021
 
Expected term
     3.1 years       4.1 years  
Expected volatility
     72.5     73.0
Risk-free interest rate
     4.2     1.1
Expected dividend yield
     0.0     0.0
Series C Redeemable Convertible Preferred Stock Warrant
 
    
December 31,
 
    
2022
   
2021
 
Expected term
     3.6 years       4.6 years  
Expected volatility
     72.5     73.0
Risk-free interest rate
     4.0     1.2
Expected dividend yield
     0.0     0.0
Series D Redeemable Convertible Preferred Stock Warrant
 
    
December 31,
 
    
2022
   
2021
 
Expected term
     1.5 years       —    
Expected volatility
     78.5     —    
Risk-free interest rate
     4.7     —    
Expected dividend yield
     0.0     —    
The redeemable convertible preferred stock warrant liabilities were measured at fair value at the issuance date and as of each subsequent fiscal year end with changes in the fair value recorded within other income (expense), net in the accompanying consolidated statements of operations and comprehensive loss.
The table below reconciles the change in value of the redeemable convertible preferred stock warrant liability from each warrant to the total redeemable convertible preferred stock warrant liability recorded within the accompanying consolidated balance sheets (amounts in thousands):
 
    
Series B
Warrants
    
Series C
Warrants
    
Series D

Tranche A
Warrants
    
Series D
Tranche B
Warrants
    
Total
 
Balance as of December 31, 2020
   $ 5      $ 794      $ —        $ —        $ 799  
Change in fair value
     3        327        —          —          330  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Balance as of December 31, 2021
     8        1,121        —          —          1,129  
Change in fair value
     42        5,169        —          —          5,211  
Issuance of warrants in connection with acquisition of Solaria (Note 3)
     —          —          6,527        1,285        7,812  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Balance as of December 31, 2022
   $  50      $  6,290      $  6,527      $  1,285      $  14,152  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Convertible Debt Embedded Derivatives
2019-A
Notes
The Company recorded a convertible debt embedded derivative liability associated with the issuance of the 2019-A Convertible Notes. The derivative liability is recorded within derivative liability on the accompanying consolidated balance sheets. See Note 13 – Borrowing Arrangements. The fair value of the convertible debt embedded derivative liability was computed as the difference between the estimated value of the convertible debt with and without features that allow the holders to convert the notes at a discount upon the Company’s subsequent equity financing (“Next Equity Financing”). The 2019-A Convertible Notes also contain a feature to convert the notes at a price of $75.0 million divided by the fully diluted capitalization table (“2019-A Valuation Cap Conversion”), which is not bifurcated as an embedded derivative.
The fair value of the convertible notes with the embedded derivative is estimated based on a probability- weighted analysis of the discounted value of the notes converting under a Next Equity Financing, a change in control, default, or maturity. The significant assumptions included in the fair value of the
2019-A
Convertible Notes with the embedded derivative liability include the time until a Next Equity Financing, the probabilities of the notes settling under each scenario, and a discount rate that reconciles the amount paid for the debt at issuance date, adjusted to reflect market changes subsequent to issuance. The fair value of the convertible notes without the embedded derivative liability is estimated based on the same methodology other than the settlement value upon a Next Equity Financing being set as the principal plus accrued interest, excluding the value of the conversion at a discount to the Next Equity Financing.
The embedded derivative liabilities in the convertible notes were measured at fair value at the issuance date and as of each subsequent fiscal year end with changes in the fair value recorded within other income (expense), net in the accompanying consolidated statements of operations and comprehensive loss.
The fair value of the
2019-A
Convertible Notes was approximately $0.1 million as of December 31, 2021. The
2019-A
Convertible notes and related derivative liability were extinguished in FY22 as part of the Series D redeemable convertible preferred stock issuance.
2020-A
Convertible Notes
The Company recorded a convertible debt embedded derivative liability associated with the issuance of the
2020-A
Convertible Notes. The derivative liability is recorded within derivative liability on the accompanying consolidated balance sheets. See Note 13 – Borrowing Arrangements. The fair value of the convertible debt embedded derivative liability was computed as the difference between the estimated value of the convertible debt with and without features that allow the holders to convert the notes at a discount upon the Company’s subsequent equity financing (“Next Equity Financing”).
The fair value of the convertible notes with the embedded derivative is estimated based on a probability- weighted analysis of the discounted value of the notes converting under a Next Equity Financing, a change in control, default, or maturity. The significant assumptions included in the fair value of the
2020-A
Convertible Notes with the embedded derivative liability include the time until a Next Equity Financing, the probabilities of the notes settling under each scenario, and a discount rate that reconciles the amount paid for the debt at issuance date, adjusted to reflect market changes subsequent to issuance. The fair value of the convertible notes without the embedded derivative liability is estimated based on the same methodology other than the settlement value upon a Next Equity Financing being set as the principal plus accrued interest, excluding the value of the conversion at a discount to the Next Equity Financing.
The embedded derivative liabilities in the convertible notes were measured at fair value at the issuance date and as of each subsequent fiscal year end with changes in the fair value recorded within other income (expense), net in the accompanying consolidated statements of operations and comprehensive loss.
The fair value of the
2020-A
Convertible Notes was approximately $4.6 million as of December 31, 2021. The
2020-A
Convertible notes and related derivative liability were extinguished as part of the Series D redeemable convertible preferred stock issuance.
2021-A
Convertible Notes
The Company recorded a convertible debt embedded derivative liability associated with the issuance of the
2021-A
Convertible Notes. The embedded derivative liability is recorded within derivative liability on the accompanying consolidated balance sheets. See Note 13 – Borrowing Arrangements. The fair value of the convertible debt embedded derivative liability was computed as the difference between the estimated value of the convertible debt with and without features that allow the holders to convert the notes at a discount upon the Company’s subsequent equity financing (“Next Equity Financing”). Certain of the notes from the
2021-A
Convertible Notes also contain a feature to convert the notes at a price of $200.0 million divided by the fully diluted capitalization table
(“2021-A
Valuation Cap Conversion”), which is not bifurcated as an embedded derivative.
The fair value of the convertible notes with the embedded derivative is estimated based on a probability- weighted analysis of the discounted value of the notes converting under a Next Equity Financing, a change in control, default, or maturity. The significant assumptions included in the fair value of the
2021-A
Convertible Notes with the embedded derivative liability include the time until a Next Equity Financing, the probabilities of the notes settling under each scenario, and a discount rate that reconciles the amount paid for the debt at issuance date, adjusted to reflect market changes subsequent to issuance. The fair value of the convertible notes without the embedded derivative liability is estimated based on the same methodology other than the settlement value upon a Next Equity Financing being set as the principal plus accrued interest, excluding the value of the conversion at a discount to the Next Equity Financing.
The embedded derivative liabilities in the convertible notes were measured at fair value at the issuance date and as of each subsequent fiscal year end with changes in the fair value recorded within other income (expense), net in the accompanying consolidated statements of operations and comprehensive loss.
The fair value of the
2021-A
Convertible Notes was approximately $4.8 million as of December 31, 2021, respectively. The
2021-A
Convertible notes and related derivative liability were extinguished as part of the Series D redeemable convertible preferred stock issuance.
The table below reconciles the embedded derivative liability from each of the series of convertible notes to the total derivative liability recorded on the accompanying consolidated balance sheets (amounts in thousands)
 
    
2019-A

Convertible
Notes
    
2020-A

Convertible
Notes
    
2021-A

Convertible
Notes
    
Totals
 
Balance as of December 31, 2020
   $ 18      $ 561      $ —        $ 579  
Issuance of
2021-A
Convertible Notes
     —          —          566        566  
Change in fair value
     17        234        85        366  
  
 
 
    
 
 
    
 
 
    
 
 
 
Balance as of December 31, 2021
     35        795        651        1,481  
Extinguishment upon Series D issuance
     (35      (795      (651      (1,481
  
 
 
    
 
 
    
 
 
    
 
 
 
Balance as of December 31, 2022
   $  —        $ —        $ —        $ —    
  
 
 
    
 
 
    
 
 
    
 
 
 
Simple Agreement for Future Equity (“SAFE”)
2019 SAFE
In July 2019, the Company entered into a SAFE agreement (“2019 SAFE”) with an investor. At the issuance date, the Company received $0.1 million in cash. The SAFE is classified as a liability in the scope of Accounting Standards Codification Topic 480 (“ASC 480”),
Distinguishing Liabilities from Equity
, as the SAFE is redeemable upon events that are outside the control of the issuer. The 2019 SAFE converts to equity at the lower of $50.0 million divided by the fully diluted capitalization table (“2019 SAFE Valuation Cap Conversion”) and a 20% discount from the share price paid by other investors upon the Next Equity Financing. The SAFE also contains features that allow for cash settlement at the $0.1 million purchase price in the event of a liquidation or dissolution event.
The fair value of the 2019 SAFE was determined based on the probability-weighted expected return method (“PWERM”), which assigns value to the multiple settlement scenarios based on the probability of occurrence. The significant assumptions included in the fair value of the 2019 SAFE include the probability of conversion under a next equity financing (estimated between 60% at issuance and 80% as of December 31, 2022) and the realizable value upon a Next Equity Financing. The realizable value upon the Next Equity Financing was determined based on the following inputs that were included in a Black-Scholes model, which contains the following inputs:
 
    
December 31,
 
    
2022
  
2021
 
Expected fair value of preferred stock
   N/A    $ 4.84  
Expected term
   N/A      0.2 years  
Volatility
   N/A      76.4
Risk-free interest rate
   N/A      0.1
The 2019 SAFE was measured at fair value at the issuance date and as of each subsequent fiscal year end with changes in the fair value recorded within other income (expense), net in the consolidated statements of operations and comprehensive loss.
In March 2022, as part of the Company’s Series D preferred stock financing, the 2019 SAFE converted into shares of Series
D-3
preferred stock. As part of the extinguishment of the 2019 SAFE, the Company recorded a gain of less than $0.1 million in other income (expense), net in the consolidated statements of operations and comprehensive loss.
2021 SAFE
In December 2021, the Company entered into a SAFE agreement (“2021 SAFE”) with an investor. At the issuance date, the Company received $5.0 million in cash. The SAFE is classified as a liability in the scope of
Accounting Standards Codification Topic 480 (“ASC 480”),
Distinguishing Liabilities from Equity
, as the SAFE is redeemable upon events that are outside the control of the issuer. The 2021 SAFE converts to equity at the lower of $175.0 million divided by the fully diluted capitalization table (“2021 SAFE Valuation Cap Conversion”) and a 20% discount from the share price paid by other investors upon the Next Equity Financing. At the time of negotiating the SAFE, the Company was in advanced negotiations to raise its next equity financing. As such, the Company recorded the fair value of the 2021 SAFE based on the value to be received upon a conversion at a 20% discount from the Next Equity Financing. As a result, the Company recorded $1.3 million to other income (expense), net for the increase in the fair value of the 2021 SAFE over its issuance price.
In March 2022, as part of the Company’s Series D preferred stock financing, the 2021 SAFE converted into shares of Series
D-1
preferred stock. As part of the extinguishment of the 2021 SAFE, the Company recorded a gain of $1.4 million in other income (expense), net in the consolidated statements of operations and comprehensive loss.
2022 SAFE
In connection with the Solaria acquisition, Complete Solar Holdings entered into the SAFE Amendment, Assignment and Assumption Agreement whereby Complete Solar Holdings assumed the rights and interests in and obligations under the SAFE from Solaria immediately at the effective time of the acquisition of Solaria. In accordance with the terms and conditions of the Merger Agreement, the SAFE was required to be converted into redeemable convertible preferred stock of the Company within 10 business days of the close of the acquisition. Immediately subsequent to acquisition close, the SAFE converted into 8,171,662 shares of series
D-8
redeemable convertible preferred stock.
XML 23 R13.htm IDEA: XBRL DOCUMENT v3.23.4
Reverse Recapitalization
9 Months Ended 12 Months Ended
Oct. 01, 2023
Dec. 31, 2022
Reverse Recapitalization [Abstract]    
Reverse Recapitalization
(4)
Reverse Recapitalization
As discussed in Note 1 – Organization, on July 18, 2023, the Company consummated the Mergers pursuant to the Amended and Restated Business Combination Agreement. The Mergers was accounted for as a reverse recapitalization, rather than a business combination, for financial accounting and reporting purposes. Accordingly, Complete Solaria was deemed the accounting acquirer (and legal acquiree) and FACT was treated as the accounting acquiree (and legal acquirer). Complete Solaria has been determined to be the accounting acquirer based on evaluation of the following facts and circumstances:
 
   
Complete Solaria’s
pre-combination
stockholders have the majority of the voting power in the post-merged company;
 
   
Legacy Complete Solaria’s stockholders have the ability to appoint a majority of the Complete Solaria Board of Directors;
 
   
Legacy Complete Solaria’s management team is considered the management team of the post-merged company;
 
   
Legacy Complete Solaria’s prior operations is comprised of the ongoing operations of the post-merged company;
 
   
Complete Solaria is the larger entity based on historical revenues and business operations; and
 
   
the post-merged company has assumed Complete Solaria’s operating name.
Under this method of accounting, the reverse recapitalization was treated as the equivalent of Complete Solaria issuing stock for the net assets of FACT, accompanied by a recapitalization. The net assets of FACT are stated at historical cost, with no goodwill or other intangible assets recorded. The consolidated assets, liabilities, and results of operations prior to the Mergers are those of Legacy Complete Solaria. All periods prior to the Mergers have been retrospectively adjusted in accordance with the Amended and Restated Business Combination Agreement for the equivalent number of preferred or common shares outstanding immediately after the Mergers to effect the reverse recapitalization.
Upon the closing of the Mergers and the PIPE Financing in July 2023, the Company received net cash proceeds of $19.7 million. The following table reconciles the elements of the Mergers to the unaudited condensed consolidated statements of cash flows and the unaudited condensed consolidated statements of stockholders’ deficit for the thirty-nine week ended October 1, 2023 (in thousands):
 
    
Recapitalization
 
Cash proceeds from FACT, net of redemptions
   $ 36,539  
Cash proceeds from PIPE Financing
     12,800  
Less: cash payment of FACT transaction costs and underwriting fees
     (10,680
Less: cash payment to FPA investors for rebates and recycled shares
     (17,831
Less: cash payment for Promissory Note
     (1,170
  
 
 
 
Net cash proceeds upon the closing of the Mergers and PIPE financing
     19,658  
Less:
non-cash
net liabilities assumed from FACT
     (10,135
  
 
 
 
Net contributions from the Mergers and PIPE financing upon closing
   $ 9,523  
  
 
 
 
Immediately upon closing of the Mergers, the Company had 45,290,553 shares issued and outstanding of Class A Common Stock. The following table presents the number of shares of Complete Solaria Common Stock outstanding immediately following the consummation of the Mergers:
 
    
Recapitalization
 
FACT Class A Ordinary Shares, outstanding prior to Mergers
     34,500,000  
FACT Class B Ordinary Shares, outstanding prior to Mergers
     8,625,000  
Bonus shares issued to sponsor
     193,976  
Bonus shares issued to PIPE investors
     120,000  
Bonus shares issued to FPA investors
     150,000  
Shares issued from PIPE financing
     1,690,000  
Shares issued from FPA agreements, net of recycled shares
     5,558,488  
Less: redemption of FACT Class A Ordinary Shares
     (31,041,243
  
 
 
 
Total shares from the Mergers and PIPE Financing
     19,796,221  
Legacy Complete Solaria shares
     20,034,257  
2022 Convertible Note Shares
     5,460,075  
  
 
 
 
Shares of Complete Solaria Common stock immediately after Mergers
     45,290,553  
  
 
 
 
In
connection
with the Mergers, the Company incurred direct and incremental costs of approximately $15.8 million related to legal, accounting, and other professional fees, which were offset against the Company’s additional
paid-in
capital. Of the $15.8 million, $5.2 million was incurred by Legacy Complete Solaria and $10.6 million was incurred by FACT. As of October 1, 2023, the Company made cash payments totaling $5.4 million to settle transaction costs. As a result of the Closing, outstanding 2022 Convertible Notes were converted into shares of Complete Solaria Common Stock.
(3)
Reverse Recapitalization
As discussed in Note 1 – Organization, on July 18, 2023, the Company consummated the Mergers pursuant to the Amended and Restated Business Combination Agreement. The Mergers was accounted for as a reverse recapitalization, rather than a business combination, for financial accounting and reporting purposes. Accordingly, Complete Solaria was deemed the accounting acquirer (and legal acquiree) and FACT was treated as the accounting acquiree (and legal acquirer). Complete Solaria has been determined to be the accounting acquirer based on evaluation of the following facts and circumstances:
 
   
Complete Solaria’s pre-combination stockholders have the majority of the voting power in the post-merged company;
 
   
Legacy Complete Solaria’s stockholders have the ability to appoint a majority of the Complete Solaria Board of Directors;
 
   
Legacy Complete Solaria’s management team is considered the management team of the post-merged company;
 
   
Legacy Complete Solaria’s prior operations is comprised of the ongoing operations of the post-merged company;
 
   
Complete Solaria is the larger entity based on historical revenues and business operations; and
 
   
the post-merged company has assumed Complete Solaria’s operating name.
Under this method of accounting, the reverse recapitalization was treated as the equivalent of Complete Solaria issuing stock for the net assets of FACT, accompanied by a recapitalization. The net assets of FACT
are stated at historical cost, with no goodwill or other intangible assets recorded. The consolidated assets, liabilities, and results of operations prior to the Mergers are those of Legacy Complete Solaria. All periods prior to the Mergers have been retrospectively adjusted in accordance with the Amended and Restated Business Combination Agreement for the equivalent number of preferred or common shares outstanding immediately after the Mergers to effect the reverse recapitalization.
Upon the closing of the Mergers and the PIPE Financing in July 2023, the Company received net cash proceeds of $19.7 million. Immediately upon closing of the Mergers, the Company had 45,290,553 shares issued and outstanding of Class A Common Stock. The following table presents the number of shares of Complete Solaria Common Stock outstanding immediately following the consummation of the Mergers:
 
    
Recapitalization
 
FACT Class A Ordinary Shares, outstanding prior to Mergers
     34,500,000  
FACT Class B Ordinary Shares, outstanding prior to Mergers
     8,625,000  
Bonus shares issued to sponsor
     193,976  
Bonus shares issued to PIPE investors
     120,000  
Bonus shares issued to FPA investors
     150,000  
Shares issued from PIPE financing
     1,690,000  
Shares issued from FPA agreements, net of recycled shares
     5,558,488  
Less: redemption of FACT Class A Ordinary Shares
     (31,041,243
  
 
 
 
Total shares from the Mergers and PIPE Financing
     19,796,221  
Legacy Complete Solaria shares
     20,034,257  
2022 Convertible Note Shares
     5,460,075  
  
 
 
 
Shares of Complete Solaria Common stock immediately after Mergers
     45,290,553  
  
 
 
 
In
connection
with the Mergers, the Company incurred direct and incremental costs of approximately $15.8 million related to legal, accounting, and other professional fees, which were offset against the Company’s additional paid-in capital. Of the $15.8 million, $5.2 million was incurred by Legacy Complete Solaria and $10.6 million was incurred by FACT. As a result of the Closing, outstanding 2022 Convertible Notes were converted into shares of Complete Solaria Common Stock.
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.23.4
Forward Purchase Agreements
9 Months Ended
Oct. 01, 2023
Forward Purchase Agreements Abstract  
Forward Purchase Agreements
(5)
Forward Purchase Agreements
In July 2023, FACT and Legacy Complete Solaria, Inc. entered into FPAs with each of (i) Meteora; (ii) Polar, and (iii) Sandia (each individually, a “Seller”, and together, the “FPA Sellers”).
Pursuant to the terms of the FPAs, the FPA Sellers may (i) purchase through a broker in the open market, from holders of Shares other than the Company or affiliates thereof, FACT’s ordinary shares, par value of $0.0001 per share, (the “Shares”). While the FPA Sellers have no obligation to purchase any Shares under the FPAs, the aggregate total Shares that may be purchased under the FPAs shall be no more than 6,720,000 in aggregate. The FPA Sellers may not beneficially own greater than 9.9% of issued and outstanding Shares following the Mergers as per the Amended and Restated Business Combination Agreement.
The key terms of the forward contracts are as follows:
 
   
The FPA Sellers can terminate the transaction following the Optional Early Termination (“OET”) Date which shall specify the quantity by which the number of shares is to be reduced (such quantity, the “Terminated Shares”). Seller shall terminate the transaction in respect of any shares sold on or prior to the maturity date. The counterparty is entitled to an amount from the seller equal to the number of terminated shares multiplied by a reset price. The reset price is initially $10.56 (the “Initial Price”) and is subject to a $5.00 floor.
 
   
The FPA contains multiple settlement outcomes. Per the terms of the agreements, the FPAs will (1) settle in cash in the event the Company is due cash upon settlement from the FPA Sellers or (2) settle in either cash or shares, at the discretion of the Company, should the settlement amount adjustment exceed the settlement amount. Should the Company elect to settle via shares, the equity will be issued in Complete Solaria Common Stock, with a per share price based on the volume-weighted average price (“VWAP”) Price over 15 scheduled trading days. The magnitude of the settlement is based on the Settlement Amount, an amount equal to the product of: (1) Number of shares issued to the
 
FPA Seller pursuant to the FPA, less the number of Terminated Shares multiplied by (2) the VWAP Price over the valuation period. The Settlement amount will be reduced by the Settlement Adjustment, an amount equal to the product of (1) Number of shares in the Pricing Date Notice, less the number of Terminated Shares multiplied by $2.00.
 
   
The Settlement occurs as of the Valuation Date, which is the earlier to occur of (a) the date that is two years after the date of the Closing Date of the Mergers (b) the date specified by Seller in a written notice to be delivered to Counterparty at Seller’s discretion (which Valuation Date shall not be earlier than the day such notice is effective) after the occurrence of certain triggering events; and (c) 90 days after delivery by the Counterparty of a written notice in the event that for any 20 trading days during a 30 consecutive trading
day-period
(the “Measurement Period”) that occurs at least 6 months after the Closing Date, the VWAP Price is less than the then applicable Reset Price.
The Company entered into four separate FPAs, three of which, associated with the obligation to issue 6,300,000 Shares, were entered into prior to the closing of the Mergers. Upon signing the FPAs, the Company incurred an obligation to issue a fixed number of shares to the FPA Sellers contingent upon the closing of the Mergers in addition to the terms and conditions associated with the settlement of the FPAs. The Company accounted for the contingent obligation to issue shares in accordance with ASC 815,
Derivatives and Hedging
, and recorded a liability and other income (expense), net based on the fair value upon of the obligation upon the signing of the FPAs. The liability was extinguished in July 2023 upon the issuance of Complete Solaria Common Stock to the FPA sellers.
Additionally, in accordance with ASC 480,
Distinguishing Liabilities from Equity
, the Company has determined that the prepaid forward contract is a financial instrument other than a share that represent or are indexed to obligations to repurchase the issuer’s equity shares by transferring assets, referred to herein as the “prepaid forward purchase liability” on its unaudited condensed consolidated balance sheets. The Company initially measured the prepaid forward purchase liability at fair value and has subsequently remeasured at fair value with changes in fair value recognized in earnings.
Through the date of issuance of the Complete Solaria Common Stock in satisfaction of the Company’s obligation to issue shares around the closing of the Mergers, the Company recorded $35.5 million to other income (expense), net associated with the issuance of 6,720,000 shares of Complete Solaria Common Stock.
As of the closing of the Mergers and issuance of the Complete Solaria Common Stock underlying the FPAs, the fair value of the prepaid FPAs was an asset balance of $0.1 million and was recorded on the Company’s unaudited condensed consolidated balance sheets and within other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive income (loss). Subsequently, the change of fair value of the prepaid forward purchase liability amounted to an expense of $6.7 million for the thirteen and thirty-nine weeks ended October 1, 2023. As of October 1, 2023, the prepaid forward purchase liabilities amounted to $6.6 million.
XML 25 R15.htm IDEA: XBRL DOCUMENT v3.23.4
Business Combination
9 Months Ended 12 Months Ended
Oct. 01, 2023
Dec. 31, 2022
Business Combination [Abstract]    
Business Combination
(6)
Business Combination
Solaria Acquisition
On November 4, 2022, Complete Solar Holdings acquired Solaria for aggregate consideration paid of $89.1 million, comprising of $0.1 million in cash, 2,844,550 shares of common stock with an aggregate fair value of $17.3 million, 6,803,549 shares of preferred stock with an aggregate fair value of $52.2 million, 78,962 common stock warrants for an aggregate value of $0.2 million, 1,376,414 preferred stock warrants for an aggregate fair value of $7.8 million, 5,382,599 stock options with an aggregate fair value of $10.0 million attributable to services provided prior to the acquisition date, and the payment of seller incurred transaction expenses of $1.5 million. In addition, the Company assumed $14.1 million of unvested Solaria stock options, which has been and will be recorded as stock-based expense over the remaining service period. Solaria designs, develops, manufactures, and generates revenue from the sale of silicon photovoltaic solar panels and licensing of its technology to third parties. At the time of the acquisition, the
Company believed that the acquisition of Solaria would establish the Company as a full system operator, with a compelling customer offering with
best-in-class
technology, financing, and project fulfilment, which would enable the Company to sell more product across more geographies in the United States and Europe. This transaction was accounted for as a business combination in accordance with ASC 805,
Business Combinations
. Refer to Note 8 – Divestiture for further details.
The following table summarized the provisional fair value of identifiable assets acquired and liabilities assumed (in thousands):
 
    
Amount
 
Cash, cash equivalents and restricted cash
   $ 5,402  
Accounts receivable
     4,822  
Inventories
     5,354  
Prepaid expenses and other current assets
     8,569  
Property and equipment
     830  
Operating lease
right-of-use
assets
     1,619  
Intangible assets
     43,100  
Other
non-current
assets
     112  
  
 
 
 
Total identifiable assets acquired
     69,808  
Accounts payable
     4,210  
Accrued expenses and other current liabilities
     11,845  
Notes payable
     20,823  
Deferred revenue
     73  
Operating lease liabilities, net of current portion
     1,132  
Warranty provision, noncurrent
     1,566  
SAFE agreements
     60,470  
  
 
 
 
Total identifiable liabilities assumed
     100,119  
  
 
 
 
Net identifiable liabilities assumed
     30,311  
Goodwill
     119,422  
  
 
 
 
Total aggregate consideration paid
   $ 89,111  
  
 
 
 
Goodwill represents the excess of the preliminary estimated consideration transferred over the fair value of the net tangible and intangible assets acquired and has been allocated to the Company’s single reporting unit. Goodwill is primarily attributable to expected post-acquisition synergies from assembled workforce and also from the expectation of integrating Solaria’s products and solutions into the Company’s own businesses to provide access to more features and resources and offers incremental revenue opportunities. Goodwill of $119.4 million is deductible over 15 years for U.S. income tax purposes.
Intangible assets acquired are as follows (in thousands):
 
    
Amount
 
Trademarks
   $ 5,700  
Developed technology
     12,700  
Customer relationships
     24,700  
  
 
 
 
Total intangible assets
   $ 43,100  
  
 
 
 
The income approach, using the relief from royalty method, was used to value trademarks and developed technology. Significant assumptions included in the valuation of trademarks and developed technology include projected revenues, the selected royalty rate and the economic life of the underlying asset.
The income approach, using the multi-period excess earning method, was used to value customer relationships. Significant assumptions included in the valuation of customer relationships include projected revenues, customer attrition and expense growth over the forecasted period.
As a result of the Solaria acquisition, the Company recognized $45.9 million of deferred tax assets. Due to the uncertainty surrounding the Company’s ability to realize such deferred income tax assets, a full valuation allowance has been established.
As of October 1, 2023, the goodwill and intangible assets recognized from the Solaria acquisition have been included in long-term held for sale – discontinued operations on the unaudited condensed consolidated balance sheets, as further described in Note 8 – Divestiture.
Unaudited Pro Forma Information
The following unaudited pro forma financial information gives effect to the acquisition of Solaria as if it were consummated on January 1, 2022 including pro forma adjustments relating to the valuation and allocation of the aggregate consideration paid, amortization of intangible assets, incremental stock-based compensation and direct transaction costs. The historical condensed consolidated financial statements have been adjusted in the unaudited combined financial information to give effect to events that are directly attributable to the Business Combination and are factually supportable. This data is presented for informational purposes only and is not intended to represent or be indicative of the results of operations that would have been reported had the acquisition occurred on January 1, 2022. Actual results may differ from the unaudited combined pro forma information presented below (in thousands):
 
    
Three Months
Ended
September 30,
2022
    
Nine Months
Ended
September 30,
2022
 
Revenues
   $ 22,267      $ 79,800  
Net loss
   $ (26,498    $ (49,935
(4)
Business Combination
Solaria Acquisition
On November 4, 2022, Complete Solar Holdings acquired Solaria for aggregate consideration paid of $89.1 million, comprising of $0.1 million in cash, 2,884,550 shares of common stock with an aggregate fair value of $17.3 million, 6,803,549 shares of preferred stock with an aggregate fair value of $52.2 million, 78,962 common stock warrants for an aggregate value of $0.2 million, 1,376,414 preferred stock warrants for an aggregate fair value of $7.8 million, 5,382,599 stock options with an aggregate fair value of $10.0 million attributable to services provided prior to the acquisition date, and the payment of seller incurred transaction expenses of $1.5 million. In addition, the Company assumed $14.1 million of unvested Solaria stock options, which will be recorded as stock-based expense over the remaining service period. Solaria designs, develops, manufactures, and generates revenue from the sale of silicon photovoltaic solar panels and licensing of its technology to third parties. This transaction was accounted for as a business combination in accordance with ASC 805,
Business Combinations
. Subsequent to the acquisition as discussed above, the Company sold certain intangible assets constituting the Solaria business in October of 2023, resulting in the Solaria business to be reflected as discontinued operations and certain intangible assets and goodwill to be recognized as held-for-sale. Refer to Note 5 – Divestitures for further details.
Acquisition costs of $1.3 million were expensed by the Company and are included in general and administrative expenses within the consolidated statements of operations and comprehensive loss for the year ended December 31, 2022.
The fair value of assets acquired and liabilities assumed was based upon a preliminary valuation and the Company’s estimates and assumptions are subject to change within the measurement period. The following table summarized the provisional fair value of identifiable assets acquired and liabilities assumed (in thousands):
 
Cash, cash equivalents and restricted cash
   $ 5,402  
Accounts receivable
     4,822  
Inventories
     5,354  
Prepaid expenses and other current assets
     8,569  
Property and equipment
     830  
Operating lease
right-of-use
asset
     1,619  
Intangible assets
     43,100  
Other
non-current
assets
     112  
  
 
 
 
Total identifiable assets acquired
     69,808  
Accounts payable
     4,210  
Accrued expenses and other current liabilities
     11,845  
Notes payable
     20,823  
Deferred revenue
     73  
Operating lease liabilities, net of current portion
     1,132  
Warranty provision, noncurrent
     1,566  
SAFE agreements
     60,470  
  
 
 
 
Total identifiable liabilities assumed
     100,119  
  
 
 
 
Net identifiable liabilities assumed
     30,311  
Goodwill
     119,422  
  
 
 
 
Total aggregate consideration paid
   $ 89,111  
  
 
 
 
Goodwill represents the excess of the preliminary estimated consideration transferred over the fair value of the net tangible and intangible assets acquired and has been allocated to the Company’s single reporting unit. Goodwill was subsequently reclassified to long-term assets held-for-sale – discontinued operations, on the Company’s balance sheet as of December 31, 2022, stemming from the sale of the Solaria business discussed in Note 5 below.
Intangible assets acquired and subsequently disposed of as part of the Solaria disposition discussed in Note 5 below are as follows (in thousands):
 
Trademarks
   $ 5,700  
Developed technology
     12,700  
Customer relationships
     24,700  
  
 
 
 
Total intangible asset
   $ 43,100  
  
 
 
 
The income approach, using the relief from royalty method, was used to value trademarks and developed technology. Significant assumptions included in the valuation of trademarks and developed technology include projected revenues, the selected royalty rate and the economic life of the underlying asset.
The income approach, using the multi-period excess earning method, was used to value customer relationships. Significant assumptions included in the valuation of customer relationships include projected revenues, customer attrition and expense growth over the forecasted period.
As a result of the Solaria acquisition, the Company recognized $45.9 million of deferred tax assets. Due to the uncertainty surrounding the Company’s ability to realize such deferred income tax assets, a full valuation allowance has been established. Refer to Note 18 – Income Taxes for additional details.
XML 26 R16.htm IDEA: XBRL DOCUMENT v3.23.4
Prepaid Expenses and Other Current Assets
9 Months Ended 12 Months Ended
Oct. 01, 2023
Dec. 31, 2022
Prepaid Expenses and Other Current Assets [Abstract]    
Prepaid Expenses and Other Current Assets
 
(7)
Prepaid Expenses and Other Current Assets
Prepaid expenses and other current assets consists of the following (in thousands):
 
    
As of
 
    
October 1,
2023
    
December 31,
2022
 
Inventory deposits
   $ 3,497      $ 6,255  
Prepaid sales commissions
     5,509        2,838  
  
 
 
    
 
 
 
Other
     941        978  
  
 
 
    
 
 
 
Total prepaid expenses and other current assets
   $ 9,947      $ 10,071  
  
 
 
    
 
 
 
(6)
Prepaid Expenses and Other Current Assets
Prepaid expenses and other current assets consists of the following (in thousands):
 
    
As of December 31,
 
    
2022
    
2021
 
Inventory deposits. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
   $ 6,255      $ —    
Prepaid sales commissions . . . . . . . . . . . . . . . . . . . . . . .
     2,838        4,771  
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
     978        184  
  
 
 
    
 
 
 
Total prepaid expenses and other current assets . . .
   $ 10,071      $ 4,955  
  
 
 
    
 
 
 
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.23.4
Divestiture
9 Months Ended 12 Months Ended
Oct. 01, 2023
Dec. 31, 2022
Divestiture [Abstract]    
Divestiture
(8)
Divestiture
Discontinued operations
As previously described in Note 1 – Organization, on August 18, 2023, the Company entered into a
Non-Binding
Letter of Intent to sell certain of Complete Solaria’s North American solar panel assets, inclusive of intellectual property and customer contracts, to Maxeon. In October 2023, the Company completed the sale of its solar panel business to Maxeon. The Company determined that this divestiture represented a strategic shift in the Company’s business and qualified as a discontinued operation. Accordingly, the results of operations and cash flows relating to Solaria have been reflected as discontinued operations in the unaudited condensed consolidated statements of operations and comprehensive income (loss) for the thirteen and thirty-nine weeks ended October 1, 2023 and the unaudited condensed consolidated statements of cash flows for the thirty-nine weeks ended October 1, 2023.
Components of amounts reflected in the unaudited condensed consolidated statements of operations and comprehensive income (loss) related to discontinued operations are presented in the table, as follows (in thousands):
 
    
Thirteen Weeks
Ended
October 1,
2023
    
Thirty-Nine
Weeks Ended
October 1,
2023
 
Revenues
   $ 3,774      $ 29,048  
Cost of revenues
     4,102        30,609  
  
 
 
    
 
 
 
Gross loss
     (328      (1,561
Operating expenses:
     
Sales and marketing
     2,425        6,855  
General and administrative
     5,681        12,572  
  
 
 
    
 
 
 
Total operating expenses
     8,106        19,427  
  
 
 
    
 
 
 
Loss from discontinued operations
     (8,434      (20,988
Other income (expense), net
     31        32  
  
 
 
    
 
 
 
Loss from discontinued operations before income taxes
     (8,403      (20,956
Income tax benefit (provision)
     (1      3  
Impairment loss from discontinued operations
     (147,505      (147,505
  
 
 
    
 
 
 
Net loss from discontinued operations
   $ (155,909    $ (168,458
  
 
 
    
 
 
 
Held for sale
As previously described in Note 1 – Organization, certain assets of the Solaria, Inc. have been reflected as assets held for sale in the periods preceding the divestiture.
The following is a summary of the major categories of assets and liabilities held for sale (in thousands):
 
    
As of
 
    
October 1,
2023
    
December 31,
2022
 
Intangible assets, net
   $ 12,299      $ 42,610  
Goodwill
     —          119,422  
  
 
 
    
 
 
 
Long-term assets held for sale
   $ 12,299      $ 162,032  
  
 
 
    
 
 
 
 
(5)
Divestiture
Discontinued
operations
As previously described in Note 1 – Organization, on August 18, 2023, the Company entered into a Non-Binding Letter of Intent to sell certain of Complete Solaria’s North American solar panel assets, inclusive of intellectual property and customer contracts, to Maxeon. In October 2023, the Company completed the sale of its solar panel business to Maxeon. The assets sold to Maxeon were the assets that allowed for the Solaria business to operate as a product manufacturer of solar panels. As such, the Company determined that the sale of these assets in effect represented a disposition of the Solaria business and constituted a strategic shift in the Company’s operations, therefore qualifying as a discontinued operation. Accordingly, the results of operations and cash flows relating to Solaria have been reflected as discontinued operations in the consolidated statements of operations and comprehensive income (loss) for the year ended December 31, 2022 and the consolidated statements of cash flows for the year ended December 31, 2022.
Components of amounts reflected in the consolidated statements of operations and comprehensive income (loss) related to discontinued operations are presented in the table, as follows (in thousands):
 
    
December 31, 2022
 
Revenues
   $ 13,325  
Cost of revenues
     12,847  
  
 
 
 
Gross profit
     478  
Operating expenses:
  
Sales and marketing
     1,315  
General and administrative
     617  
  
 
 
 
Total operating expenses
     1,932  
  
 
 
 
Net loss from discontinued operations
   $ (1,454
  
 
 
 
Held for sale
As previously described in Note 1 – Organization, certain assets of the Solaria, Inc. have been reflected as assets held for sale in the periods preceding the divestiture.
The following is a summary of the major categories of assets and liabilities held for sale (in thousands):
 
    
December 31, 2022
 
Intangible assets, net
   $ 42,610  
Goodwill
     119,422  
  
 
 
 
Long-term assets held for sale
   $ 162,032  
  
 
 
 
In October 2023, in conjunction with the divestiture, the Company recorded impairment expense of $119.4 million and $28.1 million associated with the goodwill and intangible assets, respectively, assigned to Solaria and a loss on disposal of $1.8 million.
Cash flows from discontinued operations included depreciation and amortization of $0.5 million and stock-based compensation expense of $0.5 million for year ended December 31, 2022.
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.23.4
Property and Equipment, Net
9 Months Ended 12 Months Ended
Oct. 01, 2023
Dec. 31, 2022
Property and Equipment, Net [Abstract]    
Property and Equipment, Net
 
(9)
Property and Equipment, Net
Property and equipment, net consists of the following (in thousands, except year data):
 
    
Estimated
    
As of
 
    
Useful Lives
(Years)
    
October 1,
2023
    
December 31,
2022
 
Developed software
     5      $ 6,559      $ 5,054  
Manufacturing equipment
     3        131        102  
Furniture and equipment
     3        90        90  
Leasehold improvements
     5        708        708  
     
 
 
    
 
 
 
Total property and equipment
        7,488        5,954  
Less: accumulated depreciation and amortization
        (3,303      (2,478
     
 
 
    
 
 
 
Total property and equipment, net
      $ 4,185      $ 3,476  
     
 
 
    
 
 
 
Depreciation and amortization expense on tangible assets totaled $0.3 million and $0.6 million for the thirteen and thirty-nine weeks ended October 1, 2023, respectively, and $0.2 million and $0.4 million for the three and nine months ended September 30, 2022, respectively. There were no impairment charges on tangible assets recognized for the thirteen or thirty-nine weeks ended October 1, 2023, or for the three or nine months ended September 30, 202
2
.
 
(7)
Property and Equipment, Net
Property and equipment, net consists of the following (in thousands):
 
    
As of December 31,
 
    
2022
    
2021
 
Developed software
   $ 5,054      $ 3,540  
Manufacturing equipment.
     102        70  
Furniture & equipment
     90        —    
Leasehold improvements
     708        —    
  
 
 
    
 
 
 
Total property and equipment
     5,954        3,610  
Less accumulated depreciation and amortization
     (2,478      (1,852
  
 
 
    
 
 
 
Total property and equipment, net
   $ 3,476      $ 1,758  
  
 
 
    
 
 
 
Depreciation and amortization expense totaled $0.6 million, $0.5 million and $0.3 million for the years ended December 31, 2022, 2021 and 2020, respectively.
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.23.4
Goodwill and Intangible Assets
9 Months Ended 12 Months Ended
Oct. 01, 2023
Dec. 31, 2022
Goodwill and Intangible Assets [Abstract]    
Goodwill and Intangible Assets
 
(10)
Goodwill and Intangible Assets
Goodwill
During the thirteen and thirty-nine weeks ended October 1, 2023, the Company recorded $119.4 million of goodwill impairment related to the goodwill assigned to Solaria, Inc. See Note 8 – Divestiture for additional information regarding the divestiture. The goodwill balances as of October 1, 2023 and December 31, 2022 were zero and $119.4 million, respectively. See Note 6 – Business Combination for additional information regarding the Company’s acquisitions including recognition of goodwill.
Intangible Assets
The following table provides a reconciliation of intangible assets reported as of October 1, 2023 and December 31, 2022 (in thousands, except years data):
 
    
As of October 1, 2023
 
    
Gross
Carrying
Amount
    
Impairment
    
Held for
Sale
    
Accumulated
Amortization
    
Net
Amount
 
Assembled workforce
   $ 137      $ —        $ —          (137    $ —    
Trademarks
     5,700        (3,714      (1,463      (523      —    
Customer relationship
     24,700        (16,094      (7,577      (1,029      —    
Developed technology
     12,700        (8,275      (3,259      (1,166      —    
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Total intangible assets
   $ 43,237      $ (28,083    $ (12,299    $ (2,855    $ —    
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
 
    
As of December 31, 2022
 
    
Weighted-
Average
Remaining
Life
(Years)
    
Gross
Carrying
Amount
    
Accumulated
Amortization
    
Net
Amount
 
Assembled workforce
     0.1      $ 137      $ (133    $ 4  
Trademarks
     9.8        5,700        (95      5,605  
Customer relationship
     21.8        24,700        (187      24,513  
Developed technology
     9.8        12,700        (212      12,488  
     
 
 
    
 
 
    
 
 
 
Total intangible assets
      $ 43,237      $ (627    $ 42,610  
     
 
 
    
 
 
    
 
 
 
Amortization expense related to intangible assets for the thirteen and thirty-nine weeks ended October 1, 2023 and the three and nine months ended September 30, 2022 were as follows (in thousands):
 
    
Thirteen Weeks
Ended
October 1,
2023
    
Three Months
Ended
September 30,
2022
    
Thirty-Nine

Weeks Ended
October 1,
2023
    
Nine Months
Ended
September 30,
2022
 
Assembled workforce
   $ —        $ 17      $ 4      $ 51  
Trademarks
     142        —          428        —    
Customer relationship
     279        —          843        —    
Developed technology
     317        —          953        —    
  
 
 
    
 
 
    
 
 
    
 
 
 
Total amortization expense
   $ 738      $ 17      $ 2,228      $ 51  
  
 
 
    
 
 
    
 
 
    
 
 
 
Amortization expense for the thirteen and thirty-nine weeks ended October 1, 2023 was recorded as loss from discontinued operations on the accompanying unaudited condensed consolidated statements of operations and comprehensive income (loss). For the three and nine months ended September 30, 2022, amortization expense related to intangible assets of less than $0.1 million was recorded to general and administrative expense on the accompanying unaudited condensed consolidated statements of operations and comprehensive income (loss).
The Company does not expect to recognize any future amortization expense of intangible assets as of October 1, 2023.
 
(8)
Intangible Assets, Net
Intangible assets consisted of the following (in thousands, except years data):
 
    
As of December 31, 2022
    
As of December 31, 2021
 
    
Weighted-
Average
Remaining
Life (Years)
    
Gross
Carrying
Amount
    
Accumulated
Amortization
   
Net
Amount
    
Gross
Carrying
Amount
    
Accumulated
Amortization
   
Net
Amount
 
Assembled workforce
     0.1      $  137      $  (133   $  4      $  137      $ (65   $  72  
Amortization expense related to intangible assets for the years ended December 31, 2022, 2021, and 2020 was $0.1 million, $0.1 million and zero, respectively.
For the year ended December 31, 2022, amortization expense related to intangible assets of $0.1 million and $0.1 million, respectively, was recorded in general and administrative expense on the accompanying consolidated statements of operations and comprehensive loss.
For the year ended December 31, 2020, amortization expense related to intangible assets was zero.
As of December 31, 2022, amortization expense for intangible assets for 2023 is expected to be $0.1 million. Amortization expense for intangible assets is
not
expected to be material for periods subsequent to 2023.
Assembled workforce
On January 21, 2021, the Company entered into an agreement to purchase the business assets of Current Insight, an engineering firm that develops designs for residential solar installations in a cost-effective manner for its customers. Consideration for the asset acquisition amounted to an aggregate purchase price of $0.2 million, comprised of a promissory note for $0.1 million and 30,000 shares of the Company’s common stock with an aggregate fair value of less than $0.1 million. The transaction was accounted for as an asset purchase in accordance with ASC 805,
Business Combinations
.
The Company concluded that tangible and other assets acquired in the transaction did not have material value and, as such, ascribed no consideration to them. The total purchase price was allocated exclusively to the acquired assembled workforce, which is amortized on a straight-line basis over an estimated useful life of two years.
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.23.4
Accrued Expenses and Other Current Liabilities
9 Months Ended 12 Months Ended
Oct. 01, 2023
Dec. 31, 2022
Accrued Expenses and Other Current Liabilities [Abstract]    
Accrued Expenses and Other Current Liabilities
 
(11)
Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities consist of the following (in thousands):
 
    
As of
 
    
October 1,
2023
    
December 31,
2022
 
Accrued compensation and benefits
   $ 3,666      $ 3,940  
Customer deposits
     1,167        930  
Uninvoiced contract costs
     3,554        1,914  
Inventory received but not invoiced
     1,391        972  
Accrued term loan and revolving loan amendment and final payment fees
     2,175        2,400  
Accrued legal settlements
     2,955        1,853  
Accrued taxes
     931        1,245  
Accrued rebates and credits
     880        1,076  
Operating lease liabilities, current
     720        958  
Revenue warranty
     918        —    
Deferred underwriters’ discount payable
     3,019        —    
Accrued warranty, current
     605        767  
Other accrued liabilities
     4,693        3,775  
  
 
 
    
 
 
 
Total accrued expenses and other current liabilities
   $ 26,674      $ 19,830  
  
 
 
    
 
 
 
 
(9)
Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities consist of the following (in thousands):
 
    
December 31,
 
    
2022
    
2021
 
Accrued compensation and benefits
   $ 3,940      $  3,498  
Accrued term loan and revolving loan amendment and final payment fees
     2,400        —    
Uninvoiced contract costs
     1,914        2,180  
Accrued legal settlements
     1,853        —    
Accrued taxes
     1,245        —    
Accrued rebates and credits
     1,076        —    
Inventory received but not invoiced
     972        —    
Operating lease liabilities, current
     958        390  
Customer deposits
     930        1,375  
Warranty provision, current
     767        600  
Other accrued liabilities
     3,775        1,304  
  
 
 
    
 
 
 
Total accrued expenses and other current liabilities
   $ 19,830      $ 9,347  
  
 
 
    
 
 
 
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.23.4
Employee Benefit Plan
9 Months Ended 12 Months Ended
Oct. 01, 2023
Dec. 31, 2022
Employee Benefit Plan [Abstract]    
Employee Benefit Plan
 
(12)
Employee Benefit Plan
The Company sponsors a 401(k) defined contribution and profit-sharing plan (“401(k) Plan”) for its eligible employees. This 401(k) Plan provides for
tax-deferred
salary deductions for all eligible employees. Employee contributions are voluntary. Employees may contribute the maximum amount allowed by law, as limited by the annual maximum amount as determined by the Internal Revenue Service. The Company may match employee contributions in amounts to be determined at the Company’s sole discretion. The Company made no contributions to the 401(k) Plan for the thirteen or thirty-nine weeks ended October 1, 2023 and for the three or nine months ended September 30, 2022.
 
(11)
Employee Benefit Plan
The Company sponsors a 401(k) defined contribution and profit-sharing plan (“401(k) Plan”) for its eligible employees. This 401(k) Plan provides for
tax-deferred
salary deductions for all eligible employees. Employee contributions are voluntary. Employees may contribute the maximum amount allowed by law, as limited by the annual maximum amount as determined by the Internal Revenue Service. The Company may match employee contributions in amounts to be determined at the Company’s sole discretion. The Company made no contributions to the 401(k) Plan for the years ended December 31, 2022, 2021 and 2020.
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.23.4
Other Income (Expense), Net
9 Months Ended 12 Months Ended
Oct. 01, 2023
Dec. 31, 2022
Other Income (Expense), Net [Abstract]    
Other Income (Expense), Net
(13) Other Income (Expense), Net
Other income (expense), net consists of the following (in thousands):
 
    
Thirteen
Weeks
Ended
October 1,
2023
   
Three

Months
Ended
September 30,
2022
    
Thirty-Nine

Weeks
Ended

October 1,
2023
   
Nine
Months
Ended
September 30,
2022
 
Change in fair value of redeemable convertible preferred stock warrant liability
   $ 39     $ 3      $ 9,455     $ (142
Change in fair value of Carlyle warrants
     12,689       —          12,689       —    
Change in fair value of FACT public, private placement and working capital warrants
     4,170       —          4,170       —    
Gain on extinguishment of convertible notes and SAFE agreements
(1)
     —         —          —         3,235  
Loss on CS Solis debt extinguishment
     (10,338     —          (10,338     —    
Bonus shares issued in connection with the Mergers
(2)
     (2,394     —          (2,394     —    
Issuance of forward purchase agreements
(3)
     76       —          76       —    
Change in fair value of forward purchase agreement liabilities
(4)
     (6,661     —          (6,661     —    
Issuance of shares in connection with the forward purchase agreements
(5)
     (35,490     —          (35,490     —    
Other, net
     (94     1        191       87  
  
 
 
   
 
 
    
 
 
   
 
 
 
Total other income (expense), net
   $ (38,003   $ 4      $ (28,302   $ 3,180  
  
 
 
   
 
 
    
 
 
   
 
 
 
 
(1)
 
Includes zero and $1.4 million of other income for the three and nine months ended September 30, 2022, respectively, recognized upon the conversion of related party convertible notes and SAFEs.
(2)
 
Includes $0.7 million of other expense for each of the thirteen and thirty-nine weeks ended October 1, 2023 for bonus shares issued to related parties in connection with the Mergers.
(3)
 
Includes $0.3 million of other income for each of the thirteen and thirty-nine weeks ended October 1, 2023 for forward purchase agreements entered into with related parties.
(4)
 
Includes $5.9 million of other expense for each of the thirteen and thirty-nine weeks ended October 1, 2023 for forward purchase agreements entered into with related parties.
(5)
 
Includes $30.7 million of other expense for each of the thirteen and thirty-nine weeks ended October 1, 2023 for shares issued to related parties in connection with the forward purchase agreements.
 
(12)
Other Income (Expense), Net
Other income (expense), net consists of the following (in thousands):
 
    
Years Ended December 31,
 
    
2022
    
2021
   
2020
 
Change in fair value of SAFE agreements
   $ —        $  (1,306   $  (15
Change in fair value of derivative liabilities
     —          (336     (50
Change in fair value of warrant liabilities
     (5,211      (330     24  
Gain on extinguishment of convertible notes and SAFE agreements
(1)
     3,235        —         —    
Forgiveness of Paycheck Protection Plan loan
     —          1,754       —    
Other, net
     118        (22     —    
  
 
 
    
 
 
   
 
 
 
Total other income (expense), net
   $  (1,858 )    $ (240)     $  (41
  
 
 
    
 
 
   
 
 
 
 
(1)
Includes $1.4 million of other income recognized upon the conversion of related party convertible notes and SAFEs
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.23.4
Common Stock
9 Months Ended 12 Months Ended
Oct. 01, 2023
Dec. 31, 2022
Common Stock [Abstract]    
Common Stock
(14)
Common Stock
The Company has authorized the issuance of 1,000,000,000 shares of common stock and 10,000,000 shares of preferred stock as of October 1, 2023. No preferred stock has been issued.
The Company has reserved shares of common stock for issuance related to the following:
 
    
As of
October 1,
2023
 
Common stock warrants
     27,637,266  
Employee stock purchase plan
     2,628,996  
Stock options and RSUs, issued and outstanding
     7,013,514  
Stock options and RSUs, authorized for future issuance
     8,625,023  
  
 
 
 
Total shares reserved
     45,904,799  
  
 
 
 
(13)
Common Stock
The Company has authorized the issuance of 28,978,046 and 13,547,878 shares of common stock as of December 31, 2022 and December 31, 2021, respectively.
The Company has reserved shares of common stock for issuance related to the following redeemable convertible preferred stock, stock options, common stock warrants, redeemable convertible preferred stock warrants, and future grants:
 
    
As of December 31,
 
    
2022
    
2021
 
Common stock warrants
     3,389,005        690,236  
Stock options, issued and outstanding
     4,970,395        2,135,454  
Stock options, authorized for future issuance
     369,907        141,644  
SAFE agreement
     —          341,604  
Convertible notes
     —          1,621,299  
  
 
 
    
 
 
 
Total shares reserved
     8,729,307        4,930,237  
  
 
 
    
 
 
 
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.23.4
Warrants
9 Months Ended 12 Months Ended
Oct. 01, 2023
Dec. 31, 2022
Warrants [Abstract]    
Warrants
(15)
Warrants
Series B Warrants (Converted to Common Stock Warrants)
In February 2016, the Company issued a warrant to purchase 5,054 shares of Series B preferred stock (the “Series B warrant”) in connection with a 2016 credit facility. The Series B warrant is immediately exercisable at an exercise price of $4.30 per share and has an expiration date of February 2026. The fair value of the Series B warrant was less than $0.1 million as of December 31, 2022 and as of July 18, 2023, when the Series B warrant was reclassified from warrant liability to additional
paid-in
capital, as the warrant is exercisable into shares of Complete Solaria Common Stock upon the close of the Mergers. The relative fair value of the Series B warrant at issuance was recorded as a debt issuance cost within other
non-current
liabilities on the accompanying unaudited condensed consolidated balance sheets, and changes in fair value have been recorded in other income (expense), net on the accompanying unaudited condensed consolidated statements of operations and comprehensive income (loss) for the thirteen and thirty-nine weeks ended October 1, 2023 and the three and nine months ended September 30, 2022.
Series C Warrants (Converted to Common Stock Warrants)
In July 2016, the Company issued a warrant to purchase 148,477 shares of Series C preferred stock (the “Series C warrant”) in connection with the Series C financing. The Series C warrant agreement also provided for an additional number of Series C shares calculated on a monthly basis commencing on June 2016 based on the principal balance outstanding of the notes payable outstanding. The maximum number of shares exercisable under the Series C warrant agreement is 482,969 shares of Series C preferred stock. The Series C warrant was immediately exercisable at an exercise price of $1.00 per share and has an expiration date of July 2026. The fair value of the Series C warrant was $6.3 million as of December 31, 2022. The fair value of the Series C warrant was $2.3 million as of July 18, 2023, when the Series B warrant was reclassified from redeemable convertible preferred stock warrant liability to additional
paid-in
capital, as the warrant is exercisable into shares of Complete Solaria Common Stock upon the close of the Mergers. The relative fair value of the Series C warrant at issuance was recorded as Series C preferred stock issuance costs and redeemable convertible preferred stock warrant liability on the accompanying unaudited condensed consolidated balance sheets, and changes in fair value have been recorded in other income (expense), net on the accompanying unaudited condensed consolidated statements of operations and comprehensive income (loss) for the thirteen and thirty-nine weeks ended October 1, 2023 and the three and nine months ended September 30, 2022.
Series
C-1
Warrants (Converted to Common Stock Warrants)
In January 2020, the Company issued a warrant to purchase 173,067 shares of common stock in conjunction with the Series
C-1
preferred stock financing. The warrant is immediately exercisable at an exercise price of $0.01 per share and has an expiration date of January 2030. The warrant remains outstanding as of October 1, 2023. At issuance, the relative fair value of the warrant was determined to be $0.1 million using the Black-Scholes model with the following weighted average assumptions: expected term of 10 years; expected volatility of 62.5%; risk-free interest rate of 1.5%; and no dividend yield. The fair value of the warrant was recorded within additional
paid-in
capital on the unaudited condensed consolidated balance sheets. The warrant is not remeasured in future periods as it meets the conditions for equity classification.
SVB Common Stock Warrants
In May and August 2021, the Company issued warrants to purchase 2,473 and 2,525 shares of common stock, respectively, in conjunction with the Fifth and Sixth Amendments to the Loan and Security Agreement (“Loan Agreement”) with Silicon Valley Bank (“SVB”). The warrants are immediately exercisable at exercise prices of $0.38 and $0.62 per share, respectively, and have expiration dates in 2033. The warrants remain outstanding as of October 1, 2023. At issuance, the relative fair value of the warrants
were determined to be less than $0.1 million in aggregate using the Black-Scholes model with the following weighted average assumptions: expected term of 12 years; expected volatility of 73.0%; risk-free interest rate of 1.7% and 1.3% for the May and August 2021 warrants, respectively; and no dividend yield. The fair value of the warrant was recorded within additional
paid-in-capital
on the accompanying unaudited condensed consolidated balance sheets. The warrants are not remeasured in future periods as they meet the conditions for equity classification.
Promissory Note Common Stock Warrants
In October 2021, the Company issued a warrant to purchase 24,148 shares of common stock in conjunction with the issuance of a short-term promissory note. The warrant is immediately exercisable at an exercise price of $0.01 per share and has an expiration date of October 2031. The warrant remains outstanding as of October 1, 2023. At issuance, the relative fair value of the warrant was determined to be less than $0.1 million using the Black-Scholes model with the following weighted average assumptions: expected term of 10 years; expected volatility of 73.0%; risk-free interest rate of 1.5%; and no dividend yield. The fair value of the warrant was recorded within additional
paid-in
capital on the unaudited condensed consolidated balance sheets. The warrant is not remeasured in future periods as it meets the conditions for equity classification.
Carlyle Warrants
In February 2022, as part of a debt financing from Carlyle (refer to Note 16 – Borrowing Arrangements), the Company issued a warrant to purchase 2,886,952 shares of common stock in conjunction with the redeemable investment in CS Solis. The warrant contained two tranches, the first of which is immediately exercisable for 1,995,879 shares. The second tranche, which was determined to be a separate unit of account, was exercisable upon a subsequent investment from Carlyle in CS Solis. No subsequent investment was made and the investment period expired on December 31, 2022 and the second tranche of warrants expired prior to becoming exercisable. The vested warrant had an exercise price of $0.01 per share and had an expiration date of February 2029.
At issuance, the relative fair value of the warrant was determined to be $3.4 million using the Black-Scholes model with the following weighted average assumptions: expected term of 7 years; expected volatility of 73.0%; risk-free interest rate of 1.9%; and no dividend yield. The fair value of the warrant was recorded within additional
paid-in
capital and as a discount on the long-term debt in CS Solis on the unaudited condensed consolidated balance sheets as of December 31, 2022.
In July 2023, and in connection with the closing of the Mergers, the Carlyle debt and warrants were modified. Based on the exchange ratio included in the Mergers, the 1,995,879 outstanding warrants to purchase Legacy Complete Solaria Common Stock prior to modification were exchanged into warrants to purchase 1,995,879 shares of Complete Solaria Common Stock. As part of the modification, the warrant, which expires on July 18, 2030, provides Carlyle with the right to purchase shares of Complete Solaria Common Stock based on (a) the greater of (i) 1,995,879 shares and (ii) the number of shares equal to 2.795% of Complete Solaria’s issued and outstanding shares of common stock, on a fully-diluted basis; plus (b) on and after the date that is ten (10) days after the date of the agreement, an additional 350,000 shares; plus (c) on and after the date that is thirty (30) days after the date of the agreement, if the original investment amount has not been repaid, an additional 150,000 shares; plus (d) on and after the date that is ninety (90) days after the date of the agreement, if the original investment amount has not been repaid, an additional 250,000 shares, in each case, of Complete Solaria Common Stock at a price of $0.01 per share. Of the additional warrants that become exercisable after the modification, the tranches of 350,000 warrants vesting ten days after the date of the agreement and 150,000 warrants vesting thirty days after the date of the agreement are exercisable as of October 1, 2023.
The modification of the warrant resulted in the reclassification of previously equity classified warrants to liability classification, which was accounted for in accordance with ASC 815 and ASC 718. The Company
recorded the fair value of the modified warrants as a warrant liability of $20.4 million, the
pre-modification
fair value of the warrants as a reduction to additional
paid-in
capital of $10.9 million and $9.5 million to other income (expense), net equal to the incremental value of the warrants upon the modification. The fair value of the warrant was determined based on its intrinsic value, given a nominal exercise price. At issuance, the relative fair value of the warrant was determined to be less than $20.4 million using the
Black-Scholes
model with the following weighted average assumptions: expected term of 7 years; expected volatility of 77.0%; risk-free interest rate of 3.9%; and no dividend yield. As of October 1, 2023, the fair value of the warrant was $7.7 million, and the Company recorded the adjustment of $12.7 million as other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive income (loss).
Series
D-7
Warrants (Converted to Common Stock Warrants)
In November 2022, the Company issued warrants to purchase 656,630 shares of Series
D-7
preferred stock (the “Series
D-7
warrants”) in conjunction with the Business Combination. The warrant contains two tranches. The first tranche of 518,752 shares of Series
D-7
preferred stock is exercisable at an exercise price of $2.50 per share upon consummation of a merger transaction, or at an exercise price of $2.04 per share upon remaining private and has an expiration date of April 2024. The second tranche of 137,878 shares of Series
D-7
preferred stock is exercisable at an exercise price of $5.00 per share upon consummation of a merger transaction, or at an exercise price of $4.09 per share upon remaining private and has an expiration date of April 2024. The fair value of the Series
D-7
warrants was $7.8 million as of December 31, 2022 and $2.4 million as of July 18, 2023 when the warrants were reclassified from redeemable convertible preferred stock warrant liability to additional
paid-in
capital, as the exercise price of the warrants is fixed at $2.50 per share of Complete Solaria Common Stock for the first tranche and $5.00 per share of Complete Solaria Common Stock for the second tranche upon the closing of the Mergers. The Series
D-7
Warrants remain outstanding as of October 1, 2023.
November 2022 Common Stock Warrants
In November 2022, the Company issued a warrant to a third-party service provider to purchase 78,962 shares of common stock in conjunction with the Business Combination. The warrant was immediately exercisable at an exercise price of $8.00 per share and had an expiration date of April 2024. In May 2023, the Company amended the warrant, modifying the shares of common stock to be purchased to 31,680, the exercise price to $0.01, and the expiration date to the earlier of October 2026 or the closing of an IPO. The impact of the modification was not material to the unaudited condensed consolidated financial statements. At issuance and upon the modification, the relative fair value of the warrant was determined to be $0.1 million using the Black-Scholes model with the following weighted average assumptions: expected term of 1.5 years; expected volatility of 78.5%; risk-free interest rate of 4.7%; and no dividend yield. The fair value of the warrant was recorded within additional
paid-in
capital on the unaudited condensed consolidated balance sheets. The warrant is not remeasured in future periods as it meets the conditions for equity classification. Upon the Closing of the Mergers, the warrant was net exercised into 31,680 shares of Complete Solaria Common Stock.
July 2023 Common Stock Warrants
In July 2023, the Company issued a warrant to a third-party service provider to purchase 38,981 shares of common stock in exchange for services provided in obtaining financing at the Closing of the Mergers. The warrant is immediately exercisable at a price of $0.01 per share and has an expiration date of July 2028. At issuance, the fair value of the warrant was determined to be $0.2 million, based on the intrinsic value of the warrant and the $0.01 per share exercise price. As the warrant is accounted for as an equity issuance cost, the warrant is recorded only within additional
paid-in
capital on the unaudited condensed consolidated balance sheets. The warrant is not remeasured in future periods as it meets the conditions for equity classification.
Warrant Consideration
In July 2023, in connection with the Mergers, the Company issued 6,266,572 warrants to purchase Complete Solaria Common Stock to holders of Legacy Complete Solaria Redeemable Convertible Preferred Stock, Legacy Complete Solaria Common Stock. The exercise price of the common stock warrants is $11.50 per share and the warrants expire 10 years from the date of the Mergers. The warrant consideration was issued as part of the close of the Mergers and was recorded within additional
paid-in
capital, net of the issuance costs of the Mergers. As of October 1, 2023, all warrants issued as warrant consideration remain outstanding.
Public, Private Placement, and Working Capital Warrants
In conjunction with the Mergers, Complete Solaria, as accounting acquirer, was deemed to assume 6,266,667 warrants to purchase FACT Class A Ordinary Shares that were held by the sponsor at an exercise price of $11.50 (“Private Placement Warrants”) and 8,625,000 warrants to purchase FACT’s shareholders FACT Class A Ordinary Shares at an exercise price of $11.50 (“Public Warrants”). Subsequent to the Mergers, the Private Placement Warrants and Public Warrants are exercisable for shares of Complete Solaria Common Stock and meet liability classification requirements since the warrants may be required to be settled in cash under a tender offer. In addition, Private Placement Warrants are potentially subject to a different settlement amount as a result of being held by the Sponsor which precludes the Private Placement Warrants from being considered indexed to the entity’s own stock. Therefore, these warrants are classified as liabilities on the unaudited condensed consolidated balance sheets.
The Company determined the Public and Private warrants to be classified as a liability and fair valued the warrants on the issuance date using the publicly available price for the warrants of $6.4 million. The fair value of these warrants was $2.4 million as of October 1, 2023, and the Company recorded the change in fair value of $4.0 million in other income (expense), net in the unaudited condensed consolidated statements of operations and comprehensive income (loss) for the thirteen and thirty-nine weeks ended October 1, 2023.
Additionally, at the closing of the Mergers, the Company issued 716,668 Working Capital warrants, which have identical terms as the Private Placement Warrants to the sponsor in satisfaction of certain liabilities of FACT. The warrants were fair valued at $0.3 million upon the closing of the Mergers, which was recorded in warrant liability on the unaudited condensed consolidated balance sheets. As of October 1, 2023, the Working Capital warrants had a fair value of $0.1 million, and the Company recorded the change in fair value of $0.2 million as other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive income (loss).
(14)
Warrants
Series B Warrants (Converted to Common Stock Warrants)
In February 2016, the Company issued a warrant to purchase 5,054 shares of Series B preferred stock (the “Series B warrant”) in connection with the 2016 Credit Facility. The Series B warrant is immediately exercisable at an exercise price of $4.30 per share and has an expiration date of February 2026. The fair value of the Series B warrant, as determined in accordance with the methodology described in Note 10 – Fair Value Measurements, was less than $0.1 million as of December 31, 2022 and December 31, 2021, respectively. The relative fair value of the Series B warrant at issuance was recorded into debt issuance costs and other non-current liabilities on the accompanying consolidated balance sheets, and changes in fair value have been recorded in other income (expense), net on the accompanying consolidated statements of operations and comprehensive loss for the years ended December 31, 2022, 2021 and 2020.
Series C Warrants (Converted to Common Stock Warrants)
In July 2016, the Company issued a warrant to purchase 148,477 shares of Series C preferred stock (the “Series C warrant”) in connection with the Series C financing. The Series C warrant agreement also provided for an additional number of Series C shares calculated on a monthly basis commencing on June 2016 based on the principal balance outstanding of the notes payable outstanding. The maximum number of shares exercisable under the Series C warrant agreement is 482,969 shares of Series C preferred stock. The Series C warrant was immediately exercisable at an exercise price of $1.00 per share and has an expiration date of July 2026. The fair value of the Series C warrant, as determined in accordance with the methodology described in Note 10 – Fair Value Measurements, was $6.3 million and $1.1 million as of December 31, 2022 and December 31, 2021, respectively. The relative fair value of the Series C warrant at issuance as recorded as Series C preferred stock issuance costs and other non-current liabilities on the accompanying consolidated balance sheets, and changes in fair value have been recorded in other income (expense), net on the accompanying consolidated statements of operations and comprehensive loss for the years ended December 31, 2022, 2021 and 2020.
Series C-1 Warrants (Converted to Common Stock Warrants)
In January 2020, the Company issued a warrant to purchase 173,067 shares of common stock in conjunction with the Series
C-1
preferred stock financing. The warrant is immediately exercisable at an exercise price of $0.01 per share and has an expiration date of January 2030. The warrant remains outstanding as of December 31, 2022. At issuance, the relative fair value of the warrant was determined to be $0.1 million using the Black-Scholes model, which was recorded within additional
paid-in
capital on the consolidated balance sheets. The warrant is not remeasured in future periods as it meets the conditions for equity classification.
SVB Common Stock Warrants
In May and August 2021, the Company issued warrants to purchase 2,472 and 2,525 shares of common stock, respectively, in conjunction with the Fifth and Sixth Amendments to the Loan and Security Agreement with Silicon Valley Bank. The warrants are immediately exercisable at exercise prices of $0.38 and $0.62 per share, respectively, and have expiration dates in 2033. The warrants remain outstanding as of December 31, 2022. At issuance, the relative fair value of the warrants were determined to be less than $0.1 million in aggregate using the Black-Scholes model, which was recorded within additional
paid-in-capital
on the accompanying consolidated balance sheets. The warrants are not remeasured in future periods as they meet the conditions for equity classification.
Promissory Notes Common Stock Warrants
In October 2021, the Company issued a warrant to purchase 24,148 shares of common stock in conjunction with the issuance of a short-term promissory note. The warrant is immediately exercisable at an exercise price of $0.01 per share and has an expiration date of October 2031. The warrant remains outstanding as of December 31, 2022. At issuance, the relative fair value of the warrant was determined to be less than $0.1 million using the Black-Scholes model, which was recorded within additional
paid-in
capital on the consolidated balance sheets. The warrant is not remeasured in future periods as it meets the conditions for equity classification.
Carlyle Warrants
In February 2022, as part of a debt financing from CRSEF Solis Holdings, LLC (“Carlyle”) (refer to Note 13 – Borrowing Arrangements), the Company issued a warrant to purchase 2,887,643 shares of common stock in conjunction with the redeemable investment in CS Solis. The warrant contains two tranches, the first of which is immediately exercisable for 1,995,870 shares. The second tranche, which was determined to be a separate unit of account, was exercisable upon a subsequent investment from Carlyle in CS Solis. No subsequent investment was made and investment period expired on December 31, 2022 and the second tranche of warrants expired prior to becoming exercisable. The vested warrant has an exercise price of $0.01 per share and has an expiration date of February 2029. The warrant remains outstanding as of December 31, 2022. At issuance, the relative fair value of the warrant was determined to be $3.4 million using the Black-Scholes model, which was recorded within additional
paid-in
capital and as a discount on the long-term debt in CS Solis on the consolidated balance sheets. The warrant is not remeasured in future periods as it meets the conditions for equity classification.
Series D-7 Warrants (Converted to Common Stock Warrants)
In November 2022, the company issued warrants to purchase 656,630 shares of Series D-7 preferred stock (the “Series D-7 warrants”) in conjunction with the merger agreement with Solaria. The warrant contains two tranches. The first tranche of 518,752 shares of Series D-7 preferred stock is exercisable at an exercise price of $2.50 per share upon consummation of a deSPAC transaction, or at an exercise price of $2.04 per share upon remaining private and has an expiration date of April 2024. The second tranche of 137,878 shares of Series D-7 preferred stock is exercisable at an exercise price of $
5.00
per share upon consummation of a deSPAC transaction, or at an exercise price of $
4.09
per share upon remaining private and has an expiration date of April 2024. The warrants remain outstanding as of December 31, 2022. The fair value of the Series D-7 warrants, as determined in accordance with the methodology described in Note 10 – Fair Value Measurements, was $
7.8
million as of December 31, 2022. All of the Series B, Series C, and Series D preferred stock warrants remained outstanding as of December 31, 2022 and December 31, 2021.
November 2022 Common Stock Warrants
In November 2022, the Company issued a warrant to a third-party service provider to purchase 38,136 shares of common stock in conjunction with the Business Combination. The warrant is immediately
exercisable at an exercise price of $8.00 per share and has an expiration date of April 2024. The warrant remains outstanding as of December 31, 2022. At issuance, the relative fair value of the warrant was determined to be $0.1 million using the Black-Scholes model, which was recorded within additional
paid-in
capital on the consolidated balance sheets. The warrant is not remeasured in future periods as it meets the conditions for equity classification.
The following assumptions were used to calculate the fair value of the common stock warrants issued:
 
    
Years Ended December 31,
     2022   2021
Expected term
  
1.5 
- 7.0 years
 
10.0 - 12.0 years
Expected volatility
  
73.0 - 78.5%
  73.0%
Risk-free interest rate
   1.9 - 4.7%   1.3% - 1.7%
Expected dividends
   0.0%   0.0%
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.23.4
Borrowing Arrangements
9 Months Ended 12 Months Ended
Oct. 01, 2023
Dec. 31, 2022
Borrowing Arrangements [Abstract]    
Borrowing Arrangements
(16)
Borrowing Arrangements
Convertible notes, net and convertible notes, net, due to related parties
As of October 1, 2023 and December 31, 2022, the Company’s convertible notes consisted of the following (in thousands):
 
    
As of
 
    
October 1,
2023
    
December 31,
2022
 
Convertible notes, net, noncurrent
     
2022 Convertible Notes
   $   —      $ 3,434  
2022 Convertible Notes due to related parties
       —        15,510  
  
 
 
    
 
 
 
Total convertible notes
   $   —      $ 18,944  
  
 
 
    
 
 
 
Convertible Promissory Notes with Ecosystem Integrity Fund II, LP.
On April 30, 2021, the Company issued a short-term Subordinated Convertible Promissory Note to Ecosystem Integrity Fund II, LP (“EIF”) for a total principal of $0.5 million plus accrued interest of 3.0% per annum due on June 30, 2021. The Note included a conversion feature which allows the holder to convert any portion of the note plus any unpaid accrued interest (“Conversion Amount”) into shares of Series
C-1
Preferred Stock on the maturity date of June 30, 2021 or thereafter. As of December 31, 2021 the principal and accrued interest remained outstanding and the holder did not elect to covert the note into Series
C-1
Preferred shares. The principal and accrued interest of $0.5 million was repaid in February 2022, and as such, the balance remaining at December 31, 2022 and thereafter remained zero.
2019-A
Convertible Notes
In 2019, the Company issued a series of convertible notes
(“2019-A
Convertible Notes”) for $0.1 million in proceeds, with immaterial debt issuance costs, and which were due and payable on demand by the holders after August 2020. The notes carried simple interest of 6.0% and contained a conversion feature whereby the notes would convert at 80% of the issuance price of the preferred shares in the next equity financing. The notes also contained other embedded features such as conversion options that were exercisable upon the occurrence of various contingencies. All of the embedded features were analyzed to determine whether they should be bifurcated and separately accounted for as a derivative. Pursuant to such analysis, the Company valued and bifurcated the share-settled redemption feature, which enabled the holders to convert the notes to the preferred shares at a predefined discount from the issuance price and recorded its initial fair value of less than $0.1 million as a discount on the convertible notes face amount. The debt discount was amortized to interest expense at a weighted-average effective interest rate of 17.6% through the maturity dates of the notes.
The fair value of the share-settled redemption feature was estimated based on a probability-weighted analysis of the discounted value of the notes converting under a Next Equity Financing, a change in control, default, or maturity, and the changes in fair value were recognized as a component of other income (expense), net in the accompanying unaudited condensed consolidated statements of operations and comprehensive income (loss). The Company recorded zero in expense during the thirteen and thirty-nine weeks ended October 1, 2023 and the three and nine months ended September 30, 2022, related to the change in the fair value of the convertible notes embedded derivative liability. The convertible notes were carried within the accompanying unaudited condensed consolidated balance sheets at their original issuance value, net of unamortized debt discount and issuance costs. In March 2022, as part of the Company’s Series D Preferred Stock issuance, the
2019-A
Convertible Notes converted into 62,500 shares of Series
D-2
redeemable convertible preferred stock. The Company recognized a gain on the conversion of less than $0.1 million in other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive income (loss). As the full carrying value of the note was converted to Series D Preferred Stock, the balance remaining for the note at December 31, 2022 and thereafter remained zero.
The Company did not recognize any interest expense related to the
2019-A
Convertible Notes during the thirteen and thirty-nine weeks ended October 1, 2023 and the three months ended September 2022. Interest expense recognized related to the
2019-A
Convertible Notes during the nine months ended September 30, 2022 was immaterial.
2020-A
Convertible Notes
In 2020, the Company issued a series of convertible notes
(“2020-A
Convertible Notes”) for $3.8 million in proceeds, with immaterial debt issuance costs, and which are due and payable on demand by the holders after April 2021. The notes carried simple interest of 2.0% and contained a conversion feature whereby the notes would convert at 80% of the issuance price of the preferred shares in the next equity financing. The notes also contained other embedded features such as conversion options that were exercisable upon the
occurrence of various contingencies. All of the embedded features were analyzed to determine whether they should be bifurcated and separately accounted for as a derivative. Pursuant to such analysis, the Company valued and bifurcated the share-settled redemption feature, which enables the holders to convert the notes to the preferred shares at a predefined discount from the issuance price and recorded its initial fair value of $0.5 million as a discount on the convertible notes face amount. The debt discount was amortized to interest expense at a weighted-average effective interest rate of 25.6% through the maturity dates of the notes.
The fair value of the share-settled redemption feature was estimated based on a probability-weighted analysis of the discounted value of the notes converting under a Next Equity Financing, a change in control, default, or maturity, and the changes in fair value were recognized as a component of other income (expense), net in the accompanying unaudited condensed consolidated statements of operations and comprehensive income (loss). The Company recorded zero in expense during the thirteen and thirty-nine weeks ended October 1, 2023 and the three and nine months ended September 30, 2022, related to the change in the fair value of the convertible notes embedded derivative liability. The convertible notes were carried within the accompanying unaudited condensed consolidated balance sheets at their original issuance value, net of unamortized debt discount and issuance costs. In March 2022, as part of the Company’s Series D Preferred Stock issuance, the
2020-A
Convertible Notes converted into 785,799 shares of
Series D-1
redeemable convertible preferred stock. The Company recognized a gain on the conversion of $0.9 million in other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive income (loss). As the full carrying value of the note was converted to Series D Preferred Stock, the balance remaining for the note at December 31, 2022 and thereafter remained zero.
The Company did not recognize any interest expense related to the
2020-A
Convertible Notes during the thirteen and thirty-nine weeks ended October 1, 2023 and the three months ended September 2022. Interest expense recognized during the nine months ended September 30, 2022 was immaterial.
2021-A
Convertible Notes
In 2020, the Company issued a series of convertible notes
(“2021-A
Convertible Notes”) for $4.3 million in proceeds, with immaterial debt issuance costs, and which are due and payable on demand by the holders after February 2022. The holders are existing investors and are not expected to demand cash settlement, as the Company expects to raise additional preferred financing under which the notes will convert into preferred shares. The notes carry simple interest of 2.0% and contained a conversion feature whereby the notes would convert at 80% of the issuance price of the preferred shares in the next equity financing. The notes also contained other embedded features such as conversion options that were exercisable upon the occurrence of various contingencies. All of the embedded features were analyzed to determine whether they should be bifurcated and separately accounted for as a derivative. Pursuant to such analysis, the Company valued and bifurcated the share-settled redemption feature, which enables the holders to convert the notes to the preferred shares at a predefined discount from the issuance price and recorded its initial fair value of $0.6 million as a discount on the convertible notes face amount. The debt discount is amortized to interest expense at a weighted-average effective interest rate of 18.1% through the maturity dates of the notes.
The fair value of the share-settled redemption feature was estimated based on a probability-weighted analysis of the discounted value of the notes converting under a Next Equity Financing, a change in control, default, or maturity, and the changes in fair value were recognized as a component of other income (expense), net in the unaudited condensed consolidated statements of operations and comprehensive income (loss). The Company recorded zero in expense during the thirteen and thirty-nine weeks ended October 1, 2023 and the three and nine months ended September 30, 2022, related to the change in the fair value of the convertible notes embedded derivative liability. The convertible notes were carried on the unaudited condensed consolidated balance sheets at their original issuance value, net of unamortized debt discount and issuance costs. In March 2022, as part of the Company’s Series D Preferred Stock issuance, the
2021-A
Convertible Notes converted into 869,640 shares of Series
D-1
redeemable convertible preferred stock. The Company recognized a gain on the conversion of $0.8 million in other income (expense), net on the
unaudited condensed consolidated statements of operations and comprehensive income (loss). As the full carrying value of the note was converted to Series D Preferred Stock, the balance remaining for the note at December 31, 2022 and thereafter remained zero.
As part of the
2021-A
Convertible Notes financing, the Company entered into an additional convertible note with an existing investor for $0.5 million. The note carries PIK interest of 3.0% and is due and payable on demand at any time after June 30, 2021. The note contains an embedded conversion feature, which allows the holder to convert the note into a fixed number of shares of Series
C-1
preferred stock at any time after June 30, 2021. The Company concluded the conversion feature is not required to be bifurcated as an embedded derivative liability, and the note is carried at its principal plus accrued PIK interest. As the full carrying value of the note was converted to Series D Preferred Stock, the balance remaining for the note at December 31, 2022 and thereafter remained zero.
The Company did not recognize any interest expense related to the
2021-A
Convertible Notes during the thirteen and thirty-nine weeks ended October 1, 2023 and the three months ended September 30, 2022. Interest expense recognized during the nine months ended September 30, 2022 was immaterial.
2022 Convertible Notes
In connection with the Original Business Combination Agreement, the Company has raised a series of convertible notes (“2022 Convertible Notes”) during the fiscal year ended December 31, 2022 with an aggregate purchase price of $12.0 million, and during the thirty-nine weeks ended October 1, 2023 for an additional total purchase price of $21.3 million. Additionally, as part of the acquisition of Solaria, the Company assumed a note from an existing investor for its fair value of $6.7 million. The note contained the same terms as the other 2022 Convertible Notes. The Company did not incur significant issuance costs associated with the 2022 Convertible Notes. The 2022 Convertible Notes accrued interest at a rate of 5% per annum. Immediately prior to the closing of the Mergers, the 2022 Convertible Notes were converted into the number of shares of common stock of Complete Solaria equal to (x) the principal amount together with all accrued interest of the 2022 Convertible Notes divided by 0.75, divided by (y) the price of a share of common stock of Complete Solaria used to determine the conversion ratio in the Amended and Restated Business Combination Agreement. This resulted in the issuance of 5,316,460 shares of Complete Solaria common stock to the noteholders and no debt remains outstanding associated with the 2022 Convertible Notes as of October 1, 2023.
The Company has recognized interest expense of less than $0.1 million and $0.7 million related to the 2022 Convertible Notes during the thirteen and thirty-nine weeks ended October 1, 2023. The Company did not recognize any interest expense related to the 2022 Convertible Notes during the three and nine months ended September 30, 2022.
SAFE Agreements
2019 SAFE
In September 2019, the Company issued the 2019 SAFE for $0.1 million in proceeds, with immaterial debt issuance costs. No interest was accrued on the 2019 SAFE. The 2019 SAFE contained conversion features that allowed the holder to convert the 2019 SAFE into shares of preferred stock upon the next equity financing, subject to a valuation cap. The 2019 SAFE was reported at fair value based on the probability-weighted expected return method (“PWERM”), which assigns value to the multiple settlement scenarios based on the probability of occurrence. The fair value of the 2019 SAFE was $0.2 million as of December 31, 2021 was recorded in SAFE Agreements in the accompanying unaudited condensed consolidated balance sheets. In March 2022, the Company converted the 2019 SAFE into 48,258 shares of Series
D-3
redeemable convertible preferred stock. The Company recognized a gain on the conversion of the 2019 SAFE of less than $0.1 million in other income (expense), net on the unaudited condensed
consolidated statements of operations and comprehensive income (loss). As the full carrying value of the SAFE was converted to Series D Preferred Stock, the balance remaining for the SAFE at December 31, 2022 and thereafter remained zero.
2021 SAFE
In December 2021, the Company issued the 2021 SAFE for $5.0 million in proceeds, with immaterial debt issuance costs. No interest is accrued on the 2021 SAFE. The 2021 SAFE contained conversion features that allowed the holder to convert the 2021 SAFE into shares of preferred stock upon the next equity financing, subject to a valuation cap. The 2019 SAFE was reported at fair value based on the PWERM, which assigns value to the multiple settlement scenarios based on the probability of occurrence. The fair value of the 2021 SAFE was $6.3 million as of December 31, 2021 is recorded in SAFE Agreements in the accompanying unaudited condensed consolidated balance sheets. In March 2022, the Company converted the 2021 SAFE into 1,005,366 shares of Series
D-1
redeemable convertible preferred stock. The Company recognized a gain on the conversion of the 2021 SAFE of $1.4 million in other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive income (loss). As the full carrying value of the SAFE was converted to Series D Preferred Stock, the balance remaining for the SAFE at December 31, 2022 and thereafter remained zero.
Solaria SAFE
As part of the acquisition of Solaria (refer to Note 6 – Business Combination) the Company acquired the Solaria SAFEs. The number of shares to be issued upon conversion of the SAFE notes contained various features to convert or redeem the Solaria SAFEs in the event of an equity financing, public offering, change of control or a dissolution event.
The Company historically elected to account for all of the SAFE notes at estimated fair value pursuant to the fair value option and recorded the change in estimated fair value as other income (expense), net in the unaudited condensed consolidated statements of operations and comprehensive income (loss) until the notes are converted or settled. The SAFE notes were amended through the SAFE Assumption Amendment, Assignment and Assumption Agreement on November 4, 2022, as part of the Business Combination with Complete Solar, whereby all the SAFE notes were assumed by Complete Solar. As part of the purchase price accounting discussed in Note 4 – Reverse Recapitalization, the estimated fair value of the SAFE notes was determined to be $60.5 million. Post consummation of the Business Combination the SAFE notes were converted to 8,171,662 shares of Series
D-8
preferred stock as discussed in Note 6 – Business Combination.
Notes Payable
Loan and Security Agreement
In January 2020, the Company entered into the Loan Agreement with SVB. The Loan Agreement, as amended, provided for a line of credit up to $7.0 million and has a maturity date of February 2022. Advances under the line of credit bore interest at the greater of 5.25% or the prime rate (as published in the Wall Street Journal) plus 3.5% per annum. All borrowings under the line of credit were to be secured by substantially all of the Company’s assets.
During 2021, the Company entered into several amendments to the Loan Agreement, and in May and August 2021 in connection with the Fifth and Sixth Amendments, the Company issued warrants to purchase 5,122 shares and 5,229 shares of common stock at exercise prices of $0.38 per share and $0.62 per share, respectively. The fair value of the warrants were recorded as deferred issuance costs and amortized to interest expense. As of December 31, 2022 and thereafter, there were no unamortized debt issuance costs.
Under the Loan Agreement, the Company was subject to certain reporting covenants, such as a requirement for the Company’s monthly unaudited condensed consolidated financial statements and compliance certificate, as well as a financial covenant to maintain a minimum liquidity ratio of 1.75 to 1.00. In 2021, the Loan Agreement was amended to add a new financial covenant, requiring the Company to obtain new equity of at least $15.0 million by a specified date, which the Company did not meet; however, the default was later waived by SVB.
In February 2022, as part of the transaction to raise long-term debt in CS Solis, the Company repaid the principal and accrued interest of the Loan Agreement of $6.7 million, which terminated the agreement with SVB. As such, as of December 31, 2022 and thereafter, there was no debt related to this agreement on the Company’s balance sheet.
2021 Promissory Notes
In July 2021, the Company issued a short-term promissory note for $0.5 million in proceeds, with immaterial debt issuance costs. The promissory note carried simple interest of 2.0% and were due and payable after February 2022. In February 2022, the Company repaid the 2021 Promissory Note.
In October 2021, the Company issued a short-term promissory note for $2.0 million in proceeds, with immaterial debt issuance costs. The promissory note contained a financing fee of $0.3 million, which was due and payable along with the principal amount in January 2022. In connection with the promissory note, the Company issued a warrant to purchase 50,000 shares of common stock at an exercise price of $0.01 per share. The principal and accrued interest of the note payable was repaid in January 2022, and no amounts remained outstanding as of December 31, 2022 and thereafter.
Current Insight Promissory Note
In January 2021, the Company issued a promissory note for a principal amount of $0.1 million in connection with the purchase of Current Insight, with immaterial debt issuance costs. The promissory note bears interest at 0.14% per annum and has equal monthly installments due and payable through the maturity date of January 2022. The principal and accrued interest was repaid in January 2022, and no amounts remained outstanding as of December 31, 2022 and thereafter.
2018 Bridge Notes
In December 2018, Solaria Corporation issued senior subordinated convertible secured notes (“2018 Notes”) totaling approximately $3.4 million in exchange for cash. The notes bear interest at the rate of 8% per annum and the investors are entitled to receive twice of the face value of the notes at maturity. The 2018 Notes are secured by substantially all of the assets of Solaria Corporation. In 2021, the 2018 Notes were amended extending the maturity date to December 13, 2022. In connection with the 2021 amendment, Solaria had issued warrants to purchase shares of Series
E-1
redeemable convertible preferred stock of Solaria. The warrants were exercisable immediately in whole or in part at and expire on December 13, 2031. As part of the Business Combination with Complete Solar, all the outstanding warrants issued to the lenders were assumed by the parent company, Complete Solaria as discussed in Note 6 – Business Combination.
In December 2022, the Company entered into an amendment to the 2018 Bridge Notes extending the maturity date from December 13, 2022 to December 13, 2023. In connection with the amendment, the notes will continue to bear interest at 8% per annum and are entitled to an increased repayment premium from 110% to 120% of the principal and accrued interest at the time of repayment.
The Company concluded that the modification was a troubled debt restructuring as the Company was experiencing financial difficulty and the amended terms resulted in a concession to the Company. As the future undiscounted cash payments under the modified terms exceeded the carrying amount of the Solaria
Bridge Notes on the date of modification, the modification was accounted for prospectively. The incremental repayment premium is being amortized to interest expense using the effective interest rate method. As of October 1, 2023 and December 31, 2022, the carrying value of the Bridge Notes was $10.7 million and $9.8 million, respectively. Interest expense recognized for the thirteen and thirty-nine weeks ended October 1, 2023 was $0.3 million and $1.0 million, respectively. The Company did not recognize any interest expense related to the 2018 Bridge Notes during the three and nine months ended September 30, 2022. As of October 1, 2023, the carrying value of the 2018 Bridge Notes approximates their fair value.
SCI Term Loan and Revolver Loan
In October 2020, Solaria entered into a loan agreement (“SCI Loan Agreement”) with Structural Capital Investments III, LP (“SCI”).
The SCI Loan Agreement comprises of two facilities, a term loan (the “Term Loan”) and a revolving loan (the “Revolving Loan”) (together “Original Agreement”) for $5.0 million each with a maturity date of October 31, 2023. Both the Term Loan and the Revolving Loan were fully drawn upon closing. The Term Loan was repaid prior to the acquisition of Solaria by Complete Solar and was not included in the Business Combination.
The Revolving Loan also has a term of
thirty-six
months, principal repayments at the end of the term and an annual interest rate of 7.75% or Prime rate plus 4.5%, whichever is higher. The SCI Loan Agreement required the Company to meet certain financial covenants relating to maintenance of specified restricted cash balance, achieving specified revenue target and maintaining specified contribution margin (“Financial Covenants”) over the term of each of the Revolving Loan. The Revolving Loan is collateralized substantially by all assets and property of the Company.
In the years ended December 31, 2022 and December 31, 2021, Solaria entered into several Amended and Restated Loan and Security Agreements as a forbearance agreement for SCI to forbear from exercising any rights and remedies available to it as a result of Company not meeting certain Financial Covenants required by the Original Agreement. As a result of these amendment changes were made to the Financial Covenants and Solaria recorded a total of $1.9 million amendment fees in Other Liabilities and was included in the acquired liabilities for purchase price accounting.
Solaria had historically issued warrants to purchase shares of Series
E-1
redeemable convertible preferred stock of Solaria (“SCI Series
E-1
warrants”). The warrants were fully exercisable in whole or in part at any time during the term of the Original agreement. As part of the Business Combination with Complete Solar, all the outstanding SCI Series
E-1
warrants were assumed by the parent company, Complete Solaria as discussed in Note 6 – Business Combination.
The Revolving Loan outstanding on the date of the Business Combination was fair valued at $5.0 million for the purpose of purchase price accounting discussed in Note 6 – Business Combination. The Revolving Loan principal balance at October 1, 2023 and December 31, 2022 amounted to $5.0 million. Interest expense recognized for the thirteen and thirty-nine weeks ended October 1, 2023 was $0.2 million and $0.5 million, respectively. The Company was in compliance with all the Financial Covenants as of October 1, 2023. In October 2023, the Company entered into an Assignment and Acceptance Agreement whereby Structural Capital Investments III, LP assigns the SCI debt to Kline Hill Partners Fund LP, Kline Hill Partners IV SPV LLC, Kline Hill Partners Opportunity IV SPV LLC, and Rodgers Massey Revocable Living Trust for a total purchase price of $5.0 million, as discussed in Note 22 – Subsequent Events.
Secured Credit Facility
In December 2022, the Company entered into a secured credit facility agreement with Kline Hill Partners IV SPV LLC and Kline Hill Partners Opportunity IV SPV LLC. The secured credit facility agreement allows
the Company to borrow up to 70% of the net amount of its eligible vendor purchase orders with a maximum amount of $10.0 million at any point in time. The purchase orders are backed by relevant customer sales orders which serves as a collateral. The amounts drawn under the secured credit facility may be reborrowed provided that the aggregate borrowing does not exceed $20.0 million. The repayment under the secured credit facility is the borrowed amount multiplied by 1.15x if repaid within 75 days and borrowed amount multiplied by 1.175x if repaid after 75 days. The Company may prepay any borrowed amount without premium or penalty. Under the original terms, the secured credit facility agreement was due to mature in April 2023. The Company is in the process of amending the secured credit facility agreement to extend its maturity date.
At October 1, 2023, the outstanding net debt amounted to $11.7 million, including accrued financing cost of $4.1 million, compared to December 31, 2022, where the outstanding net debt amounted to $5.6 million, including accrued financing cost of $0.1 million. The Company has recognized interest expense of zero and $3.1 million related to the Secured Credit Facility during the thirteen and thirty-nine weeks ended October 1, 2023, respectively. The Company did not recognize any interest expense related to the Secured Credit Facility during the three and nine months ended September 30, 2022. As of October 1, 2023, the total estimated fair value of the Secured Credit Facility approximates its carrying value.
Polar Settlement Agreement
In September 2023, in connection with the Mergers, the Company entered into a settlement and release agreement with Polar Multi-Strategy Master Fund (“Polar”) for the settlement of a working capital loan that had been made by Polar to the Sponsor, prior to the closing of the Mergers. As part of the settlement agreement, the Company agreed to pay Polar $0.5 million as a return of capital, which is paid in ten equal monthly installments and does not accrue interest. During the thirteen and thirty-nine weeks ended October 1, 2023, the Company made one payment of less than $0.1 million, and as of October 1, 2023, and $0.5 million remains outstanding.
Debt in CS Solis
As described above, as part of the reorganization in February 2022 of the Company, the Company received an investment from Carlyle. The investment was made pursuant to a subscription agreement, under which Carlyle contributed $25.6 million in exchange for 100 Class B Membership Units of CS Solis and the Company contributed the net assets of Complete Solar, Inc. in exchange for 100 Class A Membership Units. The Class B Membership Units are mandatorily redeemable by the Company on the three-year anniversary of the effective date of the CS Solis amended and restated LLC agreement (February 14, 2025). The Class B Membership Units accrue interest that is payable upon redemption at a rate of 10.5% (which is structured as a dividend payable based on 25% of the investment amount measured quarterly), compounded annually, and subject to increases in the event the Company declares any dividends. In connection with the investment, the Company issued a warrant to purchase 5,978,960 shares of the Company’s common stock at a price of $0.01 per share, of which, 4,132,513 shares are immediately exercisable. The Company has accounted for the mandatorily redeemable investment from Carlyle in accordance with ASC 480, Distinguishing Liabilities from Equity, and has recorded the investment as a liability, which was accreted to its redemption value under the effective interest method. The Company has recorded the warrants as a discount to the liability. Refer to Note 14 – Common Stock, for further discussion of the warrants issued in connection with the Class B Membership Units.
On July 17 and July 18, 2023, and in connection with obtaining consent for the Mergers, Legacy Complete Solaria, FACT and Carlyle entered into an Amended and Restated Consent to the Business Combination Agreement (“Carlyle Debt Modification Agreement”) and an amended and restated warrant agreement (“Carlyle Warrant Amendment”), which modified the terms of the mandatorily redeemable investment made by Carlyle in Legacy Complete Solaria.
The Carlyle Debt Modification Agreement accelerates the redemption date of the investment, which was previously February 14, 2025 and is March 31, 2024 subsequent to the modification. Additionally, as part of the amendment, the parties entered into an amended and restated warrant agreement. As part of the Carlyle Warrant Amendment, Complete Solaria issued Carlyle a warrant to purchase up to 2,745,879 shares of Complete Solaria Common Stock at a price per share of $0.01, which is inclusive of the outstanding warrant to purchase 1,995,879 shares at the time of modification. The warrant, which expires on July 18, 2030, provides Carlyle with the right to purchase shares of Complete Solaria Common Stock based on (a) the greater of (i) 1,995,879 shares and (ii) the number of shares equal to 2.795% of Complete Solaria’s issued and outstanding shares of common stock, on a fully-diluted basis; plus (b) on and after the date that is ten (10) days after the date of the agreement, an additional 350,000 shares; plus (c) on and after the date that is thirty (30) days after the date of the agreement, if the original investment amount has not been repaid, an additional 150,000 shares; plus (d) on and after the date that is ninety (90) days after the date of the agreement, if the original investment amount has not been repaid, an additional 250,000 shares, in each case, of Complete Solaria Common Stock at a price of $0.01 per share. The warrants are classified as liabilities under ASC 815 and are recorded within warrant liability on the unaudited condensed consolidated statements of operations and comprehensive income (loss).
The Company accounted for the modification of the long-term debt in CS Solis as a debt extinguishment in accordance with ASC 480 and ASC 470. As a result of the extinguishment, the Company recorded a loss on extinguishment, of $10.3 million, which is recorded within other expense on the unaudited condensed consolidated statements of operations and comprehensive income (loss). As of the modification date, the Company recorded the fair value of the new debt of $28.4 million as short-term debt in CS Solis, and the amount will be accreted to its redemption value of $31.9 million under the effective interest method.
The Company has recorded a liability of $29.2 million and zero included in short-term debt in CS Solis on the unaudited condensed consolidated balance sheets as of October 1, 2023 and December 31, 2022, respectively. The Company has recorded a liability of zero and $25.2 million included in long-term debt in CS Solis on the unaudited condensed consolidated balance sheets as of October 1, 2023 and December 31, 2022, respectively. The Company has recorded accretion of the liability as interest expense of $1.2 million and $2.7 million for the thirteen and thirty-nine weeks ended October 1, 2023, respectively, and made payments of interest expense of $0.2 million for each of the thirteen and thirty-nine weeks ended October 1, 2023. The Company has recorded accretion of the liability as interest expense of $0.7 million and $1.7 million for the three and nine months ended September 30, 2022, respectively. During the thirteen and thirty-nine weeks ended October 1, 2023, the Company recorded amortization of issuance costs as interest expense of less than $0.1 million and $0.7 million, respectively. During the three and nine months ended September 30, 2022, the Company recorded the amortization of issuance costs as interest expense of $0.4 million and $0.9 million, respectively. As of October 1, 2023, the total estimated fair value of the Company’s debt in CS Solis was $29.1 million, which was estimated based on Level 3 inputs.
(15)
Borrowing Arrangements
Convertible notes, net and convertible notes, net due to related parties
As of December 31, 2022 and December 31, 2021, the Company’s convertible notes consisted of the following (in thousands):
 
   
As of December 31,
 
   
2022
    
2021
 
Convertible notes, net
    
2019-A
Convertible Notes
  $ —        $ 115  
2020-A
Convertible Notes
    —          630  
2021-A
Convertible Notes
    —          1,145  
 
 
 
    
 
 
 
Convertible notes, net
    —          1,890  
 
 
 
    
 
 
 
Convertible notes, net due to related parties
    
2020-A
Convertible Notes
    —          3,260  
2021-A
Convertible Notes
    —          3,050  
Convertible Promissory Notes with Ecosystem Integrity Fund II, LP.
    —          510  
 
 
 
    
 
 
 
Convertible notes, net due to related parties
    —          6,820  
 
 
 
    
 
 
 
Convertible notes, net, noncurrent
    
2022 Convertible Notes
    3,434        —    
 
 
 
    
 
 
 
Convertible notes, net, noncurrent
    3,434        —    
 
 
 
    
 
 
 
Convertible notes, net due to related parties, noncurrent
    
2022 Convertible Notes
    15,510        —    
 
 
 
    
 
 
 
Convertible notes, net due to related parties, noncurrent
    15,510        —    
 
 
 
    
 
 
 
Total convertible notes
  $ 18,944      $ 8,710  
 
 
 
    
 
 
 
Convertible Promissory Notes with Ecosystem Integrity Fund II, LP.
On April 30, 2021, the Company issued a short-term Subordinated Convertible Promissory Note to Ecosystem Integrity Fund II, LP (“EIF”) for a total principal of $0.5 million plus accrued interest of 3.0% per annum due on June 30, 2021. The Note included a conversion feature which allows the holder to convert any portion of the note plus any unpaid accrued interest (“Conversion Amount”) into shares of Series
C-1
Preferred Stock on the maturity date of June 30, 2021 or thereafter. As of December 31, 2021 the principal and accrued interest remained outstanding and the holder did not elect to covert the note into Series
C-1
Preferred shares. The principal and accrued interest of $0.5 million was repaid in February 2022.
2019-A
Convertible Notes
In 2019, the Company issued a series of convertible notes
(“2019-A
Convertible Notes”) for $0.1 million in proceeds, with immaterial debt issuance costs, and which were due and payable on demand by the holders after August 2020. The notes carried simple interest of 6.0% and contained a conversion feature whereby the notes would convert at 80% of the issuance price of the preferred shares in the next equity financing. The notes also contained other embedded features such as conversion options that were exercisable upon the occurrence of various contingencies. All of the embedded features were analyzed to determine whether they should be bifurcated and separately accounted for as a derivative. Pursuant to such analysis, the Company valued and bifurcated the share-settled redemption feature, which enabled the holders to convert the notes to the preferred shares at a predefined discount from the issuance price and recorded its initial fair value of less than $0.1 million as a discount on the convertible notes face amount. The debt discount was amortized to interest expense at a weighted-average effective interest rate of 17.6% through the maturity dates of the notes.
The fair value of the share-settled redemption feature was determined in accordance with the methodology described in Note 8 – Fair Value Measurements, and the changes in fair value were recognized as a component of other income (expense), net in the accompanying consolidated statements of operations and comprehensive loss. The Company recorded zero, less than $0.1 million, and less than $0.1 million in expense during the years ended December 31, 2022, 2021 and 2020, respectively, related to the change in the fair value of the convertible notes embedded derivative liability. The convertible notes were carried within the accompanying consolidated balance sheets at their original issuance value, net of unamortized debt discount and issuance costs. In March 2022, as part of the Company’s Series D Preferred Stock issuance, the
2019-A
Convertible Notes converted into 62,500 shares of Series
D-2
redeemable convertible preferred stock. The Company recognized a loss on the conversion of less than $0.1 million in other income (expense), net on the consolidated statements of operations and comprehensive loss.
The net carrying amount of the convertible notes was as follows (in thousands):
 
    
As of December 31,
 
    
2022
   
2021
 
Principal
   $ 100     $ 100  
Unamortized debt discount
     —         —    
PIK interest added to principal balance
     16       15  
Conversion to Series D-2 redeemable convertible preferred stock
     (116     —    
  
 
 
   
 
 
 
Net carrying amount
   $ —       $ 115  
  
 
 
   
 
 
 
Interest expense related to the convertible notes was as follows (in thousands):
 
    
As of December 31,
 
    
2022
    
2021
    
2020
 
Amortization of debt discount
   $ —        $ —        $ 4  
PIK interest
     1        12        3  
  
 
 
    
 
 
    
 
 
 
Total
non-cash
interest expense
   $ 1      $ 12      $ 7  
  
 
 
    
 
 
    
 
 
 
2020-A
Convertible Notes
In 2020, the Company issued a series of convertible notes
(“2020-A
Convertible Notes”) for $3.8 million in proceeds, with immaterial debt issuance costs, and which are due and payable on demand by the holders after April 2021. The notes carried simple interest of 2.0% and contained a conversion feature whereby the
notes would convert at 80% of the issuance price of the preferred shares in the next equity financing. The notes also contained other embedded features such as conversion options that were exercisable upon the occurrence of various contingencies. All of the embedded features were analyzed to determine whether they should be bifurcated and separately accounted for as a derivative. Pursuant to such analysis, the Company valued and bifurcated the share-settled redemption feature, which enables the holders to convert the notes to the preferred shares at a predefined discount from the issuance price and recorded its initial fair value of $0.5 million as a discount on the convertible notes face amount. The debt discount was amortized to interest expense at a weighted-average effective interest rate of 25.6% through the maturity dates of the notes.
The fair value of the share-settled redemption feature was determined in accordance with the methodology described in Note 8 – Fair Value Measurements, and the changes in fair value were recognized as a component of other income (expense), net in the accompanying consolidated statements of operations and comprehensive loss. The Company recorded zero, less than $0.1 million, and less than $0.1 million in expense during the years ended December 31, 2022, 2021 and 2020 respectively, related to the change in the fair value of the convertible notes embedded derivative liability. The convertible notes were carried within the accompanying consolidated balance sheets at their original issuance value, net of unamortized debt discount and issuance costs. In March 2022, as part of the Company’s Series D Preferred Stock issuance, the
2020-A
Convertible Notes converted into 785,799 shares of Series
D-1
redeemable convertible preferred stock. The Company recognized a gain on the conversion of $0.9 million in other income (expense), net on the consolidated statements of operations and comprehensive loss.
The net carrying amount of the convertible notes was as follows (in thousands):
 
    
As of December 31,
 
    
2022
    
2021
 
Principal
   $ 3,784      $ 3,784  
Unamortized debt discount
     —          —    
PIK interest added to principal balance
     122        106  
Conversion to Series
D-1
redeemable convertible preferred stock
     (3,906      —    
  
 
 
    
 
 
 
Net carrying amount
   $ —        $ 3,890  
  
 
 
    
 
 
 
Interest expense related to the convertible notes was as follows (in thousands):
 
    
As of December 31,
 
    
2022
    
2021
    
2020
 
Amortization of debt discount . . . . . . . . . . . . . . . . . . . . . . . . .
   $ —        $ 281      $ 235  
PIK interest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
     16        74        32  
  
 
 
    
 
 
    
 
 
 
Total
non-cash
interest expense . . . . . . . . . . . . . . . . . . . . . . . .
   $ 16      $ 355      $ 267  
  
 
 
    
 
 
    
 
 
 
2021-A
Convertible Notes
In 2020, the Company issued a series of convertible notes
(“2021-A
Convertible Notes”) for $4.3 million in proceeds, with immaterial debt issuance costs, and which are due and payable on demand by the holders after February 2022. The holders are existing investors and are not expected to demand cash settlement, as the Company expects to raise additional preferred financing under which the notes will convert into preferred shares. The notes carry simple interest of 2.0% and contained a conversion feature whereby the notes would convert at 80% of the issuance price of the preferred shares in the next equity financing. The notes also contained other embedded features such as conversion options that were exercisable upon the occurrence of various contingencies. All of the embedded features were analyzed to determine whether they should be bifurcated and separately accounted for as a derivative. Pursuant to such analysis, the Company
valued and bifurcated the share-settled redemption feature, which enables the holders to convert the notes to the preferred shares at a predefined discount from the issuance price and recorded its initial fair value of $0.6 million as a discount on the convertible notes face amount. The debt discount is amortized to interest expense at a weighted-average effective interest rate of 18.1% through the maturity dates of the notes.
The fair value of the share-settled redemption feature was determined in accordance with the methodology described in Note 10 – Fair Value Measurements, and the changes in fair value were recognized as a component of other income (expense), net in the consolidated statements of operations and comprehensive loss. The Company recorded zero and $0.2 million and in expense during the year ended December 31, 2022 and December 31, 2021, respectively, related to the change in the fair value of the convertible notes embedded derivative liability. The convertible notes were carried on the consolidated balance sheets at their original issuance value, net of unamortized debt discount and issuance costs. In March 2022, as part of the Company’s Series D Preferred Stock issuance, the
2021-A
Convertible Notes converted into 869,640 shares of Series
D-1
redeemable convertible preferred stock. The Company recognized a gain on the conversion of $0.8 million in other income (expense), net on the consolidated statements of operations and comprehensive loss.
The net carrying amount of the convertible notes was as follows (in thousands):
 
    
As of December 31,
 
    
2022
    
2021
 
Principal
   $ 4,250      $ 4,250  
Unamortized debt discount
     —          (112
PIK interest added to principal balance
     74        57  
Conversion to Series
D-1
redeemable convertible preferred stock
     (4,324      —    
  
 
 
    
 
 
 
Net carrying amount
   $ —        $ 4,195  
  
 
 
    
 
 
 
Interest expense related to the convertible notes was as follows (in thousands):
 
    
As of December 31,
 
    
2022
    
2021
    
2020
 
Amortization of debt discount . . . . . . . . . . . . . . . . . . . . . . . . .
   $ 112      $ 454      $ —    
PIK interest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
     17        57        —    
  
 
 
    
 
 
    
 
 
 
Total
non-cash
interest expense . . . . . . . . . . . . . . . . . . . . . . . .
   $ 129      $ 511      $ —    
  
 
 
    
 
 
    
 
 
 
As part of the
2021-A
Convertible Notes financing, the Company entered into an additional convertible note with an existing investor for $0.5 million. The note carries PIK interest of 3.0% and is due and payable on demand at any time after June 30, 2021. The note contains an embedded conversion feature, which allows the holder to convert the note into a fixed number of shares of Series
C-1
preferred stock at any time after
June 30, 2021. The Company concluded the conversion feature is not required to be bifurcated as an embedded derivative liability, and the note is carried at its principal plus accrued PIK interest.
The net carrying amount of the
2021-A
convertible note without an embedded derivative liability was as follows (in thousands):
 
    
As of December 31,
 
    
2022
   
2021
 
Principal
   $ 500     $ 500  
Unamortized debt discount
     —         —    
PIK interest added to principal balance
     10       10  
Repayment of principal and accrued interest
     (510     —    
  
 
 
   
 
 
 
Net carrying amount
   $ —       $ 510  
  
 
 
   
 
 
 
Interest expense related to the note was as follows (in thousands):
 
    
As of December 31,
 
    
2022
    
2021
    
2020
 
Amortization of debt discount
   $ —        $ —        $ —    
PIK interest
     —          10        —    
  
 
 
    
 
 
    
 
 
 
Total
non-cash
interest expense
   $ —        $ 10      $ —    
  
 
 
    
 
 
    
 
 
 
2022 Convertible Notes
In connection with the Business Combination Agreement, the Company has raised a series of convertible notes (“2022 Convertible Notes”) in November 2022, December 2022, and February 2023 with additional investors, with an aggregate purchase price of $12.0 million. Additionally, as part of the acquisition of Solaria, the Company assumed a note from an existing investor for its fair value of $6.7 million. The note contains the same terms as the other 2022 Convertible Notes. The Company did not incur significant issuance costs associated with the 2022 Convertible Notes. The 2022 Convertible Notes will convert to common shares of Complete Solaria, Inc. at the close of the deSPAC transaction. The 2022 Convertible Notes accrue interest at a rate of 5% per annum. Immediately prior to the closing of the expected deSPAC transaction, the 2022 Convertible Notes will be converted into that number of shares of common stock of Complete Solaria equal to (x) the principal amount together with all accrued interest of the 2022 Convertible Notes divided by 0.75, divided by (y) the price of a share of common stock of Complete Solaria used to determine the conversion ratio in the Business Combination Agreement. As of December 31, 2022, the 2022 Convertible Notes have accrued $0.2 million. The carrying values of $15.5 million and $3.4 million are recorded within convertible notes, net due to related parties and convertible notes, net on the consolidated balance sheets, respectively, as of December 31, 2022. As of December 31, 2022, the total estimated fair value of the Company’s 2022 Convertible Notes was $19.8 million, which was estimated based on Level 3 inputs.
SAFE Agreements
2019 SAFE
In September 2019, the Company issued the 2019 SAFE for $0.1 million in proceeds, with immaterial debt issuance costs. No interest was accrued on the 2019 SAFE. The 2019 SAFE contained conversion features that allowed the holder to convert the 2019 SAFE into shares of preferred stock upon the next equity financing, subject to a valuation cap. The 2019 SAFE was reported at fair value in accordance with the methodology described in Note 8 – Fair Value Measurements. The fair value of the 2019 SAFE was $0.2 million as of December 31, 2021 which is recorded in SAFE Agreements in the accompanying consolidated balance sheets. In March 2022, the Company converted the 2019 SAFE into 48,258 shares of Series
D-3
redeemable convertible preferred stock. The Company recognized a gain on the conversion of the 2019 SAFE of less than $0.1 million in other income (expense), net on the consolidated statements of operations and comprehensive loss.
2021 SAFE
In December 2021, the Company issued the 2021 SAFE for $5.0 million in proceeds, with immaterial debt issuance costs. No interest is accrued on the 2021 SAFE. The 2021 SAFE contained conversion features that allowed the holder to convert the 2021 SAFE into shares of preferred stock upon the next equity financing, subject to a valuation cap. The 2021 SAFE was reported at fair value in accordance with the methodology described in Note 10 – Fair Value Measurements. The fair value of the 2021 SAFE was $6.3 million as of December 31, 2021 which is recorded in SAFE Agreements in the accompanying consolidated balance sheets. In
March 2022, the Company converted the 2021 SAFE into 1,005,366 shares of Series
D-1
redeemable convertible preferred stock. The Company recognized a gain on the conversion of the 2021 SAFE of $1.4 million in other income (expense), net on the consolidated statements of operations and comprehensive loss.
Solaria SAFE
As part of the acquisition of Solaria (refer to Note 4 – Business Combination) the Company acquired the Solaria SAFEs. The number of shares to be issued upon conversion of the SAFE notes contained various features to convert or redeem the Solaria SAFEs in the event of an equity financing, public offering, change of control or a dissolution event.
The Company historically elected to account for all of the SAFE notes at estimated fair value pursuant to the fair value option and recorded the change in estimated fair value as other income (expense), net in the consolidated statements of operations and comprehensive loss until the notes are converted or settled. The SAFE notes were amended through the SAFE Assumption Amendment, Assignment and Assumption Agreement on November 4, 2022, as part of the merger with Complete Solar, whereby all the SAFE notes were assumed by Complete Solar. As part of the purchase price accounting discussed in Note 4 - Business Combination, the estimated fair value of the SAFE notes was determined to be $60.5 million. Post consummation of the merger the SAFE notes were converted to 8,171,662 shares of Series
D-8
preferred stock as discussed in Note 4 - Business Combination.
Notes Payable
Loan and Security Agreement
In January 2020, the Company entered into a Loan and Security Agreement (the “Loan Agreement”) with Silicon Valley Bank (“SVB”). The Loan Agreement, as amended, provided for a line of credit up to $7.0 million and has a maturity date of February 2022. Advances under the line of credit bore interest at the greater of 5.25% or the prime rate (as published in the Wall Street Journal) plus 3.5% per annum. All borrowings under the line of credit were to be secured by substantially all of the Company’s assets. As of December 31, 2021, the Company had outstanding borrowings under the line of credit of $7.0 million.
During 2021, the Company entered into several amendments to the Loan Agreement, and in May and August 2021 in connection with the Fifth and Sixth Amendments, the Company issued warrants to purchase 5,122 shares and 5,229 shares of common stock at exercise prices of $0.38 per share and $0.62 per share, respectively. The fair value of the warrants were recorded as deferred issuance costs and amortized to interest expense. As of December 31, 2022 and December 31, 2021, there were no unamortized debt issuance costs.
Under the Loan Agreement, the Company was subject to certain reporting covenants, such as a requirement for the Company’s monthly unaudited financial statements and Compliance Certificate, as well as a financial covenant to maintain a minimum liquidity ratio of 1.75 to 1.00. In 2021, the Loan Agreement was amended to add a new financial covenant, requiring the Company to obtain new equity of at least $15.0 million by a specified date, which the Company did not meet; however, the default was later waived by SVB. The Company was in compliance with all reporting and financial covenants as of December 31, 2021.
In February 2022, as part of the transaction to raise long-term debt in CS Solis, the Company repaid the principal and accrued interest of the Loan Agreement of $6.7 million, which terminated the agreement with SVB.
2021 Promissory Notes
In July 2021, the Company issued a
short-term
promissory note for $0.5 million in proceeds, with immaterial debt issuance costs. The promissory note carried simple interest of 2.0% and were due and payable after February 2022. As of December 31, 2021, the carrying value of the promissory note was
$0.5 million and was recorded in Notes Payable in the accompanying consolidated balance sheets. In February 2022, the Company repaid the 2021 Promissory Note, and no amounts remain outstanding as of December 31, 2022.
In October 2021, the Company issued a short-term promissory note for $2.0 million in proceeds, with immaterial debt issuance costs. The promissory note contained a financing fee of $0.3 million, which was due and payable along with the principal amount in January 2022. In connection with the promissory note, the Company issued a warrant to purchase 50,000 shares of common stock at an exercise price of $0.01 per share. The fair value of the warrant was recorded as a debt discount and amortized to interest expense. As of December 31, 2021, the carrying value of the promissory note was $2.0 million, which was recorded in Notes Payable in the accompanying consolidated balance sheets, and the remaining unamortized debt discount was nil. The principal and accrued interest of the note payable was repaid in January 2022, and no amounts remain outstanding as of December 31, 2022.
Paycheck Protection Program Loan
In April 2020 and April 2021, the Company received loans in principal amounts of $0.9 million and $0.9 million, respectively, under the Paycheck Protection Program (the “PPP Loans”), which was established under the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) administered by the U.S. Small Business Administration (the “SBA”). The PPP Loans were evidenced by promissory notes and bore interest at 1% with no payments for the first 6 months. The PPP Loans were subject to partial or full forgiveness if the Company used all proceeds for eligible purposes, maintained certain employment levels and maintained certain compensation levels in accordance with and subject to the CARES Act and the rules, regulations and guidance. In June and October 2021, the principal and accrued interest on the PPP Loans were forgiven.
Current Insight Promissory Note
In January 2021, the Company issued a promissory note for principal of $0.1 million in connection with the purchase of Current Insight, with immaterial debt issuance costs. The promissory note bears interest at 0.14% per annum and has equal monthly installments due and payable through the maturity date of January 2022. As of December 31, 2021, the carrying value of the promissory note was less than $0.1 million. The principal and accrued interest was repaid in January 2022 and no amounts remain outstanding as of December 31, 2022.
The following table summarizes the Company’s outstanding notes payable (in thousands):
 
    
As of December 31,
 
    
  2022  
    
  2021  
 
Loan and Security Agreement
   $ —        $ 6,987  
2021 Promissory Notes
     —          2,500  
Current Insight Promissory Note
     —          20  
  
 
 
    
 
 
 
     —          9,507  
Less: Unamortized debt issuance costs and discounts
     —          —    
  
 
 
    
 
 
 
   $ —        $ 9,507  
  
 
 
    
 
 
 
2018 Bridge Notes
In December 2018, Solaria Corporation issued senior subordinated convertible secured notes (“2018 Notes”) totaling approximately $3.4 million in exchange for cash. The notes bear interest at the rate of 8% per annum and the investors are entitled to receive twice of the face value of the notes at maturity. The 2018 Notes are secured by substantially all of the assets of Solaria Corporation. In 2021, the 2018 Notes were amended extending the maturity date to December 13, 2022. In connection with the 2021 amendment,
Solaria had issued warrants to purchase shares of
Series E-1
redeemable convertible preferred stock of Solaria. The warrants were exercisable immediately in whole or in part at and expire on December 13, 2031. As part of the merger with Complete Solar, all the outstanding warrants issued to the lenders were assumed by the parent company, Complete Solaria as discussed in Note 4 – Business Combination.
As part of the purchase price accounting discussed in Note 4 – Business Combination, the estimated fair value of the 2018 Notes was determined to be $9.1 million.
In December 2022, the Company entered into an amendment to the 2018 Notes extending the maturity date from December 13, 2022 to December 13, 2023. In connection with the amendment, the notes will continue to bear interest at 8% per annum and are entitled to an increased repayment premium from 110% to 120% of the principal and accrued interest at the time of repayment.
The Company concluded that the modification was a troubled debt restructuring as the Company was experiencing financial difficulty and the amended terms resulted in a concession to the Company. As the future undiscounted cash payments under the modified terms exceeded the carrying amount of the Solaria 2018 Notes on the date of modification, the modification was accounted for prospectively. The incremental repayment premium is being amortized to interest expense using the effective interest rate method. As of December 31, 2022, the carrying value of the 2018 Notes was $9.8 million. Interest expense recognized from the date of the acquisition through December 31, 2022 was $0.7 million. As of December 31, 2022, the total estimated fair value of the Company’s 2018 Bridge Notes was $9.1 million, which was estimated based on Level 3 inputs.
SCI Term Loan and Revolver Loan
In October 2020, Solaria entered into a loan agreement (“Loan Agreement”) with Structural Capital Investments III, LP (“SCI”).
The Loan Agreement with SCI comprises of two facilities, a term loan (the “Term Loan”) and a revolving loan (the “Revolving Loan”) (together “Original Agreement”) for $5.0 million each with a maturity date of October 31, 2023. Both the Term Loan and the Revolving Loan were fully drawn upon closing. The Term Loan was repaid prior to the acquisition of Solaria by Complete Solar and was not included in the business combination.
The Revolving Loan also has a term of
thirty-six
months, principal repayments at the end of the term and an annual interest rate of 7.75% or Prime rate plus 4.5%, whichever is higher. The Loan Agreement required the Company to meet certain financial covenants relating to maintenance of specified restricted cash balance, achieving specified revenue target and maintaining specified contribution margin (“Financial covenants”) over the term of each of the Revolving Loan. The Revolving Loan is collateralized substantially by all assets and property of the Company.
In the years ended December 31, 2022 and December 31, 2021, Solaria entered into several Amended and Restated Loan and Security Agreements as a forbearance agreement for SCI to forbear from exercising any rights and remedies available to it as a result of Company not meeting certain Financial Covenants required by the Original Agreement. As a result of these amendment changes were made to the financial covenants and Solaria recorded a total of $1.9 million amendment fees in Other Liabilities and was included in the acquired liabilities for purchase price accounting.
Solaria had historically issued warrants to purchase shares of Series
E-1
redeemable convertible preferred stock of Solaria (“SCI Series
E-1
warrants”). The warrants were fully exercisable in whole or in part at any time during the term of the Original agreement. As part of the merger with Complete Solar, all the outstanding SCI Series
E-1
warrants were assumed by the parent company, Complete Solaria as discussed in Note 4 – Business Combination.
The Revolving loan outstanding on the date of merger was fair valued at $5.0 million for the purpose of purchase price accounting discussed in Note 3. The revolving loan principal balance at December 31, 2022 amounted to $5.0 million and is due on October 2023. Interest expense recognized from the date of merger to December 31,
2022 amounted to $0.1 million. The Company was in compliance with all the covenants as of December 31, 2022. As of December 31, 2022, the fair value of the Revolving Loan approximates its carrying value.
Secured Credit Facility
In December 2022, the Company entered into a secured credit facility agreement with Kline Hill Partners IV SPV LLC and Kline Hill Partners Opportunity IV SPV LLC. The secured credit facility agreement matures in April 2023, which allows the Company to borrow up to 70% of the net amount of its eligible vendor purchase orders with a maximum amount of $10.0 million at any point in time. The purchase orders are backed by relevant customer sales orders which serves as a collateral. The amounts drawn under the secured credit facility may be reborrowed provided that the aggregate borrowing does not exceed $20.0 million. The repayment under the secured credit facility is the borrowed amount multiplied by 1.15x if repaid within 75 days and borrowed amount multiplied by 1.175x if repaid after 75 days. The Company may prepay any borrowed amount without premium or penalty.
In December 2022, the Company borrowed an amount of $5.5 million against the secured credit facility. In February 2023, the Company made a repayment of $6.3 million which included aggregate financing cost amounting to $0.8 million. At December 31, 2022, the outstanding net Debt amounted to $5.6 million, including accrued financing cost of $0.1 million. As of December 31, 2022, the fair value of the Secured Credit Facility approximates its carrying value.
Long-term debt in CS Solis
As described above, as part of the reorganization in February 2022 of the Company, the Company received an investment from CRSEF. The investment was made pursuant to a subscription agreement, under which Carlyle contributed $25.6 million in exchange for 100 Class B Membership Units of CS Solis and the Company contributed the net assets of Complete Solar, Inc. in exchange for 100 Class A Membership. The Class B Membership Units are mandatorily redeemable by the Company on the three-year anniversary of the effective date of the CS Solis amended and restated LLC agreement (February 14, 2025). The Class B Membership Units accrue interest that is payable upon redemption at a rate of 10.5% (which is structured as a dividend payable based on 25% of the investment amount measured quarterly), compounded annually, and subject to increases in the event the Company declares any dividends. In connection with the investment, the Company issued a warrant to purchase 5,978,960 shares of the Company’s common stock at a price of $0.01 per share, of which, 4,132,513 shares are immediately exercisable. The Company has accounted for the mandatorily redeemable investment from Carlyle in accordance with ASC 480,
Distinguishing Liabilities from Equity
, and has recorded the investment as a liability, which is accreted to its redemption value under the effective interest method. The Company has recorded the warrants as a discount to the liability. Refer to Note 13 – Common Stock, for further discussion of the warrants issued in connection with the Class B Membership Units. As of December 31, 2022, the Company has recorded a liability of $25.2 million included in long-term debt in CS Solis on the consolidated balance sheets. For the year ended December 31, 2022, the Company has recorded accretion of the liability as interest expense of $2.4 million, and the Company has recorded the amortization of issuance costs as interest expense of $1.2 million. As of December 31, 2022, the total estimated fair value of the Company’s 2018 long-term debt in CS Solis was $24.0 million, which was estimated based on Level 3 inputs.
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.23.4
Stock-Based Compensation
9 Months Ended 12 Months Ended
Oct. 01, 2023
Dec. 31, 2022
Stock-Based Compensation [Abstract]    
Stock-Based Compensation
(17)
Stock-Based Compensation
In July 2023, the Company’s board of directors adopted and stockholders approved the 2023 Incentive Equity Plan (the “2023 Plan”). The 2023 Plan became effective immediately upon the closing of the Amended and Restated Business Combination Agreement. Initially, a maximum number of 8,763,322 shares of Complete Solaria Common Stock may be issued under the 2023 Plan. In addition, the number of shares of Complete Solaria Common Stock reserved for issuance under the 2023 Plan will automatically increase on January 1 of each year, starting on January 1, 2024 and ending on January 1, 2033, in an amount equal to the lesser of (1) 4% of the total number of shares of Complete Solaria’s Common Stock outstanding on December 31 of the preceding year, or (2) a lesser number of shares of Complete Solaria Common Stock determined by Complete Solaria’s Board prior to the date of the increase. The maximum number of shares of Complete Solaria Common Stock that may be issued on the exercise of ISOs under the 2023 Plan is three times the number of shares available for issuance upon the 2023 Plan becoming effective (or 26,289,966 shares).
Historically, awards were granted under the Amended and Restated Complete Solaria Omnibus Incentive Plan (“2022 Plan”), the Complete Solar 2011 Stock Plan (“2011 Plan”), the Solaria Corporation 2016 Stock Plan (“2016 Plan”) and the Solaria Corporation 2006 Stock Plan (“2006 Plan”) (together with the Complete Solaria, Inc. 2023 Incentive Equity Plan (“2023 Plan”), “the Plans”). The 2022 Plan is the successor of the Complete Solar 2021 Stock Plan, which was amended and assumed in connection with the acquisition of Solaria. The 2011 Plan is the Complete Solar 2011 Stock Plan that was assumed by Complete Solaria in the Required Transaction. The 2016 Plan and the 2006 Plan are the Solaria stock plans that were assumed by Complete Solaria in the Required Transaction.
Under the Plans, the Company has granted service and performance-based stock options and restricted stock units (“RSUs”).
A summary of stock option activity for the thirty-nine weeks ended October 1, 2023 under the Plans is as follows:
 
   
Options Outstanding
 
   
Number of
Shares
   
Weighted
Average
Exercise
Price per
Share
   
Weighted
Average
Contractual
Term
(Years)
   
Aggregate
Intrinsic
Value

(in thousands)
 
Outstanding—December 31, 2022
    4,970,419     $ 4.86       6.99     $ 34,180  
Options granted
    2,164,946       5.18      
Options exercised
    (67,292     0.83      
Options canceled
    (142,218     9.46      
 
 
 
   
 
 
   
 
 
   
 
 
 
Outstanding—October 1, 2023
    6,925,855     $ 4.91       7.80     $ 2,727  
 
 
 
   
 
 
   
 
 
   
 
 
 
Vested and expected to vest—October 1, 2023
    6,925,855     $ 4.91       7.80     $ 2,727  
 
 
 
   
 
 
   
 
 
   
 
 
 
Vested and exercisable—October 1, 2023
    3,037,856     $ 5.16       6.40     $ 2,245  
 
 
 
   
 
 
   
 
 
   
 
 
 
A summary of RSU activity for the thirty-nine weeks ended October 1, 2023 under the Plans is as follows:
 
    
Number of
RSUs
    
Weighted
Average
Grant
Date
Fair Value
 
Unvested at December 31, 2022
     —       
Granted
     728,600      $ 5.00  
Vested and released
     (155,473    $ 4.84  
Cancelled or forfeited
     (485,468    $ 5.07  
  
 
 
    
Unvested at October 1, 2023
     87,659      $ 5.07  
  
 
 
    
Stock-based compensation expense
The following table summarizes stock-based compensation expense and its allocation within the accompanying unaudited condensed consolidated statements of operations and comprehensive income (loss) (in thousands):
 
   
Thirteen
Weeks Ended
October 1,
2023
   
Three
Months Ended
September 30,
2022
   
Thirty-Nine

Weeks Ended
October 1,
2023
   
Nine
Months Ended
September 30,
2022
 
Cost of revenues
  $ 20     $ 1     $ 51     $ 6  
Sales and marketing
    143       37       337       91  
General and administrative
    1,416       47       1,933       120  
Loss from discontinued operations, net of tax
    535       —         1,835       —    
 
 
 
   
 
 
   
 
 
   
 
 
 
Total stock-based compensation expense
  $ 2,114     $ 85     $ 4,156     $ 217  
 
 
 
   
 
 
   
 
 
   
 
 
 
As of October 1, 2023, there was a total of $16.4 million and $0.2 million of unrecognized stock-based compensation costs related to service-based options and RSUs, respectively. Such compensation cost is expected to be recognized over a weighted-average period of approximately 2.13 years and 4.75 years for service-based options and RSUs, respectively.
In July 2023, the Company’s board of directors approved the modification to accelerate the vesting of 52,167 options for employees that were terminated. Additionally, at the same time, the board of directors approved an extension of the post termination exercise period for 280,412 vested options of terminated employees. In connection with the modifications, the Company recorded incremental stock-based compensation expense of $0.1 million.
(16)
Stock-Based Compensation
In 2011, the Company’s Board of Directors and stockholders approved the adoption of the 2011 Stock Plan (the “2011 Plan”). The 2011 Plan provides for the granting of incentive stock options, nonstatutory stock options, and restricted stock to employees,
non-employee
directors, and consultants of the Company. Options may be granted at a price per share not less than 100% of the fair market value at date of grant. If an incentive stock option is granted to a 10% stockholder, then the purchase or exercise price per share shall not be less than 110% of the fair market value per share of common stock on the grant date. Options granted
under the 2011 Plan continue to vest until the last day of employment and generally vest over four years and expire 10 years from the date of grant. A total of 2,596,764 shares of common stock was reserved for the 2011 Plan, as amended, as of December 31, 2022 and December 31, 2021.
In 2021, the Company’s Board of Directors and stockholders approved the adoption of the 2021 Stock Plan (the “2021 Plan”). The 2021 Plan provides for the granting of incentive stock options, nonstatutory stock options, and restricted stock to employees,
non-employee
directors, and consultants of the Company. Options may be granted at a price per share not less than 100% of the fair market value at date of grant. If an incentive stock option is granted to a 10% stockholder, then the purchase or exercise price per share shall not be less than 110% of the fair market value per share of common stock on the grant date. Options granted under the 2021 Plan continue to vest until the last day of employment and generally vest over four years and expire 10 years from the date of grant. A total of 241,484 shares of common stock was initially reserved for the 2021 Plan. Any shares of common stock that would have otherwise been returned to the Company’s 2011 Plan as a result of forfeiture, expiration, cancellation, termination or net issuances of awards thereunder shall be returned to the share reserve under the 2021 Plan.
In 2022, the Company’s Board of Directors and stockholders approved the adoption of the 2022 Stock Plan (the “2022 Plan”). The 2022 Plan provides for the granting of incentive stock options, nonstatutory stock options, and restricted stock to employees,
non-employee
directors, and consultants of the Company. Options may be granted at a price per share not less than 100% of the fair market value at date of grant. If an incentive stock option is granted to a 10% stockholder, then the purchase or exercise price per share shall not be less than 110% of the fair market value per share of common stock on the grant date. Options granted under the 2022 Plan continue to vest until the last day of employment and generally vest over four years and expire 10 years from the date of grant. A total of 3,225,237 shares of common stock was initially reserved for the 2022 Plan. Any shares of common stock that would have otherwise been returned to the Company’s 2011 Plan and 2021 Plan as a result of forfeiture, expiration, cancellation, termination or net issuances of awards thereunder shall be returned to the share reserve under the 2022 Plan. The 2011 Plan, 2021 Plan, and 2022 Plan are collectively referred to as the “Plans” in the notes to the financial statements, unless otherwise noted.
A summary of stock option activity for the years ended December 31, 2022 and December 31, 2021 under the Plans is as follows:
 
   
Options outstanding
 
   
Number of
shares
   
Weighted
average
exercise
price per
share
   
Weighted
average
contractual
term
(in years)
   
Aggregate
intrinsic

value
(in thousands)
 
Outstanding—January 1, 2021
    1,968,580     $ 0.58       7.87     $ 1,044  
Options granted
    212,434       0.89      
Options exercised
    (7,245     0.83      
Options canceled
    (38,315     0.62      
 
 
 
   
 
 
   
 
 
   
 
 
 
Outstanding—December 31, 2021
    2,135,454     $ 0.62       6.99     $ 2,263  
Options granted
    3,088,350       7.45      
Options exercised
    (162,034     0.48      
Options canceled
    (91,376     0.83      
 
 
 
   
 
 
   
 
 
   
 
 
 
Outstanding—December 31, 2022
    4,970,395     $ 4.87       6.99     $ 34,180  
 
 
 
   
 
 
   
 
 
   
 
 
 
Vested and expected to vest—December 31, 2022
    4,970,395     $ 4.87       6.99     $ 34,180  
 
 
 
   
 
 
   
 
 
   
 
 
 
Vested and exercisable—December 31, 2022
    2,794,862     $ 4.35       6.29     $ 22,204  
 
 
 
   
 
 
   
 
 
   
 
 
 
The weighted-average grant-date fair value of options granted for the years ended December 31, 2022 and December 31, 2021, was $7.99 per share and $0.72 per share, respectively. The total fair value of options vested for the years ended December 31, 2022 and December 31, 2021, was $10.5 million and $0.2 million, respectively. The aggregate intrinsic value of options exercised for the years ended December 31, 2022 and December 31, 2021, was $0.2 million and less than $0.1 million, respectively.
Determination of Fair Value
Prior to the Mergers, the Company estimated grant-date fair value of stock options using the Black-Scholes-Merton option- pricing model. The determination of the fair value of each stock award using this option-pricing model is affected by the Company’s assumptions regarding a number of complex and subjective variables. These variables include, but are not limited to, the expected stock price volatility over the term of the awards. Stock-based compensation is measured at the grant date based on the fair value of the award and is recognized as expense on a straight-line basis over the requisite service period, which is generally the vesting period of the respective award.
The following assumptions were used to calculate the fair value of stock-based compensation:
 
    
Years Ended December 31,
    
2022
  
2021
Expected term
   1.0 – 7.5 years    5.0 – 6.1 years
Expected volatility
   60.0% – 78.5%    52.6% – 56.7%
Risk-free interest rate
   3.4% – 4.8%    0.8% – 1.3%
Expected dividends
   0.0%    0.0%
Expected term
— The Company has opted to use the “simplified method” for estimating the expected term of options, whereby the expected term equals the arithmetic average of the vesting term and the original contractual term of the option (generally
10
years).
Expected volatility
— Due to the Company’s limited operating history and a lack of company specific historical and implied volatility data, the Company has based its estimate of expected volatility on the historical volatility of a group of peer companies that are publicly traded. The historical volatility data was computed using the daily closing prices for the selected companies’ shares during the equivalent period of the calculated expected term of the stock-based awards.
Risk-free interest rate
— The risk-free rate assumption is based on U.S. Treasury instruments with maturities similar to the expected term of the Company’s stock options.
Expected dividends
— The Company has not issued any dividends in its history and does not expect to issue dividends over the life of the options and therefore has estimated the dividend yield to be zero.
Fair value of common stoc
k — The fair value of the shares of common stock underlying the stock-based awards has historically been determined by the Board of Directors, with input from management. Because there has been no public market for the Company’s common stock, the Board of Directors has determined the fair value of the common stock on the grant-date of the stock-based award by considering a number of objective and subjective factors. Such factors include a valuation of the Company’s common stock performed by an unrelated third-party specialist, valuations of comparable companies, sales of the Company’s redeemable convertible preferred stock to unrelated third-parties, operating and financial performance, the lack of liquidity of the Company’s capital stock, as well as general and industry-specific economic outlooks. For financial reporting purposes, the Company considers the amount of time between the valuation date and the grant date to determine whether to use the latest common stock valuation or a straight-line interpolation between the two valuation dates. The determination included an evaluation of whether the subsequent valuation indicated that any significant change in valuation had occurred between the previous valuation and the grant date.
Stock-based compensation expense
The following table summarizes stock-based compensation expense and its allocation within the accompanying consolidated statements of operations and comprehensive loss (in thousands):
 
    
Years Ended December 31,
 
    
  2022  
    
  2021  
    
  2020  
 
Cost of revenues
   $ 22      $ 19      $ 8  
Sales and marketing
     168        68        37  
General and administrative
     243        113        64  
Loss from discontinued operations, net of tax
     470        —          —    
  
 
 
    
 
 
    
 
 
 
Total stock-based compensation expense
   $ 903      $ 200      $ 109  
  
 
 
    
 
 
    
 
 
 
As of December 31, 2022 there was a total of $
5.4
 million of unrecognized stock-based compensation costs related to
non-vested
stock option awards, which is expected to be recognized over a weighted-average period of approximately
2.2
years.
 
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.23.4
Employee Stock Purchase Plan
9 Months Ended
Oct. 01, 2023
Employee Stock Purchase Plan [Abstract]  
Employee Stock Purchase Plan
(18)
Employee Stock Purchase Plan
The Company adopted an Employee Stock Purchase Plan (the “ESPP Plan”) in connection with the consummation of the Mergers in July 2023. All qualified employees may voluntarily enroll to purchase the Company’s common stock through payroll deductions at a price equal to 85% of the lower of the fair market values of the stock of the offering periods or the applicable purchase date. As of October 1, 2023, 2,628,996 shares were reserved for future issuance under the ESPP Plan.
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.23.4
Commitments and Contingencies
9 Months Ended 12 Months Ended
Oct. 01, 2023
Dec. 31, 2022
Commitments and Contingencies [Abstract]    
Commitments and Contingencies
(19)
Commitments and Contingencies
Operating Leases
The Company leases its facilities under
non-cancelable
operating lease agreements. The Company’s leases have remaining terms of 0.3 years to 3.1 years. Options to renew or extend leases beyond their initial term have been excluded from measurement of the ROU assets and lease liabilities as exercise is not reasonably certain. Operating leases are reflected on the unaudited condensed consolidated balance sheets within operating lease ROU assets and the related current and
non-current
operating lease liabilities. ROU assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make lease payments arising from lease agreement. Operating lease ROU assets and liabilities are recognized at the commencement date, or the date on which the lessor makes the underlying asset available for use, based upon the present value of the lease payments over the respective lease term. Lease expense is recognized on a straight-line basis over the lease term, subject to any changes in the lease or expectation regarding the terms. Variable lease costs such as common area maintenance, property taxes and insurance are expensed as incurred. Variable lease cost was $0.1 million and $0.3 million for the thirteen and thirty-nine weeks ended October 1, 2023, respectively, and $0.1 million and $0.2 million for the three and nine months September 30, 2022, respectively. Total lease expense for the thirteen and thirty-nine weeks ended October 1, 2023 was $0.3 million and $1.0 million, respectively, and for the three and nine months ended September 30, 2022 was $0.2 million and $0.5 million, respectively.
The Company made $0.3 million and $0.8 million of cash payments related to operating leases during the thirteen and thirty-nine weeks ended October 1, 2023, respectively and made $0.1 million and $0.4 million of cash payments related to operating leases during the three and nine months ended September 30, 2022, respectively. New operating lease
right-of-use
assets obtained in exchange for operating lease liabilities were zero during the thirteen and thirty-nine weeks ended October 1, 2023 and zero and $0.2 million during the three and nine months ended September 30, 2022, respectively.
The weighted average remaining lease term and the discount rate for the Company’s operating leases are as follows:
 
    
October 1,
2023
Remaining average remaining lease term
   2.61 years
Weighted average discount rate
   15.20%
Future minimum lease payments under
non-cancelable
operating leases as of October 1, 2023 are as follows (in thousands):
 
2023 (excluding the thirty-nine weeks ended October 1, 2023)
   $ 263  
2024
     743  
2025
     592  
2026
     477  
2027 and thereafter
     —    
  
 
 
 
Total undiscounted liabilities
     2,075  
  
 
 
 
Less: imputed interest
     (565
  
 
 
 
Present value of operating lease liabilities
   $ 1,510  
  
 
 
 
Warranty Provision
The Company typically provides a
10-year
warranty on its solar energy system installations, which provides assurance over the workmanship in performing the installation, including roof leaks caused by the Company’s performance. For solar panel sales, the Company provides a
30-year
warranty that the products will be free from defects in material and workmanship. The Company will retain its warranty obligation associated with its panel sales, subsequent to the disposal of its panel business.
The Company accrues warranty costs when revenue is recognized for solar energy systems sales and panel sales, based primarily on the volume of new sales that contain warranties, historical experience with and projections of warranty claims, and estimated solar energy system and panel replacement costs. The Company records a provision for estimated warranty expenses in cost of revenues within the accompanying unaudited condensed consolidated statements of operations and comprehensive income (loss). Warranty costs primarily consist of replacement materials and equipment and labor costs for service personnel.
Activity by period relating to the Company’s warranty provision was as follows (in thousands):
 
    
Thirty-Nine

Weeks Ended
October 1,
2023
    
Year Ended
December 31,
2022
 
Warranty provision, beginning of period
   $ 3,981      $ 2,281  
Warranty liability from Business Combination
     —          1,943  
Accruals for new warranties issued
     2,100        1,492  
Settlements
     (2,060      (1,735
  
 
 
    
 
 
 
Warranty provision, end of period
   $ 4,021      $ 3,981  
  
 
 
    
 
 
 
Warranty provision, current
   $ 605      $ 767  
Warranty provision, noncurrent
   $ 3,416      $ 3,214  
Indemnification Agreements
From time to time, in its normal course of business, the Company may indemnify other parties, with which it enters into contractual relationships, including customers, lessors, and parties to other transactions with the Company. The Company may agree to hold other parties harmless against specific losses, such as those that could arise from breach of representation, covenant or third-party infringement claims. It may not be Possible to determine the maximum potential amount of liability under such indemnification agreements due to the unique facts and circumstances that are likely to be involved in each particular claim and indemnification provision. Historically, there have been no such indemnification claims. In the opinion of management, any liabilities resulting from these agreements will not have a material adverse effect on the business, financial position, results of operations, or cash flows.
Legal Matters
The Company is a party to various legal proceedings and claims which arise in the ordinary course of business. The Company records a liability when it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. If the Company determines that a loss is reasonably possible and the loss or range of loss can be reasonably estimated, the Company discloses the reasonably possible loss. The Company adjusts its accruals to reflect the impact of negotiations, settlements, rulings, advice of legal counsel and other information and events pertaining to a particular case. Legal costs are expensed as incurred. Although claims are inherently unpredictable, the Company is not aware of any matters that have a material adverse effect on the business, financial position, results of operations, or cash flows. The Company has recorded $3.0 million and $1.9 million as a loss contingency in accrued expenses and other current liabilities on the unaudited condensed consolidated balance sheets as of October 1, 2023 and December 31, 2022, respectively, primarily associated with the pending settlement of the following legal matters.
Katerra Litigation
On July 22, 2022, Katerra, Inc. filed a complaint for breach of contract and turnover of property under Section 542(b) of the Bankruptcy Code in the United States Bankruptcy Court for the Southern District of Texas. The complaint seeks damages for the amounts due under the Settlement Agreement and for attorney’s fees. The Company filed an answer to the complaint on September 6, 2022. On May 11, 2023, the parties reached a settlement in which Solaria agreed to pay Katerra $0.8 million, paid in monthly payments beginning on May 25, 2023 and ending by October 25, 2023. As of October 1, 2023, the remaining balance of payments owed in relation to the settlement was $0.1 million.
SolarPark Litigation
In January 2023, SolarPark Korea Co., LTD (“SolarPark”) demanded approximately $80.0 million during discussions between the Company and SolarPark. In February 2023, the Company submitted its statement of claim seeking approximately $26.4 million in damages against SolarPark. The ultimate outcome of this arbitration is currently unknown and could result in a material liability to the Company. However, the Company believes that the allegations lack merit and intends to vigorously defend all claims asserted. No liability has been recorded in the Company’s unaudited condensed consolidated financial statements as the likelihood of a loss is not probable at this time.
On March 16, 2023, SolarPark filed a complaint against Solaria and the Company in the United States District Court for the Northern District of California (“the court”). The complaint alleges a civil conspiracy involving misappropriation of trade secrets, defamation, tortious interference with contractual relations, inducement to breach of contract, and violation of California’s Unfair Competition Law. The complaint indicates that SolarPark has suffered in excess of $220.0 million in damages.
On May 11, 2023, SolarPark filed a motion for preliminary injunction to seek an order restraining the Company from using or disclosing SolarPark’s trade secrets, making or selling shingled modules other than those produced by SolarPark, and from soliciting solar module manufacturers to produce shingled modules using Solaria’s shingled patents. On May 18, 2023, the Company responded by filing a motion for partial dismissal and stay. On June 1, 2023, SolarPark filed an opposition to the Company’s motion for dismissal and stay and a reply in support of their motion for preliminary injunction. On June 8, 2023, the Company replied in support of its motion for partial dismissal and stay. On July 11, 2023, the court conducted a hearing to consider SolarPark and the Company’s respective motions. On August 3, 2023, the court issued a ruling, which granted the preliminary injunction motion with respect to any purported misappropriation of SolarPark’s trade secrets. The court’s ruling does not prohibit the Company from producing shingled modules or from utilizing its own patents for the manufacture of shingled modules. The court denied SolarPark’s motion seeking a defamation injunction. The court denied the Company’s motion to dismiss and granted the Company’s motion to stay the entire litigation pending the arbitration in Singapore. On September 1, 2023, the Company filed a Limited Notice of Appeal to appeal the August 2023 order granting SolarPark’s motion for preliminary injunction. On September 26, 2023, Solaria filed a Notice of Withdrawal of Appeal and will not appeal the Court’s Preliminary Injunction Order. No liability has been recorded in the Company’s unaudited condensed consolidated financial statements as the likelihood of a loss is not probable at this time.
Siemens Litigation
On July 22, 2021, Siemens filed a lawsuit for breach of contract and warranty against the Company and demanded $6.9 million plus legal fees. The case is currently in trial. The Company has recorded $2.0 million and zero as a loss contingency related to this litigation in accrued expenses and other current liabilities on the unaudited condensed consolidated balance sheets as of October 1, 2023 and December 31, 2022, respectively.
China Bridge Litigation
On August 24 2023, China Bridge Capital Limited (“China Bridge”) alleged breach of contract and demanded $6.0 million. The complaint names FACT as the defendant. The complaint alleges China Bridge and FACT entered into a financial advisory agreement in October 2022 whereby FACT engaged China Bridge to advise and assist FACT in identifying a company for FACT to acquire. As part of the agreement, China Bridge claims that FACT agreed to pay China Bridge a $6.0 million advisory fee if FACT completed such an acquisition. China Bridge claims it introduced Complete Solaria to FACT and is therefore owed the $6.0 million advisory fee. The Company believes that the allegations lack merit and intends to vigorously defend all claims asserted. No liability has been recorded in the Company’s unaudited condensed consolidated financial statements as the likelihood of a loss is not probable at this time.
Letters of Credit
The Company had $3.5 million of outstanding letters of credit related to normal business transactions as of October 1, 2023. These agreements require the Company to maintain specified amounts of cash as collateral in segregated accounts to support the letters of credit issued thereunder. As discussed in Note 2 – Summary of Significant Accounting Policies, the cash collateral in these restricted cash accounts was $3.8 million and $3.9 million as of October 1, 2023 and December 31, 2022, respectively.
(17)
Commitments and Contingencies
Operating Leases
The Company leases its facilities under
non-cancelable
operating lease agreements. The Company’s leases have remaining terms of 0.3 years to 3.8 years. Options to renew or extend leases beyond their initial term have been excluded from measurement of the ROU assets and lease liabilities as exercise is not reasonably certain. Operating leases are reflected on the consolidated balance sheets within operating lease ROU assets and the related current and
non-current
operating lease liabilities. ROU assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make lease payments arising from lease agreement. Operating lease ROU assets and liabilities are recognized at the commencement date, or the date on which the lessor makes the underlying asset available for use, based upon the present value of the lease payments over the respective lease term. Lease expense is recognized on a straight-line basis over the lease term, subject to any changes in the lease or expectation regarding the terms. Variable lease costs such as common area maintenance, property taxes and insurance are expensed as incurred. Variable lease cost was $0.2 million for the year ended December 31, 2022 and immaterial for the year ended December 31, 2021. Total operating lease expense for the years ended December 31, 2022 and December 31, 2021 was $0.7 million and $0.4 million, respectively.
The Company made $1.0 million and $0.4 million of cash payments related to operating leases during the years ended December 31, 2022 and December 31, 2021, respectively. New operating lease
right-of-use
assets obtained in exchange for operating lease liabilities were $1.9 million and $1.2 million during the years ended December 31, 2022 and December 31, 2021, respectively, including the impact of adopting ASC 842. On the date of adoption, January 1, 2021, the Company recognized right-of-use assets of approximately $1.1 million and lease liabilities of approximately $1.2 million, of which $0.4 million was included in accrued and other current liabilities and $0.8 million was included in operating lease liabilities, net of current portion on the consolidated balance sheets.
The weighted average remaining lease term and the discount rate for the Company’s operating leases are as follows:
 
    
December 31, 2022
 
Remaining average remaining lease term (years)
     3.24  
Weighted average discount rate
     14.47
Future minimum lease payments under
non-cancelable
operating leases, and future payments under the Lease Termination Agreement, as of December 31, 2022 are as follows (in thousands):
 
2023
   $ 1,048  
2024
     743  
2025
     592  
2026
     477  
2027 and thereafter
     —    
  
 
 
 
Total undiscounted liabilities
     2,860  
  
 
 
 
Less imputed interest
     (628
  
 
 
 
Present value of operation lease liabilities
   $ 2,232  
  
 
 
 
Accounting under ASC 840
Prior to the adoption of ASC 842, rent expense on operating leases was recognized on a straight-line basis over the term of the lease. In addition, certain of the Company’s operating lease agreements for facilities also include rent escalations or rent abatements during the initial lease term. The Company recorded the rent escalations as deferred rent, net of current portion on the accompanying balance sheets. The Company recognized the deferred rent liability on a straight-line basis into rent expense over the lease term commencing on the date the Company took possession of the leased space. Rent expense was $0.3 million for the year ended December 31, 2020.
Warranty Provision
The Company accrues warranty costs when revenue is recognized for solar energy systems sales and panel sales, based on the estimated future costs of meeting its warranty obligations. Warranty costs primarily consist of replacement materials and equipment and labor costs for service personnel.
Activity by period relating to the Company’s warranty provision was as follows:
 
    
Years Ended December 31,
 
    
2022
    
2021
    
2020
 
Warranty provision, beginning of period
   $ 2,281      $ 1,652      $ 1,816  
Warranty liability from the Business Combination
     1,943        
Accruals for new warranties issued
     1,492        1,516        607  
Settlements
     (1,735      (887      (771
  
 
 
    
 
 
    
 
 
 
Warranty provision, end of period
   $ 3,981      $ 2,281      $ 1,652  
  
 
 
    
 
 
    
 
 
 
Warranty provision, current
   $ 767      $ 600      $ 497  
Warranty provision, noncurrent
   $ 3,214      $ 1,681      $ 1,155  
Indemnification Agreements
From time to time, in its normal course of business, the Company may indemnify other parties, with which it enters into contractual relationships, including customers, lessors, and parties to other transactions with the Company. The Company may agree to hold other parties harmless against specific losses, such as those that could arise from breach of representation, covenant or third-party infringement claims. It may not be possible to determine the maximum potential amount of liability under such indemnification agreements due to the unique facts and circumstances that are likely to be involved in each particular claim and indemnification provision. Historically, there have been no such indemnification claims. In the opinion of management, any liabilities resulting from these agreements will not have a material adverse effect on the business, financial position, results of operations, or cash flows.
Legal Matters
The Company is a party to various legal proceedings and claims which arise in the ordinary course of business. The Company records a liability when it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. If the Company determines that a loss is reasonably possible and the loss or range of loss can be reasonably estimated, the Company discloses the reasonably possible loss. The Company adjusts its accruals to reflect the impact of negotiations, settlements, rulings, advice of legal counsel and other information and events pertaining to a particular case. Legal costs are expensed as incurred. Although claims are inherently unpredictable, the Company is not aware of any matters that have a material adverse effect on the business, financial position, results of operations, or cash flows. The Company has recorded $1.9 million and $0.2 million as a loss contingency in accrued expenses and other current liabilities on the consolidated balance sheets as of December 31, 2022 and December 31, 2021, respectively, primarily associated with the pending settlement of the following legal matters.
Katerra Litigation
On July 22, 2022, Katerra, Inc. filed a complaint for breach of contract and turnover of property under Section 542(b) of the Bankruptcy Code in the United States Bankruptcy Court for the Southern District of Texas. The complaint seeks damages for the amounts due under the Settlement Agreement and for attorney’s fees. The Company filed an answer to the complaint on September 6, 2022. No discovery has occurred.
Vendor Settlement
On January 10, 2023, a vendor entered into an agreement with the Company to settle past due performance related payments related to various tools. As part of the agreement, the Company agreed to pay $0.9 million in three equal installments. The Company paid the first installment on January 12, 2023 and will pay the second and third installments on March 31, 2023 and June 30, 2023, respectively.
SolarPark Litigation
In January 2023, SolarPark Korea Co., LTD (“
SolarPark
”) demanded approximately $80.0 million during discussions between the Company and SolarPark. In February 2023, the Company submitted its statement of claim seeking approximately $26.4 million in damages against SolarPark. The ultimate outcome of this arbitration is currently unknown and could result in a material liability to the Company. However, the Company believes that the allegations lack merit and intends to vigorously defend all claims asserted. No liability has been recorded in the Company’s consolidated financial statements as the likelihood of a loss is not probable at this time.
On March 16, 2023, SolarPark filed a complaint against Solaria and the Company in the United States District Court for the Northern District of California. The complaint alleges a civil conspiracy involving misappropriation of trade secrets, defamation, tortious interference with contractual relations, inducement to breach of contract, and violation of California’s Unfair Competition Law. The complaint indicates that SolarPark has suffered in excess of $220 million in damages. The ultimate outcome of this litigation is currently unknown and could result in a material liability to the Company. However, the Company believes that the allegations lack merit and intends to vigorously defend all claims asserted. No liability has been recorded in the Company’s consolidated financial statements as the likelihood of a loss is not probable at this time.
Letters of Credit
The Company had $3.5 million of outstanding letters of credit related to normal business transactions as of December 31, 2022. These agreements require the Company to maintain specified amounts of cash as collateral in segregated accounts to support the letters of credit issued thereunder. As discussed in Note 1, the cash collateral in these restricted cash accounts was $3.7 million as of December 31, 2022. The Company did not have any outstanding letters of credit as of December 31, 2021.
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.23.4
Income Taxes
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Income Taxes
(18)
Income Taxes
The provision for income taxes consisted of the following (in thousands):
 
    
Years Ended December 31,
 
    
  2022  
    
  2021  
    
  2020  
 
Current:
        
Federal
   $ —        $ —        $ —    
State
     27        3        3  
Foreign
     —          —          —    
  
 
 
    
 
 
    
 
 
 
Total current
   $ 27      $ 3      $ 3  
  
 
 
    
 
 
    
 
 
 
Deferred:
        
Federal
   $ —        $ —        $ —    
State
     —          —          —    
Foreign
     —          —          —    
  
 
 
    
 
 
    
 
 
 
Total deferred
     —          —          —    
  
 
 
    
 
 
    
 
 
 
Total provision
   $ 27      $ 3      $ 3  
  
 
 
    
 
 
    
 
 
 
The reconciliation of federal statutory income tax rate to our effective income tax rate is as follows (in thousands):
 
    
Years Ended December 31,
 
    
2022
    
2021
    
2020
 
Statutory federal income tax
   $ (6,184    $ (1,918    $ (1,454
State income taxes, net of federal tax benefits
     (1,207      (353      (336
Stock compensation
     64        42        22  
Non-deductible
interest expense
     78        689        257  
Mark to market adjustments
     397        —          —    
Nondeductible Expenses
     279        2        4  
PPP Loan
     —          (368      —    
Foreign earnings taxed at different rates
     157        —          —    
Other
     (8      —          —    
Valuation allowance
     6,451        1,910        1,510  
  
 
 
    
 
 
    
 
 
 
Tax Provision
   $ 27      $ 4      $ 3  
  
 
 
    
 
 
    
 
 
 
Significant components of our deferred tax assets and liabilities are as follows (in thousands):
 
    
Years Ended December 31,
 
    
      2022      
    
      2021      
 
NOL carryforwards
   $ 60,710      $ 7,931  
Credits
     195        —    
Bad debt reserve
     1,382        946  
Inventory reserve
     2,724        680  
Warranty reserve
     651        631  
Revenue warranty
     155        111  
Interest expense carryover
     3,445        170  
Accrued compensation
     678        687  
Deferred revenue
     195        639  
ASC 842 leases
     12        17  
Assembled workforce
     —          15  
Fixed assets
     328        —    
Capitalized research and development
     509        —    
Other
     2,837        28  
Total
     73,821        11,855  
Valuation allowance
     (63,737      (11,348
  
 
 
    
 
 
 
Net deferred tax assets
   $ 10,084      $ 507  
Deferred Tax Liabilities
     
Accounting method change
     (18      (38
Capitalized software
     (234      (468
Fixed assets
     —          (1
Intangibles
     (9,084      —    
Convertible debt
     (748      —    
  
 
 
    
 
 
 
Refundable and deferred income taxes
   $ —        $ —    
  
 
 
    
 
 
 
The Company has established a valuation allowance to offset the gross deferred tax assets as of December 31, 2022 and December 31, 2021, due to the uncertainty of realizing future tax benefits from its net operating loss carryforwards and other deferred tax assets. The valuation allowance balance was $63.7 million and $11.3 million for the years ended December 31, 2022 and December 31, 2021, respectively.
In assessing the realizability of deferred income tax assets, the Company considered whether it is more likely than not that some portion or all of its deferred income tax assets will be realized. The ultimate realization of deferred income tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Due to the uncertainty surrounding the Company’s ability to realize such deferred income tax assets, a full valuation allowance has been established. The valuation allowance increased by $52.4 million during the year ended December 31, 2022, and $1.9 million during the year ended December 31, 2021. During 2022 the valuation allowance increased $45.9 million due to acquired deferred tax assets.
As of December 31, 2022 and 2021, the Company had federal net operating loss carryforwards of approximately $237.7 million and $28.0 million and state net operating loss carryforwards of approximately $157.1 million and $30.2 million, respectively. Federal net operating losses that will expire between the years 2030 and 2037 total $114.6 million.
As of December 31, 2022 and 2021, the Company had state research and development credit carryforwards of approximately $1.6 million and zero, respectively. The credits do not expire.
The utilization of the Company’s net operating loss and R&D credit carryforwards may be subject to limitation due to the “change in ownership provisions” under Section 382 of the Internal Revenue Code and similar foreign provisions. Such limitations may result in the expiration of these carryforwards before their
utilization. The Company’s acquired net operating loss carryforwards have been reduced based on the estimated amount which will be lost due to these limitations.
The Company is subject to income taxes in the U.S. federal jurisdiction, and various foreign jurisdictions. Tax regulations within each jurisdiction are subject to the interpretation of the related tax laws and regulations and require significant judgment to apply. The Company’s tax years remain open for examination by all tax authorities since inception. The Company is not currently under examination in any tax jurisdictions.
As of December 31, 2022 and 2021, the Company had unrecognized tax benefits of $1.3 million and zero, respectively. The reversal of the uncertain tax benefits would not affect the Company’s effective tax rate to the extent that it continues to maintain a full valuation allowance against its deferred tax assets.
The Company applies the provisions set forth in FASB ASC Topic 740, Income Taxes, to account for the uncertainty in income taxes. In the preparation of income tax returns in federal and state jurisdictions, the Company asserts certain tax positions based on its understanding and interpretation of income tax laws.
The following is a tabular reconciliation of the total amounts of unrecognized tax benefits (in thousands):
 
    
Years Ended December 31,
 
    
    2022    
    
    2021    
 
Unrecognized tax benefits as of beginning of year
   $ —        $ —    
Increases related to prior year tax positions
     1,335        —    
Increases related to current year tax positions
     —          —    
Decreases related to prior year tax positions
     —          —    
Unrecognized tax benefits as of end of year
     —          —    
  
 
 
    
 
 
 
   $ 1,335      $ —    
  
 
 
    
 
 
 
The Company recognizes interest and penalties related to unrecognized tax benefits within the income tax expense line in the statements of operations and comprehensive loss. Accrued interest and penalties are included as part of income tax payable in the consolidated balance sheets. No accrued interest or penalties have been recorded for year ended December 31, 2022 or December 31, 2021.
The Company has not provided U.S. income or foreign withholding taxes on the undistributed earnings of its foreign subsidiary as of December 31, 2022 and December 31, 2021 because it intends to permanently reinvest such earnings outside of the United States. If these foreign earnings were to be repatriated in the future, the related U.S. tax liability will be immaterial, due to the participation exemption put in place under the 2017 Tax Cuts and Jobs Act.
On March 18, 2020, the Families First Coronavirus Response Act (FFCR Act) and, on March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) were each enacted in response to the
COVID-19
pandemic. The FFCR Act and the CARES Act contain numerous income tax provisions relating to refundable payroll tax credits, deferment of employer side social security payments, net operating loss carryback periods, alternative minimum tax credit refunds, modifications to the net interest deduction limitations and technical corrections to tax depreciation methods for qualified improvement property. The Company analyzed the provisions of the Act and determined there was no significant impact to its 2022 or 2021 tax provision.
On June 29, 2020, the California Governor signed Assembly Bill 85 (“A.B. 85”) which includes several tax measures, provides for a three-year suspension of the use of net operating losses for medium and large businesses and a three-year cap on the use of business incentive tax credits to offset no more than $5 million of tax per year. Generally, A.B. 85 suspends the use of net operating losses for taxable years 2020, 2021, and 2022 for taxpayers with taxable income of $1 million or more. The Company analyzed the provisions of the A.B. 85 and determined there was no significant impact to its 2022 or 2021 tax provision.
On December 27, 2020, the “Consolidated Appropriations Act, 2021” (the “CAA”) was signed into law. The CAA includes provisions meant to clarify and modify certain items put forth in CARES Act, while providing aid to businesses affected by the pandemic. The CAA allows deductions for expenses paid for by Paycheck Protection Program (“PPP”) and Economic Injury Disaster Loan (“EIDL”) . The Program, clarifies forgiveness of EIDL advances, and other business provisions. The Company analyzed the provisions of the CAA and determined there was no significant impact to its 2022 and 2021 tax provision.
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.23.4
Basic and Diluted Net Loss Per Share
9 Months Ended 12 Months Ended
Oct. 01, 2023
Dec. 31, 2022
Basic and Diluted Net Loss Per Share [Abstract]    
Basic and Diluted Net Loss Per Share
(20)
Basic and Diluted Net Loss Per Share
The Company uses the
two-class
method to calculate net loss per share. No dividends were declared or paid for the thirteen or thirty-nine weeks ended October 1, 2023 or for the three or nine months ended September 30, 2022. Undistributed earnings for each period are allocated to participating securities, including the redeemable convertible preferred stock, based on the contractual participation rights of the security to share in the current earnings as if all current period earnings had been distributed. As there is no contractual obligation for the redeemable convertible preferred stock to share in losses, the Company’s basic net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted-average shares of common stock outstanding during periods with undistributed losses.
The unaudited basic and diluted shares and net loss per share for the three and nine months ended September 30, 2022 have been retroactively restated to give effect to the conversion of shares of legal acquiree’s convertible instruments into shares of legal acquiree common stock as though the conversion had occurred as of the beginning of the period. The retroactive restatement is consistent with the presentation on the accompanying unaudited condensed consolidated statements of stockholders’ deficit.
The following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common stockholders for the thirteen and thirty-nine weeks ended October 1, 2023 and three and nine months ended September 30, 2022 (in thousands, except share and per share amounts):
 
   
Thirteen
Weeks Ended
October 1,
2023
   
Three
Months Ended
September 30,
2022
   
Thirty-Nine

Weeks Ended
October 1,
2023
   
Nine
Months Ended
September 30,
2022
 
Numerator:
       
Net loss from continuing operations
  $ (50,973   $ (4,146   $ (73,448   $ (10,809
Net loss from discontinued operations
    (155,909     —         (168,458     —    
 
 
 
   
 
 
   
 
 
   
 
 
 
Net loss
  $ (206,882   $ (4,146   $ (241,906   $ (10,809
Denominator:
       
Weighted average common shares outstanding, basic and diluted
    39,821,078       13,431,410       16,969,979       13,053,367  
Net loss per share:
       
Continuing operations – basic and diluted
  $ (1.28   $ (0.31   $ (4.33   $ (0.83
 
 
 
   
 
 
   
 
 
   
 
 
 
Discontinued operations – basic and diluted
  $ (3.92   $ —       $ (9.92   $ —    
 
 
 
   
 
 
   
 
 
   
 
 
 
Net loss per share – basic and diluted
  $ (5.20   $ (0.31   $ (14.25   $ (0.83
 
 
 
   
 
 
   
 
 
   
 
 
 
Basic and diluted net loss per share attributable to common stockholders is the same for the thirteen and thirty-nine weeks ended October 1, 2023 and three and nine months ended September 30, 2022 because the inclusion of potential shares of common stock would have been anti-dilutive for the periods presented.
The following table presents the potential common shares outstanding that were excluded from the computation of diluted net loss per share of common stock as of the periods presented because including them would have been antidilutive:
 
    
As of
 
    
October 1,
2023
    
December 31,
2022
 
Common stock warrants
     23,626,132        2,000,878  
Preferred stock warrants
     —          488,024  
Stock options and RSUs issued and outstanding
     7,013,514        2,430,949  
  
 
 
    
 
 
 
Potential common shares excluded from diluted net loss per share
     30,639,646        4,919,851  
  
 
 
    
 
 
 
(19)
Basic and Diluted Net Loss Per Share
The Company computes net loss per share in accordance with ASC 260. No dividends were declared or paid for the years ended December 31, 2022 and December 31, 2021. Undistributed earnings for each period are allocated to participating securities, including the redeemable convertible preferred stock, based on the contractual participation rights of the security to share in the current earnings as if all current period earnings had been distributed. As there is no contractual obligation for the redeemable convertible preferred stock to share in losses, the Company’s basic net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted-average shares of common stock outstanding during periods with undistributed losses.
The following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common stockholders for the years ended December 31, 2022, 2021 and 2020 (in thousands, except share and per share amounts):
 
    
Years Ended December 31,
 
    
2022
    
2021
    
2020
 
Numerator:
        
Net loss from continuing operations
   $ (28,023    $ (9,282    $ (5,682
Net loss from discontinued operations
     (1,454      —          —    
  
 
 
    
 
 
    
 
 
 
Net loss
   $ (29,477    $ (9,282    $ (5,682
  
 
 
    
 
 
    
 
 
 
Denominator:
        
Weighted average common shares outstanding, basic and diluted
     22,524,400        11,990,015        9,760,018  
Net loss per share:
        
Continuing operations – basic and diluted
   $ (1.24    $ (0.77    $ (0.58
Discontinued operations – basic and diluted
   $ (0.07    $ —        $ —    
Net loss per share – basic and diluted
   $ (1.31    $ (0.77    $ (0.58
Basic and diluted net loss per share attributable to common stockholders is the same for the years ended December 31, 2022, 2021 and 2020 because the inclusion of potential shares of common stock would have been anti-dilutive for the periods presented.
The following table presents the potential common shares outstanding that were excluded from the computation of diluted net loss per share of common stock as of the periods presented because including them would have been antidilutive:
 
    
As of December 31,
 
    
2022
    
2021
    
2020
 
Stock options issued and outstanding
     4,970,419        2,135,464        1,968,590  
Convertible notes
     1,912,493        1,618,585        812,531  
Preferred stock warrants
     1,152,790        488,024        488,024  
SAFE agreements
     —          388,785        19,562  
Common stock warrants
     43,135        4,999        —    
  
 
 
    
 
 
    
 
 
 
Potential common shares excluded from diluted net loss per share
     8,078,837        4,635,857        3,288,706  
  
 
 
    
 
 
    
 
 
 
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.23.4
Related Party Transactions
9 Months Ended 12 Months Ended
Oct. 01, 2023
Dec. 31, 2022
Related Party Transactions [Abstract]    
Related Party Transactions
(21)
Related Party Transactions
Related Party Convertible Promissory Notes
In 2020, the Company issued convertible promissory notes
(“2020-A
Convertible Notes”) of approximately $3.8 million to various investors, out of which $3.3 million was issued to nine related parties. The principal amount of the outstanding balance accrued interest at 2.0% per annum. In 2021, the Company subsequently issued convertible promissory notes
(“2021-A
Convertible Notes”) of approximately $4.8 million to various investors, out of which $3.6 million was issued to four related parties. The principal amount of the outstanding balance accrued interest at 2.0% per annum. Refer to Note 16 – Borrowing Arrangements for further details.
In March 2022, as part of the Company’s Series D redeemable convertible preferred stock issuance, the Company converted all of the outstanding convertible note series. As part of the conversion, the Company recognized a gain on the extinguishment of related party convertible notes of $1.4 million, which was recorded in other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive income (loss).
In October 2022 through June 2023, the Company issued convertible promissory notes (“2022 Convertible Notes”) of approximately $33.3 million to various investors, out of which $12.1 million was issued to five related parties. Additionally, the Company acquired a related party convertible note, on the same terms as the 2022 Convertible Notes as part of the acquisition of Solaria, with a fair value of $6.7 million at the time of the acquisition. The related party debt is presented as convertible notes, net, due to related parties, noncurrent in the accompanying unaudited condensed consolidated balance sheets. The principal amount of the outstanding balance on the 2022 Convertible Notes accrues at 5.0%, compounded annually. For the thirteen and thirty-nine weeks ended October 1, 2023, the Company has recognized less than $0.1 million and $0.4 million, respectively, in interest expense related to the related party 2022 Convertible Promissory Notes.
In June 2023, the Company received $3.5 million of prefunded PIPE proceeds from a related party investor in conjunction with the Company’s merger with Freedom Acquisition I Corp (refer to Note 1(a) – Description of Business and Note 4 – Reverse Recapitalization). The $3.5 million investment converted to equity for reclassification of prepaid PIPE, which is reflected in the unaudited condensed consolidated statements of redeemable convertible preferred stock and stockholders’ deficit for the thirteen and thirty-nine weeks ended October 1, 2023.
In July 2023, in connection with the Mergers, in addition to the $3.5 million of related party PIPE proceeds noted above, the Company received additional PIPE proceeds from related parties of $12.1 million, which is reflected in the unaudited condensed consolidated statements of redeemable convertible preferred stock and stockholders’ deficit for the thirteen and thirty-nine weeks ended October 1, 2023.
In July 2023, in connection with the Mergers, the Company issued 120,000 shares to a related party as a transaction bonus. As a result of the issuance, the Company recognized $0.7 million of expense within other income (expense), net in its unaudited condensed consolidated statements of operations and comprehensive income (loss) for the thirteen and thirty-nine weeks ended October 1, 2023.
In July 2023, the Company entered into a series of FPAs as described in Note 5 – Forward Purchase Agreements. In connection with the FPAs, the Company recognized other expense of $30.7 million for each of the thirteen and thirty-nine weeks ended October 1, 2023 in connection with the issuance of 5,670,000 shares of Complete Solaria Common Stock to the related party FPA Sellers. The Company also recognized other income of $0.3 million in connection with the issuance of the FPAs with related parties. As of October 1, 2023, the Company has recognized a liability associated with the FPAs of $5.6 million due to related parties in its unaudited condensed consolidated balance sheets, and the Company has recognized other expense associated with the change in fair value of the FPA liability due to related parties of $5.9 million in its unaudited condensed consolidated statements of operations and comprehensive income (loss) for both the thirteen and thirty-nine weeks ended October 1, 2023.
In September 2023, in connection with the Mergers, the Company entered into a settlement and release agreement with a related party for the settlement of a working capital loan made to the Sponsor, prior to the closing of the Mergers. As part of the settlement agreement, the Company agreed to pay the related party $0.5 million as a return of capital, which is paid in ten equal monthly installments and does not accrue interest. During each of the thirteen and thirty-nine weeks ended October 1, 2023, the Company made one payment of $0.1 million. As of October 1, 2023, $0.5 million remains outstanding.
There were no other material related party transactions during the thirteen and thirty-nine weeks ended October 1, 2023 or the three and nine months ended September 30, 2022.
(20)
Related Party Transactions
Related Party Convertible Promissory Notes
In 2020, the Company issued convertible promissory notes (“2020 Convertible Notes”) of approximately $3.8 million to various investors, out of which $3.3 million was issued to nine related parties. The related party debt is presented as convertible notes, net in the accompanying consolidated balance sheets, adjusted for deferred interest, allocated debt financing costs and derivative liability recorded as debt discount. The principal amount of the outstanding balance accrued interest at 2.0% per annum.
In 2021, the Company issued convertible promissory notes (“2021 Convertible Notes”) of approximately $4.8 million to various investors, out of which $3.6 million was issued to four related parties. The related party debt is presented as convertible notes, net’ in the accompanying consolidated balance sheets, adjusted for deferred interest, and allocated debt financing costs. The principal amount of the outstanding balance accrued interest at 2.0% per annum.
In March 2022, as part of the Company’s Series D redeemable convertible preferred stock issuance, the Company converted all of the outstanding convertible note series. As part of the conversion, the Company recognized a gain on the extinguishment of related party convertible notes of $1.4 million, which was recorded in other income (expense), net on the consolidated statements of operations and comprehensive loss.
In October through December 2022, the Company issued convertible promissory notes (“2022 Convertible Notes”) of approximately $12.0 million to various investors, out of which $8.6 million was issued to four related parties. Additionally, the Company acquired a related party convertible note, on the same terms as the 2022 Convertible Notes as part of the acquisition of Solaria with a fair value of $6.7 million at the time of the acquisition. The related party debt is presented as convertible notes, net due to related parties, noncurrent in the accompanying consolidated balance sheets. The principal amount of the outstanding balance on the 2022 Convertible Notes accrues at 5.0%, compounded annually. For the year-ended December 31, 2022, the Company has recognized $0.2 million in interest expense related to the related party 2022 Convertible Notes.
There were no other material related party transactions during the years ended December 31, 2022, 2021 or 2020.
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.23.4
Subsequent Events
9 Months Ended 12 Months Ended
Oct. 01, 2023
Dec. 31, 2022
Subsequent Events [Abstract]    
Subsequent Events
(22) Subsequent Events
In preparing the unaudited condensed consolidated financial statements as of and for the thirty-nine weeks ended October 1, 2023, the Company evaluated subsequent events for recognition and measurement purposes through November 14, 2023, which is the date the financial statements were available to be issued. The Company noted no subsequent events through November 14, 2023 that would materially impact the unaudited condensed consolidated financial statements, except for the following:
In October 2023, the Company entered into an Assignment and Acceptance Agreement (“Assignment Agreement”), whereby Structural Capital Investments III, LP assigns the SCI debt to Kline Hill Partners Fund LP, Kline Hill Partners IV SPV LLC, Kline Hill Partners Opportunity IV SPV LLC, and Rodgers Massey Revocable Living Trust for a total purchase price of $5.0 million. The Company has identified this as a related party transaction.
In October 2023, in connection with the Assignment Agreement, the Company also entered into the First Amendment to Warrant to Purchase Stock Agreements with the holders of the Series
D-7
warrants. Pursuant to the terms of the agreement, the warrants to purchase 1,376,414 shares of Series
D-7
preferred stock converted into warrants to purchase 656,630 shares of common stock (the “replacement warrants”). As a result of the warrant amendment, the Company reclassified the replacement warrants from equity to liability. The replacement warrants were remeasured to the fair value on the amendment effective date and the Company will record subsequent changes in fair value in other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive income (loss).
In October 2023, the Company completed the sale of its solar panel business to Maxeon, pursuant to the terms of the Asset Purchase Agreement (the “Disposal Agreement”). Under the terms of the Disposal Agreement, Maxeon agreed to acquire certain assets and employees of Complete Solaria, for an aggregate purchase price of approximately $11.0 million consisting of 1,100,000 shares of Maxeon ordinary shares. The Company recorded an impairment charge of $1.7 million related to a decline in the fair value of the Maxeon shares between the end of the fiscal quarter on October 1, 2023 and the disposal date of October 6, 2023. No significant transaction costs were incurred subsequent to the balance sheet date.
(21)
Subsequent Events
In connection with the Business Combination Agreement, the Company has raised a series of convertible notes (“2023 Convertible Notes”) in January 2023 and February 2023 with additional investors, with an aggregate purchase price of $11.0 million. The 2023 Convertible Notes will convert to common shares of Complete Solaria, Inc. at the Closing. The 2022 Notes accrue interest at a rate of 5% per annum. Immediately prior to the Closing, the 2023 Convertible Notes will be converted into that number of shares of common stock of Complete Solaria equal to (x) the principal amount together with all accrued interest of the 2023 Convertible Notes divided by 0.75, divided by (y) the price of a share of common stock of Complete Solaria used to determine the conversion ratio in the Business Combination Agreement.
On March 10, 2023, the Federal Deposit Insurance Corporation (“FDIC”) announced the closure of Silicon Valley Bank (“SVB”). On March 13, 2023, pursuant to a joint statement released by the U.S. Department of the Treasury, the U.S. Federal Reserve, and the FDIC, the U.S. government reassured that all depositors will be fully protected. As of the date the accompanying consolidated financial statements were issued, the Company has transferred substantially all of its cash out of SVB to other financial institutions. The Company does not currently anticipate any disruption to its ongoing operations.
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.23.4
Accounting Policies, by Policy (Policies)
9 Months Ended 12 Months Ended
Oct. 01, 2023
Dec. 31, 2022
Significant Accounting Policies [Abstract]    
Use of Estimates
(a)
Use of Estimates
The preparation of the Company’s unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses, as well as related disclosure of contingent assets and liabilities. Significant estimates and assumptions made by management include, but are not limited to, the determination of:
 
   
the allocation of the transaction price to identified performance obligations;
 
   
fair value of warrant liabilities;
 
   
the fair value of assets acquired and liabilities assumed for business combinations;
 
   
the reserve methodology for inventory obsolescence;
 
   
the reserve methodology for product warranty;
 
   
the reserve methodology for the allowance for credit losses; and
 
   
the fair value of the forward purchase agreements.
To the extent that there are material differences between these estimates and actual results, the Company’s financial condition or operating results will be affected.
 
(a)
Use of Estimates
The
preparation
of the Company’s financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses, as well as related disclosure of contingent assets and liabilities. Significant estimates and assumptions made by management include, but are not limited to, the determination of:
 
   
The allocation of the transaction price to identified performance obligations;
 
   
Fair value of warrant liabilities;
 
   
The fair value of assets acquired and liabilities assumed for business combination;
 
   
The reserve methodology for inventory obsolescence;
 
   
The reserve methodology for product warranty;
To the extent that there are material differences between these estimates and actual results, the Company’s financial condition or operating results will be affected. The Company bases its estimates on past experience and other assumptions that the Company believes are reasonable under the circumstances, and the Company evaluates these estimates on an ongoing basis. The Company has assessed the impact and are not aware of any specific events or circumstances that required an update to the Company’s estimates and assumptions or materially affected the carrying value of the Company’s assets or liabilities as of the date of issuance of this report. These estimates may change as new events occur and additional information is obtained.
Supply Chain Constraints and Risk
(b)
Supply Chain Constraints and Risk
The Company relies on a very small number of suppliers of solar energy systems and other equipment. If any of the Company’s suppliers was unable or unwilling to provide the Company with contracted quantities in a timely manner at prices, quality levels and volumes acceptable to the Company, the Company would have very limited alternatives for supply, and the Company may not be able find suitable replacements for the Company’s customers, or at all. Such an event could materially adversely affect the Company’s business, prospects, financial condition and results of operations.
In addition, the global supply chain and the Company’s industry have experienced significant disruptions in recent periods. The Company has seen supply chain challenges and logistics constraints increase, including shortages of panels, inverters, batteries and associated component parts for inverters and solar energy systems available for purchase. In certain cases, this has caused delays in critical equipment and inventory, longer lead times, and has resulted in cost volatility. These shortages and delays can be attributed in part to the
COVID-19
pandemic and resulting government action, broader macroeconomic conditions, and have been exacerbated by the ongoing conflicts in Ukraine and Israel. While the Company believes that a majority of the Company’s suppliers have secured sufficient supply to permit them to continue delivery and installations through the end of 2023, if these shortages and delays persist into 2024, they could adversely affect the timing of when battery energy storage systems can be delivered and installed, and when (or if) the Company can begin to generate revenue from those systems. In addition, the Company has experienced and is experiencing varying levels of volatility in costs of equipment and labor resulting in part from disruptions caused by general global economic conditions, including inflationary pressures and the
COVID-19
pandemic.
The Company cannot predict the full effects these events will have on the Company’s business, cash flows, liquidity, financial condition and results of operations at this time due to numerous uncertainties. In the event the Company is unable to mitigate the impact of delays or price volatility in solar energy systems, raw materials, and freight, it could materially adversely affect the Company’s business, prospects, financial condition and results of operations.
 
(b)
Supply Chain Constraints and Risk;
COVID-19
The Company relies on a very small number of suppliers of solar energy systems and other equipment. If any of Company’s suppliers was unable or unwilling to provide the Company with contracted quantities in a timely manner at prices, quality levels and volumes acceptable to the Company, the Company would have very limited alternatives for supply, and the Company may not be able find suitable replacements for the Company’s customers, or at all. Such an event could materially adversely affect the Company’s business, prospects, financial condition and results of operations.
The ongoing
COVID-19
pandemic has resulted and may continue to result in widespread adverse effects on the global and U.S. economies. Ongoing government and business responses to
COVID-19,
along with
COVID-19
variants and the resurgence of related disruptions, could have a continued material adverse impact on economic and market conditions and trigger a period of continued global and U.S. economic slowdown.
In addition, the global supply chain and the Company’s industry have experienced significant disruptions in recent periods. The Company have seen supply chain challenges and logistics constraints increase, including shortages of panels, inverters, batteries and associated component parts for inverters and solar energy systems available for purchase. In certain cases, this has caused delays in critical equipment and inventory, longer lead times, and has resulted in cost volatility. These shortages and delays can be attributed in part to the
COVID-19
pandemic and resulting government action, broader macroeconomic conditions, and have been exacerbated by the ongoing conflict in Russia and Ukraine. While the Company believes that a majority of the Company’s suppliers have secured sufficient supply to permit them to continue delivery and installations through the end of 2023, if these shortages and delays persist into 2024, they could adversely affect the timing of when battery energy storage systems can be delivered and installed, and when (or if) the Company can begin to generate revenue from those systems. In addition, the Company has experienced and is experiencing varying levels of volatility in costs of equipment and labor resulting in part from disruptions caused by general global economic conditions, including inflationary pressures and the
COVID-19
pandemic.
The Company cannot predict the full effects these events will have on the Company’s business, cash flows, liquidity, financial condition and results of operations at this time due to numerous uncertainties. In the event the Company is unable to mitigate the impact of delays or price volatility in solar energy systems, raw materials, and freight, it could materially adversely affect the Company’s business, prospects, financial condition and results of operations. For additional information on risk factors that could impact the Company’s results, please refer to “Risk
Factors
” located elsewhere in this prospectus.
Segment Information
(c)
Segment Information
The Company conducts its business in one operating segment that provides custom solar solutions through a standardized platform to its residential solar providers and companies to facilitate the sale and installation of solar energy systems under a single product group. The Company’s Chief Executive Officer (“CEO”) is the Chief Operating Decision Maker (“CODM”). The CODM allocates resources and makes operating decisions based on financial information presented on a consolidated basis. The profitability of the Company’s product group is not a determining factor in allocating resources and the CODM does not evaluate profitability below the level of the consolidated company. All the Company’s long-lived assets are maintained in the United States of America.
 
(c)
Segment Information
The Company conducts its business in one operating segment that provides custom solar solutions through a standardized platform to its residential solar providers and companies to facilitate the sale and installation of solar energy systems under a single product group. The Company’s Chief Executive Officer (“CEO”) is the Chief Operating Decision Maker (“CODM”). The CODM allocates resources and makes operating decisions based on financial information presented on a consolidated basis. The profitability of the Company’s product group is not a determining factor in allocating resources and the CODM does not evaluate profitability below the level of the consolidated company. All the Company’s long-lived assets are maintained in the United States of America. Disaggregated revenue by primary geographical market for the Company’s single segment is included in the discussion of revenue recognition within this Note 2, below.
Concentration of Risks  
(d)
Concentration of Risks
Concentration of credit risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. The Company’s cash and cash equivalents are on deposit with major financial institutions. Such deposits may be in excess of insured limits. The Company believes that the financial institutions that hold the Company’s cash are financially sound, and accordingly, minimum credit risk exists with respect to these balances. The Company has not experienced any losses due to institutional failure or bankruptcy. The Company performs credit evaluations of its customers and generally does not require collateral for sales on credit. The Company reviews accounts receivable balances to determine if any receivables will potentially be uncollectible and includes any amounts that are determined to be uncollectible in the allowance for doubtful accounts. As of December 31, 2022, three single customers had outstanding balances that represented 27%, 18%, and 14%, respectively, of the total accounts receivable balance, compared to December 31, 2021, as a single customer had an outstanding balance that represented 50%, of the total accounts receivable balance.
Concentration of customers
The Company defines major customers as those customers who generate revenues that exceed 10% of the Company’s annual net revenues. For the years ended December 31, 2022, 2021 and 2020, one customer represented 47%, 63% and 81% of gross revenues, respectively.
Concentration of suppliers
For the year ended December 31, 2022, three suppliers represented 74% of the Company’s inventory purchases. For the year ended December 31, 2021, four supplier represented 87% of the Company’s inventory purchases. For the year ended December 31, 2020, two suppliers represented 89% of the Company’s inventory purchases.
Cash and Cash Equivalents  
(e)
Cash and Cash Equivalents
The
Company considers all highly liquid securities that mature within three months or less from the original date of purchase to be cash equivalents. The Company maintains the majority of its cash balances with
commercial banks in interest bearing accounts. Cash and cash equivalents include cash held in checking and savings accounts and money market accounts consisting of highly liquid securities with original maturity dates of three months or less from the original date of purchase.
Restricted Cash
(d)
Restricted Cash
The Company classifies all cash for which usage is limited by contractual provisions as restricted cash. Restricted cash balance as of October 1, 2023 and December 31, 2022, was $3.8 million and $3.9 million, respectively. The restricted cash consists of deposits in money market accounts, which is used as cash collateral backing letters of credit related to customs duty authorities’ requirements. The Company has presented these balances under restricted cash, as a long-term asset, in the unaudited condensed consolidated balance sheets. The Company reconciles cash, cash equivalents, and restricted cash reported in the unaudited condensed consolidated balance sheets that aggregate to the beginning and ending balances shown in the unaudited condensed consolidated statements of cash flows as follows (in thousands):
 
    
As of
 
    
October 1,
2023
    
December 31,
2022
 
Cash and cash equivalents
   $ 1,661      $ 4,409  
Restricted cash
     3,758        3,907  
  
 
 
    
 
 
 
Total cash, cash equivalents, and restricted cash
   $ 5,419      $ 8,316  
  
 
 
    
 
 
 
(f)
Restricted Cash
The Company classifies all cash for which usage is limited by contractual provisions as restricted cash. Restricted cash balance as of December 31, 2022 and 2021, was $3.9 million, and zero, respectively. The restricted cash consists of deposits in money market accounts, which is used as cash collateral backing letters of credit related to customs duty authorities’ requirements. The Company has presented these balances under restricted cash, as a long term asset, in the consolidated balance sheets.
Total cash, cash equivalents and restricted cash is presented in the table below (in thousands):
 
    
As of December 31,
 
    
2022
    
2021
 
Cash and cash equivalents
   $ 4,409      $ 5,276  
Restricted cash
     3,907        —    
  
 
 
    
 
 
 
Total cash, cash equivalents and restricted cash
   $ 8,316      $ 5,276  
  
 
 
    
 
 
 
Accounts Receivable, Net  
(g)
Accounts Receivable, Net
Accounts receivable are recorded at the invoiced amount and do not bear interest. The Company maintains an allowance for doubtful accounts for estimated losses inherent in its accounts receivable portfolio. In establishing the required allowance, management considers historical losses adjusted to take into account current market conditions and customers’ financial condition, the amount of receivables in dispute, the current receivables aging and customer payment patterns. Account balances are written off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. Recoveries of accounts receivable previously written off are recorded when received.
The following table summarizes the allowance for doubtful accounts as of December 31, 2022, 2021, and 2020 (in thousands):
 
    
As of December 31,
 
    
2022
    
2021
    
2020
 
Balance at beginning of period
   $ (2,569    $ (2,288    $ (1,965
Provision charged to earnings
     (2,243      (364      (337
Amounts written off, recoveries and other adjustments
     —          83        14  
  
 
 
    
 
 
    
 
 
 
Balance at end of period
   $ (4,812    $ (2,569    $ (2,288
  
 
 
    
 
 
    
 
 
 
The Company does
not
have any
off-balance
sheet credit exposure related to its customers.
Inventories  
(h)
Inventories
Inventories consists of solar panels and the components of solar energy systems which the Company classifies as finished goods. Costs are computed under the average cost method. The Company identifies inventory which is considered obsolete or in excess of anticipated demand based on a consideration of marketability and product life cycle stage, component cost trends, demand forecasts, historical revenues, and assumptions about future demand and market conditions to state inventory at the lower of cost or net realizable value.
Revenue Recognition
(e)
Revenue Recognition
Disaggregation of revenue
Refer to the table below for the Company’s revenue recognized by product and service type (in thousands):
 
    
Thirteen
Weeks
Ended
October 1,
2023
    
Three
Months
Ended
September 30,
2022
    
Thirty-Nine

Weeks
Ended
October 1,
2023
    
Nine Months
Ended
September 30,
2022
 
Solar energy system installations
   $ 23,915      $ 11,120      $ 64,511      $ 46,214  
Software enhanced services
     675        1,140        2,376        2,760  
  
 
 
    
 
 
    
 
 
    
 
 
 
Total revenue
   $ 24,590      $ 12,260      $ 66,887      $ 48,974  
  
 
 
    
 
 
    
 
 
    
 
 
 
All of the Company’s revenue recognized by geography based on the location of the customer for the thirteen and thirty-nine weeks ended October 1, 2023 and three and nine months ended September 30, 2022 was in the United States.
Remaining performance obligations
The Company has elected the practical expedient not to disclose remaining performance obligations for contracts that are less than one year in length. The Company has deferred $1.0 million and $1.3 million associated with a long-term service contract as of October 1, 2023 and December 31, 2022, respectively.
Incremental costs of obtaining customer contracts
Incremental costs of obtaining customer contracts consist of sales commissions, which are costs paid to third-party vendors who source residential customer contracts for the sale of solar energy systems by the Company. The Company defers sales commissions and recognizes expense in accordance with the timing of the related revenue recognition. Amortization of deferred commissions is recorded as sales commissions in the accompanying unaudited condensed consolidated statements of operations and comprehensive income (loss). As of October 1, 2023 and December 31, 2022, deferred commissions were $5.5 million and $2.8 million, respectively, which were included in prepaid expenses and other current assets in the accompanying unaudited condensed consolidated balance sheets.
Deferred revenue
The Company typically invoices its customers upon completion of set milestones, generally upon installation of the solar energy system with the remaining balance invoiced upon passing the final building inspection. Standard payment terms to customers range from 30 to 60 days. When the Company receives consideration, or when such consideration is unconditionally due, from a customer prior to delivering goods or services to the customer under the terms of a customer agreement, the Company records deferred revenue. As installation projects are typically completed within
12-months,
the majority of the Company’s deferred revenue is reflected in current liabilities in the accompanying unaudited condensed consolidated balance sheets. The Company also has deferred revenue associated with a long-term service contract which is reflected in
non-current
liabilities in the accompanying unaudited condensed consolidated balance sheets. The amount of revenue recognized during the thirty-nine weeks ended October 1, 2023 and the nine months ended September 30, 2022 that was included in deferred revenue at the beginning of the year was $2.5 million and $3.9 million, respectively.
 
(i)
Revenue Recognition
Revenue is recognized when a customer obtains control of promised products and services and the Company has satisfied its performance obligations. The amount of revenue recognized reflects the consideration which the Company expects to be entitled to receive in exchange for the products and services. To achieve this core principle, the Company applies the following five steps:
Step 1. Identification of the contract(s) with a customer;
Step 2. Identification of the performance obligations in the contracts(s);
Step 3. Determination of the transaction price;
Step 4. Allocation of the transaction price to the performance obligations;
Step 5. Recognition of the revenue when, or as, the Company satisfies a performance obligation.
Service Revenues – Solar Energy System Installations
The Company generates revenue primarily from the design and installation of a solar energy system and performing post-installation services. The Company’s contracts with customers include three primary contract types:
 
   
Cash agreements
– The Company contracts directly with homeowners who purchase the solar energy system and related services from the Company. Customers are invoiced on a billing schedule, where the majority of the transaction price is due upon installation with an additional payment due when the system passes inspection by the authority having jurisdiction.
 
   
Financing partner agreements
– In its financing partner agreements, the Company contracts directly with homeowners for the purchase of the solar energy system and related services. The Company refers the homeowner to a financing partner to finance the system, and the homeowner makes payments directly to the financing partner. The Company receives consideration from the financing partner on a billing schedule where the majority of the transaction price is due upon installation with an additional payment due when the system passes inspection by the authority having jurisdiction.
 
   
Power purchase agreements
– The Company contracts directly with a distribution partner to perform the solar energy system installation, and the homeowner will finance the system through a power purchase agreement, which is signed with the Company’s distribution partner. The Company considers the distribution partner to be its customer, as the Company does not contract directly with the homeowner. The Company receives consideration from the distribution partner on a billing schedule where the majority of the transaction price is due upon installation with an additional payment due when the system passes inspection by the authority having jurisdiction.
In each of the Company’s customer contract types, the Company’s revenue consists of two performance obligations, which include the performance of the installation of the solar energy system and post-installation services.
Installation includes the design of a solar energy system, the delivery of the components of the solar energy system (i.e., photovoltaic system, inverter, battery storage, etc.), installation services and services facilitating the connection of the solar energy system to the power grid. The Company accounts for these services as inputs to a combined output, resulting in a single service-based performance obligation. The Company recognizes revenue upon the completion of installation services, which occurs upon the transfer of control of the solar energy system and title of the related hardware components to the homeowner or distribution partner.
Post-installation services consist primarily of administrative services and customer support, which the Company performs between the completion of installation and the date of inspection of the solar energy system by the authority having jurisdiction. The Company recognizes revenue at a point in time, which is when the inspection occurs.
As the Company’s contracts with customers contain multiple performance obligations, the transaction price is allocated to each performance obligation based on its standalone selling price. The Company generally determines the standalone selling price based on the estimated costs incurred in the delivery of each performance obligation, relative to the total costs to be incurred under the contract.
The Company records deferred revenue for amounts invoiced that are not subject to refund upon termination. In certain contracts with customers, the Company arranges for a third-party financing partner to provide financing to the customer. The Company collects upfront from the financing partner and the customer will provide installment payments to the financing partner. The Company records revenue in the amount received from the financing partner, net of any financing fees charged to the homeowner, which the Company considers to be a customer incentive. None of the Company’s contracts contain a significant financing component.
The Company guarantees to customers certain specified minimum solar energy production output of the solar energy system for
10-years
after the installation. The Company monitors the solar energy systems to determine whether these specified minimum outputs are being achieved. The Company will issue payments to customers if the output falls below contractually stated thresholds over the performance guarantee period. Revenue is recognized to the extent it is probable that a significant reversal of such revenue will not occur.
Revenues – Software Enhanced Services
The Company generates revenue from software enhanced services through the provision of design and proposal services. The Company’s customers for design services are solar installers who leverage the Company’s expertise and software platforms to obtain structural letters, computer aided designs and electrical reviews. The Company charges the customer a per design fixed fee for each type of service that is performed, and the Company recognizes revenue in the period the services are performed. The customer contracts contain the customer right to terminate the contract each month and are therefore enforceable only for the contracted services purchased each month. Revenue is recognized for design services in the month the services are performed.
The Company’s customers for proposal services for solar sales organizations who contract with the Company to develop proposals for their potential residential solar customers. The Company generates proposals for the customer using the HelioQuote platform. Customers may purchase a fixed number of proposals for a given month or may contract on a pay as you go basis, and the performance obligation is defined by the number of proposals purchased by the customer each month. The customer contracts contain the customer right to terminate the contract each month and are therefore enforceable only for the services purchased each month. Revenue is recognized for proposal services in the month the services are performed.
Warranties
The Company typically provides a
10-year
warranty on its solar energy system installations, which provides assurance over the workmanship in performing the installation, including roof leaks caused by the Company’s performance. For solar panel sales recognized prior to the Disposal Transaction, the Company provides a
30-year
warranty that the products will be free from defects in material and workmanship.
When the revenues are recognized for the solar energy systems installations services, the Company accrues liabilities for the estimated future costs of meeting its warranty obligations. The Company makes and revises these estimates based primarily on the volume of new sales that contain warranties, historical experience with and projections of warranty claims, and estimated solar energy system and panel replacement costs. The Company records a provision for estimated warranty expenses in cost of revenues within the accompanying consolidated statements of operations and comprehensive loss.
Shipping and handling costs and certain taxes
Revenues are recognized net of taxes collected from customers and remitted to governmental authorities. Shipping and handling costs associated with outbound freight are accounted for as a fulfillment cost and are included in both revenues and cost of revenues in the accompanying consolidated statements of operations and comprehensive loss.
Deferred revenue
The Company typically invoices its customers upon completion of set milestones, generally upon installation of the solar energy system with the remaining balance invoiced upon passing final building inspection. Standard payment terms to customers range from 30 to 60 days. When the Company receives consideration, or when such consideration is unconditionally due, from a customer prior to delivering goods or services to the customer under the terms of a customer agreement, the Company records deferred revenue. As installation projects are typically completed within
12-months,
the Company’s deferred revenue is reflected in current liabilities in the accompanying consolidated balance sheets. The amount of revenue recognized during the years ended December 31, 2022 and 2021 that was included in deferred revenue at the beginning of each period was $3.9 million and $4.5 million, respectively.
Disaggregation of revenue
Refer to the table below for the Company’s revenue recognized by product and service type (in thousands):
 
    
Years Ended December 31,
 
    
2022
    
2021
    
2020
 
Solar energy system installations
   $ 62,896      $ 66,958      $ 29,378  
Software enhanced services
     3,579        1,858        —    
  
 
 
    
 
 
    
 
 
 
Total revenue
   $ 66,475      $ 68,816      $ 29,378  
  
 
 
    
 
 
    
 
 
 
For the years ended December 31, 2022, 2021 and 2020, all revenue recognized was generated in the United States.
Remaining performance obligations
The Company has elected the practical expedient not to disclose remaining performance obligations for contracts that are less than one year in length. As of December 31, 2022, the Company has deferred $1.3 million associated with a long-term service contract, which will be recognized evenly through 2028.
Incremental costs of obtaining customer contracts
Incremental costs of obtaining customer contracts consist of sales commissions, which are costs paid to third-party vendors who source residential customer contracts for the sale of solar energy systems by the Company. The Company defers sales commissions and recognizes expense in accordance with the timing of the related revenue recognition. Amortization of deferred commissions is recorded as sales commissions in the accompanying consolidated statements of operations and comprehensive loss. As of December 31, 2022 and December 31, 2021, deferred commissions were $2.8 million and $4.8 million, respectively, which included in prepaid expenses and other current assets in the accompanying consolidated balance sheets.
Property and Equipment, Net  
(j)
Property and Equipment, Net
Property and equipment are stated at cost less accumulated depreciation and amortization. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gain or loss is included in the current period. Repair and maintenance costs are expensed as
incurred. Depreciation and amortization are calculated using the straight-line method over the following estimated useful lives of the assets:
 
    
Useful Lives
 
Manufacturing equipment
    
1-3 years
 
Developed software
     5 years  
Furniture & equipment
    
3-5
years
 
Leasehold improvements
    
3-5 years
 
Internal-Use Software  
(k)
Internal-Use
Software
The Company capitalizes costs to develop its
internal-use
software when preliminary development efforts are successfully completed, management has authorized and committed project funding, it is probable that the project will be completed, and the software will be utilized as intended. These costs include personnel and related employee benefits and expenses for employees who are directly associated with and who devote time to software projects, and external direct costs of materials and services consumed in developing or obtaining software. Costs incurred prior to meeting these criteria, together with costs incurred for training and maintenance, are expensed as incurred. Costs incurred for enhancements that are expected to provide additional material functionality are capitalized and amortized over the estimated useful life of the related upgrade. During the years ended December 31, 2022, 2021 and 2020, the Company capitalized $1.5 million, $1.1 million and $0.5 million, respectively, of
internal-use
software development costs. The remaining unamortized balance as of December 31, 2022 and December 31, 2021 of $2.7 million and $1.7 million, respectively, is included in property and equipment, net within the accompanying consolidated balance sheets.
Cost of Revenues  
(l)
Cost of Revenues
Cost of revenues includes actual cost of material, labor and related overhead incurred for revenue-producing units, and includes associated warranty costs, freight and delivery costs, depreciation, and amortization of internally developed software.
Advertising and Promotional Expenses  
(m)
Advertising and Promotional Expenses
Advertising
and promotional costs are expensed as incurred and included in sales and marketing expense in the accompanying consolidated statements of operations and comprehensive loss. Advertising costs were not material for the years ended December 31, 2022, 2021 and 2020..
Income Taxes  
(n)
Income Taxes
Income taxes are accounted for under the
asset-and-liability
method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company recognizes the effect of income tax positions only if those positions are more likely than not to be sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company recognizes accrued interest and penalties, if any, related to unrecognized tax benefits in income tax provision.
 
Foreign Currency  
(o)
Foreign Currency
The Company’s reporting currency is the US dollar. The functional currency for each of the Company’s foreign subsidiaries is the local currency, as it is the monetary unit of account of the principal economic
environments in which the Company’s foreign subsidiaries operate. Assets and liabilities of the foreign subsidiaries are translated at the current exchange rate as of the end of the period, and revenue and expenses are translated at the average exchange rates in effect during the period. The gain or loss resulting from the process of translating foreign currency financial statements into US dollar financial statements is accounted for as a foreign currency cumulative translation adjustment and is reported as a component of accumulated other comprehensive loss. Foreign currency transaction gains and losses resulting from transactions denominated in a currency other than the functional currency are recognized in Other Income (expense), net in the consolidated statements of operations and comprehensive loss.
 
Comprehensive Loss  
(p)
Comprehensive Loss
Comprehensive loss consists of two components, net loss and other comprehensive income (loss), net. The Company’s other comprehensive loss consists of foreign currency translation adjustments that result from the consolidation of its foreign entities and is reported net of tax effects.
 
Impairment of Long-Lived Assets  
(q)
Impairment of Long-Lived Assets
Long-lived assets, such as property and equipment, ROU assets, and intangible assets subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require a long-lived asset or asset group be tested for possible impairment, the Company first compares undiscounted cash flows expected to be generated by that asset or asset group to its carrying value. If the carrying value of the long-lived asset or asset group is not recoverable on an undiscounted cash flow basis, an impairment is recognized to the extent that the carrying value exceeds its fair value. Fair value is determined through various valuation techniques including discounted cash flow models, and quoted market values, as considered necessary.
There were no impairment charges for the years ended December 31, 2022, 2021 and 2020.
 
Business Combinations  
(r)
Business Combinations
The Company allocates the fair value of purchase consideration to the tangible assets acquired, liabilities assumed, and intangible assets acquired based on their estimated fair values. The excess of the fair value of purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. Such valuations require management to make significant estimates and assumptions, especially with respect to intangible assets. Significant estimates in valuing certain intangible assets include, but are not limited to, future expected cash flows from customer relationships, acquired technology, trade names from a market participant perspective, useful lives and discount rates. Management’s estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates. During the measurement period, which is one year from the acquisition date, the Company may record adjustments to the assets acquired and liabilities assumed, with the corresponding offset to goodwill. Upon the conclusion of the measurement period, any subsequent adjustments are recorded in the consolidated statements of operations and comprehensive loss.
 
Intangibles Assets, Net  
(s)
Intangibles Assets, Net
Intangible assets are recorded at the cost, less accumulated amortization. Amortization is recorded using the straight-line method. All intangible assets that have been determined to have definite lives are amortized over their estimated useful life as indicated below:
 
    
Estimated Useful Life
 
Assembled workforce
     2 years  
Deferred Transaction Costs  
(t)
Deferred Transaction Costs
Deferred transaction costs, which consist of direct incremental legal, consulting and accounting fees related to the merger with Freedom, are capitalized until they are recorded against proceeds upon the consummation of the transaction. As of December 31, 2022, the Company has recorded $1.1 million of deferred transaction costs in other noncurrent assets on the consolidated balance sheets.
 
Redeemable Convertible Preferred Stock Warrants  
(u)
Redeemable Convertible Preferred Stock Warrants
The Company has issued redeemable convertible preferred stock warrants exercisable into shares of the Company’s redeemable convertible preferred stock. The Company classifies warrants to purchase shares of convertible preferred stock that are redeemable or include an antidilution feature as liabilities. Such redeemable convertible preferred stock warrants are measured and recognized at fair value, and subject to remeasurement at each balance sheet date. At the end of each reporting period, changes in fair value during the period are recognized as a component of other income (expense), net in the accompanying consolidated statements of operations and comprehensive loss. The Company will continue to adjust the redeemable convertible preferred stock warrant liability for changes in the fair value until the earlier of the exercise or expiration of such warrants or the completion of a liquidation event, including completion of an initial public offering (“IPO”), at which time all such redeemable convertible preferred stock warrants will be converted into warrants to purchase shares of common stock, and the liability will be reclassified to additional
paid-in
capital. See Note 10 – Fair Value Measurements for details on the valuation methodology. Also see Note 14 – Warrants.
 
Stock-Based Compensation  
(v)
Stock-Based Compensation
The Company recognizes stock-based compensation expense over the requisite service period on a straight-line basis for all stock-based payments that are expected to vest to employees,
non-employees
and directors, including grants of employee stock options and other stock-based awards. Equity-classified awards issued to employees,
non-employees
such as consultants and
non-employee
directors are measured at the grant-date fair value of the award. Forfeitures are recognized as they occur. For accounting purposes, the Company estimates grant-date fair value of stock options using the Black-Scholes option pricing model. The
Black-Scholes
option pricing model requires the input of highly subjective assumptions, including the fair value of the underlying common stock prior to the Mergers, the expected term of the option the expected volatility of the price of the Company’s common stock and expected dividend yield. The Company determines these inputs as follows:
Expected Term
—Expected term represents the period that the Company’s stock-based awards are expected to be outstanding and is determined using the simplified method.
Expected Volatility
—Expected volatility is estimated by studying the volatility of comparable public companies for similar terms.
Expected Dividend
—The Black-Scholes valuation model calls for a single expected dividend yield as an input. The Company has never paid dividends and has no plans to pay dividends.
Risk-free Interest Rate
—The Company derives the risk-free interest rate assumption from the U.S. Treasury’s rates for the U.S. Treasury
zero-coupon
bonds with maturities similar to those of the expected term of the awards being valued.
Forfeitures
—The Company recognizes forfeitures as they occur.
 
Fair Value Measurements
(f)
Fair Value Measurements
The Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible. The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market.
When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels:
 
   
Level 1 inputs: Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date.
 
   
Level 2 inputs: Other than quoted prices included in Level 1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability.
 
   
Level 3 inputs: Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at the measurement date.
Financial assets and liabilities held by the Company measured at fair value on a recurring basis as of October 1, 2023 and December 31, 2022 include cash and cash equivalents, accounts receivable, accounts payable, accrued expenses, the warrant liabilities and FPA liabilities.
The carrying amounts of cash, accounts receivable, accounts payable and accrued expenses approximate their fair value because of their short-term nature (classified as Level 1).
The warrant liabilities and FPA liabilities are measured at fair value using Level 3 inputs. The Company records subsequent adjustments to reflect the increase or decrease in estimated fair value at each reporting date within the unaudited condensed consolidated statements of operations and comprehensive income (loss) as a component of other income (expense), net.
 
(w)
Fair Value Measurements
The Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible. The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market.
When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels:
 
   
Level 1 inputs: Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date.
 
   
Level 2 inputs: Other than quoted prices included in Level 1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability.
 
   
Level 3 inputs: Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at the measurement date.
The Company’s financial instruments include cash, accounts receivable, accounts payable, accrued expenses, convertible notes, SAFE agreements, notes payable, common stock warrants and redeemable convertible preferred stock warrants. The carrying amounts of cash, accounts receivable, accounts payable, accrued expenses, convertible notes and notes payable approximate their fair value because of their short- term nature (classified as level 1). The Company measures and discloses the fair value of SAFE agreements, common stock warrants and redeemable convertible preferred stock warrants under the provisions of ASC Topic 820—Fair Value Measurement (classified as level 3).
 
Convertible Debt Embedded Derivative Liabilities  
(y)
Convertible Debt Embedded Derivative Liabilities
The Company evaluates the embedded conversion feature within its convertible debt instruments under ASC
815-15
and ASC
815-40
to determine if the conversion feature meets the definition of a liability and, if so, whether to bifurcate the conversion feature and account for it as a separate derivative liability. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then
re-valued
at each reporting date, with changes in the fair value reported in the consolidated statements of operations and comprehensive loss. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the consolidated balance sheets as current or
non-current
based on whether
net-cash
settlement of the derivative instrument could be required within twelve months after the balance sheet date. The derivative is subject to
re-measurement
at the end of each reporting period, with changes in fair value recognized as a component of other income (expense), net, in the consolidated statements of operations and comprehensive loss. The Company’s embedded derivative liabilities were extinguished in the first quarter of 2022.
 
Leases  
(z)
Leases
Effective January 1, 2021, the Company early adopted Accounting Standards Update (“ASU”)
No. 2016-02,
Leases (Topic 842), as amended (“ASC 842”). The Company determines if a contract is a lease or contains a lease at the inception of the contract and reassesses that conclusion if the contract is modified. The Company’s lease agreements generally contain lease and
non-lease
components. Payments under lease
arrangements are primarily fixed. The Company combines lease and
non-lease
components and accounts for them together as a single lease component. All leases are assessed for classification as an operating lease or a finance lease. Operating lease
right-of-use
(“ROU”) assets are presented separately on the Company’s consolidated balance sheets. Operating lease liabilities are separated into a current portion and
non-current
portion and are presented separately on the Company’s consolidated balance sheets. The Company does not have finance lease ROU assets or liabilities.
ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent its obligation to make lease payments arising from the lease. The Company does not obtain and control its right to use the identified asset until the lease commencement date.
The Company’s lease liabilities are recognized at the later of January 1, 2021 and applicable lease commencement date based on the present value of the lease payments required to be paid over the lease term. Because the rate implicit in the lease is not readily determinable, the Company generally uses its incremental borrowing rate to discount the lease payments to present value. The estimated incremental borrowing rate is derived from information available at the lease commencement date. The Company’s lease terms include periods under options to extend or terminate the lease when it is reasonably certain that we will exercise that option. We generally use the base,
non-cancelable,
lease term when determining the lease assets and liabilities. The Company also records a corresponding
right-of-use
asset at the later of January 1, 2021 and applicable lease commencement date, which is calculated based on the amount of the lease liability, adjusted for any advance lease payments made, lease incentives received, and initial direct costs incurred.
Right-of-use
assets are subject to evaluation for impairment or disposal on a basis consistent with other long-lived assets.
The Company has elected, for all classes of underlying assets, not to recognize ROU assets and lease liabilities for leases with a term of twelve months or less. Lease cost for short-term leases is recognized on a straight-line basis over the lease term.
Before the adoption of ASU
2016-02
on January 1, 2021, the Company categorizes leases at their inception as either operating or capital leases, with the Company’s current lease portfolio only consisting of operating leases for office spaces. In certain lease agreements, it may receive rent holidays and other incentives. For operating leases, the Company recognizes lease costs on a straight-line basis once control of the space is achieved, without regard to deferred payment terms such as rent holidays that defer the commencement date of required payments. Additionally, incentives received are treated as a reduction of costs over the term of the agreement.
 
Direct offering costs
(g)
Direct Offering Costs
Direct offering costs represent legal, accounting and other direct costs related to the Mergers, which was consummated in July 2023. In accounting for the Mergers, direct offering costs of approximately $5.7 million were reclassified to additional
paid-in
capital and netted against the Mergers proceeds received upon close. As of October 1, 2023 and December 31, 2022, the Company had no deferred offering costs included within prepaid expenses and other current assets in its unaudited condensed consolidated balance sheets.
 
 
Warrant Liabilities
(h)
Warrant Liabilities
The Company accounts for its warrant liabilities in accordance with the guidance in ASC
815-40,
Derivatives and Hedging – Contracts in Entity’s Own Equity
, under which the warrants that do not meet the criteria for equity classification and must be recorded as liabilities. The warrant liabilities are measured at fair value at inception and at each reporting date in accordance with the guidance in ASC 820,
Fair Value Measurement
, with any subsequent changes in fair value recognized in other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive income (loss). Refer to Note 3 – Fair Value Measurements and Note 15 – Warrants.
 
 
Forward Purchase Agreements
(i)
Forward Purchase Agreements
The Company accounts for its FPAs in accordance with the guidance in ASC 480,
Distinguishing Liabilities from Equity
, as the agreements embody an obligation to transfer assets to settle a forward contract. The warrant liabilities are measured at fair value at inception and at each reporting date in accordance with the guidance in ASC 820,
Fair Value Measurement
, with any subsequent changes in fair value recognized in other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive income (loss). Refer to Note 3 – Fair Value Measurements and Note 5 – Forward Purchase Agreements.
 
 
Net Loss Per Share
(j)
Net Loss Per Share
The Company computes net loss per share following ASC 260,
Earnings Per Share
. Basic net loss per share is measured as the income or loss available to common stockholders divided by the weighted average common shares outstanding for the period. Diluted net loss per share presents the dilutive effect on a
per-share
basis from the potential exercise of options and/or warrants. The potentially dilutive effect of options or warrants are computed using the treasury stock method. Securities that potentially have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the diluted loss per share calculation.
 
(x)
Net Loss Per Share
The Company computes net loss per share in accordance with ASC 260, Earnings Per Share (“ASC 260”). Basic net loss per share is measured as the income or loss available to common stockholders divided by the weighted-average common shares outstanding for the period. Diluted net loss per share presents the dilutive effect on a per-share basis from the potential exercise of options and/or warrants. The potentially dilutive effect of options or warrants are computed using the treasury stock method. Securities that potentially have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the diluted loss per share calculation.
 
Recently Adopted Accounting Pronouncements
(k)
Recently Adopted Accounting Pronouncements
In June 2016, the FASB issued ASU
2016-13,
Financial instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments
, and subsequent related ASUs, which amends the guidance on the impairment of financial instruments by requiring measurement and recognition of expected
credit losses for financial assets held. ASU
2016-13
is effective for public and private companies’ fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2019, and December 15, 2022, respectively. The Company adopted ASU
2016-13
under the private company transition guidance beginning January 1, 2023. The adoption did not have a material impact on the Company’s unaudited condensed consolidated financial statements.
 
(aa)
Recently Adopted Accounting Pronouncements
In December 2019, the FASB issued ASU
2019-12,
Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes
. ASU
2019-12
removes certain exceptions to the general principles in Topic 740 and clarifies and amends existing guidance to improve consistent application. ASU
2019-12
will be effective for public entities for interim and annual periods beginning after December 15, 2020, with early adoption permitted. ASU
2019-12
will be effective for private entities for annual periods beginning after December 15, 2021, and interim periods beginning after December 15, 2020, with early adoption permitted. The Company adopted ASU
2019-12
under the private company transition guidance beginning January 1, 2022, and the adoption did not have an impact on the Company’s consolidated financial statements.
In May 2021, the FASB issued ASU
2021-04,
Earnings Per Share (Topic 260), Debt—Modifications and Extinguishments (Subtopic
470-50),
Compensation—Stock Compensation (Topic 718), and Derivatives and
Hedging—Contracts in Entity’s Own Equity (Subtopic
815-40):
Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options (a consensus of the FASB Emerging Issues Task Force)
. This guidance clarifies certain aspects of the current guidance to promote consistency among reporting of an issuer’s accounting for modifications or exchanges of freestanding equity-classified written call options (for example, warrants) that remain equity classified after
modification or exchange. The amendments in this update are effective for all entities for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted for all entities, including adoption in an interim period. The Company adopted ASU
2021-04
under the private company transition guidance beginning January 1, 2022, the adoption did not have an impact on the Company’s consolidated financial statements.
In August 2020, the FASB issued ASU
2020-06,
Debt—Debt with Conversion and Other Options (Subtopic
470-20)
and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic
815-40):
Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, which simplifies the accounting for convertible instruments by reducing the number of accounting models available for convertible debt instruments. This guidance also eliminates the treasury stock method to calculate diluted earnings per share for convertible instruments and requires the use of the
if-converted
method. ASU
2020-06
is effective for public and private companies’ fiscal years beginning after December 15, 2021, and December 15, 2023, respectively, and interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company adopted ASU
2020-06
under the private company transition guidance on January 1, 2022, and the adoption did not have an impact on the Company’s consolidated financial statements.
 
(ab)
Accounting Pronouncements Not Yet Adopted
In June 2016, the FASB issued ASU
2016-13,
Financial instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments
, and subsequent related ASUs, which amends the guidance on the impairment of financial instruments by requiring measurement and recognition of expected credit losses for financial assets held. ASU
2016-13
is effective for public and private companies’ fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2019, and December 15, 2022, respectively. The Company expects to adopt ASU
2016-13
under the private company transition guidance beginning January 1, 2023 and is currently evaluating the impact on the Company’s consolidated financial statements.
 
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.23.4
Summary of Significant Accounting Policies (Tables)
9 Months Ended 12 Months Ended
Oct. 01, 2023
Dec. 31, 2022
Significant Accounting Policies [Abstract]    
Schedule of Consolidated Statements of Cash Flows The Company reconciles cash, cash equivalents, and restricted cash reported in the unaudited condensed consolidated balance sheets that aggregate to the beginning and ending balances shown in the unaudited condensed consolidated statements of cash flows as follows (in thousands):
 
    
As of
 
    
October 1,
2023
    
December 31,
2022
 
Cash and cash equivalents
   $ 1,661      $ 4,409  
Restricted cash
     3,758        3,907  
  
 
 
    
 
 
 
Total cash, cash equivalents, and restricted cash
   $ 5,419      $ 8,316  
  
 
 
    
 
 
 
Total cash, cash equivalents and restricted cash is presented in the table below (in thousands):
 
    
As of December 31,
 
    
2022
    
2021
 
Cash and cash equivalents
   $ 4,409      $ 5,276  
Restricted cash
     3,907        —    
  
 
 
    
 
 
 
Total cash, cash equivalents and restricted cash
   $ 8,316      $ 5,276  
  
 
 
    
 
 
 
Schedule of Allowance for Doubtful Accounts  
The following table summarizes the allowance for doubtful accounts as of December 31, 2022, 2021, and 2020 (in thousands):
 
    
As of December 31,
 
    
2022
    
2021
    
2020
 
Balance at beginning of period
   $ (2,569    $ (2,288    $ (1,965
Provision charged to earnings
     (2,243      (364      (337
Amounts written off, recoveries and other adjustments
     —          83        14  
  
 
 
    
 
 
    
 
 
 
Balance at end of period
   $ (4,812    $ (2,569    $ (2,288
  
 
 
    
 
 
    
 
 
 
Schedule of Revenue Recognized By Product and Services
Refer to the table below for the Company’s revenue recognized by product and service type (in thousands):
 
    
Thirteen
Weeks
Ended
October 1,
2023
    
Three
Months
Ended
September 30,
2022
    
Thirty-Nine

Weeks
Ended
October 1,
2023
    
Nine Months
Ended
September 30,
2022
 
Solar energy system installations
   $ 23,915      $ 11,120      $ 64,511      $ 46,214  
Software enhanced services
     675        1,140        2,376        2,760  
  
 
 
    
 
 
    
 
 
    
 
 
 
Total revenue
   $ 24,590      $ 12,260      $ 66,887      $ 48,974  
  
 
 
    
 
 
    
 
 
    
 
 
 
Refer to the table below for the Company’s revenue recognized by product and service type (in thousands):
 
    
Years Ended December 31,
 
    
2022
    
2021
    
2020
 
Solar energy system installations
   $ 62,896      $ 66,958      $ 29,378  
Software enhanced services
     3,579        1,858        —    
  
 
 
    
 
 
    
 
 
 
Total revenue
   $ 66,475      $ 68,816      $ 29,378  
  
 
 
    
 
 
    
 
 
 
Schedule Of Property, Plant and Equipment Useful Lives   Depreciation and amortization are calculated using the straight-line method over the following estimated useful lives of the assets:
 
    
Useful Lives
 
Manufacturing equipment
    
1-3 years
 
Developed software
     5 years  
Furniture & equipment
    
3-5
years
 
Leasehold improvements
    
3-5 years
 
Schedule of Finite-Lived Intangible Assets   All intangible assets that have been determined to have definite lives are amortized over their estimated useful life as indicated below:
 
    
Estimated Useful Life
 
Assembled workforce
     2 years  
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.23.4
Fair Value Measurements (Tables)
9 Months Ended 12 Months Ended
Oct. 01, 2023
Dec. 31, 2022
Fair Value Measurements [Abstract]    
Schedule of Financial Assets and Liabilities
The following table sets forth the Company’s financial assets and liabilities that were measured at fair value, on a recurring basis (in thousands):
 
    
As of October 1, 2023
 
    
Level 1
    
Level 2
    
Level 3
    
Total
 
Financial Liabilities
           
Carlyle warrants
   $ —        $ —        $ 7,683      $ 7,683  
Public warrants
     1,413        —          —          1,413  
Private placement warrants
     —          1,027        —          1,027  
Working capital warrants
     —          117        —          117  
Forward purchase agreement liabilities
     —          —          6,586        6,586  
  
 
 
    
 
 
    
 
 
    
 
 
 
Total
   $ 1,413      $ 1,144      $ 14,269      $ 16,826  
  
 
 
    
 
 
    
 
 
    
 
 
 
    
As of December 31, 2022
 
    
Level 1
    
Level 2
    
Level 3
    
Total
 
Financial Liabilities
           
Redeemable convertible preferred stock warrant liability
   $ —        $ —        $ 14,152      $ 14,152  
  
 
 
    
 
 
    
 
 
    
 
 
 
Total
   $ —        $ —        $ 14,152      $ 14,152  
  
 
 
    
 
 
    
 
 
    
 
 
 
The following table sets forth the Company’s financial assets and liabilities that were measured at fair value, on a recurring basis (in thousands):
    
As of December 31, 2022
 
    
Level 1
    
Level 2
    
Level 3
    
Total
 
Financial Liabilities
           
Redeemable convertible preferred stock warrant liability
   $   —         $   —         $  14,152      $  14,152  
  
 
 
    
 
 
    
 
 
    
 
 
 
Total
   $ —        $ —        $ 14,152      $ 14,152  
  
 
 
    
 
 
    
 
 
    
 
 
 
    
As of December 31, 2021
 
    
Level 1
    
Level 2
    
Level 3
    
Total
 
Financial Liabilities
           
Redeemable convertible preferred stock warrant liability
   $ —        $ —        $ 1,129      $ 1,129  
Convertible debt embedded derivatives
     —          —          1,481        1,481  
SAFE agreements
     —          —          6,397        6,397  
  
 
 
    
 
 
    
 
 
    
 
 
 
Total
   $ —        $ —        $ 9,007      $ 9,007  
  
 
 
    
 
 
    
 
 
    
 
 
 
Schedule of Warrants Based on a Black Scholes Option Pricing Method. The Company valued the warrants based on a Black-Scholes Option Pricing Method, which included the following inputs:
    
October 1,
2023
   
December 31,
2022
 
Expected term
     7.0 years        
Expected volatility
     77.0     —    
Risk-free interest rate
     3.92     —    
Expected dividend yield
     0.0     —    
The expected volatility is determined based on the historical equity volatility of comparable companies over a period that matches the simulation period, which included the following inputs:
    
October 1,
2023
   
December 31,
2022
 
Common stock trading price
   $ 2.10       —    
Simulation period
     1.8 years        
Risk-free rate
     5.12     —    
Volatility
     178.0     —    
Series B Redeemable Convertible Preferred Stock Warrant
 
    
October 1,
2023
    
December 31,
2022
 
Expected term
     —         
3.1 
years
 
Expected volatility
     —          72.5
Risk-free interest rate
     —          4.2
Expected dividend yield
     —          0.0
Series C Redeemable Convertible Preferred Stock Warrant
 
    
October 1,
2023
    
December 31,
2022
 
Expected term
     —          3.6 years  
Expected volatility
     —          72.5
Risk-free interest rate
     —          4.0
Expected dividend yield
     —          0.0
Series
D-7
Redeemable Convertible Preferred Stock Warrant
 
    
October 1,
2023
    
December 31,
2022
 
Expected term
     —          1.5 years  
Expected volatility
     —          78.5
Risk-free interest rate
     —          4.7
Expected dividend yield
     —          0.0
The following assumptions were used to calculate the fair value of the redeemable convertible preferred stock warrant liability:
Series B Redeemable Convertible Preferred Stock Warrant
 
    
December 31,
 
    
2022
   
2021
 
Expected term
     3.1 years       4.1 years  
Expected volatility
     72.5     73.0
Risk-free interest rate
     4.2     1.1
Expected dividend yield
     0.0     0.0
Series C Redeemable Convertible Preferred Stock Warrant
 
    
December 31,
 
    
2022
   
2021
 
Expected term
     3.6 years       4.6 years  
Expected volatility
     72.5     73.0
Risk-free interest rate
     4.0     1.2
Expected dividend yield
     0.0     0.0
Series D Redeemable Convertible Preferred Stock Warrant
 
    
December 31,
 
    
2022
   
2021
 
Expected term
     1.5 years       —    
Expected volatility
     78.5     —    
Risk-free interest rate
     4.7     —    
Expected dividend yield
     0.0     —    
Schedule of Significant Unobservable Inputs (Level 3), and the Change in Fair Value Recorded in Other Income (Expense)  
The following table presents a reconciliation of the Company’s financial liabilities measured at fair value as of December 31, 2022 using significant unobservable inputs (Level 3), and the change in fair value recorded in other income (expense), net in the accompanying consolidated statements of operations and comprehensive loss (in thousands):
 
    
Warrant
    
Convertible
Debt
Embedded
Derivatives
    
SAFEs
 
Balance as of December 31, 2020
   $ 799      $ 579      $ 91  
Issuance of
2021-A
Convertible Notes
     —          566        —    
Issuance of 2021-Rogers SAFE
     —          —          5,000  
Change in fair value
     330        336        1,306  
  
 
 
    
 
 
    
 
 
 
Balance as of December 31, 2021
   $ 1,129      $ 1,481      $ 6,397  
Conversion of debt into preferred shares
     —          (1,481      —    
Conversion of SAFEs into preferred shares
     —          —          (6,397
Assumption of SAFEs in Solaria acquisition
     —          —          60,470  
Conversion of SAFEs from Solaria acquisition into preferred shares
     —          —          (60,470
Issuance of Series D Warrants Tranche A
     6,527        —          —    
Issuance of Series D Warrants Tranche B
     1,285        —          —    
Change in fair value
     5,211        —          —    
  
 
 
    
 
 
    
 
 
 
Balance as of December 31, 2022
   $  14,152      $ —        $ —    
  
 
 
    
 
 
    
 
 
 
Schedule of Reconciles the Change in Value of the Redeemable Convertible Preferred Stock Warrant Liability  
The table below reconciles the change in value of the redeemable convertible preferred stock warrant liability from each warrant to the total redeemable convertible preferred stock warrant liability recorded within the accompanying consolidated balance sheets (amounts in thousands):
 
    
Series B
Warrants
    
Series C
Warrants
    
Series D

Tranche A
Warrants
    
Series D
Tranche B
Warrants
    
Total
 
Balance as of December 31, 2020
   $ 5      $ 794      $ —        $ —        $ 799  
Change in fair value
     3        327        —          —          330  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Balance as of December 31, 2021
     8        1,121        —          —          1,129  
Change in fair value
     42        5,169        —          —          5,211  
Issuance of warrants in connection with acquisition of Solaria (Note 3)
     —          —          6,527        1,285        7,812  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Balance as of December 31, 2022
   $  50      $  6,290      $  6,527      $  1,285      $  14,152  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Schedule of Reconciliation of Embedded Derivative Liability  
The table below reconciles the embedded derivative liability from each of the series of convertible notes to the total derivative liability recorded on the accompanying consolidated balance sheets (amounts in thousands)
 
    
2019-A

Convertible
Notes
    
2020-A

Convertible
Notes
    
2021-A

Convertible
Notes
    
Totals
 
Balance as of December 31, 2020
   $ 18      $ 561      $ —        $ 579  
Issuance of
2021-A
Convertible Notes
     —          —          566        566  
Change in fair value
     17        234        85        366  
  
 
 
    
 
 
    
 
 
    
 
 
 
Balance as of December 31, 2021
     35        795        651        1,481  
Extinguishment upon Series D issuance
     (35      (795      (651      (1,481
  
 
 
    
 
 
    
 
 
    
 
 
 
Balance as of December 31, 2022
   $  —        $ —        $ —        $ —    
  
 
 
    
 
 
    
 
 
    
 
 
 
Schedule of Next Equity Financing Based on Inputs Included in a Black-Scholes Model   The realizable value upon the Next Equity Financing was determined based on the following inputs that were included in a Black-Scholes model, which contains the following inputs:
 
    
December 31,
 
    
2022
  
2021
 
Expected fair value of preferred stock
   N/A    $ 4.84  
Expected term
   N/A      0.2 years  
Volatility
   N/A      76.4
Risk-free interest rate
   N/A      0.1
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.23.4
Reverse Recapitalization (Tables)
9 Months Ended 12 Months Ended
Oct. 01, 2023
Dec. 31, 2022
Reverse Recapitalization [Abstract]    
Schedule of Reconciles Elements of the Merger The following table reconciles the elements of the Mergers to the unaudited condensed consolidated statements of cash flows and the unaudited condensed consolidated statements of stockholders’ deficit for the thirty-nine week ended October 1, 2023 (in thousands):
 
    
Recapitalization
 
Cash proceeds from FACT, net of redemptions
   $ 36,539  
Cash proceeds from PIPE Financing
     12,800  
Less: cash payment of FACT transaction costs and underwriting fees
     (10,680
Less: cash payment to FPA investors for rebates and recycled shares
     (17,831
Less: cash payment for Promissory Note
     (1,170
  
 
 
 
Net cash proceeds upon the closing of the Mergers and PIPE financing
     19,658  
Less:
non-cash
net liabilities assumed from FACT
     (10,135
  
 
 
 
Net contributions from the Mergers and PIPE financing upon closing
   $ 9,523  
  
 
 
 
 
Schedule of Common Stock Outstanding The following table presents the number of shares of Complete Solaria Common Stock outstanding immediately following the consummation of the Mergers:
 
    
Recapitalization
 
FACT Class A Ordinary Shares, outstanding prior to Mergers
     34,500,000  
FACT Class B Ordinary Shares, outstanding prior to Mergers
     8,625,000  
Bonus shares issued to sponsor
     193,976  
Bonus shares issued to PIPE investors
     120,000  
Bonus shares issued to FPA investors
     150,000  
Shares issued from PIPE financing
     1,690,000  
Shares issued from FPA agreements, net of recycled shares
     5,558,488  
Less: redemption of FACT Class A Ordinary Shares
     (31,041,243
  
 
 
 
Total shares from the Mergers and PIPE Financing
     19,796,221  
Legacy Complete Solaria shares
     20,034,257  
2022 Convertible Note Shares
     5,460,075  
  
 
 
 
Shares of Complete Solaria Common stock immediately after Mergers
     45,290,553  
  
 
 
 
The following table presents the number of shares of Complete Solaria Common Stock outstanding immediately following the consummation of the Mergers:
 
    
Recapitalization
 
FACT Class A Ordinary Shares, outstanding prior to Mergers
     34,500,000  
FACT Class B Ordinary Shares, outstanding prior to Mergers
     8,625,000  
Bonus shares issued to sponsor
     193,976  
Bonus shares issued to PIPE investors
     120,000  
Bonus shares issued to FPA investors
     150,000  
Shares issued from PIPE financing
     1,690,000  
Shares issued from FPA agreements, net of recycled shares
     5,558,488  
Less: redemption of FACT Class A Ordinary Shares
     (31,041,243
  
 
 
 
Total shares from the Mergers and PIPE Financing
     19,796,221  
Legacy Complete Solaria shares
     20,034,257  
2022 Convertible Note Shares
     5,460,075  
  
 
 
 
Shares of Complete Solaria Common stock immediately after Mergers
     45,290,553  
  
 
 
 
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.23.4
Business Combination (Tables)
9 Months Ended 12 Months Ended
Oct. 01, 2023
Dec. 31, 2022
Business Combination [Abstract]    
Schedule of Assets Acquired and Liabilities Assumed
The following table summarized the provisional fair value of identifiable assets acquired and liabilities assumed (in thousands):
 
    
Amount
 
Cash, cash equivalents and restricted cash
   $ 5,402  
Accounts receivable
     4,822  
Inventories
     5,354  
Prepaid expenses and other current assets
     8,569  
Property and equipment
     830  
Operating lease
right-of-use
assets
     1,619  
Intangible assets
     43,100  
Other
non-current
assets
     112  
  
 
 
 
Total identifiable assets acquired
     69,808  
Accounts payable
     4,210  
Accrued expenses and other current liabilities
     11,845  
Notes payable
     20,823  
Deferred revenue
     73  
Operating lease liabilities, net of current portion
     1,132  
Warranty provision, noncurrent
     1,566  
SAFE agreements
     60,470  
  
 
 
 
Total identifiable liabilities assumed
     100,119  
  
 
 
 
Net identifiable liabilities assumed
     30,311  
Goodwill
     119,422  
  
 
 
 
Total aggregate consideration paid
   $ 89,111  
  
 
 
 
The following table summarized the provisional fair value of identifiable assets acquired and liabilities assumed (in thousands):
 
Cash, cash equivalents and restricted cash
   $ 5,402  
Accounts receivable
     4,822  
Inventories
     5,354  
Prepaid expenses and other current assets
     8,569  
Property and equipment
     830  
Operating lease
right-of-use
asset
     1,619  
Intangible assets
     43,100  
Other
non-current
assets
     112  
  
 
 
 
Total identifiable assets acquired
     69,808  
Accounts payable
     4,210  
Accrued expenses and other current liabilities
     11,845  
Notes payable
     20,823  
Deferred revenue
     73  
Operating lease liabilities, net of current portion
     1,132  
Warranty provision, noncurrent
     1,566  
SAFE agreements
     60,470  
  
 
 
 
Total identifiable liabilities assumed
     100,119  
  
 
 
 
Net identifiable liabilities assumed
     30,311  
Goodwill
     119,422  
  
 
 
 
Total aggregate consideration paid
   $ 89,111  
  
 
 
 
Schedule of Intangible Assets Acquired
Intangible assets acquired are as follows (in thousands):
 
    
Amount
 
Trademarks
   $ 5,700  
Developed technology
     12,700  
Customer relationships
     24,700  
  
 
 
 
Total intangible assets
   $ 43,100  
  
 
 
 
Intangible assets acquired and subsequently disposed of as part of the Solaria disposition discussed in Note 5 below are as follows (in thousands):
 
Trademarks
   $ 5,700  
Developed technology
     12,700  
Customer relationships
     24,700  
  
 
 
 
Total intangible asset
   $ 43,100  
  
 
 
 
Schedule of Unaudited Combined Pro Forma Information Actual results may differ from the unaudited combined pro forma information presented below (in thousands):
 
    
Three Months
Ended
September 30,
2022
    
Nine Months
Ended
September 30,
2022
 
Revenues
   $ 22,267      $ 79,800  
Net loss
   $ (26,498    $ (49,935
 
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.23.4
Prepaid Expenses and Other Current Assets (Tables)
9 Months Ended 12 Months Ended
Oct. 01, 2023
Dec. 31, 2022
Prepaid Expenses and Other Current Assets [Abstract]    
Schedule of Prepaid Expenses and Other Current Assets
Prepaid expenses and other current assets consists of the following (in thousands):
 
    
As of
 
    
October 1,
2023
    
December 31,
2022
 
Inventory deposits
   $ 3,497      $ 6,255  
Prepaid sales commissions
     5,509        2,838  
  
 
 
    
 
 
 
Other
     941        978  
  
 
 
    
 
 
 
Total prepaid expenses and other current assets
   $ 9,947      $ 10,071  
  
 
 
    
 
 
 
Prepaid expenses and other current assets consists of the following (in thousands):
 
    
As of December 31,
 
    
2022
    
2021
 
Inventory deposits. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
   $ 6,255      $ —    
Prepaid sales commissions . . . . . . . . . . . . . . . . . . . . . . .
     2,838        4,771  
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
     978        184  
  
 
 
    
 
 
 
Total prepaid expenses and other current assets . . .
   $ 10,071      $ 4,955  
  
 
 
    
 
 
 
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.23.4
Divestiture (Tables)
9 Months Ended 12 Months Ended
Oct. 01, 2023
Dec. 31, 2022
Divestiture [Abstract]    
Schedule of Operations and Comprehensive Income (Loss) Related to Discontinued Operations
Components of amounts reflected in the unaudited condensed consolidated statements of operations and comprehensive income (loss) related to discontinued operations are presented in the table, as follows (in thousands):
 
    
Thirteen Weeks
Ended
October 1,
2023
    
Thirty-Nine
Weeks Ended
October 1,
2023
 
Revenues
   $ 3,774      $ 29,048  
Cost of revenues
     4,102        30,609  
  
 
 
    
 
 
 
Gross loss
     (328      (1,561
Operating expenses:
     
Sales and marketing
     2,425        6,855  
General and administrative
     5,681        12,572  
  
 
 
    
 
 
 
Total operating expenses
     8,106        19,427  
  
 
 
    
 
 
 
Loss from discontinued operations
     (8,434      (20,988
Other income (expense), net
     31        32  
  
 
 
    
 
 
 
Loss from discontinued operations before income taxes
     (8,403      (20,956
Income tax benefit (provision)
     (1      3  
Impairment loss from discontinued operations
     (147,505      (147,505
  
 
 
    
 
 
 
Net loss from discontinued operations
   $ (155,909    $ (168,458
  
 
 
    
 
 
 
Components of amounts reflected in the consolidated statements of operations and comprehensive income (loss) related to discontinued operations are presented in the table, as follows (in thousands):
 
    
December 31, 2022
 
Revenues
   $ 13,325  
Cost of revenues
     12,847  
  
 
 
 
Gross profit
     478  
Operating expenses:
  
Sales and marketing
     1,315  
General and administrative
     617  
  
 
 
 
Total operating expenses
     1,932  
  
 
 
 
Net loss from discontinued operations
   $ (1,454
  
 
 
 
Schedule of Major Categories of Assets and Liabilities Held for Sale
The following is a summary of the major categories of assets and liabilities held for sale (in thousands):
 
    
As of
 
    
October 1,
2023
    
December 31,
2022
 
Intangible assets, net
   $ 12,299      $ 42,610  
Goodwill
     —          119,422  
  
 
 
    
 
 
 
Long-term assets held for sale
   $ 12,299      $ 162,032  
  
 
 
    
 
 
 
The following is a summary of the major categories of assets and liabilities held for sale (in thousands):
 
    
December 31, 2022
 
Intangible assets, net
   $ 42,610  
Goodwill
     119,422  
  
 
 
 
Long-term assets held for sale
   $ 162,032  
  
 
 
 
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.23.4
Property and Equipment, Net (Tables)
9 Months Ended 12 Months Ended
Oct. 01, 2023
Dec. 31, 2022
Property and Equipment, Net [Abstract]    
Schedule of Property and Equipment, Net
Property and equipment, net consists of the following (in thousands, except year data):
 
    
Estimated
    
As of
 
    
Useful Lives
(Years)
    
October 1,
2023
    
December 31,
2022
 
Developed software
     5      $ 6,559      $ 5,054  
Manufacturing equipment
     3        131        102  
Furniture and equipment
     3        90        90  
Leasehold improvements
     5        708        708  
     
 
 
    
 
 
 
Total property and equipment
        7,488        5,954  
Less: accumulated depreciation and amortization
        (3,303      (2,478
     
 
 
    
 
 
 
Total property and equipment, net
      $ 4,185      $ 3,476  
     
 
 
    
 
 
 
Property and equipment, net consists of the following (in thousands):
 
    
As of December 31,
 
    
2022
    
2021
 
Developed software
   $ 5,054      $ 3,540  
Manufacturing equipment.
     102        70  
Furniture & equipment
     90        —    
Leasehold improvements
     708        —    
  
 
 
    
 
 
 
Total property and equipment
     5,954        3,610  
Less accumulated depreciation and amortization
     (2,478      (1,852
  
 
 
    
 
 
 
Total property and equipment, net
   $ 3,476      $ 1,758  
  
 
 
    
 
 
 
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.23.4
Goodwill and Intangible Assets (Tables)
9 Months Ended 12 Months Ended
Oct. 01, 2023
Dec. 31, 2022
Goodwill and Intangible Assets [Abstract]    
Schedule of Intangible Assets
The following table provides a reconciliation of intangible assets reported as of October 1, 2023 and December 31, 2022 (in thousands, except years data):
 
    
As of October 1, 2023
 
    
Gross
Carrying
Amount
    
Impairment
    
Held for
Sale
    
Accumulated
Amortization
    
Net
Amount
 
Assembled workforce
   $ 137      $ —        $ —          (137    $ —    
Trademarks
     5,700        (3,714      (1,463      (523      —    
Customer relationship
     24,700        (16,094      (7,577      (1,029      —    
Developed technology
     12,700        (8,275      (3,259      (1,166      —    
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Total intangible assets
   $ 43,237      $ (28,083    $ (12,299    $ (2,855    $ —    
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
 
    
As of December 31, 2022
 
    
Weighted-
Average
Remaining
Life
(Years)
    
Gross
Carrying
Amount
    
Accumulated
Amortization
    
Net
Amount
 
Assembled workforce
     0.1      $ 137      $ (133    $ 4  
Trademarks
     9.8        5,700        (95      5,605  
Customer relationship
     21.8        24,700        (187      24,513  
Developed technology
     9.8        12,700        (212      12,488  
     
 
 
    
 
 
    
 
 
 
Total intangible assets
      $ 43,237      $ (627    $ 42,610  
     
 
 
    
 
 
    
 
 
 
Intangible assets consisted of the following (in thousands, except years data):
 
    
As of December 31, 2022
    
As of December 31, 2021
 
    
Weighted-
Average
Remaining
Life (Years)
    
Gross
Carrying
Amount
    
Accumulated
Amortization
   
Net
Amount
    
Gross
Carrying
Amount
    
Accumulated
Amortization
   
Net
Amount
 
Assembled workforce
     0.1      $  137      $  (133   $  4      $  137      $ (65   $  72  
Schedule of Amortization Expense Related to Intangible Assets
Amortization expense related to intangible assets for the thirteen and thirty-nine weeks ended October 1, 2023 and the three and nine months ended September 30, 2022 were as follows (in thousands):
 
    
Thirteen Weeks
Ended
October 1,
2023
    
Three Months
Ended
September 30,
2022
    
Thirty-Nine

Weeks Ended
October 1,
2023
    
Nine Months
Ended
September 30,
2022
 
Assembled workforce
   $ —        $ 17      $ 4      $ 51  
Trademarks
     142        —          428        —    
Customer relationship
     279        —          843        —    
Developed technology
     317        —          953        —    
  
 
 
    
 
 
    
 
 
    
 
 
 
Total amortization expense
   $ 738      $ 17      $ 2,228      $ 51  
  
 
 
    
 
 
    
 
 
    
 
 
 
 
XML 52 R42.htm IDEA: XBRL DOCUMENT v3.23.4
Accrued Expenses and Other Current Liabilities (Tables)
9 Months Ended 12 Months Ended
Oct. 01, 2023
Dec. 31, 2022
Accrued Expenses and Other Current Liabilities [Abstract]    
Schedule of Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities consist of the following (in thousands):
 
    
As of
 
    
October 1,
2023
    
December 31,
2022
 
Accrued compensation and benefits
   $ 3,666      $ 3,940  
Customer deposits
     1,167        930  
Uninvoiced contract costs
     3,554        1,914  
Inventory received but not invoiced
     1,391        972  
Accrued term loan and revolving loan amendment and final payment fees
     2,175        2,400  
Accrued legal settlements
     2,955        1,853  
Accrued taxes
     931        1,245  
Accrued rebates and credits
     880        1,076  
Operating lease liabilities, current
     720        958  
Revenue warranty
     918        —    
Deferred underwriters’ discount payable
     3,019        —    
Accrued warranty, current
     605        767  
Other accrued liabilities
     4,693        3,775  
  
 
 
    
 
 
 
Total accrued expenses and other current liabilities
   $ 26,674      $ 19,830  
  
 
 
    
 
 
 
Accrued expenses and other current liabilities consist of the following (in thousands):
 
    
December 31,
 
    
2022
    
2021
 
Accrued compensation and benefits
   $ 3,940      $  3,498  
Accrued term loan and revolving loan amendment and final payment fees
     2,400        —    
Uninvoiced contract costs
     1,914        2,180  
Accrued legal settlements
     1,853        —    
Accrued taxes
     1,245        —    
Accrued rebates and credits
     1,076        —    
Inventory received but not invoiced
     972        —    
Operating lease liabilities, current
     958        390  
Customer deposits
     930        1,375  
Warranty provision, current
     767        600  
Other accrued liabilities
     3,775        1,304  
  
 
 
    
 
 
 
Total accrued expenses and other current liabilities
   $ 19,830      $ 9,347  
  
 
 
    
 
 
 
XML 53 R43.htm IDEA: XBRL DOCUMENT v3.23.4
Other Income (Expense), Net (Tables)
9 Months Ended 12 Months Ended
Oct. 01, 2023
Dec. 31, 2022
Other Income (Expense), Net [Abstract]    
Schedule of Other Income (Expense), Net
Other income (expense), net consists of the following (in thousands):
 
    
Thirteen
Weeks
Ended
October 1,
2023
   
Three

Months
Ended
September 30,
2022
    
Thirty-Nine

Weeks
Ended

October 1,
2023
   
Nine
Months
Ended
September 30,
2022
 
Change in fair value of redeemable convertible preferred stock warrant liability
   $ 39     $ 3      $ 9,455     $ (142
Change in fair value of Carlyle warrants
     12,689       —          12,689       —    
Change in fair value of FACT public, private placement and working capital warrants
     4,170       —          4,170       —    
Gain on extinguishment of convertible notes and SAFE agreements
(1)
     —         —          —         3,235  
Loss on CS Solis debt extinguishment
     (10,338     —          (10,338     —    
Bonus shares issued in connection with the Mergers
(2)
     (2,394     —          (2,394     —    
Issuance of forward purchase agreements
(3)
     76       —          76       —    
Change in fair value of forward purchase agreement liabilities
(4)
     (6,661     —          (6,661     —    
Issuance of shares in connection with the forward purchase agreements
(5)
     (35,490     —          (35,490     —    
Other, net
     (94     1        191       87  
  
 
 
   
 
 
    
 
 
   
 
 
 
Total other income (expense), net
   $ (38,003   $ 4      $ (28,302   $ 3,180  
  
 
 
   
 
 
    
 
 
   
 
 
 
 
(1)
 
Includes zero and $1.4 million of other income for the three and nine months ended September 30, 2022, respectively, recognized upon the conversion of related party convertible notes and SAFEs.
(2)
 
Includes $0.7 million of other expense for each of the thirteen and thirty-nine weeks ended October 1, 2023 for bonus shares issued to related parties in connection with the Mergers.
(3)
 
Includes $0.3 million of other income for each of the thirteen and thirty-nine weeks ended October 1, 2023 for forward purchase agreements entered into with related parties.
(4)
 
Includes $5.9 million of other expense for each of the thirteen and thirty-nine weeks ended October 1, 2023 for forward purchase agreements entered into with related parties.
(5)
 
Includes $30.7 million of other expense for each of the thirteen and thirty-nine weeks ended October 1, 2023 for shares issued to related parties in connection with the forward purchase agreements.
Other income (expense), net consists of the following (in thousands):
 
    
Years Ended December 31,
 
    
2022
    
2021
   
2020
 
Change in fair value of SAFE agreements
   $ —        $  (1,306   $  (15
Change in fair value of derivative liabilities
     —          (336     (50
Change in fair value of warrant liabilities
     (5,211      (330     24  
Gain on extinguishment of convertible notes and SAFE agreements
(1)
     3,235        —         —    
Forgiveness of Paycheck Protection Plan loan
     —          1,754       —    
Other, net
     118        (22     —    
  
 
 
    
 
 
   
 
 
 
Total other income (expense), net
   $  (1,858 )    $ (240)     $  (41
  
 
 
    
 
 
   
 
 
 
 
(1)
Includes $1.4 million of other income recognized upon the conversion of related party convertible notes and SAFEs
XML 54 R44.htm IDEA: XBRL DOCUMENT v3.23.4
Common Stock (Tables)
9 Months Ended 12 Months Ended
Oct. 01, 2023
Dec. 31, 2022
Common Stock [Abstract]    
Schedule of Reserved Shares of Common Stock
The Company has reserved shares of common stock for issuance related to the following:
 
    
As of
October 1,
2023
 
Common stock warrants
     27,637,266  
Employee stock purchase plan
     2,628,996  
Stock options and RSUs, issued and outstanding
     7,013,514  
Stock options and RSUs, authorized for future issuance
     8,625,023  
  
 
 
 
Total shares reserved
     45,904,799  
  
 
 
 
The Company has reserved shares of common stock for issuance related to the following redeemable convertible preferred stock, stock options, common stock warrants, redeemable convertible preferred stock warrants, and future grants:
 
    
As of December 31,
 
    
2022
    
2021
 
Common stock warrants
     3,389,005        690,236  
Stock options, issued and outstanding
     4,970,395        2,135,454  
Stock options, authorized for future issuance
     369,907        141,644  
SAFE agreement
     —          341,604  
Convertible notes
     —          1,621,299  
  
 
 
    
 
 
 
Total shares reserved
     8,729,307        4,930,237  
  
 
 
    
 
 
 
XML 55 R45.htm IDEA: XBRL DOCUMENT v3.23.4
Warrants (Tables)
12 Months Ended
Dec. 31, 2022
Warrants [Abstract]  
Schedule of Fair Value of The Common Stock Warrants
The following assumptions were used to calculate the fair value of the common stock warrants issued:
 
    
Years Ended December 31,
     2022   2021
Expected term
  
1.5 
- 7.0 years
 
10.0 - 12.0 years
Expected volatility
  
73.0 - 78.5%
  73.0%
Risk-free interest rate
   1.9 - 4.7%   1.3% - 1.7%
Expected dividends
   0.0%   0.0%
XML 56 R46.htm IDEA: XBRL DOCUMENT v3.23.4
Borrowing Arrangements (Tables)
9 Months Ended 12 Months Ended
Oct. 01, 2023
Dec. 31, 2022
Borrowing Arrangements [Line Items]    
Schedule of Convertible Notes
As of October 1, 2023 and December 31, 2022, the Company’s convertible notes consisted of the following (in thousands):
 
    
As of
 
    
October 1,
2023
    
December 31,
2022
 
Convertible notes, net, noncurrent
     
2022 Convertible Notes
   $   —      $ 3,434  
2022 Convertible Notes due to related parties
       —        15,510  
  
 
 
    
 
 
 
Total convertible notes
   $   —      $ 18,944  
  
 
 
    
 
 
 
As of December 31, 2022 and December 31, 2021, the Company’s convertible notes consisted of the following (in thousands):
 
   
As of December 31,
 
   
2022
    
2021
 
Convertible notes, net
    
2019-A
Convertible Notes
  $ —        $ 115  
2020-A
Convertible Notes
    —          630  
2021-A
Convertible Notes
    —          1,145  
 
 
 
    
 
 
 
Convertible notes, net
    —          1,890  
 
 
 
    
 
 
 
Convertible notes, net due to related parties
    
2020-A
Convertible Notes
    —          3,260  
2021-A
Convertible Notes
    —          3,050  
Convertible Promissory Notes with Ecosystem Integrity Fund II, LP.
    —          510  
 
 
 
    
 
 
 
Convertible notes, net due to related parties
    —          6,820  
 
 
 
    
 
 
 
Convertible notes, net, noncurrent
    
2022 Convertible Notes
    3,434        —    
 
 
 
    
 
 
 
Convertible notes, net, noncurrent
    3,434        —    
 
 
 
    
 
 
 
Convertible notes, net due to related parties, noncurrent
    
2022 Convertible Notes
    15,510        —    
 
 
 
    
 
 
 
Convertible notes, net due to related parties, noncurrent
    15,510        —    
 
 
 
    
 
 
 
Total convertible notes
  $ 18,944      $ 8,710  
 
 
 
    
 
 
 
Schedule of Company's outstanding notes payable  
The following table summarizes the Company’s outstanding notes payable (in thousands):
 
    
As of December 31,
 
    
  2022  
    
  2021  
 
Loan and Security Agreement
   $ —        $ 6,987  
2021 Promissory Notes
     —          2,500  
Current Insight Promissory Note
     —          20  
  
 
 
    
 
 
 
     —          9,507  
Less: Unamortized debt issuance costs and discounts
     —          —    
  
 
 
    
 
 
 
   $ —        $ 9,507  
  
 
 
    
 
 
 
Two Thousand And Nineteen A Convertible Notes [Member]    
Borrowing Arrangements [Line Items]    
Schedule of Convertible Notes  
The net carrying amount of the convertible notes was as follows (in thousands):
 
    
As of December 31,
 
    
2022
   
2021
 
Principal
   $ 100     $ 100  
Unamortized debt discount
     —         —    
PIK interest added to principal balance
     16       15  
Conversion to Series D-2 redeemable convertible preferred stock
     (116     —    
  
 
 
   
 
 
 
Net carrying amount
   $ —       $ 115  
  
 
 
   
 
 
 
Schedule Of Interest Expense On Convertible Debt  
Interest expense related to the convertible notes was as follows (in thousands):
 
    
As of December 31,
 
    
2022
    
2021
    
2020
 
Amortization of debt discount
   $ —        $ —        $ 4  
PIK interest
     1        12        3  
  
 
 
    
 
 
    
 
 
 
Total
non-cash
interest expense
   $ 1      $ 12      $ 7  
  
 
 
    
 
 
    
 
 
 
Two Thousand And Twenty A Convertible Notes [Member]    
Borrowing Arrangements [Line Items]    
Schedule of Convertible Notes  
The net carrying amount of the convertible notes was as follows (in thousands):
 
    
As of December 31,
 
    
2022
    
2021
 
Principal
   $ 3,784      $ 3,784  
Unamortized debt discount
     —          —    
PIK interest added to principal balance
     122        106  
Conversion to Series
D-1
redeemable convertible preferred stock
     (3,906      —    
  
 
 
    
 
 
 
Net carrying amount
   $ —        $ 3,890  
  
 
 
    
 
 
 
Schedule Of Interest Expense On Convertible Debt  
Interest expense related to the convertible notes was as follows (in thousands):
 
    
As of December 31,
 
    
2022
    
2021
    
2020
 
Amortization of debt discount . . . . . . . . . . . . . . . . . . . . . . . . .
   $ —        $ 281      $ 235  
PIK interest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
     16        74        32  
  
 
 
    
 
 
    
 
 
 
Total
non-cash
interest expense . . . . . . . . . . . . . . . . . . . . . . . .
   $ 16      $ 355      $ 267  
  
 
 
    
 
 
    
 
 
 
Two Thousand And Twenty One Convertible Notes [Member]    
Borrowing Arrangements [Line Items]    
Schedule of Convertible Notes  
The net carrying amount of the convertible notes was as follows (in thousands):
 
    
As of December 31,
 
    
2022
    
2021
 
Principal
   $ 4,250      $ 4,250  
Unamortized debt discount
     —          (112
PIK interest added to principal balance
     74        57  
Conversion to Series
D-1
redeemable convertible preferred stock
     (4,324      —    
  
 
 
    
 
 
 
Net carrying amount
   $ —        $ 4,195  
  
 
 
    
 
 
 
Schedule Of Interest Expense On Convertible Debt  
Interest expense related to the convertible notes was as follows (in thousands):
 
    
As of December 31,
 
    
2022
    
2021
    
2020
 
Amortization of debt discount . . . . . . . . . . . . . . . . . . . . . . . . .
   $ 112      $ 454      $ —    
PIK interest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
     17        57        —    
  
 
 
    
 
 
    
 
 
 
Total
non-cash
interest expense . . . . . . . . . . . . . . . . . . . . . . . .
   $ 129      $ 511      $ —    
  
 
 
    
 
 
    
 
 
 
Two Thousand And Twenty One A Convertible Notes With Embedded Derivative Liability [Member]    
Borrowing Arrangements [Line Items]    
Schedule of Convertible Notes  
The net carrying amount of the
2021-A
convertible note without an embedded derivative liability was as follows (in thousands):
 
    
As of December 31,
 
    
2022
   
2021
 
Principal
   $ 500     $ 500  
Unamortized debt discount
     —         —    
PIK interest added to principal balance
     10       10  
Repayment of principal and accrued interest
     (510     —    
  
 
 
   
 
 
 
Net carrying amount
   $ —       $ 510  
  
 
 
   
 
 
 
Schedule Of Interest Expense On Convertible Debt  
Interest expense related to the note was as follows (in thousands):
 
    
As of December 31,
 
    
2022
    
2021
    
2020
 
Amortization of debt discount
   $ —        $ —        $ —    
PIK interest
     —          10        —    
  
 
 
    
 
 
    
 
 
 
Total
non-cash
interest expense
   $ —        $ 10      $ —    
  
 
 
    
 
 
    
 
 
 
XML 57 R47.htm IDEA: XBRL DOCUMENT v3.23.4
Stock-Based Compensation (Tables)
9 Months Ended 12 Months Ended
Oct. 01, 2023
Dec. 31, 2022
Stock-Based Compensation [Abstract]    
Summary of summary of stock option activity
A summary of stock option activity for the thirty-nine weeks ended October 1, 2023 under the Plans is as follows:
 
   
Options Outstanding
 
   
Number of
Shares
   
Weighted
Average
Exercise
Price per
Share
   
Weighted
Average
Contractual
Term
(Years)
   
Aggregate
Intrinsic
Value

(in thousands)
 
Outstanding—December 31, 2022
    4,970,419     $ 4.86       6.99     $ 34,180  
Options granted
    2,164,946       5.18      
Options exercised
    (67,292     0.83      
Options canceled
    (142,218     9.46      
 
 
 
   
 
 
   
 
 
   
 
 
 
Outstanding—October 1, 2023
    6,925,855     $ 4.91       7.80     $ 2,727  
 
 
 
   
 
 
   
 
 
   
 
 
 
Vested and expected to vest—October 1, 2023
    6,925,855     $ 4.91       7.80     $ 2,727  
 
 
 
   
 
 
   
 
 
   
 
 
 
Vested and exercisable—October 1, 2023
    3,037,856     $ 5.16       6.40     $ 2,245  
 
 
 
   
 
 
   
 
 
   
 
 
 
A summary of stock option activity for the years ended December 31, 2022 and December 31, 2021 under the Plans is as follows:
 
   
Options outstanding
 
   
Number of
shares
   
Weighted
average
exercise
price per
share
   
Weighted
average
contractual
term
(in years)
   
Aggregate
intrinsic

value
(in thousands)
 
Outstanding—January 1, 2021
    1,968,580     $ 0.58       7.87     $ 1,044  
Options granted
    212,434       0.89      
Options exercised
    (7,245     0.83      
Options canceled
    (38,315     0.62      
 
 
 
   
 
 
   
 
 
   
 
 
 
Outstanding—December 31, 2021
    2,135,454     $ 0.62       6.99     $ 2,263  
Options granted
    3,088,350       7.45      
Options exercised
    (162,034     0.48      
Options canceled
    (91,376     0.83      
 
 
 
   
 
 
   
 
 
   
 
 
 
Outstanding—December 31, 2022
    4,970,395     $ 4.87       6.99     $ 34,180  
 
 
 
   
 
 
   
 
 
   
 
 
 
Vested and expected to vest—December 31, 2022
    4,970,395     $ 4.87       6.99     $ 34,180  
 
 
 
   
 
 
   
 
 
   
 
 
 
Vested and exercisable—December 31, 2022
    2,794,862     $ 4.35       6.29     $ 22,204  
 
 
 
   
 
 
   
 
 
   
 
 
 
Schedule of summary of RSU activity
A summary of RSU activity for the thirty-nine weeks ended October 1, 2023 under the Plans is as follows:
 
    
Number of
RSUs
    
Weighted
Average
Grant
Date
Fair Value
 
Unvested at December 31, 2022
     —       
Granted
     728,600      $ 5.00  
Vested and released
     (155,473    $ 4.84  
Cancelled or forfeited
     (485,468    $ 5.07  
  
 
 
    
Unvested at October 1, 2023
     87,659      $ 5.07  
  
 
 
    
 
Schedule Of Calculate The Fair Value Of Stock-based Compensation  
The following assumptions were used to calculate the fair value of stock-based compensation:
 
    
Years Ended December 31,
    
2022
  
2021
Expected term
   1.0 – 7.5 years    5.0 – 6.1 years
Expected volatility
   60.0% – 78.5%    52.6% – 56.7%
Risk-free interest rate
   3.4% – 4.8%    0.8% – 1.3%
Expected dividends
   0.0%    0.0%
Schedule of stock-based compensation expense and its allocation within the accompanying unaudited condensed consolidated statements of operations and comprehensive loss
The following table summarizes stock-based compensation expense and its allocation within the accompanying unaudited condensed consolidated statements of operations and comprehensive income (loss) (in thousands):
 
   
Thirteen
Weeks Ended
October 1,
2023
   
Three
Months Ended
September 30,
2022
   
Thirty-Nine

Weeks Ended
October 1,
2023
   
Nine
Months Ended
September 30,
2022
 
Cost of revenues
  $ 20     $ 1     $ 51     $ 6  
Sales and marketing
    143       37       337       91  
General and administrative
    1,416       47       1,933       120  
Loss from discontinued operations, net of tax
    535       —         1,835       —    
 
 
 
   
 
 
   
 
 
   
 
 
 
Total stock-based compensation expense
  $ 2,114     $ 85     $ 4,156     $ 217  
 
 
 
   
 
 
   
 
 
   
 
 
 
The following table summarizes stock-based compensation expense and its allocation within the accompanying consolidated statements of operations and comprehensive loss (in thousands):
 
    
Years Ended December 31,
 
    
  2022  
    
  2021  
    
  2020  
 
Cost of revenues
   $ 22      $ 19      $ 8  
Sales and marketing
     168        68        37  
General and administrative
     243        113        64  
Loss from discontinued operations, net of tax
     470        —          —    
  
 
 
    
 
 
    
 
 
 
Total stock-based compensation expense
   $ 903      $ 200      $ 109  
  
 
 
    
 
 
    
 
 
 
XML 58 R48.htm IDEA: XBRL DOCUMENT v3.23.4
Commitments and Contingencies (Tables)
9 Months Ended 12 Months Ended
Oct. 01, 2023
Dec. 31, 2022
Commitments and Contingencies [Abstract]    
Schedule of Weighted Average Remaining Lease Term and the Discount Rate
The weighted average remaining lease term and the discount rate for the Company’s operating leases are as follows:
 
    
October 1,
2023
Remaining average remaining lease term
   2.61 years
Weighted average discount rate
   15.20%
The weighted average remaining lease term and the discount rate for the Company’s operating leases are as follows:
 
    
December 31, 2022
 
Remaining average remaining lease term (years)
     3.24  
Weighted average discount rate
     14.47
Schedule of Future Minimum Lease Payments under Non-Cancelable
Future minimum lease payments under
non-cancelable
operating leases as of October 1, 2023 are as follows (in thousands):
 
2023 (excluding the thirty-nine weeks ended October 1, 2023)
   $ 263  
2024
     743  
2025
     592  
2026
     477  
2027 and thereafter
     —    
  
 
 
 
Total undiscounted liabilities
     2,075  
  
 
 
 
Less: imputed interest
     (565
  
 
 
 
Present value of operating lease liabilities
   $ 1,510  
  
 
 
 
Future minimum lease payments under
non-cancelable
operating leases, and future payments under the Lease Termination Agreement, as of December 31, 2022 are as follows (in thousands):
 
2023
   $ 1,048  
2024
     743  
2025
     592  
2026
     477  
2027 and thereafter
     —    
  
 
 
 
Total undiscounted liabilities
     2,860  
  
 
 
 
Less imputed interest
     (628
  
 
 
 
Present value of operation lease liabilities
   $ 2,232  
  
 
 
 
Schedule of Activity Period Relating to the Company's Warranty Provision
Activity by period relating to the Company’s warranty provision was as follows (in thousands):
 
    
Thirty-Nine

Weeks Ended
October 1,
2023
    
Year Ended
December 31,
2022
 
Warranty provision, beginning of period
   $ 3,981      $ 2,281  
Warranty liability from Business Combination
     —          1,943  
Accruals for new warranties issued
     2,100        1,492  
Settlements
     (2,060      (1,735
  
 
 
    
 
 
 
Warranty provision, end of period
   $ 4,021      $ 3,981  
  
 
 
    
 
 
 
Warranty provision, current
   $ 605      $ 767  
Warranty provision, noncurrent
   $ 3,416      $ 3,214  
Activity by period relating to the Company’s warranty provision was as follows:
 
    
Years Ended December 31,
 
    
2022
    
2021
    
2020
 
Warranty provision, beginning of period
   $ 2,281      $ 1,652      $ 1,816  
Warranty liability from the Business Combination
     1,943        
Accruals for new warranties issued
     1,492        1,516        607  
Settlements
     (1,735      (887      (771
  
 
 
    
 
 
    
 
 
 
Warranty provision, end of period
   $ 3,981      $ 2,281      $ 1,652  
  
 
 
    
 
 
    
 
 
 
Warranty provision, current
   $ 767      $ 600      $ 497  
Warranty provision, noncurrent
   $ 3,214      $ 1,681      $ 1,155  
XML 59 R49.htm IDEA: XBRL DOCUMENT v3.23.4
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Schedule of Provision For Income Taxes
The provision for income taxes consisted of the following (in thousands):
 
    
Years Ended December 31,
 
    
  2022  
    
  2021  
    
  2020  
 
Current:
        
Federal
   $ —        $ —        $ —    
State
     27        3        3  
Foreign
     —          —          —    
  
 
 
    
 
 
    
 
 
 
Total current
   $ 27      $ 3      $ 3  
  
 
 
    
 
 
    
 
 
 
Deferred:
        
Federal
   $ —        $ —        $ —    
State
     —          —          —    
Foreign
     —          —          —    
  
 
 
    
 
 
    
 
 
 
Total deferred
     —          —          —    
  
 
 
    
 
 
    
 
 
 
Total provision
   $ 27      $ 3      $ 3  
  
 
 
    
 
 
    
 
 
 
Schedule of Reconciliation of Effective Income Tax Rate
The reconciliation of federal statutory income tax rate to our effective income tax rate is as follows (in thousands):
 
    
Years Ended December 31,
 
    
2022
    
2021
    
2020
 
Statutory federal income tax
   $ (6,184    $ (1,918    $ (1,454
State income taxes, net of federal tax benefits
     (1,207      (353      (336
Stock compensation
     64        42        22  
Non-deductible
interest expense
     78        689        257  
Mark to market adjustments
     397        —          —    
Nondeductible Expenses
     279        2        4  
PPP Loan
     —          (368      —    
Foreign earnings taxed at different rates
     157        —          —    
Other
     (8      —          —    
Valuation allowance
     6,451        1,910        1,510  
  
 
 
    
 
 
    
 
 
 
Tax Provision
   $ 27      $ 4      $ 3  
  
 
 
    
 
 
    
 
 
 
Schedule of Components of Deferred Tax Assets And Liabilities
Significant components of our deferred tax assets and liabilities are as follows (in thousands):
 
    
Years Ended December 31,
 
    
      2022      
    
      2021      
 
NOL carryforwards
   $ 60,710      $ 7,931  
Credits
     195        —    
Bad debt reserve
     1,382        946  
Inventory reserve
     2,724        680  
Warranty reserve
     651        631  
Revenue warranty
     155        111  
Interest expense carryover
     3,445        170  
Accrued compensation
     678        687  
Deferred revenue
     195        639  
ASC 842 leases
     12        17  
Assembled workforce
     —          15  
Fixed assets
     328        —    
Capitalized research and development
     509        —    
Other
     2,837        28  
Total
     73,821        11,855  
Valuation allowance
     (63,737      (11,348
  
 
 
    
 
 
 
Net deferred tax assets
   $ 10,084      $ 507  
Deferred Tax Liabilities
     
Accounting method change
     (18      (38
Capitalized software
     (234      (468
Fixed assets
     —          (1
Intangibles
     (9,084      —    
Convertible debt
     (748      —    
  
 
 
    
 
 
 
Refundable and deferred income taxes
   $ —        $ —    
  
 
 
    
 
 
 
Schedule of Unrecognized Tax Benefits
The following is a tabular reconciliation of the total amounts of unrecognized tax benefits (in thousands):
 
    
Years Ended December 31,
 
    
    2022    
    
    2021    
 
Unrecognized tax benefits as of beginning of year
   $ —        $ —    
Increases related to prior year tax positions
     1,335        —    
Increases related to current year tax positions
     —          —    
Decreases related to prior year tax positions
     —          —    
Unrecognized tax benefits as of end of year
     —          —    
  
 
 
    
 
 
 
   $ 1,335      $ —    
  
 
 
    
 
 
 
XML 60 R50.htm IDEA: XBRL DOCUMENT v3.23.4
Basic and Diluted Net Loss Per Share (Tables)
9 Months Ended 12 Months Ended
Oct. 01, 2023
Dec. 31, 2022
Basic and Diluted Net Loss Per Share (Tables) [Line Items]    
Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders
The following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common stockholders for the thirteen and thirty-nine weeks ended October 1, 2023 and three and nine months ended September 30, 2022 (in thousands, except share and per share amounts):
 
   
Thirteen
Weeks Ended
October 1,
2023
   
Three
Months Ended
September 30,
2022
   
Thirty-Nine

Weeks Ended
October 1,
2023
   
Nine
Months Ended
September 30,
2022
 
Numerator:
       
Net loss from continuing operations
  $ (50,973   $ (4,146   $ (73,448   $ (10,809
Net loss from discontinued operations
    (155,909     —         (168,458     —    
 
 
 
   
 
 
   
 
 
   
 
 
 
Net loss
  $ (206,882   $ (4,146   $ (241,906   $ (10,809
Denominator:
       
Weighted average common shares outstanding, basic and diluted
    39,821,078       13,431,410       16,969,979       13,053,367  
Net loss per share:
       
Continuing operations – basic and diluted
  $ (1.28   $ (0.31   $ (4.33   $ (0.83
 
 
 
   
 
 
   
 
 
   
 
 
 
Discontinued operations – basic and diluted
  $ (3.92   $ —       $ (9.92   $ —    
 
 
 
   
 
 
   
 
 
   
 
 
 
Net loss per share – basic and diluted
  $ (5.20   $ (0.31   $ (14.25   $ (0.83
 
 
 
   
 
 
   
 
 
   
 
 
 
The following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common stockholders for the years ended December 31, 2022, 2021 and 2020 (in thousands, except share and per share amounts):
 
    
Years Ended December 31,
 
    
2022
    
2021
    
2020
 
Numerator:
        
Net loss from continuing operations
   $ (28,023    $ (9,282    $ (5,682
Net loss from discontinued operations
     (1,454      —          —    
  
 
 
    
 
 
    
 
 
 
Net loss
   $ (29,477    $ (9,282    $ (5,682
  
 
 
    
 
 
    
 
 
 
Denominator:
        
Weighted average common shares outstanding, basic and diluted
     22,524,400        11,990,015        9,760,018  
Net loss per share:
        
Continuing operations – basic and diluted
   $ (1.24    $ (0.77    $ (0.58
Discontinued operations – basic and diluted
   $ (0.07    $ —        $ —    
Net loss per share – basic and diluted
   $ (1.31    $ (0.77    $ (0.58
Schedule of Potential Common Shares Excluded from Diluted Net Loss Per Share
The following table presents the potential common shares outstanding that were excluded from the computation of diluted net loss per share of common stock as of the periods presented because including them would have been antidilutive:
 
    
As of
 
    
October 1,
2023
    
December 31,
2022
 
Common stock warrants
     23,626,132        2,000,878  
Preferred stock warrants
     —          488,024  
Stock options and RSUs issued and outstanding
     7,013,514        2,430,949  
  
 
 
    
 
 
 
Potential common shares excluded from diluted net loss per share
     30,639,646        4,919,851  
  
 
 
    
 
 
 
The following table presents the potential common shares outstanding that were excluded from the computation of diluted net loss per share of common stock as of the periods presented because including them would have been antidilutive:
 
    
As of December 31,
 
    
2022
    
2021
    
2020
 
Stock options issued and outstanding
     4,970,419        2,135,464        1,968,590  
Convertible notes
     1,912,493        1,618,585        812,531  
Preferred stock warrants
     1,152,790        488,024        488,024  
SAFE agreements
     —          388,785        19,562  
Common stock warrants
     43,135        4,999        —    
  
 
 
    
 
 
    
 
 
 
Potential common shares excluded from diluted net loss per share
     8,078,837        4,635,857        3,288,706  
  
 
 
    
 
 
    
 
 
 
XML 61 R51.htm IDEA: XBRL DOCUMENT v3.23.4
Organization (Details) - USD ($)
$ / shares in Units, $ in Millions
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2023
Oct. 01, 2023
Sep. 30, 2022
Oct. 01, 2023
Oct. 01, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Organization and Business Operations [Line Items]                  
Forward purchase agreements         1,161,512   1,161,512    
Purchase price per share (in Dollars per share)         $ 10   $ 10    
Aggregate gross proceeds (in Dollars)         $ 15.7   $ 15.7    
Additional shares         60,000   60,000    
Subscription agreements         120,000   120,000    
Aggregate gross proceeds (in Dollars)         $ 0.6   $ 0.6    
Reimbursing sponsors shares       193,976     193,976    
Counterparties issued additional shares       150,000     150,000    
Holders shares 23,256,504                
Closing holders shares         7,784,739   7,784,739    
Redeem shares value (in Dollars)   $ 82.2   $ 82.2 $ 82.2   $ 82.2    
Incurred net losses (in Dollars)     $ 4.1     $ 10.8 29.5 $ 9.2 $ 5.6
Accumulated deficit (in Dollars)   327.3   327.3 327.3   85.4    
Cash and cash equivalents (in Dollars)   1.7   $ 1.7 $ 1.7   4.4    
Redeemable convertible preferred stock (in Dollars)             $ 4.4    
Common Stock [Member]                  
Organization and Business Operations [Line Items]                  
Purchase price per share (in Dollars per share)             $ 5    
Ordinary shares outstanding         5,978,960   5,978,960    
Minimum [Member]                  
Organization and Business Operations [Line Items]                  
Incurred net losses (in Dollars)   $ 51.0              
Maximum [Member]                  
Organization and Business Operations [Line Items]                  
Incurred net losses (in Dollars)         $ 73.4        
FACT Class A Ordinary Shares [Member]                  
Organization and Business Operations [Line Items]                  
Aggregate shares         6,300,000   6,300,000    
Originally shares issued 34,500,000                
Ordinary shares outstanding 11,243,496                
Common stock shares   1   1 1   1    
Class B Ordinary Share [Member]                  
Organization and Business Operations [Line Items]                  
Common stock shares   1   1 1   1    
Solaria [Member]                  
Organization and Business Operations [Line Items]                  
Aggregate shares         420,000   420,000    
PIPE Investors [Member]                  
Organization and Business Operations [Line Items]                  
Aggregate shares         1,570,000   1,570,000    
PIPE Financing [Member]                  
Organization and Business Operations [Line Items]                  
Aggregate gross proceeds (in Dollars)         $ 3.5   $ 3.5    
PIPE Subscription Agreement [Member]                  
Organization and Business Operations [Line Items]                  
Forward purchase agreements         60,000   60,000    
Purchase price per share (in Dollars per share)         $ 5        
Maxeon [Member]                  
Organization and Business Operations [Line Items]                  
Common stock shares   1,100,000   1,100,000 1,100,000   1,100,000    
Solaria [Member]                  
Organization and Business Operations [Line Items]                  
Aggregate shares       25,494,332     25,494,332    
XML 62 R52.htm IDEA: XBRL DOCUMENT v3.23.4
Summary of Significant Accounting Policies (Details)
$ in Thousands
9 Months Ended 12 Months Ended
Oct. 01, 2023
USD ($)
Sep. 30, 2022
USD ($)
Dec. 31, 2022
USD ($)
CUSTOMER
SEGMENT
SUPPLIER
Dec. 31, 2021
USD ($)
CUSTOMER
SUPPLIER
Dec. 31, 2020
USD ($)
CUSTOMER
SUPPLIER
Significant Accounting Policies [Line Items]          
Restricted cash $ 5,419   $ 8,316 $ 5,276  
Deferred service cost 1,000   1,300    
Deferred commissions 5,500   2,800 4,800  
Deferred revenue 2,500 $ 3,900 $ 3,900 4,500  
Additional paid in capital 9,500        
Number of operating segments | SEGMENT     1    
Off-balance sheet credit exposure     $ 0    
Capitalized internal-use software development costs     1,500 1,100 $ 500
Internal-use software ,remaining unamortized balance     2,700 1,700  
Impairment charges     0 0 0
Deferred transaction costs     1,100    
Advertising Expense     $ 0 $ 0 $ 0
Customer Concentration Risk [Member] | Accounts Receivable [Member]          
Significant Accounting Policies [Line Items]          
Number of customers | CUSTOMER     3 1  
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer One [Member]          
Significant Accounting Policies [Line Items]          
Concentration risk, percentage     27.00% 50.00%  
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer Two [Member]          
Significant Accounting Policies [Line Items]          
Concentration risk, percentage     18.00%    
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer Three [Member]          
Significant Accounting Policies [Line Items]          
Concentration risk, percentage     14.00%    
Customer Concentration Risk [Member] | Revenue Benchmark [Member]          
Significant Accounting Policies [Line Items]          
Number of customers | CUSTOMER     1 1 1
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer One [Member]          
Significant Accounting Policies [Line Items]          
Concentration risk, percentage     47.00% 63.00% 81.00%
Supplier Concentration Risk [Member] | Cost of Goods and Service Benchmark [Member]          
Significant Accounting Policies [Line Items]          
Number of customers | SUPPLIER     3 4 2
Supplier Concentration Risk [Member] | Cost of Goods and Service Benchmark [Member] | Supplier Two [Member]          
Significant Accounting Policies [Line Items]          
Concentration risk, percentage         89.00%
Supplier Concentration Risk [Member] | Cost of Goods and Service Benchmark [Member] | Supplier Three [Member]          
Significant Accounting Policies [Line Items]          
Concentration risk, percentage     74.00%    
Supplier Concentration Risk [Member] | Cost of Goods and Service Benchmark [Member] | Supplier Four [Member]          
Significant Accounting Policies [Line Items]          
Concentration risk, percentage       87.00%  
Additional Paid-in Capital [Member]          
Significant Accounting Policies [Line Items]          
Additional paid in capital 5,700        
Restricted Cash [Member]          
Significant Accounting Policies [Line Items]          
Restricted cash $ 3,800   $ 3,900 $ 0  
XML 63 R53.htm IDEA: XBRL DOCUMENT v3.23.4
Summary of Significant Accounting Policies (Details) - Schedule of Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
Oct. 01, 2023
Dec. 31, 2022
Dec. 31, 2021
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]      
Cash and cash equivalents $ 1,661 $ 4,409 $ 5,276
Restricted cash 3,758 3,907 0
Total cash, cash equivalents, and restricted cash $ 5,419 $ 8,316 $ 5,276
XML 64 R54.htm IDEA: XBRL DOCUMENT v3.23.4
Summary of Significant Accounting Policies (Details) - Schedule of Allowance for Doubtful Accounts - USD ($)
$ in Thousands
9 Months Ended 12 Months Ended
Oct. 01, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Accounts Receivable, after Allowance for Credit Loss [Abstract]          
Balance at beginning of period $ 4,812 $ 2,569 $ 2,569 $ 2,288 $ 1,965
Provision charged to earnings $ 4,269 $ 716 2,074 364 337
Amounts written off, recoveries and other adjustments     0 83 14
Balance at end of period     $ 4,812 $ 2,569 $ 2,288
XML 65 R55.htm IDEA: XBRL DOCUMENT v3.23.4
Summary of Significant Accounting Policies (Details) - Schedule of Revenue Recognized By Product and Services - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Oct. 01, 2023
Sep. 30, 2022
Oct. 01, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Disaggregation Of Revenue [Line Items]              
Total revenue $ 24,590 $ 12,260 $ 66,887 $ 48,974 $ 66,475 $ 68,816 $ 29,378
Solar energy system installations [Member]              
Disaggregation Of Revenue [Line Items]              
Total revenue 23,915 11,120 64,511 46,214 62,896 66,958 29,378
Software enhanced services [Member]              
Disaggregation Of Revenue [Line Items]              
Total revenue $ 675 $ 1,140 $ 2,376 $ 2,760 $ 3,579 $ 1,858 $ 0
XML 66 R56.htm IDEA: XBRL DOCUMENT v3.23.4
Summary of Significant Accounting Policies (Details) - Schedule Of Property, Plant and Equipment Useful Lives
Oct. 01, 2023
Dec. 31, 2022
Manufacturing equipment [Member] | Minimum [Member]    
Property, Plant and Equipment [Line Items]    
Assets Useful Life   1 year
Manufacturing equipment [Member] | Maximum [Member]    
Property, Plant and Equipment [Line Items]    
Assets Useful Life   3 years
Developed software [Member]    
Property, Plant and Equipment [Line Items]    
Assets Useful Life 5 years 5 years
Furniture & equipment [Member]    
Property, Plant and Equipment [Line Items]    
Assets Useful Life 3 years  
Furniture & equipment [Member] | Minimum [Member]    
Property, Plant and Equipment [Line Items]    
Assets Useful Life   3 years
Furniture & equipment [Member] | Maximum [Member]    
Property, Plant and Equipment [Line Items]    
Assets Useful Life   5 years
Leasehold improvements [Member]    
Property, Plant and Equipment [Line Items]    
Assets Useful Life 5 years  
Leasehold improvements [Member] | Minimum [Member]    
Property, Plant and Equipment [Line Items]    
Assets Useful Life   3 years
Leasehold improvements [Member] | Maximum [Member]    
Property, Plant and Equipment [Line Items]    
Assets Useful Life   5 years
XML 67 R57.htm IDEA: XBRL DOCUMENT v3.23.4
Summary of Significant Accounting Policies (Details) -Schedule of Finite-Lived Intangible Assets
Dec. 31, 2022
Assembled workforce [Member]  
Finite-Lived Intangible Assets [Line Items]  
Assembled workforce 2 years
XML 68 R58.htm IDEA: XBRL DOCUMENT v3.23.4
Fair Value Measurements (Details)
$ / shares in Units, $ in Thousands
1 Months Ended 9 Months Ended 12 Months Ended
Oct. 31, 2023
shares
Dec. 31, 2021
USD ($)
Jul. 31, 2019
USD ($)
Oct. 01, 2023
$ / shares
shares
Dec. 31, 2022
USD ($)
shares
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Feb. 29, 2016
shares
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]                  
Outstanding warrant | shares 656,630     2,745,879          
Price per share | $ / shares       $ 0.01          
Description warrant expires       The warrant, which expires on July 18, 2030, provides Carlyle with the right to purchase shares of Complete Solaria Common Stock based on (a) the greater of (i) 1,995,879 shares and (ii) the number of shares equal to 2.795% of Complete Solaria’s issued and outstanding shares of common stock, on a fully-diluted basis; plus (b) on and after the date that is ten (10) days after the date of the amended and restated warrant agreement, an additional 350,000 shares; plus (c) on and after the date that is thirty (30) days after the date of the amended and restated warrant agreement, if the original investment amount has not been repaid, an additional 150,000 shares; plus (d) on and after the date that is ninety (90) days after the date of the amended and restated warrant agreement, if the original investment amount has not been repaid, an additional 250,000 shares, in each case, of Complete Solaria Common Stock at a price of $0.01 per share          
Unrealized gain loss on derivatives         $ (336) $ (50)    
2019 SAFE [Member]                  
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]                  
Proceeds from the issue of derivative instruments linked to entities own equity     $ 100            
Numerator considered for calculation of shares issuable upon conversion     $ 50,000            
Discount on share price percentage     20.00%            
Option indexed to issuers equity settlement alternatives cash fair value               $ 100  
Gain or loss extinguishment of derivative instruments               $ 100  
2021 SAFE [Member]                  
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]                  
Proceeds from the issue of derivative instruments linked to entities own equity   $ 5,000              
Numerator considered for calculation of shares issuable upon conversion   $ 175,000       $ 175,000      
Discount on share price percentage   20.00%       20.00%      
2021 SAFE [Member] | Other Nonoperating Income (Expense) [Member]                  
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]                  
Gain or loss extinguishment of derivative instruments           $ 1,400      
Unrealized gain loss on derivatives           1,300      
2022 SAFE [Member]                  
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]                  
Derivative instruments number of instruments converted into equity | shares         8,171,662        
2019-A Convertible Notes [Member]                  
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]                  
Numerator value of convertible debt considered for conversion price   $ 75,000       75,000      
Convertible debt at fair value   100       100      
2020-A Convertible Notes [Member]                  
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]                  
Convertible debt at fair value   4,600       4,600      
2021-A Convertible Notes [Member]                  
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]                  
Numerator value of convertible debt considered for conversion price   200,000       200,000      
Convertible debt at fair value   $ 4,800       $ 4,800      
Warrants Remaining Private Assumption Exercise Price One [Member] | Series D Preferred Stock Warrants Tranche One [Member]                  
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]                  
Warrants or rights outstanding measurement input | shares                 2.04
Warrants Remaining Private Assumption Exercise Price One [Member] | Series D Preferred Stock Warrants Tranche Two [Member]                  
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]                  
Warrants or rights outstanding measurement input | shares                 4.09
Probability Of Conversion Into Equity Instruments One [Member] | 2019 SAFE [Member]                  
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]                  
Derivatives measurement input               6.0  
Probability Of Conversion Into Equity Instruments Two [Member] | 2019 SAFE [Member]                  
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]                  
Derivatives measurement input               0.8  
Redeemable Convertible Preferred Stock Warrant Liability [Member] | Despac Acquisition Assumption Exercise Price One [Member] | Series D Preferred Stock Warrants Tranche One [Member]                  
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]                  
Warrants or rights outstanding measurement input | shares                 2.5
Redeemable Convertible Preferred Stock Warrant Liability [Member] | Despac Acquisition Assumption Exercise Price One [Member] | Series D Preferred Stock Warrants Tranche Two [Member]                  
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]                  
Warrants or rights outstanding measurement input | shares                 5
Redeemable Convertible Preferred Stock Warrant Liability [Member] | Spac Exists [Member]                  
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]                  
Warrants or rights outstanding measurement input                 0.7
Redeemable Convertible Preferred Stock Warrant Liability [Member] | Warrants Remaining Private [Member]                  
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]                  
Warrants or rights outstanding measurement input                 0.3
XML 69 R59.htm IDEA: XBRL DOCUMENT v3.23.4
Fair Value Measurements (Details) - Schedule of Financial Assets and Liabilities - USD ($)
$ in Thousands
9 Months Ended
Oct. 01, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Financial Liabilities        
Carlyle warrants $ 7,683      
Public warrants 1,413      
Private placement warrants 1,027      
Working capital warrants 117      
Forward purchase agreement liabilities [1] 6,586    
Redeemable convertible preferred stock warrant liability   14,152 $ 1,129  
Convertible debt embedded derivatives   0 1,481 $ 579
SAFE agreements     6,397  
Total 16,826 14,152 9,007  
Fair Value, Inputs, Level 1 [Member]        
Financial Liabilities        
Carlyle warrants      
Public warrants 1,413      
Private placement warrants      
Working capital warrants      
Forward purchase agreement liabilities      
Redeemable convertible preferred stock warrant liability    
Convertible debt embedded derivatives      
SAFE agreements      
Total 1,413  
Fair Value, Inputs, Level 2 [Member]        
Financial Liabilities        
Carlyle warrants      
Public warrants      
Private placement warrants 1,027      
Working capital warrants 117      
Forward purchase agreement liabilities      
Redeemable convertible preferred stock warrant liability    
Convertible debt embedded derivatives      
SAFE agreements      
Total 1,144  
Fair Value, Inputs, Level 3 [Member]        
Financial Liabilities        
Carlyle warrants 7,683      
Public warrants      
Private placement warrants      
Working capital warrants      
Forward purchase agreement liabilities 6,586      
Redeemable convertible preferred stock warrant liability   14,152 1,129  
Convertible debt embedded derivatives     1,481  
SAFE agreements     6,397  
Total $ 14,269 $ 14,152 $ 9,007  
[1] Includes $5.6 million and zero of liabilities due to related parties as of October 1, 2023 and December 31, 2022, respectively.
XML 70 R60.htm IDEA: XBRL DOCUMENT v3.23.4
Fair Value Measurements (Details) - Schedule of Warrants Based on a Black Scholes Option Pricing Method. - $ / shares
9 Months Ended 12 Months Ended
Oct. 01, 2023
Dec. 31, 2022
Dec. 31, 2021
Series B Redeemable Convertible Preferred Stock Warrant [Member]      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Expected term   3 years 1 month 6 days 4 years 1 month 6 days
Expected volatility 72.50% 73.00%
Risk-free interest rate 4.20% 1.10%
Expected dividend yield 0.00% 0.00%
Series C Redeemable Convertible Preferred Stock Warrant [Member]      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Expected term   3 years 7 months 6 days 4 years 7 months 6 days
Expected volatility 72.50% 73.00%
Risk-free interest rate 4.00% 1.20%
Expected dividend yield 0.00% 0.00%
Series D-7 Redeemable Convertible Preferred Stock Warrant [Member]      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Expected term   1 year 6 months  
Expected volatility 78.50% 0.00%
Risk-free interest rate 4.70% 0.00%
Expected dividend yield 0.00% 0.00%
Public, Private Placement and Working Capital Warrants [Member]      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Expected term 7 years  
Expected volatility 77.00%  
Risk-free interest rate 3.92%  
Expected dividend yield 0.00%  
Convertible Promissory Notes [Member]      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Expected term 1 year 9 months 18 days    
Expected volatility 178.00%  
Risk-free interest rate 5.12%  
Common stock trading price (in Dollars per share) $ 2.1  
Simulation period    
XML 71 R61.htm IDEA: XBRL DOCUMENT v3.23.4
Fair Value Measurements (Details) - Schedule of Significant Unobservable Inputs (Level 3), and the Change in Fair Value Recorded in Other Income (Expense),net - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Warrant [Member]    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Beginning Balance $ 1,129 $ 799
Change in fair value 5,211 330
Assumption of SAFEs in Solaria acquisition 0  
Ending Balance 14,152 1,129
Warrant [Member] | Convertible Debt [Member]    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Issuances   0
Warrant [Member] | Issuance of 2021-Rogers SAFE [Member]    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Issuances   0
Warrant [Member] | Conversion of debt into preferred shares [Member]    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Conversion of preferred shares 0  
Warrant [Member] | Conversion of SAFEs into preferred shares [Member]    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Conversion of preferred shares 0  
Warrant [Member] | Conversion of SAFEs from Solaria acquisition into preferred shares [Member]    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Conversion of preferred shares 0  
Warrant [Member] | Issuance of Series D Warrants Tranche A    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Issuances 6,527  
Warrant [Member] | Issuance of Series D Warrants Tranche B    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Issuances 1,285  
Convertible Debt Embedded Derivatives [member]    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Beginning Balance 1,481 579
Change in fair value 0 336
Assumption of SAFEs in Solaria acquisition 0  
Ending Balance 0 1,481
Convertible Debt Embedded Derivatives [member] | Convertible Debt [Member]    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Issuances   566
Convertible Debt Embedded Derivatives [member] | Issuance of 2021-Rogers SAFE [Member]    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Issuances   0
Convertible Debt Embedded Derivatives [member] | Conversion of debt into preferred shares [Member]    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Conversion of preferred shares (1,481)  
Convertible Debt Embedded Derivatives [member] | Conversion of SAFEs into preferred shares [Member]    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Conversion of preferred shares 0  
Convertible Debt Embedded Derivatives [member] | Conversion of SAFEs from Solaria acquisition into preferred shares [Member]    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Conversion of preferred shares 0  
Convertible Debt Embedded Derivatives [member] | Issuance of Series D Warrants Tranche A    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Issuances 0  
Convertible Debt Embedded Derivatives [member] | Issuance of Series D Warrants Tranche B    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Issuances 0  
SAFEs [member]    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Beginning Balance 6,397 91
Change in fair value 0 1,306
Assumption of SAFEs in Solaria acquisition 60,470  
Ending Balance 0 6,397
SAFEs [member] | Convertible Debt [Member]    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Issuances   0
SAFEs [member] | Issuance of 2021-Rogers SAFE [Member]    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Issuances   $ 5,000
SAFEs [member] | Conversion of debt into preferred shares [Member]    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Conversion of preferred shares 0  
SAFEs [member] | Conversion of SAFEs into preferred shares [Member]    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Conversion of preferred shares (6,397)  
SAFEs [member] | Conversion of SAFEs from Solaria acquisition into preferred shares [Member]    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Conversion of preferred shares (60,470)  
SAFEs [member] | Issuance of Series D Warrants Tranche A    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Issuances 0  
SAFEs [member] | Issuance of Series D Warrants Tranche B    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Issuances $ 0  
XML 72 R62.htm IDEA: XBRL DOCUMENT v3.23.4
Fair Value Measurements (Details) - Schedule of Reconciles the Change in Value of the Redeemable Convertible Preferred Stock Warrant Liability - USD ($)
$ in Thousands
1 Months Ended 9 Months Ended 12 Months Ended
Dec. 31, 2022
Oct. 01, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Schedule Of Reconciles The Change In Value Of The Redeemable Convertible Preferred Stock Warrant Liability [Line Items]            
Change in fair value   $ (26,314) $ 142 $ 5,211 $ 330 $ (24)
Ending   7,683        
Series B Warrants [Member]            
Schedule Of Reconciles The Change In Value Of The Redeemable Convertible Preferred Stock Warrant Liability [Line Items]            
Change in fair value $ 100          
Redeemable Convertible Preferred Stock [Member]            
Schedule Of Reconciles The Change In Value Of The Redeemable Convertible Preferred Stock Warrant Liability [Line Items]            
Beginning   14,152 1,129 1,129 799  
Change in fair value       5,211 330  
Issuance of warrants in connection with acquisition of Solaria (Note 3)       7,812    
Ending 14,152     14,152 1,129 799
Redeemable Convertible Preferred Stock [Member] | Series B Warrants [Member]            
Schedule Of Reconciles The Change In Value Of The Redeemable Convertible Preferred Stock Warrant Liability [Line Items]            
Beginning   50 8 8 5  
Change in fair value       42 3  
Issuance of warrants in connection with acquisition of Solaria (Note 3)       0    
Ending 50     50 8 5
Redeemable Convertible Preferred Stock [Member] | Series C Warrants [Member]            
Schedule Of Reconciles The Change In Value Of The Redeemable Convertible Preferred Stock Warrant Liability [Line Items]            
Beginning   6,290 1,121 1,121 794  
Change in fair value       5,169 327  
Issuance of warrants in connection with acquisition of Solaria (Note 3)       0    
Ending 6,290     6,290 1,121 794
Redeemable Convertible Preferred Stock [Member] | Series D Tranche A Warrants [Member]            
Schedule Of Reconciles The Change In Value Of The Redeemable Convertible Preferred Stock Warrant Liability [Line Items]            
Beginning   6,527 0 0 0  
Change in fair value       0 0  
Issuance of warrants in connection with acquisition of Solaria (Note 3)       6,527    
Ending 6,527     6,527 0 0
Redeemable Convertible Preferred Stock [Member] | Series D Tranche B Warrants [Member]            
Schedule Of Reconciles The Change In Value Of The Redeemable Convertible Preferred Stock Warrant Liability [Line Items]            
Beginning   $ 1,285 $ 0 0 0  
Change in fair value       0 0  
Issuance of warrants in connection with acquisition of Solaria (Note 3)       1,285    
Ending $ 1,285     $ 1,285 $ 0 $ 0
XML 73 R63.htm IDEA: XBRL DOCUMENT v3.23.4
Fair Value Measurements (Details) - Schedule of Reconciliation of Embedded Derivative Liability - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Disclosure In Tabular Form Of Reconciliation Of Embedded Derivative Liability [Line Items]    
Beginning balance $ 1,481 $ 579
Issuance of 2021-A Convertible Notes   566
Change in fair value   366
Extinguishment upon Series D issuance (1,481)  
Ending balance 0 1,481
2020-A Convertible Notes [Member]    
Disclosure In Tabular Form Of Reconciliation Of Embedded Derivative Liability [Line Items]    
Beginning balance 795 561
Issuance of 2021-A Convertible Notes   0
Change in fair value   234
Extinguishment upon Series D issuance (795)  
Ending balance 0 795
2021-A Convertible Notes [Member]    
Disclosure In Tabular Form Of Reconciliation Of Embedded Derivative Liability [Line Items]    
Beginning balance 651 0
Issuance of 2021-A Convertible Notes   566
Change in fair value   85
Extinguishment upon Series D issuance (651)  
Ending balance 0 651
2019-A Convertible Notes [Member]    
Disclosure In Tabular Form Of Reconciliation Of Embedded Derivative Liability [Line Items]    
Beginning balance 35 18
Issuance of 2021-A Convertible Notes   0
Change in fair value   17
Extinguishment upon Series D issuance (35)  
Ending balance $ 0 $ 35
XML 74 R64.htm IDEA: XBRL DOCUMENT v3.23.4
Fair Value Measurements (Details) - Schedule of Next Equity Financing Based on Inputs Included in a Black-Scholes Model - Simple Agreement For Future Equity Instruments [Member]
Dec. 31, 2021
USD ($)
yr
Expected fair value of preferred stock [Member]  
Disclosure In Tabular Form Of Significant Unobservable Inputs Used In Fair Value Measurement Of Simple Agreements For Future Equity Instruments [Line Items]  
Expected fair value of preferred stock | $ $ 4,840
Expected term [Member]  
Disclosure In Tabular Form Of Significant Unobservable Inputs Used In Fair Value Measurement Of Simple Agreements For Future Equity Instruments [Line Items]  
Derivative liability, measurement input | yr 0.2
Volatility [Member]  
Disclosure In Tabular Form Of Significant Unobservable Inputs Used In Fair Value Measurement Of Simple Agreements For Future Equity Instruments [Line Items]  
Derivative liability, measurement input 0.764
Risk-free interest rate [Member]  
Disclosure In Tabular Form Of Significant Unobservable Inputs Used In Fair Value Measurement Of Simple Agreements For Future Equity Instruments [Line Items]  
Derivative liability, measurement input 0.1
XML 75 R65.htm IDEA: XBRL DOCUMENT v3.23.4
Reverse Recapitalization (Details) - USD ($)
$ in Thousands
9 Months Ended 12 Months Ended
Oct. 01, 2023
Dec. 31, 2022
Dec. 31, 2021
Reverse Recapitalization [Line Items]      
Net cash proceeds $ 19,700 $ 19,700  
Common shares issued (in Shares) 45,312,243 19,932,429 9,806,143
Common shares outstanding (in Shares) 45,312,243 19,932,429 9,806,143
Professional fees $ 15,800 $ 15,800  
Additional paid in capital 276,438 190,624 $ 34,504
Incurred cost 5,200 5,200  
Company incurred cost 10,600 $ 10,600  
Transaction costs $ 5,400    
Common Class A [Member]      
Reverse Recapitalization [Line Items]      
Common shares issued (in Shares) 45,290,553 45,290,553  
Common shares outstanding (in Shares) 34,500,000 34,500,000  
Legacy Complete Solaria [Member]      
Reverse Recapitalization [Line Items]      
Additional paid in capital $ 15,800 $ 15,800  
Legacy Complete Solaria [Member] | Common Class A [Member]      
Reverse Recapitalization [Line Items]      
Common shares outstanding (in Shares) 45,290,553 45,290,553  
XML 76 R66.htm IDEA: XBRL DOCUMENT v3.23.4
Reverse Recapitalization (Details) - Schedule of Reconciles Elements of the Merger
$ in Thousands
9 Months Ended
Oct. 01, 2023
USD ($)
Reverse Recapitalization (Details) - Schedule of Reconciles Elements of the Merger [Line Items]  
Less: cash payment $ (1,170)
Net cash proceeds upon the closing of the merger and PIPE financing 19,658
Net contributions from the Merger and PIPE financing upon closing 9,523
PIPE [Member]  
Reverse Recapitalization (Details) - Schedule of Reconciles Elements of the Merger [Line Items]  
Cash proceeds 12,800
FACT [Member]  
Reverse Recapitalization (Details) - Schedule of Reconciles Elements of the Merger [Line Items]  
Cash proceeds 36,539
Less: cash payment (10,680)
Less: non-cash net liabilities assumed from FACT (10,135)
FPA [Member]  
Reverse Recapitalization (Details) - Schedule of Reconciles Elements of the Merger [Line Items]  
Less: cash payment $ (17,831)
XML 77 R67.htm IDEA: XBRL DOCUMENT v3.23.4
Reverse Recapitalization (Details) - Schedule of Common Stock Outstanding - shares
9 Months Ended 12 Months Ended
Oct. 01, 2023
Dec. 31, 2022
Dec. 31, 2021
Reverse Recapitalization (Details) - Schedule of Common Stock Outstanding [Line Items]      
Ordinary Shares, outstanding prior to Merger 45,312,243 19,932,429 9,806,143
Shares issued 518,752    
Less: redemption of FACT Class A Ordinary Shares (31,041,243) (31,041,243)  
Total shares from the Mergers and PIPE Financing 19,796,221 19,796,221  
Legacy Complete Solaria shares 20,034,257 20,034,257  
2022 Convertible Note Shares 5,460,075 5,460,075  
Shares of Complete Solaria Common stock immediately after merger 45,290,553 45,290,553  
FACT Class A Ordinary Shares [Member]      
Reverse Recapitalization (Details) - Schedule of Common Stock Outstanding [Line Items]      
Ordinary Shares, outstanding prior to Merger 34,500,000 34,500,000  
FACT Class B Ordinary Shares [Member]      
Reverse Recapitalization (Details) - Schedule of Common Stock Outstanding [Line Items]      
Ordinary Shares, outstanding prior to Merger 8,625,000 8,625,000  
Sponsor [Member]      
Reverse Recapitalization (Details) - Schedule of Common Stock Outstanding [Line Items]      
Bonus shares issued 193,976 193,976  
PIPE Financing [Member]      
Reverse Recapitalization (Details) - Schedule of Common Stock Outstanding [Line Items]      
Bonus shares issued 120,000 120,000  
Shares issued 1,690,000 1,690,000  
FPA Agreements [Member]      
Reverse Recapitalization (Details) - Schedule of Common Stock Outstanding [Line Items]      
Bonus shares issued 150,000 150,000  
Shares issued 5,558,488 5,558,488  
XML 78 R68.htm IDEA: XBRL DOCUMENT v3.23.4
Forward Purchase Agreements (Details) - USD ($)
9 Months Ended 12 Months Ended
Oct. 01, 2023
Sep. 30, 2022
[1]
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
[2]
Forward Purchase Agreements [Line Items]          
Ordinary shares, par value $ 0.0001   $ 0.0001 $ 0.0001  
Purchase percentage 9.90%        
Initial price $ 5        
Number of shares $ 2        
Issued shares (in shares) 518,752        
Other income (expense) $ (4,009,000) [1] $ 76,000 $ (4,810,000) [2] $ (1,330,000) [2] $ (462,000)
Fair value of prepaid forward purchase agreements 100,000        
Prepaid forward purchase liability 6,700,000        
Purchase liabilities $ 0   $ 25,200,000    
Complete Solaria Common Stock [Member]          
Forward Purchase Agreements [Line Items]          
Issued shares (in shares) 6,720,000        
FPA'S [Member]          
Forward Purchase Agreements [Line Items]          
Aggregate shares 6,720,000        
Initial price $ 10.56        
Issued shares (in shares) 6,300,000        
Other income (expense) $ 35,500,000        
Purchase liabilities $ 6,600,000        
[1] Non-cash interest expense to related parties of $0.1 million and $0.4 million during the thirteen and thirty-nine weeks ended October 1, 2023, respectively, and zero and $0.1 million during the three and nine months ended September 30, 2022, respectively.
[2] Non-cash interest expense to related parties of $0.3 million, $0.7 million and $0.2 million during the years ended December 31, 2022, 2021 and 2020, respectively.
XML 79 R69.htm IDEA: XBRL DOCUMENT v3.23.4
Business Combination (Details) - USD ($)
$ in Millions
9 Months Ended 12 Months Ended
Nov. 04, 2022
Oct. 01, 2023
Dec. 31, 2022
Business Combination [Line Items]      
Goodwill   $ 119.4  
Goodwill, period   15 years  
Acquisition costs     $ 1.3
Solaria Acquisition [Member]      
Business Combination [Line Items]      
Consideration paid $ 89.1    
Consideration paid in cash $ 0.1    
Shares, issued (in Shares) 2,844,550    
Fair value $ 17.3    
Payment of seller incurred transaction expenses 1.5    
Unvested stock options $ 14.1    
Recognized deferred tax assets   $ 45.9 $ 45.9
Solaria Acquisition [Member] | Common Stock [Member]      
Business Combination [Line Items]      
Shares, issued (in Shares) 78,962    
Fair value $ 17.3    
Solaria Acquisition [Member] | Preferred Stock [Member]      
Business Combination [Line Items]      
Shares, issued (in Shares) 6,803,549    
Fair value $ 52.2    
Solaria Acquisition [Member] | Stock Options [Member]      
Business Combination [Line Items]      
Fair value $ 10.0    
Solaria Acquisition [Member] | Warrant [Member] | Common Stock [Member]      
Business Combination [Line Items]      
Shares, issued (in Shares) 1,376,414    
Fair value $ 0.2    
Solaria Acquisition [Member] | Warrant [Member] | Preferred Stock [Member]      
Business Combination [Line Items]      
Shares, issued (in Shares) 5,382,599    
Fair value $ 7.8    
XML 80 R70.htm IDEA: XBRL DOCUMENT v3.23.4
Business Combination (Details) - Schedule of Assets Acquired and Liabilities Assumed - Business Combination [Member] - USD ($)
$ in Thousands
9 Months Ended 12 Months Ended
Oct. 01, 2023
Dec. 31, 2022
Business Combination (Details) - Schedule of Assets Acquired and Liabilities Assumed [Line Items]    
Cash, cash equivalents and restricted cash $ 5,402 $ 5,402
Accounts receivable 4,822 4,822
Inventories 5,354 5,354
Prepaid expenses and other current assets 8,569 8,569
Property and equipment 830 830
Operating lease right-of-use assets 1,619 1,619
Intangible assets 43,100 43,100
Other non-current assets 112 112
Total identifiable assets acquired 69,808 69,808
Accounts payable 4,210 4,210
Accrued expenses and other current liabilities 11,845 11,845
Notes payable 20,823 20,823
Deferred revenue 73 73
Operating lease liabilities, net of current portion 1,132 1,132
Warranty provision, noncurrent 1,566 1,566
SAFE agreements 60,470 60,470
Total identifiable liabilities assumed 100,119 100,119
Net identifiable liabilities assumed 30,311 30,311
Goodwill 119,422 119,422
Total aggregate consideration paid $ 89,111 $ 89,111
XML 81 R71.htm IDEA: XBRL DOCUMENT v3.23.4
Business Combination (Details) - Schedule of Intangible Assets Acquired - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Dec. 31, 2021
Business Combination (Details) - Schedule of Intangible Assets Acquired [Line Items]      
Total intangible asset $ 43,100 $ 43,100 $ 72
Trademarks [Member]      
Business Combination (Details) - Schedule of Intangible Assets Acquired [Line Items]      
Total intangible asset 5,700 5,700  
Developed technology [Member]      
Business Combination (Details) - Schedule of Intangible Assets Acquired [Line Items]      
Total intangible asset 12,700 12,700  
Customer relationships [Member]      
Business Combination (Details) - Schedule of Intangible Assets Acquired [Line Items]      
Total intangible asset $ 24,700 $ 24,700  
XML 82 R72.htm IDEA: XBRL DOCUMENT v3.23.4
Business Combination (Details) - Schedule of Unaudited Combined Pro Forma Information - Business Combination [Member] - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2022
Business Combination (Details) - Schedule of Unaudited Combined Pro Forma Information [Line Items]    
Revenues $ 22,267 $ 79,800
Net loss $ (26,498) $ (49,935)
XML 83 R73.htm IDEA: XBRL DOCUMENT v3.23.4
Prepaid Expenses and Other Current Assets (Details) - Schedule of Prepaid Expenses and Other Current Assets - USD ($)
$ in Thousands
Oct. 01, 2023
Dec. 31, 2022
Dec. 31, 2021
Schedule of Prepaid Expenses and Other Current Assets [Abstract]      
Inventory deposits $ 3,497 $ 6,255 $ 0
Prepaid sales commissions 5,509 2,838 4,771
Other 941 978 184
Total prepaid expenses and other current assets $ 9,947 $ 10,071 $ 4,955
XML 84 R74.htm IDEA: XBRL DOCUMENT v3.23.4
Divestiture (Details) - Schedule of Operations and Comprehensive Income (Loss) Related to Discontinued Operations - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Oct. 01, 2023
Oct. 01, 2023
Dec. 31, 2022
Schedule of Operations and Comprehensive Income Related to Discontinued Operations [Abstract]      
Revenues $ 3,774 $ 29,048 $ 13,325
Cost of revenues 4,102 30,609 12,847
Gross loss (328) (1,561) 478
Operating expenses:      
Sales and marketing 2,425 6,855 1,315
General and administrative 5,681 12,572 617
Total operating expenses 8,106 19,427 1,932
Loss from discontinued operations (8,434) (20,988) $ (1,454)
Other income (expense), net 31 32  
Loss from discontinued operations before income taxes (8,403) (20,956)  
Income tax benefit (provision) (1) 3  
Impairment loss from discontinued operations (147,505) (147,505)  
Net loss from discontinued operations $ (155,909) $ (168,458)  
XML 85 R75.htm IDEA: XBRL DOCUMENT v3.23.4
Divestiture (Details) - Schedule of Major Categories of Assets and Liabilities Held for Sale - USD ($)
$ in Thousands
Oct. 01, 2023
Dec. 31, 2022
Schedule of Major Categories of Assets and Liabilities Held for Sale [Abstract]    
Intangible assets, net $ 12,299 $ 42,610
Goodwill   119,422
Long-term assets held for sale $ 12,299 $ 162,032
XML 86 R76.htm IDEA: XBRL DOCUMENT v3.23.4
Divestiture (Details) - USD ($)
$ in Millions
9 Months Ended 12 Months Ended
Oct. 01, 2023
Dec. 31, 2022
Schedule of Operations and Comprehensive Income Related to Discontinued Operations [Abstract]    
Depreciation and amortization, discontinued operations   $ 0.5
Discontinued Operations [Member]    
Schedule of Operations and Comprehensive Income Related to Discontinued Operations [Abstract]    
Stock-based compensation expense   $ 0.5
Solaria Acquisition Member    
Schedule of Operations and Comprehensive Income Related to Discontinued Operations [Abstract]    
Impairment expense goodwill $ 119.4  
Impairment expense intangible assets 28.1  
Loss on disposal $ 1.8  
XML 87 R77.htm IDEA: XBRL DOCUMENT v3.23.4
Property and Equipment, Net (Details) - Schedule of Property and Equipment, Net - USD ($)
$ in Thousands
Oct. 01, 2023
Dec. 31, 2022
Dec. 31, 2021
Property, Plant and Equipment [Line Items]      
Total property and equipment $ 7,488 $ 5,954 $ 3,610
Less accumulated depreciation and amortization (3,303) (2,478) (1,852)
Total property and equipment, net $ 4,185 $ 3,476 1,758
Developed software [Member]      
Property, Plant and Equipment [Line Items]      
Total property and equipment 5 years 5 years  
Total property and equipment $ 6,559 $ 5,054 3,540
Manufacturing equipment [Member]      
Property, Plant and Equipment [Line Items]      
Total property and equipment 3 years    
Total property and equipment $ 131 102 70
Furniture and equipment [Member]      
Property, Plant and Equipment [Line Items]      
Total property and equipment 3 years    
Total property and equipment $ 90 90 0
Leasehold Improvements [Member]      
Property, Plant and Equipment [Line Items]      
Total property and equipment 5 years    
Total property and equipment $ 708 $ 708 $ 0
XML 88 R78.htm IDEA: XBRL DOCUMENT v3.23.4
Property and Equipment, Net (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Oct. 31, 2023
Oct. 01, 2023
Sep. 30, 2023
Sep. 30, 2022
Oct. 01, 2023
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Property and Equipment, Net [Abstract]                    
Depreciation and amortization expense   $ 300 $ 200   $ 600 $ 400   $ 600 $ 500 $ 300
Impairment charges on tangible assets $ 1,700 $ 0   $ 0 $ 0   $ 0      
XML 89 R79.htm IDEA: XBRL DOCUMENT v3.23.4
Goodwill and Intangible Assets (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Jan. 21, 2021
Oct. 01, 2023
Oct. 01, 2023
Sep. 30, 2022
Oct. 01, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Indefinite-Lived Intangible Assets [Line Items]                  
Goodwill impairment     $ 119,400,000   $ 119,400,000        
Goodwill   $ 0 $ 0   0   $ 119,400,000    
General and administrative expense       $ 100,000   $ 100,000      
Amortization expense related to intangible assets   738,000   17,000 2,228,000 51,000 100,000 $ 100,000 $ 0
Two Thousand And Twenty Three [Member]                  
Indefinite-Lived Intangible Assets [Line Items]                  
Amortization expense related to intangible assets             $ 100    
Assembled Workforce Member                  
Indefinite-Lived Intangible Assets [Line Items]                  
Amortization expense related to intangible assets   $ 0   $ 17,000 $ 4,000 $ 51,000      
Finite-lived intangible asset, useful life             2 years    
Current Insight [Member]                  
Indefinite-Lived Intangible Assets [Line Items]                  
Consideration for the asset acquisition $ 200,000                
Asset Acquisition, Liabilities Incurred $ 100,000                
Current Insight [Member] | Common Stock [Member]                  
Indefinite-Lived Intangible Assets [Line Items]                  
Asset acquisition, number of shares issued 30,000                
Asset acquisition, fair value of shares issued $ 100,000                
General and Administrative Expense [Member]                  
Indefinite-Lived Intangible Assets [Line Items]                  
Amortization expense related to intangible assets             $ 100,000 $ 100,000 $ 0
XML 90 R80.htm IDEA: XBRL DOCUMENT v3.23.4
Goodwill and Intangible Assets (Details) - Schedule of Intangible Assets - USD ($)
$ in Thousands
9 Months Ended 12 Months Ended
Oct. 01, 2023
Dec. 31, 2022
Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]      
Gross Carrying Amount $ 43,237 $ 43,237  
Impairment (28,083)    
Held for Sale (12,299)    
Accumulated Amortization (2,855) (627)  
Net Amount 0 42,610  
Assembled Workforce [Member]      
Finite-Lived Intangible Assets [Line Items]      
Gross Carrying Amount 137 137 $ 137
Impairment 0    
Held for Sale 0    
Accumulated Amortization (137) (133) (65)
Net Amount 0 $ 4 $ 72
Weighted- Average Remaining Life (Years)   1 month 6 days  
Trademarks [Member]      
Finite-Lived Intangible Assets [Line Items]      
Gross Carrying Amount 5,700 $ 5,700  
Impairment (3,714)    
Held for Sale (1,463)    
Accumulated Amortization (523) (95)  
Net Amount 0 $ 5,605  
Weighted- Average Remaining Life (Years)   9 years 9 months 18 days  
Customer relationship [Member]      
Finite-Lived Intangible Assets [Line Items]      
Gross Carrying Amount 24,700 $ 24,700  
Impairment (16,094)    
Held for Sale (7,577)    
Accumulated Amortization (1,029) (187)  
Net Amount 0 $ 24,513  
Weighted- Average Remaining Life (Years)   21 years 9 months 18 days  
Developed technology [Member]      
Finite-Lived Intangible Assets [Line Items]      
Gross Carrying Amount 12,700 $ 12,700  
Impairment (8,275)    
Held for Sale (3,259)    
Accumulated Amortization (1,166) (212)  
Net Amount $ 0 $ 12,488  
Weighted- Average Remaining Life (Years)   9 years 9 months 18 days  
XML 91 R81.htm IDEA: XBRL DOCUMENT v3.23.4
Goodwill and Intangible Assets (Details) - Schedule of Amortization Expense Related to Intangible Assets - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Oct. 01, 2023
Sep. 30, 2022
Oct. 01, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Schedule of Amortization Expense Related to Intangible Assets [Abstract]              
Total amortization expense $ 738 $ 17 $ 2,228 $ 51 $ 100 $ 100 $ 0
Assembled workforce [Member]              
Schedule of Amortization Expense Related to Intangible Assets [Abstract]              
Total amortization expense 0 17 4 51      
Trademarks [Member]              
Schedule of Amortization Expense Related to Intangible Assets [Abstract]              
Total amortization expense 142 0 428 0      
Customer relationship [Member]              
Schedule of Amortization Expense Related to Intangible Assets [Abstract]              
Total amortization expense 279 0 843 0      
Developed technology [Member]              
Schedule of Amortization Expense Related to Intangible Assets [Abstract]              
Total amortization expense $ 317 $ 0 $ 953 $ 0      
XML 92 R82.htm IDEA: XBRL DOCUMENT v3.23.4
Accrued Expenses and Other Current Liabilities (Details) - Schedule of Accrued Expenses and Other Current Liabilities - USD ($)
$ in Thousands
Oct. 01, 2023
Dec. 31, 2022
Dec. 31, 2021
Schedule of Accrued Expenses and Other Current Liabilities [Abstract]      
Accrued compensation and benefits $ 3,666 $ 3,940 $ 3,498
Customer deposits 1,167 930 1,375
Uninvoiced contract costs 3,554 1,914 2,180
Inventory received but not invoiced 1,391 972 0
Accrued term loan and revolving loan amendment and final payment fees 2,175 2,400 0
Accrued legal settlements 2,955 1,853 0
Accrued taxes 931 1,245 0
Accrued rebates and credits 880 1,076 0
Operating lease liabilities, current 720 958 390
Revenue warranty 918 0  
Deferred underwriters' discount payable 3,019 0  
Accrued warranty, current 605 767 600
Other accrued liabilities 4,693 3,775 1,304
Total accrued expenses and other current liabilities $ 26,674 $ 19,830 $ 9,347
XML 93 R83.htm IDEA: XBRL DOCUMENT v3.23.4
Other Income (Expense), Net (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended 12 Months Ended 21 Months Ended
Oct. 01, 2023
Sep. 30, 2022
Oct. 01, 2023
Dec. 31, 2022
Sep. 30, 2023
Other Income (Expense), Net [Line Items]          
Other income $ 0.3 $ 0.0 $ 0.7 $ 1.4 $ 1.4
Other expense related parties 30.7        
Related Party [Member]          
Other Income (Expense), Net [Line Items]          
Other income     0.3    
Other expense related parties $ 5.9   $ 5.9    
XML 94 R84.htm IDEA: XBRL DOCUMENT v3.23.4
Other Income (Expense), Net (Details) - Schedule of Other Income (Expense), Net - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Oct. 01, 2023
Oct. 01, 2023
[4]
Sep. 30, 2022
Oct. 01, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Schedule of Other Income (Expense), Net [Abstract]                
Change in fair value of redeemable convertible preferred stock warrant liability $ 39   $ 3 $ 9,455 $ (142)      
Change in fair value of SAFE agreements           $ 0 $ (1,306) $ (15)
Change in fair value of Carlyle warrants 12,689   12,689      
Change in fair value of derivative liabilities           0 (336) (50)
Change in fair value of warrant liabilities           (5,211) (330) 24
Change in fair value of FACT public, private placement and working capital warrants 4,170   4,170      
Gain on extinguishment of convertible notes and SAFE agreements [1]   [1] [1] 3,235 [1] 3,235 [2] 0 [2] 0 [2]
Loss on CS Solis debt extinguishment (10,338)   (10,338)      
Bonus shares issued in connection with the Merger (2,394) [3] $ (2,394) [3] (2,394) [3],[4] [3]      
Issuance of forward purchase agreements [5] 76   76      
Change in fair value of forward purchase agreement liabilities [6] (6,661)   (6,661)      
Issuance of shares in connection with the forward purchase agreements [7] (35,490)   (35,490)      
Forgiveness of Paycheck Protection Plan loan           0 1,754 0
Other, net (94)   1 191 87 118 (22) 0
Total other income (expense), net $ (38,003)   $ 4 $ (28,302) $ 3,180 $ (1,858) $ (240) $ (41)
[1] Includes zero and $1.4 million of other income for the three and nine months ended September 30, 2022, respectively, recognized upon the conversion of related party convertible notes and SAFEs.
[2] Includes $1.4 million of other income recognized upon the conversion of related party convertible notes and SAFEs
[3] Includes $0.7 million of other expense for each of the thirteen and thirty-nine weeks ended October 1, 2023 for bonus shares issued to related parties in connection with the Mergers.
[4] Includes 120,000 shares of Complete Solaria Common Stock issued to related parties.
[5] Includes $0.3 million of other income for each of the thirteen and thirty-nine weeks ended October 1, 2023 for forward purchase agreements entered into with related parties.
[6] Includes $5.9 million of other expense for each of the thirteen and thirty-nine weeks ended October 1, 2023 for forward purchase agreements entered into with related parties.
[7] Includes $30.7 million of other expense for each of the thirteen and thirty-nine weeks ended October 1, 2023 for shares issued to related parties in connection with the forward purchase agreements.
XML 95 R85.htm IDEA: XBRL DOCUMENT v3.23.4
Common Stock (Details) - shares
Oct. 01, 2023
Dec. 31, 2022
Dec. 31, 2021
Common stocks, shares authorized 1,000,000,000 60,000,000 13,547,943
Preferred stock, shares authorized 10,000,000    
Preferred stock issued    
Common Stock [Member]      
Common stocks, shares authorized   28,978,046 13,547,878
XML 96 R86.htm IDEA: XBRL DOCUMENT v3.23.4
Common Stock (Details) - Schedule of Reserved Shares of Common Stock - USD ($)
Oct. 01, 2023
Dec. 31, 2022
Dec. 31, 2021
Schedule of Reserved Shares of Common Stock [Abstract]      
Common stock warrants 27,637,266 3,389,005 690,236
Employee stock purchase plan (in Dollars) $ 2,628,996    
Stock options and RSUs, issued and outstanding 7,013,514    
Stock options and RSUs, authorized for future issuance 8,625,023    
Stock options, issued and outstanding   4,970,395 2,135,454
Stock options, authorized for future issuance   369,907 141,644
SAFE agreement   0 341,604
Convertible notes   0 1,621,299
Total shares reserved 45,904,799 8,729,307 4,930,237
XML 97 R87.htm IDEA: XBRL DOCUMENT v3.23.4
Warrants (Details) - USD ($)
1 Months Ended 9 Months Ended 12 Months Ended
Jul. 31, 2023
Jul. 18, 2023
May 31, 2023
Dec. 31, 2022
Nov. 30, 2022
Dec. 31, 2021
Oct. 31, 2021
Oct. 01, 2023
Oct. 01, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Feb. 28, 2022
Aug. 31, 2021
May 31, 2021
Jan. 31, 2020
Jul. 30, 2016
Feb. 29, 2016
Warrants [Line Items]                                      
Warrant to purchase shares (in Shares)         656,630                       173,067    
Warrant exercise price (in Dollars per share)               $ 0.01 $ 0.01                    
Fair value of warrant               $ (26,314,000)   $ 142,000 $ 5,211,000 $ 330,000 $ (24,000)            
Dividend yield                 $ 0                    
Risk free interest rate               1.90%                      
Outstanding warrants (in Shares)       3,389,005   690,236   27,637,266 27,637,266   3,389,005 690,236              
Warrent purchase shares (in Shares)               8,625,000                      
Description warrant expires               The warrant, which expires on July 18, 2030, provides Carlyle with the right to purchase shares of Complete Solaria Common Stock based on (a) the greater of (i) 1,995,879 shares and (ii) the number of shares equal to 2.795% of Complete Solaria’s issued and outstanding shares of common stock, on a fully-diluted basis; plus (b) on and after the date that is ten (10) days after the date of the amended and restated warrant agreement, an additional 350,000 shares; plus (c) on and after the date that is thirty (30) days after the date of the amended and restated warrant agreement, if the original investment amount has not been repaid, an additional 150,000 shares; plus (d) on and after the date that is ninety (90) days after the date of the amended and restated warrant agreement, if the original investment amount has not been repaid, an additional 250,000 shares, in each case, of Complete Solaria Common Stock at a price of $0.01 per share                      
Warrant vesting (in Shares)               150,000 150,000                    
Warrant liability               $ 20,400,000                      
Reduction to additional paid-in capital               9,500,000 $ 9,500,000                    
Other Income               $ 12,700,000                      
Preferred stock exercisable share (in Shares)               518,752 518,752                    
Exercise price per share (in Dollars per share)               $ 2.5                      
Working capital warrants               $ 117,000                      
Warrant [Member]                                      
Warrants [Line Items]                                      
Warrant vesting (in Shares)               350,000 350,000                    
Reduction to additional paid-in capital               $ 10,900,000 $ 10,900,000                    
Minimum [Member]                                      
Warrants [Line Items]                                      
Warrant exercise price (in Dollars per share)                               $ 0.38      
Maximum [Member]                                      
Warrants [Line Items]                                      
Warrant to purchase shares (in Shares)                             2,525        
Warrant exercise price (in Dollars per share)                             $ 0.62        
Series B Preferred Stock [Member]                                      
Warrants [Line Items]                                      
Warrant to purchase shares (in Shares)                                     5,054
Series C Preferred Stock [Member]                                      
Warrants [Line Items]                                      
Fair value of warrant   $ 2,300,000                 $ 6,300,000 $ 1,100,000              
Number of share exercisable (in Shares)       482,969       482,969 482,969   482,969                
Series B Warrants [Member]                                      
Warrants [Line Items]                                      
Warrant exercise price (in Dollars per share)                                     $ 4.3
Fair value of warrant       $ 100,000                              
Series B Warrants [Member] | Common Class A [Member]                                      
Warrants [Line Items]                                      
Fair value of warrant   $ 100,000       $ 100,000                          
Series C Warrants [Member]                                      
Warrants [Line Items]                                      
Warrant to purchase shares (in Shares)                                   148,477  
Warrant exercise price (in Dollars per share)       $ 1       $ 1 $ 1   $ 1                
Expected term               10 years                      
Expected volatility, percentage               62.50%                      
Risk free interest rate, percentage               1.50%                      
Dividend yield               $ 0                      
Series C-1 Warrants (Converted to Common Stock Warrants) [Member]                                      
Warrants [Line Items]                                      
Warrant exercise price (in Dollars per share)                                 $ 0.01    
Fair value of warrant               100,000                      
SVB Common Stock Warrants [Member]                                      
Warrants [Line Items]                                      
Fair value of warrant               $ 100,000     $ 100,000                
Expected term               12 years                      
Expected volatility, percentage               73.00%                      
SVB Common Stock Warrants [Member] | Minimum [Member]                                      
Warrants [Line Items]                                      
Warrant to purchase shares (in Shares)                               2,472      
Risk free interest rate               1.30%                      
SVB Common Stock Warrants [Member] | Maximum [Member]                                      
Warrants [Line Items]                                      
Risk free interest rate               1.70%                      
SVB Common Stock Warrants [Member] | Common Stock [Member] | Minimum [Member]                                      
Warrants [Line Items]                                      
Warrant to purchase shares (in Shares)                               2,473      
Promissory Note Common Stock Warrants [Member]                                      
Warrants [Line Items]                                      
Warrant to purchase shares (in Shares)             24,148                        
Warrant exercise price (in Dollars per share)             $ 0.01                        
Fair value of warrant             $ 100,000                        
Expected term             10 years                        
Expected volatility, percentage             73.00%                        
Risk free interest rate, percentage             1.50%                        
Dividend yield             $ 0                        
Carlyle Warrants [Member]                                      
Warrants [Line Items]                                      
Warrant to purchase shares (in Shares)                           2,887,643          
Warrant exercise price (in Dollars per share)                           $ 0.01          
Fair value of warrant               $ 7,700,000                      
Number of share exercisable (in Shares)                           1,995,870          
Expected term               7 years                      
Expected volatility, percentage               77.00%                      
Risk free interest rate               3.90%                      
Outstanding warrants (in Shares) 1,995,879                                    
Warrent purchase shares (in Shares) 1,995,879                                    
Description warrant expires               the warrant, which expires on July 18, 2030, provides Carlyle with the right to purchase shares of Complete Solaria Common Stock based on (a) the greater of (i) 1,995,879 shares and (ii) the number of shares equal to 2.795% of Complete Solaria’s issued and outstanding shares of common stock, on a fully-diluted basis; plus (b) on and after the date that is ten (10) days after the date of the agreement, an additional 350,000 shares; plus (c) on and after the date that is thirty (30) days after the date of the agreement, if the original investment amount has not been repaid, an additional 150,000 shares; plus (d) on and after the date that is ninety (90) days after the date of the agreement, if the original investment amount has not been repaid, an additional 250,000 shares, in each case, of Complete Solaria Common Stock at a price of $0.01 per share.                      
Carlyle Warrants [Member] | Warrant [Member]                                      
Warrants [Line Items]                                      
Number of share exercisable (in Shares)                           1,995,879          
Carlyle Warrants [Member] | Common Stock [Member]                                      
Warrants [Line Items]                                      
Warrant to purchase shares (in Shares)                           2,886,952          
Warrant [Member]                                      
Warrants [Line Items]                                      
Warrant to purchase shares (in Shares)         656,630                            
Expected term               7 years                    
Expected volatility, percentage               77.00%                    
Risk free interest rate, percentage               3.92%                    
Series D-7 Warrants [Member]                                      
Warrants [Line Items]                                      
Converted to common stock warrants, description               The first tranche of 518,752 shares of Series D-7 preferred stock is exercisable at an exercise price of $2.50 per share upon consummation of a merger transaction, or at an exercise price of $2.04 per share upon remaining private and has an expiration date of April 2024. The second tranche of 137,878 shares of Series D-7 preferred stock is exercisable at an exercise price of $5.00 per share upon consummation of a merger transaction, or at an exercise price of $4.09 per share upon remaining private and has an expiration date of April 2024. The fair value of the Series D-7 warrants was $7.8 million as of December 31, 2022 and $2.4 million as of July 18, 2023 when the warrants were reclassified from redeemable convertible preferred stock warrant liability to additional paid-in capital, as the exercise price of the warrants is fixed at $2.50 per share of Complete Solaria Common Stock for the first tranche and $5.00 per share of Complete Solaria Common Stock for the second tranche upon the closing of the Mergers.     The first tranche of 518,752 shares of Series D-7 preferred stock is exercisable at an exercise price of $2.50 per share upon consummation of a deSPAC transaction, or at an exercise price of $2.04 per share upon remaining private and has an expiration date of April 2024. The second tranche of 137,878 shares of Series D-7 preferred stock is exercisable at an exercise price of $5.00 per share upon consummation of a deSPAC transaction, or at an exercise price of $4.09 per share upon remaining private and has an expiration date of April 2024. The warrants remain outstanding as of December 31, 2022. The fair value of the Series D-7 warrants, as determined in accordance with the methodology described in Note 10 – Fair Value Measurements, was $7.8 million as of December 31, 2022.                
Preferred stock exercisable share (in Shares)       518,752             518,752                
Exercise price per share (in Dollars per share)                     $ 2.5                
November 2022 Common Stock Warrants [Member]                                      
Warrants [Line Items]                                      
Fair value of warrant     $ 100,000                                
Expected term     1 year 6 months                                
Expected volatility, percentage     78.50%                                
Risk free interest rate, percentage     4.70%                                
Warrent purchase shares (in Shares)         38,136                            
Exercise price per share (in Dollars per share)         $ 8                            
Purchase shares (in Shares)     31,680                                
Exercise price per share (in Dollars per share)     $ 0.01                                
Warrant exercised (in Shares)     31,680                                
November 2022 Common Stock Warrants [Member] | Business Combination Member                                      
Warrants [Line Items]                                      
Warrent purchase shares (in Shares)         78,962                            
July 2023 Common Stock Warrants [Member]                                      
Warrants [Line Items]                                      
Warrant exercise price (in Dollars per share) $ 0.01                                    
Warrent purchase shares (in Shares) 38,981                                    
July 2023 Common Stock Warrants [Member] | Private Placement [Member]                                      
Warrants [Line Items]                                      
Fair value of warrant $ 200,000                                    
Class A Common Stock Equals or Exceeds Threshold Two [Member] | Private Placement [Member]                                      
Warrants [Line Items]                                      
Exercise price per share (in Dollars per share) $ 0.01                                    
Warrant Consideration [Member]                                      
Warrants [Line Items]                                      
Expected term 10 years                                    
Warrent purchase shares (in Shares) 6,266,572                                    
Exercise price per share (in Dollars per share) $ 11.5                                    
Public, Private Placement, and Working Capital Warrants [Member]                                      
Warrants [Line Items]                                      
Fair value of warrant               $ 2,400,000                      
Warrent purchase shares (in Shares)               6,266,667                      
Exercise price per share (in Dollars per share)               $ 11.5                      
Warrant amount               $ 6,400,000                      
Other income (expense)               4,000,000                      
Public, Private Placement, and Working Capital Warrants [Member] | Private Placement [Member]                                      
Warrants [Line Items]                                      
Fair value of warrant               $ 300,000                      
Preferred stock exercisable share (in Shares)               716,668 716,668                    
Other income (expense)               $ 200,000                      
Working capital warrants               $ 100,000                      
Public, Private Placement, and Working Capital Warrants [Member] | Public Warrants [Member]                                      
Warrants [Line Items]                                      
Exercise price per share (in Dollars per share)               $ 11.5                      
CRSEF Solis Holdings, LLC [Member] | Carlyle Warrants [Member]                                      
Warrants [Line Items]                                      
Fair value of warrant               $ 3,400,000     $ 3,400,000                
Black-Scholes model [Member] | Carlyle Warrants [Member]                                      
Warrants [Line Items]                                      
Fair value of warrant               $ 20,400,000                      
Expected term               7 years                      
Expected volatility, percentage               73.00%                      
XML 98 R88.htm IDEA: XBRL DOCUMENT v3.23.4
Warrants - Schedule of Fair Value of The Common Stock Warrants (Details) - Common Stock Warrants [Member]
Dec. 31, 2022
yr
Dec. 31, 2021
yr
Measurement Input, Price Volatility [Member]    
Disclosure In Tabular Form Of Significant Unobservable Inputs Used In The Fair Value Of Warrants [Line Items]    
Warrants and Rights Outstanding, Measurement Input   73
Measurement Input, Expected Dividend Rate [Member]    
Disclosure In Tabular Form Of Significant Unobservable Inputs Used In The Fair Value Of Warrants [Line Items]    
Warrants and Rights Outstanding, Measurement Input 0 0
Maximum [Member] | Measurement Input, Expected Term [Member]    
Disclosure In Tabular Form Of Significant Unobservable Inputs Used In The Fair Value Of Warrants [Line Items]    
Warrants and Rights Outstanding, Measurement Input 1.5 10
Maximum [Member] | Measurement Input, Price Volatility [Member]    
Disclosure In Tabular Form Of Significant Unobservable Inputs Used In The Fair Value Of Warrants [Line Items]    
Warrants and Rights Outstanding, Measurement Input 73  
Maximum [Member] | Measurement Input, Risk Free Interest Rate [Member]    
Disclosure In Tabular Form Of Significant Unobservable Inputs Used In The Fair Value Of Warrants [Line Items]    
Warrants and Rights Outstanding, Measurement Input 1.9 1.3
Minimum [Member] | Measurement Input, Expected Term [Member]    
Disclosure In Tabular Form Of Significant Unobservable Inputs Used In The Fair Value Of Warrants [Line Items]    
Warrants and Rights Outstanding, Measurement Input 7 12
Minimum [Member] | Measurement Input, Price Volatility [Member]    
Disclosure In Tabular Form Of Significant Unobservable Inputs Used In The Fair Value Of Warrants [Line Items]    
Warrants and Rights Outstanding, Measurement Input 78.5  
Minimum [Member] | Measurement Input, Risk Free Interest Rate [Member]    
Disclosure In Tabular Form Of Significant Unobservable Inputs Used In The Fair Value Of Warrants [Line Items]    
Warrants and Rights Outstanding, Measurement Input 4.7 1.7
XML 99 R89.htm IDEA: XBRL DOCUMENT v3.23.4
Borrowing Arrangements (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Oct. 01, 2023
Dec. 31, 2022
Dec. 31, 2021
Sep. 30, 2023
Feb. 28, 2023
Dec. 31, 2022
Mar. 31, 2022
Feb. 28, 2022
Oct. 31, 2021
Jul. 31, 2021
Apr. 30, 2021
Jan. 31, 2021
Apr. 30, 2020
Jan. 20, 2020
Dec. 31, 2018
Oct. 01, 2023
Oct. 01, 2023
Sep. 30, 2022
Oct. 01, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Jan. 01, 2021
Borrowing Arrangements [Line Items]                                                  
Total Principal amount               $ 500,000     $ 500,000               $ 100,000         $ 100,000  
Percentage of accured interest                     3.00%               6.00%   6.00%        
Remaining balance   $ 0       $ 0                             $ 0        
Percentage of equity financing 80.00% 80.00%       80.00%                   80.00% 80.00%   80.00%   80.00%        
Initial fair value                                     $ 100,000   $ 100,000        
Expense                                     $ 0            
Redeemable convertible preferred stock (in Shares)                                     62,500   62,500        
other income expense                                     $ 100,000   $ 100,000        
Common stock outstanding (in Shares) 45,312,243 19,932,429 9,806,143     19,932,429                   45,312,243 45,312,243   45,312,243   19,932,429 9,806,143      
Interest expense                               $ 30,700,000                  
Immaterial debt issuance costs $ 100,000 $ 100,000       $ 100,000                   100,000 $ 100,000   $ 100,000   $ 100,000        
Common stock, issued (in Shares)     5,229                                     5,229      
Obtain new equity     $ 15,000,000                                     $ 15,000,000      
Repaid the principal and accrued interest               $ 6,700,000                                  
Bears interest rate           8.00%                                      
Interest expense recognized                               300,000     1,000,000   700,000        
Revolving loan 2,175,000 2,400,000 0     $ 2,400,000                   2,175,000 2,175,000   $ 2,175,000   $ 2,400,000 0      
Prime rate plus                                     4.50%   4.50%        
Total amendment fees 1,900,000 1,900,000       $ 1,900,000                   1,900,000 1,900,000   $ 1,900,000   $ 1,900,000        
Borrow, percentage           70.00%                                      
Vendor purchase net amount           $ 10,000,000                                      
Borrowing   20,000,000       20,000,000                             20,000,000        
Outstanding net debt           5,600,000                         11,700,000   5,600,000        
Accrued financing cost 4,100,000 100,000     $ 800,000 100,000                   4,100,000 4,100,000   4,100,000   100,000        
Recognized interest expense                               0     3,100,000            
Pay return capital       $ 500,000                                          
Payments for Settlement 100,000                                   100,000            
Contributed $ 25,600,000 $ 25,600       $ 25,600                   $ 25,600,000 $ 25,600,000   $ 25,600,000   $ 25,600        
Investment dividend payable percentage 25.00% 25.00%       25.00%                   25.00% 25.00%   25.00%   25.00%        
Exercisable shares (in Shares)                                     4,132,513   4,132,513        
Investment description                                     The Carlyle Debt Modification Agreement accelerates the redemption date of the investment, which was previously February 14, 2025 and is March 31, 2024 subsequent to the modification. Additionally, as part of the amendment, the parties entered into an amended and restated warrant agreement. As part of the Carlyle Warrant Amendment, Complete Solaria issued Carlyle a warrant to purchase up to 2,745,879 shares of Complete Solaria Common Stock at a price per share of $0.01, which is inclusive of the outstanding warrant to purchase 1,995,879 shares at the time of modification. The warrant, which expires on July 18, 2030, provides Carlyle with the right to purchase shares of Complete Solaria Common Stock based on (a) the greater of (i) 1,995,879 shares and (ii) the number of shares equal to 2.795% of Complete Solaria’s issued and outstanding shares of common stock, on a fully-diluted basis; plus (b) on and after the date that is ten (10) days after the date of the agreement, an additional 350,000 shares; plus (c) on and after the date that is thirty (30) days after the date of the agreement, if the original investment amount has not been repaid, an additional 150,000 shares; plus (d) on and after the date that is ninety (90) days after the date of the agreement, if the original investment amount has not been repaid, an additional 250,000 shares, in each case, of Complete Solaria Common Stock at a price of $0.01 per share. The warrants are classified as liabilities under ASC 815 and are recorded within warrant liability on the unaudited condensed consolidated statements of operations and comprehensive income (loss).            
Loss on extinguishment             $ 1,400,000                       [1] $ 3,235,000 [1] $ 3,235,000 [2] [2] [2]    
Fair value of short term debt $ 28,400,000                             $ 28,400,000 $ 28,400,000   28,400,000            
Redemption amount                                     31,900,000            
Liability 0 $ 25,200,000       $ 25,200,000                   0 0   0   25,200,000        
Interest expense                               1,200,000   $ 400,000 2,700,000 900,000          
Payment of interest 200,000                             200,000 200,000   200,000            
Long term debt fair value 29,100,000                             29,100,000 29,100,000   29,100,000            
Embedded derivative liabilities unrealized gains losses                                           366,000      
Convertible Debt   18,944,000 $ 8,710,000     18,944,000                             18,944,000 $ 8,710,000      
Notes Payable 18,944,000       18,944,000                       $ 18,944,000        
Paycheck Protection Programme Loan [Member]                                                  
Borrowing Arrangements [Line Items]                                                  
Proceeds from Issuance of Other Long-Term Debt                     $ 900,000   $ 900,000                        
Secured Credit Facility [Member]                                                  
Borrowing Arrangements [Line Items]                                                  
Proceeds from Issuance of Secured Debt           5,500,000                                      
Repayments of Secured Debt         $ 6,300,000                                        
CS Soils [Member]                                                  
Borrowing Arrangements [Line Items]                                                  
Redemption price percentage                                     10.50%   10.50%        
Loss on extinguishment                                     $ 10,300,000            
Liability $ 29,200,000 0       0                   29,200,000 $ 29,200,000   29,200,000   $ 0        
Interest expense                               $ 100,000   700,000 $ 700,000 1,700,000 2,400,000        
Long term debt fair value   24,000,000       24,000,000                             24,000,000        
Debt Related Commitment Fees and Debt Issuance Costs                                         1,200,000        
Long term debt   $ 25,200,000       $ 25,200,000                             $ 25,200,000        
Common Stock [Member]                                                  
Borrowing Arrangements [Line Items]                                                  
Redeemable convertible preferred stock (in Shares)                                 5,460,075   5,460,075            
Common stock, issued (in Shares)     5,229                                     5,229      
Purchase of common stock (in Shares)                                     5,978,960   5,978,960        
Price per share (in Dollars per share) $ 0.01 $ 0.01       $ 0.01                   $ 0.01 $ 0.01   $ 0.01   $ 0.01        
2020 Convertible Notes [Member]                                                  
Borrowing Arrangements [Line Items]                                                  
Total Principal amount                                     $ 3,800,000   $ 3,800,000        
Percentage of accured interest                                     2.00%   2.00%        
Remaining balance $ 0 $ 0       $ 0                   $ 0 $ 0   $ 0   $ 0        
Percentage of equity financing 80.00% 80.00%       80.00%                   80.00% 80.00%   80.00%   80.00%        
Initial fair value                                     $ 500,000   $ 500,000        
Weighted-average effective interest rate 25.60% 25.60%       25.60%                   25.60% 25.60%   25.60%   25.60%        
Expense                               $ 0   $ 0 $ 0 $ 0          
other income expense                                     $ 900,000   $ 900,000        
Convertible per share (in Dollars per share)                                     $ 0.75            
2021-A Convertible Notes [Member]                                                  
Borrowing Arrangements [Line Items]                                                  
Total Principal amount                                     $ 4,300,000   $ 4,300,000        
Percentage of accured interest                                     2.00%   2.00%        
Percentage of equity financing 80.00% 80.00%       80.00%                   80.00% 80.00%   80.00%   80.00%        
Initial fair value                                     $ 600,000   $ 600,000        
Weighted-average effective interest rate 18.10% 18.10%       18.10%                   18.10% 18.10%   18.10%   18.10%        
Other expense                                     $ 800,000   $ 800,000        
Redeemable convertible preferred stock (in Shares)                                     869,640   869,640        
other income expense                                         $ 200,000        
Additional convertible note                                     $ 500,000   $ 500,000        
Due and payable amount                                     3.00%   3.00%        
2021-A Convertible Notes [Member] | Tranche One [Member]                                                  
Borrowing Arrangements [Line Items]                                                  
Notes Payable   $ 0 $ 500,000     $ 0                             $ 0 $ 500,000      
2021-A Convertible Notes [Member] | Tranche Two [Member]                                                  
Borrowing Arrangements [Line Items]                                                  
Notes Payable     2,000,000                                     2,000,000      
Debt Instrument, Unamortized Discount   0       0                             $ 0        
2022 Convertible Notes [Member]                                                  
Borrowing Arrangements [Line Items]                                                  
Percentage of accured interest                                     5.00%   5.00%        
Initial fair value                                     $ 6,700,000   $ 6,700,000        
Aggregate purchase price $ 12,000,000 12,000,000       12,000,000                   $ 12,000,000 $ 12,000,000   12,000,000   $ 12,000,000        
Additional total purchase $ 21,300,000                             $ 21,300,000 $ 21,300,000   $ 21,300,000            
Convertible per share (in Dollars per share)                                         $ 0.75        
Common stock outstanding (in Shares) 5,316,460                             5,316,460 5,316,460   5,316,460            
Interest payable on convertble debt   200,000       200,000                             $ 200,000        
Convertible debt at fair value   19,800,000       19,800,000                             19,800,000        
2022 Convertible Notes [Member] | Related Party [Member]                                                  
Borrowing Arrangements [Line Items]                                                  
Convertible Debt   15,500,000       15,500,000                             15,500,000        
2022 Convertible Notes [Member] | Nonrelated Party [Member]                                                  
Borrowing Arrangements [Line Items]                                                  
Convertible Debt   3,400,000       3,400,000                             3,400,000        
2019 SAFE [Member]                                                  
Borrowing Arrangements [Line Items]                                                  
Remaining balance $ 0                             $ 0 $ 0   $ 0            
Initial fair value                                     200,000   200,000        
Other expense                                     $ 100,000   $ 100,000        
Redeemable convertible preferred stock (in Shares)                                     48,258   48,258        
2021 SAFE [Member]                                                  
Borrowing Arrangements [Line Items]                                                  
Remaining balance   0       0                             $ 0        
Initial fair value                                         6,300,000        
Other expense                                         $ 1,400,000        
Redeemable convertible preferred stock (in Shares)                                         1,005,366        
Immaterial debt issuance costs   5,000,000       5,000,000                             $ 5,000,000        
2021 Promissory Notes [Member]                                                  
Borrowing Arrangements [Line Items]                                                  
Shares, issued (in Shares)                 50,000                                
Exercise price per share (in Dollars per share)                 $ 0.01                                
Short-term promissory note                 $ 2,000,000 $ 500,000                              
Promissory note carried simple interest rate                   2.00%                              
Financing fee                 $ 300,000                                
Current Insight Promissory Note [Member]                                                  
Borrowing Arrangements [Line Items]                                                  
Immaterial debt issuance costs     $ 100,000                                     100,000     $ 100,000
Bears interest rate                       0.14%                          
2018 Bridge Notes [Member]                                                  
Borrowing Arrangements [Line Items]                                                  
Bears interest rate                             8.00%                    
Convertible secured notes                             $ 3,400,000                    
Carrying value $ 10,700,000 9,800,000       9,800,000                   $ 10,700,000 $ 10,700,000   $ 10,700,000   9,800,000        
2018 Bridge Notes [Member] | Fair Value, Inputs, Level 3 [Member]                                                  
Borrowing Arrangements [Line Items]                                                  
Notes Payable, Fair Value Disclosure   $ 9,100,000       $ 9,100,000                             9,100,000        
Minimum [Member]                                                  
Borrowing Arrangements [Line Items]                                                  
Line of credit interest rate                           3.50%                      
Exercise price per share (in Dollars per share)     $ 0.38                                            
Liquidity ratio amount                                     1   1.75        
Increased repayment premium, percentage           110.00%                                      
Minimum [Member] | 2022 Convertible Notes [Member]                                                  
Borrowing Arrangements [Line Items]                                                  
Interest expense                                     0.1            
Maximum [Member]                                                  
Borrowing Arrangements [Line Items]                                                  
Line of credit interest rate                           5.25%                      
Exercise price per share (in Dollars per share)     $ 0.62                                            
Liquidity ratio amount                                     1.75   1        
Increased repayment premium, percentage           120.00%                                      
Maximum [Member] | 2020 Convertible Notes [Member]                                                  
Borrowing Arrangements [Line Items]                                                  
Embedded derivative liabilities unrealized gains losses                                         $ 0 100,000 100,000    
Maximum [Member] | 2022 Convertible Notes [Member]                                                  
Borrowing Arrangements [Line Items]                                                  
Interest expense                                     $ 700,000            
Warrant [Member]                                                  
Borrowing Arrangements [Line Items]                                                  
Shares, issued (in Shares)     5,122                                            
Conversion Amount [Member]                                                  
Borrowing Arrangements [Line Items]                                                  
Maturity date                     Jun. 30, 2021                            
2019-A Convertible Notes [Member]                                                  
Borrowing Arrangements [Line Items]                                                  
Weighted-average effective interest rate 17.60% 17.60%       17.60%                   17.60% 17.60%   17.60%   17.60%        
Embedded derivative liabilities unrealized gains losses                                           17,000      
2019-A Convertible Notes [Member] | Maximum [Member]                                                  
Borrowing Arrangements [Line Items]                                                  
Embedded derivative liabilities unrealized gains losses                                         $ 0 $ 100,000 $ 100,000    
SAFE [Member]                                                  
Borrowing Arrangements [Line Items]                                                  
Estimated fair value                                     $ 60,500,000   $ 60,500,000        
Converted, shares (in Shares)                                     8,171,662   8,171,662        
SCI Term Loan and Revolver Loan [Member]                                                  
Borrowing Arrangements [Line Items]                                                  
Maturity date                                     Oct. 31, 2023   Oct. 31, 2023        
Revolving loan $ 5,000,000 $ 5,000,000       $ 5,000,000                   $ 5,000,000 $ 5,000,000   $ 5,000,000   $ 5,000,000        
Series D Preferred Stock [Member]                                                  
Borrowing Arrangements [Line Items]                                                  
Remaining balance   0       0                             $ 0        
Series D Preferred Stock [Member] | 2020 Convertible Notes [Member]                                                  
Borrowing Arrangements [Line Items]                                                  
Redeemable convertible preferred stock (in Shares)                                     785,799   785,799        
Loan and Security Agreement [Member]                                                  
Borrowing Arrangements [Line Items]                                                  
Line of credit                           $ 7,000,000                      
Long-Term Line of Credit   7,000,000       7,000,000                             $ 7,000,000        
Revolving Loan [Member]                                                  
Borrowing Arrangements [Line Items]                                                  
Interest expense recognized   100,000                           200,000     $ 500,000            
Interest rate                                     7.75%   7.75%        
Fair value                                     $ 5,000,000   $ 5,000,000        
Principal balance 5,000,000 $ 5,000,000       $ 5,000,000                   $ 5,000,000 $ 5,000,000   5,000,000   $ 5,000,000        
Rodgers Massey [Member]                                                  
Borrowing Arrangements [Line Items]                                                  
Interest expense recognized                                     $ 5,000,000            
Polar Settlement Agreement [Member]                                                  
Borrowing Arrangements [Line Items]                                                  
Payments for Settlement $ 500,000                                                
[1] Gain on extinguishment of convertible notes and SAFEs includes other income from related parties of zero during each of the thirteen and thirty-nine weeks ended October 1, 2023, and zero and $1.4 million during the three and nine months ended September 30, 2022, respectively.
[2] Gain on extinguishment of convertible notes and SAFEs includes other income from related parties of $1.4 million, zero and zero during the years ended December 31, 2022, 2021 and 2020, respectively.
XML 100 R90.htm IDEA: XBRL DOCUMENT v3.23.4
Borrowing Arrangements (Details) - Schedule of Convertible Notes - USD ($)
$ in Thousands
Oct. 01, 2023
Dec. 31, 2022
Dec. 31, 2021
Borrowing Arrangements [Line Items]      
Convertible Debt, Current   $ 0 $ 6,820
Convertible notes, net, noncurrent      
2022 Convertible Notes due to related parties   18,944 8,710
Total convertible notes 18,944  
Two Thousand And Nineteen A Convertible Notes [Member]      
Convertible notes, net, noncurrent      
2022 Convertible Notes due to related parties   0 115
Two Thousand And Twenty Two Convertible Notes [Member]      
Convertible notes, net, noncurrent      
2022 Convertible Notes 3,434  
Nonrelated Party [Member]      
Borrowing Arrangements [Line Items]      
Convertible Debt, Current   0 1,890
Convertible Debt, Noncurrent   3,434 0
Nonrelated Party [Member] | Two Thousand And Nineteen A Convertible Notes [Member]      
Borrowing Arrangements [Line Items]      
Convertible Debt, Current   0 115
Nonrelated Party [Member] | Two Thousand And Twenty Series A Convertible Notes [Member]      
Borrowing Arrangements [Line Items]      
Convertible Debt, Current   0 630
Nonrelated Party [Member] | Two Thousand And Twenty One Series A Convertible Notes [Member]      
Borrowing Arrangements [Line Items]      
Convertible Debt, Current   0 1,145
Nonrelated Party [Member] | Two Thousand And Twenty Two Convertible Notes [Member]      
Borrowing Arrangements [Line Items]      
Convertible Debt, Noncurrent   3,434 0
Related Party [Member]      
Borrowing Arrangements [Line Items]      
Convertible Debt, Noncurrent   15,510 0
Related Party [Member] | Two Thousand And Twenty Series A Convertible Notes [Member]      
Borrowing Arrangements [Line Items]      
Convertible Debt, Current   0 3,260
Related Party [Member] | Two Thousand And Twenty One Series A Convertible Notes [Member]      
Borrowing Arrangements [Line Items]      
Convertible Debt, Current   0 3,050
Related Party [Member] | Two Thousand And Twenty Two Convertible Notes [Member]      
Borrowing Arrangements [Line Items]      
Convertible Debt, Noncurrent   15,510 0
Convertible notes, net, noncurrent      
2022 Convertible Notes due to related parties 15,510  
Related Party [Member] | Convertible Promissory Notes With Eco System Integrity Fund Two LLC [Member]      
Borrowing Arrangements [Line Items]      
Convertible Debt, Current   $ 0 $ 510
XML 101 R91.htm IDEA: XBRL DOCUMENT v3.23.4
Borrowing Arrangements (Details) - Schedule of Net Carrying Amount of the Convertible Notes - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Debt Instrument [Line Items]    
Net carrying amount $ 18,944 $ 8,710
Two Thousand And Nineteen A Convertible Notes [Member]    
Debt Instrument [Line Items]    
Principal 100 100
Unamortized debt discount 0 0
PIK interest added to principal balance 16 15
Conversion to Series D-2 redeemable convertible preferred stock (116) 0
Net carrying amount 0 115
Two Thousand And Twenty A Convertible Notes [Member]    
Debt Instrument [Line Items]    
Principal 3,784 3,784
Unamortized debt discount 0 0
PIK interest added to principal balance 122 106
Conversion to Series D-2 redeemable convertible preferred stock (3,906) 0
Net carrying amount 0 3,890
Two Thousand And Twenty One Convertible Notes [Member]    
Debt Instrument [Line Items]    
Principal 4,250 4,250
Unamortized debt discount 0 (112)
PIK interest added to principal balance 74 57
Conversion to Series D-2 redeemable convertible preferred stock (4,324) 0
Net carrying amount 0 4,195
Two Thousand And Twenty One A Convertible Notes With Embedded Derivative Liability [Member]    
Debt Instrument [Line Items]    
Principal 500 500
Unamortized debt discount 0 0
PIK interest added to principal balance 10 10
Net carrying amount 0 510
Repayment of principal and accrued interest $ (510) $ 0
XML 102 R92.htm IDEA: XBRL DOCUMENT v3.23.4
Borrowing Arrangements (Details) - Schedule Of Interest Expense On Convertible Debt - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Two Thousand And Nineteen A Convertible Notes [Member]      
Disclosure In Tabular Form Of Interest Expense On Convertible Debt [Line Items]      
Amortization of debt discount $ 0 $ 0 $ 4
PIK Interest 1 12 3
Total non-cash interest expense 1 12 7
Two Thousand And Twenty A Convertible Notes [Member]      
Disclosure In Tabular Form Of Interest Expense On Convertible Debt [Line Items]      
Amortization of debt discount 0 281 235
PIK Interest 16 74 32
Total non-cash interest expense 16 355 267
Two Thousand And Twenty One Convertible Notes [Member]      
Disclosure In Tabular Form Of Interest Expense On Convertible Debt [Line Items]      
Amortization of debt discount 112 454 0
PIK Interest 17 57 0
Total non-cash interest expense 129 511 0
Two Thousand And Twenty One A Convertible Notes With Embedded Derivative Liability [Member]      
Disclosure In Tabular Form Of Interest Expense On Convertible Debt [Line Items]      
Amortization of debt discount 0 0 0
PIK Interest 0 10 0
Total non-cash interest expense $ 0 $ 10 $ 0
XML 103 R93.htm IDEA: XBRL DOCUMENT v3.23.4
Borrowing Arrangements (Details) - Schedule of Company's outstanding notes payable - Notes Payable, Other Payables [Member] - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Debt Instrument [Line Items]    
Long-Term Debt, Gross $ 0 $ 9,507
Less: Unamortized debt issuance costs and discounts 0 0
Other Notes Payable, Current 0 9,507
Loan And Security Agreement Member    
Debt Instrument [Line Items]    
Long-Term Debt, Gross 0 6,987
2021 Promissory Notes [Member]    
Debt Instrument [Line Items]    
Long-Term Debt, Gross 0 2,500
Current Insight Promissory Note Member    
Debt Instrument [Line Items]    
Long-Term Debt, Gross $ 0 $ 20
XML 104 R94.htm IDEA: XBRL DOCUMENT v3.23.4
Stock-Based Compensation (Details) - USD ($)
$ in Thousands
1 Months Ended 9 Months Ended 12 Months Ended
Jul. 31, 2023
Jul. 31, 2023
Oct. 01, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Jun. 30, 2023
Stock-Based Compensation [Line Items]                
Number of common stock percentage         5.00%     5.00%
Unrecognized stock-based compensation costs (in Dollars)         $ 5,400      
Recognized weighted average period         2 years 2 months 12 days      
Vesting shares   52,167            
Vested options of terminated employees   280,412            
Stock based compensation expenses (in Dollars)     $ 2,321 $ 217 $ 433 $ 200 $ 109  
Common stock shares reserved for future issuance     8,625,023          
2023 Equity Incentive Plan [Member]                
Stock-Based Compensation [Line Items]                
Maximum number of common stock 8,763,322 8,763,322            
Number of common stock percentage         4.00%      
ISOs under the 2023 Plan [Member]                
Stock-Based Compensation [Line Items]                
Issuance shares 26,289,966              
2011 Equity Incentive Plan [Member]                
Stock-Based Compensation [Line Items]                
Share based compensation by share based award purchase price of common stock percentage         100.00%      
Share based compensation by share based award vesting period         4 years      
Share based compensation by share based award expiration period         10 years      
Common stock shares reserved for future issuance         2,596,764 2,596,764    
2011 Equity Incentive Plan [Member] | Incentive Stock Option [Member]                
Stock-Based Compensation [Line Items]                
Share based compensation by share based award purchase price of common stock percentage         10.00%      
2011 Equity Incentive Plan [Member] | Ten Percent Stock Holder [Member]                
Stock-Based Compensation [Line Items]                
Share based compensation by share based award purchase price of common stock percentage         110.00%      
2021 Equity Incentive Plan [Member]                
Stock-Based Compensation [Line Items]                
Share based compensation by share based award purchase price of common stock percentage         100.00%      
Share based compensation by share based award vesting period         4 years      
Share based compensation by share based award expiration period         10 years      
Common stock shares reserved for future issuance         241,484 241,484    
2021 Equity Incentive Plan [Member] | Incentive Stock Option [Member]                
Stock-Based Compensation [Line Items]                
Share based compensation by share based award purchase price of common stock percentage         10.00%      
2021 Equity Incentive Plan [Member] | Ten Percent Stock Holder [Member]                
Stock-Based Compensation [Line Items]                
Share based compensation by share based award purchase price of common stock percentage         110.00%      
2022 Equity Incentive Plan [Member]                
Stock-Based Compensation [Line Items]                
Share based compensation by share based award purchase price of common stock percentage         100.00%      
Share based compensation by share based award vesting period         4 years      
Share based compensation by share based award expiration period         10 years      
Common stock shares reserved for future issuance         3,225,237 3,225,237    
2022 Equity Incentive Plan [Member] | Incentive Stock Option [Member]                
Stock-Based Compensation [Line Items]                
Share based compensation by share based award purchase price of common stock percentage         10.00%      
2022 Equity Incentive Plan [Member] | Ten Percent Stock Holder [Member]                
Stock-Based Compensation [Line Items]                
Share based compensation by share based award purchase price of common stock percentage         110.00%      
Board of Directors [Member]                
Stock-Based Compensation [Line Items]                
Stock based compensation expenses (in Dollars)   $ 100            
Service based option [Member]                
Stock-Based Compensation [Line Items]                
Unrecognized stock-based compensation costs (in Dollars)     $ 16,400          
Recognized weighted average period     2 years 1 month 17 days          
RSU [Member]                
Stock-Based Compensation [Line Items]                
Unrecognized stock-based compensation costs (in Dollars)     $ 200          
Recognized weighted average period     4 years 9 months          
XML 105 R95.htm IDEA: XBRL DOCUMENT v3.23.4
Stock-Based Compensation (Details) - Summary of summary of stock option activity - USD ($)
9 Months Ended 12 Months Ended
Oct. 01, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Summary Of Summary Of Stock Option Activity Abstract        
Number of shares, outstanding, beginning balance 4,970,395 2,135,454 1,968,580  
Number of shares, Options granted 2,164,946 3,088,350 212,434  
Number of shares, Options exercised (67,292) (162,034) (7,245)  
Number of shares, Options canceled (142,218) (91,376) (38,315)  
Number of shares, outstanding, ending balance 6,925,855 4,970,395 2,135,454 1,968,580
Number of shares, Vested and expected to vest 6,925,855 4,970,395    
Number of shares, Vested and exercisable 3,037,856 2,794,862    
Weighted average exercise price per share, outstanding, beginning balance $ 4.87 $ 0.62 $ 0.58  
Weighted average exercise price per share, Options granted 5.18 7.45 0.89  
Weighted average exercise price per share, Options exercised 0.83 0.48 0.83  
Weighted average exercise price per share, Options canceled 9.46 0.83 0.62  
Weighted average exercise price per share, outstanding, ending balance 4.91 4.87 $ 0.62 $ 0.58
Weighted average exercise price per share, Vested and expected to vest 4.91 4.87    
Weighted average exercise price per share, Vested and exercisable $ 5.16 $ 4.35    
Weighted Average Contractual Term (Years), outstanding, ending balance 7 years 9 months 18 days 6 years 11 months 26 days 6 years 11 months 26 days 7 years 10 months 13 days
Weighted Average Contractual Term (Years), Vested and expected to vest 7 years 9 months 18 days 6 years 11 months 26 days    
Weighted Average Contractual Term (Years), Vested and exercisable 6 years 4 months 24 days 6 years 3 months 14 days    
Aggregate intrinsic value (in thousands), outstanding beginning balance $ 34,180,000 $ 2,263,000 $ 1,044,000  
Aggregate intrinsic value (in thousands), outstanding ending balance 2,727,000 34,180,000 $ 2,263,000 $ 1,044,000
Aggregate intrinsic value (in thousands), Vested and expected to vest 2,727,000 34,180,000    
Aggregate intrinsic value (in thousands),Vested and exercisable $ 2,245,000 $ 22,204,000    
XML 106 R96.htm IDEA: XBRL DOCUMENT v3.23.4
Stock-Based Compensation (Details) - Summary of summary of stock option activity (Parentheticals) - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Summary Of Summary Of Stock Option Activity Abstract    
Share based compensation by share based award options granted during the period weighted average fair value per share $ 7.99 $ 0.72
Share based compensation by share based award options vested during the period aggregate fair value $ 10.5 $ 0.2
Share based compensation by share based award aggregate intrinsic value of options vested during the period $ 0.2 $ 0.1
XML 107 R97.htm IDEA: XBRL DOCUMENT v3.23.4
Stock-Based Compensation (Details) - Schedule of summary of RSU activity
9 Months Ended
Oct. 01, 2023
$ / shares
shares
Schedule Of Summary Of Rsu Activity Abstract  
Number of RSUs, Unvested, Ending balance | shares 87,659
Weighted average grant date fair value, Unvested, Ending balance | $ / shares $ 5.07
Number of RSUs, Granted | shares 728,600
Weighted average grant date fair valuem, Granted | $ / shares $ 5
Number of RSUs, Vested and released | shares (155,473)
Weighted average grant date fair value, Vested and released | $ / shares $ 4.84
Number of RSUs, Cancelled or forfeited | shares (485,468)
Weighted average grant date fair value, Cancelled or forfeited | $ / shares $ 5.07
XML 108 R98.htm IDEA: XBRL DOCUMENT v3.23.4
Stock-Based Compensation (Details) - Schedule Of Calculate The Fair Value Of Stock-based Compensation - Share-Based Payment Arrangement, Option [Member]
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Expected volatility, Minimum 60.00% 52.60%
Expected volatility, Maximum 78.50% 56.70%
Risk-free interest rate, Minimum 3.40% 0.80%
Risk-free interest rate, Maximum 4.80% 1.30%
Expected dividends 0.00% 0.00%
Maximum [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Expected term 7 years 6 months 6 years 1 month 6 days
Minimum [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Expected term 1 year 5 years
XML 109 R99.htm IDEA: XBRL DOCUMENT v3.23.4
Stock-Based Compensation (Details) - Schedule of stock-based compensation expense and its allocation within the accompanying unaudited condensed consolidated statements of operations and comprehensive loss - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Oct. 01, 2023
Oct. 01, 2023
Sep. 30, 2022
Oct. 01, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]                
Loss from discontinued operations, net of tax $ (8,404)   $ (20,953) $ (1,454)
Total stock-based compensation expense       2,321 217 433 200 109
Share-Based Payment Arrangement [Member]                
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]                
Loss from discontinued operations, net of tax   $ 535   1,835   470 0 0
Total stock-based compensation expense   2,114 85 4,156 217 903 200 109
Share-Based Payment Arrangement [Member] | Cost of revenues [Member]                
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]                
Share based compensation expense gross   20 1 51 6 22 19 8
Share-Based Payment Arrangement [Member] | Sales and marketing [Member]                
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]                
Share based compensation expense gross   143 37 337 91 168 68 37
Share-Based Payment Arrangement [Member] | General and administrative [Member]                
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]                
Share based compensation expense gross   $ 1,416 $ 47 $ 1,933 $ 120 $ 243 $ 113 $ 64
XML 110 R100.htm IDEA: XBRL DOCUMENT v3.23.4
Employee Stock Purchase Plan (Details)
Oct. 01, 2023
USD ($)
Employee Stock Purchase Plan [Abstract]  
Percentage of fair market values 85.00%
Reserved for future issuance $ 2,628,996
XML 111 R101.htm IDEA: XBRL DOCUMENT v3.23.4
Commitments and Contingencies (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Oct. 01, 2023
May 11, 2023
Mar. 16, 2023
Jul. 22, 2021
Jan. 01, 2021
Aug. 24, 2023
Feb. 28, 2023
Jan. 31, 2023
Oct. 01, 2023
Sep. 30, 2022
Oct. 01, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Jan. 10, 2023
Commitments and Contingencies Disclosure [Line Items]                                
Variable lease cost                 $ 100,000 $ 100,000 $ 300,000 $ 200,000 $ 200,000      
Lease expense                 300,000 200,000 1,000,000 500,000     $ 300,000  
Operating leases payments                 300,000 100,000 800,000 400,000 1,000,000 $ 400,000    
Exchange for operating lease liabilities                     245,000 245,000 1,157,000  
Accrued expenses and other current liabilities $ 14,571,000               14,571,000   14,571,000   14,474,000 5,190,000    
Payments for settlement   $ 800,000                            
Payments for settlement 100,000                   100,000          
Demanded approximately             $ 26,400,000                  
Suffered damages     $ 220,000,000                          
Legal fees       $ 6,900,000                        
Litigation in accrued expenses 2,000,000               2,000,000   2,000,000          
Breach of contract           $ 6,000,000                    
Advisory fee                     6,000,000          
Letters of credit 3,500,000               3,500,000   3,500,000   3,500,000      
Restricted cash 3,758,000               3,758,000   3,758,000   3,907,000    
Operating lease costs                     717,000 304,000 700,000 400,000    
Operating lease right of use asset 1,465,000               1,465,000   1,465,000   2,182,000 826,000    
Operating lease lease liability 1,510,000               1,510,000   1,510,000   2,232,000      
Operating lease liability current $ 720,000               $ 720,000   $ 720,000   $ 958,000 390,000    
Vendor Settlement [Member]                                
Commitments and Contingencies Disclosure [Line Items]                                
Other commitment                               $ 900,000
Accounting Standards Update 2016-02 [Member]                                
Commitments and Contingencies Disclosure [Line Items]                                
Exchange for operating lease liabilities         $ 800,000                      
Operating lease right of use asset         1,100,000                      
Operating lease lease liability         1,200,000                      
Operating lease liability current         $ 400,000                      
Minimum [Member]                                
Commitments and Contingencies Disclosure [Line Items]                                
Leases term 3 months 18 days               3 months 18 days   3 months 18 days   3 months 18 days      
Maximum [Member]                                
Commitments and Contingencies Disclosure [Line Items]                                
Leases term 3 years 1 month 6 days               3 years 1 month 6 days   3 years 1 month 6 days   3 years 9 months 18 days      
Commitments [Member]                                
Commitments and Contingencies Disclosure [Line Items]                                
Exchange for operating lease liabilities                 $ 0 $ 0 $ 0 $ 200,000 $ 1,900,000 1,200,000    
Letters of Credit [Member]                                
Commitments and Contingencies Disclosure [Line Items]                                
Restricted cash $ 3,800,000               3,800,000   3,800,000   3,900,000      
Letters of Credit [Member] | Previously Reported [Member]                                
Commitments and Contingencies Disclosure [Line Items]                                
Restricted cash                         3,700,000      
Legal Matters [Member]                                
Commitments and Contingencies Disclosure [Line Items]                                
Accrued expenses and other current liabilities $ 3,000,000               $ 3,000,000   3,000,000   $ 1,900,000 $ 200,000    
SolarPark Korea Co., LTD [Member]                                
Commitments and Contingencies Disclosure [Line Items]                                
Demanded approximately               $ 80,000,000                
China Bridge [Member]                                
Commitments and Contingencies Disclosure [Line Items]                                
Advisory fee                     $ 6,000,000          
XML 112 R102.htm IDEA: XBRL DOCUMENT v3.23.4
Commitments and Contingencies (Details) - Schedule of Weighted Average Remaining Lease Term and the Discount Rate
Oct. 01, 2023
Dec. 31, 2022
Schedule Of Weighted Average Remaining Lease Term And The Discount Rate Abstract    
Remaining average remaining lease term 2 years 7 months 9 days 3 years 2 months 26 days
Weighted average discount rate 15.20% 14.47%
XML 113 R103.htm IDEA: XBRL DOCUMENT v3.23.4
Commitments and Contingencies (Details) - Schedule of Future Minimum Lease Payments under Non-Cancelable - USD ($)
$ in Thousands
Oct. 01, 2023
Dec. 31, 2022
Schedule Of Future Minimum Lease Payments Under Non Cancelable Abstract    
2023 $ 263 $ 1,048
2024 743 743
2025 592 592
2026 477 477
2027 and thereafter 0  
2027 and thereafter   0
Total undiscounted liabilities 2,075 2,860
Less: imputed interest (565) (628)
Present value of operating lease liabilities $ 1,510 $ 2,232
XML 114 R104.htm IDEA: XBRL DOCUMENT v3.23.4
Commitments and Contingencies (Details) - Schedule of Activity Period Relating to the Company's Warranty Provision - USD ($)
$ in Thousands
9 Months Ended 12 Months Ended
Oct. 01, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Commitments and Contingencies (Details) - Schedule of Activity Period Relating to the Company's Warranty Provision [Line Items]        
Warranty provision, beginning of period $ 3,981 $ 2,281 $ 1,652 $ 1,816
Warranty provision, end of period 4,021 3,981 2,281 1,652
Warranty provision, current 605 767 600 497
Warranty provision, noncurrent 3,416 3,214 1,681 1,155
Warranty liability from Business Combination 0 1,943    
Accruals for new warranties issued 2,100 1,492 1,516 607
Settlements $ (2,060) $ (1,735) $ (887) $ (771)
XML 115 R105.htm IDEA: XBRL DOCUMENT v3.23.4
Income Taxes (Details) - Schedule of Provision For Income Taxes - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Oct. 01, 2023
Sep. 30, 2022
Oct. 01, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Current:              
Federal         $ 0 $ 0 $ 0
State         27 3 3
Foreign         0 0 0
Total current         27 3 3
Deferred:              
Federal         0 0 0
State         0 0 0
Foreign         0 0 0
Total deferred         0 0 0
Total provision $ (1) $ (1) $ 4 $ 27 $ 3 $ 3
XML 116 R106.htm IDEA: XBRL DOCUMENT v3.23.4
Income Taxes (Details) - Schedule of Reconciliation of Effective Income Tax Rate - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Oct. 01, 2023
Sep. 30, 2022
Oct. 01, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Tax Disclosure [Abstract]              
Statutory federal income tax         $ (6,184) $ (1,918) $ (1,454)
State income taxes, net of federal tax benefits         (1,207) (353) (336)
Stock compensation         64 42 22
Non-deductible interest expense         78 689 257
Mark to market adjustments         397 0 0
Nondeductible Expenses         279 2 4
PPP Loan         0 (368) 0
Foreign earnings taxed at different rates         157 0 0
Other         (8) 0 0
Valuation allowance         6,451 1,910 1,510
Tax Provision $ (1) $ (1) $ 4 $ 27 $ 3 $ 3
XML 117 R107.htm IDEA: XBRL DOCUMENT v3.23.4
Income Taxes (Details) - Schedule of Components of Deferred Tax Assets And Liabilities - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Abstract]    
NOL carryforwards $ 60,710 $ 7,931
Credits 195 0
Bad debt reserve 1,382 946
Inventory reserve 2,724 680
Warranty reserve 651 631
Revenue warranty 155 111
Interest expense carryover 3,445 170
Accrued compensation 678 687
Deferred revenue 195 639
ASC 842 leases 12 17
Assembled workforce 0 15
Fixed assets 328 0
Capitalized research and development 509 0
Other 2,837 28
Total 73,821 11,855
Valuation allowance (63,737) (11,348)
Net deferred tax assets 10,084 507
Accounting method change (18) (38)
Capitalized software (234) (468)
Fixed assets 0 (1)
Intangibles (9,084) 0
Convertible debt (748) 0
Refundable and deferred income taxes $ 0 $ 0
XML 118 R108.htm IDEA: XBRL DOCUMENT v3.23.4
Income Taxes (Details) - Schedule of Unrecognized Tax Benefits - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Abstract]    
Unrecognized tax benefits as of beginning of year $ 0 $ 0
Increases related to prior year tax positions 1,335 0
Increases related to current year tax positions 0 0
Decreases related to prior year tax positions 0 0
Unrecognized tax benefits as of end of year $ 1,335 $ 0
XML 119 R109.htm IDEA: XBRL DOCUMENT v3.23.4
Income Taxes (Details) - USD ($)
$ in Thousands
12 Months Ended
Jun. 29, 2020
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Tax Disclosure [Line Items]        
Deferred tax assets valuation allowance   $ 63,737 $ 11,348  
Valuation allowance deferred tax asset change in amount   52,400 1,900  
Acquired deferred tax assets valuation allowance increase   45,900    
Operating loss carryforwards   114,600    
Unrecognized tax benefits   1,335 0 $ 0
Unrecognized tax benefits income tax penalties and interest accrued   0 0  
Minimum threshold taxable income $ 1,000      
Research Tax Credit Carryforward [Member]        
Income Tax Disclosure [Line Items]        
Tax credit carry forward amount   1,600 0  
Investment Tax Credit Carryforward [Member]        
Income Tax Disclosure [Line Items]        
Tax credit carry forward amount $ 5,000      
Domestic Tax Authority [Member]        
Income Tax Disclosure [Line Items]        
Operating loss carryforwards   237,700 28,000  
State and Local Jurisdiction [Member]        
Income Tax Disclosure [Line Items]        
Operating loss carryforwards   $ 157,100 $ 30,200  
XML 120 R110.htm IDEA: XBRL DOCUMENT v3.23.4
Basic and Diluted Net Loss Per Share (Details) - Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Oct. 01, 2023
Oct. 01, 2023
Sep. 30, 2022
Oct. 01, 2023
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Numerator:                  
Net loss from continuing operations       $ (73,448)   $ (10,809) $ (28,023) $ (9,282) $ (5,682)
Net Loss from discontinued operations             (1,454)    
Net Loss $ (206,882) $ (206,882) $ (4,146) $ (241,906)   $ (10,809) $ (29,477) $ (9,282) $ (5,682)
Denominator:                  
Weighted average common shares outstanding, basic 39,821,078   13,431,410 16,969,979   13,053,367 22,524,400 11,990,015 9,760,018
Weighted average common shares outstanding, diluted 39,821,078   13,431,410 16,969,979   13,053,367 22,524,400 11,990,015 9,760,018
Net loss per share:                  
Continuing operations - basic $ (1.28)   $ (0.31) $ (4.33)   $ (0.83) $ (1.24) $ (0.77) $ (0.58)
Continuing operations diluted (1.28)   (0.31) (4.33) $ (0.83) (0.83) (1.24) (0.77) (0.58)
Discontinued operations - basic (3.92)   0 (9.92)   0 (0.07)
Discontinued operations diluted (3.92)   0 (9.92)   0 (0.07)
Net loss per share - basic (5.2)   (0.31) (14.25)   (0.83) (1.31) (0.77) (0.58)
Net loss per share diluted $ (5.2)   $ (0.31) $ (14.25) $ (0.83) $ (0.83) $ (1.31) $ (0.77) $ (0.58)
Continuing Operations [Member]                  
Numerator:                  
Net Loss $ (50,973)   $ (4,146) $ (73,448)   $ (10,809)      
Discontinued Operations [Member]                  
Numerator:                  
Net Loss $ (155,909)     $ (168,458)          
XML 121 R111.htm IDEA: XBRL DOCUMENT v3.23.4
Basic and Diluted Net Loss Per Share (Details) - Schedule of Potential Common Shares Excluded from Diluted Net Loss Per Share - shares
9 Months Ended 12 Months Ended
Oct. 01, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Schedule Of Potential Common Shares Excluded From Diluted Net Loss Per Share [Line Items]        
Common stock warrants 23,626,132 2,000,878    
Preferred stock warrants   488,024    
Stock options and RSUs issued and outstanding 7,013,514 2,430,949    
Potential common shares excluded from diluted net loss per share 30,639,646 4,919,851    
Previously Reported [Member]        
Schedule Of Potential Common Shares Excluded From Diluted Net Loss Per Share [Line Items]        
Common stock warrants   43,135 4,999 0
Preferred stock warrants   1,152,790 488,024 488,024
Stock options and RSUs issued and outstanding   4,970,419 2,135,464 1,968,590
Potential common shares excluded from diluted net loss per share   8,078,837 4,635,857 3,288,706
Convertible notes   1,912,493 1,618,585 812,531
SAFE agreements   0 388,785 19,562
XML 122 R112.htm IDEA: XBRL DOCUMENT v3.23.4
Related Party Transactions (Details) - USD ($)
1 Months Ended 3 Months Ended 8 Months Ended 9 Months Ended 12 Months Ended
Oct. 01, 2023
Jul. 31, 2023
Dec. 31, 2022
Nov. 04, 2022
Sep. 30, 2023
Mar. 31, 2022
Oct. 01, 2023
Jun. 01, 2023
Oct. 01, 2023
Jun. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Related Party Transaction [Line Items]                            
Related party issued     $ 8,600,000         $ 12,100,000         $ 3,600,000 $ 3,300,000
Gain on the extinguishment           $ 1,400,000     [1]   $ 3,235,000 [1] $ 3,235,000 [2] [2] [2]
Convertible accrues percentage     5.00%             5.00%   5.00%    
Interest expense related party             $ 30,700,000              
Prefund                 $ 3,500,000   70,000  
Investment converted to equity $ 3,500,000           3,500,000   3,500,000          
Addition amount   $ 3,500,000                        
Proceeds from related parties             $ 12,100,000   $ 12,100,000          
Issued shares (in shares) 518,752           518,752   518,752          
Other income (expense)                 $ 12,700,000          
Expense                 $ 0          
Issuance of shares (in shares) 5,670,000           5,670,000   5,670,000          
Purchases from related party $ 300,000                          
Due to related parties   $ 5,900,000                        
Agreed related party                   $ 500,000 500,000
Outstanding remains 500,000           $ 100,000              
Purchase Agreements [Member]                            
Related Party Transaction [Line Items]                            
Expense             30,700,000   30,700,000          
Settlement Agreement [Member]                            
Related Party Transaction [Line Items]                            
Agreed related party         $ 500,000                  
Convertible Promissory Notes [Member]                            
Related Party Transaction [Line Items]                            
Other income (expense)             700,000   $ 700,000          
Convertible Promissory Notes [Member]                            
Related Party Transaction [Line Items]                            
Issued shares (in shares)   120,000                        
Solaria Acquisition [Member]                            
Related Party Transaction [Line Items]                            
Fair value acquisition       $ 17,300,000                    
Solaria Acquisition [Member] | Convertible Promissory Notes [Member]                            
Related Party Transaction [Line Items]                            
Fair value acquisition                   $ 6,700,000   $ 6,700,000    
2020-A Convertible Notes [Member]                            
Related Party Transaction [Line Items]                            
Related party issued                           $ 3,800,000
Accrued interest percentage                           2.00%
2021-A Convertible Notes [Member]                            
Related Party Transaction [Line Items]                            
Related party issued                         $ 4,800,000  
Accrued interest percentage                 2.00%     2.00%    
2022 Convertible Notes [Member]                            
Related Party Transaction [Line Items]                            
Related party issued     $ 12,000,000         $ 33,300,000            
Related Party [Member]                            
Related Party Transaction [Line Items]                            
Interest expense related party             5,900,000   $ 5,900,000          
Due to related parties $ 5,600,000           5,600,000   5,600,000          
Related Party [Member] | Convertible Promissory Notes [Member]                            
Related Party Transaction [Line Items]                            
Interest expense related party             $ 100,000   $ 400,000     $ 200,000    
[1] Gain on extinguishment of convertible notes and SAFEs includes other income from related parties of zero during each of the thirteen and thirty-nine weeks ended October 1, 2023, and zero and $1.4 million during the three and nine months ended September 30, 2022, respectively.
[2] Gain on extinguishment of convertible notes and SAFEs includes other income from related parties of $1.4 million, zero and zero during the years ended December 31, 2022, 2021 and 2020, respectively.
XML 123 R113.htm IDEA: XBRL DOCUMENT v3.23.4
Subsequent Events (Details)
$ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
Oct. 31, 2023
USD ($)
shares
Jan. 31, 2023
USD ($)
Oct. 01, 2023
USD ($)
Sep. 30, 2022
USD ($)
Oct. 01, 2023
USD ($)
shares
Sep. 30, 2022
USD ($)
Subsequent Event [Line Items]            
Aggregate amount of purchase price $ 11,000          
Conversion shares | shares 1,376,414          
Purchase of common stock | shares 656,630       2,745,879  
Aggregate ordinary shares | shares 1,100,000          
Impairment charges $ 1,700   $ 0 $ 0 $ 0 $ 0
2023 Convertible Notes [Member]            
Subsequent Event [Line Items]            
Aggregate amount of purchase price   $ 11,000        
Debt instrument accrued interest rate   5.00%        
Debt instrument, convertible, conversion ratio   0.75        
Solaria Common Stock [Member]            
Subsequent Event [Line Items]            
Aggregate amount of purchase price $ 5,000          
XML 124 d474289d8k_htm.xml IDEA: XBRL DOCUMENT 0001838987 2023-10-01 0001838987 2022-12-31 0001838987 2021-12-31 0001838987 2022-01-01 2022-12-31 0001838987 2021-01-01 2021-12-31 0001838987 2020-01-01 2020-12-31 0001838987 2023-07-01 2023-10-01 0001838987 2022-07-01 2022-09-30 0001838987 2023-01-01 2023-10-01 0001838987 2022-01-01 2022-09-30 0001838987 2023-09-30 0001838987 2023-07-02 2023-10-01 0001838987 2023-01-02 2023-10-01 0001838987 2020-01-31 0001838987 2022-11-30 0001838987 2021-04-01 2021-04-30 0001838987 2022-02-01 2022-02-28 0001838987 2019-01-01 2019-12-31 0001838987 2023-07-01 2023-09-30 0001838987 2023-01-01 2023-09-30 0001838987 2022-01-01 2023-09-30 0001838987 2022-10-01 2023-06-01 0001838987 2022-12-31 2022-12-31 0001838987 2023-10-31 2023-10-31 0001838987 2024-01-04 2024-01-04 0001838987 2023-10-31 0001838987 2020-12-31 0001838987 2022-03-01 2022-03-31 0001838987 2023-06-30 0001838987 2023-07-01 2023-07-31 0001838987 2023-05-11 2023-05-11 0001838987 2023-07-03 2023-10-01 0001838987 2023-02-01 2023-02-28 0001838987 2023-07-31 2023-07-31 0001838987 2023-03-16 2023-03-16 0001838987 2023-03-31 0001838987 2021-07-22 2021-07-22 0001838987 2023-08-01 2023-08-24 0001838987 2023-10-01 2023-10-01 0001838987 2023-07-31 0001838987 2022-12-01 2022-12-31 0001838987 2023-02-28 0001838987 2023-09-01 2023-09-30 0001838987 2023-09-28 2023-10-01 0001838987 2020-06-29 2020-06-29 0001838987 2019-12-31 0001838987 2022-09-30 0001838987 us-gaap:CommonClassAMember 2022-12-31 0001838987 us-gaap:CommonClassBMember 2022-12-31 0001838987 cslr:BusinessCombinationMember 2022-12-31 0001838987 us-gaap:TrademarksAndTradeNamesMember 2022-12-31 0001838987 us-gaap:DevelopedTechnologyRightsMember 2022-12-31 0001838987 us-gaap:CustomerRelationshipsMember 2022-12-31 0001838987 cslr:AssembledWorkforceMember 2022-12-31 0001838987 us-gaap:TrademarksMember 2022-12-31 0001838987 cslr:TwoThousandAndTwentyTwoConvertibleNotesMember 2022-12-31 0001838987 cslr:RestrictedCashMember 2022-12-31 0001838987 srt:MinimumMember 2022-12-31 0001838987 srt:MaximumMember 2022-12-31 0001838987 us-gaap:CommonStockMember 2022-12-31 0001838987 cslr:TwoThousandAndNineteenAConvertibleNotesMember us-gaap:NonrelatedPartyMember 2022-12-31 0001838987 cslr:TwoThousandAndTwentySeriesAConvertibleNotesMember us-gaap:NonrelatedPartyMember 2022-12-31 0001838987 cslr:TwoThousandAndTwentyOneSeriesAConvertibleNotesMember us-gaap:NonrelatedPartyMember 2022-12-31 0001838987 us-gaap:NonrelatedPartyMember 2022-12-31 0001838987 cslr:TwoThousandAndTwentySeriesAConvertibleNotesMember us-gaap:RelatedPartyMember 2022-12-31 0001838987 cslr:TwoThousandAndTwentyOneSeriesAConvertibleNotesMember us-gaap:RelatedPartyMember 2022-12-31 0001838987 cslr:ConvertiblePromissoryNotesWithEcoSystemIntegrityFundTwoLlcMember us-gaap:RelatedPartyMember 2022-12-31 0001838987 cslr:TwoThousandTwentyThreeEquityIncentivePlanMember 2022-12-31 0001838987 cslr:SeriesCWarrantsMember 2022-12-31 0001838987 cslr:TwoThousandAndTwentyTwoConvertibleNotesMember us-gaap:RelatedPartyMember 2022-12-31 0001838987 us-gaap:FurnitureAndFixturesMember 2022-12-31 0001838987 cslr:ManufacturingEquipmentMember 2022-12-31 0001838987 us-gaap:SoftwareDevelopmentMember 2022-12-31 0001838987 us-gaap:LeaseholdImprovementsMember 2022-12-31 0001838987 cslr:SponsorMember 2022-12-31 0001838987 cslr:PrivateInvestmentInPublicEquityMember 2022-12-31 0001838987 cslr:ForwardPurchaseAgreementsMember 2022-12-31 0001838987 cslr:LegacyCompleteSolariaMember us-gaap:CommonClassAMember 2022-12-31 0001838987 us-gaap:SeriesDPreferredStockMember 2022-12-31 0001838987 cslr:TwoThousandTwentyAConvertibleNotesMember 2022-12-31 0001838987 cslr:TwoThousandTwentyOneSafeMember 2022-12-31 0001838987 us-gaap:SeriesCPreferredStockMember 2022-12-31 0001838987 cslr:ConvertiblePromissoryNotesMember 2022-12-31 0001838987 cslr:LegacyCompleteSolariaMember 2022-12-31 0001838987 cslr:TwoThousandTwentyOneAConvertibleNotesMember 2022-12-31 0001838987 cslr:LegalMattersMember 2022-12-31 0001838987 us-gaap:FairValueInputsLevel1Member 2022-12-31 0001838987 us-gaap:FairValueInputsLevel2Member 2022-12-31 0001838987 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001838987 cslr:TwoThousandNineteenConvertibleNotesMember 2022-12-31 0001838987 cslr:TwoThousandTwentyTwoConvertibleNotesMember 2022-12-31 0001838987 us-gaap:RelatedPartyMember 2022-12-31 0001838987 cslr:MaxeonMember 2022-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:StandbyLettersOfCreditMember 2022-12-31 0001838987 us-gaap:StandbyLettersOfCreditMember 2022-12-31 0001838987 cslr:SeriesD7WarrantsMember 2022-12-31 0001838987 cslr:TwoZeroOneEightBridgeNotesMember 2022-12-31 0001838987 cslr:SCITermLoanAndRevolverLoanMember 2022-12-31 0001838987 cslr:RevolvingLoanMember 2022-12-31 0001838987 cslr:CSSoilsMember 2022-12-31 0001838987 us-gaap:RelatedPartyMember cslr:SeriesDOneRedeemableConvertiblePreferredStockMember 2022-12-31 0001838987 us-gaap:RelatedPartyMember cslr:SeriesDFourRedeemableConvertiblePreferredStockMember cslr:IssuanceOfRedeemableConvertiblePreferredStockUponAcquisitionMember 2022-12-31 0001838987 us-gaap:RelatedPartyMember cslr:SeriesDFiveRedeemableConvertiblePreferredStockMember cslr:IssuanceOfRedeemableConvertiblePreferredStockUponAcquisitionMember 2022-12-31 0001838987 us-gaap:RelatedPartyMember cslr:SeriesDSevenRedeemableConvertiblePreferredStockMember cslr:IssuanceOfRedeemableConvertiblePreferredStockUponAcquisitionMember 2022-12-31 0001838987 us-gaap:RelatedPartyMember cslr:SeriesDEightRedeemableConvertiblePreferredStockMember cslr:IssuanceOfRedeemableConvertiblePreferredStockUponConversionOfSimpleAgreementOfFutureEquityNotesMember 2022-12-31 0001838987 srt:MinimumMember us-gaap:EquipmentMember 2022-12-31 0001838987 srt:MaximumMember us-gaap:EquipmentMember 2022-12-31 0001838987 srt:MinimumMember us-gaap:FurnitureAndFixturesMember 2022-12-31 0001838987 srt:MaximumMember us-gaap:FurnitureAndFixturesMember 2022-12-31 0001838987 srt:MinimumMember us-gaap:LeaseholdImprovementsMember 2022-12-31 0001838987 srt:MaximumMember us-gaap:LeaseholdImprovementsMember 2022-12-31 0001838987 cslr:AssembledWorkforceOneMember 2022-12-31 0001838987 us-gaap:DomesticCountryMember 2022-12-31 0001838987 us-gaap:StateAndLocalJurisdictionMember 2022-12-31 0001838987 us-gaap:ResearchMember 2022-12-31 0001838987 srt:MaximumMember cslr:CommonStockWarrantsMember us-gaap:MeasurementInputExpectedTermMember 2022-12-31 0001838987 srt:MinimumMember cslr:CommonStockWarrantsMember us-gaap:MeasurementInputExpectedTermMember 2022-12-31 0001838987 srt:MaximumMember cslr:CommonStockWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2022-12-31 0001838987 srt:MinimumMember cslr:CommonStockWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2022-12-31 0001838987 srt:MaximumMember cslr:CommonStockWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-12-31 0001838987 srt:MinimumMember cslr:CommonStockWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-12-31 0001838987 cslr:CommonStockWarrantsMember us-gaap:MeasurementInputExpectedDividendRateMember 2022-12-31 0001838987 cslr:TwoThousandAndTwentyTwoConvertibleNotesMember us-gaap:NonrelatedPartyMember 2022-12-31 0001838987 cslr:TwoThousandAndElevenEquityIncentivePlanMember 2022-12-31 0001838987 cslr:TwoThousandAndTwentyOneEquityIncentivePlanMember 2022-12-31 0001838987 cslr:TwoThousandAndTwentyTwoEquityIncentivePlanMember 2022-12-31 0001838987 cslr:TwoThousandAndNineteenAConvertibleNotesMember 2022-12-31 0001838987 cslr:TwoThousandAndTwentyAConvertibleNotesMember 2022-12-31 0001838987 cslr:TwoThousandAndTwentyOneConvertibleNotesMember 2022-12-31 0001838987 cslr:TwoThousandAndTwentyOneAConvertibleNotesWithEmbeddedDerivativeLiabilityMember 2022-12-31 0001838987 us-gaap:NotesPayableOtherPayablesMember cslr:LoanAndSecurityAgreementMember 2022-12-31 0001838987 us-gaap:NotesPayableOtherPayablesMember cslr:TwoZeroTwoOnePromissoryNotesMember 2022-12-31 0001838987 us-gaap:NotesPayableOtherPayablesMember cslr:CurrentInsightPromissoryNoteMember 2022-12-31 0001838987 us-gaap:NotesPayableOtherPayablesMember 2022-12-31 0001838987 cslr:TwoThousandTwentyTwoConvertibleNotesMember us-gaap:RelatedPartyMember 2022-12-31 0001838987 cslr:TwoThousandTwentyTwoConvertibleNotesMember us-gaap:NonrelatedPartyMember 2022-12-31 0001838987 cslr:LoanAndSecurityAgreementMember 2022-12-31 0001838987 cslr:TwoThousandTwentyOneAConvertibleNotesMember cslr:TrancheOneMember 2022-12-31 0001838987 cslr:TwoThousandTwentyOneAConvertibleNotesMember cslr:TrancheTwoMember 2022-12-31 0001838987 us-gaap:FairValueInputsLevel3Member cslr:TwoZeroOneEightBridgeNotesMember 2022-12-31 0001838987 us-gaap:FairValueInputsLevel1Member 2023-10-01 0001838987 us-gaap:FairValueInputsLevel2Member 2023-10-01 0001838987 us-gaap:FairValueInputsLevel3Member 2023-10-01 0001838987 us-gaap:CommonClassAMember 2023-10-01 0001838987 us-gaap:CommonClassBMember 2023-10-01 0001838987 cslr:BusinessCombinationMember 2023-10-01 0001838987 us-gaap:LeaseholdImprovementsMember 2023-10-01 0001838987 us-gaap:SoftwareDevelopmentMember 2023-10-01 0001838987 cslr:ManufacturingEquipmentMember 2023-10-01 0001838987 us-gaap:FurnitureAndFixturesMember 2023-10-01 0001838987 us-gaap:TrademarksMember 2023-10-01 0001838987 us-gaap:CustomerRelationshipsMember 2023-10-01 0001838987 us-gaap:DevelopedTechnologyRightsMember 2023-10-01 0001838987 cslr:AssembledWorkforceMember 2023-10-01 0001838987 cslr:TwoThousandAndTwentyTwoConvertibleNotesMember 2023-10-01 0001838987 cslr:RestrictedCashMember 2023-10-01 0001838987 srt:MinimumMember 2023-10-01 0001838987 srt:MaximumMember 2023-10-01 0001838987 cslr:SeriesCWarrantsMember 2023-10-01 0001838987 cslr:TwoThousandAndTwentyTwoConvertibleNotesMember us-gaap:RelatedPartyMember 2023-10-01 0001838987 cslr:SponsorMember 2023-10-01 0001838987 cslr:PrivateInvestmentInPublicEquityMember 2023-10-01 0001838987 cslr:ForwardPurchaseAgreementsMember 2023-10-01 0001838987 cslr:LegacyCompleteSolariaMember us-gaap:CommonClassAMember 2023-10-01 0001838987 cslr:TwoThousandTwentyAConvertibleNotesMember 2023-10-01 0001838987 cslr:TwoThousandNinteenSAFEMember 2023-10-01 0001838987 us-gaap:SeriesCPreferredStockMember 2023-10-01 0001838987 cslr:FreedomAcquisitionICorpMember 2023-10-01 0001838987 cslr:ConvertiblePromissoryNotesMember 2023-10-01 0001838987 us-gaap:AdditionalPaidInCapitalMember 2023-10-01 0001838987 cslr:LegacyCompleteSolariaMember 2023-10-01 0001838987 cslr:TwoThousandTwentyOneAConvertibleNotesMember 2023-10-01 0001838987 cslr:LegalMattersMember 2023-10-01 0001838987 cslr:FPASMember 2023-10-01 0001838987 cslr:CompleteSolariaCommonStockMember 2023-10-01 0001838987 cslr:TwoThousandNineteenConvertibleNotesMember 2023-10-01 0001838987 us-gaap:WarrantMember 2023-10-01 0001838987 cslr:TwoThousandTwentyTwoConvertibleNotesMember 2023-10-01 0001838987 us-gaap:RelatedPartyMember 2023-10-01 0001838987 cslr:MaxeonMember 2023-10-01 0001838987 us-gaap:RelatedPartyMember 2023-10-01 0001838987 us-gaap:StandbyLettersOfCreditMember 2023-10-01 0001838987 cslr:PublicPrivatePlacementAndWorkingCapitalWarrantsMember us-gaap:PrivatePlacementMember 2023-10-01 0001838987 cslr:TwoZeroOneEightBridgeNotesMember 2023-10-01 0001838987 cslr:SCITermLoanAndRevolverLoanMember 2023-10-01 0001838987 cslr:RevolvingLoanMember 2023-10-01 0001838987 us-gaap:CommonStockMember 2023-10-01 0001838987 cslr:CSSoilsMember 2023-10-01 0001838987 cslr:SolarEnergySystemInstallationsMember 2022-01-01 2022-09-30 0001838987 cslr:SoftwareServicesMember 2022-01-01 2022-09-30 0001838987 cslr:BusinessCombinationMember 2022-01-01 2022-09-30 0001838987 cslr:AssembledWorkforceMember 2022-01-01 2022-09-30 0001838987 us-gaap:TrademarksMember 2022-01-01 2022-09-30 0001838987 us-gaap:CustomerRelationshipsMember 2022-01-01 2022-09-30 0001838987 us-gaap:DevelopedTechnologyRightsMember 2022-01-01 2022-09-30 0001838987 us-gaap:StockCompensationPlanMember us-gaap:CostOfSalesMember 2022-01-01 2022-09-30 0001838987 us-gaap:StockCompensationPlanMember cslr:SalesAndMarketingMember 2022-01-01 2022-09-30 0001838987 us-gaap:StockCompensationPlanMember us-gaap:GeneralAndAdministrativeExpenseMember 2022-01-01 2022-09-30 0001838987 us-gaap:RelatedPartyMember 2022-01-01 2022-09-30 0001838987 us-gaap:StockCompensationPlanMember 2022-01-01 2022-09-30 0001838987 us-gaap:SegmentContinuingOperationsMember 2022-01-01 2022-09-30 0001838987 us-gaap:CommitmentsMember 2022-01-01 2022-09-30 0001838987 cslr:PreviouslyReportedOneMember us-gaap:RetainedEarningsUnappropriatedMember 2022-01-01 2022-09-30 0001838987 cslr:PreviouslyReportedOneMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-09-30 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:CommonStockMember 2022-01-01 2022-09-30 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:RetainedEarningsUnappropriatedMember 2022-01-01 2022-09-30 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-09-30 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-09-30 0001838987 srt:ScenarioPreviouslyReportedMember 2022-01-01 2022-09-30 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:RedeemableConvertiblePreferredStockMember 2022-01-01 2022-09-30 0001838987 cslr:PreviouslyReportedOneMember us-gaap:CommonStockMember 2022-01-01 2022-09-30 0001838987 cslr:PreviouslyReportedOneMember us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-09-30 0001838987 cslr:PreviouslyReportedOneMember 2022-01-01 2022-09-30 0001838987 cslr:PreviouslyReportedOneMember us-gaap:RedeemableConvertiblePreferredStockMember 2022-01-01 2022-09-30 0001838987 cslr:TwoThousandTwentyAConvertibleNotesMember 2022-01-01 2022-09-30 0001838987 cslr:AdjustedMember us-gaap:CommonStockMember 2022-01-01 2022-09-30 0001838987 cslr:AdjustedMember us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-09-30 0001838987 cslr:AdjustedMember us-gaap:RetainedEarningsUnappropriatedMember 2022-01-01 2022-09-30 0001838987 cslr:AdjustedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-09-30 0001838987 cslr:AdjustedMember 2022-01-01 2022-09-30 0001838987 cslr:AdjustedMember us-gaap:RedeemableConvertiblePreferredStockMember 2022-01-01 2022-09-30 0001838987 cslr:CSSoilsMember 2022-01-01 2022-09-30 0001838987 cslr:SeriesDFourRedeemableConvertiblePreferredStockMember 2022-01-01 2022-09-30 0001838987 cslr:SolarEnergySystemInstallationsMember 2022-07-01 2022-09-30 0001838987 cslr:SoftwareServicesMember 2022-07-01 2022-09-30 0001838987 cslr:BusinessCombinationMember 2022-07-01 2022-09-30 0001838987 cslr:AssembledWorkforceMember 2022-07-01 2022-09-30 0001838987 us-gaap:TrademarksMember 2022-07-01 2022-09-30 0001838987 us-gaap:CustomerRelationshipsMember 2022-07-01 2022-09-30 0001838987 us-gaap:DevelopedTechnologyRightsMember 2022-07-01 2022-09-30 0001838987 us-gaap:StockCompensationPlanMember us-gaap:CostOfSalesMember 2022-07-01 2022-09-30 0001838987 us-gaap:StockCompensationPlanMember cslr:SalesAndMarketingMember 2022-07-01 2022-09-30 0001838987 us-gaap:StockCompensationPlanMember us-gaap:GeneralAndAdministrativeExpenseMember 2022-07-01 2022-09-30 0001838987 us-gaap:RelatedPartyMember 2022-07-01 2022-09-30 0001838987 us-gaap:StockCompensationPlanMember 2022-07-01 2022-09-30 0001838987 us-gaap:SegmentContinuingOperationsMember 2022-07-01 2022-09-30 0001838987 us-gaap:CommitmentsMember 2022-07-01 2022-09-30 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:RetainedEarningsUnappropriatedMember 2022-07-01 2022-09-30 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-07-01 2022-09-30 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:RedeemableConvertiblePreferredStockMember 2022-07-01 2022-09-30 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001838987 srt:ScenarioPreviouslyReportedMember 2022-07-01 2022-09-30 0001838987 cslr:TwoThousandTwentyAConvertibleNotesMember 2022-07-01 2022-09-30 0001838987 cslr:AdjustedMember us-gaap:RedeemableConvertiblePreferredStockMember 2022-07-01 2022-09-30 0001838987 cslr:AdjustedMember us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001838987 cslr:AdjustedMember us-gaap:RetainedEarningsUnappropriatedMember 2022-07-01 2022-09-30 0001838987 cslr:AdjustedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-07-01 2022-09-30 0001838987 cslr:AdjustedMember us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001838987 cslr:AdjustedMember 2022-07-01 2022-09-30 0001838987 cslr:CSSoilsMember 2022-07-01 2022-09-30 0001838987 cslr:SeriesDFourRedeemableConvertiblePreferredStockMember 2022-07-01 2022-09-30 0001838987 cslr:SolarEnergySystemInstallationsMember 2023-01-01 2023-10-01 0001838987 cslr:SoftwareServicesMember 2023-01-01 2023-10-01 0001838987 us-gaap:WarrantMember 2023-01-01 2023-10-01 0001838987 cslr:ConvertiblePromissoryNotesMember 2023-01-01 2023-10-01 0001838987 cslr:FreedomAcquisitionICorpMember 2023-01-01 2023-10-01 0001838987 cslr:PrivateInvestmentInPublicEquityMember 2023-01-01 2023-10-01 0001838987 cslr:BusinessCombinationMember 2023-01-01 2023-10-01 0001838987 cslr:AssembledWorkforceMember 2023-01-01 2023-10-01 0001838987 us-gaap:TrademarksMember 2023-01-01 2023-10-01 0001838987 us-gaap:CustomerRelationshipsMember 2023-01-01 2023-10-01 0001838987 us-gaap:DevelopedTechnologyRightsMember 2023-01-01 2023-10-01 0001838987 us-gaap:StockCompensationPlanMember us-gaap:CostOfSalesMember 2023-01-01 2023-10-01 0001838987 us-gaap:StockCompensationPlanMember cslr:SalesAndMarketingMember 2023-01-01 2023-10-01 0001838987 us-gaap:StockCompensationPlanMember us-gaap:GeneralAndAdministrativeExpenseMember 2023-01-01 2023-10-01 0001838987 us-gaap:StockCompensationPlanMember 2023-01-01 2023-10-01 0001838987 cslr:PIPEInvestorsMember 2023-01-01 2023-10-01 0001838987 us-gaap:CommonClassAMember 2023-01-01 2023-10-01 0001838987 cslr:SolariaMember 2023-01-01 2023-10-01 0001838987 cslr:TwoThousandTwentyAConvertibleNotesMember 2023-01-01 2023-10-01 0001838987 cslr:TwoThousandTwentyOneAConvertibleNotesMember 2023-01-01 2023-10-01 0001838987 us-gaap:RelatedPartyMember 2023-01-01 2023-10-01 0001838987 us-gaap:RelatedPartyMember 2023-01-01 2023-10-01 0001838987 cslr:TwoThousandTwentyOneAConvertibleNotesMember 2023-01-01 2023-10-01 0001838987 cslr:TwoThousandTwentyTwoConvertibleNotesMember 2023-01-01 2023-10-01 0001838987 cslr:FPASMember 2023-01-01 2023-10-01 0001838987 cslr:PIPESubscriptionAgreementMember 2023-01-01 2023-10-01 0001838987 cslr:ForwardPurchaseAgreementsMember 2023-01-01 2023-10-01 0001838987 cslr:SeriesBRedeemableConvertiblePreferredStockWarrantMember 2023-01-01 2023-10-01 0001838987 cslr:SeriesCRedeemableConvertiblePreferredStockWarrantMember 2023-01-01 2023-10-01 0001838987 cslr:SeriesD7RedeemableConvertiblePreferredStockWarrantMember 2023-01-01 2023-10-01 0001838987 us-gaap:FairValueInputsLevel1Member 2023-01-01 2023-10-01 0001838987 us-gaap:FairValueInputsLevel2Member 2023-01-01 2023-10-01 0001838987 us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-10-01 0001838987 us-gaap:SegmentContinuingOperationsMember 2023-01-01 2023-10-01 0001838987 us-gaap:SegmentDiscontinuedOperationsMember 2023-01-01 2023-10-01 0001838987 cslr:SeriesC1WarrantsMember 2023-01-01 2023-10-01 0001838987 cslr:SVBCommonStockWarrantsMember 2023-01-01 2023-10-01 0001838987 cslr:CarlyleWarrantsMember cslr:CRSEFSolisHoldingsLLCMember 2023-01-01 2023-10-01 0001838987 cslr:CarlyleWarrantsMember cslr:BlackScholesModelMember 2023-01-01 2023-10-01 0001838987 cslr:CarlyleWarrantsMember 2023-01-01 2023-10-01 0001838987 cslr:PublicPrivatePlacementAndWorkingCapitalWarrantsMember 2023-01-01 2023-10-01 0001838987 cslr:PublicPrivatePlacementAndWorkingCapitalWarrantsMember us-gaap:PrivatePlacementMember 2023-01-01 2023-10-01 0001838987 cslr:SCITermLoanAndRevolverLoanMember 2023-01-01 2023-10-01 0001838987 cslr:ServiceBasedOptionMember 2023-01-01 2023-10-01 0001838987 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-10-01 0001838987 cslr:PIPEFinancingMember 2023-01-01 2023-10-01 0001838987 cslr:SeriesCWarrantsMember 2023-01-01 2023-10-01 0001838987 us-gaap:CommitmentsMember 2023-01-01 2023-10-01 0001838987 us-gaap:RelatedPartyMember us-gaap:ConvertibleNotesPayableMember 2023-01-01 2023-10-01 0001838987 cslr:TwoThousandNinteenSAFEMember 2023-01-01 2023-10-01 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:RetainedEarningsUnappropriatedMember 2023-01-01 2023-10-01 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-10-01 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:RedeemableConvertiblePreferredStockMember 2023-01-01 2023-10-01 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:CommonStockMember 2023-01-01 2023-10-01 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-10-01 0001838987 srt:ScenarioPreviouslyReportedMember 2023-01-01 2023-10-01 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember 2023-01-01 2023-10-01 0001838987 us-gaap:RetainedEarningsUnappropriatedMember 2023-01-01 2023-10-01 0001838987 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-10-01 0001838987 us-gaap:CommonStockMember 2023-01-01 2023-10-01 0001838987 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-10-01 0001838987 srt:MaximumMember cslr:SVBCommonStockWarrantsMember 2023-01-01 2023-10-01 0001838987 srt:MinimumMember cslr:SVBCommonStockWarrantsMember 2023-01-01 2023-10-01 0001838987 cslr:SolariaAcquisitionMember 2023-01-01 2023-10-01 0001838987 cslr:TwoThousandTwentyAConvertibleNotesMember us-gaap:SeriesDPreferredStockMember 2023-01-01 2023-10-01 0001838987 us-gaap:ConvertibleNotesPayableMember 2023-01-01 2023-10-01 0001838987 cslr:PurchaseAgreementsMember 2023-01-01 2023-10-01 0001838987 cslr:ChinaBridgeMember 2023-01-01 2023-10-01 0001838987 srt:MaximumMember 2023-01-01 2023-10-01 0001838987 cslr:SeriesD7WarrantsMember 2023-01-01 2023-10-01 0001838987 srt:MinimumMember cslr:TwoThousandTwentyTwoConvertibleNotesMember 2023-01-01 2023-10-01 0001838987 srt:MaximumMember cslr:TwoThousandTwentyTwoConvertibleNotesMember 2023-01-01 2023-10-01 0001838987 cslr:SAFEMember 2023-01-01 2023-10-01 0001838987 cslr:PublicPrivatePlacementAndWorkingCapitalWarrantsMember cslr:PublicWarrantsMember 2023-01-01 2023-10-01 0001838987 srt:MinimumMember 2023-01-01 2023-10-01 0001838987 cslr:RevolvingLoanMember 2023-01-01 2023-10-01 0001838987 cslr:RodgersMasseyMember 2023-01-01 2023-10-01 0001838987 cslr:CSSoilsMember 2023-01-01 2023-10-01 0001838987 us-gaap:RelatedPartyMember cslr:InConnectionWithForwardPurchaseAgreementsMember 2023-01-01 2023-10-01 0001838987 us-gaap:RelatedPartyMember cslr:IssueOfBonusSharesInConnectionWithMergerMember 2023-01-01 2023-10-01 0001838987 cslr:SeriesDFourRedeemableConvertiblePreferredStockMember 2023-01-01 2023-10-01 0001838987 cslr:SolarEnergySystemInstallationsMember 2023-07-01 2023-10-01 0001838987 cslr:SoftwareServicesMember 2023-07-01 2023-10-01 0001838987 us-gaap:TrademarksMember 2023-07-01 2023-10-01 0001838987 us-gaap:CustomerRelationshipsMember 2023-07-01 2023-10-01 0001838987 us-gaap:DevelopedTechnologyRightsMember 2023-07-01 2023-10-01 0001838987 cslr:AssembledWorkforceMember 2023-07-01 2023-10-01 0001838987 us-gaap:RelatedPartyMember 2023-07-01 2023-10-01 0001838987 us-gaap:RelatedPartyMember 2023-07-01 2023-10-01 0001838987 us-gaap:SegmentContinuingOperationsMember 2023-07-01 2023-10-01 0001838987 us-gaap:SegmentDiscontinuedOperationsMember 2023-07-01 2023-10-01 0001838987 us-gaap:CommitmentsMember 2023-07-01 2023-10-01 0001838987 us-gaap:RelatedPartyMember us-gaap:ConvertibleNotesPayableMember 2023-07-01 2023-10-01 0001838987 cslr:TwoThousandTwentyAConvertibleNotesMember 2023-07-01 2023-10-01 0001838987 us-gaap:ConvertibleNotesPayableMember 2023-07-01 2023-10-01 0001838987 cslr:PurchaseAgreementsMember 2023-07-01 2023-10-01 0001838987 srt:MinimumMember 2023-07-01 2023-10-01 0001838987 cslr:RevolvingLoanMember 2023-07-01 2023-10-01 0001838987 cslr:CSSoilsMember 2023-07-01 2023-10-01 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:RetainedEarningsUnappropriatedMember 2023-07-03 2023-10-01 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-03 2023-10-01 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:RedeemableConvertiblePreferredStockMember 2023-07-03 2023-10-01 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:CommonStockMember 2023-07-03 2023-10-01 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:AdditionalPaidInCapitalMember 2023-07-03 2023-10-01 0001838987 srt:ScenarioPreviouslyReportedMember 2023-07-03 2023-10-01 0001838987 us-gaap:CommonStockMember 2023-07-03 2023-10-01 0001838987 us-gaap:AdditionalPaidInCapitalMember 2023-07-03 2023-10-01 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember 2023-07-03 2023-10-01 0001838987 us-gaap:RetainedEarningsUnappropriatedMember 2023-07-03 2023-10-01 0001838987 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-03 2023-10-01 0001838987 us-gaap:RelatedPartyMember 2023-07-03 2023-10-01 0001838987 cslr:SeriesDFourRedeemableConvertiblePreferredStockMember 2023-07-03 2023-10-01 0001838987 cslr:AssembledWorkforceMember 2021-12-31 0001838987 cslr:RestrictedCashMember 2021-12-31 0001838987 us-gaap:CommonStockMember 2021-12-31 0001838987 cslr:TwoThousandAndNineteenAConvertibleNotesMember us-gaap:NonrelatedPartyMember 2021-12-31 0001838987 cslr:TwoThousandAndTwentySeriesAConvertibleNotesMember us-gaap:NonrelatedPartyMember 2021-12-31 0001838987 cslr:TwoThousandAndTwentyOneSeriesAConvertibleNotesMember us-gaap:NonrelatedPartyMember 2021-12-31 0001838987 us-gaap:NonrelatedPartyMember 2021-12-31 0001838987 cslr:TwoThousandAndTwentySeriesAConvertibleNotesMember us-gaap:RelatedPartyMember 2021-12-31 0001838987 cslr:TwoThousandAndTwentyOneSeriesAConvertibleNotesMember us-gaap:RelatedPartyMember 2021-12-31 0001838987 cslr:ConvertiblePromissoryNotesWithEcoSystemIntegrityFundTwoLlcMember us-gaap:RelatedPartyMember 2021-12-31 0001838987 us-gaap:SoftwareDevelopmentMember 2021-12-31 0001838987 cslr:ManufacturingEquipmentMember 2021-12-31 0001838987 us-gaap:FurnitureAndFixturesMember 2021-12-31 0001838987 us-gaap:LeaseholdImprovementsMember 2021-12-31 0001838987 cslr:LegalMattersMember 2021-12-31 0001838987 us-gaap:FairValueInputsLevel1Member 2021-12-31 0001838987 us-gaap:FairValueInputsLevel2Member 2021-12-31 0001838987 us-gaap:FairValueInputsLevel3Member 2021-12-31 0001838987 us-gaap:RelatedPartyMember 2021-12-31 0001838987 cslr:CurrentInsightPromissoryNoteMember 2021-12-31 0001838987 us-gaap:DomesticCountryMember 2021-12-31 0001838987 us-gaap:StateAndLocalJurisdictionMember 2021-12-31 0001838987 us-gaap:ResearchMember 2021-12-31 0001838987 srt:MaximumMember cslr:CommonStockWarrantsMember us-gaap:MeasurementInputExpectedTermMember 2021-12-31 0001838987 srt:MinimumMember cslr:CommonStockWarrantsMember us-gaap:MeasurementInputExpectedTermMember 2021-12-31 0001838987 cslr:CommonStockWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2021-12-31 0001838987 srt:MaximumMember cslr:CommonStockWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-12-31 0001838987 srt:MinimumMember cslr:CommonStockWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-12-31 0001838987 cslr:CommonStockWarrantsMember us-gaap:MeasurementInputExpectedDividendRateMember 2021-12-31 0001838987 cslr:TwoThousandAndTwentyTwoConvertibleNotesMember us-gaap:NonrelatedPartyMember 2021-12-31 0001838987 cslr:TwoThousandAndTwentyTwoConvertibleNotesMember us-gaap:RelatedPartyMember 2021-12-31 0001838987 cslr:TwoThousandAndTwentyTwoEquityIncentivePlanMember 2021-12-31 0001838987 cslr:TwoThousandAndElevenEquityIncentivePlanMember 2021-12-31 0001838987 cslr:TwoThousandAndTwentyOneEquityIncentivePlanMember 2021-12-31 0001838987 cslr:TwoThousandAndNineteenAConvertibleNotesMember 2021-12-31 0001838987 cslr:TwoThousandAndTwentyAConvertibleNotesMember 2021-12-31 0001838987 cslr:TwoThousandAndTwentyOneConvertibleNotesMember 2021-12-31 0001838987 cslr:TwoThousandAndTwentyOneAConvertibleNotesWithEmbeddedDerivativeLiabilityMember 2021-12-31 0001838987 cslr:ExpectedFairValueOfPreferredStockMember cslr:SimpleAgreementForFutureEquityInstrumentsMember 2021-12-31 0001838987 us-gaap:NotesPayableOtherPayablesMember cslr:LoanAndSecurityAgreementMember 2021-12-31 0001838987 us-gaap:NotesPayableOtherPayablesMember cslr:TwoZeroTwoOnePromissoryNotesMember 2021-12-31 0001838987 us-gaap:NotesPayableOtherPayablesMember cslr:CurrentInsightPromissoryNoteMember 2021-12-31 0001838987 us-gaap:NotesPayableOtherPayablesMember 2021-12-31 0001838987 cslr:TwoThousandAndTwentyOneSeriesAConvertibleNotesMember 2021-12-31 0001838987 cslr:TwoThousandAndTwentySeriesAConvertibleNotesMember 2021-12-31 0001838987 cslr:TwoThousandAndTwentyOneSimpleAgreementForFutureEquityMember 2021-12-31 0001838987 cslr:TwoThousandTwentyOneAConvertibleNotesMember cslr:TrancheOneMember 2021-12-31 0001838987 cslr:TwoThousandTwentyOneAConvertibleNotesMember cslr:TrancheTwoMember 2021-12-31 0001838987 us-gaap:MeasurementInputExpectedTermMember cslr:SimpleAgreementForFutureEquityInstrumentsMember 2021-12-31 0001838987 us-gaap:MeasurementInputRiskFreeInterestRateMember cslr:SimpleAgreementForFutureEquityInstrumentsMember 2021-12-31 0001838987 us-gaap:MeasurementInputPriceVolatilityMember cslr:SimpleAgreementForFutureEquityInstrumentsMember 2021-12-31 0001838987 cslr:SolarEnergySystemInstallationsMember 2022-01-01 2022-12-31 0001838987 cslr:SoftwareServicesMember 2022-01-01 2022-12-31 0001838987 cslr:SeriesD7RedeemableConvertiblePreferredStockWarrantMember 2022-01-01 2022-12-31 0001838987 cslr:SeriesBRedeemableConvertiblePreferredStockWarrantMember 2022-01-01 2022-12-31 0001838987 cslr:SeriesCRedeemableConvertiblePreferredStockWarrantMember 2022-01-01 2022-12-31 0001838987 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001838987 cslr:BusinessCombinationMember 2022-01-01 2022-12-31 0001838987 us-gaap:StockCompensationPlanMember us-gaap:CostOfSalesMember 2022-01-01 2022-12-31 0001838987 us-gaap:StockCompensationPlanMember cslr:SalesAndMarketingMember 2022-01-01 2022-12-31 0001838987 us-gaap:StockCompensationPlanMember us-gaap:GeneralAndAdministrativeExpenseMember 2022-01-01 2022-12-31 0001838987 us-gaap:StockCompensationPlanMember 2022-01-01 2022-12-31 0001838987 srt:ScenarioPreviouslyReportedMember 2022-01-01 2022-12-31 0001838987 cslr:SolariaMember 2022-01-01 2022-12-31 0001838987 us-gaap:CommonClassAMember 2022-01-01 2022-12-31 0001838987 cslr:SolariaMember 2022-01-01 2022-12-31 0001838987 cslr:PIPEInvestorsMember 2022-01-01 2022-12-31 0001838987 cslr:TwoThousandTwentyAConvertibleNotesMember 2022-01-01 2022-12-31 0001838987 cslr:TwoThousandTwentyOneAConvertibleNotesMember 2022-01-01 2022-12-31 0001838987 us-gaap:RelatedPartyMember 2022-01-01 2022-12-31 0001838987 cslr:TwoThousandTwentyOneAConvertibleNotesMember 2022-01-01 2022-12-31 0001838987 cslr:TwoThousandTwentyTwoConvertibleNotesMember 2022-01-01 2022-12-31 0001838987 cslr:PIPESubscriptionAgreementMember 2022-01-01 2022-12-31 0001838987 cslr:ConvertiblePromissoryNotesMember 2022-01-01 2022-12-31 0001838987 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001838987 cslr:CarlyleWarrantsMember cslr:CRSEFSolisHoldingsLLCMember 2022-01-01 2022-12-31 0001838987 us-gaap:SeriesCPreferredStockMember 2022-01-01 2022-12-31 0001838987 cslr:SVBCommonStockWarrantsMember 2022-01-01 2022-12-31 0001838987 cslr:SCITermLoanAndRevolverLoanMember 2022-01-01 2022-12-31 0001838987 cslr:SolariaAcquisitionMember cslr:ConvertiblePromissoryNotesMember 2022-01-01 2022-12-31 0001838987 cslr:PIPEFinancingMember 2022-01-01 2022-12-31 0001838987 us-gaap:CommitmentsMember 2022-01-01 2022-12-31 0001838987 cslr:AdjustedMember us-gaap:RedeemableConvertiblePreferredStockMember cslr:IssueOfRedeemableConvertiblePreferredStockUponAcquisitionMember 2022-01-01 2022-12-31 0001838987 cslr:AdjustedMember us-gaap:RedeemableConvertiblePreferredStockMember cslr:IssuanceOfRedeemableConvertiblePreferredStockUponConversionOfSimpleAgreementOfFutureEquityNotesMember 2022-01-01 2022-12-31 0001838987 us-gaap:RelatedPartyMember us-gaap:ConvertibleNotesPayableMember 2022-01-01 2022-12-31 0001838987 cslr:TwoThousandTwentyOneSafeMember 2022-01-01 2022-12-31 0001838987 cslr:TwoThousandNinteenSAFEMember 2022-01-01 2022-12-31 0001838987 us-gaap:DevelopedTechnologyRightsMember 2022-01-01 2022-12-31 0001838987 us-gaap:CustomerRelationshipsMember 2022-01-01 2022-12-31 0001838987 us-gaap:TrademarksMember 2022-01-01 2022-12-31 0001838987 cslr:AssembledWorkforceMember 2022-01-01 2022-12-31 0001838987 cslr:PreviouslyReportedOneMember us-gaap:RedeemableConvertiblePreferredStockMember 2022-01-01 2022-12-31 0001838987 cslr:PreviouslyReportedOneMember us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001838987 cslr:PreviouslyReportedOneMember us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001838987 cslr:PreviouslyReportedOneMember us-gaap:RetainedEarningsUnappropriatedMember 2022-01-01 2022-12-31 0001838987 cslr:PreviouslyReportedOneMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001838987 cslr:PreviouslyReportedOneMember 2022-01-01 2022-12-31 0001838987 cslr:SolariaAcquisitionMember 2022-01-01 2022-12-31 0001838987 cslr:TwoThousandTwentyAConvertibleNotesMember us-gaap:SeriesDPreferredStockMember 2022-01-01 2022-12-31 0001838987 cslr:SeriesD7WarrantsMember 2022-01-01 2022-12-31 0001838987 cslr:SAFEMember 2022-01-01 2022-12-31 0001838987 cslr:AdjustedMember us-gaap:RedeemableConvertiblePreferredStockMember 2022-01-01 2022-12-31 0001838987 cslr:AdjustedMember us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001838987 cslr:AdjustedMember us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001838987 cslr:AdjustedMember us-gaap:RetainedEarningsUnappropriatedMember 2022-01-01 2022-12-31 0001838987 cslr:AdjustedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001838987 cslr:AdjustedMember 2022-01-01 2022-12-31 0001838987 srt:MinimumMember 2022-01-01 2022-12-31 0001838987 srt:MaximumMember 2022-01-01 2022-12-31 0001838987 cslr:AdjustedMember us-gaap:RedeemableConvertiblePreferredStockMember cslr:IssuanceOfRedeemableConvertiblePreferredStockUponConversionOfConvertibleNotesAndSimpleAgreementForFutureEquityNotesMember 2022-01-01 2022-12-31 0001838987 cslr:RevolvingLoanMember 2022-01-01 2022-12-31 0001838987 cslr:CSSoilsMember 2022-01-01 2022-12-31 0001838987 us-gaap:SegmentDiscontinuedOperationsMember 2022-01-01 2022-12-31 0001838987 cslr:IssuanceOfTemporaryEquityUponConversionOfConvertibleDebtMember 2022-01-01 2022-12-31 0001838987 us-gaap:GeneralAndAdministrativeExpenseMember 2022-01-01 2022-12-31 0001838987 cslr:TwoThousandAndTwentyThreeMember 2022-01-01 2022-12-31 0001838987 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001838987 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001838987 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2022-01-01 2022-12-31 0001838987 cslr:SupplierThreeMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2022-01-01 2022-12-31 0001838987 cslr:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001838987 cslr:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001838987 cslr:CustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001838987 cslr:CustomerThreeMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001838987 cslr:SeriesDWarrantsTrancheAMember us-gaap:WarrantMember 2022-01-01 2022-12-31 0001838987 cslr:SeriesDWarrantsTrancheAMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2022-01-01 2022-12-31 0001838987 cslr:SeriesDWarrantsTrancheAMember cslr:SimpleAgreementForFutureEquityMember 2022-01-01 2022-12-31 0001838987 cslr:SeriesDWarrantsTrancheBMember us-gaap:WarrantMember 2022-01-01 2022-12-31 0001838987 cslr:SeriesDWarrantsTrancheBMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2022-01-01 2022-12-31 0001838987 cslr:SeriesDWarrantsTrancheBMember cslr:SimpleAgreementForFutureEquityMember 2022-01-01 2022-12-31 0001838987 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001838987 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2022-01-01 2022-12-31 0001838987 cslr:SimpleAgreementForFutureEquityMember 2022-01-01 2022-12-31 0001838987 cslr:ConversionOfSafesFromSolariaAcquisitionIntoPreferredSharesMember us-gaap:WarrantMember 2022-01-01 2022-12-31 0001838987 cslr:ConversionOfSafesFromSolariaAcquisitionIntoPreferredSharesMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2022-01-01 2022-12-31 0001838987 cslr:ConversionOfSafesFromSolariaAcquisitionIntoPreferredSharesMember cslr:SimpleAgreementForFutureEquityMember 2022-01-01 2022-12-31 0001838987 cslr:ConversionOfDebtIntoPreferredSharesMember us-gaap:WarrantMember 2022-01-01 2022-12-31 0001838987 cslr:ConversionOfDebtIntoPreferredSharesMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2022-01-01 2022-12-31 0001838987 cslr:ConversionOfDebtIntoPreferredSharesMember cslr:SimpleAgreementForFutureEquityMember 2022-01-01 2022-12-31 0001838987 cslr:ConversionOfSafesIntoPreferredSharesMember us-gaap:WarrantMember 2022-01-01 2022-12-31 0001838987 cslr:ConversionOfSafesIntoPreferredSharesMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2022-01-01 2022-12-31 0001838987 cslr:ConversionOfSafesIntoPreferredSharesMember cslr:SimpleAgreementForFutureEquityMember 2022-01-01 2022-12-31 0001838987 srt:MinimumMember us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0001838987 srt:MaximumMember us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0001838987 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0001838987 cslr:TwoThousandAndElevenEquityIncentivePlanMember 2022-01-01 2022-12-31 0001838987 cslr:TwoThousandAndElevenEquityIncentivePlanMember cslr:IncentiveStockOptionMember 2022-01-01 2022-12-31 0001838987 cslr:TwoThousandAndElevenEquityIncentivePlanMember cslr:TenPercentStockHolderMember 2022-01-01 2022-12-31 0001838987 cslr:TwoThousandAndTwentyOneEquityIncentivePlanMember 2022-01-01 2022-12-31 0001838987 cslr:TwoThousandAndTwentyOneEquityIncentivePlanMember cslr:IncentiveStockOptionMember 2022-01-01 2022-12-31 0001838987 cslr:TwoThousandAndTwentyOneEquityIncentivePlanMember cslr:TenPercentStockHolderMember 2022-01-01 2022-12-31 0001838987 cslr:TwoThousandAndTwentyTwoEquityIncentivePlanMember 2022-01-01 2022-12-31 0001838987 cslr:TwoThousandAndTwentyTwoEquityIncentivePlanMember cslr:IncentiveStockOptionMember 2022-01-01 2022-12-31 0001838987 cslr:TwoThousandAndTwentyTwoEquityIncentivePlanMember cslr:TenPercentStockHolderMember 2022-01-01 2022-12-31 0001838987 cslr:SeriesBWarrantsMember us-gaap:RedeemableConvertiblePreferredStockMember 2022-01-01 2022-12-31 0001838987 cslr:SeriesCWarrantsMember us-gaap:RedeemableConvertiblePreferredStockMember 2022-01-01 2022-12-31 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember 2022-01-01 2022-12-31 0001838987 cslr:SeriesDTrancheAWarrantsMember us-gaap:RedeemableConvertiblePreferredStockMember 2022-01-01 2022-12-31 0001838987 cslr:SeriesDTrancheBWarrantsMember us-gaap:RedeemableConvertiblePreferredStockMember 2022-01-01 2022-12-31 0001838987 cslr:TwoThousandAndNineteenAConvertibleNotesMember 2022-01-01 2022-12-31 0001838987 cslr:TwoThousandAndTwentyAConvertibleNotesMember 2022-01-01 2022-12-31 0001838987 cslr:TwoThousandAndTwentyOneConvertibleNotesMember 2022-01-01 2022-12-31 0001838987 cslr:TwoThousandAndTwentyOneAConvertibleNotesWithEmbeddedDerivativeLiabilityMember 2022-01-01 2022-12-31 0001838987 cslr:TwoThousandNineteenConvertibleNotesMember 2022-01-01 2022-12-31 0001838987 cslr:TwoThousandTwentyAConvertibleNotesMember 2022-01-01 2022-12-31 0001838987 srt:MaximumMember cslr:TwoThousandNineteenConvertibleNotesMember 2022-01-01 2022-12-31 0001838987 srt:MaximumMember cslr:TwoThousandTwentyAConvertibleNotesMember 2022-01-01 2022-12-31 0001838987 cslr:TwoThousandAndTwentyTwoSimpleAgreementForFutureEquityMember 2022-01-01 2022-12-31 0001838987 cslr:SolariaMember 2023-01-02 2023-10-01 0001838987 us-gaap:DevelopedTechnologyRightsMember 2023-01-02 2023-10-01 0001838987 us-gaap:CustomerRelationshipsMember 2023-01-02 2023-10-01 0001838987 us-gaap:TrademarksMember 2023-01-02 2023-10-01 0001838987 cslr:AssembledWorkforceMember 2023-01-02 2023-10-01 0001838987 cslr:SolariaAcquisitionMember 2022-11-04 2022-11-04 0001838987 cslr:SolariaAcquisitionMember us-gaap:PreferredStockMember 2022-11-04 2022-11-04 0001838987 cslr:SolariaAcquisitionMember us-gaap:CommonStockMember 2022-11-04 2022-11-04 0001838987 cslr:SolariaAcquisitionMember us-gaap:WarrantMember us-gaap:PreferredStockMember 2022-11-04 2022-11-04 0001838987 cslr:SolariaAcquisitionMember us-gaap:WarrantMember us-gaap:CommonStockMember 2022-11-04 2022-11-04 0001838987 cslr:SolariaAcquisitionMember us-gaap:StockOptionMember 2022-11-04 2022-11-04 0001838987 cslr:SolariaAcquisitionMember 2022-11-04 0001838987 us-gaap:TrademarksAndTradeNamesMember 2023-09-30 0001838987 us-gaap:DevelopedTechnologyRightsMember 2023-09-30 0001838987 us-gaap:CustomerRelationshipsMember 2023-09-30 0001838987 us-gaap:RelatedPartyMember cslr:SeriesDOneRedeemableConvertiblePreferredStockMember cslr:UponConversionOfConvertibleNotesAndSimpleAgreementForFutureEquityMember 2023-09-30 0001838987 us-gaap:StockCompensationPlanMember us-gaap:CostOfSalesMember 2023-07-02 2023-10-01 0001838987 us-gaap:StockCompensationPlanMember cslr:SalesAndMarketingMember 2023-07-02 2023-10-01 0001838987 us-gaap:StockCompensationPlanMember us-gaap:GeneralAndAdministrativeExpenseMember 2023-07-02 2023-10-01 0001838987 us-gaap:StockCompensationPlanMember 2023-07-02 2023-10-01 0001838987 us-gaap:SeriesBPreferredStockMember 2016-02-29 0001838987 cslr:SeriesBWarrantsMember 2016-02-29 0001838987 cslr:SeriesDPreferredStockWarrantsTrancheOneMember cslr:RedeemableConvertiblePreferredStockWarrantLiabilityMember cslr:DespacAcquisitionAssumptionExercisePriceOneMember 2016-02-29 0001838987 cslr:SeriesDPreferredStockWarrantsTrancheTwoMember cslr:RedeemableConvertiblePreferredStockWarrantLiabilityMember cslr:DespacAcquisitionAssumptionExercisePriceOneMember 2016-02-29 0001838987 cslr:SeriesDPreferredStockWarrantsTrancheOneMember cslr:WarrantsRemainingPrivateAssumptionExercisePriceOneMember 2016-02-29 0001838987 cslr:SeriesDPreferredStockWarrantsTrancheTwoMember cslr:WarrantsRemainingPrivateAssumptionExercisePriceOneMember 2016-02-29 0001838987 cslr:RedeemableConvertiblePreferredStockWarrantLiabilityMember cslr:SpacExistsMember 2016-02-29 0001838987 cslr:RedeemableConvertiblePreferredStockWarrantLiabilityMember cslr:WarrantsRemainingPrivateMember 2016-02-29 0001838987 cslr:SeriesBWarrantsMember us-gaap:CommonClassAMember 2023-07-01 2023-07-18 0001838987 us-gaap:SeriesCPreferredStockMember 2023-07-01 2023-07-18 0001838987 cslr:SeriesCWarrantsMember 2016-07-30 0001838987 cslr:SeriesC1WarrantsMember 2020-01-31 0001838987 srt:MinimumMember cslr:SVBCommonStockWarrantsMember 2021-05-31 0001838987 srt:MinimumMember cslr:SVBCommonStockWarrantsMember us-gaap:CommonStockMember 2021-05-31 0001838987 srt:MinimumMember 2021-05-31 0001838987 srt:MaximumMember 2021-08-31 0001838987 cslr:PromissoryNoteCommonStockWarrantsMember 2021-10-01 2021-10-31 0001838987 cslr:TwoZeroTwoOnePromissoryNotesMember 2021-10-01 2021-10-31 0001838987 cslr:PromissoryNoteCommonStockWarrantsMember 2021-10-31 0001838987 cslr:TwoZeroTwoOnePromissoryNotesMember 2021-10-31 0001838987 cslr:CarlyleWarrantsMember 2022-02-28 0001838987 cslr:CarlyleWarrantsMember us-gaap:CommonStockMember 2022-02-28 0001838987 cslr:CarlyleWarrantsMember us-gaap:WarrantMember 2022-02-28 0001838987 cslr:July2023CommonStockWarrantsMember us-gaap:PrivatePlacementMember 2023-07-01 2023-07-31 0001838987 cslr:WarrantConsiderationMember 2023-07-01 2023-07-31 0001838987 srt:BoardOfDirectorsChairmanMember 2023-07-01 2023-07-31 0001838987 cslr:CarlyleWarrantsMember 2023-07-01 2023-07-31 0001838987 cslr:July2023CommonStockWarrantsMember 2023-07-01 2023-07-31 0001838987 cslr:ClassACommonStockEqualsOrExceedsThresholdTwoMember us-gaap:PrivatePlacementMember 2023-07-01 2023-07-31 0001838987 cslr:TwoThousandTwentyThreeEquityIncentivePlanMember 2023-07-31 0001838987 cslr:July2023CommonStockWarrantsMember 2023-07-31 0001838987 cslr:CarlyleWarrantsMember 2023-07-31 0001838987 cslr:ConvertiblePromissoryNotesMember 2023-07-31 0001838987 us-gaap:WarrantMember 2022-11-30 0001838987 cslr:BusinessCombinationMember cslr:November2022CommonStockWarrantsMember 2022-11-01 2022-11-30 0001838987 cslr:November2022CommonStockWarrantsMember 2022-11-01 2022-11-30 0001838987 cslr:November2022CommonStockWarrantsMember 2023-05-01 2023-05-31 0001838987 cslr:ConversionAmountMember 2021-04-01 2021-04-30 0001838987 cslr:PaycheckProtectionProgrammeLoanMember 2021-04-01 2021-04-30 0001838987 cslr:LoanAndSecurityAgreementMember 2020-01-01 2020-01-20 0001838987 srt:MaximumMember 2020-01-01 2020-01-20 0001838987 srt:MinimumMember 2020-01-01 2020-01-20 0001838987 us-gaap:WarrantMember 2021-12-31 2021-12-31 0001838987 srt:MinimumMember 2021-12-31 2021-12-31 0001838987 srt:MaximumMember 2021-12-31 2021-12-31 0001838987 cslr:TwoThousandAndNineteenAConvertibleNotesMember 2021-12-31 2021-12-31 0001838987 cslr:TwoThousandAndTwentyOneAConvertibleNotesWithEmbeddedDerivativeLiabilityMember 2021-12-31 2021-12-31 0001838987 cslr:TwoThousandAndTwentyAConvertibleNotesMember 2021-12-31 2021-12-31 0001838987 cslr:TwoThousandAndTwentyOneConvertibleNotesMember 2021-12-31 2021-12-31 0001838987 cslr:TwoZeroTwoOnePromissoryNotesMember 2021-07-01 2021-07-31 0001838987 cslr:TwoZeroTwoOnePromissoryNotesMember 2021-07-31 0001838987 cslr:TwoZeroOneEightBridgeNotesMember 2018-12-01 2018-12-31 0001838987 cslr:CurrentInsightPromissoryNoteMember 2021-01-01 0001838987 us-gaap:AccountingStandardsUpdate201602Member 2021-01-01 0001838987 cslr:CurrentInsightPromissoryNoteMember 2021-01-01 2021-01-31 0001838987 cslr:SeriesBWarrantsMember 2022-12-01 2022-12-31 0001838987 srt:MinimumMember 2022-12-01 2022-12-31 0001838987 srt:MaximumMember 2022-12-01 2022-12-31 0001838987 cslr:SecuredCreditFacilityMember 2022-12-01 2022-12-31 0001838987 cslr:SettlementAgreementMember 2023-09-01 2023-09-30 0001838987 cslr:PolarSettlementAgreementMember 2023-09-28 2023-10-01 0001838987 cslr:ISOsUnderThe2023PlanMember 2023-07-31 2023-07-31 0001838987 cslr:TwoThousandTwentyTwoConvertibleNotesMember 2022-12-31 2022-12-31 0001838987 cslr:RevolvingLoanMember 2022-12-31 2022-12-31 0001838987 cslr:TwoThousandAndNineteenAConvertibleNotesMember 2022-12-31 2022-12-31 0001838987 cslr:TwoThousandAndTwentyOneAConvertibleNotesWithEmbeddedDerivativeLiabilityMember 2022-12-31 2022-12-31 0001838987 cslr:TwoThousandAndTwentyAConvertibleNotesMember 2022-12-31 2022-12-31 0001838987 cslr:TwoThousandAndTwentyOneConvertibleNotesMember 2022-12-31 2022-12-31 0001838987 cslr:TwoThousandAndTwentyThreeConvertibleNotesMember 2023-01-01 2023-01-31 0001838987 cslr:SolarParkKoreaCoLTDMember 2023-01-01 2023-01-31 0001838987 cslr:SecuredCreditFacilityMember 2023-02-01 2023-02-28 0001838987 cslr:SolarEnergySystemInstallationsMember 2020-01-01 2020-12-31 0001838987 cslr:SoftwareServicesMember 2020-01-01 2020-12-31 0001838987 us-gaap:StockCompensationPlanMember us-gaap:CostOfSalesMember 2020-01-01 2020-12-31 0001838987 us-gaap:StockCompensationPlanMember cslr:SalesAndMarketingMember 2020-01-01 2020-12-31 0001838987 us-gaap:StockCompensationPlanMember us-gaap:GeneralAndAdministrativeExpenseMember 2020-01-01 2020-12-31 0001838987 us-gaap:StockCompensationPlanMember 2020-01-01 2020-12-31 0001838987 srt:ScenarioPreviouslyReportedMember 2020-01-01 2020-12-31 0001838987 cslr:TwoThousandTwentyAConvertibleNotesMember 2020-01-01 2020-12-31 0001838987 us-gaap:RelatedPartyMember 2020-01-01 2020-12-31 0001838987 cslr:AdjustedMember us-gaap:RedeemableConvertiblePreferredStockMember 2020-01-01 2020-12-31 0001838987 cslr:AdjustedMember us-gaap:RedeemableConvertiblePreferredStockMember cslr:IssuanceOfRedeemableConvertiblePreferredStockUponConversionOfTwoThousandAndSeventeenConvertibleNotesAndTwoThousandAndTwoThousandAndNineteenSimpleAgreementForFutureEquityMember 2020-01-01 2020-12-31 0001838987 cslr:PreviouslyReportedOneMember us-gaap:CommonStockMember 2020-01-01 2020-12-31 0001838987 cslr:PreviouslyReportedOneMember us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0001838987 cslr:PreviouslyReportedOneMember us-gaap:RetainedEarningsUnappropriatedMember 2020-01-01 2020-12-31 0001838987 cslr:PreviouslyReportedOneMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-12-31 0001838987 cslr:PreviouslyReportedOneMember 2020-01-01 2020-12-31 0001838987 cslr:PreviouslyReportedOneMember us-gaap:RedeemableConvertiblePreferredStockMember 2020-01-01 2020-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:RedeemableConvertiblePreferredStockMember 2020-01-01 2020-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:CommonStockMember 2020-01-01 2020-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:RetainedEarningsUnappropriatedMember 2020-01-01 2020-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-12-31 0001838987 cslr:AdjustedMember us-gaap:RedeemableConvertiblePreferredStockMember cslr:ConversionOfConvertibleNotesMember 2020-01-01 2020-12-31 0001838987 cslr:AdjustedMember us-gaap:CommonStockMember 2020-01-01 2020-12-31 0001838987 cslr:AdjustedMember us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0001838987 cslr:AdjustedMember us-gaap:RetainedEarningsUnappropriatedMember 2020-01-01 2020-12-31 0001838987 cslr:AdjustedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-12-31 0001838987 cslr:AdjustedMember 2020-01-01 2020-12-31 0001838987 us-gaap:GeneralAndAdministrativeExpenseMember 2020-01-01 2020-12-31 0001838987 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2020-01-01 2020-12-31 0001838987 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0001838987 cslr:SupplierTwoMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2020-01-01 2020-12-31 0001838987 cslr:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0001838987 srt:MaximumMember cslr:TwoThousandNineteenConvertibleNotesMember 2020-01-01 2020-12-31 0001838987 srt:MaximumMember cslr:TwoThousandTwentyAConvertibleNotesMember 2020-01-01 2020-12-31 0001838987 cslr:SolarEnergySystemInstallationsMember 2021-01-01 2021-12-31 0001838987 cslr:SoftwareServicesMember 2021-01-01 2021-12-31 0001838987 cslr:SeriesBRedeemableConvertiblePreferredStockWarrantMember 2021-01-01 2021-12-31 0001838987 cslr:SeriesCRedeemableConvertiblePreferredStockWarrantMember 2021-01-01 2021-12-31 0001838987 us-gaap:StockCompensationPlanMember us-gaap:CostOfSalesMember 2021-01-01 2021-12-31 0001838987 us-gaap:StockCompensationPlanMember cslr:SalesAndMarketingMember 2021-01-01 2021-12-31 0001838987 us-gaap:StockCompensationPlanMember us-gaap:GeneralAndAdministrativeExpenseMember 2021-01-01 2021-12-31 0001838987 us-gaap:StockCompensationPlanMember 2021-01-01 2021-12-31 0001838987 srt:ScenarioPreviouslyReportedMember 2021-01-01 2021-12-31 0001838987 cslr:TwoThousandTwentyOneAConvertibleNotesMember 2021-01-01 2021-12-31 0001838987 us-gaap:RelatedPartyMember 2021-01-01 2021-12-31 0001838987 cslr:SeriesD7RedeemableConvertiblePreferredStockWarrantMember 2021-01-01 2021-12-31 0001838987 us-gaap:SeriesCPreferredStockMember 2021-01-01 2021-12-31 0001838987 us-gaap:CommitmentsMember 2021-01-01 2021-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:RetainedEarningsUnappropriatedMember 2021-01-01 2021-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:RedeemableConvertiblePreferredStockMember 2021-01-01 2021-12-31 0001838987 cslr:AdjustedMember us-gaap:RedeemableConvertiblePreferredStockMember cslr:AcquisitionOfAssembledWorkforceMember 2021-01-01 2021-12-31 0001838987 cslr:AdjustedMember us-gaap:CommonStockMember cslr:AcquisitionOfAssembledWorkforceMember 2021-01-01 2021-12-31 0001838987 cslr:AdjustedMember us-gaap:AdditionalPaidInCapitalMember cslr:AcquisitionOfAssembledWorkforceMember 2021-01-01 2021-12-31 0001838987 cslr:AdjustedMember us-gaap:RetainedEarningsUnappropriatedMember cslr:AcquisitionOfAssembledWorkforceMember 2021-01-01 2021-12-31 0001838987 cslr:AdjustedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember cslr:AcquisitionOfAssembledWorkforceMember 2021-01-01 2021-12-31 0001838987 cslr:AdjustedMember cslr:AcquisitionOfAssembledWorkforceMember 2021-01-01 2021-12-31 0001838987 cslr:AdjustedMember us-gaap:RedeemableConvertiblePreferredStockMember 2021-01-01 2021-12-31 0001838987 cslr:AdjustedMember us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001838987 cslr:AdjustedMember us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001838987 cslr:AdjustedMember us-gaap:RetainedEarningsUnappropriatedMember 2021-01-01 2021-12-31 0001838987 cslr:AdjustedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001838987 cslr:AdjustedMember 2021-01-01 2021-12-31 0001838987 us-gaap:GeneralAndAdministrativeExpenseMember 2021-01-01 2021-12-31 0001838987 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001838987 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2021-01-01 2021-12-31 0001838987 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001838987 cslr:SupplierFourMember us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2021-01-01 2021-12-31 0001838987 cslr:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001838987 cslr:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001838987 us-gaap:ConvertibleDebtMember us-gaap:WarrantMember 2021-01-01 2021-12-31 0001838987 us-gaap:ConvertibleDebtMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2021-01-01 2021-12-31 0001838987 us-gaap:ConvertibleDebtMember cslr:SimpleAgreementForFutureEquityMember 2021-01-01 2021-12-31 0001838987 cslr:RogersSafeMember us-gaap:WarrantMember 2021-01-01 2021-12-31 0001838987 cslr:RogersSafeMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2021-01-01 2021-12-31 0001838987 cslr:RogersSafeMember cslr:SimpleAgreementForFutureEquityMember 2021-01-01 2021-12-31 0001838987 us-gaap:WarrantMember 2021-01-01 2021-12-31 0001838987 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2021-01-01 2021-12-31 0001838987 cslr:SimpleAgreementForFutureEquityMember 2021-01-01 2021-12-31 0001838987 srt:MinimumMember us-gaap:EmployeeStockOptionMember 2021-01-01 2021-12-31 0001838987 srt:MaximumMember us-gaap:EmployeeStockOptionMember 2021-01-01 2021-12-31 0001838987 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-12-31 0001838987 cslr:SeriesBWarrantsMember us-gaap:RedeemableConvertiblePreferredStockMember 2021-01-01 2021-12-31 0001838987 cslr:SeriesCWarrantsMember us-gaap:RedeemableConvertiblePreferredStockMember 2021-01-01 2021-12-31 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember 2021-01-01 2021-12-31 0001838987 cslr:SeriesDTrancheAWarrantsMember us-gaap:RedeemableConvertiblePreferredStockMember 2021-01-01 2021-12-31 0001838987 cslr:SeriesDTrancheBWarrantsMember us-gaap:RedeemableConvertiblePreferredStockMember 2021-01-01 2021-12-31 0001838987 cslr:TwoThousandNineteenConvertibleNotesMember 2021-01-01 2021-12-31 0001838987 cslr:TwoThousandTwentyAConvertibleNotesMember 2021-01-01 2021-12-31 0001838987 srt:MaximumMember cslr:TwoThousandNineteenConvertibleNotesMember 2021-01-01 2021-12-31 0001838987 srt:MaximumMember cslr:TwoThousandTwentyAConvertibleNotesMember 2021-01-01 2021-12-31 0001838987 us-gaap:OtherNonoperatingIncomeExpenseMember cslr:TwoThousandAndTwentyOneSimpleAgreementForFutureEquityMember 2021-01-01 2021-12-31 0001838987 cslr:TwoThousandTwentyTwoConvertibleNotesMember 2022-10-01 2023-06-01 0001838987 cslr:SolariaAcquisitionMember cslr:ConvertiblePromissoryNotesMember 2022-10-01 2023-06-30 0001838987 cslr:SolariaCommonStockMember 2023-10-31 2023-10-31 0001838987 us-gaap:CommonClassAMember 2023-03-01 2023-03-31 0001838987 cslr:TwoThousandAndTwentyThreeConvertibleNotesMember 2023-01-31 0001838987 cslr:CurrentInsightMember 2021-01-21 2021-01-21 0001838987 cslr:CurrentInsightMember us-gaap:CommonStockMember 2021-01-21 2021-01-21 0001838987 us-gaap:InvestmentCreditMember 2020-06-29 0001838987 cslr:SeriesBWarrantsMember us-gaap:CommonClassAMember 2021-12-01 2021-12-31 0001838987 cslr:TwoThousandAndTwentyOneSimpleAgreementForFutureEquityMember 2021-12-01 2021-12-31 0001838987 us-gaap:AccountingStandardsUpdate201602Member 2021-01-01 2021-01-01 0001838987 cslr:VendorSettlementMember 2023-01-10 0001838987 cslr:WarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember 2024-01-04 2024-01-04 0001838987 cslr:CommonStockParValue0.0001PerShareMember 2024-01-04 2024-01-04 0001838987 cslr:TwoThousandAndNineteenAConvertibleNotesMember 2020-12-31 2020-12-31 0001838987 cslr:TwoThousandAndTwentyOneAConvertibleNotesWithEmbeddedDerivativeLiabilityMember 2020-12-31 2020-12-31 0001838987 cslr:TwoThousandAndTwentyAConvertibleNotesMember 2020-12-31 2020-12-31 0001838987 cslr:TwoThousandAndTwentyOneConvertibleNotesMember 2020-12-31 2020-12-31 0001838987 cslr:TwoThousandAndNineteenSimpleAgreementForFutureEquityMember 2019-07-31 0001838987 cslr:TwoThousandAndNineteenSimpleAgreementForFutureEquityMember 2019-12-31 0001838987 cslr:ProbabilityOfConversionIntoEquityInstrumentsOneMember cslr:TwoThousandAndNineteenSimpleAgreementForFutureEquityMember 2019-12-31 0001838987 cslr:ProbabilityOfConversionIntoEquityInstrumentsTwoMember cslr:TwoThousandAndNineteenSimpleAgreementForFutureEquityMember 2019-12-31 0001838987 cslr:TwoThousandAndNineteenSimpleAgreementForFutureEquityMember 2019-01-01 2019-12-31 0001838987 cslr:PaycheckProtectionProgrammeLoanMember 2020-04-01 2020-04-30 0001838987 cslr:TwoThousandAndNineteenSimpleAgreementForFutureEquityMember 2019-07-01 2019-07-31 0001838987 cslr:AdjustedMember us-gaap:RedeemableConvertiblePreferredStockMember 2021-12-31 0001838987 cslr:AdjustedMember us-gaap:CommonStockMember 2021-12-31 0001838987 cslr:AdjustedMember us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001838987 cslr:AdjustedMember us-gaap:RetainedEarningsUnappropriatedMember 2021-12-31 0001838987 cslr:AdjustedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001838987 cslr:AdjustedMember 2021-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-09-30 0001838987 cslr:AdjustedMember us-gaap:RedeemableConvertiblePreferredStockMember 2022-09-30 0001838987 cslr:AdjustedMember us-gaap:CommonStockMember 2022-09-30 0001838987 cslr:AdjustedMember us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001838987 cslr:AdjustedMember us-gaap:RetainedEarningsUnappropriatedMember 2022-09-30 0001838987 cslr:AdjustedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-09-30 0001838987 cslr:AdjustedMember 2022-09-30 0001838987 cslr:AdjustedMember us-gaap:RedeemableConvertiblePreferredStockMember 2022-06-30 0001838987 cslr:AdjustedMember us-gaap:CommonStockMember 2022-06-30 0001838987 cslr:AdjustedMember us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001838987 cslr:AdjustedMember us-gaap:RetainedEarningsUnappropriatedMember 2022-06-30 0001838987 cslr:AdjustedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0001838987 cslr:AdjustedMember 2022-06-30 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:RedeemableConvertiblePreferredStockMember 2022-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:RetainedEarningsUnappropriatedMember 2022-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001838987 srt:ScenarioPreviouslyReportedMember 2022-12-31 0001838987 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001838987 us-gaap:RetainedEarningsUnappropriatedMember 2022-12-31 0001838987 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember 2022-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:CommonStockMember 2022-12-31 0001838987 us-gaap:AdditionalPaidInCapitalMember 2023-10-01 0001838987 us-gaap:RetainedEarningsUnappropriatedMember 2023-10-01 0001838987 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-10-01 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember 2023-10-01 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:RedeemableConvertiblePreferredStockMember 2023-07-02 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:AdditionalPaidInCapitalMember 2023-07-02 0001838987 us-gaap:RetainedEarningsUnappropriatedMember 2023-07-02 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-02 0001838987 srt:ScenarioPreviouslyReportedMember 2023-07-02 0001838987 cslr:AdjustedMember us-gaap:CommonStockMember 2023-07-02 0001838987 cslr:AdjustedMember us-gaap:AdditionalPaidInCapitalMember 2023-07-02 0001838987 cslr:AdjustedMember us-gaap:RetainedEarningsUnappropriatedMember 2023-07-02 0001838987 cslr:AdjustedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-02 0001838987 cslr:AdjustedMember 2023-07-02 0001838987 cslr:AdjustedMember us-gaap:RedeemableConvertiblePreferredStockMember 2023-07-02 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:CommonStockMember 2023-07-02 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:RedeemableConvertiblePreferredStockMember 2022-09-30 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:CommonStockMember 2022-09-30 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001838987 srt:ScenarioPreviouslyReportedMember 2022-09-30 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:RetainedEarningsUnappropriatedMember 2022-09-30 0001838987 cslr:PreviouslyReportedOneMember us-gaap:CommonStockMember 2022-12-31 0001838987 cslr:PreviouslyReportedOneMember us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001838987 cslr:PreviouslyReportedOneMember us-gaap:RetainedEarningsUnappropriatedMember 2022-12-31 0001838987 cslr:PreviouslyReportedOneMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001838987 cslr:PreviouslyReportedOneMember 2022-12-31 0001838987 cslr:AdjustedMember us-gaap:CommonStockMember 2022-12-31 0001838987 cslr:AdjustedMember us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001838987 cslr:AdjustedMember us-gaap:RetainedEarningsUnappropriatedMember 2022-12-31 0001838987 cslr:AdjustedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001838987 cslr:AdjustedMember 2022-12-31 0001838987 cslr:PreviouslyReportedOneMember us-gaap:RedeemableConvertiblePreferredStockMember 2022-12-31 0001838987 cslr:AdjustedMember us-gaap:RedeemableConvertiblePreferredStockMember 2022-12-31 0001838987 us-gaap:WarrantMember 2022-12-31 0001838987 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2022-12-31 0001838987 cslr:SimpleAgreementForFutureEquityMember 2022-12-31 0001838987 cslr:SeriesBWarrantsMember us-gaap:RedeemableConvertiblePreferredStockMember 2022-12-31 0001838987 cslr:SeriesCWarrantsMember us-gaap:RedeemableConvertiblePreferredStockMember 2022-12-31 0001838987 cslr:SeriesDTrancheAWarrantsMember us-gaap:RedeemableConvertiblePreferredStockMember 2022-12-31 0001838987 cslr:SeriesDTrancheBWarrantsMember us-gaap:RedeemableConvertiblePreferredStockMember 2022-12-31 0001838987 cslr:TwoThousandTwentyOneAConvertibleNotesMember 2022-12-31 0001838987 cslr:TwoThousandTwentyAConvertibleNotesMember 2022-12-31 0001838987 cslr:PreviouslyReportedOneMember us-gaap:CommonStockMember 2021-12-31 0001838987 cslr:PreviouslyReportedOneMember us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001838987 cslr:PreviouslyReportedOneMember us-gaap:RetainedEarningsUnappropriatedMember 2021-12-31 0001838987 cslr:PreviouslyReportedOneMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001838987 cslr:PreviouslyReportedOneMember 2021-12-31 0001838987 cslr:PreviouslyReportedOneMember us-gaap:RedeemableConvertiblePreferredStockMember 2021-12-31 0001838987 cslr:PreviouslyReportedOneMember us-gaap:CommonStockMember 2019-12-31 0001838987 cslr:PreviouslyReportedOneMember us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001838987 cslr:PreviouslyReportedOneMember us-gaap:RetainedEarningsUnappropriatedMember 2019-12-31 0001838987 cslr:PreviouslyReportedOneMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001838987 cslr:PreviouslyReportedOneMember 2019-12-31 0001838987 cslr:AdjustedMember us-gaap:CommonStockMember 2019-12-31 0001838987 cslr:AdjustedMember us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001838987 cslr:AdjustedMember us-gaap:RetainedEarningsUnappropriatedMember 2019-12-31 0001838987 cslr:AdjustedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001838987 cslr:AdjustedMember 2019-12-31 0001838987 cslr:AdjustedMember us-gaap:RedeemableConvertiblePreferredStockMember 2019-12-31 0001838987 cslr:PreviouslyReportedOneMember us-gaap:RedeemableConvertiblePreferredStockMember 2019-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:CommonStockMember 2020-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:RetainedEarningsUnappropriatedMember 2020-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001838987 srt:ScenarioPreviouslyReportedMember 2020-12-31 0001838987 cslr:AdjustedMember us-gaap:CommonStockMember 2020-12-31 0001838987 cslr:AdjustedMember us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001838987 cslr:AdjustedMember us-gaap:RetainedEarningsUnappropriatedMember 2020-12-31 0001838987 cslr:AdjustedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001838987 cslr:AdjustedMember 2020-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:RedeemableConvertiblePreferredStockMember 2020-12-31 0001838987 cslr:AdjustedMember us-gaap:RedeemableConvertiblePreferredStockMember 2020-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:CommonStockMember 2021-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:RetainedEarningsUnappropriatedMember 2021-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001838987 srt:ScenarioPreviouslyReportedMember 2021-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:RedeemableConvertiblePreferredStockMember 2021-12-31 0001838987 us-gaap:WarrantMember 2020-12-31 0001838987 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2020-12-31 0001838987 cslr:SimpleAgreementForFutureEquityMember 2020-12-31 0001838987 us-gaap:WarrantMember 2021-12-31 0001838987 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2021-12-31 0001838987 cslr:SimpleAgreementForFutureEquityMember 2021-12-31 0001838987 cslr:SeriesBWarrantsMember us-gaap:RedeemableConvertiblePreferredStockMember 2020-12-31 0001838987 cslr:SeriesCWarrantsMember us-gaap:RedeemableConvertiblePreferredStockMember 2020-12-31 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember 2020-12-31 0001838987 cslr:SeriesDTrancheAWarrantsMember us-gaap:RedeemableConvertiblePreferredStockMember 2020-12-31 0001838987 cslr:SeriesDTrancheBWarrantsMember us-gaap:RedeemableConvertiblePreferredStockMember 2020-12-31 0001838987 cslr:SeriesBWarrantsMember us-gaap:RedeemableConvertiblePreferredStockMember 2021-12-31 0001838987 cslr:SeriesCWarrantsMember us-gaap:RedeemableConvertiblePreferredStockMember 2021-12-31 0001838987 us-gaap:RedeemableConvertiblePreferredStockMember 2021-12-31 0001838987 cslr:SeriesDTrancheAWarrantsMember us-gaap:RedeemableConvertiblePreferredStockMember 2021-12-31 0001838987 cslr:SeriesDTrancheBWarrantsMember us-gaap:RedeemableConvertiblePreferredStockMember 2021-12-31 0001838987 cslr:TwoThousandNineteenConvertibleNotesMember 2020-12-31 0001838987 cslr:TwoThousandTwentyAConvertibleNotesMember 2020-12-31 0001838987 cslr:TwoThousandTwentyOneAConvertibleNotesMember 2020-12-31 0001838987 cslr:TwoThousandNineteenConvertibleNotesMember 2021-12-31 0001838987 cslr:TwoThousandTwentyAConvertibleNotesMember 2021-12-31 0001838987 cslr:TwoThousandTwentyOneAConvertibleNotesMember 2021-12-31 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:CommonStockMember 2022-06-30 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:RetainedEarningsUnappropriatedMember 2022-06-30 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0001838987 srt:ScenarioPreviouslyReportedMember 2022-06-30 0001838987 srt:ScenarioPreviouslyReportedMember us-gaap:RedeemableConvertiblePreferredStockMember 2022-06-30 iso4217:USD utr:Year shares pure iso4217:USD shares cslr:SEGMENT cslr:CUSTOMER cslr:SUPPLIER utr:Y false 0001838987 CA 8-K 2024-01-04 Complete Solaria, Inc. DE 001-40117 93-2279786 45700 Northport Loop East Fremont 94538 510 270-2507 false false false false Common Stock, par value $0.0001 per share CSLR NASDAQ Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share CSLRW NASDAQ true false 2135454 60000000 2844550 0.62 1000 34505000 2074000 1 3000 0.7 0.3 6.0 0.8 0.764 4409000 5276000 27717000 9037000 13059000 4409000 10071000 4955000 55256000 23677000 70000 3907000 3476000 1758000 2182000 826000 72000 1330000 162032000 228183000 26403000 14474000 5190000 19830000 9347000 6397000 1890000 6820000 20403000 9507000 5407000 3852000 60114000 43003000 3214000 1681000 14152000 1129000 1481000 25204000 3434000 15510000 1274000 499000 122902000 47793000 0.0001 0.0001 13547943 19932429 19932429 9806143 9806143 3000 1000 190624000 34504000 27000 -85373000 -55896000 105281000 -21390000 228183000 26403000 66475000 68816000 29378000 46647000 40123000 17097000 19828000 28693000 12281000 21195000 25061000 10410000 6156000 5179000 3185000 13634000 5780000 3801000 40985000 36020000 17396000 -21157000 -7327000 -5115000 4986000 1712000 523000 5000 -1858000 -240000 -41000 -27996000 -9279000 -5679000 27000 3000 3000 -28023000 -9282000 -5682000 -1454000 -29477000 -9282000 -5682000 27000 -29450000 -9282000 -5682000 -1.24 -1.24 -0.77 -0.77 -0.58 -0.58 -0.07 -0.07 -1.31 -1.31 -0.77 -0.77 -0.58 -0.58 22524400 22524400 11990015 11990015 9760018 9760018 300000 700000 200000 1400000 0 0 13090720 22788000 1103289 0 180000 -40932000 0 -40752000 -13090720 -22788000 5751955 2000 22786000 0 0 22788000 0 0 6855244 2000 22966000 -40932000 0 -17964000 2800283 7419000 2322150 3661000 -1648783 -2330000 1648783 0 2330000 0 0 2330000 -137000 0 137000 0 0 137000 0 0 942500 0 84000 0 0 84000 0 0 109000 0 0 109000 0 0 0 -5682000 0 -5682000 3473650 8613000 2591893 0 2660000 -5682000 0 -3022000 -3473650 -8613000 2929165 0 8613000 0 0 8613000 0 0 9784409 2000 34239000 -46614000 0 -12373000 0 0 30000 0 17000 0 0 17000 0 0 42000 0 0 42000 0 0 15000 0 6000 0 0 6000 0 0 200000 0 0 200000 0 0 0 -9282000 0 -9282000 0 0 45000 0 265000 -9282000 0 -9017000 0 0 21734 0 0 0 0 0 0 0 9806143 -55896000 0 -21390000 2771551 11558000 0 0 0 0 0 0 6803550 52201000 8171662 60470000 0 0 2884550 0 27295000 0 0 27295000 0 0 3589000 0 0 3589000 0 0 335496 0 105000 0 0 105000 0 0 903000 0 0 903000 0 0 0 -29477000 0 -29477000 0 0 0 0 27000 27000 17746763 124229000 3220046 0 31892000 -29477000 27000 27000 -17746763 -124299000 10126286 1000 124228000 0 0 0 0 0 19932429 3000 190624000 -85373000 27000 105281000 1315287 6300000 2007556 14300000 127472 1000000 3105837 24900000 4426320 32800000 -29477000 -9282000 -5682000 -1454000 -28023000 -9282000 -5682000 -4810000 -1330000 -462000 3235000 433000 200000 109000 2074000 364000 337000 3631000 798000 100000 648000 463000 298000 5211000 330000 -24000 -336000 -50000 -1306000 -15000 1754000 468000 334000 9683000 4789000 2044000 4953000 3047000 1315000 -1600000 3038000 930000 15000 -19000 29000 1132000 3252000 3009000 -1062000 -1154000 2946000 2472000 617000 409000 157000 526000 -484000 1311000 -637000 1521000 17000 -25217000 -10995000 -6189000 -6296000 -31513000 -10995000 -6189000 9000 61000 1513000 1054000 523000 -4848000 3335000 -1063000 -584000 128000 6000 84000 3400000 1150000 510000 8600000 3600000 3274000 5000000 5501000 7239000 3987000 1431000 25000000 -9507000 100000 1500000 500000 31191000 16895000 6355000 27000 3040000 4837000 -418000 5276000 439000 857000 8316000 5276000 439000 -6000 162000 365000 150000 3589000 42000 137000 1330000 7420000 1754000 17000 120000 245000 1157000 1431000 11558000 27295000 52201000 7812000 60470000 300000 700000 200000 1400000 0 0 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td id="finb474289_6" style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(1)</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Organization </div></div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(a)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Description of Business </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Complete Solaria, Inc. (the “Company” or “Complete Solaria”) is a residential solar installer headquartered in Fremont, California, which was formed through Complete Solar Holding Corporation’s acquisition of The Solaria Corporation (“Solaria). </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Complete Solar, Inc. (“Complete Solar”) was incorporated in Delaware on February 22, 2010. Through February 2022, the Company operated as a single legal entity as Complete Solar, Inc. In February 2022, the Company implemented a holding company reorganization (the “Reorganization”) in which the Company created and incorporated Complete Solar Holding Corporation (“Complete Solar Holdings”). As a result of the Reorganization, Complete Solar Holdings became the successor entity to Complete Solar, Inc. The capitalization structure was not changed because of the Reorganization as all shares of Complete Solar, Inc common stock and preferred stock were exchanged on a one for one basis with shares of Complete Solar Holdings common stock and preferred stock. The Reorganization was accounted for as a change in reporting entity for entities under common control. The historical assets and liabilities of Complete Solar, Inc. are transferred to Complete Solar Holdings at their carrying value, and there is no change to net income, other comprehensive income, or any related per share amounts reported in the consolidated financial statements requiring retrospective application. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In October 2022, the Company entered into a business combination agreement, as amended on December 26, 2022 and January 17, 2023 (“Original Business Combination Agreement”) and as amended on May 26, 2023 (“Amended and Restated Business Combination Agreement”), with Jupiter Merger Sub I Corp., a Delaware corporation and a wholly owned subsidiary of Freedom Acquisition I Corp. (“FACT”) (“First Merger Sub”), Jupiter Merger Sub II LLC, a Delaware limited liability company and a wholly owned subsidiary of FACT (“Second Merger Sub”), Complete Solar Holding Corporation, a Delaware corporation, and Solaria, a Delaware corporation. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The transactions contemplated by the Amended and Restated Business Combination Agreement were consummated on July 18, 2023 (“Closing Date”). Following the consummation of the Merger on the Closing Date, FACT changed its name to “Complete Solaria, Inc.” </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As part of the transactions contemplated by the Amended and Restated Business Combination Agreement, FACT affected a deregistration under the Cayman Islands Companies Act and a domestication under Section 388 of the Delaware’s General Corporation Law (the “DGCL” or “Domestication”). On the Closing Date, following the Domestication, First Merger Sub merged with and into Complete Solaria, with Complete Solaria surviving such merger as a wholly owned subsidiary of FACT (the “First Merger”), and immediately following the First Merger, Complete Solaria merged with and into Second Merger Sub, with Second Merger Sub surviving as a wholly owned subsidiary of FACT (the “Second Merger”), and Second Merger Sub changed its name to CS, LLC, and immediately following the Second Merger, Solaria merged with and into a newly formed Delaware limited liability company and wholly-owned subsidiary of FACT and changed its name to The Solaria Corporation LLC (“Third Merger Sub”), with Third Merger Sub surviving as a wholly-owned subsidiary of FACT (the “Additional Merger”, and together with the First Merger and the Second Merger, the “Mergers”). </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In connection with the closing of the Mergers: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Each share of the Company’s capital stock, inclusive of shares converted from 2022 Convertible Notes, issued and outstanding immediately prior to the Closing (“Legacy Complete Solaria Capital Stock”) were cancelled and exchanged into an aggregate of 25,494,332 shares of Complete Solaria Common Stock. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">In July 2023, (i) Meteora Special Opportunity Fund I, LP (“MSOF”), Meteora Capital Partners, LP (“MCP”) and Meteora Select Trading Opportunities Master, LP (“MSTO”) (with MSOF, MCP, and </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:9%"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; line-height: normal;">MSTO collectively as “Meteora”); (ii) Polar Multi-Strategy Master Fund (“Polar”), and (iii) Diametric True Alpha Market Neutral Master Fund, LP, Diametric True Alpha Enhanced Market Neutral Master Fund, LP, and Pinebridge Partners Master Fund, LP (collectively, “Sandia”) (together, the “FPA Funding PIPE Investors”) entered into separate subscription agreements (the “FPA Funding Amount PIPE Subscription Agreements”) pursuant to which, the FPA Funding PIPE Investors subscribed for on the Closing Date, an aggregate of 6,300,000 shares of FACT Class A Ordinary Shares, less, in the case of Meteora, 1,161,512 FACT Class A Ordinary Shares purchased by Meteora separately from third parties through a broker in the open market (“Recycled Shares”) in connection with the Forward Purchase Agreements (“FPAs”). Subsequent to the Closing Date, Complete Solaria entered into an additional FPA Funding PIPE Subscription Agreement with Meteora, to subscribe for and purchase, and Complete Solaria agreed to issue and sell, an aggregate of 420,000 shares of Complete Solaria Common Stock. The Company issued shares of Complete Solaria Common Stock underlying the FPAs as of the latter of the closing of the Mergers or execution of the FPAs. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">All certain investors (the “PIPE Investors”) purchased from the Company an aggregate of 1,570,000 shares of Complete Solaria Common Stock (the “PIPE Shares”) for a purchase price of $10.00 per share, for aggregate gross proceeds of $15.7 million (the “PIPE Financing”), including $3.5 million that was funded prior to the Closing Date, pursuant to subscription agreements (the “Subscription Agreements”). At the time of the PIPE Financing, Complete Solaria issued an additional 60,000 shares to certain investors as an incentive to participate in the PIPE Financing. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">On or around the Closing Date, pursuant to the New Money PIPE Subscription Agreements, certain investors affiliated with the New Money PIPE Subscription Agreements (“New Money PIPE Investors”) agreed to subscribe for and purchase, and Complete Solaria agreed to issue and sell to the New Money PIPE Investors an aggregate of 120,000 shares of Complete Solaria Common Stock for a purchase price of $5.00 per share, for aggregate gross proceeds of $0.6 million. Pursuant to its New Money PIPE Subscription Agreement, Complete Solaria issued an additional 60,000 shares of Complete Solaria Common Stock in consideration of certain services provided by it in the structuring of its FPA and the transactions described therein. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Subsequent to the Closing, Complete Solaria issued an additional 193,976 shares of Complete Solaria Common Stock to the sponsors for reimbursing sponsors’ transfer to certain counterparties and issued an additional 150,000 shares of Complete Solaria Common Stock to an FPA investor for services provided in connection with the Mergers. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">In March 2023, holders of 23,256,504 of the originally issued 34,500,000 FACT Class A Ordinary shares exercised their rights to redeem those shares for cash, and immediately prior to the Closing there were 11,243,496 FACT Class A Ordinary Shares that remained outstanding. At the Closing, holders of 7,784,739 shares of Class A common stock of FACT exercised their rights to redeem those shares for cash, for an aggregate of approximately $82.2 million which was paid to such holders at Closing. The remaining FACT Class A Ordinary Share converted, on a one-for-one basis, into one share of Complete Solaria Common Stock. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Each issued and outstanding FACT Class B Ordinary Share converted, on a one-for-one basis, into one share of Complete Solaria Common Stock. </div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In November 2022, Complete Solar Holdings acquired Solaria (as described in Note 4 – Business Combination) and changed its name to Complete Solaria, Inc. On August 18, 2023, the Company entered into a Non-Binding Letter of Intent to sell certain of Complete Solaria’s North American solar panel assets to Maxeon, Inc. (“Maxeon”). In October 2023, the Company completed the sale of its solar panel business to Maxeon. The disposition met the criteria for held for sale and discontinued operations classification. Refer to Note 1(b) – Divestiture and Note 5 – Divestiture. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(b)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Divestiture </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On August 18, 2023, the Company entered into a Non-Binding Letter of Intent to sell certain of Complete </div><div></div><div><div style="line-height:normal;background-color:white;display: inline;"></div></div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Solaria’s North American solar panel assets to Maxeon. Subsequent to the execution of the Non-Binding Letter of Intent, on September 20, 2023, the Company and Maxeon entered into an Asset Purchase Agreement (the “Disposal Agreement”) for the sale of certain assets, inclusive of certain intellectual property and customer contracts, to Maxeon. On October 6, 2023, the Company completed the sale of certain of Complete Solaria’s North American solar panel assets, inclusive of certain intellectual property and customer contracts, to Maxeon, pursuant to the terms of the Disposal Agreement. Under the terms of the Disposal Agreement, Maxeon agreed to acquire certain assets and employees of Complete Solaria, for an aggregate purchase price consisting of 1,100,000 shares of Maxeon common stock. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">This divestiture represents a strategic shift in Complete Solaria’s business and qualifies as held for sale and as a discontinued operation. As a result, the Company classified the results of its solar panel business in discontinued operations in its consolidated statements of operations and comprehensive income (loss) for all periods presented. The cash flows related to discontinued operations have been segregated and are included in the consolidated statements of cash flows for all periods presented. Unless otherwise noted, discussion within the notes to the consolidated financial statements relates to continuing operations only and excludes the historical activities of the North American panel business. See Note 5 – Divestiture for additional information. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(c)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Liquidity and Going Concern </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Since inception, the Company has incurred recurring losses and negative cash flows from operations. The Company incurred net losses of $29.5 million, $9.2 million and $5.6 million during the years ended December 31, 2022, 2021 and 2020, respectively, and had an accumulated deficit of $85.4 million as of December 31, 2022. The Company had cash and cash equivalents of $4.4 million as of December 31, 2022. Historically, the Company’s activities have been financed through private placements of equity securities and debt. The Company expects to incur significant operating expenses as it continues to grow its business. The Company believes that its operating losses and negative operating cash flows will continue into the foreseeable future. The Company’s history of recurring losses, negative operating cash flows since inception and the need to raise additional funding to meet its obligations and finance its operations raise substantial doubt about the Company’s ability to continue as a going concern. The Company’s ability to continue as a going concern requires that the Company obtains sufficient funding to meet its obligations and finance its operations. These actions could materially impact the Company’s business, results of operations and future prospects. While the Company has been able to raise multiple rounds of financing, there can be no assurance that in the event the Company requires additional financing, such financing will be available on terms that are favorable, or at all. Failure to generate sufficient cash flows from operations, raise additional capital or reduce certain discretionary spending would have a material adverse effect on the Company’s ability to achieve its intended business objectives. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Therefore, there is substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the financial statements are issued. The accompanying financial statements have been prepared assuming the Company will continue to operate as a going concern, which contemplates the realization of assets and settlement of liabilities in the normal course of business. They do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from uncertainty related to its ability to continue as a going concern. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(d)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Basis of Presentation </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The financial statements and accompanying notes have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. </div> 25494332 6300000 1161512 420000 1570000 10 15700000 3500000 60000 120000 5 600000 60000 193976 150000 23256504 34500000 11243496 7784739 82200000 1 1 1100000 29500000 9200000 5600000 85400000 4400000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(2)</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Summary of Significant Accounting Policies </div></div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(a)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Use of Estimates </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The <div style="display:inline;">preparation</div> of the Company’s financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses, as well as related disclosure of contingent assets and liabilities. Significant estimates and assumptions made by management include, but are not limited to, the determination of: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">The allocation of the transaction price to identified performance obligations; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Fair value of warrant liabilities; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">The fair value of assets acquired and liabilities assumed for business combination; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">The reserve methodology for inventory obsolescence; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">The reserve methodology for product warranty; </div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">To the extent that there are material differences between these estimates and actual results, the Company’s financial condition or operating results will be affected. The Company bases its estimates on past experience and other assumptions that the Company believes are reasonable under the circumstances, and the Company evaluates these estimates on an ongoing basis. The Company has assessed the impact and are not aware of any specific events or circumstances that required an update to the Company’s estimates and assumptions or materially affected the carrying value of the Company’s assets or liabilities as of the date of issuance of this report. These estimates may change as new events occur and additional information is obtained. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(b)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Supply Chain Constraints and Risk; <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company relies on a very small number of suppliers of solar energy systems and other equipment. If any of Company’s suppliers was unable or unwilling to provide the Company with contracted quantities in a timely manner at prices, quality levels and volumes acceptable to the Company, the Company would have very limited alternatives for supply, and the Company may not be able find suitable replacements for the Company’s customers, or at all. Such an event could materially adversely affect the Company’s business, prospects, financial condition and results of operations. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The ongoing <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic has resulted and may continue to result in widespread adverse effects on the global and U.S. economies. Ongoing government and business responses to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19,</div> along with <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> variants and the resurgence of related disruptions, could have a continued material adverse impact on economic and market conditions and trigger a period of continued global and U.S. economic slowdown. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In addition, the global supply chain and the Company’s industry have experienced significant disruptions in recent periods. The Company have seen supply chain challenges and logistics constraints increase, including shortages of panels, inverters, batteries and associated component parts for inverters and solar energy systems available for purchase. In certain cases, this has caused delays in critical equipment and inventory, longer lead times, and has resulted in cost volatility. These shortages and delays can be attributed in part to the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic and resulting government action, broader macroeconomic conditions, and have been exacerbated by the ongoing conflict in Russia and Ukraine. While the Company believes that a majority of the Company’s suppliers have secured sufficient supply to permit them to continue delivery and installations through the end of 2023, if these shortages and delays persist into 2024, they could adversely affect the timing of when battery energy storage systems can be delivered and installed, and when (or if) the Company can begin to generate revenue from those systems. In addition, the Company has experienced and is experiencing varying levels of volatility in costs of equipment and labor resulting in part from disruptions caused by general global economic conditions, including inflationary pressures and the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic. </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company cannot predict the full effects these events will have on the Company’s business, cash flows, liquidity, financial condition and results of operations at this time due to numerous uncertainties. In the event the Company is unable to mitigate the impact of delays or price volatility in solar energy systems, raw materials, and freight, it could materially adversely affect the Company’s business, prospects, financial condition and results of operations. For additional information on risk factors that could impact the Company’s results, please refer to “Risk <div style="display:inline;">Factors</div>” located elsewhere in this prospectus. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(c)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Segment Information </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company conducts its business in one operating segment that provides custom solar solutions through a standardized platform to its residential solar providers and companies to facilitate the sale and installation of solar energy systems under a single product group. The Company’s Chief Executive Officer (“CEO”) is the Chief Operating Decision Maker (“CODM”). The CODM allocates resources and makes operating decisions based on financial information presented on a consolidated basis. The profitability of the Company’s product group is not a determining factor in allocating resources and the CODM does not evaluate profitability below the level of the consolidated company. All the Company’s long-lived assets are maintained in the United States of America. Disaggregated revenue by primary geographical market for the Company’s single segment is included in the discussion of revenue recognition within this Note 2, below. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(d)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Concentration of Risks </div></div></div></td></tr></table><div style="margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Concentration of credit risk </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. The Company’s cash and cash equivalents are on deposit with major financial institutions. Such deposits may be in excess of insured limits. The Company believes that the financial institutions that hold the Company’s cash are financially sound, and accordingly, minimum credit risk exists with respect to these balances. The Company has not experienced any losses due to institutional failure or bankruptcy. The Company performs credit evaluations of its customers and generally does not require collateral for sales on credit. The Company reviews accounts receivable balances to determine if any receivables will potentially be uncollectible and includes any amounts that are determined to be uncollectible in the allowance for doubtful accounts. As of December 31, 2022, three single customers had outstanding balances that represented 27%, 18%, and 14%, respectively, of the total accounts receivable balance, compared to December 31, 2021, as a <span style="-sec-ix-hidden:hidden96298528">single</span> customer had an outstanding balance that represented 50%, of the total accounts receivable balance. </div><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Concentration of customers </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company defines major customers as those customers who generate revenues that exceed 10% of the Company’s annual net revenues. For the years ended December 31, 2022, 2021 and 2020, one customer represented 47%, 63% and 81% of gross revenues, respectively. </div><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Concentration of suppliers </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For the year ended December 31, 2022, three suppliers represented 74% of the Company’s inventory purchases. For the year ended December 31, 2021, four supplier represented 87% of the Company’s inventory purchases. For the year ended December 31, 2020, two suppliers represented 89% of the Company’s inventory purchases. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(e)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Cash and Cash Equivalents </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="display:inline;">The</div> Company considers all highly liquid securities that mature within three months or less from the original date of purchase to be cash equivalents. The Company maintains the majority of its cash balances with </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">commercial banks in interest bearing accounts. Cash and cash equivalents include cash held in checking and savings accounts and money market accounts consisting of highly liquid securities with original maturity dates of three months or less from the original date of purchase. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(f)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Restricted Cash </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company classifies all cash for which usage is limited by contractual provisions as restricted cash. Restricted cash balance as of December 31, 2022 and 2021, was $3.9 million, and zero, respectively. The restricted cash consists of deposits in money market accounts, which is used as cash collateral backing letters of credit related to customs duty authorities’ requirements. The Company has presented these balances under restricted cash, as a long term asset, in the consolidated balance sheets. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Total cash, cash equivalents and restricted cash is presented in the table below (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:82%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash and cash equivalents</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,409</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,276</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Restricted cash</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,907</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total cash, cash equivalents and restricted cash</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,316</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,276</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(g)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Accounts Receivable, Net </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Accounts receivable are recorded at the invoiced amount and do not bear interest. The Company maintains an allowance for doubtful accounts for estimated losses inherent in its accounts receivable portfolio. In establishing the required allowance, management considers historical losses adjusted to take into account current market conditions and customers’ financial condition, the amount of receivables in dispute, the current receivables aging and customer payment patterns. Account balances are written off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. Recoveries of accounts receivable previously written off are recorded when received. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes the allowance for doubtful accounts as of December 31, 2022, 2021, and 2020 (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:75%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Balance at beginning of period</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,569</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,288</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,965</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Provision charged to earnings</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><span style="-sec-ix-hidden:hidden96297041">(2,243</span></td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(364</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(337</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Amounts written off, recoveries and other adjustments</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">83</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Balance at end of period</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4,812</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,569</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,288</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company does <div style="display:inline;">not</div> have any <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">off-balance</div> sheet credit exposure related to its customers. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(h)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Inventories </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Inventories consists of solar panels and the components of solar energy systems which the Company classifies as finished goods. Costs are computed under the average cost method. The Company identifies inventory which is considered obsolete or in excess of anticipated demand based on a consideration of marketability and product life cycle stage, component cost trends, demand forecasts, historical revenues, and assumptions about future demand and market conditions to state inventory at the lower of cost or net realizable value. </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(i)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Revenue Recognition </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Revenue is recognized when a customer obtains control of promised products and services and the Company has satisfied its performance obligations. The amount of revenue recognized reflects the consideration which the Company expects to be entitled to receive in exchange for the products and services. To achieve this core principle, the Company applies the following five steps: </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Step 1. Identification of the contract(s) with a customer; </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Step 2. Identification of the performance obligations in the contracts(s); </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Step 3. Determination of the transaction price; </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Step 4. Allocation of the transaction price to the performance obligations; </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Step 5. Recognition of the revenue when, or as, the Company satisfies a performance obligation. </div><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Service Revenues – Solar Energy System Installations </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company generates revenue primarily from the design and installation of a solar energy system and performing post-installation services. The Company’s contracts with customers include three primary contract types: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Cash agreements </div></div>– The Company contracts directly with homeowners who purchase the solar energy system and related services from the Company. Customers are invoiced on a billing schedule, where the majority of the transaction price is due upon installation with an additional payment due when the system passes inspection by the authority having jurisdiction. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Financing partner agreements </div></div>– In its financing partner agreements, the Company contracts directly with homeowners for the purchase of the solar energy system and related services. The Company refers the homeowner to a financing partner to finance the system, and the homeowner makes payments directly to the financing partner. The Company receives consideration from the financing partner on a billing schedule where the majority of the transaction price is due upon installation with an additional payment due when the system passes inspection by the authority having jurisdiction. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Power purchase agreements </div></div>– The Company contracts directly with a distribution partner to perform the solar energy system installation, and the homeowner will finance the system through a power purchase agreement, which is signed with the Company’s distribution partner. The Company considers the distribution partner to be its customer, as the Company does not contract directly with the homeowner. The Company receives consideration from the distribution partner on a billing schedule where the majority of the transaction price is due upon installation with an additional payment due when the system passes inspection by the authority having jurisdiction. </div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In each of the Company’s customer contract types, the Company’s revenue consists of two performance obligations, which include the performance of the installation of the solar energy system and post-installation services. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Installation includes the design of a solar energy system, the delivery of the components of the solar energy system (i.e., photovoltaic system, inverter, battery storage, etc.), installation services and services facilitating the connection of the solar energy system to the power grid. The Company accounts for these services as inputs to a combined output, resulting in a single service-based performance obligation. The Company recognizes revenue upon the completion of installation services, which occurs upon the transfer of control of the solar energy system and title of the related hardware components to the homeowner or distribution partner. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Post-installation services consist primarily of administrative services and customer support, which the Company performs between the completion of installation and the date of inspection of the solar energy system by the authority having jurisdiction. The Company recognizes revenue at a point in time, which is when the inspection occurs. </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As the Company’s contracts with customers contain multiple performance obligations, the transaction price is allocated to each performance obligation based on its standalone selling price. The Company generally determines the standalone selling price based on the estimated costs incurred in the delivery of each performance obligation, relative to the total costs to be incurred under the contract. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company records deferred revenue for amounts invoiced that are not subject to refund upon termination. In certain contracts with customers, the Company arranges for a third-party financing partner to provide financing to the customer. The Company collects upfront from the financing partner and the customer will provide installment payments to the financing partner. The Company records revenue in the amount received from the financing partner, net of any financing fees charged to the homeowner, which the Company considers to be a customer incentive. None of the Company’s contracts contain a significant financing component. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company guarantees to customers certain specified minimum solar energy production output of the solar energy system for <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-years</div> after the installation. The Company monitors the solar energy systems to determine whether these specified minimum outputs are being achieved. The Company will issue payments to customers if the output falls below contractually stated thresholds over the performance guarantee period. Revenue is recognized to the extent it is probable that a significant reversal of such revenue will not occur. </div><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Revenues – Software Enhanced Services </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company generates revenue from software enhanced services through the provision of design and proposal services. The Company’s customers for design services are solar installers who leverage the Company’s expertise and software platforms to obtain structural letters, computer aided designs and electrical reviews. The Company charges the customer a per design fixed fee for each type of service that is performed, and the Company recognizes revenue in the period the services are performed. The customer contracts contain the customer right to terminate the contract each month and are therefore enforceable only for the contracted services purchased each month. Revenue is recognized for design services in the month the services are performed. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company’s customers for proposal services for solar sales organizations who contract with the Company to develop proposals for their potential residential solar customers. The Company generates proposals for the customer using the HelioQuote platform. Customers may purchase a fixed number of proposals for a given month or may contract on a pay as you go basis, and the performance obligation is defined by the number of proposals purchased by the customer each month. The customer contracts contain the customer right to terminate the contract each month and are therefore enforceable only for the services purchased each month. Revenue is recognized for proposal services in the month the services are performed. </div><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Warranties </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company typically provides a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-year</div> warranty on its solar energy system installations, which provides assurance over the workmanship in performing the installation, including roof leaks caused by the Company’s performance. For solar panel sales recognized prior to the Disposal Transaction, the Company provides a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">30-year</div> warranty that the products will be free from defects in material and workmanship. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">When the revenues are recognized for the solar energy systems installations services, the Company accrues liabilities for the estimated future costs of meeting its warranty obligations. The Company makes and revises these estimates based primarily on the volume of new sales that contain warranties, historical experience with and projections of warranty claims, and estimated solar energy system and panel replacement costs. The Company records a provision for estimated warranty expenses in cost of revenues within the accompanying consolidated statements of operations and comprehensive loss. </div><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Shipping and handling costs and certain taxes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Revenues are recognized net of taxes collected from customers and remitted to governmental authorities. Shipping and handling costs associated with outbound freight are accounted for as a fulfillment cost and are included in both revenues and cost of revenues in the accompanying consolidated statements of operations and comprehensive loss. </div><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Deferred revenue </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company typically invoices its customers upon completion of set milestones, generally upon installation of the solar energy system with the remaining balance invoiced upon passing final building inspection. Standard payment terms to customers range from 30 to 60 days. When the Company receives consideration, or when such consideration is unconditionally due, from a customer prior to delivering goods or services to the customer under the terms of a customer agreement, the Company records deferred revenue. As installation projects are typically completed within <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">12-months,</div> the Company’s deferred revenue is reflected in current liabilities in the accompanying consolidated balance sheets. The amount of revenue recognized during the years ended December 31, 2022 and 2021 that was included in deferred revenue at the beginning of each period was $3.9 million and $4.5 million, respectively. </div><div style="margin-top: 18pt; margin-bottom: 0pt; text-indent: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Disaggregation of revenue </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Refer to the table below for the Company’s revenue recognized by product and service type (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:73%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Years Ended December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Solar energy system installations</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">62,896</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">66,958</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">29,378</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Software enhanced services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,579</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,858</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total revenue</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">66,475</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">68,816</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">29,378</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For the years ended December 31, 2022, 2021 and 2020, all revenue recognized was generated in the United States. </div><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Remaining performance obligations </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company has elected the practical expedient not to disclose remaining performance obligations for contracts that are less than one year in length. As of December 31, 2022, the Company has deferred $1.3 million associated with a long-term service contract, which will be recognized evenly through 2028. </div><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Incremental costs of obtaining customer contracts </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Incremental costs of obtaining customer contracts consist of sales commissions, which are costs paid to third-party vendors who source residential customer contracts for the sale of solar energy systems by the Company. The Company defers sales commissions and recognizes expense in accordance with the timing of the related revenue recognition. Amortization of deferred commissions is recorded as sales commissions in the accompanying consolidated statements of operations and comprehensive loss. As of December 31, 2022 and December 31, 2021, deferred commissions were $2.8 million and $4.8 million, respectively, which included in prepaid expenses and other current assets in the accompanying consolidated balance sheets. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(j)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Property and Equipment, Net </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Property and equipment are stated at cost less accumulated depreciation and amortization. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gain or loss is included in the current period. Repair and maintenance costs are expensed as </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">incurred. Depreciation and amortization are calculated using the straight-line method over the following estimated useful lives of the assets: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:86%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Useful Lives</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Manufacturing equipment</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">1-3 years</div></td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Developed software</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5 years</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Furniture &amp; equipment</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">3-5</div> years</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Leasehold improvements</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">3-5 years</div></td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(k)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Internal-Use</div> Software </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company capitalizes costs to develop its <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">internal-use</div> software when preliminary development efforts are successfully completed, management has authorized and committed project funding, it is probable that the project will be completed, and the software will be utilized as intended. These costs include personnel and related employee benefits and expenses for employees who are directly associated with and who devote time to software projects, and external direct costs of materials and services consumed in developing or obtaining software. Costs incurred prior to meeting these criteria, together with costs incurred for training and maintenance, are expensed as incurred. Costs incurred for enhancements that are expected to provide additional material functionality are capitalized and amortized over the estimated useful life of the related upgrade. During the years ended December 31, 2022, 2021 and 2020, the Company capitalized $1.5 million, $1.1 million and $0.5 million, respectively, of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">internal-use</div> software development costs. The remaining unamortized balance as of December 31, 2022 and December 31, 2021 of $2.7 million and $1.7 million, respectively, is included in property and equipment, net within the accompanying consolidated balance sheets. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(l)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Cost of Revenues </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Cost of revenues includes actual cost of material, labor and related overhead incurred for revenue-producing units, and includes associated warranty costs, freight and delivery costs, depreciation, and amortization of internally developed software. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(m)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Advertising and Promotional Expenses </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="display:inline;">Advertising</div> and promotional costs are expensed as incurred and included in sales and marketing expense in the accompanying consolidated statements of operations and comprehensive loss. Advertising costs were not material for the years ended December 31, 2022, 2021 and 2020.. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(n)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Income Taxes </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Income taxes are accounted for under the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">asset-and-liability</div></div> method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company recognizes the effect of income tax positions only if those positions are more likely than not to be sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company recognizes accrued interest and penalties, if any, related to unrecognized tax benefits in income tax provision. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(o)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Foreign Currency </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company’s reporting currency is the US dollar. The functional currency for each of the Company’s foreign subsidiaries is the local currency, as it is the monetary unit of account of the principal economic </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">environments in which the Company’s foreign subsidiaries operate. Assets and liabilities of the foreign subsidiaries are translated at the current exchange rate as of the end of the period, and revenue and expenses are translated at the average exchange rates in effect during the period. The gain or loss resulting from the process of translating foreign currency financial statements into US dollar financial statements is accounted for as a foreign currency cumulative translation adjustment and is reported as a component of accumulated other comprehensive loss. Foreign currency transaction gains and losses resulting from transactions denominated in a currency other than the functional currency are recognized in Other Income (expense), net in the consolidated statements of operations and comprehensive loss. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(p)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Comprehensive Loss </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Comprehensive loss consists of two components, net loss and other comprehensive income (loss), net. The Company’s other comprehensive loss consists of foreign currency translation adjustments that result from the consolidation of its foreign entities and is reported net of tax effects. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(q)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Impairment of Long-Lived Assets </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Long-lived assets, such as property and equipment, ROU assets, and intangible assets subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require a long-lived asset or asset group be tested for possible impairment, the Company first compares undiscounted cash flows expected to be generated by that asset or asset group to its carrying value. If the carrying value of the long-lived asset or asset group is not recoverable on an undiscounted cash flow basis, an impairment is recognized to the extent that the carrying value exceeds its fair value. Fair value is determined through various valuation techniques including discounted cash flow models, and quoted market values, as considered necessary. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">There were no impairment charges for the years ended December 31, 2022, 2021 and 2020. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(r)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Business Combinations </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company allocates the fair value of purchase consideration to the tangible assets acquired, liabilities assumed, and intangible assets acquired based on their estimated fair values. The excess of the fair value of purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. Such valuations require management to make significant estimates and assumptions, especially with respect to intangible assets. Significant estimates in valuing certain intangible assets include, but are not limited to, future expected cash flows from customer relationships, acquired technology, trade names from a market participant perspective, useful lives and discount rates. Management’s estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates. During the measurement period, which is one year from the acquisition date, the Company may record adjustments to the assets acquired and liabilities assumed, with the corresponding offset to goodwill. Upon the conclusion of the measurement period, any subsequent adjustments are recorded in the consolidated statements of operations and comprehensive loss. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(s)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Intangibles Assets, Net </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Intangible assets are recorded at the cost, less accumulated amortization. Amortization is recorded using the straight-line method. All intangible assets that have been determined to have definite lives are amortized over their estimated useful life as indicated below: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:68%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:78%"></td> <td style="vertical-align:bottom;width:14%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Estimated Useful Life</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Assembled workforce</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2 years</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(t)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Deferred Transaction Costs </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Deferred transaction costs, which consist of direct incremental legal, consulting and accounting fees related to the merger with Freedom, are capitalized until they are recorded against proceeds upon the consummation of the transaction. As of December 31, 2022, the Company has recorded $1.1 million of deferred transaction costs in other noncurrent assets on the consolidated balance sheets. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(u)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Redeemable Convertible Preferred Stock Warrants </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company has issued redeemable convertible preferred stock warrants exercisable into shares of the Company’s redeemable convertible preferred stock. The Company classifies warrants to purchase shares of convertible preferred stock that are redeemable or include an antidilution feature as liabilities. Such redeemable convertible preferred stock warrants are measured and recognized at fair value, and subject to remeasurement at each balance sheet date. At the end of each reporting period, changes in fair value during the period are recognized as a component of other income (expense), net in the accompanying consolidated statements of operations and comprehensive loss. The Company will continue to adjust the redeemable convertible preferred stock warrant liability for changes in the fair value until the earlier of the exercise or expiration of such warrants or the completion of a liquidation event, including completion of an initial public offering (“IPO”), at which time all such redeemable convertible preferred stock warrants will be converted into warrants to purchase shares of common stock, and the liability will be reclassified to additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital. See Note 10 – Fair Value Measurements for details on the valuation methodology. Also see Note 14 – Warrants. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(v)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Stock-Based Compensation </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company recognizes stock-based compensation expense over the requisite service period on a straight-line basis for all stock-based payments that are expected to vest to employees, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-employees</div> and directors, including grants of employee stock options and other stock-based awards. Equity-classified awards issued to employees, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-employees</div> such as consultants and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-employee</div> directors are measured at the grant-date fair value of the award. Forfeitures are recognized as they occur. For accounting purposes, the Company estimates grant-date fair value of stock options using the Black-Scholes option pricing model. The <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Black-Scholes</div> option pricing model requires the input of highly subjective assumptions, including the fair value of the underlying common stock prior to the Mergers, the expected term of the option the expected volatility of the price of the Company’s common stock and expected dividend yield. The Company determines these inputs as follows: </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Expected Term</div></div>—Expected term represents the period that the Company’s stock-based awards are expected to be outstanding and is determined using the simplified method. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Expected Volatility</div></div>—Expected volatility is estimated by studying the volatility of comparable public companies for similar terms. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Expected Dividend</div></div>—The Black-Scholes valuation model calls for a single expected dividend yield as an input. The Company has never paid dividends and has no plans to pay dividends. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Risk-free Interest Rate</div></div>—The Company derives the risk-free interest rate assumption from the U.S. Treasury’s rates for the U.S. Treasury <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">zero-coupon</div> bonds with maturities similar to those of the expected term of the awards being valued. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Forfeitures</div></div>—The Company recognizes forfeitures as they occur. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(w)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Fair Value Measurements </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible. The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market. </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Level 1 inputs: Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Level 2 inputs: Other than quoted prices included in Level 1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Level 3 inputs: Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at the measurement date. </div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company’s financial instruments include cash, accounts receivable, accounts payable, accrued expenses, convertible notes, SAFE agreements, notes payable, common stock warrants and redeemable convertible preferred stock warrants. The carrying amounts of cash, accounts receivable, accounts payable, accrued expenses, convertible notes and notes payable approximate their fair value because of their short- term nature (classified as level 1). The Company measures and discloses the fair value of SAFE agreements, common stock warrants and redeemable convertible preferred stock warrants under the provisions of ASC Topic 820—Fair Value Measurement (classified as level 3). </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(x)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Net Loss Per Share </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company computes net loss per share in accordance with ASC 260, Earnings Per Share (“ASC 260”). Basic net loss per share is measured as the income or loss available to common stockholders divided by the weighted-average common shares outstanding for the period. Diluted net loss per share presents the dilutive effect on a per-share basis from the potential exercise of options and/or warrants. The potentially dilutive effect of options or warrants are computed using the treasury stock method. Securities that potentially have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the diluted loss per share calculation. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(y)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Convertible Debt Embedded Derivative Liabilities </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company evaluates the embedded conversion feature within its convertible debt instruments under ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-15</div> and ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40</div> to determine if the conversion feature meets the definition of a liability and, if so, whether to bifurcate the conversion feature and account for it as a separate derivative liability. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-valued</div> at each reporting date, with changes in the fair value reported in the consolidated statements of operations and comprehensive loss. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the consolidated balance sheets as current or <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> based on whether <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">net-cash</div> settlement of the derivative instrument could be required within twelve months after the balance sheet date. The derivative is subject to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-measurement</div> at the end of each reporting period, with changes in fair value recognized as a component of other income (expense), net, in the consolidated statements of operations and comprehensive loss. The Company’s embedded derivative liabilities were extinguished in the first quarter of 2022. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(z)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Leases </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Effective January 1, 2021, the Company early adopted Accounting Standards Update (“ASU”) <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2016-02,</div> Leases (Topic 842), as amended (“ASC 842”). The Company determines if a contract is a lease or contains a lease at the inception of the contract and reassesses that conclusion if the contract is modified. The Company’s lease agreements generally contain lease and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-lease</div> components. Payments under lease </div><div></div><div><div style="line-height:normal;background-color:white;display: inline;"></div></div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">arrangements are primarily fixed. The Company combines lease and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-lease</div> components and accounts for them together as a single lease component. All leases are assessed for classification as an operating lease or a finance lease. Operating lease <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> (“ROU”) assets are presented separately on the Company’s consolidated balance sheets. Operating lease liabilities are separated into a current portion and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> portion and are presented separately on the Company’s consolidated balance sheets. The Company does not have finance lease ROU assets or liabilities. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent its obligation to make lease payments arising from the lease. The Company does not obtain and control its right to use the identified asset until the lease commencement date. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company’s lease liabilities are recognized at the later of January 1, 2021 and applicable lease commencement date based on the present value of the lease payments required to be paid over the lease term. Because the rate implicit in the lease is not readily determinable, the Company generally uses its incremental borrowing rate to discount the lease payments to present value. The estimated incremental borrowing rate is derived from information available at the lease commencement date. The Company’s lease terms include periods under options to extend or terminate the lease when it is reasonably certain that we will exercise that option. We generally use the base, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cancelable,</div> lease term when determining the lease assets and liabilities. The Company also records a corresponding <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> asset at the later of January 1, 2021 and applicable lease commencement date, which is calculated based on the amount of the lease liability, adjusted for any advance lease payments made, lease incentives received, and initial direct costs incurred. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Right-of-use</div></div> assets are subject to evaluation for impairment or disposal on a basis consistent with other long-lived assets. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company has elected, for all classes of underlying assets, not to recognize ROU assets and lease liabilities for leases with a term of twelve months or less. Lease cost for short-term leases is recognized on a straight-line basis over the lease term. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Before the adoption of ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-02</div> on January 1, 2021, the Company categorizes leases at their inception as either operating or capital leases, with the Company’s current lease portfolio only consisting of operating leases for office spaces. In certain lease agreements, it may receive rent holidays and other incentives. For operating leases, the Company recognizes lease costs on a straight-line basis once control of the space is achieved, without regard to deferred payment terms such as rent holidays that defer the commencement date of required payments. Additionally, incentives received are treated as a reduction of costs over the term of the agreement. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(aa)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Recently Adopted Accounting Pronouncements </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In December 2019, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-12,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</div></div>. ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-12</div> removes certain exceptions to the general principles in Topic 740 and clarifies and amends existing guidance to improve consistent application. ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-12</div> will be effective for public entities for interim and annual periods beginning after December 15, 2020, with early adoption permitted. ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-12</div> will be effective for private entities for annual periods beginning after December 15, 2021, and interim periods beginning after December 15, 2020, with early adoption permitted. The Company adopted ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-12</div> under the private company transition guidance beginning January 1, 2022, and the adoption did not have an impact on the Company’s consolidated financial statements. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In May 2021, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-04,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Earnings Per Share (Topic 260), Debt—Modifications and Extinguishments (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">470-50),</div> Compensation—Stock Compensation (Topic 718), and Derivatives and</div></div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Hedging—Contracts in Entity’s Own Equity (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40):</div> Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options (a consensus of the FASB Emerging Issues Task Force)</div></div>. This guidance clarifies certain aspects of the current guidance to promote consistency among reporting of an issuer’s accounting for modifications or exchanges of freestanding equity-classified written call options (for example, warrants) that remain equity classified after </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">modification or exchange. The amendments in this update are effective for all entities for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted for all entities, including adoption in an interim period. The Company adopted ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-04</div> under the private company transition guidance beginning January 1, 2022, the adoption did not have an impact on the Company’s consolidated financial statements. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In August 2020, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06,</div> Debt—Debt with Conversion and Other Options (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">470-20)</div> and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40):</div> Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, which simplifies the accounting for convertible instruments by reducing the number of accounting models available for convertible debt instruments. This guidance also eliminates the treasury stock method to calculate diluted earnings per share for convertible instruments and requires the use of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">if-converted</div> method. ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06</div> is effective for public and private companies’ fiscal years beginning after December 15, 2021, and December 15, 2023, respectively, and interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company adopted ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06</div> under the private company transition guidance on January 1, 2022, and the adoption did not have an impact on the Company’s consolidated financial statements. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(ab)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Accounting Pronouncements Not Yet Adopted </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In June 2016, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-13,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Financial instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</div></div>, and subsequent related ASUs, which amends the guidance on the impairment of financial instruments by requiring measurement and recognition of expected credit losses for financial assets held. ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-13</div> is effective for public and private companies’ fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2019, and December 15, 2022, respectively. The Company expects to adopt ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-13</div> under the private company transition guidance beginning January 1, 2023 and is currently evaluating the impact on the Company’s consolidated financial statements. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(a)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Use of Estimates </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The <div style="display:inline;">preparation</div> of the Company’s financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses, as well as related disclosure of contingent assets and liabilities. Significant estimates and assumptions made by management include, but are not limited to, the determination of: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">The allocation of the transaction price to identified performance obligations; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Fair value of warrant liabilities; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">The fair value of assets acquired and liabilities assumed for business combination; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">The reserve methodology for inventory obsolescence; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">The reserve methodology for product warranty; </div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">To the extent that there are material differences between these estimates and actual results, the Company’s financial condition or operating results will be affected. The Company bases its estimates on past experience and other assumptions that the Company believes are reasonable under the circumstances, and the Company evaluates these estimates on an ongoing basis. The Company has assessed the impact and are not aware of any specific events or circumstances that required an update to the Company’s estimates and assumptions or materially affected the carrying value of the Company’s assets or liabilities as of the date of issuance of this report. These estimates may change as new events occur and additional information is obtained. </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(b)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Supply Chain Constraints and Risk; <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company relies on a very small number of suppliers of solar energy systems and other equipment. If any of Company’s suppliers was unable or unwilling to provide the Company with contracted quantities in a timely manner at prices, quality levels and volumes acceptable to the Company, the Company would have very limited alternatives for supply, and the Company may not be able find suitable replacements for the Company’s customers, or at all. Such an event could materially adversely affect the Company’s business, prospects, financial condition and results of operations. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The ongoing <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic has resulted and may continue to result in widespread adverse effects on the global and U.S. economies. Ongoing government and business responses to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19,</div> along with <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> variants and the resurgence of related disruptions, could have a continued material adverse impact on economic and market conditions and trigger a period of continued global and U.S. economic slowdown. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In addition, the global supply chain and the Company’s industry have experienced significant disruptions in recent periods. The Company have seen supply chain challenges and logistics constraints increase, including shortages of panels, inverters, batteries and associated component parts for inverters and solar energy systems available for purchase. In certain cases, this has caused delays in critical equipment and inventory, longer lead times, and has resulted in cost volatility. These shortages and delays can be attributed in part to the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic and resulting government action, broader macroeconomic conditions, and have been exacerbated by the ongoing conflict in Russia and Ukraine. While the Company believes that a majority of the Company’s suppliers have secured sufficient supply to permit them to continue delivery and installations through the end of 2023, if these shortages and delays persist into 2024, they could adversely affect the timing of when battery energy storage systems can be delivered and installed, and when (or if) the Company can begin to generate revenue from those systems. In addition, the Company has experienced and is experiencing varying levels of volatility in costs of equipment and labor resulting in part from disruptions caused by general global economic conditions, including inflationary pressures and the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic. </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company cannot predict the full effects these events will have on the Company’s business, cash flows, liquidity, financial condition and results of operations at this time due to numerous uncertainties. In the event the Company is unable to mitigate the impact of delays or price volatility in solar energy systems, raw materials, and freight, it could materially adversely affect the Company’s business, prospects, financial condition and results of operations. For additional information on risk factors that could impact the Company’s results, please refer to “Risk <div style="display:inline;">Factors</div>” located elsewhere in this prospectus. </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(c)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Segment Information </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company conducts its business in one operating segment that provides custom solar solutions through a standardized platform to its residential solar providers and companies to facilitate the sale and installation of solar energy systems under a single product group. The Company’s Chief Executive Officer (“CEO”) is the Chief Operating Decision Maker (“CODM”). The CODM allocates resources and makes operating decisions based on financial information presented on a consolidated basis. The profitability of the Company’s product group is not a determining factor in allocating resources and the CODM does not evaluate profitability below the level of the consolidated company. All the Company’s long-lived assets are maintained in the United States of America. Disaggregated revenue by primary geographical market for the Company’s single segment is included in the discussion of revenue recognition within this Note 2, below. </div> 1 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(d)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Concentration of Risks </div></div></div></td></tr></table><div style="margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Concentration of credit risk </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. The Company’s cash and cash equivalents are on deposit with major financial institutions. Such deposits may be in excess of insured limits. The Company believes that the financial institutions that hold the Company’s cash are financially sound, and accordingly, minimum credit risk exists with respect to these balances. The Company has not experienced any losses due to institutional failure or bankruptcy. The Company performs credit evaluations of its customers and generally does not require collateral for sales on credit. The Company reviews accounts receivable balances to determine if any receivables will potentially be uncollectible and includes any amounts that are determined to be uncollectible in the allowance for doubtful accounts. As of December 31, 2022, three single customers had outstanding balances that represented 27%, 18%, and 14%, respectively, of the total accounts receivable balance, compared to December 31, 2021, as a <span style="-sec-ix-hidden:hidden96298528">single</span> customer had an outstanding balance that represented 50%, of the total accounts receivable balance. </div><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Concentration of customers </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company defines major customers as those customers who generate revenues that exceed 10% of the Company’s annual net revenues. For the years ended December 31, 2022, 2021 and 2020, one customer represented 47%, 63% and 81% of gross revenues, respectively. </div><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Concentration of suppliers </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For the year ended December 31, 2022, three suppliers represented 74% of the Company’s inventory purchases. For the year ended December 31, 2021, four supplier represented 87% of the Company’s inventory purchases. For the year ended December 31, 2020, two suppliers represented 89% of the Company’s inventory purchases. </div> 3 0.27 0.18 0.14 0.50 1 1 1 0.47 0.63 0.81 3 0.74 4 0.87 2 0.89 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(e)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Cash and Cash Equivalents </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="display:inline;">The</div> Company considers all highly liquid securities that mature within three months or less from the original date of purchase to be cash equivalents. The Company maintains the majority of its cash balances with </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">commercial banks in interest bearing accounts. Cash and cash equivalents include cash held in checking and savings accounts and money market accounts consisting of highly liquid securities with original maturity dates of three months or less from the original date of purchase. </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(f)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Restricted Cash </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company classifies all cash for which usage is limited by contractual provisions as restricted cash. Restricted cash balance as of December 31, 2022 and 2021, was $3.9 million, and zero, respectively. The restricted cash consists of deposits in money market accounts, which is used as cash collateral backing letters of credit related to customs duty authorities’ requirements. The Company has presented these balances under restricted cash, as a long term asset, in the consolidated balance sheets. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Total cash, cash equivalents and restricted cash is presented in the table below (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:82%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash and cash equivalents</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,409</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,276</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Restricted cash</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,907</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total cash, cash equivalents and restricted cash</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,316</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,276</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 3900000 0 <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Total cash, cash equivalents and restricted cash is presented in the table below (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:82%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash and cash equivalents</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,409</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,276</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Restricted cash</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,907</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total cash, cash equivalents and restricted cash</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,316</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,276</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 4409000 5276000 3907000 0 8316000 5276000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(g)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Accounts Receivable, Net </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Accounts receivable are recorded at the invoiced amount and do not bear interest. The Company maintains an allowance for doubtful accounts for estimated losses inherent in its accounts receivable portfolio. In establishing the required allowance, management considers historical losses adjusted to take into account current market conditions and customers’ financial condition, the amount of receivables in dispute, the current receivables aging and customer payment patterns. Account balances are written off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. Recoveries of accounts receivable previously written off are recorded when received. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes the allowance for doubtful accounts as of December 31, 2022, 2021, and 2020 (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:75%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Balance at beginning of period</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,569</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,288</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,965</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Provision charged to earnings</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><span style="-sec-ix-hidden:hidden96297041">(2,243</span></td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(364</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(337</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Amounts written off, recoveries and other adjustments</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">83</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Balance at end of period</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4,812</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,569</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,288</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company does <div style="display:inline;">not</div> have any <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">off-balance</div> sheet credit exposure related to its customers. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes the allowance for doubtful accounts as of December 31, 2022, 2021, and 2020 (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:75%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Balance at beginning of period</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,569</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,288</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,965</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Provision charged to earnings</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><span style="-sec-ix-hidden:hidden96297041">(2,243</span></td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(364</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(337</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Amounts written off, recoveries and other adjustments</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">83</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Balance at end of period</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4,812</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,569</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,288</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 2569000 2288000 1965000 364000 337000 0 83000 14000 4812000 2569000 2288000 0 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(h)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Inventories </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Inventories consists of solar panels and the components of solar energy systems which the Company classifies as finished goods. Costs are computed under the average cost method. The Company identifies inventory which is considered obsolete or in excess of anticipated demand based on a consideration of marketability and product life cycle stage, component cost trends, demand forecasts, historical revenues, and assumptions about future demand and market conditions to state inventory at the lower of cost or net realizable value. </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(i)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Revenue Recognition </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Revenue is recognized when a customer obtains control of promised products and services and the Company has satisfied its performance obligations. The amount of revenue recognized reflects the consideration which the Company expects to be entitled to receive in exchange for the products and services. To achieve this core principle, the Company applies the following five steps: </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Step 1. Identification of the contract(s) with a customer; </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Step 2. Identification of the performance obligations in the contracts(s); </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Step 3. Determination of the transaction price; </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Step 4. Allocation of the transaction price to the performance obligations; </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Step 5. Recognition of the revenue when, or as, the Company satisfies a performance obligation. </div><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Service Revenues – Solar Energy System Installations </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company generates revenue primarily from the design and installation of a solar energy system and performing post-installation services. The Company’s contracts with customers include three primary contract types: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Cash agreements </div></div>– The Company contracts directly with homeowners who purchase the solar energy system and related services from the Company. Customers are invoiced on a billing schedule, where the majority of the transaction price is due upon installation with an additional payment due when the system passes inspection by the authority having jurisdiction. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Financing partner agreements </div></div>– In its financing partner agreements, the Company contracts directly with homeowners for the purchase of the solar energy system and related services. The Company refers the homeowner to a financing partner to finance the system, and the homeowner makes payments directly to the financing partner. The Company receives consideration from the financing partner on a billing schedule where the majority of the transaction price is due upon installation with an additional payment due when the system passes inspection by the authority having jurisdiction. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Power purchase agreements </div></div>– The Company contracts directly with a distribution partner to perform the solar energy system installation, and the homeowner will finance the system through a power purchase agreement, which is signed with the Company’s distribution partner. The Company considers the distribution partner to be its customer, as the Company does not contract directly with the homeowner. The Company receives consideration from the distribution partner on a billing schedule where the majority of the transaction price is due upon installation with an additional payment due when the system passes inspection by the authority having jurisdiction. </div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In each of the Company’s customer contract types, the Company’s revenue consists of two performance obligations, which include the performance of the installation of the solar energy system and post-installation services. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Installation includes the design of a solar energy system, the delivery of the components of the solar energy system (i.e., photovoltaic system, inverter, battery storage, etc.), installation services and services facilitating the connection of the solar energy system to the power grid. The Company accounts for these services as inputs to a combined output, resulting in a single service-based performance obligation. The Company recognizes revenue upon the completion of installation services, which occurs upon the transfer of control of the solar energy system and title of the related hardware components to the homeowner or distribution partner. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Post-installation services consist primarily of administrative services and customer support, which the Company performs between the completion of installation and the date of inspection of the solar energy system by the authority having jurisdiction. The Company recognizes revenue at a point in time, which is when the inspection occurs. </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As the Company’s contracts with customers contain multiple performance obligations, the transaction price is allocated to each performance obligation based on its standalone selling price. The Company generally determines the standalone selling price based on the estimated costs incurred in the delivery of each performance obligation, relative to the total costs to be incurred under the contract. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company records deferred revenue for amounts invoiced that are not subject to refund upon termination. In certain contracts with customers, the Company arranges for a third-party financing partner to provide financing to the customer. The Company collects upfront from the financing partner and the customer will provide installment payments to the financing partner. The Company records revenue in the amount received from the financing partner, net of any financing fees charged to the homeowner, which the Company considers to be a customer incentive. None of the Company’s contracts contain a significant financing component. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company guarantees to customers certain specified minimum solar energy production output of the solar energy system for <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-years</div> after the installation. The Company monitors the solar energy systems to determine whether these specified minimum outputs are being achieved. The Company will issue payments to customers if the output falls below contractually stated thresholds over the performance guarantee period. Revenue is recognized to the extent it is probable that a significant reversal of such revenue will not occur. </div><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Revenues – Software Enhanced Services </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company generates revenue from software enhanced services through the provision of design and proposal services. The Company’s customers for design services are solar installers who leverage the Company’s expertise and software platforms to obtain structural letters, computer aided designs and electrical reviews. The Company charges the customer a per design fixed fee for each type of service that is performed, and the Company recognizes revenue in the period the services are performed. The customer contracts contain the customer right to terminate the contract each month and are therefore enforceable only for the contracted services purchased each month. Revenue is recognized for design services in the month the services are performed. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company’s customers for proposal services for solar sales organizations who contract with the Company to develop proposals for their potential residential solar customers. The Company generates proposals for the customer using the HelioQuote platform. Customers may purchase a fixed number of proposals for a given month or may contract on a pay as you go basis, and the performance obligation is defined by the number of proposals purchased by the customer each month. The customer contracts contain the customer right to terminate the contract each month and are therefore enforceable only for the services purchased each month. Revenue is recognized for proposal services in the month the services are performed. </div><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Warranties </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company typically provides a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-year</div> warranty on its solar energy system installations, which provides assurance over the workmanship in performing the installation, including roof leaks caused by the Company’s performance. For solar panel sales recognized prior to the Disposal Transaction, the Company provides a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">30-year</div> warranty that the products will be free from defects in material and workmanship. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">When the revenues are recognized for the solar energy systems installations services, the Company accrues liabilities for the estimated future costs of meeting its warranty obligations. The Company makes and revises these estimates based primarily on the volume of new sales that contain warranties, historical experience with and projections of warranty claims, and estimated solar energy system and panel replacement costs. The Company records a provision for estimated warranty expenses in cost of revenues within the accompanying consolidated statements of operations and comprehensive loss. </div><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Shipping and handling costs and certain taxes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Revenues are recognized net of taxes collected from customers and remitted to governmental authorities. Shipping and handling costs associated with outbound freight are accounted for as a fulfillment cost and are included in both revenues and cost of revenues in the accompanying consolidated statements of operations and comprehensive loss. </div><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Deferred revenue </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company typically invoices its customers upon completion of set milestones, generally upon installation of the solar energy system with the remaining balance invoiced upon passing final building inspection. Standard payment terms to customers range from 30 to 60 days. When the Company receives consideration, or when such consideration is unconditionally due, from a customer prior to delivering goods or services to the customer under the terms of a customer agreement, the Company records deferred revenue. As installation projects are typically completed within <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">12-months,</div> the Company’s deferred revenue is reflected in current liabilities in the accompanying consolidated balance sheets. The amount of revenue recognized during the years ended December 31, 2022 and 2021 that was included in deferred revenue at the beginning of each period was $3.9 million and $4.5 million, respectively. </div><div style="margin-top: 18pt; margin-bottom: 0pt; text-indent: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Disaggregation of revenue </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Refer to the table below for the Company’s revenue recognized by product and service type (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:73%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Years Ended December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Solar energy system installations</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">62,896</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">66,958</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">29,378</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Software enhanced services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,579</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,858</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total revenue</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">66,475</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">68,816</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">29,378</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For the years ended December 31, 2022, 2021 and 2020, all revenue recognized was generated in the United States. </div><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Remaining performance obligations </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company has elected the practical expedient not to disclose remaining performance obligations for contracts that are less than one year in length. As of December 31, 2022, the Company has deferred $1.3 million associated with a long-term service contract, which will be recognized evenly through 2028. </div><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Incremental costs of obtaining customer contracts </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Incremental costs of obtaining customer contracts consist of sales commissions, which are costs paid to third-party vendors who source residential customer contracts for the sale of solar energy systems by the Company. The Company defers sales commissions and recognizes expense in accordance with the timing of the related revenue recognition. Amortization of deferred commissions is recorded as sales commissions in the accompanying consolidated statements of operations and comprehensive loss. As of December 31, 2022 and December 31, 2021, deferred commissions were $2.8 million and $4.8 million, respectively, which included in prepaid expenses and other current assets in the accompanying consolidated balance sheets. </div> 3900000 4500000 <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Refer to the table below for the Company’s revenue recognized by product and service type (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:73%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Years Ended December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Solar energy system installations</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">62,896</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">66,958</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">29,378</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Software enhanced services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,579</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,858</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total revenue</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">66,475</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">68,816</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">29,378</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 62896000 66958000 29378000 3579000 1858000 0 66475000 68816000 29378000 1300000 2800000 4800000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(j)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Property and Equipment, Net </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Property and equipment are stated at cost less accumulated depreciation and amortization. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gain or loss is included in the current period. Repair and maintenance costs are expensed as </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">incurred. Depreciation and amortization are calculated using the straight-line method over the following estimated useful lives of the assets: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:86%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Useful Lives</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Manufacturing equipment</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">1-3 years</div></td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Developed software</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5 years</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Furniture &amp; equipment</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">3-5</div> years</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Leasehold improvements</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">3-5 years</div></td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table> Depreciation and amortization are calculated using the straight-line method over the following estimated useful lives of the assets: <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:86%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Useful Lives</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Manufacturing equipment</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">1-3 years</div></td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Developed software</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5 years</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Furniture &amp; equipment</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">3-5</div> years</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Leasehold improvements</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">3-5 years</div></td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table> P1Y P3Y P5Y P3Y P5Y P3Y P5Y <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(k)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Internal-Use</div> Software </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company capitalizes costs to develop its <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">internal-use</div> software when preliminary development efforts are successfully completed, management has authorized and committed project funding, it is probable that the project will be completed, and the software will be utilized as intended. These costs include personnel and related employee benefits and expenses for employees who are directly associated with and who devote time to software projects, and external direct costs of materials and services consumed in developing or obtaining software. Costs incurred prior to meeting these criteria, together with costs incurred for training and maintenance, are expensed as incurred. Costs incurred for enhancements that are expected to provide additional material functionality are capitalized and amortized over the estimated useful life of the related upgrade. During the years ended December 31, 2022, 2021 and 2020, the Company capitalized $1.5 million, $1.1 million and $0.5 million, respectively, of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">internal-use</div> software development costs. The remaining unamortized balance as of December 31, 2022 and December 31, 2021 of $2.7 million and $1.7 million, respectively, is included in property and equipment, net within the accompanying consolidated balance sheets. </div> 1500000 1100000 500000 2700000 1700000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(l)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Cost of Revenues </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Cost of revenues includes actual cost of material, labor and related overhead incurred for revenue-producing units, and includes associated warranty costs, freight and delivery costs, depreciation, and amortization of internally developed software. </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(m)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Advertising and Promotional Expenses </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="display:inline;">Advertising</div> and promotional costs are expensed as incurred and included in sales and marketing expense in the accompanying consolidated statements of operations and comprehensive loss. Advertising costs were not material for the years ended December 31, 2022, 2021 and 2020.. </div> 0 0 0 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(n)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Income Taxes </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Income taxes are accounted for under the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">asset-and-liability</div></div> method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company recognizes the effect of income tax positions only if those positions are more likely than not to be sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company recognizes accrued interest and penalties, if any, related to unrecognized tax benefits in income tax provision. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(o)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Foreign Currency </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company’s reporting currency is the US dollar. The functional currency for each of the Company’s foreign subsidiaries is the local currency, as it is the monetary unit of account of the principal economic </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">environments in which the Company’s foreign subsidiaries operate. Assets and liabilities of the foreign subsidiaries are translated at the current exchange rate as of the end of the period, and revenue and expenses are translated at the average exchange rates in effect during the period. The gain or loss resulting from the process of translating foreign currency financial statements into US dollar financial statements is accounted for as a foreign currency cumulative translation adjustment and is reported as a component of accumulated other comprehensive loss. Foreign currency transaction gains and losses resulting from transactions denominated in a currency other than the functional currency are recognized in Other Income (expense), net in the consolidated statements of operations and comprehensive loss. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(p)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Comprehensive Loss </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Comprehensive loss consists of two components, net loss and other comprehensive income (loss), net. The Company’s other comprehensive loss consists of foreign currency translation adjustments that result from the consolidation of its foreign entities and is reported net of tax effects. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(q)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Impairment of Long-Lived Assets </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Long-lived assets, such as property and equipment, ROU assets, and intangible assets subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require a long-lived asset or asset group be tested for possible impairment, the Company first compares undiscounted cash flows expected to be generated by that asset or asset group to its carrying value. If the carrying value of the long-lived asset or asset group is not recoverable on an undiscounted cash flow basis, an impairment is recognized to the extent that the carrying value exceeds its fair value. Fair value is determined through various valuation techniques including discounted cash flow models, and quoted market values, as considered necessary. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">There were no impairment charges for the years ended December 31, 2022, 2021 and 2020. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> 0 0 0 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(r)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Business Combinations </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company allocates the fair value of purchase consideration to the tangible assets acquired, liabilities assumed, and intangible assets acquired based on their estimated fair values. The excess of the fair value of purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. Such valuations require management to make significant estimates and assumptions, especially with respect to intangible assets. Significant estimates in valuing certain intangible assets include, but are not limited to, future expected cash flows from customer relationships, acquired technology, trade names from a market participant perspective, useful lives and discount rates. Management’s estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates. During the measurement period, which is one year from the acquisition date, the Company may record adjustments to the assets acquired and liabilities assumed, with the corresponding offset to goodwill. Upon the conclusion of the measurement period, any subsequent adjustments are recorded in the consolidated statements of operations and comprehensive loss. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(s)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Intangibles Assets, Net </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Intangible assets are recorded at the cost, less accumulated amortization. Amortization is recorded using the straight-line method. All intangible assets that have been determined to have definite lives are amortized over their estimated useful life as indicated below: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:68%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:78%"></td> <td style="vertical-align:bottom;width:14%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Estimated Useful Life</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Assembled workforce</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2 years</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table> All intangible assets that have been determined to have definite lives are amortized over their estimated useful life as indicated below: <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:68%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:78%"></td> <td style="vertical-align:bottom;width:14%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Estimated Useful Life</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Assembled workforce</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2 years</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table> P2Y <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(t)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Deferred Transaction Costs </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Deferred transaction costs, which consist of direct incremental legal, consulting and accounting fees related to the merger with Freedom, are capitalized until they are recorded against proceeds upon the consummation of the transaction. As of December 31, 2022, the Company has recorded $1.1 million of deferred transaction costs in other noncurrent assets on the consolidated balance sheets. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> 1100000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(u)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Redeemable Convertible Preferred Stock Warrants </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company has issued redeemable convertible preferred stock warrants exercisable into shares of the Company’s redeemable convertible preferred stock. The Company classifies warrants to purchase shares of convertible preferred stock that are redeemable or include an antidilution feature as liabilities. Such redeemable convertible preferred stock warrants are measured and recognized at fair value, and subject to remeasurement at each balance sheet date. At the end of each reporting period, changes in fair value during the period are recognized as a component of other income (expense), net in the accompanying consolidated statements of operations and comprehensive loss. The Company will continue to adjust the redeemable convertible preferred stock warrant liability for changes in the fair value until the earlier of the exercise or expiration of such warrants or the completion of a liquidation event, including completion of an initial public offering (“IPO”), at which time all such redeemable convertible preferred stock warrants will be converted into warrants to purchase shares of common stock, and the liability will be reclassified to additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital. See Note 10 – Fair Value Measurements for details on the valuation methodology. Also see Note 14 – Warrants. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(v)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Stock-Based Compensation </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company recognizes stock-based compensation expense over the requisite service period on a straight-line basis for all stock-based payments that are expected to vest to employees, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-employees</div> and directors, including grants of employee stock options and other stock-based awards. Equity-classified awards issued to employees, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-employees</div> such as consultants and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-employee</div> directors are measured at the grant-date fair value of the award. Forfeitures are recognized as they occur. For accounting purposes, the Company estimates grant-date fair value of stock options using the Black-Scholes option pricing model. The <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Black-Scholes</div> option pricing model requires the input of highly subjective assumptions, including the fair value of the underlying common stock prior to the Mergers, the expected term of the option the expected volatility of the price of the Company’s common stock and expected dividend yield. The Company determines these inputs as follows: </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Expected Term</div></div>—Expected term represents the period that the Company’s stock-based awards are expected to be outstanding and is determined using the simplified method. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Expected Volatility</div></div>—Expected volatility is estimated by studying the volatility of comparable public companies for similar terms. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Expected Dividend</div></div>—The Black-Scholes valuation model calls for a single expected dividend yield as an input. The Company has never paid dividends and has no plans to pay dividends. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Risk-free Interest Rate</div></div>—The Company derives the risk-free interest rate assumption from the U.S. Treasury’s rates for the U.S. Treasury <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">zero-coupon</div> bonds with maturities similar to those of the expected term of the awards being valued. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Forfeitures</div></div>—The Company recognizes forfeitures as they occur. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(w)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Fair Value Measurements </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible. The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market. </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Level 1 inputs: Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Level 2 inputs: Other than quoted prices included in Level 1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Level 3 inputs: Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at the measurement date. </div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company’s financial instruments include cash, accounts receivable, accounts payable, accrued expenses, convertible notes, SAFE agreements, notes payable, common stock warrants and redeemable convertible preferred stock warrants. The carrying amounts of cash, accounts receivable, accounts payable, accrued expenses, convertible notes and notes payable approximate their fair value because of their short- term nature (classified as level 1). The Company measures and discloses the fair value of SAFE agreements, common stock warrants and redeemable convertible preferred stock warrants under the provisions of ASC Topic 820—Fair Value Measurement (classified as level 3). </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(x)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Net Loss Per Share </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company computes net loss per share in accordance with ASC 260, Earnings Per Share (“ASC 260”). Basic net loss per share is measured as the income or loss available to common stockholders divided by the weighted-average common shares outstanding for the period. Diluted net loss per share presents the dilutive effect on a per-share basis from the potential exercise of options and/or warrants. The potentially dilutive effect of options or warrants are computed using the treasury stock method. Securities that potentially have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the diluted loss per share calculation. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(y)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Convertible Debt Embedded Derivative Liabilities </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company evaluates the embedded conversion feature within its convertible debt instruments under ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-15</div> and ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40</div> to determine if the conversion feature meets the definition of a liability and, if so, whether to bifurcate the conversion feature and account for it as a separate derivative liability. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-valued</div> at each reporting date, with changes in the fair value reported in the consolidated statements of operations and comprehensive loss. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the consolidated balance sheets as current or <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> based on whether <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">net-cash</div> settlement of the derivative instrument could be required within twelve months after the balance sheet date. The derivative is subject to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-measurement</div> at the end of each reporting period, with changes in fair value recognized as a component of other income (expense), net, in the consolidated statements of operations and comprehensive loss. The Company’s embedded derivative liabilities were extinguished in the first quarter of 2022. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(z)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Leases </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Effective January 1, 2021, the Company early adopted Accounting Standards Update (“ASU”) <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2016-02,</div> Leases (Topic 842), as amended (“ASC 842”). The Company determines if a contract is a lease or contains a lease at the inception of the contract and reassesses that conclusion if the contract is modified. The Company’s lease agreements generally contain lease and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-lease</div> components. Payments under lease </div><div></div><div><div style="line-height:normal;background-color:white;display: inline;"></div></div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">arrangements are primarily fixed. The Company combines lease and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-lease</div> components and accounts for them together as a single lease component. All leases are assessed for classification as an operating lease or a finance lease. Operating lease <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> (“ROU”) assets are presented separately on the Company’s consolidated balance sheets. Operating lease liabilities are separated into a current portion and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> portion and are presented separately on the Company’s consolidated balance sheets. The Company does not have finance lease ROU assets or liabilities. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent its obligation to make lease payments arising from the lease. The Company does not obtain and control its right to use the identified asset until the lease commencement date. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company’s lease liabilities are recognized at the later of January 1, 2021 and applicable lease commencement date based on the present value of the lease payments required to be paid over the lease term. Because the rate implicit in the lease is not readily determinable, the Company generally uses its incremental borrowing rate to discount the lease payments to present value. The estimated incremental borrowing rate is derived from information available at the lease commencement date. The Company’s lease terms include periods under options to extend or terminate the lease when it is reasonably certain that we will exercise that option. We generally use the base, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cancelable,</div> lease term when determining the lease assets and liabilities. The Company also records a corresponding <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> asset at the later of January 1, 2021 and applicable lease commencement date, which is calculated based on the amount of the lease liability, adjusted for any advance lease payments made, lease incentives received, and initial direct costs incurred. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Right-of-use</div></div> assets are subject to evaluation for impairment or disposal on a basis consistent with other long-lived assets. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company has elected, for all classes of underlying assets, not to recognize ROU assets and lease liabilities for leases with a term of twelve months or less. Lease cost for short-term leases is recognized on a straight-line basis over the lease term. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Before the adoption of ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-02</div> on January 1, 2021, the Company categorizes leases at their inception as either operating or capital leases, with the Company’s current lease portfolio only consisting of operating leases for office spaces. In certain lease agreements, it may receive rent holidays and other incentives. For operating leases, the Company recognizes lease costs on a straight-line basis once control of the space is achieved, without regard to deferred payment terms such as rent holidays that defer the commencement date of required payments. Additionally, incentives received are treated as a reduction of costs over the term of the agreement. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(aa)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Recently Adopted Accounting Pronouncements </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In December 2019, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-12,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</div></div>. ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-12</div> removes certain exceptions to the general principles in Topic 740 and clarifies and amends existing guidance to improve consistent application. ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-12</div> will be effective for public entities for interim and annual periods beginning after December 15, 2020, with early adoption permitted. ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-12</div> will be effective for private entities for annual periods beginning after December 15, 2021, and interim periods beginning after December 15, 2020, with early adoption permitted. The Company adopted ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-12</div> under the private company transition guidance beginning January 1, 2022, and the adoption did not have an impact on the Company’s consolidated financial statements. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In May 2021, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-04,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Earnings Per Share (Topic 260), Debt—Modifications and Extinguishments (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">470-50),</div> Compensation—Stock Compensation (Topic 718), and Derivatives and</div></div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Hedging—Contracts in Entity’s Own Equity (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40):</div> Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options (a consensus of the FASB Emerging Issues Task Force)</div></div>. This guidance clarifies certain aspects of the current guidance to promote consistency among reporting of an issuer’s accounting for modifications or exchanges of freestanding equity-classified written call options (for example, warrants) that remain equity classified after </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">modification or exchange. The amendments in this update are effective for all entities for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted for all entities, including adoption in an interim period. The Company adopted ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-04</div> under the private company transition guidance beginning January 1, 2022, the adoption did not have an impact on the Company’s consolidated financial statements. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In August 2020, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06,</div> Debt—Debt with Conversion and Other Options (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">470-20)</div> and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40):</div> Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, which simplifies the accounting for convertible instruments by reducing the number of accounting models available for convertible debt instruments. This guidance also eliminates the treasury stock method to calculate diluted earnings per share for convertible instruments and requires the use of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">if-converted</div> method. ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06</div> is effective for public and private companies’ fiscal years beginning after December 15, 2021, and December 15, 2023, respectively, and interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company adopted ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-06</div> under the private company transition guidance on January 1, 2022, and the adoption did not have an impact on the Company’s consolidated financial statements. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(ab)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Accounting Pronouncements Not Yet Adopted </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In June 2016, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-13,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Financial instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</div></div>, and subsequent related ASUs, which amends the guidance on the impairment of financial instruments by requiring measurement and recognition of expected credit losses for financial assets held. ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-13</div> is effective for public and private companies’ fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2019, and December 15, 2022, respectively. The Company expects to adopt ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-13</div> under the private company transition guidance beginning January 1, 2023 and is currently evaluating the impact on the Company’s consolidated financial statements. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(3)</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Reverse Recapitalization </div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As discussed in Note 1 – Organization, on July 18, 2023, the Company consummated the Mergers pursuant to the Amended and Restated Business Combination Agreement. The Mergers was accounted for as a reverse recapitalization, rather than a business combination, for financial accounting and reporting purposes. Accordingly, Complete Solaria was deemed the accounting acquirer (and legal acquiree) and FACT was treated as the accounting acquiree (and legal acquirer). Complete Solaria has been determined to be the accounting acquirer based on evaluation of the following facts and circumstances: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Complete Solaria’s pre-combination stockholders have the majority of the voting power in the post-merged company; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Legacy Complete Solaria’s stockholders have the ability to appoint a majority of the Complete Solaria Board of Directors; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Legacy Complete Solaria’s management team is considered the management team of the post-merged company; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Legacy Complete Solaria’s prior operations is comprised of the ongoing operations of the post-merged company; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Complete Solaria is the larger entity based on historical revenues and business operations; and </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">the post-merged company has assumed Complete Solaria’s operating name. </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Under this method of accounting, the reverse recapitalization was treated as the equivalent of Complete Solaria issuing stock for the net assets of FACT, accompanied by a recapitalization. The net assets of FACT </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">are stated at historical cost, with no goodwill or other intangible assets recorded. The consolidated assets, liabilities, and results of operations prior to the Mergers are those of Legacy Complete Solaria. All periods prior to the Mergers have been retrospectively adjusted in accordance with the Amended and Restated Business Combination Agreement for the equivalent number of preferred or common shares outstanding immediately after the Mergers to effect the reverse recapitalization. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Upon the closing of the Mergers and the PIPE Financing in July 2023, the Company received net cash proceeds of $19.7 million. Immediately upon closing of the Mergers, the Company had 45,290,553 shares issued and outstanding of Class A Common Stock. The following table presents the number of shares of Complete Solaria Common Stock outstanding immediately following the consummation of the Mergers: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:84%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Recapitalization</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">FACT Class A Ordinary Shares, outstanding prior to Mergers</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">34,500,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">FACT Class B Ordinary Shares, outstanding prior to Mergers</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,625,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Bonus shares issued to sponsor</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">193,976</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Bonus shares issued to PIPE investors</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">120,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Bonus shares issued to FPA investors</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shares issued from PIPE financing</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,690,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shares issued from FPA agreements, net of recycled shares</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,558,488</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: redemption of FACT Class A Ordinary Shares</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(31,041,243</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total shares from the Mergers and PIPE Financing</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19,796,221</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Legacy Complete Solaria shares</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,034,257</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2022 Convertible Note Shares</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,460,075</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shares of Complete Solaria Common stock immediately after Mergers</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">45,290,553</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In <div style="display:inline;">connection</div> with the Mergers, the Company incurred direct and incremental costs of approximately $15.8 million related to legal, accounting, and other professional fees, which were offset against the Company’s additional paid-in capital. Of the $15.8 million, $5.2 million was incurred by Legacy Complete Solaria and $10.6 million was incurred by FACT. As a result of the Closing, outstanding 2022 Convertible Notes were converted into shares of Complete Solaria Common Stock. </div> 19700000 45290553 45290553 The following table presents the number of shares of Complete Solaria Common Stock outstanding immediately following the consummation of the Mergers: <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:84%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Recapitalization</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">FACT Class A Ordinary Shares, outstanding prior to Mergers</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">34,500,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">FACT Class B Ordinary Shares, outstanding prior to Mergers</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,625,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Bonus shares issued to sponsor</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">193,976</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Bonus shares issued to PIPE investors</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">120,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Bonus shares issued to FPA investors</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shares issued from PIPE financing</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,690,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shares issued from FPA agreements, net of recycled shares</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,558,488</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: redemption of FACT Class A Ordinary Shares</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(31,041,243</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total shares from the Mergers and PIPE Financing</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19,796,221</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Legacy Complete Solaria shares</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,034,257</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2022 Convertible Note Shares</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,460,075</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shares of Complete Solaria Common stock immediately after Mergers</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">45,290,553</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 34500000 8625000 193976 120000 150000 1690000 5558488 31041243 19796221 20034257 5460075 45290553 15800000 15800000 5200000 10600000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(4)</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Business Combination </div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Solaria Acquisition </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On November 4, 2022, Complete Solar Holdings acquired Solaria for aggregate consideration paid of $89.1 million, comprising of $0.1 million in cash, <span style="-sec-ix-hidden:hidden96297040">2,884,550</span> shares of common stock with an aggregate fair value of $17.3 million, 6,803,549 shares of preferred stock with an aggregate fair value of $52.2 million, 78,962 common stock warrants for an aggregate value of $0.2 million, 1,376,414 preferred stock warrants for an aggregate fair value of $7.8 million, 5,382,599 stock options with an aggregate fair value of $10.0 million attributable to services provided prior to the acquisition date, and the payment of seller incurred transaction expenses of $1.5 million. In addition, the Company assumed $14.1 million of unvested Solaria stock options, which will be recorded as stock-based expense over the remaining service period. Solaria designs, develops, manufactures, and generates revenue from the sale of silicon photovoltaic solar panels and licensing of its technology to third parties. This transaction was accounted for as a business combination in accordance with ASC 805, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Business Combinations</div></div>. Subsequent to the acquisition as discussed above, the Company sold certain intangible assets constituting the Solaria business in October of 2023, resulting in the Solaria business to be reflected as discontinued operations and certain intangible assets and goodwill to be recognized as held-for-sale. Refer to Note 5 – Divestitures for further details. </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Acquisition costs of $1.3 million were expensed by the Company and are included in general and administrative expenses within the consolidated statements of operations and comprehensive loss for the year ended December 31, 2022. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The fair value of assets acquired and liabilities assumed was based upon a preliminary valuation and the Company’s estimates and assumptions are subject to change within the measurement period. The following table summarized the provisional fair value of identifiable assets acquired and liabilities assumed (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:87%"></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash, cash equivalents and restricted cash</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,402</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accounts receivable</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,822</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Inventories</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,354</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Prepaid expenses and other current assets</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,569</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Property and equipment</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">830</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating lease <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> asset</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,619</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Intangible assets</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">43,100</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> assets</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">112</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total identifiable assets acquired</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">69,808</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accounts payable</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,210</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued expenses and other current liabilities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,845</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Notes payable</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,823</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred revenue</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">73</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating lease liabilities, net of current portion</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,132</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warranty provision, noncurrent</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,566</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SAFE agreements</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">60,470</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total identifiable liabilities assumed</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100,119</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net identifiable liabilities assumed</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30,311</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Goodwill</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">119,422</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total aggregate consideration paid</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">89,111</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Goodwill represents the excess of the preliminary estimated consideration transferred over the fair value of the net tangible and intangible assets acquired and has been allocated to the Company’s single reporting unit. Goodwill was subsequently reclassified to long-term assets held-for-sale – discontinued operations, on the Company’s balance sheet as of December 31, 2022, stemming from the sale of the Solaria business discussed in Note 5 below. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Intangible assets acquired and subsequently disposed of as part of the Solaria disposition discussed in Note 5 below are as follows (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:88%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Trademarks</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,700</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Developed technology</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,700</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer relationships</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">24,700</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total intangible asset</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">43,100</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The income approach, using the relief from royalty method, was used to value trademarks and developed technology. Significant assumptions included in the valuation of trademarks and developed technology include projected revenues, the selected royalty rate and the economic life of the underlying asset. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The income approach, using the multi-period excess earning method, was used to value customer relationships. Significant assumptions included in the valuation of customer relationships include projected revenues, customer attrition and expense growth over the forecasted period. </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As a result of the Solaria acquisition, the Company recognized $45.9 million of deferred tax assets. Due to the uncertainty surrounding the Company’s ability to realize such deferred income tax assets, a full valuation allowance has been established. Refer to Note 18 – Income Taxes for additional details. </div> 89100000 100000 17300000 6803549 52200000 78962 200000 1376414 7800000 5382599 10000000 1500000 14100000 1300000 The following table summarized the provisional fair value of identifiable assets acquired and liabilities assumed (in thousands): <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:87%"></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash, cash equivalents and restricted cash</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,402</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accounts receivable</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,822</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Inventories</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,354</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Prepaid expenses and other current assets</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,569</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Property and equipment</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">830</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating lease <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> asset</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,619</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Intangible assets</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">43,100</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> assets</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">112</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total identifiable assets acquired</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">69,808</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accounts payable</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,210</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued expenses and other current liabilities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,845</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Notes payable</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,823</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred revenue</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">73</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating lease liabilities, net of current portion</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,132</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warranty provision, noncurrent</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,566</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SAFE agreements</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">60,470</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total identifiable liabilities assumed</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100,119</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net identifiable liabilities assumed</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30,311</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Goodwill</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">119,422</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total aggregate consideration paid</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">89,111</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 5402000 4822000 5354000 8569000 830000 1619000 43100000 112000 69808000 4210000 11845000 20823000 73000 1132000 1566000 60470000 100119000 30311000 119422000 89111000 <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Intangible assets acquired and subsequently disposed of as part of the Solaria disposition discussed in Note 5 below are as follows (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:88%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Trademarks</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,700</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Developed technology</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,700</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer relationships</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">24,700</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total intangible asset</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">43,100</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 5700000 12700000 24700000 43100000 45900000 <div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(5)</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Divestiture </div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;"><div style="display:inline;">Discontinued </div>operations </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As previously described in Note 1 – Organization, on August 18, 2023, the Company entered into a Non-Binding Letter of Intent to sell certain of Complete Solaria’s North American solar panel assets, inclusive of intellectual property and customer contracts, to Maxeon. In October 2023, the Company completed the sale of its solar panel business to Maxeon. The assets sold to Maxeon were the assets that allowed for the Solaria business to operate as a product manufacturer of solar panels. As such, the Company determined that the sale of these assets in effect represented a disposition of the Solaria business and constituted a strategic shift in the Company’s operations, therefore qualifying as a discontinued operation. Accordingly, the results of operations and cash flows relating to Solaria have been reflected as discontinued operations in the consolidated statements of operations and comprehensive income (loss) for the year ended December 31, 2022 and the consolidated statements of cash flows for the year ended December 31, 2022. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Components of amounts reflected in the consolidated statements of operations and comprehensive income (loss) related to discontinued operations are presented in the table, as follows (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:80%"></td> <td style="vertical-align:bottom;width:13%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Revenues</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13,325</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cost of revenues</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,847</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Gross profit</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">478</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating expenses:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sales and marketing</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,315</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">General and administrative</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">617</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total operating expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,932</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss from discontinued operations</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,454</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Held for sale </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As previously described in Note 1 – Organization, certain assets of the Solaria, Inc. have been reflected as assets held for sale in the periods preceding the divestiture. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following is a summary of the major categories of assets and liabilities held for sale (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:80%"></td> <td style="vertical-align:bottom;width:12%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Intangible assets, net</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,610</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Goodwill</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">119,422</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Long-term assets held for sale</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">162,032</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In October 2023, in conjunction with the divestiture, the Company recorded impairment expense of $119.4 million and $28.1 million associated with the goodwill and intangible assets, respectively, assigned to Solaria and a loss on disposal of $1.8 million. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Cash flows from discontinued operations included depreciation and amortization of $0.5 million and stock-based compensation expense of $0.5 million for year ended December 31, 2022. </div> <div style="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Components of amounts reflected in the consolidated statements of operations and comprehensive income (loss) related to discontinued operations are presented in the table, as follows (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:80%"></td> <td style="vertical-align:bottom;width:13%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Revenues</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13,325</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cost of revenues</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,847</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Gross profit</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">478</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating expenses:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sales and marketing</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,315</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">General and administrative</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">617</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total operating expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,932</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss from discontinued operations</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,454</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 13325000 12847000 478000 1315000 617000 1932000 1454000 <div style="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following is a summary of the major categories of assets and liabilities held for sale (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:80%"></td> <td style="vertical-align:bottom;width:12%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Intangible assets, net</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,610</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Goodwill</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">119,422</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Long-term assets held for sale</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">162,032</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 42610000 119422000 162032000 119400000 28100000 1800000 500000 500000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(6)</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Prepaid Expenses and Other Current Assets </div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Prepaid expenses and other current assets consists of the following (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:81%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Inventory deposits. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,255</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Prepaid sales commissions . . . . . . . . . . . . . . . . . . . . . . .</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,838</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,771</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">978</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">184</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total prepaid expenses and other current assets . . .</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,071</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,955</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Prepaid expenses and other current assets consists of the following (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:81%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Inventory deposits. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,255</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Prepaid sales commissions . . . . . . . . . . . . . . . . . . . . . . .</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,838</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,771</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">978</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">184</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total prepaid expenses and other current assets . . .</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,071</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,955</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 6255000 0 2838000 4771000 978000 184000 10071000 4955000 <div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(7)</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Property and Equipment, Net </div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Property and equipment, net consists of the following (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:81%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Developed software</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,054</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,540</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Manufacturing equipment.</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">102</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">70</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Furniture &amp; equipment</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">90</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Leasehold improvements</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">708</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total property and equipment</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,954</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,610</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less accumulated depreciation and amortization</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,478</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,852</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total property and equipment, net</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,476</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,758</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Depreciation and amortization expense totaled $0.6 million, $0.5 million and $0.3 million for the years ended December 31, 2022, 2021 and 2020, respectively. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Property and equipment, net consists of the following (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:81%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Developed software</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,054</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,540</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Manufacturing equipment.</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">102</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">70</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Furniture &amp; equipment</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">90</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Leasehold improvements</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">708</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total property and equipment</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,954</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,610</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less accumulated depreciation and amortization</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,478</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,852</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total property and equipment, net</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,476</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,758</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 5054000 3540000 102000 70000 90000 0 708000 0 5954000 3610000 2478000 1852000 3476000 1758000 600000 500000 300000 <div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(8)</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Intangible Assets, Net </div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Intangible assets consisted of the following (in thousands, except years data): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:47%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted-<br/>Average<br/>Remaining<br/>Life (Years)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Gross<br/>Carrying<br/>Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated<br/>Amortization</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net<br/>Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Gross<br/>Carrying<br/>Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated<br/>Amortization</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net<br/>Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Assembled workforce</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 137</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> (133</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 137</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(65</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 72</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Amortization expense related to intangible assets for the years ended December 31, 2022, 2021, and 2020 was $0.1 million, $0.1 million and zero, respectively. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For the year ended December 31, 2022, amortization expense related to intangible assets of $0.1 million and $0.1 million, respectively, was recorded in general and administrative expense on the accompanying consolidated statements of operations and comprehensive loss.<div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div>For the year ended December 31, 2020, amortization expense related to intangible assets was zero. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As of December 31, 2022, amortization expense for intangible assets for 2023 is expected to be $0.1 million. Amortization expense for intangible assets is <div style="display:inline;">not</div> expected to be material for periods subsequent to 2023. </div><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Assembled workforce </div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On January 21, 2021, the Company entered into an agreement to purchase the business assets of Current Insight, an engineering firm that develops designs for residential solar installations in a cost-effective manner for its customers. Consideration for the asset acquisition amounted to an aggregate purchase price of $0.2 million, comprised of a promissory note for $0.1 million and 30,000 shares of the Company’s common stock with an aggregate fair value of less than $0.1 million. The transaction was accounted for as an asset purchase in accordance with ASC 805, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Business Combinations</div></div>. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company concluded that tangible and other assets acquired in the transaction did not have material value and, as such, ascribed no consideration to them. The total purchase price was allocated exclusively to the acquired assembled workforce, which is amortized on a straight-line basis over an estimated useful life of two years. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Intangible assets consisted of the following (in thousands, except years data): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:47%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted-<br/>Average<br/>Remaining<br/>Life (Years)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Gross<br/>Carrying<br/>Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated<br/>Amortization</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net<br/>Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Gross<br/>Carrying<br/>Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated<br/>Amortization</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net<br/>Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Assembled workforce</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 137</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> (133</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 137</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(65</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 72</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table> P0Y1M6D 137000 -133000 4000 137000 -65000 72000 100000 100000 0 100000 100000 0 100 200000 100000 30000 100000 P2Y <div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(9)</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Accrued Expenses and Other Current Liabilities </div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Accrued expenses and other current liabilities consist of the following (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:80%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued compensation and benefits</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,940</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 3,498</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued term loan and revolving loan amendment and final payment fees</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,400</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Uninvoiced contract costs</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,914</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,180</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued legal settlements</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,853</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued taxes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,245</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued rebates and credits</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,076</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Inventory received but not invoiced</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">972</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating lease liabilities, current</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">958</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">390</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer deposits</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">930</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,375</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warranty provision, current</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">767</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other accrued liabilities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,775</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,304</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total accrued expenses and other current liabilities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19,830</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,347</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Accrued expenses and other current liabilities consist of the following (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:80%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued compensation and benefits</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,940</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 3,498</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued term loan and revolving loan amendment and final payment fees</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,400</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Uninvoiced contract costs</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,914</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,180</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued legal settlements</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,853</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued taxes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,245</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued rebates and credits</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,076</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Inventory received but not invoiced</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">972</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating lease liabilities, current</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">958</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">390</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer deposits</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">930</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,375</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warranty provision, current</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">767</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other accrued liabilities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,775</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,304</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total accrued expenses and other current liabilities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19,830</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,347</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 3940000 3498000 2400000 0 1914000 2180000 1853000 0 1245000 0 -1076000 0 972000 0 958000 390000 930000 1375000 767000 600000 3775000 1304000 19830000 9347000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(10)</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Fair Value Measurements </div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth the Company’s financial assets and liabilities that were measured at fair value, on a recurring basis (in thousands): </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following table presents a reconciliation of the Company’s financial liabilities measured at fair value as of December 31, 2022 using significant unobservable inputs (Level 3), and the change in fair value recorded in other income (expense), net in the accompanying consolidated statements of operations and comprehensive loss (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:71%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Warrant</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Convertible<br/>Debt<br/>Embedded<br/>Derivatives</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">SAFEs</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Balance as of December 31, 2020</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">799</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">579</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">91</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-A</div> Convertible Notes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">566</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of 2021-Rogers SAFE</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">330</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">336</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,306</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Balance as of December 31, 2021</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,129</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,481</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,397</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Conversion of debt into preferred shares</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,481</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Conversion of SAFEs into preferred shares</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(6,397</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Assumption of SAFEs in Solaria acquisition</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">60,470</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Conversion of SAFEs from Solaria acquisition into preferred shares</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(60,470</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Series D Warrants Tranche A</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,527</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Series D Warrants Tranche B</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,285</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,211</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Balance as of December 31, 2022</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 14,152</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The fair value of accounts receivable, accounts payable, and accrued expenses approximated their carrying values as of December 31, 2022 and December 31, 2021, due to their short-term nature. As of December 31, 2022, all of the Company’s outstanding debit is carried at an amortized cost basis. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">There were no transfers between Level 1, Level 2 or Level 3 fair value hierarchy categories of financial instruments for the years ended December 31, 2022 and December 31, 2021. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:70%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Financial Liabilities</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Redeemable convertible preferred stock warrant liability</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">  —   </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">  —   </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 14,152</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 14,152</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14,152</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14,152</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="font-size:1pt"> <td style="height:12pt"></td> <td colspan="16" style="height:12pt"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Financial Liabilities</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Redeemable convertible preferred stock warrant liability</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,129</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,129</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Convertible debt embedded derivatives</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,481</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,481</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SAFE agreements</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,397</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,397</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,007</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,007</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div></div><div><div style="line-height:normal;background-color:white;display: inline;"></div></div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Redeemable Convertible Preferred Stock Warrant Liability </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company historically issued redeemable convertible warrants to a bank to purchase shares of Series B preferred stock in February 2016 and issued redeemable convertible warrants to an investor to purchase shares of Series C preferred stock. Refer to Note 14 - Warrants. The Company issued Series D preferred stock warrants in conjunction with the merger agreement with Solaria. Refer to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Note 3-Business</div> Combination. The exercise prices for the two tranches of Series D preferred stock warrants are based on a future round of stock price, with an assumption of $2.50 and $5.00 upon consummation of a deSPAC acquisition and $2.04 and $4.09 upon remaining private, respectively. As the warrants have a contingent exercise price, the Company valuated the warrants based on a Black Scholes option pricing model, using a probability weighted estimate of the warrant valuations, given a deSPAC exist scenario and a stay private scenario, weighted at <span style="-sec-ix-hidden:hidden96295648">70</span>% and <span style="-sec-ix-hidden:hidden96295649">30</span>%, respectively. The following assumptions were used to calculate the fair value of the redeemable convertible preferred stock warrant liability: </div><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Series B Redeemable Convertible Preferred Stock Warrant </div></div></div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:79%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected term</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.1 years</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.1 years</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected volatility</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">72.5</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">73.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free interest rate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.2</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.1</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected dividend yield</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr></table><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Series C Redeemable Convertible Preferred Stock Warrant </div></div></div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:79%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected term</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.6 years</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.6 years</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected volatility</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">72.5</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">73.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free interest rate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.2</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected dividend yield</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr></table><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Series D Redeemable Convertible Preferred Stock Warrant </div></div></div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:77%"></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected term</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.5 years</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected volatility</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">78.5</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free interest rate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.7</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected dividend yield</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The redeemable convertible preferred stock warrant liabilities were measured at fair value at the issuance date and as of each subsequent fiscal year end with changes in the fair value recorded within other income (expense), net in the accompanying consolidated statements of operations and comprehensive loss. </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The table below reconciles the change in value of the redeemable convertible preferred stock warrant liability from each warrant to the total redeemable convertible preferred stock warrant liability recorded within the accompanying consolidated balance sheets (amounts in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:67%"></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Series B<br/>Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Series C<br/>Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Series D</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Tranche A<br/>Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Series D<br/>Tranche B<br/>Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Balance as of December 31, 2020</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">794</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">799</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">327</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">330</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Balance as of December 31, 2021</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,121</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,129</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,169</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,211</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of warrants in connection with acquisition of Solaria (Note 3)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,527</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,285</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,812</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Balance as of December 31, 2022</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 50</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 6,290</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 6,527</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 1,285</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 14,152</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Convertible Debt Embedded Derivatives </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-A</div> Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company recorded a convertible debt embedded derivative liability associated with the issuance of the 2019-A Convertible Notes. The derivative liability is recorded within derivative liability on the accompanying consolidated balance sheets. See Note 13 – Borrowing Arrangements. The fair value of the convertible debt embedded derivative liability was computed as the difference between the estimated value of the convertible debt with and without features that allow the holders to convert the notes at a discount upon the Company’s subsequent equity financing (“Next Equity Financing”). The 2019-A Convertible Notes also contain a feature to convert the notes at a price of $75.0 million divided by the fully diluted capitalization table (“2019-A Valuation Cap Conversion”), which is not bifurcated as an embedded derivative. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The fair value of the convertible notes with the embedded derivative is estimated based on a probability- weighted analysis of the discounted value of the notes converting under a Next Equity Financing, a change in control, default, or maturity. The significant assumptions included in the fair value of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-A</div> Convertible Notes with the embedded derivative liability include the time until a Next Equity Financing, the probabilities of the notes settling under each scenario, and a discount rate that reconciles the amount paid for the debt at issuance date, adjusted to reflect market changes subsequent to issuance. The fair value of the convertible notes without the embedded derivative liability is estimated based on the same methodology other than the settlement value upon a Next Equity Financing being set as the principal plus accrued interest, excluding the value of the conversion at a discount to the Next Equity Financing. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The embedded derivative liabilities in the convertible notes were measured at fair value at the issuance date and as of each subsequent fiscal year end with changes in the fair value recorded within other income (expense), net in the accompanying consolidated statements of operations and comprehensive loss. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The fair value of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-A</div> Convertible Notes was approximately $0.1 million as of December 31, 2021. The <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-A</div> Convertible notes and related derivative liability were extinguished in FY22 as part of the Series D redeemable convertible preferred stock issuance. </div><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-A</div> Convertible Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company recorded a convertible debt embedded derivative liability associated with the issuance of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-A</div> Convertible Notes. The derivative liability is recorded within derivative liability on the accompanying consolidated balance sheets. See Note 13 – Borrowing Arrangements. The fair value of the convertible debt embedded derivative liability was computed as the difference between the estimated value of the convertible debt with and without features that allow the holders to convert the notes at a discount upon the Company’s subsequent equity financing (“Next Equity Financing”). </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The fair value of the convertible notes with the embedded derivative is estimated based on a probability- weighted analysis of the discounted value of the notes converting under a Next Equity Financing, a change in control, default, or maturity. The significant assumptions included in the fair value of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-A</div> Convertible Notes with the embedded derivative liability include the time until a Next Equity Financing, the probabilities of the notes settling under each scenario, and a discount rate that reconciles the amount paid for the debt at issuance date, adjusted to reflect market changes subsequent to issuance. The fair value of the convertible notes without the embedded derivative liability is estimated based on the same methodology other than the settlement value upon a Next Equity Financing being set as the principal plus accrued interest, excluding the value of the conversion at a discount to the Next Equity Financing. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The embedded derivative liabilities in the convertible notes were measured at fair value at the issuance date and as of each subsequent fiscal year end with changes in the fair value recorded within other income (expense), net in the accompanying consolidated statements of operations and comprehensive loss. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The fair value of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-A</div> Convertible Notes was approximately $4.6 million as of December 31, 2021. The <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-A</div> Convertible notes and related derivative liability were extinguished as part of the Series D redeemable convertible preferred stock issuance. </div><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-A</div> Convertible Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company recorded a convertible debt embedded derivative liability associated with the issuance of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-A</div> Convertible Notes. The embedded derivative liability is recorded within derivative liability on the accompanying consolidated balance sheets. See Note 13 – Borrowing Arrangements. The fair value of the convertible debt embedded derivative liability was computed as the difference between the estimated value of the convertible debt with and without features that allow the holders to convert the notes at a discount upon the Company’s subsequent equity financing (“Next Equity Financing”). Certain of the notes from the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-A</div> Convertible Notes also contain a feature to convert the notes at a price of $200.0 million divided by the fully diluted capitalization table <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(“2021-A</div> Valuation Cap Conversion”), which is not bifurcated as an embedded derivative. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The fair value of the convertible notes with the embedded derivative is estimated based on a probability- weighted analysis of the discounted value of the notes converting under a Next Equity Financing, a change in control, default, or maturity. The significant assumptions included in the fair value of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-A</div> Convertible Notes with the embedded derivative liability include the time until a Next Equity Financing, the probabilities of the notes settling under each scenario, and a discount rate that reconciles the amount paid for the debt at issuance date, adjusted to reflect market changes subsequent to issuance. The fair value of the convertible notes without the embedded derivative liability is estimated based on the same methodology other than the settlement value upon a Next Equity Financing being set as the principal plus accrued interest, excluding the value of the conversion at a discount to the Next Equity Financing. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The embedded derivative liabilities in the convertible notes were measured at fair value at the issuance date and as of each subsequent fiscal year end with changes in the fair value recorded within other income (expense), net in the accompanying consolidated statements of operations and comprehensive loss. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The fair value of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-A</div> Convertible Notes was approximately $4.8 million as of December 31, 2021, respectively. The <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-A</div> Convertible notes and related derivative liability were extinguished as part of the Series D redeemable convertible preferred stock issuance. </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The table below reconciles the embedded derivative liability from each of the series of convertible notes to the total derivative liability recorded on the accompanying consolidated balance sheets (amounts in thousands) </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:63%"></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-A</div><br/>Convertible<br/>Notes</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-A</div><br/>Convertible<br/>Notes</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-A</div><br/>Convertible<br/>Notes</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Totals</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Balance as of December 31, 2020</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">561</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">579</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-A</div> Convertible Notes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">566</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">566</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">234</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">85</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">366</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Balance as of December 31, 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">35</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">795</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">651</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,481</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Extinguishment upon Series D issuance</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(35</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(795</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(651</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,481</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Balance as of December 31, 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> —  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Simple Agreement for Future Equity (“SAFE”) </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">2019 SAFE </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In July 2019, the Company entered into a SAFE agreement (“2019 SAFE”) with an investor. At the issuance date, the Company received $0.1 million in cash. The SAFE is classified as a liability in the scope of Accounting Standards Codification Topic 480 (“ASC 480”), <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Distinguishing Liabilities from Equity</div></div>, as the SAFE is redeemable upon events that are outside the control of the issuer. The 2019 SAFE converts to equity at the lower of $50.0 million divided by the fully diluted capitalization table (“2019 SAFE Valuation Cap Conversion”) and a 20% discount from the share price paid by other investors upon the Next Equity Financing. The SAFE also contains features that allow for cash settlement at the $0.1 million purchase price in the event of a liquidation or dissolution event. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The fair value of the 2019 SAFE was determined based on the probability-weighted expected return method (“PWERM”), which assigns value to the multiple settlement scenarios based on the probability of occurrence. The significant assumptions included in the fair value of the 2019 SAFE include the probability of conversion under a next equity financing (estimated between <span style="-sec-ix-hidden:hidden96295793">60</span>% at issuance and <span style="-sec-ix-hidden:hidden96295794">80</span>% as of December 31, 2022) and the realizable value upon a Next Equity Financing. The realizable value upon the Next Equity Financing was determined based on the following inputs that were included in a Black-Scholes model, which contains the following inputs: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:81%"></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected fair value of preferred stock</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">N/A</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.84</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected term</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">N/A</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.2 years</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Volatility</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">N/A</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><span style="-sec-ix-hidden:hidden96295795">76.4</span></td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free interest rate</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">N/A</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.1</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The 2019 SAFE was measured at fair value at the issuance date and as of each subsequent fiscal year end with changes in the fair value recorded within other income (expense), net in the consolidated statements of operations and comprehensive loss. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In March 2022, as part of the Company’s Series D preferred stock financing, the 2019 SAFE converted into shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">D-3</div> preferred stock. As part of the extinguishment of the 2019 SAFE, the Company recorded a gain of less than $0.1 million in other income (expense), net in the consolidated statements of operations and comprehensive loss. </div><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">2021 SAFE </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In December 2021, the Company entered into a SAFE agreement (“2021 SAFE”) with an investor. At the issuance date, the Company received $5.0 million in cash. The SAFE is classified as a liability in the scope of </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Accounting Standards Codification Topic 480 (“ASC 480”), <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Distinguishing Liabilities from Equity</div></div>, as the SAFE is redeemable upon events that are outside the control of the issuer. The 2021 SAFE converts to equity at the lower of $175.0 million divided by the fully diluted capitalization table (“2021 SAFE Valuation Cap Conversion”) and a 20% discount from the share price paid by other investors upon the Next Equity Financing. At the time of negotiating the SAFE, the Company was in advanced negotiations to raise its next equity financing. As such, the Company recorded the fair value of the 2021 SAFE based on the value to be received upon a conversion at a 20% discount from the Next Equity Financing. As a result, the Company recorded $1.3 million to other income (expense), net for the increase in the fair value of the 2021 SAFE over its issuance price. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In March 2022, as part of the Company’s Series D preferred stock financing, the 2021 SAFE converted into shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">D-1</div> preferred stock. As part of the extinguishment of the 2021 SAFE, the Company recorded a gain of $1.4 million in other income (expense), net in the consolidated statements of operations and comprehensive loss. </div><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">2022 SAFE </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In connection with the Solaria acquisition, Complete Solar Holdings entered into the SAFE Amendment, Assignment and Assumption Agreement whereby Complete Solar Holdings assumed the rights and interests in and obligations under the SAFE from Solaria immediately at the effective time of the acquisition of Solaria. In accordance with the terms and conditions of the Merger Agreement, the SAFE was required to be converted into redeemable convertible preferred stock of the Company within 10 business days of the close of the acquisition. Immediately subsequent to acquisition close, the SAFE converted into 8,171,662 shares of series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">D-8</div> redeemable convertible preferred stock. </div> The following table sets forth the Company’s financial assets and liabilities that were measured at fair value, on a recurring basis (in thousands): <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:70%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Financial Liabilities</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Redeemable convertible preferred stock warrant liability</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">  —   </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">  —   </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 14,152</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 14,152</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14,152</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14,152</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="font-size:1pt"> <td style="height:12pt"></td> <td colspan="16" style="height:12pt"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Financial Liabilities</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Redeemable convertible preferred stock warrant liability</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,129</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,129</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Convertible debt embedded derivatives</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,481</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,481</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SAFE agreements</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,397</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,397</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,007</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,007</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following table presents a reconciliation of the Company’s financial liabilities measured at fair value as of December 31, 2022 using significant unobservable inputs (Level 3), and the change in fair value recorded in other income (expense), net in the accompanying consolidated statements of operations and comprehensive loss (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:71%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Warrant</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Convertible<br/>Debt<br/>Embedded<br/>Derivatives</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">SAFEs</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Balance as of December 31, 2020</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">799</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">579</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">91</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-A</div> Convertible Notes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">566</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of 2021-Rogers SAFE</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">330</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">336</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,306</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Balance as of December 31, 2021</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,129</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,481</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,397</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Conversion of debt into preferred shares</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,481</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Conversion of SAFEs into preferred shares</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(6,397</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Assumption of SAFEs in Solaria acquisition</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">60,470</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Conversion of SAFEs from Solaria acquisition into preferred shares</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(60,470</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Series D Warrants Tranche A</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,527</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Series D Warrants Tranche B</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,285</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,211</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Balance as of December 31, 2022</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 14,152</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 799000 579000 91000 0 566000 0 0 0 5000000 330000 336000 1306000 1129000 1481000 6397000 0 -1481000 0 0 0 -6397000 0 0 60470000 0 0 -60470000 6527000 0 0 1285000 0 0 5211000 0 0 14152000 0 0 14152000 14152000 14152000 14152000 1129000 1129000 1481000 1481000 6397000 6397000 9007000 9007000 2.5 5 2.04 4.09 The following assumptions were used to calculate the fair value of the redeemable convertible preferred stock warrant liability: <div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Series B Redeemable Convertible Preferred Stock Warrant </div></div></div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:79%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected term</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.1 years</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.1 years</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected volatility</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">72.5</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">73.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free interest rate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.2</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.1</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected dividend yield</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr></table><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Series C Redeemable Convertible Preferred Stock Warrant </div></div></div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:79%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected term</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.6 years</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.6 years</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected volatility</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">72.5</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">73.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free interest rate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.2</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected dividend yield</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr></table><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Series D Redeemable Convertible Preferred Stock Warrant </div></div></div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:77%"></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected term</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.5 years</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected volatility</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">78.5</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free interest rate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.7</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected dividend yield</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table> P3Y1M6D P4Y1M6D 0.725 0.73 0.042 0.011 0 0 P3Y7M6D P4Y7M6D 0.725 0.73 0.04 0.012 0 0 P1Y6M 0.785 0 0.047 0 0 0 <div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The table below reconciles the change in value of the redeemable convertible preferred stock warrant liability from each warrant to the total redeemable convertible preferred stock warrant liability recorded within the accompanying consolidated balance sheets (amounts in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:67%"></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Series B<br/>Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Series C<br/>Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Series D</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Tranche A<br/>Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Series D<br/>Tranche B<br/>Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Balance as of December 31, 2020</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">794</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">799</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">327</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">330</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Balance as of December 31, 2021</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,121</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,129</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,169</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,211</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of warrants in connection with acquisition of Solaria (Note 3)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,527</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,285</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,812</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Balance as of December 31, 2022</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 50</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 6,290</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 6,527</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 1,285</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 14,152</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 5000 794000 0 0 799000 3000 327000 0 0 330000 8000 1121000 0 0 1129000 42000 5169000 0 0 5211000 0 0 6527000 1285000 7812000 50000 6290000 6527000 1285000 14152000 75000000 100000 4600000 200000000 4800000 <div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The table below reconciles the embedded derivative liability from each of the series of convertible notes to the total derivative liability recorded on the accompanying consolidated balance sheets (amounts in thousands) </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:63%"></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-A</div><br/>Convertible<br/>Notes</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-A</div><br/>Convertible<br/>Notes</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-A</div><br/>Convertible<br/>Notes</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Totals</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Balance as of December 31, 2020</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">561</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">579</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-A</div> Convertible Notes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">566</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">566</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">234</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">85</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">366</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Balance as of December 31, 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">35</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">795</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">651</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,481</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Extinguishment upon Series D issuance</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(35</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(795</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(651</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,481</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Balance as of December 31, 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> —  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 18000 561000 0 579000 0 0 566000 566000 17000 234000 85000 366000 35000 795000 651000 1481000 -35000 -795000 -651000 -1481000 0 0 0 0 100000 50000000 0.20 100000 The realizable value upon the Next Equity Financing was determined based on the following inputs that were included in a Black-Scholes model, which contains the following inputs: <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:81%"></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="4" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected fair value of preferred stock</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">N/A</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.84</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected term</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">N/A</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.2 years</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Volatility</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">N/A</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><span style="-sec-ix-hidden:hidden96295795">76.4</span></td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free interest rate</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">N/A</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.1</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr></table> 4840 0.2 0.1 100000 5000000 175000000 0.20 0.20 1300000 1400000 8171662 <div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(11)</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Employee Benefit Plan </div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company sponsors a 401(k) defined contribution and profit-sharing plan (“401(k) Plan”) for its eligible employees. This 401(k) Plan provides for <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">tax-deferred</div> salary deductions for all eligible employees. Employee contributions are voluntary. Employees may contribute the maximum amount allowed by law, as limited by the annual maximum amount as determined by the Internal Revenue Service. The Company may match employee contributions in amounts to be determined at the Company’s sole discretion. The Company made no contributions to the 401(k) Plan for the years ended December 31, 2022, 2021 and 2020. </div> <div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(12)</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Other Income (Expense), Net </div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Other income (expense), net consists of the following (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:74%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Years Ended December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value of SAFE agreements</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> (1,306</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> (15</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value of derivative liabilities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(336</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(50</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value of warrant liabilities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(5,211</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(330</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">24</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Gain on extinguishment of convertible notes and SAFE agreements<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,235</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Forgiveness of Paycheck Protection Plan loan</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,754</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other, net</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">118</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(22</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total other income (expense), net</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> (1,858</td> <td style="white-space:nowrap;vertical-align:bottom">)</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(240)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> (41</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">Includes $1.4 million of other income recognized upon the conversion of related party convertible notes and SAFEs </div></div></td></tr></table> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Other income (expense), net consists of the following (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:74%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Years Ended December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value of SAFE agreements</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> (1,306</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> (15</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value of derivative liabilities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(336</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(50</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value of warrant liabilities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(5,211</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(330</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">24</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Gain on extinguishment of convertible notes and SAFE agreements<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,235</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Forgiveness of Paycheck Protection Plan loan</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,754</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other, net</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">118</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(22</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total other income (expense), net</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> (1,858</td> <td style="white-space:nowrap;vertical-align:bottom">)</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(240)</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> (41</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">Includes $1.4 million of other income recognized upon the conversion of related party convertible notes and SAFEs </div></div></td></tr></table> 0 -1306000 -15000 0 -336000 -50000 -5211000 -330000 24000 3235000 0 0 0 1754000 0 118000 -22000 0 -1858000 -240000 -41000 1400000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(13)</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Common Stock </div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company has authorized the issuance of 28,978,046 and 13,547,878 shares of common stock as of December 31, 2022 and December 31, 2021, respectively. </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company has reserved shares of common stock for issuance related to the following redeemable convertible preferred stock, stock options, common stock warrants, redeemable convertible preferred stock warrants, and future grants: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:78%"></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common stock warrants</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,389,005</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">690,236</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock options, issued and outstanding</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,970,395</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,135,454</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock options, authorized for future issuance</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">369,907</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">141,644</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SAFE agreement</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">341,604</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Convertible notes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,621,299</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total shares reserved</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,729,307</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,930,237</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 28978046 13547878 <div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company has reserved shares of common stock for issuance related to the following redeemable convertible preferred stock, stock options, common stock warrants, redeemable convertible preferred stock warrants, and future grants: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:78%"></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common stock warrants</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,389,005</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">690,236</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock options, issued and outstanding</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,970,395</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,135,454</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock options, authorized for future issuance</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">369,907</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">141,644</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SAFE agreement</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">341,604</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Convertible notes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,621,299</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total shares reserved</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,729,307</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,930,237</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 3389005 690236 4970395 2135454 369907 141644 0 341604 0 1621299 8729307 4930237 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(14)</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Warrants </div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Series B Warrants (Converted to Common Stock Warrants) </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In February 2016, the Company issued a warrant to purchase 5,054 shares of Series B preferred stock (the “Series B warrant”) in connection with the 2016 Credit Facility. The Series B warrant is immediately exercisable at an exercise price of $4.30 per share and has an expiration date of February 2026. The fair value of the Series B warrant, as determined in accordance with the methodology described in Note 10 – Fair Value Measurements, was less than $0.1 million as of December 31, 2022 and December 31, 2021, respectively. The relative fair value of the Series B warrant at issuance was recorded into debt issuance costs and other non-current liabilities on the accompanying consolidated balance sheets, and changes in fair value have been recorded in other income (expense), net on the accompanying consolidated statements of operations and comprehensive loss for the years ended December 31, 2022, 2021 and 2020. </div><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Series C Warrants (Converted to Common Stock Warrants) </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In July 2016, the Company issued a warrant to purchase 148,477 shares of Series C preferred stock (the “Series C warrant”) in connection with the Series C financing. The Series C warrant agreement also provided for an additional number of Series C shares calculated on a monthly basis commencing on June 2016 based on the principal balance outstanding of the notes payable outstanding. The maximum number of shares exercisable under the Series C warrant agreement is 482,969 shares of Series C preferred stock. The Series C warrant was immediately exercisable at an exercise price of $1.00 per share and has an expiration date of July 2026. The fair value of the Series C warrant, as determined in accordance with the methodology described in Note 10 – Fair Value Measurements, was $6.3 million and $1.1 million as of December 31, 2022 and December 31, 2021, respectively. The relative fair value of the Series C warrant at issuance as recorded as Series C preferred stock issuance costs and other non-current liabilities on the accompanying consolidated balance sheets, and changes in fair value have been recorded in other income (expense), net on the accompanying consolidated statements of operations and comprehensive loss for the years ended December 31, 2022, 2021 and 2020. </div><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Series C-1 Warrants (Converted to Common Stock Warrants) </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In January 2020, the Company issued a warrant to purchase 173,067 shares of common stock in conjunction with the Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">C-1</div> preferred stock financing. The warrant is immediately exercisable at an exercise price of $0.01 per share and has an expiration date of January 2030. The warrant remains outstanding as of December 31, 2022. At issuance, the relative fair value of the warrant was determined to be $0.1 million using the Black-Scholes model, which was recorded within additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital on the consolidated balance sheets. The warrant is not remeasured in future periods as it meets the conditions for equity classification. </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">SVB Common Stock Warrants </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In May and August 2021, the Company issued warrants to purchase 2,472 and 2,525 shares of common stock, respectively, in conjunction with the Fifth and Sixth Amendments to the Loan and Security Agreement with Silicon Valley Bank. The warrants are immediately exercisable at exercise prices of $0.38 and $0.62 per share, respectively, and have expiration dates in 2033. The warrants remain outstanding as of December 31, 2022. At issuance, the relative fair value of the warrants were determined to be less than $0.1 million in aggregate using the Black-Scholes model, which was recorded within additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in-capital</div></div> on the accompanying consolidated balance sheets. The warrants are not remeasured in future periods as they meet the conditions for equity classification. </div><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Promissory Notes Common Stock Warrants </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In October 2021, the Company issued a warrant to purchase 24,148 shares of common stock in conjunction with the issuance of a short-term promissory note. The warrant is immediately exercisable at an exercise price of $0.01 per share and has an expiration date of October 2031. The warrant remains outstanding as of December 31, 2022. At issuance, the relative fair value of the warrant was determined to be less than $0.1 million using the Black-Scholes model, which was recorded within additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital on the consolidated balance sheets. The warrant is not remeasured in future periods as it meets the conditions for equity classification. </div><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Carlyle Warrants </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In February 2022, as part of a debt financing from CRSEF Solis Holdings, LLC (“Carlyle”) (refer to Note 13 – Borrowing Arrangements), the Company issued a warrant to purchase 2,887,643 shares of common stock in conjunction with the redeemable investment in CS Solis. The warrant contains two tranches, the first of which is immediately exercisable for 1,995,870 shares. The second tranche, which was determined to be a separate unit of account, was exercisable upon a subsequent investment from Carlyle in CS Solis. No subsequent investment was made and investment period expired on December 31, 2022 and the second tranche of warrants expired prior to becoming exercisable. The vested warrant has an exercise price of $0.01 per share and has an expiration date of February 2029. The warrant remains outstanding as of December 31, 2022. At issuance, the relative fair value of the warrant was determined to be $3.4 million using the Black-Scholes model, which was recorded within additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital and as a discount on the long-term debt in CS Solis on the consolidated balance sheets. The warrant is not remeasured in future periods as it meets the conditions for equity classification. </div><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Series D-7 Warrants (Converted to Common Stock Warrants) </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In November 2022, the company issued warrants to purchase 656,630 shares of Series D-7 preferred stock (the “Series D-7 warrants”) in conjunction with the merger agreement with Solaria. The warrant contains two tranches. The first tranche of 518,752 shares of Series D-7 preferred stock is exercisable at an exercise price of $2.50 per share upon consummation of a deSPAC transaction, or at an exercise price of $2.04 per share upon remaining private and has an expiration date of April 2024. The second tranche of 137,878 shares of Series D-7 preferred stock is exercisable at an exercise price of $<div style="display:inline;">5.00</div> per share upon consummation of a deSPAC transaction, or at an exercise price of $<div style="display:inline;">4.09</div> per share upon remaining private and has an expiration date of April 2024. The warrants remain outstanding as of December 31, 2022. The fair value of the Series D-7 warrants, as determined in accordance with the methodology described in Note 10 – Fair Value Measurements, was $<div style="display:inline;">7.8</div> million as of December 31, 2022. All of the Series B, Series C, and Series D preferred stock warrants remained outstanding as of December 31, 2022 and December 31, 2021. </div><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">November 2022 Common Stock Warrants </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In November 2022, the Company issued a warrant to a third-party service provider to purchase 38,136 shares of common stock in conjunction with the Business Combination. The warrant is immediately </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">exercisable at an exercise price of $8.00 per share and has an expiration date of April 2024. The warrant remains outstanding as of December 31, 2022. At issuance, the relative fair value of the warrant was determined to be $0.1 million using the Black-Scholes model, which was recorded within additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital on the consolidated balance sheets. The warrant is not remeasured in future periods as it meets the conditions for equity classification. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following assumptions were used to calculate the fair value of the common stock warrants issued: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:65%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Years Ended December 31,</div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;">2022</td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;">2021</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected term</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="display:inline;">1.5 </div>- 7.0 years</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10.0 - 12.0 years</div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected volatility</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">73.0 - 78.5%</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">73.0%</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free interest rate</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;text-align:center;">1.9 - 4.7%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">1.3% - 1.7%</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected dividends</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">0.0%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">0.0%</td></tr></table> 5054 4.3 100000 100000 148477 482969 1 6300000 1100000 173067 0.01 100000 2472 2525 0.38 0.62 100000 24148 0.01 100000 2887643 1995870 0.01 3400000 656630 The first tranche of 518,752 shares of Series D-7 preferred stock is exercisable at an exercise price of $2.50 per share upon consummation of a deSPAC transaction, or at an exercise price of $2.04 per share upon remaining private and has an expiration date of April 2024. The second tranche of 137,878 shares of Series D-7 preferred stock is exercisable at an exercise price of $5.00 per share upon consummation of a deSPAC transaction, or at an exercise price of $4.09 per share upon remaining private and has an expiration date of April 2024. The warrants remain outstanding as of December 31, 2022. The fair value of the Series D-7 warrants, as determined in accordance with the methodology described in Note 10 – Fair Value Measurements, was $7.8 million as of December 31, 2022. 518752 2.5 38136 8 100000 <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following assumptions were used to calculate the fair value of the common stock warrants issued: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:65%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Years Ended December 31,</div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;">2022</td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;">2021</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected term</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="display:inline;">1.5 </div>- 7.0 years</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10.0 - 12.0 years</div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected volatility</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">73.0 - 78.5%</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">73.0%</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free interest rate</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;text-align:center;">1.9 - 4.7%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">1.3% - 1.7%</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected dividends</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom">0.0%</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:center;">0.0%</td></tr></table> 1.5 7 10 12 73 78.5 73 1.9 4.7 1.3 1.7 0 0 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(15)</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Borrowing Arrangements </div></div></td></tr></table><div style="margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Convertible notes, net and convertible notes, net due to related parties </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As of December 31, 2022 and December 31, 2021, the Company’s convertible notes consisted of the following (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:81%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Convertible notes, net</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-A</div> Convertible Notes</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">115</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-A</div> Convertible Notes</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">630</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-A</div> Convertible Notes</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,145</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Convertible notes, net</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,890</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Convertible notes, net due to related parties</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-A</div> Convertible Notes</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,260</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-A</div> Convertible Notes</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,050</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Convertible Promissory Notes with Ecosystem Integrity Fund II, LP.</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">510</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Convertible notes, net due to related parties</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,820</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Convertible notes, net, noncurrent</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2022 Convertible Notes</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,434</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Convertible notes, net, noncurrent</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,434</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Convertible notes, net due to related parties, noncurrent</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2022 Convertible Notes</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">15,510</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Convertible notes, net due to related parties, noncurrent</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">15,510</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total convertible notes</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18,944</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,710</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Convertible Promissory Notes with Ecosystem Integrity Fund II, LP. </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On April 30, 2021, the Company issued a short-term Subordinated Convertible Promissory Note to Ecosystem Integrity Fund II, LP (“EIF”) for a total principal of $0.5 million plus accrued interest of 3.0% per annum due on June 30, 2021. The Note included a conversion feature which allows the holder to convert any portion of the note plus any unpaid accrued interest (“Conversion Amount”) into shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">C-1</div> Preferred Stock on the maturity date of June 30, 2021 or thereafter. As of December 31, 2021 the principal and accrued interest remained outstanding and the holder did not elect to covert the note into Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">C-1</div> Preferred shares. The principal and accrued interest of $0.5 million was repaid in February 2022. </div><div></div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-A</div> Convertible Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In 2019, the Company issued a series of convertible notes <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(“2019-A</div> Convertible Notes”) for $0.1 million in proceeds, with immaterial debt issuance costs, and which were due and payable on demand by the holders after August 2020. The notes carried simple interest of 6.0% and contained a conversion feature whereby the notes would convert at 80% of the issuance price of the preferred shares in the next equity financing. The notes also contained other embedded features such as conversion options that were exercisable upon the occurrence of various contingencies. All of the embedded features were analyzed to determine whether they should be bifurcated and separately accounted for as a derivative. Pursuant to such analysis, the Company valued and bifurcated the share-settled redemption feature, which enabled the holders to convert the notes to the preferred shares at a predefined discount from the issuance price and recorded its initial fair value of less than $0.1 million as a discount on the convertible notes face amount. The debt discount was amortized to interest expense at a weighted-average effective interest rate of 17.6% through the maturity dates of the notes. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The fair value of the share-settled redemption feature was determined in accordance with the methodology described in Note 8 – Fair Value Measurements, and the changes in fair value were recognized as a component of other income (expense), net in the accompanying consolidated statements of operations and comprehensive loss. The Company recorded zero, less than $0.1 million, and less than $0.1 million in expense during the years ended December 31, 2022, 2021 and 2020, respectively, related to the change in the fair value of the convertible notes embedded derivative liability. The convertible notes were carried within the accompanying consolidated balance sheets at their original issuance value, net of unamortized debt discount and issuance costs. In March 2022, as part of the Company’s Series D Preferred Stock issuance, the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-A</div> Convertible Notes converted into 62,500 shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">D-2</div> redeemable convertible preferred stock. The Company recognized a loss on the conversion of less than $0.1 million in other income (expense), net on the consolidated statements of operations and comprehensive loss. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The net carrying amount of the convertible notes was as follows (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:83%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Principal</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unamortized debt discount</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">PIK interest added to principal balance</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">16</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">15</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Conversion to Series D-2 redeemable convertible preferred stock</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(116</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net carrying amount</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">115</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Interest expense related to the convertible notes was as follows (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:81%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Amortization of debt discount</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">PIK interest</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> interest expense</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-A</div> Convertible Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In 2020, the Company issued a series of convertible notes <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(“2020-A</div> Convertible Notes”) for $3.8 million in proceeds, with immaterial debt issuance costs, and which are due and payable on demand by the holders after April 2021. The notes carried simple interest of 2.0% and contained a conversion feature whereby the </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">notes would convert at 80% of the issuance price of the preferred shares in the next equity financing. The notes also contained other embedded features such as conversion options that were exercisable upon the occurrence of various contingencies. All of the embedded features were analyzed to determine whether they should be bifurcated and separately accounted for as a derivative. Pursuant to such analysis, the Company valued and bifurcated the share-settled redemption feature, which enables the holders to convert the notes to the preferred shares at a predefined discount from the issuance price and recorded its initial fair value of $0.5 million as a discount on the convertible notes face amount. The debt discount was amortized to interest expense at a weighted-average effective interest rate of 25.6% through the maturity dates of the notes. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The fair value of the share-settled redemption feature was determined in accordance with the methodology described in Note 8 – Fair Value Measurements, and the changes in fair value were recognized as a component of other income (expense), net in the accompanying consolidated statements of operations and comprehensive loss. The Company recorded zero, less than $0.1 million, and less than $0.1 million in expense during the years ended December 31, 2022, 2021 and 2020 respectively, related to the change in the fair value of the convertible notes embedded derivative liability. The convertible notes were carried within the accompanying consolidated balance sheets at their original issuance value, net of unamortized debt discount and issuance costs. In March 2022, as part of the Company’s Series D Preferred Stock issuance, the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-A</div> Convertible Notes converted into 785,799 shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">D-1</div> redeemable convertible preferred stock. The Company recognized a gain on the conversion of $0.9 million in other income (expense), net on the consolidated statements of operations and comprehensive loss. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The net carrying amount of the convertible notes was as follows (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:82%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Principal</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,784</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,784</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unamortized debt discount</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">PIK interest added to principal balance</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">122</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">106</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Conversion to Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">D-1</div> redeemable convertible preferred stock</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(3,906</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net carrying amount</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,890</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Interest expense related to the convertible notes was as follows (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:82%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Amortization of debt discount . . . . . . . . . . . . . . . . . . . . . . . . .</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">281</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">235</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">PIK interest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">16</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">74</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">32</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> interest expense . . . . . . . . . . . . . . . . . . . . . . . .</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">16</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">355</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">267</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-A</div> Convertible Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In 2020, the Company issued a series of convertible notes <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(“2021-A</div> Convertible Notes”) for $4.3 million in proceeds, with immaterial debt issuance costs, and which are due and payable on demand by the holders after February 2022. The holders are existing investors and are not expected to demand cash settlement, as the Company expects to raise additional preferred financing under which the notes will convert into preferred shares. The notes carry simple interest of 2.0% and contained a conversion feature whereby the notes would convert at 80% of the issuance price of the preferred shares in the next equity financing. The notes also contained other embedded features such as conversion options that were exercisable upon the occurrence of various contingencies. All of the embedded features were analyzed to determine whether they should be bifurcated and separately accounted for as a derivative. Pursuant to such analysis, the Company </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">valued and bifurcated the share-settled redemption feature, which enables the holders to convert the notes to the preferred shares at a predefined discount from the issuance price and recorded its initial fair value of $0.6 million as a discount on the convertible notes face amount. The debt discount is amortized to interest expense at a weighted-average effective interest rate of 18.1% through the maturity dates of the notes. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The fair value of the share-settled redemption feature was determined in accordance with the methodology described in Note 10 – Fair Value Measurements, and the changes in fair value were recognized as a component of other income (expense), net in the consolidated statements of operations and comprehensive loss. The Company recorded zero and $0.2 million and in expense during the year ended December 31, 2022 and December 31, 2021, respectively, related to the change in the fair value of the convertible notes embedded derivative liability. The convertible notes were carried on the consolidated balance sheets at their original issuance value, net of unamortized debt discount and issuance costs. In March 2022, as part of the Company’s Series D Preferred Stock issuance, the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-A</div> Convertible Notes converted into 869,640 shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">D-1</div> redeemable convertible preferred stock. The Company recognized a gain on the conversion of $0.8 million in other income (expense), net on the consolidated statements of operations and comprehensive loss. </div><div style="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The net carrying amount of the convertible notes was as follows (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:82%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Principal</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unamortized debt discount</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(112</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">PIK interest added to principal balance</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">74</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">57</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Conversion to Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">D-1</div> redeemable convertible preferred stock</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4,324</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net carrying amount</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,195</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Interest expense related to the convertible notes was as follows (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:82%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Amortization of debt discount . . . . . . . . . . . . . . . . . . . . . . . . .</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">112</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">454</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">PIK interest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">57</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> interest expense . . . . . . . . . . . . . . . . . . . . . . . .</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">129</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">511</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As part of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-A</div> Convertible Notes financing, the Company entered into an additional convertible note with an existing investor for $0.5 million. The note carries PIK interest of 3.0% and is due and payable on demand at any time after June 30, 2021. The note contains an embedded conversion feature, which allows the holder to convert the note into a fixed number of shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">C-1</div> preferred stock at any time after </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">June 30, 2021. The Company concluded the conversion feature is not required to be bifurcated as an embedded derivative liability, and the note is carried at its principal plus accrued PIK interest. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The net carrying amount of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-A</div> convertible note without an embedded derivative liability was as follows (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:83%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Principal</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unamortized debt discount</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">PIK interest added to principal balance</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Repayment of principal and accrued interest</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(510</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net carrying amount</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">510</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Interest expense related to the note was as follows (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:82%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Amortization of debt discount</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">PIK interest</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> interest expense</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">2022 Convertible Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In connection with the Business Combination Agreement, the Company has raised a series of convertible notes (“2022 Convertible Notes”) in November 2022, December 2022, and February 2023 with additional investors, with an aggregate purchase price of $12.0 million. Additionally, as part of the acquisition of Solaria, the Company assumed a note from an existing investor for its fair value of $6.7 million. The note contains the same terms as the other 2022 Convertible Notes. The Company did not incur significant issuance costs associated with the 2022 Convertible Notes. The 2022 Convertible Notes will convert to common shares of Complete Solaria, Inc. at the close of the deSPAC transaction. The 2022 Convertible Notes accrue interest at a rate of 5% per annum. Immediately prior to the closing of the expected deSPAC transaction, the 2022 Convertible Notes will be converted into that number of shares of common stock of Complete Solaria equal to (x) the principal amount together with all accrued interest of the 2022 Convertible Notes divided by 0.75, divided by (y) the price of a share of common stock of Complete Solaria used to determine the conversion ratio in the Business Combination Agreement. As of December 31, 2022, the 2022 Convertible Notes have accrued $0.2 million. The carrying values of $15.5 million and $3.4 million are recorded within convertible notes, net due to related parties and convertible notes, net on the consolidated balance sheets, respectively, as of December 31, 2022. As of December 31, 2022, the total estimated fair value of the Company’s 2022 Convertible Notes was $19.8 million, which was estimated based on Level 3 inputs. </div><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">SAFE Agreements </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">2019 SAFE </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In September 2019, the Company issued the 2019 SAFE for $0.1 million in proceeds, with immaterial debt issuance costs. No interest was accrued on the 2019 SAFE. The 2019 SAFE contained conversion features that allowed the holder to convert the 2019 SAFE into shares of preferred stock upon the next equity financing, subject to a valuation cap. The 2019 SAFE was reported at fair value in accordance with the methodology described in Note 8 – Fair Value Measurements. The fair value of the 2019 SAFE was $0.2 million as of December 31, 2021 which is recorded in SAFE Agreements in the accompanying consolidated balance sheets. In March 2022, the Company converted the 2019 SAFE into 48,258 shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">D-3</div> redeemable convertible preferred stock. The Company recognized a gain on the conversion of the 2019 SAFE of less than $0.1 million in other income (expense), net on the consolidated statements of operations and comprehensive loss. </div><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">2021 SAFE </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In December 2021, the Company issued the 2021 SAFE for $5.0 million in proceeds, with immaterial debt issuance costs. No interest is accrued on the 2021 SAFE. The 2021 SAFE contained conversion features that allowed the holder to convert the 2021 SAFE into shares of preferred stock upon the next equity financing, subject to a valuation cap. The 2021 SAFE was reported at fair value in accordance with the methodology described in Note 10 – Fair Value Measurements. The fair value of the 2021 SAFE was $6.3 million as of December 31, 2021 which is recorded in SAFE Agreements in the accompanying consolidated balance sheets. In </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">March 2022, the Company converted the 2021 SAFE into 1,005,366 shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">D-1</div> redeemable convertible preferred stock. The Company recognized a gain on the conversion of the 2021 SAFE of $1.4 million in other income (expense), net on the consolidated statements of operations and comprehensive loss. </div><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Solaria SAFE </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As part of the acquisition of Solaria (refer to Note 4 – Business Combination) the Company acquired the Solaria SAFEs. The number of shares to be issued upon conversion of the SAFE notes contained various features to convert or redeem the Solaria SAFEs in the event of an equity financing, public offering, change of control or a dissolution event. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company historically elected to account for all of the SAFE notes at estimated fair value pursuant to the fair value option and recorded the change in estimated fair value as other income (expense), net in the consolidated statements of operations and comprehensive loss until the notes are converted or settled. The SAFE notes were amended through the SAFE Assumption Amendment, Assignment and Assumption Agreement on November 4, 2022, as part of the merger with Complete Solar, whereby all the SAFE notes were assumed by Complete Solar. As part of the purchase price accounting discussed in Note 4 - Business Combination, the estimated fair value of the SAFE notes was determined to be $60.5 million. Post consummation of the merger the SAFE notes were converted to 8,171,662 shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">D-8</div> preferred stock as discussed in Note 4 - Business Combination. </div><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Notes Payable </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Loan and Security Agreement </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In January 2020, the Company entered into a Loan and Security Agreement (the “Loan Agreement”) with Silicon Valley Bank (“SVB”). The Loan Agreement, as amended, provided for a line of credit up to $7.0 million and has a maturity date of February 2022. Advances under the line of credit bore interest at the greater of 5.25% or the prime rate (as published in the Wall Street Journal) plus 3.5% per annum. All borrowings under the line of credit were to be secured by substantially all of the Company’s assets. As of December 31, 2021, the Company had outstanding borrowings under the line of credit of $7.0 million. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">During 2021, the Company entered into several amendments to the Loan Agreement, and in May and August 2021 in connection with the Fifth and Sixth Amendments, the Company issued warrants to purchase 5,122 shares and 5,229 shares of common stock at exercise prices of $0.38 per share and $0.62 per share, respectively. The fair value of the warrants were recorded as deferred issuance costs and amortized to interest expense. As of December 31, 2022 and December 31, 2021, there were no unamortized debt issuance costs. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Under the Loan Agreement, the Company was subject to certain reporting covenants, such as a requirement for the Company’s monthly unaudited financial statements and Compliance Certificate, as well as a financial covenant to maintain a minimum liquidity ratio of 1.75 to 1.00. In 2021, the Loan Agreement was amended to add a new financial covenant, requiring the Company to obtain new equity of at least $15.0 million by a specified date, which the Company did not meet; however, the default was later waived by SVB. The Company was in compliance with all reporting and financial covenants as of December 31, 2021. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In February 2022, as part of the transaction to raise long-term debt in CS Solis, the Company repaid the principal and accrued interest of the Loan Agreement of $6.7 million, which terminated the agreement with SVB. </div><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">2021 Promissory Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In July 2021, the Company issued a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">short-term</div> promissory note for $0.5 million in proceeds, with immaterial debt issuance costs. The promissory note carried simple interest of 2.0% and were due and payable after February 2022. As of December 31, 2021, the carrying value of the promissory note was </div> <div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">$0.5 million and was recorded in Notes Payable in the accompanying consolidated balance sheets. In February 2022, the Company repaid the 2021 Promissory Note, and no amounts remain outstanding as of December 31, 2022. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In October 2021, the Company issued a short-term promissory note for $2.0 million in proceeds, with immaterial debt issuance costs. The promissory note contained a financing fee of $0.3 million, which was due and payable along with the principal amount in January 2022. In connection with the promissory note, the Company issued a warrant to purchase 50,000 shares of common stock at an exercise price of $0.01 per share. The fair value of the warrant was recorded as a debt discount and amortized to interest expense. As of December 31, 2021, the carrying value of the promissory note was $2.0 million, which was recorded in Notes Payable in the accompanying consolidated balance sheets, and the remaining unamortized debt discount was nil. The principal and accrued interest of the note payable was repaid in January 2022, and no amounts remain outstanding as of December 31, 2022. </div> <div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Paycheck Protection Program Loan </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In April 2020 and April 2021, the Company received loans in principal amounts of $0.9 million and $0.9 million, respectively, under the Paycheck Protection Program (the “PPP Loans”), which was established under the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) administered by the U.S. Small Business Administration (the “SBA”). The PPP Loans were evidenced by promissory notes and bore interest at 1% with no payments for the first 6 months. The PPP Loans were subject to partial or full forgiveness if the Company used all proceeds for eligible purposes, maintained certain employment levels and maintained certain compensation levels in accordance with and subject to the CARES Act and the rules, regulations and guidance. In June and October 2021, the principal and accrued interest on the PPP Loans were forgiven. </div> <div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Current Insight Promissory Note </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In January 2021, the Company issued a promissory note for principal of $0.1 million in connection with the purchase of Current Insight, with immaterial debt issuance costs. The promissory note bears interest at 0.14% per annum and has equal monthly installments due and payable through the maturity date of January 2022. As of December 31, 2021, the carrying value of the promissory note was less than $0.1 million. The principal and accrued interest was repaid in January 2022 and no amounts remain outstanding as of December 31, 2022. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes the Company’s outstanding notes payable (in thousands): </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:84%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">  2022  </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">  2021  </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Loan and Security Agreement</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,987</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2021 Promissory Notes</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Current Insight Promissory Note</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,507</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: Unamortized debt issuance costs and discounts</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,507</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">2018 Bridge Notes </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In December 2018, Solaria Corporation issued senior subordinated convertible secured notes (“2018 Notes”) totaling approximately $3.4 million in exchange for cash. The notes bear interest at the rate of 8% per annum and the investors are entitled to receive twice of the face value of the notes at maturity. The 2018 Notes are secured by substantially all of the assets of Solaria Corporation. In 2021, the 2018 Notes were amended extending the maturity date to December 13, 2022. In connection with the 2021 amendment, </div> <div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Solaria had issued warrants to purchase shares of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Series E-1</div> redeemable convertible preferred stock of Solaria. The warrants were exercisable immediately in whole or in part at and expire on December 13, 2031. As part of the merger with Complete Solar, all the outstanding warrants issued to the lenders were assumed by the parent company, Complete Solaria as discussed in Note 4 – Business Combination. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As part of the purchase price accounting discussed in Note 4 – Business Combination, the estimated fair value of the 2018 Notes was determined to be $9.1 million. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In December 2022, the Company entered into an amendment to the 2018 Notes extending the maturity date from December 13, 2022 to December 13, 2023. In connection with the amendment, the notes will continue to bear interest at 8% per annum and are entitled to an increased repayment premium from 110% to 120% of the principal and accrued interest at the time of repayment. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company concluded that the modification was a troubled debt restructuring as the Company was experiencing financial difficulty and the amended terms resulted in a concession to the Company. As the future undiscounted cash payments under the modified terms exceeded the carrying amount of the Solaria 2018 Notes on the date of modification, the modification was accounted for prospectively. The incremental repayment premium is being amortized to interest expense using the effective interest rate method. As of December 31, 2022, the carrying value of the 2018 Notes was $9.8 million. Interest expense recognized from the date of the acquisition through December 31, 2022 was $0.7 million. As of December 31, 2022, the total estimated fair value of the Company’s 2018 Bridge Notes was $9.1 million, which was estimated based on Level 3 inputs. </div> <div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">SCI Term Loan and Revolver Loan </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In October 2020, Solaria entered into a loan agreement (“Loan Agreement”) with Structural Capital Investments III, LP (“SCI”). </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Loan Agreement with SCI comprises of two facilities, a term loan (the “Term Loan”) and a revolving loan (the “Revolving Loan”) (together “Original Agreement”) for $5.0 million each with a maturity date of October 31, 2023. Both the Term Loan and the Revolving Loan were fully drawn upon closing. The Term Loan was repaid prior to the acquisition of Solaria by Complete Solar and was not included in the business combination. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Revolving Loan also has a term of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">thirty-six</div> months, principal repayments at the end of the term and an annual interest rate of 7.75% or Prime rate plus 4.5%, whichever is higher. The Loan Agreement required the Company to meet certain financial covenants relating to maintenance of specified restricted cash balance, achieving specified revenue target and maintaining specified contribution margin (“Financial covenants”) over the term of each of the Revolving Loan. The Revolving Loan is collateralized substantially by all assets and property of the Company. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In the years ended December 31, 2022 and December 31, 2021, Solaria entered into several Amended and Restated Loan and Security Agreements as a forbearance agreement for SCI to forbear from exercising any rights and remedies available to it as a result of Company not meeting certain Financial Covenants required by the Original Agreement. As a result of these amendment changes were made to the financial covenants and Solaria recorded a total of $1.9 million amendment fees in Other Liabilities and was included in the acquired liabilities for purchase price accounting. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Solaria had historically issued warrants to purchase shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">E-1</div> redeemable convertible preferred stock of Solaria (“SCI Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">E-1</div> warrants”). The warrants were fully exercisable in whole or in part at any time during the term of the Original agreement. As part of the merger with Complete Solar, all the outstanding SCI Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">E-1</div> warrants were assumed by the parent company, Complete Solaria as discussed in Note 4 – Business Combination. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Revolving loan outstanding on the date of merger was fair valued at $5.0 million for the purpose of purchase price accounting discussed in Note 3. The revolving loan principal balance at December 31, 2022 amounted to $5.0 million and is due on October 2023. Interest expense recognized from the date of merger to December 31, </div> <div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">2022 amounted to $0.1 million. The Company was in compliance with all the covenants as of December 31, 2022. As of December 31, 2022, the fair value of the Revolving Loan approximates its carrying value. </div> <div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Secured Credit Facility </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In December 2022, the Company entered into a secured credit facility agreement with Kline Hill Partners IV SPV LLC and Kline Hill Partners Opportunity IV SPV LLC. The secured credit facility agreement matures in April 2023, which allows the Company to borrow up to 70% of the net amount of its eligible vendor purchase orders with a maximum amount of $10.0 million at any point in time. The purchase orders are backed by relevant customer sales orders which serves as a collateral. The amounts drawn under the secured credit facility may be reborrowed provided that the aggregate borrowing does not exceed $20.0 million. The repayment under the secured credit facility is the borrowed amount multiplied by 1.15x if repaid within 75 days and borrowed amount multiplied by 1.175x if repaid after 75 days. The Company may prepay any borrowed amount without premium or penalty. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In December 2022, the Company borrowed an amount of $5.5 million against the secured credit facility. In February 2023, the Company made a repayment of $6.3 million which included aggregate financing cost amounting to $0.8 million. At December 31, 2022, the outstanding net Debt amounted to $5.6 million, including accrued financing cost of $0.1 million. As of December 31, 2022, the fair value of the Secured Credit Facility approximates its carrying value. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; text-indent: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Long-term debt in CS Solis </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As described above, as part of the reorganization in February 2022 of the Company, the Company received an investment from CRSEF. The investment was made pursuant to a subscription agreement, under which Carlyle contributed $25.6 million in exchange for 100 Class B Membership Units of CS Solis and the Company contributed the net assets of Complete Solar, Inc. in exchange for 100 Class A Membership. The Class B Membership Units are mandatorily redeemable by the Company on the three-year anniversary of the effective date of the CS Solis amended and restated LLC agreement (February 14, 2025). The Class B Membership Units accrue interest that is payable upon redemption at a rate of 10.5% (which is structured as a dividend payable based on 25% of the investment amount measured quarterly), compounded annually, and subject to increases in the event the Company declares any dividends. In connection with the investment, the Company issued a warrant to purchase 5,978,960 shares of the Company’s common stock at a price of $0.01 per share, of which, 4,132,513 shares are immediately exercisable. The Company has accounted for the mandatorily redeemable investment from Carlyle in accordance with ASC 480, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Distinguishing Liabilities from Equity</div></div>, and has recorded the investment as a liability, which is accreted to its redemption value under the effective interest method. The Company has recorded the warrants as a discount to the liability. Refer to Note 13 – Common Stock, for further discussion of the warrants issued in connection with the Class B Membership Units. As of December 31, 2022, the Company has recorded a liability of $25.2 million included in long-term debt in CS Solis on the consolidated balance sheets. For the year ended December 31, 2022, the Company has recorded accretion of the liability as interest expense of $2.4 million, and the Company has recorded the amortization of issuance costs as interest expense of $1.2 million. As of December 31, 2022, the total estimated fair value of the Company’s 2018 long-term debt in CS Solis was $24.0 million, which was estimated based on Level 3 inputs. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As of December 31, 2022 and December 31, 2021, the Company’s convertible notes consisted of the following (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:81%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Convertible notes, net</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-A</div> Convertible Notes</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">115</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-A</div> Convertible Notes</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">630</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-A</div> Convertible Notes</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,145</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Convertible notes, net</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,890</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Convertible notes, net due to related parties</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-A</div> Convertible Notes</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,260</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-A</div> Convertible Notes</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,050</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Convertible Promissory Notes with Ecosystem Integrity Fund II, LP.</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">510</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Convertible notes, net due to related parties</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,820</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Convertible notes, net, noncurrent</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2022 Convertible Notes</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,434</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Convertible notes, net, noncurrent</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,434</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Convertible notes, net due to related parties, noncurrent</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2022 Convertible Notes</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">15,510</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Convertible notes, net due to related parties, noncurrent</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">15,510</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total convertible notes</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18,944</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,710</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 0 115000 0 630000 0 1145000 0 1890000 0 3260000 0 3050000 0 510000 0 6820000 3434000 0 3434000 0 15510000 0 15510000 0 18944000 8710000 500000 0.03 2021-06-30 500000 100000 0.06 0.80 100000 0.176 0 100000 100000 62500 100000 <div style="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The net carrying amount of the convertible notes was as follows (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:83%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Principal</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unamortized debt discount</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">PIK interest added to principal balance</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">16</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">15</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Conversion to Series D-2 redeemable convertible preferred stock</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(116</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net carrying amount</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">115</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 100000 100000 0 0 16000 15000 -116000 0 0 115000 <div style="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Interest expense related to the convertible notes was as follows (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:81%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Amortization of debt discount</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">PIK interest</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> interest expense</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 0 0 4000 1000 12000 3000 1000 12000 7000 3800000 0.02 0.80 500000 0.256 0 100000 100000 785799 900000 <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The net carrying amount of the convertible notes was as follows (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:82%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Principal</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,784</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,784</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unamortized debt discount</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">PIK interest added to principal balance</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">122</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">106</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Conversion to Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">D-1</div> redeemable convertible preferred stock</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(3,906</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net carrying amount</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,890</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 3784000 3784000 0 0 122000 106000 -3906000 0 0 3890000 <div style="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Interest expense related to the convertible notes was as follows (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:82%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Amortization of debt discount . . . . . . . . . . . . . . . . . . . . . . . . .</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">281</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">235</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">PIK interest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">16</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">74</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">32</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> interest expense . . . . . . . . . . . . . . . . . . . . . . . .</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">16</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">355</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">267</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 0 281000 235000 16000 74000 32000 16000 355000 267000 4300000 0.02 0.80 600000 0.181 200000 869640 800000 <div style="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The net carrying amount of the convertible notes was as follows (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:82%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Principal</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unamortized debt discount</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(112</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">PIK interest added to principal balance</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">74</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">57</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Conversion to Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">D-1</div> redeemable convertible preferred stock</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4,324</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net carrying amount</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,195</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 4250000 4250000 0 112000 74000 57000 -4324000 0 0 4195000 <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Interest expense related to the convertible notes was as follows (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:82%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Amortization of debt discount . . . . . . . . . . . . . . . . . . . . . . . . .</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">112</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">454</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">PIK interest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">57</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> interest expense . . . . . . . . . . . . . . . . . . . . . . . .</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">129</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">511</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 112000 454000 0 17000 57000 0 129000 511000 0 500000 0.03 <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The net carrying amount of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-A</div> convertible note without an embedded derivative liability was as follows (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:83%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Principal</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unamortized debt discount</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">PIK interest added to principal balance</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Repayment of principal and accrued interest</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(510</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net carrying amount</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">510</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 500000 500000 0 0 10000 10000 -510000 0 0 510000 <div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Interest expense related to the note was as follows (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:82%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Amortization of debt discount</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">PIK interest</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> interest expense</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 0 0 0 0 10000 0 0 10000 0 12000000 6700000 0.05 0.75 200000 15500000 3400000 19800000 100000 200000 48258 100000 5000000 6300000 1005366 1400000 60500000 8171662 7000000 0.0525 0.035 7000000 5122 5229 0.38 0.62 1.75 1 15000000 6700000 500000 0.02 500000 0 2000000 300000 50000 0.01 2000000 0 900000 900000 100000 0.0014 100000 <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes the Company’s outstanding notes payable (in thousands): </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:84%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">  2022  </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">  2021  </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Loan and Security Agreement</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,987</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2021 Promissory Notes</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Current Insight Promissory Note</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,507</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: Unamortized debt issuance costs and discounts</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,507</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> 0 6987000 0 2500000 0 20000 0 9507000 0 0 0 9507000 3400000 0.08 9100000 0.08 1.10 1.20 9800000 700000 9100000 5000000 2023-10-31 0.0775 0.045 1900000 5000000 5000000 100000 0.70 10000000 20000000 5500000 6300000 800000 5600000 100000 25600 0.105 0.25 5978960 0.01 4132513 25200000 2400000 1200000 24000000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(16)</div></div></td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Stock-Based Compensation </div></div> </td> </tr> </table> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In 2011, the Company’s Board of Directors and stockholders approved the adoption of the 2011 Stock Plan (the “2011 Plan”). The 2011 Plan provides for the granting of incentive stock options, nonstatutory stock options, and restricted stock to employees, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-employee</div> directors, and consultants of the Company. Options may be granted at a price per share not less than 100% of the fair market value at date of grant. If an incentive stock option is granted to a 10% stockholder, then the purchase or exercise price per share shall not be less than 110% of the fair market value per share of common stock on the grant date. Options granted </div> <div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">under the 2011 Plan continue to vest until the last day of employment and generally vest over four years and expire 10 years from the date of grant. A total of 2,596,764 shares of common stock was reserved for the 2011 Plan, as amended, as of December 31, 2022 and December 31, 2021. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In 2021, the Company’s Board of Directors and stockholders approved the adoption of the 2021 Stock Plan (the “2021 Plan”). The 2021 Plan provides for the granting of incentive stock options, nonstatutory stock options, and restricted stock to employees, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-employee</div> directors, and consultants of the Company. Options may be granted at a price per share not less than 100% of the fair market value at date of grant. If an incentive stock option is granted to a 10% stockholder, then the purchase or exercise price per share shall not be less than 110% of the fair market value per share of common stock on the grant date. Options granted under the 2021 Plan continue to vest until the last day of employment and generally vest over four years and expire 10 years from the date of grant. A total of 241,484 shares of common stock was initially reserved for the 2021 Plan. Any shares of common stock that would have otherwise been returned to the Company’s 2011 Plan as a result of forfeiture, expiration, cancellation, termination or net issuances of awards thereunder shall be returned to the share reserve under the 2021 Plan. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In 2022, the Company’s Board of Directors and stockholders approved the adoption of the 2022 Stock Plan (the “2022 Plan”). The 2022 Plan provides for the granting of incentive stock options, nonstatutory stock options, and restricted stock to employees, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-employee</div> directors, and consultants of the Company. Options may be granted at a price per share not less than 100% of the fair market value at date of grant. If an incentive stock option is granted to a 10% stockholder, then the purchase or exercise price per share shall not be less than 110% of the fair market value per share of common stock on the grant date. Options granted under the 2022 Plan continue to vest until the last day of employment and generally vest over four years and expire 10 years from the date of grant. A total of 3,225,237 shares of common stock was initially reserved for the 2022 Plan. Any shares of common stock that would have otherwise been returned to the Company’s 2011 Plan and 2021 Plan as a result of forfeiture, expiration, cancellation, termination or net issuances of awards thereunder shall be returned to the share reserve under the 2022 Plan. The 2011 Plan, 2021 Plan, and 2022 Plan are collectively referred to as the “Plans” in the notes to the financial statements, unless otherwise noted. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">A summary of stock option activity for the years ended December 31, 2022 and December 31, 2021 under the Plans is as follows: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:65%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Options outstanding</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Number of<br/>shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted<br/>average<br/>exercise<br/>price per<br/>share</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted<br/>average<br/>contractual<br/>term<br/>(in years)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Aggregate<br/>intrinsic</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">value<br/>(in thousands)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding—January 1, 2021</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,968,580</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.58</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7.87</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,044</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Options granted</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">212,434</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.89</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Options exercised</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(7,245</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.83</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Options canceled</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(38,315</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.62</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding—December 31, 2021</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,135,454</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.62</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6.99</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,263</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Options granted</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,088,350</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7.45</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Options exercised</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(162,034</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.48</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Options canceled</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(91,376</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.83</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding—December 31, 2022</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,970,395</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.87</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6.99</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">34,180</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Vested and expected to vest—December 31, 2022</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,970,395</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.87</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6.99</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">34,180</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Vested and exercisable—December 31, 2022</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,794,862</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.35</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6.29</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">22,204</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The weighted-average grant-date fair value of options granted for the years ended December 31, 2022 and December 31, 2021, was $7.99 per share and $0.72 per share, respectively. The total fair value of options vested for the years ended December 31, 2022 and December 31, 2021, was $10.5 million and $0.2 million, respectively. The aggregate intrinsic value of options exercised for the years ended December 31, 2022 and December 31, 2021, was $0.2 million and less than $0.1 million, respectively. </div><div></div><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Determination of Fair Value </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Prior to the Mergers, the Company estimated grant-date fair value of stock options using the Black-Scholes-Merton option- pricing model. The determination of the fair value of each stock award using this option-pricing model is affected by the Company’s assumptions regarding a number of complex and subjective variables. These variables include, but are not limited to, the expected stock price volatility over the term of the awards. Stock-based compensation is measured at the grant date based on the fair value of the award and is recognized as expense on a straight-line basis over the requisite service period, which is generally the vesting period of the respective award. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following assumptions were used to calculate the fair value of stock-based compensation: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:66%"></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Years Ended December 31,</div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected term</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">1.0 – 7.5 years</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">5.0 – 6.1 years</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected volatility</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">60.0% – 78.5%</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">52.6% – 56.7%</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free interest rate</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">3.4% – 4.8%</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">0.8% – 1.3%</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected dividends</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">0.0%</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">0.0%</td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Expected term </div></div>— The Company has opted to use the “simplified method” for estimating the expected term of options, whereby the expected term equals the arithmetic average of the vesting term and the original contractual term of the option (generally <div style="display:inline;">10</div> years). </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Expected volatility </div></div>— Due to the Company’s limited operating history and a lack of company specific historical and implied volatility data, the Company has based its estimate of expected volatility on the historical volatility of a group of peer companies that are publicly traded. The historical volatility data was computed using the daily closing prices for the selected companies’ shares during the equivalent period of the calculated expected term of the stock-based awards. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Risk-free interest rate </div></div>— The risk-free rate assumption is based on U.S. Treasury instruments with maturities similar to the expected term of the Company’s stock options. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Expected dividends </div></div>— The Company has not issued any dividends in its history and does not expect to issue dividends over the life of the options and therefore has estimated the dividend yield to be zero. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair value of common stoc</div></div>k — The fair value of the shares of common stock underlying the stock-based awards has historically been determined by the Board of Directors, with input from management. Because there has been no public market for the Company’s common stock, the Board of Directors has determined the fair value of the common stock on the grant-date of the stock-based award by considering a number of objective and subjective factors. Such factors include a valuation of the Company’s common stock performed by an unrelated third-party specialist, valuations of comparable companies, sales of the Company’s redeemable convertible preferred stock to unrelated third-parties, operating and financial performance, the lack of liquidity of the Company’s capital stock, as well as general and industry-specific economic outlooks. For financial reporting purposes, the Company considers the amount of time between the valuation date and the grant date to determine whether to use the latest common stock valuation or a straight-line interpolation between the two valuation dates. The determination included an evaluation of whether the subsequent valuation indicated that any significant change in valuation had occurred between the previous valuation and the grant date. </div><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Stock-based compensation expense </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes stock-based compensation expense and its allocation within the accompanying consolidated statements of operations and comprehensive loss (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:79%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Years Ended December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">  2022  </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">  2021  </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">  2020  </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cost of revenues</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">22</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sales and marketing</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">168</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">68</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">37</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">General and administrative</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">243</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">113</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">64</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Loss from discontinued operations, net of tax</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">470</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total stock-based compensation expense</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">903</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">109</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As of December 31, 2022 there was a total of $<div style="display:inline;">5.4</div> million of unrecognized stock-based compensation costs related to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-vested</div> stock option awards, which is expected to be recognized over a weighted-average period of approximately <div style="display:inline;">2.2</div> years. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> 1 0.10 1.10 P4Y P10Y 2596764 2596764 1 0.10 1.10 P4Y P10Y 241484 241484 1 0.10 1.10 P4Y P10Y 3225237 3225237 <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">A summary of stock option activity for the years ended December 31, 2022 and December 31, 2021 under the Plans is as follows: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:65%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Options outstanding</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Number of<br/>shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted<br/>average<br/>exercise<br/>price per<br/>share</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted<br/>average<br/>contractual<br/>term<br/>(in years)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Aggregate<br/>intrinsic</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">value<br/>(in thousands)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding—January 1, 2021</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,968,580</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.58</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7.87</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,044</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Options granted</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">212,434</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.89</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Options exercised</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(7,245</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.83</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Options canceled</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(38,315</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.62</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding—December 31, 2021</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,135,454</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.62</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6.99</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,263</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Options granted</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,088,350</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7.45</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Options exercised</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(162,034</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.48</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Options canceled</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(91,376</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.83</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding—December 31, 2022</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,970,395</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.87</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6.99</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">34,180</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Vested and expected to vest—December 31, 2022</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,970,395</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.87</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6.99</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">34,180</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Vested and exercisable—December 31, 2022</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,794,862</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.35</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6.29</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">22,204</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 1968580 0.58 P7Y10M13D 1044000 212434 0.89 7245 0.83 38315 0.62 2135454 0.62 P6Y11M26D 2263000 3088350 7.45 162034 0.48 91376 0.83 4970395 4.87 P6Y11M26D 34180000 4970395 4.87 P6Y11M26D 34180000 2794862 4.35 P6Y3M14D 22204000 7.99 0.72 10500000 200000 200000 100000 <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following assumptions were used to calculate the fair value of stock-based compensation: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:66%"></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="3" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Years Ended December 31,</div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected term</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">1.0 – 7.5 years</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">5.0 – 6.1 years</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected volatility</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">60.0% – 78.5%</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">52.6% – 56.7%</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free interest rate</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">3.4% – 4.8%</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">0.8% – 1.3%</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected dividends</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">0.0%</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">0.0%</td></tr></table> P1Y P7Y6M P5Y P6Y1M6D 0.60 0.785 0.526 0.567 0.034 0.048 0.008 0.013 0 0 <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes stock-based compensation expense and its allocation within the accompanying consolidated statements of operations and comprehensive loss (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:79%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Years Ended December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">  2022  </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">  2021  </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">  2020  </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cost of revenues</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">22</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sales and marketing</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">168</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">68</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">37</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">General and administrative</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">243</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">113</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">64</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Loss from discontinued operations, net of tax</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">470</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total stock-based compensation expense</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">903</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">109</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 22000 19000 8000 168000 68000 37000 243000 113000 64000 470000 0 0 903000 200000 109000 5400000 P2Y2M12D <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(17)</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Commitments and Contingencies </div></div></td></tr></table><div style="margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Operating Leases </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company leases its facilities under <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cancelable</div> operating lease agreements. The Company’s leases have remaining terms of 0.3 years to 3.8 years. Options to renew or extend leases beyond their initial term have been excluded from measurement of the ROU assets and lease liabilities as exercise is not reasonably certain. Operating leases are reflected on the consolidated balance sheets within operating lease ROU assets and the related current and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> operating lease liabilities. ROU assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make lease payments arising from lease agreement. Operating lease ROU assets and liabilities are recognized at the commencement date, or the date on which the lessor makes the underlying asset available for use, based upon the present value of the lease payments over the respective lease term. Lease expense is recognized on a straight-line basis over the lease term, subject to any changes in the lease or expectation regarding the terms. Variable lease costs such as common area maintenance, property taxes and insurance are expensed as incurred. Variable lease cost was $0.2 million for the year ended December 31, 2022 and immaterial for the year ended December 31, 2021. Total operating lease expense for the years ended December 31, 2022 and December 31, 2021 was $0.7 million and $0.4 million, respectively. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company made $1.0 million and $0.4 million of cash payments related to operating leases during the years ended December 31, 2022 and December 31, 2021, respectively. New operating lease <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets obtained in exchange for operating lease liabilities were $1.9 million and $1.2 million during the years ended December 31, 2022 and December 31, 2021, respectively, including the impact of adopting ASC 842. On the date of adoption, January 1, 2021, the Company recognized right-of-use assets of approximately $1.1 million and lease liabilities of approximately $1.2 million, of which $0.4 million was included in accrued and other current liabilities and $0.8 million was included in operating lease liabilities, net of current portion on the consolidated balance sheets. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The weighted average remaining lease term and the discount rate for the Company’s operating leases are as follows: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:80%"></td> <td style="vertical-align:bottom;width:15%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2022</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Remaining average remaining lease term (years)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.24</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average discount rate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14.47</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr></table><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Future minimum lease payments under <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cancelable</div> operating leases, and future payments under the Lease Termination Agreement, as of December 31, 2022 are as follows (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:90%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2023</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,048</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">743</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2025</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">592</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2026</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">477</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2027 and thereafter</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total undiscounted liabilities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,860</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less imputed interest</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(628</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Present value of operation lease liabilities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,232</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Accounting under ASC 840 </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Prior to the adoption of ASC 842, rent expense on operating leases was recognized on a straight-line basis over the term of the lease. In addition, certain of the Company’s operating lease agreements for facilities also include rent escalations or rent abatements during the initial lease term. The Company recorded the rent escalations as deferred rent, net of current portion on the accompanying balance sheets. The Company recognized the deferred rent liability on a straight-line basis into rent expense over the lease term commencing on the date the Company took possession of the leased space. Rent expense was $0.3 million for the year ended December 31, 2020. </div><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Warranty Provision </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company accrues warranty costs when revenue is recognized for solar energy systems sales and panel sales, based on the estimated future costs of meeting its warranty obligations. Warranty costs primarily consist of replacement materials and equipment and labor costs for service personnel. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Activity by period relating to the Company’s warranty provision was as follows: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:75%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Years Ended December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warranty provision, beginning of period</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,281</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,652</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,816</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warranty liability from the Business Combination</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,943</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accruals for new warranties issued</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,492</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,516</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">607</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Settlements</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,735</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(887</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(771</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warranty provision, end of period</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,981</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,281</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,652</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warranty provision, current</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">767</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">497</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warranty provision, noncurrent</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,214</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,681</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,155</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Indemnification Agreements </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">From time to time, in its normal course of business, the Company may indemnify other parties, with which it enters into contractual relationships, including customers, lessors, and parties to other transactions with the Company. The Company may agree to hold other parties harmless against specific losses, such as those that could arise from breach of representation, covenant or third-party infringement claims. It may not be possible to determine the maximum potential amount of liability under such indemnification agreements due to the unique facts and circumstances that are likely to be involved in each particular claim and indemnification provision. Historically, there have been no such indemnification claims. In the opinion of management, any liabilities resulting from these agreements will not have a material adverse effect on the business, financial position, results of operations, or cash flows. </div><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Legal Matters </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company is a party to various legal proceedings and claims which arise in the ordinary course of business. The Company records a liability when it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. If the Company determines that a loss is reasonably possible and the loss or range of loss can be reasonably estimated, the Company discloses the reasonably possible loss. The Company adjusts its accruals to reflect the impact of negotiations, settlements, rulings, advice of legal counsel and other information and events pertaining to a particular case. Legal costs are expensed as incurred. Although claims are inherently unpredictable, the Company is not aware of any matters that have a material adverse effect on the business, financial position, results of operations, or cash flows. The Company has recorded $1.9 million and $0.2 million as a loss contingency in accrued expenses and other current liabilities on the consolidated balance sheets as of December 31, 2022 and December 31, 2021, respectively, primarily associated with the pending settlement of the following legal matters. </div><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Katerra Litigation </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On July 22, 2022, Katerra, Inc. filed a complaint for breach of contract and turnover of property under Section 542(b) of the Bankruptcy Code in the United States Bankruptcy Court for the Southern District of Texas. The complaint seeks damages for the amounts due under the Settlement Agreement and for attorney’s fees. The Company filed an answer to the complaint on September 6, 2022. No discovery has occurred. </div><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Vendor Settlement </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On January 10, 2023, a vendor entered into an agreement with the Company to settle past due performance related payments related to various tools. As part of the agreement, the Company agreed to pay $0.9 million in three equal installments. The Company paid the first installment on January 12, 2023 and will pay the second and third installments on March 31, 2023 and June 30, 2023, respectively. </div><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">SolarPark Litigation </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In January 2023, SolarPark Korea Co., LTD (“<div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">SolarPark</div></div>”) demanded approximately $80.0 million during discussions between the Company and SolarPark. In February 2023, the Company submitted its statement of claim seeking approximately $26.4 million in damages against SolarPark. The ultimate outcome of this arbitration is currently unknown and could result in a material liability to the Company. However, the Company believes that the allegations lack merit and intends to vigorously defend all claims asserted. No liability has been recorded in the Company’s consolidated financial statements as the likelihood of a loss is not probable at this time. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On March 16, 2023, SolarPark filed a complaint against Solaria and the Company in the United States District Court for the Northern District of California. The complaint alleges a civil conspiracy involving misappropriation of trade secrets, defamation, tortious interference with contractual relations, inducement to breach of contract, and violation of California’s Unfair Competition Law. The complaint indicates that SolarPark has suffered in excess of $220 million in damages. The ultimate outcome of this litigation is currently unknown and could result in a material liability to the Company. However, the Company believes that the allegations lack merit and intends to vigorously defend all claims asserted. No liability has been recorded in the Company’s consolidated financial statements as the likelihood of a loss is not probable at this time. </div><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Letters of Credit </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company had $3.5 million of outstanding letters of credit related to normal business transactions as of December 31, 2022. These agreements require the Company to maintain specified amounts of cash as collateral in segregated accounts to support the letters of credit issued thereunder. As discussed in Note 1, the cash collateral in these restricted cash accounts was $3.7 million as of December 31, 2022. The Company did not have any outstanding letters of credit as of December 31, 2021. </div> P0Y3M18D P3Y9M18D 200000 700000 400000 1000000 400000 1900000 1200000 1100000 1200000 400000 800000 <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The weighted average remaining lease term and the discount rate for the Company’s operating leases are as follows: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:80%"></td> <td style="vertical-align:bottom;width:15%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2022</div></div></td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Remaining average remaining lease term (years)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.24</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average discount rate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14.47</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr></table> P3Y2M26D 0.1447 <div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Future minimum lease payments under <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cancelable</div> operating leases, and future payments under the Lease Termination Agreement, as of December 31, 2022 are as follows (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:90%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2023</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,048</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">743</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2025</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">592</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2026</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">477</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2027 and thereafter</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total undiscounted liabilities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,860</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less imputed interest</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(628</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Present value of operation lease liabilities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,232</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 1048000 743000 592000 477000 0 2860000 628000 2232000 300000 <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Activity by period relating to the Company’s warranty provision was as follows: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:75%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Years Ended December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warranty provision, beginning of period</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,281</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,652</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,816</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warranty liability from the Business Combination</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,943</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accruals for new warranties issued</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,492</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,516</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">607</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Settlements</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,735</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(887</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(771</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warranty provision, end of period</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,981</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,281</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,652</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warranty provision, current</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">767</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">497</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warranty provision, noncurrent</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,214</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,681</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,155</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table> 2281000 1652000 1816000 1943000 1492000 1516000 607000 -1735000 -887000 -771000 3981000 2281000 1652000 767000 600000 497000 3214000 1681000 1155000 1900000 200000 900000 80000000 26400000 220000000 3500000 3700000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(18)</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Income Taxes </div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The provision for income taxes consisted of the following (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:79%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Years Ended December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">  2022  </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">  2021  </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">  2020  </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Current:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Federal</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">State</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foreign</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total current</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Federal</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">State</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foreign</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total deferred</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 7em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total provision</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The reconciliation of federal statutory income tax rate to our effective income tax rate is as follows (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:75%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Years Ended December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Statutory federal income tax</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(6,184</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,918</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,454</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">State income taxes, net of federal tax benefits</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,207</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(353</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(336</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock compensation</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">64</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">22</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-deductible</div> interest expense</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">78</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">689</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">257</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Mark to market adjustments</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">397</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Nondeductible Expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">279</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">PPP Loan</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(368</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foreign earnings taxed at different rates</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">157</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(8</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Valuation allowance</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,451</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,910</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,510</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Tax Provision</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><span style="-sec-ix-hidden:hidden96295799">4</span></td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Significant components of our deferred tax assets and liabilities are as follows (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:76%"></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Years Ended December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">      2022      </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">      2021      </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">NOL carryforwards</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">60,710</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,931</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Credits</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">195</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Bad debt reserve</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,382</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">946</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Inventory reserve</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,724</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">680</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warranty reserve</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">651</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">631</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Revenue warranty</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">155</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">111</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Interest expense carryover</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,445</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">170</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued compensation</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">678</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">687</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred revenue</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">195</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">639</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">ASC 842 leases</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Assembled workforce</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">15</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fixed assets</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">328</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Capitalized research and development</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">509</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,837</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">28</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">73,821</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,855</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Valuation allowance</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(63,737</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(11,348</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net deferred tax assets</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,084</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">507</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1pt"> <td style="height:6pt"></td> <td colspan="4" style="height:6pt"></td> <td colspan="4" style="height:6pt"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Deferred Tax Liabilities</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accounting method change</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(18</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(38</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Capitalized software</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(234</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(468</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fixed assets</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Intangibles</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(9,084</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Convertible debt</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(748</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Refundable and deferred income taxes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company has established a valuation allowance to offset the gross deferred tax assets as of December 31, 2022 and December 31, 2021, due to the uncertainty of realizing future tax benefits from its net operating loss carryforwards and other deferred tax assets. The valuation allowance balance was $63.7 million and $11.3 million for the years ended December 31, 2022 and December 31, 2021, respectively. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In assessing the realizability of deferred income tax assets, the Company considered whether it is more likely than not that some portion or all of its deferred income tax assets will be realized. The ultimate realization of deferred income tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Due to the uncertainty surrounding the Company’s ability to realize such deferred income tax assets, a full valuation allowance has been established. The valuation allowance increased by $52.4 million during the year ended December 31, 2022, and $1.9 million during the year ended December 31, 2021. During 2022 the valuation allowance increased $45.9 million due to acquired deferred tax assets. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As of December 31, 2022 and 2021, the Company had federal net operating loss carryforwards of approximately $237.7 million and $28.0 million and state net operating loss carryforwards of approximately $157.1 million and $30.2 million, respectively. Federal net operating losses that will expire between the years 2030 and 2037 total $114.6 million. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As of December 31, 2022 and 2021, the Company had state research and development credit carryforwards of approximately $1.6 million and zero, respectively. The credits do not expire. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The utilization of the Company’s net operating loss and R&amp;D credit carryforwards may be subject to limitation due to the “change in ownership provisions” under Section 382 of the Internal Revenue Code and similar foreign provisions. Such limitations may result in the expiration of these carryforwards before their </div><div></div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">utilization. The Company’s acquired net operating loss carryforwards have been reduced based on the estimated amount which will be lost due to these limitations. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company is subject to income taxes in the U.S. federal jurisdiction, and various foreign jurisdictions. Tax regulations within each jurisdiction are subject to the interpretation of the related tax laws and regulations and require significant judgment to apply. The Company’s tax years remain open for examination by all tax authorities since inception. The Company is not currently under examination in any tax jurisdictions. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As of December 31, 2022 and 2021, the Company had unrecognized tax benefits of $1.3 million and zero, respectively. The reversal of the uncertain tax benefits would not affect the Company’s effective tax rate to the extent that it continues to maintain a full valuation allowance against its deferred tax assets. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company applies the provisions set forth in FASB ASC Topic 740, Income Taxes, to account for the uncertainty in income taxes. In the preparation of income tax returns in federal and state jurisdictions, the Company asserts certain tax positions based on its understanding and interpretation of income tax laws. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following is a tabular reconciliation of the total amounts of unrecognized tax benefits (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:76%"></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Years Ended December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    2022    </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    2021    </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unrecognized tax benefits as of beginning of year</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Increases related to prior year tax positions</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,335</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Increases related to current year tax positions</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Decreases related to prior year tax positions</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unrecognized tax benefits as of end of year</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,335</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company recognizes interest and penalties related to unrecognized tax benefits within the income tax expense line in the statements of operations and comprehensive loss. Accrued interest and penalties are included as part of income tax payable in the consolidated balance sheets. No accrued interest or penalties have been recorded for year ended December 31, 2022 or December 31, 2021. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company has not provided U.S. income or foreign withholding taxes on the undistributed earnings of its foreign subsidiary as of December 31, 2022 and December 31, 2021 because it intends to permanently reinvest such earnings outside of the United States. If these foreign earnings were to be repatriated in the future, the related U.S. tax liability will be immaterial, due to the participation exemption put in place under the 2017 Tax Cuts and Jobs Act. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On March 18, 2020, the Families First Coronavirus Response Act (FFCR Act) and, on March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) were each enacted in response to the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic. The FFCR Act and the CARES Act contain numerous income tax provisions relating to refundable payroll tax credits, deferment of employer side social security payments, net operating loss carryback periods, alternative minimum tax credit refunds, modifications to the net interest deduction limitations and technical corrections to tax depreciation methods for qualified improvement property. The Company analyzed the provisions of the Act and determined there was no significant impact to its 2022 or 2021 tax provision. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On June 29, 2020, the California Governor signed Assembly Bill 85 (“A.B. 85”) which includes several tax measures, provides for a three-year suspension of the use of net operating losses for medium and large businesses and a three-year cap on the use of business incentive tax credits to offset no more than $5 million of tax per year. Generally, A.B. 85 suspends the use of net operating losses for taxable years 2020, 2021, and 2022 for taxpayers with taxable income of $1 million or more. The Company analyzed the provisions of the A.B. 85 and determined there was no significant impact to its 2022 or 2021 tax provision. </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On December 27, 2020, the “Consolidated Appropriations Act, 2021” (the “CAA”) was signed into law. The CAA includes provisions meant to clarify and modify certain items put forth in CARES Act, while providing aid to businesses affected by the pandemic. The CAA allows deductions for expenses paid for by Paycheck Protection Program (“PPP”) and Economic Injury Disaster Loan (“EIDL”) . The Program, clarifies forgiveness of EIDL advances, and other business provisions. The Company analyzed the provisions of the CAA and determined there was no significant impact to its 2022 and 2021 tax provision. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The provision for income taxes consisted of the following (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:79%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Years Ended December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">  2022  </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">  2021  </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">  2020  </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Current:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Federal</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">State</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foreign</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total current</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Federal</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">State</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foreign</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total deferred</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 7em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total provision</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 0 0 0 27000 3000 3000 0 0 0 27000 3000 3000 0 0 0 0 0 0 0 0 0 0 0 0 27000 3000 3000 <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The reconciliation of federal statutory income tax rate to our effective income tax rate is as follows (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:75%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Years Ended December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Statutory federal income tax</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(6,184</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,918</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,454</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">State income taxes, net of federal tax benefits</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,207</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(353</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(336</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock compensation</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">64</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">22</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-deductible</div> interest expense</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">78</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">689</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">257</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Mark to market adjustments</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">397</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Nondeductible Expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">279</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">PPP Loan</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(368</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foreign earnings taxed at different rates</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">157</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(8</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Valuation allowance</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,451</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,910</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,510</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Tax Provision</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><span style="-sec-ix-hidden:hidden96295799">4</span></td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> -6184000 -1918000 -1454000 -1207000 -353000 -336000 64000 42000 22000 78000 689000 257000 397000 0 0 279000 2000 4000 0 -368000 0 157000 0 0 -8000 0 0 6451000 1910000 1510000 27000 3000 <div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Significant components of our deferred tax assets and liabilities are as follows (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:76%"></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Years Ended December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">      2022      </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">      2021      </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">NOL carryforwards</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">60,710</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,931</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Credits</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">195</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Bad debt reserve</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,382</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">946</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Inventory reserve</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,724</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">680</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warranty reserve</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">651</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">631</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Revenue warranty</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">155</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">111</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Interest expense carryover</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,445</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">170</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued compensation</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">678</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">687</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred revenue</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">195</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">639</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">ASC 842 leases</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Assembled workforce</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">15</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fixed assets</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">328</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Capitalized research and development</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">509</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,837</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">28</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">73,821</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,855</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Valuation allowance</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(63,737</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(11,348</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net deferred tax assets</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,084</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">507</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1pt"> <td style="height:6pt"></td> <td colspan="4" style="height:6pt"></td> <td colspan="4" style="height:6pt"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Deferred Tax Liabilities</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accounting method change</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(18</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(38</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Capitalized software</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(234</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(468</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fixed assets</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Intangibles</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(9,084</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Convertible debt</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(748</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Refundable and deferred income taxes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 60710000 7931000 195000 0 1382000 946000 2724000 680000 651000 631000 155000 111000 3445000 170000 678000 687000 195000 639000 12000 17000 0 15000 328000 0 509000 0 2837000 28000 73821000 11855000 63737000 11348000 10084000 507000 -18000 -38000 234000 468000 0 1000 9084000 0 -748000 0 0 0 63700000 11300000 52400000 1900000 45900000 237700000 28000000 157100000 30200000 114600000 1600000 0 1300000 0 <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following is a tabular reconciliation of the total amounts of unrecognized tax benefits (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:76%"></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Years Ended December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    2022    </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    2021    </div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unrecognized tax benefits as of beginning of year</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Increases related to prior year tax positions</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,335</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Increases related to current year tax positions</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Decreases related to prior year tax positions</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unrecognized tax benefits as of end of year</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,335</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 0 0 1335000 0 0 0 0 0 0 1335000 0 0 0 5000000 1000000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(19)</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Basic and Diluted Net Loss Per Share </div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company computes net loss per share in accordance with ASC 260. No dividends were declared or paid for the years ended December 31, 2022 and December 31, 2021. Undistributed earnings for each period are allocated to participating securities, including the redeemable convertible preferred stock, based on the contractual participation rights of the security to share in the current earnings as if all current period earnings had been distributed. As there is no contractual obligation for the redeemable convertible preferred stock to share in losses, the Company’s basic net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted-average shares of common stock outstanding during periods with undistributed losses. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common stockholders for the years ended December 31, 2022, 2021 and 2020 (in thousands, except share and per share amounts): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:62%"></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Years Ended December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Numerator:</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss from continuing operations</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(28,023</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(9,282</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(5,682</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss from discontinued operations</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,454</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(29,477</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(9,282</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(5,682</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Denominator:</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average common shares outstanding, basic and diluted</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">22,524,400</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,990,015</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,760,018</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss per share:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Continuing operations – basic and diluted</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1.24</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.77</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.58</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Discontinued operations – basic and diluted</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.07</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss per share – basic and diluted</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1.31</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.77</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.58</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Basic and diluted net loss per share attributable to common stockholders is the same for the years ended December 31, 2022, 2021 and 2020 because the inclusion of potential shares of common stock would have been anti-dilutive for the periods presented. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following table presents the potential common shares outstanding that were excluded from the computation of diluted net loss per share of common stock as of the periods presented because including them would have been antidilutive: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:67%"></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock options issued and outstanding</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,970,419</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,135,464</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,968,590</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Convertible notes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,912,493</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,618,585</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">812,531</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred stock warrants</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,152,790</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">488,024</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">488,024</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SAFE agreements</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">388,785</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19,562</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common stock warrants</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">43,135</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,999</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Potential common shares excluded from diluted net loss per share</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,078,837</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,635,857</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,288,706</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common stockholders for the years ended December 31, 2022, 2021 and 2020 (in thousands, except share and per share amounts): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:62%"></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Years Ended December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Numerator:</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss from continuing operations</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(28,023</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(9,282</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(5,682</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss from discontinued operations</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,454</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(29,477</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(9,282</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(5,682</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Denominator:</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average common shares outstanding, basic and diluted</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">22,524,400</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,990,015</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,760,018</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss per share:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Continuing operations – basic and diluted</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1.24</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.77</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.58</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Discontinued operations – basic and diluted</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.07</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss per share – basic and diluted</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1.31</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.77</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.58</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr></table> -28023000 -9282000 -5682000 -1454000 -29477000 -9282000 -5682000 22524400 22524400 11990015 11990015 9760018 9760018 -1.24 -1.24 -0.77 -0.77 -0.58 -0.58 -0.07 -0.07 -1.31 -1.31 -0.77 -0.77 -0.58 -0.58 <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following table presents the potential common shares outstanding that were excluded from the computation of diluted net loss per share of common stock as of the periods presented because including them would have been antidilutive: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:67%"></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="10" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock options issued and outstanding</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,970,419</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,135,464</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,968,590</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Convertible notes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,912,493</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,618,585</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">812,531</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred stock warrants</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,152,790</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">488,024</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">488,024</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SAFE agreements</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">388,785</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19,562</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common stock warrants</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">43,135</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,999</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Potential common shares excluded from diluted net loss per share</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,078,837</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,635,857</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,288,706</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 4970419 2135464 1968590 1912493 1618585 812531 1152790 488024 488024 0 388785 19562 43135 4999 0 8078837 4635857 3288706 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(20)</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Related Party Transactions </div></div></td></tr></table><div style="margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Related Party Convertible Promissory Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In 2020, the Company issued convertible promissory notes (“2020 Convertible Notes”) of approximately $3.8 million to various investors, out of which $3.3 million was issued to nine related parties. The related party debt is presented as convertible notes, net in the accompanying consolidated balance sheets, adjusted for deferred interest, allocated debt financing costs and derivative liability recorded as debt discount. The principal amount of the outstanding balance accrued interest at 2.0% per annum. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In 2021, the Company issued convertible promissory notes (“2021 Convertible Notes”) of approximately $4.8 million to various investors, out of which $3.6 million was issued to four related parties. The related party debt is presented as convertible notes, net’ in the accompanying consolidated balance sheets, adjusted for deferred interest, and allocated debt financing costs. The principal amount of the outstanding balance accrued interest at 2.0% per annum. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In March 2022, as part of the Company’s Series D redeemable convertible preferred stock issuance, the Company converted all of the outstanding convertible note series. As part of the conversion, the Company recognized a gain on the extinguishment of related party convertible notes of $1.4 million, which was recorded in other income (expense), net on the consolidated statements of operations and comprehensive loss. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In October through December 2022, the Company issued convertible promissory notes (“2022 Convertible Notes”) of approximately $12.0 million to various investors, out of which $8.6 million was issued to four related parties. Additionally, the Company acquired a related party convertible note, on the same terms as the 2022 Convertible Notes as part of the acquisition of Solaria with a fair value of $6.7 million at the time of the acquisition. The related party debt is presented as convertible notes, net due to related parties, noncurrent in the accompanying consolidated balance sheets. The principal amount of the outstanding balance on the 2022 Convertible Notes accrues at 5.0%, compounded annually. For the year-ended December 31, 2022, the Company has recognized $0.2 million in interest expense related to the related party 2022 Convertible Notes. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">There were no other material related party transactions during the years ended December 31, 2022, 2021 or 2020. </div> 3800000 3300000 0.02 4800000 3600000 0.02 1400000 12000000 8600000 6700000 0.05 200000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(21)</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Subsequent Events </div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In connection with the Business Combination Agreement, the Company has raised a series of convertible notes (“2023 Convertible Notes”) in January 2023 and February 2023 with additional investors, with an aggregate purchase price of $11.0 million. The 2023 Convertible Notes will convert to common shares of Complete Solaria, Inc. at the Closing. The 2022 Notes accrue interest at a rate of 5% per annum. Immediately prior to the Closing, the 2023 Convertible Notes will be converted into that number of shares of common stock of Complete Solaria equal to (x) the principal amount together with all accrued interest of the 2023 Convertible Notes divided by 0.75, divided by (y) the price of a share of common stock of Complete Solaria used to determine the conversion ratio in the Business Combination Agreement. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On March 10, 2023, the Federal Deposit Insurance Corporation (“FDIC”) announced the closure of Silicon Valley Bank (“SVB”). On March 13, 2023, pursuant to a joint statement released by the U.S. Department of the Treasury, the U.S. Federal Reserve, and the FDIC, the U.S. government reassured that all depositors will be fully protected. As of the date the accompanying consolidated financial statements were issued, the Company has transferred substantially all of its cash out of SVB to other financial institutions. The Company does not currently anticipate any disruption to its ongoing operations. </div> 11000000 0.05 0.75 1661000 4409000 10425000 5396000 26003000 27717000 12503000 13059000 9947000 10071000 50114000 55256000 3758000 3907000 4185000 3476000 1465000 2182000 198000 1330000 12299000 162032000 72019000 228183000 14571000 14474000 26674000 19830000 27934000 20403000 2421000 5407000 29194000 6586000 107380000 60114000 3416000 3214000 10240000 14152000 25204000 3434000 15510000 976000 790000 1274000 122802000 122902000 0.0001 0.0001 1000000000 60000000 45312243 45312243 19932429 19932429 7000 3000 276438000 190624000 51000 27000 -327279000 -85373000 -50783000 105281000 72019000 228183000 24590000 12260000 66887000 48974000 18354000 8266000 51788000 33792000 6236000 3994000 15099000 15182000 8755000 3572000 23221000 15694000 2214000 1604000 5216000 4607000 6345000 2027000 22965000 6194000 17314000 7203000 51402000 26495000 -11078000 -3209000 -36303000 -11313000 1902000 941000 8870000 2672000 9000 26000 -38003000 4000 -28302000 3180000 -50974000 -4146000 -73449000 -10805000 -1000 -1000 4000 -50973000 -4146000 -73448000 -10809000 -8404000 -20953000 -147505000 -147505000 -155909000 -168458000 -206882000 -4146000 -241906000 -10809000 10000 24000 -206872000 -4146000 -241882000 -10809000 -1.28 -1.28 -0.31 -0.31 -4.33 -4.33 -0.83 -0.83 -3.92 -3.92 0 0 -9.92 -9.92 0 0 -5.2 -5.2 -0.31 -0.31 -14.25 -14.25 -0.83 -0.83 39821078 39821078 13431410 13431410 16969979 16969979 13053367 13053367 100000 400000 0 100000 36900000 36900000 0 1400000 34311133 155630000 7089948 37096000 -120397000 41000 -83260000 -34311133 -155630000 12909773 3000 155627000 0 0 155630000 0 19999721 3000 192723000 -120397000 41000 72370000 0 0 5460075 2000 40950000 0 0 40952000 0 0 13458293 2000 5218000 0 0 5220000 0 0 350000 0 3500000 0 0 3500000 0 0 4697000 0 0 4697000 0 -1000 2000 0 0 1000 0 0 5558488 1000 35489000 0 0 35490000 0 0 463976 0 2394000 0 0 2394000 0 0 161000 0 0 161000 0 0 -10862000 0 0 -10862000 0 0 2114000 0 0 2114000 0 0 21690 0 52000 0 0 52000 0 0 0 0 10000 10000 0 0 0 -206882000 0 -206882000 0 45312243 7000 276438000 -327279000 51000 -50783000 34311133 155630000 6959618 34997000 -85373000 27000 -50349000 -34311133 -155630000 12972811 3000 155627000 0 0 155630000 0 19932429 3000 190624000 -85373000 27000 105281000 0 0 5460075 2000 40950000 0 0 40952000 0 0 13458293 2000 5218000 0 0 5220000 0 0 350000 0 3500000 0 0 3500000 0 0 4697000 0 0 4697000 0 -1000 2000 0 0 1000 0 0 5558488 1000 35489000 0 0 35490000 0 0 463976 0 2394000 0 0 2394000 0 0 161000 0 0 161000 0 0 -10862000 0 0 -10862000 0 0 67292 0 57000 0 0 57000 0 0 4156000 0 0 4156000 0 0 21690 0 52000 0 0 52000 0 0 0 0 24000 24000 0 0 0 -241906000 0 -241906000 0 45312243 7000 276438000 -327279000 51000 -50783000 19335921 42959000 3931068 0 6703000 -62559000 0 -55856000 -19335921 -42959000 7306130 1000 42958000 0 0 42959000 0 0 11237198 1000 49661000 -62559000 0 -12897000 0 0 10867 0 9000 0 0 9000 0 0 85000 0 0 85000 0 0 0 -4146000 0 -4146000 0 0 11248065 1000 49755000 -66705000 0 -16949000 16564370 31401000 3739572 0 3105000 -55896000 0 -52791000 -16564370 -31401000 6066571 1000 31400000 0 0 31401000 0 0 9806143 1000 34505000 -55896000 0 -21390000 2771551 11558000 0 0 0 0 0 0 0 0 103353 0 28000 0 0 28000 0 0 3447000 0 0 3447000 0 0 217000 0 0 217000 0 0 0 -10809000 0 -10809000 2771551 11558000 9909496 1000 38197000 -66705000 0 -28507000 -2771551 -11558000 1338569 0 11558000 0 0 11558000 0 0 11248065 1000 49755000 -66705000 0 -16949000 1315287 6300000 4508488 120000 -241906000 -10809000 -168458000 -73448000 -10809000 2321000 217000 -4009000 76000 717000 304000 3235000 622000 463000 4269000 716000 2144000 3091000 76000 6661000 10338000 -26314000 142000 2493000 2581000 35490000 2394000 52000 11823000 3036000 3896000 5047000 8326000 -504000 -1132000 15000 4372000 190000 1587000 -2056000 -359000 -316000 255000 -584000 -1766000 -231000 -47152000 -17197000 190000 -46962000 -17197000 29000 1505000 1048000 -1534000 -1048000 14102000 -9653000 -9507000 17750000 3500000 500000 25000000 57000 28000 4219000 15600000 1317000 45575000 13704000 24000 -2897000 -4541000 8316000 5276000 5419000 735000 1602000 1000 -38000 245000 10862000 30625000 202000 3447000 6550000 10680000 21561000 19390000 155630000 35490000 2394000 1000 3500000 100000 400000 0 100000 0 0 0 1400000 300000 300000 0 0 5900000 5900000 0 0 30700000 30700000 0 0 700000 700000 0 0 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(1)</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Organization </div></div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(a)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Description of Business</div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Complete Solaria, Inc. (the “Company” or “Complete Solaria”) is a residential solar installer headquartered in Fremont, California, which was formed through Complete Solar Holding Corporation’s acquisition of The Solaria Corporation (“Solaria”). </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Complete Solar, Inc. (“Complete Solar”) was incorporated in Delaware on February 22, 2010. Through February 2022, the Company operated as a single legal entity as Complete Solar, Inc. In February 2022, the Company implemented a holding company reorganization (the “Reorganization”) in which the Company created and incorporated Complete Solar Holding Corporation (“Complete Solar Holdings”). As a result of the Reorganization, Complete Solar Holdings became the successor entity to Complete Solar, Inc. The capitalization structure was not changed because of the Reorganization as all shares of Complete Solar, Inc common stock and preferred stock were exchanged on a one for one basis with shares of Complete Solar Holdings common stock and preferred stock. The Reorganization was accounted for as a change in reporting entity for entities under common control. The historical assets and liabilities of Complete Solar, Inc. are transferred to Complete Solar Holdings at their carrying value, and there is no change to net income, other comprehensive income (loss), or any related per share amounts reported in the unaudited condensed consolidated financial statements requiring retrospective application. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In October 2022, the Company entered into a business combination agreement, as amended on December 26, 2022 and January 17, 2023 (“Original Business Combination Agreement”) and as amended on May 26, 2023 (“Amended and Restated Business Combination Agreement”), with Jupiter Merger Sub I Corp., a Delaware corporation and a wholly owned subsidiary of Freedom Acquisition I Corp. (“FACT”) (“First Merger Sub”), Jupiter Merger Sub II LLC, a Delaware limited liability company and a wholly owned subsidiary of FACT (“Second Merger Sub”), Complete Solar Holding Corporation, a Delaware corporation, and Solaria, a Delaware corporation. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The transactions contemplated by the Amended and Restated Business Combination Agreement were consummated on July 18, 2023 (“Closing Date”). Following the consummation of the Merger on the Closing Date, FACT changed its name to “Complete Solaria, Inc.” </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As part of the transactions contemplated by the Amended and Restated Business Combination Agreement, FACT affected a deregistration under the Cayman Islands Companies Act and a domestication under Section 388 of the Delaware’s General Corporation Law (the “DGCL” or “Domestication”). On the Closing Date, following the Domestication, First Merger Sub merged with and into Complete Solaria, with Complete Solaria surviving such merger as a wholly owned subsidiary of FACT (the “First Merger”), and immediately following the First Merger, Complete Solaria merged with and into Second Merger Sub, with Second Merger Sub surviving as a wholly owned subsidiary of FACT (the “Second Merger”), and Second Merger Sub changed its name to CS, LLC, and immediately following the Second Merger, Solaria merged with and into a newly formed Delaware limited liability company and wholly-owned subsidiary of FACT and changed its name to The Solaria Corporation LLC (“Third Merger Sub”), with Third Merger Sub surviving as a wholly-owned subsidiary of FACT (the “Additional Merger”, and together with the First Merger and the Second Merger, the “Mergers”). </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In connection with the closing of the Mergers: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Each share of the Company’s capital stock, inclusive of shares converted from 2022 Convertible Notes, issued and outstanding immediately prior to the Closing (“Legacy Complete Solaria Capital Stock”) were cancelled and exchanged into an aggregate of 25,494,332 shares of Complete Solaria Common Stock. </div></td></tr></table><div style="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">In July 2023, (i) Meteora Special Opportunity Fund I, LP (“MSOF”), Meteora Capital Partners, LP (“MCP”) and Meteora Select Trading Opportunities Master, LP (“MSTO”) (with MSOF, MCP, and MSTO collectively as “Meteora”); (ii) Polar Multi-Strategy Master Fund (“Polar”), and (iii) Diametric True Alpha Market Neutral Master Fund, LP, Diametric True Alpha Enhanced Market Neutral Master Fund, LP, and Pinebridge Partners Master Fund, LP (collectively, “Sandia”) (together, the “FPA Funding PIPE Investors”) entered into separate subscription agreements (the “FPA Funding Amount PIPE Subscription Agreements”) pursuant to which, the FPA Funding PIPE Investors subscribed for on the Closing Date, an aggregate of 6,300,000 shares of FACT Class A Ordinary Shares, less, in the case of Meteora, 1,161,512 FACT Class A Ordinary Shares purchased by Meteora separately from third parties through a broker in the open market (“Recycled Shares”) in connection with the Forward Purchase Agreements (“FPAs”). Subsequent to the Closing Date, Complete Solaria entered into an additional FPA Funding PIPE Subscription Agreement with Meteora, to subscribe for and purchase, and Complete Solaria agreed to issue and sell, an aggregate of 420,000 shares of Complete Solaria Common Stock. The Company issued shares of Complete Solaria Common Stock underlying the FPAs as of the latter of the closing of the Mergers or execution of the FPAs. </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">All certain investors (the “PIPE Investors”) purchased from the Company an aggregate of 1,570,000 shares of Complete Solaria Common Stock (the “PIPE Shares”) for a purchase price of $10.00 per share, for aggregate gross proceeds of $15.7 million (the “PIPE Financing”), including $3.5 million that was funded prior to the Closing Date, pursuant to subscription agreements (the “Subscription Agreements”). At the time of the PIPE Financing, Complete Solaria issued an additional 60,000 shares to certain investors as an incentive to participate in the PIPE Financing. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">On or around the Closing Date, pursuant to the New Money PIPE Subscription Agreements, certain investors affiliated with the New Money PIPE Subscription Agreements (“New Money PIPE Investors”) agreed to subscribe for and purchase, and Complete Solaria agreed to issue and sell to the New Money PIPE Investors an aggregate of 120,000 shares of Complete Solaria Common Stock for a purchase price of $5.00 per share, for aggregate gross proceeds of $0.6 million. Pursuant to its New Money PIPE Subscription Agreement, Complete Solaria issued an additional 60,000 shares of Complete Solaria Common Stock in consideration of certain services provided by it in the structuring of its FPA and the transactions described therein. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Subsequent to the Closing, Complete Solaria issued an additional 193,976 shares of Complete Solaria Common Stock to the sponsors for reimbursing sponsors’ transfer to certain counterparties and issued an additional 150,000 shares of Complete Solaria Common Stock to an FPA investor for services provided in connection with the Mergers. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">In March 2023, holders of 23,256,504 of the originally issued 34,500,000 FACT Class A Ordinary shares exercised their rights to redeem those shares for cash, and immediately prior to the Closing there were 11,243,496 FACT Class A Ordinary Shares that remained outstanding. At the Closing, holders of 7,784,739 shares of Class A common stock of FACT exercised their rights to redeem those shares for cash, for an aggregate of approximately $82.2 million which was paid to such holders at Closing. The remaining FACT Class A Ordinary Share converted, on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-for-one</div></div> basis, into one share of Complete Solaria Common Stock; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Each issued and outstanding FACT Class B Ordinary Share converted, on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-for-one</div></div> basis, into one share of Complete Solaria Common Stock. </div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In November 2022, Complete Solar Holdings acquired Solaria (as described in Note 6 – Business Combination) and changed its name to Complete Solaria, Inc. On August 18, 2023, the Company entered into a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-Binding</div> Letter of Intent to sell certain of Complete Solaria’s North American solar panel assets to Maxeon, Inc. (“Maxeon”). In October 2023, the Company completed the sale of its solar panel business to Maxeon. The disposition met the criteria for held for sale and discontinued operations classification as of October 1, 2023. Refer to Note 1(c) – Divestiture, Note 8 – Divestiture, and Note 22 – Subsequent Events. </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(b)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Basis of Presentation of Unaudited Interim Condensed Consolidated Financial Statements</div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The accompanying unaudited interim condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions for interim reporting as prescribed by the Securities and Exchange Commission. Accordingly, they do not include all of the information and footnotes required by GAAP for complete condensed consolidated financial statements. The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. Intercompany accounts and transactions are eliminated upon consolidation. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Effective January 1, 2023, the Company changed its fiscal quarters to four thirteen-week periods within a standard calendar year. Each annual reporting period begins on January 1 and ends on December 31. Since the fiscal quarter change was made after the end of fiscal 2022, the Company will continue to report prior year financial information based on its prior year fiscal calendar. The Company’s financial results for the thirteen and thirty-nine weeks ended October 1, 2023 are compared to its results for the three and nine months ended September 30, 2022. The comparison of these periods is primarily affected by the difference of one day between the first three quarters of fiscal 2023 and first three quarters of 2022, which the Company notes is immaterial. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary to make the unaudited condensed consolidated financial statements not misleading have been included. The information included in this report should be read in conjunction with the audited consolidated financial statements as of and for the year ended December 31, 2022, as filed with the Securities and Exchange Commission (“SEC”) on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-4.</div> The condensed consolidated balance sheet as of December 31, 2022 included herein was derived from the audited consolidated financial statements as of that date. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Interim financial results are not necessarily indicative of the results that may be expected for any future period. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(c)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Divestiture</div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On August 18, 2023, the Company entered into a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-Binding</div> Letter of Intent to sell certain of Complete Solaria’s North American solar panel assets to Maxeon. On September 20, 2023, the Company and Maxeon entered into an Asset Purchase Agreement (the “Disposal Agreement”) for the sale of certain assets, inclusive of certain intellectual property and customer contracts, to Maxeon. On October 6, 2023, the Company completed the sale of certain of Complete Solaria’s North American solar panel assets, inclusive of certain intellectual property and customer contracts, to Maxeon, pursuant to the terms of the Disposal Agreement. Under the terms of the Disposal Agreement, Maxeon agreed to acquire certain assets and employees of Complete Solaria, for an aggregate purchase price consisting of 1,100,000 shares of Maxeon common stock. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">This divestiture represents a strategic shift in Complete Solaria’s business and qualifies as held for sale and as a discontinued operation as of October 1, 2023. Based on the held for sale classification of the assets, the Company has reduced the carrying value of the disposal group to its fair value, less cost to sell and recorded an impairment loss associated with the held for sale intangible assets and goodwill. As a result, the Company classified the results of its solar panel business in discontinued operations in its unaudited condensed consolidated statements of operations and comprehensive income (loss) for all periods presented. The cash flows related to discontinued operations have been segregated and are included in the unaudited condensed consolidated statements of cash flows for all periods presented. Unless otherwise noted, discussion within the notes to the unaudited condensed consolidated financial statements relates to continuing operations only and excludes the historical activities of the North American panel business. See Note 8 – Divestiture for additional information. </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(d)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Liquidity and Going Concern</div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Since inception, the Company has incurred recurring losses and negative cash flows from operations. The Company incurred net losses of $51.0 million and $73.4 million during the thirteen and thirty-nine weeks ended October 1, 2023, respectively, and net losses of $4.1 million and $10.8 million during the three and nine months ended September 30, 2022, respectively, and had an accumulated deficit of $327.3 million as of October 1, 2023. The Company had cash and cash equivalents of $1.7 million as of October 1, 2023. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. These unaudited condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. Historically, the Company’s activities have been financed through private placements of equity securities, debt and proceeds from the Merger. The Company expects to incur significant operating expenses as it continues to grow its business. The Company believes that its operating losses and negative operating cash flows will continue into the foreseeable future. The Company’s history of recurring losses, negative operating cash flows since inception and the need to raise additional funding to meet its obligations and finance its operations raise substantial doubt about the Company’s ability to continue as a going concern. The Company’s ability to continue as a going concern requires that the Company obtains sufficient funding to meet its obligations and finance its operations. If the Company is not able to secure adequate additional funding when needed, the Company will need to reevaluate its operating plan and may be forced to make reductions in spending, extend payment terms with suppliers, liquidate assets where possible, or suspend or curtail planned programs or cease operations entirely. These actions could materially impact the Company’s business, results of operations and future prospects. While the Company has been able to raise multiple rounds of financing, there can be no assurance that in the event the Company requires additional financing, such financing will be available on terms that are favorable, or at all. Failure to generate sufficient cash flows from operations, raise additional capital or reduce certain discretionary spending would have a material adverse effect on the Company’s ability to achieve its intended business objectives.</div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Therefore, there is substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the unaudited condensed consolidated financial statements are issued. The accompanying unaudited condensed consolidated financial statements have been prepared assuming the Company will continue to operate as a going concern, which contemplates the realization of assets and settlement of liabilities in the normal course of business. They do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from uncertainty related to its ability to continue as a going concern. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(e)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Immaterial Correction of Prior Period Financial Statements</div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Subsequent to the issuance of the Company’s unaudited condensed consolidated financial statements for the three and nine months ended September 30, 2022, the Company identified a misstatement in redeemable convertible preferred stock and other income (expense), net, related to the accounting for the issuance of its Series D preferred stock and conversion of SAFEs and convertible notes. Such misstatement relates to the use of an incorrect factor for the conversion of these instruments into preferred stock. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company considered both quantitative and qualitative factors and determined the effect of the misstatement was immaterial to the previously issued unaudited condensed consolidated financial statements for the three and nine months ended September 30, 2022. The Company identified and corrected the misstatement prior to the issuance of the consolidated financial statements for the year ended December 31, 2022, which were filed in FACT’s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-4</div> registration statement. The adjustment in the fourth quarter resulted in a $4.4 million decrease in redeemable convertible preferred stock and other income (expense), net, as well as net loss. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The accompanying unaudited condensed consolidated statements of operations and comprehensive income (loss) and statements of stockholders’ deficit for the three and nine months ended September 30, 2022 </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">reflect such adjustment. Accordingly, the accompanying unaudited condensed consolidated statements of cash flows reflect such adjustment, and there was no change to net cash used in operating activities from continuing operations, net cash used in investing activities from continuing operations, or net cash provided by financing activities from continuing operations for the nine months ended September <div style="display:inline;">30</div>, <div style="display:inline;">2022</div>. </div> 25494332 6300000 1161512 420000 1570000 10 15700000 3500000 60000 120000 5 600000 60000 193976 150000 23256504 34500000 11243496 7784739 82200000 1 1 1100000 51000000 73400000 4100000 10800000 327300000 1700000 4400000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(2)</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Summary of Significant Accounting Policies </div></div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(a)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Use of Estimates</div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The preparation of the Company’s unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses, as well as related disclosure of contingent assets and liabilities. Significant estimates and assumptions made by management include, but are not limited to, the determination of: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">the allocation of the transaction price to identified performance obligations; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">fair value of warrant liabilities; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">the fair value of assets acquired and liabilities assumed for business combinations; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">the reserve methodology for inventory obsolescence; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">the reserve methodology for product warranty; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">the reserve methodology for the allowance for credit losses; and </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">the fair value of the forward purchase agreements. </div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">To the extent that there are material differences between these estimates and actual results, the Company’s financial condition or operating results will be affected. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(b)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Supply Chain Constraints and Risk</div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company relies on a very small number of suppliers of solar energy systems and other equipment. If any of the Company’s suppliers was unable or unwilling to provide the Company with contracted quantities in a timely manner at prices, quality levels and volumes acceptable to the Company, the Company would have very limited alternatives for supply, and the Company may not be able find suitable replacements for the Company’s customers, or at all. Such an event could materially adversely affect the Company’s business, prospects, financial condition and results of operations. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In addition, the global supply chain and the Company’s industry have experienced significant disruptions in recent periods. The Company has seen supply chain challenges and logistics constraints increase, including shortages of panels, inverters, batteries and associated component parts for inverters and solar energy systems available for purchase. In certain cases, this has caused delays in critical equipment and inventory, longer lead times, and has resulted in cost volatility. These shortages and delays can be attributed in part to the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic and resulting government action, broader macroeconomic conditions, and have been exacerbated by the ongoing conflicts in Ukraine and Israel. While the Company believes that a majority of the Company’s suppliers have secured sufficient supply to permit them to continue delivery and installations through the end of 2023, if these shortages and delays persist into 2024, they could adversely affect the timing of when battery energy storage systems can be delivered and installed, and when (or if) the Company can begin to generate revenue from those systems. In addition, the Company has experienced and is experiencing varying levels of volatility in costs of equipment and labor resulting in part from disruptions caused by general global economic conditions, including inflationary pressures and the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic. </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company cannot predict the full effects these events will have on the Company’s business, cash flows, liquidity, financial condition and results of operations at this time due to numerous uncertainties. In the event the Company is unable to mitigate the impact of delays or price volatility in solar energy systems, raw materials, and freight, it could materially adversely affect the Company’s business, prospects, financial condition and results of operations. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(c)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Segment Information</div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company conducts its business in one operating segment that provides custom solar solutions through a standardized platform to its residential solar providers and companies to facilitate the sale and installation of solar energy systems under a single product group. The Company’s Chief Executive Officer (“CEO”) is the Chief Operating Decision Maker (“CODM”). The CODM allocates resources and makes operating decisions based on financial information presented on a consolidated basis. The profitability of the Company’s product group is not a determining factor in allocating resources and the CODM does not evaluate profitability below the level of the consolidated company. All the Company’s long-lived assets are maintained in the United States of America. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(d)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Restricted Cash </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company classifies all cash for which usage is limited by contractual provisions as restricted cash. Restricted cash balance as of October 1, 2023 and December 31, 2022, was $3.8 million and $3.9 million, respectively. The restricted cash consists of deposits in money market accounts, which is used as cash collateral backing letters of credit related to customs duty authorities’ requirements. The Company has presented these balances under restricted cash, as a long-term asset, in the unaudited condensed consolidated balance sheets. The Company reconciles cash, cash equivalents, and restricted cash reported in the unaudited condensed consolidated balance sheets that aggregate to the beginning and ending balances shown in the unaudited condensed consolidated statements of cash flows as follows (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:80%"></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash and cash equivalents</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,661</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,409</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Restricted cash</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,758</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,907</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total cash, cash equivalents, and restricted cash</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,419</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,316</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(e)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Revenue Recognition</div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td></tr></table><div style="margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Disaggregation of revenue </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Refer to the table below for the Company’s revenue recognized by product and service type (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:60%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Thirteen<br/> Weeks<br/> Ended<br/> October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three<br/> Months<br/> Ended<br/> September 30,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Thirty-Nine</div><br/> Weeks<br/> Ended<br/> October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months<br/> Ended<br/> September 30,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Solar energy system installations</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">23,915</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,120</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">64,511</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">46,214</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Software enhanced services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">675</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,140</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,376</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,760</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total revenue</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">24,590</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,260</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">66,887</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">48,974</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">All of the Company’s revenue recognized by geography based on the location of the customer for the thirteen and thirty-nine weeks ended October 1, 2023 and three and nine months ended September 30, 2022 was in the United States. </div><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Remaining performance obligations </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company has elected the practical expedient not to disclose remaining performance obligations for contracts that are less than one year in length. The Company has deferred $1.0 million and $1.3 million associated with a long-term service contract as of October 1, 2023 and December 31, 2022, respectively. </div><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Incremental costs of obtaining customer contracts </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Incremental costs of obtaining customer contracts consist of sales commissions, which are costs paid to third-party vendors who source residential customer contracts for the sale of solar energy systems by the Company. The Company defers sales commissions and recognizes expense in accordance with the timing of the related revenue recognition. Amortization of deferred commissions is recorded as sales commissions in the accompanying unaudited condensed consolidated statements of operations and comprehensive income (loss). As of October 1, 2023 and December 31, 2022, deferred commissions were $5.5 million and $2.8 million, respectively, which were included in prepaid expenses and other current assets in the accompanying unaudited condensed consolidated balance sheets. </div><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Deferred revenue </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company typically invoices its customers upon completion of set milestones, generally upon installation of the solar energy system with the remaining balance invoiced upon passing the final building inspection. Standard payment terms to customers range from 30 to 60 days. When the Company receives consideration, or when such consideration is unconditionally due, from a customer prior to delivering goods or services to the customer under the terms of a customer agreement, the Company records deferred revenue. As installation projects are typically completed within <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">12-months,</div> the majority of the Company’s deferred revenue is reflected in current liabilities in the accompanying unaudited condensed consolidated balance sheets. The Company also has deferred revenue associated with a long-term service contract which is reflected in <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> liabilities in the accompanying unaudited condensed consolidated balance sheets. The amount of revenue recognized during the thirty-nine weeks ended October 1, 2023 and the nine months ended September 30, 2022 that was included in deferred revenue at the beginning of the year was $2.5 million and $3.9 million, respectively. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(f)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Fair Value Measurements</div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible. The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Level 1 inputs: Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Level 2 inputs: Other than quoted prices included in Level 1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Level 3 inputs: Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at the measurement date. </div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Financial assets and liabilities held by the Company measured at fair value on a recurring basis as of October 1, 2023 and December 31, 2022 include cash and cash equivalents, accounts receivable, accounts payable, accrued expenses, the warrant liabilities and FPA liabilities. </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The carrying amounts of cash, accounts receivable, accounts payable and accrued expenses approximate their fair value because of their short-term nature (classified as Level 1). </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The warrant liabilities and FPA liabilities are measured at fair value using Level 3 inputs. The Company records subsequent adjustments to reflect the increase or decrease in estimated fair value at each reporting date within the unaudited condensed consolidated statements of operations and comprehensive income (loss) as a component of other income (expense), net. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(g)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Direct Offering Costs</div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Direct offering costs represent legal, accounting and other direct costs related to the Mergers, which was consummated in July 2023. In accounting for the Mergers, direct offering costs of approximately $5.7 million were reclassified to additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital and netted against the Mergers proceeds received upon close. As of October 1, 2023 and December 31, 2022, the Company had no deferred offering costs included within prepaid expenses and other current assets in its unaudited condensed consolidated balance sheets. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(h)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Warrant Liabilities</div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company accounts for its warrant liabilities in accordance with the guidance in ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Derivatives and Hedging – Contracts in Entity’s Own Equity</div></div>, under which the warrants that do not meet the criteria for equity classification and must be recorded as liabilities. The warrant liabilities are measured at fair value at inception and at each reporting date in accordance with the guidance in ASC 820, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair Value Measurement</div></div>, with any subsequent changes in fair value recognized in other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive income (loss). Refer to Note 3 – Fair Value Measurements and Note 15 – Warrants. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(i)</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Forward Purchase Agreements </div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company accounts for its FPAs in accordance with the guidance in ASC 480, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Distinguishing Liabilities from Equity</div></div>, as the agreements embody an obligation to transfer assets to settle a forward contract. The warrant liabilities are measured at fair value at inception and at each reporting date in accordance with the guidance in ASC 820, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair Value Measurement</div></div>, with any subsequent changes in fair value recognized in other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive income (loss). Refer to Note 3 – Fair Value Measurements and Note 5 – Forward Purchase Agreements. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(j)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Net Loss Per Share</div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company computes net loss per share following ASC 260, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Earnings Per Share</div></div>. Basic net loss per share is measured as the income or loss available to common stockholders divided by the weighted average common shares outstanding for the period. Diluted net loss per share presents the dilutive effect on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">per-share</div> basis from the potential exercise of options and/or warrants. The potentially dilutive effect of options or warrants are computed using the treasury stock method. Securities that potentially have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the diluted loss per share calculation. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(k)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Recently Adopted Accounting Pronouncements</div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In June 2016, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-13,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Financial instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</div></div>, and subsequent related ASUs, which amends the guidance on the impairment of financial instruments by requiring measurement and recognition of expected </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">credit losses for financial assets held. ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-13</div> is effective for public and private companies’ fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2019, and December 15, 2022, respectively. The Company adopted ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-13</div> under the private company transition guidance beginning January 1, 2023. The adoption did not have a material impact on the Company’s unaudited condensed consolidated financial statements. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(a)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Use of Estimates</div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The preparation of the Company’s unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses, as well as related disclosure of contingent assets and liabilities. Significant estimates and assumptions made by management include, but are not limited to, the determination of: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">the allocation of the transaction price to identified performance obligations; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">fair value of warrant liabilities; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">the fair value of assets acquired and liabilities assumed for business combinations; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">the reserve methodology for inventory obsolescence; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">the reserve methodology for product warranty; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">the reserve methodology for the allowance for credit losses; and </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">the fair value of the forward purchase agreements. </div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">To the extent that there are material differences between these estimates and actual results, the Company’s financial condition or operating results will be affected. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(b)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Supply Chain Constraints and Risk</div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company relies on a very small number of suppliers of solar energy systems and other equipment. If any of the Company’s suppliers was unable or unwilling to provide the Company with contracted quantities in a timely manner at prices, quality levels and volumes acceptable to the Company, the Company would have very limited alternatives for supply, and the Company may not be able find suitable replacements for the Company’s customers, or at all. Such an event could materially adversely affect the Company’s business, prospects, financial condition and results of operations. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In addition, the global supply chain and the Company’s industry have experienced significant disruptions in recent periods. The Company has seen supply chain challenges and logistics constraints increase, including shortages of panels, inverters, batteries and associated component parts for inverters and solar energy systems available for purchase. In certain cases, this has caused delays in critical equipment and inventory, longer lead times, and has resulted in cost volatility. These shortages and delays can be attributed in part to the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic and resulting government action, broader macroeconomic conditions, and have been exacerbated by the ongoing conflicts in Ukraine and Israel. While the Company believes that a majority of the Company’s suppliers have secured sufficient supply to permit them to continue delivery and installations through the end of 2023, if these shortages and delays persist into 2024, they could adversely affect the timing of when battery energy storage systems can be delivered and installed, and when (or if) the Company can begin to generate revenue from those systems. In addition, the Company has experienced and is experiencing varying levels of volatility in costs of equipment and labor resulting in part from disruptions caused by general global economic conditions, including inflationary pressures and the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic. </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company cannot predict the full effects these events will have on the Company’s business, cash flows, liquidity, financial condition and results of operations at this time due to numerous uncertainties. In the event the Company is unable to mitigate the impact of delays or price volatility in solar energy systems, raw materials, and freight, it could materially adversely affect the Company’s business, prospects, financial condition and results of operations. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(c)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Segment Information</div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company conducts its business in one operating segment that provides custom solar solutions through a standardized platform to its residential solar providers and companies to facilitate the sale and installation of solar energy systems under a single product group. The Company’s Chief Executive Officer (“CEO”) is the Chief Operating Decision Maker (“CODM”). The CODM allocates resources and makes operating decisions based on financial information presented on a consolidated basis. The profitability of the Company’s product group is not a determining factor in allocating resources and the CODM does not evaluate profitability below the level of the consolidated company. All the Company’s long-lived assets are maintained in the United States of America. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(d)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Restricted Cash </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company classifies all cash for which usage is limited by contractual provisions as restricted cash. Restricted cash balance as of October 1, 2023 and December 31, 2022, was $3.8 million and $3.9 million, respectively. The restricted cash consists of deposits in money market accounts, which is used as cash collateral backing letters of credit related to customs duty authorities’ requirements. The Company has presented these balances under restricted cash, as a long-term asset, in the unaudited condensed consolidated balance sheets. The Company reconciles cash, cash equivalents, and restricted cash reported in the unaudited condensed consolidated balance sheets that aggregate to the beginning and ending balances shown in the unaudited condensed consolidated statements of cash flows as follows (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:80%"></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash and cash equivalents</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,661</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,409</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Restricted cash</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,758</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,907</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total cash, cash equivalents, and restricted cash</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,419</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,316</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 3800000 3900000 The Company reconciles cash, cash equivalents, and restricted cash reported in the unaudited condensed consolidated balance sheets that aggregate to the beginning and ending balances shown in the unaudited condensed consolidated statements of cash flows as follows (in thousands): <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:80%"></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash and cash equivalents</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,661</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,409</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Restricted cash</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,758</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,907</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total cash, cash equivalents, and restricted cash</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,419</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,316</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 1661000 4409000 3758000 3907000 5419000 8316000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(e)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Revenue Recognition</div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td></tr></table><div style="margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Disaggregation of revenue </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Refer to the table below for the Company’s revenue recognized by product and service type (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:60%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Thirteen<br/> Weeks<br/> Ended<br/> October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three<br/> Months<br/> Ended<br/> September 30,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Thirty-Nine</div><br/> Weeks<br/> Ended<br/> October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months<br/> Ended<br/> September 30,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Solar energy system installations</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">23,915</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,120</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">64,511</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">46,214</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Software enhanced services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">675</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,140</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,376</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,760</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total revenue</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">24,590</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,260</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">66,887</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">48,974</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">All of the Company’s revenue recognized by geography based on the location of the customer for the thirteen and thirty-nine weeks ended October 1, 2023 and three and nine months ended September 30, 2022 was in the United States. </div><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Remaining performance obligations </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company has elected the practical expedient not to disclose remaining performance obligations for contracts that are less than one year in length. The Company has deferred $1.0 million and $1.3 million associated with a long-term service contract as of October 1, 2023 and December 31, 2022, respectively. </div><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Incremental costs of obtaining customer contracts </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Incremental costs of obtaining customer contracts consist of sales commissions, which are costs paid to third-party vendors who source residential customer contracts for the sale of solar energy systems by the Company. The Company defers sales commissions and recognizes expense in accordance with the timing of the related revenue recognition. Amortization of deferred commissions is recorded as sales commissions in the accompanying unaudited condensed consolidated statements of operations and comprehensive income (loss). As of October 1, 2023 and December 31, 2022, deferred commissions were $5.5 million and $2.8 million, respectively, which were included in prepaid expenses and other current assets in the accompanying unaudited condensed consolidated balance sheets. </div><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Deferred revenue </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company typically invoices its customers upon completion of set milestones, generally upon installation of the solar energy system with the remaining balance invoiced upon passing the final building inspection. Standard payment terms to customers range from 30 to 60 days. When the Company receives consideration, or when such consideration is unconditionally due, from a customer prior to delivering goods or services to the customer under the terms of a customer agreement, the Company records deferred revenue. As installation projects are typically completed within <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">12-months,</div> the majority of the Company’s deferred revenue is reflected in current liabilities in the accompanying unaudited condensed consolidated balance sheets. The Company also has deferred revenue associated with a long-term service contract which is reflected in <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> liabilities in the accompanying unaudited condensed consolidated balance sheets. The amount of revenue recognized during the thirty-nine weeks ended October 1, 2023 and the nine months ended September 30, 2022 that was included in deferred revenue at the beginning of the year was $2.5 million and $3.9 million, respectively. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Refer to the table below for the Company’s revenue recognized by product and service type (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:60%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Thirteen<br/> Weeks<br/> Ended<br/> October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three<br/> Months<br/> Ended<br/> September 30,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Thirty-Nine</div><br/> Weeks<br/> Ended<br/> October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months<br/> Ended<br/> September 30,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Solar energy system installations</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">23,915</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,120</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">64,511</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">46,214</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Software enhanced services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">675</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,140</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,376</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,760</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total revenue</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">24,590</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,260</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">66,887</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">48,974</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 23915000 11120000 64511000 46214000 675000 1140000 2376000 2760000 24590000 12260000 66887000 48974000 1000000 1300000 5500000 2800000 2500000 3900000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(f)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Fair Value Measurements</div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible. The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Level 1 inputs: Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Level 2 inputs: Other than quoted prices included in Level 1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Level 3 inputs: Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at the measurement date. </div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Financial assets and liabilities held by the Company measured at fair value on a recurring basis as of October 1, 2023 and December 31, 2022 include cash and cash equivalents, accounts receivable, accounts payable, accrued expenses, the warrant liabilities and FPA liabilities. </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The carrying amounts of cash, accounts receivable, accounts payable and accrued expenses approximate their fair value because of their short-term nature (classified as Level 1). </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The warrant liabilities and FPA liabilities are measured at fair value using Level 3 inputs. The Company records subsequent adjustments to reflect the increase or decrease in estimated fair value at each reporting date within the unaudited condensed consolidated statements of operations and comprehensive income (loss) as a component of other income (expense), net. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(g)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Direct Offering Costs</div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Direct offering costs represent legal, accounting and other direct costs related to the Mergers, which was consummated in July 2023. In accounting for the Mergers, direct offering costs of approximately $5.7 million were reclassified to additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital and netted against the Mergers proceeds received upon close. As of October 1, 2023 and December 31, 2022, the Company had no deferred offering costs included within prepaid expenses and other current assets in its unaudited condensed consolidated balance sheets. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> 5700000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(h)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Warrant Liabilities</div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company accounts for its warrant liabilities in accordance with the guidance in ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Derivatives and Hedging – Contracts in Entity’s Own Equity</div></div>, under which the warrants that do not meet the criteria for equity classification and must be recorded as liabilities. The warrant liabilities are measured at fair value at inception and at each reporting date in accordance with the guidance in ASC 820, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair Value Measurement</div></div>, with any subsequent changes in fair value recognized in other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive income (loss). Refer to Note 3 – Fair Value Measurements and Note 15 – Warrants. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(i)</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Forward Purchase Agreements </div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company accounts for its FPAs in accordance with the guidance in ASC 480, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Distinguishing Liabilities from Equity</div></div>, as the agreements embody an obligation to transfer assets to settle a forward contract. The warrant liabilities are measured at fair value at inception and at each reporting date in accordance with the guidance in ASC 820, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair Value Measurement</div></div>, with any subsequent changes in fair value recognized in other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive income (loss). Refer to Note 3 – Fair Value Measurements and Note 5 – Forward Purchase Agreements. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(j)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Net Loss Per Share</div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company computes net loss per share following ASC 260, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Earnings Per Share</div></div>. Basic net loss per share is measured as the income or loss available to common stockholders divided by the weighted average common shares outstanding for the period. Diluted net loss per share presents the dilutive effect on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">per-share</div> basis from the potential exercise of options and/or warrants. The potentially dilutive effect of options or warrants are computed using the treasury stock method. Securities that potentially have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the diluted loss per share calculation. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">(k)</div></div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Recently Adopted Accounting Pronouncements</div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In June 2016, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-13,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Financial instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</div></div>, and subsequent related ASUs, which amends the guidance on the impairment of financial instruments by requiring measurement and recognition of expected </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">credit losses for financial assets held. ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-13</div> is effective for public and private companies’ fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2019, and December 15, 2022, respectively. The Company adopted ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2016-13</div> under the private company transition guidance beginning January 1, 2023. The adoption did not have a material impact on the Company’s unaudited condensed consolidated financial statements. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(3)</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Fair Value Measurements </div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth the Company’s financial assets and liabilities that were measured at fair value, on a recurring basis (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:74%"></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of October 1, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Financial Liabilities</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Carlyle warrants</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,683</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,683</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Public warrants</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,413</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,413</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Private placement warrants</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,027</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,027</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Working capital warrants</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">117</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">117</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Forward purchase agreement liabilities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,586</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,586</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,413</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,144</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14,269</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">16,826</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="font-size:1pt"> <td style="height:9.75pt"></td> <td colspan="16" style="height:9.75pt"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Financial Liabilities</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Redeemable convertible preferred stock warrant liability</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14,152</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14,152</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14,152</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14,152</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Carlyle Warrants </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As part of the Company’s amended and restated warrant agreement with CRSEF Solis Holdings, LLC (“Carlyle”), the Company issued Carlyle a warrant to purchase up to 2,745,879 shares of Complete Solaria Common Stock at a price per share of $0.01, which is inclusive of the outstanding warrant to purchase 1,995,879 shares at the time of modification. The warrant, which expires on July 18, 2030, provides Carlyle with the right to purchase shares of Complete Solaria Common Stock based on (a) the greater of (i) 1,995,879 shares and (ii) the number of shares equal to 2.795% of Complete Solaria’s issued and outstanding shares of common stock, on a fully-diluted basis; plus (b) on and after the date that is ten (10) days after the date of the amended and restated warrant agreement, an additional 350,000 shares; plus (c) on and after the date that is thirty (30) days after the date of the amended and restated warrant agreement, if the original investment amount has not been repaid, an additional 150,000 shares; plus (d) on and after the date that is ninety (90) days after the date of the amended and restated warrant agreement, if the original investment amount has not been repaid, an additional 250,000 shares, in each case, of Complete Solaria Common Stock at a price of $0.01 per share. As the warrant is exercisable into a variable number of shares based on the Company’s fully diluted capitalization table, the Company has classified the warrants as liabilities. The Company valued the warrants based on a Black-Scholes Option Pricing Method, which included the following inputs: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:79%"></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected term</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7.0 years</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected volatility</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">77.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free interest rate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.92</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected dividend yield</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table><div></div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Public, Private Placement and Working Capital Warrants </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The public, private placement and working capital warrants are measured at fair value on a recurring basis. The public warrants were valued based on the closing price of the publicly traded instrument. The private placement and working capital warrants were valued using observable inputs for similar publicly traded instruments. </div><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Forward Purchase Agreement Liabilities </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The FPA liabilities are measured at fair value on a recurring basis using a Monte Carlo simulation analysis. The expected volatility is determined based on the historical equity volatility of comparable companies over a period that matches the simulation period, which included the following inputs: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:79%"></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common stock trading price</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.10</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Simulation period</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.8 years</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free rate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.12</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Volatility</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">178.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Redeemable Convertible Preferred Stock Warrant Liabilities </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company historically issued redeemable convertible warrants, which were classified as liabilities and adjusted to fair value using the Black Scholes Option Pricing Method. The terms of the redeemable convertible preferred stock warrants are described in Note 15 – Warrants. </div><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Series B Redeemable Convertible Preferred Stock Warrant </div></div></div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:80%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected term</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="display:inline;">3.1 </div>years</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected volatility</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">72.5</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free interest rate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.2</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected dividend yield</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr></table><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Series C Redeemable Convertible Preferred Stock Warrant </div></div></div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:80%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected term</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.6 years</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected volatility</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">72.5</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free interest rate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected dividend yield</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr></table><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">D-7</div> Redeemable Convertible Preferred Stock Warrant </div></div></div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:80%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected term</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.5 years</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected volatility</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">78.5</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free interest rate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.7</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected dividend yield</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr></table><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The redeemable convertible preferred stock warrant liabilities were measured at fair value at the issuance date and as of each subsequent reporting period with changes in the fair value recorded within other income (expense), net in the accompanying unaudited condensed consolidated statements of operations and comprehensive income (loss). As described in Note 15 – Warrants, the redeemable convertible preferred stock warrant liabilities were reclassified to additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital upon the closing of the Mergers. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth the Company’s financial assets and liabilities that were measured at fair value, on a recurring basis (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:74%"></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of October 1, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Financial Liabilities</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Carlyle warrants</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,683</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,683</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Public warrants</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,413</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,413</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Private placement warrants</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,027</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,027</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Working capital warrants</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">117</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">117</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Forward purchase agreement liabilities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,586</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,586</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,413</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,144</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14,269</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">16,826</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="font-size:1pt"> <td style="height:9.75pt"></td> <td colspan="16" style="height:9.75pt"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Financial Liabilities</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Redeemable convertible preferred stock warrant liability</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14,152</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14,152</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14,152</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14,152</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 7683000 7683000 1413000 1413000 1027000 1027000 117000 117000 6586000 6586000 1413000 1144000 14269000 16826000 14152000 14152000 14152000 14152000 2745879 0.01 The warrant, which expires on July 18, 2030, provides Carlyle with the right to purchase shares of Complete Solaria Common Stock based on (a) the greater of (i) 1,995,879 shares and (ii) the number of shares equal to 2.795% of Complete Solaria’s issued and outstanding shares of common stock, on a fully-diluted basis; plus (b) on and after the date that is ten (10) days after the date of the amended and restated warrant agreement, an additional 350,000 shares; plus (c) on and after the date that is thirty (30) days after the date of the amended and restated warrant agreement, if the original investment amount has not been repaid, an additional 150,000 shares; plus (d) on and after the date that is ninety (90) days after the date of the amended and restated warrant agreement, if the original investment amount has not been repaid, an additional 250,000 shares, in each case, of Complete Solaria Common Stock at a price of $0.01 per share The Company valued the warrants based on a Black-Scholes Option Pricing Method, which included the following inputs: <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:79%"></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected term</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7.0 years</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected volatility</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">77.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free interest rate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.92</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected dividend yield</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table>The expected volatility is determined based on the historical equity volatility of comparable companies over a period that matches the simulation period, which included the following inputs: <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:79%"></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common stock trading price</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.10</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Simulation period</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.8 years</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">— </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free rate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.12</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Volatility</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">178.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Series B Redeemable Convertible Preferred Stock Warrant </div></div></div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:80%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected term</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="display:inline;">3.1 </div>years</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected volatility</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">72.5</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free interest rate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.2</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected dividend yield</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr></table><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Series C Redeemable Convertible Preferred Stock Warrant </div></div></div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:80%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected term</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.6 years</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected volatility</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">72.5</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free interest rate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected dividend yield</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr></table><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">D-7</div> Redeemable Convertible Preferred Stock Warrant </div></div></div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:80%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected term</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.5 years</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected volatility</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">78.5</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free interest rate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.7</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected dividend yield</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr></table> P7Y 0.77 0.0392 0 2.1 P1Y9M18D 0.0512 1.78 P3Y1M6D 0.725 0.042 0 P3Y7M6D 0.725 0.04 0 P1Y6M 0.785 0.047 0 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(4)</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Reverse Recapitalization </div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As discussed in Note 1 – Organization, on July 18, 2023, the Company consummated the Mergers pursuant to the Amended and Restated Business Combination Agreement. The Mergers was accounted for as a reverse recapitalization, rather than a business combination, for financial accounting and reporting purposes. Accordingly, Complete Solaria was deemed the accounting acquirer (and legal acquiree) and FACT was treated as the accounting acquiree (and legal acquirer). Complete Solaria has been determined to be the accounting acquirer based on evaluation of the following facts and circumstances: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Complete Solaria’s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-combination</div> stockholders have the majority of the voting power in the post-merged company; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Legacy Complete Solaria’s stockholders have the ability to appoint a majority of the Complete Solaria Board of Directors; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Legacy Complete Solaria’s management team is considered the management team of the post-merged company; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Legacy Complete Solaria’s prior operations is comprised of the ongoing operations of the post-merged company; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Complete Solaria is the larger entity based on historical revenues and business operations; and </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">the post-merged company has assumed Complete Solaria’s operating name. </div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Under this method of accounting, the reverse recapitalization was treated as the equivalent of Complete Solaria issuing stock for the net assets of FACT, accompanied by a recapitalization. The net assets of FACT are stated at historical cost, with no goodwill or other intangible assets recorded. The consolidated assets, liabilities, and results of operations prior to the Mergers are those of Legacy Complete Solaria. All periods prior to the Mergers have been retrospectively adjusted in accordance with the Amended and Restated Business Combination Agreement for the equivalent number of preferred or common shares outstanding immediately after the Mergers to effect the reverse recapitalization. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Upon the closing of the Mergers and the PIPE Financing in July 2023, the Company received net cash proceeds of $19.7 million. The following table reconciles the elements of the Mergers to the unaudited condensed consolidated statements of cash flows and the unaudited condensed consolidated statements of stockholders’ deficit for the thirty-nine week ended October 1, 2023 (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:87%"></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Recapitalization</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash proceeds from FACT, net of redemptions</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">36,539</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash proceeds from PIPE Financing</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,800</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: cash payment of FACT transaction costs and underwriting fees</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(10,680</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: cash payment to FPA investors for rebates and recycled shares</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(17,831</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: cash payment for Promissory Note</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,170</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net cash proceeds upon the closing of the Mergers and PIPE financing</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19,658</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> net liabilities assumed from FACT</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(10,135</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net contributions from the Mergers and PIPE financing upon closing</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,523</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Immediately upon closing of the Mergers, the Company had 45,290,553 shares issued and outstanding of Class A Common Stock. The following table presents the number of shares of Complete Solaria Common Stock outstanding immediately following the consummation of the Mergers: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:87%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Recapitalization</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">FACT Class A Ordinary Shares, outstanding prior to Mergers</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">34,500,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">FACT Class B Ordinary Shares, outstanding prior to Mergers</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,625,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Bonus shares issued to sponsor</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">193,976</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Bonus shares issued to PIPE investors</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">120,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Bonus shares issued to FPA investors</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shares issued from PIPE financing</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,690,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shares issued from FPA agreements, net of recycled shares</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,558,488</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: redemption of FACT Class A Ordinary Shares</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(31,041,243</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total shares from the Mergers and PIPE Financing</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19,796,221</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Legacy Complete Solaria shares</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,034,257</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2022 Convertible Note Shares</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,460,075</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shares of Complete Solaria Common stock immediately after Mergers</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">45,290,553</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In <div style="display:inline;">connection</div> with the Mergers, the Company incurred direct and incremental costs of approximately $15.8 million related to legal, accounting, and other professional fees, which were offset against the Company’s additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital. Of the $15.8 million, $5.2 million was incurred by Legacy Complete Solaria and $10.6 million was incurred by FACT. As of October 1, 2023, the Company made cash payments totaling $5.4 million to settle transaction costs. As a result of the Closing, outstanding 2022 Convertible Notes were converted into shares of Complete Solaria Common Stock. </div> 19700000 The following table reconciles the elements of the Mergers to the unaudited condensed consolidated statements of cash flows and the unaudited condensed consolidated statements of stockholders’ deficit for the thirty-nine week ended October 1, 2023 (in thousands): <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:87%"></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Recapitalization</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash proceeds from FACT, net of redemptions</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">36,539</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash proceeds from PIPE Financing</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,800</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: cash payment of FACT transaction costs and underwriting fees</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(10,680</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: cash payment to FPA investors for rebates and recycled shares</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(17,831</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: cash payment for Promissory Note</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,170</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net cash proceeds upon the closing of the Mergers and PIPE financing</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19,658</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> net liabilities assumed from FACT</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(10,135</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net contributions from the Mergers and PIPE financing upon closing</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,523</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 36539000 12800000 10680000 17831000 1170000 19658000 10135000 9523000 45290553 45290553 The following table presents the number of shares of Complete Solaria Common Stock outstanding immediately following the consummation of the Mergers: <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:87%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Recapitalization</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">FACT Class A Ordinary Shares, outstanding prior to Mergers</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">34,500,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">FACT Class B Ordinary Shares, outstanding prior to Mergers</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,625,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Bonus shares issued to sponsor</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">193,976</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Bonus shares issued to PIPE investors</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">120,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Bonus shares issued to FPA investors</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shares issued from PIPE financing</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,690,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shares issued from FPA agreements, net of recycled shares</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,558,488</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: redemption of FACT Class A Ordinary Shares</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(31,041,243</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total shares from the Mergers and PIPE Financing</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19,796,221</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Legacy Complete Solaria shares</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,034,257</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2022 Convertible Note Shares</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,460,075</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shares of Complete Solaria Common stock immediately after Mergers</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">45,290,553</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 34500000 8625000 193976 120000 150000 1690000 5558488 31041243 19796221 20034257 5460075 45290553 15800000 15800000 5200000 10600000 5400000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(5)</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Forward Purchase Agreements </div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In July 2023, FACT and Legacy Complete Solaria, Inc. entered into FPAs with each of (i) Meteora; (ii) Polar, and (iii) Sandia (each individually, a “Seller”, and together, the “FPA Sellers”). </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the terms of the FPAs, the FPA Sellers may (i) purchase through a broker in the open market, from holders of Shares other than the Company or affiliates thereof, FACT’s ordinary shares, par value of $0.0001 per share, (the “Shares”). While the FPA Sellers have no obligation to purchase any Shares under the FPAs, the aggregate total Shares that may be purchased under the FPAs shall be no more than 6,720,000 in aggregate. The FPA Sellers may not beneficially own greater than 9.9% of issued and outstanding Shares following the Mergers as per the Amended and Restated Business Combination Agreement. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The key terms of the forward contracts are as follows: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">The FPA Sellers can terminate the transaction following the Optional Early Termination (“OET”) Date which shall specify the quantity by which the number of shares is to be reduced (such quantity, the “Terminated Shares”). Seller shall terminate the transaction in respect of any shares sold on or prior to the maturity date. The counterparty is entitled to an amount from the seller equal to the number of terminated shares multiplied by a reset price. The reset price is initially $10.56 (the “Initial Price”) and is subject to a $5.00 floor. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">The FPA contains multiple settlement outcomes. Per the terms of the agreements, the FPAs will (1) settle in cash in the event the Company is due cash upon settlement from the FPA Sellers or (2) settle in either cash or shares, at the discretion of the Company, should the settlement amount adjustment exceed the settlement amount. Should the Company elect to settle via shares, the equity will be issued in Complete Solaria Common Stock, with a per share price based on the volume-weighted average price (“VWAP”) Price over 15 scheduled trading days. The magnitude of the settlement is based on the Settlement Amount, an amount equal to the product of: (1) Number of shares issued to the </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:9%"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; line-height: normal;">FPA Seller pursuant to the FPA, less the number of Terminated Shares multiplied by (2) the VWAP Price over the valuation period. The Settlement amount will be reduced by the Settlement Adjustment, an amount equal to the product of (1) Number of shares in the Pricing Date Notice, less the number of Terminated Shares multiplied by $2.00. </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:5%"> </td> <td style="width:3%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">The Settlement occurs as of the Valuation Date, which is the earlier to occur of (a) the date that is two years after the date of the Closing Date of the Mergers (b) the date specified by Seller in a written notice to be delivered to Counterparty at Seller’s discretion (which Valuation Date shall not be earlier than the day such notice is effective) after the occurrence of certain triggering events; and (c) 90 days after delivery by the Counterparty of a written notice in the event that for any 20 trading days during a 30 consecutive trading <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">day-period</div> (the “Measurement Period”) that occurs at least 6 months after the Closing Date, the VWAP Price is less than the then applicable Reset Price. </div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company entered into four separate FPAs, three of which, associated with the obligation to issue 6,300,000 Shares, were entered into prior to the closing of the Mergers. Upon signing the FPAs, the Company incurred an obligation to issue a fixed number of shares to the FPA Sellers contingent upon the closing of the Mergers in addition to the terms and conditions associated with the settlement of the FPAs. The Company accounted for the contingent obligation to issue shares in accordance with ASC 815, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Derivatives and Hedging</div></div>, and recorded a liability and other income (expense), net based on the fair value upon of the obligation upon the signing of the FPAs. The liability was extinguished in July 2023 upon the issuance of Complete Solaria Common Stock to the FPA sellers. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Additionally, in accordance with ASC 480, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Distinguishing Liabilities from Equity</div></div>, the Company has determined that the prepaid forward contract is a financial instrument other than a share that represent or are indexed to obligations to repurchase the issuer’s equity shares by transferring assets, referred to herein as the “prepaid forward purchase liability” on its unaudited condensed consolidated balance sheets. The Company initially measured the prepaid forward purchase liability at fair value and has subsequently remeasured at fair value with changes in fair value recognized in earnings. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Through the date of issuance of the Complete Solaria Common Stock in satisfaction of the Company’s obligation to issue shares around the closing of the Mergers, the Company recorded $35.5 million to other income (expense), net associated with the issuance of 6,720,000 shares of Complete Solaria Common Stock. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As of the closing of the Mergers and issuance of the Complete Solaria Common Stock underlying the FPAs, the fair value of the prepaid FPAs was an asset balance of $0.1 million and was recorded on the Company’s unaudited condensed consolidated balance sheets and within other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive income (loss). Subsequently, the change of fair value of the prepaid forward purchase liability amounted to an expense of $6.7 million for the thirteen and thirty-nine weeks ended October 1, 2023. As of October 1, 2023, the prepaid forward purchase liabilities amounted to $6.6 million. </div> 0.0001 6720000 0.099 10.56 5 2 6300000 35500000 6720000 100000 6700000 6600000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(6)</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Business Combination </div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Solaria Acquisition </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On November 4, 2022, Complete Solar Holdings acquired Solaria for aggregate consideration paid of $89.1 million, comprising of $0.1 million in cash, 2,844,550 shares of common stock with an aggregate fair value of $17.3 million, 6,803,549 shares of preferred stock with an aggregate fair value of $52.2 million, 78,962 common stock warrants for an aggregate value of $0.2 million, 1,376,414 preferred stock warrants for an aggregate fair value of $7.8 million, 5,382,599 stock options with an aggregate fair value of $10.0 million attributable to services provided prior to the acquisition date, and the payment of seller incurred transaction expenses of $1.5 million. In addition, the Company assumed $14.1 million of unvested Solaria stock options, which has been and will be recorded as stock-based expense over the remaining service period. Solaria designs, develops, manufactures, and generates revenue from the sale of silicon photovoltaic solar panels and licensing of its technology to third parties. At the time of the acquisition, the </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Company believed that the acquisition of Solaria would establish the Company as a full system operator, with a compelling customer offering with <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">best-in-class</div></div> technology, financing, and project fulfilment, which would enable the Company to sell more product across more geographies in the United States and Europe. This transaction was accounted for as a business combination in accordance with ASC 805, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Business Combinations</div></div>. Refer to Note 8 – Divestiture for further details. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following table summarized the provisional fair value of identifiable assets acquired and liabilities assumed (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:90%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash, cash equivalents and restricted cash</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,402</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accounts receivable</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,822</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Inventories</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,354</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Prepaid expenses and other current assets</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,569</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Property and equipment</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">830</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating lease <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,619</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Intangible assets</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">43,100</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> assets</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">112</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total identifiable assets acquired</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">69,808</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accounts payable</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,210</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued expenses and other current liabilities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,845</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Notes payable</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,823</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred revenue</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">73</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating lease liabilities, net of current portion</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,132</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warranty provision, noncurrent</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,566</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SAFE agreements</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">60,470</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total identifiable liabilities assumed</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100,119</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net identifiable liabilities assumed</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30,311</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Goodwill</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">119,422</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total aggregate consideration paid</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">89,111</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Goodwill represents the excess of the preliminary estimated consideration transferred over the fair value of the net tangible and intangible assets acquired and has been allocated to the Company’s single reporting unit. Goodwill is primarily attributable to expected post-acquisition synergies from assembled workforce and also from the expectation of integrating Solaria’s products and solutions into the Company’s own businesses to provide access to more features and resources and offers incremental revenue opportunities. Goodwill of $119.4 million is deductible over 15 years for U.S. income tax purposes. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Intangible assets acquired are as follows (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:91%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Trademarks</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,700</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Developed technology</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,700</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer relationships</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">24,700</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total intangible assets</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">43,100</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The income approach, using the relief from royalty method, was used to value trademarks and developed technology. Significant assumptions included in the valuation of trademarks and developed technology include projected revenues, the selected royalty rate and the economic life of the underlying asset. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The income approach, using the multi-period excess earning method, was used to value customer relationships. Significant assumptions included in the valuation of customer relationships include projected revenues, customer attrition and expense growth over the forecasted period. </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As a result of the Solaria acquisition, the Company recognized $45.9 million of deferred tax assets. Due to the uncertainty surrounding the Company’s ability to realize such deferred income tax assets, a full valuation allowance has been established. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As of October 1, 2023, the goodwill and intangible assets recognized from the Solaria acquisition have been included in long-term held for sale – discontinued operations on the unaudited condensed consolidated balance sheets, as further described in Note 8 – Divestiture. </div><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Unaudited Pro Forma Information</div> </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following unaudited pro forma financial information gives effect to the acquisition of Solaria as if it were consummated on January 1, 2022 including pro forma adjustments relating to the valuation and allocation of the aggregate consideration paid, amortization of intangible assets, incremental stock-based compensation and direct transaction costs. The historical condensed consolidated financial statements have been adjusted in the unaudited combined financial information to give effect to events that are directly attributable to the Business Combination and are factually supportable. This data is presented for informational purposes only and is not intended to represent or be indicative of the results of operations that would have been reported had the acquisition occurred on January 1, 2022. Actual results may differ from the unaudited combined pro forma information presented below (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:77%"></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months<br/> Ended<br/> September 30,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months<br/> Ended<br/> September 30,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Revenues</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">22,267</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">79,800</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(26,498</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(49,935</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr></table> 89100000 100000 2844550 17300000 6803549 52200000 78962 200000 1376414 7800000 5382599 10000000 1500000 14100000 <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following table summarized the provisional fair value of identifiable assets acquired and liabilities assumed (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:90%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash, cash equivalents and restricted cash</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,402</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accounts receivable</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,822</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Inventories</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,354</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Prepaid expenses and other current assets</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,569</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Property and equipment</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">830</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating lease <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,619</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Intangible assets</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">43,100</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> assets</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">112</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total identifiable assets acquired</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">69,808</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accounts payable</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,210</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued expenses and other current liabilities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,845</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Notes payable</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,823</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred revenue</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">73</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating lease liabilities, net of current portion</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,132</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warranty provision, noncurrent</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,566</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SAFE agreements</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">60,470</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total identifiable liabilities assumed</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100,119</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net identifiable liabilities assumed</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30,311</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Goodwill</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">119,422</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total aggregate consideration paid</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">89,111</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 5402000 4822000 5354000 8569000 830000 1619000 43100000 112000 69808000 4210000 11845000 20823000 73000 1132000 1566000 60470000 100119000 30311000 119422000 89111000 119400000 P15Y <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Intangible assets acquired are as follows (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:91%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Trademarks</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,700</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Developed technology</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,700</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer relationships</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">24,700</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total intangible assets</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">43,100</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 5700000 12700000 24700000 43100000 45900000 Actual results may differ from the unaudited combined pro forma information presented below (in thousands): <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:77%"></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months<br/> Ended<br/> September 30,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months<br/> Ended<br/> September 30,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Revenues</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">22,267</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">79,800</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(26,498</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(49,935</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr></table> 22267000 79800000 -26498000 -49935000 <div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(7)</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Prepaid Expenses and Other Current Assets </div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Prepaid expenses and other current assets consists of the following (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:79%"></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Inventory deposits</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,497</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,255</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Prepaid sales commissions</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,509</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,838</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">941</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">978</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total prepaid expenses and other current assets</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,947</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,071</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Prepaid expenses and other current assets consists of the following (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:79%"></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Inventory deposits</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,497</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,255</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Prepaid sales commissions</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,509</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,838</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">941</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">978</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total prepaid expenses and other current assets</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,947</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,071</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 3497000 6255000 5509000 2838000 941000 978000 9947000 10071000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(8)</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Divestiture </div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Discontinued operations </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As previously described in Note 1 – Organization, on August 18, 2023, the Company entered into a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-Binding</div> Letter of Intent to sell certain of Complete Solaria’s North American solar panel assets, inclusive of intellectual property and customer contracts, to Maxeon. In October 2023, the Company completed the sale of its solar panel business to Maxeon. The Company determined that this divestiture represented a strategic shift in the Company’s business and qualified as a discontinued operation. Accordingly, the results of operations and cash flows relating to Solaria have been reflected as discontinued operations in the unaudited condensed consolidated statements of operations and comprehensive income (loss) for the thirteen and thirty-nine weeks ended October 1, 2023 and the unaudited condensed consolidated statements of cash flows for the thirty-nine weeks ended October 1, 2023. </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Components of amounts reflected in the unaudited condensed consolidated statements of operations and comprehensive income (loss) related to discontinued operations are presented in the table, as follows (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:75%"></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Thirteen Weeks<br/> Ended<br/> October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Thirty-Nine<br/> Weeks Ended<br/> October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Revenues</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,774</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">29,048</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cost of revenues</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,102</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30,609</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Gross loss</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(328</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,561</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating expenses:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sales and marketing</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,425</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,855</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">General and administrative</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,681</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,572</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total operating expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,106</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19,427</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Loss from discontinued operations</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(8,434</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(20,988</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other income (expense), net</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">31</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">32</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Loss from discontinued operations before income taxes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(8,403</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(20,956</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Income tax benefit (provision)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Impairment loss from discontinued operations</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(147,505</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(147,505</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss from discontinued operations</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(155,909</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(168,458</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Held for sale </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As previously described in Note 1 – Organization, certain assets of the Solaria, Inc. have been reflected as assets held for sale in the periods preceding the divestiture. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following is a summary of the major categories of assets and liabilities held for sale (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:79%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Intangible assets, net</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,299</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,610</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Goodwill</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">119,422</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Long-term assets held for sale</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,299</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">162,032</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Components of amounts reflected in the unaudited condensed consolidated statements of operations and comprehensive income (loss) related to discontinued operations are presented in the table, as follows (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:75%"></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Thirteen Weeks<br/> Ended<br/> October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Thirty-Nine<br/> Weeks Ended<br/> October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Revenues</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,774</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">29,048</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cost of revenues</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,102</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30,609</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Gross loss</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(328</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,561</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating expenses:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sales and marketing</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,425</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,855</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">General and administrative</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,681</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,572</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total operating expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,106</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19,427</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Loss from discontinued operations</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(8,434</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(20,988</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other income (expense), net</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">31</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">32</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Loss from discontinued operations before income taxes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(8,403</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(20,956</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Income tax benefit (provision)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Impairment loss from discontinued operations</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(147,505</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(147,505</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss from discontinued operations</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(155,909</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(168,458</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 3774000 29048000 4102000 30609000 -328000 -1561000 2425000 6855000 5681000 12572000 8106000 19427000 8434000 20988000 31000 32000 -8403000 -20956000 1000 -3000 -147505000 -147505000 -155909000 -168458000 <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following is a summary of the major categories of assets and liabilities held for sale (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:79%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Intangible assets, net</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,299</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,610</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Goodwill</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">119,422</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Long-term assets held for sale</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,299</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">162,032</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 12299000 42610000 119422000 12299000 162032000 <div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(9)</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Property and Equipment, Net </div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Property and equipment, net consists of the following (in thousands, except year data): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:69%"></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Estimated</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Useful Lives<br/> (Years)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Developed software</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,559</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,054</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Manufacturing equipment</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">131</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">102</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Furniture and equipment</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">90</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">90</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Leasehold improvements</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">708</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">708</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total property and equipment</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,488</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,954</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: accumulated depreciation and amortization</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(3,303</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,478</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total property and equipment, net</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,185</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,476</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div></div><div><div style="line-height:normal;background-color:white;display: inline;"></div></div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Depreciation and amortization expense on tangible assets totaled $0.3 million and $0.6 million for the thirteen and thirty-nine weeks ended October 1, 2023, respectively, and $0.2 million and $0.4 million for the three and nine months ended September 30, 2022, respectively. There were no impairment charges on tangible assets recognized for the thirteen or thirty-nine weeks ended October 1, 2023, or for the three or nine months ended September 30, 202<div style="display:inline;">2</div>. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Property and equipment, net consists of the following (in thousands, except year data): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:69%"></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Estimated</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Useful Lives<br/> (Years)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Developed software</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,559</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,054</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Manufacturing equipment</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">131</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">102</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Furniture and equipment</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">90</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">90</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Leasehold improvements</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">708</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">708</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total property and equipment</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,488</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,954</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: accumulated depreciation and amortization</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(3,303</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,478</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total property and equipment, net</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,185</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,476</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> P5Y 6559000 5054000 P3Y 131000 102000 P3Y 90000 90000 P5Y 708000 708000 7488000 5954000 3303000 2478000 4185000 3476000 300000 600000 200000 400000 0 0 0 0 <div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(10)</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Goodwill and Intangible Assets </div></div></td></tr></table><div style="margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Goodwill </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">During the thirteen and thirty-nine weeks ended October 1, 2023, the Company recorded $119.4 million of goodwill impairment related to the goodwill assigned to Solaria, Inc. See Note 8 – Divestiture for additional information regarding the divestiture. The goodwill balances as of October 1, 2023 and December 31, 2022 were zero and $119.4 million, respectively. See Note 6 – Business Combination for additional information regarding the Company’s acquisitions including recognition of goodwill. </div><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Intangible Assets </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following table provides a reconciliation of intangible assets reported as of October 1, 2023 and December 31, 2022 (in thousands, except years data): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:53%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="18" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of October 1, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Gross<br/> Carrying<br/> Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Impairment</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Held for<br/> Sale</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated<br/> Amortization</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net<br/> Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Assembled workforce</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">137</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(137</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Trademarks</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,700</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(3,714</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,463</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(523</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer relationship</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">24,700</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(16,094</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(7,577</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,029</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Developed technology</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,700</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(8,275</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(3,259</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,166</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total intangible assets</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">43,237</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(28,083</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(12,299</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,855</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:64%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted-<br/> Average<br/> Remaining<br/> Life<br/> (Years)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Gross<br/> Carrying<br/> Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated<br/> Amortization</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net<br/> Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Assembled workforce</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">137</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(133</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Trademarks</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,700</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(95</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,605</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer relationship</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">24,700</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(187</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">24,513</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Developed technology</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,700</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(212</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,488</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total intangible assets</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">43,237</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(627</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,610</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Amortization expense related to intangible assets for the thirteen and thirty-nine weeks ended October 1, 2023 and the three and nine months ended September 30, 2022 were as follows (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:53%"></td> <td style="vertical-align:bottom;width:9%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:9%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:9%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:9%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Thirteen Weeks<br/> Ended<br/> October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months<br/> Ended<br/> September 30,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Thirty-Nine</div><br/> Weeks Ended<br/> October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months<br/> Ended<br/> September 30,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Assembled workforce</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">51</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Trademarks</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">142</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">428</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer relationship</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">279</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">843</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Developed technology</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">317</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">953</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total amortization expense</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">738</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,228</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">51</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Amortization expense for the thirteen and thirty-nine weeks ended October 1, 2023 was recorded as loss from discontinued operations on the accompanying unaudited condensed consolidated statements of operations and comprehensive income (loss). For the three and nine months ended September 30, 2022, amortization expense related to intangible assets of less than $0.1 million was recorded to general and administrative expense on the accompanying unaudited condensed consolidated statements of operations and comprehensive income (loss). </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company does not expect to recognize any future amortization expense of intangible assets as of October 1, 2023. </div> 119400000 119400000 0 119400000 <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following table provides a reconciliation of intangible assets reported as of October 1, 2023 and December 31, 2022 (in thousands, except years data): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:53%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="18" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of October 1, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Gross<br/> Carrying<br/> Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Impairment</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Held for<br/> Sale</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated<br/> Amortization</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net<br/> Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Assembled workforce</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">137</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(137</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Trademarks</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,700</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(3,714</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,463</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(523</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer relationship</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">24,700</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(16,094</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(7,577</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,029</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Developed technology</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,700</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(8,275</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(3,259</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,166</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total intangible assets</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">43,237</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(28,083</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(12,299</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,855</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:64%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted-<br/> Average<br/> Remaining<br/> Life<br/> (Years)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Gross<br/> Carrying<br/> Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated<br/> Amortization</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net<br/> Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Assembled workforce</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">137</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(133</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Trademarks</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,700</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(95</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,605</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer relationship</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">24,700</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(187</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">24,513</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Developed technology</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9.8</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,700</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(212</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,488</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total intangible assets</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">43,237</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(627</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,610</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 137000 0 0 -137000 0 5700000 -3714000 1463000 -523000 0 24700000 -16094000 7577000 -1029000 0 12700000 -8275000 3259000 -1166000 0 43237000 -28083000 12299000 -2855000 0 P0Y1M6D 137000 -133000 4000 P9Y9M18D 5700000 -95000 5605000 P21Y9M18D 24700000 -187000 24513000 P9Y9M18D 12700000 -212000 12488000 43237000 -627000 42610000 <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Amortization expense related to intangible assets for the thirteen and thirty-nine weeks ended October 1, 2023 and the three and nine months ended September 30, 2022 were as follows (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:53%"></td> <td style="vertical-align:bottom;width:9%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:9%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:9%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:9%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Thirteen Weeks<br/> Ended<br/> October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months<br/> Ended<br/> September 30,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Thirty-Nine</div><br/> Weeks Ended<br/> October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine Months<br/> Ended<br/> September 30,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Assembled workforce</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">51</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Trademarks</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">142</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">428</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer relationship</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">279</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">843</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Developed technology</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">317</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">953</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total amortization expense</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">738</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,228</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">51</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 0 17000 4000 51000 142000 0 428000 0 279000 0 843000 0 317000 0 953000 0 738000 17000 2228000 51000 100000 100000 <div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(11)</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Accrued Expenses and Other Current Liabilities </div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Accrued expenses and other current liabilities consist of the following (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:80%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued compensation and benefits</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,666</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,940</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer deposits</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,167</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">930</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Uninvoiced contract costs</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,554</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,914</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Inventory received but not invoiced</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,391</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">972</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued term loan and revolving loan amendment and final payment fees</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,175</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,400</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued legal settlements</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,955</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,853</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued taxes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">931</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,245</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued rebates and credits</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">880</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,076</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating lease liabilities, current</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">720</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">958</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Revenue warranty</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">918</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred underwriters’ discount payable</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,019</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued warranty, current</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">605</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">767</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other accrued liabilities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,693</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,775</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total accrued expenses and other current liabilities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">26,674</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19,830</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Accrued expenses and other current liabilities consist of the following (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:80%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued compensation and benefits</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,666</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,940</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Customer deposits</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,167</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">930</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Uninvoiced contract costs</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,554</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,914</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Inventory received but not invoiced</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,391</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">972</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued term loan and revolving loan amendment and final payment fees</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,175</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,400</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued legal settlements</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,955</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,853</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued taxes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">931</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,245</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued rebates and credits</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">880</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,076</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating lease liabilities, current</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">720</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">958</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Revenue warranty</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">918</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred underwriters’ discount payable</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,019</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued warranty, current</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">605</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">767</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other accrued liabilities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,693</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,775</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total accrued expenses and other current liabilities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">26,674</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19,830</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 3666000 3940000 1167000 930000 3554000 1914000 1391000 972000 2175000 2400000 2955000 1853000 931000 1245000 -880000 -1076000 720000 958000 918000 0 3019000 0 605000 767000 4693000 3775000 26674000 19830000 <div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(12)</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Employee Benefit Plan </div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company sponsors a 401(k) defined contribution and profit-sharing plan (“401(k) Plan”) for its eligible employees. This 401(k) Plan provides for <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">tax-deferred</div> salary deductions for all eligible employees. Employee contributions are voluntary. Employees may contribute the maximum amount allowed by law, as limited by the annual maximum amount as determined by the Internal Revenue Service. The Company may match employee contributions in amounts to be determined at the Company’s sole discretion. The Company made no contributions to the 401(k) Plan for the thirteen or thirty-nine weeks ended October 1, 2023 and for the three or nine months ended September 30, 2022. </div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">(13) Other Income (Expense), Net </div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Other income (expense), net consists of the following (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:66%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Thirteen<br/> Weeks<br/> Ended<br/> October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Months<br/> Ended<br/> September 30,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Thirty-Nine</div><br/> Weeks<br/> Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine<br/> Months<br/> Ended<br/> September 30,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value of redeemable convertible preferred stock warrant liability</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">39</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,455</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(142</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value of Carlyle warrants</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,689</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,689</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value of FACT public, private placement and working capital warrants</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,170</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,170</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Gain on extinguishment of convertible notes and SAFE agreements<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,235</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Loss on CS Solis debt extinguishment</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(10,338</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(10,338</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Bonus shares issued in connection with the Mergers<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(2)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,394</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,394</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of forward purchase agreements<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(3)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">76</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">76</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value of forward purchase agreement liabilities<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(6,661</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(6,661</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of shares in connection with the forward purchase agreements<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(5)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(35,490</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(35,490</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other, net</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(94</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">191</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">87</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total other income (expense), net</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(38,003</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(28,302</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,180</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Includes zero and $1.4 million of other income for the three and nine months ended September 30, 2022, respectively, recognized upon the conversion of related party convertible notes and SAFEs. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(2)</div> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Includes $0.7 million of other expense for each of the thirteen and thirty-nine weeks ended October 1, 2023 for bonus shares issued to related parties in connection with the Mergers. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(3)</div> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Includes $0.3 million of other income for each of the thirteen and thirty-nine weeks ended October 1, 2023 for forward purchase agreements entered into with related parties. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Includes $5.9 million of other expense for each of the thirteen and thirty-nine weeks ended October 1, 2023 for forward purchase agreements entered into with related parties. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(5)</div> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Includes $30.7 million of other expense for each of the thirteen and thirty-nine weeks ended October 1, 2023 for shares issued to related parties in connection with the forward purchase agreements. </div></td></tr></table> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Other income (expense), net consists of the following (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:66%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Thirteen<br/> Weeks<br/> Ended<br/> October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Months<br/> Ended<br/> September 30,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Thirty-Nine</div><br/> Weeks<br/> Ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine<br/> Months<br/> Ended<br/> September 30,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value of redeemable convertible preferred stock warrant liability</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">39</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,455</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(142</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value of Carlyle warrants</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,689</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,689</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value of FACT public, private placement and working capital warrants</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,170</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,170</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Gain on extinguishment of convertible notes and SAFE agreements<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,235</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Loss on CS Solis debt extinguishment</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(10,338</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(10,338</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Bonus shares issued in connection with the Mergers<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(2)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,394</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,394</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of forward purchase agreements<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(3)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">76</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">76</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value of forward purchase agreement liabilities<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(6,661</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(6,661</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of shares in connection with the forward purchase agreements<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(5)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(35,490</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(35,490</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other, net</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(94</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">191</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">87</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total other income (expense), net</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(38,003</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(28,302</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,180</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Includes zero and $1.4 million of other income for the three and nine months ended September 30, 2022, respectively, recognized upon the conversion of related party convertible notes and SAFEs. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(2)</div> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Includes $0.7 million of other expense for each of the thirteen and thirty-nine weeks ended October 1, 2023 for bonus shares issued to related parties in connection with the Mergers. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(3)</div> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Includes $0.3 million of other income for each of the thirteen and thirty-nine weeks ended October 1, 2023 for forward purchase agreements entered into with related parties. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Includes $5.9 million of other expense for each of the thirteen and thirty-nine weeks ended October 1, 2023 for forward purchase agreements entered into with related parties. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(5)</div> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Includes $30.7 million of other expense for each of the thirteen and thirty-nine weeks ended October 1, 2023 for shares issued to related parties in connection with the forward purchase agreements. </div></td></tr></table> -39000 -3000 -9455000 142000 12689000 12689000 -4170000 -4170000 3235000 10338000 10338000 2394000 2394000 76000 76000 -6661000 -6661000 35490000 35490000 -94000 1000 191000 87000 -38003000 4000 -28302000 3180000 0 1400000 700000 300000 300000 5900000 5900000 30700000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(14)</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Common Stock </div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company has authorized the issuance of 1,000,000,000 shares of common stock and 10,000,000 shares of preferred stock as of October 1, 2023. No preferred stock has been issued. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company has reserved shares of common stock for issuance related to the following: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:89%"></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of<br/> October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common stock warrants</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">27,637,266</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Employee stock purchase plan</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,628,996</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock options and RSUs, issued and outstanding</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,013,514</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock options and RSUs, authorized for future issuance</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,625,023</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total shares reserved</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">45,904,799</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 1000000000 10000000 <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company has reserved shares of common stock for issuance related to the following: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:89%"></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of<br/> October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common stock warrants</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">27,637,266</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Employee stock purchase plan</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,628,996</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock options and RSUs, issued and outstanding</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,013,514</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock options and RSUs, authorized for future issuance</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,625,023</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total shares reserved</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">45,904,799</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 27637266 2628996 7013514 8625023 45904799 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(15)</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Warrants </div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Series B Warrants (Converted to Common Stock Warrants) </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In February 2016, the Company issued a warrant to purchase 5,054 shares of Series B preferred stock (the “Series B warrant”) in connection with a 2016 credit facility. The Series B warrant is immediately exercisable at an exercise price of $4.30 per share and has an expiration date of February 2026. The fair value of the Series B warrant was less than $0.1 million as of December 31, 2022 and as of July 18, 2023, when the Series B warrant was reclassified from warrant liability to additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital, as the warrant is exercisable into shares of Complete Solaria Common Stock upon the close of the Mergers. The relative fair value of the Series B warrant at issuance was recorded as a debt issuance cost within other <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> liabilities on the accompanying unaudited condensed consolidated balance sheets, and changes in fair value have been recorded in other income (expense), net on the accompanying unaudited condensed consolidated statements of operations and comprehensive income (loss) for the thirteen and thirty-nine weeks ended October 1, 2023 and the three and nine months ended September 30, 2022. </div><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Series C Warrants (Converted to Common Stock Warrants) </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In July 2016, the Company issued a warrant to purchase 148,477 shares of Series C preferred stock (the “Series C warrant”) in connection with the Series C financing. The Series C warrant agreement also provided for an additional number of Series C shares calculated on a monthly basis commencing on June 2016 based on the principal balance outstanding of the notes payable outstanding. The maximum number of shares exercisable under the Series C warrant agreement is 482,969 shares of Series C preferred stock. The Series C warrant was immediately exercisable at an exercise price of $1.00 per share and has an expiration date of July 2026. The fair value of the Series C warrant was $6.3 million as of December 31, 2022. The fair value of the Series C warrant was $2.3 million as of July 18, 2023, when the Series B warrant was reclassified from redeemable convertible preferred stock warrant liability to additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital, as the warrant is exercisable into shares of Complete Solaria Common Stock upon the close of the Mergers. The relative fair value of the Series C warrant at issuance was recorded as Series C preferred stock issuance costs and redeemable convertible preferred stock warrant liability on the accompanying unaudited condensed consolidated balance sheets, and changes in fair value have been recorded in other income (expense), net on the accompanying unaudited condensed consolidated statements of operations and comprehensive income (loss) for the thirteen and thirty-nine weeks ended October 1, 2023 and the three and nine months ended September 30, 2022. </div><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">C-1</div> Warrants (Converted to Common Stock Warrants) </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In January 2020, the Company issued a warrant to purchase 173,067 shares of common stock in conjunction with the Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">C-1</div> preferred stock financing. The warrant is immediately exercisable at an exercise price of $0.01 per share and has an expiration date of January 2030. The warrant remains outstanding as of October 1, 2023. At issuance, the relative fair value of the warrant was determined to be $0.1 million using the Black-Scholes model with the following weighted average assumptions: expected term of 10 years; expected volatility of 62.5%; risk-free interest rate of 1.5%; and no dividend yield. The fair value of the warrant was recorded within additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital on the unaudited condensed consolidated balance sheets. The warrant is not remeasured in future periods as it meets the conditions for equity classification. </div><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">SVB Common Stock Warrants </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In May and August 2021, the Company issued warrants to purchase 2,473 and 2,525 shares of common stock, respectively, in conjunction with the Fifth and Sixth Amendments to the Loan and Security Agreement (“Loan Agreement”) with Silicon Valley Bank (“SVB”). The warrants are immediately exercisable at exercise prices of $0.38 and $0.62 per share, respectively, and have expiration dates in 2033. The warrants remain outstanding as of October 1, 2023. At issuance, the relative fair value of the warrants </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">were determined to be less than $0.1 million in aggregate using the Black-Scholes model with the following weighted average assumptions: expected term of 12 years; expected volatility of 73.0%; risk-free interest rate of 1.7% and 1.3% for the May and August 2021 warrants, respectively; and no dividend yield. The fair value of the warrant was recorded within additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in-capital</div></div> on the accompanying unaudited condensed consolidated balance sheets. The warrants are not remeasured in future periods as they meet the conditions for equity classification. </div><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Promissory Note Common Stock Warrants </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In October 2021, the Company issued a warrant to purchase 24,148 shares of common stock in conjunction with the issuance of a short-term promissory note. The warrant is immediately exercisable at an exercise price of $0.01 per share and has an expiration date of October 2031. The warrant remains outstanding as of October 1, 2023. At issuance, the relative fair value of the warrant was determined to be less than $0.1 million using the Black-Scholes model with the following weighted average assumptions: expected term of 10 years; expected volatility of 73.0%; risk-free interest rate of 1.5%; and no dividend yield. The fair value of the warrant was recorded within additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital on the unaudited condensed consolidated balance sheets. The warrant is not remeasured in future periods as it meets the conditions for equity classification. </div><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Carlyle Warrants </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In February 2022, as part of a debt financing from Carlyle (refer to Note 16 – Borrowing Arrangements), the Company issued a warrant to purchase 2,886,952 shares of common stock in conjunction with the redeemable investment in CS Solis. The warrant contained two tranches, the first of which is immediately exercisable for 1,995,879 shares. The second tranche, which was determined to be a separate unit of account, was exercisable upon a subsequent investment from Carlyle in CS Solis. No subsequent investment was made and the investment period expired on December 31, 2022 and the second tranche of warrants expired prior to becoming exercisable. The vested warrant had an exercise price of $0.01 per share and had an expiration date of February 2029. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">At issuance, the relative fair value of the warrant was determined to be $3.4 million using the Black-Scholes model with the following weighted average assumptions: expected term of 7 years; expected volatility of 73.0%; risk-free interest rate of 1.9%; and no dividend yield. The fair value of the warrant was recorded within additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital and as a discount on the long-term debt in CS Solis on the unaudited condensed consolidated balance sheets as of December 31, 2022. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In July 2023, and in connection with the closing of the Mergers, the Carlyle debt and warrants were modified. Based on the exchange ratio included in the Mergers, the 1,995,879 outstanding warrants to purchase Legacy Complete Solaria Common Stock prior to modification were exchanged into warrants to purchase 1,995,879 shares of Complete Solaria Common Stock. As part of the modification, the warrant, which expires on July 18, 2030, provides Carlyle with the right to purchase shares of Complete Solaria Common Stock based on (a) the greater of (i) 1,995,879 shares and (ii) the number of shares equal to 2.795% of Complete Solaria’s issued and outstanding shares of common stock, on a fully-diluted basis; plus (b) on and after the date that is ten (10) days after the date of the agreement, an additional 350,000 shares; plus (c) on and after the date that is thirty (30) days after the date of the agreement, if the original investment amount has not been repaid, an additional 150,000 shares; plus (d) on and after the date that is ninety (90) days after the date of the agreement, if the original investment amount has not been repaid, an additional 250,000 shares, in each case, of Complete Solaria Common Stock at a price of $0.01 per share. Of the additional warrants that become exercisable after the modification, the tranches of 350,000 warrants vesting ten days after the date of the agreement and 150,000 warrants vesting thirty days after the date of the agreement are exercisable as of October 1, 2023. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The modification of the warrant resulted in the reclassification of previously equity classified warrants to liability classification, which was accounted for in accordance with ASC 815 and ASC 718. The Company </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">recorded the fair value of the modified warrants as a warrant liability of $20.4 million, the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-modification</div> fair value of the warrants as a reduction to additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital of $10.9 million and $9.5 million to other income (expense), net equal to the incremental value of the warrants upon the modification. The fair value of the warrant was determined based on its intrinsic value, given a nominal exercise price. At issuance, the relative fair value of the warrant was determined to be less than $20.4 million using the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Black-Scholes</div> model with the following weighted average assumptions: expected term of 7 years; expected volatility of 77.0%; risk-free interest rate of 3.9%; and no dividend yield. As of October 1, 2023, the fair value of the warrant was $7.7 million, and the Company recorded the adjustment of $12.7 million as other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive income (loss). </div><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">D-7</div> Warrants (Converted to Common Stock Warrants) </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In November 2022, the Company issued warrants to purchase 656,630 shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">D-7</div> preferred stock (the “Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">D-7</div> warrants”) in conjunction with the Business Combination. The warrant contains two tranches. The first tranche of 518,752 shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">D-7</div> preferred stock is exercisable at an exercise price of $2.50 per share upon consummation of a merger transaction, or at an exercise price of $2.04 per share upon remaining private and has an expiration date of April 2024. The second tranche of 137,878 shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">D-7</div> preferred stock is exercisable at an exercise price of $5.00 per share upon consummation of a merger transaction, or at an exercise price of $4.09 per share upon remaining private and has an expiration date of April 2024. The fair value of the Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">D-7</div> warrants was $7.8 million as of December 31, 2022 and $2.4 million as of July 18, 2023 when the warrants were reclassified from redeemable convertible preferred stock warrant liability to additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital, as the exercise price of the warrants is fixed at $2.50 per share of Complete Solaria Common Stock for the first tranche and $5.00 per share of Complete Solaria Common Stock for the second tranche upon the closing of the Mergers. The Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">D-7</div> Warrants remain outstanding as of October 1, 2023. </div><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">November 2022 Common Stock Warrants </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In November 2022, the Company issued a warrant to a third-party service provider to purchase 78,962 shares of common stock in conjunction with the Business Combination. The warrant was immediately exercisable at an exercise price of $8.00 per share and had an expiration date of April 2024. In May 2023, the Company amended the warrant, modifying the shares of common stock to be purchased to 31,680, the exercise price to $0.01, and the expiration date to the earlier of October 2026 or the closing of an IPO. The impact of the modification was not material to the unaudited condensed consolidated financial statements. At issuance and upon the modification, the relative fair value of the warrant was determined to be $0.1 million using the Black-Scholes model with the following weighted average assumptions: expected term of 1.5 years; expected volatility of 78.5%; risk-free interest rate of 4.7%; and no dividend yield. The fair value of the warrant was recorded within additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital on the unaudited condensed consolidated balance sheets. The warrant is not remeasured in future periods as it meets the conditions for equity classification. Upon the Closing of the Mergers, the warrant was net exercised into 31,680 shares of Complete Solaria Common Stock. </div><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">July 2023 Common Stock Warrants </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In July 2023, the Company issued a warrant to a third-party service provider to purchase 38,981 shares of common stock in exchange for services provided in obtaining financing at the Closing of the Mergers. The warrant is immediately exercisable at a price of $0.01 per share and has an expiration date of July 2028. At issuance, the fair value of the warrant was determined to be $0.2 million, based on the intrinsic value of the warrant and the $0.01 per share exercise price. As the warrant is accounted for as an equity issuance cost, the warrant is recorded only within additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital on the unaudited condensed consolidated balance sheets. The warrant is not remeasured in future periods as it meets the conditions for equity classification. </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Warrant Consideration </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In July 2023, in connection with the Mergers, the Company issued 6,266,572 warrants to purchase Complete Solaria Common Stock to holders of Legacy Complete Solaria Redeemable Convertible Preferred Stock, Legacy Complete Solaria Common Stock. The exercise price of the common stock warrants is $11.50 per share and the warrants expire 10 years from the date of the Mergers. The warrant consideration was issued as part of the close of the Mergers and was recorded within additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital, net of the issuance costs of the Mergers. As of October 1, 2023, all warrants issued as warrant consideration remain outstanding. </div><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Public, Private Placement, and Working Capital Warrants </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In conjunction with the Mergers, Complete Solaria, as accounting acquirer, was deemed to assume 6,266,667 warrants to purchase FACT Class A Ordinary Shares that were held by the sponsor at an exercise price of $11.50 (“Private Placement Warrants”) and 8,625,000 warrants to purchase FACT’s shareholders FACT Class A Ordinary Shares at an exercise price of $11.50 (“Public Warrants”). Subsequent to the Mergers, the Private Placement Warrants and Public Warrants are exercisable for shares of Complete Solaria Common Stock and meet liability classification requirements since the warrants may be required to be settled in cash under a tender offer. In addition, Private Placement Warrants are potentially subject to a different settlement amount as a result of being held by the Sponsor which precludes the Private Placement Warrants from being considered indexed to the entity’s own stock. Therefore, these warrants are classified as liabilities on the unaudited condensed consolidated balance sheets. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company determined the Public and Private warrants to be classified as a liability and fair valued the warrants on the issuance date using the publicly available price for the warrants of $6.4 million. The fair value of these warrants was $2.4 million as of October 1, 2023, and the Company recorded the change in fair value of $4.0 million in other income (expense), net in the unaudited condensed consolidated statements of operations and comprehensive income (loss) for the thirteen and thirty-nine weeks ended October 1, 2023. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Additionally, at the closing of the Mergers, the Company issued 716,668 Working Capital warrants, which have identical terms as the Private Placement Warrants to the sponsor in satisfaction of certain liabilities of FACT. The warrants were fair valued at $0.3 million upon the closing of the Mergers, which was recorded in warrant liability on the unaudited condensed consolidated balance sheets. As of October 1, 2023, the Working Capital warrants had a fair value of $0.1 million, and the Company recorded the change in fair value of $0.2 million as other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive income (loss). </div> 5054 4.3 100000 100000 148477 482969 1 6300000 2300000 173067 0.01 100000 P10Y 0.625 0.015 0 2473 2525 0.38 0.62 100000 P12Y 0.73 0.017 0.013 24148 0.01 100000 P10Y 0.73 0.015 0 2886952 1995879 0.01 3400000 P7Y 0.73 0.019 0 1995879 1995879 the warrant, which expires on July 18, 2030, provides Carlyle with the right to purchase shares of Complete Solaria Common Stock based on (a) the greater of (i) 1,995,879 shares and (ii) the number of shares equal to 2.795% of Complete Solaria’s issued and outstanding shares of common stock, on a fully-diluted basis; plus (b) on and after the date that is ten (10) days after the date of the agreement, an additional 350,000 shares; plus (c) on and after the date that is thirty (30) days after the date of the agreement, if the original investment amount has not been repaid, an additional 150,000 shares; plus (d) on and after the date that is ninety (90) days after the date of the agreement, if the original investment amount has not been repaid, an additional 250,000 shares, in each case, of Complete Solaria Common Stock at a price of $0.01 per share. 350000 150000 20400000 10900000 9500000 20400000 P7Y 0.77 0.039 7700000 12700000 656630 The first tranche of 518,752 shares of Series D-7 preferred stock is exercisable at an exercise price of $2.50 per share upon consummation of a merger transaction, or at an exercise price of $2.04 per share upon remaining private and has an expiration date of April 2024. The second tranche of 137,878 shares of Series D-7 preferred stock is exercisable at an exercise price of $5.00 per share upon consummation of a merger transaction, or at an exercise price of $4.09 per share upon remaining private and has an expiration date of April 2024. The fair value of the Series D-7 warrants was $7.8 million as of December 31, 2022 and $2.4 million as of July 18, 2023 when the warrants were reclassified from redeemable convertible preferred stock warrant liability to additional paid-in capital, as the exercise price of the warrants is fixed at $2.50 per share of Complete Solaria Common Stock for the first tranche and $5.00 per share of Complete Solaria Common Stock for the second tranche upon the closing of the Mergers. 518752 2.5 78962 8 31680 0.01 100000 P1Y6M 0.785 0.047 31680 38981 0.01 200000 0.01 6266572 11.5 P10Y 6266667 11.5 8625000 11.5 6400000 2400000 4000000 716668 300000 100000 200000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(16)</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Borrowing Arrangements </div></div></td></tr></table><div style="margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Convertible notes, net and convertible notes, net, due to related parties </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As of October 1, 2023 and December 31, 2022, the Company’s convertible notes consisted of the following (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:80%"></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Convertible notes, net, noncurrent</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2022 Convertible Notes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">  —</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,434</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2022 Convertible Notes due to related parties</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">  —</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">15,510</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total convertible notes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">  —</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18,944</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div></div><div><div style="line-height:normal;background-color:white;display: inline;"></div></div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Convertible Promissory Notes with Ecosystem Integrity Fund II, LP. </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On April 30, 2021, the Company issued a short-term Subordinated Convertible Promissory Note to Ecosystem Integrity Fund II, LP (“EIF”) for a total principal of $0.5 million plus accrued interest of 3.0% per annum due on June 30, 2021. The Note included a conversion feature which allows the holder to convert any portion of the note plus any unpaid accrued interest (“Conversion Amount”) into shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">C-1</div> Preferred Stock on the maturity date of June 30, 2021 or thereafter. As of December 31, 2021 the principal and accrued interest remained outstanding and the holder did not elect to covert the note into Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">C-1</div> Preferred shares. The principal and accrued interest of $0.5 million was repaid in February 2022, and as such, the balance remaining at December 31, 2022 and thereafter remained zero. </div><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-A</div> Convertible Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In 2019, the Company issued a series of convertible notes <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(“2019-A</div> Convertible Notes”) for $0.1 million in proceeds, with immaterial debt issuance costs, and which were due and payable on demand by the holders after August 2020. The notes carried simple interest of 6.0% and contained a conversion feature whereby the notes would convert at 80% of the issuance price of the preferred shares in the next equity financing. The notes also contained other embedded features such as conversion options that were exercisable upon the occurrence of various contingencies. All of the embedded features were analyzed to determine whether they should be bifurcated and separately accounted for as a derivative. Pursuant to such analysis, the Company valued and bifurcated the share-settled redemption feature, which enabled the holders to convert the notes to the preferred shares at a predefined discount from the issuance price and recorded its initial fair value of less than $0.1 million as a discount on the convertible notes face amount. The debt discount was amortized to interest expense at a weighted-average effective interest rate of 17.6% through the maturity dates of the notes. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The fair value of the share-settled redemption feature was estimated based on a probability-weighted analysis of the discounted value of the notes converting under a Next Equity Financing, a change in control, default, or maturity, and the changes in fair value were recognized as a component of other income (expense), net in the accompanying unaudited condensed consolidated statements of operations and comprehensive income (loss). The Company recorded zero in expense during the thirteen and thirty-nine weeks ended October 1, 2023 and the three and nine months ended September 30, 2022, related to the change in the fair value of the convertible notes embedded derivative liability. The convertible notes were carried within the accompanying unaudited condensed consolidated balance sheets at their original issuance value, net of unamortized debt discount and issuance costs. In March 2022, as part of the Company’s Series D Preferred Stock issuance, the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-A</div> Convertible Notes converted into 62,500 shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">D-2</div> redeemable convertible preferred stock. The Company recognized a gain on the conversion of less than $0.1 million in other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive income (loss). As the full carrying value of the note was converted to Series D Preferred Stock, the balance remaining for the note at December 31, 2022 and thereafter remained zero. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company did not recognize any interest expense related to the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-A</div> Convertible Notes during the thirteen and thirty-nine weeks ended October 1, 2023 and the three months ended September 2022. Interest expense recognized related to the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2019-A</div> Convertible Notes during the nine months ended September 30, 2022 was immaterial. </div><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-A</div> Convertible Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In 2020, the Company issued a series of convertible notes <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(“2020-A</div> Convertible Notes”) for $3.8 million in proceeds, with immaterial debt issuance costs, and which are due and payable on demand by the holders after April 2021. The notes carried simple interest of 2.0% and contained a conversion feature whereby the notes would convert at 80% of the issuance price of the preferred shares in the next equity financing. The notes also contained other embedded features such as conversion options that were exercisable upon the </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">occurrence of various contingencies. All of the embedded features were analyzed to determine whether they should be bifurcated and separately accounted for as a derivative. Pursuant to such analysis, the Company valued and bifurcated the share-settled redemption feature, which enables the holders to convert the notes to the preferred shares at a predefined discount from the issuance price and recorded its initial fair value of $0.5 million as a discount on the convertible notes face amount. The debt discount was amortized to interest expense at a weighted-average effective interest rate of 25.6% through the maturity dates of the notes. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The fair value of the share-settled redemption feature was estimated based on a probability-weighted analysis of the discounted value of the notes converting under a Next Equity Financing, a change in control, default, or maturity, and the changes in fair value were recognized as a component of other income (expense), net in the accompanying unaudited condensed consolidated statements of operations and comprehensive income (loss). The Company recorded zero in expense during the thirteen and thirty-nine weeks ended October 1, 2023 and the three and nine months ended September 30, 2022, related to the change in the fair value of the convertible notes embedded derivative liability. The convertible notes were carried within the accompanying unaudited condensed consolidated balance sheets at their original issuance value, net of unamortized debt discount and issuance costs. In March 2022, as part of the Company’s Series D Preferred Stock issuance, the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-A</div> Convertible Notes converted into 785,799 shares of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Series D-1</div> redeemable convertible preferred stock. The Company recognized a gain on the conversion of $0.9 million in other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive income (loss). As the full carrying value of the note was converted to Series D Preferred Stock, the balance remaining for the note at December 31, 2022 and thereafter remained zero. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company did not recognize any interest expense related to the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-A</div> Convertible Notes during the thirteen and thirty-nine weeks ended October 1, 2023 and the three months ended September 2022. Interest expense recognized during the nine months ended September 30, 2022 was immaterial. </div><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-A</div> Convertible Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In 2020, the Company issued a series of convertible notes <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(“2021-A</div> Convertible Notes”) for $4.3 million in proceeds, with immaterial debt issuance costs, and which are due and payable on demand by the holders after February 2022. The holders are existing investors and are not expected to demand cash settlement, as the Company expects to raise additional preferred financing under which the notes will convert into preferred shares. The notes carry simple interest of 2.0% and contained a conversion feature whereby the notes would convert at 80% of the issuance price of the preferred shares in the next equity financing. The notes also contained other embedded features such as conversion options that were exercisable upon the occurrence of various contingencies. All of the embedded features were analyzed to determine whether they should be bifurcated and separately accounted for as a derivative. Pursuant to such analysis, the Company valued and bifurcated the share-settled redemption feature, which enables the holders to convert the notes to the preferred shares at a predefined discount from the issuance price and recorded its initial fair value of $0.6 million as a discount on the convertible notes face amount. The debt discount is amortized to interest expense at a weighted-average effective interest rate of 18.1% through the maturity dates of the notes. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The fair value of the share-settled redemption feature was estimated based on a probability-weighted analysis of the discounted value of the notes converting under a Next Equity Financing, a change in control, default, or maturity, and the changes in fair value were recognized as a component of other income (expense), net in the unaudited condensed consolidated statements of operations and comprehensive income (loss). The Company recorded zero in expense during the thirteen and thirty-nine weeks ended October 1, 2023 and the three and nine months ended September 30, 2022, related to the change in the fair value of the convertible notes embedded derivative liability. The convertible notes were carried on the unaudited condensed consolidated balance sheets at their original issuance value, net of unamortized debt discount and issuance costs. In March 2022, as part of the Company’s Series D Preferred Stock issuance, the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-A</div> Convertible Notes converted into 869,640 shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">D-1</div> redeemable convertible preferred stock. The Company recognized a gain on the conversion of $0.8 million in other income (expense), net on the </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">unaudited condensed consolidated statements of operations and comprehensive income (loss). As the full carrying value of the note was converted to Series D Preferred Stock, the balance remaining for the note at December 31, 2022 and thereafter remained zero. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As part of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-A</div> Convertible Notes financing, the Company entered into an additional convertible note with an existing investor for $0.5 million. The note carries PIK interest of 3.0% and is due and payable on demand at any time after June 30, 2021. The note contains an embedded conversion feature, which allows the holder to convert the note into a fixed number of shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">C-1</div> preferred stock at any time after June 30, 2021. The Company concluded the conversion feature is not required to be bifurcated as an embedded derivative liability, and the note is carried at its principal plus accrued PIK interest. As the full carrying value of the note was converted to Series D Preferred Stock, the balance remaining for the note at December 31, 2022 and thereafter remained zero. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company did not recognize any interest expense related to the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2021-A</div> Convertible Notes during the thirteen and thirty-nine weeks ended October 1, 2023 and the three months ended September 30, 2022. Interest expense recognized during the nine months ended September 30, 2022 was immaterial. </div><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">2022 Convertible Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In connection with the Original Business Combination Agreement, the Company has raised a series of convertible notes (“2022 Convertible Notes”) during the fiscal year ended December 31, 2022 with an aggregate purchase price of $12.0 million, and during the thirty-nine weeks ended October 1, 2023 for an additional total purchase price of $21.3 million. Additionally, as part of the acquisition of Solaria, the Company assumed a note from an existing investor for its fair value of $6.7 million. The note contained the same terms as the other 2022 Convertible Notes. The Company did not incur significant issuance costs associated with the 2022 Convertible Notes. The 2022 Convertible Notes accrued interest at a rate of 5% per annum. Immediately prior to the closing of the Mergers, the 2022 Convertible Notes were converted into the number of shares of common stock of Complete Solaria equal to (x) the principal amount together with all accrued interest of the 2022 Convertible Notes divided by 0.75, divided by (y) the price of a share of common stock of Complete Solaria used to determine the conversion ratio in the Amended and Restated Business Combination Agreement. This resulted in the issuance of 5,316,460 shares of Complete Solaria common stock to the noteholders and no debt remains outstanding associated with the 2022 Convertible Notes as of October 1, 2023. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company has recognized interest expense of less than $0.1 million and $0.7 million related to the 2022 Convertible Notes during the thirteen and thirty-nine weeks ended October 1, 2023. The Company did not recognize any interest expense related to the 2022 Convertible Notes during the three and nine months ended September 30, 2022. </div><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">SAFE Agreements </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">2019 SAFE </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In September 2019, the Company issued the 2019 SAFE for $0.1 million in proceeds, with immaterial debt issuance costs. No interest was accrued on the 2019 SAFE. The 2019 SAFE contained conversion features that allowed the holder to convert the 2019 SAFE into shares of preferred stock upon the next equity financing, subject to a valuation cap. The 2019 SAFE was reported at fair value based on the probability-weighted expected return method (“PWERM”), which assigns value to the multiple settlement scenarios based on the probability of occurrence. The fair value of the 2019 SAFE was $0.2 million as of December 31, 2021 was recorded in SAFE Agreements in the accompanying unaudited condensed consolidated balance sheets. In March 2022, the Company converted the 2019 SAFE into 48,258 shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">D-3</div> redeemable convertible preferred stock. The Company recognized a gain on the conversion of the 2019 SAFE of less than $0.1 million in other income (expense), net on the unaudited condensed </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">consolidated statements of operations and comprehensive income (loss). As the full carrying value of the SAFE was converted to Series D Preferred Stock, the balance remaining for the SAFE at December 31, 2022 and thereafter remained zero. </div><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">2021 SAFE </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In December 2021, the Company issued the 2021 SAFE for $5.0 million in proceeds, with immaterial debt issuance costs. No interest is accrued on the 2021 SAFE. The 2021 SAFE contained conversion features that allowed the holder to convert the 2021 SAFE into shares of preferred stock upon the next equity financing, subject to a valuation cap. The 2019 SAFE was reported at fair value based on the PWERM, which assigns value to the multiple settlement scenarios based on the probability of occurrence. The fair value of the 2021 SAFE was $6.3 million as of December 31, 2021 is recorded in SAFE Agreements in the accompanying unaudited condensed consolidated balance sheets. In March 2022, the Company converted the 2021 SAFE into 1,005,366 shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">D-1</div> redeemable convertible preferred stock. The Company recognized a gain on the conversion of the 2021 SAFE of $1.4 million in other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive income (loss). As the full carrying value of the SAFE was converted to Series D Preferred Stock, the balance remaining for the SAFE at December 31, 2022 and thereafter remained zero. </div><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Solaria SAFE </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As part of the acquisition of Solaria (refer to Note 6 – Business Combination) the Company acquired the Solaria SAFEs. The number of shares to be issued upon conversion of the SAFE notes contained various features to convert or redeem the Solaria SAFEs in the event of an equity financing, public offering, change of control or a dissolution event. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company historically elected to account for all of the SAFE notes at estimated fair value pursuant to the fair value option and recorded the change in estimated fair value as other income (expense), net in the unaudited condensed consolidated statements of operations and comprehensive income (loss) until the notes are converted or settled. The SAFE notes were amended through the SAFE Assumption Amendment, Assignment and Assumption Agreement on November 4, 2022, as part of the Business Combination with Complete Solar, whereby all the SAFE notes were assumed by Complete Solar. As part of the purchase price accounting discussed in Note 4 – Reverse Recapitalization, the estimated fair value of the SAFE notes was determined to be $60.5 million. Post consummation of the Business Combination the SAFE notes were converted to 8,171,662 shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">D-8</div> preferred stock as discussed in Note 6 – Business Combination. </div><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Notes Payable </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Loan and Security Agreement </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In January 2020, the Company entered into the Loan Agreement with SVB. The Loan Agreement, as amended, provided for a line of credit up to $7.0 million and has a maturity date of February 2022. Advances under the line of credit bore interest at the greater of 5.25% or the prime rate (as published in the Wall Street Journal) plus 3.5% per annum. All borrowings under the line of credit were to be secured by substantially all of the Company’s assets. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">During 2021, the Company entered into several amendments to the Loan Agreement, and in May and August 2021 in connection with the Fifth and Sixth Amendments, the Company issued warrants to purchase 5,122 shares and 5,229 shares of common stock at exercise prices of $0.38 per share and $0.62 per share, respectively. The fair value of the warrants were recorded as deferred issuance costs and amortized to interest expense. As of December 31, 2022 and thereafter, there were no unamortized debt issuance costs. </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Under the Loan Agreement, the Company was subject to certain reporting covenants, such as a requirement for the Company’s monthly unaudited condensed consolidated financial statements and compliance certificate, as well as a financial covenant to maintain a minimum liquidity ratio of 1.75 to 1.00. In 2021, the Loan Agreement was amended to add a new financial covenant, requiring the Company to obtain new equity of at least $15.0 million by a specified date, which the Company did not meet; however, the default was later waived by SVB. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In February 2022, as part of the transaction to raise long-term debt in CS Solis, the Company repaid the principal and accrued interest of the Loan Agreement of $6.7 million, which terminated the agreement with SVB. As such, as of December 31, 2022 and thereafter, there was no debt related to this agreement on the Company’s balance sheet. </div><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">2021 Promissory Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In July 2021, the Company issued a short-term promissory note for $0.5 million in proceeds, with immaterial debt issuance costs. The promissory note carried simple interest of 2.0% and were due and payable after February 2022. In February 2022, the Company repaid the 2021 Promissory Note. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In October 2021, the Company issued a short-term promissory note for $2.0 million in proceeds, with immaterial debt issuance costs. The promissory note contained a financing fee of $0.3 million, which was due and payable along with the principal amount in January 2022. In connection with the promissory note, the Company issued a warrant to purchase 50,000 shares of common stock at an exercise price of $0.01 per share. The principal and accrued interest of the note payable was repaid in January 2022, and no amounts remained outstanding as of December 31, 2022 and thereafter. </div><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Current Insight Promissory Note </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In January 2021, the Company issued a promissory note for a principal amount of $0.1 million in connection with the purchase of Current Insight, with immaterial debt issuance costs. The promissory note bears interest at 0.14% per annum and has equal monthly installments due and payable through the maturity date of January 2022. The principal and accrued interest was repaid in January 2022, and no amounts remained outstanding as of December 31, 2022 and thereafter. </div><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">2018 Bridge Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In December 2018, Solaria Corporation issued senior subordinated convertible secured notes (“2018 Notes”) totaling approximately $3.4 million in exchange for cash. The notes bear interest at the rate of 8% per annum and the investors are entitled to receive twice of the face value of the notes at maturity. The 2018 Notes are secured by substantially all of the assets of Solaria Corporation. In 2021, the 2018 Notes were amended extending the maturity date to December 13, 2022. In connection with the 2021 amendment, Solaria had issued warrants to purchase shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">E-1</div> redeemable convertible preferred stock of Solaria. The warrants were exercisable immediately in whole or in part at and expire on December 13, 2031. As part of the Business Combination with Complete Solar, all the outstanding warrants issued to the lenders were assumed by the parent company, Complete Solaria as discussed in Note 6 – Business Combination. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In December 2022, the Company entered into an amendment to the 2018 Bridge Notes extending the maturity date from December 13, 2022 to December 13, 2023. In connection with the amendment, the notes will continue to bear interest at 8% per annum and are entitled to an increased repayment premium from 110% to 120% of the principal and accrued interest at the time of repayment. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company concluded that the modification was a troubled debt restructuring as the Company was experiencing financial difficulty and the amended terms resulted in a concession to the Company. As the future undiscounted cash payments under the modified terms exceeded the carrying amount of the Solaria </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Bridge Notes on the date of modification, the modification was accounted for prospectively. The incremental repayment premium is being amortized to interest expense using the effective interest rate method. As of October 1, 2023 and December 31, 2022, the carrying value of the Bridge Notes was $10.7 million and $9.8 million, respectively. Interest expense recognized for the thirteen and thirty-nine weeks ended October 1, 2023 was $0.3 million and $1.0 million, respectively. The Company did not recognize any interest expense related to the 2018 Bridge Notes during the three and nine months ended September 30, 2022. As of October 1, 2023, the carrying value of the 2018 Bridge Notes approximates their fair value. </div><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">SCI Term Loan and Revolver Loan </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In October 2020, Solaria entered into a loan agreement (“SCI Loan Agreement”) with Structural Capital Investments III, LP (“SCI”). </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The SCI Loan Agreement comprises of two facilities, a term loan (the “Term Loan”) and a revolving loan (the “Revolving Loan”) (together “Original Agreement”) for $5.0 million each with a maturity date of October 31, 2023. Both the Term Loan and the Revolving Loan were fully drawn upon closing. The Term Loan was repaid prior to the acquisition of Solaria by Complete Solar and was not included in the Business Combination. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Revolving Loan also has a term of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">thirty-six</div> months, principal repayments at the end of the term and an annual interest rate of 7.75% or Prime rate plus 4.5%, whichever is higher. The SCI Loan Agreement required the Company to meet certain financial covenants relating to maintenance of specified restricted cash balance, achieving specified revenue target and maintaining specified contribution margin (“Financial Covenants”) over the term of each of the Revolving Loan. The Revolving Loan is collateralized substantially by all assets and property of the Company. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In the years ended December 31, 2022 and December 31, 2021, Solaria entered into several Amended and Restated Loan and Security Agreements as a forbearance agreement for SCI to forbear from exercising any rights and remedies available to it as a result of Company not meeting certain Financial Covenants required by the Original Agreement. As a result of these amendment changes were made to the Financial Covenants and Solaria recorded a total of $1.9 million amendment fees in Other Liabilities and was included in the acquired liabilities for purchase price accounting. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Solaria had historically issued warrants to purchase shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">E-1</div> redeemable convertible preferred stock of Solaria (“SCI Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">E-1</div> warrants”). The warrants were fully exercisable in whole or in part at any time during the term of the Original agreement. As part of the Business Combination with Complete Solar, all the outstanding SCI Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">E-1</div> warrants were assumed by the parent company, Complete Solaria as discussed in Note 6 – Business Combination. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Revolving Loan outstanding on the date of the Business Combination was fair valued at $5.0 million for the purpose of purchase price accounting discussed in Note 6 – Business Combination. The Revolving Loan principal balance at October 1, 2023 and December 31, 2022 amounted to $5.0 million. Interest expense recognized for the thirteen and thirty-nine weeks ended October 1, 2023 was $0.2 million and $0.5 million, respectively. The Company was in compliance with all the Financial Covenants as of October 1, 2023. In October 2023, the Company entered into an Assignment and Acceptance Agreement whereby Structural Capital Investments III, LP assigns the SCI debt to Kline Hill Partners Fund LP, Kline Hill Partners IV SPV LLC, Kline Hill Partners Opportunity IV SPV LLC, and Rodgers Massey Revocable Living Trust for a total purchase price of $5.0 million, as discussed in Note 22 – Subsequent Events. </div><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Secured Credit Facility </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In December 2022, the Company entered into a secured credit facility agreement with Kline Hill Partners IV SPV LLC and Kline Hill Partners Opportunity IV SPV LLC. The secured credit facility agreement allows </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">the Company to borrow up to 70% of the net amount of its eligible vendor purchase orders with a maximum amount of $10.0 million at any point in time. The purchase orders are backed by relevant customer sales orders which serves as a collateral. The amounts drawn under the secured credit facility may be reborrowed provided that the aggregate borrowing does not exceed $20.0 million. The repayment under the secured credit facility is the borrowed amount multiplied by 1.15x if repaid within 75 days and borrowed amount multiplied by 1.175x if repaid after 75 days. The Company may prepay any borrowed amount without premium or penalty. Under the original terms, the secured credit facility agreement was due to mature in April 2023. The Company is in the process of amending the secured credit facility agreement to extend its maturity date. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">At October 1, 2023, the outstanding net debt amounted to $11.7 million, including accrued financing cost of $4.1 million, compared to December 31, 2022, where the outstanding net debt amounted to $5.6 million, including accrued financing cost of $0.1 million. The Company has recognized interest expense of zero and $3.1 million related to the Secured Credit Facility during the thirteen and thirty-nine weeks ended October 1, 2023, respectively. The Company did not recognize any interest expense related to the Secured Credit Facility during the three and nine months ended September 30, 2022. As of October 1, 2023, the total estimated fair value of the Secured Credit Facility approximates its carrying value. </div><div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Polar Settlement Agreement </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In September 2023, in connection with the Mergers, the Company entered into a settlement and release agreement with Polar Multi-Strategy Master Fund (“Polar”) for the settlement of a working capital loan that had been made by Polar to the Sponsor, prior to the closing of the Mergers. As part of the settlement agreement, the Company agreed to pay Polar $0.5 million as a return of capital, which is paid in ten equal monthly installments and does not accrue interest. During the thirteen and thirty-nine weeks ended October 1, 2023, the Company made one payment of less than $0.1 million, and as of October 1, 2023, and $0.5 million remains outstanding. </div><div style="margin-top: 18pt; margin-bottom: 0pt; text-indent: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Debt in CS Solis </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As described above, as part of the reorganization in February 2022 of the Company, the Company received an investment from Carlyle. The investment was made pursuant to a subscription agreement, under which Carlyle contributed $25.6 million in exchange for 100 Class B Membership Units of CS Solis and the Company contributed the net assets of Complete Solar, Inc. in exchange for 100 Class A Membership Units. The Class B Membership Units are mandatorily redeemable by the Company on the three-year anniversary of the effective date of the CS Solis amended and restated LLC agreement (February 14, 2025). The Class B Membership Units accrue interest that is payable upon redemption at a rate of 10.5% (which is structured as a dividend payable based on 25% of the investment amount measured quarterly), compounded annually, and subject to increases in the event the Company declares any dividends. In connection with the investment, the Company issued a warrant to purchase 5,978,960 shares of the Company’s common stock at a price of $0.01 per share, of which, 4,132,513 shares are immediately exercisable. The Company has accounted for the mandatorily redeemable investment from Carlyle in accordance with ASC 480, Distinguishing Liabilities from Equity, and has recorded the investment as a liability, which was accreted to its redemption value under the effective interest method. The Company has recorded the warrants as a discount to the liability. Refer to Note 14 – Common Stock, for further discussion of the warrants issued in connection with the Class B Membership Units. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On July 17 and July 18, 2023, and in connection with obtaining consent for the Mergers, Legacy Complete Solaria, FACT and Carlyle entered into an Amended and Restated Consent to the Business Combination Agreement (“Carlyle Debt Modification Agreement”) and an amended and restated warrant agreement (“Carlyle Warrant Amendment”), which modified the terms of the mandatorily redeemable investment made by Carlyle in Legacy Complete Solaria. </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Carlyle Debt Modification Agreement accelerates the redemption date of the investment, which was previously February 14, 2025 and is March 31, 2024 subsequent to the modification. Additionally, as part of the amendment, the parties entered into an amended and restated warrant agreement. As part of the Carlyle Warrant Amendment, Complete Solaria issued Carlyle a warrant to purchase up to 2,745,879 shares of Complete Solaria Common Stock at a price per share of $0.01, which is inclusive of the outstanding warrant to purchase 1,995,879 shares at the time of modification. The warrant, which expires on July 18, 2030, provides Carlyle with the right to purchase shares of Complete Solaria Common Stock based on (a) the greater of (i) 1,995,879 shares and (ii) the number of shares equal to 2.795% of Complete Solaria’s issued and outstanding shares of common stock, on a fully-diluted basis; plus (b) on and after the date that is ten (10) days after the date of the agreement, an additional 350,000 shares; plus (c) on and after the date that is thirty (30) days after the date of the agreement, if the original investment amount has not been repaid, an additional 150,000 shares; plus (d) on and after the date that is ninety (90) days after the date of the agreement, if the original investment amount has not been repaid, an additional 250,000 shares, in each case, of Complete Solaria Common Stock at a price of $0.01 per share. The warrants are classified as liabilities under ASC 815 and are recorded within warrant liability on the unaudited condensed consolidated statements of operations and comprehensive income (loss). </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company accounted for the modification of the long-term debt in CS Solis as a debt extinguishment in accordance with ASC 480 and ASC 470. As a result of the extinguishment, the Company recorded a loss on extinguishment, of $10.3 million, which is recorded within other expense on the unaudited condensed consolidated statements of operations and comprehensive income (loss). As of the modification date, the Company recorded the fair value of the new debt of $28.4 million as short-term debt in CS Solis, and the amount will be accreted to its redemption value of $31.9 million under the effective interest method. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company has recorded a liability of $29.2 million and zero included in short-term debt in CS Solis on the unaudited condensed consolidated balance sheets as of October 1, 2023 and December 31, 2022, respectively. The Company has recorded a liability of zero and $25.2 million included in long-term debt in CS Solis on the unaudited condensed consolidated balance sheets as of October 1, 2023 and December 31, 2022, respectively. The Company has recorded accretion of the liability as interest expense of $1.2 million and $2.7 million for the thirteen and thirty-nine weeks ended October 1, 2023, respectively, and made payments of interest expense of $0.2 million for each of the thirteen and thirty-nine weeks ended October 1, 2023. The Company has recorded accretion of the liability as interest expense of $0.7 million and $1.7 million for the three and nine months ended September 30, 2022, respectively. During the thirteen and thirty-nine weeks ended October 1, 2023, the Company recorded amortization of issuance costs as interest expense of less than $0.1 million and $0.7 million, respectively. During the three and nine months ended September 30, 2022, the Company recorded the amortization of issuance costs as interest expense of $0.4 million and $0.9 million, respectively. As of October 1, 2023, the total estimated fair value of the Company’s debt in CS Solis was $29.1 million, which was estimated based on Level 3 inputs. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As of October 1, 2023 and December 31, 2022, the Company’s convertible notes consisted of the following (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:80%"></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Convertible notes, net, noncurrent</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2022 Convertible Notes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">  —</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,434</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2022 Convertible Notes due to related parties</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">  —</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">15,510</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total convertible notes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">  —</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18,944</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 3434000 15510000 18944000 500000 0.03 2021-06-30 500000 0 100000 0.06 0.80 100000 0.176 0 62500 100000 0 3800000 0.02 0.80 500000 0.256 0 0 0 0 785799 900000 0 4300000 0.02 0.80 600000 0.181 869640 800000 500000 0.03 0 12000000 21300000 6700000 0.05 0.75 5316460 0.1 700000 100000 200000 48258 100000 0 5000000 6300000 1005366 1400000 0 60500000 8171662 7000000 0.0525 0.035 5122 5229 0.38 0.62 1.75 1 15000000 6700000 500000 0.02 2000000 300000 50000 0.01 100000 0.0014 3400000 0.08 0.08 1.10 1.20 10700000 9800000 300000 1000000 5000000 2023-10-31 0.0775 0.045 1900000 5000000 5000000 200000 500000 5000000 0.70 10000000 20000000 11700000 4100000 5600000 100000 0 3100000 500000 100000 500000 25600000 0.105 0.25 5978960 0.01 4132513 The Carlyle Debt Modification Agreement accelerates the redemption date of the investment, which was previously February 14, 2025 and is March 31, 2024 subsequent to the modification. Additionally, as part of the amendment, the parties entered into an amended and restated warrant agreement. As part of the Carlyle Warrant Amendment, Complete Solaria issued Carlyle a warrant to purchase up to 2,745,879 shares of Complete Solaria Common Stock at a price per share of $0.01, which is inclusive of the outstanding warrant to purchase 1,995,879 shares at the time of modification. The warrant, which expires on July 18, 2030, provides Carlyle with the right to purchase shares of Complete Solaria Common Stock based on (a) the greater of (i) 1,995,879 shares and (ii) the number of shares equal to 2.795% of Complete Solaria’s issued and outstanding shares of common stock, on a fully-diluted basis; plus (b) on and after the date that is ten (10) days after the date of the agreement, an additional 350,000 shares; plus (c) on and after the date that is thirty (30) days after the date of the agreement, if the original investment amount has not been repaid, an additional 150,000 shares; plus (d) on and after the date that is ninety (90) days after the date of the agreement, if the original investment amount has not been repaid, an additional 250,000 shares, in each case, of Complete Solaria Common Stock at a price of $0.01 per share. The warrants are classified as liabilities under ASC 815 and are recorded within warrant liability on the unaudited condensed consolidated statements of operations and comprehensive income (loss). 10300000 28400000 31900000 29200000 0 0 25200000 1200000 2700000 200000 700000 1700000 100000 700000 400000 900000 29100000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(17)</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Stock-Based Compensation </div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In July 2023, the Company’s board of directors adopted and stockholders approved the 2023 Incentive Equity Plan (the “2023 Plan”). The 2023 Plan became effective immediately upon the closing of the Amended and Restated Business Combination Agreement. Initially, a maximum number of 8,763,322 shares of Complete Solaria Common Stock may be issued under the 2023 Plan. In addition, the number of shares of Complete Solaria Common Stock reserved for issuance under the 2023 Plan will automatically increase on January 1 of each year, starting on January 1, 2024 and ending on January 1, 2033, in an amount equal to the lesser of (1) 4% of the total number of shares of Complete Solaria’s Common Stock outstanding on December 31 of the preceding year, or (2) a lesser number of shares of Complete Solaria Common Stock determined by Complete Solaria’s Board prior to the date of the increase. The maximum number of shares of Complete Solaria Common Stock that may be issued on the exercise of ISOs under the 2023 Plan is three times the number of shares available for issuance upon the 2023 Plan becoming effective (or 26,289,966 shares). </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Historically, awards were granted under the Amended and Restated Complete Solaria Omnibus Incentive Plan (“2022 Plan”), the Complete Solar 2011 Stock Plan (“2011 Plan”), the Solaria Corporation 2016 Stock Plan (“2016 Plan”) and the Solaria Corporation 2006 Stock Plan (“2006 Plan”) (together with the Complete Solaria, Inc. 2023 Incentive Equity Plan (“2023 Plan”), “the Plans”). The 2022 Plan is the successor of the Complete Solar 2021 Stock Plan, which was amended and assumed in connection with the acquisition of Solaria. The 2011 Plan is the Complete Solar 2011 Stock Plan that was assumed by Complete Solaria in the Required Transaction. The 2016 Plan and the 2006 Plan are the Solaria stock plans that were assumed by Complete Solaria in the Required Transaction. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Under the Plans, the Company has granted service and performance-based stock options and restricted stock units (“RSUs”). </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">A summary of stock option activity for the thirty-nine weeks ended October 1, 2023 under the Plans is as follows: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:65%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Options Outstanding</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Number of<br/> Shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted<br/> Average<br/> Exercise<br/> Price per<br/> Share</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted<br/> Average<br/> Contractual<br/> Term<br/> (Years)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Aggregate<br/> Intrinsic<br/> Value</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding—December 31, 2022</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><span style="-sec-ix-hidden:hidden96297042">4,970,419</span></td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><span style="-sec-ix-hidden:hidden96297043">4.86</span></td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6.99</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">34,180</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Options granted</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,164,946</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.18</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Options exercised</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(67,292</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.83</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Options canceled</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(142,218</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9.46</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding—October 1, 2023</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,925,855</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.91</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7.80</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,727</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Vested and expected to vest—October 1, 2023</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,925,855</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.91</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7.80</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,727</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Vested and exercisable—October 1, 2023</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,037,856</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.16</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6.40</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,245</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">A summary of RSU activity for the thirty-nine weeks ended October 1, 2023 under the Plans is as follows: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:81%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Number of<br/> RSUs</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted<br/> Average<br/> Grant<br/> Date<br/> Fair Value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unvested at December 31, 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Granted</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">728,600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.00</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Vested and released</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(155,473</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.84</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cancelled or forfeited</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(485,468</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.07</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unvested at October 1, 2023</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">87,659</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.07</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr></table><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Stock-based compensation expense </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes stock-based compensation expense and its allocation within the accompanying unaudited condensed consolidated statements of operations and comprehensive income (loss) (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:63%"></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Thirteen<br/> Weeks Ended<br/> October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three<br/> Months Ended<br/> September 30,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Thirty-Nine</div><br/> Weeks Ended<br/> October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine<br/> Months Ended<br/> September 30,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cost of revenues</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">51</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sales and marketing</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">143</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">37</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">337</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">91</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">General and administrative</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,416</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">47</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,933</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">120</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Loss from discontinued operations, net of tax</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">535</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,835</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total stock-based compensation expense</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,114</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">85</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,156</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">217</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As of October 1, 2023, there was a total of $16.4 million and $0.2 million of unrecognized stock-based compensation costs related to service-based options and RSUs, respectively. Such compensation cost is expected to be recognized over a weighted-average period of approximately 2.13 years and 4.75 years for service-based options and RSUs, respectively. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In July 2023, the Company’s board of directors approved the modification to accelerate the vesting of 52,167 options for employees that were terminated. Additionally, at the same time, the board of directors approved an extension of the post termination exercise period for 280,412 vested options of terminated employees. In connection with the modifications, the Company recorded incremental stock-based compensation expense of $0.1 million. </div> 8763322 0.04 26289966 <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">A summary of stock option activity for the thirty-nine weeks ended October 1, 2023 under the Plans is as follows: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:65%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Options Outstanding</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Number of<br/> Shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted<br/> Average<br/> Exercise<br/> Price per<br/> Share</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted<br/> Average<br/> Contractual<br/> Term<br/> (Years)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Aggregate<br/> Intrinsic<br/> Value</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(in thousands)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding—December 31, 2022</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><span style="-sec-ix-hidden:hidden96297042">4,970,419</span></td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><span style="-sec-ix-hidden:hidden96297043">4.86</span></td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6.99</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">34,180</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Options granted</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,164,946</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.18</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Options exercised</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(67,292</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.83</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Options canceled</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(142,218</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9.46</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outstanding—October 1, 2023</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,925,855</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.91</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7.80</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,727</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Vested and expected to vest—October 1, 2023</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,925,855</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.91</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7.80</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,727</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Vested and exercisable—October 1, 2023</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,037,856</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.16</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6.40</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,245</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> P6Y11M26D 34180000 2164946 5.18 67292 0.83 142218 9.46 6925855 4.91 P7Y9M18D 2727000 6925855 4.91 P7Y9M18D 2727000 3037856 5.16 P6Y4M24D 2245000 <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">A summary of RSU activity for the thirty-nine weeks ended October 1, 2023 under the Plans is as follows: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:81%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Number of<br/> RSUs</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Weighted<br/> Average<br/> Grant<br/> Date<br/> Fair Value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unvested at December 31, 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Granted</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">728,600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.00</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Vested and released</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(155,473</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.84</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cancelled or forfeited</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(485,468</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.07</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unvested at October 1, 2023</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">87,659</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.07</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr></table> 728600 5 155473 4.84 485468 5.07 87659 5.07 <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes stock-based compensation expense and its allocation within the accompanying unaudited condensed consolidated statements of operations and comprehensive income (loss) (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:63%"></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Thirteen<br/> Weeks Ended<br/> October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three<br/> Months Ended<br/> September 30,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Thirty-Nine</div><br/> Weeks Ended<br/> October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine<br/> Months Ended<br/> September 30,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cost of revenues</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">51</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sales and marketing</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">143</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">37</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">337</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">91</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">General and administrative</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,416</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">47</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,933</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">120</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Loss from discontinued operations, net of tax</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">535</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,835</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total stock-based compensation expense</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,114</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">85</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,156</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">217</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 20000 1000 51000 6000 143000 37000 337000 91000 1416000 47000 1933000 120000 535000 1835000 2114000 85000 4156000 217000 16400000 200000 P2Y1M17D P4Y9M 52167 280412 100000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(18)</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Employee Stock Purchase Plan </div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company adopted an Employee Stock Purchase Plan (the “ESPP Plan”) in connection with the consummation of the Mergers in July 2023. All qualified employees may voluntarily enroll to purchase the Company’s common stock through payroll deductions at a price equal to 85% of the lower of the fair market values of the stock of the offering periods or the applicable purchase date. As of October 1, 2023, 2,628,996 shares were reserved for future issuance under the ESPP Plan. </div> 0.85 2628996 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(19)</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Commitments and Contingencies </div></div></td></tr></table><div style="margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Operating Leases </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company leases its facilities under <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cancelable</div> operating lease agreements. The Company’s leases have remaining terms of 0.3 years to 3.1 years. Options to renew or extend leases beyond their initial term have been excluded from measurement of the ROU assets and lease liabilities as exercise is not reasonably certain. Operating leases are reflected on the unaudited condensed consolidated balance sheets within operating lease ROU assets and the related current and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> operating lease liabilities. ROU assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make lease payments arising from lease agreement. Operating lease ROU assets and liabilities are recognized at the commencement date, or the date on which the lessor makes the underlying asset available for use, based upon the present value of the lease payments over the respective lease term. Lease expense is recognized on a straight-line basis over the lease term, subject to any changes in the lease or expectation regarding the terms. Variable lease costs such as common area maintenance, property taxes and insurance are expensed as incurred. Variable lease cost was $0.1 million and $0.3 million for the thirteen and thirty-nine weeks ended October 1, 2023, respectively, and $0.1 million and $0.2 million for the three and nine months September 30, 2022, respectively. Total lease expense for the thirteen and thirty-nine weeks ended October 1, 2023 was $0.3 million and $1.0 million, respectively, and for the three and nine months ended September 30, 2022 was $0.2 million and $0.5 million, respectively. </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company made $0.3 million and $0.8 million of cash payments related to operating leases during the thirteen and thirty-nine weeks ended October 1, 2023, respectively and made $0.1 million and $0.4 million of cash payments related to operating leases during the three and nine months ended September 30, 2022, respectively. New operating lease <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">right-of-use</div></div> assets obtained in exchange for operating lease liabilities were zero during the thirteen and thirty-nine weeks ended October 1, 2023 and zero and $0.2 million during the three and nine months ended September 30, 2022, respectively. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The weighted average remaining lease term and the discount rate for the Company’s operating leases are as follows: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:90%"></td> <td style="vertical-align:bottom;width:2%"></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">October 1,<br/> 2023</div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Remaining average remaining lease term</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">2.61 years</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average discount rate</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">15.20%</td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Future minimum lease payments under <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cancelable</div> operating leases as of October 1, 2023 are as follows (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:90%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2023 (excluding the thirty-nine weeks ended October 1, 2023)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">263</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">743</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2025</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">592</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2026</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">477</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2027 and thereafter</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total undiscounted liabilities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,075</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: imputed interest</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(565</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Present value of operating lease liabilities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,510</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Warranty Provision </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company typically provides a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-year</div> warranty on its solar energy system installations, which provides assurance over the workmanship in performing the installation, including roof leaks caused by the Company’s performance. For solar panel sales, the Company provides a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">30-year</div> warranty that the products will be free from defects in material and workmanship. The Company will retain its warranty obligation associated with its panel sales, subsequent to the disposal of its panel business. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company accrues warranty costs when revenue is recognized for solar energy systems sales and panel sales, based primarily on the volume of new sales that contain warranties, historical experience with and projections of warranty claims, and estimated solar energy system and panel replacement costs. The Company records a provision for estimated warranty expenses in cost of revenues within the accompanying unaudited condensed consolidated statements of operations and comprehensive income (loss). Warranty costs primarily consist of replacement materials and equipment and labor costs for service personnel. </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Activity by period relating to the Company’s warranty provision was as follows (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:77%"></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Thirty-Nine</div><br/> Weeks Ended<br/> October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended<br/> December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warranty provision, beginning of period</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,981</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,281</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warranty liability from Business Combination</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,943</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accruals for new warranties issued</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,100</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,492</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Settlements</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,060</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,735</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warranty provision, end of period</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,021</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,981</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warranty provision, current</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">605</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">767</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warranty provision, noncurrent</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,416</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,214</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Indemnification Agreements </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">From time to time, in its normal course of business, the Company may indemnify other parties, with which it enters into contractual relationships, including customers, lessors, and parties to other transactions with the Company. The Company may agree to hold other parties harmless against specific losses, such as those that could arise from breach of representation, covenant or third-party infringement claims. It may not be Possible to determine the maximum potential amount of liability under such indemnification agreements due to the unique facts and circumstances that are likely to be involved in each particular claim and indemnification provision. Historically, there have been no such indemnification claims. In the opinion of management, any liabilities resulting from these agreements will not have a material adverse effect on the business, financial position, results of operations, or cash flows. </div><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Legal Matters </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company is a party to various legal proceedings and claims which arise in the ordinary course of business. The Company records a liability when it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. If the Company determines that a loss is reasonably possible and the loss or range of loss can be reasonably estimated, the Company discloses the reasonably possible loss. The Company adjusts its accruals to reflect the impact of negotiations, settlements, rulings, advice of legal counsel and other information and events pertaining to a particular case. Legal costs are expensed as incurred. Although claims are inherently unpredictable, the Company is not aware of any matters that have a material adverse effect on the business, financial position, results of operations, or cash flows. The Company has recorded $3.0 million and $1.9 million as a loss contingency in accrued expenses and other current liabilities on the unaudited condensed consolidated balance sheets as of October 1, 2023 and December 31, 2022, respectively, primarily associated with the pending settlement of the following legal matters. </div><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Katerra Litigation </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On July 22, 2022, Katerra, Inc. filed a complaint for breach of contract and turnover of property under Section 542(b) of the Bankruptcy Code in the United States Bankruptcy Court for the Southern District of Texas. The complaint seeks damages for the amounts due under the Settlement Agreement and for attorney’s fees. The Company filed an answer to the complaint on September 6, 2022. On May 11, 2023, the parties reached a settlement in which Solaria agreed to pay Katerra $0.8 million, paid in monthly payments beginning on May 25, 2023 and ending by October 25, 2023. As of October 1, 2023, the remaining balance of payments owed in relation to the settlement was $0.1 million. </div><div></div><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">SolarPark Litigation </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In January 2023, SolarPark Korea Co., LTD (“SolarPark”) demanded approximately $80.0 million during discussions between the Company and SolarPark. In February 2023, the Company submitted its statement of claim seeking approximately $26.4 million in damages against SolarPark. The ultimate outcome of this arbitration is currently unknown and could result in a material liability to the Company. However, the Company believes that the allegations lack merit and intends to vigorously defend all claims asserted. No liability has been recorded in the Company’s unaudited condensed consolidated financial statements as the likelihood of a loss is not probable at this time. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On March 16, 2023, SolarPark filed a complaint against Solaria and the Company in the United States District Court for the Northern District of California (“the court”). The complaint alleges a civil conspiracy involving misappropriation of trade secrets, defamation, tortious interference with contractual relations, inducement to breach of contract, and violation of California’s Unfair Competition Law. The complaint indicates that SolarPark has suffered in excess of $220.0 million in damages. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On May 11, 2023, SolarPark filed a motion for preliminary injunction to seek an order restraining the Company from using or disclosing SolarPark’s trade secrets, making or selling shingled modules other than those produced by SolarPark, and from soliciting solar module manufacturers to produce shingled modules using Solaria’s shingled patents. On May 18, 2023, the Company responded by filing a motion for partial dismissal and stay. On June 1, 2023, SolarPark filed an opposition to the Company’s motion for dismissal and stay and a reply in support of their motion for preliminary injunction. On June 8, 2023, the Company replied in support of its motion for partial dismissal and stay. On July 11, 2023, the court conducted a hearing to consider SolarPark and the Company’s respective motions. On August 3, 2023, the court issued a ruling, which granted the preliminary injunction motion with respect to any purported misappropriation of SolarPark’s trade secrets. The court’s ruling does not prohibit the Company from producing shingled modules or from utilizing its own patents for the manufacture of shingled modules. The court denied SolarPark’s motion seeking a defamation injunction. The court denied the Company’s motion to dismiss and granted the Company’s motion to stay the entire litigation pending the arbitration in Singapore. On September 1, 2023, the Company filed a Limited Notice of Appeal to appeal the August 2023 order granting SolarPark’s motion for preliminary injunction. On September 26, 2023, Solaria filed a Notice of Withdrawal of Appeal and will not appeal the Court’s Preliminary Injunction Order. No liability has been recorded in the Company’s unaudited condensed consolidated financial statements as the likelihood of a loss is not probable at this time. </div><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Siemens Litigation </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On July 22, 2021, Siemens filed a lawsuit for breach of contract and warranty against the Company and demanded $6.9 million plus legal fees. The case is currently in trial. The Company has recorded $2.0 million and zero as a loss contingency related to this litigation in accrued expenses and other current liabilities on the unaudited condensed consolidated balance sheets as of October 1, 2023 and December 31, 2022, respectively. </div><div style="margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">China Bridge Litigation </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On August 24 2023, China Bridge Capital Limited (“China Bridge”) alleged breach of contract and demanded $6.0 million. The complaint names FACT as the defendant. The complaint alleges China Bridge and FACT entered into a financial advisory agreement in October 2022 whereby FACT engaged China Bridge to advise and assist FACT in identifying a company for FACT to acquire. As part of the agreement, China Bridge claims that FACT agreed to pay China Bridge a $6.0 million advisory fee if FACT completed such an acquisition. China Bridge claims it introduced Complete Solaria to FACT and is therefore owed the $6.0 million advisory fee. The Company believes that the allegations lack merit and intends to vigorously defend all claims asserted. No liability has been recorded in the Company’s unaudited condensed consolidated financial statements as the likelihood of a loss is not probable at this time. </div><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Letters of Credit </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company had $3.5 million of outstanding letters of credit related to normal business transactions as of October 1, 2023. These agreements require the Company to maintain specified amounts of cash as collateral in segregated accounts to support the letters of credit issued thereunder. As discussed in Note 2 – Summary of Significant Accounting Policies, the cash collateral in these restricted cash accounts was $3.8 million and $3.9 million as of October 1, 2023 and December 31, 2022, respectively. </div> P0Y3M18D P3Y1M6D 100000 300000 100000 200000 300000 1000000 200000 500000 300000 800000 100000 400000 0 0 0 200000 <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The weighted average remaining lease term and the discount rate for the Company’s operating leases are as follows: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:90%"></td> <td style="vertical-align:bottom;width:2%"></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">October 1,<br/> 2023</div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Remaining average remaining lease term</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">2.61 years</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average discount rate</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">15.20%</td></tr></table> P2Y7M9D 0.152 <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Future minimum lease payments under <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cancelable</div> operating leases as of October 1, 2023 are as follows (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:90%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2023 (excluding the thirty-nine weeks ended October 1, 2023)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">263</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">743</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2025</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">592</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2026</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">477</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2027 and thereafter</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total undiscounted liabilities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,075</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less: imputed interest</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(565</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Present value of operating lease liabilities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,510</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 263000 743000 592000 477000 0 2075000 565000 1510000 <div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Activity by period relating to the Company’s warranty provision was as follows (in thousands): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:77%"></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Thirty-Nine</div><br/> Weeks Ended<br/> October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year Ended<br/> December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warranty provision, beginning of period</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,981</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,281</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warranty liability from Business Combination</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,943</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accruals for new warranties issued</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,100</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,492</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Settlements</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,060</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,735</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warranty provision, end of period</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,021</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,981</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warranty provision, current</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">605</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">767</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warranty provision, noncurrent</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,416</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,214</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table> 3981000 2281000 0 1943000 2100000 1492000 -2060000 -1735000 4021000 3981000 605000 767000 3416000 3214000 3000000 1900000 800000 100000 80000000 26400000 220000000 6900000 2000000 6000000 6000000 6000000 3500000 3800000 3900000 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(20)</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Basic and Diluted Net Loss Per Share </div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company uses the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">two-class</div> method to calculate net loss per share. No dividends were declared or paid for the thirteen or thirty-nine weeks ended October 1, 2023 or for the three or nine months ended September 30, 2022. Undistributed earnings for each period are allocated to participating securities, including the redeemable convertible preferred stock, based on the contractual participation rights of the security to share in the current earnings as if all current period earnings had been distributed. As there is no contractual obligation for the redeemable convertible preferred stock to share in losses, the Company’s basic net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted-average shares of common stock outstanding during periods with undistributed losses. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The unaudited basic and diluted shares and net loss per share for the three and nine months ended September 30, 2022 have been retroactively restated to give effect to the conversion of shares of legal acquiree’s convertible instruments into shares of legal acquiree common stock as though the conversion had occurred as of the beginning of the period. The retroactive restatement is consistent with the presentation on the accompanying unaudited condensed consolidated statements of stockholders’ deficit. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common stockholders for the thirteen and thirty-nine weeks ended October 1, 2023 and three and nine months ended September 30, 2022 (in thousands, except share and per share amounts): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:63%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Thirteen<br/> Weeks Ended<br/> October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three<br/> Months Ended<br/> September 30,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Thirty-Nine</div><br/> Weeks Ended<br/> October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine<br/> Months Ended<br/> September 30,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Numerator:</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss from continuing operations</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(50,973</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4,146</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(73,448</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(10,809</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss from discontinued operations</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(155,909</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(168,458</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(206,882</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4,146</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(241,906</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(10,809</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Denominator:</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="display:inline;">Weighted average common shares outstanding, basic and diluted</div></div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">39,821,078</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13,431,410</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">16,969,979</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13,053,367</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Net loss per share:</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Continuing operations – basic and diluted</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1.28</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.31</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4.33</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.83</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Discontinued operations – basic and diluted</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(3.92</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(9.92</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss per share – basic and diluted</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(5.20</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.31</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(14.25</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.83</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Basic and diluted net loss per share attributable to common stockholders is the same for the thirteen and thirty-nine weeks ended October 1, 2023 and three and nine months ended September 30, 2022 because the inclusion of potential shares of common stock would have been anti-dilutive for the periods presented. </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following table presents the potential common shares outstanding that were excluded from the computation of diluted net loss per share of common stock as of the periods presented because including them would have been antidilutive: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:79%"></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common stock warrants</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">23,626,132</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,000,878</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred stock warrants</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">488,024</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock options and RSUs issued and outstanding</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,013,514</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,430,949</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Potential common shares excluded from diluted net loss per share</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30,639,646</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,919,851</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common stockholders for the thirteen and thirty-nine weeks ended October 1, 2023 and three and nine months ended September 30, 2022 (in thousands, except share and per share amounts): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:63%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Thirteen<br/> Weeks Ended<br/> October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three<br/> Months Ended<br/> September 30,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Thirty-Nine</div><br/> Weeks Ended<br/> October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine<br/> Months Ended<br/> September 30,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Numerator:</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss from continuing operations</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(50,973</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4,146</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(73,448</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(10,809</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss from discontinued operations</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(155,909</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(168,458</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(206,882</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4,146</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(241,906</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(10,809</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Denominator:</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="display:inline;">Weighted average common shares outstanding, basic and diluted</div></div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">39,821,078</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13,431,410</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">16,969,979</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13,053,367</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Net loss per share:</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Continuing operations – basic and diluted</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1.28</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.31</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4.33</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.83</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Discontinued operations – basic and diluted</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(3.92</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(9.92</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss per share – basic and diluted</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(5.20</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.31</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(14.25</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.83</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> -50973000 -4146000 -73448000 -10809000 -155909000 -168458000 -206882000 -4146000 -241906000 -10809000 39821078 39821078 13431410 13431410 16969979 16969979 13053367 13053367 -1.28 -1.28 -0.31 -0.31 -4.33 -4.33 -0.83 -0.83 -3.92 -3.92 0 0 -9.92 -9.92 0 0 -5.2 -5.2 -0.31 -0.31 -14.25 -14.25 -0.83 -0.83 <div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The following table presents the potential common shares outstanding that were excluded from the computation of diluted net loss per share of common stock as of the periods presented because including them would have been antidilutive: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:79%"></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As of</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">October 1,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common stock warrants</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">23,626,132</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,000,878</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred stock warrants</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">488,024</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock options and RSUs issued and outstanding</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,013,514</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,430,949</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Potential common shares excluded from diluted net loss per share</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30,639,646</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,919,851</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 23626132 2000878 488024 7013514 2430949 30639646 4919851 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(21)</div></div></td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Related Party Transactions </div></div></td></tr></table><div style="margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Related Party Convertible Promissory Notes </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In 2020, the Company issued convertible promissory notes <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(“2020-A</div> Convertible Notes”) of approximately $3.8 million to various investors, out of which $3.3 million was issued to nine related parties. The principal amount of the outstanding balance accrued interest at 2.0% per annum. In 2021, the Company subsequently issued convertible promissory notes <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(“2021-A</div> Convertible Notes”) of approximately $4.8 million to various investors, out of which $3.6 million was issued to four related parties. The principal amount of the outstanding balance accrued interest at 2.0% per annum. Refer to Note 16 – Borrowing Arrangements for further details. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In March 2022, as part of the Company’s Series D redeemable convertible preferred stock issuance, the Company converted all of the outstanding convertible note series. As part of the conversion, the Company recognized a gain on the extinguishment of related party convertible notes of $1.4 million, which was recorded in other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive income (loss). </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In October 2022 through June 2023, the Company issued convertible promissory notes (“2022 Convertible Notes”) of approximately $33.3 million to various investors, out of which $12.1 million was issued to five related parties. Additionally, the Company acquired a related party convertible note, on the same terms as the 2022 Convertible Notes as part of the acquisition of Solaria, with a fair value of $6.7 million at the time of the acquisition. The related party debt is presented as convertible notes, net, due to related parties, noncurrent in the accompanying unaudited condensed consolidated balance sheets. The principal amount of the outstanding balance on the 2022 Convertible Notes accrues at 5.0%, compounded annually. For the thirteen and thirty-nine weeks ended October 1, 2023, the Company has recognized less than $0.1 million and $0.4 million, respectively, in interest expense related to the related party 2022 Convertible Promissory Notes. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In June 2023, the Company received $3.5 million of prefunded PIPE proceeds from a related party investor in conjunction with the Company’s merger with Freedom Acquisition I Corp (refer to Note 1(a) – Description of Business and Note 4 – Reverse Recapitalization). The $3.5 million investment converted to equity for reclassification of prepaid PIPE, which is reflected in the unaudited condensed consolidated statements of redeemable convertible preferred stock and stockholders’ deficit for the thirteen and thirty-nine weeks ended October 1, 2023. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In July 2023, in connection with the Mergers, in addition to the $3.5 million of related party PIPE proceeds noted above, the Company received additional PIPE proceeds from related parties of $12.1 million, which is reflected in the unaudited condensed consolidated statements of redeemable convertible preferred stock and stockholders’ deficit for the thirteen and thirty-nine weeks ended October 1, 2023. </div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In July 2023, in connection with the Mergers, the Company issued 120,000 shares to a related party as a transaction bonus. As a result of the issuance, the Company recognized $0.7 million of expense within other income (expense), net in its unaudited condensed consolidated statements of operations and comprehensive income (loss) for the thirteen and thirty-nine weeks ended October 1, 2023. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In July 2023, the Company entered into a series of FPAs as described in Note 5 – Forward Purchase Agreements. In connection with the FPAs, the Company recognized other expense of $30.7 million for each of the thirteen and thirty-nine weeks ended October 1, 2023 in connection with the issuance of 5,670,000 shares of Complete Solaria Common Stock to the related party FPA Sellers. The Company also recognized other income of $0.3 million in connection with the issuance of the FPAs with related parties. As of October 1, 2023, the Company has recognized a liability associated with the FPAs of $5.6 million due to related parties in its unaudited condensed consolidated balance sheets, and the Company has recognized other expense associated with the change in fair value of the FPA liability due to related parties of $5.9 million in its unaudited condensed consolidated statements of operations and comprehensive income (loss) for both the thirteen and thirty-nine weeks ended October 1, 2023. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In September 2023, in connection with the Mergers, the Company entered into a settlement and release agreement with a related party for the settlement of a working capital loan made to the Sponsor, prior to the closing of the Mergers. As part of the settlement agreement, the Company agreed to pay the related party $0.5 million as a return of capital, which is paid in ten equal monthly installments and does not accrue interest. During each of the thirteen and thirty-nine weeks ended October 1, 2023, the Company made one payment of $0.1 million. As of October 1, 2023, $0.5 million remains outstanding. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">There were no other material related party transactions during the thirteen and thirty-nine weeks ended October 1, 2023 or the three and nine months ended September 30, 2022. </div> 3800000 3300000 0.02 4800000 3600000 0.02 1400000 33300000 12100000 6700000 0.05 100000 400000 3500000 3500000 3500000 12100000 12100000 120000 700000 700000 30700000 30700000 5670000 300000 5600000 5900000 500000 100000 500000 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">(22) Subsequent Events </div></div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In preparing the unaudited condensed consolidated financial statements as of and for the thirty-nine weeks ended October 1, 2023, the Company evaluated subsequent events for recognition and measurement purposes through November 14, 2023, which is the date the financial statements were available to be issued. The Company noted no subsequent events through November 14, 2023 that would materially impact the unaudited condensed consolidated financial statements, except for the following: </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In October 2023, the Company entered into an Assignment and Acceptance Agreement (“Assignment Agreement”), whereby Structural Capital Investments III, LP assigns the SCI debt to Kline Hill Partners Fund LP, Kline Hill Partners IV SPV LLC, Kline Hill Partners Opportunity IV SPV LLC, and Rodgers Massey Revocable Living Trust for a total purchase price of $5.0 million. The Company has identified this as a related party transaction. </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In October 2023, in connection with the Assignment Agreement, the Company also entered into the First Amendment to Warrant to Purchase Stock Agreements with the holders of the Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">D-7</div> warrants. Pursuant to the terms of the agreement, the warrants to purchase 1,376,414 shares of Series <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">D-7</div> preferred stock converted into warrants to purchase 656,630 shares of common stock (the “replacement warrants”). As a result of the warrant amendment, the Company reclassified the replacement warrants from equity to liability. The replacement warrants were remeasured to the fair value on the amendment effective date and the Company will record subsequent changes in fair value in other income (expense), net on the unaudited condensed consolidated statements of operations and comprehensive income (loss). </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In October 2023, the Company completed the sale of its solar panel business to Maxeon, pursuant to the terms of the Asset Purchase Agreement (the “Disposal Agreement”). Under the terms of the Disposal Agreement, Maxeon agreed to acquire certain assets and employees of Complete Solaria, for an aggregate purchase price of approximately $11.0 million consisting of 1,100,000 shares of Maxeon ordinary shares. The Company recorded an impairment charge of $1.7 million related to a decline in the fair value of the Maxeon shares between the end of the fiscal quarter on October 1, 2023 and the disposal date of October 6, 2023. No significant transaction costs were incurred subsequent to the balance sheet date. </div> 5000000 1376414 656630 11000000 1100000 1700000 EXCEL 125 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

R"$BWJUA):$9W3M^F\IB ;I&74P@ MK]9EP=M,*KU;-XX?'J:JVR3+!4_ &Y4U,9!G-);/DK"H;)99S:>=)2W$?DKR MQX_,C_$EX;#0>1K,'$%5?G M+7$DP[A;6ZYZRW3"') 1IBP^@]8$K&4T)SG!R@?!@Q!U\X4H'C'S)V@#5%': M,L,@5FFJL@4;TXL1[>.E[$B(,N0#F>-X4*EH29+TPN4R>H#.3&LJ+%DJ0E7P ML ]E(1X!#.E<.TW4XGZS MQB^*LQ+I!**OUFE8#JN L&Q1P4+_MU8?I7M9$&N$REND).*SWZ%H$2BQ"=:_ M&D9T4/'W^AG\;/SD" M7O$-\I W#F1D3&;L"WE-VGLP\LVSUW:HKDV?6+W5,%A*XCI*W%#]Z^ B4IVU M9N=&"OKS6)$%E\S64-'((TG7)J&AF7)M@L4A2](S62_L(3 M3\'(.J23T\2P(6J<61D=P>!NF9%>T-;$H $KJZ],-TZ!@BK*N"XW*4S?KH-Y M1N'"/#')B*N!UI=\HLZ(-' M]@.8@,Q<"$ZYB)?^5ACL)*MK88_KLL[$@%T1AX!R57TT#70Y-C5C/3UX;1NW"6FG@]X4/2DNE1L;:IUVL-96LK M]-0/C_LBM11XEA'T3LA&;R(( X06?(DM@GS6PK=7PTZZWFY(42J)-G-3ZU(, M#6R>4-\PP)2!=V#N+/BOVX-Z!!9D3HF,$P5@:A99P=2*-4W!^I6##2D5=\6] M%PR<&;A )^0!RWF9\Z^'/!F):%JN/GI\<(UG#P+<#5'V@.F+^7X/1-%W].S% MQ9A^GL5G)X\.^K1Q&E^>7]'_CTXN#]Z739)_$:R_B\[C,U*&OHNNXM/QQ<&A M =FS8X1^SDI2@IFA/LMJ"U&5-95[BFQ0"V2Q*H2%[3(G[,!*IO]=N(/ELJR: MDLW-KHK-VFS!\?TR(^0P$.1D+T?\Y^;X%^)J$?\G3M6#FVU1V!&7 .R$H#8^ M!X3'\7AR0K]GE!_U]>G.@-V"/2$C3A(\P\GL23"U[B(KZZNL025_&CR[,#L/ =DF<84@M3 M+JIDO=QX(VC"@\1L_OA*O MM3Q_0T:L8O&),%[FNT/B!6P=$@ATM\/MM,7+." BG(PP!'XL-BS(3DLS:&20 MHX1ZZJ0#I#ZW OMJ5!)95E%!UM;\EZA^&Y.P-(?-UBRW66P*G(=#Z[OQZ*0K M7\:C4_^!M\?8A1"R68OC=B]?)MNZ@NLE+$>P(]:-55J5TT9!X3#!G_O+1Z@@ M9"TS88Y>KE99S3+&!- MB[FL[^Y2;XDB MKIWA7?4[V]866%2E6U]0"S D>RO$H9;?C.F')(B2&H*&%9 M0=VC3J 7*60K$EW9[XX2'::$JV/]JV#4UU:>VV9*8/[<^YPZ)V M718,6=+FK 5&ZN *&D]#?(0(8P%LY3GXX;[!QM@](*DN>TEEPC6T M<'@NE^S:@X;99CGK-K366L+)(W!@-D7I^8V8LL2#:J]KXC154I#./J_(ICT] MP5I$:F"_5#C)HBQ3=DLXX:OJAALEJBW3*A\,L0?_K?.LQ_U3$ T& MW%R1@ FBO7*W@DAQY-CD8XQ2:;B6#'VX'!^%+U .!O M' !X;1+$DX140X1KX6P!/Q++$"LW9K8LLM]:H[)JE7PB9O2[^ %:"=N54\"% M-:^L6+?J=(=IVG^R+;:?;3JA!K)PZHR^[?-1L77A:_:!#*=^;(7CU"X"W\]F M&4T!KQE[@EKALO OB2HNY(S+M8&AC25M>JC Z!S?KN ,3-);FHM,2WB^9!'% M3HMLF'1[]/;;,")&K&2E=*5RWQ:+-B(?XL$L M5P!_ - =(4G,:$%&W>_"]-C;-.\M+C$#']][Q=Z L<[VF'2K)/V5,)SC$25^ M2-1!A!C[;000ZOQE.0OM2?EG /%,XQ%R]18CQ S#5C 2EJ@XZP*(1>"JH]X6 M)VZ+;YAOLU;5WZ+G^-US>8TL *"+N&VA2AR9C!=)R1Z>-423[(:Q?\4:&IG" M%=>( ]+Y=ED-4[!OS]P_U6D ^&TBVKU#\03 YRI@"Y&JV8[R#="R1H*=:SZ6 M4"#I/8E#5)PR:]K$8;C@FL0,V0W3-!B9<8 L]HX+PA-LR(0!>R8L-A&$5G^IB#)&)I%$D#O#MT'CM6.I7LU M[S^.)%W'X"EO6 M0[K$LNT.@KP%/=+-L"['+$PD(5%#9>:YC0G8*T%9/, ME@'/ HY:L?P5/IW[J\_B/_/Q-@QFEF2?TAL\(IV Q-7!X>(H>L;\"7YUD5A/ MV6C23TO[J9A2="1QZ)%$6"2Y0Q?KR2H#_N>&.%AA0A M];+]9TN,$=0EX52_@.4+;HIT<(]0MSQZTEQD"EPZ4X"5?!KF\8\V9F.V< :3 MPG^<%0>'RZ/H[XJ(KP*D"W'(T0K+-*@5 YB[PXPCF9VJ"AU=WSR-KL;GQVP6%& MRI_F>KRUN1[7+M=C_^F(_NY]G+,KG,5K)TR. 518T_[,7G\]BGXA ?"*$#MZ M2VAULP3%=T-F*Z)LA#",9+O TT+L!L]YY07[F5S0?IXG%:R7<#9Z_IB?/SC\ M"&7WS M@;\Y'I_&@6R"'E^U,@'?VH0N5#SNKSA7)SI\7Y)"'YU.+HX>A] 5G>?)%SV M$[\,)NXD__#ES?O"$<)P%&[2_1Q*6/QSI/TY%>C]/R>W[,7]<\O>_^&Y9=VY MOS:U;-_8K=2R_U5I71VJAZDGW@^_!?$^-$'63""/MDS"4 F<(OWK5M4)"/92 M,A.\%3_+JEF[@M8^L]DAX00V=%IOP84]3_3_HG1ZY+;[%JA3U^I6UO0'!JA5 MM=GE7THR&9PH("2;_0'_<;@[.9Z&Y("&4;M.@[A3_T9VYX3"R@T2)?0B!!Y6 MH^RD$/:GWF'9U?9YWA;]#HXI5#F7S!)1FVR"C=\ADL=(8,$OE(#CWSD@S$A5 MEP-X.1X&X&E2<2??.T'PR7!FSC\_5?!;FN#_#VF"P"G+%K9RP6+_T9\MG9#F M^99/^"V?\%L^X;\XGQ VW"YAAY(_I+A+&IAJ!+)3!<9P=%_UMG7.OHW*)E)H MKAQGS;^0*;]E,W[+9OR6S?C5V8QA^E(0[.6THXPM9IM4PX)&O>.[%!U%/4M' M63>>P8IV5A,]U;U,J2!1P'LF:?0O)8%M$@NL)/.2%&0H!;[Z#LR@WO[8Y@XR MJQCT>0B5EXVQ\8^ZG?[:XY,6;US>VV#.FCJP^Z[N8?K< M,TW%(E'S+D6_7B6_=MPK.&O6M,JD6=MT>9I0:J?B-/Z$Z!;;/H4XKUE#[FE; MSBYU%NOP.O+]LLR'M4 Y4!6,!M@)&&GL(%-!'8,BSF':=M6!MOG$*:=\7LV: M4+4C2.?<-FN9# .=$Y^K2TJE?' (.M*<=#.N:T2M>/$1.NFLET"C+ASGX3(N M,BW [*1#X&P^W\%Q!C6-PRQ8MD0XZP4)%#QU/U1PBY+V(23R.9N<)*"!:8UL M!<^I7A6B_M1P#D+.5?93)W68=FL>;@,V+@KI%F"G]=8$-@FE4PJ8ENVT(77/ M[=YFV QDTTANG7(4#\HE:;)EV[#,[>2IJK/!2X3)Y?=Q-+[Z7E!K?/9]/]'& M.NLX,7$//&/APY68)ZTZW&9';>B__BI,&A&@#3,%!D*_G/T)6F"!/ M8RS'U..">&E7XY/O=SH^B@*>,+BD[5!1V/ PDOELNN+ #>!P##OZY21F7OQKP7$J*U2].L^VEY6T#RGH5P;[NWILCA1H7;N3S;"0WO ML[0&5P\:.U8<(US>5F[!SGI7EW_X>@3MYJ[<<;ZK1U^T'B26@QZ. MW%C]&RH9L))5\PN79.CD&S7M2,.8M9+Y+[*@K+(%YWBM$-*%>I5:34=015-S MX0"$N..(#R#H!EH/H+/$.3?I3UKGL1WE5S(=N^*.H)8#W_U.-NRWJHYN54EHYQUSX3_>^K653L6>T'"_=T2R#=+]YJ1N+G!%34\!3.8-_!/$*E=78=8 MRLFZFLRK$3\?PQ<2E@98G)5Z#TUW%^=V.J3J65_$$WC$P<]6-C1!*1=$&?O- MB6P/)_'YQ:/H2'Z=7%W)K^/XT<5Y='3PUHHB>,^KA6"GL>D)&'%V2B,.3R_. M^,?I)0VZ5GL@@&!LK\9ZR37@&60RV3R#JU-2R,.-&SP>;ODLOAI/[);[NS_H MJ-+6G*(M'"M.$[V!D0@H?C&2+)G8-PC MWH:,7V[<8U8XJ4]2[B6DT^/"@5RB8Y$Z[UB>S6FCFQD( +&!. B \/X;8BHI M\J%D%2(&0U($RD+ #KUAT _U)E.R[J)YRYEY.H>X"/L\D9"4,],"D*AL(4*4 M""AOB$ AYD^29[\SY7*H>,3Y1T,5??8S+4;1^C+F"$'JO 1Q:U'J2O;?$8Q6 M66T>$0!CMR L19 BY^E;UF^8'UDZ)\=>YC:IPAX(_%MZ^P;/!0WY$EF2WB'Q&='#-0EJ&M*KL_B8GNF[B>3 M8T4BJW7].+JA']&8Y*YB?*]R3Q7HP_K(UHW9^W@B0R>[ANZJ>O-ZGV2RT=0Z MU2F*8+H]I8:3>_3Y,W;3WB<3:,]^=*[S40\D"/91E:C9.WEKNKC@:!2N M.;(2XP'IZB(#08;B/BA:M<#EH+GJQ'W TNH1ZRWAA!@@PJ]ME=5(K;C/)<.5 M3XB9B3F,K(? I7-G:QO##?$-L]=^D(7MXK_X BDM*Z#K.M\I_N(=0C.K7>Q8 MK1/:X_ <7J^%1B6Q^1R^Z]I(CAK/.!H09AR;\?5\#/D=P[L-!KR309+^B>.U M7#9I@YX!/]NS\U@0'DAGFT:4O@Q=E#4W=9 1JD ?+BGIEW RF['!'.>$<5$= MV%$N#LIE)VVA!;6!*M1-4]IQZ3W5K^(J6F%S2126O\^WQ&J01NB_[%6VCGH9 M'KGHO^V:M _"9Z>#;,_NS#Q+S!(.TP65-M7GL5F%W&9KKF&86U#;&)@H[M:; ML&=K7 ACTVO]MW,#7N5M\P[C&V)!W@4E6!.8+1E'7F@?H^B7H+IR-R5;TDTZ MF7I^3M<3HT-YCDL[/;Q0J#4^.18PED# M>JUV*GEN.Y7<6):^7Z'E>ZIW]SFQ&4!J'*D/A1WG3NVESTE10N[/?L75P8>= M1S+>2Y[*GEN1TX8%D3G"GH.A*^2 -]D#1I,0]1PV08GO18S8"$D1,[*XX:@4 M1WUL_11$+EG*3@/L2:0@]QYQACS"T3UB9%2MNT3&%HD]VCS[!$(PPHZ8)W)+ M&^X3H"UNP)(R9Q.;=#LU=T"BV0)I\2,QPH10=)-I.>)@-P\&26?O%;+LF/*4 M!YH.YY4#<(C)9Y+2H.$:+=):S>DP9RC'1Z)(531 MG/G?\_5BXA;J2G"!I<)*B4"V20EMZ"$(ZB+A:K""1)D6>4[EV$SN5-ZL" M%^]VPIS;UI#0!L%N31BT/W ](/Y*0KC\+Q1;.Q(814_=B9$1XXTV15"?2]]= M(HD6Q$$+!3-7)P36)+O42'1 ?=^4;;0H)1?-(_ .S26K-2_ %0O;\:I[<1[]Y8K462_=I(WYC"974F5F)$I_K3]?)P.18V(A#L;8<( MZG;%J /+J*,#<>5RW:E!L9,&Q;OB^W3UHRMCQ,3S-9V;;>^@CY!]-#:,1Q)I MH!!(S4)O\LBII:X""Z*:10AX<;#NNW*#(25QR(O5^%8NA#NK7V$>> MK90._(%W>AC@E0\K+ 0FPSI7$HC@;N#/K>X*QFW&NW>EUF%!=*=QSM=60B/@ M-XINEMEZ;4-JI#^DN2\-YC&J#37))Q.H+CW$4Z50'E)-U^J1W22SRJP0CF$M M<8%03*&MK(*H^F=VU>O,1=K7% EZ-M><]Z8^"Z4)#JC/VWR>J=K,P+6<(LP MG9:C;UV,EG^>+D9_GK:/_\UFS_.M1+)^F/@^?1\O M)O'5HPOIQ?CH_ IM&A_%IY=7^]H]GL;GEX^B<7Q%SW=S3'RS1YKN[!+])"^N MXBM.)=%YORX5$4D$ U!#ZI/5"H=3W_\7=UKP9Y%X[VM%"?]OM5GGVNE^,=U4=R7 M'<@M0MY6@(6F3#RW59F2&=?Y+JC8K(R DU/C6!]B1D +MZM67[6$]%]0KSUT M$ERSRN^@_J(.AK0TRMW+6@,(V:/7C@P_RW2M\=_ Z M*5J4A+6LQ?@K'1^?BD [>"8N#Q/XW\[UJQ=M140+2^\OR6K])!A^>GQ^\ J% MCUQ'DZU@V"BQT5N@ M_^/@,#_B9"4NK;)*^=-M+=V6AD@VLU7C;?EI'.7)M*R4S\F5 .9+%"*[&(9D M\_&4QZ+N2*O2S.*97R:07LZ8+#FKR-DE4J(L@1;]+L3K>!MG.-@F9^?03_^N MB*971]$UZFB;K+8&$]'QJM1"H>>6C00/'1P6N!IN33;]0^RW;?LI2 0# MEAW3(L>NR]S!8^=[_ ULX]IT>:'FRA%2K:&*^:DJ.O^ MW9/.#;LC'C#7':!#699F"2?2Z?2(R_FI.,$Z:^R72!QOD&R!:PTR,EU>CFME MB9;XY0KM1(K;K"H+]TJ\K?C&_EV)-&(M?[#YGNLG.3"6]7]$'W/+D$,&YE*B MN!3'=P_1Y$7O>+8=Y37*6H3R9G %FP'868$/+W7Q9$M5EJ%9-HJK[+!>SY$= MVR:JLAF =E%M7L9G]]<__#9"XAH.=W8\4P\Z _KSJZCAT*;=!YBV2PT5!]D_EGHT4#'PMH2B9]25F=-O=E! M3ST/#HV7EI\OAUK?#18??*F*=7"X/F("\9]SL[*G6X]N)0WYM(K8-R\+%*/= M+?ZD<]\@.]IU19W5MQ!E&#M<=1]NRV.WAY?EYHWG"<9VF.ECEO>FV:83!+O? MB&6OH);8_F:O8!V]XGBM\I%7_5KK6/P@B00@ME6[.'KWYH-[5N190]0M!98R M:1!K#T53K B$X)H25N:W!Q\,(G]AXZ6E1-?AVNST8$++UYEX]"TWZ_;@E'"S M]C<-FMUH+K=4)[^<]Z:UI:O)5@FZY"7B%RFDG\)G4UOV8+LH!\?I6K#SK*H; M6W#)-3QD5RM_"5XG(BFLQM:>>JN?S;&D&=Z+]F3H]HSBTW4 TVDE];GS9;:6 MUX%+6VT-;]V'@L(;[09!!KK?#NQ/BC_%7^D;P(W"WG$<4/)ENFJTWY*L0T.3 MP5[:OB/.X.Y796IL]Q'M7*R9V;RBO"DV2$@O#.0/R7]F$J@3,9QE$A[>AHOG M7^$+(M*MCJ*?;4N/I\$;4KM9=J[S!'/L3K\\%_;K>C2=!Z]+L;:M7CS44V\7 MF;M>?&'>4%8-MFS5 (?/W;_WCKU5XR?3":#F:UYT$NZKIQOU/ -PS,()I.T# M@A)W2_\#+R2N[_.:WSAB0UVJS_OE_%OPV_7N8.)VV!/KO!I)V8;]9]\>K $W MQU("-M,)L6AZ%NU^F:VY;;)>*I,/=S>,( M9#-&*4^TP%'TV@%YH%<>I&C0[K>RN6D<.@@K*[2'@V69OKN@0,:[T&R)' (: MMN<1[ZLMM&V3[<6LQ90BE^->VT46)M*Q42#A]DRVO%=GP_;95GMV.8C.$1HX M(@CHM:3%0U'J2@\L*0C<;Z#LC?C/-L:,O>>-9@)>EM)KH)S/P?V12@72?C+/WA+L^=^K,_1B.LV4>@]%"K(B/>J)?;/&J@2A-V=+SMC^JZ MGSH^QY"#['?"2%>;;7J5%B*N'+#;9X(_YR0)(E]+,I6Q.S+>M=/AKH[$YD:< M2J(4I1*9>7SPW#WI'#QS!C:$=J^U7 MH?FA7@G![L"AK:VCL\ IKAVMN1MU[CI:A_VGC=EJ9[WB7M2"O2\J4@[*5:R. M,>L/ A$W&3<3VO1N7(LVV62$7A%D@&M+[.&ZEB\(3;C%OAN/QLZ+&[JIM\#% M7;K8E"C*HN>B+0>(9,LKVZ+(*S5FQ4SK:NWP+6<.+*A GF[Y7?J6_1?UN/\G!%9" M;.!X'<)762%=C42\:-3H2^XE>,O%O&M=]I11QTU0,,RM4:Q/3)"?$8E@D(6] M7KC5OMZ_RX4,,RP2[?,A8]C*#7MU]AZ&TI=Q#&_=3O-L%KD>_+8=WIS]\#SK M>\2SW5]_\VTUW6?/,B0 %M):^7B.>L"7MM?-.SA*T"KEF.0LQ-^+LIH;CM*0 MQ+_[]JZJ;^^J^O:NJF_OJOIW>E?5D.M^/M@O,VSN]0^\,RH4K@01?'1S_>)Y M4"@=R^=^DE!H!IIC\<4J^1_R$JI['8IWUSG&5[VF*MKSGJJ\\YXJYP&1&_:. M).2D#7D]MX#^AT$Y"&@'7JT#J,[ZE,:E<=(RA!>K G!&XJRE@P[2^\SLWE_5 1[H'TL52UE!< M><<=YS>8]-BWB9$QJE0&S3!=JPX-$3^#R:8AK]X^M2^95N6S:8?&_!)ME@H6 M^S8BJ]^YH+*KU?%*/FP59Z@\1)YPA^3"7J-;B_FQP;A>KQSG26HJANY&<J\;UYF(7O6^N"\TAU6Q6(O@&& M7D /^#91"=Z3@\/-4<=3,20D.[Q6GGLG:Q!HQ)4>?4+B;G' EA.HJ63?BHNE#HNYYPV%8+ !WHC M_U:Z02>/+;5J>7*!="[2B*6V)6%94#H4PDTM2!=@@%\'UQE4D=DXC QQ%AB= MN.[DAO#W/0O!M=*:.J>_;=S S>S#W3-K\^^TDNU[?X L#UYE]#UE>S2.[>/U MW2S:V0GY9> 8/302[RBZ"\V8L^Y8O%NV;^'7#?=VH>9Z_4G0A'-'G8WL[X@$ M@@IPUKFY*]4*N\F=M'B),V"=@-.(QQH2=#:%TR%_N%I656B-5;Z1B47 M-!HX!=?3!X?5"*-S>N^9F4/(E:];#[OO>TF6-%][YU+/875+?=6+,B K%N B M@';-&:W=&D69A(M2,@VC:UAKXXNKP-7OC/A6G,@217VM&;2F"W">>\JOB&$R MA[:@:GN'![P+_^B[C;5P(':>$=9IQ _4IWM1>K4%ER!]R%2&6<">'EV7)\3G&Z^LX=8I[OHS3SR-"G:"S"A87?ZTX?&W?.:(\EXS)/=[T M/6ZL\SC);K'<)5[)VQYK>"LDI<-WIY1>H.YNQ^=6&_!.7L[,S5:.);@"32AJ MX;0CP-FJ#1J"7(-)-"XG,=A5N(0?48@7.5RQUZ7)XJJ_7R#"=;N @UU;=@_C MPLGQR47,ES8Y.?) S^;'WG6LC]F?1"C3HSUT\0NQBO]&LUW=U9_W_9_[7^GY MD"0-_<^QFF=)D_ST X&UL[5Q9<]M&$G[GKYA2G"VIBJ( \/9515%6 M)5MVHK*\\X6'*9G+Q^2=_=9*]?IF41RT3<9"POETN>K2]%G#Z\.O%/S!?O MY=VBP"\N7K]<\3MQ*XI_K6XR^'1AJ41R*9)!KPBQ0/ MN?.>H22S-/V$'WZ,7IUXR)"(15@@!0XO]V(JXA@) 1N_:9HG=DF./,BH6KTY&)RP2AY>DCO3"-<_J?/:BQW?X)"\N\ M2)=Z,G"PE(EZY8]:#\Z$D;=C0J G!(=.Z.H)71)4<49B7?&"OWZ9I0\LP]% M#=^0;F@V2",3W,7;(H.G$N85KZ^YS-@O/"X%>R=X7F8"MJC(7UX40!R'7(2: MT*4B%.P@-&;OTJ18Y.Q-$HFH8?YT_WP_V$/@ J2RH@5&M,M@+\6?PZ+#/+_- M B_H-C&T?_J5"#NLJZ8'>]CI6DUWB5[W.$VS?T]F>9&!.?^G2>F*9J^9)KKX M\WS%0_'J!'PX%]F].'G]C^_\@?>B2>"O1*PF?L^*W]M'_1A#VT_HM'O&=NGR MPT*P>1H#-,GDCA5\%@N6"W@ <%.6@S1"- M+#,,EP64$7F M[%0F,#4M _W:91_2@L>M:\O; MVXJAUI1G\1H$>^!9QE'J9XRD"5[4W@W;@U'7O+9NREDLPVJ.W^[Y73O:O-*W MK9M,WO-"L%4,QH"*K:95 [U@6/_4^@AXC?*'?"6!^X9)_M!]WP(@(AE3CXZO=Z^-IK!X,QOAFT1\% :Q]< M6BQ1_<:M/TO_[T4$7))MA6ER+[)"XGOPF;G(T#P M,-/1GPKRGK'/@&K?C^P M;ZQ(AXPUIO#1J!KD7/&L0&&;C)V#9F_?3MDIT@N\%WIU^N2_.&N[2S*9YR40-QQRNTR15AM> MKO!CT![V^NW1<,SR!0>VD'LD$PLP0F" 9Y+C%TMPM%O2+3@@!X7+$-0.VTG3 M<-8SKX. _["0X0(X8#()XS*'/,$H!/(8D#I!81H9\MOC<8T56 GG%9"Y((UE M&LFY##FF(!V"&TW%+"H>5Y)$2-@_RWC-_!%:6M=K [OIO8S@D?5?J2$IPU2C MQL:A>L $)L*U3OD9D8(MA#W-<.:I/&L0!S;^5$HU."G)&6"L?BI^*\'T<$0+0)D2T')V1D. M&I^C ,A?A"!$\ M;60B0TO?.X-MUOCE([^YAYMV&YXQ'D<1-!'F[?:_M>9YF MW3 4/LG00F;@U*?=K\.3U 8*QB"1*PG(DA?DCGR9EO "EL&2M& S(3"!7G$9 M;8KB-XH2/25* B$611G_B40):J( T80)#@X6@LFWCT((@PL55'00)XO*>5$' MXE%DHI(B91\;XRUCG%U"]/YT?ALNTA@X_GE%RT-H#]%-WPG( M32*+E B3D:95Y4\R68%G/V\Y28L;05MO'E=0C.$TD2W9L..QM>"9#=C5\WO8 MH4+%P"$.^]X.>2_S3^=SL!S4N4"C8AE:7+MB@CE MEGHS:X85QFF.&PSQZPYS3:6 M:_1'!NS 9QTQ5=2+?BUSPJG4M2ME0JAV@DJV%RJ5(:&]Y,83=S"XHPY0)@[Y M7YC)&3D.^RD%7?M]I4S_A46D#KN%C0).+H_4[X%(;3:OV_$;,=H\'P:=/OM^ M)T:;8;T.&,M.B#:C%%1KP:;?6K"!,O"O(YYWK'A7Y\,C.?:!E0,X'AW(\?!@ MCC\<;<@U]]K3%S&E$[HS5-$ZE21_)!>B;"XO(=K\5F*$@#0PA941QA1,47T$ M<22Y$UC)*8"LR$-$2#,$3AP'CU-XGB&B2R[N$&@:P<66RG5J=ZH;369LT0ED?63R: M39.Q?X:A?ZY1HS%OM3%-)'=!^W9R_29O7?*8W+Q9(1YV(L?8D>L/\?^QW_K1 M ,,AQ'^^<1B4W\PL-G'UK#WZ9V W 57W>H-]K%F;$V;5-CM>O!O (#<]09/ M<.NK5F(P5JW%$7X>M+OC84O)G6OKB<2L4-6BXZVJ1#0.@72W1,D M+"EB@9VU)J"2Y:K8(&$+81Y"UIH3!FPW3[UV;^@U,C'/TF4CC4.Y(]+ GKMC M)B(ZY1:\0%K,)MC"=9K(3?N]>_8E[$LPZF_-;MSZ?AM@=VOH?A,(W';K5B^V M]:$>C( ^ER)+(*O"GFOZGS[Y8JO]3<8 ,,PPQ17^RXXWVJ5I8]R22X*#@QT M0Y"8W)<6R'=RB?2VS+?-(F *=DW1RA< S.>4<"2\*'4#I(D<\!?'NW#1[?.! MY4OJFR"?4J$B-G"6&,-_IU *:4E5]0*P$[HG*58K23Y'%YZ)X@$[0+H+W[9M M>"@X32?>4?)" EI!9;F&10MQEY)M *\57CO5*%6M*(6J=%3GZD#U=?Y7SPN: MQ?+_%&)9N(77EAM>"&21X0BW,!+4X( M0U!"FKI_Q:%!]N4;#I%0BQ5H+Y/ MA6.(*$/SVOK,>G?]I=4NY77@3LFG'><$MF+J5WA09&L(ZIEW MS8U1JD;9L$OEYJX2CVIMJ!;]/06>*NR^K-X^4+2!%6U?P7VH:!Z)MJ^9T"#: MU3<1S=;C^YO95(\_VOS(7O:?IRZ?RQP[H:@-C*+?NBS_DFI%-^E(8S.\ MH&8+/MV%K6HKF[9]006^5BDS*+0M%@O@!+ 'XP;RD4H#&H5QT:H2803:=R:" .?+I5.550Y:T@QL+Y1 M=E9C!6KTC@F291W?IP;.D*DZ,W)CFZ"Y1@DS_,4,L!"FV0=0+07Z05=[E SVBL;RX@)S=.;+%=I$<@Y^+I O4^G@ MUQ 7=*6W?T%EQRJ?.J-(ZPG +LT434]0Y4OCH(CP## MZ>"]7.TXM'8 7Y]YZ:H*U&7N^_PD'L'6U--K\]3<_E%ZW&4#P&U.W!5EJNS^V$?(N-2QC'ZG0J:L.%K%7B>/&NWW&O6L)^I'D_YBE5]D.H6D[T] M1#<4Y!Q27JYW%;+A!C,XQ(249-9WFHP)+R%8TW .\E=9.M-F=@Z!'2\+T24, M=<)I%C-;O&E6:F'#"O6](SJI;-S--D*#A5#=!L+\R7N'$Q24KL- M3F[;4GEUK+F=(=3AXL,.;;C9C*;1H,__XS1GIT;M2^#]P?AO%_S;%X[U!:NZ MOWWA*_D":;1Z\?]H7_"K=:L09-GXVT..]A#_;P_YRA[BUUUC3^&\WR.J,EC3 MSH7IS6_O0JU";B1GM75DVK^C\FW5 Z(1&-<_Y-32'V%9-O!K=6U_.-YW?NF> M8\*_YJK4'[*@VV-0V74'3Q](=J&&'/?9H&\:W&\>T4&A(%U0QY,R>UN]6SL^ MA7EG[!2GP@O./K-'D@>4HTTU_?9AV*W$J[C.;3\\>[DN*2>U:CK:LGV[WNL$F#B]?74B=WL-@S MK^/;D@.AC><+Y4>TOLPW;IQQMZ951@OXNB+3F*@C0+3=6SP]XUF4PXK5[PC M%%_."Q7C6*7NNO7H!@X;-^S- MR4S ;B: GG@9SO)Y\_'-^W>;E1,JY@[@2/&@W7T) 4&NU$61(E:;EX.4#J^BO47'H#51CFY8+JY-Q$_L2C'W;5;$3?G5U/_#8R'NRP5QG M;+,9^-/%!#RKUQGU-EK2^,#K!+K/[MS)Q ?#0:>WI[>NYOKZOE?='OXJ ?'+ M8B S#L\.S:GW/M_)[7S)&I>I3YUB])QS@#5UO'8U7E7X;B!.VLEZKS^M-M9LU=,;ZZM@:39VLVN,Y!INU;0W?L!B?V-7W_[";, $ M?WRC?E\S(8"U=_N=VT!5!'[ *Q>S]22Z"&11$$<0T=8CX7]"-]^^LYE-: M>76B[C7:(N:=.O6=5+\\LKPAL&4(V9FZ$SD3FQMYX-E,W8X,7/D>FYDS9/K! ME*GA &R:) 7Q'/TXL(D.[BB$YCMB;/ \:OM#OST8!(X9YL8,1TT_TKYP_C( M'9+C'TS @_<4_V1 /NM_9L,$_I3!!?5OP*B9CCU#6R*IJV\SLE//9J=I/'&Z^["S#Q!Y)*$A 18 K:J_ MON< )$79DNIL]V%W1B\)"9W[^HS+@_ MV_$WEIK]:SHS5B.@_[VKZMYH M?[=1&O)+4_ $;CHXQ0;T,W1NO_\N'/:N=F7\7S*VE7^_R;]_R/HW0>VPI=/^ M&=M;S:EAJ3 X.@92)B3[25E@(?O^NW$4AE?LDUYP666>76ITAK"%G&98KQ&.L4[DJ# M81M#UF9"5L$M- !*(S"_M RNN$%"2U0I21.YF=$"LJ3/4;_(,6":HU^-SCDR M(9O5KI*-J\"9F>.;3 3/:O-"+ER8&@JEW1LF4R@#YH)-442GN):M U>##+!T M3RKC6G 78TK!^UJT[26_ED)C.*=D.8.%<^?6X,QY>YC>?W$&+.XTE"(][C0" M.XSHLXO7X2S1Q Q 8DP6-#(CQ:5P:6]TQ/8I=1R>>5;Z?JBY$Y^K#+!.%R-KA 4&LY;]6\4?L14DO5^/:3XY.M2 M92D!8+0]*+A0UIR7V%M^ORB,\ZO %IXYA'E3+!A9+@:W0(D'@T>#)$CP0 MFNG:N+^B'QH_>P)Q$.4&&037]A:@,HK929[#!?L9F80&&V/-P2Z5*\(&SIZ@ M]A'#KAD#A#\"GKJ&EG;4Q)3DW<'0<08I23P_8NA@7:5I? ,7!"4FT/9L[>AI MV[OGM->JC&M@%2MRVZYS@E4+\,1CETPJME J78DL8X0(QV\(>RX78I9!;1)] M(D=!ZGT10%4FTBI?D@A8)OSP", 7SW4&#W4NG!:"//(J!J^)F"+%HF-I47@/ M=I$H,48T)%2ZQXP;8\=.&JQ6I@!W6L6-AJ>_X*'.[TS<\2WQBR_!?[B5-$UK M=5J6^0SKATD@+B/&9R)'E KT1C'.+>BM?# ] MF,\QB8/H0_ 6:)U$DDP9-['S[?)*SR2/'QY_8 ]^;R+GU2[\>@=&%X"%2QVJ M$FZ6F(]* %+7S7?AY&*$I^(L:]"W87++"3:$%W22034,F2N9>1E8U;]2\C(5 MULTPMD$:_[3!F&M(8\$%-$=_F\R^T4*;_"M*H$N(2,2FK<@%VJ[/)4* K0"^ M,H\0/-TJZG%UOF6G@DJO2H.AF+/+DY<'HY/[K?+-M+KO*(;-_YXMI6&^VL;3;RO5DE$M\+M MS&V[@ TZ#7O!<-QC9[N,88<>'J<(E6<@^C"N/!IF6$U337FR3C*JL$?W:3@* MQG&XVQHI/V(RR'Y*K_T9\30,PA%Y_^D5ULHWX-J59;XIRR08#L:5;ZGDN;-( M*8;QH':"]QTM9J6ON2ONGUAU@=1!O&.38!#%)Q]:L[LEL!WE]F0M>UFIY:9B?GT$.( MMZS5%N%#0%D01.\R0.)J/A/C$'A\T,A%'OD-'M@0D' M7OAI2VPSTBWL!L/)7EDRRNN]Q[388WO\!@BK<= ?UR.P89>&%_8TA)WBI;O7 M#X.H'^.@?%'8R-KJ_AEY:$_>:#(,HB@\V;.#U]:H>MC?:# ZH3L^RF&Q\%9$ M*':4\%3GTA^BZ&A0U^, B/TYZO5V6@>\F;F3#T2'4E;_H%5PD9Z+7;?A^S^Y M#<\M]>:%]5KX):N4._W_]>GF\7!\OU\?+]?%R?;Q<_]7+ M]?&2<;QD'"\9_^>7C%U?\;JMC\=NCZ5OZG1.P#W1?T=N5IO/]E/WM;J[$??? M_#_BWB^0_3.8HVKO8C3H,.V_H_L7JPKW*7JFK%6Y>UP"QSV9!/#WN<*"5"_D MH/G/#+=_ %!+ P04 " $@B18,$ @&N@( !%%P &0 'AL+W=O#W/OUF_'8);DJI1N9M:KP)C.VE!Z/=C5V:ZMDRDIE,9Y-)F?C4NIJ<'7! M:S?VZL+4OM"5NK'"U64I[>ZM*LSV&_ MF.WO*OIS2O824SC^*[9!]N3E0"2U\Z:,RD!0ZBK\EW>1AX["J\D!A5E4F#'N ML!&C?">]O+JP9BLL2<,:_6!761O@=$6'LO 6;S7T_!5WN/ :Q%-VO0O9T]:?!S MXD=B,AV*V61V\H2]D];;$[9W\O/>BOG2>8L@>23D8"FLBH5NO)&?+B9.P2VSX62 M22Y,)H[TL?@$+6/E.1[P=$/J0[:,9RPL\%-+<<0J&K\W.JUE4>P@)'[[]=5L M-CE?()V5Y8?I>5#V9J5\KF *?QLY !!!UD7AXQ'YZFI9>:BP+ "7CL#1 T$> M-K\:763>CJ&O&YI\;DV]RH%H: 8)<%"2!W4MC5:#H;/AR M-AG"+Z*X-3\27Q\YHLIXZ%1AB' MW=4T*A!*3Q H2",,A_03$$!VK:W&WYCT:.RU)2_2-IH24U/Q0DIA&? 5 2T4 ME198%+*D]R&IR8(+R!0\*AJK>Q;\WJ6(I,3 H->%Q@J8DX07PQ= )7'_S@)M MKROM0Q0_FTY&IV>]7/X87HH;DF[/C<(1FJY>_DU,$&[Q[!1%062%,7;T()8H MZC#!M>#(*P^?*6 I,1)3*H>*&<.^%[FR[13#?0YO-8[I:'H<[="Y)-+E37E4 M&S+1W@TZ]I7FNLI6S"VK8PR[)-JEUC%,1)Q MQYV'D#0U@B.<9;MI/&:9_HTIC%?47:+4 3D$Z-Y*XQ//GL1^!+E!.VM@,0L_ M:HH\YFJIFEH$5^[W5%HH@7SA37([#)U4[LM[C)4E%U,3&-Z8HB[5\RV/I52A M-LIBRHZB3;)_^SZ_::.&8T@8"(KIJ:#Y/ZTY[*WDHIC*G0L16LH5XJY.5<-E MAP\<9 _(8O]JSE0-.TG42YJU-:@0E+AO.'3^?%A*F* @_LL^&*B5]#HY7@U% M026XGXP/ZLN]9*2 (@VBI4L'$XKN&BHE>-W%T_[64D$;#V/UUV%7 MA >:$,<77=+/6#MYTD>LSI%XR@XV7<]MJ,P M;NP];R8Z)(S@9A..U\R3557"?B;*4BU&VND5G"4*N%RZ\S < M)\?B]823,9J('NV:4.LY15WP/A'WBC#\SFCHK&C$[V4[2C+O+\7)A'J$4TE- MX+M"ST,Z<-"TA:\[_&<&0> 4X!!CS8B(GD'8F%6D@7,FT1R@7-R8E=[@R;F/ M(?!D$H; 1:RC6VS4WZ_7WI,81/WX&8F_N,5HE+$X&>U'U[8C57PJ--P]BD6* M3-_A]8.)9U^$]C,:^BMV(KZYN1V&QI&;IKK9:]]NZ?!A)[QRCU+6;=K[:\RH M=S8R"?--RH?.0/;@'O-S7W)(U::2XI2WG"^NQ:OIZ5"\0PAL)$5&@/F[2E?D MVCPZ$FYM!RR\>#6!!>T(0ZU=3HI_:+G$#HM5P M_T.88;C"-?<.5T:GCH>BPO3WV.EV'=W?AB(JK#WI^$C,V_I](/+"U/@S9/+% MK=@]S*%,ZLY]-'0T5 "=QNE0.NY\C@;=I2R:'7%QG;8,$1P2; DTU:-'55>R M1IBID!W$(?_"P*]3)K#9@+^2!3>)4T3"4R<0=_N?UOG2%SZ4P /<^ZV,"AW=*6IEPY='ZI%O ;A/HP\)#N'"6PNBNU-O(BYLHN31'M1 MB?XPL6>CERVQ3=Z# NN5"DSSP^XYZB%24ZE;NO80Z9\3;ZB\Q8]P31C=6Q[^ M.XB4SEV0@'76P!J)QSZ6C3N?-DN*4_J Z\(5+7SE;%?;;\3S\&ET+QX^,'^2 M=D57G$)E4)V,7IX.A T?;<.#-VO^4+HTWIN2?^9*(L)) .\S8WSS0!NT7\ZO M_@%02P,$% @ !((D6)'@P^@N"P PB4 !D !X;"]W;W)K&UL[5I;;]LX%G[WKR \P6 **(XE7V*W:8 TF4L7F+;H9>=A ML0^T1-ML)=%#4DD]OWZ_0U(7QXZ;'0QV%XN\M+9$'I[K=SZ>^.).Z2]F+81E M7XN\-"_[:VLWS\_.3+H6!3<#M1$EWBR5+KC%5[TZ,QLM>.8V%?E9,AQ.SPHN MR_[EA7OV3E]>J,KFLA3O-#-547"]?25R=?>R'_?K!^_E:FWIP=GEQ8:OQ =A M/VW>:7P[:Z1DLA"ED:ID6BQ?]J_BY]=C6N\6_%V*.]/YS,B2A5)?Z,OK[&5_ M2 J)7*26)'#\=RNN19Z3(*CQ>Y#9;XZDC=W/M?2?G.VP9<&-N%;Y;S*SZY?] M69]E8LFKW+Y7=[^(8,^$Y*4J-^Y?=N?7CI(^2RMC51$V0X-"EOY__C7XH;-A M-GQ@0Q(V)(_=, H;1LY0KYDSZX9;?GFAU1W3M!K2Z(/SC=L-:V1)4?Q@-=Y* M[+.7KRJ#)\:P:U4L9,G)MQ=G%I+I_5D:I+SR4I('I,S9KZJT:\-^+#.1'=A_ M?7Q_G!P1< :3&KN2VJY7R5&);U,[8,,X8LDP&1U2Z/CV&Y$.V,AO3XZH,VK< M/'+R1O^&F]D_KA;&:B3R/P]YW L<'Q9(Q?W<;'@J7O91O4;H6]&__/Z[>#I\ M<F/3K&C4@[K^,/T&3OHV@\JYUIR=I7^7DDCW;.W)7NC M;D6Q$)J-?60CVK3)A15^!_M%Y9DL5P;P@HU:9(TD ";CJY46*X[5J0*.94+[ MTS9<9DPMVSELWS%9LI2;-;2(9N-Q-)D,F5ES MV$4KL:_ &M1^^@5P8->,EYVSEUQJ=LOS2CBQ\?E@U)XYC6;#4309SSORX*^E MT&3,(T5.DD'2BCR?1?-I9"B-A0)\PAW#0?#)@S<6BT7E>6+7#"K&*653.&UC5:W MB&^&#Q)JX95="Y\4(9LRR(YP4N;>;/@6K#"I%1FPUU FRYSHR$FDQ.3EEG&#!@LQ)_&XDS_87Y6WPMA.ANXX M(F)W:YFNV9H;MA"B=)K>83>^H?NF2I-U>.EVG5(GS&KU&*I$.R6T(") "1P\ MPS8"#LD&S:&9,')%QV7B%I1@@T\%+ZLE#*Z0?MY#*U%2JQ'<=?-"Y!*Z432YW0LV=M<&WZDJAZ<,Y8PTZWNQ M8@"*"DXV6X2F0##(;J6CD)<.$I ?9(%O[G"T6J(>Z(E;LX#H4UF>ICDB?Q#< M#/N(,Y^=%@Y:F[(AP0KF:>:* M"P47#)A%D^D^-HCJJ)25#N&[4NZDAM:ZO\]&>Q1U9$2N%PZKZG(W2+L_C M*!XEO=\\(F_;)(K(^L9X^'K:^W#UTX] 62U$X6(^'4;C\^$AKQS*)[@UBN'S M-]#CFXM'PV@4Q[V?E,"K7()EXSY#)2YQ3:#\W9'K\#RXNP'*W1*C)^3A-I\06;F77CM5UP(UZCIU MYX:N$]#E^^]F27S^ HB-F.:$S2YJB&]52I#=QD))[4L2&.3;O0Y'R>:*<-=K:MA1E4[K:B)H MI3-2[=*4YTV%J VYCUSG>D7C/=>9X_E@W'(U@^9&JKO8N9#'$[857'O.\FGP M84!' ,P1\:]L4VDXEX3N(TH;JRW/@1"%@-89VAMLJ8S/65\&ME6=(I$=4!LL MP!E9]RC^15L:F3(LTK M(BC.+9Y4-DGV",FU $J9SS[?0]R-;_M^CD"/@R%$3QHV!WI4J@($))?+IJ K MW$QUOB5O.,<-V#?\552YE:>>,-4X@Z1Q=.IAOZ4'8_@G7758V%'O-%L<-C5:9H^N"I"*-!CT+E9'4,[H.*;RZ.+&K!FKH44F7P M(Z]P _$-+Z-H^]:G2 M+BJ2,'K /C6'@*PQ-XD#3/II)%FV2VU;E9"JS*UB2[3G,I4.RMI]*SJ$">!] M:@]=USH,'FI+NCVP.Z$]:2#J3(=@W=]P>:'N'T8_P;^D2ZL!SSZC2#SM\85% MV:;NE9]OEJZ7U\!%.AUA*_!H02W]CVX_W7=>]N[F:!BV9S=H8^0[[H M7#]3]'SC<6LM#5'M%%(>B';K9^2V#2RO33SOA!9WNME#5Y4="=U(P5$4K$ZL M"'L<':%S#HY[G*^)"M"U$TXG('#]G7:2P=3#N>6>&SGZ)WR! M=#2#GG7K1B;D_A:!#:6RCMC09-(#1Q#!L']!+2"3%.3;IE5X\',HT"DS9Y^_ M/K9N]"Q.T*-L/VG3,$/83TR@C#.U.:O@6SB.^$X+'0=BTF9Q-R:M3Q8TU]^C M(Q_7X/GUB/8-!(7/O?>A;X!$)$F43,_QX9QN/4-'[7-EZ-4/R30:SV?L&7T> MSZ/Y:(+/A^:4?V8&./X_F '._ SP\'6_:X KX3 ^:L9^'LE"BT8,M[M3B5 < MW5;A)S*^#?$,-QY)DVB7P\UUE,81H;AW@*$#![L)3L*.YL@#N4QL-H0%NSFO#"Q5YH2]Z#(L3A3X&=IX_A\%%-XN_KMD]MY@ MOGL%J<#>[O'^F7A#^Y/'3JMZ8I M_X$QRM,4Y6F*\C1%^2NG*.])&!WA*CUNYPFOO?"/_*L(?S0.?SA%668")N2P M[-#O%LXZ/Y-!;%;NUT.&.1[@?S'3/&U^H'3E?I=SUB[WOV[ZE>N51-[D8HFM MP\'YI._92_W%JHW[T&PO=V]R:W-H965T9)1<94]05*TL6 EE4@K+4LR:A@*[Q']:68"^I9#4N49)C+A.<@<#DVIL[9S-?Z MI<+7!#=R1P8=R8+S!]VYCL:&K1W"%$.E&1@UCSC#--5$Y,;/FM-H3&K@KKQE M_UC&3K$LF,093[\ED8K'QL" ")=LG:H[OOF$=3R!Y@MY*LL_;"K=P#,@7$O% MLQI,'F1)7K7LJ<[##F!@OP)P:X#[5H!7 [PRT,JS,JQ+IMAD)/@&A-8F-BV4 MN2G1%$V2ZU6\5X)F$\*IR5Q@P9((KIZH+B1*8'D$MRI& ;.U$)@KF$J)2HXL M1>8TR IKZHN*VGV%>@@W/%>QA*L\PF@/?M:.=]P6 HOB;()UM\%>N*V,MZ'J M@NV8X-JNM\^A=O@EAEWP*KC;XH[7Y-XK^;Q#?[4O"/R%XDQ&\2XK>Q'U:,[=0?^J?P]GQO M-7%7DY>:8:W)*LV0TX$F2>!+H'E8\I0.QB1?P8=J=;I4 GR M!=%0%5$Y8:9E*JG.=?Y(K%P\TQE4<)D0XS%XIC_L4]LSW2#H;)V2+$5M.,L2 MJ0]3"8$9V$-PS8$WZ%3Q#'T'AOU!YS-7+(7BS>$MLR?/73CDJQ>'VI.C@>NXYRW+]#[F1),RYO0 M^JU>O2=NF%@EE,04EP2UN_W %'=T55'\:*\YA92A-?@%02P,$% @ !((D6#2D;O3?!@ :Q0 !D !X;"]W;W)K M&UL[5A9;QLW$'[7KR!4H["!C;2'3L\R+C3:W=BF$ M8Y^J4MG+[M*YU7F_;_.EJ+CMZ950.)EK4W&'3[/HVY41O/!$5=E/XWC4K[A4 MW:L+O_?>7%WHM2NE$N\-L^NJXN;^A2CUYK*;=+<;'^1BZ6BC?W6QX@OQ4;@? M5^\-OOH-ET)60EFI%3-B?MF]3LYO!G3?7_A)BHUMK1EI,M/ZECY>%Y?=F ") M4N2..'#\W(D;49;$"#!^KWEV&Y%$V%YON7_K=8?"=J?8;$+]>E]7_9)MQ-LR[+U];IJB8&@DJJ\,L_U79H$4SB1PC2 MFB!]*D%6$V1>T8#,J_62.WYU8?2&&;H-;K3PMO'4T$8J\N)'9W J0>>N7L*( MUDFW-N*B[\"0MOMY3?PB$*>/$$_9&ZWBY.(I7&:'0)TG/RER'LL"^3I$3A98]W,\\N^;%WVR_7,.H.P M_?60H0.?P6$^E,KG=L5S<=E%KEIA[D3WZNNODE'\_)"2_Q"S/94'C MC].,@Y=Z]D*J0JJ%OZ(5+EBFYXQ7>DU+U!PJ2$$T<5HKOBXD;0!X@6H75E:7 MLN"T;1U^JBV?EDYBVI2-X)L,2W8*>EMO8,HDK/ ,B*1\S"83+O4M5" MY/BL%!'CELUUB:)MV:D_@>T@TIZ==WY82N.$4.QG(6XM\Y_WS]["-YT/XDY MBF4G+(O&XP%^TVD4#R:=&PTK0@.SO3&(DCAE61R-XFGGE0%F1L#9:99.V!D[ M3:+A*&%GG716^-,T&J1#-HHFPV'GE5 @*OT- M7J ,2DHE:@!L&(TF"4O2:#A..S]HAUOZ@00V ;@12Z;@.>Y\3[#F1E>/&O)T M$@VR :%.XV@ZF1!LV-(T+JD9GT5,H=-F"%$G/IV.G*Z#M)K9,LB=M9YS5"5AJ*I&#GXPHE@W$TC(?>$=MEYZUX M"NT)2(;#:!I/04T?(T >DDV^$V6!J,)0 /_][:3,A7$8-Q"A5H2LH+#]J$MN M)(\8K-%C2PY7SRA&=QF'B*Y)EGLXZKB' E(7'E,N? K3;K&K+CU$NJB3@HXE M^&VGF2V*BO\&MCD2;Z&-%"'W@U"*Q5+RF2REHY-]$)_GV#61=M">] QAA Z# M5B,J6J/=P...JX5$HM;<0UR=4%RGTRD6@S0:)7'GE=;%1I9E,&7ZG"4^IBGX MU.(9BE=UV"8M3LDHC>(L/=0WCA;GPWWC='BD8O\+9?I[X7!&;H)-*3=P T-C MV4093HA-*5P38Q[$^+D%(^.6[+I"Y.1<,4O'#!)%V;@%N5NN?74&(\@':T3C M&E4'&8J0<_>AD/O)#4#(&-3T00HD;Y#R6O6 C6U#X:%V>0VO\+O>?20+/FT# MF@&%$LC=%EN*Y]K]N%KLCM@&]O+LZF.WY(YQBGP1HJ25C?(CL6?R!9$M%9_"LO?4R>J_/D4]T*P]/"59E*7# MAT,3JO)D,*['):07]?K!>/+D(2F)LN3H>#1*QH]/14DTQ=SR]"D ;7_P?]O_ M*VW_85 \VNH_[_!/[^RAH7<>-!5@@2M_6ZOP8K*1:&Z?&6._2,-D*&3DN]UL M60<+6> $D'H#5@&=?X&!)4[222_9[5BK<^GSJQ&VV.I#U^5#Y9%H*^'??]P;[JF+II[?/J-GHU!E8)EPN6VE-A&YZ7CU._0O=[_UGH,A8N&?N2PD MHC*&IYUFMWE)N_8/2/W=]? ,]X:;A832I9B#-.Z-AUUFPM-6^'!ZY5^'9MIA M8O'+I>"%,'0!YW.-)*X_2$#SOGCU)U!+ P04 " $@B18WWK#_C8$ #1 M"P &0 'AL+W=OO&#"& M(0.,>.FT)0&^@A:P&R-.VH>B#RMR)"Y,H_Y6WDG:>3LI"<^Q4%P4('$Y<\Z#T\N^H;<$?W)_) MS/&-09AAK(T$1I]'O,0L,X+(C.\;F\,)D\5Y+NN7$ MI^=WD@I"ZF=@10+7WRM>4HJT"W^@GGJ:%!@R+]X(NZB%A:\(F\"M*'2JX+I( M,&G@OVSG#\(6 1YYMG,OW+IW$;9*_!SK'OB!"Z$?1DT&M;-?8=R#J&8/6\R) M=M&.K+SH_=&&O\\72DLJZW^: E_+[3?+-5 _526+<>80EA7*1W3FQQ^"H7_6 MY/1_).P@!/U="/IMTM];<.W"NI,3:(OIP1W^O"OH+A;4BI16():@4X2ER*BE M\6(%75[0B:@4<2D7\"G&4L,S,@D)8>SDM'.M-*<6@@F<&_[.-X7+*H,;ZD@* MJ.;$ B50V5#]8&[65$.=*WRDIED2DQ)+O68280!','0'@PE]!ZX_Z'=N65$M MJ0@J:2S9F0P1!%$ @1]V/E6RX'2/ATX1Q<2GO\X-4E=+198 STLI'M'<*E(U M\L?FO_-5:)9!V1@:&+G]\9ALF9 M-ZC4*37:N,JKS'J;(%5$S%G=@8F1Y4)J M_J,^Z$9NY$=P MW0[8_&<-*JJL["$?3=8&SB$!'/D(+4I@&?Z/52"+34K%CQ M14914 K)/VU4D8E'?B^B1IEE6P%T,-P=T+-GDZU3+C5B36$WSQ\+*BY8(SXH M0--^]A-IVH=+KY8JT;X[V;.[%1Z^U-9OT":Q3I?5D=<]KE9R3[6UJ1&_[C.' M>GKP-45I#*.?0IBD,BYMKN*4R1457$,T*(9B5? ?I. 7E^W^C1X3[:$3M'F# M#Q VM9U6+#>WG>[H?P"7([4'V MF.7EV1[<"++''\9A$)Z]AEN#VBU)*W(M9LF@8>!;Y+X'N!N\0C=PQX/PC<"U M@*5OX(X&XS<"=P^E.U"Z9C=XB:+H%Q29!KRMN/U<;4!CDF69:>&_Q%#3P^7M M34TY$I+,,*FH;*I"UP/4[G0WKY[;,KLQ"G93_/Q?4$L#!!0 ( 2")%C' M8ODKPP< /$6 9 >&PO=V]R:W-H965TZW5^!LJ\UGFPOAV->R4/9\D#NW>3T:V307);=#O1$* MOJRT*;F#1[,>V8T1/".FLAC%83@;E5RJP<49O?MH+LYTY0JIQ$?#;%66W-R_ M%87>G@^B0?/B=[G.';X879QM^%K<"/?'YJ.!IU$K)9.E4%9JQ8Q8G0\NH]=7 M$Z0G@C^EV-K.FJ$E2ZT_X\/[['P0HD*B$*E#"1Q^[L25* H4!&I\J64.VBV1 ML;MNI+\CV\&6);?B2A>?9.;R\T$R8)E8\:IPO^OM+Z*V9XKR4EU8^L^VGG82 M#UA:6:?+FADT**7RO_QKC4.'(0F?8(AKAOBY#..:84R&>LW(K&ON^,69T5MF MD!JDX8*P(6ZP1BKTXHTS\%4"G[OX6>ML*XN"<96Q]\IQM9;+0K!+:X6S9R,' M>R#E**WEO?7RXB?D+=BO6KG_JO#_%%\0, (C&LMC!L+W\8')?Z6 MNB$+HX#%83SN4^@P^[5(AVSLV>,#ZHQ;P,]&3 M?M&8\*_MAJ?B? 9;86Y$X.+'W^(9N&;/KO_1\+V4)BT*$P.27]!V!V4UZ_M M212>LN_@W7Z^KHQ4:^9R 7_2."$4L=##_2L%&[*M$)\M$QB8#,)*+X5A=6 % MQ'FERPU7]U#>4FV0ZCB*%L,))&Y18-'2*[9N-I1 *@T41 ?D!7= [31):4FX MM7*M_(<;77 C>0 V0$#>",$^:"=8PG[\(8FCZ V[AG)HG725$0RJ.^-9)K%2 M@! L/DW M831]WS<^@*WM1E#9+NX[)LQ:$]Y6%F"V%G%<2N45?K8M-?@D;/X&%$^_5-(2 MGP6VM*B(%'VS5O2ZZX]A3W @("M=0*>C/3A^VAA])S/$A22I5!:2-\+D3@3W M(HS8:(.^_2A*P8X^R>6&Q1// M'Q;%GC\)XOD4N<9!/%UX M]F@VZ[#?:D?1\]!!QVP"/&3W29P$83(F0T] _D>>._I$ M8X/(7C'OBN? '@ZC%GH VN\_Z4*\&"8-S O48QK,PNE3B$9 W,*:()3P-(W& M_0"BZ 9$L RHX6F2),_":Q;[J)C$P2P*CRY+"'7YS6>#^ J#IA7=VO98&$;F M2RMN38O,!DH)/A%+Z<<'SW,#B5.[*.S6*&[KQ+;[R0:9==OH\HGVOB7I]4QR MZU7[@/O0/__^B6S:Y5&$<$W@;QIU_1I-XI9H$B??RY7YHJ5.)N/#B3&&+1OB MQ73\( UXGZ>.V7R<-,I"],>)5[C7K?_*-YY$Y@>P# V0EJ MA'H[9V_#'+*^2?8ELV%R^KCA!UBCNZ]K51 O0!M#WNM%V?=H_WWUNGH$^SD)GG]A3KXT_S#OAD_$S5/VHY_ZO4>E6-HZ8SU$ M2[%G_[ _,/IE2E\ ^@+Q-\7^PU7%S3V+HR8HN@ $F0.AAL(7 .9H#/="H9A++".9;Y50FH* M/%EY',#%,-!#TP%'6CQE@1;@E*)NO>AG#HZP[I58K7PLL)(K\+P' @M$W;#! M.U=8*[+:B6V6D++=$PDZJU(UZF3P&D\SWA> L'0X" >=?J9;:7+]_5:P9F" MW?&B$D\W+=\3( 64Y?Z:#C,&8]_;2F$T MZ#T5VKWF@\,2"\ MP2 H0,5ME>:X2(U<"B3WK:%UMS_ ES4,-&H]<"?A 2/\P@*4"[3'#.MSG6, @Q/+#L8^Z^P^>&])I#H.S0<4@$.^"5M5UFQJ@I6 MR!7YT&VU+]\/NZJ_TAEU;A4AMM=TV8IA K[T%XSMV_8^]Y*N,4<[&ULS5;;;MLX$'WW5Q!J4;2 $-UOB6T@<;K8 ELD2+?;AT4? M:&ED$Y5(E:3LY.]W2-F*BSK>=)&'?;%X.7.&,SPSYG0KY#>U!M#DOFVXFCEK MK;MSSU/E&EJJSD0'''=J(5NJ<2I7GNHDT,H:M8T7^G[JM91Q9SZU:[=R/A6] M;AB'6TE4W[94/EQ!([8S)W#V"W=LM=9FP9M/.[J"3Z _=[<29][(4K$6N&*" M$PGUS+D,SA>QP5O 7PRVZF!,3"1+(;Z9R8=JYOCF0-! J0T#Q<\&%M TA@B/ M\7W'Z8PNC>'A>,_^FXT=8UE2!0O1?&&57L^!+#5XI& MV5^R'; )@LM>:='NC/$$+>/#E][O\G!@D/M/&(0[@_"Y!M'.(+*!#B>S85U3 M3>=3*;9$&C2RF8'-C;7&:!@WM_A)2]QE:*?GEV4I>ZC(^WO4A0)%**_(C5Z# M)(M>2N":_,'HDC5,,U!33Z-/8^F5._ZK@3]\@K\@'P77:T7>\PJJ(_:+T_9! M>(+ PV#'B,-]Q%?A2<:;4I\1/W!)Z(?1L0.=-K^&\HQ$@WEXXCC1> &1Y8M> MY +(WY=+I26*_^NQNQAB.R' MK,1C5N)3["\@R]/\;X/@'?G%U._A< @7%E[NX,T!O!38ZI0FHB:((;5HL&,R MOB)O&<<5T2NT5^_.)Y<*,1.4I5@B%2H+)0:M&:/,)GNOI6B-6SHT/_2\! XU MTXJ\)I&;IJG]%K$_6=BN@>85=$(91. &:4:*R)]\YHQO!"LM(;="PH%"3.0F M28S((H@G'_@&HQ'R ?MT"=AFT5NO"1>:C.:!&Q4!*;)P/*$&V9)&T.%X$C:B MV9AXAR7L_%5KH_V113@>A@GX[J$)=6[:RHE5"83>>XCRL_2R4T'$I-IS@?X-W!X M=>YXGUGHDR+))W> ">F!;*F4E.L'4@0Y>?,J#X/P8G(--2"\(CUV*+F5#!.A M[&9V02JF2M$C%09+EPU@GOV@&&WW9]T3/[I._81D:389]$CW&3D06.RF181\ M699,_A0:,T5_3:&O29BZ:1;C("C,?5;Y8_(YU0YUO>( M?U;%8+60J#C6A+#]F*:!8OVRKZ).B@TS[\&#BL-&E6(+>%KV5O"&R8__J^P' MM>.@<*,X._9WY1V\J#"*E7UH&C%B*0^/JW%U?,M>VB><]P@?'L(?J5PQKC!I M-9KZ9UGB$#D\+H>)%IU]GRV%QI39X1K?XR - /=K(?1^8AR,+_SY/U!+ P04 M " $@B18NTGPM(T" !8!P &0 'AL+W=OSG33KI) Q:5>[:6SGO$_.>VH?3[92/>H*T< 39T)/@\J8^B(,=5XA)WHD M:Q3VS4HJ3HR=JC+4M4)2>!%G81)%9R$G5 39Q*\M5#:1:\.HP(4"O>:R&UXS^8P(,Q2XH@86C(A):"S:!81YBYDUF.0%S#NXD\)4 M&FY$@46/?CZLCY,!0&@]=<:2G;%9,DC\F)L11/$;2*(D[4MH6'Z-^0C21IX, MI)-V=4X]+_V;.L.WJZ4VRF[E[WTE;XCC?J([WA>Z)CE. WM^-:H-!MGA07P6 M7?;9_4>PW\R/._/C(?KK-]DPYBA.CJ&_D)\JA+GD-1'/H&LIM%0:"(RC^.CQ MV!UKBRH@MUM,T>6Z:2"B@%I)BSC1%5%4E% [U-'AP7F21)>MUN']2GQY#+9K M C4:D-&2+AD"MMGHD4V!:M@3.?B&%JB]RI"G$YL&*M5_//[D//X/G3=[*=QK M7AQ5Z7NZMAFOA6GZ6+?:71M7OEN&O\*;.^>.J)(*#0Q75AJ-WIX&H)H^WDR, MK'TK7$IC&ZL?5O;J0^4"[/N5E&8W<1_H+M/L)U!+ P04 " $@B18AQ!S M E0% "L$ &0 'AL+W=O[EQBQ/^WV=Y5!0W9-+$+@REZJ@ M!H=JT==+!73FA K>CX)@T"\H$][XS,W=J/&9+ UG FX4T6514/5T"5RNSKW0 M6T]\8HOY)5M3<>>20KM9%%+8P6 M%$Q4;_I8QV%#8!@<$(AJ@>A;!>):(':.5I8YM]Y20\=G2JZ(LKL1S7ZXV#AI M](8)^RO>&H6K#.7,^*/)09$KDHP&[K9S789046 M'0 ;D6LI3*[).S&#V1[Y2;M\&+4 ]-&SQKUH[=YEU(KX,3,]$H0^B8(HWF=0 MN_A;R'HDKL2C%G/B)MJQPXN_/]KDGXNI-@K3^M]]@:]PD_VXMM1/]9)F<.YA M+6M0#^"-7[\*!\&;?4Z_$-A6")(F!$D;^O[*B2E%A"&=TRC@S3^2(Q"/[P+^1GZ0IOKMA$I'C@ZHF5/$GQ*ZQ M- DC?S OAE$8O=D9'H1Y?S&Y(\MRREGFHYWL@1JTE^,/@01O"$;(L;<- M6T:7S%#^K#'QPY.@4;@UZOR*;8<@N<.C0=F2Z=SAH<;-P AI0#LEMQ?OWQ&Z MP/C;?1J]/VZ0=]^Q'\5IYW>IM=4PN26WDC.-E#\UN_JZ8>#'\9 \@WTUT[F4 MHM1$YQ3SCC"M2_R=T'BT4]0=:L5,[G+H&M0"%%H7'>.?'X^23>2=B8Z"OO=;W4B15UQZB>C8%/9[DS'E6Q5H5T7K9"$HY ,3SIWTF:7;"EI+(IX MZ =!C&)')+'C:.C'0>3&L1\.@XY-'"0+7L[0CR^@I$NOH["78-/EW/J#?FYI M0;><>\:5O]TN;-$7%0^ ;6#D%I8&"LL!<5 U$1^K72_!'5[XDQUE&C2"PM=:!['9M@C1='0>_D:^/KT#CK@6;YFN?,FLTL MG*E(S/FS KA?N[-!:+:?.I#IGCHP+>;7-'#5/:AH]4-G!4U@W3EM8_ ]>G MD7>VV/Z9"<(F/YE#CGZ3)OE82AD/L!=%&G_FF;A+ZPW18 M13Q* O=., #;3:2U=[P@ZY-]9_+^QH6PL!1K[\D:84IAJKMA,]MYU!6#( MM[81>N95QG07OJ^+"EJNQ[(#@3,KJ5IN\%&M?=TIX*4#M8W/@B#Q6UX+;SYU ML1LUG\J-:6H!-XKH3=MR]7@%C=S.O-#;!6[K=65LP)]/.[Z&.S!?NQN%3_Z> MI:Q;$+J6@BA8S;S+\&(1VWR7\%L-6WTP)E;)4LI[^_!S.?,"6Q T4!C+P/'? M RR@:2P1EO'7P.GME[3 P_&._9/3CEJ67,-"-K_7I:EF7N:1$E9\TYA;N?T) M!CT3RU?(1KM?LNUS6>R18J.-; ;X'/NKECJ/_B&,?R3/VO:E M AOHN'@D%=>$;TPE5?TWE,3@5*WUAHL"B%R1D 9!L/LCNN*HSL:+GD\[/BY* M$A[+PEZL0"GD'1)=%!TEEZ#(X*DQ^45^EVG+6@((5PR4X^]J'KI$T81E-,^34=]>V=GS5+NVW-Y]U700X0)X[FN# UR=I#0((SH) MXY/ @YVQ@E8;LU$'&Y3ARA.*/1Q]D88WNU[L>Q-/:![$-,WS8Y9^S3;1O[>- M[4>:T2!.>G.@RCBE69J=M) +X6$!K;7&[L!PZ)=1_$6*#MSWJGG\G[R!$R7@ M!W[9 *+% RA3V_$+I]*!<]@[^GREG9?H&]D. %;YL-]K%QK,^JP=(]412\\>M*:,>Y?0*-\@NX.HPF-)_%+Y"O>C)(2, YI M$B/Z\M,UX6N%70!AR/MW&0O9!Q+9Z2#&\I^:(J3!7=MEX#QN.@EJ[FX[&S=@(TW_=]]']9>K2W2'\I_3^)O:9JW6- M[VD#*X0&XW3B$=7?;OH'(SMW05A*@]<--ZSP0@C*)N#\2J+"X<$NL+]BSO\! M4$L#!!0 ( 2")%AA\+ZUK0\ #Y) 9 >&PO=V]R:W-H965TJJ]A5ARW8U6(H1/YI%:\AC^5+>G>J4$]VG3,CAU;7MXNN0R M/+IX1>_=J(M741(',A0WBNEDN>1JLU0DED4W>$?/_FO MCVQD2 3"BY$"A__=BXD( B0$;'Q*:1[E1^+&\NN,^C7)#K+,N!:3*/A-^O'B M]='XB/EBSI,@_A"M?Q2I/ .DYT6!IG_9VJQU[2/F)3J.ENEFX& I0_-__CG5 M0VG#N&V#FVYP]]W02S?T2%##&8GU X_YQ2L5K9G"U4 -7Y!N:#=((T.\Q6FL MX%,)^^*+W[A2/(SUJ],8J.%[IUZZ\\KL=%MVGK%W41@O-'L3^L)OV#_9O=]Q M=Q X!3%R6=Q,EBMW)\7W7MQEMF,QUW9[30SMWOZ#\+JL9[:[.]CIY:KM$;W> M ZIE_[F?BYO?Q?UG::T7?YFA/V4\BNQ4PE %!PK<[08O%"X.(5#S=,:IW =L[69@,26B7*6P N ML(%E#_I,+SAPQ*)YP0&P.!=*P49-IQTCR>^_&[NN?9XO2BG2V\[Y"9,A\Z(P M3,%K+>,%'(L<,0\HR9C-N2<#&6^Z[%<@5Z<#K#*Y7,)*'HM@P\1GH3RI^2P0 MC,>,A]D[ MB3GD"&G_>[/9NMA#)"P"*?@61F\4HJ3JSX0!!7E]3D#@T3()OL844E?$S:7(0\]&=Y6C"BG MP_BM$F*)>N"!!CY5="]]5&>DT"I*N@L3NK0RQZD0'@^\)."H+[QDMD0,!]5 M+ 4;]4!_@EC 3W].0F&,'",M;4!^P4)AR0J.F?$ & ;S2F(=@V'0/F-J813# M:2N^(1LO+3"R00B4RV198C3EK^P9"0065571MBJ Z_[8MB:59Z>#[N]AQSR,(+N%L$_Z,6@6K@(TI1G/%'BZ[I_[.OL M&=<=AYR6AQFFV8?X[:AGV<.RWWH&%PPOQ@U_3\(6/X2SA07/$V0H3 !0+ %"_@,G>AXQ2X:$W^=@Y;=,H4;@V.9A]Y M$(@-N^+A7;X/M)0M-M:82XR.L<.QJEY%TD,,ZHV)47@U= L'JZO"^-N]J'N; M1B6Y=J]78T4)+(HJ4&4< -+."!TJ33R[[#*FFT-D,_>I! F'-O@93GYM0!1 M?1$+!5F^"48ST19;@0]^"WJ^171(-/*"Q*X"[MUUIMXB@GV S+X(BBN>1P&4 M;+AT3;4-6C^X&Y1J( <4<2O4@'Z)Z@ E(0? "K()B?I&<*7/BX_N(Q2(W! 6 MC'I=^\4Y4U+?=>9P^< >[!5@TBI%+Z<[>D$*=[J]%Q1ND*,&^\_U4;VMU;D!$$&#ILC%7?H:E8%NQ@L*^;ZJ'S1[MK.W@&IT$'/ MJ1YM'$5_(4^A2]W73[ZX:]A/X!J#%U_4O-F$JV #]UZVX'*V[UIX/2NN8F-B MOIC%12IIHG1&XYC",BJ=/ 0R.P1NQSEG5Y%21H>7>,PMA0!]\A="&T;E4FM2P7DAO ML9HSM%P)7"%*6$K)=5HMN#/ A1/*!Y*HW_/BY(PMFA# M)9E=4;ZMDYD6GQ(C82YLY9(JDO\2M6Q!^DON&S\GH"D^ Q"0D6_SC7"Q)D5H;;)Q0.6PY.C?GU6TBNO TA5P#7C^[$E>35 MI" W;,.;9ZR/N,W80D9@0>,9=?Q K>P\$$RX0&H4J'RN5;ZX#':,"VI3C>>% M6@^JH;3ZU[G:"SQ%\ZPPNB=[19E_S$^(%.2H8(-4GQ_+DVV!\9:/I32+MVOY M3PG8&##B=D=G@Q=-YU/X&9WK/+0 P?+=MI5%A*7S) @V'5\&"7H5=3#.V2I( M-#N>G= 2[%7-X[2)0*@"209E5S&4N<>.?0+O;G1]47H[>9/!JK57>@/;LJ'Z M-]QE9WH/GKF0"GS^N+?WL=*\$\&52CRXA/%\B7&&,CQ('P'5!#Z608>N<^LT MX(%M6@^;,&;'K>&FR]ZG3!?G%9Z-.6,C1I:AYK$N;@R+60PJ=2AT*9TM>$3;<>TB2[#2 MSJ?H5!26Q<]JYI VDG[HC#"P_A+=F]3+Y.K[-HB&@Z$U[-G;34TD6_\OXP-? M5\YK+X(?9JN2YG,R0+^#T6O#\!D/NE@:A%2%\]'8.AL>7 5<81Z&92!P,0/X MP$^KB?^CNK3CIBYM6[YY"?L"5$B_FS7X3$94U@['WEIJ87FT)JO89(EDB^@F M^U!=AE($WA+G8TA2]LTI90-I/[I MYKW1J@1IO,9$A!2-*+W$V"]-",=%2<@3P$W@'$L&$6KS2D.EXM,3A;3JA!T0 MP&-30E;2=A*%*J%F/'UT0O]5NP;=P4,I_9BZ CM2^GYW](53^CR?;X> 4LK_ MA.[? _134KIXFH5-VAE6^-2]R/L8X.'$9&,!K,-JKVEE+65FM(ZMV.+3A 34H/L6[RAUA34W7L4U0:4]R.1 3%94_(I0$5/W< 5.IQ MJO)\P12">P'.33(+I&>!UN0] M\G0#X)M73S[[+5)WZ+B3M%M?!J+&A""WB;JZJ=^96C,A@P=6K(2R4E^#0\G/ M",5%:C_#X:C9?JXO)[\"JL!B=LG>*Z@ZL>$T->A%-0'U Q: S&RV,>%]A4%/ M[7@T3+>9/1[;4D@N>_Z(#14TMH;NH)K[U_G,JV4RDLRP=TJP+X]T>5N,==FT M:#ZF64#%5]ME(YEJ9+<*$XH >S8GD-X2!R/;*@DP4C($\]P3H@0F464?6D(^ M-Q/9L@R+M8CCP,0=J#$7Z=0!Q[+-IZP*,(#2PSJ9 M_0YH9V(HI#M #->;0\NE,14BIN)"7;*81.%-,9$=I7*6_:469T=7K(4W%3$Z!JV9I$WBX)^];'LBLZ% MN^3W7 ;@&V4/0@M"I%"=!8YZ;I%!AP M]:SG_:Y=?N8$*T2N.*<7<@#':Y MP"'A>Y$?!'%%G^3*HCX&MG^,2-C4Z&"K"6!6W$&,#)4C?* @,H4X-:])Q[69_$ M@Z0"YP\J/C(G[*X-*E"X*=LJ2(M3$45]D]5/;?(7#97<3&38U.1XI(]>-MLH MTFK3KRFZZ_99JMH>:^*E1)I\9X>)[RON8TV\RYI&>GIGB'@1^5$0W6+LTIZ2,[/8/&RW\X?MUWCB1SKQ MG> Z27,6Z['SN/5WG>KXC1%S1V]EZQIXJ653PQ&P'GK 5ZD9C6\8YRO/ZS9D M!*@X,LPL(VF!&0,(QN]US?$)I=-G" 7 [>'[[8 Z3][KMS]B\R5MPV._PV'Q!N^=O%7&A-OK/D.GIC6WT:FGWID^FGLYNF& MI@\SE*>9/?XP?7-MQEG9CU& RH&(]/;M)&\^IZ?D>69]2KGWQ%/*(VO8[WV= M*67]9$/*V23(WW=(^:\UH*R? A)J \I_/B;L/]E\(!*4AH\.3K<:1HV\/SH! MM4VG-[PZ2?@'I/B- [ M[7M_?S*8?:FTAEPU'_\J37N9_#Q)A_/R7E/+B$_;. ?:SLMG_Z9R]LU6.?N, MK!(3Z6=O*J-E.%?F0/AA'>: ,YIZN%A3&C'#KXS *AHS,]\?>?:A9=;,Z9[! M2APW,U_>[-"7.0NJV>R99G#R"_JGZ;=$3DL_44-0B;_<@_TV2"/,K]7D[^8_ M#G1)OXES6BPWORSTCJM;M*5 S&&KW1T-CLQ7%K(_XFA%/W@SB^(X6M++A8 D M0N$"^'P>05:8_H$'Y#^9=/$_4$L#!!0 ( 2")%@*ATT5AB( ;) 9 M >&PO=V]R:W-H965T_/@ 0X*$CEG.M:G=B M62:!1J/O;J"?WR7IG]E,B-RYGT=Q]N)XEN>+GY\^S48S,0^R5K(0,?QEDJ3S M((=?T^G3;)&*8$POS:.G?KM]_G0>A/'QR^?TW77Z\GFRS*,P%M>IDRWG\R!= MO1)1QOPSN)=X,%[HMQM>\.4+_K8O=.0+ M'5HH0T;+>AWDP_G+5TD*;X3Q MU!FD:1!/!>Q0GCU_FL/8^,33D1SG%8_C-XQSZ7Q(XGR6.6_BL1C7O'^U_GW/ M7S/ 4P!1K\Q7*WOEKQWQUU'>Z_AMOU,'T/K77XM1R^GPZ_X:<#H:T1T: MK[,3HIW_&0RS/ 5B_M\ZG/.0W?HAD<%_SA;!2+PX!@[.1'HKCE_^\Q_>>?M9 MW7KW-)BU^JY>?7?=Z#N0V=IQZJ$\\"B=/0$1%02[&SB* 9T3F##(GF3A 5J?_^C[WL6SK#H??I.%&4X"(^,KDR2*>!$G80S?),L,)LA. M?SZBV8^,V;,"* M>MOKN3VO??0IR8.H9J7F-%[?O>QV+9BOTV0>9EF2KN1L=V$^<]Z,DFP%Z)D[ M[^)<3-,P7SEOEX#P=^]TN?O&>GL(,I3)@3&@"T>!0N MX!-L[Y-VJP<"/(I0>2VB908:;)0B?"$,#K2^ M$2F2R]691__Y;>_R; !XI4]-V\;OP-M5@E( R($0)9,@3)W;($*<\5IH^K-, MY'D$ Z9B+.:+W$)1D#FPG'!.Y(#FP!CQ'<#6)<-@&$:PY6=W9 H@1'$0K8!A MU?#C,!OAFN%/UK2:N0EF8&:@&=Q2YQ=QGSMO_EH2(0$- G7$4Q=W;X82"W"& M;^5I$KG*%'$=(*@Y0@LON21N< I^(<,WC&7?P>; ,D?)- [_1H SHHSY(HE! M!"!X";R<(MTD<^&:-8,B#Y3C$%0)@8WR8/F5)%(X) M9UD./UC4XO! N@%B.),2=@Y2>H8VWZW0LT9)EITR%:LM1YA3).2_19H@(!(R M8( 4P4"X\EF8YD+$$@?PR^HL!O4 JQ9_PC:BV5 KGOGE5 CZC5Z9LZG![]R( M12Y%:5O);R7F@(8+="L,50FM2I\XX!A'AYT/;P.T59THE"3%BZ^^1/LW"E(@ M^S&)P,_:DF$0 64A]8-1"!N1XQ@ <9*&4R"ZB!B,GJ U\.;#0F#@._/O,M\AB#" (,%:1-LDD+(T4LI4V3@^D??EM)'+_]((E# R4CUJPC M(H+;( U!61/[PB;!US!.RQE$D<*()@@I>^1NDTSYFX$>"U111-(S08P*_ZQ0 M>RTCV%;A#,/),AT%+(N ]P2@''Z+5D0A+(E( 2'?%X373MS-(PK8/6.VB]@];[$;0>:13U-)C'^U!^-"8Z#/O2>M[!SMZGQ#D(F:\F M9)(M=^#[EBD>6=+>8Q+:@"V]R1+L7$0NB>H*CQ+[RRWAC6]:!,.NT)X*3$/@ MD&C4ZM%@&RH1-T6-J0@F(!CEJY+J"4X3IQ(Y5_N2M!Y+VKJPV3L2-;%,6E!8 M"U_Z55'0JV4&<&88J)P/,2Q%H90IL!1NB"VP9X#&- BS781V#4PZ1&-(@ D0 M*$"S$D$J6;>*8@(^ "$Q!?"F:+$NP$4 H)0ICF:VY[?:RLYF,5J6,UN(%O)A M8*(QD"V, X#)@%IU/M]K==1\L,_ZC6A5X:1@!!HA"U6PZR:)P&D+;!0'P$1S MPB^1&CD= >MBP*:3XIB4=DP.9*V#("#T-/+ M$$+\AK5%_6ZU:DDTQ+BNDX5 II-PA)Z=+55P() 6B#RY#Q]$.@6_T%T#DQ376F10,)$$P))H M$D8J0HL@D4#I@!1#*0B_(ZXB<*75#COBKR61D'-R?RJ]3A689>\._C9EAYMI M'*1977!V#;SC\#9$2AZNG';KHN>:7YRL]*Q,M $#OQ7LRZP<&RB4(F=2460H M]3F8,T,AWWT4)-?'&T0,;C^86K!&L()HP;:7C=OL=KQSMWO>-I!> =1:B=HM MP(V* I"!D+ Z9.D,XRQS@#$>(W%L3[#(-=5,C,TG)"H+ ZTBP^']"%&2@_6! ML0&OB T G/"%9N,:<5^?'GF0-57/Y3LKHHV0[6*JM9R;P=LW!:5D%$KC+T&M M%2\TAO!5%([?09%IH1I(#>S_D1!C$ :TZ>$1,)<3938*RGE-HP@%E'_R'3 H_ M)%L._P\, AP_(-W!+#D*%F6X[XB,,4.#3)V;VD8[42Q::MPH))-13@X9K#-V MYB#BDK$V#J[_>//Q@[(%5/P.N!!T2B;GD(0U!\D0 K<[[.$A+3C92,08\\P: M 2%;4@=)FX)5]EJ!/'PS2@T03R)%1?SB"I7N(7Q0, MT\81P[R-.^*<$('@5E"*_YP+)[QGM6;V\X(BI!-2<6MKX%>,9)AD*Q7]$ MB0;)F[)$1]HD9ZAT5\$6!?DG*44 Q;P*AMHK<2O#9.A:54A^L1Q&X0C^#'B@ M+V2(B%U=C-HY5&0QQG*-:$D(I!%+)F"(CAHX1^ +.E0VR&)0ILK8R2SR<\8Z M@7F*8*5!P@LCBU8.5G&\TTI&V=&MVA&1Y+]BI!!&SL/(B*4&EM<%")(Q7<:L M@2+.74IOP\Q724H'+YHQ0AX)AS(&)&M(FB!S M[$>!S"3@)\CK, ^B\&^"E@5,+454J1'EI/;^QI)GGYP;^_/Z*B<_^(Q&%I#\7M1![VUQ]A46#)"U@]# ' MP89K>G)A&!,([HRB]E9^%5]Z*X:I MC'B-(M*HI,YA80S-+PPR055GP$GP$X MT38A[[GE]WYRI"T%Y /<1_&3$R1K%'6@@[3;_0>2ZDV>8OWVOQ.PVH/HE*NQ M.BT[VH*E!4-5\[@&/-I=)IH,-XC)'9-5Z MLW8Q0X*GL(KD>IWHKVQ?3&O^$*Q8&"RG2\ >Z_OZD.G;<$+Q1R"T\!X^:J[O7S;%DE /W(MT%"J^SV0E0:=/.\%1'!DP M &;1WV&2(UMPDC]:-9E"&D*=3B*U0>PN;<1R4 ^F6EMQT))5JIM,=9<_\\QQ M4DU8E&WIWS1YE3?21#V**L-@'8% 7M!6J5(/B.0[7% 6\9E*,B"J2"SA7A> M^1QE,J101;3:K JE'0$T:"A%I0:CD->$ 1(,F^:"Y,B=P( ?@E*\K2#%=:!7 M0PL)L (_G"_GP&0 \QCE!L?? .=>ZZ*'3WNM=KLE,ZZ25\J"K9!=9)",*=XL M[FJF=R5V5 1'81I>2X8$$[XG;2@TJ'(G$@$0Q!//=)Y0!SI(D;!LW&):.7L MYJ@J[C0'\?,,/)L[9&=>@DR3$NP1B;:[ *B;A G):%BP)3HK:CL'8L\"9FHL M),9$AA,E\90+Q\PS;LW'*N^/P$H"_#N&KEG(!MXC8161UE!=5-8_Q8 M$?+:/5-;@(D8&[X'D.50!&EF6;( 2M<\CJ#,9DZH*9T.U-@"]@M^[)702,/^FTNB:-B'L99T"R&@79K,@]9[2M M%?]$97#[Y>VEW)],XE"URV3ZA@J"ZU;?:=Q]<;"BSV^ M"Z-(%KTOI9M9HK8*A95I*D 2!F>5PLK(W"M:YP(8.(17"'3/ ]L!;6L??JJ0 MS'I1(0D]1W\;WM #VT%" %T>H:+ /F$N&;-S0*LGMR '&3:,E&^$PZ?+4 ML2SA,%T@=,9@GZ5:US8]# OC@A&]TIRFO0"J!C%S\'2B"SS.3)K+QAQ&!HB* M*\'U+PHDD?L=N50S*L"KTE.!Q C1@4I51*IT$)FZ-:B,FFQ*@EN(LMM0)]U M- '$6-DSIMU'> %'U?T/48))X-:4VB\S1?E-Y?6<_FSM?HZS/L=F885R&9Y9 M-4!1@#$@P_:E&31 VH. M:K=GW4949S>4)3%*F!K1EY9S<_7.^83FOHY=MH0R^ M*Q7#*5].J7$Q M3'!Q+1JCLAC#,"RMTK6&)%TE8<".+?G\>7$L5P9UZX+P#$ )Y"#*$AF7ICTC M"B>VS\)[I$L<;45F>E.19IT<\QI(6$5K:ZO&UH3U,QDL2U+4]N16%&R &XPD M"N/+!UB%2T^0)#DZ[^BL9#)AAG6#R+>W01BQUP 2/E?1052*JN0,7U41*@HH MRA#C6ZUEKU2(4<45R]EX7LH0Q0(TV5Z4GG>2/C85*N35FJEF6K M6IG1G0U7]5\-_9JN5LE0:$[+Q"Y#)WNZ6Z5(4LN=209*G#;/^A=-B_T$VY#M(\QE)4NL/A_;5; M^\=WOSLWU[\[[]]?U?_]UP4F,Y8Q2D3S61*>R1@KFYT/Z+:NB*Y&G",-B;P^ MI9CDLJZ(J%:T]ZP"^JR&IH'0%%'?@.,,8@X1]@9+(+(6RVMX^HKS?V_9%%CM MY'!JWUPF$2=JD%*$?#T""2?;XY!)<_/,QHT61CJ$&25HUV\9HP M-P]6F/T%;B(4B7&1+]=.;W&F0^>4G7$BV)YA9]%YXK=-B8:@%.[:9C!"WC(- MA,2K+#8+&3E>R^O=.^%$&6/R..A%#Q3)BC7BQ@$NK!$XL2 'L*4?(F9!2Z"= M+ ^,!VF/D<^(J%JZ3C/,Y-J;*B0 MB2?#,45Z P//Q$3=(K[MDN8)4AZLQOTF); E*+W6^8Z0&)'VG4\/T&E*4K4= M(UY?>;J?1OR% +F"1E\E=T,<3[.Z(" 6I=_B46O-W(/*W%+6-D$64)0@ M!J4*5D&TDG70Y '(&(2"4WK')%3/Z-1M$,2<:+96>1(Q M5E?NH-EI9(?U60(JD9P8V4>6-]+" ]%*@X!D +8&8CIERR%92@3$2WGB%V]% M*@K05%ZI5'AN;L18C")9#;C2\&6-2; "N%T*)=S+B[Y[:9V?-%XV+H@LU4\T M5DVX^!VAV76ZKM?QW9[7T76-:$T:9W%EY T17C5S[.P,9PYK";A!3E"N:H3! MKB)\,+BY\ZGI90@$AM$5,UR%8_ 5':ZN*[!*YTTZR*BJ5QXT,:MB MD%R%-&1"BOEIRF2#HO!+:O)"*B549_MI.'1DS+XU2BI1X^*)C];!#:\H [_B M?96'K1#/DV5*T3[IVQL%VWHV25$-)DH3_]*=F%06YET06OESW]1'-4-R+2$; MQV >&H68VA9Z#^[AJ!SVQN/S;P=7GVA<11&5:$]=>/E*SB/1N/Z,"A M!O1*VMR\;.0$L$%3E?,R.<'4'J8 *]@(7-Q;/- #$%Y'53AA?UXDJ:&^8O>:MT/$>NP/1VZP#RW,M+"Y12M8.]%9\*N:+O MZ;M?A"FG\PT)@=Z;C UE&B5:YE#*IB$_L!X/6LV?!'QBS3@><1*>UBP'7:,P MY(5M56'VC ]A MG Q/'1EBY[B23G$H.PD]F!.O?2KC5?9#BOK-8Q#F+2<=JZ12S3G:."V'6=R!2?&XALM2:E->8U=DQ->L MZK,O>MNE1*PY%KMN847\V.\9*S07MH:YOJ5U$8&8,D$O,S"JR8W0^1.OG*WV MC<*YAR3#;:"9ICEFI0HB,058!Y*90$<(2#6H@TL/OL_GH0BK%!9ZM0C;]1Y& M\C-3&N7L!LN&B7LYRT H.R6P;YL OM!B9)R"*DB M*:@\!(2H5U9Z#5>ROA< E=.!,19+#"?4-9)9W^KEQ.OMKQO+^F8L6Y>_U4?; M'MJ.Q>[!0O/C= W=6([D1?16*Q2O=R1OZE5?GG?:1_)*2=U;Q?6ZO891C8?Z ME^VFA^JQ6)ZZX_KGES%C4@MHG9"J+D)#[?>@0]]]\+;RZ[^>FC! M(7E%Y#@L'Y3,0MF']#=SAW=0HX,>YP-MJA8. -9S3JD%4 M0*8IFR_9;L;+M9:83R@53O\>_=:($*66-YQ4:VI]LY!;1T9 MPLNXH1#6;"1.S/65K\\[\6"<4SWY+S58*MM;-978-C'O$YW$/4>#DA=A8] $ ML/C4M3'I.9[O=*1J!]5_1@?]8$7XGP__7"AK;F\=CN3BJ?F0UE:YTR]J:TNM M>/3!S%)/GW#-#8?F264Z_E)KF&/.NN@7+4XHQDY@PDM[%'8N' MGDV'GDW?<<^F@YGTC9M)!ROI*[5.4CV3OHJ5U'$O^EWU\S$L)9C4:Y\WV4J> M<])Q+]N[F$$=BA5]C=C=!UWW/[ V+[I.QZ\QQ,X1 ML;T>PG!^H:)H>VN\]6.K^?,]J_EP[UK>Z[>\[T/+JT#@5U;SCZ3953K%SB V MJ^Y=#\I_Q1IMW74[ M?G<';=UUO+E-6<2U;J482P]S@1PC;\_^BC,$Y@;;CSZP2S8-LS%F8B-[&5[E_X MQ0. M>C2V=YRML\@:R/N@BJ6P+9T4ATS75C^;@\FB>KVO&@JK:QQN+F M>G!EWB:]10-#ZUK A_8OU'VUJJ"L[VDH2RHK;0T!ID-?P[+JM/H:;FIAV% . MM'8[9N#U:728'H4TRZV3Y7SSO]@X^3?=AGB\!*7?^6C<.^>$] _] D M[TL0M=ET;I]$O3G8ML=&>%^=JK]LZ[OB /6A]=U_:^N[AT21O\_N=G,Z8X^] MJ^(>X:M#C[W]]]C[5-KPAJN;BTW'3:DN.&OR,'[<+G[^'EKHV>6H\FYVTQ6S M[8O/<<0^O]M=0_^K;;I?'1KE?3^-\AHUFDV,Q>4;5H7'9^DQ;UWSE?*.\7%C M\P;S8F/VQBI%)IR)'!]O+FVAKAQA].4:#6['<[#VT4S _@,CYY+6X.,T#>:Z M#8V^$%I>C:)^],K6-YY>9OK9N6]>36PW2V]+GFPA*Z( M'/'X)?+7%Y3;;I#W$TN1."DNHE#6UB1,X:%S>45![8R&64>)HH""0'A)%8XR MA0VC-866V\()-ERTDL-\KX6Z^UZVTP!>4I87QG*EU2C IDBXZ"+"M$PF;]*H M/(C\"K*#L2@?K8FCEJ[E)##5WA6\O(P$);&FR\B(ZTS!!L216JRM8Q;N576U MB;-9Q)10J_#WF&T^RT>0_TN[>^Y)N=2?W7A@\]"'R''2ROJ>B)S00@&L%'21 MU:5">U367?8D-A0^=RII7!=X,JN SMW+/A>D5RU@]93O8@W7)B;03[>/U,=+ M>/'BZ#WLRL].I02LQI56:CFKE(69(/.HARZLARZLC]R%]4%A\77IJZ_N*NM@N;;/O5#LD;NO/F;GU7*(F<:$Y8P.[5=G MWW#[U:%2SZ-#^]4?I/UJ;4XC_B]NOQIM:+^JJDJ"1VVVVE%= 2VP:ONI;M\[ M59Y-5!>QF5U&=U2KJHRDIM6QF MDN^;+V ??,4&?1]OWKP]M.>SV_,=&O,=&O,=&O/MN3&????[4U!<\"^58+P. M\N#E<[*GKT04(88 UA?'WK'Q+0 Y>7$\\'X>^,=/X+HLQDA=ORYDRO2B5CWI2E9Y[CA&>93/*C M\Q?\[%UY_J*HJS3)U;M2Z#K+9'E_J=+B[N61>]0^>)_<+"MZ<';^8B5OU+6J M/J[>E;@[ZZC$2:9RG12Y*-7BY=&%^^PJH/6\X+=$W>G>M2!)YD7QB6[>Q"^/ M'&)(I2JJB(+$GUMUI=*4"(&-/QJ:1]V1M+%_W5+_@66'+'.IU561_I[$U?+E MT?1(Q&HAZ[1Z7]S]I!IYQD0O*E+-G^+.K/7#(Q'5NBJR9C,XR)+<_)6?&SWT M-DR=/1N\9H/WT U^L\%G00UG+-8K6?751%].KV$(F)Q561P#BU)OR_.*E"G-6=10^G24/+V4)J)7XJ\6FKQ M.H]5/+#_ZO!^USM X QB=;)YK6R7WD&*;Z/*%HYK"<_Q_"&&#F]_I2);^&:[ M=X =OU.US_3\1ZI:_.MBKJL2#OWO(:T;HL$P40KR9WHE(_7R"%&L57FKCLZ_ M_\X-G>=#$O^/B&W('W3R!X>H/\K5#E(:YO/8G9R(O3I^DXN?Z_2>7<$2U5+Q M:YG??__=U',GS[68%[*,1;$0<5(BQQ2E%C(N5A4HR3P6FB@OBS16]&*U*HM; MO"%"1!+T(Y531A*O_ZB3ZEZ\2V4NCND]G> YSWD9/>5[]_F)+3ZTNWGQ7$4R M4T(M%HISFTBR3,6)K!3XKE<0@JA%::&3_(88I=L+9-2X8?&]TI4D?B]K+%%: MDXSS)#<:N+@IE<)JQ,2;/*D2F:;WEI"43)*LSD1>9W-5$MVI-0E]R_<\H9<2 M^J5GI*U454I<%ZDL$TD/,E!EA8/&/=@7B=8UCJ_!4;E6#0E'9T*=<4*L&/VO MSWOH*8VI8X'BQ6=)*'WH-.30-!6R1O*$[!%)*I(\0I732H#L8*AZZ*T/CTH@'OYE19U70OU1RU14!7.5PA!& MSF/W1 1/6\M5185%#]%"YZ(;VD!)!K\=1\A6BDGY;GL"8B-2_-Z(!ZT=>R

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

-8?20$3;8T.P6BP^0"X99K>]9!:GIY.!W M>W/"56*P\6,)G4=''[RY4_K;M5+?V(^JK)OCV4W;;E[/YTU^(RK>_*$VHC9G M5DI7O#4O]7K>;+3@17,C1%N5<]_SXGG%93U[^V9WK:6>VR]4*_)6JMH<[ ]\ ME>*N^76^?\EN92.O92G;^^/9\'\I9JR2M:SD3U$SQ?;$5Z%;F3\Y?-E#7O'K9CC2\NL+;D".9[%G+KB2NFF'=PS7YX;Q M5I@W;U]UK7HORU;H,]Z*#UIU&UFO^\N87S&W?L90#KN_VT)\K7^G&-5J)7-Q MIO*N$G6[+4':J;H5F2[X6_8\RW_*QV/[ UI!9Q:5? M2W-"?RP&1CJ>OVO>%;(5!3M5=2'J9OM?HTI9&"(+T@>0_H20__H69 @@RDA M PLR!)#AE)"A!1D!R&A*R,B"C %D/"5D;$$F #*9$C*Q(%, F4X)F5J0&8#, M:"&_Z#6OY<_AA!VY/12Z/5JFRZZJN+YG:L4NY;J6YF.\;ME)GJNN;J6-"0U# MK)CW7&KVE9>=8'\)WG1:]!]H;#SDE@6Q7"Z$,7(CV(7(^4::WLA(+2.M+(B] M\E[I.ZX+MNQT?L,-Z,E:BZ=%B*2R(+;*NZZ1M6@:TVRK:UD_*3[DD@6Q3)9: M;+@LV/F/31]:&L;K@GUI;TPO[+33VL9$-ED0Z^3,=%>;5K:F==A(R!T+8GF8 MOO[&],3OAQ([_][)3?^!E^RS:&U$9(X%L3H^*%7]P3LI&F$ MVSR0.A;$[C !67?B=VY!'^G$)];)>;4IU;T0[)VHQ4JV;%ERNQG[2"(^L42V MQ?6QSE4EV-%#2;[8OQE]F*00B\0$OTK5[+)5^3>;"L>W/="JO\?V7>8C2?C$DGALH0/H MKQ[!?D-%UO")K=&W MD.U3K$.=.3;TU]BSJ7PJEHY V?V!L/<>2*_W"9D"5\ M8DN8VT[F0Y&=R;+KTR$3V]@G9;I52Q/Z[$$.9(F V!(7_4$#M^1]U^#*-.*& M#P."=D$&2!4!L2HNN^M&?._,F]CY[5YX"9 @ F)![!(S$_V6)KGM&\1+=GV_ M?7'OU# VU1ZE1I8) MB2V#$SL[5(9(-2&Q:F!FY]R0(1)/2"P>D#SM5SH23T@L'CN!&FLX(9PX(=;- M+I,:!4.""8D%,YY2C6(BP83$@CF46SWU8(@4$TZ9OK C&Q,I)GS&!&:TJI%C MPBDS&2+)1M8,IA.0 M8KA.C-A"&-,)2,A",;6%#B\SZ4EM3&2AF-A"X^.4(YWW&$DHILZ (*4]?)4@ M"27$$H*83@M*D(028@EA3+L%)4A"";&$\.BT@XDDE!!+R!F=?KPE7[%+<^VB ML[N;"9)00BPAB.G>FTA"";&$1C%M.*2>A%@]<+#?B>D)7*0\W4(S=N16-5)/ M,N5B,Q<3N2(N6DQ,H9IWLTN(V)Y),2R^?7A-E8 2+?I,2^ M>21[[/2(?HQPEYW;F'!;#'6J'C/)K&'X (3IZTO/+AKTR,V$08-'%"X?]-[AGTWAT%#!Q1NY/2> M87W;8=#( 87;.3UB'[FKBU"&L?#@WDZ/V$@0=*\QP=V='K&3,*C;F.">3X_8 M2AC4;4QPYZ?WK"O@1E+,A0?W?'J3+H)S:AP_1(#Z*0(8U*GQ_WF, +&0#N\\ M&NK? 85"HGZBP),-2./W)WZJP/:Q O/A[X!1[N',[W]#U!+ P04 " $@B18(EQP M%RD# !80@ &@ 'AL+U]R96QS+W=OM=[6 44^8MMA %,Q#Y*78K8;==P0#.*4>] 3Y'UGE*-=G8'V* M*G6N?HW;]?Q\V$]/S\?IXG6WW4_7JZ=Y/OX8AFGS-.[6T^7A..[/GSP<3KOU M?%Z>'H?C>O.R?AP'[UP>3E]GK&ZNOLZ\N'L[CO\S\?#P\+P9?QXVOW?C?O[' MX.'/X?0R/8WCO+JX6Y\>Q_EZ-;QN/V]/P_O%+L^35Q>W]]>KT^V]K8:E WD) MY)GN WE[U]@"]??=C&Z"W5[T]0&^O>GN WE[U]@"]O>KM 7I[U=L#]/:JMP?H M[55O#] [J-X!H'=0O0- [Z!Z!X#>H=LL >@=5.\ T#NHW@&@=U"] T#OH'H' M@-Y!]0X O8/J'0!Z1]4[ O2.JG<$Z!U5[PC0.ZK>$:!W[#:[ 7I'U3L"](ZJ M=P3H'57O"- [JMX1H'=4O2- [Z1Z)X#>2?5. +V3ZIT >B?5.P'T3JIW NB= MNC\K 7HGU3L!]$ZJ=P+HG53O!- [J=X)H'=6O3- [ZQZ9X#>6?7. +VSZIT! M>F?5.P/TSJIW!NB=N\,F +VSZIT!>F?5.P/TSJIW!NA=5.\"T+NHW@6@=U&] M"T#OHGH7@-Y%]2X O8OJ70!Z%]6[ /0NW6%!@-Y%]2X O8OJ70!Z5]6[ O2N MJG<%Z%U5[PK0NZK>%:!W5;TK0.^J>E> WE7UK@"]J^I= 7K7[K W0.^J>E> MWDWU;@"]F^K= 'HWU;L!]&ZJ=P/HW53O!M"[J=X-H'=3O1M [Z9Z-X#>3?5N M +U;5]8!Z&VNK^L _#;7%78<0'!S767' 0PWUY5V'$!Q7!E&ULS=M/ M;YLP&,?QMQ)QK0*V 1NFII=VUZV'O0$&3H/"/V&W2]_]'-)6VM1%JS)IWTM0 ML/W\'FSI<_/UM^?)NM6A[P:WB7;>3Y^2Q-4[VU5#W_GAV2J MZGWU8!,EA$[JAN:WE/5+0AQ6+G/\F'$?^'/"R[NN3G>>VL:O[ M:O9?JC[,2@Y=XOQS9UU\OL0[/8[;;5O;9JP?^[ D=M-LJ\;MK/5]%Y^*7IU/ M]F&'[>E77IR_E#D7&&;>S^/DPHG-]N-QKT=R7+V>0B$[^_;\)[XEAM(7?Y\] MGG9CF[_,#MO[8YSWRWFX9'E

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end XML 126 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 127 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 128 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.4 html 878 763 1 true 209 0 false 9 false false R1.htm 1001 - Document - Cover Page Sheet http://www.completesolaria.com/role/CoverPage Cover Page Cover 1 false false R2.htm 1002 - Statement - Unaudited Condensed Consolidated Balance Sheets Sheet http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets Unaudited Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 1003 - Statement - Unaudited Condensed Consolidated Balance Sheets (Parentheticals) Sheet http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheetsParentheticals Unaudited Condensed Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 1004 - Statement - Unaudited Condensed Consolidated Statements Of Operations And Comprehensive Income (Loss) Sheet http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss Unaudited Condensed Consolidated Statements Of Operations And Comprehensive Income (Loss) Statements 4 false false R5.htm 1005 - Statement - Unaudited Condensed Consolidated Statements Of Operations And Comprehensive Income (Loss) (Parentheticals) Sheet http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossParentheticals Unaudited Condensed Consolidated Statements Of Operations And Comprehensive Income (Loss) (Parentheticals) Statements 5 false false R6.htm 1006 - Statement - Unaudited Condensed Consolidated Statements of Stockholders' Deficit Sheet http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit Unaudited Condensed Consolidated Statements of Stockholders' Deficit Statements 6 false false R7.htm 1007 - Statement - Unaudited Condensed Consolidated Statements of Stockholders' Deficit (Parentheticals) Sheet http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficitParentheticals Unaudited Condensed Consolidated Statements of Stockholders' Deficit (Parentheticals) Statements 7 false false R8.htm 1008 - Statement - Unaudited Condensed Consolidated Statements of Cash Flows Sheet http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows Unaudited Condensed Consolidated Statements of Cash Flows Statements 8 false false R9.htm 1009 - Statement - Unaudited Condensed Consolidated Statements of Cash Flows (Parentheticals) Sheet http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlowsParentheticals Unaudited Condensed Consolidated Statements of Cash Flows (Parentheticals) Statements 9 false false R10.htm 1010 - Disclosure - Organization Sheet http://www.completesolaria.com/role/Organization Organization Notes 10 false false R11.htm 1011 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.completesolaria.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 11 false false R12.htm 1012 - Disclosure - Fair Value Measurements Sheet http://www.completesolaria.com/role/FairValueMeasurements Fair Value Measurements Notes 12 false false R13.htm 1013 - Disclosure - Reverse Recapitalization Sheet http://www.completesolaria.com/role/ReverseRecapitalization Reverse Recapitalization Notes 13 false false R14.htm 1014 - Disclosure - Forward Purchase Agreements Sheet http://www.completesolaria.com/role/ForwardPurchaseAgreements Forward Purchase Agreements Notes 14 false false R15.htm 1015 - Disclosure - Business Combination Sheet http://www.completesolaria.com/role/BusinessCombination Business Combination Notes 15 false false R16.htm 1016 - Disclosure - Prepaid Expenses and Other Current Assets Sheet http://www.completesolaria.com/role/PrepaidExpensesAndOtherCurrentAssets Prepaid Expenses and Other Current Assets Notes 16 false false R17.htm 1017 - Disclosure - Divestiture Sheet http://www.completesolaria.com/role/Divestiture Divestiture Notes 17 false false R18.htm 1018 - Disclosure - Property and Equipment, Net Sheet http://www.completesolaria.com/role/PropertyAndEquipmentNet Property and Equipment, Net Notes 18 false false R19.htm 1019 - Disclosure - Goodwill and Intangible Assets Sheet http://www.completesolaria.com/role/GoodwillAndIntangibleAssets Goodwill and Intangible Assets Notes 19 false false R20.htm 1020 - Disclosure - Accrued Expenses and Other Current Liabilities Sheet http://www.completesolaria.com/role/AccruedExpensesAndOtherCurrentLiabilities Accrued Expenses and Other Current Liabilities Notes 20 false false R21.htm 1021 - Disclosure - Employee Benefit Plan Sheet http://www.completesolaria.com/role/EmployeeBenefitPlan Employee Benefit Plan Notes 21 false false R22.htm 1022 - Disclosure - Other Income (Expense), Net Sheet http://www.completesolaria.com/role/OtherIncomeExpenseNet Other Income (Expense), Net Notes 22 false false R23.htm 1023 - Disclosure - Common Stock Sheet http://www.completesolaria.com/role/CommonStock Common Stock Notes 23 false false R24.htm 1024 - Disclosure - Warrants Sheet http://www.completesolaria.com/role/Warrants Warrants Notes 24 false false R25.htm 1025 - Disclosure - Borrowing Arrangements Sheet http://www.completesolaria.com/role/BorrowingArrangements Borrowing Arrangements Notes 25 false false R26.htm 1026 - Disclosure - Stock-Based Compensation Sheet http://www.completesolaria.com/role/StockBasedCompensation Stock-Based Compensation Notes 26 false false R27.htm 1027 - Disclosure - Employee Stock Purchase Plan Sheet http://www.completesolaria.com/role/EmployeeStockPurchasePlan Employee Stock Purchase Plan Notes 27 false false R28.htm 1028 - Disclosure - Commitments and Contingencies Sheet http://www.completesolaria.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 28 false false R29.htm 1029 - Disclosure - Income Taxes Sheet http://www.completesolaria.com/role/IncomeTaxes Income Taxes Notes 29 false false R30.htm 1030 - Disclosure - Basic and Diluted Net Loss Per Share Sheet http://www.completesolaria.com/role/BasicAndDilutedNetLossPerShare Basic and Diluted Net Loss Per Share Notes 30 false false R31.htm 1031 - Disclosure - Related Party Transactions Sheet http://www.completesolaria.com/role/RelatedPartyTransactions Related Party Transactions Notes 31 false false R32.htm 1032 - Disclosure - Subsequent Events Sheet http://www.completesolaria.com/role/SubsequentEvents Subsequent Events Notes 32 false false R33.htm 1033 - Disclosure - Accounting Policies, by Policy (Policies) Sheet http://www.completesolaria.com/role/AccountingPoliciesByPolicyPolicies Accounting Policies, by Policy (Policies) Policies http://www.completesolaria.com/role/SummaryOfSignificantAccountingPolicies 33 false false R34.htm 1034 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.completesolaria.com/role/SummaryOfSignificantAccountingPolicies 34 false false R35.htm 1035 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.completesolaria.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.completesolaria.com/role/FairValueMeasurements 35 false false R36.htm 1036 - Disclosure - Reverse Recapitalization (Tables) Sheet http://www.completesolaria.com/role/ReverseRecapitalizationTables Reverse Recapitalization (Tables) Tables http://www.completesolaria.com/role/ReverseRecapitalization 36 false false R37.htm 1037 - Disclosure - Business Combination (Tables) Sheet http://www.completesolaria.com/role/BusinessCombinationTables Business Combination (Tables) Tables http://www.completesolaria.com/role/BusinessCombination 37 false false R38.htm 1038 - Disclosure - Prepaid Expenses and Other Current Assets (Tables) Sheet http://www.completesolaria.com/role/PrepaidExpensesAndOtherCurrentAssetsTables Prepaid Expenses and Other Current Assets (Tables) Tables http://www.completesolaria.com/role/PrepaidExpensesAndOtherCurrentAssets 38 false false R39.htm 1039 - Disclosure - Divestiture (Tables) Sheet http://www.completesolaria.com/role/DivestitureTables Divestiture (Tables) Tables http://www.completesolaria.com/role/Divestiture 39 false false R40.htm 1040 - Disclosure - Property and Equipment, Net (Tables) Sheet http://www.completesolaria.com/role/PropertyAndEquipmentNetTables Property and Equipment, Net (Tables) Tables http://www.completesolaria.com/role/PropertyAndEquipmentNet 40 false false R41.htm 1041 - Disclosure - Goodwill and Intangible Assets (Tables) Sheet http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsTables Goodwill and Intangible Assets (Tables) Tables http://www.completesolaria.com/role/GoodwillAndIntangibleAssets 41 false false R42.htm 1042 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables) Sheet http://www.completesolaria.com/role/AccruedExpensesAndOtherCurrentLiabilitiesTables Accrued Expenses and Other Current Liabilities (Tables) Tables http://www.completesolaria.com/role/AccruedExpensesAndOtherCurrentLiabilities 42 false false R43.htm 1043 - Disclosure - Other Income (Expense), Net (Tables) Sheet http://www.completesolaria.com/role/OtherIncomeExpenseNetTables Other Income (Expense), Net (Tables) Tables http://www.completesolaria.com/role/OtherIncomeExpenseNet 43 false false R44.htm 1044 - Disclosure - Common Stock (Tables) Sheet http://www.completesolaria.com/role/CommonStockTables Common Stock (Tables) Tables http://www.completesolaria.com/role/CommonStock 44 false false R45.htm 1045 - Disclosure - Warrants (Tables) Sheet http://www.completesolaria.com/role/WarrantsTables Warrants (Tables) Tables http://www.completesolaria.com/role/Warrants 45 false false R46.htm 1046 - Disclosure - Borrowing Arrangements (Tables) Sheet http://www.completesolaria.com/role/BorrowingArrangementsTables Borrowing Arrangements (Tables) Tables http://www.completesolaria.com/role/BorrowingArrangements 46 false false R47.htm 1047 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.completesolaria.com/role/StockBasedCompensationTables Stock-Based Compensation (Tables) Tables http://www.completesolaria.com/role/StockBasedCompensation 47 false false R48.htm 1048 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.completesolaria.com/role/CommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://www.completesolaria.com/role/CommitmentsAndContingencies 48 false false R49.htm 1049 - Disclosure - Income Taxes (Tables) Sheet http://www.completesolaria.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://www.completesolaria.com/role/IncomeTaxes 49 false false R50.htm 1050 - Disclosure - Basic and Diluted Net Loss Per Share (Tables) Sheet http://www.completesolaria.com/role/BasicAndDilutedNetLossPerShareTables Basic and Diluted Net Loss Per Share (Tables) Tables http://www.completesolaria.com/role/BasicAndDilutedNetLossPerShare 50 false false R51.htm 1051 - Disclosure - Organization (Details) Sheet http://www.completesolaria.com/role/OrganizationDetails Organization (Details) Details http://www.completesolaria.com/role/Organization 51 false false R52.htm 1052 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesTables 52 false false R53.htm 1053 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of Consolidated Statements of Cash Flows Sheet http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetailsScheduleOfConsolidatedStatementsOfCashFlows Summary of Significant Accounting Policies (Details) - Schedule of Consolidated Statements of Cash Flows Details http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesTables 53 false false R54.htm 1054 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of Allowance for Doubtful Accounts Sheet http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetailsScheduleOfAllowanceForDoubtfulAccounts Summary of Significant Accounting Policies (Details) - Schedule of Allowance for Doubtful Accounts Details http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesTables 54 false false R55.htm 1055 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of Revenue Recognized By Product and Services Sheet http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetailsScheduleOfRevenueRecognizedByProductAndServices Summary of Significant Accounting Policies (Details) - Schedule of Revenue Recognized By Product and Services Details http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesTables 55 false false R56.htm 1056 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule Of Property, Plant and Equipment Useful Lives Sheet http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetailsScheduleOfPropertyPlantAndEquipmentUsefulLives Summary of Significant Accounting Policies (Details) - Schedule Of Property, Plant and Equipment Useful Lives Details http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesTables 56 false false R57.htm 1057 - Disclosure - Summary of Significant Accounting Policies (Details) -Schedule of Finite-Lived Intangible Assets Sheet http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetailsScheduleOfFiniteLivedIntangibleAssets Summary of Significant Accounting Policies (Details) -Schedule of Finite-Lived Intangible Assets Details http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesTables 57 false false R58.htm 1058 - Disclosure - Fair Value Measurements (Details) Sheet http://www.completesolaria.com/role/FairValueMeasurementsDetails Fair Value Measurements (Details) Details http://www.completesolaria.com/role/FairValueMeasurementsTables 58 false false R59.htm 1059 - Disclosure - Fair Value Measurements (Details) - Schedule of Financial Assets and Liabilities Sheet http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfFinancialAssetsAndLiabilities Fair Value Measurements (Details) - Schedule of Financial Assets and Liabilities Details http://www.completesolaria.com/role/FairValueMeasurementsTables 59 false false R60.htm 1060 - Disclosure - Fair Value Measurements (Details) - Schedule of Warrants Based on a Black Scholes Option Pricing Method. Sheet http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfWarrantsBasedOnABlackScholesOptionPricingMethod Fair Value Measurements (Details) - Schedule of Warrants Based on a Black Scholes Option Pricing Method. Details http://www.completesolaria.com/role/FairValueMeasurementsTables 60 false false R61.htm 1061 - Disclosure - Fair Value Measurements (Details) - Schedule of Significant Unobservable Inputs (Level 3), and the Change in Fair Value Recorded in Other Income (Expense),net Sheet http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfSignificantUnobservableInputsLevel3AndTheChangeInFairValueRecordedInOtherIncomeExpenseNet Fair Value Measurements (Details) - Schedule of Significant Unobservable Inputs (Level 3), and the Change in Fair Value Recorded in Other Income (Expense),net Details http://www.completesolaria.com/role/FairValueMeasurementsTables 61 false false R62.htm 1062 - Disclosure - Fair Value Measurements (Details) - Schedule of Reconciles the Change in Value of the Redeemable Convertible Preferred Stock Warrant Liability Sheet http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfReconcilesTheChangeInValueOfTheRedeemableConvertiblePreferredStockWarrantLiability Fair Value Measurements (Details) - Schedule of Reconciles the Change in Value of the Redeemable Convertible Preferred Stock Warrant Liability Details http://www.completesolaria.com/role/FairValueMeasurementsTables 62 false false R63.htm 1063 - Disclosure - Fair Value Measurements (Details) - Schedule of Reconciliation of Embedded Derivative Liability Sheet http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfReconciliationOfEmbeddedDerivativeLiability Fair Value Measurements (Details) - Schedule of Reconciliation of Embedded Derivative Liability Details http://www.completesolaria.com/role/FairValueMeasurementsTables 63 false false R64.htm 1064 - Disclosure - Fair Value Measurements (Details) - Schedule of Next Equity Financing Based on Inputs Included in a Black-Scholes Model Sheet http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfNextEquityFinancingBasedOnInputsIncludedInABlackScholesModel Fair Value Measurements (Details) - Schedule of Next Equity Financing Based on Inputs Included in a Black-Scholes Model Details http://www.completesolaria.com/role/FairValueMeasurementsTables 64 false false R65.htm 1065 - Disclosure - Reverse Recapitalization (Details) Sheet http://www.completesolaria.com/role/ReverseRecapitalizationDetails Reverse Recapitalization (Details) Details http://www.completesolaria.com/role/ReverseRecapitalizationTables 65 false false R66.htm 1066 - Disclosure - Reverse Recapitalization (Details) - Schedule of Reconciles Elements of the Merger Sheet http://www.completesolaria.com/role/ReverseRecapitalizationDetailsScheduleOfReconcilesElementsOfTheMerger Reverse Recapitalization (Details) - Schedule of Reconciles Elements of the Merger Details http://www.completesolaria.com/role/ReverseRecapitalizationTables 66 false false R67.htm 1067 - Disclosure - Reverse Recapitalization (Details) - Schedule of Common Stock Outstanding Sheet http://www.completesolaria.com/role/ReverseRecapitalizationDetailsScheduleOfCommonStockOutstanding Reverse Recapitalization (Details) - Schedule of Common Stock Outstanding Details http://www.completesolaria.com/role/ReverseRecapitalizationTables 67 false false R68.htm 1068 - Disclosure - Forward Purchase Agreements (Details) Sheet http://www.completesolaria.com/role/ForwardPurchaseAgreementsDetails Forward Purchase Agreements (Details) Details http://www.completesolaria.com/role/ForwardPurchaseAgreements 68 false false R69.htm 1069 - Disclosure - Business Combination (Details) Sheet http://www.completesolaria.com/role/BusinessCombinationDetails Business Combination (Details) Details http://www.completesolaria.com/role/BusinessCombinationTables 69 false false R70.htm 1070 - Disclosure - Business Combination (Details) - Schedule of Assets Acquired and Liabilities Assumed Sheet http://www.completesolaria.com/role/BusinessCombinationDetailsScheduleOfAssetsAcquiredAndLiabilitiesAssumed Business Combination (Details) - Schedule of Assets Acquired and Liabilities Assumed Details http://www.completesolaria.com/role/BusinessCombinationTables 70 false false R71.htm 1071 - Disclosure - Business Combination (Details) - Schedule of Intangible Assets Acquired Sheet http://www.completesolaria.com/role/BusinessCombinationDetailsScheduleOfIntangibleAssetsAcquired Business Combination (Details) - Schedule of Intangible Assets Acquired Details http://www.completesolaria.com/role/BusinessCombinationTables 71 false false R72.htm 1072 - Disclosure - Business Combination (Details) - Schedule of Unaudited Combined Pro Forma Information Sheet http://www.completesolaria.com/role/BusinessCombinationDetailsScheduleOfUnauditedCombinedProFormaInformation Business Combination (Details) - Schedule of Unaudited Combined Pro Forma Information Details http://www.completesolaria.com/role/BusinessCombinationTables 72 false false R73.htm 1073 - Disclosure - Prepaid Expenses and Other Current Assets (Details) - Schedule of Prepaid Expenses and Other Current Assets Sheet http://www.completesolaria.com/role/PrepaidExpensesAndOtherCurrentAssetsDetailsScheduleOfPrepaidExpensesAndOtherCurrentAssets Prepaid Expenses and Other Current Assets (Details) - Schedule of Prepaid Expenses and Other Current Assets Details http://www.completesolaria.com/role/PrepaidExpensesAndOtherCurrentAssetsTables 73 false false R74.htm 1074 - Disclosure - Divestiture (Details) - Schedule of Operations and Comprehensive Income (Loss) Related to Discontinued Operations Sheet http://www.completesolaria.com/role/DivestitureDetailsScheduleOfOperationsAndComprehensiveIncomeLossRelatedToDiscontinuedOperations Divestiture (Details) - Schedule of Operations and Comprehensive Income (Loss) Related to Discontinued Operations Details http://www.completesolaria.com/role/DivestitureTables 74 false false R75.htm 1075 - Disclosure - Divestiture (Details) - Schedule of Major Categories of Assets and Liabilities Held for Sale Sheet http://www.completesolaria.com/role/DivestitureDetailsScheduleOfMajorCategoriesOfAssetsAndLiabilitiesHeldForSale Divestiture (Details) - Schedule of Major Categories of Assets and Liabilities Held for Sale Details http://www.completesolaria.com/role/DivestitureTables 75 false false R76.htm 1076 - Disclosure - Divestiture (Details) Sheet http://www.completesolaria.com/role/DivestitureDetails Divestiture (Details) Details http://www.completesolaria.com/role/DivestitureTables 76 false false R77.htm 1077 - Disclosure - Property and Equipment, Net (Details) - Schedule of Property and Equipment, Net Sheet http://www.completesolaria.com/role/PropertyAndEquipmentNetDetailsScheduleOfPropertyAndEquipmentNet Property and Equipment, Net (Details) - Schedule of Property and Equipment, Net Details http://www.completesolaria.com/role/PropertyAndEquipmentNetTables 77 false false R78.htm 1078 - Disclosure - Property and Equipment, Net (Details) Sheet http://www.completesolaria.com/role/PropertyAndEquipmentNetDetails Property and Equipment, Net (Details) Details http://www.completesolaria.com/role/PropertyAndEquipmentNetTables 78 false false R79.htm 1079 - Disclosure - Goodwill and Intangible Assets (Details) Sheet http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetails Goodwill and Intangible Assets (Details) Details http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsTables 79 false false R80.htm 1080 - Disclosure - Goodwill and Intangible Assets (Details) - Schedule of Intangible Assets Sheet http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetailsScheduleOfIntangibleAssets Goodwill and Intangible Assets (Details) - Schedule of Intangible Assets Details http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsTables 80 false false R81.htm 1081 - Disclosure - Goodwill and Intangible Assets (Details) - Schedule of Amortization Expense Related to Intangible Assets Sheet http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetailsScheduleOfAmortizationExpenseRelatedToIntangibleAssets Goodwill and Intangible Assets (Details) - Schedule of Amortization Expense Related to Intangible Assets Details http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsTables 81 false false R82.htm 1082 - Disclosure - Accrued Expenses and Other Current Liabilities (Details) - Schedule of Accrued Expenses and Other Current Liabilities Sheet http://www.completesolaria.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetailsScheduleOfAccruedExpensesAndOtherCurrentLiabilities Accrued Expenses and Other Current Liabilities (Details) - Schedule of Accrued Expenses and Other Current Liabilities Details http://www.completesolaria.com/role/AccruedExpensesAndOtherCurrentLiabilitiesTables 82 false false R83.htm 1083 - Disclosure - Other Income (Expense), Net (Details) Sheet http://www.completesolaria.com/role/OtherIncomeExpenseNetDetails Other Income (Expense), Net (Details) Details http://www.completesolaria.com/role/OtherIncomeExpenseNetTables 83 false false R84.htm 1084 - Disclosure - Other Income (Expense), Net (Details) - Schedule of Other Income (Expense), Net Sheet http://www.completesolaria.com/role/OtherIncomeExpenseNetDetailsScheduleOfOtherIncomeExpenseNet Other Income (Expense), Net (Details) - Schedule of Other Income (Expense), Net Details http://www.completesolaria.com/role/OtherIncomeExpenseNetTables 84 false false R85.htm 1085 - Disclosure - Common Stock (Details) Sheet http://www.completesolaria.com/role/CommonStockDetails Common Stock (Details) Details http://www.completesolaria.com/role/CommonStockTables 85 false false R86.htm 1086 - Disclosure - Common Stock (Details) - Schedule of Reserved Shares of Common Stock Sheet http://www.completesolaria.com/role/CommonStockDetailsScheduleOfReservedSharesOfCommonStock Common Stock (Details) - Schedule of Reserved Shares of Common Stock Details http://www.completesolaria.com/role/CommonStockTables 86 false false R87.htm 1087 - Disclosure - Warrants (Details) Sheet http://www.completesolaria.com/role/WarrantsDetails Warrants (Details) Details http://www.completesolaria.com/role/WarrantsTables 87 false false R88.htm 1088 - Disclosure - Warrants - Schedule of Fair Value of The Common Stock Warrants (Details) Sheet http://www.completesolaria.com/role/WarrantsScheduleOfFairValueOfTheCommonStockWarrantsDetails Warrants - Schedule of Fair Value of The Common Stock Warrants (Details) Details 88 false false R89.htm 1089 - Disclosure - Borrowing Arrangements (Details) Sheet http://www.completesolaria.com/role/BorrowingArrangementsDetails Borrowing Arrangements (Details) Details http://www.completesolaria.com/role/BorrowingArrangementsTables 89 false false R90.htm 1090 - Disclosure - Borrowing Arrangements (Details) - Schedule of Convertible Notes Notes http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfConvertibleNotes Borrowing Arrangements (Details) - Schedule of Convertible Notes Details http://www.completesolaria.com/role/BorrowingArrangementsTables 90 false false R91.htm 1091 - Disclosure - Borrowing Arrangements (Details) - Schedule of Net Carrying Amount of the Convertible Notes Notes http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfNetCarryingAmountOfTheConvertibleNotes Borrowing Arrangements (Details) - Schedule of Net Carrying Amount of the Convertible Notes Details http://www.completesolaria.com/role/BorrowingArrangementsTables 91 false false R92.htm 1092 - Disclosure - Borrowing Arrangements (Details) - Schedule Of Interest Expense On Convertible Debt Sheet http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfInterestExpenseOnConvertibleDebt Borrowing Arrangements (Details) - Schedule Of Interest Expense On Convertible Debt Details http://www.completesolaria.com/role/BorrowingArrangementsTables 92 false false R93.htm 1093 - Disclosure - Borrowing Arrangements (Details) - Schedule of Company's outstanding notes payable Notes http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfCompanySOutstandingNotesPayable Borrowing Arrangements (Details) - Schedule of Company's outstanding notes payable Details http://www.completesolaria.com/role/BorrowingArrangementsTables 93 false false R94.htm 1094 - Disclosure - Stock-Based Compensation (Details) Sheet http://www.completesolaria.com/role/StockBasedCompensationDetails Stock-Based Compensation (Details) Details http://www.completesolaria.com/role/StockBasedCompensationTables 94 false false R95.htm 1095 - Disclosure - Stock-Based Compensation (Details) - Summary of summary of stock option activity Sheet http://www.completesolaria.com/role/StockBasedCompensationDetailsSummaryOfSummaryOfStockOptionActivity Stock-Based Compensation (Details) - Summary of summary of stock option activity Details http://www.completesolaria.com/role/StockBasedCompensationTables 95 false false R96.htm 1096 - Disclosure - Stock-Based Compensation (Details) - Summary of summary of stock option activity (Parentheticals) Sheet http://www.completesolaria.com/role/StockBasedCompensationDetailsSummaryOfSummaryOfStockOptionActivityParentheticals Stock-Based Compensation (Details) - Summary of summary of stock option activity (Parentheticals) Details http://www.completesolaria.com/role/StockBasedCompensationTables 96 false false R97.htm 1097 - Disclosure - Stock-Based Compensation (Details) - Schedule of summary of RSU activity Sheet http://www.completesolaria.com/role/StockBasedCompensationDetailsScheduleOfSummaryOfRsuActivity Stock-Based Compensation (Details) - Schedule of summary of RSU activity Details http://www.completesolaria.com/role/StockBasedCompensationTables 97 false false R98.htm 1098 - Disclosure - Stock-Based Compensation (Details) - Schedule Of Calculate The Fair Value Of Stock-based Compensation Sheet http://www.completesolaria.com/role/StockBasedCompensationDetailsScheduleOfCalculateTheFairValueOfStockBasedCompensation Stock-Based Compensation (Details) - Schedule Of Calculate The Fair Value Of Stock-based Compensation Details http://www.completesolaria.com/role/StockBasedCompensationTables 98 false false R99.htm 1099 - Disclosure - Stock-Based Compensation (Details) - Schedule of stock-based compensation expense and its allocation within the accompanying unaudited condensed consolidated statements of operations and comprehensive loss Sheet http://www.completesolaria.com/role/StockBasedCompensationDetailsScheduleOfStockBasedCompensationExpenseAndItsAllocationWithinTheAccompanyingUnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss Stock-Based Compensation (Details) - Schedule of stock-based compensation expense and its allocation within the accompanying unaudited condensed consolidated statements of operations and comprehensive loss Details http://www.completesolaria.com/role/StockBasedCompensationTables 99 false false R100.htm 1100 - Disclosure - Employee Stock Purchase Plan (Details) Sheet http://www.completesolaria.com/role/EmployeeStockPurchasePlanDetails Employee Stock Purchase Plan (Details) Details http://www.completesolaria.com/role/EmployeeStockPurchasePlan 100 false false R101.htm 1101 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.completesolaria.com/role/CommitmentsAndContingenciesDetails Commitments and Contingencies (Details) Details http://www.completesolaria.com/role/CommitmentsAndContingenciesTables 101 false false R102.htm 1102 - Disclosure - Commitments and Contingencies (Details) - Schedule of Weighted Average Remaining Lease Term and the Discount Rate Sheet http://www.completesolaria.com/role/CommitmentsAndContingenciesDetailsScheduleOfWeightedAverageRemainingLeaseTermAndTheDiscountRate Commitments and Contingencies (Details) - Schedule of Weighted Average Remaining Lease Term and the Discount Rate Details http://www.completesolaria.com/role/CommitmentsAndContingenciesTables 102 false false R103.htm 1103 - Disclosure - Commitments and Contingencies (Details) - Schedule of Future Minimum Lease Payments under Non-Cancelable Sheet http://www.completesolaria.com/role/CommitmentsAndContingenciesDetailsScheduleOfFutureMinimumLeasePaymentsUnderNonCancelable Commitments and Contingencies (Details) - Schedule of Future Minimum Lease Payments under Non-Cancelable Details http://www.completesolaria.com/role/CommitmentsAndContingenciesTables 103 false false R104.htm 1104 - Disclosure - Commitments and Contingencies (Details) - Schedule of Activity Period Relating to the Company's Warranty Provision Sheet http://www.completesolaria.com/role/CommitmentsAndContingenciesDetailsScheduleOfActivityPeriodRelatingToTheCompanysWarrantyProvision Commitments and Contingencies (Details) - Schedule of Activity Period Relating to the Company's Warranty Provision Details http://www.completesolaria.com/role/CommitmentsAndContingenciesTables 104 false false R105.htm 1105 - Disclosure - Income Taxes (Details) - Schedule of Provision For Income Taxes Sheet http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfProvisionForIncomeTaxes Income Taxes (Details) - Schedule of Provision For Income Taxes Details http://www.completesolaria.com/role/IncomeTaxesTables 105 false false R106.htm 1106 - Disclosure - Income Taxes (Details) - Schedule of Reconciliation of Effective Income Tax Rate Sheet http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfReconciliationOfEffectiveIncomeTaxRate Income Taxes (Details) - Schedule of Reconciliation of Effective Income Tax Rate Details http://www.completesolaria.com/role/IncomeTaxesTables 106 false false R107.htm 1107 - Disclosure - Income Taxes (Details) - Schedule of Components of Deferred Tax Assets And Liabilities Sheet http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfComponentsOfDeferredTaxAssetsAndLiabilities Income Taxes (Details) - Schedule of Components of Deferred Tax Assets And Liabilities Details http://www.completesolaria.com/role/IncomeTaxesTables 107 false false R108.htm 1108 - Disclosure - Income Taxes (Details) - Schedule of Unrecognized Tax Benefits Sheet http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfUnrecognizedTaxBenefits Income Taxes (Details) - Schedule of Unrecognized Tax Benefits Details http://www.completesolaria.com/role/IncomeTaxesTables 108 false false R109.htm 1109 - Disclosure - Income Taxes (Details) Sheet http://www.completesolaria.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://www.completesolaria.com/role/IncomeTaxesTables 109 false false R110.htm 1110 - Disclosure - Basic and Diluted Net Loss Per Share (Details) - Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders Sheet http://www.completesolaria.com/role/BasicAndDilutedNetLossPerShareDetailsScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholders Basic and Diluted Net Loss Per Share (Details) - Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders Details http://www.completesolaria.com/role/BasicAndDilutedNetLossPerShareTables 110 false false R111.htm 1111 - Disclosure - Basic and Diluted Net Loss Per Share (Details) - Schedule of Potential Common Shares Excluded from Diluted Net Loss Per Share Sheet http://www.completesolaria.com/role/BasicAndDilutedNetLossPerShareDetailsScheduleOfPotentialCommonSharesExcludedFromDilutedNetLossPerShare Basic and Diluted Net Loss Per Share (Details) - Schedule of Potential Common Shares Excluded from Diluted Net Loss Per Share Details http://www.completesolaria.com/role/BasicAndDilutedNetLossPerShareTables 111 false false R112.htm 1112 - Disclosure - Related Party Transactions (Details) Sheet http://www.completesolaria.com/role/RelatedPartyTransactionsDetails Related Party Transactions (Details) Details http://www.completesolaria.com/role/RelatedPartyTransactions 112 false false R113.htm 1113 - Disclosure - Subsequent Events (Details) Sheet http://www.completesolaria.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://www.completesolaria.com/role/SubsequentEvents 113 false false All Reports Book All Reports cslr-20240104.xsd cslr-20240104_cal.xml cslr-20240104_def.xml cslr-20240104_lab.xml cslr-20240104_pre.xml d474289d8k.htm d474289dex991.htm http://fasb.org/srt/2023 http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true JSON 131 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "d474289d8k.htm d474289dex991.htm": { "nsprefix": "cslr", "nsuri": "http://www.completesolaria.com/20240104", "dts": { "schema": { "local": [ "cslr-20240104.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd", "https://xbrl.sec.gov/naics/2023/naics-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] }, "calculationLink": { "local": [ "cslr-20240104_cal.xml" ] }, "definitionLink": { "local": [ "cslr-20240104_def.xml" ] }, "labelLink": { "local": [ "cslr-20240104_lab.xml" ] }, "presentationLink": { "local": [ "cslr-20240104_pre.xml" ] }, "inline": { "local": [ "d474289d8k.htm", "d474289dex991.htm" ] } }, "keyStandard": 592, "keyCustom": 171, "axisStandard": 39, "axisCustom": 4, "memberStandard": 59, "memberCustom": 137, "hidden": { "total": 17, "http://fasb.org/us-gaap/2023": 13, "http://xbrl.sec.gov/dei/2023": 3, "http://www.completesolaria.com/20240104": 1 }, "contextCount": 878, "entityCount": 1, "segmentCount": 209, "elementCount": 1222, "unitCount": 9, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 2733, "http://fasb.org/srt/2023": 15, "http://xbrl.sec.gov/dei/2023": 26 }, "report": { "R1": { "role": "http://www.completesolaria.com/role/CoverPage", "longName": "1001 - Document - Cover Page", "shortName": "Cover Page", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "P01_04_2024To01_04_2024", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289d8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_04_2024To01_04_2024", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289d8k.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets", "longName": "1002 - Statement - Unaudited Condensed Consolidated Balance Sheets", "shortName": "Unaudited Condensed Consolidated Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "PAsOn10_01_2023", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true }, "uniqueAnchor": { "contextRef": "PAsOn10_01_2023", "name": "us-gaap:AccountsReceivableNetCurrent", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "unique": true } }, "R3": { "role": "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheetsParentheticals", "longName": "1003 - Statement - Unaudited Condensed Consolidated Balance Sheets (Parentheticals)", "shortName": "Unaudited Condensed Consolidated Balance Sheets (Parentheticals)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "PAsOn10_01_2023", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "PAsOn10_01_2023", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R4": { "role": "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss", "longName": "1004 - Statement - Unaudited Condensed Consolidated Statements Of Operations And Comprehensive Income (Loss)", "shortName": "Unaudited Condensed Consolidated Statements Of Operations And Comprehensive Income (Loss)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "P07_01_2023To10_01_2023", "name": "us-gaap:Revenues", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true }, "uniqueAnchor": { "contextRef": "P07_01_2023To10_01_2023", "name": "us-gaap:CostOfRevenue", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "unique": true } }, "R5": { "role": "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossParentheticals", "longName": "1005 - Statement - Unaudited Condensed Consolidated Statements Of Operations And Comprehensive Income (Loss) (Parentheticals)", "shortName": "Unaudited Condensed Consolidated Statements Of Operations And Comprehensive Income (Loss) (Parentheticals)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "P07_01_2023To10_01_2023", "name": "us-gaap:InterestExpense", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true }, "uniqueAnchor": { "contextRef": "P07_01_2023To10_01_2023_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis", "name": "us-gaap:InterestExpense", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "unique": true } }, "R6": { "role": "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit", "longName": "1006 - Statement - Unaudited Condensed Consolidated Statements of Stockholders' Deficit", "shortName": "Unaudited Condensed Consolidated Statements of Stockholders' Deficit", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "PAsOn12_31_2019_AdjustedMembersrtRestatementAxis", "name": "us-gaap:StockholdersEquity", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "PAsOn12_31_2019_AdjustedMembersrtRestatementAxis", "name": "us-gaap:StockholdersEquity", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R7": { "role": "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficitParentheticals", "longName": "1007 - Statement - Unaudited Condensed Consolidated Statements of Stockholders' Deficit (Parentheticals)", "shortName": "Unaudited Condensed Consolidated Statements of Stockholders' Deficit (Parentheticals)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "P01_01_2023To10_01_2023_InConnectionWithForwardPurchaseAgreementsMemberCSLREventAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis", "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues", "unitRef": "Unit_shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To10_01_2023_InConnectionWithForwardPurchaseAgreementsMemberCSLREventAxis_RelatedPartyMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis", "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues", "unitRef": "Unit_shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R8": { "role": "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows", "longName": "1008 - Statement - Unaudited Condensed Consolidated Statements of Cash Flows", "shortName": "Unaudited Condensed Consolidated Statements of Cash Flows", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "8", "firstAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:NetIncomeLoss", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true }, "uniqueAnchor": { "contextRef": "P01_01_2022To12_31_2022", "name": "us-gaap:OperatingLeaseExpense", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "unique": true } }, "R9": { "role": "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlowsParentheticals", "longName": "1009 - Statement - Unaudited Condensed Consolidated Statements of Cash Flows (Parentheticals)", "shortName": "Unaudited Condensed Consolidated Statements of Cash Flows (Parentheticals)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "9", "firstAnchor": { "contextRef": "P07_03_2023To10_01_2023_SeriesDFourRedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis", "name": "cslr:ForwardPurchaseAgreementOtherIncome", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P07_03_2023To10_01_2023_SeriesDFourRedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis", "name": "cslr:ForwardPurchaseAgreementOtherIncome", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R10": { "role": "http://www.completesolaria.com/role/Organization", "longName": "1010 - Disclosure - Organization", "shortName": "Organization", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPolicies", "longName": "1011 - Disclosure - Summary of Significant Accounting Policies", "shortName": "Summary of Significant Accounting Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R12": { "role": "http://www.completesolaria.com/role/FairValueMeasurements", "longName": "1012 - Disclosure - Fair Value Measurements", "shortName": "Fair Value Measurements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.completesolaria.com/role/ReverseRecapitalization", "longName": "1013 - Disclosure - Reverse Recapitalization", "shortName": "Reverse Recapitalization", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "cslr:ReverseRecapitalizationTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "cslr:ReverseRecapitalizationTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.completesolaria.com/role/ForwardPurchaseAgreements", "longName": "1014 - Disclosure - Forward Purchase Agreements", "shortName": "Forward Purchase Agreements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "cslr:ForwardPurchaseAgreementsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "cslr:ForwardPurchaseAgreementsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.completesolaria.com/role/BusinessCombination", "longName": "1015 - Disclosure - Business Combination", "shortName": "Business Combination", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.completesolaria.com/role/PrepaidExpensesAndOtherCurrentAssets", "longName": "1016 - Disclosure - Prepaid Expenses and Other Current Assets", "shortName": "Prepaid Expenses and Other Current Assets", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:OtherCurrentAssetsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:OtherCurrentAssetsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.completesolaria.com/role/Divestiture", "longName": "1017 - Disclosure - Divestiture", "shortName": "Divestiture", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.completesolaria.com/role/PropertyAndEquipmentNet", "longName": "1018 - Disclosure - Property and Equipment, Net", "shortName": "Property and Equipment, Net", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.completesolaria.com/role/GoodwillAndIntangibleAssets", "longName": "1019 - Disclosure - Goodwill and Intangible Assets", "shortName": "Goodwill and Intangible Assets", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R20": { "role": "http://www.completesolaria.com/role/AccruedExpensesAndOtherCurrentLiabilities", "longName": "1020 - Disclosure - Accrued Expenses and Other Current Liabilities", "shortName": "Accrued Expenses and Other Current Liabilities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R21": { "role": "http://www.completesolaria.com/role/EmployeeBenefitPlan", "longName": "1021 - Disclosure - Employee Benefit Plan", "shortName": "Employee Benefit Plan", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R22": { "role": "http://www.completesolaria.com/role/OtherIncomeExpenseNet", "longName": "1022 - Disclosure - Other Income (Expense), Net", "shortName": "Other Income (Expense), Net", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R23": { "role": "http://www.completesolaria.com/role/CommonStock", "longName": "1023 - Disclosure - Common Stock", "shortName": "Common Stock", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "cslr:CommonStockTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "cslr:CommonStockTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R24": { "role": "http://www.completesolaria.com/role/Warrants", "longName": "1024 - Disclosure - Warrants", "shortName": "Warrants", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "24", "firstAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "cslr:WarrantsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "cslr:WarrantsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R25": { "role": "http://www.completesolaria.com/role/BorrowingArrangements", "longName": "1025 - Disclosure - Borrowing Arrangements", "shortName": "Borrowing Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "25", "firstAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:SubordinatedBorrowingsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:SubordinatedBorrowingsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R26": { "role": "http://www.completesolaria.com/role/StockBasedCompensation", "longName": "1026 - Disclosure - Stock-Based Compensation", "shortName": "Stock-Based Compensation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "26", "firstAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R27": { "role": "http://www.completesolaria.com/role/EmployeeStockPurchasePlan", "longName": "1027 - Disclosure - Employee Stock Purchase Plan", "shortName": "Employee Stock Purchase Plan", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "27", "firstAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R28": { "role": "http://www.completesolaria.com/role/CommitmentsAndContingencies", "longName": "1028 - Disclosure - Commitments and Contingencies", "shortName": "Commitments and Contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "28", "firstAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R29": { "role": "http://www.completesolaria.com/role/IncomeTaxes", "longName": "1029 - Disclosure - Income Taxes", "shortName": "Income Taxes", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "29", "firstAnchor": { "contextRef": "P01_01_2022To12_31_2022", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2022To12_31_2022", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R30": { "role": "http://www.completesolaria.com/role/BasicAndDilutedNetLossPerShare", "longName": "1030 - Disclosure - Basic and Diluted Net Loss Per Share", "shortName": "Basic and Diluted Net Loss Per Share", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "30", "firstAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R31": { "role": "http://www.completesolaria.com/role/RelatedPartyTransactions", "longName": "1031 - Disclosure - Related Party Transactions", "shortName": "Related Party Transactions", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "31", "firstAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R32": { "role": "http://www.completesolaria.com/role/SubsequentEvents", "longName": "1032 - Disclosure - Subsequent Events", "shortName": "Subsequent Events", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "32", "firstAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R33": { "role": "http://www.completesolaria.com/role/AccountingPoliciesByPolicyPolicies", "longName": "1033 - Disclosure - Accounting Policies, by Policy (Policies)", "shortName": "Accounting Policies, by Policy (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "33", "firstAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:UseOfEstimates", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:UseOfEstimates", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R34": { "role": "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesTables", "longName": "1034 - Disclosure - Summary of Significant Accounting Policies (Tables)", "shortName": "Summary of Significant Accounting Policies (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "34", "firstAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R35": { "role": "http://www.completesolaria.com/role/FairValueMeasurementsTables", "longName": "1035 - Disclosure - Fair Value Measurements (Tables)", "shortName": "Fair Value Measurements (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "35", "firstAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R36": { "role": "http://www.completesolaria.com/role/ReverseRecapitalizationTables", "longName": "1036 - Disclosure - Reverse Recapitalization (Tables)", "shortName": "Reverse Recapitalization (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "36", "firstAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "cslr:ScheduleOfReconcilesElementsOfTheMergerTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "cslr:ReverseRecapitalizationTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "cslr:ScheduleOfReconcilesElementsOfTheMergerTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "cslr:ReverseRecapitalizationTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R37": { "role": "http://www.completesolaria.com/role/BusinessCombinationTables", "longName": "1037 - Disclosure - Business Combination (Tables)", "shortName": "Business Combination (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "37", "firstAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R38": { "role": "http://www.completesolaria.com/role/PrepaidExpensesAndOtherCurrentAssetsTables", "longName": "1038 - Disclosure - Prepaid Expenses and Other Current Assets (Tables)", "shortName": "Prepaid Expenses and Other Current Assets (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "38", "firstAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:OtherCurrentAssetsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:OtherCurrentAssetsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R39": { "role": "http://www.completesolaria.com/role/DivestitureTables", "longName": "1039 - Disclosure - Divestiture (Tables)", "shortName": "Divestiture (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "39", "firstAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "srt:CondensedStatementOfComprehensiveIncomeTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "srt:CondensedStatementOfComprehensiveIncomeTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R40": { "role": "http://www.completesolaria.com/role/PropertyAndEquipmentNetTables", "longName": "1040 - Disclosure - Property and Equipment, Net (Tables)", "shortName": "Property and Equipment, Net (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "40", "firstAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R41": { "role": "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsTables", "longName": "1041 - Disclosure - Goodwill and Intangible Assets (Tables)", "shortName": "Goodwill and Intangible Assets (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "41", "firstAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R42": { "role": "http://www.completesolaria.com/role/AccruedExpensesAndOtherCurrentLiabilitiesTables", "longName": "1042 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)", "shortName": "Accrued Expenses and Other Current Liabilities (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "42", "firstAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R43": { "role": "http://www.completesolaria.com/role/OtherIncomeExpenseNetTables", "longName": "1043 - Disclosure - Other Income (Expense), Net (Tables)", "shortName": "Other Income (Expense), Net (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "43", "firstAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R44": { "role": "http://www.completesolaria.com/role/CommonStockTables", "longName": "1044 - Disclosure - Common Stock (Tables)", "shortName": "Common Stock (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "44", "firstAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "cslr:ScheduleOfReservedSharesOfCommonStockTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "cslr:CommonStockTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "cslr:ScheduleOfReservedSharesOfCommonStockTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "cslr:CommonStockTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R45": { "role": "http://www.completesolaria.com/role/WarrantsTables", "longName": "1045 - Disclosure - Warrants (Tables)", "shortName": "Warrants (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "45", "firstAnchor": { "contextRef": "P01_01_2022To12_31_2022", "name": "cslr:DisclosureInTabularFormOfSignificantUnobservableInputsUsedInTheFairValueOfWarrantsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2022To12_31_2022", "name": "cslr:DisclosureInTabularFormOfSignificantUnobservableInputsUsedInTheFairValueOfWarrantsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R46": { "role": "http://www.completesolaria.com/role/BorrowingArrangementsTables", "longName": "1046 - Disclosure - Borrowing Arrangements (Tables)", "shortName": "Borrowing Arrangements (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "46", "firstAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:ConvertibleDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SubordinatedBorrowingsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:ConvertibleDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SubordinatedBorrowingsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R47": { "role": "http://www.completesolaria.com/role/StockBasedCompensationTables", "longName": "1047 - Disclosure - Stock-Based Compensation (Tables)", "shortName": "Stock-Based Compensation (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "47", "firstAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R48": { "role": "http://www.completesolaria.com/role/CommitmentsAndContingenciesTables", "longName": "1048 - Disclosure - Commitments and Contingencies (Tables)", "shortName": "Commitments and Contingencies (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "48", "firstAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R49": { "role": "http://www.completesolaria.com/role/IncomeTaxesTables", "longName": "1049 - Disclosure - Income Taxes (Tables)", "shortName": "Income Taxes (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "49", "firstAnchor": { "contextRef": "P01_01_2022To12_31_2022", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2022To12_31_2022", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R50": { "role": "http://www.completesolaria.com/role/BasicAndDilutedNetLossPerShareTables", "longName": "1050 - Disclosure - Basic and Diluted Net Loss Per Share (Tables)", "shortName": "Basic and Diluted Net Loss Per Share (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "50", "firstAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R51": { "role": "http://www.completesolaria.com/role/OrganizationDetails", "longName": "1051 - Disclosure - Organization (Details)", "shortName": "Organization (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "cslr:ForwardPurchaseAgreements", "unitRef": "Unit_shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "cslr:ForwardPurchaseAgreements", "unitRef": "Unit_shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R52": { "role": "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetails", "longName": "1052 - Disclosure - Summary of Significant Accounting Policies (Details)", "shortName": "Summary of Significant Accounting Policies (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "PAsOn10_01_2023", "name": "us-gaap:RestrictedCashCurrent", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true }, "uniqueAnchor": { "contextRef": "PAsOn10_01_2023", "name": "us-gaap:RevenueRemainingPerformanceObligation", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "div", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "unique": true } }, "R53": { "role": "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetailsScheduleOfConsolidatedStatementsOfCashFlows", "longName": "1053 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of Consolidated Statements of Cash Flows", "shortName": "Summary of Significant Accounting Policies (Details) - Schedule of Consolidated Statements of Cash Flows", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "PAsOn10_01_2023", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true }, "uniqueAnchor": { "contextRef": "PAsOn10_01_2023", "name": "us-gaap:OtherRestrictedAssetsCurrent", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "unique": true } }, "R54": { "role": "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetailsScheduleOfAllowanceForDoubtfulAccounts", "longName": "1054 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of Allowance for Doubtful Accounts", "shortName": "Summary of Significant Accounting Policies (Details) - Schedule of Allowance for Doubtful Accounts", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "PAsOn12_31_2022", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock", "us-gaap:TradeAndOtherAccountsReceivablePolicy", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true }, "uniqueAnchor": { "contextRef": "PAsOn12_31_2019", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock", "us-gaap:TradeAndOtherAccountsReceivablePolicy", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "unique": true } }, "R55": { "role": "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetailsScheduleOfRevenueRecognizedByProductAndServices", "longName": "1055 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of Revenue Recognized By Product and Services", "shortName": "Summary of Significant Accounting Policies (Details) - Schedule of Revenue Recognized By Product and Services", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "P07_01_2023To10_01_2023", "name": "us-gaap:Revenues", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true }, "uniqueAnchor": { "contextRef": "P07_01_2023To10_01_2023_SolarEnergySystemInstallationsMembersrtProductOrServiceAxis", "name": "us-gaap:Revenues", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "us-gaap:RevenueRecognitionPolicyTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "unique": true } }, "R56": { "role": "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetailsScheduleOfPropertyPlantAndEquipmentUsefulLives", "longName": "1056 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule Of Property, Plant and Equipment Useful Lives", "shortName": "Summary of Significant Accounting Policies (Details) - Schedule Of Property, Plant and Equipment Useful Lives", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "PAsOn12_31_2022_EquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis_MinimumMembersrtRangeAxis", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "PAsOn12_31_2022_EquipmentMemberusgaapPropertyPlantAndEquipmentByTypeAxis_MinimumMembersrtRangeAxis", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R57": { "role": "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetailsScheduleOfFiniteLivedIntangibleAssets", "longName": "1057 - Disclosure - Summary of Significant Accounting Policies (Details) -Schedule of Finite-Lived Intangible Assets", "shortName": "Summary of Significant Accounting Policies (Details) -Schedule of Finite-Lived Intangible Assets", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "PAsOn12_31_2022_AssembledWorkforceOneMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis", "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "PAsOn12_31_2022_AssembledWorkforceOneMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis", "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R58": { "role": "http://www.completesolaria.com/role/FairValueMeasurementsDetails", "longName": "1058 - Disclosure - Fair Value Measurements (Details)", "shortName": "Fair Value Measurements (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "P10_31_2023To10_31_2023", "name": "us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets", "unitRef": "Unit_shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "div", "us-gaap:SubsequentEventsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true }, "uniqueAnchor": { "contextRef": "P07_01_2019To07_31_2019_TwoThousandAndNineteenSimpleAgreementForFutureEquityMemberusgaapOptionIndexedToIssuersEquityTypeAxis", "name": "cslr:ProceedsFromTheIssueOfDerivativeInstrumentsLinkedToEntitiesOwnEquity", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "unique": true } }, "R59": { "role": "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfFinancialAssetsAndLiabilities", "longName": "1059 - Disclosure - Fair Value Measurements (Details) - Schedule of Financial Assets and Liabilities", "shortName": "Fair Value Measurements (Details) - Schedule of Financial Assets and Liabilities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "PAsOn10_01_2023", "name": "us-gaap:FinancialLiabilitiesFairValueDisclosure", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "cslr:WarrantLiabilitiesPublicWarrants", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "unique": true } }, "R60": { "role": "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfWarrantsBasedOnABlackScholesOptionPricingMethod", "longName": "1060 - Disclosure - Fair Value Measurements (Details) - Schedule of Warrants Based on a Black Scholes Option Pricing Method.", "shortName": "Fair Value Measurements (Details) - Schedule of Warrants Based on a Black Scholes Option Pricing Method.", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "P01_01_2022To12_31_2022_SeriesBRedeemableConvertiblePreferredStockWarrantMemberusgaapStatementClassOfStockAxis", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2022To12_31_2022_SeriesBRedeemableConvertiblePreferredStockWarrantMemberusgaapStatementClassOfStockAxis", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R61": { "role": "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfSignificantUnobservableInputsLevel3AndTheChangeInFairValueRecordedInOtherIncomeExpenseNet", "longName": "1061 - Disclosure - Fair Value Measurements (Details) - Schedule of Significant Unobservable Inputs (Level 3), and the Change in Fair Value Recorded in Other Income (Expense),net", "shortName": "Fair Value Measurements (Details) - Schedule of Significant Unobservable Inputs (Level 3), and the Change in Fair Value Recorded in Other Income (Expense),net", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "PAsOn12_31_2021_WarrantMemberusgaapFairValueByLiabilityClassAxis", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true }, "uniqueAnchor": { "contextRef": "PAsOn12_31_2020_WarrantMemberusgaapFairValueByLiabilityClassAxis", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "unique": true } }, "R62": { "role": "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfReconcilesTheChangeInValueOfTheRedeemableConvertiblePreferredStockWarrantLiability", "longName": "1062 - Disclosure - Fair Value Measurements (Details) - Schedule of Reconciles the Change in Value of the Redeemable Convertible Preferred Stock Warrant Liability", "shortName": "Fair Value Measurements (Details) - Schedule of Reconciles the Change in Value of the Redeemable Convertible Preferred Stock Warrant Liability", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:FairValueAdjustmentOfWarrants", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true }, "uniqueAnchor": { "contextRef": "P01_01_2022To12_31_2022_RedeemableConvertiblePreferredStockMemberusgaapStatementClassOfStockAxis", "name": "us-gaap:FairValueAdjustmentOfWarrants", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "cslr:ScheduleOfReconcilesTheChangeInValueOfTheRedeemableConvertiblePreferredStockWarrantLiabilityTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "unique": true } }, "R63": { "role": "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfReconciliationOfEmbeddedDerivativeLiability", "longName": "1063 - Disclosure - Fair Value Measurements (Details) - Schedule of Reconciliation of Embedded Derivative Liability", "shortName": "Fair Value Measurements (Details) - Schedule of Reconciliation of Embedded Derivative Liability", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "PAsOn12_31_2021", "name": "us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true }, "uniqueAnchor": { "contextRef": "P01_01_2021To12_31_2021", "name": "cslr:EmbeddedDerivativeLiabilityInstrumentsIssuedDuringThePeriodValue", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "cslr:DisclosureInTabularFormOfReconciliationOfEmbeddedDerivativeLiabilityTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "unique": true } }, "R64": { "role": "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfNextEquityFinancingBasedOnInputsIncludedInABlackScholesModel", "longName": "1064 - Disclosure - Fair Value Measurements (Details) - Schedule of Next Equity Financing Based on Inputs Included in a Black-Scholes Model", "shortName": "Fair Value Measurements (Details) - Schedule of Next Equity Financing Based on Inputs Included in a Black-Scholes Model", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "PAsOn12_31_2021_ExpectedFairValueOfPreferredStockMemberusgaapMeasurementInputTypeAxis_SimpleAgreementForFutureEquityInstrumentsMemberusgaapOptionIndexedToIssuersEquityTypeAxis", "name": "us-gaap:LiabilitiesFairValueDisclosure", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-1", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "PAsOn12_31_2021_ExpectedFairValueOfPreferredStockMemberusgaapMeasurementInputTypeAxis_SimpleAgreementForFutureEquityInstrumentsMemberusgaapOptionIndexedToIssuersEquityTypeAxis", "name": "us-gaap:LiabilitiesFairValueDisclosure", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-1", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R65": { "role": "http://www.completesolaria.com/role/ReverseRecapitalizationDetails", "longName": "1065 - Disclosure - Reverse Recapitalization (Details)", "shortName": "Reverse Recapitalization (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:RestructuringReserveSettledWithoutCash2", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "div", "cslr:ReverseRecapitalizationTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:RestructuringReserveSettledWithoutCash2", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "div", "cslr:ReverseRecapitalizationTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R66": { "role": "http://www.completesolaria.com/role/ReverseRecapitalizationDetailsScheduleOfReconcilesElementsOfTheMerger", "longName": "1066 - Disclosure - Reverse Recapitalization (Details) - Schedule of Reconciles Elements of the Merger", "shortName": "Reverse Recapitalization (Details) - Schedule of Reconciles Elements of the Merger", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:RepaymentsOfNotesPayable", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ix:continuation", "cslr:ReverseRecapitalizationTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:RepaymentsOfNotesPayable", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ix:continuation", "cslr:ReverseRecapitalizationTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R67": { "role": "http://www.completesolaria.com/role/ReverseRecapitalizationDetailsScheduleOfCommonStockOutstanding", "longName": "1067 - Disclosure - Reverse Recapitalization (Details) - Schedule of Common Stock Outstanding", "shortName": "Reverse Recapitalization (Details) - Schedule of Common Stock Outstanding", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "PAsOn10_01_2023", "name": "us-gaap:CommonStockSharesOutstanding", "unitRef": "Unit_shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true }, "uniqueAnchor": { "contextRef": "PAsOn10_01_2023", "name": "us-gaap:TemporaryEquityShareSubscriptions", "unitRef": "Unit_shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "unique": true } }, "R68": { "role": "http://www.completesolaria.com/role/ForwardPurchaseAgreementsDetails", "longName": "1068 - Disclosure - Forward Purchase Agreements (Details)", "shortName": "Forward Purchase Agreements (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "68", "firstAnchor": { "contextRef": "PAsOn10_01_2023", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "Unit_USD_per_Share", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "us-gaap:CommonStockParOrStatedValuePerShare", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "cslr:PurchasePercentage", "unitRef": "Unit_pure", "xsiNil": "false", "lang": null, "decimals": "3", "ancestors": [ "div", "cslr:ForwardPurchaseAgreementsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "unique": true } }, "R69": { "role": "http://www.completesolaria.com/role/BusinessCombinationDetails", "longName": "1069 - Disclosure - Business Combination (Details)", "shortName": "Business Combination (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "69", "firstAnchor": { "contextRef": "PAsOn10_01_2023", "name": "us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "PAsOn10_01_2023", "name": "us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R70": { "role": "http://www.completesolaria.com/role/BusinessCombinationDetailsScheduleOfAssetsAcquiredAndLiabilitiesAssumed", "longName": "1070 - Disclosure - Business Combination (Details) - Schedule of Assets Acquired and Liabilities Assumed", "shortName": "Business Combination (Details) - Schedule of Assets Acquired and Liabilities Assumed", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "70", "firstAnchor": { "contextRef": "PAsOn10_01_2023_BusinessCombinationMemberusgaapBusinessAcquisitionAxis", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "PAsOn10_01_2023_BusinessCombinationMemberusgaapBusinessAcquisitionAxis", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R71": { "role": "http://www.completesolaria.com/role/BusinessCombinationDetailsScheduleOfIntangibleAssetsAcquired", "longName": "1071 - Disclosure - Business Combination (Details) - Schedule of Intangible Assets Acquired", "shortName": "Business Combination (Details) - Schedule of Intangible Assets Acquired", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "71", "firstAnchor": { "contextRef": "PAsOn09_30_2023", "name": "us-gaap:FiniteLivedIntangibleAssetsNet", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "PAsOn09_30_2023", "name": "us-gaap:FiniteLivedIntangibleAssetsNet", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R72": { "role": "http://www.completesolaria.com/role/BusinessCombinationDetailsScheduleOfUnauditedCombinedProFormaInformation", "longName": "1072 - Disclosure - Business Combination (Details) - Schedule of Unaudited Combined Pro Forma Information", "shortName": "Business Combination (Details) - Schedule of Unaudited Combined Pro Forma Information", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "72", "firstAnchor": { "contextRef": "P07_01_2022To09_30_2022_BusinessCombinationMemberusgaapBusinessAcquisitionAxis", "name": "us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsRevenuesAndGainsRecognized", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P07_01_2022To09_30_2022_BusinessCombinationMemberusgaapBusinessAcquisitionAxis", "name": "us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsRevenuesAndGainsRecognized", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R73": { "role": "http://www.completesolaria.com/role/PrepaidExpensesAndOtherCurrentAssetsDetailsScheduleOfPrepaidExpensesAndOtherCurrentAssets", "longName": "1073 - Disclosure - Prepaid Expenses and Other Current Assets (Details) - Schedule of Prepaid Expenses and Other Current Assets", "shortName": "Prepaid Expenses and Other Current Assets (Details) - Schedule of Prepaid Expenses and Other Current Assets", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "73", "firstAnchor": { "contextRef": "PAsOn10_01_2023", "name": "us-gaap:PrepaidRent", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "us-gaap:OtherCurrentAssetsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "PAsOn10_01_2023", "name": "us-gaap:PrepaidRent", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "us-gaap:OtherCurrentAssetsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R74": { "role": "http://www.completesolaria.com/role/DivestitureDetailsScheduleOfOperationsAndComprehensiveIncomeLossRelatedToDiscontinuedOperations", "longName": "1074 - Disclosure - Divestiture (Details) - Schedule of Operations and Comprehensive Income (Loss) Related to Discontinued Operations", "shortName": "Divestiture (Details) - Schedule of Operations and Comprehensive Income (Loss) Related to Discontinued Operations", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "74", "firstAnchor": { "contextRef": "P07_02_2023To10_01_2023", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "srt:CondensedStatementOfComprehensiveIncomeTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P07_02_2023To10_01_2023", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "srt:CondensedStatementOfComprehensiveIncomeTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R75": { "role": "http://www.completesolaria.com/role/DivestitureDetailsScheduleOfMajorCategoriesOfAssetsAndLiabilitiesHeldForSale", "longName": "1075 - Disclosure - Divestiture (Details) - Schedule of Major Categories of Assets and Liabilities Held for Sale", "shortName": "Divestiture (Details) - Schedule of Major Categories of Assets and Liabilities Held for Sale", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "75", "firstAnchor": { "contextRef": "PAsOn10_01_2023", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "srt:ScheduleOfCondensedFinancialStatementsTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "PAsOn10_01_2023", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "srt:ScheduleOfCondensedFinancialStatementsTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R76": { "role": "http://www.completesolaria.com/role/DivestitureDetails", "longName": "1076 - Disclosure - Divestiture (Details)", "shortName": "Divestiture (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "76", "firstAnchor": { "contextRef": "P01_01_2022To12_31_2022", "name": "us-gaap:DepreciationAndAmortizationDiscontinuedOperations", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "div", "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2022To12_31_2022", "name": "us-gaap:DepreciationAndAmortizationDiscontinuedOperations", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "div", "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R77": { "role": "http://www.completesolaria.com/role/PropertyAndEquipmentNetDetailsScheduleOfPropertyAndEquipmentNet", "longName": "1077 - Disclosure - Property and Equipment, Net (Details) - Schedule of Property and Equipment, Net", "shortName": "Property and Equipment, Net (Details) - Schedule of Property and Equipment, Net", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "77", "firstAnchor": { "contextRef": "PAsOn10_01_2023", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "PAsOn10_01_2023", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R78": { "role": "http://www.completesolaria.com/role/PropertyAndEquipmentNetDetails", "longName": "1078 - Disclosure - Property and Equipment, Net (Details)", "shortName": "Property and Equipment, Net (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "78", "firstAnchor": { "contextRef": "P07_02_2023To10_01_2023", "name": "us-gaap:UtilitiesOperatingExpenseDepreciationAndAmortization", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P07_02_2023To10_01_2023", "name": "us-gaap:UtilitiesOperatingExpenseDepreciationAndAmortization", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R79": { "role": "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetails", "longName": "1079 - Disclosure - Goodwill and Intangible Assets (Details)", "shortName": "Goodwill and Intangible Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "79", "firstAnchor": { "contextRef": "P07_02_2023To10_01_2023", "name": "us-gaap:GoodwillAndIntangibleAssetImpairment", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "div", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P07_02_2023To10_01_2023", "name": "us-gaap:GoodwillAndIntangibleAssetImpairment", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "div", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R80": { "role": "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetailsScheduleOfIntangibleAssets", "longName": "1080 - Disclosure - Goodwill and Intangible Assets (Details) - Schedule of Intangible Assets", "shortName": "Goodwill and Intangible Assets (Details) - Schedule of Intangible Assets", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "80", "firstAnchor": { "contextRef": "PAsOn10_01_2023", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "PAsOn10_01_2023", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R81": { "role": "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetailsScheduleOfAmortizationExpenseRelatedToIntangibleAssets", "longName": "1081 - Disclosure - Goodwill and Intangible Assets (Details) - Schedule of Amortization Expense Related to Intangible Assets", "shortName": "Goodwill and Intangible Assets (Details) - Schedule of Amortization Expense Related to Intangible Assets", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "81", "firstAnchor": { "contextRef": "P07_01_2023To10_01_2023", "name": "us-gaap:AmortizationOfIntangibleAssets", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true }, "uniqueAnchor": { "contextRef": "P07_01_2023To10_01_2023_TrademarksMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis", "name": "us-gaap:AmortizationOfIntangibleAssets", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "unique": true } }, "R82": { "role": "http://www.completesolaria.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetailsScheduleOfAccruedExpensesAndOtherCurrentLiabilities", "longName": "1082 - Disclosure - Accrued Expenses and Other Current Liabilities (Details) - Schedule of Accrued Expenses and Other Current Liabilities", "shortName": "Accrued Expenses and Other Current Liabilities (Details) - Schedule of Accrued Expenses and Other Current Liabilities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "82", "firstAnchor": { "contextRef": "PAsOn10_01_2023", "name": "us-gaap:CompensationAndBenefitsTrust", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "PAsOn10_01_2023", "name": "us-gaap:CompensationAndBenefitsTrust", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R83": { "role": "http://www.completesolaria.com/role/OtherIncomeExpenseNetDetails", "longName": "1083 - Disclosure - Other Income (Expense), Net (Details)", "shortName": "Other Income (Expense), Net (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "83", "firstAnchor": { "contextRef": "P07_01_2023To10_01_2023", "name": "us-gaap:InterestIncomeOther", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "div", "td", "tr", "table", "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P07_01_2023To10_01_2023", "name": "us-gaap:InterestIncomeOther", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "div", "td", "tr", "table", "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R84": { "role": "http://www.completesolaria.com/role/OtherIncomeExpenseNetDetailsScheduleOfOtherIncomeExpenseNet", "longName": "1084 - Disclosure - Other Income (Expense), Net (Details) - Schedule of Other Income (Expense), Net", "shortName": "Other Income (Expense), Net (Details) - Schedule of Other Income (Expense), Net", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "84", "firstAnchor": { "contextRef": "P07_02_2023To10_01_2023", "name": "cslr:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock1", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P07_02_2023To10_01_2023", "name": "cslr:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock1", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R85": { "role": "http://www.completesolaria.com/role/CommonStockDetails", "longName": "1085 - Disclosure - Common Stock (Details)", "shortName": "Common Stock (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "85", "firstAnchor": { "contextRef": "PAsOn10_01_2023", "name": "us-gaap:CommonStockSharesAuthorized", "unitRef": "Unit_shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true }, "uniqueAnchor": { "contextRef": "PAsOn10_01_2023", "name": "us-gaap:PreferredStockSharesAuthorized", "unitRef": "Unit_shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "div", "cslr:CommonStockTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "unique": true } }, "R86": { "role": "http://www.completesolaria.com/role/CommonStockDetailsScheduleOfReservedSharesOfCommonStock", "longName": "1086 - Disclosure - Common Stock (Details) - Schedule of Reserved Shares of Common Stock", "shortName": "Common Stock (Details) - Schedule of Reserved Shares of Common Stock", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "86", "firstAnchor": { "contextRef": "PAsOn10_01_2023", "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "unitRef": "Unit_shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "cslr:ScheduleOfReservedSharesOfCommonStockTableTextBlock", "cslr:CommonStockTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true }, "uniqueAnchor": { "contextRef": "PAsOn10_01_2023", "name": "us-gaap:EmployeeStockOwnershipPlanESOPDeferredShares", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "cslr:ScheduleOfReservedSharesOfCommonStockTableTextBlock", "cslr:CommonStockTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "unique": true } }, "R87": { "role": "http://www.completesolaria.com/role/WarrantsDetails", "longName": "1087 - Disclosure - Warrants (Details)", "shortName": "Warrants (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "87", "firstAnchor": { "contextRef": "PAsOn11_30_2022", "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "unitRef": "Unit_shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "PAsOn11_30_2022", "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "unitRef": "Unit_shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R88": { "role": "http://www.completesolaria.com/role/WarrantsScheduleOfFairValueOfTheCommonStockWarrantsDetails", "longName": "1088 - Disclosure - Warrants - Schedule of Fair Value of The Common Stock Warrants (Details)", "shortName": "Warrants - Schedule of Fair Value of The Common Stock Warrants (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "88", "firstAnchor": { "contextRef": "PAsOn12_31_2021_CommonStockWarrantsMemberusgaapClassOfWarrantOrRightAxis_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis", "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput", "unitRef": "Unit_pure", "xsiNil": "false", "lang": null, "decimals": "1", "ancestors": [ "td", "tr", "table", "cslr:DisclosureInTabularFormOfSignificantUnobservableInputsUsedInTheFairValueOfWarrantsTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "PAsOn12_31_2021_CommonStockWarrantsMemberusgaapClassOfWarrantOrRightAxis_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis", "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput", "unitRef": "Unit_pure", "xsiNil": "false", "lang": null, "decimals": "1", "ancestors": [ "td", "tr", "table", "cslr:DisclosureInTabularFormOfSignificantUnobservableInputsUsedInTheFairValueOfWarrantsTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R89": { "role": "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "longName": "1089 - Disclosure - Borrowing Arrangements (Details)", "shortName": "Borrowing Arrangements (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "89", "firstAnchor": { "contextRef": "P02_01_2022To02_28_2022", "name": "us-gaap:DebtInstrumentIssuedPrincipal", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "div", "us-gaap:SubordinatedBorrowingsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P02_01_2022To02_28_2022", "name": "us-gaap:DebtInstrumentIssuedPrincipal", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "div", "us-gaap:SubordinatedBorrowingsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R90": { "role": "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfConvertibleNotes", "longName": "1090 - Disclosure - Borrowing Arrangements (Details) - Schedule of Convertible Notes", "shortName": "Borrowing Arrangements (Details) - Schedule of Convertible Notes", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "90", "firstAnchor": { "contextRef": "PAsOn12_31_2022", "name": "us-gaap:ConvertibleDebtCurrent", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ConvertibleDebtTableTextBlock", "us-gaap:SubordinatedBorrowingsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "PAsOn12_31_2022", "name": "us-gaap:ConvertibleDebtCurrent", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ConvertibleDebtTableTextBlock", "us-gaap:SubordinatedBorrowingsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R91": { "role": "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfNetCarryingAmountOfTheConvertibleNotes", "longName": "1091 - Disclosure - Borrowing Arrangements (Details) - Schedule of Net Carrying Amount of the Convertible Notes", "shortName": "Borrowing Arrangements (Details) - Schedule of Net Carrying Amount of the Convertible Notes", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "91", "firstAnchor": { "contextRef": "PAsOn12_31_2022", "name": "us-gaap:ConvertibleDebt", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ConvertibleDebtTableTextBlock", "us-gaap:SubordinatedBorrowingsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true }, "uniqueAnchor": { "contextRef": "PAsOn12_31_2022_TwoThousandAndNineteenAConvertibleNotesMemberusgaapLongtermDebtTypeAxis", "name": "us-gaap:DebtInstrumentCarryingAmount", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ConvertibleDebtTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "unique": true } }, "R92": { "role": "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfInterestExpenseOnConvertibleDebt", "longName": "1092 - Disclosure - Borrowing Arrangements (Details) - Schedule Of Interest Expense On Convertible Debt", "shortName": "Borrowing Arrangements (Details) - Schedule Of Interest Expense On Convertible Debt", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "92", "firstAnchor": { "contextRef": "P12_31_2022To12_31_2022_TwoThousandAndNineteenAConvertibleNotesMemberusgaapLongtermDebtTypeAxis", "name": "us-gaap:AmortizationOfDebtDiscountPremium", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "cslr:DisclosureInTabularFormOfInterestExpenseOnConvertibleDebt", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P12_31_2022To12_31_2022_TwoThousandAndNineteenAConvertibleNotesMemberusgaapLongtermDebtTypeAxis", "name": "us-gaap:AmortizationOfDebtDiscountPremium", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "cslr:DisclosureInTabularFormOfInterestExpenseOnConvertibleDebt", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R93": { "role": "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfCompanySOutstandingNotesPayable", "longName": "1093 - Disclosure - Borrowing Arrangements (Details) - Schedule of Company's outstanding notes payable", "shortName": "Borrowing Arrangements (Details) - Schedule of Company's outstanding notes payable", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "93", "firstAnchor": { "contextRef": "PAsOn12_31_2022_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis", "name": "us-gaap:DebtInstrumentCarryingAmount", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "cslr:DisclosureInTabularFormOfNotesPayableTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "PAsOn12_31_2022_NotesPayableOtherPayablesMemberusgaapLongtermDebtTypeAxis", "name": "us-gaap:DebtInstrumentCarryingAmount", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "cslr:DisclosureInTabularFormOfNotesPayableTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R94": { "role": "http://www.completesolaria.com/role/StockBasedCompensationDetails", "longName": "1094 - Disclosure - Stock-Based Compensation (Details)", "shortName": "Stock-Based Compensation (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "94", "firstAnchor": { "contextRef": "PAsOn12_31_2022", "name": "srt:FinancingReceivableNonaccrualToOutstandingPercent", "unitRef": "Unit_pure", "xsiNil": "false", "lang": null, "decimals": "3", "ancestors": [ "div", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true }, "uniqueAnchor": { "contextRef": "P01_01_2022To12_31_2022", "name": "cslr:UnrecognizedStockbasedCompensation", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "unique": true } }, "R95": { "role": "http://www.completesolaria.com/role/StockBasedCompensationDetailsSummaryOfSummaryOfStockOptionActivity", "longName": "1095 - Disclosure - Stock-Based Compensation (Details) - Summary of summary of stock option activity", "shortName": "Stock-Based Compensation (Details) - Summary of summary of stock option activity", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "95", "firstAnchor": { "contextRef": "PAsOn12_31_2022", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "Unit_shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "unitRef": "Unit_shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "unique": true } }, "R96": { "role": "http://www.completesolaria.com/role/StockBasedCompensationDetailsSummaryOfSummaryOfStockOptionActivityParentheticals", "longName": "1096 - Disclosure - Stock-Based Compensation (Details) - Summary of summary of stock option activity (Parentheticals)", "shortName": "Stock-Based Compensation (Details) - Summary of summary of stock option activity (Parentheticals)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "96", "firstAnchor": { "contextRef": "P01_01_2022To12_31_2022", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "unitRef": "Unit_USD_per_Share", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2022To12_31_2022", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "unitRef": "Unit_USD_per_Share", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R97": { "role": "http://www.completesolaria.com/role/StockBasedCompensationDetailsScheduleOfSummaryOfRsuActivity", "longName": "1097 - Disclosure - Stock-Based Compensation (Details) - Schedule of summary of RSU activity", "shortName": "Stock-Based Compensation (Details) - Schedule of summary of RSU activity", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "97", "firstAnchor": { "contextRef": "PAsOn10_01_2023", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "unitRef": "Unit_shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "PAsOn10_01_2023", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "unitRef": "Unit_shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R98": { "role": "http://www.completesolaria.com/role/StockBasedCompensationDetailsScheduleOfCalculateTheFairValueOfStockBasedCompensation", "longName": "1098 - Disclosure - Stock-Based Compensation (Details) - Schedule Of Calculate The Fair Value Of Stock-based Compensation", "shortName": "Stock-Based Compensation (Details) - Schedule Of Calculate The Fair Value Of Stock-based Compensation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "98", "firstAnchor": { "contextRef": "P01_01_2022To12_31_2022_EmployeeStockOptionMemberusgaapAwardTypeAxis", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum", "unitRef": "Unit_pure", "xsiNil": "false", "lang": null, "decimals": "3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2022To12_31_2022_EmployeeStockOptionMemberusgaapAwardTypeAxis", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum", "unitRef": "Unit_pure", "xsiNil": "false", "lang": null, "decimals": "3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R99": { "role": "http://www.completesolaria.com/role/StockBasedCompensationDetailsScheduleOfStockBasedCompensationExpenseAndItsAllocationWithinTheAccompanyingUnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss", "longName": "1099 - Disclosure - Stock-Based Compensation (Details) - Schedule of stock-based compensation expense and its allocation within the accompanying unaudited condensed consolidated statements of operations and comprehensive loss", "shortName": "Stock-Based Compensation (Details) - Schedule of stock-based compensation expense and its allocation within the accompanying unaudited condensed consolidated statements of operations and comprehensive loss", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "99", "firstAnchor": { "contextRef": "P07_01_2023To10_01_2023", "name": "us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true }, "uniqueAnchor": { "contextRef": "P07_02_2023To10_01_2023_StockCompensationPlanMemberusgaapAwardTypeAxis", "name": "us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "unique": true } }, "R100": { "role": "http://www.completesolaria.com/role/EmployeeStockPurchasePlanDetails", "longName": "1100 - Disclosure - Employee Stock Purchase Plan (Details)", "shortName": "Employee Stock Purchase Plan (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "100", "firstAnchor": { "contextRef": "PAsOn10_01_2023", "name": "us-gaap:FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerSharePercentCurrencies", "unitRef": "Unit_pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "div", "us-gaap:ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "PAsOn10_01_2023", "name": "us-gaap:FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerSharePercentCurrencies", "unitRef": "Unit_pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "div", "us-gaap:ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R101": { "role": "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetails", "longName": "1101 - Disclosure - Commitments and Contingencies (Details)", "shortName": "Commitments and Contingencies (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "101", "firstAnchor": { "contextRef": "P07_01_2023To10_01_2023", "name": "us-gaap:VariableLeaseCost", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P07_01_2023To10_01_2023", "name": "us-gaap:VariableLeaseCost", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R102": { "role": "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetailsScheduleOfWeightedAverageRemainingLeaseTermAndTheDiscountRate", "longName": "1102 - Disclosure - Commitments and Contingencies (Details) - Schedule of Weighted Average Remaining Lease Term and the Discount Rate", "shortName": "Commitments and Contingencies (Details) - Schedule of Weighted Average Remaining Lease Term and the Discount Rate", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "102", "firstAnchor": { "contextRef": "PAsOn10_01_2023", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "td", "tr", "table", "us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "PAsOn10_01_2023", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "td", "tr", "table", "us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R103": { "role": "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetailsScheduleOfFutureMinimumLeasePaymentsUnderNonCancelable", "longName": "1103 - Disclosure - Commitments and Contingencies (Details) - Schedule of Future Minimum Lease Payments under Non-Cancelable", "shortName": "Commitments and Contingencies (Details) - Schedule of Future Minimum Lease Payments under Non-Cancelable", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "103", "firstAnchor": { "contextRef": "PAsOn10_01_2023", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "cslr:ScheduleOfFutureMinimumLeasePaymentsUnderNonCancelableTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "PAsOn10_01_2023", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "cslr:ScheduleOfFutureMinimumLeasePaymentsUnderNonCancelableTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R104": { "role": "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetailsScheduleOfActivityPeriodRelatingToTheCompanysWarrantyProvision", "longName": "1104 - Disclosure - Commitments and Contingencies (Details) - Schedule of Activity Period Relating to the Company's Warranty Provision", "shortName": "Commitments and Contingencies (Details) - Schedule of Activity Period Relating to the Company's Warranty Provision", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "104", "firstAnchor": { "contextRef": "PAsOn12_31_2022", "name": "us-gaap:ExtendedProductWarrantyAccrual", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "cslr:ScheduleOfActivityPeriodRelatingToTheCompanysWarrantyProvisionTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true }, "uniqueAnchor": { "contextRef": "PAsOn12_31_2019", "name": "us-gaap:ExtendedProductWarrantyAccrual", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "cslr:ScheduleOfActivityPeriodRelatingToTheCompanysWarrantyProvisionTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "unique": true } }, "R105": { "role": "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfProvisionForIncomeTaxes", "longName": "1105 - Disclosure - Income Taxes (Details) - Schedule of Provision For Income Taxes", "shortName": "Income Taxes (Details) - Schedule of Provision For Income Taxes", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "105", "firstAnchor": { "contextRef": "P01_01_2022To12_31_2022", "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2022To12_31_2022", "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R106": { "role": "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfReconciliationOfEffectiveIncomeTaxRate", "longName": "1106 - Disclosure - Income Taxes (Details) - Schedule of Reconciliation of Effective Income Tax Rate", "shortName": "Income Taxes (Details) - Schedule of Reconciliation of Effective Income Tax Rate", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "106", "firstAnchor": { "contextRef": "P01_01_2022To12_31_2022", "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2022To12_31_2022", "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R107": { "role": "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfComponentsOfDeferredTaxAssetsAndLiabilities", "longName": "1107 - Disclosure - Income Taxes (Details) - Schedule of Components of Deferred Tax Assets And Liabilities", "shortName": "Income Taxes (Details) - Schedule of Components of Deferred Tax Assets And Liabilities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "107", "firstAnchor": { "contextRef": "PAsOn12_31_2022", "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "PAsOn12_31_2022", "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R108": { "role": "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfUnrecognizedTaxBenefits", "longName": "1108 - Disclosure - Income Taxes (Details) - Schedule of Unrecognized Tax Benefits", "shortName": "Income Taxes (Details) - Schedule of Unrecognized Tax Benefits", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "108", "firstAnchor": { "contextRef": "PAsOn12_31_2021", "name": "us-gaap:UnrecognizedTaxBenefits", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true }, "uniqueAnchor": { "contextRef": "P01_01_2022To12_31_2022", "name": "us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "unique": true } }, "R109": { "role": "http://www.completesolaria.com/role/IncomeTaxesDetails", "longName": "1109 - Disclosure - Income Taxes (Details)", "shortName": "Income Taxes (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "109", "firstAnchor": { "contextRef": "PAsOn12_31_2022", "name": "us-gaap:DeferredTaxAssetsValuationAllowance", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true }, "uniqueAnchor": { "contextRef": "P01_01_2022To12_31_2022", "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "unique": true } }, "R110": { "role": "http://www.completesolaria.com/role/BasicAndDilutedNetLossPerShareDetailsScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholders", "longName": "1110 - Disclosure - Basic and Diluted Net Loss Per Share (Details) - Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders", "shortName": "Basic and Diluted Net Loss Per Share (Details) - Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "110", "firstAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "us-gaap:IncomeLossFromContinuingOperations", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true }, "uniqueAnchor": { "contextRef": "P01_01_2022To12_31_2022", "name": "us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "unique": true } }, "R111": { "role": "http://www.completesolaria.com/role/BasicAndDilutedNetLossPerShareDetailsScheduleOfPotentialCommonSharesExcludedFromDilutedNetLossPerShare", "longName": "1111 - Disclosure - Basic and Diluted Net Loss Per Share (Details) - Schedule of Potential Common Shares Excluded from Diluted Net Loss Per Share", "shortName": "Basic and Diluted Net Loss Per Share (Details) - Schedule of Potential Common Shares Excluded from Diluted Net Loss Per Share", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "111", "firstAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "cslr:CommonStockWarrants", "unitRef": "Unit_shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P01_01_2023To10_01_2023", "name": "cslr:CommonStockWarrants", "unitRef": "Unit_shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R112": { "role": "http://www.completesolaria.com/role/RelatedPartyTransactionsDetails", "longName": "1112 - Disclosure - Related Party Transactions (Details)", "shortName": "Related Party Transactions (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "112", "firstAnchor": { "contextRef": "P12_31_2022To12_31_2022", "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "div", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P12_31_2022To12_31_2022", "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "div", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } }, "R113": { "role": "http://www.completesolaria.com/role/SubsequentEventsDetails", "longName": "1113 - Disclosure - Subsequent Events (Details)", "shortName": "Subsequent Events (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "113", "firstAnchor": { "contextRef": "P10_31_2023To10_31_2023", "name": "cslr:AggregateAmountOfPurchasePrice", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "div", "us-gaap:SubsequentEventsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P10_31_2023To10_31_2023", "name": "cslr:AggregateAmountOfPurchasePrice", "unitRef": "Unit_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "div", "us-gaap:SubsequentEventsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d474289dex991.htm", "first": true, "unique": true } } }, "tag": { "us-gaap_RelatedPartyTransactionAmountsOfTransaction": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionAmountsOfTransaction", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction, Amounts of Transaction", "terseLabel": "Related party issued", "documentation": "Amount of transactions with related party during the financial reporting period." } } }, "auth_ref": [ "r163", "r756" ] }, "us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncrementalCommonSharesAttributableToEquityForwardAgreements", "presentation": [ "http://www.completesolaria.com/role/BasicAndDilutedNetLossPerShareDetailsScheduleOfPotentialCommonSharesExcludedFromDilutedNetLossPerShare" ], "lang": { "en-us": { "role": { "label": "Incremental Common Shares Attributable to Dilutive Effect of Equity Forward Agreements", "terseLabel": "SAFE agreements", "documentation": "Additional shared included in the calculation of diluted EPS as a result of the potentially dilutive effect of equity forward arrangements using the reverse treasury stock method." } } }, "auth_ref": [ "r408", "r1002" ] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfFinancialAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Fair Value, Inputs, Level 1 [Member]", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r554", "r579", "r584", "r701", "r767", "r1026", "r1027", "r1028" ] }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetailsScheduleOfFutureMinimumLeasePaymentsUnderNonCancelable" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedLabel": "Less: imputed interest", "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease." } } }, "auth_ref": [ "r747" ] }, "us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncrementalCommonSharesAttributableToContingentlyIssuableShares", "presentation": [ "http://www.completesolaria.com/role/BasicAndDilutedNetLossPerShareDetailsScheduleOfPotentialCommonSharesExcludedFromDilutedNetLossPerShare" ], "lang": { "en-us": { "role": { "label": "Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares", "terseLabel": "Stock options and RSUs issued and outstanding", "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of contingently issuable shares. Contingently issuable shares are those shares that are issuable for little or no cash contingent on certain conditions being met." } } }, "auth_ref": [ "r393", "r394", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r408" ] }, "us-gaap_OperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiability", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetails", "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetailsScheduleOfFutureMinimumLeasePaymentsUnderNonCancelable" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Liability", "verboseLabel": "Operating lease lease liability", "terseLabel": "Present value of operating lease liabilities", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease." } } }, "auth_ref": [ "r738" ] }, "us-gaap_GoodwillAndIntangibleAssetImpairment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetImpairment", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Asset Impairment", "terseLabel": "Goodwill impairment", "documentation": "Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill." } } }, "auth_ref": [] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfFinancialAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Fair Value, Inputs, Level 3 [Member]", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r554", "r579", "r580", "r581", "r582", "r583", "r584", "r701", "r769", "r1014", "r1015", "r1026", "r1027", "r1028" ] }, "us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncrementalCommonSharesAttributableToConversionOfDebtSecurities", "presentation": [ "http://www.completesolaria.com/role/BasicAndDilutedNetLossPerShareDetailsScheduleOfPotentialCommonSharesExcludedFromDilutedNetLossPerShare" ], "lang": { "en-us": { "role": { "label": "Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities", "terseLabel": "Convertible notes", "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method." } } }, "auth_ref": [ "r396", "r397", "r408" ] }, "us-gaap_FairValueInputsLevel2Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel2Member", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfFinancialAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Fair Value, Inputs, Level 2 [Member]", "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets." } } }, "auth_ref": [ "r554", "r579", "r584", "r701", "r768", "r1014", "r1015", "r1026", "r1027", "r1028" ] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetailsScheduleOfAccruedExpensesAndOtherCurrentLiabilities", "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Liability, Current", "terseLabel": "Operating lease liabilities, current", "verboseLabel": "Operating lease liability current", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r738" ] }, "us-gaap_RelatedPartyTransactionRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionRate", "presentation": [ "http://www.completesolaria.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction, Rate", "terseLabel": "Accrued interest percentage", "documentation": "Identify the stated interest rate per the agreement, for example, leasing and debt arrangements between related parties." } } }, "auth_ref": [] }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "presentation": [ "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "terseLabel": "Schedule of Amortization Expense Related to Intangible Assets", "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets." } } }, "auth_ref": [ "r92" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.completesolaria.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1053" ] }, "us-gaap_LongtermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeDomain", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfCompanySOutstandingNotesPayable", "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfConvertibleNotes", "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfInterestExpenseOnConvertibleDebt", "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfNetCarryingAmountOfTheConvertibleNotes", "http://www.completesolaria.com/role/BorrowingArrangementsTables", "http://www.completesolaria.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Type [Domain]", "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r58", "r96" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems", "presentation": [ "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Indefinite-Lived Intangible Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "srt_StatementScenarioAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementScenarioAxis", "presentation": [ "http://www.completesolaria.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetailsScheduleOfAccruedExpensesAndOtherCurrentLiabilities", "http://www.completesolaria.com/role/CommonStockDetailsScheduleOfReservedSharesOfCommonStock", "http://www.completesolaria.com/role/DivestitureDetailsScheduleOfMajorCategoriesOfAssetsAndLiabilitiesHeldForSale", "http://www.completesolaria.com/role/DivestitureDetailsScheduleOfOperationsAndComprehensiveIncomeLossRelatedToDiscontinuedOperations", "http://www.completesolaria.com/role/OtherIncomeExpenseNetDetailsScheduleOfOtherIncomeExpenseNet" ], "lang": { "en-us": { "role": { "label": "srt_StatementScenarioAxis", "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts." } } }, "auth_ref": [ "r388", "r588", "r1063", "r1065", "r1118" ] }, "us-gaap_DebtInstrumentIssuedPrincipal": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentIssuedPrincipal", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Issued, Principal", "terseLabel": "Total Principal amount", "documentation": "Amount of principal of debt issued." } } }, "auth_ref": [ "r867" ] }, "srt_TitleOfIndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "TitleOfIndividualAxis", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]", "documentation": "Information by title of individual or nature of relationship to individual or group of individuals." } } }, "auth_ref": [ "r1123", "r1203" ] }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsDisclosureTextBlock", "presentation": [ "http://www.completesolaria.com/role/RelatedPartyTransactions" ], "lang": { "en-us": { "role": { "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "Related Party Transactions", "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r753", "r754", "r755", "r757", "r760", "r875", "r876", "r877", "r939", "r940", "r941", "r960", "r961" ] }, "srt_ScenarioUnspecifiedDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScenarioUnspecifiedDomain", "presentation": [ "http://www.completesolaria.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetailsScheduleOfAccruedExpensesAndOtherCurrentLiabilities", "http://www.completesolaria.com/role/CommonStockDetailsScheduleOfReservedSharesOfCommonStock", "http://www.completesolaria.com/role/DivestitureDetailsScheduleOfMajorCategoriesOfAssetsAndLiabilitiesHeldForSale", "http://www.completesolaria.com/role/DivestitureDetailsScheduleOfOperationsAndComprehensiveIncomeLossRelatedToDiscontinuedOperations", "http://www.completesolaria.com/role/OtherIncomeExpenseNetDetailsScheduleOfOtherIncomeExpenseNet" ], "lang": { "en-us": { "role": { "label": "srt_ScenarioUnspecifiedDomain", "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts." } } }, "auth_ref": [ "r388", "r588", "r1063", "r1118" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 29.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Operating lease liabilities, net of current portion", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r738" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.completesolaria.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "terseLabel": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "us-gaap_PaymentsToAcquireSoftware": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireSoftware", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 40.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payments to Acquire Software", "negatedLabel": "Capitalization of internal-use software costs", "documentation": "The cash outflow associated with the acquisition from vendors of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization." } } }, "auth_ref": [ "r220" ] }, "us-gaap_RelatedPartyTransactionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionLineItems", "presentation": [ "http://www.completesolaria.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r937", "r938", "r941" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period", "terseLabel": "Share based compensation by share based award expiration period", "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r1033" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.completesolaria.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "terseLabel": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r1055" ] }, "us-gaap_FinancialGuaranteeInsuranceContractsClaimLiabilityWeightedAverageRiskFreeDiscountRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancialGuaranteeInsuranceContractsClaimLiabilityWeightedAverageRiskFreeDiscountRate", "presentation": [ "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Financial Guarantee Insurance Contracts, Claim Liability, Weighted Average Risk Free Discount Rate", "terseLabel": "Risk free interest rate", "documentation": "This element represents the weighted average risk free rate used to discount the claim liability related to financial guarantee insurance contracts." } } }, "auth_ref": [ "r171" ] }, "us-gaap_AccountingStandardsUpdate201602Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingStandardsUpdate201602Member", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Accounting Standards Update 2016-02 [Member]", "documentation": "Accounting Standards Update 2016-02 Leases (Topic 842)." } } }, "auth_ref": [ "r732" ] }, "us-gaap_RestructuringReserveSettledWithoutCash2": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringReserveSettledWithoutCash2", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/ReverseRecapitalizationDetails" ], "lang": { "en-us": { "role": { "label": "Restructuring Reserve, Settled without Cash", "terseLabel": "Net cash proceeds", "documentation": "Amount of decrease in the reserve for full or partial settlement through consideration other than cash." } } }, "auth_ref": [ "r526", "r528" ] }, "us-gaap_DebtConversionByUniqueDescriptionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtConversionByUniqueDescriptionAxis", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfSignificantUnobservableInputsLevel3AndTheChangeInFairValueRecordedInOtherIncomeExpenseNet" ], "lang": { "en-us": { "role": { "label": "Debt Conversion Description [Axis]", "documentation": "Information by description of debt issuances converted in a noncash or part noncash transaction." } } }, "auth_ref": [ "r75", "r77" ] }, "us-gaap_OperatingLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseCost", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 36.0 } }, "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetails", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Cost", "terseLabel": "Non-cash lease expense", "positiveLabel": "Operating lease costs", "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability." } } }, "auth_ref": [ "r741", "r1038" ] }, "us-gaap_VariableLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableLeaseCost", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Variable Lease, Cost", "terseLabel": "Variable lease cost", "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases." } } }, "auth_ref": [ "r742", "r1038" ] }, "us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueTreasuryStockReissued", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Value, Treasury Stock Reissued", "terseLabel": "Issuance of common stock upon the reverse capitalization, net of offering costs", "documentation": "Value of treasury shares or units reissued. Excludes reissuance of shares or units in treasury for award under share-based payment arrangement." } } }, "auth_ref": [ "r30", "r113", "r193", "r194", "r241" ] }, "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Significant Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsNetExcludingGoodwill", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetailsScheduleOfIntangibleAssets" ], "lang": { "en-us": { "role": { "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Net Amount", "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges." } } }, "auth_ref": [ "r88", "r91" ] }, "us-gaap_DebtInstrumentConvertibleConversionRatio1": { "xbrltype": "pureItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentConvertibleConversionRatio1", "presentation": [ "http://www.completesolaria.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Convertible, Conversion Ratio", "terseLabel": "Debt instrument, convertible, conversion ratio", "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount." } } }, "auth_ref": [ "r56", "r110", "r239", "r240", "r548" ] }, "us-gaap_ConversionOfStockSharesConverted1": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConversionOfStockSharesConverted1", "presentation": [ "http://www.completesolaria.com/role/ReverseRecapitalizationDetailsScheduleOfCommonStockOutstanding" ], "lang": { "en-us": { "role": { "label": "Conversion of Stock, Shares Converted", "terseLabel": "2022 Convertible Note Shares", "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r75", "r76", "r77" ] }, "us-gaap_DeferredRevenueNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredRevenueNoncurrent", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 28.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Deferred Revenue, Noncurrent", "terseLabel": "Deferred revenue, noncurrent", "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent." } } }, "auth_ref": [ "r1092" ] }, "cslr_IncomeTaxDisclosureTable": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "IncomeTaxDisclosureTable", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetails", "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfProvisionForIncomeTaxes" ], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Table]", "documentation": "Income tax disclosure." } } }, "auth_ref": [] }, "us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AcceleratedShareRepurchasesFinalPricePaidPerShare", "presentation": [ "http://www.completesolaria.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "label": "Accelerated Share Repurchases, Final Price Paid Per Share", "terseLabel": "Purchase price per share (in Dollars per share)", "documentation": "Final price paid per share for the purchase of the targeted number of shares, determined by an average market price over a fixed period of time." } } }, "auth_ref": [ "r242" ] }, "us-gaap_ConversionOfStockAmountIssued1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConversionOfStockAmountIssued1", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Conversion of Stock, Amount Issued", "terseLabel": "Conversion of preferred stock into common stock", "documentation": "The value of the financial instrument issued [noncash or part noncash] in the conversion of stock. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r75", "r76", "r77" ] }, "cslr_TrancheOneMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "TrancheOneMember", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Tranche One [Member]" } } }, "auth_ref": [] }, "us-gaap_LesseeLeasesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeLeasesPolicyTextBlock", "presentation": [ "http://www.completesolaria.com/role/AccountingPoliciesByPolicyPolicies" ], "lang": { "en-us": { "role": { "label": "Lessee, Leases [Policy Text Block]", "terseLabel": "Leases", "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee." } } }, "auth_ref": [ "r740" ] }, "cslr_Settlements": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "Settlements", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetailsScheduleOfActivityPeriodRelatingToTheCompanysWarrantyProvision" ], "lang": { "en-us": { "role": { "label": "Settlements", "terseLabel": "Settlements", "documentation": "Settlements." } } }, "auth_ref": [] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetails", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Additional Paid-in Capital [Member]", "verboseLabel": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r624", "r625", "r626", "r879", "r1114", "r1115", "r1116", "r1194", "r1232" ] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 33.0 } }, "presentation": [ "http://www.completesolaria.com/role/ReverseRecapitalizationDetails", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital", "verboseLabel": "Additional paid in capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r195", "r1039", "r1228" ] }, "us-gaap_ProfessionalFees": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProfessionalFees", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/ReverseRecapitalizationDetails" ], "lang": { "en-us": { "role": { "label": "Professional Fees", "terseLabel": "Professional fees", "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer." } } }, "auth_ref": [ "r1050", "r1230", "r1231" ] }, "cslr_AccrualsForNewWarrantiesIssued": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "AccrualsForNewWarrantiesIssued", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetailsScheduleOfActivityPeriodRelatingToTheCompanysWarrantyProvision" ], "lang": { "en-us": { "role": { "label": "Accruals For New Warranties Issued", "terseLabel": "Accruals for new warranties issued", "documentation": "Accruals for new warranties issued." } } }, "auth_ref": [] }, "us-gaap_AcceleratedShareRepurchasesInitialPricePaidPerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AcceleratedShareRepurchasesInitialPricePaidPerShare", "presentation": [ "http://www.completesolaria.com/role/ForwardPurchaseAgreementsDetails" ], "lang": { "en-us": { "role": { "label": "Accelerated Share Repurchases, Initial Price Paid Per Share", "terseLabel": "Initial price", "documentation": "The price paid per share to immediately purchase the targeted number of shares on the date of executing the accelerated share repurchase agreement." } } }, "auth_ref": [ "r242" ] }, "cslr_TrancheAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "TrancheAxis", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfCompanySOutstandingNotesPayable" ], "lang": { "en-us": { "role": { "label": "Tranche [Axis]" } } }, "auth_ref": [] }, "cslr_WarrantyLiabilityFromBusinessCombination": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "WarrantyLiabilityFromBusinessCombination", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetailsScheduleOfActivityPeriodRelatingToTheCompanysWarrantyProvision" ], "lang": { "en-us": { "role": { "label": "Warranty Liability From Business Combination", "terseLabel": "Warranty liability from Business Combination", "documentation": "Warranty liability from Business Combination." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetUsefulLife", "presentation": [ "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetails", "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetailsScheduleOfFiniteLivedIntangibleAssets" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Asset, Useful Life", "verboseLabel": "Assembled workforce", "terseLabel": "Finite-lived intangible asset, useful life", "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/CommonStockDetails", "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetails", "http://www.completesolaria.com/role/OrganizationDetails", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r30", "r63", "r318", "r347", "r348", "r349", "r371", "r372", "r373", "r375", "r385", "r387", "r413", "r488", "r494", "r576", "r624", "r625", "r626", "r653", "r654", "r678", "r680", "r681", "r682", "r683", "r685", "r695", "r719", "r720", "r721", "r722", "r723", "r725", "r752", "r851", "r852", "r853", "r879", "r957" ] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityDomain", "presentation": [ "http://www.completesolaria.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Entity [Domain]", "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt", "terseLabel": "Additional convertible note", "documentation": "Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital." } } }, "auth_ref": [ "r97" ] }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 41.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payments to Acquire Businesses, Net of Cash Acquired", "negatedLabel": "Payments for acquisition of business, net of cash acquired", "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase." } } }, "auth_ref": [ "r68" ] }, "cslr_PublicWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "PublicWarrantsMember", "presentation": [ "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Public Warrants Member", "terseLabel": "Public Warrants [Member]" } } }, "auth_ref": [] }, "cslr_TrancheDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "TrancheDomain", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfCompanySOutstandingNotesPayable" ], "lang": { "en-us": { "role": { "label": "Tranche [Domain]" } } }, "auth_ref": [] }, "cslr_PublicPrivatePlacementAndWorkingCapitalWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "PublicPrivatePlacementAndWorkingCapitalWarrantsMember", "presentation": [ "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Public Private Placement And Working Capital Warrants Member", "terseLabel": "Public, Private Placement, and Working Capital Warrants [Member]" } } }, "auth_ref": [] }, "us-gaap_ConvertibleNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConvertibleNotesPayable", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfConvertibleNotes" ], "lang": { "en-us": { "role": { "label": "Convertible Notes Payable", "terseLabel": "2022 Convertible Notes", "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder." } } }, "auth_ref": [ "r43", "r270", "r1216" ] }, "cslr_InterestPayableOnConvertibleDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "InterestPayableOnConvertibleDebt", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Interest Payable On Convertible Debt", "terseLabel": "Interest payable on convertble debt", "documentation": "Interest payable on convertible debt." } } }, "auth_ref": [] }, "cslr_WarrantConsiderationMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "WarrantConsiderationMember", "presentation": [ "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Warrant Consideration Member", "terseLabel": "Warrant Consideration [Member]" } } }, "auth_ref": [] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LegalEntityAxis", "presentation": [ "http://www.completesolaria.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "us-gaap_ConvertibleDebtCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConvertibleDebtCurrent", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfConvertibleNotes" ], "lang": { "en-us": { "role": { "label": "Convertible Debt, Current", "terseLabel": "Convertible Debt, Current", "documentation": "The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder." } } }, "auth_ref": [ "r187" ] }, "us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Debt Conversion, Converted Instrument, Warrants or Options Issued", "terseLabel": "Shares, issued (in Shares)", "documentation": "The number of warrants issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r75", "r77" ] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfConvertibleNotes", "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfWarrantsBasedOnABlackScholesOptionPricingMethod", "http://www.completesolaria.com/role/ForwardPurchaseAgreementsDetails", "http://www.completesolaria.com/role/OrganizationDetails", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlowsParentheticals", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossParentheticals", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficitParentheticals", "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Related Party, Type [Axis]", "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r585", "r756", "r757", "r802", "r803", "r804", "r805", "r806", "r807", "r808", "r809", "r810", "r811", "r812", "r813", "r903", "r904", "r905", "r906", "r907", "r929", "r931", "r962", "r1204" ] }, "cslr_July2023CommonStockWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "July2023CommonStockWarrantsMember", "presentation": [ "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "July2023 Common Stock Warrants Member", "terseLabel": "July 2023 Common Stock Warrants [Member]" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationDisclosureTextBlock", "presentation": [ "http://www.completesolaria.com/role/BusinessCombination" ], "lang": { "en-us": { "role": { "label": "Business Combination Disclosure [Text Block]", "terseLabel": "Business Combination", "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable)." } } }, "auth_ref": [ "r256", "r663" ] }, "cslr_SCITermLoanAndRevolverLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "SCITermLoanAndRevolverLoanMember", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "SCITerm Loan And Revolver Loan Member", "terseLabel": "SCI Term Loan and Revolver Loan [Member]" } } }, "auth_ref": [] }, "us-gaap_ConvertibleDebtMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConvertibleDebtMember", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfSignificantUnobservableInputsLevel3AndTheChangeInFairValueRecordedInOtherIncomeExpenseNet" ], "lang": { "en-us": { "role": { "label": "Convertible Debt [Member]", "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock." } } }, "auth_ref": [ "r236", "r546", "r547", "r552", "r553", "r554", "r557", "r558", "r559", "r560", "r561", "r1013", "r1014", "r1015", "r1016", "r1017" ] }, "cslr_ForgivenessOfPaycheckProtectionPlanLoan": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ForgivenessOfPaycheckProtectionPlanLoan", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/OtherIncomeExpenseNetDetailsScheduleOfOtherIncomeExpenseNet" ], "lang": { "en-us": { "role": { "label": "Forgiveness of Paycheck Protection Plan Loan", "terseLabel": "Forgiveness of Paycheck Protection Plan loan", "documentation": "Forgiveness of paycheck protection plan loan." } } }, "auth_ref": [] }, "us-gaap_ConversionOfStockSharesIssued1": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConversionOfStockSharesIssued1", "presentation": [ "http://www.completesolaria.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "label": "Conversion of Stock, Shares Issued", "terseLabel": "Originally shares issued", "documentation": "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r75", "r76", "r77" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations", "totalLabel": "Net cash used in operating activities from continuing operations", "documentation": "Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r221", "r222", "r223" ] }, "us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfFinancialAssetsAndLiabilities", "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfReconciliationOfEmbeddedDerivativeLiability" ], "lang": { "en-us": { "role": { "label": "Embedded Derivative, Fair Value of Embedded Derivative Liability", "terseLabel": "Convertible debt embedded derivatives", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "documentation": "Fair value as of the balance sheet date of the embedded derivative or group of embedded derivatives classified as a liability." } } }, "auth_ref": [ "r144" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/DivestitureDetailsScheduleOfOperationsAndComprehensiveIncomeLossRelatedToDiscontinuedOperations": { "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.completesolaria.com/role/DivestitureDetailsScheduleOfOperationsAndComprehensiveIncomeLossRelatedToDiscontinuedOperations" ], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, General and Administrative Expense", "terseLabel": "General and administrative", "documentation": "Amount of general and administrative expense attributable to disposal group, including, but not limited to, discontinued operation." } } }, "auth_ref": [ "r184" ] }, "cslr_TwoThousandTwentyTwoConvertibleNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "TwoThousandTwentyTwoConvertibleNotesMember", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Two Thousand Twenty Two Convertible Notes Member", "terseLabel": "2022 Convertible Notes [Member]" } } }, "auth_ref": [] }, "cslr_IncentiveStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "IncentiveStockOptionMember", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "label": "Incentive Stock Option [Member]", "documentation": "Incentive stock option." } } }, "auth_ref": [] }, "cslr_ScheduleOfReservedSharesOfCommonStockAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ScheduleOfReservedSharesOfCommonStockAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Reserved Shares Of Common Stock Abstract" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInDiscontinuedOperations", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 37.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Discontinued Operations", "terseLabel": "Net cash provided by operating activities from discontinued operations", "documentation": "Increase (decrease) in cash associated with the entity's discontinued operations." } } }, "auth_ref": [ "r221" ] }, "cslr_TwoThousandNinteenSAFEMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "TwoThousandNinteenSAFEMember", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Two Thousand Ninteen SAFEMember", "terseLabel": "2019 SAFE [Member]" } } }, "auth_ref": [] }, "cslr_CommonStockDetailsScheduleofReservedSharesofCommonStockTable": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "CommonStockDetailsScheduleofReservedSharesofCommonStockTable", "presentation": [ "http://www.completesolaria.com/role/CommonStockDetailsScheduleOfReservedSharesOfCommonStock" ], "lang": { "en-us": { "role": { "label": "Common Stock (Details) - Schedule of Reserved Shares of Common Stock [Table]" } } }, "auth_ref": [] }, "us-gaap_SubadvisoryFeesForMutualFunds": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubadvisoryFeesForMutualFunds", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Subadvisory Fees for Mutual Funds", "terseLabel": "Advisory fee", "documentation": "Subadvisory fees that the funds adviser pays for out of the management fee, which it receives from the fund." } } }, "auth_ref": [ "r277" ] }, "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfCompanySOutstandingNotesPayable" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net", "terseLabel": "Less: Unamortized debt issuance costs and discounts", "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs." } } }, "auth_ref": [ "r161", "r552", "r564", "r1014", "r1015" ] }, "us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BasicAndDilutedNetLossPerShareDetailsScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholders" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Basic", "terseLabel": "Net Loss from discontinued operations", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) from discontinued operations available to common shareholders." } } }, "auth_ref": [] }, "cslr_CommonStockDetailsScheduleofReservedSharesofCommonStockLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "CommonStockDetailsScheduleofReservedSharesofCommonStockLineItems", "presentation": [ "http://www.completesolaria.com/role/CommonStockDetailsScheduleOfReservedSharesOfCommonStock" ], "lang": { "en-us": { "role": { "label": "Schedule of Reserved Shares of Common Stock [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtConversionConvertedInstrumentSharesIssued1", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Debt Conversion, Converted Instrument, Shares Issued", "terseLabel": "Converted, shares (in Shares)", "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period." } } }, "auth_ref": [ "r75", "r77" ] }, "cslr_StockOptionsAndRSUsIssuedAndOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "StockOptionsAndRSUsIssuedAndOutstanding", "presentation": [ "http://www.completesolaria.com/role/CommonStockDetailsScheduleOfReservedSharesOfCommonStock" ], "lang": { "en-us": { "role": { "label": "Stock Options And RSUs Issued And Outstanding", "terseLabel": "Stock options and RSUs, issued and outstanding", "documentation": "Number of stock options and RSUs, issued and outstanding." } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 42.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities from continuing operations", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r358" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationOtherIncome", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/DivestitureDetailsScheduleOfOperationsAndComprehensiveIncomeLossRelatedToDiscontinuedOperations": { "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.completesolaria.com/role/DivestitureDetailsScheduleOfOperationsAndComprehensiveIncomeLossRelatedToDiscontinuedOperations" ], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Other Income", "terseLabel": "Other income (expense), net", "documentation": "Amount of other income attributable to disposal group, including, but not limited to, discontinued operation." } } }, "auth_ref": [ "r184" ] }, "cslr_ScheduleOfSummaryOfRsuActivityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ScheduleOfSummaryOfRsuActivityAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Summary Of Rsu Activity Abstract" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 25.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities", "terseLabel": "Accrued expenses and other current liabilities", "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other." } } }, "auth_ref": [ "r1103" ] }, "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromDebtNetOfIssuanceCosts", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 45.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from Debt, Net of Issuance Costs", "terseLabel": "Proceeds from issuance of convertible notes, net of issuance cost", "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination." } } }, "auth_ref": [ "r355" ] }, "cslr_TotalShareReserved": { "xbrltype": "sharesItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "TotalShareReserved", "presentation": [ "http://www.completesolaria.com/role/CommonStockDetailsScheduleOfReservedSharesOfCommonStock" ], "lang": { "en-us": { "role": { "label": "Total Share Reserved", "terseLabel": "Total shares reserved", "documentation": "Number of shares reserved." } } }, "auth_ref": [] }, "us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfReconciliationOfEmbeddedDerivativeLiability" ], "lang": { "en-us": { "role": { "label": "Embedded Derivative, Gain (Loss) on Embedded Derivative, Net", "terseLabel": "Change in fair value", "verboseLabel": "Embedded derivative liabilities unrealized gains losses", "documentation": "Net Increase or Decrease in the fair value of the embedded derivative or group of embedded derivatives included in earnings in the period." } } }, "auth_ref": [ "r1193" ] }, "cslr_TwoThousandTwentyOneSafeMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "TwoThousandTwentyOneSafeMember", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Two Thousand Twenty One Safe Member", "terseLabel": "2021 SAFE [Member]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 38.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities from continuing operations", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r358" ] }, "cslr_SummaryOfSummaryOfStockOptionActivityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "SummaryOfSummaryOfStockOptionActivityAbstract", "lang": { "en-us": { "role": { "label": "Summary Of Summary Of Stock Option Activity Abstract" } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/CommonStockDetails", "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetails", "http://www.completesolaria.com/role/OrganizationDetails", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r30", "r318", "r347", "r348", "r349", "r371", "r372", "r373", "r375", "r385", "r387", "r413", "r488", "r494", "r576", "r624", "r625", "r626", "r653", "r654", "r678", "r680", "r681", "r682", "r683", "r685", "r695", "r719", "r720", "r721", "r722", "r723", "r725", "r752", "r851", "r852", "r853", "r879", "r957" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash flows from financing activities from continuing operations" } } }, "auth_ref": [] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accumulated Other Comprehensive Income", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r16", "r29", "r66", "r680", "r683", "r752", "r851", "r852", "r1100", "r1101", "r1102", "r1114", "r1115", "r1116" ] }, "cslr_CurrentInsightPromissoryNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "CurrentInsightPromissoryNoteMember", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfCompanySOutstandingNotesPayable" ], "lang": { "en-us": { "role": { "label": "Current Insight Promissory Note Member", "terseLabel": "Current Insight Promissory Note [Member]" } } }, "auth_ref": [] }, "cslr_ScheduleOfStockBasedCompensationExpenseAndItsAllocationWithinTheAccompanyingUnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ScheduleOfStockBasedCompensationExpenseAndItsAllocationWithinTheAccompanyingUnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Stock Based Compensation Expense And Its Allocation Within The Accompanying Unaudited Condensed Consolidated Statements Of Operations And Comprehensive Loss Abstract" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash flows from investing activities from continuing operations" } } }, "auth_ref": [] }, "cslr_StockOptionsAuthorizedForFutureIssuance": { "xbrltype": "sharesItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "StockOptionsAuthorizedForFutureIssuance", "presentation": [ "http://www.completesolaria.com/role/CommonStockDetailsScheduleOfReservedSharesOfCommonStock" ], "lang": { "en-us": { "role": { "label": "Stock Options Authorized For Future Issuance", "terseLabel": "Stock options, authorized for future issuance", "documentation": "Stock options authorized for future issuance." } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r221", "r222", "r223" ] }, "cslr_TwoZeroTwoOnePromissoryNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "TwoZeroTwoOnePromissoryNotesMember", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfCompanySOutstandingNotesPayable" ], "lang": { "en-us": { "role": { "label": "Two Zero Two One Promissory Notes Member", "terseLabel": "2021 Promissory Notes [Member]" } } }, "auth_ref": [] }, "cslr_SalesAndMarketingMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "SalesAndMarketingMember", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetailsScheduleOfStockBasedCompensationExpenseAndItsAllocationWithinTheAccompanyingUnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Sales And Marketing Member", "terseLabel": "Sales and marketing [Member]" } } }, "auth_ref": [] }, "cslr_ReverseRecapitalizationTheEstimatedFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ReverseRecapitalizationTheEstimatedFairValue", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Reverse Recapitalization The Estimated Fair Value", "terseLabel": "Estimated fair value", "documentation": "Reverse recapitalization the estimated fair value." } } }, "auth_ref": [] }, "cslr_StockOptionsIssuedAndOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "StockOptionsIssuedAndOutstanding", "presentation": [ "http://www.completesolaria.com/role/CommonStockDetailsScheduleOfReservedSharesOfCommonStock" ], "lang": { "en-us": { "role": { "label": "Stock Options Issued And Outstanding", "terseLabel": "Stock options, issued and outstanding", "documentation": "Stock options issued and outstanding." } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash flows from operating activities from continuing operations" } } }, "auth_ref": [] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities", "totalLabel": "Total liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r52", "r364", "r484", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r670", "r673", "r674", "r708", "r909", "r1004", "r1052", "r1148", "r1205", "r1206" ] }, "cslr_ClassACommonStockEqualsOrExceedsThresholdTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ClassACommonStockEqualsOrExceedsThresholdTwoMember", "presentation": [ "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Class ACommon Stock Equals Or Exceeds Threshold Two Member", "terseLabel": "Class A Common Stock Equals or Exceeds Threshold Two [Member]" } } }, "auth_ref": [] }, "cslr_TwoZeroOneEightBridgeNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "TwoZeroOneEightBridgeNotesMember", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Two Zero One Eight Bridge Notes Member", "terseLabel": "2018 Bridge Notes [Member]" } } }, "auth_ref": [] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 6.0 }, "http://www.completesolaria.com/role/StockBasedCompensationDetailsScheduleOfStockBasedCompensationExpenseAndItsAllocationWithinTheAccompanyingUnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetails", "http://www.completesolaria.com/role/StockBasedCompensationDetailsScheduleOfStockBasedCompensationExpenseAndItsAllocationWithinTheAccompanyingUnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Expense", "terseLabel": "Stock-based compensation expense", "definitionGuidance": "Stock based compensation expenses (in Dollars)", "totalLabel": "Total stock-based compensation expense", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r619", "r628" ] }, "cslr_CommonStockCapitalSharesReservedSimpleAgreementForFutureEquity": { "xbrltype": "sharesItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "CommonStockCapitalSharesReservedSimpleAgreementForFutureEquity", "presentation": [ "http://www.completesolaria.com/role/CommonStockDetailsScheduleOfReservedSharesOfCommonStock" ], "lang": { "en-us": { "role": { "label": "Common Stock Capital Shares Reserved Simple Agreement For Future Equity", "terseLabel": "SAFE agreement", "documentation": "Common stock capital shares reserved simple agreement for future equity." } } }, "auth_ref": [] }, "cslr_CSSoilsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "CSSoilsMember", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "CSSoils Member", "terseLabel": "CS Soils [Member]" } } }, "auth_ref": [] }, "cslr_VendorSettlementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "VendorSettlementMember", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Vendor Settlement [Member]", "documentation": "Vendor Settlement." } } }, "auth_ref": [] }, "cslr_ShareBasedCompensationExpenseGross": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ShareBasedCompensationExpenseGross", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/StockBasedCompensationDetailsScheduleOfStockBasedCompensationExpenseAndItsAllocationWithinTheAccompanyingUnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_AllocatedShareBasedCompensationExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetailsScheduleOfStockBasedCompensationExpenseAndItsAllocationWithinTheAccompanyingUnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Share Based Compensation Expense Gross", "terseLabel": "Share based compensation expense gross", "documentation": "Gross amount of share based compensation." } } }, "auth_ref": [] }, "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConvertiblePreferredStockSharesIssuedUponConversion", "presentation": [ "http://www.completesolaria.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Convertible Preferred Stock, Shares Issued upon Conversion", "terseLabel": "Conversion shares", "documentation": "Number of shares issued for each share of convertible preferred stock that is converted." } } }, "auth_ref": [ "r44", "r110", "r193", "r239", "r572" ] }, "cslr_CommonStockCapitalSharesReservedConvertibleNotes": { "xbrltype": "sharesItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "CommonStockCapitalSharesReservedConvertibleNotes", "presentation": [ "http://www.completesolaria.com/role/CommonStockDetailsScheduleOfReservedSharesOfCommonStock" ], "lang": { "en-us": { "role": { "label": "Common Stock Capital Shares Reserved Convertible Notes", "terseLabel": "Convertible notes", "documentation": "Common stock capital shares reserved convertible notes." } } }, "auth_ref": [] }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetailsScheduleOfStockBasedCompensationExpenseAndItsAllocationWithinTheAccompanyingUnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 16.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts Payable and Other Accrued Liabilities, Current", "terseLabel": "Accrued expenses and other current liabilities", "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer." } } }, "auth_ref": [] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesIssued", "presentation": [ "http://www.completesolaria.com/role/CommonStockDetails" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock issued", "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt." } } }, "auth_ref": [ "r193", "r567" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "cslr_WarrantsDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "WarrantsDetailsTable", "presentation": [ "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Warrants (Details) [Table]" } } }, "auth_ref": [] }, "cslr_RepaidThePrincipalAndAccruedInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "RepaidThePrincipalAndAccruedInterest", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Repaid The Principal And Accrued Interest", "terseLabel": "Repaid the principal and accrued interest", "documentation": "The amount of repaid principal and accrued interest." } } }, "auth_ref": [] }, "cslr_ConvertibleSecuredNotes": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ConvertibleSecuredNotes", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Convertible Secured Notes", "terseLabel": "Convertible secured notes", "documentation": "The amount of convertible secured notes." } } }, "auth_ref": [] }, "cslr_CRSEFSolisHoldingsLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "CRSEFSolisHoldingsLLCMember", "presentation": [ "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "CRSEFSolis Holdings LLCMember", "terseLabel": "CRSEF Solis Holdings, LLC [Member]" } } }, "auth_ref": [] }, "cslr_LegalMattersMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "LegalMattersMember", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Legal Matters Member", "terseLabel": "Legal Matters [Member]" } } }, "auth_ref": [] }, "us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableAllowanceForCreditLossTableTextBlock", "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable, Allowance for Credit Loss [Table Text Block]", "terseLabel": "Schedule of Allowance for Doubtful Accounts", "documentation": "Tabular disclosure of allowance for credit loss on accounts receivable." } } }, "auth_ref": [ "r1132" ] }, "cslr_InterestRate": { "xbrltype": "percentItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "InterestRate", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Interest Rate", "terseLabel": "Interest rate", "documentation": "Percentage of interest rate." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensation", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/DivestitureDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Noncash Expense", "terseLabel": "Stock-based compensation expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r23" ] }, "us-gaap_DepositAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepositAssets", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetailsScheduleOfAccruedExpensesAndOtherCurrentLiabilities" ], "lang": { "en-us": { "role": { "label": "Deposit Assets", "terseLabel": "Customer deposits", "documentation": "The carrying amount of the asset transferred to a third party to serve as a deposit, which typically serves as security against failure by the transferor to perform under terms of an agreement." } } }, "auth_ref": [ "r1090" ] }, "cslr_IncreasedRepaymentPremiumPercentage": { "xbrltype": "percentItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "IncreasedRepaymentPremiumPercentage", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Increased Repayment Premium Percentage", "terseLabel": "Increased repayment premium, percentage", "documentation": "Percentage of increased repayment premium, percentage." } } }, "auth_ref": [] }, "cslr_PrimeRatePlus": { "xbrltype": "percentItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "PrimeRatePlus", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Prime Rate Plus", "terseLabel": "Prime rate plus", "documentation": "Percentage of prime rate plus." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.completesolaria.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "cslr_BlackScholesModelMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "BlackScholesModelMember", "presentation": [ "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Black Scholes Model Member", "terseLabel": "Black-Scholes model [Member]" } } }, "auth_ref": [] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://www.completesolaria.com/role/CommonStockDetails" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r193", "r911" ] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Cash paid during the year for interest", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r356", "r359", "r360" ] }, "cslr_SolarParkKoreaCoLTDMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "SolarParkKoreaCoLTDMember", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Solar Park Korea Co LTDMember", "terseLabel": "SolarPark Korea Co., LTD [Member]" } } }, "auth_ref": [] }, "us-gaap_RedeemableNoncontrollingInterestEquityPreferredCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RedeemableNoncontrollingInterestEquityPreferredCarryingAmount", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficitParentheticals" ], "lang": { "en-us": { "role": { "label": "Redeemable Noncontrolling Interest, Equity, Preferred, Carrying Amount", "terseLabel": "Redeemable non controlling interest equity preferred carrying amount", "documentation": "As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of preferred shares (regardless of class), preferred partnership units (regardless of class), preferential membership interests, or any other form of preferred equity regardless of investee entity legal form." } } }, "auth_ref": [ "r104", "r105", "r106", "r107" ] }, "us-gaap_TreasuryStockCommonShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockCommonShares", "presentation": [ "http://www.completesolaria.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "label": "Treasury Stock, Common, Shares", "terseLabel": "Common stock shares", "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r113" ] }, "cslr_OutstandingNetDebtAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "OutstandingNetDebtAmount", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Outstanding Net Debt Amount", "terseLabel": "Outstanding net debt", "documentation": "The amount of outstanding net debt." } } }, "auth_ref": [] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.completesolaria.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1054" ] }, "us-gaap_ProceedsFromRepaymentsOfDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromRepaymentsOfDebt", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/ReverseRecapitalizationDetailsScheduleOfReconcilesElementsOfTheMerger" ], "lang": { "en-us": { "role": { "label": "Proceeds from (Repayments of) Debt", "terseLabel": "Net cash proceeds upon the closing of the merger and PIPE financing", "documentation": "The net cash inflow or outflow in aggregate debt due to repayments and proceeds from additional borrowings." } } }, "auth_ref": [] }, "cslr_SeriesC1WarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "SeriesC1WarrantsMember", "presentation": [ "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Series C1 Warrants Member", "terseLabel": "Series C-1 Warrants (Converted to Common Stock Warrants) [Member]" } } }, "auth_ref": [] }, "us-gaap_CostOfSalesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfSalesPolicyTextBlock", "presentation": [ "http://www.completesolaria.com/role/AccountingPoliciesByPolicyPolicies" ], "lang": { "en-us": { "role": { "label": "Cost of Goods and Service [Policy Text Block]", "terseLabel": "Cost of Revenues", "documentation": "Disclosure of accounting policy for cost of product sold and service rendered." } } }, "auth_ref": [ "r1078" ] }, "us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsHeldForSaleNotPartOfDisposalGroup", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/DivestitureDetailsScheduleOfMajorCategoriesOfAssetsAndLiabilitiesHeldForSale": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.completesolaria.com/role/DivestitureDetailsScheduleOfMajorCategoriesOfAssetsAndLiabilitiesHeldForSale" ], "lang": { "en-us": { "role": { "label": "Asset, Held-for-Sale, Not Part of Disposal Group", "totalLabel": "Long-term assets held for sale", "documentation": "Amount of assets held-for-sale that are not part of a disposal group." } } }, "auth_ref": [ "r231" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders' deficit", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r200", "r272", "r831", "r1039", "r1109", "r1129", "r1198" ] }, "cslr_ChinaBridgeMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ChinaBridgeMember", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "China Bridge Member", "terseLabel": "China Bridge [Member]" } } }, "auth_ref": [] }, "us-gaap_EmployeeStockOwnershipPlanESOPFairValueOfSharesSubjectToRepurchaseObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeStockOwnershipPlanESOPFairValueOfSharesSubjectToRepurchaseObligation", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/EmployeeStockPurchasePlanDetails" ], "lang": { "en-us": { "role": { "label": "Employee Stock Ownership Plan (ESOP), Fair Value of Shares Subject to Repurchase Obligation", "terseLabel": "Reserved for future issuance", "documentation": "Fair value of the shares allocated that are subject to a repurchase obligation." } } }, "auth_ref": [ "r124" ] }, "cslr_RecognizedInterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "RecognizedInterestExpense", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Recognized Interest Expense", "terseLabel": "Recognized interest expense", "documentation": "The amount of recognized interest expense." } } }, "auth_ref": [] }, "cslr_SVBCommonStockWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "SVBCommonStockWarrantsMember", "presentation": [ "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "SVBCommon Stock Warrants Member", "terseLabel": "SVB Common Stock Warrants [Member]" } } }, "auth_ref": [] }, "cslr_ScheduleOfFutureMinimumLeasePaymentsUnderNonCancelableAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ScheduleOfFutureMinimumLeasePaymentsUnderNonCancelableAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Future Minimum Lease Payments Under Non Cancelable Abstract" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax", "terseLabel": "Foreign currency translation", "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r17", "r19", "r716", "r724" ] }, "cslr_ScheduleOfWeightedAverageRemainingLeaseTermAndTheDiscountRateAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ScheduleOfWeightedAverageRemainingLeaseTermAndTheDiscountRateAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Weighted Average Remaining Lease Term And The Discount Rate Abstract" } } }, "auth_ref": [] }, "us-gaap_CostOfRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfRevenue", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Cost of Revenue", "terseLabel": "Cost of revenues", "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period." } } }, "auth_ref": [ "r212", "r364", "r484", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r708", "r1148" ] }, "us-gaap_LiabilityForCatastropheClaimsByCatastrophicEventAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilityForCatastropheClaimsByCatastrophicEventAxis", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Catastrophic Event [Axis]", "documentation": "Information by type of catastrophic event, for example, but not limited to, earthquake, windstorm, fire or explosion." } } }, "auth_ref": [ "r281" ] }, "cslr_CarlyleWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "CarlyleWarrantsMember", "presentation": [ "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Carlyle Warrants Member", "terseLabel": "Carlyle Warrants [Member]" } } }, "auth_ref": [] }, "cslr_ExercisableShares": { "xbrltype": "sharesItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ExercisableShares", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Exercisable Shares", "terseLabel": "Exercisable shares (in Shares)", "documentation": "Exercisable shares." } } }, "auth_ref": [] }, "cslr_LesseeOperatingLeaseLiabilityPaymentDueAfterYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "LesseeOperatingLeaseLiabilityPaymentDueAfterYearFour", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetailsScheduleOfFutureMinimumLeasePaymentsUnderNonCancelable" ], "lang": { "en-us": { "role": { "label": "Lessee Operating Lease Liability Payment Due After Year Four", "terseLabel": "2027 and thereafter", "documentation": "Lessee operating lease liability payment due after year four." } } }, "auth_ref": [] }, "cslr_PromissoryNoteCommonStockWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "PromissoryNoteCommonStockWarrantsMember", "presentation": [ "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Promissory Note Common Stock Warrants Member", "terseLabel": "Promissory Note Common Stock Warrants [Member]" } } }, "auth_ref": [] }, "cslr_InvestmentDividendPayablePercentage": { "xbrltype": "percentItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "InvestmentDividendPayablePercentage", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Investment Dividend Payable Percentage", "terseLabel": "Investment dividend payable percentage", "documentation": "Investment dividend payable percentage." } } }, "auth_ref": [] }, "cslr_ScheduleOfActivityPeriodRelatingToTheCompanysWarrantyProvisionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ScheduleOfActivityPeriodRelatingToTheCompanysWarrantyProvisionAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Activity Period Relating To The Companys Warranty Provision Abstract" } } }, "auth_ref": [] }, "us-gaap_CatastrophicEventDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CatastrophicEventDomain", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Catastrophic Event [Domain]", "documentation": "Catastrophic event, for example, but not limited to, earthquake, windstorm, fire or explosion." } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationTable", "presentation": [ "http://www.completesolaria.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "cslr_CommitmentsandContingenciesDetailsScheduleofActivityPeriodRelatingtotheCompanysWarrantyProvisionTable": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "CommitmentsandContingenciesDetailsScheduleofActivityPeriodRelatingtotheCompanysWarrantyProvisionTable", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetailsScheduleOfActivityPeriodRelatingToTheCompanysWarrantyProvision" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies (Details) - Schedule of Activity Period Relating to the Company's Warranty Provision [Table]" } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementPolicyPolicyTextBlock", "presentation": [ "http://www.completesolaria.com/role/AccountingPoliciesByPolicyPolicies" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurement, Policy [Policy Text Block]", "terseLabel": "Fair Value Measurements", "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities." } } }, "auth_ref": [] }, "cslr_CommitmentsandContingenciesDetailsScheduleofActivityPeriodRelatingtotheCompanysWarrantyProvisionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "CommitmentsandContingenciesDetailsScheduleofActivityPeriodRelatingtotheCompanysWarrantyProvisionLineItems", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetailsScheduleOfActivityPeriodRelatingToTheCompanysWarrantyProvision" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies (Details) - Schedule of Activity Period Relating to the Company's Warranty Provision [Line Items]" } } }, "auth_ref": [] }, "cslr_WarrantyProvisionCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "WarrantyProvisionCurrent", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetailsScheduleOfActivityPeriodRelatingToTheCompanysWarrantyProvision" ], "lang": { "en-us": { "role": { "label": "Warranty Provision Current", "terseLabel": "Warranty provision, current", "documentation": "Warranty provision, current." } } }, "auth_ref": [] }, "cslr_SeriesD7WarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "SeriesD7WarrantsMember", "presentation": [ "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Series D7 Warrants Member", "terseLabel": "Series D-7 Warrants [Member]" } } }, "auth_ref": [] }, "us-gaap_ConvertibleDebtNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConvertibleDebtNoncurrent", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfConvertibleNotes" ], "lang": { "en-us": { "role": { "label": "Convertible Debt, Noncurrent", "verboseLabel": "Convertible Debt, Noncurrent", "documentation": "Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock." } } }, "auth_ref": [ "r58" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetailsSummaryOfSummaryOfStockOptionActivityParentheticals" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value", "terseLabel": "Share based compensation by share based award aggregate intrinsic value of options vested during the period", "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock." } } }, "auth_ref": [ "r611" ] }, "cslr_WarrantyProvisionsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "WarrantyProvisionsNoncurrent", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetailsScheduleOfActivityPeriodRelatingToTheCompanysWarrantyProvision" ], "lang": { "en-us": { "role": { "label": "Warranty Provisions Noncurrent", "terseLabel": "Warranty provision, noncurrent", "documentation": "Warranty provision, noncurrent." } } }, "auth_ref": [] }, "cslr_InvestmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "InvestmentDescription", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Investment Description", "terseLabel": "Investment description", "documentation": "Investment description." } } }, "auth_ref": [] }, "cslr_November2022CommonStockWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "November2022CommonStockWarrantsMember", "presentation": [ "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "November2022 Common Stock Warrants Member", "terseLabel": "November 2022 Common Stock Warrants [Member]" } } }, "auth_ref": [] }, "us-gaap_CurrentForeignTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentForeignTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfProvisionForIncomeTaxes": { "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfProvisionForIncomeTaxes" ], "lang": { "en-us": { "role": { "label": "Current Foreign Tax Expense (Benefit)", "terseLabel": "Foreign", "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r1077", "r1110" ] }, "us-gaap_DomesticCountryMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DomesticCountryMember", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Domestic Tax Authority [Member]", "terseLabel": "Domestic Tax Authority [Member]", "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentFeeAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentFeeAmount", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Fee Amount", "terseLabel": "Total amendment fees", "documentation": "Amount of the fee that accompanies borrowing money under the debt instrument." } } }, "auth_ref": [ "r57" ] }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "presentation": [ "http://www.completesolaria.com/role/PropertyAndEquipmentNet" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment Disclosure [Text Block]", "terseLabel": "Property and Equipment, Net", "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r230", "r299", "r303", "r304" ] }, "us-gaap_IncomeTaxesPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxesPaidNet", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Income Taxes Paid, Net", "negatedLabel": "Cash paid during the year for income taxes", "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes." } } }, "auth_ref": [ "r74" ] }, "us-gaap_InventoryPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryPolicyTextBlock", "presentation": [ "http://www.completesolaria.com/role/AccountingPoliciesByPolicyPolicies" ], "lang": { "en-us": { "role": { "label": "Inventory, Policy [Policy Text Block]", "terseLabel": "Inventories", "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost." } } }, "auth_ref": [ "r294", "r325", "r337", "r509", "r510", "r511", "r795", "r1000" ] }, "cslr_NumeratorConsideredForCalculationOfSharesIssuableUponConversion": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "NumeratorConsideredForCalculationOfSharesIssuableUponConversion", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Numerator Considered For Calculation Of Shares Issuable Upon Conversion", "terseLabel": "Numerator considered for calculation of shares issuable upon conversion", "documentation": "Numerator considered for calculation of shares issuable upon conversion." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxReconciliationNondeductibleExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationNondeductibleExpense", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfReconciliationOfEffectiveIncomeTaxRate" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount, Total", "terseLabel": "Nondeductible Expenses", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses." } } }, "auth_ref": [ "r1181" ] }, "us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeFinancialInstrumentsLiabilitiesMember", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfSignificantUnobservableInputsLevel3AndTheChangeInFairValueRecordedInOtherIncomeExpenseNet" ], "lang": { "en-us": { "role": { "label": "Derivative Financial Instruments, Liabilities [Member]", "terseLabel": "Convertible Debt Embedded Derivatives [member]", "documentation": "This item represents derivative instrument obligations meeting the definition of a liability which are reported as of the balance sheet date. Derivative instrument obligations are generally measured at fair value, and adjustments to the carrying amount of hedged items reflect changes in their fair value (that is, losses) that are attributable to the risk being hedged and that arise while the hedge is in effect." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.completesolaria.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1054" ] }, "cslr_DiscountOnSharePricePercentage": { "xbrltype": "percentItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "DiscountOnSharePricePercentage", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Discount On Share Price Percentage", "terseLabel": "Discount on share price percentage", "documentation": "Discount on share price percentage." } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsOther", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfComponentsOfDeferredTaxAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Other", "terseLabel": "Other", "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other." } } }, "auth_ref": [ "r127", "r1184" ] }, "us-gaap_OtherLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesNoncurrent", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Other Liabilities, Noncurrent", "terseLabel": "Due to related parties", "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r59" ] }, "us-gaap_PayableCommonStockRedeemed": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PayableCommonStockRedeemed", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "label": "Payable, Common Stock Redeemed", "terseLabel": "Redeem shares value (in Dollars)", "documentation": "Amount of payable for common stock reacquired. Includes, but is not limited to, unit, membership interest, or other ownership interest." } } }, "auth_ref": [ "r902", "r980", "r1052" ] }, "cslr_ProceedsFromTheIssueOfDerivativeInstrumentsLinkedToEntitiesOwnEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ProceedsFromTheIssueOfDerivativeInstrumentsLinkedToEntitiesOwnEquity", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Proceeds From The Issue Of Derivative Instruments Linked To Entities Own Equity", "terseLabel": "Proceeds from the issue of derivative instruments linked to entities own equity", "documentation": "Proceeds from the issue of derivative instruments linked to entities own equity." } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsTaxCreditCarryforwards", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfComponentsOfDeferredTaxAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Tax Credit Carryforwards", "terseLabel": "Credits", "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards." } } }, "auth_ref": [ "r126", "r127", "r1184" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://www.completesolaria.com/role/ForwardPurchaseAgreementsDetails", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheetsParentheticals" ], "lang": { "en-us": { "role": { "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (in Dollars per share)", "verboseLabel": "Ordinary shares, par value", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r194" ] }, "cslr_NumeratorValueOfConvertibleDebtConsideredForConversionPrice": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "NumeratorValueOfConvertibleDebtConsideredForConversionPrice", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Numerator Value Of Convertible Debt Considered For Conversion Price", "terseLabel": "Numerator value of convertible debt considered for conversion price", "documentation": "Numerator value of convertible debt considered for conversion price." } } }, "auth_ref": [] }, "us-gaap_OtherGeneralExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherGeneralExpense", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/ForwardPurchaseAgreementsDetails" ], "lang": { "en-us": { "role": { "label": "Other General Expense", "terseLabel": "Prepaid forward purchase liability", "documentation": "Amount of general expenses not normally included in Other Operating Costs and Expenses." } } }, "auth_ref": [ "r216" ] }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentFederalTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfProvisionForIncomeTaxes": { "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfProvisionForIncomeTaxes" ], "lang": { "en-us": { "role": { "label": "Current Federal Tax Expense (Benefit)", "terseLabel": "Federal", "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r1077", "r1110", "r1187" ] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/BusinessCombinationDetails", "http://www.completesolaria.com/role/CoverPage", "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfReconcilesTheChangeInValueOfTheRedeemableConvertiblePreferredStockWarrantLiability", "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfWarrantsBasedOnABlackScholesOptionPricingMethod", "http://www.completesolaria.com/role/OrganizationDetails", "http://www.completesolaria.com/role/RelatedPartyTransactionsDetails", "http://www.completesolaria.com/role/ReverseRecapitalizationDetails", "http://www.completesolaria.com/role/ReverseRecapitalizationDetailsScheduleOfCommonStockOutstanding", "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetails", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlowsParentheticals", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficitParentheticals", "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]", "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r308", "r332", "r333", "r334", "r364", "r392", "r395", "r406", "r408", "r416", "r417", "r484", "r537", "r539", "r540", "r541", "r544", "r545", "r567", "r568", "r569", "r570", "r574", "r708", "r867", "r868", "r869", "r870", "r879", "r880", "r881", "r882", "r883", "r884", "r885", "r886", "r887", "r888", "r889", "r891", "r911", "r933", "r957", "r981", "r982", "r983", "r984", "r985", "r1062", "r1107", "r1119" ] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities, Current", "totalLabel": "Total current liabilities", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r54", "r324", "r364", "r484", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r670", "r673", "r674", "r708", "r1039", "r1148", "r1205", "r1206" ] }, "us-gaap_WarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantMember", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/BusinessCombinationDetails", "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfSignificantUnobservableInputsLevel3AndTheChangeInFairValueRecordedInOtherIncomeExpenseNet", "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfWarrantsBasedOnABlackScholesOptionPricingMethod", "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Warrant [Member]", "terseLabel": "Public, Private Placement and Working Capital Warrants [Member]", "verboseLabel": "Warrant [Member]", "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount." } } }, "auth_ref": [ "r1042", "r1043", "r1046", "r1047", "r1048", "r1049" ] }, "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "label": "Business Acquisition, Transaction Costs", "terseLabel": "Payment of seller incurred transaction expenses", "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition." } } }, "auth_ref": [] }, "cslr_SettlementAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "SettlementAgreementMember", "presentation": [ "http://www.completesolaria.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Settlement Agreement Member", "terseLabel": "Settlement Agreement [Member]" } } }, "auth_ref": [] }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfProvisionForIncomeTaxes": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfProvisionForIncomeTaxes" ], "lang": { "en-us": { "role": { "label": "Current Income Tax Expense (Benefit), Total", "totalLabel": "Total current", "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations." } } }, "auth_ref": [ "r255", "r650", "r658", "r1110" ] }, "cslr_RelatedPartyTransactionsDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "RelatedPartyTransactionsDetailsTable", "presentation": [ "http://www.completesolaria.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transactions (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://www.completesolaria.com/role/PropertyAndEquipmentNetDetailsScheduleOfPropertyAndEquipmentNet", "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetailsScheduleOfPropertyPlantAndEquipmentUsefulLives" ], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Domain]", "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [ "r232" ] }, "us-gaap_OtherTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/DivestitureDetailsScheduleOfOperationsAndComprehensiveIncomeLossRelatedToDiscontinuedOperations": { "parentTag": "us-gaap_GainLossOnDispositionOfRealEstateDiscontinuedOperations", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://www.completesolaria.com/role/DivestitureDetailsScheduleOfOperationsAndComprehensiveIncomeLossRelatedToDiscontinuedOperations" ], "lang": { "en-us": { "role": { "label": "Other Tax Expense (Benefit)", "negatedLabel": "Income tax benefit (provision)", "documentation": "Amount of other income tax expense (benefit)." } } }, "auth_ref": [ "r365", "r1180", "r1185" ] }, "cslr_CustomerTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "CustomerTwoMember", "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Customer Two [Member]", "documentation": "Customer two." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfReconciliationOfEffectiveIncomeTaxRate" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount", "terseLabel": "Stock compensation", "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement." } } }, "auth_ref": [ "r1181" ] }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 19.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax", "terseLabel": "Foreign currency translation adjustment", "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r18", "r202", "r714", "r715", "r718" ] }, "us-gaap_IncomeTaxReconciliationOtherAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationOtherAdjustments", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfReconciliationOfEffectiveIncomeTaxRate" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount", "terseLabel": "Mark to market adjustments", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments." } } }, "auth_ref": [ "r1181" ] }, "us-gaap_OffBalanceSheetCreditLossLiabilityCreditLossExpenseReversal": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OffBalanceSheetCreditLossLiabilityCreditLossExpenseReversal", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Off-Balance-Sheet, Credit Loss, Liability, Credit Loss Expense (Reversal)", "terseLabel": "Off-balance\u00a0sheet credit exposure", "documentation": "Amount of expense (reversal of expense) for expected credit loss for off-balance sheet credit exposure. Excludes off-balance sheet credit exposure accounted for as insurance and instrument accounted for under derivatives and hedging." } } }, "auth_ref": [ "r499" ] }, "cslr_PurchaseAgreementsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "PurchaseAgreementsMember", "presentation": [ "http://www.completesolaria.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Purchase Agreements Member", "terseLabel": "Purchase Agreements [Member]" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentInterestRateStatedPercentage", "presentation": [ "http://www.completesolaria.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Debt instrument accrued interest rate", "documentation": "Contractual interest rate for funds borrowed, under the debt agreement." } } }, "auth_ref": [ "r55", "r547" ] }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskBenchmarkDomain", "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Benchmark [Domain]", "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "auth_ref": [ "r81", "r83", "r157", "r158", "r441", "r988" ] }, "us-gaap_OtherExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherExpenses", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Other Expenses", "terseLabel": "Other income (expense)", "verboseLabel": "Other expense", "documentation": "Amount of expense classified as other." } } }, "auth_ref": [ "r215" ] }, "cslr_CustomerThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "CustomerThreeMember", "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Customer Three [Member]", "documentation": "Customer three." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfReconciliationOfEffectiveIncomeTaxRate" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount", "terseLabel": "State income taxes, net of federal tax benefits", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit)." } } }, "auth_ref": [ "r1181" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetailsSummaryOfSummaryOfStockOptionActivity" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Number of shares, Options granted", "documentation": "Gross number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r600" ] }, "us-gaap_WarrantsAndRightsOutstanding": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantsAndRightsOutstanding", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 24.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Warrants and Rights Outstanding", "terseLabel": "Warrant liability", "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price." } } }, "auth_ref": [] }, "us-gaap_CommitmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsMember", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Commitments [Member]", "terseLabel": "Commitments [Member]", "documentation": "This element represents significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements." } } }, "auth_ref": [ "r190", "r271" ] }, "cslr_SubsequentEventsDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "SubsequentEventsDetailsTable", "presentation": [ "http://www.completesolaria.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Events (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByBenchmarkAxis", "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Benchmark [Axis]", "documentation": "Information by benchmark of concentration risk." } } }, "auth_ref": [ "r81", "r83", "r157", "r158", "r441", "r861", "r988" ] }, "us-gaap_DebtInstrumentMaturityDate": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentMaturityDate", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Maturity Date", "terseLabel": "Maturity date", "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format." } } }, "auth_ref": [ "r307", "r1013", "r1197" ] }, "cslr_SupplierThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "SupplierThreeMember", "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Supplier Three [Member]", "documentation": "Supplier three." } } }, "auth_ref": [] }, "cslr_SolariaCommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "SolariaCommonStockMember", "presentation": [ "http://www.completesolaria.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Solaria Common Stock Member", "terseLabel": "Solaria Common Stock [Member]" } } }, "auth_ref": [] }, "us-gaap_DeferredChargesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredChargesPolicyTextBlock", "presentation": [ "http://www.completesolaria.com/role/AccountingPoliciesByPolicyPolicies" ], "lang": { "en-us": { "role": { "label": "Deferred Charges, Policy [Policy Text Block]", "terseLabel": "Deferred Transaction Costs", "documentation": "Disclosure of accounting policy for deferral and amortization of significant deferred charges." } } }, "auth_ref": [ "r330" ] }, "us-gaap_InvestmentCreditMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentCreditMember", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Investment Tax Credit Carryforward [Member]", "terseLabel": "Investment Tax Credit Carryforward [Member]", "documentation": "Investment tax credit carryforwards arising from certain qualifying capital expenditures including, but not limited to, rehabilitation, energy, advanced coal project and gasification project." } } }, "auth_ref": [ "r125" ] }, "us-gaap_SoftwareDevelopmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SoftwareDevelopmentMember", "presentation": [ "http://www.completesolaria.com/role/PropertyAndEquipmentNetDetailsScheduleOfPropertyAndEquipmentNet", "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetailsScheduleOfPropertyPlantAndEquipmentUsefulLives" ], "lang": { "en-us": { "role": { "label": "Software Development [Member]", "terseLabel": "Developed software [Member]", "documentation": "Internally developed software for sale, licensing or long-term internal use." } } }, "auth_ref": [] }, "cslr_SupplierFourMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "SupplierFourMember", "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Supplier Four [Member]", "documentation": "Supplier four." } } }, "auth_ref": [] }, "cslr_AggregateAmountOfPurchasePrice": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "AggregateAmountOfPurchasePrice", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Aggregate Amount Of Purchase Price", "terseLabel": "Aggregate amount of purchase price", "documentation": "Aggregate amount of purchase price." } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetails", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating lease right-of-use assets", "verboseLabel": "Operating lease right of use asset", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r737" ] }, "cslr_AggregateSharesOfCommonStock": { "xbrltype": "sharesItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "AggregateSharesOfCommonStock", "presentation": [ "http://www.completesolaria.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Aggregate Shares Of Common Stock", "terseLabel": "Aggregate ordinary shares", "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury." } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "label": "Business Acquisition, Goodwill, Expected Tax Deductible Amount", "terseLabel": "Goodwill", "documentation": "The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes." } } }, "auth_ref": [ "r138" ] }, "us-gaap_FairValueByLiabilityClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByLiabilityClassAxis", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetails", "http://www.completesolaria.com/role/FairValueMeasurementsDetails", "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfSignificantUnobservableInputsLevel3AndTheChangeInFairValueRecordedInOtherIncomeExpenseNet" ], "lang": { "en-us": { "role": { "label": "Liability Class [Axis]", "documentation": "Information by class of liability." } } }, "auth_ref": [ "r153", "r264" ] }, "cslr_SupplierTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "SupplierTwoMember", "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Supplier Two [Member]", "documentation": "Supplier two." } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAxis", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetails", "http://www.completesolaria.com/role/BusinessCombinationDetailsScheduleOfAssetsAcquiredAndLiabilitiesAssumed", "http://www.completesolaria.com/role/BusinessCombinationDetailsScheduleOfUnauditedCombinedProFormaInformation", "http://www.completesolaria.com/role/DivestitureDetails", "http://www.completesolaria.com/role/RelatedPartyTransactionsDetails", "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Business Acquisition [Axis]", "documentation": "Information by business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r130", "r132", "r662", "r1029", "r1030" ] }, "us-gaap_DerivativeLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 20.0 } }, "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfFinancialAssetsAndLiabilities", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Derivative Liability, Current", "terseLabel": "Forward purchase agreement liabilities", "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r340" ] }, "cslr_TwoThousandAndTwentyThreeConvertibleNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "TwoThousandAndTwentyThreeConvertibleNotesMember", "presentation": [ "http://www.completesolaria.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Two Thousand And Twenty Three Convertible Notes [Member]", "terseLabel": "2023 Convertible Notes [Member]" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfReconciliationOfEmbeddedDerivativeLiability", "http://www.completesolaria.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Name [Domain]", "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r58", "r370", "r546", "r547", "r548", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r731", "r1013", "r1014", "r1015", "r1016", "r1017", "r1108" ] }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentUnamortizedDiscount", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfNetCarryingAmountOfTheConvertibleNotes" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Unamortized Discount", "negatedLabel": "Unamortized debt discount", "documentation": "Amount, after accumulated amortization, of debt discount." } } }, "auth_ref": [ "r159", "r162", "r1151" ] }, "cslr_RestrictedCashMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "RestrictedCashMember", "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Restricted Cash Member", "terseLabel": "Restricted Cash [Member]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://www.completesolaria.com/role/PropertyAndEquipmentNetDetailsScheduleOfPropertyAndEquipmentNet", "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetailsScheduleOfPropertyPlantAndEquipmentUsefulLives" ], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Axis]", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r25" ] }, "us-gaap_PropertyPlantAndEquipmentNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNetAbstract", "lang": { "en-us": { "role": { "label": "Property and Equipment, Net [Abstract]" } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAcquireeDomain", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetails", "http://www.completesolaria.com/role/BusinessCombinationDetailsScheduleOfAssetsAcquiredAndLiabilitiesAssumed", "http://www.completesolaria.com/role/BusinessCombinationDetailsScheduleOfUnauditedCombinedProFormaInformation", "http://www.completesolaria.com/role/DivestitureDetails", "http://www.completesolaria.com/role/RelatedPartyTransactionsDetails", "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Business Acquisition, Acquiree [Domain]", "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "auth_ref": [ "r662", "r1029", "r1030" ] }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentStateAndLocalTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfProvisionForIncomeTaxes": { "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfProvisionForIncomeTaxes" ], "lang": { "en-us": { "role": { "label": "Current State and Local Tax Expense (Benefit)", "terseLabel": "State", "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r1077", "r1110", "r1187" ] }, "us-gaap_PrivatePlacementMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrivatePlacementMember", "presentation": [ "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Private Placement [Member]", "verboseLabel": "Private Placement [Member]", "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts." } } }, "auth_ref": [] }, "cslr_NumberOfCustomers": { "xbrltype": "integerItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "NumberOfCustomers", "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Number of Customers", "terseLabel": "Number of customers", "documentation": "Number of customers." } } }, "auth_ref": [] }, "cslr_SignificantAccountingPoliciesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "SignificantAccountingPoliciesLineItems", "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Significant Accounting Policies [Line Items]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetailsScheduleOfCalculateTheFairValueOfStockBasedCompensation" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum", "terseLabel": "Expected volatility, Minimum", "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetailsScheduleOfCalculateTheFairValueOfStockBasedCompensation" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum", "terseLabel": "Expected volatility, Maximum", "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetailsScheduleOfCalculateTheFairValueOfStockBasedCompensation" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum", "terseLabel": "Risk-free interest rate, Minimum", "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionProFormaInformationTextBlock", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationTables" ], "lang": { "en-us": { "role": { "label": "Business Acquisition, Pro Forma Information [Table Text Block]", "terseLabel": "Schedule of Unaudited Combined Pro Forma Information", "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate." } } }, "auth_ref": [ "r1069", "r1070" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetailsScheduleOfCalculateTheFairValueOfStockBasedCompensation" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum", "terseLabel": "Risk-free interest rate, Maximum", "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [] }, "us-gaap_FinancingReceivableDeferredIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancingReceivableDeferredIncome", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Financing Receivable, Deferred Commitment Fee", "terseLabel": "Financing fee", "documentation": "Amount of fee received for commitment to originate or purchase financing receivable where likelihood of commitment being exercised is remote, to be recognized as service income." } } }, "auth_ref": [ "r449" ] }, "cslr_DeferredCommission": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "DeferredCommission", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Commission", "terseLabel": "Deferred commissions", "documentation": "Amount of deferred commission." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentLineItems", "presentation": [ "http://www.completesolaria.com/role/PropertyAndEquipmentNetDetailsScheduleOfPropertyAndEquipmentNet", "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetailsScheduleOfPropertyPlantAndEquipmentUsefulLives" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "presentation": [ "http://www.completesolaria.com/role/OtherIncomeExpenseNetTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Other Nonoperating Income (Expense) [Table Text Block]", "terseLabel": "Schedule of Other Income (Expense), Net", "documentation": "Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items." } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationsPolicy", "presentation": [ "http://www.completesolaria.com/role/AccountingPoliciesByPolicyPolicies" ], "lang": { "en-us": { "role": { "label": "Business Combinations Policy [Policy Text Block]", "terseLabel": "Business Combinations", "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy." } } }, "auth_ref": [ "r128" ] }, "cslr_AssembledWorkforceOneMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "AssembledWorkforceOneMember", "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetailsScheduleOfFiniteLivedIntangibleAssets" ], "lang": { "en-us": { "role": { "label": "Assembled Workforce One [Member]", "terseLabel": "Assembled workforce [Member]", "documentation": "Assembled workforce one." } } }, "auth_ref": [] }, "us-gaap_DerivativesEmbeddedDerivatives": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativesEmbeddedDerivatives", "presentation": [ "http://www.completesolaria.com/role/AccountingPoliciesByPolicyPolicies" ], "lang": { "en-us": { "role": { "label": "Derivatives, Embedded Derivatives [Policy Text Block]", "terseLabel": "Convertible Debt Embedded Derivative Liabilities", "documentation": "Disclosure of accounting policy for embedded derivatives, including how such derivatives are identified and analyzed for possible separation from their host contracts." } } }, "auth_ref": [ "r4", "r7", "r12", "r13" ] }, "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseRemainingLeaseTerm", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Remaining Lease Term", "terseLabel": "Leases term", "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r1200" ] }, "cslr_SoftwareServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "SoftwareServicesMember", "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetailsScheduleOfRevenueRecognizedByProductAndServices" ], "lang": { "en-us": { "role": { "label": "Software Services Member", "terseLabel": "Software enhanced services [Member]" } } }, "auth_ref": [] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfFinancialAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r554", "r579", "r580", "r581", "r582", "r583", "r584", "r701", "r767", "r768", "r769", "r1014", "r1015", "r1026", "r1027", "r1028" ] }, "cslr_ScheduleOfRevenueRecognizedByProductAndServicesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ScheduleOfRevenueRecognizedByProductAndServicesAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Revenue Recognized By Product And Services Abstract" } } }, "auth_ref": [] }, "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTaxAbstract", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]", "terseLabel": "Comprehensive income (loss):" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfComponentsOfDeferredTaxAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Warranty Reserves", "terseLabel": "Warranty reserve", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from warranty reserves." } } }, "auth_ref": [ "r127", "r1184" ] }, "cslr_AccountsReceivableAllowanceForCreditLossAmountsWrittenOffRecoveriesAndOtherAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "AccountsReceivableAllowanceForCreditLossAmountsWrittenOffRecoveriesAndOtherAdjustments", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetailsScheduleOfAllowanceForDoubtfulAccounts" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable Allowance for Credit Loss Amounts Written Off Recoveries And Other Adjustments", "terseLabel": "Amounts written off, recoveries and other adjustments", "documentation": "Accounts receivable, allowance for credit loss, amounts written off, recoveries and other adjustments." } } }, "auth_ref": [] }, "cslr_SolarEnergySystemInstallationsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "SolarEnergySystemInstallationsMember", "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetailsScheduleOfRevenueRecognizedByProductAndServices" ], "lang": { "en-us": { "role": { "label": "Solar Energy System Installations Member", "terseLabel": "Solar energy system installations [Member]" } } }, "auth_ref": [] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 35.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r197", "r241", "r830", "r855", "r860", "r871", "r912", "r1039" ] }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeasesFutureMinimumPaymentsDueThereafter", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetailsScheduleOfFutureMinimumLeasePaymentsUnderNonCancelable" ], "lang": { "en-us": { "role": { "label": "Operating Leases, Future Minimum Payments, Due Thereafter", "terseLabel": "2027 and thereafter", "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date." } } }, "auth_ref": [ "r288", "r291" ] }, "us-gaap_DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowed": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowed", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Derivative Asset, Securities Purchased under Agreements to Resell, Securities Borrowed", "terseLabel": "Additional total purchase", "documentation": "Amount, after the effects of master netting arrangements, of derivative assets, securities purchased under agreements to resell and securities borrowed. Includes assets not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r998", "r999", "r1099" ] }, "us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfOtherCurrentAssetsTableTextBlock", "presentation": [ "http://www.completesolaria.com/role/PrepaidExpensesAndOtherCurrentAssetsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Other Current Assets [Table Text Block]", "terseLabel": "Schedule of Prepaid Expenses and Other Current Assets", "documentation": "Tabular disclosure of the carrying amounts of other current assets." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "presentation": [ "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "terseLabel": "Schedule of Intangible Assets", "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment." } } }, "auth_ref": [ "r90", "r92" ] }, "us-gaap_FinancingReceivableModificationToTotalFinancingReceivablesExcludingAccruedInterestPercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancingReceivableModificationToTotalFinancingReceivablesExcludingAccruedInterestPercent", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Financing Receivable, Excluding Accrued Interest, Modified in Period, to Total Financing Receivables, Percentage", "terseLabel": "Percentage of accured interest", "documentation": "Percentage, excluding accrued interest, of financing receivable modified during period for debtor experiencing financial difficulty to total financing receivables." } } }, "auth_ref": [ "r447" ] }, "us-gaap_ClassOfWarrantOrRightAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightAxis", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/BusinessCombinationDetails", "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetailsScheduleOfActivityPeriodRelatingToTheCompanysWarrantyProvision", "http://www.completesolaria.com/role/FairValueMeasurementsDetails", "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfReconcilesTheChangeInValueOfTheRedeemableConvertiblePreferredStockWarrantLiability", "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfWarrantsBasedOnABlackScholesOptionPricingMethod", "http://www.completesolaria.com/role/WarrantsDetails", "http://www.completesolaria.com/role/WarrantsScheduleOfFairValueOfTheCommonStockWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Axis]", "documentation": "Information by type of warrant or right issued." } } }, "auth_ref": [ "r114" ] }, "us-gaap_OtherCurrentAssetsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCurrentAssetsTextBlock", "presentation": [ "http://www.completesolaria.com/role/PrepaidExpensesAndOtherCurrentAssets" ], "lang": { "en-us": { "role": { "label": "Other Current Assets [Text Block]", "terseLabel": "Prepaid Expenses and Other Current Assets", "documentation": "The entire disclosure for other current assets." } } }, "auth_ref": [] }, "us-gaap_RetainedEarningsAppropriated": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAppropriated", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "label": "Retained Earnings, Appropriated", "terseLabel": "Accumulated deficit (in Dollars)", "documentation": "A segregation of retained earnings which is unavailable for dividend distribution. Includes also retained earnings appropriated for loss contingencies." } } }, "auth_ref": [ "r108", "r109", "r201", "r363", "r829" ] }, "us-gaap_CompensationRelatedCostsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CompensationRelatedCostsPolicyTextBlock", "presentation": [ "http://www.completesolaria.com/role/AccountingPoliciesByPolicyPolicies" ], "lang": { "en-us": { "role": { "label": "Compensation Related Costs, Policy [Policy Text Block]", "terseLabel": "Stock-Based Compensation", "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense." } } }, "auth_ref": [ "r117" ] }, "us-gaap_CapitalizedContractCostNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CapitalizedContractCostNetCurrent", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetailsScheduleOfAccruedExpensesAndOtherCurrentLiabilities" ], "lang": { "en-us": { "role": { "label": "Capitalized Contract Cost, Net, Current", "terseLabel": "Uninvoiced contract costs", "documentation": "Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer; classified as current." } } }, "auth_ref": [ "r512" ] }, "us-gaap_RedeemableConvertiblePreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RedeemableConvertiblePreferredStockMember", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfReconcilesTheChangeInValueOfTheRedeemableConvertiblePreferredStockWarrantLiability", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Redeemable Convertible Preferred Stock [Member]", "documentation": "Description of type or class of redeemable convertible preferred stock. Convertible redeemable preferred stock possess conversion and redemption features. The stock has redemption features that are outside the control of the issuer." } } }, "auth_ref": [] }, "us-gaap_AccountsReceivableNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableNetAbstract", "lang": { "en-us": { "role": { "label": "Accounts Receivable, after Allowance for Credit Loss [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationAndAmortization", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Depreciation, Depletion and Amortization, Nonproduction", "terseLabel": "Depreciation and amortization", "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production." } } }, "auth_ref": [ "r24", "r95" ] }, "us-gaap_ClassOfWarrantOrRightDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightDomain", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/BusinessCombinationDetails", "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetailsScheduleOfActivityPeriodRelatingToTheCompanysWarrantyProvision", "http://www.completesolaria.com/role/FairValueMeasurementsDetails", "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfReconcilesTheChangeInValueOfTheRedeemableConvertiblePreferredStockWarrantLiability", "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfWarrantsBasedOnABlackScholesOptionPricingMethod", "http://www.completesolaria.com/role/WarrantsDetails", "http://www.completesolaria.com/role/WarrantsScheduleOfFairValueOfTheCommonStockWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Domain]", "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months." } } }, "auth_ref": [] }, "us-gaap_OptionIndexedToIssuersEquitySettlementAlternativesCashAtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OptionIndexedToIssuersEquitySettlementAlternativesCashAtFairValue", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Option Contract Indexed to Equity, Settlement, Cash, Amount", "terseLabel": "Option indexed to issuers equity settlement alternatives cash fair value", "documentation": "Amount that would be paid upon settlement of option contract indexed to equity." } } }, "auth_ref": [ "r42" ] }, "us-gaap_GainLossOnContractTermination": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainLossOnContractTermination", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Gain (Loss) on Contract Termination", "terseLabel": "Breach of contract", "documentation": "Gain (loss) related to the termination of a contract between the parties. The termination may be due to many causes including early termination of a lease by a lessee, a breach of contract by one party, or a failure to perform." } } }, "auth_ref": [ "r223" ] }, "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentFederalStateAndLocalTaxExpenseBenefitAbstract", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfProvisionForIncomeTaxes" ], "lang": { "en-us": { "role": { "label": "Current Federal, State and Local, Tax Expense (Benefit) [Abstract]", "terseLabel": "Current:" } } }, "auth_ref": [] }, "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFederalStateAndLocalTaxExpenseBenefitAbstract", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfProvisionForIncomeTaxes" ], "lang": { "en-us": { "role": { "label": "Deferred Federal, State and Local, Tax Expense (Benefit) [Abstract]", "terseLabel": "Deferred:" } } }, "auth_ref": [] }, "us-gaap_CostsAndExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostsAndExpenses", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Costs and Expenses", "terseLabel": "Expense", "documentation": "Total costs of sales and operating expenses for the period." } } }, "auth_ref": [ "r208" ] }, "srt_MajorCustomersAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MajorCustomersAxis", "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]", "documentation": "Information by name or description of a single external customer or a group of external customers." } } }, "auth_ref": [ "r441", "r1021", "r1153", "r1221", "r1222" ] }, "us-gaap_DerivativeInstrumentsAndHedgesLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsAndHedgesLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 30.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedges, Liabilities, Noncurrent", "terseLabel": "Derivative liability", "documentation": "Fair value of liability arising from contracts that meet the criteria of being accounted for as derivative instruments, financial instrument or contract used to mitigate a specified risk (hedge), energy marketing activities (trading activities), expected to be settled after one year or beyond the normal operating cycle, if longer. Examples of energy marketing activities include, but are not limited to, trading of electricity, coal, natural gas and oil using financial instruments, including, but not limited to, forward contracts, options and swaps." } } }, "auth_ref": [] }, "us-gaap_CompensationAndBenefitsTrust": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CompensationAndBenefitsTrust", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetailsScheduleOfAccruedExpensesAndOtherCurrentLiabilities" ], "lang": { "en-us": { "role": { "label": "Compensation and Benefits Trust", "terseLabel": "Accrued compensation and benefits", "documentation": "The value of a trust established to hold the stock of an employee compensation and benefits plan as of the balance sheet date." } } }, "auth_ref": [] }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForDoubtfulAccountsReceivable", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetailsScheduleOfAllowanceForDoubtfulAccounts" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable, Allowance for Credit Loss", "periodStartLabel": "Balance at beginning of period", "periodEndLabel": "Balance at end of period", "documentation": "Amount of allowance for credit loss on accounts receivable." } } }, "auth_ref": [ "r336", "r446", "r495", "r498", "r500", "r1218" ] }, "us-gaap_OperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLossCarryforwards", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Operating Loss Carryforwards", "terseLabel": "Operating loss carryforwards", "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws." } } }, "auth_ref": [ "r126" ] }, "us-gaap_Revenues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Revenues", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetailsScheduleOfRevenueRecognizedByProductAndServices", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Revenues", "terseLabel": "Revenues", "verboseLabel": "Total revenue", "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)." } } }, "auth_ref": [ "r351", "r364", "r419", "r420", "r431", "r434", "r435", "r439", "r440", "r441", "r484", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r708", "r817", "r1148" ] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Operating Income (Loss)", "totalLabel": "Loss from continuing operations", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r418", "r432", "r436", "r438", "r1005" ] }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture", "terseLabel": "Stock-based compensation", "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r120", "r193", "r194", "r241" ] }, "us-gaap_SubsequentEventLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventLineItems", "presentation": [ "http://www.completesolaria.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Line Items]", "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event." } } }, "auth_ref": [ "r726", "r762" ] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Inventory, Net", "terseLabel": "Inventories", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r338", "r995", "r1039" ] }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueNewIssues", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Issuance of common stock options", "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering." } } }, "auth_ref": [ "r30", "r193", "r194", "r241", "r879", "r957", "r982", "r1051" ] }, "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/OtherIncomeExpenseNetDetailsScheduleOfOtherIncomeExpenseNet" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan", "terseLabel": "Issuance of forward purchase agreements", "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan." } } }, "auth_ref": [ "r30", "r193", "r194", "r241" ] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://www.completesolaria.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Axis]", "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r726", "r762" ] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive income (loss), net of tax", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r67", "r343", "r345", "r352", "r815", "r838" ] }, "us-gaap_SharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesIssued", "presentation": [ "http://www.completesolaria.com/role/ForwardPurchaseAgreementsDetails", "http://www.completesolaria.com/role/RelatedPartyTransactionsDetails", "http://www.completesolaria.com/role/ReverseRecapitalizationDetailsScheduleOfCommonStockOutstanding", "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Issued shares (in Shares)", "terseLabel": "Shares issued", "verboseLabel": "Issued shares (in shares)", "definitionGuidance": "Preferred stock exercisable share (in Shares)", "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury." } } }, "auth_ref": [ "r30" ] }, "us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfCommonStockOutstandingRollForwardTableTextBlock", "presentation": [ "http://www.completesolaria.com/role/ReverseRecapitalizationTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Common Stock Outstanding Roll Forward [Table Text Block]", "terseLabel": "Schedule of Common Stock Outstanding", "documentation": "Tabular disclosure of the change in common stock outstanding." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Value, Restricted Stock Award, Gross", "terseLabel": "Vesting of restricted stock units", "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period." } } }, "auth_ref": [ "r30", "r193", "r194", "r241" ] }, "us-gaap_SubsidiarySaleOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsidiarySaleOfStockAxis", "presentation": [ "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Sale of Stock [Axis]", "documentation": "Information by type of sale of the entity's stock." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueAcquisitions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueAcquisitions", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Value, Acquisitions", "terseLabel": "Issuance of common stock in connection with business combination", "documentation": "Value of stock issued pursuant to acquisitions during the period." } } }, "auth_ref": [ "r30", "r63", "r241" ] }, "us-gaap_PaymentsForCapitalImprovements": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForCapitalImprovements", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Payments for Capital Improvements", "terseLabel": "Pay return capital", "documentation": "The cash outflow for acquisition of or capital improvements to properties held for investment (operating, managed, leased) or for use." } } }, "auth_ref": [ "r220" ] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://www.completesolaria.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Domain]", "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r726", "r762" ] }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Value, Stock Options Exercised", "terseLabel": "Exercise of common stock options", "documentation": "Value of stock issued as a result of the exercise of stock options." } } }, "auth_ref": [ "r30", "r63", "r241" ] }, "us-gaap_ConcentrationRiskPercentage1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskPercentage1", "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk, Percentage", "terseLabel": "Concentration risk, percentage", "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division." } } }, "auth_ref": [ "r81", "r83", "r157", "r158", "r441" ] }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Value, Conversion of Convertible Securities", "terseLabel": "Conversion of 2022 Convertible Notes into common stock", "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities." } } }, "auth_ref": [ "r30", "r63", "r241" ] }, "us-gaap_ConcentrationRiskByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByTypeAxis", "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Type [Axis]", "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender." } } }, "auth_ref": [ "r81", "r83", "r157", "r158", "r441", "r988", "r1068" ] }, "us-gaap_FairValueAdjustmentOfWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAdjustmentOfWarrants", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 15.0 } }, "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfReconcilesTheChangeInValueOfTheRedeemableConvertiblePreferredStockWarrantLiability", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows", "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value Adjustment of Warrants", "terseLabel": "Change in fair value of warrant liabilities", "positiveLabel": "Change in fair value", "verboseLabel": "Fair value of warrant", "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability." } } }, "auth_ref": [ "r6", "r24" ] }, "us-gaap_DepreciationAndAmortizationDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationAndAmortizationDiscontinuedOperations", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/DivestitureDetails" ], "lang": { "en-us": { "role": { "label": "Depreciation and Amortization, Discontinued Operations", "terseLabel": "Depreciation and amortization, discontinued operations", "documentation": "Amount of deprecation and amortization expense attributable to property, plant and equipment and intangible assets of discontinued operations." } } }, "auth_ref": [ "r321", "r1104" ] }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetails", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficitParentheticals" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Issuance of common stock options (in Shares)", "definitionGuidance": "Stock issued during the period shares new issues", "verboseLabel": "Issuance shares", "documentation": "Number of new stock issued during the period." } } }, "auth_ref": [ "r30", "r193", "r194", "r241", "r867", "r957", "r982" ] }, "us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativeProceedsReceivedOnAllTransactions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsidiaryOrEquityMethodInvesteeCumulativeProceedsReceivedOnAllTransactions", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/ReverseRecapitalizationDetailsScheduleOfReconcilesElementsOfTheMerger" ], "lang": { "en-us": { "role": { "label": "Subsidiary or Equity Method Investee, Cumulative Proceeds Received on All Transactions", "terseLabel": "Net contributions from the Merger and PIPE financing upon closing", "documentation": "Cumulative amount of cash and other consideration received by subsidiary or equity method investee in exchange for shares or stock issued or sold. Include amounts of cash received, fair value of non-cash assets received, fair value of liabilities assumed, and fair value of any other forms of consideration." } } }, "auth_ref": [] }, "us-gaap_OptionIndexedToIssuersEquityTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OptionIndexedToIssuersEquityTypeAxis", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetails", "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfNextEquityFinancingBasedOnInputsIncludedInABlackScholesModel" ], "lang": { "en-us": { "role": { "label": "Option Indexed to Issuer's Equity, Type [Axis]", "documentation": "Information by type of freestanding contracts issued by an entity that are indexed to, and potentially settled in, an entity's own stock." } } }, "auth_ref": [ "r103", "r149", "r150", "r263" ] }, "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable", "presentation": [ "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Indefinite-Lived Intangible Assets [Table]", "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity." } } }, "auth_ref": [ "r40", "r229" ] }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsValuationAllowance", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetails", "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfComponentsOfDeferredTaxAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Valuation Allowance", "negatedLabel": "Valuation allowance", "verboseLabel": "Deferred tax assets valuation allowance", "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized." } } }, "auth_ref": [ "r646" ] }, "cslr_FreedomAcquisitionICorpMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "FreedomAcquisitionICorpMember", "presentation": [ "http://www.completesolaria.com/role/ReverseRecapitalizationDetailsScheduleOfReconcilesElementsOfTheMerger" ], "lang": { "en-us": { "role": { "label": "Freedom Acquisition ICorp Member", "terseLabel": "FACT [Member]" } } }, "auth_ref": [] }, "us-gaap_FurnitureAndFixturesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FurnitureAndFixturesMember", "presentation": [ "http://www.completesolaria.com/role/PropertyAndEquipmentNetDetailsScheduleOfPropertyAndEquipmentNet", "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetailsScheduleOfPropertyPlantAndEquipmentUsefulLives" ], "lang": { "en-us": { "role": { "label": "Furniture and Fixtures [Member]", "verboseLabel": "Furniture\u00a0& equipment [Member]", "terseLabel": "Furniture and equipment [Member]", "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases." } } }, "auth_ref": [] }, "cslr_ForwardPurchaseAgreementsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ForwardPurchaseAgreementsMember", "presentation": [ "http://www.completesolaria.com/role/ReverseRecapitalizationDetailsScheduleOfCommonStockOutstanding", "http://www.completesolaria.com/role/ReverseRecapitalizationDetailsScheduleOfReconcilesElementsOfTheMerger" ], "lang": { "en-us": { "role": { "label": "Forward Purchase Agreements Member", "terseLabel": "FPA [Member]", "definitionGuidance": "FPA Agreements [Member]" } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent", "terseLabel": "Share based compensation by share based award purchase price of common stock percentage", "documentation": "Purchase price of common stock expressed as a percentage of its fair value." } } }, "auth_ref": [] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductOrServiceAxis", "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetailsScheduleOfRevenueRecognizedByProductAndServices" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]", "documentation": "Information by product and service, or group of similar products and similar services." } } }, "auth_ref": [ "r439", "r796", "r842", "r843", "r844", "r845", "r846", "r847", "r993", "r1019", "r1040", "r1073", "r1143", "r1144", "r1153", "r1221" ] }, "us-gaap_UnsecuredDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnsecuredDebt", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Unsecured Debt", "terseLabel": "Immaterial debt issuance costs", "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of uncollateralized debt obligations (with maturities initially due after one year or beyond the operating cycle if longer)." } } }, "auth_ref": [ "r43", "r270", "r1216" ] }, "cslr_ReverseRecapitalizationDetailsScheduleofReconcilesElementsoftheMergerLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ReverseRecapitalizationDetailsScheduleofReconcilesElementsoftheMergerLineItems", "presentation": [ "http://www.completesolaria.com/role/ReverseRecapitalizationDetailsScheduleOfReconcilesElementsOfTheMerger" ], "lang": { "en-us": { "role": { "label": "Reverse Recapitalization (Details) - Schedule of Reconciles Elements of the Merger [Line Items]" } } }, "auth_ref": [] }, "us-gaap_OtherShortTermBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherShortTermBorrowings", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 19.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other Short-Term Borrowings", "terseLabel": "Short-term debt with CS Solis", "documentation": "Amount of borrowings classified as other, maturing within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r46", "r908" ] }, "us-gaap_CommonClassAMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonClassAMember", "presentation": [ "http://www.completesolaria.com/role/OrganizationDetails", "http://www.completesolaria.com/role/ReverseRecapitalizationDetails", "http://www.completesolaria.com/role/ReverseRecapitalizationDetailsScheduleOfCommonStockOutstanding", "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Common Class A [Member]", "terseLabel": "FACT Class A Ordinary Shares [Member]", "definitionGuidance": "Common Class A [Member]", "documentation": "Classification of common stock representing ownership interest in a corporation." } } }, "auth_ref": [ "r1232" ] }, "cslr_PrivateInvestmentInPublicEquityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "PrivateInvestmentInPublicEquityMember", "presentation": [ "http://www.completesolaria.com/role/ReverseRecapitalizationDetailsScheduleOfCommonStockOutstanding", "http://www.completesolaria.com/role/ReverseRecapitalizationDetailsScheduleOfReconcilesElementsOfTheMerger" ], "lang": { "en-us": { "role": { "label": "Private Investment In Public Equity Member", "terseLabel": "PIPE [Member]", "verboseLabel": "PIPE Financing [Member]" } } }, "auth_ref": [] }, "cslr_ScheduleOfReconcilesElementsOfTheMergerAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ScheduleOfReconcilesElementsOfTheMergerAbstract", "lang": { "en-us": { "role": { "label": "Schedule of Reconciles Elements of the Merger [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 17.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Issuance of Stock and Warrants for Services or Claims", "terseLabel": "Issuance of common stock in connection with forward purchase agreements", "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims." } } }, "auth_ref": [ "r24" ] }, "us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfComponentsOfDeferredTaxAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Liabilities, Deferred Expense, Capitalized Software", "negatedLabel": "Capitalized software", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from capitalized software." } } }, "auth_ref": [ "r127", "r1184" ] }, "srt_RestatementAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RestatementAxis", "presentation": [ "http://www.completesolaria.com/role/BasicAndDilutedNetLossPerShareDetailsScheduleOfPotentialCommonSharesExcludedFromDilutedNetLossPerShare", "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetails", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period [Axis]", "documentation": "Information by adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision." } } }, "auth_ref": [ "r319", "r371", "r372", "r373", "r374", "r375", "r378", "r379", "r380", "r381", "r383", "r384", "r385", "r386", "r387", "r388", "r412", "r489", "r490", "r654", "r691", "r695", "r696", "r697", "r736", "r751", "r752", "r851", "r852", "r853", "r854", "r855", "r856", "r857", "r858", "r859", "r860", "r864" ] }, "cslr_CommonStockParValue0.0001PerShareMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "CommonStockParValue0.0001PerShareMember", "presentation": [ "http://www.completesolaria.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Common Stock Par Value 0.0001 Per Share [Member]", "terseLabel": "Common Stock Par Value 0.0001 Per Share [Member]", "documentation": "Common stock par value 0.0001 per share." } } }, "auth_ref": [] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Loss from continuing operations before income taxes", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r5", "r204", "r274", "r418", "r432", "r436", "r438", "r817", "r834", "r1005" ] }, "cslr_WarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "WarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember", "presentation": [ "http://www.completesolaria.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Warrants Each Whole Warrant Exercisable For One Share Of Common Stock At Exercise Price Of 11.50 Per Share [Member]", "terseLabel": "Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share [Member]", "documentation": "Warrants each whole warrant exercisable for one share of common stock at exercise price of 11.50 per share." } } }, "auth_ref": [] }, "cslr_SeriesDWarrantsTrancheAMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "SeriesDWarrantsTrancheAMember", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfSignificantUnobservableInputsLevel3AndTheChangeInFairValueRecordedInOtherIncomeExpenseNet" ], "lang": { "en-us": { "role": { "label": "Series D Warrants Tranche A [Member]", "terseLabel": "Issuance of Series D Warrants Tranche A" } } }, "auth_ref": [] }, "srt_RestatementDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RestatementDomain", "presentation": [ "http://www.completesolaria.com/role/BasicAndDilutedNetLossPerShareDetailsScheduleOfPotentialCommonSharesExcludedFromDilutedNetLossPerShare", "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetails", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period [Domain]", "terseLabel": "Revision of Prior Period [Domain]", "documentation": "Adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision." } } }, "auth_ref": [ "r319", "r371", "r372", "r373", "r374", "r375", "r378", "r379", "r380", "r381", "r383", "r384", "r385", "r386", "r387", "r388", "r412", "r489", "r490", "r654", "r691", "r695", "r696", "r697", "r736", "r751", "r752", "r851", "r852", "r853", "r854", "r855", "r856", "r857", "r858", "r859", "r860", "r864" ] }, "cslr_RetroactiveApplicationOfRecapitalizationValue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "RetroactiveApplicationOfRecapitalizationValue", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Retroactive Application Of Recapitalization Value", "terseLabel": "Retroactive application of recapitalization", "documentation": "Retroactive application of recapitalization." } } }, "auth_ref": [] }, "cslr_SeriesDWarrantsTrancheBMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "SeriesDWarrantsTrancheBMember", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfSignificantUnobservableInputsLevel3AndTheChangeInFairValueRecordedInOtherIncomeExpenseNet" ], "lang": { "en-us": { "role": { "label": "Series D Warrants Tranche B [Member]", "terseLabel": "Issuance of Series D Warrants Tranche B" } } }, "auth_ref": [] }, "cslr_ReclassificationOfPrepaidPIPEinShares": { "xbrltype": "sharesItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ReclassificationOfPrepaidPIPEinShares", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Reclassification Of Prepaid PIPEin Shares", "terseLabel": "Reclassification of prepaid PIPE(2) (in Shares)", "documentation": "Reclassification of prepaid PIPE in Shares." } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationsAbstract", "lang": { "en-us": { "role": { "label": "Business Combination [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseAndOtherAssetsCurrentAbstract", "lang": { "en-us": { "role": { "label": "Prepaid Expenses and Other Current Assets [Abstract]" } } }, "auth_ref": [] }, "cslr_IssuanceOfCommonStockBonusSharesInConnectionWithMerger": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "IssuanceOfCommonStockBonusSharesInConnectionWithMerger", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/OtherIncomeExpenseNetDetailsScheduleOfOtherIncomeExpenseNet", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Issuance Of Common Stock Bonus Shares In Connection With Merger", "terseLabel": "Issuance of common stock bonus shares in connection with Merger(4)", "negatedLabel": "Bonus shares issued in connection with the Merger", "documentation": "Issuance of common stock bonus shares in connection with Merger." } } }, "auth_ref": [] }, "us-gaap_LossContingencyDamagesSoughtValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingencyDamagesSoughtValue", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Loss Contingency, Damages Sought, Value", "terseLabel": "Suffered damages", "documentation": "The value (monetary amount) of the award the plaintiff seeks in the legal matter." } } }, "auth_ref": [ "r1140", "r1141", "r1142" ] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 5.0 }, "http://www.completesolaria.com/role/PrepaidExpensesAndOtherCurrentAssetsDetailsScheduleOfPrepaidExpensesAndOtherCurrentAssets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.completesolaria.com/role/PrepaidExpensesAndOtherCurrentAssetsDetailsScheduleOfPrepaidExpensesAndOtherCurrentAssets", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Prepaid Expense and Other Assets, Current", "terseLabel": "Prepaid expenses and other current assets", "totalLabel": "Total prepaid expenses and other current assets", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r1098" ] }, "cslr_ScheduleOfReconcilesTheChangeInValueOfTheRedeemableConvertiblePreferredStockWarrantLiabilityTable": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ScheduleOfReconcilesTheChangeInValueOfTheRedeemableConvertiblePreferredStockWarrantLiabilityTable", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfReconcilesTheChangeInValueOfTheRedeemableConvertiblePreferredStockWarrantLiability" ], "lang": { "en-us": { "role": { "label": "Schedule Of Reconciles The Change In Value Of The Redeemable Convertible Preferred Stock Warrant Liability [Table]", "documentation": "Schedule Of Reconciles The Change In Value Of The Redeemable Convertible Preferred Stock Warrant Liability." } } }, "auth_ref": [] }, "cslr_IssuanceOfCommonStockBonusSharesInConnectionWithMergerinShares": { "xbrltype": "sharesItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "IssuanceOfCommonStockBonusSharesInConnectionWithMergerinShares", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Issuance Of Common Stock Bonus Shares In Connection With Mergerin Shares", "terseLabel": "Issuance of common stock bonus shares in connection with Merger(4) (in Shares)", "documentation": "Issuance of common stock bonus shares in connection with Merger in Shares." } } }, "auth_ref": [] }, "cslr_ScheduleOfReconcilesTheChangeInValueOfTheRedeemableConvertiblePreferredStockWarrantLiabilityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ScheduleOfReconcilesTheChangeInValueOfTheRedeemableConvertiblePreferredStockWarrantLiabilityAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Reconciles The Change In Value Of The Redeemable Convertible Preferred Stock Warrant Liability [Abstract]", "documentation": "Schedule of reconciles the change in value of the redeemable convertible preferred stock warrant liability." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsLineItems", "presentation": [ "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetailsScheduleOfIntangibleAssets", "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetailsScheduleOfFiniteLivedIntangibleAssets" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r797" ] }, "cslr_ReclassificationOfLegacyCompleteSolariaCommonStockIntoCompleteSolariaCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ReclassificationOfLegacyCompleteSolariaCommonStockIntoCompleteSolariaCommonStock", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Reclassification Of Legacy Complete Solaria Common Stock Into Complete Solaria Common Stock", "terseLabel": "Reclassification of Legacy Complete Solaria common stock into Complete Solaria Common Stock", "documentation": "Reclassification of Legacy Complete Solaria common stock into Complete Solaria Common Stock." } } }, "auth_ref": [] }, "us-gaap_InterestPayableCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPayableCurrentAndNoncurrent", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Interest Payable", "terseLabel": "Payment of interest", "documentation": "Amount of interest payable on debt, including, but not limited to, trade payables." } } }, "auth_ref": [ "r165", "r1215" ] }, "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfComponentsOfDeferredTaxAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Liabilities, Intangible Assets", "negatedLabel": "Intangibles", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill." } } }, "auth_ref": [ "r127", "r1184" ] }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Domain]", "documentation": "Title of individual, or nature of relationship to individual or group of individuals." } } }, "auth_ref": [] }, "cslr_RetroactiveApplicationOfRecapitalizationinShares": { "xbrltype": "sharesItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "RetroactiveApplicationOfRecapitalizationinShares", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Retroactive Application Of Recapitalizationin Shares", "terseLabel": "Retroactive application of recapitalization (in Shares)", "documentation": "Retroactive application of recapitalization in shares." } } }, "auth_ref": [] }, "cslr_ScheduleOfReconcilesTheChangeInValueOfTheRedeemableConvertiblePreferredStockWarrantLiabilityLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ScheduleOfReconcilesTheChangeInValueOfTheRedeemableConvertiblePreferredStockWarrantLiabilityLineItems", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfReconcilesTheChangeInValueOfTheRedeemableConvertiblePreferredStockWarrantLiability" ], "lang": { "en-us": { "role": { "label": "Schedule Of Reconciles The Change In Value Of The Redeemable Convertible Preferred Stock Warrant Liability [Line Items]", "documentation": "Schedule Of Reconciles The Change In Value Of The Redeemable Convertible Preferred Stock Warrant Liability." } } }, "auth_ref": [] }, "cslr_IssuanceOfWarrantsInConnectionWithAcquisition": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "IssuanceOfWarrantsInConnectionWithAcquisition", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfReconcilesTheChangeInValueOfTheRedeemableConvertiblePreferredStockWarrantLiability" ], "lang": { "en-us": { "role": { "label": "Issuance Of Warrants In Connection With Acquisition", "terseLabel": "Issuance of warrants in connection with acquisition of Solaria (Note 3)", "documentation": "Issuance of warrants in connection with acquisition." } } }, "auth_ref": [] }, "us-gaap_FinanceLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 23.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Liability, Noncurrent", "terseLabel": "Warranty provision, noncurrent", "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent." } } }, "auth_ref": [ "r738" ] }, "cslr_SeriesBWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "SeriesBWarrantsMember", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfReconcilesTheChangeInValueOfTheRedeemableConvertiblePreferredStockWarrantLiability", "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Series BWarrants Member", "verboseLabel": "Series B Warrants [Member]", "terseLabel": "Series B Warrants [Member]" } } }, "auth_ref": [] }, "us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerSharePlannedSaleInvestmentsNotIdentifiedDescription": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerSharePlannedSaleInvestmentsNotIdentifiedDescription", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetails", "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Planned Sale, Investments Not Identified, Description", "terseLabel": "Description warrant expires", "documentation": "Description of remaining actions required to complete the sale or liquidation of an investment in certain entities that calculate net asset value per share, including, but not limited to, by unit, membership interest, or other ownership interest, but has not yet identified the specific investment to be sold or liquidated." } } }, "auth_ref": [ "r154" ] }, "cslr_AdjustedMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "AdjustedMember", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Adjusted [Member]", "documentation": "Adjusted." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://www.completesolaria.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r1059" ] }, "cslr_ConvertibleLongTermNotesPayableNonCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ConvertibleLongTermNotesPayableNonCurrent", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 26.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Convertible Long Term Notes Payable Non Current", "terseLabel": "Convertible notes, net, noncurrent", "documentation": "Convertible long term notes payable non current." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetailsScheduleOfIntangibleAssetsAcquired", "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetails", "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetailsScheduleOfAmortizationExpenseRelatedToIntangibleAssets", "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetailsScheduleOfIntangibleAssets", "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetailsScheduleOfFiniteLivedIntangibleAssets" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "documentation": "Information by major type or class of finite-lived intangible assets." } } }, "auth_ref": [ "r520", "r521", "r522", "r523", "r797", "r801" ] }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentUsefulLife", "presentation": [ "http://www.completesolaria.com/role/PropertyAndEquipmentNetDetailsScheduleOfPropertyAndEquipmentNet", "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetailsScheduleOfPropertyPlantAndEquipmentUsefulLives" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Useful Life", "verboseLabel": "Assets Useful Life", "terseLabel": "Total property and equipment", "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment." } } }, "auth_ref": [] }, "cslr_OptionLinkedToIssuersEquityShareFairValueNonCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "OptionLinkedToIssuersEquityShareFairValueNonCurrent", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 21.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Option Linked To Issuers Equity Share Fair Value Non Current", "verboseLabel": "SAFE agreements", "documentation": "Option linked to issuers equity share fair value non current." } } }, "auth_ref": [] }, "cslr_SeriesCWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "SeriesCWarrantsMember", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfReconcilesTheChangeInValueOfTheRedeemableConvertiblePreferredStockWarrantLiability", "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Series CWarrants Member", "verboseLabel": "Series C Warrants [Member]", "terseLabel": "Series C Warrants [Member]" } } }, "auth_ref": [] }, "cslr_ConvertibleNotePayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ConvertibleNotePayableCurrent", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 22.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Convertible Note Payable Current", "verboseLabel": "Convertible notes, net", "documentation": "Convertible note payable current." } } }, "auth_ref": [] }, "cslr_ReverseRecapitalizationDetailsScheduleofReconcilesElementsoftheMergerTable": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ReverseRecapitalizationDetailsScheduleofReconcilesElementsoftheMergerTable", "presentation": [ "http://www.completesolaria.com/role/ReverseRecapitalizationDetailsScheduleOfReconcilesElementsOfTheMerger" ], "lang": { "en-us": { "role": { "label": "Reverse Recapitalization (Details) - Schedule of Reconciles Elements of the Merger [Table]" } } }, "auth_ref": [] }, "us-gaap_MembersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MembersEquity", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Members' Equity", "terseLabel": "Obtain new equity", "documentation": "Amount of ownership interest in limited liability company (LLC), attributable to the parent entity." } } }, "auth_ref": [ "r241", "r414", "r415", "r416", "r417" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://www.completesolaria.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r1058" ] }, "cslr_ImpairmentLossFromDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ImpairmentLossFromDiscontinuedOperations", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "parentTag": "cslr_DiscontinuedOperationNetIncomeLossFromDiscontinuedOperation", "weight": 1.0, "order": 18.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Impairment Loss From Discontinued Operations", "terseLabel": "Impairment loss from discontinued operations", "documentation": "Amount of impairment loss from discontinued operations." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetailsScheduleOfIntangibleAssetsAcquired", "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetails", "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetailsScheduleOfAmortizationExpenseRelatedToIntangibleAssets", "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetailsScheduleOfIntangibleAssets", "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetailsScheduleOfFiniteLivedIntangibleAssets" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "auth_ref": [ "r90", "r92" ] }, "cslr_SeriesDTrancheAWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "SeriesDTrancheAWarrantsMember", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfReconcilesTheChangeInValueOfTheRedeemableConvertiblePreferredStockWarrantLiability" ], "lang": { "en-us": { "role": { "label": "Series D Tranche A Warrants [Member]", "terseLabel": "Series D Tranche A Warrants [Member]" } } }, "auth_ref": [] }, "cslr_StockholdersDeficitEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "StockholdersDeficitEquityAbstract", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Stockholders Deficit Equity Abstract", "terseLabel": "Stockholders' (deficit) equity:" } } }, "auth_ref": [] }, "cslr_DiscontinuedOperationNetIncomeLossFromDiscontinuedOperation": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "DiscontinuedOperationNetIncomeLossFromDiscontinuedOperation", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_IncomeLossFromContinuingOperations", "weight": 1.0, "order": 5.0 }, "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 16.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Discontinued Operation Net Income Loss From Discontinued Operation", "totalLabel": "Net loss from discontinued operations", "terseLabel": "Loss from discontinued operations, net of income taxes", "documentation": "Discontinued operation net income loss from discontinued operation." } } }, "auth_ref": [] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.completesolaria.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r1057" ] }, "cslr_SeriesDTrancheBWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "SeriesDTrancheBWarrantsMember", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfReconcilesTheChangeInValueOfTheRedeemableConvertiblePreferredStockWarrantLiability" ], "lang": { "en-us": { "role": { "label": "Series D Tranche B Warrants [Member]", "terseLabel": "Series D Tranche B Warrants [Member]" } } }, "auth_ref": [] }, "cslr_IncomeStatementTable": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "IncomeStatementTable", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossParentheticals" ], "lang": { "en-us": { "role": { "label": "Income Statement [Table]", "documentation": "Income statement." } } }, "auth_ref": [] }, "cslr_DisclosureInTabularFormOfReconciliationOfEmbeddedDerivativeLiabilityLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "DisclosureInTabularFormOfReconciliationOfEmbeddedDerivativeLiabilityLineItems", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfReconciliationOfEmbeddedDerivativeLiability" ], "lang": { "en-us": { "role": { "label": "Disclosure In Tabular Form Of Reconciliation Of Embedded Derivative Liability [Line Items]", "documentation": "Disclosure in tabular form of reconciliation of embedded derivative liability [Line items]." } } }, "auth_ref": [] }, "srt_NameOfMajorCustomerDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "NameOfMajorCustomerDomain", "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Customer [Domain]", "documentation": "Single external customer or group of external customers." } } }, "auth_ref": [ "r441", "r1021", "r1153", "r1221", "r1222" ] }, "us-gaap_NumberOfOperatingSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfOperatingSegments", "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Number of Operating Segments", "terseLabel": "Number of operating segments", "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues." } } }, "auth_ref": [ "r1122" ] }, "cslr_DisclosureInTabularFormOfReconciliationOfEmbeddedDerivativeLiabilityTable": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "DisclosureInTabularFormOfReconciliationOfEmbeddedDerivativeLiabilityTable", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfReconciliationOfEmbeddedDerivativeLiability" ], "lang": { "en-us": { "role": { "label": "Disclosure In Tabular Form Of Reconciliation Of Embedded Derivative Liability [Table]", "documentation": "Disclosure in tabular form of reconciliation of embedded derivative liability." } } }, "auth_ref": [] }, "us-gaap_ConvertibleDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConvertibleDebtTableTextBlock", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsTables" ], "lang": { "en-us": { "role": { "label": "Convertible Debt [Table Text Block]", "terseLabel": "Schedule of Convertible Notes", "documentation": "Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.completesolaria.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r1056" ] }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetailsScheduleOfIntangibleAssets" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "terseLabel": "Accumulated Amortization", "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r329", "r522" ] }, "cslr_IncomeStatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "IncomeStatementLineItems", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossParentheticals" ], "lang": { "en-us": { "role": { "label": "Income Statement [Line Items]", "documentation": "Income statement." } } }, "auth_ref": [] }, "cslr_ReverseRecapitalizationDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ReverseRecapitalizationDetailsLineItems", "presentation": [ "http://www.completesolaria.com/role/ReverseRecapitalizationDetails" ], "lang": { "en-us": { "role": { "label": "Reverse Recapitalization [Line Items]" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 15.0 } }, "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetails", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts Payable and Accrued Liabilities, Current", "terseLabel": "Accounts payable", "verboseLabel": "Accrued expenses and other current liabilities", "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits." } } }, "auth_ref": [ "r50" ] }, "cslr_TemporaryEquityStockIssuedDuringThePeriodShares": { "xbrltype": "sharesItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "TemporaryEquityStockIssuedDuringThePeriodShares", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Temporary Equity Stock Issued During The Period Shares", "terseLabel": "Redeemable convertible preferred Stock upon conversion note (in Shares)", "documentation": "Temporary equity stock issued during the period shares." } } }, "auth_ref": [] }, "cslr_EmbeddedDerivativeLiabilityInstrumentsIssuedDuringThePeriodValue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "EmbeddedDerivativeLiabilityInstrumentsIssuedDuringThePeriodValue", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfReconciliationOfEmbeddedDerivativeLiability" ], "lang": { "en-us": { "role": { "label": "Embedded Derivative Liability Instruments Issued During The Period Value", "terseLabel": "Issuance of\u00a02021-A\u00a0Convertible Notes", "documentation": "Embedded derivative liability instruments issued during the period value." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.completesolaria.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "terseLabel": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "cslr_ExtinguishmentOfEmbeddedDerivativeLiabilityUponIssuance": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ExtinguishmentOfEmbeddedDerivativeLiabilityUponIssuance", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfReconciliationOfEmbeddedDerivativeLiability" ], "lang": { "en-us": { "role": { "label": "Extinguishment Of Embedded Derivative Liability Upon Issuance", "terseLabel": "Extinguishment upon Series D issuance", "documentation": "Extinguishment of embedded derivative liability upon issuance." } } }, "auth_ref": [] }, "cslr_PreviouslyReportedOneMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "PreviouslyReportedOneMember", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Previously Reported One [Member]", "terseLabel": "Previously Reported [Member]", "documentation": "Previously Reported One." } } }, "auth_ref": [] }, "cslr_TwoThousandNineteenConvertibleNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "TwoThousandNineteenConvertibleNotesMember", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfReconciliationOfEmbeddedDerivativeLiability" ], "lang": { "en-us": { "role": { "label": "Two Thousand Nineteen Convertible Notes Member", "terseLabel": "2019-A Convertible Notes [Member]" } } }, "auth_ref": [] }, "cslr_EventDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "EventDomain", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlowsParentheticals", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficitParentheticals" ], "lang": { "en-us": { "role": { "label": "Event [Domain]", "documentation": "Event." } } }, "auth_ref": [] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 34.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive income", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r65", "r66", "r202", "r335", "r828", "r856", "r860" ] }, "cslr_EventAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "EventAxis", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlowsParentheticals", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficitParentheticals" ], "lang": { "en-us": { "role": { "label": "Event [Axis]", "documentation": "Event." } } }, "auth_ref": [] }, "cslr_TwoThousandTwentyAConvertibleNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "TwoThousandTwentyAConvertibleNotesMember", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfReconciliationOfEmbeddedDerivativeLiability", "http://www.completesolaria.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Two Thousand Twenty AConvertible Notes Member", "verboseLabel": "2020-A Convertible Notes [Member]", "terseLabel": "2020 Convertible Notes [Member]" } } }, "auth_ref": [] }, "cslr_TwoThousandTwentyOneAConvertibleNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "TwoThousandTwentyOneAConvertibleNotesMember", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfReconciliationOfEmbeddedDerivativeLiability", "http://www.completesolaria.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Two Thousand Twenty One AConvertible Notes Member", "terseLabel": "2021-A Convertible Notes [Member]" } } }, "auth_ref": [] }, "cslr_IssuanceOfRedeemableConvertiblePreferredStockUponConversionOfTwoThousandAndSeventeenConvertibleNotesAndTwoThousandAndTwoThousandAndNineteenSimpleAgreementForFutureEquityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "IssuanceOfRedeemableConvertiblePreferredStockUponConversionOfTwoThousandAndSeventeenConvertibleNotesAndTwoThousandAndTwoThousandAndNineteenSimpleAgreementForFutureEquityMember", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Issuance Of Redeemable Convertible Preferred Stock Upon Conversion Of Two Thousand And Seventeen Convertible Notes And Two Thousand And Two Thousand And Nineteen Simple Agreement For Future Equity [Member]", "documentation": "Issuance of redeemable convertible preferred stock upon conversion of two thousand and seventeen convertible notes and two thousand and two thousand and nineteen simple agreement for future equity." } } }, "auth_ref": [] }, "cslr_DisclosureInTabularFormOfSignificantUnobservableInputsUsedInFairValueMeasurementOfSimpleAgreementsForFutureEquityInstrumentsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "DisclosureInTabularFormOfSignificantUnobservableInputsUsedInFairValueMeasurementOfSimpleAgreementsForFutureEquityInstrumentsTable", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfNextEquityFinancingBasedOnInputsIncludedInABlackScholesModel" ], "lang": { "en-us": { "role": { "label": "Disclosure In Tabular Form Of Significant Unobservable Inputs Used In Fair Value Measurement Of Simple Agreements For Future Equity Instruments [Table]", "documentation": "Disclosure In Tabular Form Of Significant Unobservable Inputs Used In Fair Value Measurement Of Simple Agreements For Future Equity Instruments." } } }, "auth_ref": [] }, "cslr_DisclosureInTabularFormOfSignificantUnobservableInputsUsedInFairValueMeasurementOfSimpleAgreementsForFutureEquityInstrumentsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "DisclosureInTabularFormOfSignificantUnobservableInputsUsedInFairValueMeasurementOfSimpleAgreementsForFutureEquityInstrumentsLineItems", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfNextEquityFinancingBasedOnInputsIncludedInABlackScholesModel" ], "lang": { "en-us": { "role": { "label": "Disclosure In Tabular Form Of Significant Unobservable Inputs Used In Fair Value Measurement Of Simple Agreements For Future Equity Instruments [Line Items]", "documentation": "Disclosure In Tabular Form Of Significant Unobservable Inputs Used In Fair Value Measurement Of Simple Agreements For Future Equity Instruments [Line Items]." } } }, "auth_ref": [] }, "cslr_ConversionOfConvertibleNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ConversionOfConvertibleNotesMember", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Conversion Of Convertible Notes [Member]", "documentation": "Conversion of convertible notes." } } }, "auth_ref": [] }, "cslr_ExpectedFairValueOfPreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ExpectedFairValueOfPreferredStockMember", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfNextEquityFinancingBasedOnInputsIncludedInABlackScholesModel" ], "lang": { "en-us": { "role": { "label": "Expected Fair Value Of Preferred Stock [Member]", "terseLabel": "Expected fair value of preferred stock [Member]", "documentation": "Expected Fair Value Of Preferred Stock." } } }, "auth_ref": [] }, "cslr_AcquisitionOfAssembledWorkforceMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "AcquisitionOfAssembledWorkforceMember", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Acquisition Of Assembled Workforce [Member]", "documentation": "Acquisition of assembled workforce." } } }, "auth_ref": [] }, "cslr_SimpleAgreementForFutureEquityInstrumentsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "SimpleAgreementForFutureEquityInstrumentsMember", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfNextEquityFinancingBasedOnInputsIncludedInABlackScholesModel" ], "lang": { "en-us": { "role": { "label": "Simple Agreement For Future Equity Instruments [Member]", "terseLabel": "Simple Agreement For Future Equity Instruments [Member]" } } }, "auth_ref": [] }, "us-gaap_DeferredRevenueCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredRevenueCurrent", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 18.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Deferred Revenue, Current", "terseLabel": "Deferred revenue, current", "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current." } } }, "auth_ref": [ "r1091" ] }, "cslr_IssuanceOfRedeemableConvertiblePreferredStockUponConversionOfConvertibleNotesAndSimpleAgreementForFutureEquityNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "IssuanceOfRedeemableConvertiblePreferredStockUponConversionOfConvertibleNotesAndSimpleAgreementForFutureEquityNotesMember", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Issuance Of Redeemable Convertible Preferred Stock Upon Conversion Of Convertible Notes And Simple Agreement For Future Equity Notes [Member]", "documentation": "Issuance of redeemable convertible preferred stock upon conversion of convertible notes and simple agreement for future equity notes." } } }, "auth_ref": [] }, "cslr_ReverseRecapitalizationDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ReverseRecapitalizationDetailsTable", "presentation": [ "http://www.completesolaria.com/role/ReverseRecapitalizationDetails" ], "lang": { "en-us": { "role": { "label": "Reverse Recapitalization (Details) [Table]" } } }, "auth_ref": [] }, "cslr_IssueOfRedeemableConvertiblePreferredStockUponAcquisitionMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "IssueOfRedeemableConvertiblePreferredStockUponAcquisitionMember", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Issue Of Redeemable Convertible Preferred Stock Upon Acquisition [Member]", "documentation": "Issue of redeemable convertible preferred stock upon acquisition." } } }, "auth_ref": [] }, "cslr_LegacyCompleteSolariaMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "LegacyCompleteSolariaMember", "presentation": [ "http://www.completesolaria.com/role/ReverseRecapitalizationDetails" ], "lang": { "en-us": { "role": { "label": "Legacy Complete Solaria Member", "terseLabel": "Legacy Complete Solaria [Member]" } } }, "auth_ref": [] }, "cslr_IssuanceOfRedeemableConvertiblePreferredStockUponConversionOfSimpleAgreementOfFutureEquityNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "IssuanceOfRedeemableConvertiblePreferredStockUponConversionOfSimpleAgreementOfFutureEquityNotesMember", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficitParentheticals" ], "lang": { "en-us": { "role": { "label": "Issuance Of Redeemable Convertible Preferred Stock Upon Conversion Of Simple Agreement Of Future Equity Notes [Member]", "documentation": "Issuance of redeemable convertible preferred stock upon conversion of simple agreement of future equity notes." } } }, "auth_ref": [] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Summary of Significant Accounting Policies", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r225", "r362" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetails", "http://www.completesolaria.com/role/OrganizationDetails", "http://www.completesolaria.com/role/StockBasedCompensationDetailsScheduleOfCalculateTheFairValueOfStockBasedCompensation", "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetailsScheduleOfPropertyPlantAndEquipmentUsefulLives", "http://www.completesolaria.com/role/WarrantsDetails", "http://www.completesolaria.com/role/WarrantsScheduleOfFairValueOfTheCommonStockWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]", "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median." } } }, "auth_ref": [ "r532", "r533", "r534", "r535", "r578", "r587", "r615", "r616", "r617", "r770", "r794", "r848", "r899", "r900", "r963", "r964", "r965", "r966", "r976", "r990", "r991", "r1007", "r1018", "r1031", "r1041", "r1044", "r1138", "r1150", "r1208", "r1209", "r1210", "r1211", "r1212" ] }, "us-gaap_OtherSellingAndMarketingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherSellingAndMarketingExpense", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/DivestitureDetailsScheduleOfOperationsAndComprehensiveIncomeLossRelatedToDiscontinuedOperations": { "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.completesolaria.com/role/DivestitureDetailsScheduleOfOperationsAndComprehensiveIncomeLossRelatedToDiscontinuedOperations" ], "lang": { "en-us": { "role": { "label": "Other Selling and Marketing Expense", "terseLabel": "Sales and marketing", "documentation": "Amount of selling and marketing expense classified as other." } } }, "auth_ref": [ "r214" ] }, "us-gaap_OtherAssetImpairmentCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetImpairmentCharges", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/PropertyAndEquipmentNetDetails", "http://www.completesolaria.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Other Asset Impairment Charges", "terseLabel": "Impairment charges on tangible assets", "verboseLabel": "Impairment charges", "documentation": "The charge against earnings resulting from the write down of long lived assets other than goodwill due to the difference between the carrying value and lower fair value." } } }, "auth_ref": [ "r1104", "r1137" ] }, "us-gaap_AssetImpairmentCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetImpairmentCharges", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Asset Impairment Charges", "terseLabel": "Impairment charges", "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill." } } }, "auth_ref": [ "r24", "r94" ] }, "us-gaap_InterestExpenseDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpenseDebt", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Interest Expense, Debt", "terseLabel": "Interest expense", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt." } } }, "auth_ref": [ "r218", "r559", "r566", "r1016", "r1017" ] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetails", "http://www.completesolaria.com/role/OrganizationDetails", "http://www.completesolaria.com/role/StockBasedCompensationDetailsScheduleOfCalculateTheFairValueOfStockBasedCompensation", "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetailsScheduleOfPropertyPlantAndEquipmentUsefulLives", "http://www.completesolaria.com/role/WarrantsDetails", "http://www.completesolaria.com/role/WarrantsScheduleOfFairValueOfTheCommonStockWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum [Member]", "documentation": "Upper limit of the provided range." } } }, "auth_ref": [ "r532", "r533", "r534", "r535", "r587", "r794", "r848", "r899", "r900", "r963", "r964", "r965", "r966", "r976", "r990", "r991", "r1007", "r1018", "r1031", "r1041", "r1150", "r1207", "r1208", "r1209", "r1210", "r1211", "r1212" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetails", "http://www.completesolaria.com/role/OrganizationDetails", "http://www.completesolaria.com/role/StockBasedCompensationDetailsScheduleOfCalculateTheFairValueOfStockBasedCompensation", "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetailsScheduleOfPropertyPlantAndEquipmentUsefulLives", "http://www.completesolaria.com/role/WarrantsDetails", "http://www.completesolaria.com/role/WarrantsScheduleOfFairValueOfTheCommonStockWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]", "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median." } } }, "auth_ref": [ "r532", "r533", "r534", "r535", "r578", "r587", "r615", "r616", "r617", "r770", "r794", "r848", "r899", "r900", "r963", "r964", "r965", "r966", "r976", "r990", "r991", "r1007", "r1018", "r1031", "r1041", "r1044", "r1138", "r1150", "r1208", "r1209", "r1210", "r1211", "r1212" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetailsScheduleOfFutureMinimumLeasePaymentsUnderNonCancelable" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "terseLabel": "2023", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r747" ] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MinimumMember", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetails", "http://www.completesolaria.com/role/OrganizationDetails", "http://www.completesolaria.com/role/StockBasedCompensationDetailsScheduleOfCalculateTheFairValueOfStockBasedCompensation", "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetailsScheduleOfPropertyPlantAndEquipmentUsefulLives", "http://www.completesolaria.com/role/WarrantsDetails", "http://www.completesolaria.com/role/WarrantsScheduleOfFairValueOfTheCommonStockWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum [Member]", "documentation": "Lower limit of the provided range." } } }, "auth_ref": [ "r532", "r533", "r534", "r535", "r587", "r794", "r848", "r899", "r900", "r963", "r964", "r965", "r966", "r976", "r990", "r991", "r1007", "r1018", "r1031", "r1041", "r1150", "r1207", "r1208", "r1209", "r1210", "r1211", "r1212" ] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareAbstract", "lang": { "en-us": { "role": { "label": "Basic and Diluted Net Loss Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetailsScheduleOfFutureMinimumLeasePaymentsUnderNonCancelable" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "terseLabel": "2026", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r747" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetailsScheduleOfFutureMinimumLeasePaymentsUnderNonCancelable" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "terseLabel": "2025", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r747" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetailsScheduleOfFutureMinimumLeasePaymentsUnderNonCancelable" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "terseLabel": "2024", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r747" ] }, "us-gaap_AdditionsToOtherAssetsAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionsToOtherAssetsAmount", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Additions to Other Assets, Amount", "terseLabel": "Addition amount", "documentation": "Amount of significant additions in the period in other assets (current, noncurrent, or unclassified)." } } }, "auth_ref": [ "r1090" ] }, "us-gaap_PaymentsForReinsurance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForReinsurance", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Payments for Reinsurance", "terseLabel": "Payments for settlement", "documentation": "Cash payments made for reinsurance during the current period." } } }, "auth_ref": [ "r22" ] }, "us-gaap_OperatingLeaseExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseExpense", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Expense", "terseLabel": "Non-cash lease expense", "documentation": "Amount of operating lease expense. Excludes sublease income." } } }, "auth_ref": [ "r1199" ] }, "srt_ScheduleOfCondensedFinancialStatementsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScheduleOfCondensedFinancialStatementsTableTextBlock", "presentation": [ "http://www.completesolaria.com/role/DivestitureTables" ], "lang": { "en-us": { "role": { "label": "Condensed Financial Statements [Table Text Block]", "terseLabel": "Schedule of Major Categories of Assets and Liabilities Held for Sale", "documentation": "Tabular disclosure of condensed financial statements, including, but not limited to, the balance sheet, income statement, and statement of cash flows." } } }, "auth_ref": [ "r1087", "r1113" ] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxes" ], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes", "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information." } } }, "auth_ref": [ "r366", "r630", "r637", "r642", "r648", "r655", "r659", "r660", "r661", "r872" ] }, "us-gaap_DebtWeightedAverageInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtWeightedAverageInterestRate", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Debt, Weighted Average Interest Rate", "terseLabel": "Weighted-average effective interest rate", "documentation": "Weighted average interest rate of debt outstanding." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetailsSummaryOfSummaryOfStockOptionActivity" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term", "terseLabel": "Weighted Average Contractual Term (Years), Vested and exercisable", "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r613" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Schedule of Significant Unobservable Inputs (Level 3), and the Change in Fair Value Recorded in Other Income (Expense)", "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability." } } }, "auth_ref": [ "r33", "r153" ] }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued", "terseLabel": "Unrecognized tax benefits income tax penalties and interest accrued", "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return." } } }, "auth_ref": [ "r638" ] }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "presentation": [ "http://www.completesolaria.com/role/BasicAndDilutedNetLossPerShareTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "terseLabel": "Schedule of Potential Common Shares Excluded from Diluted Net Loss Per Share", "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities." } } }, "auth_ref": [ "r79" ] }, "us-gaap_RestrictedStockUnitsRSUMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedStockUnitsRSUMember", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "label": "Restricted Stock Units (RSUs) [Member]", "terseLabel": "RSU [Member]", "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetailsSummaryOfSummaryOfStockOptionActivity" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Weighted Average Contractual Term (Years), outstanding, ending balance", "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r248" ] }, "us-gaap_IncomeTaxPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxPolicyTextBlock", "presentation": [ "http://www.completesolaria.com/role/AccountingPoliciesByPolicyPolicies" ], "lang": { "en-us": { "role": { "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income Taxes", "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements." } } }, "auth_ref": [ "r346", "r633", "r634", "r642", "r643", "r647", "r649", "r866" ] }, "us-gaap_EarningsPerSharePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerSharePolicyTextBlock", "presentation": [ "http://www.completesolaria.com/role/AccountingPoliciesByPolicyPolicies" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Net Loss Per Share", "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements." } } }, "auth_ref": [ "r79", "r80" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetailsSummaryOfSummaryOfStockOptionActivity" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Weighted Average Contractual Term (Years), Vested and expected to vest", "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r612" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfWarrantsBasedOnABlackScholesOptionPricingMethod", "http://www.completesolaria.com/role/StockBasedCompensationDetailsScheduleOfCalculateTheFairValueOfStockBasedCompensation", "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term", "terseLabel": "Expected term", "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r614" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfWarrantsBasedOnABlackScholesOptionPricingMethod" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]", "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis." } } }, "auth_ref": [ "r32" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfWarrantsBasedOnABlackScholesOptionPricingMethod" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]", "terseLabel": "Schedule of Warrants Based on a Black Scholes Option Pricing Method.", "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis." } } }, "auth_ref": [ "r32" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetailsScheduleOfAssetsAcquiredAndLiabilitiesAssumed" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory", "terseLabel": "Inventories", "documentation": "The amount of inventory recognized as of the acquisition date." } } }, "auth_ref": [ "r133", "r134" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetailsScheduleOfAssetsAcquiredAndLiabilitiesAssumed" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment", "terseLabel": "Property and equipment", "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date." } } }, "auth_ref": [ "r133", "r134" ] }, "us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationChangeInEnactedTaxRate", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfReconciliationOfEffectiveIncomeTaxRate" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount", "terseLabel": "Foreign earnings taxed at different rates", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates." } } }, "auth_ref": [ "r632", "r636" ] }, "us-gaap_SeriesCPreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SeriesCPreferredStockMember", "presentation": [ "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Series C Preferred Stock [Member]", "terseLabel": "Series C Preferred Stock [Member]", "documentation": "Series C preferred stock." } } }, "auth_ref": [ "r1093", "r1094", "r1152" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetailsScheduleOfAssetsAcquiredAndLiabilitiesAssumed" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net", "terseLabel": "Net identifiable liabilities assumed", "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed." } } }, "auth_ref": [ "r133", "r134" ] }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostChangeDueToSubsequentInterimMeasurementWeightedAverageExpectedLongTermRateOfReturnOnPlanAssets": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostChangeDueToSubsequentInterimMeasurementWeightedAverageExpectedLongTermRateOfReturnOnPlanAssets", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Change Due to Subsequent Interim Measurement, Weighted-Average Expected Long-Term Rate of Return on Plan Assets", "terseLabel": "Due and payable amount", "documentation": "Weighted average rate of return on plan assets, used to determine net periodic benefit cost (credit) of defined benefit plan, in subsequent interim measurement." } } }, "auth_ref": [ "r586" ] }, "us-gaap_SeriesBPreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SeriesBPreferredStockMember", "presentation": [ "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Series B Preferred Stock [Member]", "terseLabel": "Series B Preferred Stock [Member]", "documentation": "Series B preferred stock." } } }, "auth_ref": [ "r1093", "r1094", "r1152" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfSignificantUnobservableInputsLevel3AndTheChangeInFairValueRecordedInOtherIncomeExpenseNet" ], "lang": { "en-us": { "role": { "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]", "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3." } } }, "auth_ref": [ "r33", "r153" ] }, "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, Low", "terseLabel": "Consideration paid in cash", "documentation": "For contingent consideration arrangements and indemnification assets recognized in connection with a business combination, this element represents an estimate of the low-end of the potential range (undiscounted) of the consideration which may be paid." } } }, "auth_ref": [ "r137" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfSignificantUnobservableInputsLevel3AndTheChangeInFairValueRecordedInOtherIncomeExpenseNet" ], "lang": { "en-us": { "role": { "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings", "terseLabel": "Change in fair value", "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3)." } } }, "auth_ref": [ "r704" ] }, "us-gaap_SeriesDPreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SeriesDPreferredStockMember", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Series D Preferred Stock [Member]", "terseLabel": "Series D Preferred Stock [Member]", "documentation": "Series D preferred stock." } } }, "auth_ref": [ "r1093", "r1094", "r1152" ] }, "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High", "terseLabel": "Consideration paid", "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid." } } }, "auth_ref": [ "r137" ] }, "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfReconciliationOfEffectiveIncomeTaxRate" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount", "terseLabel": "Statutory federal income tax", "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations." } } }, "auth_ref": [ "r636" ] }, "us-gaap_GoodwillGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillGross", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Goodwill, Gross", "terseLabel": "Goodwill", "documentation": "Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r515", "r518", "r1012" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfSignificantUnobservableInputsLevel3AndTheChangeInFairValueRecordedInOtherIncomeExpenseNet" ], "lang": { "en-us": { "role": { "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "cslr_TotalOtherIncomeexpenseNet1": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "TotalOtherIncomeexpenseNet1", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/OtherIncomeExpenseNetDetailsScheduleOfOtherIncomeExpenseNet" ], "lang": { "en-us": { "role": { "label": "Total Other Incomeexpense Net1", "terseLabel": "Total other income (expense), net", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Other Share Increase (Decrease) in Period, Weighted Average Exercise Price", "terseLabel": "Exercise price per share (in Dollars per share)", "documentation": "Weighted average price at which grantees could acquire or could have acquired the underlying shares with respect to any other type of change in shares reserved for issuance." } } }, "auth_ref": [] }, "us-gaap_MandatorilyRedeemablePreferredStockFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MandatorilyRedeemablePreferredStockFairValueDisclosure", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfFinancialAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Mandatorily Redeemable Preferred Stock, Fair Value Disclosure", "terseLabel": "Redeemable convertible preferred stock warrant liability", "documentation": "Fair value portion of shares that an entity is required to redeem for cash or other assets at a fixed or determinable date or upon the occurrence of an event." } } }, "auth_ref": [ "r101" ] }, "us-gaap_OtherLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilities", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/ForwardPurchaseAgreementsDetails" ], "lang": { "en-us": { "role": { "label": "Other Liabilities", "terseLabel": "Purchase liabilities", "verboseLabel": "Liability", "documentation": "Amount of liabilities classified as other." } } }, "auth_ref": [ "r166", "r820", "r904", "r905", "r1052", "r1227" ] }, "cslr_ChangeInFairValueOfSimpleAgreementForFutureEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ChangeInFairValueOfSimpleAgreementForFutureEquity", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/OtherIncomeExpenseNetDetailsScheduleOfOtherIncomeExpenseNet" ], "lang": { "en-us": { "role": { "label": "Change In Fair Value Of Simple Agreement for Future Equity", "terseLabel": "Change in fair value of SAFE agreements", "documentation": "Change In Fair Value Of Simple Agreement for Future Equity." } } }, "auth_ref": [] }, "us-gaap_OtherNonoperatingIncomeExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingIncomeExpenseMember", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Other Nonoperating Income (Expense) [Member]", "documentation": "Primary financial statement caption encompassing other nonoperating income (expense)." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetailsSummaryOfSummaryOfStockOptionActivity" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price", "terseLabel": "Weighted average exercise price per share, Options canceled", "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated." } } }, "auth_ref": [ "r602" ] }, "cslr_ChangeInFairValueOfDerivativeLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ChangeInFairValueOfDerivativeLiabilities", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/OtherIncomeExpenseNetDetailsScheduleOfOtherIncomeExpenseNet" ], "lang": { "en-us": { "role": { "label": "Change In Fair Value Of Derivative Liabilities", "terseLabel": "Change in fair value of derivative liabilities", "documentation": "Change in fair value of derivative liabilities." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetailsSummaryOfSummaryOfStockOptionActivity" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "terseLabel": "Weighted average exercise price per share, Options granted", "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options." } } }, "auth_ref": [ "r600" ] }, "cslr_ChangeInFairValueOfWarrantLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ChangeInFairValueOfWarrantLiabilities", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/OtherIncomeExpenseNetDetailsScheduleOfOtherIncomeExpenseNet" ], "lang": { "en-us": { "role": { "label": "Change In Fair Value Of Warrant Liabilities", "terseLabel": "Change in fair value of warrant liabilities", "documentation": "Change in fair value of warrant liabilities." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetailsSummaryOfSummaryOfStockOptionActivity" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "terseLabel": "Weighted average exercise price per share, Options exercised", "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares." } } }, "auth_ref": [ "r601" ] }, "cslr_IssuanceOfSharesInConnectionWithTheForwardPurchaseAgreements": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "IssuanceOfSharesInConnectionWithTheForwardPurchaseAgreements", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/OtherIncomeExpenseNetDetailsScheduleOfOtherIncomeExpenseNet" ], "lang": { "en-us": { "role": { "label": "Issuance Of Shares In Connection With The Forward Purchase Agreements", "negatedLabel": "Issuance of shares in connection with the forward purchase agreements", "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims." } } }, "auth_ref": [] }, "us-gaap_LossContingenciesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingenciesTable", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Loss Contingencies [Table]", "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations." } } }, "auth_ref": [ "r531", "r532", "r533", "r536", "r1141", "r1142" ] }, "cslr_ManufacturingEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ManufacturingEquipmentMember", "presentation": [ "http://www.completesolaria.com/role/PropertyAndEquipmentNetDetailsScheduleOfPropertyAndEquipmentNet" ], "lang": { "en-us": { "role": { "label": "Manufacturing Equipment Member", "terseLabel": "Manufacturing equipment [Member]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 31.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Equity, Attributable to Parent", "totalLabel": "Total stockholders' (deficit) equity", "periodStartLabel": "Balance", "periodEndLabel": "Balance", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r194", "r198", "r199", "r226", "r913", "r930", "r958", "r959", "r1039", "r1052", "r1109", "r1129", "r1198", "r1232" ] }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ArrangementsAndNonarrangementTransactionsMember", "presentation": [ "http://www.completesolaria.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]", "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r667" ] }, "cslr_AssembledWorkforceMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "AssembledWorkforceMember", "presentation": [ "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetails", "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetailsScheduleOfAmortizationExpenseRelatedToIntangibleAssets", "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetailsScheduleOfIntangibleAssets" ], "lang": { "en-us": { "role": { "label": "Assembled Workforce Member", "verboseLabel": "Assembled Workforce [Member]", "terseLabel": "Assembled workforce [Member]" } } }, "auth_ref": [] }, "us-gaap_DerivativeInstrumentRiskAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentRiskAxis", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "label": "Derivative Instrument [Axis]", "documentation": "Information by type of derivative contract." } } }, "auth_ref": [ "r143", "r145", "r146", "r147", "r898", "r900", "r916", "r917", "r918", "r920", "r921", "r922", "r923", "r925", "r926", "r927", "r928", "r945", "r946", "r947", "r948", "r951", "r952", "r953", "r954", "r967", "r968", "r972", "r974", "r999", "r1042", "r1044" ] }, "us-gaap_LossContingenciesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingenciesLineItems", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r531", "r532", "r533", "r536", "r1141", "r1142" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "cslr_PeriodDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "PeriodDomain", "presentation": [ "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Period [Domain]", "documentation": "Period." } } }, "auth_ref": [] }, "us-gaap_AccruedProfessionalFeesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedProfessionalFeesCurrent", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetailsScheduleOfAccruedExpensesAndOtherCurrentLiabilities" ], "lang": { "en-us": { "role": { "label": "Accrued Professional Fees, Current", "terseLabel": "Accrued legal settlements", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r53" ] }, "cslr_PeriodAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "PeriodAxis", "presentation": [ "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Period [Axis]", "documentation": "Period." } } }, "auth_ref": [] }, "cslr_TwoThousandAndTwentyThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "TwoThousandAndTwentyThreeMember", "presentation": [ "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Two Thousand And Twenty Three [Member]", "documentation": "Two thousand and twenty three." } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingencies" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r235", "r529", "r530", "r989", "r1139" ] }, "us-gaap_IncomeTaxAuthorityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityDomain", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Income Tax Authority [Domain]", "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes." } } }, "auth_ref": [] }, "cslr_CurrentInsightMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "CurrentInsightMember", "presentation": [ "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Current Insight [Member]" } } }, "auth_ref": [] }, "us-gaap_LossContingencyAccrualCarryingValueCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingencyAccrualCarryingValueCurrent", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Loss Contingency, Accrual, Current", "terseLabel": "Litigation in accrued expenses", "documentation": "Amount of loss contingency liability expected to be resolved within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r531" ] }, "cslr_AssetAcquisitionNumberOfSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "AssetAcquisitionNumberOfSharesIssued", "presentation": [ "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Asset Acquisition, Number of shares issued", "terseLabel": "Asset acquisition, number of shares issued", "documentation": "Asset Acquisition, Number of shares issued." } } }, "auth_ref": [] }, "us-gaap_TrademarksAndTradeNamesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TrademarksAndTradeNamesMember", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetailsScheduleOfIntangibleAssetsAcquired" ], "lang": { "en-us": { "role": { "label": "Trademarks and Trade Names [Member]", "terseLabel": "Trademarks [Member]", "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof." } } }, "auth_ref": [ "r135" ] }, "cslr_LossOnExtinguishment": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "LossOnExtinguishment", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/OtherIncomeExpenseNetDetailsScheduleOfOtherIncomeExpenseNet" ], "lang": { "en-us": { "role": { "label": "Loss On Extinguishment", "negatedLabel": "Loss on CS Solis debt extinguishment", "documentation": "The amount of loss on extinguishment of long term debt." } } }, "auth_ref": [] }, "cslr_ScheduleOfAmortizationExpenseRelatedToIntangibleAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ScheduleOfAmortizationExpenseRelatedToIntangibleAssetsAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Amortization Expense Related To Intangible Assets Abstract" } } }, "auth_ref": [] }, "cslr_ScheduleOfIntangibleAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ScheduleOfIntangibleAssetsAbstract", "lang": { "en-us": { "role": { "label": "Schedule of Intangible Assets [Abstract]" } } }, "auth_ref": [] }, "cslr_GoodwillandIntangibleAssetsDetailsScheduleofAmortizationExpenseRelatedtoIntangibleAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "GoodwillandIntangibleAssetsDetailsScheduleofAmortizationExpenseRelatedtoIntangibleAssetsTable", "presentation": [ "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetailsScheduleOfAmortizationExpenseRelatedToIntangibleAssets" ], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets (Details) - Schedule of Amortization Expense Related to Intangible Assets [Table]" } } }, "auth_ref": [] }, "cslr_SummaryofSignificantAccountingPoliciesDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "SummaryofSignificantAccountingPoliciesDetailsTable", "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies (Details) [Table]" } } }, "auth_ref": [] }, "cslr_GoodwillandIntangibleAssetsDetailsScheduleofAmortizationExpenseRelatedtoIntangibleAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "GoodwillandIntangibleAssetsDetailsScheduleofAmortizationExpenseRelatedtoIntangibleAssetsLineItems", "presentation": [ "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetailsScheduleOfAmortizationExpenseRelatedToIntangibleAssets" ], "lang": { "en-us": { "role": { "label": "Schedule of Amortization Expense Related to Intangible Assets [Abstract]" } } }, "auth_ref": [] }, "cslr_ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Accrued Expenses And Other Current Liabilities Abstract" } } }, "auth_ref": [] }, "us-gaap_StockDividendsShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockDividendsShares", "presentation": [ "http://www.completesolaria.com/role/ReverseRecapitalizationDetailsScheduleOfCommonStockOutstanding" ], "lang": { "en-us": { "role": { "label": "Stock Dividends, Shares", "terseLabel": "Total shares from the Mergers and PIPE Financing", "documentation": "Number of shares of common and preferred stock issued as dividends during the period. Excludes stock splits." } } }, "auth_ref": [ "r30" ] }, "us-gaap_PrepaidRent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidRent", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/PrepaidExpensesAndOtherCurrentAssetsDetailsScheduleOfPrepaidExpensesAndOtherCurrentAssets": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.completesolaria.com/role/PrepaidExpensesAndOtherCurrentAssetsDetailsScheduleOfPrepaidExpensesAndOtherCurrentAssets" ], "lang": { "en-us": { "role": { "label": "Prepaid Rent", "terseLabel": "Inventory deposits", "documentation": "Amount of asset related to consideration paid in advance for rent that provides economic benefits within a future period of one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r996", "r1010", "r1133" ] }, "cslr_AccruedExpensesandOtherCurrentLiabilitiesDetailsScheduleofAccruedExpensesandOtherCurrentLiabilitiesTable": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "AccruedExpensesandOtherCurrentLiabilitiesDetailsScheduleofAccruedExpensesandOtherCurrentLiabilitiesTable", "presentation": [ "http://www.completesolaria.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetailsScheduleOfAccruedExpensesAndOtherCurrentLiabilities" ], "lang": { "en-us": { "role": { "label": "Accrued Expenses and Other Current Liabilities (Details) - Schedule of Accrued Expenses and Other Current Liabilities [Table]" } } }, "auth_ref": [] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossParentheticals" ], "lang": { "en-us": { "role": { "label": "Other Nonoperating Income (Expense)", "terseLabel": "Other income (expense), net", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r219" ] }, "us-gaap_ReclassificationsOfTemporaryToPermanentEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReclassificationsOfTemporaryToPermanentEquity", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Reclassifications of Temporary to Permanent Equity", "terseLabel": "Reclassification of prepaid PIPE(2)", "documentation": "The difference between the carrying amount of a financial instrument subject to a registration payment arrangement recorded as temporary equity prior to adoption of FSP EITF 00-19-2 and the carrying amount reclassified to permanent equity upon the adoption of FSP EITF 00-19-2. Recorded as a cumulative effect adjustment to the beginning balance of retained earnings. Does not apply to registration payment arrangements that are no longer outstanding upon adoption of FSP EITF 00-19-2." } } }, "auth_ref": [ "r237", "r263" ] }, "cslr_AccruedExpensesandOtherCurrentLiabilitiesDetailsScheduleofAccruedExpensesandOtherCurrentLiabilitiesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "AccruedExpensesandOtherCurrentLiabilitiesDetailsScheduleofAccruedExpensesandOtherCurrentLiabilitiesLineItems", "presentation": [ "http://www.completesolaria.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetailsScheduleOfAccruedExpensesAndOtherCurrentLiabilities" ], "lang": { "en-us": { "role": { "label": "Schedule of Accrued Expenses and Other Current Liabilities [Abstract]" } } }, "auth_ref": [] }, "cslr_AccruedRebatesAndCredits": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "AccruedRebatesAndCredits", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetailsScheduleOfAccruedExpensesAndOtherCurrentLiabilities" ], "lang": { "en-us": { "role": { "label": "Accrued Rebates And Credits", "negatedLabel": "Accrued rebates and credits", "documentation": "The amount of accrued rebates and credits." } } }, "auth_ref": [] }, "cslr_DeferredUnderwritersDiscountPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "DeferredUnderwritersDiscountPayable", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetailsScheduleOfAccruedExpensesAndOtherCurrentLiabilities" ], "lang": { "en-us": { "role": { "label": "Deferred Underwriters Discount Payable", "terseLabel": "Deferred underwriters' discount payable", "documentation": "The amount of deferred underwriters discount payable." } } }, "auth_ref": [] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://www.completesolaria.com/role/CommonStockDetails", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlowsParentheticals", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficitParentheticals" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r371", "r372", "r373", "r413", "r796", "r865", "r891", "r901", "r903", "r904", "r905", "r906", "r907", "r911", "r914", "r915", "r916", "r917", "r918", "r920", "r921", "r922", "r923", "r925", "r926", "r927", "r928", "r929", "r931", "r935", "r936", "r943", "r944", "r945", "r946", "r947", "r948", "r949", "r950", "r951", "r952", "r953", "r954", "r957", "r1045" ] }, "cslr_RevenueWarranty": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "RevenueWarranty", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetailsScheduleOfAccruedExpensesAndOtherCurrentLiabilities" ], "lang": { "en-us": { "role": { "label": "Revenue Warranty", "terseLabel": "Revenue warranty", "documentation": "The amount of revenue warranty." } } }, "auth_ref": [] }, "cslr_CustomerOneMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "CustomerOneMember", "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Customer One [Member]", "documentation": "Customer one." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxAuthorityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityAxis", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Income Tax Authority [Axis]", "documentation": "Information by tax jurisdiction." } } }, "auth_ref": [ "r28" ] }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeasesFutureMinimumPaymentsDue", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetailsScheduleOfFutureMinimumLeasePaymentsUnderNonCancelable" ], "lang": { "en-us": { "role": { "label": "Operating Leases, Future Minimum Payments Due", "terseLabel": "Total undiscounted liabilities", "documentation": "Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year." } } }, "auth_ref": [ "r288", "r291" ] }, "cslr_GainOnExtinguishmentOfConvertibleNotesAndSAFEAgreements": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "GainOnExtinguishmentOfConvertibleNotesAndSAFEAgreements", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/OtherIncomeExpenseNetDetailsScheduleOfOtherIncomeExpenseNet" ], "lang": { "en-us": { "role": { "label": "Gain On Extinguishment Of Convertible Notes And SAFEAgreements", "terseLabel": "Gain on extinguishment of convertible notes and SAFE agreements", "documentation": "The amount of gain on extinguishment of convertible notes and SAFE agreements." } } }, "auth_ref": [] }, "cslr_OtherIncomeExpenseNetDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "OtherIncomeExpenseNetDetailsTable", "presentation": [ "http://www.completesolaria.com/role/OtherIncomeExpenseNetDetails" ], "lang": { "en-us": { "role": { "label": "Other Income (Expense), Net (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "presentation": [ "http://www.completesolaria.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Financial Instruments [Domain]", "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "auth_ref": [ "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r562", "r573", "r686", "r764", "r765", "r766", "r767", "r768", "r769", "r770", "r771", "r772", "r773", "r774", "r775", "r776", "r777", "r778", "r779", "r780", "r781", "r782", "r783", "r784", "r785", "r786", "r787", "r788", "r789", "r790", "r791", "r792", "r793", "r837", "r1079", "r1080", "r1081", "r1082", "r1084", "r1085", "r1086", "r1124", "r1125", "r1126", "r1127" ] }, "cslr_ReimbursingSponsors": { "xbrltype": "sharesItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ReimbursingSponsors", "presentation": [ "http://www.completesolaria.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "label": "Reimbursing Sponsors", "terseLabel": "Reimbursing sponsors shares" } } }, "auth_ref": [] }, "cslr_OtherIncomeExpenseNetDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "OtherIncomeExpenseNetDetailsLineItems", "presentation": [ "http://www.completesolaria.com/role/OtherIncomeExpenseNetDetails" ], "lang": { "en-us": { "role": { "label": "Other Income (Expense), Net [Line Items]" } } }, "auth_ref": [] }, "us-gaap_OtherAdditionalCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAdditionalCapital", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetails", "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Other Additional Capital", "terseLabel": "Additional paid in capital", "verboseLabel": "Reduction to additional paid-in capital", "documentation": "Amount of additional paid-in capital (APIC) classified as other." } } }, "auth_ref": [ "r64", "r827" ] }, "cslr_ScheduleOfOtherIncomeExpenseNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ScheduleOfOtherIncomeExpenseNetAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Other Income Expense Net Abstract" } } }, "auth_ref": [] }, "cslr_OtherIncomeExpenseNetDetailsScheduleofOtherIncomeExpenseNetTable": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "OtherIncomeExpenseNetDetailsScheduleofOtherIncomeExpenseNetTable", "presentation": [ "http://www.completesolaria.com/role/OtherIncomeExpenseNetDetailsScheduleOfOtherIncomeExpenseNet" ], "lang": { "en-us": { "role": { "label": "Other Income (Expense), Net (Details) - Schedule of Other Income (Expense), Net [Table]" } } }, "auth_ref": [] }, "cslr_OtherIncomeExpenseNetDetailsScheduleofOtherIncomeExpenseNetLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "OtherIncomeExpenseNetDetailsScheduleofOtherIncomeExpenseNetLineItems", "presentation": [ "http://www.completesolaria.com/role/OtherIncomeExpenseNetDetailsScheduleOfOtherIncomeExpenseNet" ], "lang": { "en-us": { "role": { "label": "Schedule of Other Income (Expense), Net [Abstract]" } } }, "auth_ref": [] }, "cslr_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock1": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock1", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/OtherIncomeExpenseNetDetailsScheduleOfOtherIncomeExpenseNet" ], "lang": { "en-us": { "role": { "label": "Proceeds From Issuance Of Redeemable Convertible Preferred Stock1", "negatedLabel": "Change in fair value of redeemable convertible preferred stock warrant liability", "documentation": "The cash inflow from issuance of callable preferred stock which is identified as being convertible to another type of financial security at the option of the issuer or the holder." } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "presentation": [ "http://www.completesolaria.com/role/AccountingPoliciesByPolicyPolicies" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Restricted Cash", "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits." } } }, "auth_ref": [ "r73", "r265" ] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Assets, Current", "totalLabel": "Total current assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r323", "r339", "r364", "r484", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r669", "r673", "r708", "r1039", "r1148", "r1149", "r1205" ] }, "us-gaap_PlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameDomain", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "label": "Plan Name [Domain]", "documentation": "Plan name for share-based payment arrangement." } } }, "auth_ref": [ "r1154", "r1155", "r1156", "r1157", "r1158", "r1159", "r1160", "r1161", "r1162", "r1163", "r1164", "r1165", "r1166", "r1167", "r1168", "r1169", "r1170", "r1171", "r1172", "r1173", "r1174", "r1175", "r1176", "r1177", "r1178", "r1179" ] }, "us-gaap_AssetsFairValueAdjustment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsFairValueAdjustment", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Assets, Fair Value Adjustment", "terseLabel": "Initial fair value", "documentation": "Amount of addition (reduction) to the amount at which an asset could be incurred (settled) in a current transaction between willing parties." } } }, "auth_ref": [] }, "us-gaap_DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance", "presentation": [ "http://www.completesolaria.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Compensation Arrangement with Individual, Shares Authorized for Issuance", "terseLabel": "Issuance of shares (in shares)", "documentation": "The maximum number of shares authorized for issuance under the deferred compensation arrangement as of the balance sheet date." } } }, "auth_ref": [ "r116" ] }, "us-gaap_LiabilitiesFairValueAdjustment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesFairValueAdjustment", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/OtherIncomeExpenseNetDetailsScheduleOfOtherIncomeExpenseNet" ], "lang": { "en-us": { "role": { "label": "Liabilities, Fair Value Adjustment", "terseLabel": "Change in fair value of forward purchase agreement liabilities", "documentation": "Amount of addition (reduction) to the amount at which a liability could be incurred (settled) in a current transaction between willing parties." } } }, "auth_ref": [] }, "cslr_SimpleAgreementForFutureEquityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "SimpleAgreementForFutureEquityMember", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfSignificantUnobservableInputsLevel3AndTheChangeInFairValueRecordedInOtherIncomeExpenseNet" ], "lang": { "en-us": { "role": { "label": "Simple Agreement for Future Equity [Member]", "terseLabel": "SAFEs [member]" } } }, "auth_ref": [] }, "us-gaap_StockOptionPlanExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockOptionPlanExpense", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 19.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Stock or Unit Option Plan Expense", "terseLabel": "Issuance of restricted stock units in connection with vendor services", "documentation": "Amount of noncash expense for option under share-based payment arrangement." } } }, "auth_ref": [ "r24" ] }, "us-gaap_CashCashEquivalentsAndShortTermInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsAndShortTermInvestments", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, and Short-Term Investments", "terseLabel": "Cash and cash equivalents (in Dollars)", "documentation": "Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable." } } }, "auth_ref": [ "r1098" ] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://www.completesolaria.com/role/CommonStockDetails", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlowsParentheticals", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficitParentheticals" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r371", "r372", "r373", "r413", "r796", "r865", "r891", "r901", "r903", "r904", "r905", "r906", "r907", "r911", "r914", "r915", "r916", "r917", "r918", "r920", "r921", "r922", "r923", "r925", "r926", "r927", "r928", "r929", "r931", "r935", "r936", "r943", "r944", "r945", "r946", "r947", "r948", "r949", "r950", "r951", "r952", "r953", "r954", "r957", "r1045" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/DivestitureDetailsScheduleOfOperationsAndComprehensiveIncomeLossRelatedToDiscontinuedOperations": { "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.completesolaria.com/role/DivestitureDetailsScheduleOfOperationsAndComprehensiveIncomeLossRelatedToDiscontinuedOperations" ], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Costs of Goods Sold", "terseLabel": "Cost of revenues", "documentation": "Amount of costs of goods sold attributable to disposal group, including, but not limited to, discontinued operation." } } }, "auth_ref": [ "r184", "r322" ] }, "us-gaap_OwnshareLendingArrangementSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OwnshareLendingArrangementSharesIssued", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Own-share Lending Arrangement, Shares, Issued", "terseLabel": "Common stock, issued (in Shares)", "documentation": "The number of shares issued in connection with an own-share lending arrangement entered into by the entity, in contemplation of a convertible debt offering or other financing." } } }, "auth_ref": [ "r98" ] }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetails", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "terseLabel": "Operating lease right-of-use assets obtained in exchange for new operating lease liabilities", "verboseLabel": "Exchange for operating lease liabilities", "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability." } } }, "auth_ref": [ "r744", "r1038" ] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesOutstanding", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Shares, Outstanding", "periodStartLabel": "Balance (in Shares)", "periodEndLabel": "Balance (in Shares)", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetails", "http://www.completesolaria.com/role/ForwardPurchaseAgreementsDetails", "http://www.completesolaria.com/role/StockBasedCompensationDetails", "http://www.completesolaria.com/role/StockBasedCompensationDetailsScheduleOfCalculateTheFairValueOfStockBasedCompensation", "http://www.completesolaria.com/role/StockBasedCompensationDetailsScheduleOfStockBasedCompensationExpenseAndItsAllocationWithinTheAccompanyingUnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss", "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r617", "r618" ] }, "us-gaap_StatementOperatingActivitiesSegmentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOperatingActivitiesSegmentAxis", "presentation": [ "http://www.completesolaria.com/role/BasicAndDilutedNetLossPerShareDetailsScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholders", "http://www.completesolaria.com/role/DivestitureDetails" ], "lang": { "en-us": { "role": { "label": "Operating Activities [Axis]", "documentation": "Information by continuing and discontinuing operations." } } }, "auth_ref": [] }, "cslr_ConversionOfSafesFromSolariaAcquisitionIntoPreferredSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ConversionOfSafesFromSolariaAcquisitionIntoPreferredSharesMember", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfSignificantUnobservableInputsLevel3AndTheChangeInFairValueRecordedInOtherIncomeExpenseNet" ], "lang": { "en-us": { "role": { "label": "Conversion of SAFEs From Solaria Acquisition Into Preferred Shares [Member]", "terseLabel": "Conversion of SAFEs from Solaria acquisition into preferred shares [Member]" } } }, "auth_ref": [] }, "us-gaap_UnrealizedGainLossOnDerivatives": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrealizedGainLossOnDerivatives", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0, "order": 29.0 } }, "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetails", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Unrealized Gain (Loss) on Derivatives", "negatedLabel": "Change in fair value of derivative liability", "verboseLabel": "Unrealized gain loss on derivatives", "documentation": "The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period." } } }, "auth_ref": [ "r24", "r951", "r952", "r953", "r954", "r971" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/DivestitureDetailsScheduleOfOperationsAndComprehensiveIncomeLossRelatedToDiscontinuedOperations": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.completesolaria.com/role/DivestitureDetailsScheduleOfOperationsAndComprehensiveIncomeLossRelatedToDiscontinuedOperations" ], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Gross Profit (Loss)", "totalLabel": "Gross loss", "documentation": "Amount of gross profit attributable to disposal group, including, but not limited to, discontinued operation." } } }, "auth_ref": [ "r184", "r322" ] }, "cslr_ConversionOfSafesIntoPreferredSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ConversionOfSafesIntoPreferredSharesMember", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfSignificantUnobservableInputsLevel3AndTheChangeInFairValueRecordedInOtherIncomeExpenseNet" ], "lang": { "en-us": { "role": { "label": "Conversion of SAFEs Into Preferred Shares [Member]", "terseLabel": "Conversion of SAFEs into preferred shares [Member]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherNoncurrentAssets", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0, "order": 23.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Other Noncurrent Assets", "negatedLabel": "Other noncurrent assets", "documentation": "Amount of increase (decrease) in noncurrent assets classified as other." } } }, "auth_ref": [ "r1103" ] }, "us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/DivestitureDetailsScheduleOfOperationsAndComprehensiveIncomeLossRelatedToDiscontinuedOperations": { "parentTag": "us-gaap_GainLossOnDispositionOfRealEstateDiscontinuedOperations", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.completesolaria.com/role/DivestitureDetailsScheduleOfOperationsAndComprehensiveIncomeLossRelatedToDiscontinuedOperations" ], "lang": { "en-us": { "role": { "label": "Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax", "terseLabel": "Impairment loss from discontinued operations", "documentation": "Amount before tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation." } } }, "auth_ref": [ "r178", "r180", "r182" ] }, "cslr_ConversionOfDebtIntoPreferredSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ConversionOfDebtIntoPreferredSharesMember", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfSignificantUnobservableInputsLevel3AndTheChangeInFairValueRecordedInOtherIncomeExpenseNet" ], "lang": { "en-us": { "role": { "label": "Conversion of Debt Into Preferred Shares [Member]", "terseLabel": "Conversion of debt into preferred shares [Member]" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrentAbstract", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets:" } } }, "auth_ref": [] }, "cslr_RogersSafeMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "RogersSafeMember", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfSignificantUnobservableInputsLevel3AndTheChangeInFairValueRecordedInOtherIncomeExpenseNet" ], "lang": { "en-us": { "role": { "label": "Rogers SAFE [Member]", "terseLabel": "Issuance of 2021-Rogers SAFE [Member]" } } }, "auth_ref": [] }, "cslr_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAssumption": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAssumption", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfSignificantUnobservableInputsLevel3AndTheChangeInFairValueRecordedInOtherIncomeExpenseNet" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Assumption", "terseLabel": "Assumption of SAFEs in Solaria acquisition", "documentation": "Fair value measurement with unobservable inputs reconciliation recurring basis liability assumption." } } }, "auth_ref": [] }, "us-gaap_LossContingencyDamagesAwardedValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingencyDamagesAwardedValue", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Loss Contingency, Damages Awarded, Value", "terseLabel": "Demanded approximately", "documentation": "Amount of damages awarded to the plaintiff in the legal matter." } } }, "auth_ref": [ "r1140", "r1141", "r1142" ] }, "us-gaap_PreferredUnitsContributedCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredUnitsContributedCapital", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Preferred Units, Contributed Capital", "terseLabel": "Contributed", "documentation": "The amount of capital contributed by the preferred partners." } } }, "auth_ref": [ "r112" ] }, "cslr_DerivativeInstrumentsNumberOfInstrumentsConvertedIntoEquity": { "xbrltype": "sharesItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "DerivativeInstrumentsNumberOfInstrumentsConvertedIntoEquity", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Derivative Instruments Number Of Instruments Converted Into Equity", "terseLabel": "Derivative instruments number of instruments converted into equity", "documentation": "Derivative instruments number of instruments converted into equity." } } }, "auth_ref": [] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationRevenue", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/DivestitureDetailsScheduleOfOperationsAndComprehensiveIncomeLossRelatedToDiscontinuedOperations": { "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.completesolaria.com/role/DivestitureDetailsScheduleOfOperationsAndComprehensiveIncomeLossRelatedToDiscontinuedOperations" ], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Revenue", "terseLabel": "Revenues", "documentation": "Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation." } } }, "auth_ref": [ "r184", "r322" ] }, "cslr_GainLossOnExtinguishmentOfDerivativeInstruments": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "GainLossOnExtinguishmentOfDerivativeInstruments", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Gain Loss On Extinguishment Of Derivative Instruments", "terseLabel": "Gain or loss extinguishment of derivative instruments", "documentation": "Gain loss on extinguishment of derivative instruments." } } }, "auth_ref": [] }, "cslr_RedeemableConvertiblePreferredStockWarrantLiabilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "RedeemableConvertiblePreferredStockWarrantLiabilityMember", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Redeemable Convertible Preferred Stock Warrant Liability [Member]", "documentation": "Redeemable Convertible Preferred Stock Warrant Liability." } } }, "auth_ref": [] }, "us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/DivestitureDetailsScheduleOfOperationsAndComprehensiveIncomeLossRelatedToDiscontinuedOperations": { "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.completesolaria.com/role/DivestitureDetailsScheduleOfOperationsAndComprehensiveIncomeLossRelatedToDiscontinuedOperations" ], "lang": { "en-us": { "role": { "label": "Discontinued Operation, Tax Effect of Gain (Loss) from Disposal of Discontinued Operation", "negatedLabel": "Loss from discontinued operations", "documentation": "Amount of tax expense (benefit) on gain (loss) not previously recognized resulting from the disposal of a discontinued operation." } } }, "auth_ref": [ "r180", "r182", "r186", "r1188" ] }, "cslr_DespacAcquisitionAssumptionExercisePriceOneMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "DespacAcquisitionAssumptionExercisePriceOneMember", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Despac Acquisition Assumption Exercise Price One [Member]", "documentation": "Despac Acquisition Assumption Exercise Price One." } } }, "auth_ref": [] }, "cslr_WarrantsRemainingPrivateAssumptionExercisePriceOneMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "WarrantsRemainingPrivateAssumptionExercisePriceOneMember", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Warrants Remaining Private Assumption Exercise Price One [Member]", "documentation": "Warrants Remaining Private Assumption Exercise Price One." } } }, "auth_ref": [] }, "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "presentation": [ "http://www.completesolaria.com/role/AccruedExpensesAndOtherCurrentLiabilities" ], "lang": { "en-us": { "role": { "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]", "terseLabel": "Accrued Expenses and Other Current Liabilities", "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationTables" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]", "terseLabel": "Schedule of summary of RSU activity", "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year." } } }, "auth_ref": [ "r118" ] }, "cslr_SpacExistsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "SpacExistsMember", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Spac Exists [Member]", "documentation": "Spac Exists." } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares", "terseLabel": "Shares, issued (in Shares)", "documentation": "Number of shares of equity interests issued or issuable to acquire entity." } } }, "auth_ref": [ "r259" ] }, "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/StockBasedCompensationDetailsScheduleOfStockBasedCompensationExpenseAndItsAllocationWithinTheAccompanyingUnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "parentTag": "us-gaap_AllocatedShareBasedCompensationExpense", "weight": -1.0, "order": 2.0 }, "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "parentTag": "cslr_DiscontinuedOperationNetIncomeLossFromDiscontinuedOperation", "weight": 1.0, "order": 17.0 } }, "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetailsScheduleOfStockBasedCompensationExpenseAndItsAllocationWithinTheAccompanyingUnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of Tax", "terseLabel": "Loss from discontinued operations, net of tax", "documentation": "Amount after tax of income (loss) from operations classified as a discontinued operation. Excludes gain (loss) on disposal and provision for gain (loss) until disposal." } } }, "auth_ref": [ "r178", "r179", "r186" ] }, "cslr_WarrantsRemainingPrivateMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "WarrantsRemainingPrivateMember", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Warrants Remaining Private [Member]", "documentation": "Warrants Remaining Private." } } }, "auth_ref": [] }, "us-gaap_TypeOfArrangementAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TypeOfArrangementAxis", "presentation": [ "http://www.completesolaria.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r667" ] }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFederalIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfProvisionForIncomeTaxes": { "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfProvisionForIncomeTaxes" ], "lang": { "en-us": { "role": { "label": "Deferred Federal Income Tax Expense (Benefit)", "terseLabel": "Federal", "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r1110", "r1186", "r1187" ] }, "us-gaap_IncomeStatementLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationAxis", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetails", "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetails", "http://www.completesolaria.com/role/StockBasedCompensationDetailsScheduleOfStockBasedCompensationExpenseAndItsAllocationWithinTheAccompanyingUnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Income Statement Location [Axis]", "documentation": "Information by location in the income statement." } } }, "auth_ref": [ "r524", "r527", "r941" ] }, "cslr_ProbabilityOfConversionIntoEquityInstrumentsTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ProbabilityOfConversionIntoEquityInstrumentsTwoMember", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Probability Of Conversion Into Equity Instruments Two [Member]", "documentation": "Probability Of Conversion Into Equity Instruments Two." } } }, "auth_ref": [] }, "cslr_ProbabilityOfConversionIntoEquityInstrumentsOneMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ProbabilityOfConversionIntoEquityInstrumentsOneMember", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Probability Of Conversion Into Equity Instruments One [Member]", "documentation": "Probability Of Conversion Into Equity Instruments One." } } }, "auth_ref": [] }, "us-gaap_IncomeStatementLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationDomain", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetails", "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetails", "http://www.completesolaria.com/role/StockBasedCompensationDetailsScheduleOfStockBasedCompensationExpenseAndItsAllocationWithinTheAccompanyingUnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Income Statement Location [Domain]", "documentation": "Location in the income statement." } } }, "auth_ref": [ "r527", "r941" ] }, "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredForeignIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfProvisionForIncomeTaxes": { "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfProvisionForIncomeTaxes" ], "lang": { "en-us": { "role": { "label": "Deferred Foreign Income Tax Expense (Benefit)", "terseLabel": "Foreign", "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r255", "r1110", "r1186" ] }, "cslr_TwoThousandAndTwentySeriesAConvertibleNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "TwoThousandAndTwentySeriesAConvertibleNotesMember", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfConvertibleNotes", "http://www.completesolaria.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Two Thousand And Twenty Series A Convertible Notes [Member]", "verboseLabel": "2020-A\u00a0Convertible Notes [Member]", "terseLabel": "Two Thousand And Twenty Series A Convertible Notes [Member]" } } }, "auth_ref": [] }, "cslr_TwoThousandAndTwentyOneSeriesAConvertibleNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "TwoThousandAndTwentyOneSeriesAConvertibleNotesMember", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfConvertibleNotes", "http://www.completesolaria.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Two Thousand And Twenty One Series A Convertible Notes [Member]", "verboseLabel": "2021-A\u00a0Convertible Notes [Member]", "terseLabel": "Two Thousand And Twenty One Series A Convertible Notes [Member]" } } }, "auth_ref": [] }, "cslr_TwoThousandAndNineteenSimpleAgreementForFutureEquityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "TwoThousandAndNineteenSimpleAgreementForFutureEquityMember", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Two Thousand And Nineteen Simple Agreement For Future Equity [Member]", "terseLabel": "2019 SAFE [Member]", "documentation": "Two Thousand And Nineteen Simple Agreement For Future Equity." } } }, "auth_ref": [] }, "us-gaap_LineOfCreditAssumed1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditAssumed1", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Line of Credit Assumed", "terseLabel": "Line of credit", "documentation": "The fair value of line of credit assumed in noncash investing or financing activities." } } }, "auth_ref": [ "r75", "r76", "r77" ] }, "us-gaap_AdvertisingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdvertisingExpense", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Advertising Expense", "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line." } } }, "auth_ref": [ "r629" ] }, "cslr_TwoThousandAndTwentyOneSimpleAgreementForFutureEquityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "TwoThousandAndTwentyOneSimpleAgreementForFutureEquityMember", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Two Thousand And Twenty One Simple Agreement For Future Equity [Member]", "terseLabel": "2021 SAFE [Member]", "documentation": "Two Thousand And Twenty One Simple Agreement For Future Equity." } } }, "auth_ref": [] }, "cslr_TwoThousandAndTwentyTwoSimpleAgreementForFutureEquityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "TwoThousandAndTwentyTwoSimpleAgreementForFutureEquityMember", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Two Thousand And Twenty Two Simple Agreement For Future Equity [Member]", "terseLabel": "2022 SAFE [Member]", "documentation": "Two Thousand And Twenty Two Simple Agreement For Future Equity." } } }, "auth_ref": [] }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfProvisionForIncomeTaxes": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfProvisionForIncomeTaxes" ], "lang": { "en-us": { "role": { "label": "Deferred Income Tax Expense (Benefit)", "totalLabel": "Total deferred", "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r24", "r255", "r305", "r657", "r658", "r1110" ] }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationTables" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]", "terseLabel": "Summary of summary of stock option activity", "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value." } } }, "auth_ref": [ "r35", "r37", "r118" ] }, "cslr_SeriesDPreferredStockWarrantsTrancheOneMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "SeriesDPreferredStockWarrantsTrancheOneMember", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Series D Preferred Stock Warrants Tranche One [Member]", "terseLabel": "Series D Preferred Stock Warrants Tranche One [Member]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "terseLabel": "Schedule Of Calculate The Fair Value Of Stock-based Compensation", "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions." } } }, "auth_ref": [ "r249" ] }, "cslr_SeriesDPreferredStockWarrantsTrancheTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "SeriesDPreferredStockWarrantsTrancheTwoMember", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Series D Preferred Stock Warrants Tranche Two [Member]", "verboseLabel": "Series D Preferred Stock Warrants Tranche Two [Member]" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension", "presentation": [ "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetailsScheduleOfIntangibleAssets" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Asset, Weighted Average Period before Next Renewal or Extension", "terseLabel": "Weighted- Average Remaining Life (Years)", "documentation": "Weighted average period before the next renewal or extension (both explicit and implicit) for intangible assets that have been renewed or extended, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r36" ] }, "us-gaap_TrademarksMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TrademarksMember", "presentation": [ "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetailsScheduleOfAmortizationExpenseRelatedToIntangibleAssets", "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetailsScheduleOfIntangibleAssets" ], "lang": { "en-us": { "role": { "label": "Trademarks [Member]", "terseLabel": "Trademarks [Member]", "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style." } } }, "auth_ref": [ "r135" ] }, "cslr_ScheduleOfFinancialAssetsAndLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ScheduleOfFinancialAssetsAndLiabilitiesAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Financial Assets And Liabilities Abstract" } } }, "auth_ref": [] }, "us-gaap_NotesPayableFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NotesPayableFairValueDisclosure", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Notes Payable, Fair Value Disclosure", "terseLabel": "Notes Payable, Fair Value Disclosure", "documentation": "Fair value portion of notes payable." } } }, "auth_ref": [ "r51" ] }, "cslr_FairValueMeasurementsDetailsScheduleofFinancialAssetsandLiabilitiesTable": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "FairValueMeasurementsDetailsScheduleofFinancialAssetsandLiabilitiesTable", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfFinancialAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurements (Details) - Schedule of Financial Assets and Liabilities [Table]" } } }, "auth_ref": [] }, "cslr_FairValueMeasurementsDetailsScheduleofFinancialAssetsandLiabilitiesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "FairValueMeasurementsDetailsScheduleofFinancialAssetsandLiabilitiesLineItems", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfFinancialAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurements (Details) - Schedule of Financial Assets and Liabilities [Line Items]" } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfFinancialAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Domain]", "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r554", "r579", "r580", "r581", "r582", "r583", "r584", "r767", "r768", "r769", "r1014", "r1015", "r1026", "r1027", "r1028" ] }, "cslr_FinancialLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "FinancialLiabilitiesAbstract", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfFinancialAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Financial Liabilities Abstract", "terseLabel": "Financial Liabilities" } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetailsScheduleOfWeightedAverageRemainingLeaseTermAndTheDiscountRate" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Weighted average discount rate", "documentation": "Weighted average discount rate for operating lease calculated at point in time." } } }, "auth_ref": [ "r746", "r1038" ] }, "us-gaap_AdvertisingCostsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdvertisingCostsPolicyTextBlock", "presentation": [ "http://www.completesolaria.com/role/AccountingPoliciesByPolicyPolicies" ], "lang": { "en-us": { "role": { "label": "Advertising Cost [Policy Text Block]", "terseLabel": "Advertising and Promotional Expenses", "documentation": "Disclosure of accounting policy for advertising cost." } } }, "auth_ref": [ "r295" ] }, "cslr_WarrantLiabilitiesPrivateWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "WarrantLiabilitiesPrivateWarrants", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfFinancialAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Warrant Liabilities Private Warrants", "terseLabel": "Private placement warrants", "documentation": "Warrant liabilities private warrants." } } }, "auth_ref": [] }, "cslr_WarrantLiabilitiesPublicWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "WarrantLiabilitiesPublicWarrants", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfFinancialAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Warrant Liabilities Public Warrants", "terseLabel": "Public warrants", "documentation": "Warrant liabilities public warrants." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]", "terseLabel": "Schedule of Unrecognized Tax Benefits", "documentation": "Tabular disclosure of the change in unrecognized tax benefits." } } }, "auth_ref": [ "r1034", "r1182" ] }, "us-gaap_RepaymentsOfLongtermLoansFromVendors": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfLongtermLoansFromVendors", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Repayments of Long-Term Loans from Vendors", "terseLabel": "Vendor purchase net amount", "documentation": "Cash outflows under financing arrangements with vendors (seller-financed debt), which had a maturity date at inception of more than one year (or more than one operating cycle, if longer); such debt may have arisen from purchases of property, plant and equipment or other productive assets." } } }, "auth_ref": [ "r224" ] }, "us-gaap_AssetsHeldInTrust": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsHeldInTrust", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Asset, Held-in-Trust", "terseLabel": "Long-term assets held for sale \u2013 discontinued operations", "documentation": "The total amount of cash and securities held by third party trustees pursuant to terms of debt instruments or other agreements as of the date of each statement of financial position presented, which can be used by the trustee only to pay the noncurrent portion of specified obligations." } } }, "auth_ref": [ "r1106" ] }, "cslr_SeriesD7RedeemableConvertiblePreferredStockWarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "SeriesD7RedeemableConvertiblePreferredStockWarrantMember", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfWarrantsBasedOnABlackScholesOptionPricingMethod" ], "lang": { "en-us": { "role": { "label": "Series D7 Redeemable Convertible Preferred Stock Warrant Member", "terseLabel": "Series D-7 Redeemable Convertible Preferred Stock Warrant [Member]" } } }, "auth_ref": [] }, "cslr_WorkingCapitalWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "WorkingCapitalWarrants", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfFinancialAssetsAndLiabilities", "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Working Capital Warrants", "terseLabel": "Working capital warrants", "documentation": "Working capital warrants." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized", "presentation": [ "http://www.completesolaria.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized", "terseLabel": "Additional shares", "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement." } } }, "auth_ref": [] }, "cslr_SeriesBRedeemableConvertiblePreferredStockWarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "SeriesBRedeemableConvertiblePreferredStockWarrantMember", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfWarrantsBasedOnABlackScholesOptionPricingMethod" ], "lang": { "en-us": { "role": { "label": "Series BRedeemable Convertible Preferred Stock Warrant Member", "terseLabel": "Series B Redeemable Convertible Preferred Stock Warrant [Member]" } } }, "auth_ref": [] }, "us-gaap_InterestIncomeOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestIncomeOther", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/OtherIncomeExpenseNetDetails" ], "lang": { "en-us": { "role": { "label": "Interest Income, Other", "terseLabel": "Other income", "documentation": "Amount of interest income earned from interest bearing assets classified as other." } } }, "auth_ref": [] }, "cslr_ScheduleOfWarrantsBasedOnABlackScholesOptionPricingMethodAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ScheduleOfWarrantsBasedOnABlackScholesOptionPricingMethodAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Warrants Based On ABlack Scholes Option Pricing Method Abstract" } } }, "auth_ref": [] }, "cslr_SimpleAgreementForFutureEquityfairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "SimpleAgreementForFutureEquityfairValueDisclosure", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfFinancialAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Simple Agreement for Future EquityFair Value Disclosure", "terseLabel": "SAFE agreements", "documentation": "Simple agreement for future equity\u00a0fair value disclosure." } } }, "auth_ref": [] }, "us-gaap_NotesIssued1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NotesIssued1", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Notes Issued", "terseLabel": "Short-term promissory note", "documentation": "The fair value of notes issued in noncash investing and financing activities." } } }, "auth_ref": [ "r75", "r76", "r77" ] }, "cslr_SeriesCRedeemableConvertiblePreferredStockWarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "SeriesCRedeemableConvertiblePreferredStockWarrantMember", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfWarrantsBasedOnABlackScholesOptionPricingMethod" ], "lang": { "en-us": { "role": { "label": "Series CRedeemable Convertible Preferred Stock Warrant Member", "terseLabel": "Series C Redeemable Convertible Preferred Stock Warrant [Member]" } } }, "auth_ref": [] }, "us-gaap_StockIssued1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssued1", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Stock Issued", "terseLabel": "Common stock issued in asset purchase", "documentation": "The fair value of stock issued in noncash financing activities." } } }, "auth_ref": [ "r75", "r76", "r77" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetailsScheduleOfAssetsAcquiredAndLiabilitiesAssumed" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, to be Paid", "terseLabel": "Operating lease liabilities, net of current portion", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease." } } }, "auth_ref": [ "r747" ] }, "cslr_ConvertiblePromissoryNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ConvertiblePromissoryNotesMember", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfWarrantsBasedOnABlackScholesOptionPricingMethod", "http://www.completesolaria.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Convertible Promissory Notes Member", "terseLabel": "Convertible Promissory Notes [Member]" } } }, "auth_ref": [] }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueTableTextBlock", "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "Disaggregation of Revenue [Table Text Block]", "terseLabel": "Schedule of Revenue Recognized By Product and Services", "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r1153" ] }, "us-gaap_CapitalizedComputerSoftwareAdditions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CapitalizedComputerSoftwareAdditions", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Capitalized Computer Software, Additions", "terseLabel": "Capitalized internal-use software development costs", "documentation": "Additions made to capitalized computer software costs during the period." } } }, "auth_ref": [ "r90" ] }, "us-gaap_SegmentDiscontinuedOperationsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentDiscontinuedOperationsMember", "presentation": [ "http://www.completesolaria.com/role/BasicAndDilutedNetLossPerShareDetailsScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholders", "http://www.completesolaria.com/role/DivestitureDetails" ], "lang": { "en-us": { "role": { "label": "Discontinued Operations [Member]", "documentation": "Component or group of components disposed of or classified as held-for-sale and representing a strategic shift that has or will have a major effect on operations and financial results. Includes a business or nonprofit activity on acquisition classified as held-for-sale." } } }, "auth_ref": [ "r21", "r175", "r176", "r177" ] }, "us-gaap_UnrecognizedTaxBenefits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefits", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetails", "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfUnrecognizedTaxBenefits" ], "lang": { "en-us": { "role": { "label": "Unrecognized Tax Benefits", "periodStartLabel": "Unrecognized tax benefits as of beginning of year", "periodEndLabel": "Unrecognized tax benefits as of end of year", "terseLabel": "Unrecognized tax benefits", "documentation": "Amount of unrecognized tax benefits." } } }, "auth_ref": [ "r631", "r639" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://www.completesolaria.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r1060" ] }, "us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeasesOfLesseeDisclosureTextBlock", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesTables" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Disclosure [Table Text Block]", "terseLabel": "Schedule of Weighted Average Remaining Lease Term and the Discount Rate", "documentation": "Tabular disclosure for lessee's operating leases. Includes, but is not limited to, description of lessee's operating lease, existence and terms of renewal or purchase options and escalation clauses, restrictions imposed by lease, such as those concerning dividends, additional debt, and further leasing, rent holidays, rent concessions, or leasehold improvement incentives and unusual provisions or conditions." } } }, "auth_ref": [ "r285", "r287", "r288", "r289", "r290" ] }, "us-gaap_CostOfSalesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfSalesMember", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetailsScheduleOfStockBasedCompensationExpenseAndItsAllocationWithinTheAccompanyingUnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Cost of Sales [Member]", "terseLabel": "Cost of revenues [Member]", "documentation": "Primary financial statement caption encompassing cost of sales." } } }, "auth_ref": [] }, "us-gaap_OtherNoncashIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNoncashIncomeExpense", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.completesolaria.com/role/ForwardPurchaseAgreementsDetails", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Other Noncash Income (Expense)", "negatedLabel": "Non-cash interest expense", "terseLabel": "Other income (expense)", "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other." } } }, "auth_ref": [ "r223" ] }, "us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CapitalizedComputerSoftwareAccumulatedAmortization", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Capitalized Computer Software, Accumulated Amortization", "terseLabel": "Internal-use software ,remaining unamortized balance", "documentation": "For each balance sheet presented, the amount of accumulated amortization for capitalized computer software costs." } } }, "auth_ref": [ "r1235" ] }, "us-gaap_DisaggregationOfRevenueLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueLineItems", "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetailsScheduleOfRevenueRecognizedByProductAndServices" ], "lang": { "en-us": { "role": { "label": "Disaggregation Of Revenue [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r577", "r1019", "r1020", "r1021", "r1022", "r1023", "r1024", "r1025" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://www.completesolaria.com/role/BasicAndDilutedNetLossPerShareDetailsScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholders", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Diluted", "terseLabel": "Net loss per share attributable to common stockholders, diluted", "verboseLabel": "Net loss per share diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r353", "r378", "r379", "r381", "r382", "r384", "r392", "r406", "r407", "r408", "r412", "r696", "r697", "r816", "r839", "r1003" ] }, "srt_BoardOfDirectorsChairmanMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "BoardOfDirectorsChairmanMember", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "label": "Board of Directors Chairman [Member]", "terseLabel": "Board of Directors [Member]", "documentation": "Leader of board of directors." } } }, "auth_ref": [ "r1123" ] }, "us-gaap_DisaggregationOfRevenueTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueTable", "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetailsScheduleOfRevenueRecognizedByProductAndServices" ], "lang": { "en-us": { "role": { "label": "Disaggregation of Revenue [Table]", "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r577", "r1019", "r1020", "r1021", "r1022", "r1023", "r1024", "r1025" ] }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfUnrecognizedTaxBenefits" ], "lang": { "en-us": { "role": { "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions", "terseLabel": "Decreases related to prior year tax positions", "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns." } } }, "auth_ref": [ "r640" ] }, "us-gaap_FairValueByBalanceSheetGroupingTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByBalanceSheetGroupingTable", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, by Balance Sheet Grouping [Table]", "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities." } } }, "auth_ref": [ "r151", "r155", "r156" ] }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfUnrecognizedTaxBenefits" ], "lang": { "en-us": { "role": { "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions", "terseLabel": "Increases related to prior year tax positions", "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns." } } }, "auth_ref": [ "r640" ] }, "us-gaap_FairValueHedgeAssetsAtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueHedgeAssetsAtFairValue", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/ForwardPurchaseAgreementsDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value Hedge Assets", "terseLabel": "Fair value of prepaid forward purchase agreements", "documentation": "Fair value of all derivative assets designated as fair value hedging instruments." } } }, "auth_ref": [ "r145" ] }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingPolicyPolicyTextBlock", "presentation": [ "http://www.completesolaria.com/role/AccountingPoliciesByPolicyPolicies" ], "lang": { "en-us": { "role": { "label": "Segment Reporting, Policy [Policy Text Block]", "terseLabel": "Segment Information", "documentation": "Disclosure of accounting policy for segment reporting." } } }, "auth_ref": [ "r425", "r426", "r427", "r428", "r429", "r430", "r440", "r1006" ] }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfUnrecognizedTaxBenefits" ], "lang": { "en-us": { "role": { "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions", "terseLabel": "Increases related to current year tax positions", "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return." } } }, "auth_ref": [ "r641" ] }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "presentation": [ "http://www.completesolaria.com/role/Divestiture" ], "lang": { "en-us": { "role": { "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]", "terseLabel": "Divestiture", "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component." } } }, "auth_ref": [ "r173", "r230" ] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyDomain", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfConvertibleNotes", "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfWarrantsBasedOnABlackScholesOptionPricingMethod", "http://www.completesolaria.com/role/ForwardPurchaseAgreementsDetails", "http://www.completesolaria.com/role/OrganizationDetails", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlowsParentheticals", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossParentheticals", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficitParentheticals", "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Related Party, Type [Domain]", "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r585", "r756", "r757", "r903", "r904", "r905", "r906", "r907", "r929", "r931", "r962" ] }, "us-gaap_RevenueRemainingPerformanceObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRemainingPerformanceObligation", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Revenue, Remaining Performance Obligation, Amount", "terseLabel": "Deferred service cost", "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue." } } }, "auth_ref": [ "r302" ] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UseOfEstimates", "presentation": [ "http://www.completesolaria.com/role/AccountingPoliciesByPolicyPolicies" ], "lang": { "en-us": { "role": { "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r84", "r85", "r86", "r296", "r297", "r300", "r301" ] }, "us-gaap_OtherOperatingIncomeExpenseNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherOperatingIncomeExpenseNet", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/OtherIncomeExpenseNetDetailsScheduleOfOtherIncomeExpenseNet" ], "lang": { "en-us": { "role": { "label": "Other Operating Income (Expense), Net", "terseLabel": "Other, net", "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations." } } }, "auth_ref": [] }, "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "presentation": [ "http://www.completesolaria.com/role/PropertyAndEquipmentNetDetailsScheduleOfPropertyAndEquipmentNet", "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetailsScheduleOfPropertyPlantAndEquipmentUsefulLives" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Table]", "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r25" ] }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetailsScheduleOfStockBasedCompensationExpenseAndItsAllocationWithinTheAccompanyingUnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]", "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements." } } }, "auth_ref": [ "r121" ] }, "us-gaap_PropertyPlantAndEquipmentGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentGross", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/PropertyAndEquipmentNetDetailsScheduleOfPropertyAndEquipmentNet": { "parentTag": "us-gaap_PropertyPlantAndEquipmentOtherNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.completesolaria.com/role/PropertyAndEquipmentNetDetailsScheduleOfPropertyAndEquipmentNet" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Gross", "terseLabel": "Total property and equipment", "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r232", "r327", "r833" ] }, "us-gaap_TypeOfAdoptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TypeOfAdoptionMember", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Accounting Standards Update [Domain]", "documentation": "Amendment to accounting standards." } } }, "auth_ref": [ "r316", "r317", "r318", "r319", "r320", "r374", "r375", "r376", "r377", "r388", "r451", "r452", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r525", "r624", "r625", "r626", "r651", "r652", "r653", "r654", "r664", "r665", "r666", "r675", "r676", "r677", "r678", "r679", "r680", "r681", "r682", "r683", "r684", "r685", "r687", "r688", "r689", "r690", "r691", "r692", "r693", "r694", "r695", "r696", "r697", "r698", "r705", "r706", "r709", "r710", "r711", "r712", "r727", "r728", "r733", "r734", "r735", "r736", "r748", "r749", "r750", "r751", "r752", "r798", "r799", "r800", "r849", "r850", "r851", "r852", "r853", "r854", "r855", "r856", "r857", "r858", "r859", "r860" ] }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentAbstract", "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Net", "terseLabel": "Property and equipment, net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r25", "r818", "r833", "r1039" ] }, "us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionPurchasesFromRelatedParty", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction, Purchases from Related Party", "terseLabel": "Purchases from related party", "documentation": "Purchases during the period (excluding transactions that are eliminated in consolidated or combined financial statements) with related party." } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetailsScheduleOfConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_RestrictedCashCurrent", "weight": 1.0, "order": 1.0 }, "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetailsScheduleOfConsolidatedStatementsOfCashFlows", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r72", "r326", "r994" ] }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsPolicyTextBlock", "presentation": [ "http://www.completesolaria.com/role/AccountingPoliciesByPolicyPolicies" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash and Cash Equivalents", "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value." } } }, "auth_ref": [ "r73" ] }, "us-gaap_SegmentContinuingOperationsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentContinuingOperationsMember", "presentation": [ "http://www.completesolaria.com/role/BasicAndDilutedNetLossPerShareDetailsScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholders" ], "lang": { "en-us": { "role": { "label": "Continuing Operations [Member]", "documentation": "Component of an entity expected to operate in the foreseeable future." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "presentation": [ "http://www.completesolaria.com/role/AccountingPoliciesByPolicyPolicies" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "terseLabel": "Property and Equipment, Net", "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r25", "r299", "r303", "r832" ] }, "us-gaap_LongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebt", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt", "terseLabel": "Long term debt", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation." } } }, "auth_ref": [ "r43", "r270", "r553", "r565", "r1014", "r1015", "r1216" ] }, "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityCommitmentFeePercentage", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Line of Credit Facility, Commitment Fee Percentage", "terseLabel": "Line of credit interest rate", "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used." } } }, "auth_ref": [] }, "us-gaap_ProvisionForDoubtfulAccounts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProvisionForDoubtfulAccounts", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetailsScheduleOfAllowanceForDoubtfulAccounts", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable, Credit Loss Expense (Reversal)", "terseLabel": "Provision for credit losses", "verboseLabel": "Provision charged to earnings", "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable." } } }, "auth_ref": [ "r354", "r499" ] }, "us-gaap_SegmentOperatingActivitiesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentOperatingActivitiesDomain", "presentation": [ "http://www.completesolaria.com/role/BasicAndDilutedNetLossPerShareDetailsScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholders", "http://www.completesolaria.com/role/DivestitureDetails" ], "lang": { "en-us": { "role": { "label": "Operating Activities [Domain]", "documentation": "Operations of an entity including continuing and discontinued operations." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetailsSummaryOfSummaryOfStockOptionActivity" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value", "terseLabel": "Aggregate intrinsic value (in thousands),Vested and exercisable", "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r613" ] }, "cslr_ForwardPurchaseAgreements": { "xbrltype": "sharesItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ForwardPurchaseAgreements", "presentation": [ "http://www.completesolaria.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "label": "Forward Purchase Agreements", "terseLabel": "Forward purchase agreements" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetailsSummaryOfSummaryOfStockOptionActivity" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number", "terseLabel": "Number of shares, Vested and expected to vest", "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r612" ] }, "cslr_SubscriptionAgreements": { "xbrltype": "sharesItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "SubscriptionAgreements", "presentation": [ "http://www.completesolaria.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "label": "Subscription Agreements", "terseLabel": "Subscription agreements" } } }, "auth_ref": [] }, "us-gaap_TemporaryEquitySharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TemporaryEquitySharesIssued", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficitParentheticals" ], "lang": { "en-us": { "role": { "label": "Temporary Equity, Shares Issued", "terseLabel": "Temporary equity shares issued", "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer." } } }, "auth_ref": [ "r191" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetailsSummaryOfSummaryOfStockOptionActivity" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value", "terseLabel": "Aggregate intrinsic value (in thousands), Vested and expected to vest", "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r612" ] }, "cslr_CriteriaAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "CriteriaAxis", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "label": "Criteria [Axis]", "documentation": "Criteria." } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationLineItems", "presentation": [ "http://www.completesolaria.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "cslr_CounterpartiesIssuedAdditional": { "xbrltype": "sharesItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "CounterpartiesIssuedAdditional", "presentation": [ "http://www.completesolaria.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "label": "Counterparties Issued Additional", "terseLabel": "Counterparties issued additional shares" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetailsSummaryOfSummaryOfStockOptionActivity" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number", "terseLabel": "Number of shares, Vested and exercisable", "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r613" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetailsScheduleOfAssetsAcquiredAndLiabilitiesAssumed" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation", "terseLabel": "Operating lease right-of-use assets", "documentation": "Amount of lease obligation assumed in business combination." } } }, "auth_ref": [ "r134" ] }, "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityRemainingBorrowingCapacity", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Line of Credit Facility, Remaining Borrowing Capacity", "terseLabel": "Remaining balance", "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding)." } } }, "auth_ref": [ "r48" ] }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfProvisionForIncomeTaxes": { "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfProvisionForIncomeTaxes" ], "lang": { "en-us": { "role": { "label": "Deferred State and Local Income Tax Expense (Benefit)", "terseLabel": "State", "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r1110", "r1186", "r1187" ] }, "cslr_CriteriaDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "CriteriaDomain", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "label": "Criteria [Domain]", "documentation": "Criteria." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.completesolaria.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Type", "terseLabel": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "cslr_AggregateGrossProceeds": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "AggregateGrossProceeds", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "label": "Aggregate Gross Proceeds", "terseLabel": "Aggregate gross proceeds (in Dollars)" } } }, "auth_ref": [] }, "us-gaap_CostsIncurredDevelopmentCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostsIncurredDevelopmentCosts", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/ReverseRecapitalizationDetails" ], "lang": { "en-us": { "role": { "label": "Costs Incurred, Development Costs", "terseLabel": "Incurred cost", "documentation": "Development costs incurred, including capitalized costs and costs charged to expense, in oil and gas activities." } } }, "auth_ref": [ "r164" ] }, "us-gaap_TemporaryEquityShareSubscriptions": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TemporaryEquityShareSubscriptions", "presentation": [ "http://www.completesolaria.com/role/ReverseRecapitalizationDetailsScheduleOfCommonStockOutstanding" ], "lang": { "en-us": { "role": { "label": "Temporary Equity, Share Subscriptions", "negatedLabel": "Less: redemption of FACT Class A Ordinary Shares", "documentation": "The number of securities classified as temporary equity that have been allocated to investors to buy. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer." } } }, "auth_ref": [ "r191" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetailsScheduleOfAssetsAcquiredAndLiabilitiesAssumed" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets", "terseLabel": "Intangible assets", "documentation": "Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date." } } }, "auth_ref": [ "r134" ] }, "cslr_TenPercentStockHolderMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "TenPercentStockHolderMember", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "label": "Ten Percent Stock Holder [Member]", "documentation": "Ten percent stock holder." } } }, "auth_ref": [] }, "us-gaap_CustomerConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CustomerConcentrationRiskMember", "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Customer Concentration Risk [Member]", "terseLabel": "Customer Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer." } } }, "auth_ref": [ "r82", "r441" ] }, "us-gaap_TemporaryEquitySharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TemporaryEquitySharesOutstanding", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Temporary Equity, Shares Outstanding", "periodStartLabel": "Redeemable, Balance (in Shares)", "periodEndLabel": "Redeemable, Balance (in Shares)", "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer." } } }, "auth_ref": [ "r191" ] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Gross Profit", "totalLabel": "Gross profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r209", "r364", "r418", "r432", "r436", "r438", "r484", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r708", "r1005", "r1148" ] }, "cslr_ScheduleOfReconcilesElementsOfTheMergerTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ScheduleOfReconcilesElementsOfTheMergerTableTextBlock", "presentation": [ "http://www.completesolaria.com/role/ReverseRecapitalizationTables" ], "lang": { "en-us": { "role": { "label": "Schedule Of Reconciles Elements Of The Merger Table Text Block", "terseLabel": "Schedule of Reconciles Elements of the Merger", "documentation": "Tabular disclosure of the reconciles elements of the merger." } } }, "auth_ref": [] }, "cslr_TrancheTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "TrancheTwoMember", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Tranche Two [Member]" } } }, "auth_ref": [] }, "cslr_ScheduleOfReservedSharesOfCommonStockTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ScheduleOfReservedSharesOfCommonStockTableTextBlock", "presentation": [ "http://www.completesolaria.com/role/CommonStockTables" ], "lang": { "en-us": { "role": { "label": "Schedule Of Reserved Shares Of Common Stock Table Text Block", "terseLabel": "Schedule of Reserved Shares of Common Stock", "documentation": "Tabular disclosure of reserved shares of common stock." } } }, "auth_ref": [] }, "us-gaap_LineOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCredit", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Long-Term Line of Credit", "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement." } } }, "auth_ref": [ "r43", "r270", "r1216" ] }, "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy", "presentation": [ "http://www.completesolaria.com/role/AccountingPoliciesByPolicyPolicies" ], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]", "terseLabel": "Intangibles Assets, Net", "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined." } } }, "auth_ref": [ "r26" ] }, "cslr_DisclosureInTabularFormOfSignificantUnobservableInputsUsedInTheFairValueOfWarrantsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "DisclosureInTabularFormOfSignificantUnobservableInputsUsedInTheFairValueOfWarrantsTableTextBlock", "presentation": [ "http://www.completesolaria.com/role/WarrantsTables" ], "lang": { "en-us": { "role": { "label": "Disclosure In Tabular Form Of Significant Unobservable Inputs Used In The Fair Value Of Warrants [Table Text Block]", "terseLabel": "Schedule of Fair Value of The Common Stock Warrants", "documentation": "Disclosure in tabular form of significant unobservable inputs used in the fair value of warrants." } } }, "auth_ref": [] }, "cslr_TwoThousandAndTwentyTwoConvertibleNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "TwoThousandAndTwentyTwoConvertibleNotesMember", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfConvertibleNotes" ], "lang": { "en-us": { "role": { "label": "Two Thousand And Twenty Two Convertible Notes [Member]", "verboseLabel": "Two Thousand And Twenty Two Convertible Notes [Member]" } } }, "auth_ref": [] }, "cslr_BorrowingArrangementsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "BorrowingArrangementsTable", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfConvertibleNotes", "http://www.completesolaria.com/role/BorrowingArrangementsTables" ], "lang": { "en-us": { "role": { "label": "Borrowing Arrangements [Table]" } } }, "auth_ref": [] }, "cslr_ScheduleOfConvertibleNotesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ScheduleOfConvertibleNotesAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Convertible Notes [Abstract]" } } }, "auth_ref": [] }, "cslr_TwoThousandAndTwentyAConvertibleNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "TwoThousandAndTwentyAConvertibleNotesMember", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfInterestExpenseOnConvertibleDebt", "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfNetCarryingAmountOfTheConvertibleNotes", "http://www.completesolaria.com/role/BorrowingArrangementsTables" ], "lang": { "en-us": { "role": { "label": "Two Thousand And Twenty A Convertible Notes [Member]" } } }, "auth_ref": [] }, "cslr_ConvertiblePromissoryNotesWithEcoSystemIntegrityFundTwoLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ConvertiblePromissoryNotesWithEcoSystemIntegrityFundTwoLlcMember", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfConvertibleNotes" ], "lang": { "en-us": { "role": { "label": "Convertible Promissory Notes With Eco System Integrity Fund Two LLC [Member]" } } }, "auth_ref": [] }, "us-gaap_InventoryAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryAdjustments", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetailsScheduleOfAccruedExpensesAndOtherCurrentLiabilities" ], "lang": { "en-us": { "role": { "label": "Inventory Adjustments", "terseLabel": "Inventory received but not invoiced", "documentation": "Amount of inventory reserves for last-in first-out (LIFO) and other inventory valuation methods." } } }, "auth_ref": [ "r87", "r1095" ] }, "us-gaap_CustomerFunds": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CustomerFunds", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.completesolaria.com/role/RelatedPartyTransactionsDetails", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Customer Funds", "verboseLabel": "Long-term deposits", "terseLabel": "Prefund", "documentation": "Carrying amount as of the balance sheet date of amounts received from and refundable to customers unless used by them to obtain goods and services from the entity." } } }, "auth_ref": [ "r45" ] }, "cslr_TwoThousandAndNineteenAConvertibleNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "TwoThousandAndNineteenAConvertibleNotesMember", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfConvertibleNotes", "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfInterestExpenseOnConvertibleDebt", "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfNetCarryingAmountOfTheConvertibleNotes", "http://www.completesolaria.com/role/BorrowingArrangementsTables", "http://www.completesolaria.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Two Thousand And Nineteen A Convertible Notes [Member]", "verboseLabel": "2019-A Convertible Notes [Member]", "terseLabel": "Two Thousand And Nineteen A Convertible Notes [Member]" } } }, "auth_ref": [] }, "cslr_ConvertibleNotesNetNoncurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ConvertibleNotesNetNoncurrentAbstract", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfConvertibleNotes" ], "lang": { "en-us": { "role": { "label": "Convertible Notes Net Noncurrent Abstract", "terseLabel": "Convertible notes, net, noncurrent" } } }, "auth_ref": [] }, "cslr_PaidInKindInterestPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "PaidInKindInterestPayable", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfNetCarryingAmountOfTheConvertibleNotes" ], "lang": { "en-us": { "role": { "label": "Paid In Kind Interest Payable", "terseLabel": "PIK interest added to principal balance", "documentation": "Paid in kind interest payable." } } }, "auth_ref": [] }, "us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsMaximumNumberOfShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesSubjectToMandatoryRedemptionSettlementTermsMaximumNumberOfShares", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "label": "Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Maximum Number of Shares", "terseLabel": "Maximum number of common stock", "documentation": "The maximum number of shares that the issuer could be required to issue to redeem the instrument, if applicable." } } }, "auth_ref": [ "r102" ] }, "cslr_TwoThousandAndTwentyOneConvertibleNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "TwoThousandAndTwentyOneConvertibleNotesMember", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfInterestExpenseOnConvertibleDebt", "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfNetCarryingAmountOfTheConvertibleNotes", "http://www.completesolaria.com/role/BorrowingArrangementsTables" ], "lang": { "en-us": { "role": { "label": "Two Thousand And Twenty One Convertible Notes [Member]" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsDeferredIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsDeferredIncome", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfComponentsOfDeferredTaxAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Deferred Income", "terseLabel": "Deferred revenue", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income." } } }, "auth_ref": [ "r127", "r1184" ] }, "cslr_TwoThousandAndTwentyOneAConvertibleNotesWithEmbeddedDerivativeLiabilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "TwoThousandAndTwentyOneAConvertibleNotesWithEmbeddedDerivativeLiabilityMember", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfInterestExpenseOnConvertibleDebt", "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfNetCarryingAmountOfTheConvertibleNotes", "http://www.completesolaria.com/role/BorrowingArrangementsTables" ], "lang": { "en-us": { "role": { "label": "Two Thousand And Twenty One A Convertible Notes With Embedded Derivative Liability [Member]", "terseLabel": "Two Thousand And Twenty One A Convertible Notes With Embedded Derivative Liability [Member]" } } }, "auth_ref": [] }, "us-gaap_StockCompensationPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockCompensationPlanMember", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetailsScheduleOfStockBasedCompensationExpenseAndItsAllocationWithinTheAccompanyingUnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Member]", "terseLabel": "Share-Based Payment Arrangement [Member]", "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares." } } }, "auth_ref": [ "r1121" ] }, "cslr_RepaymentOfPrincipalAndAccruedInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "RepaymentOfPrincipalAndAccruedInterest", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfNetCarryingAmountOfTheConvertibleNotes" ], "lang": { "en-us": { "role": { "label": "Repayment of principal and accrued interest", "documentation": "Repayment of principal and accrued interest." } } }, "auth_ref": [] }, "cslr_BorrowingArrangementsDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "BorrowingArrangementsDetailsLineItems", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfConvertibleNotes", "http://www.completesolaria.com/role/BorrowingArrangementsTables" ], "lang": { "en-us": { "role": { "label": "Borrowing Arrangements [Line Items]" } } }, "auth_ref": [] }, "cslr_ConversionOfLoanIntoRedeemableConvertiblePreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ConversionOfLoanIntoRedeemableConvertiblePreferredStockValue", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfNetCarryingAmountOfTheConvertibleNotes" ], "lang": { "en-us": { "role": { "label": "Conversion Of Loan Into Redeemable Convertible Preferred Stock Value", "terseLabel": "Conversion to Series D-2 redeemable convertible preferred stock", "documentation": "Conversion of loan into redeemable convertible preferred stock value." } } }, "auth_ref": [] }, "cslr_DisclosureInTabularFormOfInterestExpenseOnConvertibleDebt": { "xbrltype": "textBlockItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "DisclosureInTabularFormOfInterestExpenseOnConvertibleDebt", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsTables" ], "lang": { "en-us": { "role": { "label": "Disclosure In Tabular Form Of Interest Expense On Convertible Debt", "terseLabel": "Schedule Of Interest Expense On Convertible Debt", "documentation": "Disclosure in tabular form of interest expense on convertible debt [Table text block]." } } }, "auth_ref": [] }, "us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedArrangementsToObtainGoodsAndServicesAbstract", "lang": { "en-us": { "role": { "label": "Employee Stock Purchase Plan [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsGross", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfComponentsOfDeferredTaxAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Gross, Total", "terseLabel": "Total", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards." } } }, "auth_ref": [ "r645" ] }, "cslr_DisclosureInTabularFormOfNotesPayableTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "DisclosureInTabularFormOfNotesPayableTableTextBlock", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsTables" ], "lang": { "en-us": { "role": { "label": "Disclosure In Tabular Form Of Notes Payable [Table Text Block]", "terseLabel": "Schedule of Company's outstanding notes payable", "documentation": "Disclosure in tabular form of notes payable [Table text block]." } } }, "auth_ref": [] }, "cslr_ScheduleOfFutureMinimumLeasePaymentsUnderNonCancelableTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ScheduleOfFutureMinimumLeasePaymentsUnderNonCancelableTableTextBlock", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesTables" ], "lang": { "en-us": { "role": { "label": "Schedule Of Future Minimum Lease Payments Under Non Cancelable Table Text Block", "terseLabel": "Schedule of Future Minimum Lease Payments under Non-Cancelable" } } }, "auth_ref": [] }, "cslr_DisclosureInTabularFormOfInterestExpenseOnConvertibleDebtTable": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "DisclosureInTabularFormOfInterestExpenseOnConvertibleDebtTable", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfInterestExpenseOnConvertibleDebt" ], "lang": { "en-us": { "role": { "label": "Disclosure In Tabular Form Of Interest Expense On Convertible Debt [Table]", "documentation": "Disclosure in tabular form of interest expense on convertible debt [Table]." } } }, "auth_ref": [] }, "us-gaap_RepaymentsOfNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfNotesPayable", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/ReverseRecapitalizationDetailsScheduleOfReconcilesElementsOfTheMerger" ], "lang": { "en-us": { "role": { "label": "Repayments of Notes Payable", "negatedLabel": "Less: cash payment", "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation." } } }, "auth_ref": [ "r71" ] }, "cslr_ScheduleOfActivityPeriodRelatingToTheCompanysWarrantyProvisionTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ScheduleOfActivityPeriodRelatingToTheCompanysWarrantyProvisionTableTextBlock", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesTables" ], "lang": { "en-us": { "role": { "label": "Schedule Of Activity Period Relating To The Companys Warranty Provision Table Text Block", "terseLabel": "Schedule of Activity Period Relating to the Company's Warranty Provision" } } }, "auth_ref": [] }, "cslr_DisclosureInTabularFormOfInterestExpenseOnConvertibleDebtLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "DisclosureInTabularFormOfInterestExpenseOnConvertibleDebtLineItems", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfInterestExpenseOnConvertibleDebt" ], "lang": { "en-us": { "role": { "label": "Disclosure In Tabular Form Of Interest Expense On Convertible Debt [Line Items]", "documentation": "Disclosure in tabular form of interest expense on convertible debt [Line items]." } } }, "auth_ref": [] }, "cslr_TotalNonCashInterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "TotalNonCashInterestExpense", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfInterestExpenseOnConvertibleDebt" ], "lang": { "en-us": { "role": { "label": "Total Non Cash Interest Expense", "terseLabel": "Total\u00a0non-cash\u00a0interest expense", "documentation": "Total non cash interest expense." } } }, "auth_ref": [] }, "us-gaap_LegalFees": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LegalFees", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Legal Fees", "terseLabel": "Legal fees", "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings." } } }, "auth_ref": [ "r213" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetailsScheduleOfSummaryOfRsuActivity" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "negatedLabel": "Number of RSUs, Cancelled or forfeited", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period." } } }, "auth_ref": [ "r609" ] }, "cslr_BasicandDilutedNetLossPerShareTablesTable": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "BasicandDilutedNetLossPerShareTablesTable", "presentation": [ "http://www.completesolaria.com/role/BasicAndDilutedNetLossPerShareTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetailsScheduleOfSummaryOfRsuActivity" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Number of RSUs, Granted", "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r607" ] }, "cslr_BasicandDilutedNetLossPerShareTablesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "BasicandDilutedNetLossPerShareTablesLineItems", "presentation": [ "http://www.completesolaria.com/role/BasicAndDilutedNetLossPerShareTables" ], "lang": { "en-us": { "role": { "label": "Basic and Diluted Net Loss Per Share (Tables) [Line Items]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetailsScheduleOfSummaryOfRsuActivity" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted average grant date fair valuem, Granted", "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r607" ] }, "cslr_OrganizationDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "OrganizationDetailsTable", "presentation": [ "http://www.completesolaria.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "label": "Organization (Details) [Table]" } } }, "auth_ref": [] }, "cslr_NotesPayableOutstanding": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "NotesPayableOutstanding", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfCompanySOutstandingNotesPayable" ], "lang": { "en-us": { "role": { "label": "Notes Payable Outstanding", "terseLabel": "Other Notes Payable, Current", "documentation": "Notes payable outstanding." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetailsScheduleOfSummaryOfRsuActivity" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Number of RSUs, Unvested, Ending balance", "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date." } } }, "auth_ref": [ "r604", "r605" ] }, "us-gaap_InterestExpenseBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpenseBorrowings", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Interest Expense, Borrowings", "terseLabel": "Interest expense recognized", "documentation": "Aggregate amount of interest expense on all borrowings." } } }, "auth_ref": [ "r278" ] }, "us-gaap_ConvertibleDebtFairValueDisclosures": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConvertibleDebtFairValueDisclosures", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Convertible Debt, Fair Value Disclosures", "terseLabel": "Convertible debt at fair value", "documentation": "Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetailsScheduleOfSummaryOfRsuActivity" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Weighted average grant date fair value, Unvested, Ending balance", "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [ "r604", "r605" ] }, "cslr_PIPEInvestorsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "PIPEInvestorsMember", "presentation": [ "http://www.completesolaria.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "label": "PIPEInvestors Member", "terseLabel": "PIPE Investors [Member]" } } }, "auth_ref": [] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "terseLabel": "Unvested stock options", "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement." } } }, "auth_ref": [ "r622" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetailsScheduleOfSummaryOfRsuActivity" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period", "negatedLabel": "Number of RSUs, Vested and released", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period." } } }, "auth_ref": [ "r608" ] }, "us-gaap_PropertyPlantAndEquipmentOtherAccumulatedDepreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentOtherAccumulatedDepreciation", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/PropertyAndEquipmentNetDetailsScheduleOfPropertyAndEquipmentNet": { "parentTag": "us-gaap_PropertyPlantAndEquipmentOtherNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.completesolaria.com/role/PropertyAndEquipmentNetDetailsScheduleOfPropertyAndEquipmentNet" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Other, Accumulated Depreciation", "negatedLabel": "Less accumulated depreciation and amortization", "documentation": "Amount of accumulated depreciation of long-lived, physical assets used to produce goods and services and not intended for resale, classified as other." } } }, "auth_ref": [] }, "cslr_SolariaMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "SolariaMember", "presentation": [ "http://www.completesolaria.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "label": "Solaria Member", "terseLabel": "Solaria [Member]" } } }, "auth_ref": [] }, "cslr_ServiceBasedOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ServiceBasedOptionMember", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "label": "Service Based Option [Member]", "terseLabel": "Service based option [Member]", "documentation": "Service based option." } } }, "auth_ref": [] }, "us-gaap_SharePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharePrice", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfWarrantsBasedOnABlackScholesOptionPricingMethod" ], "lang": { "en-us": { "role": { "label": "Share Price", "terseLabel": "Common stock trading price (in Dollars per share)", "documentation": "Price of a single share of a number of saleable stocks of a company." } } }, "auth_ref": [] }, "cslr_StockBasedCompensationDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "StockBasedCompensationDetailsTable", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "label": "Stock-Based Compensation (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetailsScheduleOfSummaryOfRsuActivity" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted average grant date fair value, Vested and released", "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement." } } }, "auth_ref": [ "r608" ] }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsLiabilitiesNet", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfComponentsOfDeferredTaxAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Net, Total", "totalLabel": "Net deferred tax assets", "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting." } } }, "auth_ref": [ "r1183" ] }, "us-gaap_FinancialInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancialInstrumentAxis", "presentation": [ "http://www.completesolaria.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Financial Instrument [Axis]", "documentation": "Information by type of financial instrument." } } }, "auth_ref": [ "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r496", "r497", "r501", "r502", "r504", "r506", "r507", "r508", "r562", "r573", "r686", "r764", "r765", "r766", "r767", "r768", "r769", "r770", "r771", "r772", "r773", "r774", "r775", "r776", "r777", "r778", "r779", "r780", "r781", "r782", "r783", "r784", "r785", "r786", "r787", "r788", "r789", "r790", "r791", "r792", "r793", "r837", "r1009", "r1079", "r1080", "r1081", "r1082", "r1084", "r1085", "r1086", "r1124", "r1125", "r1126", "r1127" ] }, "cslr_VestedSharesExerciseOfPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "VestedSharesExerciseOfPeriod", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "label": "Vested Shares Exercise Of Period", "terseLabel": "Vested options of terminated employees", "documentation": "VestedSharesExerciseOfPeriod." } } }, "auth_ref": [] }, "us-gaap_InterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpense", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 12.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossParentheticals" ], "lang": { "en-us": { "role": { "label": "Interest Expense", "negatedLabel": "Interest expense", "terseLabel": "Interest Expense", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense." } } }, "auth_ref": [ "r161", "r279", "r350", "r422", "r729", "r942", "r1050", "r1229" ] }, "us-gaap_PropertyPlantAndEquipmentOtherNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentOtherNet", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/PropertyAndEquipmentNetDetailsScheduleOfPropertyAndEquipmentNet": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.completesolaria.com/role/PropertyAndEquipmentNetDetailsScheduleOfPropertyAndEquipmentNet" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Other, Net", "totalLabel": "Total property and equipment, net", "documentation": "Amount after depreciation of long-lived, physical assets used to produce goods and services and not intended for resale, classified as other." } } }, "auth_ref": [] }, "cslr_ISOsUnderThe2023PlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ISOsUnderThe2023PlanMember", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "label": "ISOs Under The2023 Plan [Member]", "terseLabel": "ISOs under the 2023 Plan [Member]", "documentation": "ISOs under the 2023 plan." } } }, "auth_ref": [] }, "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomePolicyPolicyTextBlock", "presentation": [ "http://www.completesolaria.com/role/AccountingPoliciesByPolicyPolicies" ], "lang": { "en-us": { "role": { "label": "Comprehensive Income, Policy [Policy Text Block]", "terseLabel": "Comprehensive Loss", "documentation": "Disclosure of accounting policy for comprehensive income." } } }, "auth_ref": [] }, "us-gaap_RepaymentsOfSecuredDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfSecuredDebt", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Repayments of Secured Debt", "documentation": "The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt." } } }, "auth_ref": [ "r71" ] }, "cslr_PIPEFinancingMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "PIPEFinancingMember", "presentation": [ "http://www.completesolaria.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "label": "PIPEFinancing Member", "terseLabel": "PIPE Financing [Member]" } } }, "auth_ref": [] }, "cslr_TwoThousandTwentyThreeEquityIncentivePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "TwoThousandTwentyThreeEquityIncentivePlanMember", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "label": "Two Thousand Twenty Three Equity Incentive Plan [Member]", "terseLabel": "2023 Equity Incentive Plan [Member]", "documentation": "Two thousand twenty three equity incentive plan." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period", "terseLabel": "Share based compensation by share based award vesting period", "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition." } } }, "auth_ref": [ "r1032" ] }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions", "presentation": [ "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable", "terseLabel": "Number of share exercisable (in Shares)", "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied." } } }, "auth_ref": [ "r119" ] }, "us-gaap_LongtermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeAxis", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfCompanySOutstandingNotesPayable", "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfConvertibleNotes", "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfInterestExpenseOnConvertibleDebt", "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfNetCarryingAmountOfTheConvertibleNotes", "http://www.completesolaria.com/role/BorrowingArrangementsTables", "http://www.completesolaria.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Type [Axis]", "documentation": "Information by type of long-term debt." } } }, "auth_ref": [ "r58" ] }, "cslr_RecognizedWeightedAveragePeriod": { "xbrltype": "durationItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "RecognizedWeightedAveragePeriod", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "label": "Recognized Weighted Average Period", "terseLabel": "Recognized weighted average period", "documentation": "Recognized weighted average period." } } }, "auth_ref": [] }, "us-gaap_SalesRevenueNetMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SalesRevenueNetMember", "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Revenue Benchmark [Member]", "terseLabel": "Revenue Benchmark [Member]", "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation." } } }, "auth_ref": [ "r441", "r1067" ] }, "cslr_TwoThousandAndTwentyOneEquityIncentivePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "TwoThousandAndTwentyOneEquityIncentivePlanMember", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "label": "Two Thousand And Twenty One Equity Incentive Plan [Member]", "terseLabel": "2021 Equity Incentive Plan [Member]", "documentation": "Two thousand and twenty one equity incentive plan." } } }, "auth_ref": [] }, "cslr_PIPESubscriptionAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "PIPESubscriptionAgreementMember", "presentation": [ "http://www.completesolaria.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "label": "PIPESubscription Agreement Member", "terseLabel": "PIPE Subscription Agreement [Member]" } } }, "auth_ref": [] }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Selling, General and Administrative Expense", "terseLabel": "Sales and marketing", "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc." } } }, "auth_ref": [ "r214" ] }, "cslr_TwoThousandAndElevenEquityIncentivePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "TwoThousandAndElevenEquityIncentivePlanMember", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "label": "Two Thousand And Eleven Equity Incentive Plan [Member]", "terseLabel": "2011 Equity Incentive Plan [Member]", "documentation": "Two thousand and eleven equity incentive plan." } } }, "auth_ref": [] }, "cslr_OrganizationAndBusinessOperationsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "OrganizationAndBusinessOperationsLineItems", "presentation": [ "http://www.completesolaria.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "label": "Organization and Business Operations [Line Items]", "documentation": "Organization and Business Operations [Line Items]." } } }, "auth_ref": [] }, "us-gaap_NotesPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NotesPayableCurrent", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 17.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Notes Payable, Current", "terseLabel": "Notes payable, net", "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer." } } }, "auth_ref": [ "r50" ] }, "cslr_MaxeonMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "MaxeonMember", "presentation": [ "http://www.completesolaria.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "label": "Maxeon Member", "terseLabel": "Maxeon [Member]" } } }, "auth_ref": [] }, "cslr_TwoThousandAndTwentyTwoEquityIncentivePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "TwoThousandAndTwentyTwoEquityIncentivePlanMember", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "label": "Two Thousand And Twenty Two Equity Incentive Plan [Member]", "terseLabel": "2022 Equity Incentive Plan [Member]", "documentation": "Two thousand and twenty two equity incentive plan." } } }, "auth_ref": [] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationGoodwill1", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/DivestitureDetailsScheduleOfMajorCategoriesOfAssetsAndLiabilitiesHeldForSale": { "parentTag": "us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.completesolaria.com/role/DivestitureDetailsScheduleOfMajorCategoriesOfAssetsAndLiabilitiesHeldForSale" ], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Goodwill", "terseLabel": "Goodwill", "documentation": "Amount classified as goodwill attributable to disposal group held for sale or disposed of." } } }, "auth_ref": [ "r15", "r174", "r185", "r233" ] }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfComponentsOfDeferredTaxAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Operating Loss Carryforwards", "terseLabel": "NOL carryforwards", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards." } } }, "auth_ref": [ "r127", "r1184" ] }, "us-gaap_CustomerRelationshipsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CustomerRelationshipsMember", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetailsScheduleOfIntangibleAssetsAcquired", "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetailsScheduleOfAmortizationExpenseRelatedToIntangibleAssets", "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetailsScheduleOfIntangibleAssets" ], "lang": { "en-us": { "role": { "label": "Customer Relationships [Member]", "terseLabel": "Customer relationships [Member]", "verboseLabel": "Customer relationship [Member]", "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships." } } }, "auth_ref": [ "r136" ] }, "cslr_StockBasedCompensationDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "StockBasedCompensationDetailsLineItems", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "label": "Stock-Based Compensation [Line Items]" } } }, "auth_ref": [] }, "us-gaap_SalesCommissionsAndFees": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SalesCommissionsAndFees", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Sales Commissions and Fees", "terseLabel": "Sales commissions", "documentation": "Primarily represents commissions incurred in the period based upon the sale by commissioned employees or third parties of the entity's goods or services, and fees for sales assistance or product enhancements performed by third parties (such as a distributor or value added reseller)." } } }, "auth_ref": [ "r214" ] }, "cslr_AggregateShares": { "xbrltype": "sharesItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "AggregateShares", "presentation": [ "http://www.completesolaria.com/role/ForwardPurchaseAgreementsDetails", "http://www.completesolaria.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "label": "Aggregate Shares", "terseLabel": "Aggregate shares" } } }, "auth_ref": [] }, "us-gaap_RepaymentsOfRelatedPartyDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfRelatedPartyDebt", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 47.0 } }, "presentation": [ "http://www.completesolaria.com/role/RelatedPartyTransactionsDetails", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Repayments of Related Party Debt", "negatedLabel": "Repayment of convertible notes to related parties", "terseLabel": "Agreed related party", "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates." } } }, "auth_ref": [ "r71" ] }, "cslr_UnrecognizedStockbasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "UnrecognizedStockbasedCompensation", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "label": "Unrecognized Stockbased Compensation", "terseLabel": "Unrecognized stock-based compensation costs (in Dollars)", "documentation": "Amount of unrecognized stock-based compensation." } } }, "auth_ref": [] }, "us-gaap_IncomeLossFromContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperations", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.completesolaria.com/role/BasicAndDilutedNetLossPerShareDetailsScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholders", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent", "totalLabel": "Net loss from continuing operations, net of tax", "verboseLabel": "Net loss from continuing operations", "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent." } } }, "auth_ref": [ "r139", "r210", "r223", "r378", "r379", "r381", "r382", "r405", "r408" ] }, "us-gaap_DebtConversionNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtConversionNameDomain", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfSignificantUnobservableInputsLevel3AndTheChangeInFairValueRecordedInOtherIncomeExpenseNet" ], "lang": { "en-us": { "role": { "label": "Debt Conversion, Name [Domain]", "documentation": "The name of the original debt issue that has been converted in a noncash (or part noncash) transaction during the accounting period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r75", "r77" ] }, "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsPerBasicShare", "presentation": [ "http://www.completesolaria.com/role/BasicAndDilutedNetLossPerShareDetailsScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholders", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Income (Loss) from Continuing Operations, Per Basic Share", "terseLabel": "Net loss from continuing operations per share attributable to common stockholders, basic", "verboseLabel": "Continuing operations - basic", "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r203", "r273", "r275", "r353", "r374", "r378", "r379", "r381", "r382", "r392", "r406", "r407", "r697", "r816", "r1220" ] }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayable", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 24.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Accounts Payable", "terseLabel": "Accounts payable", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business." } } }, "auth_ref": [ "r23" ] }, "us-gaap_ShorttermDebtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShorttermDebtFairValue", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Short-Term Debt, Fair Value", "terseLabel": "Fair value of short term debt", "documentation": "This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents the amount of short-term debt existing as of the balance sheet date." } } }, "auth_ref": [] }, "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsPerDilutedShare", "presentation": [ "http://www.completesolaria.com/role/BasicAndDilutedNetLossPerShareDetailsScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholders", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Income (Loss) from Continuing Operations, Per Diluted Share", "terseLabel": "Net loss from continuing operations per share attributable to common stockholders, diluted", "verboseLabel": "Continuing operations diluted", "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r203", "r353", "r374", "r378", "r379", "r381", "r382", "r392", "r406", "r407", "r408", "r697", "r816", "r1220" ] }, "us-gaap_DebtInstrumentAnnualPrincipalPayment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentAnnualPrincipalPayment", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Annual Principal Payment", "terseLabel": "Aggregate purchase price", "documentation": "Amount of the total principal payments made during the annual reporting period." } } }, "auth_ref": [ "r43" ] }, "us-gaap_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProfitLoss", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Incurred net losses (in Dollars)", "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r322", "r342", "r344", "r357", "r364", "r374", "r386", "r387", "r418", "r432", "r436", "r438", "r484", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r668", "r671", "r672", "r697", "r708", "r817", "r835", "r878", "r932", "r955", "r956", "r1005", "r1036", "r1037", "r1051", "r1102", "r1148" ] }, "us-gaap_LongTermDebtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtFairValue", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Fair Value", "terseLabel": "Long term debt fair value", "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission." } } }, "auth_ref": [] }, "cslr_PreferredStockWarrants": { "xbrltype": "sharesItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "PreferredStockWarrants", "presentation": [ "http://www.completesolaria.com/role/BasicAndDilutedNetLossPerShareDetailsScheduleOfPotentialCommonSharesExcludedFromDilutedNetLossPerShare" ], "lang": { "en-us": { "role": { "label": "Preferred Stock Warrants", "terseLabel": "Preferred stock warrants", "documentation": "Number of preferred stock warrants." } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities:" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://www.completesolaria.com/role/BasicAndDilutedNetLossPerShareDetailsScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholders", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic", "terseLabel": "Net loss per share attributable to common stockholders, basic", "verboseLabel": "Net loss per share - basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r353", "r378", "r379", "r381", "r382", "r384", "r390", "r392", "r406", "r407", "r408", "r412", "r696", "r697", "r816", "r839", "r1003" ] }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare", "presentation": [ "http://www.completesolaria.com/role/BasicAndDilutedNetLossPerShareDetailsScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholders", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share", "terseLabel": "Net loss from discontinued operations per share attributable to common stockholders, diluted", "verboseLabel": "Discontinued operations diluted", "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation." } } }, "auth_ref": [ "r262", "r395", "r406", "r407" ] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://www.completesolaria.com/role/BasicAndDilutedNetLossPerShare" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Text Block]", "terseLabel": "Basic and Diluted Net Loss Per Share", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r389", "r409", "r410", "r411" ] }, "cslr_CommonStockWarrants": { "xbrltype": "sharesItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "CommonStockWarrants", "presentation": [ "http://www.completesolaria.com/role/BasicAndDilutedNetLossPerShareDetailsScheduleOfPotentialCommonSharesExcludedFromDilutedNetLossPerShare" ], "lang": { "en-us": { "role": { "label": "Common Stock Warrants", "terseLabel": "Common stock warrants", "documentation": "Number of common stock warrants." } } }, "auth_ref": [] }, "cslr_ScheduleOfPotentialCommonSharesExcludedFromDilutedNetLossPerShareLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ScheduleOfPotentialCommonSharesExcludedFromDilutedNetLossPerShareLineItems", "presentation": [ "http://www.completesolaria.com/role/BasicAndDilutedNetLossPerShareDetailsScheduleOfPotentialCommonSharesExcludedFromDilutedNetLossPerShare" ], "lang": { "en-us": { "role": { "label": "Schedule Of Potential Common Shares Excluded From Diluted Net Loss Per Share [Line Items]", "documentation": "Schedule of potential common shares excluded from diluted net loss per share." } } }, "auth_ref": [] }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxAbstract", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest [Abstract]", "terseLabel": "Discontinued operations (Note 8):" } } }, "auth_ref": [] }, "us-gaap_GainLossOnDispositionOfAssets1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainLossOnDispositionOfAssets1", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/DivestitureDetails" ], "lang": { "en-us": { "role": { "label": "Gain (Loss) on Disposition of Assets", "terseLabel": "Loss on disposal", "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee." } } }, "auth_ref": [ "r1104" ] }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare", "presentation": [ "http://www.completesolaria.com/role/BasicAndDilutedNetLossPerShareDetailsScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholders", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share", "terseLabel": "Net loss from discontinued operations per share attributable to common stockholders, basic", "verboseLabel": "Discontinued operations - basic", "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation." } } }, "auth_ref": [ "r205", "r353", "r395", "r406", "r407", "r1214", "r1220" ] }, "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/DivestitureDetailsScheduleOfOperationsAndComprehensiveIncomeLossRelatedToDiscontinuedOperations": { "parentTag": "us-gaap_GainLossOnDispositionOfRealEstateDiscontinuedOperations", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.completesolaria.com/role/DivestitureDetailsScheduleOfOperationsAndComprehensiveIncomeLossRelatedToDiscontinuedOperations" ], "lang": { "en-us": { "role": { "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax", "totalLabel": "Loss from discontinued operations before income taxes", "documentation": "Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal." } } }, "auth_ref": [ "r178", "r179", "r180", "r181", "r182", "r183", "r205", "r1219" ] }, "us-gaap_DebtInstrumentCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentCarryingAmount", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfCompanySOutstandingNotesPayable", "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfNetCarryingAmountOfTheConvertibleNotes" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Gross", "terseLabel": "Principal", "verboseLabel": "Long-Term Debt, Gross", "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt." } } }, "auth_ref": [ "r43", "r270", "r563" ] }, "srt_ScenarioPreviouslyReportedMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScenarioPreviouslyReportedMember", "presentation": [ "http://www.completesolaria.com/role/BasicAndDilutedNetLossPerShareDetailsScheduleOfPotentialCommonSharesExcludedFromDilutedNetLossPerShare", "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetails", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Previously Reported [Member]", "terseLabel": "Previously Reported [Member]", "documentation": "Represents amount as previously reported before adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision." } } }, "auth_ref": [ "r319", "r371", "r373", "r374", "r375", "r378", "r379", "r387", "r412", "r654", "r691", "r695", "r696", "r736", "r851", "r852", "r853", "r854", "r855", "r856", "r857", "r858", "r859", "r860", "r864", "r1071", "r1074", "r1075", "r1076", "r1117", "r1130", "r1131", "r1195", "r1201", "r1202" ] }, "cslr_IncomeTaxDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "IncomeTaxDisclosureLineItems", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetails", "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfProvisionForIncomeTaxes" ], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Line Items]", "documentation": "Income tax disclosure." } } }, "auth_ref": [] }, "us-gaap_LettersOfCreditOutstandingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LettersOfCreditOutstandingAmount", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Letters of Credit Outstanding, Amount", "terseLabel": "Letters of credit", "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date." } } }, "auth_ref": [] }, "us-gaap_SupplierConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplierConcentrationRiskMember", "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Supplier Concentration Risk [Member]", "terseLabel": "Supplier Concentration Risk [Member]", "documentation": "Reflects the percentage that purchases in the period from one or more significant suppliers is to cost of goods or services, as defined by the entity, such as total cost of sales or services, product line cost of sales or services, segment cost of sales or services. Risk is the materially adverse effects of loss of a material supplier or a supplier of critically needed goods or services." } } }, "auth_ref": [ "r82" ] }, "cslr_IncomeTaxReconciliationPaycheckProtectionProgramLoan": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "IncomeTaxReconciliationPaycheckProtectionProgramLoan", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfReconciliationOfEffectiveIncomeTaxRate" ], "lang": { "en-us": { "role": { "label": "Income Tax Reconciliation Paycheck Protection Program Loan", "terseLabel": "PPP Loan", "documentation": "Income tax reconciliation paycheck protection program loan." } } }, "auth_ref": [] }, "cslr_IncomeTaxReconciliationNonDeductibleInterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "IncomeTaxReconciliationNonDeductibleInterestExpense", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfReconciliationOfEffectiveIncomeTaxRate" ], "lang": { "en-us": { "role": { "label": "Income Tax Reconciliation Non Deductible Interest Expense", "terseLabel": "Non-deductible interest expense", "documentation": "Income tax reconciliation non deductible interest expense." } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationAcquisitionRelatedCosts", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Acquisition Related Costs", "definitionGuidance": "Acquisition costs", "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities." } } }, "auth_ref": [ "r129" ] }, "cslr_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBaddebtReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBaddebtReserves", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfComponentsOfDeferredTaxAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Baddebt Reserves", "terseLabel": "Bad debt reserve", "documentation": "Deferred tax assets tax deferred expense reserves and accruals baddebt reserves." } } }, "auth_ref": [] }, "us-gaap_InvestmentSoldNotYetPurchasedBalancePrincipalAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentSoldNotYetPurchasedBalancePrincipalAmount", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Security Sold Short, Principal Amount", "terseLabel": "Principal balance", "documentation": "For investments which are quantified by principal amount, principal balance held at close of period." } } }, "auth_ref": [ "r1234" ] }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRecognitionPolicyTextBlock", "presentation": [ "http://www.completesolaria.com/role/AccountingPoliciesByPolicyPolicies" ], "lang": { "en-us": { "role": { "label": "Revenue [Policy Text Block]", "terseLabel": "Revenue Recognition", "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources." } } }, "auth_ref": [ "r935", "r992", "r1001" ] }, "cslr_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsInventoryReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsInventoryReserves", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfComponentsOfDeferredTaxAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Inventory Reserves", "terseLabel": "Inventory reserve", "documentation": "Deferred tax assets tax deferred expense reserves and accruals inventory reserves." } } }, "auth_ref": [] }, "us-gaap_TaxCreditCarryforwardNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TaxCreditCarryforwardNameDomain", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Tax Credit Carryforward, Name [Domain]", "documentation": "The name of the tax credit carryforward." } } }, "auth_ref": [ "r125" ] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingencies", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies (Note 19)", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r60", "r167", "r823", "r910" ] }, "cslr_DeferredTaxAssetsRevenueWarranty": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "DeferredTaxAssetsRevenueWarranty", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfComponentsOfDeferredTaxAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets Revenue Warranty", "terseLabel": "Revenue warranty", "documentation": "Deferred tax assets revenue warranty." } } }, "auth_ref": [] }, "srt_ScheduleOfCondensedFinancialStatementsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScheduleOfCondensedFinancialStatementsTable", "presentation": [ "http://www.completesolaria.com/role/DivestitureDetailsScheduleOfMajorCategoriesOfAssetsAndLiabilitiesHeldForSale" ], "lang": { "en-us": { "role": { "label": "Condensed Financial Statements [Table]", "documentation": "Disclosure of information about condensed financial statements, including, but not limited to, the balance sheet, income statement, and statement of cash flows." } } }, "auth_ref": [ "r311", "r312", "r313", "r314", "r370", "r1064" ] }, "cslr_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsAccruedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsAccruedCompensation", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfComponentsOfDeferredTaxAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Accrued Compensation", "terseLabel": "Accrued compensation", "documentation": "Deferred tax assets tax deferred expense compensation and benefits accrued compensation." } } }, "auth_ref": [] }, "cslr_DeferredTaxAssetsLeases": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "DeferredTaxAssetsLeases", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfComponentsOfDeferredTaxAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets Leases", "terseLabel": "ASC 842 leases", "documentation": "Deferred tax assets leases." } } }, "auth_ref": [] }, "us-gaap_AccruedIncomeTaxes": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedIncomeTaxes", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetailsScheduleOfAccruedExpensesAndOtherCurrentLiabilities" ], "lang": { "en-us": { "role": { "label": "Accrued Income Taxes", "terseLabel": "Accrued taxes", "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due. This amount is the total of current and noncurrent accrued income taxes." } } }, "auth_ref": [ "r188", "r189", "r254", "r269", "r822" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "lang": { "en-us": { "role": { "label": "Stock-Based Compensation [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherCommitmentsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCommitmentsDomain", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Other Commitments [Domain]", "documentation": "Other future obligation." } } }, "auth_ref": [] }, "cslr_DeferredTaxAssetsCapitalizedResearchAndDevelopment": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "DeferredTaxAssetsCapitalizedResearchAndDevelopment", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfComponentsOfDeferredTaxAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets Capitalized Research And Development", "terseLabel": "Capitalized research and development", "documentation": "Deferred tax assets capitalized research and development." } } }, "auth_ref": [] }, "us-gaap_OtherCommitmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCommitmentsAxis", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Other Commitments [Axis]", "documentation": "Information by type of other commitment." } } }, "auth_ref": [] }, "us-gaap_TaxCreditCarryforwardAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TaxCreditCarryforwardAmount", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Tax Credit Carryforward, Amount", "terseLabel": "Tax credit carry forward amount", "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws." } } }, "auth_ref": [ "r126" ] }, "cslr_DeferredTaxAssetsAssembledWorkforce": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "DeferredTaxAssetsAssembledWorkforce", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfComponentsOfDeferredTaxAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets Assembled Workforce", "terseLabel": "Assembled workforce", "documentation": "Deferred tax assets assembled workforce." } } }, "auth_ref": [] }, "us-gaap_AmortizationOfDebtDiscountPremium": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfDebtDiscountPremium", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfInterestExpenseOnConvertibleDebt" ], "lang": { "en-us": { "role": { "label": "Amortization of Debt Discount (Premium)", "verboseLabel": "Amortization of debt discount", "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense." } } }, "auth_ref": [ "r24", "r159", "r218", "r561" ] }, "cslr_DeferredTaxLiabilitiesAccountingMethodChange": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "DeferredTaxLiabilitiesAccountingMethodChange", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfComponentsOfDeferredTaxAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Liabilities Accounting Method Change", "terseLabel": "Accounting method change", "documentation": "Deferred tax liabilities accounting method change." } } }, "auth_ref": [] }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAccruedLiabilitiesCurrent", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetailsScheduleOfAccruedExpensesAndOtherCurrentLiabilities" ], "lang": { "en-us": { "role": { "label": "Other Accrued Liabilities, Current", "terseLabel": "Other accrued liabilities", "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r53" ] }, "cslr_DeferredTaxLiabilitiesConvertibleDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "DeferredTaxLiabilitiesConvertibleDebt", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfComponentsOfDeferredTaxAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Liabilities Convertible Debt", "terseLabel": "Convertible debt", "documentation": "Deferred tax liabilities convertible debt." } } }, "auth_ref": [] }, "us-gaap_TradeAndOtherAccountsReceivablePolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TradeAndOtherAccountsReceivablePolicy", "presentation": [ "http://www.completesolaria.com/role/AccountingPoliciesByPolicyPolicies" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable [Policy Text Block]", "terseLabel": "Accounts Receivable, Net", "documentation": "Disclosure of accounting policy for accounts receivable." } } }, "auth_ref": [ "r282", "r283", "r284", "r444", "r445", "r450" ] }, "cslr_RefundableAndDeferredIncomeTaxes": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "RefundableAndDeferredIncomeTaxes", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfComponentsOfDeferredTaxAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Refundable And Deferred Income Taxes", "totalLabel": "Refundable and deferred income taxes", "documentation": "Refundable and deferred income taxes." } } }, "auth_ref": [] }, "cslr_AcquiredDeferredTaxAssetsValuationAllowanceIncrease": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "AcquiredDeferredTaxAssetsValuationAllowanceIncrease", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Acquired Deferred Tax Assets Valuation Allowance Increase", "terseLabel": "Acquired deferred tax assets valuation allowance increase", "documentation": "Acquired deferred tax assets valuation allowance increase." } } }, "auth_ref": [] }, "cslr_MinimumThresholdTaxableIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "MinimumThresholdTaxableIncome", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Minimum Threshold Taxable Income", "terseLabel": "Minimum threshold taxable income", "documentation": "Minimum threshold taxable income." } } }, "auth_ref": [] }, "cslr_ScheduleOfEarningsPerShareBasicAndDilutedTable": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTable", "presentation": [ "http://www.completesolaria.com/role/BasicAndDilutedNetLossPerShareDetailsScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholders" ], "lang": { "en-us": { "role": { "label": "Schedule of Earnings Per Share Basic and Diluted [Table]", "documentation": "Schedule of earnings per share basic and diluted." } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0, "order": 20.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable, net", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r23" ] }, "cslr_ScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholdersAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholdersAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Basic And Diluted Net Loss Per Share Attributable To Common Stockholders Abstract" } } }, "auth_ref": [] }, "us-gaap_TaxCreditCarryforwardAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TaxCreditCarryforwardAxis", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Tax Credit Carryforward [Axis]", "documentation": "Information by specific tax credit related to an unused tax credit." } } }, "auth_ref": [ "r125" ] }, "cslr_ScheduleOfEarningsPerShareBasicAndDilutedLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedLineItems", "presentation": [ "http://www.completesolaria.com/role/BasicAndDilutedNetLossPerShareDetailsScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholders" ], "lang": { "en-us": { "role": { "label": "Schedule of Earnings Per Share Basic and Diluted [Line Items]", "documentation": "Schedule of earnings per share basic and diluted." } } }, "auth_ref": [] }, "us-gaap_DepositsPaidForSecuritiesBorrowedAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepositsPaidForSecuritiesBorrowedAtCarryingValue", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Deposits Paid for Securities Borrowed, at Carrying Value", "terseLabel": "Borrowing", "documentation": "This is the amount of cash advanced as security in return for borrowing securities from another party." } } }, "auth_ref": [ "r169" ] }, "cslr_NumeratorAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "NumeratorAbstract", "presentation": [ "http://www.completesolaria.com/role/BasicAndDilutedNetLossPerShareDetailsScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholders" ], "lang": { "en-us": { "role": { "label": "Numerator Abstract", "terseLabel": "Numerator:" } } }, "auth_ref": [] }, "us-gaap_BankingRegulationMaximumLeveragePayoutAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BankingRegulationMaximumLeveragePayoutAmount", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Banking Regulation, Maximum Leverage Payout Amount", "terseLabel": "Liquidity ratio amount", "documentation": "Amount of global systemically important bank's (GSIB) eligible retained income multiplied by applicable maximum leverage payout ratio as defined by regulatory framework." } } }, "auth_ref": [ "r819" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Accounts receivable, net", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r442", "r443" ] }, "cslr_DenominatorAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "DenominatorAbstract", "presentation": [ "http://www.completesolaria.com/role/BasicAndDilutedNetLossPerShareDetailsScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholders" ], "lang": { "en-us": { "role": { "label": "Denominator Abstract", "terseLabel": "Denominator:" } } }, "auth_ref": [] }, "srt_CondensedFinancialStatementsCaptionsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CondensedFinancialStatementsCaptionsLineItems", "presentation": [ "http://www.completesolaria.com/role/DivestitureDetailsScheduleOfMajorCategoriesOfAssetsAndLiabilitiesHeldForSale" ], "lang": { "en-us": { "role": { "label": "Schedule of Major Categories of Assets and Liabilities Held for Sale [Abstract]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r311", "r312", "r313", "r314", "r370", "r1064" ] }, "us-gaap_ProductWarrantyAccrualClassifiedCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProductWarrantyAccrualClassifiedCurrent", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetailsScheduleOfAccruedExpensesAndOtherCurrentLiabilities" ], "lang": { "en-us": { "role": { "label": "Product Warranty Accrual, Current", "terseLabel": "Accrued warranty, current", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r53", "r1146", "r1147" ] }, "us-gaap_DeferredTaxAssetInterestCarryforward": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetInterestCarryforward", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfComponentsOfDeferredTaxAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Asset, Interest Carryforward", "terseLabel": "Interest expense carryover", "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible interest carryforward." } } }, "auth_ref": [ "r1184" ] }, "us-gaap_InternalUseSoftwarePolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InternalUseSoftwarePolicy", "presentation": [ "http://www.completesolaria.com/role/AccountingPoliciesByPolicyPolicies" ], "lang": { "en-us": { "role": { "label": "Internal Use Software, Policy [Policy Text Block]", "terseLabel": "Internal-Use\u00a0Software", "documentation": "Disclosure of accounting policy for costs incurred when both (1) the software is acquired, internally developed, or modified solely to meet the entity's internal needs, and (2) during the software's development or modification, no substantive plan exists or is being developed to market the software externally." } } }, "auth_ref": [ "r8", "r9" ] }, "cslr_NetLossPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "NetLossPerShareAbstract", "presentation": [ "http://www.completesolaria.com/role/BasicAndDilutedNetLossPerShareDetailsScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholders" ], "lang": { "en-us": { "role": { "label": "Net Loss Per Share Abstract", "terseLabel": "Net loss per share:" } } }, "auth_ref": [] }, "cslr_ScheduleOfPotentialCommonSharesExcludedFromDilutedNetLossPerShareTable": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ScheduleOfPotentialCommonSharesExcludedFromDilutedNetLossPerShareTable", "presentation": [ "http://www.completesolaria.com/role/BasicAndDilutedNetLossPerShareDetailsScheduleOfPotentialCommonSharesExcludedFromDilutedNetLossPerShare" ], "lang": { "en-us": { "role": { "label": "Schedule Of Potential Common Shares Excluded From Diluted Net Loss Per Share [Table]", "documentation": "Schedule of potential common shares excluded from diluted net loss per share." } } }, "auth_ref": [] }, "cslr_ScheduleOfPotentialCommonSharesExcludedFromDilutedNetLossPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ScheduleOfPotentialCommonSharesExcludedFromDilutedNetLossPerShareAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Potential Common Shares Excluded From Diluted Net Loss Per Share Abstract" } } }, "auth_ref": [] }, "us-gaap_DeferredRevenueRevenueRecognized1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredRevenueRevenueRecognized1", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Revenue, Revenue Recognized", "terseLabel": "Deferred revenue", "documentation": "Amount of revenue recognized that was previously reported as deferred or unearned revenue." } } }, "auth_ref": [] }, "us-gaap_AssetAcquisitionConsiderationTransferred": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetAcquisitionConsiderationTransferred", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Asset Acquisition, Consideration Transferred", "terseLabel": "Consideration for the asset acquisition", "documentation": "Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer." } } }, "auth_ref": [ "r1035", "r1190", "r1191", "r1192" ] }, "cslr_RecapitalizationOfLegacyCompleteSolariaCommonStockIntoCompleteSolariaCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "RecapitalizationOfLegacyCompleteSolariaCommonStockIntoCompleteSolariaCommonStock", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Recapitalization Of Legacy Complete Solaria Common Stock Into Complete Solaria Common Stock", "terseLabel": "Recapitalization of Legacy Complete Solaria Common stock into Complete Solaria Common Stock" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetailsSummaryOfSummaryOfStockOptionActivityParentheticals" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value", "terseLabel": "Share based compensation by share based award options vested during the period aggregate fair value", "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares." } } }, "auth_ref": [ "r611" ] }, "us-gaap_DebtInstrumentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentLineItems", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfCompanySOutstandingNotesPayable", "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfNetCarryingAmountOfTheConvertibleNotes" ], "lang": { "en-us": { "role": { "label": "Debt Instrument [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r370", "r546", "r547", "r548", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r731", "r1013", "r1014", "r1015", "r1016", "r1017", "r1108" ] }, "cslr_ReclassificationOfInvestorRelatedToPIPEFunds": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ReclassificationOfInvestorRelatedToPIPEFunds", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Reclassification Of Investor Related To PIPEFunds", "terseLabel": "Reclassification of investor related to PIPE funds" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentAxis", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfReconciliationOfEmbeddedDerivativeLiability", "http://www.completesolaria.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r43", "r187", "r188", "r268", "r270", "r370", "r546", "r547", "r548", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r731", "r1013", "r1014", "r1015", "r1016", "r1017", "r1108" ] }, "cslr_PolarSettlementAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "PolarSettlementAgreementMember", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Polar Settlement Agreement Member", "terseLabel": "Polar Settlement Agreement [Member]" } } }, "auth_ref": [] }, "us-gaap_SharesIssuedPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesIssuedPricePerShare", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Shares Issued, Price Per Share", "terseLabel": "Price per share (in Dollars per share)", "documentation": "Per share or per unit amount of equity securities issued." } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfSignificantUnobservableInputsLevel3AndTheChangeInFairValueRecordedInOtherIncomeExpenseNet" ], "lang": { "en-us": { "role": { "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances", "terseLabel": "Issuances", "documentation": "Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r152" ] }, "cslr_DirectOfferingCostsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "DirectOfferingCostsPolicyTextBlock", "presentation": [ "http://www.completesolaria.com/role/AccountingPoliciesByPolicyPolicies" ], "lang": { "en-us": { "role": { "label": "Direct Offering Costs Policy Text Block", "terseLabel": "Direct offering costs", "documentation": "Disclosure of accounting policy for direct offering costs." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetailsSummaryOfSummaryOfStockOptionActivity" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period", "negatedLabel": "Number of shares, Options canceled", "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan." } } }, "auth_ref": [ "r602" ] }, "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfWarrantsBasedOnABlackScholesOptionPricingMethod" ], "lang": { "en-us": { "role": { "label": "Share-Based Goods and Nonemployee Services Transaction, Valuation Method, Expected Term", "terseLabel": "Simulation period", "documentation": "Period an equity-based award is expected to be outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r286" ] }, "cslr_ForwardPurchaseAgreementPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ForwardPurchaseAgreementPolicyTextBlock", "presentation": [ "http://www.completesolaria.com/role/AccountingPoliciesByPolicyPolicies" ], "lang": { "en-us": { "role": { "label": "Forward Purchase Agreement Policy Text Block", "terseLabel": "Forward Purchase Agreements", "documentation": "The policy disclosure of forward purchase agreements." } } }, "auth_ref": [] }, "cslr_SAFEMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "SAFEMember", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "SAFEMember", "terseLabel": "SAFE [Member]" } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfSignificantUnobservableInputsLevel3AndTheChangeInFairValueRecordedInOtherIncomeExpenseNet" ], "lang": { "en-us": { "role": { "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements", "terseLabel": "Conversion of preferred shares", "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r152" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetailsSummaryOfSummaryOfStockOptionActivityParentheticals" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Share based compensation by share based award options granted during the period weighted average fair value per share", "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology." } } }, "auth_ref": [ "r610" ] }, "cslr_ScheduleOfPropertyPlantAndEquipmentUsefulLivesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ScheduleOfPropertyPlantAndEquipmentUsefulLivesTableTextBlock", "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "Schedule Of Property, Plant and Equipment Useful Lives [Table Text Block]", "terseLabel": "Schedule Of Property, Plant and Equipment Useful Lives", "documentation": "Schedule of property, plant and equipment useful lives." } } }, "auth_ref": [] }, "cslr_ScheduleOfReconcilesTheChangeInValueOfTheRedeemableConvertiblePreferredStockWarrantLiabilityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ScheduleOfReconcilesTheChangeInValueOfTheRedeemableConvertiblePreferredStockWarrantLiabilityTableTextBlock", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "label": "Schedule Of Reconciles The Change In Value Of The Redeemable Convertible Preferred Stock Warrant Liability [Table Text Block]", "terseLabel": "Schedule of Reconciles the Change in Value of the Redeemable Convertible Preferred Stock Warrant Liability", "documentation": "Schedule of reconciles the change in value of the redeemable convertible preferred stock warrant liability." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentTable", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfCompanySOutstandingNotesPayable", "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfNetCarryingAmountOfTheConvertibleNotes" ], "lang": { "en-us": { "role": { "label": "Schedule of Long-Term Debt Instruments [Table]", "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r58", "r110", "r111", "r159", "r160", "r162", "r168", "r238", "r240", "r370", "r546", "r547", "r548", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r731", "r1013", "r1014", "r1015", "r1016", "r1017", "r1108" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetailsSummaryOfSummaryOfStockOptionActivity" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value", "periodStartLabel": "Aggregate intrinsic value (in thousands), outstanding beginning balance", "periodEndLabel": "Aggregate intrinsic value (in thousands), outstanding ending balance", "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding." } } }, "auth_ref": [ "r115" ] }, "cslr_DisclosureInTabularFormOfSignificantUnobservableInputsUsedInFairValueMeasurementOfSimpleAgreementsForFutureEquityInstrumentsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "DisclosureInTabularFormOfSignificantUnobservableInputsUsedInFairValueMeasurementOfSimpleAgreementsForFutureEquityInstrumentsTableTextBlock", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "label": "Disclosure In Tabular Form Of Significant Unobservable Inputs Used In Fair Value Measurement Of Simple Agreements For Future Equity Instruments [Table Text Block]", "terseLabel": "Schedule of Next Equity Financing Based on Inputs Included in a Black-Scholes Model", "documentation": "Disclosure in tabular form of significant unobservable inputs used in fair value measurement of simple agreements for future equity instruments." } } }, "auth_ref": [] }, "cslr_DisclosureInTabularFormOfReconciliationOfEmbeddedDerivativeLiabilityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "DisclosureInTabularFormOfReconciliationOfEmbeddedDerivativeLiabilityTableTextBlock", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "label": "Disclosure In Tabular Form Of Reconciliation Of Embedded Derivative Liability [Table Text Block]", "terseLabel": "Schedule of Reconciliation of Embedded Derivative Liability", "documentation": "Disclosure in tabular form of reconciliation of embedded derivative liability." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetailsSummaryOfSummaryOfStockOptionActivity" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "periodStartLabel": "Number of shares, outstanding, beginning balance", "periodEndLabel": "Number of shares, outstanding, ending balance", "documentation": "Number of options outstanding, including both vested and non-vested options." } } }, "auth_ref": [ "r596", "r597" ] }, "cslr_ConversionAmountMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ConversionAmountMember", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Conversion Amount Member", "terseLabel": "Conversion Amount [Member]" } } }, "auth_ref": [] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetails", "http://www.completesolaria.com/role/FairValueMeasurementsDetails", "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfSignificantUnobservableInputsLevel3AndTheChangeInFairValueRecordedInOtherIncomeExpenseNet" ], "lang": { "en-us": { "role": { "label": "Fair Value by Liability Class [Domain]", "documentation": "Represents classes of liabilities measured and disclosed at fair value." } } }, "auth_ref": [ "r33" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetailsSummaryOfSummaryOfStockOptionActivity" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodStartLabel": "Weighted average exercise price per share, outstanding, beginning balance", "periodEndLabel": "Weighted average exercise price per share, outstanding, ending balance", "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan." } } }, "auth_ref": [ "r596", "r597" ] }, "cslr_ScheduleOfFiniteLivedIntangibleAssetsEstimatedUsefulLifeTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ScheduleOfFiniteLivedIntangibleAssetsEstimatedUsefulLifeTableTextBlock", "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "Schedule Of Finite Lived Intangible Assets Estimated Useful Life [Table Text Block]", "terseLabel": "Schedule of Finite-Lived Intangible Assets", "documentation": "Schedule of finite lived intangible assets estimated useful life." } } }, "auth_ref": [] }, "us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TemporaryEquityStockIssuedDuringPeriodValueNewIssues", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Temporary Equity, Stock Issued During Period, Value, New Issues", "terseLabel": "Redeemable convertible preferred Stock upon conversion note", "documentation": "Value of new stock classified as temporary equity issued during the period." } } }, "auth_ref": [] }, "cslr_SupplyChainConstraintsAndRiskAndUncertaintiesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "SupplyChainConstraintsAndRiskAndUncertaintiesPolicyTextBlock", "presentation": [ "http://www.completesolaria.com/role/AccountingPoliciesByPolicyPolicies" ], "lang": { "en-us": { "role": { "label": "Supply Chain Constraints and Risk and Uncertainties [Policy Text Block]", "terseLabel": "Supply Chain Constraints and Risk", "documentation": "Supply chain constraints and risk and uncertainties." } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 1.0 }, "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_IncomeLossFromContinuingOperations", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.completesolaria.com/role/BasicAndDilutedNetLossPerShareDetailsScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholders", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Attributable to Parent", "totalLabel": "Net loss", "terseLabel": "Net loss", "verboseLabel": "Net Loss", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r206", "r223", "r276", "r322", "r342", "r344", "r349", "r364", "r374", "r378", "r379", "r381", "r382", "r386", "r387", "r405", "r418", "r432", "r436", "r438", "r484", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r697", "r708", "r836", "r932", "r955", "r956", "r1005", "r1050", "r1148" ] }, "us-gaap_EquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquipmentMember", "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetailsScheduleOfPropertyPlantAndEquipmentUsefulLives" ], "lang": { "en-us": { "role": { "label": "Equipment [Member]", "terseLabel": "Manufacturing equipment [Member]", "documentation": "Tangible personal property used to produce goods and services." } } }, "auth_ref": [] }, "cslr_IssuanceOfRedeemableConveritblePreferredStockUponConversionOfConvertibleDebtOne": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "IssuanceOfRedeemableConveritblePreferredStockUponConversionOfConvertibleDebtOne", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Issuance Of Redeemable Converitble Preferred Stock Upon Conversion Of Convertible Debt One", "terseLabel": "Issuance of Series C redeemable convertible preferred stock upon conversion of convertible debt", "documentation": "Issuance of redeemable converitble preferred stock upon conversion of convertible debt one." } } }, "auth_ref": [] }, "srt_CondensedStatementOfComprehensiveIncomeTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CondensedStatementOfComprehensiveIncomeTable", "presentation": [ "http://www.completesolaria.com/role/DivestitureDetails", "http://www.completesolaria.com/role/DivestitureDetailsScheduleOfOperationsAndComprehensiveIncomeLossRelatedToDiscontinuedOperations" ], "lang": { "en-us": { "role": { "label": "Condensed Statement of Comprehensive Income [Table]", "documentation": "Disclosure of information about condensed statement of comprehensive income (loss) including, but not limited to, statements of comprehensive income (loss) of consolidated entities and consolidation eliminations." } } }, "auth_ref": [ "r310", "r370", "r1064" ] }, "cslr_WarrantsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "WarrantsLineItems", "presentation": [ "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Warrants [Line Items]", "documentation": "Warrants [Line Items]." } } }, "auth_ref": [] }, "cslr_IssuanceOfRedeemableConveritblePreferredStockUponConversionOfConvertibleDebtTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "IssuanceOfRedeemableConveritblePreferredStockUponConversionOfConvertibleDebtTwo", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Issuance Of Redeemable Converitble Preferred Stock Upon Conversion Of Convertible Debt Two", "terseLabel": "Issuance of Series\u00a0C-1\u00a0redeemable convertible preferred stock upon conversion of convertible", "documentation": "Issuance of redeemable converitble preferred stock upon conversion of convertible debt two." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Payments", "terseLabel": "Dividend yield", "documentation": "The estimated amount of dividends to be paid to holders of the underlying shares (expected dividends) over the option's term. Dividends are taken into account because payment of dividends to shareholders reduces the fair value of the underlying shares, and option holders generally do not receive dividends." } } }, "auth_ref": [ "r616" ] }, "cslr_FairValueOfDebtDerivativeLiabilitiesRelatingToTheIssuanceOfConvertibleNotes": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "FairValueOfDebtDerivativeLiabilitiesRelatingToTheIssuanceOfConvertibleNotes", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Fair Value Of Debt Derivative Liabilities Relating To The Issuance Of Convertible Notes", "terseLabel": "Fair value of debt derivative liabilities related to issuance of convertible notes", "documentation": "Fair value of debt derivative liabilities related to issuance of convertible notes." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfWarrantsBasedOnABlackScholesOptionPricingMethod", "http://www.completesolaria.com/role/StockBasedCompensationDetailsScheduleOfCalculateTheFairValueOfStockBasedCompensation" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "terseLabel": "Expected dividend yield", "verboseLabel": "Expected dividends", "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term." } } }, "auth_ref": [ "r616" ] }, "us-gaap_TemporaryEquityAccretionToRedemptionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TemporaryEquityAccretionToRedemptionValue", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Temporary Equity, Accretion to Redemption Value", "terseLabel": "Redemption amount", "documentation": "Value of accretion of temporary equity to its redemption value during the period." } } }, "auth_ref": [] }, "cslr_NotesPayableIssuedInAssetPurchase": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "NotesPayableIssuedInAssetPurchase", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Notes Payable Issued In Asset Purchase", "terseLabel": "Notes payable issued in asset purchase", "documentation": "Notes payable issued in asset purchase." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfWarrantsBasedOnABlackScholesOptionPricingMethod", "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "terseLabel": "Expected volatility", "verboseLabel": "Expected volatility, percentage", "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period." } } }, "auth_ref": [ "r615" ] }, "cslr_IssuanceOfRedeemableConvertiblePreferredStockThreeFourAndFiveUponConversionOfConversionOfConvertibleDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "IssuanceOfRedeemableConvertiblePreferredStockThreeFourAndFiveUponConversionOfConversionOfConvertibleDebt", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Issuance Of Redeemable Convertible Preferred Stock Three Four And Five Upon Conversion Of Conversion Of Convertible Debt", "terseLabel": "Issuance of Series\u00a0D-1,\u00a0D-2\u00a0and\u00a0D-3\u00a0redeemable convertible preferred stock upon conversion of convertible debt, net of issuance costs of $1,431", "documentation": "Issuance of redeemable convertible preferred stock three four and five upon conversion of conversion of convertible debt." } } }, "auth_ref": [] }, "cslr_warrantsPurchaseShares": { "xbrltype": "sharesItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "warrantsPurchaseShares", "presentation": [ "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "warrants Purchase Shares", "terseLabel": "Warrent purchase shares (in Shares)", "documentation": "Warrants purchase shares." } } }, "auth_ref": [] }, "us-gaap_GoodwillSubsequentRecognitionOfDeferredTaxAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillSubsequentRecognitionOfDeferredTaxAsset", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "label": "Goodwill, Subsequent Recognition of Deferred Tax Asset", "terseLabel": "Recognized deferred tax assets", "documentation": "Amount of (increase) decrease to an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from the subsequent recognition of deferred tax assets." } } }, "auth_ref": [ "r516" ] }, "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetailsScheduleOfUnauditedCombinedProFormaInformation" ], "lang": { "en-us": { "role": { "label": "Business Combination, Separately Recognized Transactions, Net Gains and Losses", "terseLabel": "Net loss", "documentation": "The net gains or losses recognized for each transaction with the acquiree that was recognized separately from the acquisition of assets and assumptions of liabilities in the business combination." } } }, "auth_ref": [ "r131" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfWarrantsBasedOnABlackScholesOptionPricingMethod", "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "terseLabel": "Risk-free interest rate", "verboseLabel": "Risk free interest rate, percentage", "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [ "r617" ] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.completesolaria.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "terseLabel": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "presentation": [ "http://www.completesolaria.com/role/AccountingPoliciesByPolicyPolicies" ], "lang": { "en-us": { "role": { "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]", "terseLabel": "Foreign Currency", "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy." } } }, "auth_ref": [ "r713" ] }, "cslr_AcquisitionOfBusinessThroughIssuanceOfCommonStockAndOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "AcquisitionOfBusinessThroughIssuanceOfCommonStockAndOptions", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Acquisition Of Business Through Issuance Of Common Stock And Options", "terseLabel": "Acquisition of business through issuance of common stock and stock options", "documentation": "Acquisition of business through issuance of common stock and options." } } }, "auth_ref": [] }, "us-gaap_EquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestments", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Equity Method Investments", "terseLabel": "Investment converted to equity", "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized." } } }, "auth_ref": [ "r424", "r483", "r1089", "r1128" ] }, "cslr_WarrantLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "WarrantLiability", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Warrant Liability", "terseLabel": "Warrant liability", "documentation": "Warrant liability." } } }, "auth_ref": [] }, "cslr_AcquisitionOfBusinessThroughIssuanceOfRedeemableConvertiblePreferredStockAndStockOptionsValue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "AcquisitionOfBusinessThroughIssuanceOfRedeemableConvertiblePreferredStockAndStockOptionsValue", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Acquisition Of Business Through Issuance Of Redeemable Convertible Preferred Stock And Stock Options Value", "terseLabel": "Acquisition of business through issuance of Series D redeemable convertible preferred stock", "documentation": "Acquisition of business through issuance of redeemable convertible preferred stock and stock options value." } } }, "auth_ref": [] }, "us-gaap_CostOfGoodsTotalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfGoodsTotalMember", "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Cost of Goods and Service Benchmark [Member]", "terseLabel": "Cost of Goods and Service Benchmark [Member]", "documentation": "Cost of product sold and service rendered, when it serves as benchmark in concentration of risk calculation." } } }, "auth_ref": [ "r1067" ] }, "us-gaap_NetInvestmentHedgeDerivativeLiabilitiesAtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetInvestmentHedgeDerivativeLiabilitiesAtFairValue", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/ReverseRecapitalizationDetailsScheduleOfReconcilesElementsOfTheMerger" ], "lang": { "en-us": { "role": { "label": "Derivative Instruments in Hedges, Net Investment in Foreign Operations, Liabilities, Fair Value", "negatedLabel": "Less: non-cash net liabilities assumed from FACT", "documentation": "Fair value of all derivative liabilities designated as hedges of net investment in foreign operations." } } }, "auth_ref": [ "r145" ] }, "cslr_AcquisitionOfBusinessThroughTheIssuanceOfRedeemableConvertiblePreferredStockAndWarrantsValue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "AcquisitionOfBusinessThroughTheIssuanceOfRedeemableConvertiblePreferredStockAndWarrantsValue", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Acquisition Of Business Through The Issuance Of Redeemable Convertible Preferred Stock And Warrants Value", "terseLabel": "Acquisition of business through issuance of Series D redeemable convertible preferred stock warrants", "documentation": "Acquisition of business through the issuance of redeemable convertible preferred stock and warrants value." } } }, "auth_ref": [] }, "cslr_GainOnExtinguishmentOfConvertibleNotesAndSimpleAgreementForFutureEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "GainOnExtinguishmentOfConvertibleNotesAndSimpleAgreementForFutureEquity", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlowsParentheticals" ], "lang": { "en-us": { "role": { "label": "Gain On Extinguishment Of Convertible Notes And Simple Agreement For Future Equity", "terseLabel": "Gain on extinguishment of convertible notes and simple agreement for future equity", "documentation": "Gain on extinguishment of convertible notes and simple agreement for future equity." } } }, "auth_ref": [] }, "cslr_WarrantVesting": { "xbrltype": "sharesItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "WarrantVesting", "presentation": [ "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Warrant Vesting", "terseLabel": "Warrant vesting (in Shares)", "documentation": "The number of warrant vesting." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetails", "http://www.completesolaria.com/role/ForwardPurchaseAgreementsDetails", "http://www.completesolaria.com/role/StockBasedCompensationDetails", "http://www.completesolaria.com/role/StockBasedCompensationDetailsScheduleOfCalculateTheFairValueOfStockBasedCompensation", "http://www.completesolaria.com/role/StockBasedCompensationDetailsScheduleOfStockBasedCompensationExpenseAndItsAllocationWithinTheAccompanyingUnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss", "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Award Type [Domain]", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r617", "r618" ] }, "cslr_TemporaryEquityStockIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "TemporaryEquityStockIssuanceCosts", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlowsParentheticals" ], "lang": { "en-us": { "role": { "label": "Temporary Equity Stock Issuance Costs", "terseLabel": "Temporary equity stock issuance costs", "documentation": "Temporary equity stock issuance costs." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetailsScheduleOfCalculateTheFairValueOfStockBasedCompensation" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r590", "r591", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r617", "r618" ] }, "cslr_ForwardPurchaseAgreementOtherIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ForwardPurchaseAgreementOtherIncome", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlowsParentheticals" ], "lang": { "en-us": { "role": { "label": "Forward Purchase Agreement Other Income", "terseLabel": "Forward purchase agreement other income", "documentation": "Forward purchase agreement other income." } } }, "auth_ref": [] }, "us-gaap_ResearchMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchMember", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Research Tax Credit Carryforward [Member]", "terseLabel": "Research Tax Credit Carryforward [Member]", "documentation": "Research tax credit carryforwards arising from certain qualifying expenditures incurred to develop new products and processes." } } }, "auth_ref": [ "r125" ] }, "us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtRelatedCommitmentFeesAndDebtIssuanceCosts", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Debt Related Commitment Fees and Debt Issuance Costs", "documentation": "Represents the charge against earnings during the period for commitment fees and debt issuance expenses." } } }, "auth_ref": [ "r218" ] }, "cslr_ForwardPurchaseAgreementOtherExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ForwardPurchaseAgreementOtherExpense", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlowsParentheticals" ], "lang": { "en-us": { "role": { "label": "Forward Purchase Agreement Other Expense", "terseLabel": "Forward purchase agreement other expense", "documentation": "Forward purchase agreement other expense." } } }, "auth_ref": [] }, "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsForNewAccountingPronouncementsAxis", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Accounting Standards Update [Axis]", "documentation": "Information by amendment to accounting standards." } } }, "auth_ref": [ "r316", "r317", "r318", "r319", "r320", "r374", "r375", "r376", "r377", "r388", "r451", "r452", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r525", "r624", "r625", "r626", "r651", "r652", "r653", "r654", "r664", "r665", "r666", "r675", "r676", "r677", "r678", "r679", "r680", "r681", "r682", "r683", "r684", "r685", "r687", "r688", "r689", "r690", "r691", "r692", "r693", "r694", "r695", "r696", "r697", "r698", "r705", "r706", "r709", "r710", "r711", "r712", "r727", "r728", "r733", "r734", "r735", "r736", "r748", "r749", "r750", "r751", "r752", "r798", "r799", "r800", "r849", "r850", "r851", "r852", "r853", "r854", "r855", "r856", "r857", "r858", "r859", "r860" ] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetailsScheduleOfCalculateTheFairValueOfStockBasedCompensation" ], "lang": { "en-us": { "role": { "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "documentation": "Disclosure of information about share-based payment arrangement." } } }, "auth_ref": [ "r590", "r591", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r617", "r618" ] }, "srt_CondensedStatementOfComprehensiveIncomeTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CondensedStatementOfComprehensiveIncomeTableTextBlock", "presentation": [ "http://www.completesolaria.com/role/DivestitureTables" ], "lang": { "en-us": { "role": { "label": "Condensed Statement of Comprehensive Income [Table Text Block]", "terseLabel": "Schedule of Operations and Comprehensive Income (Loss) Related to Discontinued Operations", "documentation": "Tabular disclosure of condensed statement of comprehensive income (loss) including, but not limited to, statements of comprehensive income (loss) of consolidated entities and consolidation eliminations." } } }, "auth_ref": [ "r1087", "r1113" ] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "presentation": [ "http://www.completesolaria.com/role/GoodwillAndIntangibleAssets" ], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "terseLabel": "Goodwill and Intangible Assets", "documentation": "The entire disclosure for goodwill and intangible assets." } } }, "auth_ref": [ "r227" ] }, "cslr_CommonStockIssuedForwardPurchaseAgreementExpensesIncurred": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "CommonStockIssuedForwardPurchaseAgreementExpensesIncurred", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlowsParentheticals" ], "lang": { "en-us": { "role": { "label": "Common Stock Issued Forward Purchase Agreement Expenses Incurred", "terseLabel": "Common stock issued forward purchase agreements expenses incurred", "documentation": "Common stock issued forward purchase agreements expenses incurred." } } }, "auth_ref": [] }, "cslr_PurchaseShares": { "xbrltype": "sharesItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "PurchaseShares", "presentation": [ "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Purchase Shares", "terseLabel": "Purchase shares (in Shares)", "documentation": "Purchase shares." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxReconciliationOtherReconcilingItems": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationOtherReconcilingItems", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfReconciliationOfEffectiveIncomeTaxRate" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount, Total", "terseLabel": "Other", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments." } } }, "auth_ref": [ "r1181" ] }, "cslr_CommonStockBonusSharesIssuedInConnectionWithMergerExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "CommonStockBonusSharesIssuedInConnectionWithMergerExpenses", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlowsParentheticals" ], "lang": { "en-us": { "role": { "label": "Common Stock Bonus Shares Issued In Connection With Merger Expenses", "terseLabel": "Common stock bonues shares issued in connection with merger expenses", "documentation": "Common stock bonus shares issued in connection with merger expenses." } } }, "auth_ref": [] }, "srt_CondensedStatementOfIncomeCaptionsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CondensedStatementOfIncomeCaptionsLineItems", "presentation": [ "http://www.completesolaria.com/role/DivestitureDetails", "http://www.completesolaria.com/role/DivestitureDetailsScheduleOfOperationsAndComprehensiveIncomeLossRelatedToDiscontinuedOperations" ], "lang": { "en-us": { "role": { "label": "Schedule of Operations and Comprehensive Income Related to Discontinued Operations [Abstract]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r311", "r370", "r1064" ] }, "cslr_ConvertedToCommonStockWarrantsDescription": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ConvertedToCommonStockWarrantsDescription", "presentation": [ "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Converted To Common Stock Warrants Description", "terseLabel": "Converted to common stock warrants, description", "documentation": "Converted to common stock warrants description." } } }, "auth_ref": [] }, "cslr_IssuanceOfTemporaryEquityUponConversionOfConvertibleDebtMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "IssuanceOfTemporaryEquityUponConversionOfConvertibleDebtMember", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlowsParentheticals" ], "lang": { "en-us": { "role": { "label": "Issuance Of Temporary Equity Upon Conversion Of Convertible Debt [Member]", "terseLabel": "Issuance Of Temporary Equity Upon Conversion Of Convertible Debt [Member]", "documentation": "Issuance of temporary equity upon conversion of convertible debt." } } }, "auth_ref": [] }, "cslr_WarrantAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "WarrantAmount", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Warrant Amount", "terseLabel": "Warrant amount", "documentation": "Warrant amount." } } }, "auth_ref": [] }, "cslr_ReverseRecapitalizationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ReverseRecapitalizationAbstract", "lang": { "en-us": { "role": { "label": "Reverse Recapitalization [Abstract]" } } }, "auth_ref": [] }, "cslr_ForwardPurchaseAgreementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ForwardPurchaseAgreementsAbstract", "lang": { "en-us": { "role": { "label": "Forward Purchase Agreements Abstract" } } }, "auth_ref": [] }, "cslr_DisclosureInTabularFormOfSignificantUnobservableInputsUsedInTheFairValueOfWarrantsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "DisclosureInTabularFormOfSignificantUnobservableInputsUsedInTheFairValueOfWarrantsTable", "presentation": [ "http://www.completesolaria.com/role/WarrantsScheduleOfFairValueOfTheCommonStockWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure In Tabular Form Of Significant Unobservable Inputs Used In The Fair Value Of Warrants [Table]" } } }, "auth_ref": [] }, "cslr_ReverseRecapitalizationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ReverseRecapitalizationTextBlock", "presentation": [ "http://www.completesolaria.com/role/ReverseRecapitalization" ], "lang": { "en-us": { "role": { "label": "Reverse Recapitalization Text Block", "terseLabel": "Reverse Recapitalization", "documentation": "The entire disclosure for reverse recapitalization." } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfSignificantUnobservableInputsLevel3AndTheChangeInFairValueRecordedInOtherIncomeExpenseNet" ], "lang": { "en-us": { "role": { "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value", "periodStartLabel": "Beginning Balance", "periodEndLabel": "Ending Balance", "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r33" ] }, "us-gaap_PreferredStockConvertibleConversionPriceDecrease": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockConvertibleConversionPriceDecrease", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Convertible, Conversion Price, Decrease", "terseLabel": "Convertible per share (in Dollars per share)", "documentation": "Per share decrease in conversion price of convertible preferred stock. Excludes change due to standard antidilution provision." } } }, "auth_ref": [ "r571", "r575" ] }, "cslr_ForwardPurchaseAgreementsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ForwardPurchaseAgreementsTextBlock", "presentation": [ "http://www.completesolaria.com/role/ForwardPurchaseAgreements" ], "lang": { "en-us": { "role": { "label": "Forward Purchase Agreements Text Block", "terseLabel": "Forward Purchase Agreements", "documentation": "The entire disclosure of forward purchase agreements." } } }, "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/BusinessCombinationDetails", "http://www.completesolaria.com/role/CommonStockDetails", "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetails", "http://www.completesolaria.com/role/OrganizationDetails", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit", "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "verboseLabel": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r1042", "r1043", "r1044", "r1046", "r1047", "r1048", "r1049", "r1114", "r1115", "r1194", "r1225", "r1232" ] }, "cslr_CommonStockWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "CommonStockWarrantsMember", "presentation": [ "http://www.completesolaria.com/role/WarrantsScheduleOfFairValueOfTheCommonStockWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Common Stock Warrants [Member]" } } }, "auth_ref": [] }, "us-gaap_FinancingReceivableUnamortizedLoanFeeCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancingReceivableUnamortizedLoanFeeCost", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Financing Receivable, Unamortized Loan Cost (Fee)", "terseLabel": "Accrued financing cost", "documentation": "Amount of unamortized loan commitment, origination, and other costs (fees) on financing receivable recognized as adjustment to yield. Excludes financing receivable covered under loss sharing agreement." } } }, "auth_ref": [ "r446", "r448", "r1061" ] }, "cslr_EmployeeBenefitPlanAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "EmployeeBenefitPlanAbstract", "lang": { "en-us": { "role": { "label": "Employee Benefit Plan [Abstract]" } } }, "auth_ref": [] }, "us-gaap_WarrantExercisePriceDecrease": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantExercisePriceDecrease", "presentation": [ "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Warrant, Exercise Price, Decrease", "terseLabel": "Exercise price per share (in Dollars per share)", "documentation": "Per share decrease in exercise price of warrant. Excludes change due to standard antidilution provision." } } }, "auth_ref": [ "r575" ] }, "cslr_PaycheckProtectionProgrammeLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "PaycheckProtectionProgrammeLoanMember", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Paycheck Protection Programme Loan [Member]" } } }, "auth_ref": [] }, "cslr_CommonStockAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "CommonStockAbstract", "lang": { "en-us": { "role": { "label": "Common Stock [Abstract]" } } }, "auth_ref": [] }, "cslr_DisclosureInTabularFormOfSignificantUnobservableInputsUsedInTheFairValueOfWarrantsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "DisclosureInTabularFormOfSignificantUnobservableInputsUsedInTheFairValueOfWarrantsLineItems", "presentation": [ "http://www.completesolaria.com/role/WarrantsScheduleOfFairValueOfTheCommonStockWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure In Tabular Form Of Significant Unobservable Inputs Used In The Fair Value Of Warrants [Line Items]" } } }, "auth_ref": [] }, "cslr_SecuredCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "SecuredCreditFacilityMember", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Secured Credit Facility [Member]" } } }, "auth_ref": [] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensation" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Text Block]", "terseLabel": "Stock-Based Compensation", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r589", "r592", "r620", "r621", "r623", "r1032" ] }, "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsRevenuesAndGainsRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationSeparatelyRecognizedTransactionsRevenuesAndGainsRecognized", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetailsScheduleOfUnauditedCombinedProFormaInformation" ], "lang": { "en-us": { "role": { "label": "Business Combination, Separately Recognized Transactions, Revenues and Gains Recognized", "terseLabel": "Revenues", "documentation": "The revenues and gains recognized recorded for each transaction with the acquiree that is recognized separately from the acquisition of assets and assumptions of liabilities in the business combination." } } }, "auth_ref": [ "r131" ] }, "cslr_CommonStockTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "CommonStockTextBlock", "presentation": [ "http://www.completesolaria.com/role/CommonStock" ], "lang": { "en-us": { "role": { "label": "Common Stock Text Block", "terseLabel": "Common Stock", "documentation": "The entire disclosure for common stock." } } }, "auth_ref": [] }, "cslr_LoanAndSecurityAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "LoanAndSecurityAgreementMember", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfCompanySOutstandingNotesPayable" ], "lang": { "en-us": { "role": { "label": "Loan And Security Agreement Member", "terseLabel": "Loan and Security Agreement [Member]" } } }, "auth_ref": [] }, "us-gaap_WarrantExercisePriceIncrease": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantExercisePriceIncrease", "presentation": [ "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Warrant, Exercise Price, Increase", "terseLabel": "Exercise price per share (in Dollars per share)", "documentation": "Per share increase in exercise price of warrant. Excludes change due to standard antidilution provision." } } }, "auth_ref": [ "r575" ] }, "us-gaap_InvestmentIncomeInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentIncomeInterest", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Investment Income, Interest", "terseLabel": "Interest income", "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities." } } }, "auth_ref": [ "r217", "r421" ] }, "cslr_RevolvingLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "RevolvingLoanMember", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Revolving Loan Member", "terseLabel": "Revolving Loan [Member]" } } }, "auth_ref": [] }, "cslr_WarrantsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "WarrantsAbstract", "lang": { "en-us": { "role": { "label": "Warrants [Abstract]" } } }, "auth_ref": [] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductsAndServicesDomain", "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetailsScheduleOfRevenueRecognizedByProductAndServices" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]", "documentation": "Product or service, or a group of similar products or similar services." } } }, "auth_ref": [ "r439", "r796", "r842", "r843", "r844", "r845", "r846", "r847", "r993", "r1019", "r1040", "r1073", "r1143", "r1144", "r1153", "r1221" ] }, "us-gaap_DebtInstrumentRedemptionPricePercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentRedemptionPricePercentage", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Redemption Price, Percentage", "terseLabel": "Redemption price percentage", "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer." } } }, "auth_ref": [ "r41" ] }, "cslr_WarrantsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "WarrantsTextBlock", "presentation": [ "http://www.completesolaria.com/role/Warrants" ], "lang": { "en-us": { "role": { "label": "Warrants Text Block", "terseLabel": "Warrants", "documentation": "The entire disclosure on information about warrants." } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetailsScheduleOfWeightedAverageRemainingLeaseTermAndTheDiscountRate" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Weighted Average Remaining Lease Term", "terseLabel": "Remaining average remaining lease term", "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r745", "r1038" ] }, "cslr_RodgersMasseyMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "RodgersMasseyMember", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Rodgers Massey Member", "terseLabel": "Rodgers Massey [Member]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInDepositOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInDepositOtherAssets", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0, "order": 32.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Deposit Assets", "negatedLabel": "Long-term deposits", "documentation": "The increase (decrease) during the reporting period in moneys or securities given as security including, but not limited to, contract, escrow, or earnest money deposits, retainage (if applicable), deposits with clearing organizations and others, collateral, or margin deposits." } } }, "auth_ref": [ "r23" ] }, "us-gaap_RelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyMember", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfConvertibleNotes", "http://www.completesolaria.com/role/OtherIncomeExpenseNetDetails", "http://www.completesolaria.com/role/RelatedPartyTransactionsDetails", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlowsParentheticals", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossParentheticals", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficitParentheticals" ], "lang": { "en-us": { "role": { "label": "Related Party [Member]", "terseLabel": "Related Party", "verboseLabel": "Related Party [Member]", "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family." } } }, "auth_ref": [ "r367", "r368", "r756", "r757", "r758", "r759", "r903", "r904", "r905", "r906", "r907", "r929", "r931", "r962" ] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://www.completesolaria.com/role/AccountingPoliciesByPolicyPolicies" ], "lang": { "en-us": { "role": { "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recently Adopted Accounting Pronouncements", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "us-gaap_Cash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Cash", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/ReverseRecapitalizationDetails" ], "lang": { "en-us": { "role": { "label": "Cash", "terseLabel": "Transaction costs", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r293", "r824", "r890", "r919", "r1039", "r1052", "r1088" ] }, "us-gaap_DerivativeFloorInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeFloorInterestRate", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Derivative, Floor Interest Rate", "terseLabel": "Promissory note carried simple interest rate", "documentation": "Floor rate on an interest rate derivative such as an interest rate floor or collar. If market rates falls below the floor rate, a payment or receipt is triggered on the contract." } } }, "auth_ref": [] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net decrease in cash, cash equivalents and restricted cash", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r14", "r221" ] }, "us-gaap_ConvertibleNotesPayableMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConvertibleNotesPayableMember", "presentation": [ "http://www.completesolaria.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Convertible Notes Payable [Member]", "terseLabel": "Convertible Promissory Notes [Member]", "documentation": "Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder." } } }, "auth_ref": [ "r187", "r268" ] }, "us-gaap_ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEmployeeStockOwnershipPlanESOPDisclosuresTextBlock", "presentation": [ "http://www.completesolaria.com/role/EmployeeStockPurchasePlan" ], "lang": { "en-us": { "role": { "label": "Employee Stock Ownership Plan (ESOP) Disclosures [Table Text Block]", "terseLabel": "Employee Stock Purchase Plan", "documentation": "Tabular disclosure of the details pertaining to each employee stock ownership plan." } } }, "auth_ref": [ "r122" ] }, "us-gaap_StockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockOptionMember", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "label": "Equity Option [Member]", "terseLabel": "Stock Options [Member]", "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option)." } } }, "auth_ref": [ "r1044" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments and Contingencies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationConsiderationTransferred1", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetailsScheduleOfAssetsAcquiredAndLiabilitiesAssumed" ], "lang": { "en-us": { "role": { "label": "Business Combination, Consideration Transferred", "terseLabel": "Total aggregate consideration paid", "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer." } } }, "auth_ref": [ "r10", "r11", "r27" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodStartLabel": "Cash, cash equivalents, and restricted cash at beginning of period", "periodEndLabel": "Cash, cash equivalents, and restricted cash at end of period", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r72", "r221", "r361" ] }, "us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteRedeemablePreferredStockIssuePolicy", "presentation": [ "http://www.completesolaria.com/role/AccountingPoliciesByPolicyPolicies" ], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note, Redeemable Preferred Stock, Issue, Policy [Policy Text Block]", "terseLabel": "Redeemable Convertible Preferred Stock Warrants", "documentation": "Disclosure of accounting policy for redeemable preferred stock issued. This disclosure may include the accounting treatment for the difference, if there is any, between the carrying value and redemption amount. For example, describe whether the issuer accretes changes in the redemption value." } } }, "auth_ref": [ "r0", "r191", "r192" ] }, "us-gaap_RelatedPartyTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionDomain", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfReconciliationOfEmbeddedDerivativeLiability", "http://www.completesolaria.com/role/OrganizationDetails", "http://www.completesolaria.com/role/OtherIncomeExpenseNetDetails", "http://www.completesolaria.com/role/RelatedPartyTransactionsDetails", "http://www.completesolaria.com/role/ReverseRecapitalizationDetails", "http://www.completesolaria.com/role/ReverseRecapitalizationDetailsScheduleOfCommonStockOutstanding", "http://www.completesolaria.com/role/ReverseRecapitalizationDetailsScheduleOfReconcilesElementsOfTheMerger" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Domain]", "documentation": "Transaction between related party." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationTables" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]", "terseLabel": "Schedule of stock-based compensation expense and its allocation within the accompanying unaudited condensed consolidated statements of operations and comprehensive loss", "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement." } } }, "auth_ref": [ "r121" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationIntangibleAssets", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/DivestitureDetailsScheduleOfMajorCategoriesOfAssetsAndLiabilitiesHeldForSale": { "parentTag": "us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.completesolaria.com/role/DivestitureDetailsScheduleOfMajorCategoriesOfAssetsAndLiabilitiesHeldForSale" ], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Intangible Assets", "terseLabel": "Intangible assets, net", "documentation": "Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of." } } }, "auth_ref": [ "r15", "r174", "r185", "r233" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.completesolaria.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "us-gaap_NonrelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonrelatedPartyMember", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfConvertibleNotes" ], "lang": { "en-us": { "role": { "label": "Nonrelated Party [Member]", "terseLabel": "Nonrelated Party [Member]", "documentation": "Party not related to reporting entity." } } }, "auth_ref": [ "r1111", "r1112" ] }, "us-gaap_MeasurementInputPriceVolatilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputPriceVolatilityMember", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfNextEquityFinancingBasedOnInputsIncludedInABlackScholesModel", "http://www.completesolaria.com/role/WarrantsScheduleOfFairValueOfTheCommonStockWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input, Price Volatility [Member]", "terseLabel": "Volatility [Member]", "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns." } } }, "auth_ref": [ "r1196" ] }, "us-gaap_LeaseholdImprovementsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseholdImprovementsMember", "presentation": [ "http://www.completesolaria.com/role/PropertyAndEquipmentNetDetailsScheduleOfPropertyAndEquipmentNet", "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetailsScheduleOfPropertyPlantAndEquipmentUsefulLives" ], "lang": { "en-us": { "role": { "label": "Leasehold Improvements [Member]", "verboseLabel": "Leasehold improvements [Member]", "terseLabel": "Leasehold Improvements [Member]", "documentation": "Additions or improvements to assets held under a lease arrangement." } } }, "auth_ref": [ "r232" ] }, "us-gaap_RepaymentsOfMediumTermNotes": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfMediumTermNotes", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 56.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Repayments of Medium-term Notes", "negatedLabel": "Principal repayment of notes payable", "documentation": "The cash outflow to pay off borrowing used to receive debt funding on a regular basis with maturities ranging from 5-10 years." } } }, "auth_ref": [ "r71" ] }, "us-gaap_OtherIncomeAndExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherIncomeAndExpensesAbstract", "lang": { "en-us": { "role": { "label": "Other Income (Expense), Net [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightOutstanding", "presentation": [ "http://www.completesolaria.com/role/CommonStockDetailsScheduleOfReservedSharesOfCommonStock", "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right, Outstanding", "terseLabel": "Common stock warrants", "verboseLabel": "Outstanding warrants (in Shares)", "documentation": "Number of warrants or rights outstanding." } } }, "auth_ref": [] }, "us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancialSupportToNonconsolidatedLegalEntityAxis", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Financial Support to Nonconsolidated Legal Entity [Axis]", "documentation": "Information by financial support arrangement provided to a nonconsolidated legal entity that is required to comply with or operate in accordance with requirements that are similar to those included in Rule 2a-7 of the Investment Company Act of 1940 for registered money market funds." } } }, "auth_ref": [ "r2", "r873", "r874" ] }, "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfReconciliationOfEffectiveIncomeTaxRate" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount", "terseLabel": "Valuation allowance", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets." } } }, "auth_ref": [ "r1181" ] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_MeasurementInputRiskFreeInterestRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputRiskFreeInterestRateMember", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfNextEquityFinancingBasedOnInputsIncludedInABlackScholesModel", "http://www.completesolaria.com/role/WarrantsScheduleOfFairValueOfTheCommonStockWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input, Risk Free Interest Rate [Member]", "terseLabel": "Risk-free interest rate [Member]", "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss." } } }, "auth_ref": [ "r1196" ] }, "us-gaap_PaymentsForLegalSettlements": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForLegalSettlements", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Payments for Legal Settlements", "terseLabel": "Payments for Settlement", "verboseLabel": "Payments for settlement", "documentation": "The amount of cash paid for the settlement of litigation or for other legal issues during the period." } } }, "auth_ref": [ "r22" ] }, "us-gaap_MeasurementInputTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputTypeDomain", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetails", "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfNextEquityFinancingBasedOnInputsIncludedInABlackScholesModel", "http://www.completesolaria.com/role/WarrantsScheduleOfFairValueOfTheCommonStockWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input Type [Domain]", "documentation": "Measurement input used to determine value of asset and liability." } } }, "auth_ref": [] }, "us-gaap_DerivativeContractTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeContractTypeDomain", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "label": "Derivative Contract [Domain]", "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "auth_ref": [ "r898", "r900", "r916", "r917", "r918", "r920", "r921", "r922", "r923", "r925", "r926", "r927", "r928", "r945", "r946", "r947", "r948", "r951", "r952", "r953", "r954", "r967", "r968", "r972", "r974", "r1042", "r1044" ] }, "us-gaap_PaidInKindInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaidInKindInterest", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfInterestExpenseOnConvertibleDebt", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlowsParentheticals" ], "lang": { "en-us": { "role": { "label": "Paid-in-Kind Interest", "terseLabel": "Non cash interest expenses", "verboseLabel": "PIK Interest", "documentation": "Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r24" ] }, "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfComponentsOfDeferredTaxAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Liabilities, Property, Plant and Equipment", "negatedLabel": "Fixed assets", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment." } } }, "auth_ref": [ "r127", "r1184" ] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://www.completesolaria.com/role/SubsequentEvents" ], "lang": { "en-us": { "role": { "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r761", "r763" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetailsScheduleOfAssetsAcquiredAndLiabilitiesAssumed" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other", "terseLabel": "Accrued expenses and other current liabilities", "documentation": "Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date." } } }, "auth_ref": [ "r134" ] }, "us-gaap_AccountsReceivableMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableMember", "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable [Member]", "documentation": "Due from customers or clients for goods or services that have been delivered or sold." } } }, "auth_ref": [ "r988" ] }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]", "terseLabel": "Supplemental schedule of noncash investing and financing activities:" } } }, "auth_ref": [] }, "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/DivestitureDetails" ], "lang": { "en-us": { "role": { "label": "Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)", "terseLabel": "Impairment expense intangible assets", "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value." } } }, "auth_ref": [ "r1104", "r1136" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetailsScheduleOfAssetsAcquiredAndLiabilitiesAssumed" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other", "terseLabel": "Warranty provision, noncurrent", "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date." } } }, "auth_ref": [ "r134" ] }, "us-gaap_RetainedEarningsUnappropriatedMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsUnappropriatedMember", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Retained Earnings, Unappropriated [Member]", "terseLabel": "Accumulated Deficit", "documentation": "A segregation of retained earnings which is available for dividend distribution. Earnings not paid out as dividends but instead reinvested in the core business or used to pay off debt. Unappropriated profit is part of shareholder equity. Also called cumulative distributions or earned surplus or accumulated earnings or unappropriated profit." } } }, "auth_ref": [ "r196" ] }, "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetails", "http://www.completesolaria.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value", "terseLabel": "Fair value", "verboseLabel": "Fair value acquisition", "documentation": "Fair value at acquisition-date of the equity interest in the acquiree held by the acquirer, immediately before the acquisition date for businesses combined in stages." } } }, "auth_ref": [ "r38" ] }, "us-gaap_LeaseAndRentalExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseAndRentalExpense", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Operating Leases, Rent Expense", "terseLabel": "Lease expense", "documentation": "Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line." } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "presentation": [ "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights", "terseLabel": "Warrant to purchase shares (in Shares)", "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares." } } }, "auth_ref": [ "r575" ] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.completesolaria.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "label": "Fair Value Measurements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskCreditRisk": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskCreditRisk", "presentation": [ "http://www.completesolaria.com/role/AccountingPoliciesByPolicyPolicies" ], "lang": { "en-us": { "role": { "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "terseLabel": "Concentration of Risks", "documentation": "Disclosure of accounting policy for credit risk." } } }, "auth_ref": [ "r170", "r298" ] }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0, "order": 22.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid expenses and other current assets", "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other." } } }, "auth_ref": [ "r23" ] }, "us-gaap_AccruedLiabilitiesAndOtherLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedLiabilitiesAndOtherLiabilities", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetailsScheduleOfAccruedExpensesAndOtherCurrentLiabilities" ], "lang": { "en-us": { "role": { "label": "Accrued Liabilities and Other Liabilities", "terseLabel": "Total accrued expenses and other current liabilities", "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other." } } }, "auth_ref": [] }, "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOfIntangibleAssetsFinitelived", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetailsScheduleOfIntangibleAssets" ], "lang": { "en-us": { "role": { "label": "Impairment of Intangible Assets, Finite-Lived", "terseLabel": "Impairment", "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value." } } }, "auth_ref": [ "r1104", "r1136" ] }, "us-gaap_OptionIndexedToIssuersEquityTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OptionIndexedToIssuersEquityTypeDomain", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetails", "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfNextEquityFinancingBasedOnInputsIncludedInABlackScholesModel" ], "lang": { "en-us": { "role": { "label": "Option Indexed to Issuer's Equity, Type [Domain]", "documentation": "Description of the type of freestanding contract issued by a Company that is indexed to, and potentially settled in, a Company's own stock. Specifically, the pertinent rights and privileges of the securities outstanding." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0, "order": 15.0 }, "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfProvisionForIncomeTaxes": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfProvisionForIncomeTaxes", "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfReconciliationOfEffectiveIncomeTaxRate", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Income Tax Expense (Benefit)", "negatedLabel": "Income tax benefit (provision)", "totalLabel": "Total provision", "terseLabel": "Tax Provision", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r292", "r306", "r386", "r387", "r423", "r635", "r656", "r841" ] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.completesolaria.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetailsScheduleOfAssetsAcquiredAndLiabilitiesAssumed" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-Term Debt", "terseLabel": "Notes payable", "documentation": "Amount of long-term debt due within one year or within the normal operating cycle, if longer, assumed at the acquisition date." } } }, "auth_ref": [ "r134" ] }, "us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireOtherPropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 39.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payments to Acquire Other Property, Plant, and Equipment", "negatedLabel": "Purchase of property and equipment", "documentation": "Amount of cash outflow from the acquisition of or improvements to long-lived, physical assets used to produce goods and services and not intended for resale, classified as other." } } }, "auth_ref": [ "r220" ] }, "us-gaap_DerivativeLiabilityMeasurementInput": { "xbrltype": "decimalItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilityMeasurementInput", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetails", "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfNextEquityFinancingBasedOnInputsIncludedInABlackScholesModel" ], "lang": { "en-us": { "role": { "label": "Derivative Liability, Measurement Input", "terseLabel": "Derivatives measurement input", "verboseLabel": "Derivative liability, measurement input", "documentation": "Value of input used to measure derivative liability." } } }, "auth_ref": [ "r703" ] }, "us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/OtherIncomeExpenseNetDetailsScheduleOfOtherIncomeExpenseNet", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants", "terseLabel": "Issuance of common stock warrants", "verboseLabel": "Change in fair value of Carlyle warrants", "documentation": "Value of preferred stock and warrants for common stock issued." } } }, "auth_ref": [] }, "us-gaap_OtherPrepaidExpenseCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherPrepaidExpenseCurrent", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/PrepaidExpensesAndOtherCurrentAssetsDetailsScheduleOfPrepaidExpensesAndOtherCurrentAssets": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.completesolaria.com/role/PrepaidExpensesAndOtherCurrentAssetsDetailsScheduleOfPrepaidExpensesAndOtherCurrentAssets" ], "lang": { "en-us": { "role": { "label": "Other Prepaid Expense, Current", "terseLabel": "Other", "documentation": "Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r1096", "r1133" ] }, "us-gaap_RelatedPartyTransactionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionAxis", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfReconciliationOfEmbeddedDerivativeLiability", "http://www.completesolaria.com/role/OrganizationDetails", "http://www.completesolaria.com/role/OtherIncomeExpenseNetDetails", "http://www.completesolaria.com/role/RelatedPartyTransactionsDetails", "http://www.completesolaria.com/role/ReverseRecapitalizationDetails", "http://www.completesolaria.com/role/ReverseRecapitalizationDetailsScheduleOfCommonStockOutstanding", "http://www.completesolaria.com/role/ReverseRecapitalizationDetailsScheduleOfReconcilesElementsOfTheMerger" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Axis]", "documentation": "Information by type of related party transaction." } } }, "auth_ref": [ "r756", "r757", "r1204" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "Organization [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SubordinatedBorrowingsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubordinatedBorrowingsDisclosureTextBlock", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangements" ], "lang": { "en-us": { "role": { "label": "Subordinated Borrowings Disclosure [Text Block]", "terseLabel": "Borrowing Arrangements", "documentation": "The entire disclosure for borrowings under subordinated debt agreements that qualify as available in computing net capital under SEC's uniform net capital rule, including restrictive covenants, collateral, interest rates and due dates, amounts due by date and amount owed in total." } } }, "auth_ref": [ "r280" ] }, "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount", "terseLabel": "Valuation allowance deferred tax asset change in amount", "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset." } } }, "auth_ref": [ "r644" ] }, "us-gaap_ProceedsFromIssuanceOfSecuredDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfSecuredDebt", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Proceeds from Issuance of Secured Debt", "documentation": "The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt." } } }, "auth_ref": [ "r69" ] }, "us-gaap_PreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockMember", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "label": "Preferred Stock [Member]", "terseLabel": "Preferred Stock [Member]", "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company." } } }, "auth_ref": [ "r1042", "r1043", "r1046", "r1047", "r1048", "r1049", "r1225", "r1232" ] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.completesolaria.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "us-gaap_SubordinatedBorrowingsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubordinatedBorrowingsAbstract", "lang": { "en-us": { "role": { "label": "Borrowing Arrangements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromSecuredNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSecuredNotesPayable", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 43.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from Secured Notes Payable", "terseLabel": "Proceeds from issuance of notes payable, net", "documentation": "The cash inflow from borrowings supported by a written promise to pay an obligation that is collateralized (backed by pledge, mortgage or other lien in the entity's assets)." } } }, "auth_ref": [ "r69" ] }, "us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsPropertyPlantAndEquipment", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetailsScheduleOfComponentsOfDeferredTaxAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Property, Plant and Equipment", "terseLabel": "Fixed assets", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment." } } }, "auth_ref": [] }, "us-gaap_DevelopedTechnologyRightsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DevelopedTechnologyRightsMember", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetailsScheduleOfIntangibleAssetsAcquired", "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetailsScheduleOfAmortizationExpenseRelatedToIntangibleAssets", "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetailsScheduleOfIntangibleAssets" ], "lang": { "en-us": { "role": { "label": "Developed Technology Rights [Member]", "terseLabel": "Developed technology [Member]", "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property." } } }, "auth_ref": [ "r258" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectAbstract", "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OperatingLeasePayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeasePayments", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Payments", "terseLabel": "Operating leases payments", "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use." } } }, "auth_ref": [ "r739", "r743" ] }, "us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancialSupportToNonconsolidatedLegalEntityDomain", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Financial Support to Nonconsolidated Legal Entity [Domain]", "documentation": "Financial support arrangement provided to a nonconsolidated legal entity that is required to comply with or operate in accordance with requirements that are similar to those included in Rule 2a-7 of the Investment Company Act of 1940 for registered money market funds." } } }, "auth_ref": [ "r2", "r873", "r874" ] }, "us-gaap_OtherNoncashIncomeTaxExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNoncashIncomeTaxExpense", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Other Noncash Income Tax Expense", "terseLabel": "other income expense", "documentation": "The portion of the noncash component of income tax expense for the period other than the portion from the net change in the entity's deferred tax assets and liabilities." } } }, "auth_ref": [ "r223" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/DivestitureDetailsScheduleOfOperationsAndComprehensiveIncomeLossRelatedToDiscontinuedOperations": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.completesolaria.com/role/DivestitureDetailsScheduleOfOperationsAndComprehensiveIncomeLossRelatedToDiscontinuedOperations" ], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Operating Income (Loss)", "totalLabel": "Total operating expenses", "documentation": "Amount of operating income (loss) attributable to disposal group, including, but not limited to, discontinued operation." } } }, "auth_ref": [ "r184" ] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0, "order": 21.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventories", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r23" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetailsSummaryOfSummaryOfStockOptionActivity" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price", "terseLabel": "Weighted average exercise price per share, Vested and expected to vest", "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r612" ] }, "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": { "xbrltype": "decimalItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantsAndRightsOutstandingMeasurementInput", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetails", "http://www.completesolaria.com/role/WarrantsScheduleOfFairValueOfTheCommonStockWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Warrants and Rights Outstanding, Measurement Input", "terseLabel": "Warrants or rights outstanding measurement input", "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur." } } }, "auth_ref": [ "r703" ] }, "us-gaap_ProceedsFromStockOptionsExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromStockOptionsExercised", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 49.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from Stock Options Exercised", "terseLabel": "Proceeds from exercise of common stock options", "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement." } } }, "auth_ref": [ "r20", "r39" ] }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTextBlock", "presentation": [ "http://www.completesolaria.com/role/PropertyAndEquipmentNetTables" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Table Text Block]", "terseLabel": "Schedule of Property and Equipment, Net", "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r25" ] }, "us-gaap_LoansHeldForSaleFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LoansHeldForSaleFairValueDisclosure", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetailsScheduleOfIntangibleAssets" ], "lang": { "en-us": { "role": { "label": "Loan, Held-for-Sale, Fair Value Disclosure", "negatedLabel": "Held for Sale", "documentation": "Fair value portion of loans held-for-sale including, but not limited to, mortgage loans and finance receivables." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.completesolaria.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "City Area Code", "terseLabel": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_InterestCostsIncurred": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestCostsIncurred", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/ReverseRecapitalizationDetails" ], "lang": { "en-us": { "role": { "label": "Interest Costs Incurred", "terseLabel": "Company incurred cost", "documentation": "Total interest costs incurred during the period and either capitalized or charged against earnings." } } }, "auth_ref": [ "r730" ] }, "us-gaap_IncreaseDecreaseInUnearnedPremiums": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInUnearnedPremiums", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 28.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Unearned Premiums", "terseLabel": "Deferred revenue", "documentation": "Amount of increase (decrease) unearned premiums written. Excludes portion of unearned premiums amortized into income." } } }, "auth_ref": [ "r23" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetailsSummaryOfSummaryOfStockOptionActivity" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price", "terseLabel": "Weighted average exercise price per share, Vested and exercisable", "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r613" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.completesolaria.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "terseLabel": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_SubordinatedBorrowingInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubordinatedBorrowingInterestRate", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Subordinated Borrowing, Interest Rate", "terseLabel": "Borrow, percentage", "documentation": "Stated interest rate of the subordinated debt." } } }, "auth_ref": [] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Assets", "totalLabel": "Total assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r267", "r331", "r364", "r418", "r433", "r437", "r484", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r669", "r673", "r708", "r821", "r924", "r1039", "r1052", "r1148", "r1149", "r1205" ] }, "us-gaap_OtherRestrictedAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherRestrictedAssetsCurrent", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetailsScheduleOfConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_RestrictedCashCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetailsScheduleOfConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Other Restricted Assets, Current", "terseLabel": "Restricted cash", "documentation": "Amount of current assets that are pledged or subject to withdrawal restrictions, classified as other." } } }, "auth_ref": [ "r986", "r987", "r1097" ] }, "us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfMergerRelatedCostsFinancingActivities", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Payments of Merger Related Costs, Financing Activities", "terseLabel": "Fair value", "documentation": "The cash outflow for financing costs associated with business combinations." } } }, "auth_ref": [ "r70" ] }, "cslr_ScheduleOfMajorCategoriesOfAssetsAndLiabilitiesHeldForSaleAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ScheduleOfMajorCategoriesOfAssetsAndLiabilitiesHeldForSaleAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Major Categories Of Assets And Liabilities Held For Sale Abstract" } } }, "auth_ref": [] }, "us-gaap_UtilitiesOperatingExpenseDepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UtilitiesOperatingExpenseDepreciationAndAmortization", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/PropertyAndEquipmentNetDetails" ], "lang": { "en-us": { "role": { "label": "Utilities Operating Expense, Depreciation and Amortization", "terseLabel": "Depreciation and amortization expense", "documentation": "Amount of operating expense for depreciation and amortization of regulated operation." } } }, "auth_ref": [ "r211" ] }, "us-gaap_DerivativesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativesPolicyTextBlock", "presentation": [ "http://www.completesolaria.com/role/AccountingPoliciesByPolicyPolicies" ], "lang": { "en-us": { "role": { "label": "Derivatives, Policy [Policy Text Block]", "terseLabel": "Warrant Liabilities", "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities." } } }, "auth_ref": [ "r31", "r140", "r141", "r142", "r148", "r369" ] }, "cslr_OperatingExpensesAbstract0": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "OperatingExpensesAbstract0", "presentation": [ "http://www.completesolaria.com/role/DivestitureDetailsScheduleOfOperationsAndComprehensiveIncomeLossRelatedToDiscontinuedOperations" ], "lang": { "en-us": { "role": { "label": "Operating Expenses Abstract0", "terseLabel": "Operating expenses:" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Shares, Restricted Stock Award, Gross", "terseLabel": "Vesting of restricted stock units (in Shares)", "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards." } } }, "auth_ref": [ "r30", "r241" ] }, "cslr_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ScheduleOfPrepaidExpensesAndOtherCurrentAssetsAbstract", "lang": { "en-us": { "role": { "label": "Schedule of Prepaid Expenses and Other Current Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationTables" ], "lang": { "en-us": { "role": { "label": "Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]", "terseLabel": "Schedule of Intangible Assets Acquired", "documentation": "Tabular disclosure of finite-lived and indefinite-lived intangible assets acquired as part of a business combination." } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "presentation": [ "http://www.completesolaria.com/role/Organization" ], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "Organization", "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure." } } }, "auth_ref": [ "r172", "r260", "r862", "r863" ] }, "cslr_BusinessCombinationDetailsScheduleofUnauditedCombinedProFormaInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "BusinessCombinationDetailsScheduleofUnauditedCombinedProFormaInformationTable", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetailsScheduleOfUnauditedCombinedProFormaInformation" ], "lang": { "en-us": { "role": { "label": "Business Combination (Details) - Schedule of Unaudited Combined Pro Forma Information [Table]" } } }, "auth_ref": [] }, "srt_InterestBearingLiabilitiesAverageRatePaid": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "InterestBearingLiabilitiesAverageRatePaid", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Interest-Bearing Liabilities, Average Rate Paid", "terseLabel": "Bears interest rate", "documentation": "Average rate paid on interest-bearing liabilities." } } }, "auth_ref": [ "r1083" ] }, "cslr_ScheduleOfPropertyAndEquipmentNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ScheduleOfPropertyAndEquipmentNetAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Property And Equipment Net Abstract" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "presentation": [ "http://www.completesolaria.com/role/BasicAndDilutedNetLossPerShareDetailsScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholders", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Weighted-average shares used to compute net loss per share attributable to common stockholders, diluted", "verboseLabel": "Weighted average common shares outstanding, diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r391", "r408" ] }, "us-gaap_DeferredCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredCosts", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Costs, Noncurrent", "terseLabel": "Deferred transaction costs", "documentation": "Amount of deferred cost, excluding capitalized cost related to contract with customer; classified as noncurrent." } } }, "auth_ref": [ "r266", "r1090" ] }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsNet", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetailsScheduleOfIntangibleAssetsAcquired", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Net", "verboseLabel": "Intangible assets, net", "terseLabel": "Total intangible asset", "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r228", "r797" ] }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "presentation": [ "http://www.completesolaria.com/role/CommonStockDetailsScheduleOfReservedSharesOfCommonStock", "http://www.completesolaria.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "label": "Common Stock, Capital Shares Reserved for Future Issuance", "terseLabel": "Stock options and RSUs, authorized for future issuance", "verboseLabel": "Common stock shares reserved for future issuance", "documentation": "Aggregate number of common shares reserved for future issuance." } } }, "auth_ref": [ "r61" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "presentation": [ "http://www.completesolaria.com/role/BasicAndDilutedNetLossPerShareDetailsScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholders", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Weighted-average shares used to compute net loss per share attributable to common stockholders, basic", "verboseLabel": "Weighted average common shares outstanding, basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r390", "r408" ] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Goodwill", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetailsScheduleOfAssetsAcquiredAndLiabilitiesAssumed" ], "lang": { "en-us": { "role": { "label": "Goodwill", "terseLabel": "Goodwill", "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r328", "r513", "r814", "r1012", "r1039", "r1134", "r1135" ] }, "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Net loss from continuing operations", "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r261", "r364", "r374", "r418", "r432", "r436", "r438", "r484", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r697", "r708", "r834", "r1005", "r1148" ] }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsGross", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetailsScheduleOfIntangibleAssets" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Gross", "terseLabel": "Gross Carrying Amount", "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r228", "r801" ] }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesAcquisitions", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Shares, Acquisitions", "terseLabel": "Issuance of common stock in connection with business combination (in Shares)", "documentation": "Number of shares of stock issued during the period pursuant to acquisitions." } } }, "auth_ref": [ "r193", "r194", "r241" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/BusinessCombinationDetails", "http://www.completesolaria.com/role/CoverPage", "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfReconcilesTheChangeInValueOfTheRedeemableConvertiblePreferredStockWarrantLiability", "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfWarrantsBasedOnABlackScholesOptionPricingMethod", "http://www.completesolaria.com/role/OrganizationDetails", "http://www.completesolaria.com/role/RelatedPartyTransactionsDetails", "http://www.completesolaria.com/role/ReverseRecapitalizationDetails", "http://www.completesolaria.com/role/ReverseRecapitalizationDetailsScheduleOfCommonStockOutstanding", "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetails", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlowsParentheticals", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficitParentheticals", "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r308", "r332", "r333", "r334", "r364", "r392", "r395", "r406", "r408", "r416", "r417", "r484", "r537", "r539", "r540", "r541", "r544", "r545", "r567", "r568", "r569", "r570", "r574", "r708", "r867", "r868", "r869", "r870", "r879", "r880", "r881", "r882", "r883", "r884", "r885", "r886", "r887", "r888", "r889", "r891", "r911", "r933", "r957", "r981", "r982", "r983", "r984", "r985", "r1062", "r1107", "r1119" ] }, "cslr_ScheduleOfCommonStockOutstandingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ScheduleOfCommonStockOutstandingAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Common Stock Outstanding Abstract" } } }, "auth_ref": [] }, "us-gaap_CommonClassBMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonClassBMember", "presentation": [ "http://www.completesolaria.com/role/OrganizationDetails", "http://www.completesolaria.com/role/ReverseRecapitalizationDetailsScheduleOfCommonStockOutstanding" ], "lang": { "en-us": { "role": { "label": "Common Class B [Member]", "verboseLabel": "Class B Ordinary Share [Member]", "terseLabel": "FACT Class B Ordinary Shares [Member]", "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation." } } }, "auth_ref": [ "r1232" ] }, "cslr_ReverseRecapitalizationDetailsScheduleofCommonStockOutstandingLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ReverseRecapitalizationDetailsScheduleofCommonStockOutstandingLineItems", "presentation": [ "http://www.completesolaria.com/role/ReverseRecapitalizationDetailsScheduleOfCommonStockOutstanding" ], "lang": { "en-us": { "role": { "label": "Reverse Recapitalization (Details) - Schedule of Common Stock Outstanding [Line Items]" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetailsSummaryOfSummaryOfStockOptionActivity", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period", "terseLabel": "Exercise of common stock options (in Shares)", "negatedLabel": "Number of shares, Options exercised", "documentation": "Number of share options (or share units) exercised during the current period." } } }, "auth_ref": [ "r30", "r193", "r194", "r241", "r601" ] }, "cslr_ReverseRecapitalizationDetailsScheduleofCommonStockOutstandingTable": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ReverseRecapitalizationDetailsScheduleofCommonStockOutstandingTable", "presentation": [ "http://www.completesolaria.com/role/ReverseRecapitalizationDetailsScheduleOfCommonStockOutstanding" ], "lang": { "en-us": { "role": { "label": "Reverse Recapitalization (Details) - Schedule of Common Stock Outstanding [Table]" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities", "terseLabel": "Conversion of 2022 Convertible Notes into common stock (in Shares)", "verboseLabel": "Redeemable convertible preferred stock (in Shares)", "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities." } } }, "auth_ref": [ "r30", "r62", "r110", "r241", "r556" ] }, "us-gaap_ProceedsFromNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromNotesPayable", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/ReverseRecapitalizationDetailsScheduleOfReconcilesElementsOfTheMerger" ], "lang": { "en-us": { "role": { "label": "Proceeds from Notes Payable", "terseLabel": "Cash proceeds", "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation." } } }, "auth_ref": [ "r69" ] }, "cslr_SponsorMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "SponsorMember", "presentation": [ "http://www.completesolaria.com/role/ReverseRecapitalizationDetailsScheduleOfCommonStockOutstanding" ], "lang": { "en-us": { "role": { "label": "Sponsor Member", "terseLabel": "Sponsor [Member]", "documentation": "Sponsor [Member]." } } }, "auth_ref": [] }, "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract", "lang": { "en-us": { "role": { "label": "Divestiture [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://www.completesolaria.com/role/ReverseRecapitalizationDetails", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheetsParentheticals" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued", "verboseLabel": "Common shares issued (in Shares)", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r194" ] }, "srt_FinancingReceivableNonaccrualToOutstandingPercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "FinancingReceivableNonaccrualToOutstandingPercent", "presentation": [ "http://www.completesolaria.com/role/RelatedPartyTransactionsDetails", "http://www.completesolaria.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "label": "Financing Receivable, Nonaccrual to Outstanding, Percent", "terseLabel": "Number of common stock percentage", "verboseLabel": "Convertible accrues percentage", "documentation": "Percentage of nonaccrual to total financing receivable outstanding." } } }, "auth_ref": [ "r309" ] }, "cslr_ScheduleOfOperationsAndComprehensiveIncomeLossRelatedToDiscontinuedOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ScheduleOfOperationsAndComprehensiveIncomeLossRelatedToDiscontinuedOperationsAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Operations And Comprehensive Income Loss Related To Discontinued Operations Abstract" } } }, "auth_ref": [] }, "cslr_BonusSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "BonusSharesIssued", "presentation": [ "http://www.completesolaria.com/role/ReverseRecapitalizationDetailsScheduleOfCommonStockOutstanding" ], "lang": { "en-us": { "role": { "label": "Bonus Shares Issued", "terseLabel": "Bonus shares issued", "documentation": "Bonus shares." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesReverseStockSplits", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Shares, Reverse Stock Splits", "terseLabel": "Issuance of common stock upon the reverse capitalization, net of offering costs (in Shares)", "documentation": "Reduction in the number of shares during the period as a result of a reverse stock split." } } }, "auth_ref": [ "r30" ] }, "us-gaap_RelatedPartyTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsAbstract", "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "auth_ref": [] }, "cslr_ForwardPurchaseAgreementsDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ForwardPurchaseAgreementsDetailsTable", "presentation": [ "http://www.completesolaria.com/role/ForwardPurchaseAgreementsDetails" ], "lang": { "en-us": { "role": { "label": "Forward Purchase Agreements (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 32.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Common Stock, Value, Issued", "terseLabel": "Common stock", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r194", "r825", "r1039" ] }, "cslr_LegacyInShares": { "xbrltype": "sharesItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "LegacyInShares", "presentation": [ "http://www.completesolaria.com/role/ReverseRecapitalizationDetailsScheduleOfCommonStockOutstanding" ], "lang": { "en-us": { "role": { "label": "Legacy In Shares", "terseLabel": "Legacy Complete Solaria shares", "documentation": "Legacyin shares." } } }, "auth_ref": [] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://www.completesolaria.com/role/CommonStockDetails", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheetsParentheticals" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares Authorized", "terseLabel": "Common stocks, shares authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r194", "r911" ] }, "us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherIncomeAndOtherExpenseDisclosureTextBlock", "presentation": [ "http://www.completesolaria.com/role/OtherIncomeExpenseNet" ], "lang": { "en-us": { "role": { "label": "Other Income and Other Expense Disclosure [Text Block]", "terseLabel": "Other Income (Expense), Net", "documentation": "The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions." } } }, "auth_ref": [ "r243", "r250" ] }, "cslr_FPASMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "FPASMember", "presentation": [ "http://www.completesolaria.com/role/ForwardPurchaseAgreementsDetails" ], "lang": { "en-us": { "role": { "label": "FPASMember", "terseLabel": "FPA'S [Member]" } } }, "auth_ref": [] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/ReverseRecapitalizationDetails", "http://www.completesolaria.com/role/ReverseRecapitalizationDetailsScheduleOfCommonStockOutstanding", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheetsParentheticals" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, shares outstanding", "definitionGuidance": "Common shares outstanding (in Shares)", "verboseLabel": "Ordinary Shares, outstanding prior to Merger", "presentationGuidance": "Common stock outstanding (in Shares)", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r30", "r194", "r911", "r930", "r1232", "r1233" ] }, "us-gaap_OtherGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherGeneralAndAdministrativeExpense", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Other General and Administrative Expense", "terseLabel": "General and administrative expense", "documentation": "Amount of general and administrative expense classified as other." } } }, "auth_ref": [ "r214", "r1231" ] }, "srt_SafeguardingAssetPlatformOperatorCryptoAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SafeguardingAssetPlatformOperatorCryptoAsset", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetailsScheduleOfAssetsAcquiredAndLiabilitiesAssumed" ], "lang": { "en-us": { "role": { "label": "Safeguarding Asset, Platform Operator, Crypto-Asset", "terseLabel": "SAFE agreements", "documentation": "Fair value of asset to safeguard crypto-asset held for platform user." } } }, "auth_ref": [ "r315" ] }, "cslr_CompleteSolariaCommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "CompleteSolariaCommonStockMember", "presentation": [ "http://www.completesolaria.com/role/ForwardPurchaseAgreementsDetails" ], "lang": { "en-us": { "role": { "label": "Complete Solaria Common Stock Member", "terseLabel": "Complete Solaria Common Stock [Member]" } } }, "auth_ref": [] }, "cslr_ForwardPurchaseAgreementsDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ForwardPurchaseAgreementsDetailsLineItems", "presentation": [ "http://www.completesolaria.com/role/ForwardPurchaseAgreementsDetails" ], "lang": { "en-us": { "role": { "label": "Forward Purchase Agreements [Line Items]" } } }, "auth_ref": [] }, "cslr_PurchasePercentage": { "xbrltype": "percentItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "PurchasePercentage", "presentation": [ "http://www.completesolaria.com/role/ForwardPurchaseAgreementsDetails" ], "lang": { "en-us": { "role": { "label": "Purchase Percentage", "terseLabel": "Purchase percentage", "documentation": "Purchase percentage." } } }, "auth_ref": [] }, "us-gaap_RestrictedCashCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedCashCurrent", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetailsScheduleOfConsolidatedStatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetails", "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetailsScheduleOfConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Restricted Cash, Current", "verboseLabel": "Restricted cash", "totalLabel": "Total cash, cash equivalents, and restricted cash", "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits." } } }, "auth_ref": [ "r1088", "r1105" ] }, "us-gaap_ProceedsFromRelatedPartyDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromRelatedPartyDebt", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Proceeds from Related Party Debt", "terseLabel": "Proceeds from related parties", "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates." } } }, "auth_ref": [ "r69" ] }, "cslr_BusinessCombinationDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "BusinessCombinationDetailsTable", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TemporaryEquityCarryingAmountAttributableToParent", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Temporary Equity, Carrying Amount, Attributable to Parent", "periodStartLabel": "Redeemable, Balance", "periodEndLabel": "Redeemable, Balance", "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer." } } }, "auth_ref": [ "r537", "r539", "r540", "r541", "r544", "r545", "r627", "r826" ] }, "us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncrementalCommonSharesAttributableToConversionOfPreferredStock", "presentation": [ "http://www.completesolaria.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "label": "Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock", "terseLabel": "Closing holders shares", "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method." } } }, "auth_ref": [ "r396", "r397", "r408" ] }, "us-gaap_ExcessStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ExcessStockSharesIssued", "presentation": [ "http://www.completesolaria.com/role/ReverseRecapitalizationDetailsScheduleOfCommonStockOutstanding" ], "lang": { "en-us": { "role": { "label": "Excess Stock, Shares Issued", "terseLabel": "Shares of Complete Solaria Common stock immediately after merger", "documentation": "Number of excess stock shares of an entity that have been sold or granted to shareholders." } } }, "auth_ref": [] }, "cslr_SolariaAcquisitionMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "SolariaAcquisitionMember", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetails", "http://www.completesolaria.com/role/DivestitureDetails", "http://www.completesolaria.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Solaria Acquisition Member", "terseLabel": "Solaria Acquisition [Member]" } } }, "auth_ref": [] }, "us-gaap_IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights", "presentation": [ "http://www.completesolaria.com/role/BasicAndDilutedNetLossPerShareDetailsScheduleOfPotentialCommonSharesExcludedFromDilutedNetLossPerShare" ], "lang": { "en-us": { "role": { "label": "Incremental Common Shares Attributable to Participating Nonvested Shares with Non-forfeitable Dividend Rights", "terseLabel": "Potential common shares excluded from diluted net loss per share", "documentation": "This element represents nonvested share-based payment awards that contain non-forfeitable rights to dividends or dividend equivalents (whether paid or unpaid). Basic and dilutive earnings per share are generally disclosed for such shares using the two-class method." } } }, "auth_ref": [ "r78" ] }, "cslr_BusinessCombinationDetailsScheduleofUnauditedCombinedProFormaInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "BusinessCombinationDetailsScheduleofUnauditedCombinedProFormaInformationLineItems", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetailsScheduleOfUnauditedCombinedProFormaInformation" ], "lang": { "en-us": { "role": { "label": "Business Combination (Details) - Schedule of Unaudited Combined Pro Forma Information [Line Items]" } } }, "auth_ref": [] }, "cslr_GoodwillPeriods": { "xbrltype": "durationItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "GoodwillPeriods", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "label": "Goodwill Periods", "terseLabel": "Goodwill, period", "documentation": "Duration of goodwill, period." } } }, "auth_ref": [] }, "cslr_BusinessCombinationDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "BusinessCombinationDetailsLineItems", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination [Line Items]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "auth_ref": [] }, "cslr_ScheduleOfAssetsAcquiredAndLiabilitiesAssumedAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ScheduleOfAssetsAcquiredAndLiabilitiesAssumedAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Assets Acquired And Liabilities Assumed Abstract" } } }, "auth_ref": [] }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 57.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations", "terseLabel": "Effect of exchange rate changes", "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r717" ] }, "us-gaap_FinancialLiabilitiesFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancialLiabilitiesFairValueDisclosure", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfFinancialAssetsAndLiabilities", "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfReconcilesTheChangeInValueOfTheRedeemableConvertiblePreferredStockWarrantLiability" ], "lang": { "en-us": { "role": { "label": "Financial Liabilities Fair Value Disclosure", "terseLabel": "Carlyle warrants", "periodStartLabel": "Beginning", "periodEndLabel": "Ending", "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities." } } }, "auth_ref": [] }, "us-gaap_ExcessStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ExcessStockSharesAuthorized", "presentation": [ "http://www.completesolaria.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "label": "Excess Stock, Shares Authorized", "terseLabel": "Holders shares", "documentation": "Maximum number of excess stock shares permitted to be issued." } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresTextBlock", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurements" ], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value Measurements", "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information." } } }, "auth_ref": [ "r699" ] }, "cslr_BusinessCombinationDetailsScheduleofAssetsAcquiredandLiabilitiesAssumedTable": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "BusinessCombinationDetailsScheduleofAssetsAcquiredandLiabilitiesAssumedTable", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetailsScheduleOfAssetsAcquiredAndLiabilitiesAssumed" ], "lang": { "en-us": { "role": { "label": "Business Combination (Details) - Schedule of Assets Acquired and Liabilities Assumed [Table]" } } }, "auth_ref": [] }, "cslr_BusinessCombinationMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "BusinessCombinationMember", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetailsScheduleOfAssetsAcquiredAndLiabilitiesAssumed", "http://www.completesolaria.com/role/BusinessCombinationDetailsScheduleOfUnauditedCombinedProFormaInformation", "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination Member", "terseLabel": "Business Combination [Member]" } } }, "auth_ref": [] }, "us-gaap_RestrictedCash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedCash", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetails", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Restricted Cash", "terseLabel": "Restricted cash", "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits." } } }, "auth_ref": [ "r1088", "r1105", "r1213", "r1217" ] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeStockOptionMember", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetailsScheduleOfCalculateTheFairValueOfStockBasedCompensation" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Option [Member]", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "cslr_BusinessCombinationDetailsScheduleofIntangibleAssetsAcquiredLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "BusinessCombinationDetailsScheduleofIntangibleAssetsAcquiredLineItems", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetailsScheduleOfIntangibleAssetsAcquired" ], "lang": { "en-us": { "role": { "label": "Business Combination (Details) - Schedule of Intangible Assets Acquired [Line Items]" } } }, "auth_ref": [] }, "us-gaap_PlanNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameAxis", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "label": "Plan Name [Axis]", "documentation": "Information by plan name for share-based payment arrangement." } } }, "auth_ref": [ "r1154", "r1155", "r1156", "r1157", "r1158", "r1159", "r1160", "r1161", "r1162", "r1163", "r1164", "r1165", "r1166", "r1167", "r1168", "r1169", "r1170", "r1171", "r1172", "r1173", "r1174", "r1175", "r1176", "r1177", "r1178", "r1179" ] }, "cslr_ScheduleOfIntangibleAssetsAcquiredAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ScheduleOfIntangibleAssetsAcquiredAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Intangible Assets Acquired Abstract" } } }, "auth_ref": [] }, "cslr_BusinessCombinationDetailsScheduleofAssetsAcquiredandLiabilitiesAssumedLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "BusinessCombinationDetailsScheduleofAssetsAcquiredandLiabilitiesAssumedLineItems", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetailsScheduleOfAssetsAcquiredAndLiabilitiesAssumed" ], "lang": { "en-us": { "role": { "label": "Business Combination (Details) - Schedule of Assets Acquired and Liabilities Assumed [Line Items]" } } }, "auth_ref": [] }, "us-gaap_PrepaidAdvertising": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidAdvertising", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/PrepaidExpensesAndOtherCurrentAssetsDetailsScheduleOfPrepaidExpensesAndOtherCurrentAssets": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.completesolaria.com/role/PrepaidExpensesAndOtherCurrentAssetsDetailsScheduleOfPrepaidExpensesAndOtherCurrentAssets" ], "lang": { "en-us": { "role": { "label": "Prepaid Advertising", "terseLabel": "Prepaid sales commissions", "documentation": "Amount of consideration paid in advance for advertising that provides economic benefits within a future period of one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r997", "r1011", "r1133" ] }, "cslr_ScheduleOfUnauditedCombinedProFormaInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ScheduleOfUnauditedCombinedProFormaInformationAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Unaudited Combined Pro Forma Information Abstract" } } }, "auth_ref": [] }, "cslr_BusinessCombinationDetailsScheduleofIntangibleAssetsAcquiredTable": { "xbrltype": "stringItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "BusinessCombinationDetailsScheduleofIntangibleAssetsAcquiredTable", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetailsScheduleOfIntangibleAssetsAcquired" ], "lang": { "en-us": { "role": { "label": "Business Combination (Details) - Schedule of Intangible Assets Acquired [Table]" } } }, "auth_ref": [] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetails", "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetailsScheduleOfAmortizationExpenseRelatedToIntangibleAssets" ], "lang": { "en-us": { "role": { "label": "Amortization of Intangible Assets", "verboseLabel": "Amortization expense related to intangible assets", "terseLabel": "Total amortization expense", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r24", "r89", "r93" ] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "presentation": [ "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetailsScheduleOfIntangibleAssets", "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetailsScheduleOfFiniteLivedIntangibleAssets" ], "lang": { "en-us": { "role": { "label": "Schedule of Finite-Lived Intangible Assets [Table]", "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r90", "r92", "r797" ] }, "us-gaap_ShortTermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermDebtTypeDomain", "presentation": [ "http://www.completesolaria.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Short-Term Debt, Type [Domain]", "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing." } } }, "auth_ref": [ "r47" ] }, "us-gaap_LiabilitiesFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesFairValueDisclosure", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfNextEquityFinancingBasedOnInputsIncludedInABlackScholesModel" ], "lang": { "en-us": { "role": { "label": "Liabilities, Fair Value Disclosure", "terseLabel": "Expected fair value of preferred stock", "documentation": "Fair value of financial and nonfinancial obligations." } } }, "auth_ref": [ "r151" ] }, "us-gaap_GainLossOnDispositionOfRealEstateDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainLossOnDispositionOfRealEstateDiscontinuedOperations", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/DivestitureDetailsScheduleOfOperationsAndComprehensiveIncomeLossRelatedToDiscontinuedOperations": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.completesolaria.com/role/DivestitureDetailsScheduleOfOperationsAndComprehensiveIncomeLossRelatedToDiscontinuedOperations" ], "lang": { "en-us": { "role": { "label": "Gain (Loss) on Disposition of Real Estate, Discontinued Operations", "totalLabel": "Net loss from discontinued operations", "documentation": "Amount of difference between the carrying amount and the sales price of real estate properties sold as part of discontinued operations." } } }, "auth_ref": [] }, "us-gaap_EmployeeStockOwnershipPlanESOPDeferredShares": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeStockOwnershipPlanESOPDeferredShares", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/CommonStockDetailsScheduleOfReservedSharesOfCommonStock" ], "lang": { "en-us": { "role": { "label": "Employee Stock Ownership Plan (ESOP), Deferred Shares", "terseLabel": "Employee stock purchase plan (in Dollars)", "documentation": "Represents the carrying amount of shares held by the ESOP as of the balance sheet date in which no ESOP participant has a vested interest and no lender has a claim." } } }, "auth_ref": [ "r123" ] }, "us-gaap_FinancingReceivableExcludingAccruedInterestRevolvingConvertedToTermLoan": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancingReceivableExcludingAccruedInterestRevolvingConvertedToTermLoan", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetailsScheduleOfAccruedExpensesAndOtherCurrentLiabilities", "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Financing Receivable, Excluding Accrued Interest, Revolving, Converted to Term Loan", "terseLabel": "Accrued term loan and revolving loan amendment and final payment fees", "verboseLabel": "Revolving loan", "documentation": "Amortized cost excluding accrued interest, of revolving financing receivable converted to term loan." } } }, "auth_ref": [ "r503", "r505", "r1008" ] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://www.completesolaria.com/role/BasicAndDilutedNetLossPerShareTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r1120" ] }, "us-gaap_ExtendedProductWarrantyAccrual": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ExtendedProductWarrantyAccrual", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetailsScheduleOfActivityPeriodRelatingToTheCompanysWarrantyProvision" ], "lang": { "en-us": { "role": { "label": "Extended Product Warranty Accrual", "periodStartLabel": "Warranty provision, beginning of period", "periodEndLabel": "Warranty provision, end of period", "documentation": "Amount as of the balance sheet date of the aggregate extended product warranty liability. Does not include the ending balance for the standard product warranty liability." } } }, "auth_ref": [ "r1146", "r1147" ] }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingLeaseLiability", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 26.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Lease Liability", "terseLabel": "Operating lease liabilities", "documentation": "Amount of increase (decrease) in obligation for operating lease." } } }, "auth_ref": [ "r1072", "r1103" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.completesolaria.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "terseLabel": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised", "presentation": [ "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised", "terseLabel": "Warrant exercised (in Shares)", "documentation": "Number of non-option equity instruments exercised by participants." } } }, "auth_ref": [ "r34" ] }, "us-gaap_ShortTermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermDebtTypeAxis", "presentation": [ "http://www.completesolaria.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Short-Term Debt, Type [Axis]", "documentation": "Information by type of short-term debt arrangement." } } }, "auth_ref": [ "r49" ] }, "us-gaap_StateAndLocalJurisdictionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StateAndLocalJurisdictionMember", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "State and Local Jurisdiction [Member]", "terseLabel": "State and Local Jurisdiction [Member]", "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity." } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net loss from continuing operations to net cash used in operating activities:" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromRepaymentsOfNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromRepaymentsOfNotesPayable", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 51.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from (Repayments of) Notes Payable", "terseLabel": "Proceeds from Mergers and PIPE Financing from related parties", "documentation": "Amount of cash inflow (outflow) from long-term debt supported by a written promise to pay an obligation." } } }, "auth_ref": [] }, "us-gaap_TimeDepositsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TimeDepositsAtCarryingValue", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Time Deposits, at Carrying Value", "terseLabel": "Carrying value", "documentation": "Any certificate of deposit or savings account held by a bank or other financial institution for a short-term specified period of time. Because of their short-term, time deposits are considered highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months." } } }, "auth_ref": [ "r1088" ] }, "us-gaap_StandbyLettersOfCreditMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StandbyLettersOfCreditMember", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Standby Letters of Credit [Member]", "terseLabel": "Letters of Credit [Member]", "documentation": "An irrevocable undertaking (typically by a financial institution) to guarantee payment of a specified financial obligation." } } }, "auth_ref": [ "r3", "r1145", "r1223", "r1224" ] }, "us-gaap_SupplementalCashFlowElementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalCashFlowElementsAbstract", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Elements [Abstract]", "terseLabel": "Supplemental disclosures of cash flow information:" } } }, "auth_ref": [] }, "us-gaap_AssetAcquisitionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetAcquisitionDomain", "presentation": [ "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Asset Acquisition [Domain]", "documentation": "Asset acquisition." } } }, "auth_ref": [ "r1189" ] }, "us-gaap_AssetAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetAcquisitionAxis", "presentation": [ "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Asset Acquisition [Axis]", "documentation": "Information by asset acquisition." } } }, "auth_ref": [ "r1189" ] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromRepaymentsOfSecuredDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromRepaymentsOfSecuredDebt", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 44.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from (Repayments of) Secured Debt", "terseLabel": "Principal repayment of notes payable", "documentation": "Amount of cash inflow (outflow) from long-term debt wholly or partially secured by collateral. Excludes tax exempt secured debt." } } }, "auth_ref": [] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.completesolaria.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1054" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetailsScheduleOfSummaryOfRsuActivity" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted average grant date fair value, Cancelled or forfeited", "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event." } } }, "auth_ref": [ "r609" ] }, "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CompensationAndEmployeeBenefitPlansTextBlock", "presentation": [ "http://www.completesolaria.com/role/EmployeeBenefitPlan" ], "lang": { "en-us": { "role": { "label": "Compensation and Employee Benefit Plans [Text Block]", "terseLabel": "Employee Benefit Plan", "documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans." } } }, "auth_ref": [ "r244", "r245", "r246", "r247" ] }, "us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Asset Acquisition, Consideration Transferred, Equity Interest Issued and Issuable", "terseLabel": "Asset acquisition, fair value of shares issued", "documentation": "Amount of acquirer's equity interest issued and issuable as part of consideration transferred in asset acquisition." } } }, "auth_ref": [ "r1190", "r1191", "r1192" ] }, "us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetAcquisitionConsiderationTransferredContingentConsideration", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Asset Acquisition, Consideration Transferred, Contingent Consideration", "terseLabel": "Asset Acquisition, Liabilities Incurred", "documentation": "Amount of contingent consideration recognized as part of consideration transferred in asset acquisition." } } }, "auth_ref": [ "r1190", "r1191", "r1192" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.completesolaria.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1054" ] }, "cslr_ResidualMergerProceeds": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ResidualMergerProceeds", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Residual Merger Proceeds", "terseLabel": "Residual Merger proceeds", "documentation": "Residual Merger proceeds." } } }, "auth_ref": [] }, "cslr_IssuanceOfCommonStockWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "IssuanceOfCommonStockWarrants", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Issuance Of Common Stock Warrants", "terseLabel": "Issuance of common stock warrants" } } }, "auth_ref": [] }, "us-gaap_ConvertibleDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConvertibleDebt", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfConvertibleNotes", "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfNetCarryingAmountOfTheConvertibleNotes" ], "lang": { "en-us": { "role": { "label": "Convertible Debt", "presentationGuidance": "Convertible Debt", "terseLabel": "2022 Convertible Notes due to related parties", "verboseLabel": "Net carrying amount", "documentation": "Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company." } } }, "auth_ref": [ "r43", "r270", "r1216" ] }, "cslr_IssuanceOfSeriesDRedeemableConvertiblePreferredStockUponConversionOfSAFE": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "IssuanceOfSeriesDRedeemableConvertiblePreferredStockUponConversionOfSAFE", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Issuance Of Series DRedeemable Convertible Preferred Stock Upon Conversion Of SAFE", "terseLabel": "Issuance of Series D redeemable convertible preferred stock upon conversion of SAFE" } } }, "auth_ref": [] }, "cslr_IssuanceOfSeriesDRedeemableConvertiblePreferredStockUponConversionOfConvertibleDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "IssuanceOfSeriesDRedeemableConvertiblePreferredStockUponConversionOfConvertibleDebt", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Issuance Of Series DRedeemable Convertible Preferred Stock Upon Conversion Of Convertible Debt", "terseLabel": "Issuance of Series D redeemable convertible preferred stock upon conversion of convertible debt" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromConvertibleDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromConvertibleDebt", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 46.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from Convertible Debt", "terseLabel": "Proceeds from issuance of convertible notes, net of issuance cost, due to related parties", "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder." } } }, "auth_ref": [ "r69" ] }, "cslr_IssuanceOfConvertibleNotesIssuedToRelatedPartiesIntoCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "IssuanceOfConvertibleNotesIssuedToRelatedPartiesIntoCommonStock", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Issuance Of Convertible Notes Issued To Related Parties Into Common Stock", "terseLabel": "Conversion of 2022 Convertible Notes issued to related parties into common stock" } } }, "auth_ref": [] }, "us-gaap_OtherLongTermDebtNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLongTermDebtNoncurrent", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 25.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other Long-Term Debt, Noncurrent", "terseLabel": "Long-term debt with CS Solis", "documentation": "Amount of long-term debt classified as other, payable after one year or the operating cycle, if longer." } } }, "auth_ref": [ "r58", "r908" ] }, "us-gaap_NotesPayableOtherPayablesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NotesPayableOtherPayablesMember", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfCompanySOutstandingNotesPayable" ], "lang": { "en-us": { "role": { "label": "Notes Payable, Other Payables [Member]", "documentation": "A written promise to pay a note to a third party." } } }, "auth_ref": [] }, "us-gaap_LongTermNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermNotesPayable", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 27.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Notes Payable, Noncurrent", "terseLabel": "Convertible notes due to related parties, noncurrent", "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion." } } }, "auth_ref": [ "r58" ] }, "cslr_IssuanceOfCommonStockInConnectionWithTheMerger": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "IssuanceOfCommonStockInConnectionWithTheMerger", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Issuance Of Common Stock In Connection With The Merger", "terseLabel": "Issuance of common stock bonus shares in connection with the Mergers(6)" } } }, "auth_ref": [] }, "us-gaap_MeasurementInputTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputTypeAxis", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetails", "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfNextEquityFinancingBasedOnInputsIncludedInABlackScholesModel", "http://www.completesolaria.com/role/WarrantsScheduleOfFairValueOfTheCommonStockWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input Type [Axis]", "documentation": "Information by type of measurement input used to determine value of asset and liability." } } }, "auth_ref": [ "r702" ] }, "us-gaap_GoodwillImpairmentLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillImpairmentLoss", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/DivestitureDetails" ], "lang": { "en-us": { "role": { "label": "Goodwill, Impairment Loss", "terseLabel": "Impairment expense goodwill", "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r24", "r514", "r517", "r519", "r1012" ] }, "cslr_IssuanceOfConvertibleNotesIntoCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "IssuanceOfConvertibleNotesIntoCommonStock", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Issuance Of Convertible Notes Into Common Stock", "terseLabel": "Conversion of 2022 Convertible Notes into common stock", "documentation": "Conversion of 2022 Convertible Notes into common stock." } } }, "auth_ref": [] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other Assets, Noncurrent", "terseLabel": "Other noncurrent assets", "documentation": "Amount of noncurrent assets classified as other." } } }, "auth_ref": [ "r330" ] }, "us-gaap_InterestExpenseOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpenseOther", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/OtherIncomeExpenseNetDetails", "http://www.completesolaria.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Interest Expense, Other", "terseLabel": "Other expense related parties", "verboseLabel": "Interest expense", "definitionGuidance": "Interest expense related party", "documentation": "Amount of interest expense classified as other." } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]", "terseLabel": "Schedule of Components of Deferred Tax Assets And Liabilities", "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets." } } }, "auth_ref": [ "r252" ] }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]", "terseLabel": "Schedule of Provision For Income Taxes", "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years." } } }, "auth_ref": [ "r253" ] }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "presentation": [ "http://www.completesolaria.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "terseLabel": "Schedule of Reconciliation of Effective Income Tax Rate", "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations." } } }, "auth_ref": [ "r251" ] }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainsLossesOnExtinguishmentOfDebt", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/RelatedPartyTransactionsDetails", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Gain (Loss) on Extinguishment of Debt", "negatedLabel": "Gain on extinguishment of convertible notes and SAFEs(2)", "terseLabel": "Loss on extinguishment", "verboseLabel": "Gain on the extinguishment", "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity." } } }, "auth_ref": [ "r24", "r99", "r100" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetailsScheduleOfAssetsAcquiredAndLiabilitiesAssumed" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents", "terseLabel": "Cash, cash equivalents and restricted cash", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r134" ] }, "cslr_ModificationOfCarlyleWarrant": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ModificationOfCarlyleWarrant", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Modification Of Carlyle Warrant", "terseLabel": "Modification of Carlyle warrant", "documentation": "Modification of Carlyle warrant." } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetailsScheduleOfAssetsAcquiredAndLiabilitiesAssumed" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables", "terseLabel": "Accounts receivable", "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date." } } }, "auth_ref": [ "r134" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetailsScheduleOfAssetsAcquiredAndLiabilitiesAssumed" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities", "totalLabel": "Total identifiable liabilities assumed", "documentation": "Amount of liabilities assumed at the acquisition date." } } }, "auth_ref": [ "r134" ] }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "label": "Sale of Stock, Number of Shares Issued in Transaction", "terseLabel": "Ordinary shares outstanding", "verboseLabel": "Purchase of common stock (in Shares)", "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction." } } }, "auth_ref": [] }, "us-gaap_OtherCommitment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCommitment", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/CommitmentsAndContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Other Commitment", "terseLabel": "Other commitment", "documentation": "Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions." } } }, "auth_ref": [] }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "presentation": [ "http://www.completesolaria.com/role/AccountingPoliciesByPolicyPolicies" ], "lang": { "en-us": { "role": { "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]", "terseLabel": "Impairment of Long-Lived Assets", "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets." } } }, "auth_ref": [ "r1", "r234" ] }, "cslr_IssuanceOfRedeemableConvertiblePreferredStockUponConversionShare": { "xbrltype": "sharesItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "IssuanceOfRedeemableConvertiblePreferredStockUponConversionShare", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Issuance Of Redeemable Convertible Preferred Stock Upon Conversion Share", "terseLabel": "Issuance of Series D-1, D-2, and D-3 redeemable convertible preferred stock upon conversion of convertible notes and SAFEs(1) (in Shares)", "documentation": "Issuance of Series D-1, D-2, and D-3 redeemable convertible preferred stock upon conversion of convertible notes and SAFEs shares." } } }, "auth_ref": [] }, "us-gaap_NotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NotesPayable", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails", "http://www.completesolaria.com/role/BorrowingArrangementsDetailsScheduleOfConvertibleNotes" ], "lang": { "en-us": { "role": { "label": "Notes Payable", "verboseLabel": "Notes Payable", "terseLabel": "Total convertible notes", "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r43", "r270", "r1216" ] }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments", "terseLabel": "Conversion of preferred warrant", "documentation": "The net amount of stock issued during the period upon the conversion of convertible securities, net of adjustments (for example, to additional paid in capital) including the write-off of an equity component recognized to record the convertible debt instrument as two separate components - a debt component and an equity component. This item is meant to disclose the value of shares issued on conversion of convertible securities that were recorded as two separate (debt and equity) components." } } }, "auth_ref": [] }, "us-gaap_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "General and Administrative Expense", "terseLabel": "General and administrative", "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line." } } }, "auth_ref": [ "r214", "r936" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedBalanceSheetsParentheticals" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable, Allowance for Credit Loss, Current", "terseLabel": "Accounts receivable, net of allowance for credit losses (in Dollars)", "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current." } } }, "auth_ref": [ "r336", "r446", "r495" ] }, "cslr_IssuanceOfRedeemableConvertiblePreferredStockUponConversionOf": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "IssuanceOfRedeemableConvertiblePreferredStockUponConversionOf", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Issuance Of Redeemable Convertible Preferred Stock Upon Conversion Of", "terseLabel": "Issuance of Series D-1, D-2, and D-3 redeemable convertible preferred stock upon conversion of convertible notes and SAFEs(1)", "documentation": "Issuance of Series D-1, D-2, and D-3 redeemable convertible preferred stock upon conversion of convertible notes and SAFEs" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Schedule of Financial Assets and Liabilities", "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r700", "r701" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetailsScheduleOfAssetsAcquiredAndLiabilitiesAssumed" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets", "terseLabel": "Prepaid expenses and other current assets", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date." } } }, "auth_ref": [ "r134" ] }, "cslr_SeriesDOneRedeemableConvertiblePreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "SeriesDOneRedeemableConvertiblePreferredStockMember", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficitParentheticals" ], "lang": { "en-us": { "role": { "label": "Series D One Redeemable Convertible Preferred Stock [Member]", "documentation": "Series d one redeemable convertible preferred stock." } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetailsScheduleOfAssetsAcquiredAndLiabilitiesAssumed" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets", "totalLabel": "Total identifiable assets acquired", "documentation": "Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date." } } }, "auth_ref": [ "r134" ] }, "cslr_SeriesDFourRedeemableConvertiblePreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "SeriesDFourRedeemableConvertiblePreferredStockMember", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlowsParentheticals", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficitParentheticals" ], "lang": { "en-us": { "role": { "label": "Series D Four Redeemable Convertible Preferred Stock [Member]", "terseLabel": "Series D Four Redeemable Convertible Preferred Stock [Member]", "documentation": "Series d four redeemable convertible preferred stock." } } }, "auth_ref": [] }, "cslr_SeriesDFiveRedeemableConvertiblePreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "SeriesDFiveRedeemableConvertiblePreferredStockMember", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficitParentheticals" ], "lang": { "en-us": { "role": { "label": "Series D Five Redeemable Convertible Preferred Stock [Member]", "documentation": "Series d five redeemable convertible preferred stock." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "presentation": [ "http://www.completesolaria.com/role/AccruedExpensesAndOtherCurrentLiabilitiesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Accrued Liabilities [Table Text Block]", "terseLabel": "Schedule of Accrued Expenses and Other Current Liabilities", "documentation": "Tabular disclosure of the components of accrued liabilities." } } }, "auth_ref": [] }, "cslr_SeriesDSevenRedeemableConvertiblePreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "SeriesDSevenRedeemableConvertiblePreferredStockMember", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficitParentheticals" ], "lang": { "en-us": { "role": { "label": "Series D Seven Redeemable Convertible Preferred Stock [Member]", "documentation": "Series d seven redeemable convertible preferred stock." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]", "terseLabel": "Schedule of Assets Acquired and Liabilities Assumed", "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree." } } }, "auth_ref": [ "r257" ] }, "us-gaap_DerivativeLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilities", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfFinancialAssetsAndLiabilities" ], "lang": { "en-us": { "role": { "label": "Derivative Liability", "terseLabel": "Total", "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r340", "r341", "r707", "r892", "r893", "r894", "r895", "r896", "r897", "r898", "r899", "r900", "r925", "r927", "r928", "r968", "r969", "r970", "r972", "r973", "r974", "r975", "r999", "r1226" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetailsScheduleOfAssetsAcquiredAndLiabilitiesAssumed" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets", "terseLabel": "Other non-current assets", "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date." } } }, "auth_ref": [ "r134" ] }, "cslr_SeriesDEightRedeemableConvertiblePreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "SeriesDEightRedeemableConvertiblePreferredStockMember", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficitParentheticals" ], "lang": { "en-us": { "role": { "label": "Series D Eight Redeemable Convertible Preferred Stock [Member]", "documentation": "Series d eight redeemable convertible preferred stock." } } }, "auth_ref": [] }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleOfStockNameOfTransactionDomain", "presentation": [ "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Sale of Stock [Domain]", "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement." } } }, "auth_ref": [] }, "us-gaap_SaleOfStockPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleOfStockPricePerShare", "presentation": [ "http://www.completesolaria.com/role/ForwardPurchaseAgreementsDetails" ], "lang": { "en-us": { "role": { "label": "Sale of Stock, Price Per Share", "terseLabel": "Number of shares", "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock", "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Cash and Cash Equivalents [Table Text Block]", "terseLabel": "Schedule of Consolidated Statements of Cash Flows", "documentation": "Tabular disclosure of the components of cash and cash equivalents." } } }, "auth_ref": [] }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfCommonStock", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 48.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from Issuance of Common Stock", "terseLabel": "Proceeds from issuance of long-term debt with CS Solis, net of issuance cost", "documentation": "The cash inflow from the additional capital contribution to the entity." } } }, "auth_ref": [ "r20" ] }, "cslr_IssuanceOfRedeemableConvertiblePreferredStockUponAcquisitionMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "IssuanceOfRedeemableConvertiblePreferredStockUponAcquisitionMember", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficitParentheticals" ], "lang": { "en-us": { "role": { "label": "Issuance Of Redeemable Convertible Preferred Stock Upon Acquisition [Member]", "documentation": "Issuance of redeemable convertible preferred stock upon acquisition." } } }, "auth_ref": [] }, "us-gaap_MeasurementInputExpectedTermMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputExpectedTermMember", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetailsScheduleOfNextEquityFinancingBasedOnInputsIncludedInABlackScholesModel", "http://www.completesolaria.com/role/WarrantsScheduleOfFairValueOfTheCommonStockWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input, Expected Term [Member]", "terseLabel": "Expected term [Member]", "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date." } } }, "auth_ref": [ "r1196" ] }, "cslr_UponConversionOfConvertibleNotesAndSimpleAgreementForFutureEquityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "UponConversionOfConvertibleNotesAndSimpleAgreementForFutureEquityMember", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficitParentheticals" ], "lang": { "en-us": { "role": { "label": "Upon Conversion Of Convertible Notes And Simple Agreement For Future Equity [Member]", "documentation": "Upon conversion of convertible notes and simple agreement for future equity." } } }, "auth_ref": [] }, "us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfConvertiblePreferredStock", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "label": "Proceeds from Issuance of Convertible Preferred Stock", "terseLabel": "Redeemable convertible preferred stock (in Dollars)", "documentation": "The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock." } } }, "auth_ref": [ "r20" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetailsScheduleOfAssetsAcquiredAndLiabilitiesAssumed" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable", "terseLabel": "Accounts payable", "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date." } } }, "auth_ref": [ "r134" ] }, "cslr_InConnectionWithForwardPurchaseAgreementsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "InConnectionWithForwardPurchaseAgreementsMember", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficitParentheticals" ], "lang": { "en-us": { "role": { "label": "In Connection With Forward Purchase Agreements [Member]", "presentationGuidance": "In Connection With Forward Purchase Agreements [Member]", "documentation": "In connection with forward purchase agreements." } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/BusinessCombinationDetailsScheduleOfAssetsAcquiredAndLiabilitiesAssumed" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue", "terseLabel": "Deferred revenue", "documentation": "Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date." } } }, "auth_ref": [ "r134" ] }, "cslr_IssueOfBonusSharesInConnectionWithMergerMember": { "xbrltype": "domainItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "IssueOfBonusSharesInConnectionWithMergerMember", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficitParentheticals" ], "lang": { "en-us": { "role": { "label": "Issue Of Bonus Shares In Connection With Merger [Member]", "documentation": "Issue of bonus shares in connection with merger." } } }, "auth_ref": [] }, "us-gaap_DisclosureTextBlockSupplementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureTextBlockSupplementAbstract", "lang": { "en-us": { "role": { "label": "Accrued Expenses and Other Current Liabilities [Abstract]" } } }, "auth_ref": [] }, "cslr_IssuanceOfForwardPurchaseAgreement": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "IssuanceOfForwardPurchaseAgreement", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0, "order": 12.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Issuance Of Forward Purchase Agreement", "negatedLabel": "Issuance of forward purchase agreements", "documentation": "Issuance of forward purchase agreements." } } }, "auth_ref": [] }, "cslr_ChangeInFairValueOfConvertibleNote": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ChangeInFairValueOfConvertibleNote", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Change In Fair Value Of Convertible Note", "terseLabel": "Change in fair value of forward purchase agreement liabilities", "documentation": "Represents the amount of change in fair value of convertible note." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTaxExpenseEffectOfChangeInAllocationMethodology": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTaxExpenseEffectOfChangeInAllocationMethodology", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Tax Expense Effect of Change in Allocation Methodology", "terseLabel": "Outstanding remains", "documentation": "Amount of increase (decrease) in tax expense resulting from change in methodology used to allocate tax expense to members of a group for which a consolidated tax return is filed." } } }, "auth_ref": [ "r642" ] }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceInitialPublicOffering", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/OrganizationDetails" ], "lang": { "en-us": { "role": { "label": "Proceeds from Issuance Initial Public Offering", "terseLabel": "Aggregate gross proceeds (in Dollars)", "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public." } } }, "auth_ref": [ "r20" ] }, "us-gaap_OperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpenses", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Operating Expenses", "totalLabel": "Total operating expenses", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense." } } }, "auth_ref": [] }, "cslr_LossOnCSSolisDebtExtinguishment": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "LossOnCSSolisDebtExtinguishment", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Loss On CSSolis Debt Extinguishment", "terseLabel": "Loss on CS Solis debt extinguishment" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromIssuanceOfMediumTermNotes": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfMediumTermNotes", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 54.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from Issuance of Medium-term Notes", "terseLabel": "Proceeds from issuance of notes payable, net", "documentation": "The cash inflow from a debt funding received on a regular basis with maturities ranging from 5-10 years." } } }, "auth_ref": [ "r69" ] }, "cslr_IssuanceOfCommonStockBonusesInConnectionWithTheMerger": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "IssuanceOfCommonStockBonusesInConnectionWithTheMerger", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 18.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Issuance Of Common Stock Bonuses In Connection With The Merger", "terseLabel": "Issuance of common stock bonus shares in connection with the Mergers" } } }, "auth_ref": [] }, "cslr_AccretionOfLongtermDebtInCSSolis": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "AccretionOfLongtermDebtInCSSolis", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 16.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Accretion Of Longterm Debt In CSSolis", "terseLabel": "Accretion of debt in CS Solis" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfOtherLongTermDebt", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Proceeds from Issuance of Other Long-Term Debt", "documentation": "Amount of cash inflow from issuance of long-term debt classified as other." } } }, "auth_ref": [ "r69" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares", "presentation": [ "http://www.completesolaria.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares", "terseLabel": "Vesting shares", "documentation": "Number of options vested." } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskTypeDomain", "presentation": [ "http://www.completesolaria.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Type [Domain]", "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "auth_ref": [ "r81", "r83", "r157", "r158", "r441", "r988" ] }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetails", "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Price per share", "verboseLabel": "Warrant exercise price (in Dollars per share)", "documentation": "Exercise price per share or per unit of warrants or rights outstanding." } } }, "auth_ref": [ "r575" ] }, "cslr_UnrealizedGainLossDueToChangeInFairValueOfConvertibleNotes": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "UnrealizedGainLossDueToChangeInFairValueOfConvertibleNotes", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0, "order": 30.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Unrealized Gain Loss Due To Change In Fair Value Of Convertible Notes", "negatedLabel": "Change in fair value of convertible notes", "documentation": "Unrealized gain loss due to change in fair value of convertible notes." } } }, "auth_ref": [] }, "cslr_GainOnPaycheckProtectionDebtForgiven": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "GainOnPaycheckProtectionDebtForgiven", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0, "order": 31.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Gain On Paycheck Protection Debt Forgiven", "negatedLabel": "Forgiveness of Paycheck Protection Plan loans", "documentation": "Gain on paycheck protection debt forgiven." } } }, "auth_ref": [] }, "cslr_ChangeInReserveForExcessAndObsoleteInventory": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ChangeInReserveForExcessAndObsoleteInventory", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 35.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Change in Reserve for Excess and Obsolete Inventory", "terseLabel": "Change in reserve for excess and obsolete inventory", "documentation": "Change in reserve for excess and obsolete inventory." } } }, "auth_ref": [] }, "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfPrivatePlacement", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/OtherIncomeExpenseNetDetailsScheduleOfOtherIncomeExpenseNet" ], "lang": { "en-us": { "role": { "label": "Proceeds from Issuance of Private Placement", "negatedLabel": "Change in fair value of FACT public, private placement and working capital warrants", "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement." } } }, "auth_ref": [ "r20" ] }, "us-gaap_OperatingExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpensesAbstract", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "label": "Operating Expenses [Abstract]", "terseLabel": "Operating expenses:" } } }, "auth_ref": [] }, "cslr_WarrantyProvisionNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "WarrantyProvisionNoncurrent", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 27.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Warranty Provision Noncurrent", "terseLabel": "Warranty provision, noncurrent" } } }, "auth_ref": [] }, "us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerSharePercentCurrencies": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerSharePercentCurrencies", "presentation": [ "http://www.completesolaria.com/role/EmployeeStockPurchasePlanDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Percent Currencies", "terseLabel": "Percentage of fair market values", "documentation": "The percentage of the total value of investments that are currencies for a given category of investments for which net asset value per share is calculated." } } }, "auth_ref": [] }, "us-gaap_GeneralAndAdministrativeExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralAndAdministrativeExpenseMember", "presentation": [ "http://www.completesolaria.com/role/GoodwillAndIntangibleAssetsDetails", "http://www.completesolaria.com/role/StockBasedCompensationDetailsScheduleOfStockBasedCompensationExpenseAndItsAllocationWithinTheAccompanyingUnauditedCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "General and Administrative Expense [Member]", "terseLabel": "General and administrative [Member]", "documentation": "Primary financial statement caption encompassing general and administrative expense." } } }, "auth_ref": [ "r207" ] }, "us-gaap_OtherIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherIncome", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/RelatedPartyTransactionsDetails", "http://www.completesolaria.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Other Income", "terseLabel": "Other Income", "verboseLabel": "Other income (expense)", "documentation": "Amount of revenue and income classified as other." } } }, "auth_ref": [ "r840", "r934", "r977", "r978", "r979" ] }, "us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesPurchaseOfAssets", "presentation": [ "http://www.completesolaria.com/role/FairValueMeasurementsDetails", "http://www.completesolaria.com/role/SubsequentEventsDetails", "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Shares, Purchase of Assets", "terseLabel": "Issuance of common stock in connection with forward purchase agreements(3) (in Shares)", "verboseLabel": "Outstanding warrant", "presentationGuidance": "Purchase of common stock", "documentation": "Number of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination." } } }, "auth_ref": [] }, "cslr_IncreaseDecreaseInDeferredRentPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "IncreaseDecreaseInDeferredRentPayable", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 34.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase Decrease In Deferred Rent Payable", "terseLabel": "Deferred rent", "documentation": "Increase decrease in deferred rent payable." } } }, "auth_ref": [] }, "cslr_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsNetOfLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "IncreaseDecreaseInOperatingLeaseRightOfUseAssetsNetOfLiabilities", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0, "order": 33.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase Decrease In Operating Lease Right Of Use Assets Net Of Liabilities", "negatedLabel": "Operating lease\u00a0right-of-use\u00a0assets and lease liabilities", "documentation": "Increase decrease in operating lease right of use assets net of liabilities." } } }, "auth_ref": [] }, "us-gaap_EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee", "presentation": [ "http://www.completesolaria.com/role/BorrowingArrangementsDetails" ], "lang": { "en-us": { "role": { "label": "Equity Ownership, Excluding Consolidated Entity and Equity Method Investee, Percentage", "terseLabel": "Percentage of equity financing", "documentation": "Percentage of ownership of equity interest excluding interest in entity that is consolidated and equity method investee." } } }, "auth_ref": [ "r1066" ] }, "cslr_ReclassificationOfLiabilityclassifiedWarrantsToEquityclassifiedWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ReclassificationOfLiabilityclassifiedWarrantsToEquityclassifiedWarrants", "crdr": "debit", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Reclassification Of Liabilityclassified Warrants To Equityclassified Warrants", "terseLabel": "Reclassification of liability-classified warrants to equity-classified warrants" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValuePurchaseOfAssets", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Value, Purchase of Assets", "terseLabel": "Issuance of common stock in connection with forward purchase agreements(3)", "documentation": "Value of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination." } } }, "auth_ref": [] }, "cslr_ProceedsFromMergerAndPIPEFinancing": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ProceedsFromMergerAndPIPEFinancing", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 50.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds From Merger And PIPEFinancing", "terseLabel": "Proceeds from Mergers and PIPE Financing" } } }, "auth_ref": [] }, "us-gaap_MeasurementInputExpectedDividendRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputExpectedDividendRateMember", "presentation": [ "http://www.completesolaria.com/role/WarrantsScheduleOfFairValueOfTheCommonStockWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input, Expected Dividend Rate [Member]", "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year." } } }, "auth_ref": [ "r1196" ] }, "cslr_PaymentsForIssuanceOfSeriesDRedeemableConvertiblePreferredStock": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "PaymentsForIssuanceOfSeriesDRedeemableConvertiblePreferredStock", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 52.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payments For Issuance Of Series DRedeemable Convertible Preferred Stock", "negatedLabel": "Payments for issuance of Series D redeemable convertible preferred stock" } } }, "auth_ref": [] }, "cslr_ProceedsFromIssuanceOfDerivativeInstrumentsLinkedToIssuersEquityInstruments": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "ProceedsFromIssuanceOfDerivativeInstrumentsLinkedToIssuersEquityInstruments", "crdr": "debit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 53.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds From Issuance Of Derivative Instruments Linked To Issuers Equity Instruments", "terseLabel": "Proceeds from issuance of SAFE agreements", "documentation": "Proceeds from issuance of derivative instruments linked to issuers equity instruments." } } }, "auth_ref": [] }, "cslr_PaymentForIssuanceCostsRedeemableConvertiblePreferredStock": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "PaymentForIssuanceCostsRedeemableConvertiblePreferredStock", "crdr": "credit", "calculation": { "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 55.0 } }, "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payment For Issuance Costs Redeemable Convertible Preferred Stock", "negatedLabel": "Payments for issuance costs of Series\u00a0D-1,\u00a0D-2\u00a0and\u00a0D-3\u00a0redeemable convertible preferred stock", "documentation": "Payment for issuance costs redeemable convertible preferred stock." } } }, "auth_ref": [] }, "cslr_CarlyleWarrantModification": { "xbrltype": "monetaryItemType", "nsuri": "http://www.completesolaria.com/20240104", "localname": "CarlyleWarrantModification", "crdr": "credit", "presentation": [ "http://www.completesolaria.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Carlyle Warrant Modification", "negatedLabel": "Carlyle warrant modification" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "1", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481288/505-10-05-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "4", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482338/360-10-05-4" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "15", "Paragraph": "12", "Subparagraph": "(f)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481410/810-10-15-12" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "15", "Paragraph": "12", "Subparagraph": "(f)(2)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481410/810-10-15-12" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "SubTopic": "15", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481116/815-15-25-1" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "SubTopic": "20", "Topic": "940", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "13", "SubTopic": "10", "Topic": "480", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481766/480-10-25-13" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "5B", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480588/815-10-25-5B" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "6", "SubTopic": "50", "Topic": "350", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482610/350-50-25-6" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "1", "SubTopic": "40", "Topic": "350", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482633/350-40-30-1" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "7", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-7" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "8", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-8" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480526/815-10-35-1" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1", "SubTopic": "15", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481051/815-15-35-1" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "SubTopic": "20", "Topic": "205", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-10" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a-c)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-12" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1D", "SubTopic": "20", "Topic": "205", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-1D" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(g)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "30", "Topic": "350", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c),(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(2)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "SubTopic": "30", "Topic": "350", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(g)(1)", "SubTopic": "10", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2A" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b),(d)", "SubTopic": "30", "Topic": "350", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "e", "SubTopic": "470", "Topic": "942", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "SubTopic": "40", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.17)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19,20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19,20,22)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.24)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.25)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-30)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.30(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "45", "Paragraph": "68B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-68B" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "330", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-1" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "((a)(1),(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-4" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "20", "Section": "25", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481284/470-20-25-22" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "20", "Section": "50", "Paragraph": "2A", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-2A" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "50", "Section": "40", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-2" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "50", "Section": "40", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-4" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Section": "25", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481766/480-10-25-4" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481648/480-10-50-2" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Section": "55", "Paragraph": "63", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481620/480-10-55-63" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Subparagraph": "(12)(c)", "Section": "S99", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-3A" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Subparagraph": "(16)(c)", "Paragraph": "3A", "Section": "S99", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-3A" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Subparagraph": "14", "Paragraph": "3A", "Section": "S99", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-3A" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Subparagraph": "15", "Paragraph": "3A", "Section": "S99", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-3A" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481142/505-10-45-3" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481142/505-10-45-4" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB TOPIC 4.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-5" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(b),(f(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "40", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480489/718-40-50-1" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "40", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480489/718-40-50-1" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "40", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480489/718-40-50-1" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "05", "Paragraph": "4", "Subparagraph": "(a)-(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479515/805-10-05-4" }, "r129": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "25", "Paragraph": "23", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479405/805-10-25-23" }, "r130": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r131": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r132": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3" }, "r133": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "55", "Paragraph": "37", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479303/805-10-55-37" }, "r134": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1" }, "r135": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-14" }, "r136": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-20" }, "r137": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r138": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r139": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-18" }, "r140": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1" }, "r141": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r142": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4" }, "r143": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r144": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r145": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r146": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r147": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r148": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-7" }, "r149": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "40", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-4" }, "r150": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "40", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5" }, "r151": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r152": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r153": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r154": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "6A", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A" }, "r155": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-11" }, "r156": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-12" }, "r157": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20" }, "r158": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r159": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A" }, "r160": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2" }, "r161": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r162": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8" }, "r163": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r164": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "932", "SubTopic": "235", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-18" }, "r165": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.15(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r166": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.15)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r167": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.17)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r168": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3" }, "r169": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3" }, "r170": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "825", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1" }, "r171": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "40", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-9" }, "r172": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//205/tableOfContent" }, "r173": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//205-20/tableOfContent" }, "r174": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-11" }, "r175": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-1A" }, "r176": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-1B" }, "r177": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-1C" }, "r178": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-3" }, "r179": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-3A" }, "r180": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-3B" }, "r181": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-4" }, "r182": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1" }, "r183": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B" }, "r184": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B" }, "r185": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B" }, "r186": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C" }, "r187": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r188": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r189": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r190": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r191": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r192": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r193": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r194": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r195": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r196": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r197": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r198": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r199": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r200": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r201": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-03(30)(a)(3)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r202": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r203": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-1" }, "r204": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r205": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r206": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r207": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r208": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r209": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.1,2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r210": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.13)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r211": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.2(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r212": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r213": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r214": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r215": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4,6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r216": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r217": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r218": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r219": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r220": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r221": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r222": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r223": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r224": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(c)", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r225": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r226": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r227": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//350/tableOfContent" }, "r228": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r229": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r230": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//360/tableOfContent" }, "r231": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "15", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482309/360-10-15-4" }, "r232": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r233": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r234": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.CC)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480091/360-10-S99-2" }, "r235": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//440/tableOfContent" }, "r236": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481284/470-20-25-10" }, "r237": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-3A" }, "r238": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6" }, "r239": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6" }, "r240": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7" }, "r241": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r242": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481138/505-30-25-5" }, "r243": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "610", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//610/tableOfContent" }, "r244": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "710", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//710/tableOfContent" }, "r245": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "712", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//712/tableOfContent" }, "r246": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "715", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//715/tableOfContent" }, "r247": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//718/tableOfContent" }, "r248": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(e)(1)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r249": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(f)(2)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r250": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "720", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//720/tableOfContent" }, "r251": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "12", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r252": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r253": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "9", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r254": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r255": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r256": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//805/tableOfContent" }, "r257": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Paragraph": "1", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1" }, "r258": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "38", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-38" }, "r259": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r260": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//810/tableOfContent" }, "r261": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r262": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 5.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479836/810-10-S99-5" }, "r263": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-3" }, "r264": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r265": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r266": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r267": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r268": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r269": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r270": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r271": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r272": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r273": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r274": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r275": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r276": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r277": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.14)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r278": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.7,8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r279": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r280": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "470", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480876/942-470-45-1" }, "r281": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-3" }, "r282": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11B", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-11B" }, "r283": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-15" }, "r284": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-6" }, "r285": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-4" }, "r286": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r287": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "840", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481440/840-10-50-2" }, "r288": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "840", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "40", "Subparagraph": "(Note 3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481418/840-10-55-40" }, "r289": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "840", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481501/840-20-50-1" }, "r290": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "840", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481501/840-20-50-2" }, "r291": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "840", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481501/840-20-50-2" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "210", "Topic": "946", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-20" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "270", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482989/270-10-45-6" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "SubTopic": "35", "Topic": "720", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483406/720-35-50-1" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(2))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1405", "Paragraph": "(a)", "Subparagraph": "(2)", "Publisher": "SEC" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "04", "Paragraph": "(a)", "Publisher": "SEC" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "04", "Paragraph": "a", "Publisher": "SEC" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "5", "Subsection": "04", "Paragraph": "c", "Subparagraph": "Schedule I", "Publisher": "SEC" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "7", "Subsection": "05", "Paragraph": "c", "Subparagraph": "Schedule II", "Publisher": "SEC" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "9", "Subsection": "06", "Publisher": "SEC" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Staff Accounting Bulletin (SAB)", "Number": "Topic 5", "Section": "FF", "Subsection": "Q1", "Publisher": "SEC" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-10" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(210.5-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(n))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-12" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 11.M.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//260/tableOfContent" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-23" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "26", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-26" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-42" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "44", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-44" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "48", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-48" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "48", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-48" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "51", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-51" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-52" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "53", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-53" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "54", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-54" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-4" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-1" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-2" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-42" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481598/310-20-45-1" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481598/310-20-45-2" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-1" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-3B" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-6A" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//330/tableOfContent" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-1" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-4" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "340", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479483/340-40-50-3" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-2" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147477123/405-50-65-1" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-3" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-6" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-8" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//718/tableOfContent" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.E.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "720", "SubTopic": "35", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483406/720-35-50-1" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//740/tableOfContent" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-10B" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-15" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A" }, "r640": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A" }, "r641": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A" }, "r642": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r643": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19" }, "r644": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r645": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r646": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r647": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20" }, "r648": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21" }, "r649": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r650": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r651": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r652": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r653": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r654": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r655": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r656": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r657": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r658": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r659": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2" }, "r660": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1" }, "r661": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2" }, "r662": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r663": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r664": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3" }, "r665": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3" }, "r666": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3" }, "r667": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "808", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1" }, "r668": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r669": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r670": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r671": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r672": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r673": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r674": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r675": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r676": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r677": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r678": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r679": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r680": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r681": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r682": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r683": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r684": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r685": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r686": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5" }, "r687": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r688": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r689": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r690": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r691": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r692": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r693": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r694": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r695": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r696": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r697": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r698": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2" }, "r699": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r700": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r701": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r702": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r703": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r704": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r705": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482477/820-10-65-13" }, "r706": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482477/820-10-65-13" }, "r707": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10" }, "r708": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r709": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6" }, "r710": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6" }, "r711": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6" }, "r712": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6" }, "r713": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//830/tableOfContent" }, "r714": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481839/830-10-45-9" }, "r715": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482014/830-20-35-3" }, "r716": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-5" }, "r717": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r718": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-12" }, "r719": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r720": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r721": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r722": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r723": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r724": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-21" }, "r725": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r726": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2" }, "r727": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "832", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483482/832-10-65-1" }, "r728": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "832", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483482/832-10-65-1" }, "r729": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1" }, "r730": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1" }, "r731": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1" }, "r732": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-1" }, "r733": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5" }, "r734": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5" }, "r735": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5" }, "r736": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5" }, "r737": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r738": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r739": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5" }, "r740": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-1" }, "r741": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r742": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r743": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r744": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r745": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r746": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r747": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r748": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r749": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r750": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r751": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r752": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r753": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//850/tableOfContent" }, "r754": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r755": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r756": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r757": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r758": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2" }, "r759": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r760": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6" }, "r761": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//855/tableOfContent" }, "r762": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r763": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r764": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r765": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r766": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r767": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r768": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r769": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r770": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r771": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r772": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r773": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r774": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r775": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r776": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r777": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1" }, "r778": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7" }, "r779": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r780": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r781": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r782": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(4)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r783": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r784": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r785": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r786": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r787": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r788": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r789": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r790": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r791": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r792": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r793": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r794": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r795": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "330", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482105/912-330-50-1" }, "r796": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r797": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5" }, "r798": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2" }, "r799": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2" }, "r800": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2" }, "r801": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "928", "SubTopic": "340", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1" }, "r802": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r803": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r804": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r805": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r806": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r807": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r808": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r809": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r810": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r811": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r812": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r813": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r814": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r815": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r816": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r817": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r818": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1" }, "r819": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480696/942-505-50-1" }, "r820": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r821": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r822": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r823": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r824": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r825": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r826": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r827": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r828": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r829": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r830": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r831": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r832": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r833": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r834": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r835": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r836": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r837": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r838": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r839": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r840": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r841": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r842": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r843": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r844": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r845": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r846": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r847": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r848": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r849": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r850": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r851": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r852": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r853": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r854": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r855": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r856": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r857": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r858": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r859": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r860": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r861": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r862": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-1" }, "r863": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-2" }, "r864": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-3" }, "r865": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r866": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r867": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r868": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r869": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r870": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r871": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r872": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13" }, "r873": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-15" }, "r874": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-16" }, "r875": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2" }, "r876": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5" }, "r877": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6" }, "r878": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r879": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r880": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2" }, "r881": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27" }, "r882": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r883": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r884": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r885": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r886": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r887": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r888": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r889": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r890": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-21" }, "r891": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r892": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r893": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r894": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r895": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r896": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r897": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r898": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r899": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r900": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r901": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r902": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(10)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r903": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r904": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r905": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r906": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r907": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r908": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r909": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r910": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r911": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r912": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r913": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r914": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r915": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r916": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r917": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r918": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r919": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r920": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r921": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r922": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r923": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r924": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r925": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r926": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r927": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r928": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r929": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r930": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r931": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r932": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r933": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3" }, "r934": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r935": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r936": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r937": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r938": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r939": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r940": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r941": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r942": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r943": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r944": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r945": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r946": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r947": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r948": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r949": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r950": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r951": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r952": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r953": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r954": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r955": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r956": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r957": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r958": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r959": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r960": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r961": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r962": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r963": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r964": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r965": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r966": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r967": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r968": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r969": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r970": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5A", "Subparagraph": "(SX 210.12-13A(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A" }, "r971": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5A", "Subparagraph": "(SX 210.12-13A(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A" }, "r972": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r973": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r974": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r975": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r976": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r977": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column E)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r978": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r979": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column E)(Footnote 6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r980": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "405", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480191/946-405-45-1" }, "r981": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1" }, "r982": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r983": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r984": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r985": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r986": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480632/954-210-45-4" }, "r987": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480602/954-210-50-2" }, "r988": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2" }, "r989": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1" }, "r990": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r991": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r992": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r993": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r994": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r995": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r996": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r997": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(g)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r998": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-20" }, "r999": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22" }, "r1000": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r1001": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r1002": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "35", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-35" }, "r1003": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r1004": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r1005": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r1006": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482785/280-10-55-47" }, "r1007": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r1008": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "79", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479294/326-20-55-79" }, "r1009": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8" }, "r1010": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5" }, "r1011": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5" }, "r1012": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24" }, "r1013": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r1014": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r1015": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r1016": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E" }, "r1017": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F" }, "r1018": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r1019": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r1020": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r1021": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r1022": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r1023": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r1024": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r1025": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r1026": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1027": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1028": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r1029": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r1030": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r1031": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r1032": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1033": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1034": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "217", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482663/740-10-55-217" }, "r1035": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479908/805-50-55-1" }, "r1036": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r1037": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K" }, "r1038": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "53", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53" }, "r1039": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r1040": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2" }, "r1041": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r1042": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r1043": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r1044": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r1045": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r1046": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r1047": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r1048": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r1049": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r1050": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r1051": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11" }, "r1052": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r1053": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1054": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r1055": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r1056": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r1057": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r1058": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r1059": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r1060": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r1061": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "SubTopic": "20", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-3" }, "r1062": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3" }, "r1063": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-10" }, "r1064": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-11" }, "r1065": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-3" }, "r1066": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "321", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-1" }, "r1067": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r1068": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "SubTopic": "825", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r1069": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "SubTopic": "10", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r1070": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(3)", "SubTopic": "10", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r1071": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "SubTopic": "10", "Topic": "250", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r1072": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "SubTopic": "20", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r1073": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4H", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H" }, "r1074": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "250", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r1075": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "250", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r1076": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "SubTopic": "10", "Topic": "250", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r1077": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r1078": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Topic": "705", "Publisher": "FASB", "URI": "https://asc.fasb.org//705/tableOfContent" }, "r1079": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r1080": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(1)", "Publisher": "SEC" }, "r1081": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(2)", "Publisher": "SEC" }, "r1082": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(3)", "Publisher": "SEC" }, "r1083": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(4)", "Publisher": "SEC" }, "r1084": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(i)", "Publisher": "SEC" }, "r1085": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(ii)", "Publisher": "SEC" }, "r1086": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(iii)", "Publisher": "SEC" }, "r1087": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "04", "Paragraph": "(a)", "Publisher": "SEC" }, "r1088": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r1089": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r1090": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r1091": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r1092": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r1093": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r1094": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r1095": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r1096": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r1097": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r1098": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r1099": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r1100": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r1101": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r1102": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r1103": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r1104": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r1105": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r1106": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r1107": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r1108": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r1109": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r1110": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r1111": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r1112": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r1113": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r1114": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r1115": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r1116": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r1117": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-12" }, "r1118": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r1119": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55" }, "r1120": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r1121": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r1122": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18" }, "r1123": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13" }, "r1124": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9" }, "r1125": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r1126": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r1127": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r1128": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r1129": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r1130": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r1131": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r1132": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r1133": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1" }, "r1134": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r1135": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r1136": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3" }, "r1137": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-2" }, "r1138": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r1139": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450/tableOfContent" }, "r1140": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1" }, "r1141": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r1142": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r1143": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r1144": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r1145": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-3" }, "r1146": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8" }, "r1147": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8" }, "r1148": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r1149": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r1150": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r1151": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r1152": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r1153": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r1154": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1155": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1156": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1157": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1158": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1159": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1160": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1161": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1162": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1163": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1164": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1165": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1166": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1167": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1168": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1169": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1170": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1171": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1172": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1173": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1174": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1175": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1176": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1177": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1178": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1179": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r1180": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r1181": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r1182": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A" }, "r1183": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r1184": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6" }, "r1185": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r1186": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r1187": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r1188": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r1189": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "15", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480123/805-50-15-3" }, "r1190": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480060/805-50-25-1" }, "r1191": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-1" }, "r1192": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-2" }, "r1193": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "15", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//815-15/tableOfContent" }, "r1194": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r1195": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r1196": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r1197": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r1198": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r1199": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4" }, "r1200": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3" }, "r1201": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r1202": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r1203": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2" }, "r1204": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r1205": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r1206": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r1207": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r1208": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r1209": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r1210": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r1211": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r1212": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r1213": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r1214": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r1215": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r1216": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r1217": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r1218": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r1219": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r1220": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r1221": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r1222": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r1223": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-15" }, "r1224": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-16" }, "r1225": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r1226": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r1227": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r1228": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r1229": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r1230": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(k)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r1231": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r1232": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r1233": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r1234": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r1235": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "985", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1" } } } ZIP 132 0001193125-24-002445-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-24-002445-xbrl.zip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�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

      G8BERR"-4-=D(7_,9>Y M96)2LWQ9@URU%R@!,77V MQ,=G.^KRXN?,V^=Q_M*2=E+.X3?L4X3JE#KZ5V<__[08=3S@@L51H8T3UNPEQ89==8_6O3/; Q$OKM@5F\4FC4+15H)I[7*-JSAF'!(;-:5 M^4"E.E]Q&GF/E82]!QTIP[-SGO/P)YI4@!_'=#MDTB\V2N]\_ M+6V8=,_L\U;+!NE08IC4L@-KNG<'>;W>-]=K?=?K_1:NUY5]T3G?P]MU!%KM M?1BD\8RO!5<+Z>3C,#KXJT5U#K0&RP<5'GAM:O.?5[E)[>NN?7UYL6?WZ."O M"X4#O>!)8"CZ\!722V[-%RZ\NJ-%0I5S%WRA$C8F?=C.;>KLH\UWO%KITY>; MYI;-O64R>/DEC?HC)Q8ZJ1-OYWZ=[^/].IQK])"[0-3=B3350"6N#OX.Z<#_ M?NLI^^)Z'V_2$6BJDBN&6LKLKH*97^HJTI_V?6S82%]IKMZ.*Z]S^_S\RCZ[ MNMJS2W(U MN NV=@\PL-H]LSOG1:3H;M^#(] AN-LYIF8B%SHX$WI1+ETQ?LNL-\__5C$? MM[=P:<[MLPNX-Y?GF[LSC1W=V-$'; L\+$1,2;,YD$H4_O#%+KP4595^B M< #WW,-.YI_$"UV#5Y2.G9\6P^F\G[)^3),_)R'S)]JY.O>L&?W$F(DU$$(S M13^+",LM!S&6G \=9($N9>-U=$MW:^)X+J@B2V+P3ZU[+H=9L)A94_@O\("[ MX):_/C_)46EZQGRIS-JJDTDUF<-B36N0VD1_^X06&^YFX621S?(FRSY_4M:CFQP0>Z1Q/N) M]#Q+L#/5*B$O1*W_@>VFWF"2\]G5PI4HM8?#")28:JSK2OX),F&68!0HD8FW M),N&I+Z-)]Y@6UPF:8R_XI_N!_=IT@]A6O_K^*GX'SB;998.R,\SB9/G81M; M8)HY:B3&K^LU<:ZN3XM)F)RM:2O./EE0OK&U^QP^[_32M1:MG$7&QZ)]X/TY&GNN*X!?^#RK$RQ:V$N[85U=GX."W_O5/_-:OAB'1-Z,Q MY!@A)[P^ZP/'BRPD/!'1$R,U6+4A++H[H(;2=O^"5Y#&S0;_+LV?G=VI:\PMWKE/A[.WOFC8K-/3GPEU$G,C\HGR]_<1U_1FJ];43>7H,W-:=O=RPO[K'U6O#P%!5%Y?XY=46SI'ETN"DOOTCW:C\UXS54ZM[M7'?O\ MNLSJ8H8KV9I];RRMEZT_TY--9C^>]8C/.FI^]>)2XH97!9N+]49Y+]!)DLCK MI1SEQ,"PB)Z\OD 6RQ"1F&Z>SM(Q@C'(L9EU>9XX4]6_,Q:^3U2=,I"=9"D0 M:AT9Q&(9ZL22)<7(_?U [J#+[>>-!$M9\F*WW/+V:1$9E-N04^LNT'FM?#I1 M\5XO6+:/XXD?3H5XX)TDX?0>V=_Q.;#V=$=^#ZDX3K@W6*X3$R;9_#VNY.]A M\G\"9DV=5?\N!Q+LSL*>+0QXP(E+Y:PS1*DIBW3Z$1EG>T(SRR+C-GWPA%GT MY1FVPB=)BAJ)L>-1MU%Y?207[*E^CRMB;XAO<#G5!G\:.T&*7=[22+'2#D6 MT2<1*V;^#!X>.\QM''N^U\=8X2A,PJ?03QROCW@D)X(+& B? >3P&1B@#(EY M2$(H^J,@],/AE"^R%\&]=B(DQ$7:7.P88-S1BBZ 9=W]RDAK;QYNK:O6N;WM M=LAEX?5JVXV.Q-?()[/\)'K]3ZRL:+?A!0IN>ZU:6'SR\51Z=9#HN@S2B!+\K MX,U^?%HC43RFY9:D(X>/[A-1/ ]WA;GM%%$\#VB%T>\E4?SN; M)7PWLW@:][2Z;6\\1H)LM@%8:2\*VC/F0MH)A.3(&7(@=Y%6'@QD/&C$_,ZZ MW^??N6.P)L M( (M M)I=7[=]Y%EUNEM[9!GT[D2GG/$"EK50NE2TBO[6(T6]A (\YR!V,VOC?F M\N*LU:YR6&;!9*C"QF1]T1[@0Z6+2LT*TMY?Q'8?6OT1Y@/-W1@+!P$IY/]( MRV])#NO,NKY#%+4W\.#JTGR5DW,3N)^SR=[P7#? ;-T^O_[I5ZN,VIHHIR.R M$!V7 M$)BXLO"+C]FJSH?XEKR[AG!&5UL8W<5U9*UB7FBWZRX/YQ[>F7W5V;>[=P3*$>G< FP3=D0ESG5>1K5^T]V^ M?>=V][R8?]_MVW9 M?[?;5_3*/K\HYO5W^XH>@8+\$F'H+^'X(OJ/5-#77-077%2UE%]\!ZXK^XVT MFCM^,;O[1B][.+?O7C<=]X43BUSRVUQQ2R[YJ[+?M3R0KM5).#A)8V&F8EG# M-W+C16$F*A__C"?@O@>#H,?MMM!HVQ?M1IOOG#RYFX5K-!?R14ZO*P8>7!#Q M&5LX9XNZ#W;V6==N[QUA_.'<0/+'ZM?CL)4GTI@I] MXDR;_/GKKIOY"[FL7WA5=_L*GMF=]KZY+T<068 S%*5B;H[/ &8V%[>6BTN. MRFY?UW;;OCK;('%YHS%SUY+)&AMU6>>M^QP&PT<1C3^(WHZG[CHM^ZJS0=KL M1EDN=RL_*-H/69+;7,Q:+J9:UJ^\JKM]-R_W[5X>SO6;S:H;AJGNRJJ,UDD8 MX=X4W"444GZLZ(KR2[MAF!?)XW$W^"N>VL )0:AQ?HNTTJ MS1&2GPH16([OAWW5?KN,YQ1YX7&+!.7+@R%=[U-+SQ!I5&/-B^Y/D00-.X80 M-RGU] Z#X4DBHK$:2(XF7+."5W"2VU88E(ZKY_C$(1^/!+;]ID55M+268J2U M8(S#+G#CEY*E9P3N7J!XRWO"#Y\UM^T\HM9/6>DH>'(+BDFUSQ=CX^_[ M08FX?3UOZT9/?:$&.7_FK4SI>MY0NJ[?EHT<5\"KOV\K<[M1F_53M71<&/3*5@I$ M+?WE=WAV;%JHNH?-T82_7G.= M],(]ZG6C1F_;OU#MSA[>J"-05;=I#$, 8SO"SAIHJX^\R>$#CNJX;&KIOIHK MM_6+UCG;[$4[K'A+$Y;>#U-DTQBC&9^X,>OGBL;]9<,Z+&G61(_S780VW-'* M"_I@'UC.9!*%3G]D6VFLND)BS%@,.)P9A5/'3Z;66"2CT+4I%IO&'';E\'"B MO60*P;DE[M&I]0"[X@U@AYBN6S>R,AN.X:NSIE@8J5O\9/4 + KYBYM/RK+( MF#MCQD+VI%03P7:FNN.6 #D1CKT^;.E 1VS!H!:1/\75('FZK9YCBAJ_5.]4O-:=?N#GE#YN['_HKU.)9MSY3S6O!EWE.1D8*(HQ$ MWZ'FN*IYK=$3,9]X6:EO9['QX I="L_WJW_G^2ISN]BU_IT7JXS^D=K5*>YAUL$GJYX;Z?V#F:>QK/IH.,5LOY MOLI&$^(%'4)5TC+KXRQ!F?C9^X&J,G]T?I35"E7 )+;[QNAD M[BI>@L3Y(9-SI]8'-!!"J59EWV=0PG$:T<%5^FPV\RI+AO&K("M]6'CX2G^4 MO4/JQNQ5-FSJ(/5]LZTFINLH@:M3T2)&X\N+1\*=;1[=OM)YXCM^..R1[!Z- M23A\)#A;90VD"T*N,GO[@?*-CO]OF/TDOB-="6OPP4A,W^N\-/[4#[&-9WWY M6>.F7.U)9E+G(PU5LU14H#0I">*BZ/ 71%U^T5[=%5YJ#U(>A4^_.7^;UP(+ M?)O%XUW*TWE%,,)XNT6OK_"(5EN'#UG/=JNP('G7:8.&>/'RX)_U)%_5,\%X M'G+T>_WY'Z=E!Z$^);4:FW_C">R$-BBT/OL]C,"SN2&5X 08 M)'4B\ 4"X6OU18X3=<3&/L7P"A_-I114SL3LHJ-]*-PAU,7HYX;6;Z"KPN 4 MQF;=]Y,0 4K%V?7E\-P<2,E+XMR -%#)>"RZHQ)O Q]ULU]Q6_$D^W4RZ_*[9_!7L1X9;)$8#+!CMD;,(6HHAP&JPFQQV_* Q!-_BWJABR%H>/![ M!XERD6<-&1-EAKP*Y/-9_X%M]08RPL!#* &FP83[<-GQ]/E36T9FT&PM;:J. M+7H'A$]BAQPMJU#/9.3 P2(3"(8@(R).7(6(LU[9TUU:9V^PM_M;?0H6-G?7 M89DY[S7F.>>Y5J%??)E5AH7]X+&Y&'UP']1K[@>WYF38&%P?3(X08K4+2)Q" M&*A%<\:J>:S:^UHWF X,=#;;F"&*3U^4++\QG^M&$I>';9M/'9 M/O^RZA;R2ZT7Y+5:9;4/-A+RQ2RD<%,Y-(4(,8$GXF@$)5'T/@C?1S;2P/U- M+SJ>QA"KV V\6G!I;G)K MM9V;<]%N7*G&E3I.5^I\LT4R8<%L;,1C43QJXYJSGEMPK=KV]2:;;S1"L1&* M!^PL(V$NYNBYEJG:Y8?R/\!G<2$##?0;$*O"JQ$CF\8\V M5D*<5F$'#:J];"TDLHOK]6A,?:&K/-P,X;T0E_?0'PDW]06B\21"[Y,7.$'? MYU>^@QP&L'Z1CL M E;Q&)WX%$8(D '?GYG?<_)Q4X+OHF.WFF1.$[=<:]QR+7&:0AFU%^"=^2L- M^-H]>\EH-J159(R)B#L+_NY%&*W21%?A8%D6F3O]Y7FIV.YCV&ZI/V^;+ ;, MG=-BLB+/%H.1K 4KD,T<N$C >3'']+LO0* MQ7'8]ZBJ5I^UH>J'4MI\Q<;B\ DR+#T)+!?'_BC#@*MR-;\18L0X(<@-+T@G M+',>'2_ $W@??,BJY>\'O!V5O9YV:KW;IT7,MEKN!0Q_:RK1-BK9YV1G,Q8^ M%VD+\%"H*^2,L5_.WYJ2;\$F?C"^CP XX]OE!$2UI#F7WZ'6:1%%:IDB(T[" M_O>3GA,+KD<'8"F*A%F%NSB5]6*6PY6)!7>#RV_3/'J5/&($ +]-HPB/ M$@GAUR7!MI/=.7AFKXN&V0O7X4LDL$6F)4'6G,FD(VS),VSQ(5[$^S7O2F0) MXY++L5]-SM1Z"7.]0EJOOEPO&>&@1GYQEKC/.1U\MG0V M> V//.H$\\6^)YAOYL#OG:ZL'/O9]:K]XGP;>#^&> M_"VB$%?HJM/NO*L(T]<* &FP.@MDFO+V8B(TZ(?CL1?'%/G=!UFV>:B/7*\; MEYZ'+7$V)-.*.$3[\K*89MMMT78$=AP'_UYENQVQ!*35 MDU=*QE1EN'-#DO!Z??Q7S"2\N&$Z&;-A7;+;JW/"F\V< ->U/7Z(GJ';C<<'XZ[V8?= MV(?Y>/K9O\\#UWR1+7:BHR ?J#1BJ5?/W%#CGP]RG>3*X;?,@KK* M1[^?/DXG8IEBNN6#7>=VJV:VU>,(5KYT]]L[M?M=^_RLX:W:EN3\3?=_)Z9^ MM='' ^UXC1#-+9[^XM9N4KNU-NJ7Y@Q4B=(=.P.7^R9*C\ Z_91& 1'6R!OB MC"?O,E';2-HE)*U>0OC>)SCX\*=X:W?L>FUWK#D 56)VFP>@J>/83;GZ63BQ M&(4^47Y%X1,SU#?R= EYJI?NSEBY+1HM#;IYXQ)UJT=@9T3J82&?C@VKV^S" M+NS"P7F&&X=2ER$Y&CMFL1U39P[B^C!R$/NT?S4"IKM-]XNM>F)Q;#G]?CI. M?:+0GD"2;4$/S,JKP84%V8*93+$;*ZX_J[FH].T!B;Q-;VR=%:?VU7F] MB:!C:EYZ;,9[LPN[L N-"[4.%^IHVM/-5T>_BTW5G7;!IK@X!"]J?W:O5L/A M\GQM@?A#MQN.K]BQV8?=V(?Y1:<;K$C[,+==BFH9DJ#"%@O;$7U+9-=MW=)# MEN7/::JR\?8I15W'^R([@=B;G&3;F.1"I?"Z3B>Y22[36ZK.>;:,>;;JG&=W MP3RQK0L64V)KE[BJMPO]NTUK@N/+]XBJ;/PRKU15]=B"Y9EMRU53+;BEN^O< MP.K@HQZ$+V@)_KR^Z,#_+EI-P;@R?G:U8/RJ*1@7^1[E-[)-VRMKQ;,^)Y^H M!=YG;($W>Q7WK.%)H9.[*AG'3FAS:\9M4.1],4FD&'2=Q#F ,O(K746.@J&^ M,O*SR_UJ=M(\_?FK&#M@(P9#^MMG;R!+?M[\'QI+JQGHS7[5 MM5^$0Z(=N76B:*JVYV8^CCS\2$<3+)C'_U&O]AUIJLW1O3J#Z M_?0WYZ\PNO6=..82/B,M=A*+_B]N&F%L%U-B[2*'\;%#>>2 YJ8[YRS_$K6Y M-6YM;/Q/S^%8VXV+CF:._B06@TQPNJB^K5&=LZ%\OI MC(MZV]PT*F,)E;&3DN)R;>2%.P.0O2G#PT:"2V:3T/(*J)QYF,-\_I@SEK9& M'EK/3KP(EFF.YWXPN]4;1],6&Y99RP)I7S:3M4%FJV="^[..N:P$B[VHF OY M_S"?YS!R8P$G%AEZ"G.I +667R1"?]5^DSX9]V+!M2@%H<^]=.%@ Q?GSW^+ M0$0.PGIOW#$(W#A!9/23D,AH4Q[?!?UP+!X2&#*6!7T.^PR87D+^ON[4K@ST MKN$>[M_"Y.^#39(W$GV,LKMPO*PA3XA+(G)3TN]\0F).[C<_@H8/GS^RN'Y93:PL[1ANU!^G%JEAF'Y$L+*F;M>N(Y!*%-C MLPL, X3)@1C"YTYHGK$5I[U8_"?%;KWP*=R:RAH5,]\&OY(U(SQDSZVL&YE3 M7'(S@8FZ^J-_MCG)(LB5$94&!>:N9@ZWH-2>SM+U*+WRB^,_.]/XIU^-">EG M_W-F"DO,J3C<%>;6F9G;2&<793+PFOYY)Y-J71#,1J'*/^L??6>5T7>K=\;( M(IY>8=5_ME76+U;[].(R^QEO5_9C4[E8I%W@/8X%5Q)NW3^2L/_3KU17@8+G M%B\XT;LZ2VYH+D%,-^)?2F;FL]9&,E/F,@NY6O([M>ZS2E5E(3N>_[7L*W=Z M[@6%PIMDDC?HC!ZM=X1N]-(;Y M(4.6]B]D-VGK#DPV6 ]TV^&!,%HAJ!''P(O&\%TG 95#+5IB^ ,&U%B'@KWI M82H?Q3G8B XJ"K 0?5\:A6!T.G"]X^1$# 9LF,)J!L%;!>I\TAH4247R* M5PL?QQ:E#CG08,$B_4_JQ1Z7]!+P@A4*31AF/ 2MDLUV II"+.,_X;-OLD?G M1O 8.4$\$+! ;E&O=Y3#D/WY3[F8!@Y M<$?NXCA=^A"%XW$8/(#2^6[.7QOW2,J13/'RAP'J(5R(5ZY;3(,TEZZE5ZZU MB&FE9;=:1<)#BY^I:OBDK"*&Y+K"?'3^D. M^RBR0 8%=1U17L([DIMQPIN#5V\N;AUKIJG=M6T3S#/VN@EO7J> _SP.% MX_6+'W^OU!UL0L\+6"69:GP;WNNCH;GAF)'1Z+*&S3PLD#4A4NXH14W*CW4\ M72=SGUS/11ENC9PGP[?BRP,/LG';XK0_PC_T(Z\G\.-<9:M5+>A1>.Q8'@(F MLLJK4CH-OH^!!7@ &;LQ19GD=[,A.D7;R;; ;.V/T&64/CKJ(30-,*:!-^$$ MM\SJ.3%\)'S"B8,9$B?>F%Z7QF*0^I;O#4@>O! ]XV>@K4P&T,QE"#:=#PE M>0XYFS+KX.80$2CGB,\-UP\P@P?1X-2P92.70-5T-[0X9=Z0>QH;B==PSH@:U:,)< M-%92?;EHOK%HDL5A 8?# 1 VT-+QC;^\J)&PX:JU7X0-1UU)?+'O)2V%W-@^ M5;7LSSG9^]*G_26(.(2EWRL>B&.I-9-V$098P3#*."=[(A #;VMM #=*''QK M3![-?S06@4MY1?SEP LP2NA,Z2<#(8ZGW^DGF'J *OXK6,W> M$[J;&O4N5U+E%KZJ);P- WR[) ;_7(1NC.= M2QM+<3DA"]L;P,+TR5@,$MPC@D8B+(0*_1)+X1];S7J[ ER@7?]C<'6#\-2_ 5Y[_3>#>\NSK$UU+ M,D_9K<-H/+D'^]>(L:.QQ.Z")W@\EJM$%(H%4==+$\(]JZ#:PM>WNY=J"FXWUM4 P_>%$D1,D4R0^>/)BID0X,J/K2Q2Z:3]1 M2T$1%\>G:E5OX EWL];7Y<5!\#'OY3;6*-8NUH^[BKL]SU\1V"(]3=E&GP2.0^ MSDID#L=0P;@47[9VOS;0S<=NJ 4W#!%%I?= MU%JU#'#WC8?CVX=_S6W0,X^(O&:*\)59N7>#"'O3)-35+(".%_TO4B!F#'?Q MJ[BVYG"4$\OUU46KQ8*WX:VKG;>NW6J(ZW A\%1;=*RMWX2#AYH;L2Q@J-L@ M2]R2;'CZ>LI>@H%IM")RH]T@,^GK"O,67^/R*&5HSOCJ^SZII M2#(JI3,><*$X>E:2L#7(Q5V9W_591,(:R]E9\(.,YMAF.M1(35A2HJL1M;&R_9^ ML38N_0Q2BO^K%_WSUP^BE] ?/H)6<4'PRY]& MWA.U@HN;?=K*/CWZ_"Y M=A0,U_(/+QD5G((X[Q7$>1]"P\'I6?/"[:T_I;+)M5=0HW@_S8#E:^CQ?7W= MY%=V_X!DFNZ34(.O@!L#YI(1QFI;23&]G@TS#D MK=_#Y(B0ER^]XA4WG)JS+=FOW5AT=)S,NXU_YU\C]O_]%.[P?U+X%';$FJAV M:YNS1[94I-N3MMZ%PTA"9'=R"W;38=%HW!$81>3-N*3*&OX1".F(6A MLL;X6?^-Y^5^< :BL7L:-;.A0U>_V?*:<]P M.1RSYK8$AM.8,R^[PO]VO.!S&,=WLNOY7?#1B0+XV)+7>GOIHNYAE.,<_0G: MY3!+M]N$60[AC.V< 8%E[&L[6H=>BW9L!=3-+C2[T.Q"$PS>,1S>:IVO&XS, M*AB9;3I6;;O=:6!4>W!$=MES:MMG5VL#536'J+Y#M'.NT87=O=X@34<36\W' M5G4P'O6^*WI8N)B$6*DY$!'66,8C)VJP39,:6LAY"WXD\QW+Z<$!B#W]_\,84-6RN^?IGR[O<[6],GN;DO.SD M-(9)<[;6=;:V':$I:<]EGUWN6_7 D49F!E$X+K,GFI#-;OD9GV"?Y#;=9+O4 M!'*.5O,X:!/_?9;$_5Y(:O% X@\^.8'2VKIV'J$ M__1'PKIIC+%U%'7/^%:T_!_4XLNUO]EA(ZLDA'O>:;I>[]O!6P/)15UGN;&9 MFC-:KW#<=@2KP1@=I(7TOK&0MB4$WN^3A=2V.U?GC86T9P=O8Q;2ZF=YWQ11 MV?NIJ%8RP!WWUYO]J'9A^WL TDX^!?JC%^5 M2/T=C(3(ZU<-]:(XTH('<_9SP9F:YWG]].OC2!CI''0OG'X?/*\DMB+P,SS2 M:G;VPXDSE3\)7/QIE K7$C\F(HCAPLV M'$^<8$I:[/(=? OT= (OQ:&YHN"QG#*^#=71!1\>)U4/M M?6K);=WL'D7">L9_!; 4X(/$ ^P\V!/)LQ"!]5D\"9^G#C/__]E[]^;$D61] M^*LH>K8CNB,P@\#&N#W;$?AVUOOK:3MLSVR<]Y\.&0JC'2$QDK";\^G?S*R2 M5+J!,!((J-F-&1L+J929E;?*S$?ZK:TYKOQ[1V;UV&2NX0[&@5$QCDSX,D,HN,TNW*8F$4RZ?W;\/X2!5O1KQ$!$UL*M@MZ M3:8],WC_X/"?'Y[ AWID%B.GY,=9MWW6ZY[TN*N $JL-F&5-C2$R_)\?6A_H M=X%]3;^+E5W]\R'-O"'L[X>#PFYVV/A9V:L3S.[%O+/WQ$&]900JKM^S07Q-KU80X M1G:G>3*5\A_+7KG@?5)W&S@H^/8_/^C'H=@+:R?NH#=;(,4B5_A+B_Y9'D8- M0%,P-Y'=6A5E?K7,V"+UOU)&;!6>'+3,M'==9&1K69F(*!849$%UNU2QH" + M.HH%6V'!D^,;UBX9*74VE\'%,,VO2LBT^'PN_P,_=R*G1%M M<5@%T8? ^EUAV;Y'QX=7%:WXH/B@^*#X4(<%%KLAWG,O M:\B>?0UW_1#GY S#(_C# ;6_%B\OS<,,-LS=*/W'<&:ANS?7&M&, MY_UVI@6>Y7Q9/@!ZI+)7BOTI1 M*?[O;'ZJV^B*_T/K/E5<4%Q07%!*6&2YDP[Z?N*@_G3)[&%[Z0^>$"A^57EBQ MAZ?ON\(BVL$BY*X]B=""SJE\ -G\L)E+BSKX8+GLY\":#5F>&% \GX#,8]23 M%V8NGADX)NR+8;T9<^^#3*'PWO+/X]"'$,F*,_KG7+P#2)3 6=-;K8\??EUP MIV3G&L\X-'L=6&#T"MH736]V3Z//^&M$'\M=;QJUO<%+&-K81:_L%]\9?/CZ M1*TNSDB[1%>.Z@.,S!?]=;F,:"$+R^.C=)]4EV?\SYRTO>:):9SSF.Y M'002##YQ.6TXMN#J,MY>1<8[N1HI0R&M#W^9%B+\.519VMI-L?Q^I@]T'J0O MEQJIY!+?L!I[/TST@WD(NFIHSX;]%_XTG4$0:WA,\\:&RV%"'QD"AG*S<)%J*S-M[88] MNS/#G6OMEMXE9- 5G@PB"W_!51=X_&7R\4WM 7_'KWYW?*;IQ]I1P""OJ5UR3GX6O!DO\[LWEH^6;Z8T)%!4OW L\+BY/X7QX=RW!-0UI-;)M+ M49XFPKR591E?3S3-'UW,//C0$X51^(;/IDW[G[\R^\G<@>EA#Z Y8!&DJ__& M064'XS1I%] ".(&0N/ 'H(2AC>CX62-=B'?A5].C&IPF9 MI-'"=5P+HMSC0N]L)F=TD@]YFD\9YG!^1"I!T@CQ]A"Q^% ;Y&2*PK]?6D ; MNCDG_U7F[;PGSJ?$0NG+=R-QT9U+Y,K*-O'](Z]%NGK32R!>X MKQ4?W\O'IS=GXWP\:;8R^#B;.J3;@)X3(]B@!CS@\;Y_J1D1R3?+\3(WPX_@ M>P_ <].&M=Q3+I"M)T7E[K'6\9;W6)EBNP,4/VZVTKUT?#>XP:+1BN&J&_"1 M-T6?^)59<\*>1_L96L2Q\QHHS,@KP^T8S9X+@Y)G@&FW)@'- C_UHB>8_C:;S@")_!LCCPV M.#)_'HW-X9#97_A_,'HXZ1[W/GP]!?6#EW_]2/3O/@MEG1( M[(Y048/<,=HD4O)?2-GPSGY@@YGK D'A@N^.[0:_7AB>Z?T9$.V)#<:V^?>, M>11R8J1T8<$>26RKEOZCQ>?I/CGR;%T&@CEEXC!O0= EPJWV*7?E1XYE.6_$ M['#O>, "<+EF*#'@7(+ #V86\@B9C26 Q.F0_3E^]]*)$%^TG)1.T30.OD-> M[J*WAQ$C5Z':A;9BZ+@X8)0HT)[ZYXFH.T7">"8/DWB<\\RRQ+ F4H[XNZ # M_2X>=G'W<'7]<'1Y]^U;__[Q^DOPPVI5+SR3<=K]>,X3DE]:8IU?6B)3D7-@ M17Q('%F)FYU]+'Q,)9[?B7UCZ8]%;MDN?,L*"HIV9S1C=].[2=+3= MD9.=GYR'IKW.0POWE>@[-5+W0 I!KW^B6XXN*7,G^]>DF1UA/&((2K$;AG?, M]L@C[J-?]T(![,4\NN3>F.-'??"TAW)H$KCU 06?@(!ZH;!"1.T7Q1-:%")-;4DU$!)SK^V=MX%9H2EH7"HDO" MHF]>6(XW(2RJ?[ZH8GYU+)"X+0Y[W/Q@"=I/%\NWW,4J6^[/D(X/L">VJZCC M&=$I-7Q&^="H1O6HO20A>MINGI1:H_IQGQ1Z_<1K,ZJ]//'J--.G3V6)EW+: MWSTMV/3^.AJYC&DFQG',\S47A$'9A_=L8"3F#=#R5I!RCZS#<;-<.#]E'"J4 MK1TS#7JSW-E:&[ ,^V, PN E@O$L(?:W&364!F =3RX*T'+/3( K0K=-V4 M2I:M'3, 5ZS.HG9'MG;,-.@5%KJHX$ 5(]3SP'C'#( J1M@A MV=HQ Z"*$:HK1KA2Q0@5%"._1]SG5#Y9V 8[HHU. _59V_U^C\O,!"T"A>(%JT,F?*7(Y;0LO%+[EL#/=,;A_VG.4=' L]POCX,Q&\XL=C=Z UB#TR+>: $+TG1W-ID[.Y& M\,D[0-O6!^K9*. IZGY>D_3,+.>-5"HG"*E+KGM1>98"[Z.-7)!FTOK!WWR' M T,Z/BC^=]\W:0D6J_IGPR)KY(T9 W7_R9@X,P&YZ8^=F0<:W_O\1=NCZB_4 MB>65?W57+_\J/CA&W;*\6ZIZIETNK0FPO7Y[=G_]&L ;UKG :?]Y<:EX41M> M7,7(CWS9W!($."DGD-+,>C-'0* SN,_5M% M<.$+)<"#D;N!GGL7UOL?CU=RTOPH.I+I+$-Z+_4\YEW',4IZUI:>RRU)S^E9 M&HI>R<_NR<^5<+SZFY&C+1W=*9':@DAMR+ ID=ICD2K38)U59;!4E=B2D.4R M/).*2@$.ID0L*L89_G?F^2CEH?[SBE7@[$G$T=D'CU$)T/:"CDZ[W(IR)4); M$R$5=RBIJDZJ5.BAI*I6T4>G4V[Y^\+H0PHCIC\71Q'!_4J2J[R[KQJFB",S MN@C>09R6N2_/GUH-#?__.2_4D,NW=F=]Y>[NNKYEW=>GN%"']2DNU&%]B@MU M6)^JF*AEQ<1JX]/VP"5?_TA@;Y*8/96!VA<1VE8:4V_HJ$*4&.V'&*E4II(K ME&YOF]("0 MV7SN$Q\19PS^GIF>21_ I8^.9;BFH7WZ[OA,ZWS>^W"&IEH%Q(IVXZU]&1+J M/T"G?D2F?8YME-H_/-':4-"C1.OP1&O#H5#*-^DV3E2GPEY+UK9R?GJCW=N+ MP0U*LBIH<6WT],IRPJK,?+_*"147%!<4%Q07%!<4%U3UQ3:KR5=#0"_;$2]Y MMHQ84-5%4;N:Z$P?8U36%ZJ$:.-"M*TZCFZC?:;D:'_D2.4OE3RIK*62I]K) M4XDB<=S03U2R\IU!7P>"OJ$S0VBB>D:EI2RP_LD!Q0?%!\4'Q0?%AVWSX;<4 M.&\$))F+LMJK I\QC3Z(/X>,HQ"9I8-7SQEDD4@T65W$M-^)V3\X9K>T:C43S_7+AS7==[PJQ)NNEB=A$LM MWF9% KT9'N%,SW U!L=?'9HCB*H8KNN9^6^,\;=@G@^!#UZW^(&\.%H :3LS M7QLQPX?X#F]N^)IA(>0K?G/L6+ F#]%8Q4WH8YND#Z^$E7@#1$G59E-!2B$2 M1)O3 QT;P*@N6/ 5M3;3YQX):'M+JAN^X O57>BXJ//@5#ZD@KKUQ7/XW#^YP MC[=>W&?]].8\"3#9OCW\#GO;!_;UI?O3:\F1\C?'?@%5,<$'/\VGK$B0?!(& MR=UE!3TGS71:EQL]V/<6T@64BHGR^3SG4.LSRYK#AQ:)Y,"8D@[\/X[7S+%L M \8*KB$1^9\OC:D6T2M@<4,#%3D8XZX%1FG/YFCF#@PA\(:=M4.:&3B\F]!X MB_>/-'[Q&K#*D3&S_(;FN$ HV$;P);[[/'#* MS!$X:+"+06//)E/D)C9=$&KX4!/@RFGJ5&L'T^I@(>TE^\ 7SD&F@<] +]^T M\NF%UT4<0DC!&.$]> DK(CM!67L#9ANNZ31(U4JJ$O0*XYHV :O- :>UJ6$. M<<]RAJ/"ADM#FXAF"6Y)75;P=J#G7#9"N'.4[;^8+Q@;4[QP4?#](E8IDF(T M#@6(F2G2^#T/-*HV87"CH6,Y+V!OX5-\,4/\'>E&YE*LALQ(#A? UN&_X3N! M'015#G^9&I8VM68>6G%W1L(($@4K:F@*+2IPW_+BWA9+%996DFPMQ)$0C$RV*-F<&"+AP M'D)A2^__I/O%.0_\-JS\TF%/05#]I.X*=SO%R@M1_PK')R/HGNS?K[M"TFNF6 MS;@_$Z^3T8*!BUPU;HYCPB<%"7:916*>'0#@%@;JP\-F)H0A9&QO_K?=QO>8 M&N#@"ED+L&[A=L%)3$PC3(.S&'@]9_"79!(6[I:]S&!4P.5V:\&^/)10?<-T M51F P\@ !!L'U#K:(M/FX61\0R7^J)G#?WYX@OL^,HNWX/2GX'0,?YQUVV>] M;JOUXY1;-O@"&_;])1?W>.\/]RA9KK+$QI]QOD5?2P7WFI4>0O/,;2QBT[* M+V!"0;&2D85==HD>$N'(&P4YFC((I#N__I:T#?)AA3".J0D/I&E#W:EE6KD4 MT'O""!(_>\T3TY:K2-#>G,NV1S-FOA-\XG+:X$_G25Z:EDURR@*]^J2ST3E?+9EY3/)3P82SIBGO?(A0!]"]*W MVU4FW$S?V6SKEKK=:E50;5*Z,$3E*Y)0J"(6E=;8D+91:0V5UE!I#976J(EQ MV+CZJT5:HP[^TG$S#059*+/1 -'UIGB0\@KTJR[/DTZ=3LTAA6MLO[C73PUKOF![O%*'#@)QZF*)CHY-HYT]ZT-!)M9 MA@M1\.1N]"#\39,6=3<*>L^BUK-@BL&<"(UKN+! /10:N?H!O$ (,I&^X(9M M_L291[3/#+,Q"<]ZL?]*J1%R=X3R]+CRA-_2'I5P#WT'8NGLVX6>SXK),NT3 M#P"$-\5MJO12-.>^N<)XJ9H&V_0Q-Y,;@Z894V-(;K'__R ]03PNS!@ M]+MXV,7=P]7UP]'EW;=O_?O'ZR_!#ZM!:_ ]==;^>,[[3+^TQ#J_M,2>R9D' M008T,1&"WZS;^5AX"H1X?C?VC:4_%KGER9[=LH(!@[UE\P4UL59-B&/4F-P\ MF4J36):]GRE)<^%[E8&;JF$ M8SWAN+/9QN7C %#L=E]42MS]IY7!LBM\AQ40;#=\NGH8J+<+ME?D:7G(!KAF MY@)=G\;L'BYVAK1!\\X*=.FL0-^BGW< NGK?)69+7J"2G#V1G&VXB!DA1+KU M1DE,+21F)YBL,GCO=2$OP]+GJ&!O[WV[_-#J?PS3_N9X$"NE__:=^77WY])Y MN[W QME'R:A+]J[=.58B4F<1J86#MA^82/LB).7QM;-)GVR_@(T.#6U7<4%Q M07%!<:$^7%#G0^N7Y^@''.RO?XY:JUB_HWST>@I&74+]TS,E(766D%I$^MV3 MO:CFVA,A*1/8^KA7&6?5^2G;@5,"4X7 ;,J- M*R8S9?MS2F;6EYD*V%R^>_=YH7^GSG)V.7.JN*"XH+B@N% ?+JBSG/7/3E1?=A*5#)%9=>XN^^)@ ZXM4-G MAFW.]?2[2UE@_<,?Q0?%!\6'0^8#61KX%X[G_1J8-C'@^:"0YQ[-R12HVG]Q M&4<'03B4FQD!1PE,C@!HZ+%_0 +8YF\+4:(8\CZ"CQ'B%;!0 ;?.^5>;[C-K5^!G9)_%DN&S!P M28<+4<3N76? V-"[<9W)TYA1V_C=*')HI9;R;Z;]%QL^.=>V3Y@K=V\VE\3D MZ=R6,&PXK"+K.F?F8!0[ ?1"F M*YA1;Y($ (\; '/K@1PU9U-K"&(PWOFXLA:XR4+ M['#++)G"G62>M$.6'+678B"F./(Q NX*$2X]I(. D20PM>=Y"#_%#8@7X6_F MX'R%:DV&K_0RD3_1-T%=**.9B4VW!'QI$?D>PYOU+=!B-MDC[Q*>TX]0FA;D M679NPRVW.2 Y@['A!:P5-H5T)BHVM#>PMB'?3L 4D S/@=UH!IJU/KA@D0) MQ*XA0QPLX$\"/D_&A PA(1$Z;8 _N S89@MXO5"UW/_G^N'W)+ FFN47$%^^ M!@%A,IE9OHENMB2W 6BAE[L0 F ;#&8NX>FN"P\9T4%&9$P\3H+J"V M;=RU M:7Q<"890X/S^AN/ UX?>6QP9/X\&IO#(;._\/\@J,[)Z5GGP]\')2* MC+B(&KCP;8X_?.U)M\F$&&MSK8YOZC(R$6@;E@,@-K5W8/X\1KSYPW:>/>:^ MXN-N[2GX%G\ CV_M4)W\SH$">?%70D]X"44AN<;K8P4M@#XBT*.3[O$IWTK9 M!,M5Y NWU\A!_8U7F40-KM0)6DV67$.[L(S!7T>/@[&#@$(39\BL8&>%EB'K MAE^T5!!?$#Y->NN] /XY[98(_-/3RP/^*?+E4P6>4P1RX7C7(1=2!2:[A+Y0 M>SG9;=F02XW*%(?\[;3S""9RI_TN[*"#Z;X3\4/<&T\ PI9:5I=C7-.'\5D" M^_W7_GX764B)PPSXY<7]U $SI;*,^X"1C\A'.9Z7W'MR_X,8_L?BE(#DZ9>= M'= +M_(>-WN5S>Q3=;A%50;&48>M&3;?8Y]17I7?#AX>6=)AF-(=I>F.HHG)DP]?3[O- M8Y&:7.F N\WS--?QRIUNHC;!Y(XI\O0&VW@JN M/@!3ZV5,D^>LJ]C3;<*8-\?A'BHZ-C&(C?BY/ MQSO,&(PU;_;LL;]G5*MF(ITU]#TT!E=1]=* , >\C),PEPTPO\.O@S\')]4# M9\*T3WC:9WOL@M[;VN^$"E3"+1D4P4\/U@S- 4;%%%?VGYUXT"BB1DH@.^AJ) MLT-1]1)4EM'Y/U%#W*ITG+"KHXX "4NLL:GUXR_'XK..DL>>J9HU+@J&]F*@ M*(Q@91Z=2]D+ZW:D =N)$0Z9M6PY1W18LK;'Y0-;WUM[6:J+UK$F5:?A.3NN MZ7V5I^)==K+R%+;N$G"%OM2;5]=]?+*T[&[-TM- 0%.NARRX2P_H^U/0'4,Z MIN]U6ZT?^LFB(H;4U5WNL+*?5&:0JS P)$EL%$;G(V&,]:GW\\&L%ZS]= M:?V]?.Y( 6*SUP%F1.S2(&9L=D^CSSC+HH_E(S.-SLS@.88V=G';_ +N _BD M5* !4GJ).QLV_V^_&@69FM*^Y/9\_2VIB.4X5=B(5 J*G*10UVN9MB$53,;_ M+$HUFB>F+8=KJ-S/8Z$X%H$$G[B<-KPNY!UL[N7F!3+2 NO;'%7%7FX5>^!) MU*Z*?7?-J7ZZW*"N4\<>L&P+=>S;9LIN%+(+?]4'W87[QF8OCF\:I+."/1QW M7S$1@E6/PU?T;X?1-S#N@0WI&J8'&Q=V9V81+D7 WFPPS@EM\^J T&*56B& M]D:)UDJBE2EXG+__ 8A.G?'&YW*=.Z:YJZV5FBIV$? M+$I@8!\*V51[ #SPV**J^V"W.:]X.]C+83Q+VF:?DH0)IV*324)]S22A6/K2 M)&'UJ4&U07&#IBN05(9Q(QG&=DTRC, ZFX>>/#-('I1C&:YI:,8 Y,XS\8\- MVJQ %O%7[5\0[ -IO'@>,HRA^B 0Q2"!F@&;*;B/80@ ?VPFTH:AO &(L; M%+(FHN3<$!-'?OX /G&4)R(6Z\L2I<$?D)P9N9$[@;>(#,"N,P M-AHA'5XCQQ(_E4A BI5_OZD!Y8P!:BVR,"'EL)HL$'1[:/*%B%O]SMP76%#X MTHUH;>B@NNAV(B&Y;YC0[5) .H@FD*5,1=RT!.=O>DM[GGD@>IZG#8UYN"*L MQ\QZ4W@]B3[2.2!FFB6"T/>EUTBL>9'[FJ6H(<@%/7@WDCZZ#.YX"S?,'DZP M=)Q[J(CALVH5,3? LBYN%3ZA[C7T4[W1[:;KOB2[[E5FUWO"KA>3LV9^RCFK MG2_PI%$L0?-SG?6X;MK=5SE]=8UMN1QK*PG4Q*'1KM'C6;+A.I+ AGA3=.YAM1YRDE/LUGWHV.-F_J M.O R1ZBO,!DSQ9<*\FKBN_BB80(-PSN,U!C0E]0,$W3Q,'UJ>IKT);PYYO0\ M^E;I&M W?H(NYCI.J$+/ %L_A[<=S@;2)\=. MO#V87TI%739<_("I;(B;(41\-8-N]X#7N"@P41"QLNS703>+GN()-T5ZDO"C MDF$M! :,LC4NX[Y%_(%#!CQ+/$4XDC+W@TP E3]C#1(\,-6$SJ%0213AAU;, M2LD=RXML%,6!/,0#$T6_B1@P:F!11FJOC51;&2DD!,F^=BOB_NLP[O\.L8M#['!/NPT7TUBZIP@-I=KVD1A^,_>/G[O&26CB-8 .V2'>68>=.";;EM';7+MYWL9)MY^;^;60RN#5%!Y] M7<96;>8ZG5TWO' V%J]L:M.-^ZNL:N*F^\W=(N;E=1,SVU9L?^AWA$[H_=$ M+F6U$;69:H22^P>-Y@W^F=@-9MM#OEIEOVR)9NCN'O-ZXY M*8(4K[LUS1H<+L_+,<&+>'ZZ95AU%8 6,]TW#CSUE5&'$MCK>V,^&+/!7]J] M"P+%Q9#*@"W'L _#GDH4N1L%](C(@=3X!L10&=>#8FLY5C+C-/'TI+*X92\M MX9I\+-WR[8&9VQ]K1K7@5/J]][8JUC9SEUG(_YTE!U%7'.5]U?7>]I59/;F8 MDQQ=CXU5)T;;Z:9HE1>M@I%[9I8D^X(9N2*\+FF3Y]U]5?LE"GGI(G@'4UU3JFS*2_\R?$- M:]'TJOTH6%]>]DJ$D/K:6>@'Z-NJ8- ;O9-R??3/N\['DCE8N4]^G"Y6R.!! MC3-&N[ /JZ[&.ZZNC&C?W?$.&/JA,\.2@GIZ(J4LL/X.N>+#MEWRP^/ ;WF# MN79P6L?VY_F46VRU1*!V>%K/>B0"GP-Q5KQEX\X#^$?NHY"[4DJ44.948IPK M+,=U.$#ZQ<81[1%X@#1,'RYWF47#B7%&]7Q!/:"W;+11RAGMESE#B M5:_.9.+8CSB'OCRUWAW=IU NOC M"UIA]9U=A.J3%EDS%#V)I-G^5#20\H%YS'UE0ZZRL+ Y\K0JFT99"8Q?TGZY MXLWR=!A-8@Z,6N KBS&\T;3*8L/A&^*>#DW0]QKQ)XF64J]1%-(@^@(JU!%- MY]!>Z*.]FI=YVBUS7F9OY7F9>OG#+8O?LH)3SMV94]C=];EM_9@'Q%]43;6L M2%KV8.!]3%2KK\+%[UFJT2QXNB4"LHW#H,+X)>GJK0X)$4ARC5KJTOL7?P[?4%M;,OC],$%A#M*7/\)FAP5=:"%I/HG, M!>]TB#4B!M=\3M OV6Q0-V&/;LSPYUK[9;>;5!#1M#8$136A#!=\!K3 MF3L8&QY;UI^75:L%&O&9N7>C1S:8N82=S -ZB NS9D E<" M,:RYQGXR=V!Z9!0,7S/LX!-LB3%YK^F2UOU,KEZ+N]SC3<(_AJQ,CA[*YF7P M+9F+F4_+XN(?CU<_ILS]01&"S,QV<3>_F8&-I<%-.3^IN(SZ=)%J4]/E?6%# MH"R23=I#[2[G1ASGSL_@3P,;.X<,=-($-,@0&6X,!F! J4O]"N+$L(WCD.H@*"Q/RW+;]> MJYDU@RLIZL'DB[6:C5'PJ;D/08R7[P!40V%3X!MU$:+\DWB#J1FR9^GO \?S M^1@-/ID#5G\$9L1EF/&@JZ_ 0&] M>0F RK$!K_',F"TO;-' Q^4/]X(]0&1V^/QDN("O K[DLC'IS\Z+=E: M7ZZER=8KS.HUCD_3N;BTUW59Q.NZ+.IUA=>/3!N4!TAPS.>ZC#1:4+>AP9L! MSUSGU1R*(DTPOAB'XYT-2[.));$5BY< 4@QFO$,:%;(&@NN/04R>#0]<.FQV M9K0$_.N_9[;P">&O_ NX7G#HX)(I/";0=E)E?*".^6"BJ3'G7?G1!?S=)L9/ M_R!SY)*!1$# MQ8MYGP^HQ0-9OXZ6*4H+%P]$$;*]Y:CBN-=NG'731\X%)#Q')-&PUC0.2%-_ MVW$ =EJ^/PX0VGQI#'"YE1B@1,\_.U%9XA9ZO[O;;786>+? OBK($ ^ ZD & M/"?3EQALP" MUW-L#L;Q]![N8#,6#9>^AZ>&.3PR!98OA-146!Q8Z@6>06IC0Y2,HL6]:7(% M1+,E2*SI##V4,=,'%QV^'-RK5YS&6E!*ZQ>S64L=RXCD70%^A]O=H3BMGWG/R^RO>/M.\>_&W/R M OJS%["9(@C-\);=9%/PKC_=]/&C"DWT)[K4SJ2'W#^>2&UN6PM?=YN M')^FH4Z+C%LNGVR]B&P\T9PF6[FO?M).SR;)B3CB*8]&;@!R8X[@)QKM#P\= M:WWP[X8\SA>S31&CFU_ B337PLY.?IM'$W8GW/-/)-U)F.+ I)?2?S0R9B=72"S5]I[OT-T2WGO;L;>#>.FI,SR, H"FD00 M1>DNB)XZ"3'CX5-ET9.GO3$0Y%3\5$EA2EYZNCPM7&4\A9'1"VB)%PQY:QE< M516M'8DX3?8]5DWM9FC/(B$XT,M5PYWZ9J& 30X[:"ZG_#$S=M!+M2NWQXO+[1'D%R/.U?CH7*QVMH MW[Y=:I]$:9]XQ["B[Q,=X:$6P"2MF+AS7Y> C?:3)"S^F_UQCIP&; M)WH"PXN_ZQ;S2;W>::-[G%%QLZ*7(&&UF/8KXWH;K[Y\Y-R.*P4D"ADA_\W1 M?/AH,&8>Y]G(=#T2(*[T%C@2J!KJ6I=8(R;KC;.SDT;O-*,NCM^6L\9CJ'4# M9L@V)V7+P0UDL,TIO(75T6Z'Z&Z&]7#XA5B!Z91J8+W9LP=JG M%*!]<)0BE M%A.6[T[.5_#^$V/(W1_IE\2N$"K!C#[*M MM'\"RPIV5?[J \?MND>(VR?XML>7[UW,Y;^4Z_MVEF+U[I#OB\**LJK!]:3O M F_8?OUA5='I[M67_C=>>6A./>K.9/K=WBJZ[RU"%26 MN'KC[DWWI-OH9C7_IAHN4 P*-!7A90%Q$WU%:;]WPMP7X)*1.!1T+,,UC0(^ M;S-@62:.MQ#4)R77*4";K= 0BC2-;+J MFLH< J#W&J=RA:3'],K(;(HWC+E[X,.XH/^3(]-+96WYSEZ[>;*P^X:" M ;2$L\F$.WHB4?!XW[\D^1(N24/#?KL\/D7;D[B)X$7/>*[N-BS[(/ MEUFH78^SPA^\0N\0S'/)DB"9D92Y.J'F)5ZX7#;-%C[XN-DZRW[PNF1]U_'T MPMXK63V7T7XE,DJ%>[ 6T?&TV1-D7-*ITTP6CFI]RTJVV3?"_IJ&*$'A!,A% MP!5$9L,B9,YN%CI$+S'F:]7U1#3#(5R4W33@"M,='F$V=J[AS$54!**=V2W@ M,Y('$@C6O;CV45C:^"&,;),B?S!8,/Y2A^/03J^A9V"^K9KHO,!P%<^RX)V> M35N$5@N./J4RW'CE[4JEXNE:UQ4*8T]VJV3\9)5WZ]:M9+R[RNI/=[%D/*4* M*?WR];>D5I3GU E5GH)WH&1-J)*U3!5>P[KTT\V6FF\VR-B@0B\AYNBMU?&? MXZ_N2W;Y).I("ZM].U5Q4E5'U+ Z(C>[=&5Z \O!9][:8 QFEN'> )ON1H^@ M/>D^MO^'[3RC[XB*Y]:>PE[XPV-#N'[,0C&,A(],REJC<3?J5%.4Z5@6KQX MXLTF_#B75SK//+XCPVD^_'0ZM9<'6=C#M3@;F%/>U^ MC.8#\W5^:0D+FC/_G+9.YFC@[LG'PE//SX-IPO(W5OQR)^/+%0!-]);A3&AB M59I@7C0FN'DR]<\+ P(4O$_J;N!U@9C8__S0"65$S/ 6-\ !.E-? 'K\TJ)_ MEF, <+]LHZ.<_Y=F:US'9FN$-CE[JO&!\;H*_J+2+FO!U2]5KR%6W;MG[6\' MKN[Z)_8DH2D$+[54D)GW*972^U_2?RP21WE]>\A/126<;RE=3-[2XK.O]WK> M^4UK/Y(+")CW!+R3[YV\[FD^S>QZ^U_9I==7&,*6[M24O9@C\4OM";TF.8NW M5;Z3T*?-=.C+:4N3I]ZU7>NU43-[9@2+76==XR>NV-4(+E"( G+!7K8P_=EQ%9%^=TUDQ&0Z4I0 M:?.Z)"M'I0S#CK*L5K#-84O2#,\6L5Z7#<.1$5Y4 U,QHK-^IA"=JT)T/E&( MSDB([$$H[\-WUC(*KC(,>;SD:E4ZK/J">5TBHJUC=90(WEYIXI8D*#4.!L,A M73+_-)PQK AS>;,\3;HA_(IT;\@B520]]XH]^SM6-==?#7I(ZE.A_JK3G,/'B ]UD5U.45U/7T\@KJWE]F5_R6!U"0E55V MU]WULKM^=A'\2B9X%?H=J)RT=UU.>*%@14)1:67L/I!>WZ7]N,;Y$=!L9[)1 MV?YFE2>IA1V"*BY\7^ZLF@NWDBS=)=DLO="EW=+/COJB.4J6?!H[7I+0RRL5 M"\VYPS_>_V59F5/7Z-)\82+ N^1PIXN3N=\=VY5FL+UO:MN/IS?G2<1*?7OX M'5CA,V;WI041^>6[?W/L%RSMIE T)TN8[.WKA%G"3CQ+.#)_LN'1_S'70:9! MN-<^SZG269^E*VJ6LAY;KH,J23Q42Y-CI%PMQ]>?[4:FCX M_\]YYB%6S;,SZRM7+=3U+>N^/A70U_Z,8K\L7DE^E')\=EL,2G)\RO14>F<; MC'"5I[([ZU.>2AW6IS)&:SLD.96XJI9B=VLI#L"Y5J=EVW?7VC\>]N-<0[G_ MM9 G?5_D*8V7T6AWU4G9/MD*=5)6$UNACLF4N=A]DW//91,,9*"\NPDG< $6TV]N&]NV^J:Q#S@". M\#L178FL_P&J E$?B:@A39&DL'>_68-E>[($+:$LQ6Z+E[ZGXI6!P*M.*U2> M7)U6U'1]*FJO^6G%?IF]MO);=IN!>HF5^HU>6_D&RBHIWZ"FZU/YF>JS]_[TS@MENME ^T'SZ0\EV4[Z)\E\/E M@DKQE'E^J3*4^Y&A/ #76Z4N5W.W*RI2WFK>4C]I5%AJIISVS=6ZJZRE\OQK MO3[E^==A?X^QX+\Y"Z\JL$CLJ>HU3U6VYNF+O@&(?.C/4(_6T M/*4LL/X.P.'QX;<86/NO,5CQO*7JO?124[9X9=SO//1U\3(KSR/*N9\ F%/XR1EI_UAL MN]!@W=J>[X(0-TMU&4']B F:^X 7]WAN8(5 9> M_>20CYEQE7?]N(=^%]^]@J\6DH\?$3TX.>0,4_S>/),DBP@N\&@" M#QGCFHZ&QOQHS@SWB(&:0C$(5532X&B@,.!5(?X< >V:6AP+7NOH_&M$CDBA M&'8&7UTV,8"P0\V9^9X/EP 3Z$I)?H8@$" E&K/8P.?21,(42@^Q?I,,YV+& M-\:2%RQ9C;:%%+1!"MH_VKU"45R9:O3-\(!IM$E-6[MAS^[, /N#RXA,:\(_ M21M!"-NS[B8OZTRFS MA^&E/W3N3GR5EB$_1;+V<11VR2D3;DPJ-4*B% J'%KDO2]\DO<@5WJC-G\#( ME+!<3P^3)PE'A1&,>Y@F>F; =_;%L-Z,N?=!IE!X[S2Y5GZW]BKOUDF\VSB, M%T4VZHS^.1>< 9_Z_,T<^F/PLEH?/_Q:_NH[JZS^.)\S4AJKV>L (R)6:5\T MO=D]C3[C[(H^IN^^B0#A&?0?RIBAC5WC M($.E14J9"O1&F)N8-4J4[C5/3%M.:J#/>Q[+Y1DSWPD^A_ MDANB941H.Q_V;!B7?Y MN=?/GIP@#X@FL3QSKR\Q]V#CIZXS8&SH-7A\;4[@?L "<'B&\"K$%XA]&*S< M\^$B]()X)/ &'A"%%?C1U)ASO67#UR;XR?-<%$>^Y> M<;X.#!>8#HZ7.9E:K([AFQXY9OGI]37"MVYF^(9TQ'5P'SHG*H-E"UIS8KXY M,VL8A63^$A)>_SV#D.3NS88;C\VI>']P+4(*P7Z@\RY,4%R# O?G?7O(O_8[ M\\<.T.X5*,>2,3,,C3V90)/TL^G>AFU8\_^#CR%4 M&C+,*\%Z43AHP?"O.::<4#">F?9LCF;N@/)-*&$>^/LN_&;-,;[!,!-OCUDC M>'^XFPM;QC=?65.[G[E(78K2^"OC8SW3B^OR5\.:B7M+C\(KB/I''FAI"SX! M?K )D2EXFX;0+]*)@5"Q!=X7>8-7/.97TPIRIY&E4[ZN89;2Z.] MI?W.# \>@+P1'@J),.S2%Z[JI<62ML2-_F*3I)+T#T!Q.3:SR>/@.AX\-F?" MM$]">C_S0DEA-G#=I.HPG360S"-P /Y#"Z%;34$NN1G@IGP"*FD,]T-YMQQ/ MY)@"O1GJGR466YB JU S_P]8IV]PNSL[_;?OK)C*^?&[\=.EBV)EJT]H24JBL#N#4%U@YI O8'Y=P^<&]SCR7QZ6V35D0E(B0:H M V_*;:,U;X3%V<+CX=HM4$AI;9PVX*'G&'ETFF4:SZ8%EH4KHO272%T&X1GJ MZ*4:\-FP2*%[8P8.$%I]N!Y6Y[@F6!QPJ$+'B];+]2HL>F9'[D/>\'AP57J4">X+?=?-YV&$>3FYPG. M$JU/"^;YA"N2*(C43&?X2/YN=$YT-Y*>\\@&Z#? N[_+Z^2^=!%-G1'0MALG MK72I9'7_D:GF(PB-08I8U-8:8*B*]@+^+W7=MV_]^\?K+\$/JU4U\Y.+T^['3+USPL7:A:\ M3^IN P=%RB8E)^XL*O+$#?1F"\1#%.;_TJ)_EE?Q\K.QQ G,VH<]XH"/SO=2 M5_<]_G+.B/\W\ -%58[>B!_.E$-/)3?M79<;-&N5B4:Y]]DKHNN[M!\/I/$G M/%!]5ZO/CO60Q!,9E\(9Y/6 A;/#7S88FR M_",OL;8EY;GYUO[X1I+H<24H46\U6GO(JP.2ANWKUMI,?5#.:D%G]?;_1;4- M!IW ^([45R .3/9>&P\\R_UR;YC#6_O_ .5AO%9QV:-(E&TKMELSV M[>O:C %+RHW=ZN@R.G^+VL&NCMH%3_GV2+U^6K#1Y(/@;XYAPW9S'D("Q;#& M!7GH7)GJJ.JG@CUX;?ALV:8L61E_WG=M7)60;%]AU\8YKGXFBAK)58?!:+OS M?G5?GPHVR_"2OJ?K10[AC&25H6B':J3V\(1DE?%J6V=[AM^ZP6AROQR2PQL1 M5C>7Y/ XL'A(6U8]*P5;>*I@.=B?=&L_&<\SRW!OX*%WHR 3)HJ![^S%VFR/ M"UUODZV"R5X'5>E:4J6KOG*EZW'YE:Y;O>5!%T'JK5TOR(O/(E,ULZIF=I=K M9O>;]-55SBK2+R%]:Y<4XH&DYOJ\SL@(IJ/6H19OH]D:F0!W(XP^@HJK>Y=- MS-DD$?%$44XU$<^^IN\.12SB0QB46"BQR)@GL6VQ2&5]*P-1415$*Q1B[E$Y MT.)ME*Z\VPTKFSXMV7[!Y7[SOU[F-,W_MA* :@6@YH:SHPY+5?70[J):*2XH M+JA*NMV)%CBX:.G3R$L,#&B+#DE=Y_S@%0.063][MB7- \M5@&A I,] M3^V\5P!49'+H$E#ST.14A2;*'5-.<9W7I[A0A_4IT./-H'^U6_5&_\+QYG5" M_UI$KZK1O_+CFZA3B!@;1M.LPB*:CIL8<".2B&AJC MQF>HH3&[0'H%MUB_5@@%M_@.N,5W>[^E]4LV3GN5#1M0[%\R7WB_V:]F32C0 MQ4V"+FYZ-QW ,)\=DXAMZ]?:(,LHIU7!+FX'=G'K+HW>WHM.RUW@_;;5;0:" M>&6(F\J9?0_TXM:/'/=(<]""&2K%^^SY*AA?;.TNW^RG71*$+[I!S M=#UEPKCL0:%@;LC+OM0 M,ZK*=?>P7%>17F$\[ER*;B'&H]9<]7^'D-ZK!!52)?X.5"@6C8K?>DJPW5-8 M ;6 @=R^)'32LZI4-=,6"D-7-LDU-->;K^0N!U1RZ[M0KZRD4+%_!\SQZ5YT MQ]69_;6VP9W*BLGW_73VT$J6%!<4%Q075&YP%P$E=R2&J37ZG IB#IO_M8YB M.B>5I9*4 .Q"'-/N*OA)Y;PI%[K6ZU- M%B/>+X*9>@-JA>A3-)<_B3B5!-2<[SZYTQ"> M6_)O]5X&3IQ"\0 M2%]+M;D2;&*C?G")63!D"AVQ<-:S=NB(I6ZN=5 .>]VS1OK%WT,B&0/6=&L&BP T5N*$:EY*8!*# #;<_'&!WI&4?YD:H:2E[."U% ME>4K<,.-@QN^RP$NJ^SUN-$^J6R^JA* 0N-U]U< U!0%!7"X>8##3>ZG QA9 M5(5,Y$#U5(AQN%4EJ^OE=LE_5CZKPC:L ;[=]O6O&D>R->;74,^>;+"'3WFR M"MVP!B[3%M -J][BQ? -CQN==KFZ7N$;5H!O> #!F.KOWJ^>5L6%.G!!Q;4* MX7"E3.+:"(<'8*H4\^O@IV3XLOK9!D=9[Y=[HH/]>##XN$G=4(YK*[( MMJ+Q(@KF4,$B;%!<4%Q065,U3PA[N=#OJK?>[ASI= <)ETLQ1SJ"XQ+3Z#TM=JY5 'Z#L%@N MF T_^/@6?<^;<=0'[P^/#2\-:S"S#.35=^;S:>OF0%Q_Z7C^)4W.HP3LA$@,(3O5#YB_#R0^)$0\9%%D(D5()8E(&#P*- M!R0D)*QAXY# EHNS, M[(D)!X5SR0L )H ZB(453 MC:;6S$,D%@2*C"F +0^!3^W!_X#ZOQ8O?16^\[?@E>O3ZOG+.2/^7]7ZHIH ]J'U95^) MKJ;5U^\454VK7V=:??F>>FDG6*T:S++?>\'(/;H\2,%0Q?-JQOU69MS79K?5 M?I;5 4E+_75S;6H.E+.LQN1O>4Q^;39ENAQPQQWI71"+^NOJ#8J%E,6)SF!5IZCU3QHJGW(47N1F%"![91GU,CI\EL!Q1SL?GW M)R7OQ?=-OZ^;O%0J+O57V+5QKE5![RX7,:ZS_^OZ?G5?GPI6U>S[38P_KZ?/ M4P,CMHV:@LL YL]Z,N?6+:LHE'S_D\YD5C?7+PB6!UVXK2 N:E!7O#OBL@\EY[6N\]]OTBN(BZV17D%< MU"\=OQ#BXA 2\]4"5M0F-UO[E/VAB$VA$7-*;)38O&,LW:&+C2I17*%2?(]J M$#<*;''HFTP)RRX:\EKV#^RW@"B3K>HX#JXP4G%!<4%Q064E=Q%$8Y_3G96" M8ARZ$Z.D1<5$2D+*@]>HC82HH*BVCE;=UZ?<\3JL3W&A#NLKWF204];?JZ*F M-UV)BS^'+[-R=)%S/\2Q, ?996 9L!SQ&ID%8_(KF8M^:Z/=MGF1.07W?()!X?Y. M[O/ !YO'(]';&0 7?*>&@"01+HN%$ 9QQ!IC\/?,],R@=.C1L0S7-.+28" M"8D"E2CQB#. @CPW2U5\.:%6$%AQ6Y@:_\B=^((&7>B32R%3YTFVF\ M\@0;TI A2&,/EJ*AKTMM!_B) __BVR*]H>*@%T-0Z AJ 6([=?4=X336N/32^Z9.]B*?":!<-K%@7#2 ML$4?M2G(F0&J;]+4;B>PP5%"K#GJ4,<-FF*0:;C'!=N80 G*X%]C@5AQT7D. MD%G\ )O*'P,CLP!N M$B[)D,R=+8WZ"Q<9&??HJ9.OAT:6(3QP+QG1=&^XG; M#%A$[;>(PON?Y$C&[#P!S'G'-THTN0S":>S1.8/A<9J2"Z\UH MMQ_ \A^/2.5L,6HMA;\Z30M20R;2IWF<'=P:&YRUA3@[\WA+UI"A6@27)0GI MX^*^U:@Q:YE7 \8ONZU#N!T+&#\V7EDH+#DFC!(HB5ETR_KO:NE&M)KM(N8K MG/E!MMTK8-Q7HL4#[\>[!_3PEDF[ M[X[M[@OY.LWC9=1SL7MS@"$N=VE,.QV<- @="D'>0)L$O9[H^V(T@_3/^89C M!QJ'8F;ZFAB_"FJ,@;/:@-MY: C-5R9\ZEPEDU1!6ES[^'1*!NH#7AT?%'>= M)2^<4I>GYUZNA85%K"90HLQW3F>\W%('9:5LXBXT@U'J&O>GRZ:A-.7LI#Y"A63GD\]F^N M(XNY[>3%UA,Z^IE&%-EZ#N>13?T@1:*?Q2-RC.\$UF&TX@)XK7_8'H-8$0]@ MEAB4,GV+-.!]7)N#\IZZSH"Q89#<,2>X;\$;M'@S4SR>;8+*B_QWZM@7?II0 MW2%-@I@R()$(O3,A.CT>C1!"IZ!M-D1G=#N*8:*@)8F9.9N*]=A 9(Q8$/Y/ M@NSU9L__!2.B$=@GZGSNO0Z,:7+=^(XNFSH4.<$B)2L!Q(.W!TM(] G#^PF$ M/<[0L9R7.9#0&[CF,P4]9"VTGD;F1#_7T AH9 4T"1M6Y '2QBB^I(UE=KXC MMYF-#ZZ!,YRP]X%%UX7I,;W(-P&")_6K"%R0:;29T9]>X&M ;&YKOQLNW#CR M&B384Q%.9PCF8N90F'I+>N1J!F'S"T<2IN#0BV+6&%SS(RH/$_VG37"0;RR9 MB:W"@>IQK]$^R? 2JH?0O3KJB-(D4 3 0W+7$EHBGM)#P7FQ"<7%T%Y M54G>:*"O4EL1/K P! ;]92_;DW>8#1'G^QOA8L6&@V=+31LV$],^B2*PS_F. MO.?#?_A&!+(Y4T;9!#L(""; G3'<@B!;'6^9A[BOAUIZ37P@^91(7^ "!0LN MU07*!#%_-$:L>M$_67:JLZ;/9&:X3(*&81I>+]5E"FY7NTX=.PC8ELM]FIF]U2J2>I=>7R>6TANMUDFCT^UN)YS2-Q5.!2Q? M?JJU7A"U8<.L+SU-46%4%6%4<)Y=@TBJ7Z3F2_M$.PE=:W)XCT-_-^N,_7.\ M0@SOZ KE*;^X<(I3)1[PD&<6Q'#D]*=W)!&.EQE&0<@KW!JVD12!1)$&!']< M2:27$?B/[%5@>V']6BJZF,Z>@97P9Z #?3 8&_:+*%NP?=>Q\!D&SM:"K3 C M M(=E\AW)4R5]=S8Q/H[+!NVYAJ96EY#@>XREL%@7(S%+VG*0F24>?@XG;D8 M/OI!'9 * )JWN>$P/]K'6+\DRX)/Y5 M.GJ6GY(HDQ72@:$43HN;>9X4[QYK1YD;G[M-BPZLY?7!:X9U/$.QZQ<5TSPP M5 +L@4%$3XJ5CUD"=ET'3PQCXV*&-YFK3%3^EAL#MY;5?32U>\?S2SU]!/]4:WFSZ$V8B[ MV1/N9C(SA9)<>).HP@)$B2(!%F5QAUU6\,TQN,$4<=]&?PB80,FZ/)A (M!9H<(O-M0O#_BML(GG\ M\R*XF%OH^(W(: HCW<#L-R\Z)=^&6IG(3X/UFCZXE*@JEX1QW^ [$)73-_K< MB.9JQ-:30S_PGE=<6-\>!G0(EUB@[*Y!)TM] M")_0H\/XP1MS X%__P_Z;(\^2(>O_=N9N;9A?=:F%L0OFR:5:;^/5)WBI.ID M.#^Q)H,^]@ XKNN\@8Y=(&;D\W!?49S5H6_KS9XA'@!WE8(<*9I)%D@:=(22 M5W>I)SO=(#"8^7AG[/0HM+[E"2*9?XO/&'='DVPCQN7YU RVQ2R3AT$#]7R( MX,P+HM:4 ;%I:_YNS'G,-GN9@2*CU)^9W35Y8XZHV1",'I!M' 6 7N9Q])OA M H/X L)H:TV/_3_BGG?N'<67.$F])I2?E]__,4@K7%,&"%GH MV,C2\FG0;I\M"F-BS3"8BOD)>MT, O0B#19$C LL;\;78* ;2#5$U/(NYM$U MHK.U#V(Z%,)$N6RZXM;FG4E!A]*MS0\R_D-! QOV<9>]L&NQ1NIF*B:#A:U/ M*2U*G8RZ+[1"O 6I0./%;M"TJ/-3"DVSHO&0IO%VB+PRB% UDGD/,X>4(1*1 M=K)M%5AE\&';//61'/:5VUM!7\WLQ^!V!!9 J[ =(%;TB,RZF(P<;*Z5DD<:4<#2)7)=X(D==M8PBM3>&W9;XS.C;P9)P MP1-8+:T8(A.N'\#/@L4-,43A/7Y+0PH,'ZEG]V5FT285N^(;X_L*]B8X=WWJ M!2V6ZUI%5;UO,^E9/93+$WL5O.H*&N2]K]I*.Y54FA-Y='$1Y]7\02+>P0$0 M.'8 ]D9:B!I"F%'6Y8T!7W.>2;+P>^*4!X]\?,T"'>PO4_^"(-PY6.A@E-HQ MN"R0QQ, #=4L;#+45;3/>.V4_/;!4( )Q)SGVMAY0_EHB)[[D3&S.(TMBMG? M#%#9%%T]_GD1/SK'B\@G#C=XV$(=J1A4 6G&>'FE7MM0IB!LL3Q'ZNA%:F&G M1D$<>Z)9COURA.<6PB;8VN4C'JJ8";H]W*:3-/B'N^@R>. M0_#VP)9P-@G$BHEI!,G-WHXV._S<[I7$4!%&K>N\X$3Y!!(FLR+^C?,VN>7V-ME'_.XHU!@] &"X];0IKP(3/+*[F) M=CD'6:=B$X#/##]+PRS_/^8Z\)\[FT5*CV:RF[KBMKU17V=ZMNF,T42N\7:=N=<>P MHE76?[R+=<BAQ:^+D>#NW2V9-E M.;1A]:\15>MJ(U9DNF3&7+\KD6Z^I3K4K,U5%P*WEO74R=-N4FXNYC"B@\S4 M:#PS5OG3)IV6=0*:X$:.Y(OL_C;./:O;&FN=_;4:K8SLYX+#/QJI*I__[=[Q M7Z5::OU3K%9ZH$!TBK7DW"KN0="Y1@QG>_73JO6"S++=/.!.K=V\I<9&UH6E M>7K<58-O\$=Q3P6_DSHV#.6 ,@ K#)_^([I3@"-9J%A,X"P@-4!9>P+>P\_OKC&A!]0Y(3Z M&W2V^R E%I4D\TJMX%<]&6FA5P?B8\&R/>YOQOV<(D4T]\)'O0$]>RL0KDD: M72*-OD.D24[XC&I!%^T=N0C^_OZ>]E((@I"83&D$I<+1K2\=U[&-5Q-(H/7- M84-[8);)1ES%70.!P0L82,7W@WC9_67_X?H1/PTK[HTA5E9XO%3R>4X/^:/Y MV-0>)WB.&W:N],5UO+TN=M/'BWZ\)C]\+YY<9UB$#S)!]T_X*;Q$)%4TKG_D MP04H[2EW2+VP%&5DNG!1EY>@>)E/E&I>:)BK04V9HQF\$-SE!1A&[V3&BH/Y M5&E\Z2 >I4<"?5]X%_G,G3H>3H -RE)PX(THJ6&3J>700D$Q@SSP]\JX<"#Y MX,&E&<-F\-O26] R ]X%_H;FSBQ&@V:#>@_^U)>927>B<.W?,YO'?.G4Q#(C MR]V@!&D#^AVD4;R+:;EL.GNN'PZ,OX#O@" ' M"'@F\T2(C0>N"%&>5\:E4VM'IT0^K-$@ XQ(SY>0VC["!B2.V!#4%IH0_X Z MYMH_F;J2.[!374OQI%69(77A(8J%9\C5?I<4BLCRHZ_2@J\8A)A< 17-)K^U MGXQGL(7N#;SQW4A.<-"9)I["75C.X*]"U8\?P <;&%,\8H27S3^BJVQTP\C! MJ7E4NT@R3_W@+MS RZS)E4G*?:M@LWRBE :/][W/7[),M[2X]M0_3YQ IMXN M#@&G(?P;'[O#+&N*D%SV"V7;\'=AC7EFE#_MXN[AZOKAZ/+NV[?^_>/UE^"' MU0"R^R^](2"_W2$B>W6@ZZ)KD#XL_#Q$'Q\4^0#?\I47_+,?%Y;4$"1]Q;?]R87=]W^-OYXSX?U,:,>Y? MED11)3TD/>U=EQ[Y#=%\Q=^X,L%17%F%*_J&N%+%=B:;FZK1^F4P8&PT6K+1 M@9[Y#E0^0FVL/HL*$8F;ICT$3G[1CNBC]X\_R4&W73#$(O"<"AKR? E_)]S[ M^[Y='.\]^_SI4L1'F:U#*W6K)P^B9!>=,L;B9V_=1&^Y6._O95I117F@TJ+7 M7EK2O2V-LUZZNZ4T(:E*;^^3>LYLD-F>8E[[%IO4SN_>004J=!*[56GH?1$; M?2?$)ET.U#C)J*ZKO:H^"!=[R4F:TN:%M/GRDX/M>U!*F]=,;(H<.&U?;-+: M?+.J7-+)TY]+-&]PR]+D+N=;JRMWD33C V6G/T6^S'UY_M1J:/C_SWD*.G:\ MLUM++%L+U/A5=V")M0EOE56H*#14KL&^",$:@5YYAOX,PK8=S+ =1-CVC7G> M%^V/9&-+QE"^H-?ED!-S&6T[]RZ;F+-)WZ:ZL*!:_A+)]ITI!7V8"KI4.=F& M#M^:G*C ;6]#!<6-.G'CP *WS1R?4_5R3%M'%;S*%=C?LHGW\OU PS-ET??# MABANU(D;?*/!OU%_X ^Q_IK#ZNMLM_2>=N&:PQ>6.VYWTYVH !)C=Z97C;L!?<=I \V9$VG MKO.3L#2M^<+ITTF\ MLY\"L!9[9 >&-Q90Q41([.=,(9VYH@.Q_-;.RFB8;.QL%V_L3*.H)+LZD28F MB AB#W.P76;[)@+LTB!U/II#\]_$*"L.(PP_QQHQ0QCBH-&3LR&28+IQ$1PP MCOLE(UI+^RF!.B#=/H;]"QSA>$,9O:?P3O&F';T3M#'FC$ZC8L80E:H1MN;E MC%:5NR%7'$EZLM)(TNXV9P._Y_6Z*[W>:>V& Y^NM/Y>?/TYK9R;G@ZL+>5K MW>?V]E;BPMF&Y_8&2@L1"1>AR44#!$N?RL]1E;ERNS[2!=]![S(VX1W DN>1 M!$B.]"[7X'&\)S'9D,]@FTS8T.3^!QCBM[&#,N?2]"8$YC#X%!3VZC#E9)0+'+$1BY8M6Q7+-=)Z^0Z:9)_%OFC;T#$T%APD4P$!-4% ^.)L&[X7/P_ WA*H#ZX7C;SSX*[>2!BT-[*+)<<6D9Y#C0M'P#-; < *@ MJ S Y([AC:.Y>-%P0/Y6X:/ #V=L*+"UPA%'8K2WX&G@DTAJ56/1M;0A^"JGHU&_/[1191WF3!_ M[ P7#GQJ+QKXE' XEO@7*'-7;.IXIN_UPR([<@26#.?=JD^0UO )G^ V27B< ME/QB$U](F\O2P0/PU?_I%"+9><&93>7.QEH#8 M%9$SRJ@N='*30YS2J>@5)WDK5W?9Y.^('<_DM YZ2VT#N@3),%!SK9\O+S5 M<%2O%DZ_>&"OC@7N:%WF/4L33%O1@4@\8J ASQ*09'#:$CH<#HWX'>1_ZCE4Q]Y2'\4^Q[GWSGA6%90G#= MG6O"BP)!TZ0O ':3 :_BZ^>Y6&:\P!@'X_=>17QJ4> MT5A/7-W1T)@?S2'R/4(0@&!7"\/921Y$-[4+1X3AP:'2SLI=T8Z*'J>)S)Y(6880BF;08@AP".> M@XS78,OYNZ*D M$'$9%T9JR*;< UP?]_5SSUA%T)V+2YHCZ"&-DK+]P! '>WAOP/L\13C0)8_( M/][%P-J>N>I-!8(+V,3!V&2T->2+X=Z8TH-]Q_S8(/?XA4A@UWR>$1_X+@V]A)OT4D/3 MY[R*@#W8?J3?A>3'-RNG56(#FZA6+()G!U\.X[+X@?2+JV%8"&)Z?QX*&GH;(N7"O5B@##)^P50WCX,U M@7QC#I?$)W(AT5%!WPKN+R[@8; XKN(8]W.-3AXYM3'7,32Q+.'5,"T^KMK1 M3)\_A6> ^ $J%W,T("CG!#0D1#V2GTM)U,4>$2=-:>^*8E+Y$7"9)^6O-5[/ M(@ZN)L:0!58O:VL1L02=(U@K$=0N'Q0?]PIN&"O0A5J>5Z4OAS8)J3)BC% 8 MJ*16D[+QH8U/VG=R$I 5EG0Q9;_R#LBVLM?D ^.QB44X6)IHS0N>'O/#WO*] M@S4.CN4P; /K"P@4!SB)GUMSAS-V>IUW8CWGZ?$A3RO+)B"VGXW8?E[G_'JS M5#J \_"X.:; 6*9W,GDNV 6O&*7^AB@+RS"5A&M\-_J=;B&\4&H #,/B/B;! M2?5LSL>M,LP-$'X$T@X2<)5Z@P[?G(FT111P!+!]0/T\AV,BSC% '2Y-4P<9 M(A!C+'K]7^;?B\4.+_B3[H-'%QF_4'?FH"4T.0Z'$\O%=58\,A![(G4*CURH MKOKQ;)7"KDYKQZH?.ZV57D^O6_5C1U]I_6U5_5A%]2/2=:/UC*LKW6)G@Y%: MK9']*PBT(Q<9"+PXB#$B8#CAY$E1VD+TG/@9I18_GDP?1R93A5$C"*P&'A8_ M.#_,@S+19W )_X*8_H:?L,QK<$!6N*XN[)48\'<8!>]@Q(^4_A^^LO8O+'3# MO6%CR>OMG]KC_9_:MV^7Y!)D77(WG3JNC_MF+EW.Q7OYD^F @\?C(:1K)SB_ M-1 1R4LF"9])$6BS:7XM5HB&+G5)A?IC0;JX\HJ[TP455S:F'\-Z'=Q_(1HE M[/ZAG&Z@9D$O.B2B6C'IRTLT:UB$/'X)/'N#/+K[+:>PV MQ@A$ >ZBX0WB5AL9/:7W(,E,WA@7X,RBTC?W8#&,1.G+24 M>33LQ60L_/DP,_M'OV\;7)VFYU\_>$'RG0S114)Y@^_*=L0ZSJZD<30=Z6D[1Z-* M+"_:6#,RT[)",SYW(C9',FY25ITBN2I8VI8C.U2"1W0@PZ=:VMKE(YY2F%GS M(+;3BS=DWL UGU%//CNO6, 0/Q]RF>.^&+;Y?R+E$[="[<3Y?]PHB6[\(6_I M"=+;/(%[^?!X?1,4\X=_PAP%F3)PM]'44Y>60=4(L,JISZVE".P:PJOC^A[\ M4&O.3_UX#<5R[_8^.!3$_>E=1E\459MK;>]V\4'T60IM\>@(O=72+BW#$WVS M%YIHXAF;4XU>AA**@:P%Q6U2_TI(HC J# <9)$\!;^U!<]D"^M("A/^Z<'4& M%0O80P,/D*VY?&HK#OF"M8KS+W\,3*<:/ZS> J%R/11!(7U1_X;<1A"]OU2] MX8;5&YAOB,IZ0ZG6CTE_GGPN]!YD8J)*,HJ]S @GF4F0G9]=-(6EIME M%SL\A/>XQW.KW%:OG(.ZR\='Q[3B0[U$G<$4%B"M6=^;$O!DBPJR*!?!%V\W%[5:'%Q[2XJ M/HS@L#Y6\K$D9P8D@Z #*S&^SU DX1>J$;FE>][:4LZ\H( [DXECTQUE(7_$ MO8Y+O_Y[!J*.2W=L#'FRI)F7J=EI"J7[+:'>%S6?EA&L%:SE>'48F

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